<SEC-DOCUMENT>0000200406-20-000056.txt : 20201023
<SEC-HEADER>0000200406-20-000056.hdr.sgml : 20201023
<ACCEPTANCE-DATETIME>20201023160601
ACCESSION NUMBER:		0000200406-20-000056
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		87
CONFORMED PERIOD OF REPORT:	20200927
FILED AS OF DATE:		20201023
DATE AS OF CHANGE:		20201023

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JOHNSON & JOHNSON
		CENTRAL INDEX KEY:			0000200406
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				221024240
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			0103

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-03215
		FILM NUMBER:		201257832

	BUSINESS ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
		BUSINESS PHONE:		732-524-2455

	MAIL ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>jnj-20200927.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:fc2d7a08-4b3d-4935-bed1-d6009b2c298f,g:489318f6-0cc0-48fd-9e8b-f08139bc7aae,d:ef97c24c8c144887ab2ad376fc457d4d--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:jnj="http://www.jnj.com/20200927" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>jnj-20200927</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83L2ZyYWc6YzQwZjI5NDRiYmEyNDliNWIzYTIwZmFlODI5NWFkYWMvdGFibGU6ZGM4ZGUxMzAyOGQ3NDIyY2E3MzM5MzVjZGFlNDI5MDEvdGFibGVyYW5nZTpkYzhkZTEzMDI4ZDc0MjJjYTczMzkzNWNkYWU0MjkwMV80LTEtMS0xLTA_36d75e0e-efb5-4dab-81d4-50554b9ce723">0000200406</ix:nonNumeric><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83L2ZyYWc6YzQwZjI5NDRiYmEyNDliNWIzYTIwZmFlODI5NWFkYWMvdGFibGU6ZGM4ZGUxMzAyOGQ3NDIyY2E3MzM5MzVjZGFlNDI5MDEvdGFibGVyYW5nZTpkYzhkZTEzMDI4ZDc0MjJjYTczMzkzNWNkYWU0MjkwMV81LTEtMS0xLTA_2c261340-9709-4124-9062-9c8a2975533b">1/3</ix:nonNumeric><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83L2ZyYWc6YzQwZjI5NDRiYmEyNDliNWIzYTIwZmFlODI5NWFkYWMvdGFibGU6ZGM4ZGUxMzAyOGQ3NDIyY2E3MzM5MzVjZGFlNDI5MDEvdGFibGVyYW5nZTpkYzhkZTEzMDI4ZDc0MjJjYTczMzkzNWNkYWU0MjkwMV85LTEtMS0xLTA_2659e3cf-7a78-4a25-bb8f-7cd71b606897">2020</ix:nonNumeric><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83L2ZyYWc6YzQwZjI5NDRiYmEyNDliNWIzYTIwZmFlODI5NWFkYWMvdGFibGU6ZGM4ZGUxMzAyOGQ3NDIyY2E3MzM5MzVjZGFlNDI5MDEvdGFibGVyYW5nZTpkYzhkZTEzMDI4ZDc0MjJjYTczMzkzNWNkYWU0MjkwMV8xMC0xLTEtMS0w_d6ac164f-b79b-46c4-95d9-86c851d03ead">Q3</ix:nonNumeric><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83L2ZyYWc6YzQwZjI5NDRiYmEyNDliNWIzYTIwZmFlODI5NWFkYWMvdGFibGU6ZGM4ZGUxMzAyOGQ3NDIyY2E3MzM5MzVjZGFlNDI5MDEvdGFibGVyYW5nZTpkYzhkZTEzMDI4ZDc0MjJjYTczMzkzNWNkYWU0MjkwMV8xMS0xLTEtMS0w_61145116-6d4f-4288-8744-e6929ccfc923">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i4ae18f8aab5b4bd6b80b50402d6ad212_D20191230-20200927" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xMDM1L2ZyYWc6MTUwYzNmOTI5ZjNmNDQzOThhZDQ4Nzg1OGUxNjIyYzAvdGV4dHJlZ2lvbjoxNTBjM2Y5MjlmM2Y0NDM5OGFkNDg3ODU4ZTE2MjJjMF8xMDQ0NTM2MDQ2MzkyMw_ce166846-b503-4139-b5f5-f14f5ea2d0f8">1 month, 6 days</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="jnj-20200927.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i740dc05b85c94cbd8b1e84ec97346f67_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica954f234b4c423aabac439f22fd6daf_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A0.250NotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95ced2b952ea496781eca3d5a59848c3_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A0.650NotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7eeea2693d75423da856f563c79a259d_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A5.50NotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93ee65cdd19a4436bcecdbb64e5cca1c_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A1.150NotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f968c9419a148cfbb615118ff18f037_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A1.650NotesDue2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ide9df46b8f0d4705b774d10707a6d751_I20201019"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i19e7a320a15a49fc9131f6215c942e21_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i5b511957d9f045e087992edabfe78505_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cf38c3475e441fb8f8267516f5f6e04_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6c8c63ebbdd45008cb5ac80e7d4a988_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f90ce64276d4c29ad4a8c7f4dbd288f_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06b919224a104e2480ce4da569369152_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0b01ffae8c54eaaaf665643769f3f44_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieca44093d50140b480558060c22367cb_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i381677b70c5d4be996221d9099a8ee95_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ccc8ddbfa5a467ca8eaf499f719d902_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib840c9f8515640ed990015d6449203d6_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b3f9043c47442aea143141642e7e123_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2de08cb9d744bf28bfcab44717ebd79_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb8ed1a3c397427ca991016ed24db8d2_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71bc7ed79cf044f986c36306dd76232b_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dff82851aa243f2a42e09821411d92e_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac644cecdd17481eae30c88e9f63b87d_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7b18211b77c4d9eb325dfecb4003ccc_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c31dab756544c419618439f97c12092_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c15ea54ac1647959505ff89d74c73c7_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3494e72aac944cd896896e8cc599429d_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9918090831a94bfa90e6639a0e7860b0_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80a9937f67434d319d5d9d0009f19170_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie369dd88ecfb42bfbd08a15bc21a6097_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8623b760505a465db7f09f7ad1d524db_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d1eb0b5e3974db0ba19099436b2cc65_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i110288df68f94473b99fed3695503e08_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a6ecd40aacc418a87faf0c09967e825_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e3164724e36436c908b66cd22c3a21a_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7973ae70802a4ed0a4cd812adebb0210_I20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f437ae6f74d4fa69aa4dac8e499093a_I20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic23a7f58f6e14cc1977521f182c06612_I20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i400557913e3646cfba478852d03d7924_I20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i018cbb188f0842968a546fe435cdf833_I20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0a2a626a2c244b9a56b493374930da0_I20181230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i140bd62410d04a73af76e67490f68df5_I20181230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf518ea8aaf64e96abb8d9041f120b48_I20181230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1caf669d3c9842f4b9c8d11879c80aec_I20181230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad718c4ff9e7438d82af65c75127f1f7_I20181230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35bcfc36a3ac40618bf4b3ef88484093_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd34e4a6c9104502985d3b5bd4a98c8e_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9597fec02bb4c31b44fbbd09919bb16_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8998fcc3526244dcad040549c8bdf899_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i146724b9ab654ac3b05e3567213370a2_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PatentsAndTrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if455a0c82eec4663ab4937953a47b1a0_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PatentsAndTrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifeaa5dc31fed4356a01542e92bc1b4ac_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ec1428acbd748a3ac5a614e4bca5b5b_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68c2ad5bd3504e018130bc2faeb63dfc_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d2f1f6cd2a34b9fb4eb1093a33dc1ae_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f84e8435dc0421d8a89f9ea0bce9608_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PurchasedInProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99b4dc37a244428f8b6a328e6563293f_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PurchasedInProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9cdf38955a64506988afbdd28653b69_I20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PurchasedInProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:BermekimabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1db1cbb21378478cbff6ba1c2021c6dc_I20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:VerbSurgicalInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PurchasedInProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i478b4ff4ed674722bb2570839bc53e96_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31bf8455628944da8b015d8b789a9fc4_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87651ba4e20740f0bd2d7665498709be_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i498b81f2554f4e868dce4daa5736066a_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31c5bebe5faa45388656d1dcb0238be9_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic80539fe5fa44b869a360326b6dee52a_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e833bc35e3f438d8cfbc47be4f35753_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e4dc688e2e648e983fbdf67f462f0a2_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11ef6f75bfcc45848502de0139e92200_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if53c990c748f468ba05775d5cf223ac0_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PatentsAndTrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b287ab5933f41b09d0eeee590ddb648_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i602f0b572b2642298407a8c186b700b3_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e99b66377d146a5bc59616148618bc1_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i757aee8078ce429aba0fb497a4a57b0f_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6caa54ad7b144dcca2cb08b4b3dab964_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ca4ea76af704d238626f606c2f2e2e8_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83cd1045196f4066b8afc93059b316f1_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48769359a9544223b2b381ebae848550_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaae72c759e44c0aa87a7f502152047c_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie75c8583c4cb4e56a35e19da1d9c0fd3_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cdbac75c4d1489bad27bcb720ec8453_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i050dea3d0ebc4bb39fdec4f937d89696_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i284822c0f6cd4ad4a13ee1cb4f3bbce6_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id52cfbe2faf44e1db50daba2fb27ff4a_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i617cd2e5232f4d6481542c77f053e8a4_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1025e2524ffe4b48931a58f4b78c7f2d_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bb6927b7d714bc09b33449c20da1770_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b83b2d252c447a2ba19f24dd30e3a65_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e39ee9dee804ae5bee2adb6bb8d7288_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic36d3ae76596417b9c30e054d1545171_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47fda4f228854b19a6da483cbeb232ad_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie01d8f5ff2bc4b4682da0fc787c482ec_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia68d65479ce04918b459702f999497d0_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic909e487ce0146d4a1a529a11bf4b714_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcb888be82354cb9a97b576afd3ebbf7_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i622f3878a0cb45db81deff9052aa0056_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b7b0c17478b4846abf9b2e8b4cc1801_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc70d684244d4d12a5436ed3961b9126_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6882d65422ca4fe5ba1de209627b9d21_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9e976af5cc446eebaf01b985dbc4a42_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a09f1a4ea2c46e6b142985640accc45_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1382ae0806f411facc9962211302f96_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifca93b84479747ca8e694826d35cf5f8_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59bb85378baf48b8aad7ccdddb9509d9_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i901027a3abc14517a3a903a087117d8c_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29f87aaf8f2a484fafdef882e2e279a3_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7428937974c844969210c80b4d1269bb_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i758bf9c10aaa4c5b85d3f371f710849d_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f3e6000257046239c2aa58024508811_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61bf4b75f5dc4a5d90e74e58ea5c592f_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i639cb007bfcd4af88897696baacb9819_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4251ad0c6ca846ebb628818d56f1251a_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4f491ac1fa844caacdc4e58ecd253f6_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32bc7bed7811453990b8957e62697591_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i292a1d5f47644ba2864bd3beb562b985_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01029a1173314478b27e2a88c1698d60_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0ba4e704712428ca90c45899f493ec2_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e6b13cc13d249cea0793a26e097bf2b_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb79bc61a7fd4785baa0abe8babcf4e9_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i192bf62c991e495aacd95b6a130d406f_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice1f7153b23149e6b9bdf5779859e8cf_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f095d9205a94f68b57c820821576001_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ec08d548cc34c89bc05df02e4c29100_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d1186e0f9dd4e6cbaa910c65af648f8_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i350db5668e464af6b375c3b4bbd5f0e8_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaac6fa6375624cbf89f14f995817172f_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d932d154b6049149af36416558320a0_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e091eab1cd14f03b93bd9d094df209a_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i372abf170594420094ccb2d5bcf0ec43_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e53d4b575e548578cb08588b7acfcac_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c3a289ef5b14159b92eb7f4023a3e8d_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54d1f30235984b0d92230944638bbefc_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a1e39c45d4d40a5aeeb99e4ac32a934_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d23a00fc837488e8322cd4fa9f6eb80_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9954b9535f4046ada0661eb9c93f272f_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbc5ce6f7f184806bd9942142222b820_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c0ed7d0f118415182ad2034719558ca_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4f1f0010d2342a8967ad0c59c55d4ec_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i227f787e18a34f9bb38cccba24d02a79_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7af68fed7c3b4b4c8cd6739097abf04a_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SaleOfSubsidiaryGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a666010da7f4d2eb9c1b6cf6bd24a16_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SaleOfSubsidiaryGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i468e8ec1c58344b5a45790f5c51e8c09_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ab4dfe0a05c498895f727f1d1cdb016_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida55a615e74b412f9e17f752df014784_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia08c2e302e194315ab73624c233b25e5_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6e8354567bd4a978607e65d30a26741_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SaleOfSubsidiaryGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43f2992b3ca941c3ad80001e95066a6b_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SaleOfSubsidiaryGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5173f4423f0449ce945bc91eb4676e98_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8abc68185a784fcca778998cec6761df_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i095e59b2969f4ed8b53a10dc8c2219bc_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e85a98890fd4f78b3493cdc6bbec1d5_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c27b77222684cf6918b97cd45fc5ace_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithReadilyDeterminableValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0c4a4ae70f84c9bbbc600bb0718afe2_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithReadilyDeterminableValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24df639c9fc04ceeb8bd2cfaeedf32ae_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithReadilyDeterminableValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0439badcd60b4553a7b6551b725bd8d8_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithoutReadilyDeterminableValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8128a659f3a049a29db2519c8d080e12_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithoutReadilyDeterminableValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3f03d1d353d4af1b97302c91561ce50_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithoutReadilyDeterminableValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ed67e743095488a967574c1fa9c061f_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9ed98fbd4de41809e2bbc7eb1afd160_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic041dfb9d11749aea360ec6976d75398_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i075b4e0d383b4d769029c92ebf7473f2_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b7b583681fa4180bb4ba14738b78ba9_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26a4a5bdc75a469cbac1c40a5b7f4419_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf7ba8da4a85439f9212ec5c6c3cdbbc_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f6fc756c33f4aefbaa09c8db437ba3d_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0c4a50667354367b5d5bc0ba2591ec7_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1132e994a254a868feebb3f706ca20f_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49bd4ba56a684b248e46d6b51af825e4_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id07a8860c7464a1e83cd897bd0e82400_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i075f06ffede94a0786d62da3dcbb7230_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c550e4021f14358b75cb96f31b7315e_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f95053789564fc7ab821eb34ad95a92_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc1339831aaa4cbb833e93308c747d53_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3463d9cf730744ada323be8c796f5190_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9134ec591ce4337a548a5cdf634d5d0_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a53e8456ab744c7beec3f2ef4378d29_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id49a521ff2d04c15901e39f520471d2b_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3da82ce120b1479b8130fc2f67172a04_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1a4bb7f18ff46a49d5c2a061670c81f_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie37a55c0ed28487097c8fd0b33e77426_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8a100e64514437c862f0d1cd3d7ab0d_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac96af33cfc442a5917405a3caa3be5c_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">jnj:OtherReverseRepurchaseAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6d334f7d7524737a5a1e0b9b48367dd_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e99c71717f340a685ff09c95429db3f_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a2ca294220e4bf68ba6b1a11fa1739a_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7828932564cc42808d3bc1319ed98668_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ff57a4b24ad4de3bb98f30bf0dbc693_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2280350b15814286becfc035a03921a3_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5f928f37d1542b3bf86cc736479d215_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ffd52d1e0664f24b3f3822ede7a0cd1_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idce2d47fd1804a3f98973754ffded2a3_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i935d5ef44a4142eb80b98b85c665cdae_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1916a7de9304cc59832dd469de21cc9_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if11c31b2d6a44925b98b6b61c64e2daa_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1647f236f4204443831bf07df847e56f_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fe7d6eeef6547a081274e2ede3f5ff9_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.250NotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9b43d320de345feb114bcda4919416f_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.250NotesDue2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1538e33ce6b24f88a81816a950b4b247_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.250NotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i056990540d404780b0b73129befbc636_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.25Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19d6e666640143e29c89b138db0f6d22_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.25Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica2fd4caec424e239a481a2bcaf79e6b_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.25Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafefab750a92478c87896b310434e7fe_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.73Debenturesdue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e92a5dbc9214a8d9f87742c76176ff2_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.73Debenturesdue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieea3231abf62476ea5bcf5de0b5578f9_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.73Debenturesdue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02e32328220f4303a40455ed4b2da979_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.375Notesdue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if268019a4de94135a6b62c5f0e256440_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.375Notesdue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13cce8a254e449e083f46c20c1bbe797_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.375Notesdue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieef980882cf74f48864a6d1029945cef_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.05Notesdue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i536828fe3d9e41f894d6e23d6416769c_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.05Notesdue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7c53e72904247ce8947b14425657966_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.05Notesdue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1ca9536dcaf404e8afcb2da4501ac6a_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.650NotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2e2c07a5d624a8598c2fdc999a47461_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.650NotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01dae954e6b6449b91fb72ad27b9bc51_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.650NotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i136b1f0e6fd14acaa8a68b132e09a0a6_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.50NotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i645cefa2669b4e44b397f9618653aa80_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.50NotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3150eb2704984084ac3204e1f7084267_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.50NotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f424501f76142b7a914b49ea7286203_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.625Notesdue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76b7bfb69eb9403b99deb7e7eef8d40a_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.625Notesdue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52179e2f9d674e078511c80f498c6c0a_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.625Notesdue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbc85d394a774ed9868d5b95e674664e_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0550NotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4dbf413e19e4cef9e7278a102ee7157_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A055NotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i078e08bd46af4e3f9e215207cc204105_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A055NotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i159981f414cb4bb18af0fbaee7927deb_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i668b41dcf7f44976bf86a2f9db667fb5_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1eeb605be014548afd510c0c8aa8eb3_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i165c4f1ce2ed4d76ab34c44c41db1255_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.95Notesdue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2686d72e0c343febe8ff2bd5ac5e63a_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.95Notesdue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab1049268d7f4fe8b4d96cce87cafc93_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.95Notesdue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6059fa37b091494880a716afab863d00_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A095NotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd980a324e5844119be04d1bb8b21864_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A095NotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8948fc5022044e38940be61c4706a21_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A095NotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae91b5c8065840b89f68ae84c662b898_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.900Notesdue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia36b73a057224ba4affcfc6bb3cea2e1_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.900Notesdue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e79dc01a22a42a1b246532434f100c4_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.900Notesdue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7a2d03254ee4d5f9a357de70108e5b0_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.150NotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21be7fdecb314fed8cd5a7cb7f876fdf_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.150NotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51f2a2865858445bb19a36565773cc28_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.150NotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9acb3bf537f748f9b2c3359991790afe_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.95Notesdue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35c7685f5dd046aeb031adc37a8ca784_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.95Notesdue2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1333214536b64c51ab1dacec5ddd05c6_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.95Notesdue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1245a84acd304e199ac2b7dc8d467d7e_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1300NotesDue2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icca8ff318ac34efc92f4216ddfb91fb2_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A130NotesDue2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ea632070b0e40e898b52619bced26b7_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A130NotesDue2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1378408d96d46e39591826c2abb98dc_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.95Debenturesdue2033Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5f87b6d74d749babe28b84569bdf760_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.95Debenturesdue2033Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i995150be58c746e482284b146887f7d3_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.95Debenturesdue2033Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2622b7e579a8492eb15ec639424f7c89_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.375Notesdue2033Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id36151c33f4848bbbcff81875e541568_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.375Notesdue2033Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e0d64b50fd84e3a8c7f405b55ccc1c7_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.375Notesdue2033Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id41e1a92e44e4a829be6caa81c1fccec_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.650NotesDue2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7803914447c4a189138f7ee1b3e91b1_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.650NotesDue2035Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i256f4cdb5243490987a08f155c79ea6b_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.650NotesDue2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62ebec4387da4562b9e6654db09a6b96_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.55Notesdue2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69ab97fe3bda4a55b6837fd20fb4462a_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.55Notesdue2036Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i480827ff0c054590abd0ec468b49c4e6_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.55Notesdue2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5536eadd4c94ef6a5ab2937cc959359_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.95Notesdue2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1b4030a20b24ff0a711318c1a843cce_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.95Notesdue2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1da6151136fb464ca1c2c5796b81d7fc_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.95Notesdue2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8ef119f549949d08c1ae0df1c64dac7_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.625Notesdue2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86d6509ed13b4aaf912a2823edcb1029_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.625Notesdue2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8a5b10c02c54e47ab7d11d7d166c538_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.625Notesdue2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9aa446f74b2d40f4aedc83ea2ea53439_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.400Notesdue2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f66b72f3c7f424b8a380c66e8da7d27_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.400Notesdue2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48a1bd53e02644e6b26acc106519b804_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.400Notesdue2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic49fdd1ce30c46f8badb4ff4bd1017bd_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.85Debenturesdue2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd0f7065260a48cda35109d9ae5386a1_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.85Debenturesdue2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5951d9504b1a4dff8f25e5796b4c0a9a_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.85Debenturesdue2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i387cbe08835047789169cf51f45ee5fe_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Debenturesdue2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide6e5e064d024312addc5538bdaa7c85_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Debenturesdue2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib69bdfb1b7b94a449af780c7ad54b9da_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Debenturesdue2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcd460ebbac7457b8cb0a76ce59423a5_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A210NotesDue2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c89e14a0fa3403581aa0e9723a4286c_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A210NotesDue2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98dd15586d034500902f9f3c99a576a5_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A210NotesDue2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i324a2081f5854fad8130ebd189647549_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.85Notesdue2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1eb3f36ba8a74f5480d62d0a81bbc354_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.85Notesdue2041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b41d3fa848d4b0ea4f78009aec60a63_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.85Notesdue2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bdf805eaea4472d81e2786f92535e75_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Notesdue2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24b0208298044a269325b9653684ec98_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Notesdue2043Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4ff4a9f1fb34cd2b7cbea524a570fba_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Notesdue2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if02c9f9f84d64647b122e66b2b1a6f36_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.70Notesdue2046Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i171dded75a42462f8691992184163a6a_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.70Notesdue2046Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e60bc8e3f0942bd832fc02168754abe_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.70Notesdue2046Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3acfd6e023d48c49956f11aca1794a8_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.75Notesdue2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8fdd90a9a534e91a456c1d33c226809_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.75Notesdue2047Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3dc5cdf91884ac5a55987be998ef035_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.75Notesdue2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dc08c035fa24dcca70c9fdd3ca863ed_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.500Notesdue2048Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43d605e8071140abb14e4a1b5c23edad_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.500Notesdue2048Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5c0678f2622446789e384e30ddb3b34_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.500Notesdue2048Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1da88ade9134203bd9ab5f43e40ea74_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2250NotesDue2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9d8b34477a34cff93a83812f0c68017_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A225NotesDue2050Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5044fde7f5e441ac9def46cca0d955d7_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A225NotesDue2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37cb21206af94c5da0e8b41d9ff52e60_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2450NotesDue2060Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i930c3d7cca544f488362ecf22d4ba011_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2450NotesDue2060Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ecc4cdda5b24f6c8a06cf84bffb3461_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2450NotesDue2060Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i709d0243b3794243b831d6b6a562bf4b_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:NotesDuePeriodFifteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i278399ba66af46a19d5e0d9c2a66430e_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:NotesDuePeriodFifteenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i719d92c03acf4660873bf7164fbd0cdf_D20181231-20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib12c2507851947309a7a823e9e3770dc_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f434199d52940ed909adbee7e2ad0a8_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ae18f8aab5b4bd6b80b50402d6ad212_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic847fc16c1a54fb78d5fe18b8a9bd17b_D20191230-20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf5f634dad614276bd22344f56a80048_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">jnj:AccruedTaxesOnIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib105bdc301f94aa0bdad8883c084fba1_D20191230-20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76991a953ea2430ab905037bfcac327d_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97db63a5b1bf481bbea39077a0761ca9_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dbd3aef0b5a4bbc9dc149f14c7e3d3b_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ac819dd65a24ccea1e79d719e0d1cff_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32b2b3e0644f45ff8702ea89bf54ad06_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a18f6b9ab22475b952191fef9a136c7_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62d4b60ec8e44411a7c22519b07bcb56_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7d38e2b061c40569b6a15416f6b0063_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba89a9d0fc0d402d9b56774badd78c07_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7aca824b885d4113af57a768e99be46f_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idee3ed30241e424493acca72e673afcd_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad56cf144ec847a8a16206fa418498c9_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebebc2fd778f40798d1314b14d68d59c_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib49a989cb90342ab8cacece521c7d896_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a657cd2705e49199faed73d18529a9f_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i686763308513427ab8b79b989e11e0b5_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b2070364dbe40199c021a5f19b0d7cd_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i240092c4b65b491c93381937b17173a3_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33664fe4d1f148e7bd9e8ade82e1790b_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b60bad991094d70b3aa1309c7d2f70c_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0247279f84684992bafc7f3bcd811a4c_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i258eab55a2d94c38a37a02b6761520fb_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d95454e2f2b47bba671c0f16ef3678d_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55c350243936480182afafc99c54f755_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b916937f8b4417f970a191c21a50d7b_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbdf62a6d4e04d9497cf6a3f7fe73fcc_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38c6793cfc6744c19666a02341ec9b31_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeebc720734846059822e5b88d5728d4_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3b1c962253f40358196e13a8dba4ab4_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2da046285a854cbfba8fbfe14771ce6a_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9b2fae840754a6ea4f68f1acc7268f9_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id933df11eed64928a3b3481a8a126bb8_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ffccfe4dfab435e94684d4fcf3d976f_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie757ee9c942f4859aab86954bd239d38_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i735a40d88d7e46dc9295f42c61e9310a_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4183cb021584ec6b8420859ed1b2c0d_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9db0932464f74a4a8916179795da088d_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8013563982e4faf92e1d4712047488c_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice288e8c219a4507ad03507ff5dd2f25_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6167e7598a3a497a987f9d52e44c47c0_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife45c684b85a4e89bfaae65632c76bed_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2317353ffc6a4b6699b4670f8065adb7_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cf576db9a634f2bbe83401cc15ae8ad_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5501bef72d543db9d17b8fb2870aa8f_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d0c5dfa391d4390b7907e241d878e21_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b497129d20c4ad3a9e5f5c96133de85_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib88a939963264141828fb4d58e203838_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccf1e8f3a0074a97b0f52772a56a8633_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bb84639aa354224b5d50732c027f3ca_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72078429833b482abb75ff2f963b1c95_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a72efbbc13f4a9899424dc34768f292_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d8fa9621c1a4788aeed3179569fe294_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a9f94d741d04069bba045fd793e2102_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i282eb35f5a6f4308a0133f28f9e9fe51_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86ef51c7d032407cb30caef60d2e438e_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fc5a0ba168445cf92dcf88ef880150d_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d63809b7b464394a1928e0d87c2b8e9_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1d3e97e875047218ce5d543119f6e23_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e589fe2a250489bae1d93a267c01624_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc8fefdc8c3146ef985668dfce568821_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0e7b1947201413e85946bcaada77275_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14fbc68dbd2745caa0dcaf30d0e59cd9_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee45030c44e44d0aaff586a9a06e0532_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61637434781b4c8998469b74ad8a39e4_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63c4e377a3ae40f4bcb7d5a4e5f8b84b_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61b21fa64d6040eb9fbae0bbae8c3b11_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58e8bc1a90394483be831705847d06fd_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia03a4e20bbbf43c28052fd90303aab5e_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc43c3a1acde44b7a8a4d40d89e4efd5_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id798043e75334798bf5217fb399c1997_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4cf6ca49a8e404cbbfb2fcf0ee82a44_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d496bd90754417ebede4d9829a52df5_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0d8e990787d47c0b75a6b3923da8b2b_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ae786e5f2804cd8b49c7613a74391d2_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5751770904eb4b40aae931e43968e339_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if752582ef2ea49b69e87bafa1de27a77_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie724f8c70c1e47fa9a3509c07877098c_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4c4a17d7588422db6a82c1ac5960f10_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4360908e63cc43f4afd75a1169c42e6a_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i585883c87d6f468ebbe4454a07b867aa_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae3a3a38435f49649638b494f6bccee6_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iede096f8f0704067b69be6dae6af81dc_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7c75ec32bd0476981aaefd378fca34c_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7eb47e278e24b51ba738fd66bd6e91e_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95d2bc3ef16c46d9b02250368f6f79fe_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19f91fce38e74e8abff653dd29e4e05b_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08464ba4d52a4eb3914d1d9e020164be_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33b4445ad1ea4e698cc11d61facc127b_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i077f80fe22fa40258a7a8564873d966a_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ddf71a7398d40838d9e518d97fe48b0_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2686d4d38b79478aa2b6dcfb62ab0339_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if59b92da44574ef0b138a6fef376b519_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie69aec39506048e693f8810a2bec2f05_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99ad086b9b774548b75e48c3ae0dd0a6_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fd225a39cf14e8fb13dbb1438b30e84_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0494a1212b6c4384ad100f4b232c73a5_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a475264ce8941ce924ce89da6c1b1f8_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62a183893e91467983b0dbd1d2467359_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7721a842d6e04cd68272b2ceb8cd492d_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie377154beabf45b18b5f586329899114_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae10ea720f56417c9b64a77097323def_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7d047e2d661467cbcc58d9b0a2b8f87_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a3e920df42c47f494f7fad0bdd00892_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1f5496c4f57420a9c9179ba0ecf286a_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80fc979b7821412b9354bc3c8c18f543_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0580a0f80a854712a683ccfae2bc01c7_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20a3b648a6b14250804ce2ee299db44a_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4377262270cc41a59014888c45de668a_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1ac04085de547c09d5d0c96ced99ebf_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08189f8df3194c738e0366b591e994da_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a49b61963434f44bc5c32db3f151981_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4107f09a348348f5836beb164c41a295_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia54c27d99b0c4b6e8967c1db2422520a_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28a313fee6cc48c980ee757740247668_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57b326234b5040d2924a11d5a5d2f80a_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1cced7a8930436b8bb62f6c2b776b00_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49584bdd90da4200830477e258a1f18a_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71de0a16958d4a86a067f40d027e87df_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5991575feed545c4b92cb368006afbca_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice0ca647d51147ab8d51aff745fcf585_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d625ffa896248a38279e2b4a29f3219_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38b3cd6b638a4e2096aef80289a086d8_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:UNITEDSTATESExportsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ed049d22c86487cbbb24c08237cf4b6_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:UNITEDSTATESExportsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4bef45a84dc4c01abdc1d98d90dcf34_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:UNITEDSTATESExportsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i600cf308c1784241b70b032c5d68bd00_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:UNITEDSTATESExportsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63fb4ada15044f6c8fa99130ea93d6ab_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79355bad3e5e445082550bcd9d3f6dcf_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i898fcee3d0f945379eea001f50fec410_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia77eb74fc24d4dee978633e876eeed4c_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd37483bbf104452b66657df9eec0a8e_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb87e2b919d04ce0890e77ecba398e3c_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7fe0e4ddc03461a8b43fc91268211aa_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4219375293b47b3b667294bccd3f0d2_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2a1050013c34d03af84c0a422360167_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3e62d93a7b248c084cbe02d4097ea9b_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41d2ba995c114bea8112dc3f01a44747_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1735f2c1b584a5387b7afb371b2cced_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3f96f7c0ee0405d828605b25d8ad883_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic017a6711bd74dc0bfa3467c9d21905e_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f8cb419ecd94801b4d8467fb355264b_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia794884513314c399f7a15b03dabd0e8_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab4590d1e9a54db1808fa18df4d4b0e7_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dc4de912284470885b7eab6009487a0_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a91bcb926e849978bced69fbb28f834_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2550784b68a94c5e9a6680ddeb5a5dd9_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id05fcdc5a97449168a9c27235f88a4a3_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae663d548ab040e1b558e27622a655de_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a44552997a1438b8dd35f1ec093c504_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a72154c44cf41628c31a554960fb0ef_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e256d64e1f14cda9becb9ce95293d74_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9f32d7f981b49809c5a26d11cfd4bef_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1fa30f3e8d749dcb44364f361265101_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib09c328bd9b9495b850d67bcb81cf0e9_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dc3572916fc412292b0f22a60e8ffa9_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfb0a635e286413fa05216c24bd242a7_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc83cb6294cb49adb420c6d0d9a84038_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24c66572a6274c88bc620e4593e2bee7_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i833f6bdd0ed74fd890f7d87af9bf634b_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d16336042034ca19612e535c7203721_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f0843036b964e08a45d950a3620e639_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic56e7a163c104637a12666dccee0cccf_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0b694b680c54fd3954e2c9de825640c_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71cf25bbc69049d7a04ce269ab9edbfc_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9c6b2cd97644d858ea79595de3d0fb8_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7d0e75dc93a4714a87669d7c1755832_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib59aee6a72054b5cb1cbd5bddc82a106_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e3f978416814668818a1ac3d0016e08_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5ccf929f2094fa7b1f560a94aef5455_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie48cd916e4a74a618757c125457112d0_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31dea148331149cca5a80f720044788b_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecdff515762e495ab6fc8d22e512e250_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1be2f593ae2b4c93ac28c4879f064560_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d8ceba2b66d44b3a34e55b430bf0cd0_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie11aec75a6e74827a118fcb88d74e00f_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97c1b4ea6d1a4ecb97e3016e1eee457b_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d39e83bc807453883a50f25b55fa036_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04e9c913340f4fd9bd58f8191b92c901_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27a5631c2fb54ff69c55c3cfd8c73d66_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7577089dcd244daaab8e65459409715a_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e213faa318546279e9fd452570893b7_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib040cfc0c5614b24b802c847b9882e83_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb1464cedac54631af9b25c35805ce37_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d6bb0f027f641e382fb220073c0b43f_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f59ef10b8cc46cda0b50f4338e55776_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e29ce41396f48e889d97e03233e6707_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd7af9434c1d463397ad836760e61d27_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8bc6696056e49588142a93df17780a2_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie776bdb04f934182825e29d6f3d24312_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id50261a61f02491c979c43c1a7e12622_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a00e22875b445d8a301f09f4917837d_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86d495dddd6e45b0b86fb85e4b21a2dd_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7387eb05ef5c4fdb842526c456bbe3c5_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i313ef0d43b1b446cba4d11086db5cb51_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib77203578b1e4210a44754b41d738e9c_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1173e423785c44f1b4f1120ba26ad0c8_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73165b608c644bd1908c9df7d2a34b56_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d0350d7f7b0426fae4ab3e96ce6a2d0_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idab010351da041bdb2cbf40ef950465c_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ede8c86463a4ca1900b7e1fd0a2b799_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0bb26554dca476f8295e07cd23d1a30_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ab4cc6bdbc94b5cbf46487897a3b4c1_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f63caca7fb446d981bd3f55e5f83321_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58ab3c81d40b4648b33db3b797bc2e2e_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42d8379119de4f56aacbfe9fb385c84a_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie267eb4c95db4a2490afebd4e223298d_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie025a2f5e9ec4234a5ed0d872620533d_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i022b92c911e04342ae67e207f4d0515e_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e38b2e1ebc14377b3723fca5ed4fc49_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i836e6925162d4ab1800fa82a7ab90e71_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccc032099418444abc0b942948f6db9c_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7969cdb22dd40dcad77977375507b7c_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib23a110014b24e3e9dee37ef5d241637_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i400fe3ea80954d2fa120c009dd823c28_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb55b5529292435b9665dbde03853a33_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i760f73e5eac14ceaa22fe96b46943bbb_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie059b332397c41f9a9a476949ab0f9db_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77166f2077334d64bae7a52b781efe80_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia076593d3cf644b2a4c230fb8aa33f2b_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cbc3463e1ae4fa096e2ee9db46c6632_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic670fa5873324341b652814d7990b6ae_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39d249731b8e4bafa48866d9284ba875_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74965ae98cf74a79a669cab97dcec19d_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37b6d89c8f7649f59cd7ed840dc6187b_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03e4b6fa743e46aba9b64898e02d6610_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i864fefcfe9ef4b1f8253371aa4da89d9_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c99f12082bc4cb2903b1862521cb302_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75a1d3c0a8c34a149a347f13a9e28320_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc9abc58a71044878c2aa7ae09ff8f8c_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia105d1087fa6441a9079ac5df861898e_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacb6b77961a1479ebecb82fdc6fe00d7_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c08f4679ad1446eb19be39cc3bbf8cb_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0c2f0fa25124f8b90b673fc8d30c977_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3b86ebc40de4d02b5a15198e05e4dd2_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04d10f41995549958614dc5d62ead9fa_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15bd82bcfc384cd1be06ff3479f7fe56_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77bd07ae97df45fe8f18bc29a8766b16_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf7cf5a1f5484ad28076d05cc5bf5456_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb272bfc6aa14c8d833db65bd2d89c9f_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i024b31141065487eb47c8f27eacf8b94_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26d2bebfc5134ffea7bebf182f6bfe88_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09fc122a66fd43d987b35c926766da1e_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i838fec96a85e490a91abbe0f423852cd_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i205f53eb2b4844e4b0c11273e65d1efa_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49d169f73b2a460ba9c3d0d74492a3fb_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc2604a22a5446d1b2baa44602c72c6b_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4603cfe6fe1046c6af473d0b35dc1e66_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f7c241d8ff946ad9a3f1e8650b6d548_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e5b1f4897dc44e3889d6a11570ac3c3_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcd6dab96cbe45f7959c3a93eca497ca_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54ccc3c917cf4242a4f575583368ce21_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5377031ce1bd478a865faa89ac9e836d_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief1076e1d3ec4608a9c69b0854bd5c3d_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d0623be30d649bdb8c119d1fb380cf5_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5493cd95e9040eca88efc765e25c90b_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8154cbc3358471d81b6c9e0cfca602b_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia65c328603194766a57c17632de4fa37_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5abf17b6cb264cb197714b4eaa2858f6_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebb810100f164a6f90ad8126497b2fee_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id795ffd344cd44f3ae87465d76b3b61d_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i020804ccc75241b39a2537441aa2abb8_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i466ad16e878648bfa865eeba3f05858e_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i702c3ba78f294a499d08adca2c3e05d3_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d5788dcb82e4eee98bd8058fbf39537_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa520d7163634d8fae3b61f2452fa6a9_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3397044102204bdea03afee12e1ddbe8_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i230206d0e0be406ea6ed74138f698967_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8af9975ac5e84f31902e2dc3297b1c31_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc11f05a7e144bb8a612662099fd1476_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec74f00dc144400fbf71837c3f85d010_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88615927a6634ebe93715f2ce1c8ffed_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i542156a6acd14373931ce4b7ccae05f5_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4492bef684ea46c1a3ae25b9fe930f14_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i721706f8e045481c86dc8e07627a8f0c_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69abd303a0a949469442142f029642f9_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba3f0ee0c4f3486faa522e60acb01051_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4a66bae60fa4ef0af457100fe8a6b2b_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b81e17f99cf4307aca1954a29ad581c_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c1f3898bb4b45dda42e758bda36a669_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5054190d146a4cd188e4ff52a2ac195c_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia396ef4400a04721bcb9eb751d28c14c_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e196f60c8f84d0e863995c395467711_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fe837c300e64a599158923b9a3e0ccb_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73c197aa1c3f4a2983242ba4675beaa2_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic939d8552fd24ed6815d0c7676ad9233_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a78f12a5dbb4fbfba94b0044e46b502_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8646c210ca8d446ebfb79435ca8cbfcd_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bb13790d6ad4aad86f8fce7a1c50f3b_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9d9bffedef249fdb93057aafdd09a8a_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbaf2076fc654fa1a5fe9210a7f4452c_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2778860e516341fdac7a99b7214a99dc_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dd83f9144404cd69bdacd864d641631_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i752cd2edd61e4f58b473965cea3aafd4_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic26bca171f714ec08510fa419cbd9f78_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfe3e7487808413aa0811c36064223df_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieec92b888fc2475ba4b45585fa0376f8_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1205be94e68d4cda8b85bdc70cf76ba2_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4cb44ddf8cc45cf985f507e2ad63eed_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d9559b960f641bb99edabc691773a8a_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b155857af2742ec98b26f0e8bd6f63c_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02575caf89d44152bc3372011aef005e_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i425fac1e024e4a3985d9c88eadccb208_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ea9ee18248c41a0990af9a8bd2d9634_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c4aac1ba6bb45aab22decf4191b4c08_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97b82273e4234a9a905cbcb65c575356_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ddb0f73dd2a4c0a8d3fcfa0f7522b98_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5381d639283543639418c19ee2938e11_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1910340b47b743deb6e4133b4aa1b30c_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40dc71d902444824a22852a9b082d005_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cf7bb68342d478abe812d2082348d36_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i705ab2d26ecf4df3a64a2a7de556d9ba_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9749eeca9e1e4d8db5458ec220a2454c_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5920e241198f48f38ebd20ae56e19795_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfe72bbf690841b18512fbf1d62a9972_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff059545ae6e4221920a372b17db3e2f_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9675c62f8e7451998e302272f33726b_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b963caee0e54df9b30e44510c6584c3_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc13c87f32fe44c191a0a792e991354a_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81b57ee3c6154482a279f76aead7f4af_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib57a13d3edd943ca817dd9ead9e296ae_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ca84dcf326c430cbe701477a9c57a9e_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77adc61bfc404ed98cdd17cd48df3b1c_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i372932b60c2c4cedac8377b6bac57e40_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc0025ae94a8482b889201ee8f579b2a_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e76cc62521e4a5b9a91e983d896f049_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ee09d3943c845e39af6dba238d48fe3_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34735177370944c4801a9842bf884fbd_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i796fcef4d74540e6bf307cbf351c2bed_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b57e3ca4ff34279b822c3d9d12fc1e1_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9465452a2864f51a42faf1511d0fd43_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72c72074c6ba43788b7c9742c486d2df_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ba0577bcdd34b8d86faec42ec29417e_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0693b80dea945c2978dab63fda27374_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e3e511ff0b44224b63d2ea86eadb7e7_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45dfcb3ffb3e4a97a4cd1f22832657d1_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf94b5c46b474da196e27de4e267114a_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62b6d2dac7db484986c41d5f29e1baf5_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5446e8f0ab454edea3b3c38dd20556eb_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67ccf902b8ca4f778d40454a90bd5dd6_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4109c4932c754685876797c6af614e62_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i330bc9af1877499b8065d4b7b3fa2e01_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3c3b9971d0b4acc9e1042b91d15ebe2_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4955df2646f4d2db40aeaab35a9f11e_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e0a71362e3743e4b1f4d0012e92b109_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53f5011996b74418b2ae013de7b25fe8_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabef23428a1c4d3b94722d03cb22cc1f_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09245da0ca9744d097847bbacddaaba3_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c8552621f43462f820822d0db06546b_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i268dbe75625d4f94821b1992136466b5_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54921a8e1bae412499c1ed6066b7babb_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00b989b237614d92886abe9728179769_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18c083bcea8740cb90e264a1f6f78d34_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica56f357873048e8b05d7f37a64550b7_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd88bb111cfc4697a30d5ec9e6455e68_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7c1dfd0ab824a55aa683fc2853c811c_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7515a418c4d04e6696b8dea069d6787d_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea069e1f599749b4955a9badba8f5442_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c31b8af359a42f99b7d8bce11dc8b0e_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3bad18a87304c4cbc3c2dc4d1ce3cb1_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa05f30dbe0343b0b935c997aa17c4a3_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfb336e5668642d095d254e92dbd3662_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if54134f7c5b24e07917d778ac41dce41_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id920a9ae68314dba941e6bd37d23c794_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99dbd0f9ca734810b3b3cebdf13dccf7_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5ea83560e2c4220bda25b528dac795f_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc48547d5c2d45b18b0cffc58b8418d0_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2930e4636157460e97c87253a644ebee_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idde0b706304b45b88a9d831118eea942_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3555c8eb101047b7b3e6f5fd9a92fdfa_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c8089c225324cd2bee3241e1f84f5e1_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf2f109a663b489da13497ab8eee8ac3_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32579ea231594ff8ac2d8f4ae4ce03a9_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i121970d9573c4f7ead61761fc53904c1_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5ea45ba97f246528bda5b3f66a608de_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i398b379cf9824522a2ced7cf59facc66_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia701d7201ccb4861bb77be7093c08db4_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8263c917767241278ccdb61c3e4e2803_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4175bbda9cfe43b6be2edab57371b4ab_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib373300898e546d283fc33d0388ff705_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1044002d40e647fd8326e72b1451460f_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42c60d3862824ccd828e4b74762f6418_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if420f4bfc54a4c239ff4a7c3b49fa4b8_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16cf6062a6ae470696458b6461568e25_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d4fcfc7f7e247ac9b236ab2cc9b7610_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i191ce2e499304831a66740e08cdd128a_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37e02e11e60a431296858d46dcb92eb9_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37fe03909d0c42c2a5d1a9b179769776_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic80413ba702646b38fbb6b8bcb646200_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if047c787f50d450e8de9249ed46afe73_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9a361df298440088f461b4343dc1a17_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94465a7eb96141d99ff73e62a319bfb8_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0698ee2dd7914e2abe8fa68b898a1a28_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if08abe1920f04bf98dd739839be93b65_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i217e2c9aa29f4999bafbb343189c1d78_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic56fe73198cf4b13a4b507b21a942116_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i318c310c110a410ebd87a7483d92e09c_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2be36e5216d54100a37a610a312db40a_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e63c1418afa4562877a6c19653bb704_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73eb95bb08bd41cb8d99dd2c4a0b8742_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3aa4dd5cd6a94deb9b074d8cc077c127_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia179bce14d4544eda2428c53ec509422_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a8eaf42923c495eb5579fd7097cba34_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i010426648d814b3aa129307a75a78d2a_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id454beb1da294c5abf1642ce831df07b_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie15c767fe2ab4976b0a06babdc79238d_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id44c86afd635403a91e902792dfb4c5c_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e2e06db53a2451dbf125d3629e771b6_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cd752a9056749c1b4ecc334a21ed7c3_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8257d323d64145da8c90884eb259a7d2_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c2832df4f35417caf2fffb8cb822af6_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5075a6f43b343338c5062f76a48e067_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01d88a3108764d0bb869889f44b14203_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id644fa2e713f49e1a5ae05b7fc4e4f1c_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ed3772815cc4a3faa703e73bf58e0a1_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba2b4531ff2140fabce85ea3fb293461_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63eb447b40dd454fb968053fddf79121_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i013947f80a9443098796115f97595392_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a0434c21b524a9bb6ea856dd5969c76_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80e3dc1f3fb94925ba1c451b2ab83aee_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id389da37c3cb472483e3c18b6f953869_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00da0f84c86847d7a8655fdf18a81a3d_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41759335282246b889e936ec23f879ff_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43ecfa483f6c4bd19953e3fdca33dd8d_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9f66f37ff7a44b583b3c5e7100eff8d_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57a9bf838edd4528ace0d2c9eba6e86d_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d744e86513440f39ebc068eda44b32b_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95265ffca9d34d798871d9fa7c192928_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i861817aea75241f3a7830b21a7873c16_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57cdedd2e4924130b9f973dccbf1425f_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i966b90600060495180cde77fff0831e5_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33cef8db85f6459a8f53ef7046c5bfa7_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21c25d970b094401ac14010054e1f3ca_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8c574d380a348e68b4cc617a801ea6e_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id37ad7cfc12b41428d45ab46b67de2b0_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i892fd133b58a4cadb07bdf935bc6af34_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9a6429a54d841c1bcde5ff62985a777_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id21567f828814171bae17a473a89e0af_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96d11501e2ac4574bacde0ae4de62fd8_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i762b4c937c7f46559a1d1ebdea00839f_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ca2df401f3e4b03a03bb594e14680e5_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0242667ce51c4802826573ff14607be2_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a3f0f519f304581a495ee44fa8e215e_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d38ab9af5db42ec82566d7e0b60d483_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7d07f6f95354ba9ad6ec0fd6afb8f1d_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic78f1097f5d748cb869eb5b503824ebe_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6563c54cfc0a46558fb408ed4e9fd465_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bb45cec18df4abb9e67780a9955c6f4_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c8d711197c44ef8aa825b062094402b_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f4b21e1fd1a4652b30fc4578fce9c11_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a3a40f9c30840b1927ebacddcf845ac_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3694631e7fff4ce1b73ec6332f8f1114_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic32d7dcacf84400d91757b36f9215e72_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a75613a853b432d954dc4de396f1b7b_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ff9e6b244664dcc8c57f0d6c1e416d0_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia756fd0cfb2e474196776e501a411735_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31cd8eb3320a41a397704a1328b8854c_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fd6606fa19d4019bc87ef7e6ba6eb73_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34aaafb86ca14d2d9716c717162ad440_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7fe0b9644764d87866372cd691decb6_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia85d0ddfb054423a9895f28c3b06f8cf_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4763443528342868e35179cf61ecdde_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i333c0de72c3a4698981d349cac512c7e_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id724502ba8f2486cac318bef4c54fd96_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69ceed544ddc4d9b88e01a94fdf9e5a1_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i392f000005e74b13ae8ec4fd2245bab8_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0ebe2acbb28427fb07907d3d7cc84c8_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d4f2c99a1f249c49d42d6f746af5a57_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8603b809d89437c8397bde709854409_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f2972e6f6484e36b1d2a91c5cc8c877_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c5a38578aa04cd7a11950dd9aea6179_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8308cb00a64487ca422779891052509_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72b87b179f8b450ca58c7e90f207c8cf_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5882b17221ff476797f83dbe3709f9f7_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1276e4c945994ec68e5b1a60f0f2e568_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebff1eb342264ce2915080aaeaaff91f_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9141ca3c0a1c484a869bed176ba77cae_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e756c09a365446ba32b0f4451a03c98_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id74229a2d6f0451fb97e2c96709af358_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18dad1ee5f9340d5a35c3c37e4cec4ab_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideea0ce4a35c49a0a45ee282bf1b4beb_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id554573e94b84b8cab2eb20188d60570_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49cd0b4d91974b7da8bf40cd67d178c1_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53b2c0aad4df4af0b03896d334176f20_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2badccfe6cf04b1c9d7f2fa0fc294693_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d5c80efe6b1469391e9a4a07886a5a9_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idff7cfe33b4c4b039394833c97daf9f1_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe12ceed34eb4a389dbacc45771bab50_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaec3c39feb634238a2be7772b9926fde_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73fa6421e055482c920a5e447a1f8675_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9b7a1c7831f4541b7d5fbf0ef0a1e55_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7db38f4a02ec46bd9364e821dfd12084_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08b63855cabe4bbdbeb0a69f02efd745_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie736ef5792a9408d9d187416e6bf80ae_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1666eaae52c4401935f050f08c6ad04_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icff6620acad14e70ba4ae22cb2b1c5ab_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dcb3df9a1d84367b2ad2572e6f5d507_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide630ed019df43bb97fc9e366da29198_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1940a237e8c44075af2c9cefe451512d_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1111a41f19b54df1a08a52959ba8a81a_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if89b08d6774845f39dbd843c88a623e4_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ab8b554e029447da97b0eeb058f7784_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i362aa1da8517434aa7ec7cdae445543f_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ef01fc2d1d144f591e77eb42bf26fa1_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a7520101a8347d8b81b529c44f5e031_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7455b437e0ee48eb9473a4538a82626d_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i331b2defbc4b495580cbf5071b32f36e_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i700c383f769a4f039b3dadd10d216a66_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a16cc194cf149e188ec098d494aa4eb_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61e9bd42de204e38b485cae7266baf3f_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ebcff1d99364d61b75d91cd03f2edbd_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f5862c1f9554aeaad6ec3149da92dcd_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56570f28521e4309bb5acfbc1d861206_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4772bb2f70594c609f15d55b5b840ce3_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96b312422bef422894f64737926c8653_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94c1dc95b63b47a19b2b55e786fda0a6_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i620ad18d8b8e4ee4b483bbd4fc7e9e5a_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79e0912ed4304749a55e7ac7a0fe0ec5_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc0fcc5f2a24455490a6a544350ae618_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86a18dd116e24e96b3485a5f6169baf3_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b766c43eb6240ba8bbdaa57b4a094d3_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i228a88e232a3439ba7508d3f89efab11_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8e0f6bad1de4c50a2da26602cdee485_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5478e07cbf10492b94c7f95ded249535_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd8aa81948f24b89a510f6d5974fe76b_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5470093de4834bc093bb3471c8a0d68a_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9e844cd7770412489bfc37a68ec0c16_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1801a6a1406d4302bae15df4fc5e6e72_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia35085eaa6c748a5bfddc85e2da15d60_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if25d735005cc4622a33272df76697e88_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5faf7b6f7a9d42c58b9a332270703b95_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59e7895988ef4dae840116b8f041c33c_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic339811f8c7445d4af842ec97e4900dc_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e17bddbdca5483e9fb788af9d2d8cd4_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83d80cb8b62742239c836bc6aed6077c_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf702c0dd8c14d8a908386735f728ab2_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06f5aba171ac42868d1d0f93dc180a43_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62ede8edf37b48389570fe7528e37670_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4eb2ce198ed40b7b248f09b87ca97ce_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic63cd8e33f3e404aa8678a6a0bd21989_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd0f4a74ca2f4dac9fb438dfe7c99571_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i257430a4bde64ea48d158e7205d2c483_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ec3b3d8e35c4d95bf1c4fbbecbbe0dd_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2e2712a0d5049f5a4531ceefce9f03a_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80bf15618213433798636c636144fd62_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i680358c8ea674cb9ad8f59a84f3e2968_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i506f1906854848fab0375dee9395568d_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic59c453b839243f1910be25d60212165_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92e00f4cd50544f1a6fc1c21b5eff033_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9a73c4de08348d0aebe04a72f25b265_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa548762232c4bf1ab0a3a867110e217_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80e7c2e2168a439eb1b8ec9732ba396f_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i159a3081cf544186938c908e8fa7c674_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i126743cd6a3047e9838e7e77686dec4f_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f7d40b1ae56403c89c4041e353c5f2d_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i279d140c5f3b4e169fdb57f7f0df5aa2_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id82df2ce137f4d92afc976d33692c8bf_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b733e335d8e4c1fb383d893bb64d6c6_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i078e82fb2a1e41d6810522efa7753a85_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3b18e1cdfb2424b8ef0500cab9b37e1_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i549bc38f2f2e4815adbcbdca90f24d9e_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46022c7e16be41ff96edd7e762e38dc9_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafa8ab4bd43341708edcefb67a5354af_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i445e1d6a7f2f49918827c8cb78f49926_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c6117a9799b4fe0b16e620b0cb21f30_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3f23ca283834dfca4b73d913c0b495a_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i662c0af4be474f6287c7693841b01f99_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if783cccc272c4ee5b8d37788be2343c1_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib233b0caa2d24cce930843ce9532eb98_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e809c62413f4b6eaf0f1f74674cd8a3_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c35c71d39d448d08df9def2add49a90_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1321854500714d2386badf8f4f85c1b7_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08939ac29dae4ffeb1039b346ac2884e_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61d23b7f2d4241a38597ec38811725dd_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e5acb865e574efe9eca9f998ed83da8_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i421903ae07dc46e8b1403cf39867c316_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97a2b98ae57b4c268d8ebab5c60642d4_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35f618e2b32f4a35bc3855d06290605d_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b15a4efca2e45b29ee3e92ad084572f_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i656d3fc14e6a4325bd24b770e013526b_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8258fdc417094593a4a129bf9b40a2af_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52d7cf57476d45a5ad57d74c0085b847_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d714fa9dc89438e93a39c79621b1d01_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1851455e464849f5bd9f21eb2518567d_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66ae8fc90597499185a5d9eff2fa78f6_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ef142f0f71444aab8fd23edf4a5fc2d_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib11b611985894d70b30457565b4d7fa7_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8de79cd48b68455aa26dbbe51313f2ee_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1531b5603bb54e4c933c82c142112323_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39a68f7975ed486181d4f5f3f67d31c7_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8fb64d50c40401c93c4477200e096b0_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6aa2716ac6604a51a4a3c42da27fccb4_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56e42d0e762d48c888f6a1c64e9490e6_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea38e5177c29474eb554d7141dcd0f68_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5049c06813234998b24265d8cb35cedc_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie31d7e3dc1b64e3eb43c6b2090aa773e_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59920036dbf249039599856c49398657_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84b634865f474f6b8bc070ee303b8b91_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaffa1a11347d4888924b6e99e98c8764_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7042183f12643f98389d82808fc723d_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75a76bf8abad43c5960ec48d79f04f36_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if38c2f57b46d452f93dafc3b162a0fde_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i296b0e556e1b48a3bf64b25710ec956e_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i260e88f62d2843a188e4c53283699a2e_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie77c8050b8fd472e8e5678efee8c7de9_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4444b1a6e50447f2aad3784749794afb_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i625fb1ccccb948cba7bfb675b72f1fc5_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab8d758e1db8401fbac59a2421221ac2_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f6c0b9d80c34d16ae17316c585ff15c_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e71fdd99cd04db297741c300cd7ab55_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i963e0700cb4d4671b572343d69b2232f_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc4c63f509c84cbe8f5ff6e2c6ca1ebb_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67aaaec919ba4dc6be289f8f6538f686_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9886d032efa5433a993723420ebb6645_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01334be3ea4e40c3b74d0c4ce690baf7_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66d42047ed1546a99c98157dc227337c_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1029f059b6514bd2b972b5ccf27ad129_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a6480a1e04142e5bd0b115b8b7beda4_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied4375401e354a6bbb3e8ac51c6e0bf0_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b2e30c0de694d49b6f122976eebf086_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17aa526e89604821b23f94ff90695ac7_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a837853bdd94ee2b05b75ff02e99532_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac6c465d42c648babbe737db5a107e69_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if61ce55cf8dc49728545a3f242ea36bf_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i708a5f3cd9c14d6b90cc957a086ad592_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9958a497e25348dbb14e5c5271ce2fb9_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i245a692de7db476e92675c28db36afcb_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2abfd02ddda74dfb962822b218cefdb2_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7338276873e1496e803482ff1f8104cd_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7bcddb586564ee4905b520cba578975_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d02bf81fd4147c3961e6b66bf6df83c_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d33df78c2d74a9794b67f99c431b4c4_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e88a966742642f7beacda981f64e553_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0fbb6beed0b4039960cc5369a53a72b_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5a04b866c0148a38d04d0efd708709f_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4593bade2d004b69994c70585546ce89_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b89d826ccd04092ab54bd782548a003_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i453c063241274887b6d6b9fd8f525a52_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea21a9f89725422d8afcbf963b29af87_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cbcdfd43e8f485799e205dfb983107b_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a1e0fd24f2240dfbfc672acac04a0c6_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i120a34db825e4d07a1e15b8566101ff7_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b6741314c5f4ad1b9cf58499b18ac5b_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fbd398566b04e5496711b52c150ddcf_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52a54bb5fdd2493ab00d5b1e8462304f_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie84d5ea9d4f740178ee2bd661a5b76bb_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ef0bd79dd674186aa6f73f88e7a8163_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i444727e6684545a7a9f22d74975fa1b6_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33ce4e97b0f24651ad32677d55f5fc93_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c18e167d7fe4b04a6ac423556324888_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i708014e4e6e44faf8244b75bda858331_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie499303b87b94c58b5bfac0841a99079_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7c244381d0c4963b4d71699e772e533_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e8ec55bd4294e1d97f2c5160d99527e_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1168ff1f8da940379fbadf2e0fb141f7_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28eeee657bbb42488adc0e5f6326d3e0_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52821a5a2b214804b0a20989602dc348_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9afc9d0e42b478ea02c980b18106ca2_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i938f7adae1b841d3aa77845e6f04e5bf_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife1a6848c3604397bdf131dedd495ada_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ae290a5603746f8b45d01b27ea9d896_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52dbcdb545674f538361e9912a01a050_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i080887d60f0940a59368f26c445c633c_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7d6c21b42a6409195bfc194bb649b2d_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bdc0915d2ea4d4ebcf9bd0941e693ad_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i091d9a98d2f448dda83641c2c3ce380a_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if32c09ac0b5647a1ad0e4dc7ce139472_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4126d8e6b9664efda5bedc99ff1ad067_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e561884e759475b9165f1413e1beae5_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74d121d1b483489e95a357c286e4c8ac_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bdb1c21f8014a99a12c45d0019dd537_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e4204b60fad4fc7a1648e3538b6dc63_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dbb3222fd984af2a17fc6f092a9ae02_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66b302567e9241048a2995dae38b25c6_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4150ce8a62e645fb8abfee3ebb12c773_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b18393bc5c64f7b83e0397afdb39c21_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ae77b0256144a08b4e114c88ef9700d_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4067541252a744ed90386e112cdd837b_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa10b3392f3547b5aa32d11feeed9344_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47a7c165a7d648d29d77c01df838e0c8_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93f441a7dbae4cb0928cf691ada790e5_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jnj:AdvancedSterilizationProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4048e18828d34f3daefe8f21a5eb3078_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i390edd640d8a484e89238123183ad634_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic337c3dd3159462ebc2978ca7661b3b5_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e8913d91dfd40939075cfdac19606a5_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02c1a908c32b4cb8a265199c069d86b6_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:WesternHemisphereExcludingUSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia292ce2a3c634451b0fd283ea27bc5cc_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:WesternHemisphereExcludingUSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id25c49104c0e46f0bbff08ef9bf0330f_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:WesternHemisphereExcludingUSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i875527922e5949c8a80b0260e40653b8_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:WesternHemisphereExcludingUSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67ea74e368284b5383248520a5e39f2a_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:AsiaPacificAfricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb167b63c624424bb3e66daffa308d4b_D20190701-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:AsiaPacificAfricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i557d36686f0d404b8f74fbd282b65bac_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:AsiaPacificAfricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e7337ef99574e5ab6458deb6e8bb89b_D20181231-20190929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:AsiaPacificAfricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0178d1d89bd4d1a9069a8e871ea628f_D20201001-20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:MomentaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e557174a06c44d49bfcc86bb2b3d0fd_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="chf"><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unit><xbrli:unit id="chfPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i88a026e754eb416abcce4c71f9725a45_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb9d663934dc4e77a2227f263e7e9b90_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39abb4a782c7412fb74f873a3b89e52c_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cc26d706e3948b0839e40d3e0521660_D20191230-20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:BermekimabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i514e624a05cb4ac3b06eb3d5591e1ae9_I20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:BermekimabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fe29d550e3c4c2ba9f8054b3e1472ce_I20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:VerbSurgicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80809b7f6de042b2930962754b585f17_I20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jnj:AdvancedSterilizationProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f42cd49f093497bb053a9863a95db49_D20190401-20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jnj:AdvancedSterilizationProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88ab1a165c864c2099402645c6315d0f_D20190401-20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7bbcc036f7349cb94794a2287751afb_I20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf3d6533ad0042b69ef23b269adffb17_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24e7ef5b16d34adf9098ddac81e8905a_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PurchasedInProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="jpy"><xbrli:measure>iso4217:JPY</xbrli:measure></xbrli:unit><xbrli:context id="ic5e8b6d3c30e45ffaa54a4a9227592ed_D20190117-20190117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-17</xbrli:startDate><xbrli:endDate>2019-01-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0d30897acc34d6aa8fc665dca7ddd1c_I20190116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i273f8b995c6b4f499a8b328d60523fbe_D20181231-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia56f405e259a45239a2888912d6a9972_I20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ba1319bb59843d6a0cf051fb471834a_D20191230-20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2b1e0bfe69940ce9a25d129f9820402_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jnj:SupplyChainMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claimant"><xbrli:measure>jnj:claimant</xbrli:measure></xbrli:unit><xbrli:context id="i0b429fd585e64f27b994198388c6251a_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:AsrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0930560d9bb641e1bf17cd07a2da8aca_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PinnacleAcetabularCupSystemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f0486c287ba4a878933882831daf68c_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PelvicMeshesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd9edb018cc04c2d919c3af6e6effdc2_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RisperdalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib10ac8fdffb7462695332fde36b80854_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic41bf8ae137a4af1b760ea9606804331_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TalcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c15628b0bdb4b959f8610f3fd7e5d48_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:InvokanaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id21618e853834a89ac8ad0c7b9c482b7_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PhysiomeshMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="patient"><xbrli:measure>jnj:patient</xbrli:measure></xbrli:unit><xbrli:context id="icb6f889e341146e590594ffb796f5067_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:DePuyASRU.S.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea72f2ed06994c33932765fa19c03cd3_D20190930-20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-30</xbrli:startDate><xbrli:endDate>2019-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i488a067b9a194c0186abeac5734fa68b_D20191230-20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ae80716a299488b87b2be5a3f4dbfb5_D20180701-20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:BabyPowderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2018-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06c65d19de8543ca8bdc65646de599c7_D20200601-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:BabyPowderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4f17482cf3c41e598a0357f6aaae45c_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OpioidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b7242888eaf4e6d93abf906006a26fe_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63a02018e9aa4b8fab85aa8bf8d518c8_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4957f58a493d49f5bef49186ecf1dbf7_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia877cf56320947748ba1727613e928d1_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12cbe2e6652048f1abbf81f0d8f8b6cc_D20200101-20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb5dd3fead9e4921a49ec475665dfe71_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09487d9b040c41f5b1f1ac6a4eb69ecb_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5110f18fd4f34d9986fb039d56af95c6_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic998353501c74da5afda8d2b3ead50c5_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i023474a55b284cd99429e03503a8a901_D20200629-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82b8a8526a0b4f7c9f84a00039d7fa45_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a9ec615fd2b43679132d3c41485de92_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98f8797e4aa74fdd9e5fa8711131743e_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82ffccf862f04217ba5474adbd9d48c9_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i867dc8a2a19c4423b9b7ee18ce1d36b5_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i405860c539564ee5b8e0b222554dba38_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i410f9ae233db4a80981d7bcef1e0749a_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c3e80cad55d41f6a3525d636c512e88_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2a9ba204bdd4530ae30c6d71d30d92f_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cd238e746ca494b962a8cdfec78532f_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5ccab87c7704f459a110126f42d578f_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">jnj:AssetWriteoffMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib44160c8cfcb4364a86afc1ebf7ea5db_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7153539e0f5345cc86253ed5aadc3d3c_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic763bc82f42c427fa881f68d00497d2c_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id36fda814d6046bfa30b6bdd0fe5d257_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">jnj:AssetWriteoffMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i254209b7e3f54f69a129c76d5b0d3e93_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7392cf4986564b5e9e2afd38679fb669_D20191230-20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61bba3fc154c46aba1e0aeb8dc224242_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c0bc17c52f34567b49e094ed620eb73_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">jnj:AssetWriteoffMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5b06f3dcb1c4d1f94c7dbe9b3ce5ef1_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib046be1bad564ea69c1c677f161cf688_I20200927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-27</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ief97c24c8c144887ab2ad376fc457d4d_1"></div><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%;">UNITED STATES </span></div><div style="text-align:center;margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center;margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">Washington, D.C. 20549</span></div><div style="text-align:center;margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%;">FORM <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDY1_d80e5d91-10bc-4fd6-bae9-71adb38abe96">10-Q</ix:nonNumeric> </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"></td><td style="width:7.099%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.195%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:84.406%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6N2NmMzJkNjU5Mzg0NGE2ZDgxMDNhZGNiNDc1Yzg5MDYvdGFibGVyYW5nZTo3Y2YzMmQ2NTkzODQ0YTZkODEwM2FkY2I0NzVjODkwNl8xLTAtMS0xLTA_430d0d31-0c21-4d72-b5d8-c2b9f1b11d07">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:12pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Quarterly Report Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</span></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">for the quarterly period ended <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8xMjI_3c9cd2c8-5ca0-4cf0-842f-c176f97afd9c">September 27, 2020</ix:nonNumeric> </span></div><div style="text-align:center;margin-top:6pt;"><span><br/></span></div><div style="text-align:center;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">or</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%;"><tr><td style="width:1.0%;"></td><td style="width:7.111%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.498%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:84.091%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6ODVlNGVlNTQ1ZWQ4NDI3YmFmY2M4MGVlZjQ0YjQ3ZjQvdGFibGVyYW5nZTo4NWU0ZWU1NDVlZDg0MjdiYWZjYzgwZWVmNDRiNDdmNF8xLTAtMS0xLTA_f722f032-d00c-48bc-9fa5-531badd9768e">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:12pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Transition Report Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934<br/>for the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to</span></td></tr></table></div><div style="text-align:center;margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Commission file number <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDY2_74c42b04-a550-48c0-909f-dc0d84e31600">1-3215</ix:nonNumeric> </span></div><div style="text-align:center;margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDY5_c6373354-f728-405d-b335-0eb8b1c9ef36">Johnson &amp; Johnson</ix:nonNumeric> </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"></td><td style="width:48.533%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.532%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:48.535%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center;margin-bottom:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6YjI2NTEyMDMzZTUzNDdiYzlhMjQyZjBiNjA1NGMyYmYvdGFibGVyYW5nZTpiMjY1MTIwMzNlNTM0N2JjOWEyNDJmMGI2MDU0YzJiZl8wLTAtMS0xLTA_a2bc52b6-cc98-403f-9e8c-69c3c07a4ef2">New Jersey</ix:nonNumeric></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6YjI2NTEyMDMzZTUzNDdiYzlhMjQyZjBiNjA1NGMyYmYvdGFibGVyYW5nZTpiMjY1MTIwMzNlNTM0N2JjOWEyNDJmMGI2MDU0YzJiZl8wLTItMS0xLTA_d439bb62-f021-45e7-93e2-7f33072e4d05">22-1024240</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDU5_fc79d604-0377-4788-80b8-e941ab81e810">One Johnson &amp; Johnson Plaza</ix:nonNumeric> </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDcw_b98860c5-5d50-48da-b439-e728463f2e0f">New Brunswick</ix:nonNumeric>, <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDYw_e41f52c3-bd5a-420a-a88b-5d8ec1d56d59">New Jersey</ix:nonNumeric> <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDYx_5f16fbbf-9a2f-4191-b89b-22af0e3d53d3">08933</ix:nonNumeric> </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Address of principal executive offices)</span></div><div style="text-align:center;margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Registrant&#8217;s telephone number, including area code (<ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDYy_6601a897-2929-416f-bd45-23d2c1695929">732</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDYz_b2925baa-a64e-4e9b-9b0c-e1f40149bda3">524-0400</ix:nonNumeric> </span></div><div style="text-indent:15.75pt;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9745;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDY0_a0dba964-f1bc-460e-9748-6c9f3c5c2c76">Yes</ix:nonNumeric> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9744;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> No</span></div><div style="text-indent:15.75pt;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files). </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9745;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDY3_7fcb7cdd-3038-4663-96b6-b0ed79d2e4a5">Yes</ix:nonNumeric> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9744;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> No</span></div><div style="text-indent:15.75pt;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.783%;"><tr><td style="width:1.0%;"></td><td style="width:12.797%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:35.002%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:3.280%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:40.440%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:2.981%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6ZGQ4ZDM4MTg5OWFkNDZjYzkyOTRlYzE4ODAxNTNjYzkvdGFibGVyYW5nZTpkZDhkMzgxODk5YWQ0NmNjOTI5NGVjMTg4MDE1M2NjOV8wLTEtMS0xLTA_3fffc9d5-186b-4b4e-805e-5d6bd27ce03b">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9745;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accelerated filer </span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9744;</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-accelerated filer </span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9744;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Smaller reporting company </span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6ZGQ4ZDM4MTg5OWFkNDZjYzkyOTRlYzE4ODAxNTNjYzkvdGFibGVyYW5nZTpkZDhkMzgxODk5YWQ0NmNjOTI5NGVjMTg4MDE1M2NjOV8xLTQtMS0xLTA_fef8a347-56df-403c-8329-8585a565b99d">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Emerging growth company </span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6ZGQ4ZDM4MTg5OWFkNDZjYzkyOTRlYzE4ODAxNTNjYzkvdGFibGVyYW5nZTpkZDhkMzgxODk5YWQ0NmNjOTI5NGVjMTg4MDE1M2NjOV8yLTItMS0xLTA_0d0ca6a2-37b6-4a6f-8cad-d8fcc791baac">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If&#160;an&#160;emerging&#160;growth&#160;company,&#160;indicated&#160;by&#160;check&#160;mark&#160;if&#160;the&#160;registrant&#160;has&#160;elected&#160;not&#160;to&#160;use&#160;the&#160;extended&#160;transition period&#160;for&#160;complying with&#160;any&#160;new&#160;or&#160;revised&#160;financial&#160;accounting&#160;standards&#160;provided pursuant&#160;to&#160;Section&#160;13(a)&#160;of&#160;the&#160;Exchange&#160;Act. &#9744;</span></div><div style="text-indent:15.75pt;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDY4_9c99668e-7f2e-4f13-b171-d5ba5463a384">&#9744;</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Yes </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9745;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> No</span></div><div style="text-indent:15.75pt;margin-top:6pt;"><span><br/></span></div><div style="text-indent:15.75pt;margin-top:6pt;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="text-indent:15.75pt;margin-top:6pt;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">SECURITIES REGISTERED PURSUANT TO SECTION&#160;12(b) OF THE ACT</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"></td><td style="width:41.798%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.809%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:42.093%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Title of each class</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trading Symbol</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i740dc05b85c94cbd8b1e84ec97346f67_D20191230-20200927" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM18xLTAtMS0xLTA_1d82deb1-772b-45b8-a4cf-447f225708ba">Common Stock, Par Value $1.00</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i740dc05b85c94cbd8b1e84ec97346f67_D20191230-20200927" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM18xLTEtMS0xLTA_81d3d079-aedc-43e1-85f4-67256d929286">JNJ</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i740dc05b85c94cbd8b1e84ec97346f67_D20191230-20200927" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM18xLTItMS0xLTA_cd878712-181a-484d-a3a2-41437927be54">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ica954f234b4c423aabac439f22fd6daf_D20191230-20200927" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM18yLTAtMS0xLTA_a1f00778-e60c-468e-b4c4-eaf3e3116427">0.250% Notes Due January 2022</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ica954f234b4c423aabac439f22fd6daf_D20191230-20200927" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM18yLTEtMS0xLTA_5c9a7bfa-e046-48cc-9f31-7514badc9cbb">JNJ22</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ica954f234b4c423aabac439f22fd6daf_D20191230-20200927" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM18yLTItMS0xLTA_590514af-7a4b-4fa8-8f00-050cd7e8a866">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i95ced2b952ea496781eca3d5a59848c3_D20191230-20200927" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM18zLTAtMS0xLTA_2408a962-893d-4733-8a5c-0b1461033801">0.650% Notes Due May 2024</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i95ced2b952ea496781eca3d5a59848c3_D20191230-20200927" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM18zLTEtMS0xLTA_750d24e7-1530-4be4-86a0-86c86f838d65">JNJ24</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i95ced2b952ea496781eca3d5a59848c3_D20191230-20200927" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM18zLTItMS0xLTA_b0466538-08f3-4c67-bb4d-09ff79fe34d9">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i7eeea2693d75423da856f563c79a259d_D20191230-20200927" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM180LTAtMS0xLTA_6b4bd982-9876-4705-b49e-c76c7d6ee92e">5.50% Notes Due November 2024</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i7eeea2693d75423da856f563c79a259d_D20191230-20200927" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM180LTEtMS0xLTA_b71d9596-3011-4823-b651-0e3890d99e20">JNJ24BP</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i7eeea2693d75423da856f563c79a259d_D20191230-20200927" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM180LTItMS0xLTA_88f3f2ab-3382-4b6d-9c10-2e801e1316d3">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i93ee65cdd19a4436bcecdbb64e5cca1c_D20191230-20200927" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM181LTAtMS0xLTA_2eb657d3-273e-4c79-ab5a-c69e11bb7847">1.150% Notes Due November 2028</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i93ee65cdd19a4436bcecdbb64e5cca1c_D20191230-20200927" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM181LTEtMS0xLTA_d41d0e10-b7a0-4e77-8ad3-de202cca685d">JNJ28</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i93ee65cdd19a4436bcecdbb64e5cca1c_D20191230-20200927" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM181LTItMS0xLTA_4f23c3b8-0b0d-4ef6-8981-f9338d372a49">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i2f968c9419a148cfbb615118ff18f037_D20191230-20200927" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM182LTAtMS0xLTA_bf195739-eea7-49b3-921c-00c442e89bfb">1.650% Notes Due May 2035</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i2f968c9419a148cfbb615118ff18f037_D20191230-20200927" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM182LTEtMS0xLTA_d8cf6aa4-0d56-44be-b4cc-61254dc70b0b">JNJ35</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i2f968c9419a148cfbb615118ff18f037_D20191230-20200927" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM182LTItMS0xLTA_6609451b-9c7f-4059-aec4-409e64bfff12">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-indent:15.75pt;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date.</span></div><div style="text-indent:15.75pt;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On October 19, 2020, <ix:nonFraction unitRef="shares" contextRef="ide9df46b8f0d4705b774d10707a6d751_I20201019" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8xOTk4_5cd0bb14-6b95-42b8-a709-b2d64beb0b6d">2,632,542,672</ix:nonFraction> shares of Common Stock, $1.00 par value, were outstanding.</span></div><div style="text-indent:15.75pt;margin-top:6pt;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_4"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div><span><br/></span></div><div id="ief97c24c8c144887ab2ad376fc457d4d_10"></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">JOHNSON &amp; JOHNSON AND SUBSIDIARIES</span></div><div style="text-align:center;margin-top:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">TABLE OF CONTENTS</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:85.157%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.917%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.700%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:3.726%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Page</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">No.</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_16">Part I &#8212; Financial Information</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_19">Item&#160;1. Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_19">1</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_22">Consolidated Balance Sheets &#8212; </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_22">Septe</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_22">m</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_22">ber</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_22"> 2</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_22">7</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_22">, 2020 and December 29, 2019</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_22">1</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_28">Consolidated Statements of Earnings for the Fiscal </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_28">Third</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_28"> Quarter Ended </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_28">September</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_28"> 2</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_28">7</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_28">, 2020 and </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_28">September</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_28"> </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_28">29</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_28">, 2019</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_28">2</a></span></div></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_31">Consolidated Statements of Earnings for the Fiscal </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_31">Nine</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_31"> Months Ended </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_31">September</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_31"> 2</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_31">7</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_31">, 2020 and </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_31">September</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_31"> </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_31">29</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_31">, 2019</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_31">3</a></span></div></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_34">Consolidated Statements of Comprehensive Income for the Fiscal </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_34">Third</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_34"> Quarter and Fiscal </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_34">Nine</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_34"> Months Ended </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_34">September</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_34"> 2</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_34">7</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_34">, 2020 and </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_34">September</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_34"> </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_34">29</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_34">, 2019</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_34">4</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_40">Consolidated Statements of Equity for the Fiscal </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_40">Third </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_40">Quarter and Fiscal </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_40">N</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_40">ine</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_40"> Months Ended </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_40">September</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_40"> 2</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_40">7</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_40">, 2020 and </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_40">Septem</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_40">ber</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_40"> </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_40">29</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_40">, 2019</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_40">5</a></span></div></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_46">Consolidated Statements of Cash Flows for the Fiscal </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_46">Nine</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_46"> Months Ended </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_46">September</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_46"> 2</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_46">7</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_46">, 2020 and </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_46">September</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_46"> </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_46">29</a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_46">, 2019</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_46">7</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_49">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_49">8</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_97">Item 1A. Risk Factors</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_97">47</a></span></div></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_100">Item&#160;2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_100">48</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_103">Item&#160;3. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_103">66</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_106">Item&#160;4. Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_106">66</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_109">Part II &#8212; Other Information</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_109">67</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_112">Item&#160;1 - Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_112">67</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_115">Item&#160;2 - Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_115">67</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_118">Item&#160;6 - Exhibits</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_118">68</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_121">Signatures</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_121">69</a></span></div></td></tr><tr><td colspan="12" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="height:21pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-align:center;margin-top:8pt;margin-bottom:8pt;"><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </span></div><div style="text-align:center;"><span><br/></span></div><div style="text-indent:18pt;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">This Quarterly Report on Form 10-Q </span><span style="background-color:rgb(255,255,255, 0.0);color:#212121;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">and Johnson &amp; Johnson's other publicly available documents contain </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8220;</span><span style="background-color:rgb(255,255,255, 0.0);color:#212121;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">forward-looking statements</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8221;</span><span style="background-color:rgb(255,255,255, 0.0);color:#212121;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995.&#160;Management and representatives of Johnson &amp; Johnson and its subsidiaries (the Company) also may from time to time make forward-looking statements. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Forward-looking statements do not relate strictly to historical or current facts and reflect management&#8217;s assumptions, views, plans, objectives and projections about the future. Forward-looking statements may be identified by the use of words such as &#8220;plans,&#8221; &#8220;expects,&#8221; &#8220;will,&#8221; &#8220;anticipates,&#8221; &#8220;estimates,&#8221; and other words of similar meaning in conjunction with, among other things: discussions of future operations, expected operating results, financial performance; impact of planned acquisitions and dispositions; impact and timing of restructuring initiatives including associated cost savings and other benefits; the Company's strategy for growth; product development activities; regulatory approvals; market position and expenditures.</span></div><div style="text-indent:18pt;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Because forward-looking statements are based on current beliefs, expectations and assumptions regarding future events, they are subject to uncertainties, risks and changes that are difficult to predict and many of which are outside of the Company's control. Investors should realize that if underlying assumptions prove inaccurate, or known or unknown risks or uncertainties materialize, the Company&#8217;s actual results and financial condition could vary materially from expectations and projections expressed or implied in its forward-looking statements. Investors are therefore cautioned not to rely on these forward-looking statements. Risks and uncertainties include, but are not limited to:</span></div><div style="margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Risks Related to Product Development, Market Success and Competition</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Challenges and uncertainties inherent in innovation and development of new and improved products and technologies on which the Company&#8217;s continued growth and success depend, including uncertainty of clinical outcomes, additional analysis of existing clinical data, obtaining regulatory approvals, health plan coverage and customer access, and initial and continued commercial success;  </span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Challenges to the Company&#8217;s ability to obtain and protect adequate patent and other intellectual property rights for new and existing products and technologies in the United States and other important markets;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The impact of patent expirations, typically followed by the introduction of competing biosimilars and generics and resulting revenue and market share losses;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Increasingly aggressive and frequent challenges to the Company&#8217;s patents by competitors and others seeking to launch competing generic, biosimilar or other products and increased receptivity of courts, the United States Patent and Trademark Office and other decision makers to such challenges, potentially resulting in loss of market exclusivity and rapid decline in sales for the relevant product sooner than expected;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Competition in research and development of new and improved products, processes and technologies, which can result in product and process obsolescence;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Competition to reach agreement with third parties for collaboration, licensing, development and marketing agreements for products and technologies;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Competition based on cost-effectiveness, product performance, technological advances and patents attained by competitors; and</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Allegations that the Company&#8217;s products infringe the patents and other intellectual property rights of third parties, which could adversely affect the Company&#8217;s ability to sell the products in question and require the payment of money damages and future royalties.</span></div><div style="margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Risks Related to Product Liability, Litigation and Regulatory Activity</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Product efficacy or safety concerns, whether or not based on scientific evidence, potentially resulting in product withdrawals, recalls, regulatory action on the part of the United States Food and Drug Administration (or international counterparts), declining sales, reputational damage, increased litigation expense and share price impact;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Impact, including declining sales and reputational damage, of significant litigation or government action adverse to the Company, including product liability claims and allegations related to pharmaceutical marketing practices and contracting strategies;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Impact of an adverse judgment or settlement and the adequacy of reserves related to legal proceedings, including patent litigation, product liability, personal injury claims, securities class actions, government investigations, employment and other legal proceedings;</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Increased scrutiny of the health care industry by government agencies and state attorneys general resulting in investigations and prosecutions, which carry the risk of significant civil and criminal penalties, including, but not limited to, debarment from government business; </span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Failure to meet compliance obligations in the McNEIL-PPC, Inc. Consent Decree or any other compliance agreements with governments or government agencies, which could result in significant sanctions;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Potential changes to applicable laws and regulations affecting United States&#160;and international operations, including relating to: approval of new products; licensing and patent rights; sales and promotion of health care products; access to, and reimbursement and pricing for, health care products and services; environmental protection and sourcing of raw materials;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Compliance with local regulations and laws that may restrict the Company&#8217;s ability to manufacture or sell its products in relevant markets including, requirements to comply with medical device reporting regulations and other requirements such as the European Union's Medical Devices Regulation;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Changes in domestic and international tax laws and regulations, including changes related to The Tax Cuts and Jobs Act in the United States, the Federal Act on Tax Reform and AHV Financing in Switzerland, increasing audit scrutiny by tax authorities around the world and exposures to additional tax liabilities potentially in excess of existing reserves; and</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Issuance of new or revised accounting standards by the Financial Accounting Standards Board and regulations by the Securities and Exchange Commission.</span></div><div style="margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Risks Related to the Company&#8217;s Strategic Initiatives and Healthcare Market Trends</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Pricing pressures resulting from trends toward health care cost containment, including the continued consolidation among health care providers and other market participants, trends toward managed care, the shift toward governments increasingly becoming the primary payers of health care expenses, significant new entrants to the health care markets seeking to reduce costs and government pressure on companies to voluntarily reduce costs and price increases;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Restricted spending patterns of individual, institutional and governmental purchasers of health care products and services due to economic hardship and budgetary constraints; </span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Challenges to the Company&#8217;s ability to realize its strategy for growth including through externally sourced innovations, such as development collaborations, strategic acquisitions, licensing and marketing agreements, and the potential heightened costs of any such external arrangements due to competitive pressures;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The potential that the expected strategic benefits and opportunities from any planned or completed acquisition or divestiture by the Company may not be realized or may take longer to realize than expected; and</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The potential that the expected benefits and opportunities related to past and ongoing restructuring actions may not be realized or may take longer to realize than expected.</span></div><div style="margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Risks Related to Economic Conditions, Financial Markets and Operating Internationally</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The risks associated with global operations, including the impact of global public health crises and pandemics, such as the outbreak of the novel coronavirus (COVID-19), on the Company and its customers and suppliers, including foreign governments in countries in which the Company operates.</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Impact of inflation and fluctuations in interest rates and currency exchange rates and the potential effect of such fluctuations on revenues, expenses and resulting margins;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Potential changes in export/import and trade laws, regulations and policies of the United States and other countries, including any increased trade restrictions or tariffs and potential drug reimportation legislation;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The impact on international operations from financial instability in international economies, sovereign risk, possible imposition of governmental controls and restrictive economic policies, and unstable international governments and legal systems; </span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Changes to global climate, extreme weather and natural disasters that could affect demand for the Company's products and services, cause disruptions in manufacturing and distribution networks, alter the availability of goods and services within the supply chain, and affect the overall design and integrity of the Company's products and operations; </span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The impact of armed conflicts and terrorist attacks in the United States and other parts of the world including social and economic disruptions and instability of financial and other markets; and</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Risks Related to Supply Chain and Operations </span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Difficulties and delays in manufacturing, internally through third party providers or otherwise within the supply chain, that may lead to voluntary or involuntary business interruptions or shutdowns, product shortages, withdrawals or suspensions of products from the market, and potential regulatory action;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Interruptions and breaches of the Company's information technology systems or those of the Company's vendors which, could result in reputational, competitive, operational or other business harm as well as financial costs and regulatory action; </span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Reliance on global supply chains and production and distribution processes that are complex and subject to increasing regulatory requirements that may adversely affect supply, sourcing and pricing of materials used in the Company&#8217;s products; and</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The potential that the expected benefits and opportunities related to restructuring actions contemplated for the global supply chain, including the Company's transaction with Jabil Inc., may not be realized or may take longer to realize than expected, including due to any required approvals from applicable regulatory authorities. Disruptions associated with the announced global supply chain actions may adversely affect supply and sourcing of materials used in the Company's products.</span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Investors also should carefully read the Risk Factors described in Item 1A of the Company's Annual Report on Form 10-K for the fiscal year ended December 29, 2019, for a description of certain risks that could, among other things, cause the Company&#8217;s actual results to differ materially from those expressed in its forward-looking statements. Investors should understand that it is not possible to predict or identify all such factors and should not consider the risks described above to be a complete statement of all potential risks and uncertainties. The Company does not undertake to publicly update any forward-looking statement that may be made from time to time, whether as a result of new information or future events or developments.</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Part&#160;I &#8212; FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div id="ief97c24c8c144887ab2ad376fc457d4d_19"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Item&#160;1 &#8212; FINANCIAL STATEMENTS</span></div><div style="text-align:center;"><span><br/></span></div><div id="ief97c24c8c144887ab2ad376fc457d4d_22"></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">JOHNSON &amp; JOHNSON AND SUBSIDIARIES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Unaudited; Dollars in Millions Except Share and Per Share Data)</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.684%;"><tr><td style="width:1.0%;"></td><td style="width:69.418%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.540%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.122%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.540%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.680%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ASSETS</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMy0yLTEtMS0w_44602f05-ded9-4bde-9ffe-c85186d4d832">18,965</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMy00LTEtMS0w_b7ae095f-691f-4ef0-a627-d35b1648e17e">17,305</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNC0yLTEtMS0w_5a765319-9078-40f9-9ba7-61b4b073554d">11,816</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNC00LTEtMS0w_e0b2f7db-73cc-45b0-b4e3-65e4a432daa9">1,982</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Accounts receivable, trade, less allowances for doubtful accounts and credit losses $<ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNS0wLTEtMS0wL3RleHRyZWdpb246MjE3NjI2NDgzYTcyNDQwOGIzYmEyY2NlYjk0NGZkZmVfMTA0NDUzNjA0NjM5ODE_c24da1e6-b023-4f9a-9efc-86c79c2643ef">292</ix:nonFraction> (2019, $<ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNS0wLTEtMS0wL3RleHRyZWdpb246MjE3NjI2NDgzYTcyNDQwOGIzYmEyY2NlYjk0NGZkZmVfMTA0NDUzNjA0NjM5ODg_4c400fec-d1d8-47e2-8d9b-64dd411df410">226</ix:nonFraction>)</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNS0yLTEtMS0w_4d2bfcc5-871c-44a3-a803-40abca796688">14,579</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNS00LTEtMS0w_55507c6b-a75e-43a7-860c-e136887cca2b">14,481</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inventories (Note 2)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNi0yLTEtMS0w_8df49b90-f4d9-450e-b81b-3672c537c51a">9,599</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNi00LTEtMS0w_cac03f7e-d689-4047-be77-d85ffb2ec5d2">9,020</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaid expenses and other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNy0yLTEtMS0w_e8e09e19-715b-4dfb-ae3e-1d482a1d3d32">2,528</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNy00LTEtMS0w_0a7cc2ba-20e5-450c-bb2f-701435a4a32e">2,392</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets held for sale (Note 10)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfOC0yLTEtMS0w_1a342349-ae61-4dc9-b026-cdbbd8077ee0">91</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfOC00LTEtMS0w_fc5cbe6e-35c1-41b1-9c70-20b901673302">94</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total current assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfOS0yLTEtMS0w_7f9a5949-addd-402e-b0bf-b45b6c5511f9">57,578</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfOS00LTEtMS0w_00cb0a3e-721b-46c9-803d-ee53a32cc146">45,274</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property, plant and equipment at cost</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTAtMi0xLTEtMA_6209de32-6f1d-4424-b4a3-fa719f16ebae">45,162</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTAtNC0xLTEtMA_00080521-6ec4-49d6-ac40-8ab73ca23043">43,332</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTEtMi0xLTEtMA_56269715-35f3-469e-9fdf-0ecc485d262b">27,307</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTEtNC0xLTEtMA_eb5d8118-af90-4ecd-808c-18ef7af67bad">25,674</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTItMi0xLTEtMA_d434514e-818b-490c-83fd-2837b9a2d29d">17,855</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTItNC0xLTEtMA_4bea2553-27f6-4474-a148-81cb39bf3848">17,658</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets, net (Note 3)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTMtMi0xLTEtMA_c19db8ec-8166-49e3-b85e-6900acde88e9">47,006</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTMtNC0xLTEtMA_bcd445e5-07e3-4f10-978a-47835e365360">47,643</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill (Note 3)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTQtMi0xLTEtMA_28c8e653-54c8-4fd4-aab7-9254e71dc511">34,307</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTQtNC0xLTEtMA_4fa02e9c-6564-4c76-b4df-600e95faf865">33,639</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred taxes on income (Note 5)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTUtMi0xLTEtMA_865c67bf-95dc-40ff-8547-c4ea20fd0e4a">7,816</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTUtNC0xLTEtMA_ea668e76-534a-49ab-9d82-d2101c3db9db">7,819</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTYtMi0xLTEtMA_2a58d66b-c761-47db-90ee-e1fbe85c8a26">6,131</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTYtNC0xLTEtMA_9c680ba2-0ae7-4eab-9655-f300ef22b977">5,695</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTctMi0xLTEtMA_959e5866-858a-4169-a21f-5bd9a6d2858b">170,693</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTctNC0xLTEtMA_bc9b11d5-25d9-4afd-ad04-56007d6fa6cb">157,728</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</span></div></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loans and notes payable</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjAtMi0xLTEtMA_722bdd65-e3a1-42bb-a64a-6fa8c2afbdbd">5,078</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjAtNC0xLTEtMA_cc9f9a92-d3e9-46f3-af9d-b6d80c02c4d7">1,202</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjEtMi0xLTEtMA_673e2a61-c444-45e1-b13b-929741f574d6">7,044</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjEtNC0xLTEtMA_3b475664-d6e9-40e6-9f28-9aa34ac1de6a">8,544</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjItMi0xLTEtMA_2261a590-f6f8-4c50-bf8a-3fe48bdf300e">9,629</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjItNC0xLTEtMA_8538ab96-0518-478d-91a3-bec172cca1c4">9,715</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued rebates, returns and promotions</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="jnj:AccruedRebatesReturnsAndPromotions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjMtMi0xLTEtMA_8a206d7d-92c4-4a83-af3b-d5613501f627">12,418</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="jnj:AccruedRebatesReturnsAndPromotions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjMtNC0xLTEtMA_1f3f6150-2977-4c21-bfd2-9ed22e8ca8e8">10,883</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued compensation and employee related obligations</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjQtMi0xLTEtMA_22117b9a-1ab7-467c-906d-c8ff2b81a7ac">3,012</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjQtNC0xLTEtMA_cd696b0f-dfab-4fb0-9389-9829d0532fd1">3,354</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued taxes on income (Note 5)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjUtMi0xLTEtMA_0169df65-7c15-4d6b-98f6-8bf61412e9f1">1,666</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjUtNC0xLTEtMA_f4950a90-1388-488d-97cb-3baae77c8d57">2,266</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjYtMi0xLTEtMA_74bc7451-8fa1-42ea-b87f-3db60f13950e">38,847</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjYtNC0xLTEtMA_06755a17-9993-4e79-8460-7a0c2a7ab808">35,964</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term debt (Note 4)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjctMi0xLTEtMA_45745bcd-886d-4221-a106-a477490b5e49">32,680</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjctNC0xLTEtMA_f64fe4b4-a8ed-421d-9307-2192c414a898">26,494</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Deferred taxes on income </span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">(Note 5)</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjgtMi0xLTEtMA_ffbf5b86-cd47-4bd0-b373-cf0dbc97f37a">5,615</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjgtNC0xLTEtMA_62370745-ebd9-48aa-bea1-1ad7c2ad8259">5,958</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee related obligations (Note 6)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjktMi0xLTEtMA_f8802e12-8bc7-4249-90c6-f1fb383ec9e4">10,184</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjktNC0xLTEtMA_d3c7a060-85dc-4bc0-b49b-d7681dc1e30f">10,663</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term taxes payable (Note 5)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzAtMi0xLTEtMA_4d3534e9-8615-40e7-9430-4a45d74f991e">6,745</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzAtNC0xLTEtMA_9f39c925-ec8a-4f92-95fb-22b82bf2e851">7,444</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzEtMi0xLTEtMA_24f3f943-dfe2-492a-b395-e449a2aae625">12,149</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzEtNC0xLTEtMA_4ca5a183-803e-4eec-ac4f-9bc5413bfa4c">11,734</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzItMi0xLTEtMA_fab4febd-5887-44e3-a305-e171a72f1d45">106,220</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzItNC0xLTEtMA_a08d603e-428e-4659-9e66-dc4b7c961148">98,257</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commitments and Contingencies (Note 11)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzMtMi0xLTEtMA_7f64ce59-2b70-4224-a994-daf3bcc1457a"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzMtNC0xLTEtMA_c74fb250-7c25-426f-9b7c-7aeb06a10b4f"></ix:nonFraction></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Common stock &#8212; par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjM1ZmVmOWVkNzU1YzRmYmJhMzEwYjhlMzIzZmE3MDFmXzEwNDQ1MzYwNDYzOTg0_56db7bfe-478a-490b-b9e7-36bfbd8df038"><ix:nonFraction unitRef="usdPerShare" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjM1ZmVmOWVkNzU1YzRmYmJhMzEwYjhlMzIzZmE3MDFmXzEwNDQ1MzYwNDYzOTg0_631aaff1-0bf3-460b-b2b1-cb8e1c70b37d">1.00</ix:nonFraction></ix:nonFraction> per share (authorized <ix:nonFraction unitRef="shares" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjM1ZmVmOWVkNzU1YzRmYmJhMzEwYjhlMzIzZmE3MDFmXzEwNDQ1MzYwNDY0MDAw_0cb682e2-22a1-4ea0-a42d-dc42e5f879a7"><ix:nonFraction unitRef="shares" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjM1ZmVmOWVkNzU1YzRmYmJhMzEwYjhlMzIzZmE3MDFmXzEwNDQ1MzYwNDY0MDAw_c79997e3-c1ad-4504-a3ef-fdd723b30988">4,320,000,000</ix:nonFraction></ix:nonFraction> shares; issued <ix:nonFraction unitRef="shares" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjM1ZmVmOWVkNzU1YzRmYmJhMzEwYjhlMzIzZmE3MDFmXzEwNDQ1MzYwNDY0MDE2_01c5ebc8-3ef0-4a1f-8550-4e043182ccc3"><ix:nonFraction unitRef="shares" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjM1ZmVmOWVkNzU1YzRmYmJhMzEwYjhlMzIzZmE3MDFmXzEwNDQ1MzYwNDY0MDE2_bb835870-cfe7-4e5c-b84c-54d3d3d8b4c6">3,119,843,000</ix:nonFraction></ix:nonFraction> shares)</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzUtMi0xLTEtMA_39fd2a15-cdec-4070-a125-1474b8b690f4">3,120</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzUtNC0xLTEtMA_9c44d6dc-b223-4387-bda4-3b3d4c52c12a">3,120</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated other comprehensive income (loss) (Note 7)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzYtMi0xLTEtMA_524089c8-7ff7-4988-b1f0-2426c8367151">14,938</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzYtNC0xLTEtMA_118756e5-1c0f-4730-b435-4b5f433b8abd">15,891</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retained earnings</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzctMi0xLTEtMA_cf360d12-98f9-455e-be6d-f22711868d95">114,831</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzctNC0xLTEtMA_1e78b947-65b5-4ad8-86e1-4f9edfe670e2">110,659</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Less: common stock held in treasury, at cost (<ix:nonFraction unitRef="shares" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjMyY2VlNjgxOWZlMTQwNDM4YTUzOTcxODAwM2RkYjViXzEwNDQ1MzYwNDYzOTY4_3613c73e-7f3b-413c-bf6e-3f55c491cf41">487,676,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjMyY2VlNjgxOWZlMTQwNDM4YTUzOTcxODAwM2RkYjViXzEwNDQ1MzYwNDYzOTgy_74ffcc46-20c0-4648-ba65-21cb1b28f68d">487,336,000</ix:nonFraction> shares)</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzgtMi0xLTEtMA_b15d1275-3d87-4587-974d-fb690df92633">38,540</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzgtNC0xLTEtMA_9f8df658-c522-467f-ba38-6d1564a1e262">38,417</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzktMi0xLTEtMA_8a0add02-0b2d-47b7-9f10-db1b91040a6a">64,473</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzktNC0xLTEtMA_35119ec2-23e6-4908-af6b-5e3c3233d1e2">59,471</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities and shareholders' equity</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNDAtMi0xLTEtMA_e6ac8678-f8a6-4021-9bdb-00a85999d9b8">170,693</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNDAtNC0xLTEtMA_cb85b7be-3b7a-49cd-aa6d-b832f9796308">157,728</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See Notes to Consolidated Financial Statements</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">1</span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">JOHNSON &amp; JOHNSON AND SUBSIDIARIES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CONSOLIDATED STATEMENTS OF EARNINGS</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Unaudited; Dollars &amp; Shares in Millions Except Per Share Amounts)</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%;"><tr><td style="width:1.0%;"></td><td style="width:54.782%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.535%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.635%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.535%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.752%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.535%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.635%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.535%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.756%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>to Sales</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>to Sales</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales to customers (Note 9)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMi0yLTEtMS0w_f7d100d0-b0e6-4de8-9811-19ff6e815cbf">21,082</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="3" name="jnj:SalesRevenueGoodsNetPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMi00LTEtMS0w_44a99801-e141-410f-aed9-7c0462f7f4fe">100.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMi02LTEtMS0w_21d704f8-aa05-4ac6-a1b3-23ef7f7e838f">20,729</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="3" name="jnj:SalesRevenueGoodsNetPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMi04LTEtMS0w_4bcf5bf5-8bdb-47e3-8559-05d9b2a57551">100.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of products sold</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMy0yLTEtMS0w_eabd3b66-a297-4a5f-91e2-d4b6b521880d">6,972</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="3" name="jnj:CostOfGoodsSoldPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMy00LTEtMS0w_4a1d2f9b-dda5-462f-a245-9c27ed9b39d8">33.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMy02LTEtMS0w_34dab90e-85cf-4dfd-97fb-f08cbd5c0d39">6,867</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="3" name="jnj:CostOfGoodsSoldPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMy04LTEtMS0w_81955a0f-cd1b-407d-a610-161b6b9f5dec">33.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNC0yLTEtMS0w_65f758d4-f912-45df-8813-35a79524a6c8">14,110</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="3" name="jnj:GrossProfitPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNC00LTEtMS0w_cb5cd405-c33a-47d7-9610-11e38a0c43dd">66.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNC02LTEtMS0w_3f6d9f23-0d3d-40cc-8108-1214dd80a63e">13,862</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="3" name="jnj:GrossProfitPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNC04LTEtMS0w_2d26f8c3-2ea8-4fbc-aa4f-cbdbd2e021cd">66.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Selling, marketing and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNS0yLTEtMS0w_983ebabe-b022-4334-ad49-c0345d4bbec0">5,431</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="3" name="jnj:SellingGeneralAndAdministrativeExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNS00LTEtMS0w_f9f96c11-d042-408c-ae8f-b837d4773f63">25.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNS02LTEtMS0w_1b762672-cb64-4093-9704-d50a9f188242">5,374</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="3" name="jnj:SellingGeneralAndAdministrativeExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNS04LTEtMS0w_98626f97-668d-4f7e-8379-c099fe79920f">26.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNi0yLTEtMS0w_7e6f1daa-fd45-4667-8665-3aebd78b3a12">2,840</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="3" name="jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNi00LTEtMS0w_eb3cabb7-6d3d-4648-906f-1a57e14af258">13.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNi02LTEtMS0w_aab00d74-cf57-4110-bb70-c0888e37bb50">2,599</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="3" name="jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNi04LTEtMS0w_af8a2d3f-0930-4948-b49e-8d071b90132a">12.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">In-process research and development</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNy0yLTEtMS0w_af7f7377-d0a5-4776-a4fc-83135e921064">138</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="3" name="jnj:ResearchAndDevelopmentInProcessPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNy00LTEtMS0w_6c49b1ed-1b45-486b-9efc-b869d3c19de6">0.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNy02LTEtMS0w_2bc4a921-5392-4086-88bd-68633200521a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="3" format="ixt:zerodash" name="jnj:ResearchAndDevelopmentInProcessPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNy04LTEtMS0w_bdfbc936-4306-462c-bb97-0ed3298c2035">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfOC0yLTEtMS0w_9bf10956-354d-4f23-827d-c0f0ae826c36">12</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="3" sign="-" name="jnj:InvestmentIncomeInterestPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfOC00LTEtMS0w_486ff22f-807e-4592-a9bc-f429e0e4a79b">0.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfOC02LTEtMS0w_27a930e7-bac9-43d4-9712-cd86095bbfa9">89</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="3" sign="-" name="jnj:InvestmentIncomeInterestPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfOC04LTEtMS0w_62752186-ca11-4d0b-83ea-68192ad8df72">0.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense, net of portion capitalized</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfOS0yLTEtMS0w_61ceabc5-71fc-4b3d-9bb0-5afceb4ce109">44</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="3" name="jnj:InterestExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfOS00LTEtMS0w_4b967d75-f867-432e-9d79-aee58db6935f">0.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfOS02LTEtMS0w_5f048eb3-9e9c-450a-a47b-ec57bb2d0542">48</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="3" name="jnj:InterestExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfOS04LTEtMS0w_5a4404f8-29a6-4084-90ca-c86b1004f4e9">0.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense, net</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTAtMi0xLTEtMA_1ced99e9-77bc-4dea-9351-e5a490b92250">1,200</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="3" name="jnj:OtherNonOperatingIncomeExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTAtNC0xLTEtMA_dceab8c0-03b6-426e-8c76-9b584bbab189">5.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTAtNi0xLTEtMA_06712c1e-6da4-4182-a39e-decb35ff827b">4,214</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="3" name="jnj:OtherNonOperatingIncomeExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTAtOC0xLTEtMA_236852e5-3489-45d6-837c-e63ace9af09c">20.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restructuring (Note 12)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTEtMi0xLTEtMA_c4140ec0-9f69-4c28-9cdc-874ec093d3f8">68</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="3" name="jnj:Restructuringchargepercenttosales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTEtNC0xLTEtMA_859a7b0e-4fdb-4c78-be29-ed8f4ac839bc">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTEtNi0xLTEtMA_0f5970f1-475e-4869-bf56-1a71713543bd">69</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="3" name="jnj:Restructuringchargepercenttosales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTEtOC0xLTEtMA_50283d42-15a3-4334-b2af-91e06b7b9646">0.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Earnings before provision for taxes on income</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTItMi0xLTEtMA_6db34a2f-1191-440a-8f0b-569728d2a33c">4,401</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="3" name="jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTItNC0xLTEtMA_7e40e63d-62a3-46d7-8cbe-b497a216a3d2">20.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTItNi0xLTEtMA_ccd3366b-8684-4b7d-8d76-da02165e94c3">1,647</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="3" name="jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTItOC0xLTEtMA_d4f7ab64-d1cd-4a43-b3cb-dabcddace10f">7.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Provision for (benefit from) taxes on income (Note 5)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTMtMi0xLTEtMA_fc09a00a-c0d5-4375-af40-6b49ce9827e9">847</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="3" name="jnj:IncomeTaxExpenseBenefitPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTMtNC0xLTEtMA_3630e514-0e9c-4a61-8eae-68eacbb3e955">4.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTMtNi0xLTEtMA_6a92b807-76d1-4dfe-b75f-9bf54fe1a4b9">106</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="3" sign="-" name="jnj:IncomeTaxExpenseBenefitPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTMtOC0xLTEtMA_324713fb-41ba-4b43-b208-6dc79c397f4c">0.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NET EARNINGS </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTQtMi0xLTEtMA_a1da807a-f7b4-4c05-b7c2-09fb6ad45d05">3,554</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="3" name="jnj:NetIncomeAttributableToParentPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTQtNC0xLTEtMA_aac1b3f7-0a3c-4ec1-a980-90de3416ee5d">16.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTQtNi0xLTEtMA_f4ec7529-89f2-48a9-a68e-c7b0db6e8eb7">1,753</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="3" name="jnj:NetIncomeAttributableToParentPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTQtOC0xLTEtMA_09dd3b55-ecb1-4089-b7fa-c96269f17b88">8.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NET EARNINGS PER SHARE (Note 8)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTctMi0xLTEtMA_64f74664-eb79-414a-a500-c54b7c5650eb">1.35</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTctNi0xLTEtMA_86eec0ab-8694-47ab-bc44-b15f59ab714c">0.67</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTgtMi0xLTEtMA_c4606401-bff4-4fa8-8353-f2481740f075">1.33</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTgtNi0xLTEtMA_8ecf556b-b8fa-4ffd-a19a-314efd711ddf">0.66</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">AVG. SHARES OUTSTANDING</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMjEtMi0xLTEtMA_b99f5a97-38b0-4727-9077-db79e9b0eaab">2,632.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMjEtNi0xLTEtMA_0c4811ec-099f-4f73-9536-15d12d5a25d7">2,635.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMjItMi0xLTEtMA_6e4a8162-1c34-42dc-98e3-a751068eada7">2,669.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMjItNi0xLTEtMA_07f7582d-685c-4f28-9a4e-ee4a3508429c">2,669.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See Notes to Consolidated Financial Statements</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">JOHNSON &amp; JOHNSON AND SUBSIDIARIES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CONSOLIDATED STATEMENTS OF EARNINGS</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Unaudited; Dollars &amp; Shares in Millions Except Per Share Amounts)</span></div><div id="ief97c24c8c144887ab2ad376fc457d4d_31"></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:510.00pt;"><tr><td style="width:1.0pt;"></td><td style="width:283.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:52.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:48.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:52.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:48.25pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>to Sales</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>to Sales</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales to customers (Note 9)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMi0yLTEtMS0w_d5afe357-e0cb-4af0-8e07-e605ffd6335e">60,109</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" name="jnj:SalesRevenueGoodsNetPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMi00LTEtMS0w_80fa9018-1582-4b37-aa0c-09cf22c8b08b">100.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMi02LTEtMS0w_8a9de1d4-8ba8-4b03-880e-0cad29cd68d3">61,312</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="3" name="jnj:SalesRevenueGoodsNetPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMi04LTEtMS0w_6aefbe73-d733-4a89-8eac-822db74266ab">100.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of products sold</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMy0yLTEtMS0w_e4f821ab-751d-47c0-8c25-4e07c2039066">20,613</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" name="jnj:CostOfGoodsSoldPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMy00LTEtMS0w_55ab2821-5f0f-44d3-82af-277de8077815">34.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMy02LTEtMS0w_4a5172e3-f1b6-4087-a8fb-fddc597723c6">20,422</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="3" name="jnj:CostOfGoodsSoldPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMy04LTEtMS0w_b2112631-3627-418b-b35b-c76323dd39d4">33.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNC0yLTEtMS0w_66929c6f-48a8-4d9c-ada6-8a5a3accadc7">39,496</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" name="jnj:GrossProfitPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNC00LTEtMS0w_5fd479c8-5a1a-4ca9-a880-9a7ba147bca4">65.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNC02LTEtMS0w_45d28164-a896-4142-8a0a-2f06eee2afdf">40,890</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="3" name="jnj:GrossProfitPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNC04LTEtMS0w_3cbafe15-bf9b-4358-a042-5b5eb981012b">66.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Selling, marketing and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNS0yLTEtMS0w_ec572a9b-95bc-4593-bc6c-5fc50bd26cd7">15,627</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" name="jnj:SellingGeneralAndAdministrativeExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNS00LTEtMS0w_e7f529a4-617d-419b-acdb-faf0312a9f97">26.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNS02LTEtMS0w_7a61b751-5cdd-48f7-9d3b-acca2f315f7b">16,139</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="3" name="jnj:SellingGeneralAndAdministrativeExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNS04LTEtMS0w_159bc9f1-3f76-496f-b83b-f95e5b1fcf85">26.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNi0yLTEtMS0w_2d39ff17-8fe7-45a6-8733-18c1eec17f8d">8,127</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" name="jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNi00LTEtMS0w_8c8f6a35-f0ac-4eba-bcf0-075e1474be83">13.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNi02LTEtMS0w_01a0d875-1255-453b-a622-f440ecacec15">8,123</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="3" name="jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNi04LTEtMS0w_16f7a6ef-ece3-4332-a9e2-e1a09bc7b345">13.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">In-process research and development</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNy0yLTEtMS0w_2d5787a1-65cd-4952-8700-6ff996b0208c">144</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" name="jnj:ResearchAndDevelopmentInProcessPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNy00LTEtMS0w_37cc5bbf-5261-420b-8892-378cc3f88991">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNy02LTEtMS0w_51f81a40-9952-4d33-9067-c59e03f5887d">890</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="3" name="jnj:ResearchAndDevelopmentInProcessPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNy04LTEtMS0w_bf92866f-c6f7-4502-b569-46367b61ff64">1.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfOC0yLTEtMS0w_ae83485c-f45c-4aa6-97c6-01f6ce9b55ce">98</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" sign="-" name="jnj:InvestmentIncomeInterestPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfOC00LTEtMS0w_517ce4be-9ffd-44d6-940d-e2c59d3f3b0d">0.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfOC02LTEtMS0w_41b701f3-777b-46d0-a4fc-a3fde4bfdc39">276</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="3" sign="-" name="jnj:InvestmentIncomeInterestPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfOC04LTEtMS0w_5114496e-b74c-404f-a249-be6754f524a5">0.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense, net of portion capitalized</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfOS0yLTEtMS0w_c75c35b9-b85d-4942-ac4c-b700e7fa1d1a">114</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" name="jnj:InterestExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfOS00LTEtMS0w_ccb25316-16ce-4a43-ae95-529b221b0b9a">0.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfOS02LTEtMS0w_5fce77db-9d04-40a6-b648-649b1025d39f">233</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="3" name="jnj:InterestExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfOS04LTEtMS0w_181bd5ed-f849-488d-9df6-5732fd436c29">0.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense, net</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTAtMi0xLTEtMA_53c57836-188a-452e-a064-3c64792f2372">545</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" name="jnj:OtherNonOperatingIncomeExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTAtNC0xLTEtMA_3e9566d2-7b6e-46f6-8926-503811adebfb">0.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTAtNi0xLTEtMA_27a34e34-4ae8-43c1-8a9f-88b01fa0023b">2,509</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="3" name="jnj:OtherNonOperatingIncomeExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTAtOC0xLTEtMA_4470cc65-6385-44cc-b5b7-d767b3ec1203">4.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restructuring (Note 12)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTEtMi0xLTEtMA_dfc7dd34-b35c-480f-aa2b-03012324f294">187</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" name="jnj:Restructuringchargepercenttosales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTEtNC0xLTEtMA_240da3b2-2266-4fb2-8237-1a760b837aac">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTEtNi0xLTEtMA_fb4993aa-4226-4282-96af-8285f41efec7">162</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="3" name="jnj:Restructuringchargepercenttosales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTEtOC0xLTEtMA_946c2707-4609-483e-a124-d81e5590c032">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Earnings before provision for taxes on income</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTItMi0xLTEtMA_f198fda5-5561-4c9a-9f31-b79073f3f7f8">14,850</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" name="jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTItNC0xLTEtMA_884f3084-2f38-4838-a198-4f9ad40c99ae">24.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTItNi0xLTEtMA_81d2fe3a-0314-439d-a29b-957f29be3605">13,110</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="3" name="jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTItOC0xLTEtMA_f0986608-378a-4beb-bc23-1e1e78aea17e">21.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Provision for taxes on income (Note 5)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTMtMi0xLTEtMA_1b8b5d3a-894b-4f99-99ee-a8cd4101ce31">1,874</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" name="jnj:IncomeTaxExpenseBenefitPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTMtNC0xLTEtMA_26c4bb50-f328-479b-af5f-4a555488f018">3.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTMtNi0xLTEtMA_93cb3dfb-98ea-41dc-bb92-278e30645143">2,001</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="3" name="jnj:IncomeTaxExpenseBenefitPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTMtOC0xLTEtMA_284972d4-22a2-462c-aa96-80527af96ad5">3.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NET EARNINGS </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTQtMi0xLTEtMA_469e83d5-eefb-439b-8d25-d9abeeffa946">12,976</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" name="jnj:NetIncomeAttributableToParentPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTQtNC0xLTEtMA_dfb48363-4c19-4a0e-9407-93109c015a06">21.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTQtNi0xLTEtMA_8d5ee663-ce7e-4579-b29f-9940816d0149">11,109</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="3" name="jnj:NetIncomeAttributableToParentPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTQtOC0xLTEtMA_c4c51db2-9159-42b5-8ce8-ef49c1147a9e">18.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NET EARNINGS PER SHARE (Note 8)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTctMi0xLTEtMA_940638ea-92d8-4e50-ab7d-eac026ea269f">4.93</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTctNi0xLTEtMA_216b171e-e94b-4976-8247-cee866917b2f">4.19</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTgtMi0xLTEtMA_22027dbd-e80d-4115-aca4-7f2a019c974e">4.86</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTgtNi0xLTEtMA_d3eee002-4de6-4337-acc5-0b9f6d50af31">4.13</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">AVG. SHARES OUTSTANDING</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMjEtMi0xLTEtMA_a15889c6-9dfe-47d3-8d06-ea95e56f27e4">2,633.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMjEtNi0xLTEtMA_cbd078f9-bf2e-4b56-a5a5-9fa77f56a927">2,649.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMjItMi0xLTEtMA_527255fb-164e-4a19-9a09-6ce25da63540">2,670.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMjItNi0xLTEtMA_d2101681-b078-423f-8e37-a1b18fb57350">2,688.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="27" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">See Notes to Consolidated Financial Statements</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">3</span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">JOHNSON &amp; JOHNSON AND SUBSIDIARIES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Unaudited; Dollars in Millions)</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%;"><tr><td style="width:1.0%;"></td><td style="width:43.458%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.694%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.976%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.694%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.976%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.988%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.829%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.285%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMy0xLTEtMS0w_4325d983-8e43-426f-85b1-a4614737048d">3,554</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMy0zLTEtMS0w_d2b03559-5f86-44da-8393-c8c785720b2b">1,753</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMy01LTEtMS0w_6493c957-83ae-43c1-92e5-71950760377d">12,976</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMy03LTEtMS0w_9214b60b-5e58-4a46-ae74-f4e0caa9aee7">11,109</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfNi0xLTEtMS0w_91b82478-7eef-4aca-ab18-78a85ef6559a">222</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfNi0zLTEtMS0w_fcc6394e-ce82-4017-9b01-2467476aed71">667</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfNi01LTEtMS0w_3a33330c-19de-4b8c-b9c7-da5c30cb295f">741</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfNi03LTEtMS0w_425691ca-bf8c-419e-ac78-7e57812dca3d">575</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Securities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Unrealized holding gain (loss) arising during period</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfOS0xLTEtMS0w_8b2eb160-48b0-46d1-b175-ec1529628a90">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfOS0zLTEtMS0w_817952cc-51c9-4135-b140-75d28bb12d61">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfOS01LTEtMS0w_eff20fe4-f0c0-4d08-bb33-ea166c5a9c08">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfOS03LTEtMS0w_5c02907f-e5b2-4be8-a4dc-8c80212e67a7">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Reclassifications to earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTAtMS0xLTEtMA_0f939a8d-726c-424a-984f-346016c91778">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTAtMy0xLTEtMA_4a452cf2-51bd-4e30-a34d-a2730e8084b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTAtNS0xLTEtMA_dac9a723-2363-4240-84f3-e97bfe5e546a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTAtNy0xLTEtMA_3a031ab1-5b14-47d1-91db-06e31940fb58">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Net change</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTItMS0xLTEtMA_2a7edfe3-0fba-4428-a753-5892d5965b49">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTItMy0xLTEtMA_59978200-9eb6-445e-8a44-bd3953c0dc69">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTItNS0xLTEtMA_7c3257ae-3602-48b6-a6e5-a4d83b368762">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTItNy0xLTEtMA_ffc4dc77-7866-4658-9de4-250126e253ec">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee benefit plans:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Prior service cost amortization during period</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTUtMS0xLTEtMA_9450f8b1-2bbf-41a6-9eda-03e12a0485f0">6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" name="jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTUtMy0xLTEtMA_58af5337-e3ca-4f84-9f24-604553f25c32">6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTUtNS0xLTEtMA_011a0f14-10a6-459f-b1f0-a2cb3fe12c57">17</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTUtNy0xLTEtMA_3c577f16-fceb-437c-b2ef-8992ec528e17">18</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Gain (loss) amortization during period</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" sign="-" name="jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTYtMS0xLTEtMA_58816430-9e31-452b-8a65-e55c6e2a16dd">203</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" sign="-" name="jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTYtMy0xLTEtMA_b91b3cc7-1656-41a3-9a0e-55efb5de88cf">142</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" sign="-" name="jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTYtNS0xLTEtMA_4a300a31-aebf-486b-8e48-7b352108bd7e">604</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" sign="-" name="jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTYtNy0xLTEtMA_edb1a134-94c6-454d-b820-19eafd892593">460</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Net change</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTgtMS0xLTEtMA_423d3d10-4c6f-4c4e-a66e-5ff51aa4445d">197</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTgtMy0xLTEtMA_229b53ef-1a10-44da-9fc0-ab2f64a80b89">136</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTgtNS0xLTEtMA_b1ac8fbb-7292-44eb-aeac-db98948cef65">587</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTgtNy0xLTEtMA_07f5e0b0-08b6-48c3-9f1f-372a4c76b932">442</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives &amp; hedges:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Unrealized gain (loss) arising during period</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjEtMS0xLTEtMA_66fc24e5-7f7f-470c-832d-a639c81e7264">199</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjEtMy0xLTEtMA_68a387de-24da-4631-ae96-475639aff3ff">1,922</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjEtNS0xLTEtMA_5bbe15c1-7125-4a64-b3a9-f1221e85cc44">1,052</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjEtNy0xLTEtMA_943bfff7-db50-410b-bb15-9eafd03c1149">1,706</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Reclassifications to earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjItMS0xLTEtMA_a6492a58-6131-4cee-9c78-9a4f921363b7">24</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjItMy0xLTEtMA_f8f1eb24-02a6-4e44-9631-6ee91bd238c7">1,955</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjItNS0xLTEtMA_167e0cc4-aa9b-4c28-bc72-aa33524792f1">54</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjItNy0xLTEtMA_440f2aee-dc0c-4094-a7ad-e9c474bebe57">1,885</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Net change</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjMtMS0xLTEtMA_d038a438-8b0e-4e63-af9b-8a4e9c3a9390">175</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjMtMy0xLTEtMA_ef09d1c8-a25e-4ebf-bbd1-6f8da8faf264">33</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjMtNS0xLTEtMA_5403bdc4-5b09-42b6-948d-c16abc7b03b6">1,106</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjMtNy0xLTEtMA_0da64223-4c43-4a49-ab65-4e45a810350f">179</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjUtMS0xLTEtMA_7821426b-c8a6-43b8-87bd-bcf3229afefa">595</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjUtMy0xLTEtMA_a07fccd8-0acc-4e14-b23d-1e6387acbe5a">564</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjUtNS0xLTEtMA_0140894a-e812-4443-8a0d-9beafa18aac4">953</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjUtNy0xLTEtMA_d5f7290e-e7aa-471b-b21b-99e12227d0b8">311</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Comprehensive income </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjctMS0xLTEtMA_6c710068-2c6e-4e01-a5da-498d713bb67b">4,149</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjctMy0xLTEtMA_f7715b1e-6920-4a36-9687-746b25206734">1,189</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjctNS0xLTEtMA_6203fea8-fbea-4ae9-8b20-eb2a28322e59">13,929</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjctNy0xLTEtMA_98be30fb-26ce-4565-837b-e3ba80df617a">10,798</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See Notes to Consolidated Financial Statements</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%;"><tr><td style="width:1.0%;"></td><td style="width:98.900%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">The tax effects in other comprehensive income for the fiscal third quarter were as follows for 2020 and 2019, respectively: Foreign Currency Translation: $<ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMC0wLTEtMS0zODY5L3RleHRyZWdpb246NzMzZjU0YTI2NmU1NDYzOGE4YjUxYjhiMDJiMmYyYmZfMTA0NDUzNjA0NjQxNjU_6305954c-85da-493e-a81f-cf5516c35e1e">139</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMC0wLTEtMS0zODY5L3RleHRyZWdpb246NzMzZjU0YTI2NmU1NDYzOGE4YjUxYjhiMDJiMmYyYmZfMTA0NDUzNjA0NjQxODY_9723b399-0e5e-414d-b9ca-e51f72942438">94</ix:nonFraction> million; Employee Benefit Plans: $<ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMC0wLTEtMS0zODY5L3RleHRyZWdpb246NzMzZjU0YTI2NmU1NDYzOGE4YjUxYjhiMDJiMmYyYmZfMTA0NDUzNjA0NjQxOTE_e64dc264-3cd4-48e4-925e-da882e750d89">56</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMC0wLTEtMS0zODY5L3RleHRyZWdpb246NzMzZjU0YTI2NmU1NDYzOGE4YjUxYjhiMDJiMmYyYmZfMTA0NDUzNjA0NjQxOTY_f0bf5490-13a3-4568-a4cc-d7effc7f1ea8">34</ix:nonFraction> million; Derivatives &amp; Hedges: $<ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMC0wLTEtMS0zODY5L3RleHRyZWdpb246NzMzZjU0YTI2NmU1NDYzOGE4YjUxYjhiMDJiMmYyYmZfMTA0NDUzNjA0NjQxODE_c67476e3-0060-4817-beb1-a85e490d7dd6">47</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMC0wLTEtMS0zODY5L3RleHRyZWdpb246NzMzZjU0YTI2NmU1NDYzOGE4YjUxYjhiMDJiMmYyYmZfMTA0NDUzNjA0NjQyMDA_6bc8f72a-be28-43eb-9100-44b446ae1292">9</ix:nonFraction> million.</span></div></td></tr><tr><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">The tax effects in other comprehensive income for the fiscal nine months were as follows for 2020 and 2019, respectively: Foreign Currency Translation: $<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMi0wLTEtMS00MDMxL3RleHRyZWdpb246ZDE2ZmQwNGQ0ZjRmNDRkZjkzZTlkZjI0YmI2YThjNGZfMTA0NDUzNjA0NjQxNjY_f09cc489-e297-48b5-86d3-e0ccd4f041da">207</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMi0wLTEtMS00MDMxL3RleHRyZWdpb246ZDE2ZmQwNGQ0ZjRmNDRkZjkzZTlkZjI0YmI2YThjNGZfMTA0NDUzNjA0NjQxNzc_f8091cbc-584b-473e-8f91-959e333aea3b">50</ix:nonFraction> million; Employee Benefit Plans: $<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMi0wLTEtMS00MDMxL3RleHRyZWdpb246ZDE2ZmQwNGQ0ZjRmNDRkZjkzZTlkZjI0YmI2YThjNGZfMTA0NDUzNjA0NjQxODM_bdbea3ea-fe85-4409-8366-1ec4cb82d2bc">167</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMi0wLTEtMS00MDMxL3RleHRyZWdpb246ZDE2ZmQwNGQ0ZjRmNDRkZjkzZTlkZjI0YmI2YThjNGZfMTA0NDUzNjA0NjQxODg_88eb769d-aaeb-41ec-982d-3a9d040c9705">69</ix:nonFraction> million; Derivatives &amp; Hedges: $<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMi0wLTEtMS00MDMxL3RleHRyZWdpb246ZDE2ZmQwNGQ0ZjRmNDRkZjkzZTlkZjI0YmI2YThjNGZfMTA0NDUzNjA0NjQxNzI_a26872b6-3567-4c5a-b0b9-668348e04e04">293</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMi0wLTEtMS00MDMxL3RleHRyZWdpb246ZDE2ZmQwNGQ0ZjRmNDRkZjkzZTlkZjI0YmI2YThjNGZfMTA0NDUzNjA0NjQxOTM_39324909-e8b2-4f25-b440-c224b53da0fb">48</ix:nonFraction> million.</span></div></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">4</span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">JOHNSON&#160;&amp; JOHNSON AND SUBSIDIARIES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CONSOLIDATED STATEMENTS OF EQUITY</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Unaudited; Dollars in Millions)</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fiscal Third Quarter Ended September&#160;27, 2020 </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%;"><tr><td style="width:1.0%;"></td><td style="width:38.107%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.885%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.708%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.885%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.708%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.822%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.708%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.032%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.708%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.037%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retained<br/>Earnings</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common Stock<br/>Issued Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Treasury<br/>Stock<br/>Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, June 28, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0cf38c3475e441fb8f8267516f5f6e04_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMS0xLTEtMS0w_ff9f399a-38f2-45f9-9ba3-5433a6ee374a">62,978</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if6c8c63ebbdd45008cb5ac80e7d4a988_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMS0zLTEtMS0w_b6410c71-444b-492b-a051-a0c46705608f">113,898</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1f90ce64276d4c29ad4a8c7f4dbd288f_I20200628" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMS01LTEtMS0w_b6267a6c-526e-4980-b9b4-1afb7f312855">15,533</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i06b919224a104e2480ce4da569369152_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMS03LTEtMS0w_e03cd917-fb85-4129-828e-de60a97463c7">3,120</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="id0b01ffae8c54eaaaf665643769f3f44_I20200628" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMS05LTEtMS0w_0ca0198c-8530-423b-a54a-3329224937a7">38,507</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMi0xLTEtMS0w_a5b3e34d-ea63-4e66-a12e-805d923cd58d">3,554</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieca44093d50140b480558060c22367cb_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMi0zLTEtMS0w_27cec79d-15f1-4962-b5b8-20aa6566c9f3">3,554</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Cash dividends paid ($<ix:nonFraction unitRef="usdPerShare" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMy0wLTEtMS00MDQzL3RleHRyZWdpb246Njc4NTFjYTE5YWRjNDAxY2JlNDg3YjEzMjVlZTRlNDZfMTA0NDUzNjA0NjM5MTc_c5e744ca-21d1-4bb5-87cc-168bfce4f289">1.01</ix:nonFraction> per share)</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMy0xLTEtMS0w_bd57f065-0bd3-47b1-9451-4f2dfcc61d49">2,659</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ieca44093d50140b480558060c22367cb_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMy0zLTEtMS0w_3135c3cb-f109-43d0-b22d-e942b2b246b3">2,659</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee compensation and stock option plans</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfNC0xLTEtMS0w_364a0467-90eb-474c-8d43-bcf2df9877c1">559</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieca44093d50140b480558060c22367cb_D20200629-20200927" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfNC0zLTEtMS0w_86a1ce3c-7384-49d6-b3d1-d5cd78e219cf">109</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i381677b70c5d4be996221d9099a8ee95_D20200629-20200927" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfNC05LTEtMS0w_5902bb4a-b458-428c-866a-475bde303b9a">450</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Repurchase of common stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfNS0xLTEtMS0w_7204d9b5-6ba5-4349-9d6a-776be62bf926">483</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i381677b70c5d4be996221d9099a8ee95_D20200629-20200927" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfNS05LTEtMS0w_3f70a68c-1737-4eec-a984-58519d29dd3d">483</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfNi0xLTEtMS0w_a1fe1221-9608-491e-92dc-cf8d6900640a">71</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ieca44093d50140b480558060c22367cb_D20200629-20200927" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfNi0zLTEtMS0w_462ab206-1a82-43ed-a382-70e0db2fda02">71</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfNy0xLTEtMS0w_a1619b40-d2c6-4fca-b444-5c07f0f333b6">595</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4ccc8ddbfa5a467ca8eaf499f719d902_D20200629-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfNy01LTEtMS0w_ded25dd3-5902-46b8-98cb-3b514716e7d3">595</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, September 27, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfOC0xLTEtMS0w_0e4c7263-8330-4b3b-926a-7eaf3694ec80">64,473</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib840c9f8515640ed990015d6449203d6_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfOC0zLTEtMS0w_ceaad7ce-8ae9-45db-910d-6d7ef2e7013d">114,831</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7b3f9043c47442aea143141642e7e123_I20200927" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfOC01LTEtMS0w_3030ca3e-92b4-4dd7-8e0a-c583815c1397">14,938</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie2de08cb9d744bf28bfcab44717ebd79_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfOC03LTEtMS0w_32ef2d5e-8adb-422f-962b-90b110bf10cb">3,120</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ifb8ed1a3c397427ca991016ed24db8d2_I20200927" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfOC05LTEtMS0w_59982943-ab65-436f-ba26-8b8212ba21f3">38,540</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fiscal Nine Months Ended September&#160;27, 2020</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%;"><tr><td style="width:1.0%;"></td><td style="width:38.107%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.885%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.708%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.885%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.708%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.822%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.708%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.032%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.708%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.037%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retained<br/>Earnings</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common Stock<br/>Issued Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Treasury<br/>Stock<br/>Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 29, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMS0xLTEtMS0w_f4cba539-4e39-4fbf-b1a7-26191ca7bad4">59,471</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i71bc7ed79cf044f986c36306dd76232b_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMS0zLTEtMS0w_8a8ffe6c-9f0a-40c8-834f-6a79c00986b0">110,659</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4dff82851aa243f2a42e09821411d92e_I20191229" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMS01LTEtMS0w_0d2a3da8-cf1b-42fb-8a8a-e6b64c2f42f8">15,891</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iac644cecdd17481eae30c88e9f63b87d_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMS03LTEtMS0w_38a27bbe-4bd6-463c-8405-1f9b262df9fc">3,120</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia7b18211b77c4d9eb325dfecb4003ccc_I20191229" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMS05LTEtMS0w_57d7a6cb-124a-48a2-8a44-f1f183f2be09">38,417</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMi0xLTEtMS0w_471f90de-a2e3-493b-9547-7c970e2e4b0c">12,976</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5c31dab756544c419618439f97c12092_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMi0zLTEtMS0w_e5fa1d34-06b1-4413-b1c7-325c26007330">12,976</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Cash dividends paid ($<ix:nonFraction unitRef="usdPerShare" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMy0wLTEtMS00MDQ3L3RleHRyZWdpb246Yjg5NTc0MmVmN2I4NGUzMGJhYjM3NGQ1ODM1OWQyNzlfMTA0NDUzNjA0NjM5MTc_248343fa-35f1-4f39-afbd-ac33309c27ae">2.97</ix:nonFraction> per share)</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMy0xLTEtMS0w_96144096-0d77-4f90-b77c-e3526fed2918">7,823</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5c31dab756544c419618439f97c12092_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMy0zLTEtMS0w_08c3b7d3-be2c-4093-ae78-d69baeebfa90">7,823</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee compensation and stock option plans</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfNC0xLTEtMS0w_6895de2e-3750-4e23-be99-c7f1dbe747d0">1,866</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5c31dab756544c419618439f97c12092_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfNC0zLTEtMS0w_89779ff4-09ba-4099-ac02-30e8c00f7e3b">911</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8c15ea54ac1647959505ff89d74c73c7_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfNC05LTEtMS0w_e55334d9-ca26-47de-ad38-f36752d04c2d">2,777</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Repurchase of common stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfNS0xLTEtMS0w_18d10667-40c3-401a-a8b5-df400f58a6e8">2,900</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i8c15ea54ac1647959505ff89d74c73c7_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfNS05LTEtMS0w_66119b36-db60-428a-812f-3a1f9ce58cc2">2,900</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfNi0xLTEtMS0w_3c1eeced-f18f-4552-b2db-2c900af6e368">70</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5c31dab756544c419618439f97c12092_D20191230-20200927" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfNi0zLTEtMS0w_02415cbc-34dc-4b9d-bf0a-0fbcf66f5b0b">70</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfNy0xLTEtMS0w_0117366e-4ee2-42fb-a8b5-cb5a0918e4b5">953</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3494e72aac944cd896896e8cc599429d_D20191230-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfNy01LTEtMS0w_f08be09a-2578-4410-bc83-be55e66195ba">953</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, September 27, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfOC0xLTEtMS0w_5e1f9fb7-889c-4969-87e2-34bf0c48c597">64,473</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib840c9f8515640ed990015d6449203d6_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfOC0zLTEtMS0w_ee1cbe29-a841-4f13-b0d1-1f4b4c550dc7">114,831</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7b3f9043c47442aea143141642e7e123_I20200927" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfOC01LTEtMS0w_7b79ee06-7b93-43d4-a556-8662ddbe7052">14,938</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie2de08cb9d744bf28bfcab44717ebd79_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfOC03LTEtMS0w_e8ce8f07-72ab-4756-ac21-aabf96d67372">3,120</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ifb8ed1a3c397427ca991016ed24db8d2_I20200927" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfOC05LTEtMS0w_e9303d1f-ffa9-4fc2-a8e9-bc9007b01167">38,540</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fiscal Third Quarter Ended September&#160;29, 2019 </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%;"><tr><td style="width:1.0%;"></td><td style="width:37.985%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.782%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.717%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.929%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.717%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.879%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.717%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.076%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.717%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.081%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retained<br/>Earnings</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common Stock<br/>Issued Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Treasury<br/>Stock<br/>Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, June 30, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9918090831a94bfa90e6639a0e7860b0_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfMS0xLTEtMS0w_3a6810aa-8498-4d1f-a2ce-e27e52473db0">60,785</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i80a9937f67434d319d5d9d0009f19170_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfMS0zLTEtMS0w_64613661-e930-4e8a-8713-17f4da3716c4">109,809</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie369dd88ecfb42bfbd08a15bc21a6097_I20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfMS01LTEtMS0w_05edf793-98e4-4b7a-9a04-f021c6224e53">14,969</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8623b760505a465db7f09f7ad1d524db_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfMS03LTEtMS0w_e06813e9-c990-434d-8e33-3e4afdf0bcae">3,120</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7d1eb0b5e3974db0ba19099436b2cc65_I20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfMS05LTEtMS0w_4e3ad379-ee27-4cf2-8695-63d5721e41ca">37,175</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfMy0xLTEtMS0w_4fe568ce-5f9a-4f70-8aa7-539143a054ed">1,753</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i110288df68f94473b99fed3695503e08_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfMy0zLTEtMS0w_58ff3722-08ff-4e56-ac3b-4bfd793dad56">1,753</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Cash dividends paid ($<ix:nonFraction unitRef="usdPerShare" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfNC0wLTEtMS00MDUxL3RleHRyZWdpb246ODg5ZjBiNjc3NWI5NDIwNzhjYzg1Nzk5OTZkMWMzMjdfMTA0NDUzNjA0NjM5MTc_e356dc83-1c53-4d7b-97ff-e88a59b7d490">0.95</ix:nonFraction> per share)</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfNC0xLTEtMS0w_94a69ddb-d117-4660-9543-cb88867c34fd">2,499</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i110288df68f94473b99fed3695503e08_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfNC0zLTEtMS0w_c3de2405-0176-4155-9778-c108e4632f4b">2,499</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee compensation and stock option plans</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfNS0xLTEtMS0w_399fab99-87b6-4cf0-b9a2-bed65bd3f82c">363</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i110288df68f94473b99fed3695503e08_D20190701-20190929" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfNS0zLTEtMS0w_2778e7c3-e0d8-46e4-b8f0-7ac3c207e6db">179</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6a6ecd40aacc418a87faf0c09967e825_D20190701-20190929" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfNS05LTEtMS0w_913b721f-bac4-4ce6-9f54-0c9adfdeb97d">184</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Repurchase of common stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfNi0xLTEtMS0w_ded3f35e-130c-499b-9610-3a68f997d85d">1,628</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6a6ecd40aacc418a87faf0c09967e825_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfNi05LTEtMS0w_8d0b618c-91a9-4186-86e1-924a0b11fb8f">1,628</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfOC0xLTEtMS0w_7f522029-5e70-426f-bc3e-89ae6973cf0a">564</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7e3164724e36436c908b66cd22c3a21a_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfOC01LTEtMS0w_8d83c160-6ba3-41c8-9cea-8c3ceca9654a">564</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, September 29, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7973ae70802a4ed0a4cd812adebb0210_I20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfOS0xLTEtMS0w_241d4205-27ef-4fa5-bd8d-e1332d61a88b">58,210</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0f437ae6f74d4fa69aa4dac8e499093a_I20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfOS0zLTEtMS0w_5f99dcc7-5ef1-4b33-addf-cb3382fc16bc">109,242</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic23a7f58f6e14cc1977521f182c06612_I20190929" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfOS01LTEtMS0w_132a4b3a-46a7-47e5-982d-0eaf259789fb">15,533</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i400557913e3646cfba478852d03d7924_I20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfOS03LTEtMS0w_5fcdd670-933b-4f8c-a794-d92ff1782acd">3,120</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i018cbb188f0842968a546fe435cdf833_I20190929" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfOS05LTEtMS0w_bd8110eb-e603-425d-a492-77272edd0aab">38,619</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fiscal Nine Months Ended September&#160;29, 2019</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%;"><tr><td style="width:1.0%;"></td><td style="width:37.985%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.782%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.717%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.929%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.717%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.879%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.717%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.076%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.717%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.081%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retained<br/>Earnings</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common Stock<br/>Issued Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Treasury<br/>Stock<br/>Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 30, 2018</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id0a2a626a2c244b9a56b493374930da0_I20181230" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfMS0xLTEtMS0w_6e215857-e091-4e83-b3fa-c0ea2a0ea3e2">59,752</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i140bd62410d04a73af76e67490f68df5_I20181230" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfMS0zLTEtMS0w_d473cadf-5586-44d4-8c3f-5d2083f75a90">106,216</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idf518ea8aaf64e96abb8d9041f120b48_I20181230" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfMS01LTEtMS0w_0ec39cbc-5ece-4b3d-bbcb-2bbdd37f5732">15,222</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1caf669d3c9842f4b9c8d11879c80aec_I20181230" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfMS03LTEtMS0w_b0d0ea7e-64ad-4cd1-a523-5a3777c5555b">3,120</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iad718c4ff9e7438d82af65c75127f1f7_I20181230" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfMS05LTEtMS0w_77e970fe-1a81-4243-a815-af4230b7979f">34,362</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfMy0xLTEtMS0w_31d130a7-d41f-4399-b88d-7ca8793578aa">11,109</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i35bcfc36a3ac40618bf4b3ef88484093_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfMy0zLTEtMS0w_ca019b91-6f7e-4b70-8e71-fff6d2aa4058">11,109</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Cash dividends paid ($<ix:nonFraction unitRef="usdPerShare" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfNC0wLTEtMS00MDU1L3RleHRyZWdpb246ODc2YmNmM2E3YzFlNDI2MWE4MzMzY2E2YzFmNDQzZTZfMTA0NDUzNjA0NjM5MTc_f12dc2f0-69f9-43d5-8c15-34e1c189a904">2.80</ix:nonFraction> per share)</span></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfNC0xLTEtMS0w_d3c90068-890d-4931-811c-1c3d354fcde8">7,417</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i35bcfc36a3ac40618bf4b3ef88484093_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfNC0zLTEtMS0w_e569848a-b11c-4ce4-a4cf-8e6d764701b6">7,417</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee compensation and stock option plans</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfNS0xLTEtMS0w_1804b026-ef32-4ff9-a754-e565beca7612">1,397</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i35bcfc36a3ac40618bf4b3ef88484093_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfNS0zLTEtMS0w_1069b611-6e0b-42b9-bcf4-de3364b2ea26">666</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icd34e4a6c9104502985d3b5bd4a98c8e_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfNS05LTEtMS0w_b572a2a7-f892-4133-937d-27765d9eacf7">2,063</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Repurchase of common stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfNi0xLTEtMS0w_8d90fb14-2795-4ad9-9089-93acf1d99ba7">6,320</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icd34e4a6c9104502985d3b5bd4a98c8e_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfNi05LTEtMS0w_6ae905fd-30b0-4af1-a528-bcabc30bdcf0">6,320</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfOC0xLTEtMS0w_b91de991-2245-4e90-924e-3aa4f6a1da63">311</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia9597fec02bb4c31b44fbbd09919bb16_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfOC01LTEtMS0w_8b8cb256-1d0f-450b-9622-8be3873b6d7d">311</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, September 29, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7973ae70802a4ed0a4cd812adebb0210_I20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfOS0xLTEtMS0w_6f09dcb6-7e34-47bc-bb74-60faaa34007e">58,210</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0f437ae6f74d4fa69aa4dac8e499093a_I20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfOS0zLTEtMS0w_649c7194-ef95-4322-ad1a-ab603cf33013">109,242</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic23a7f58f6e14cc1977521f182c06612_I20190929" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfOS01LTEtMS0w_d806509e-213b-43b3-8b35-9444b61cb431">15,533</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i400557913e3646cfba478852d03d7924_I20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfOS03LTEtMS0w_b030e400-ca58-4e96-8498-850cd9c65bb6">3,120</ix:nonFraction></span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i018cbb188f0842968a546fe435cdf833_I20190929" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfOS05LTEtMS0w_70a50cc7-8f62-4eb6-a9c2-37860f3773c0">38,619</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;margin-top:13pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See Notes to Consolidated Financial Statements</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">6</span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_46"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">JOHNSON &amp; JOHNSON AND SUBSIDIARIES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Unaudited; Dollars in Millions)</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%;"><tr><td style="width:1.0%;"></td><td style="width:76.319%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.533%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.457%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.533%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.458%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29,<br/>2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CASH FLOWS FROM OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMy0yLTEtMS0w_fc1f329b-2239-4984-8629-8d22fbd17493">12,976</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMy00LTEtMS0w_052a2729-8667-4fad-8121-ced4b3c71d70">11,109</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments to reconcile net earnings to cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization of property and intangibles</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNS0yLTEtMS0w_c24360db-a8d1-44be-88b2-7311f6d4722f">5,291</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNS00LTEtMS0w_9d56e844-6de1-4041-b6cc-77ebf044a498">5,193</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock based compensation</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNi0yLTEtMS0w_9246888a-bb5c-4e00-ac30-f2bc6573aec3">845</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNi00LTEtMS0w_9c5016a4-a5e5-4210-ac44-8c9ac8c91e64">817</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset write-downs</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfOS0yLTEtMS0w_5d20722b-382b-4ff9-8052-2c3240ec6be5">198</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfOS00LTEtMS0w_d0eb4418-d9c4-443f-b68e-82cc38a82651">1,019</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Contingent consideration reversal</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTAtMi0xLTEtMA_3d328b25-ce53-4b52-9d07-e972c0c203f5">1,148</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTAtNC0xLTEtMA_adbc3f88-2ae0-47c5-a914-7e62bec0d9fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net gain on sale of assets/businesses</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTEtMi0xLTEtMA_362c3556-e33d-4645-ace7-7ab9d75ba39b">60</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTEtNC0xLTEtMA_69387a68-3a13-41c6-a92a-eef827f9a473">2,125</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax provision</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTMtMi0xLTEtMA_4555fdee-23e1-4d70-8a22-13901610902e">238</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTMtNC0xLTEtMA_7acb118a-4b5b-4fae-b366-5d5f43e98866">2,126</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Credit losses and accounts receivable allowances </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTQtMi0xLTEtMA_a164a749-11d4-441b-b575-8dadca16838d">74</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTQtNC0xLTEtMA_0ac48b04-0d4a-491c-a65d-34fe2a2964e6">15</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Changes in assets and liabilities, net of effects from acquisitions and divestitures:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase in accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTYtMi0xLTEtMA_2a3bc301-99d5-4bcd-bd85-40eee6eb12a4">440</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTYtNC0xLTEtMA_b4b7e102-ab48-4beb-8c89-595b83df06e4">665</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase in inventories</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTctMi0xLTEtMA_cde0f789-4368-496f-b2aa-939031809f99">784</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTctNC0xLTEtMA_12e8443f-9581-4ae1-9007-e880f030bb9f">424</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Decrease)/Increase in accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTgtMi0xLTEtMA_bef0440f-49be-479a-95fe-7176c6ec6ea3">119</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTgtNC0xLTEtMA_7036adde-0530-4d2f-a0b9-b3d11ba8f639">2,273</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase in other current and non-current assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTktMi0xLTEtMA_5cf3ce4e-fe42-49aa-9236-23541aeda1ef">1,983</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTktNC0xLTEtMA_8a51888a-fba2-41a2-af51-0140b20ec4c8">81</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase in other current and non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjAtMi0xLTEtMA_b6498dd5-c643-4e7e-9194-e4cec50e3b10">581</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjAtNC0xLTEtMA_902a2e50-2b3e-4f51-be10-5feb572631db">2,043</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NET CASH FLOWS FROM OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjItMi0xLTEtMA_2d41f361-0619-4edd-9e44-24c0a007fb67">15,193</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjItNC0xLTEtMA_142a9eac-a8c9-478a-8767-610ed48715ad">17,018</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CASH FLOWS FROM INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additions to property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjUtMi0xLTEtMA_cb03d7e9-0924-434c-b965-d5b45d2e6ccd">2,024</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjUtNC0xLTEtMA_ab82f27f-9dc9-4659-9cda-c0739c182ab2">2,238</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from the disposal of assets/businesses, net</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:ProceedsFromSaleOfProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjYtMi0xLTEtMA_1eb1dc60-bd9a-4031-b494-62bf43ee69f4">100</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjYtNC0xLTEtMA_f203c7e7-ea06-4790-ad65-c97cba3d28fa">3,103</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisitions, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjctMi0xLTEtMA_d85803c8-9e0e-4e42-8145-10681ab2ad1d">949</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjctNC0xLTEtMA_3706ae77-b533-41e3-a176-a2aff7eb1022">5,562</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchases of investments</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjgtMi0xLTEtMA_600026f9-4ba5-4d4c-9638-b4af77e593ad">16,243</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjgtNC0xLTEtMA_8335ab2e-e0a1-4a15-bc4c-4e24cf5b24a6">2,684</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales of investments</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjktMi0xLTEtMA_0e5704e9-b372-4b91-8a7e-f9b877fe58eb">6,585</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjktNC0xLTEtMA_034f5acc-31cc-4c35-9dd6-fca807b11c5d">2,459</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from credit support agreements, net</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="jnj:Proceedsfromcreditsupportagreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzAtMi0xLTEtMA_8c91018b-f846-498b-937d-97dd9097d6bf">125</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="jnj:Proceedsfromcreditsupportagreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzAtNC0xLTEtMA_3e971918-6091-4ef6-9adb-fc7f378b086b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (primarily licenses and milestones)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzEtMi0xLTEtMA_843f34ba-4ccc-49b0-be8a-437bba6d1867">516</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzEtNC0xLTEtMA_36d9bb26-09e6-4b81-b73d-c69376ed3ade">72</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NET CASH USED BY INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzMtMi0xLTEtMA_5edb2395-f75c-47bb-83fa-25e30b51e85b">12,922</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzMtNC0xLTEtMA_61118061-d8a9-4c55-a894-744974c81db0">4,850</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CASH FLOWS FROM FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dividends to shareholders</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfOrdinaryDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzYtMi0xLTEtMA_d92debfe-7066-4978-b072-0c62266e0c2d">7,823</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfOrdinaryDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzYtNC0xLTEtMA_2aa661c9-3bdb-4181-8ee4-e0d9def919a1">7,417</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzctMi0xLTEtMA_96754261-9351-4969-95fc-1a324072dd35">2,900</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzctNC0xLTEtMA_4398e625-5c35-4012-b414-33ee9d4879c4">6,320</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from short-term debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzgtMi0xLTEtMA_04a503a4-146a-4897-9435-83e1b3ff0c7e">3,335</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzgtNC0xLTEtMA_757930dd-3adf-4e13-93cf-c00c80cbf3d6">148</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Repayment of short-term debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzktMi0xLTEtMA_b8450636-79f3-4b23-b701-f01999de0b1b">310</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzktNC0xLTEtMA_7a714b34-9204-41db-8157-778720a9977e">87</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from long-term debt, net of issuance costs</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDAtMi0xLTEtMA_a059d1a3-9430-41a0-8a83-caf3eb5fe8e2">7,431</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDAtNC0xLTEtMA_72284f30-b84f-445b-a932-8eda657fe932">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Repayment of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDEtMi0xLTEtMA_0ee16d2b-1cb1-4f6f-9e0a-c35a30361fca">562</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDEtNC0xLTEtMA_a62087b8-80c9-4ca6-9050-3552c1e9344f">1,008</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from the exercise of stock options/employee withholding tax on stock awards, net</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="jnj:ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDItMi0xLTEtMA_be4e47b1-ae10-4d79-bdc4-b455586d4060">922</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="jnj:ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDItNC0xLTEtMA_54c96273-3ca8-4608-9446-ae76712e1c23">580</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDMtMi0xLTEtMA_88f2beef-033e-4274-8a49-e2169f09d4f1">569</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDMtNC0xLTEtMA_ff099ebf-a5f2-45de-beb6-69d57bde4e70">160</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NET CASH USED BY FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDUtMi0xLTEtMA_ca79e4b4-965c-43d8-bd6c-9f1e68494532">476</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDUtNC0xLTEtMA_3b374b1f-160d-41a8-8463-0a831723fb70">13,943</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDctMi0xLTEtMA_154773b0-08c6-4fad-ab7f-6717f234a2bb">135</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDctNC0xLTEtMA_51c9f43a-8ce3-4b2a-a489-86f4619851b9">83</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase/(Decrease) in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDgtMi0xLTEtMA_dd78edf2-6a4a-49ee-9b50-e7057b794884">1,660</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDgtNC0xLTEtMA_3a3e3676-a3b0-45c7-90d6-cf2e691ce69b">1,858</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and Cash equivalents, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDktMi0xLTEtMA_e4a1a820-cf8c-4e74-9701-78bb4f603e2e">17,305</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id0a2a626a2c244b9a56b493374930da0_I20181230" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDktNC0xLTEtMA_9cdde73a-d323-48a4-945f-6a3647c3e4ce">18,107</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CASH AND CASH EQUIVALENTS, END OF PERIOD</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNTAtMi0xLTEtMA_ef45e464-37bf-4bac-916d-a4c9aab5c652">18,965</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7973ae70802a4ed0a4cd812adebb0210_I20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNTAtNC0xLTEtMA_7dd2938e-2717-46e4-8182-c59e267f9b35">16,249</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value of assets acquired</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNTctMi0xLTEtMA_80e6eb80-1dc1-432c-b656-b327d8dd2b2a">1,173</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNTctNC0xLTEtMA_295bbfef-238c-4a82-8558-a757c59bc245">6,861</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value of liabilities assumed and noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNTgtMi0xLTEtMA_c9e83071-6d41-4db4-b2ce-7cc7986e8cdf">224</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNTgtNC0xLTEtMA_0363410b-99eb-4d20-a87b-e3181d416433">1,299</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash paid for acquisitions</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNTktMi0xLTEtMA_35de148c-77e1-4589-bfeb-90c1b2c1a555">949</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNTktNC0xLTEtMA_6c9f7782-7c98-4a00-b3ac-f5746f81ea00">5,562</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See Notes to Consolidated Financial Statements</span></div><div style="position:relative;width:100%;height:27pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">7</span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="ief97c24c8c144887ab2ad376fc457d4d_52"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> NOTE 1 &#8212; <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81Mi9mcmFnOmI0OTgwM2YxYzg4MzQzMGZhNzc2ZTM4ZDhjMmNmNGZjL3RleHRyZWdpb246YjQ5ODAzZjFjODgzNDMwZmE3NzZlMzhkOGMyY2Y0ZmNfMjc3MA_59fbad18-9410-490f-b82a-b270efaf42ae" continuedAt="icf401325e16b4e3287d1aecd92340019" escape="true">The accompanying unaudited interim consolidated financial statements and related notes should be read in conjunction with the audited Consolidated Financial Statements of Johnson &amp; Johnson and its subsidiaries (the Company) and related notes as contained in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. The unaudited interim financial statements include all adjustments (consisting only of normal recurring adjustments) and accruals necessary in the judgment of management for a fair statement of the results for the periods presented.</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="icf401325e16b4e3287d1aecd92340019"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Columns and rows within tables may not add due to rounding. Percentages have been calculated using actual, non-rounded figures.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81Mi9mcmFnOmI0OTgwM2YxYzg4MzQzMGZhNzc2ZTM4ZDhjMmNmNGZjL3RleHRyZWdpb246YjQ5ODAzZjFjODgzNDMwZmE3NzZlMzhkOGMyY2Y0ZmNfMjc2Nw_cd54a57b-270f-4a94-9687-b66c3c99387e" escape="true"><div style="margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The extent to which COVID-19 impacts the Company&#8217;s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts COVID-19 as of September 27, 2020 and through the date of this report. The accounting matters assessed included, but were not limited to, the Company&#8217;s allowance for doubtful accounts and credit losses, inventory and related reserves, accrued rebates and associated reserves, and the carrying value of the goodwill and other long-lived assets. While there was not a material impact to the Company&#8217;s consolidated financial statements as of and for the quarter ended September 27, 2020, the Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the Company&#8217;s consolidated financial statements in future reporting periods.</span></div></ix:nonNumeric><div style="margin-top:3pt;"><span><br/></span></div><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81Mi9mcmFnOmI0OTgwM2YxYzg4MzQzMGZhNzc2ZTM4ZDhjMmNmNGZjL3RleHRyZWdpb246YjQ5ODAzZjFjODgzNDMwZmE3NzZlMzhkOGMyY2Y0ZmNfMjc2OA_9f020f7e-0e64-4e21-b92e-393398de2b89" escape="true"><div style="margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">New Accounting Standards</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company assesses the adoption impacts of recently issued accounting standards by the Financial Accounting Standards Board on the Company's financial statements as well as material updates to previous assessments, if any, from the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. There were no new material accounting standards issued in the fiscal third quarter of 2020 that impacted the Company.</span></div><div style="margin-top:3pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Recently Adopted Accounting Standards</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There were no new accounting standards adopted in the fiscal third quarter of 2020.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i8998fcc3526244dcad040549c8bdf899_D20191230-20200628" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81Mi9mcmFnOmI0OTgwM2YxYzg4MzQzMGZhNzc2ZTM4ZDhjMmNmNGZjL3RleHRyZWdpb246YjQ5ODAzZjFjODgzNDMwZmE3NzZlMzhkOGMyY2Y0ZmNfMjc2OQ_6fe4b6ba-e094-4bef-bce3-3857a640d1bd" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Reclassification</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certain prior period amounts have been reclassified to conform to current year presentation.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div id="ief97c24c8c144887ab2ad376fc457d4d_58"></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 2 &#8212; <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RleHRyZWdpb246YmJlMzUzM2RlZTMxNDYwM2IwOTBiM2QwNmU2MTQ4OWZfMTYy_e856db3c-6b70-4971-9507-c1838c35a31f" continuedAt="ia6bebf43ceac48eeb4fd5031edca4dfd" escape="true">INVENTORIES </ix:nonNumeric></span></div><ix:continuation id="ia6bebf43ceac48eeb4fd5031edca4dfd"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RleHRyZWdpb246YmJlMzUzM2RlZTMxNDYwM2IwOTBiM2QwNmU2MTQ4OWZfMTY0_11e4bb24-7ba7-4264-b2cb-62a7bf02e9a2" escape="true"><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.070%;"><tr><td style="width:1.0%;"></td><td style="width:51.896%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.736%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:20.622%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.736%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:22.310%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Raw materials and supplies</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RhYmxlOjA0ZDliMGI2Y2UwODRhYWViYzUzOGE2MGI3NjFhMTIyL3RhYmxlcmFuZ2U6MDRkOWIwYjZjZTA4NGFhZWJjNTM4YTYwYjc2MWExMjJfMS0yLTEtMS0w_d55221f6-c471-4702-a6b4-2939d871a33b">1,363</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RhYmxlOjA0ZDliMGI2Y2UwODRhYWViYzUzOGE2MGI3NjFhMTIyL3RhYmxlcmFuZ2U6MDRkOWIwYjZjZTA4NGFhZWJjNTM4YTYwYjc2MWExMjJfMS00LTEtMS0w_958c513d-f5cb-41cf-967b-5384c871c9d9">1,117</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goods in process</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RhYmxlOjA0ZDliMGI2Y2UwODRhYWViYzUzOGE2MGI3NjFhMTIyL3RhYmxlcmFuZ2U6MDRkOWIwYjZjZTA4NGFhZWJjNTM4YTYwYjc2MWExMjJfMi0yLTEtMS0w_8c5faeb2-8678-40c1-b878-c627f6cab269">1,916</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RhYmxlOjA0ZDliMGI2Y2UwODRhYWViYzUzOGE2MGI3NjFhMTIyL3RhYmxlcmFuZ2U6MDRkOWIwYjZjZTA4NGFhZWJjNTM4YTYwYjc2MWExMjJfMi00LTEtMS0w_af6d8693-1c7a-4802-baa9-6290cb3b43a6">1,832</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RhYmxlOjA0ZDliMGI2Y2UwODRhYWViYzUzOGE2MGI3NjFhMTIyL3RhYmxlcmFuZ2U6MDRkOWIwYjZjZTA4NGFhZWJjNTM4YTYwYjc2MWExMjJfMy0yLTEtMS0w_7d261c1b-fed3-49d5-9e3d-da3a6eb05e89">6,320</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RhYmxlOjA0ZDliMGI2Y2UwODRhYWViYzUzOGE2MGI3NjFhMTIyL3RhYmxlcmFuZ2U6MDRkOWIwYjZjZTA4NGFhZWJjNTM4YTYwYjc2MWExMjJfMy00LTEtMS0w_19e7c27c-de62-4de5-88b7-4c499a1bf949">6,071</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Total inventories </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RhYmxlOjA0ZDliMGI2Y2UwODRhYWViYzUzOGE2MGI3NjFhMTIyL3RhYmxlcmFuZ2U6MDRkOWIwYjZjZTA4NGFhZWJjNTM4YTYwYjc2MWExMjJfNC0yLTEtMS0w_120c7fbb-1357-45ec-b915-45ca25689e38">9,599</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RhYmxlOjA0ZDliMGI2Y2UwODRhYWViYzUzOGE2MGI3NjFhMTIyL3RhYmxlcmFuZ2U6MDRkOWIwYjZjZTA4NGFhZWJjNTM4YTYwYjc2MWExMjJfNC00LTEtMS0w_9547fc98-55d3-4d22-b636-5d41e4162930">9,020</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">See Note 10 to the Consolidated Financial Statements for details on assets held for sale and the related divestitures.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">8</span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 3 &#8212; <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfMTY3Mg_efe49d53-e6df-4ae0-861a-f91509985405" continuedAt="i94e815deb1434ff7ae4de85a4d1c7a93" escape="true">INTANGIBLE ASSETS AND GOODWILL</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i94e815deb1434ff7ae4de85a4d1c7a93"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Intangible assets that have finite useful lives are amortized over their estimated useful lives. The latest annual impairment assessment of goodwill and indefinite lived intangible assets was completed in the fiscal fourth quarter of 2019. Future impairment tests for goodwill and indefinite lived intangible assets will be performed annually in the fiscal fourth quarter, or sooner, if warranted.</span></div><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="jnj:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfMTY2NA_de3b1998-f240-4bdb-b092-4688527ca6c0" continuedAt="i7b93bb8d4eba42c4a4041b36db36ed7e" escape="true"><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%;"><tr><td style="width:1.0%;"></td><td style="width:61.104%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.587%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.325%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.587%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:16.697%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and trademarks &#8212; gross</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i146724b9ab654ac3b05e3567213370a2_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMi0yLTEtMS0w_6c1ce250-a8ef-4cb1-9d05-9cf2d5bc3e6e">38,381</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if455a0c82eec4663ab4937953a47b1a0_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMi00LTEtMS0w_f8de8994-7031-457e-87b0-41ccb6b9475a">36,634</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i146724b9ab654ac3b05e3567213370a2_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMy0yLTEtMS0w_ed83e089-d183-4949-bdb1-8570adc58b96">16,098</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if455a0c82eec4663ab4937953a47b1a0_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMy00LTEtMS0w_b3f8056f-c832-4d19-a329-99083b5e325a">13,154</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and trademarks &#8212; net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i146724b9ab654ac3b05e3567213370a2_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfNC0yLTEtMS0w_a2f01e5a-3fc8-4afb-aabd-bfd87c47ff0e">22,283</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if455a0c82eec4663ab4937953a47b1a0_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfNC00LTEtMS0w_082efd03-df04-4fe2-b32c-57ad358dc5f8">23,480</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer relationships and other intangibles &#8212; gross</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifeaa5dc31fed4356a01542e92bc1b4ac_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfNS0yLTEtMS0w_d32266b4-b40c-4f68-a5bc-81e9854338e2">22,455</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ec1428acbd748a3ac5a614e4bca5b5b_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfNS00LTEtMS0w_fc52839f-769c-47c6-ba4e-cadc8587a8d6">22,056</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less accumulated amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifeaa5dc31fed4356a01542e92bc1b4ac_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfNi0yLTEtMS0w_801c1806-3ccb-46cf-8ac4-e265c7bf9e7d">10,427</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ec1428acbd748a3ac5a614e4bca5b5b_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfNi00LTEtMS0w_30354650-17d9-41e7-b6b9-bfc98f8c5b74">9,462</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer relationships and other intangibles&#160;&#8212; net*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifeaa5dc31fed4356a01542e92bc1b4ac_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfNy0yLTEtMS0w_79ef8944-f597-407b-8544-6c9cdbd60db4">12,028</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ec1428acbd748a3ac5a614e4bca5b5b_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfNy00LTEtMS0w_8debf9f5-0805-462e-bbdc-3dcf31eb3ded">12,594</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i68c2ad5bd3504e018130bc2faeb63dfc_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfOS0yLTEtMS0w_1282cc7b-5227-4e66-82dc-48d1416012a4">6,995</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7d2f1f6cd2a34b9fb4eb1093a33dc1ae_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfOS00LTEtMS0w_8c0f62fd-ac45-434c-af7d-4dd47ba64d4a">6,922</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Purchased in-process research and development </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9f84e8435dc0421d8a89f9ea0bce9608_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMTAtMi0xLTEtMA_6b1bf4e6-df4f-4ee9-aa63-ac986ea28bdf">5,700</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i99b4dc37a244428f8b6a328e6563293f_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMTAtNC0xLTEtMA_ee7c3e66-b67d-465d-8479-34e934e38bb7">4,647</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total intangible assets with indefinite lives</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMTEtMi0xLTEtMA_b9de1e1c-a982-4c59-a629-63322ce4653a">12,695</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMTEtNC0xLTEtMA_441d8f1a-7a9a-42de-8f8b-ac926b52490e">11,569</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total intangible assets &#8212; net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMTItMi0xLTEtMA_b6aefd27-e84a-4fab-a202-46d3bf60e8b8">47,006</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMTItNC0xLTEtMA_461e965a-ba2e-4f78-b708-00cbfdbf5f93">47,643</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">*The majority is comprised of customer relationships</span></div></ix:nonNumeric><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"><ix:continuation id="i7b93bb8d4eba42c4a4041b36db36ed7e" continuedAt="ie5356cd7a1af4c31b881cbec894e75d4">(1) </ix:continuation></sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><ix:continuation id="ie5356cd7a1af4c31b881cbec894e75d4">In the fiscal first quarter of 2020, the Company completed the acquisition of bermekimab and certain related assets from XBiotech Inc., as well as the acquisition of all outstanding shares in Verb Surgical Inc. and recorded in-process research and development intangible assets of $<ix:nonFraction unitRef="usd" contextRef="ia9cdf38955a64506988afbdd28653b69_I20200329" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfNzgz_b51ccb51-5db6-489e-a002-5b2c71fef426">0.8</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i1db1cbb21378478cbff6ba1c2021c6dc_I20200329" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfNzkw_7c9fe85f-08bc-4528-afc5-afe79432dd7a">0.4</ix:nonFraction> billion, respectively.</ix:continuation>  </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfMTY3MQ_071aea31-00a7-4aee-a7a1-6f73f9493a51" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Goodwill as of September&#160;27, 2020 was allocated by segment of business as follows:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.859%;"><tr><td style="width:1.0%;"></td><td style="width:40.177%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.578%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.205%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:2.447%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.984%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:2.292%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.361%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:2.447%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.209%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consumer Health</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharmaceutical</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Medical Devices</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at December 29, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i478b4ff4ed674722bb2570839bc53e96_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfMS0yLTEtMS0w_16af8e1a-0344-457e-9cbf-457b2a8704ba">9,736</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i31bf8455628944da8b015d8b789a9fc4_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfMS00LTEtMS0w_ebdd338c-669d-476d-92dd-0c90ec5bad90">9,169</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i87651ba4e20740f0bd2d7665498709be_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfMS02LTEtMS0w_26e5b592-4e6e-4e18-8f62-d724f93b9ee0">14,734</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfMS04LTEtMS0w_82234fe0-47b6-4435-b99a-7a1b4a8852e6">33,639</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill, related to acquisitions</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i498b81f2554f4e868dce4daa5736066a_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfMi0yLTEtMS0w_5bf3965d-7282-4288-84e7-5b8da106936f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i31c5bebe5faa45388656d1dcb0238be9_D20191230-20200927" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfMi00LTEtMS0w_e1de5385-1dcf-466e-a4c5-da39b0889fdd">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic80539fe5fa44b869a360326b6dee52a_D20191230-20200927" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfMi02LTEtMS0w_8622f181-9b9a-42d3-ad70-4c4d7595164a">183</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfMi04LTEtMS0w_f6ce72dd-ba5a-43b7-bf96-eeb7d5d95b69">184</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency translation/Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i498b81f2554f4e868dce4daa5736066a_D20191230-20200927" decimals="-6" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfNC0yLTEtMS0w_7aaaf092-582c-4b44-8b95-5b4bed5694e8">171</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i31c5bebe5faa45388656d1dcb0238be9_D20191230-20200927" decimals="-6" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfNC00LTEtMS0w_e8d6c34c-7c81-497d-b204-df6cf766cbe3">280</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic80539fe5fa44b869a360326b6dee52a_D20191230-20200927" decimals="-6" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfNC02LTEtMS0w_5c219464-2354-465d-a655-48e7f1c17535">33</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfNC04LTEtMS0w_14c5ef29-6d66-461e-8da4-a06c6dc37eed">484</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at September 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3e833bc35e3f438d8cfbc47be4f35753_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfNS0yLTEtMS0w_6d8f27e1-d112-45ad-a624-7349b8bae62c">9,907</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5e4dc688e2e648e983fbdf67f462f0a2_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfNS00LTEtMS0w_15ab8aa3-ba68-4e45-a289-6e0566cd6afa">9,450</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i11ef6f75bfcc45848502de0139e92200_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfNS02LTEtMS0w_0a7cf8c1-09da-4293-ace3-7300c213325c">14,950</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfNS04LTEtMS0w_57772442-ff01-4e23-9522-04024dcb207a">34,307</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The weighted average amortization period for patents and trademarks is <ix:nonNumeric contextRef="if53c990c748f468ba05775d5cf223ac0_D20191230-20200927" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfOTUz_3378d790-83db-427d-9d63-4f729fbb7884">12</ix:nonNumeric> years. The weighted average amortization period for customer relationships and other intangible assets is <ix:nonNumeric contextRef="i1b287ab5933f41b09d0eeee590ddb648_D20191230-20200927" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfMTA2Mg_8a62b1c1-03a0-47c5-ab1a-2f1109a8b820">21</ix:nonNumeric> years. The amortization expense of amortizable intangible assets included in cost of products sold was $<ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfMTE2OA_051dc47c-a7c2-4741-baf5-f8914a9b38a6">1.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfNzY5NjU4MTM5NjEzMQ_03c089aa-a6d3-4515-bb1a-b7bc7e84f512">1.1</ix:nonFraction>&#160;billion for the fiscal third quarters ended September&#160;27, 2020 and September&#160;29, 2019, respectively. The amortization expense of amortizable intangible assets included in cost of products sold was $<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfMTI5Nw_bf6dec43-8053-44a1-a52d-437758c2a47d">3.4</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfNzY5NjU4MTM5NjIwMQ_bfefb6f8-d156-4ed8-a17a-c5f83ceef340">3.3</ix:nonFraction>&#160;billion for the fiscal nine months ended September&#160;27, 2020 and September&#160;29, 2019, respectively. Intangible asset write-downs are included in Other (income) expense, net. </span></div><div><span><br/></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfMTY1MA_13b61952-28b1-45e5-b864-6118b8d6eb70" escape="true"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The estimated amortization expense for approved products, before tax, for the five succeeding years is approximately:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%;"><tr><td style="width:1.0%;"></td><td style="width:18.528%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.833%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:18.114%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.833%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.908%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.833%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.908%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.833%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.910%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="margin-top:13pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">(Dollars in Millions)</span></div></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2021</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2022</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2023</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2024</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$<ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjIyMTg5ZDM1NzI5YTQ4YTdhOWJkYWMyOTc3MTY2N2M5L3RhYmxlcmFuZ2U6MjIxODlkMzU3MjlhNDhhN2E5YmRhYzI5NzcxNjY3YzlfMi0wLTEtMS0w_a70321dd-faa3-498d-8c56-247664d91717">4,500</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjIyMTg5ZDM1NzI5YTQ4YTdhOWJkYWMyOTc3MTY2N2M5L3RhYmxlcmFuZ2U6MjIxODlkMzU3MjlhNDhhN2E5YmRhYzI5NzcxNjY3YzlfMi0yLTEtMS0w_9302a872-5b30-4c95-b6c5-f20db9b537c3">4,300</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjIyMTg5ZDM1NzI5YTQ4YTdhOWJkYWMyOTc3MTY2N2M5L3RhYmxlcmFuZ2U6MjIxODlkMzU3MjlhNDhhN2E5YmRhYzI5NzcxNjY3YzlfMi00LTEtMS0w_49003649-cd05-4073-8e63-89c3a6ea89b2">4,100</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjIyMTg5ZDM1NzI5YTQ4YTdhOWJkYWMyOTc3MTY2N2M5L3RhYmxlcmFuZ2U6MjIxODlkMzU3MjlhNDhhN2E5YmRhYzI5NzcxNjY3YzlfMi02LTEtMS0w_cb20eb4a-f787-4f2a-8791-c55414b0e3ac">4,100</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjIyMTg5ZDM1NzI5YTQ4YTdhOWJkYWMyOTc3MTY2N2M5L3RhYmxlcmFuZ2U6MjIxODlkMzU3MjlhNDhhN2E5YmRhYzI5NzcxNjY3YzlfMi04LTEtMS0w_abe9afdb-c699-4256-a64d-49739ae83b5b">3,900</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> See Note 10 to the Consolidated Financial Statements for additional details related to acquisitions and divestitures.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">9</span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 4 &#8212; <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIxMTk_afb31473-cbd9-44c0-8c97-cca1b1e5ac66" continuedAt="ia84572cb3f7943ea817a6d83a31caa62" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia84572cb3f7943ea817a6d83a31caa62" continuedAt="i23f1c28ea37f4d12bc9441f7451ba911"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company uses forward foreign exchange contracts to manage its exposure to the variability of cash flows, primarily related to the foreign exchange rate changes of future intercompany product and third-party purchases of materials denominated in a foreign currency. The Company uses cross currency interest rate swaps to manage currency risk primarily related to borrowings. Both types of derivatives are designated as cash flow hedges. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Additionally, the Company uses interest rate swaps as an instrument to manage interest rate risk related to fixed rate borrowings.  These derivatives are designated as fair value hedges. The Company uses cross currency interest rate swaps and forward foreign exchange contracts designated as net investment hedges.  Additionally, the Company uses forward foreign exchange contracts to offset its exposure to certain foreign currency assets and liabilities. These forward foreign exchange contracts are not designated as hedges, and therefore, changes in the fair values of these derivatives are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company does not enter into derivative financial instruments for trading or speculative purposes, or that contain credit risk related contingent features. The Company maintains credit support agreements (CSA) with certain derivative counterparties establishing collateral thresholds based on respective credit ratings and netting agreements. As of September&#160;27, 2020, the total amount of cash collateral held by the Company under the CSA amounted to $<ix:nonFraction unitRef="usd" contextRef="i602f0b572b2642298407a8c186b700b3_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CollateralAlreadyPostedAggregateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTY3Mg_7e190cf0-e6eb-4faf-b5b9-19b8de4b0330">380</ix:nonFraction> million, net. On an ongoing basis, the Company monitors counter-party credit ratings. The Company considers credit non-performance risk to be low, because the Company primarily enters into agreements with commercial institutions that have at least an investment grade credit rating.  Refer to the table on significant financial assets and liabilities measured at fair value contained in this footnote for receivables and payables with these commercial institutions. As of September&#160;27, 2020, the Company had notional amounts outstanding for forward foreign exchange contracts and cross currency interest rate swaps of $<ix:nonFraction unitRef="usd" contextRef="i602f0b572b2642298407a8c186b700b3_I20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMjI2OQ_c32dd89e-83c0-400f-a11b-a610a24a06dd">43.6</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i2e99b66377d146a5bc59616148618bc1_I20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMjI3Ng_52631cc2-9aef-4b4b-9300-6478a3f17c38">26.5</ix:nonFraction>&#160;billion, respectively.  As of December&#160;29, 2019, the Company had notional amounts outstanding for forward foreign exchange contracts and cross currency interest rate swaps of $<ix:nonFraction unitRef="usd" contextRef="i757aee8078ce429aba0fb497a4a57b0f_I20191229" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMjQzMQ_e326afe5-1e3e-4f46-b5ae-74149d68da7a">45.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i6caa54ad7b144dcca2cb08b4b3dab964_I20191229" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMjQzOA_12beea9b-36c9-4400-96f6-761f29b8ac99">20.1</ix:nonFraction> billion, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">All derivative instruments are recorded on the balance sheet at fair value. Changes in the fair value of derivatives are recorded each period in current earnings or other comprehensive income, depending on whether the derivative is designated as part of a hedge transaction, and if so, the type of hedge transaction.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The designation as a cash flow hedge is made at the entrance date of the derivative contract. At inception, all derivatives are expected to be highly effective. Foreign exchange contracts designated as cash flow hedges are accounted for under the forward method and all gains/losses associated with these contracts will be recognized in the income statement when the hedged item impacts earnings. Changes in the fair value of these derivatives are recorded in accumulated other comprehensive income until the underlying transaction affects earnings and are then reclassified to earnings in the same account as the hedged transaction. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Gains and losses associated with interest rate swaps and changes in fair value of hedged debt attributable to changes in interest rates are recorded to interest expense in the period in which they occur.  Gains and losses on net investment hedges are accounted for through the currency translation account within accumulated other comprehensive income. The portion excluded from effectiveness testing is recorded through interest (income) expense using the spot method. On an ongoing basis, the Company assesses whether each derivative continues to be highly effective in offsetting changes of hedged items. If and when a derivative is no longer expected to be highly effective, hedge accounting is discontinued. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company designated its Euro denominated notes issued in May 2016 with due dates ranging from 2022 to 2035 as a net investment hedge of the Company's investments in certain of its international subsidiaries that use the Euro as their functional currency in order to reduce the volatility caused by changes in exchange rates. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of September&#160;27, 2020, the balance of deferred net gain on derivatives included in accumulated other comprehensive income was $<ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfNDU2OQ_1c6eb287-b186-4c46-99c3-a9660f45da6a">811</ix:nonFraction>&#160;million after-tax. For additional information, see the Consolidated Statements of Comprehensive Income and Note 7. The Company expects that substantially all of the amounts related to forward foreign exchange contracts will be reclassified into earnings over the <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:DescriptionOfReclassificationOfCashFlowHedgeGainLoss" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfNDgyNw_c90b8a4c-a369-44b3-9624-93856d2819f3">next 12 months</ix:nonNumeric> as a result of transactions that are expected to occur over that period. The maximum length of time over which the Company is hedging transaction exposure is <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" format="ixt-sec:durmonth" name="us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfNDk4OA_9e8cc91f-06aa-4014-8d8b-f61fe22a61d9">18</ix:nonNumeric> months, excluding interest rate contracts and </span><span style="background-color:rgb(255,255,255, 0.0);color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">net investment hedge</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> contracts. The amount ultimately realized in earnings may differ as foreign exchange rates change. Realized gains and losses are ultimately determined by actual exchange rates at maturity of the derivative.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span><br/></span></div><div><span><br/></span></div><ix:continuation id="i23f1c28ea37f4d12bc9441f7451ba911" continuedAt="i65ace9a586974d5fb60478c9070546a8"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIwMzE_2474f013-6a7f-4499-8511-b58d18c437b5" continuedAt="i6f83028b46974a82bf11ee312b7247ee" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of the activity related to derivatives and hedges for the fiscal third quarters ended in 2020 and 2019, net of tax:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:19.102%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.259%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.836%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.547%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.413%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.125%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.970%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.836%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.836%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.413%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.563%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The effects of fair value, net investment and cash flow hedging:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on net investment hedging relationship:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5ca4ea76af704d238626f606c2f2e2e8_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtMS0xLTEtMA_55b909a3-ed5c-42ad-b882-c0b65d298803">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i83cd1045196f4066b8afc93059b316f1_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtMi0xLTEtMA_7dcd781e-a0e6-41c7-bc96-78266768f345">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i48769359a9544223b2b381ebae848550_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtMy0xLTEtMA_64e44393-3ce7-44d9-a120-074b3b1cb220">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idaae72c759e44c0aa87a7f502152047c_D20200629-20200927" decimals="-6" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtNC0xLTEtMA_3c3514ef-e55b-477b-8078-7ec46027367a">39</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie75c8583c4cb4e56a35e19da1d9c0fd3_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtNS0xLTEtMA_6f94a20b-d20c-49eb-b5a8-9e6b0f9048a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4cdbac75c4d1489bad27bcb720ec8453_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtNi0xLTEtMA_18037f1d-cdd7-4f28-aad7-222225645381">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i050dea3d0ebc4bb39fdec4f937d89696_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtNy0xLTEtMA_8935aa74-95a1-4a91-80a9-714a78e42e1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i284822c0f6cd4ad4a13ee1cb4f3bbce6_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtOC0xLTEtMA_5b329035-60f0-4a27-a4d1-7cc91e2da303">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id52cfbe2faf44e1db50daba2fb27ff4a_D20190701-20190929" decimals="-6" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtOS0xLTEtMA_369e038e-05e7-429d-a42e-ec286f5e23ce">39</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i617cd2e5232f4d6481542c77f053e8a4_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtMTAtMS0xLTA_4b204f45-2d5c-4004-96b9-a1542247e13d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5ca4ea76af704d238626f606c2f2e2e8_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtMS0xLTEtMA_d3251f99-7ccc-4081-97b9-5c091dfc738b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i83cd1045196f4066b8afc93059b316f1_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtMi0xLTEtMA_dc421062-56a5-421e-9311-86adffabec81">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i48769359a9544223b2b381ebae848550_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtMy0xLTEtMA_9ff383aa-6b27-46f6-878d-45e76440e341">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idaae72c759e44c0aa87a7f502152047c_D20200629-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtNC0xLTEtMA_67c6bb92-bbf6-4dbe-9907-0a425acfde25">39</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie75c8583c4cb4e56a35e19da1d9c0fd3_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtNS0xLTEtMA_25e695f5-b068-4307-b0c1-f16bb875d44b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4cdbac75c4d1489bad27bcb720ec8453_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtNi0xLTEtMA_5c55071a-6819-499e-a96f-c2ac5e2c0c5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i050dea3d0ebc4bb39fdec4f937d89696_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtNy0xLTEtMA_54536791-e788-4fb1-bc9a-dc2aa3003df6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i284822c0f6cd4ad4a13ee1cb4f3bbce6_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtOC0xLTEtMA_510e8a51-a06d-46d0-85c7-902d6bcb23d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id52cfbe2faf44e1db50daba2fb27ff4a_D20190701-20190929" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtOS0xLTEtMA_e0174639-706e-45a8-bb64-1e492125f822">39</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i617cd2e5232f4d6481542c77f053e8a4_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtMTAtMS0xLTA_8ac6a81a-cf6b-49c3-80df-9ab8736a8e8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on cash flow hedging relationship:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1025e2524ffe4b48931a58f4b78c7f2d_D20200629-20200927" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtMS0xLTEtMA_62b14444-3a89-4a1c-b5f1-2e6a8212aae4">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i9bb6927b7d714bc09b33449c20da1770_D20200629-20200927" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtMi0xLTEtMA_d8e0f745-94ee-4881-8dab-151b8e513318">81</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6b83b2d252c447a2ba19f24dd30e3a65_D20200629-20200927" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtMy0xLTEtMA_70f22e30-67fe-4ffa-86f9-bd19af6cb730">13</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3e39ee9dee804ae5bee2adb6bb8d7288_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtNC0xLTEtMA_164a3344-72b3-4ba6-be19-46ba1ab46468">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic36d3ae76596417b9c30e054d1545171_D20200629-20200927" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtNS0xLTEtMA_45a7cdfa-1f69-4a1c-8466-d2a08f533e07">8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i47fda4f228854b19a6da483cbeb232ad_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtNi0xLTEtMA_15d5d3e8-9a95-4b1c-9790-1132087f3c38">8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie01d8f5ff2bc4b4682da0fc787c482ec_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtNy0xLTEtMA_90788a46-bdac-49af-ac3c-c4fd4a3320d2">77</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia68d65479ce04918b459702f999497d0_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtOC0xLTEtMA_fc46901b-a24d-4cd0-9735-12ffb2bb5fb2">1,911</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic909e487ce0146d4a1a529a11bf4b714_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtOS0xLTEtMA_f3cf1c08-bc24-44d3-99b5-a61bdf13989c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifcb888be82354cb9a97b576afd3ebbf7_D20190701-20190929" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtMTAtMS0xLTA_fec63794-746f-44d4-8ef5-d2b764cff547">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1025e2524ffe4b48931a58f4b78c7f2d_D20200629-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItMS0xLTEtMA_4613a4b6-7acd-4b71-be25-1ac34404e6cb">16</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9bb6927b7d714bc09b33449c20da1770_D20200629-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItMi0xLTEtMA_b017949e-5253-45c0-81c6-81323e623484">156</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6b83b2d252c447a2ba19f24dd30e3a65_D20200629-20200927" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItMy0xLTEtMA_8fcc55d2-c57f-4116-adec-5633d847653c">36</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3e39ee9dee804ae5bee2adb6bb8d7288_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItNC0xLTEtMA_d04bebcb-6f15-40c9-848f-971c70196cd6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic36d3ae76596417b9c30e054d1545171_D20200629-20200927" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItNS0xLTEtMA_a2e00250-08aa-400c-89d0-c6a5bb64a8b9">41</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i47fda4f228854b19a6da483cbeb232ad_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItNi0xLTEtMA_9c852968-98a1-41ca-9aaf-6d45773caef6">23</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie01d8f5ff2bc4b4682da0fc787c482ec_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItNy0xLTEtMA_a25148e2-f12a-4d6e-95c3-4c68da7f791f">197</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia68d65479ce04918b459702f999497d0_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItOC0xLTEtMA_7adfd155-23dc-4daa-98aa-c09d7aa7c751">1,939</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic909e487ce0146d4a1a529a11bf4b714_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItOS0xLTEtMA_3d484468-6e6a-43ef-92b2-6accaf82723b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifcb888be82354cb9a97b576afd3ebbf7_D20190701-20190929" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItMTAtMS0xLTA_359e7f42-dd3e-4c30-9432-c6aaeba30ca7">5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i622f3878a0cb45db81deff9052aa0056_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtMS0xLTEtMA_ce68361a-65ac-4dd8-882e-d39ff1966bdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8b7b0c17478b4846abf9b2e8b4cc1801_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtMi0xLTEtMA_6358ec84-c6da-46d1-ae53-42f112be377a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idc70d684244d4d12a5436ed3961b9126_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtMy0xLTEtMA_a4190cb7-35f0-49be-9844-ed91c4703f1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6882d65422ca4fe5ba1de209627b9d21_D20200629-20200927" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtNC0xLTEtMA_df0a51cb-3d2c-4198-9403-0b322eefed5d">84</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic9e976af5cc446eebaf01b985dbc4a42_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtNS0xLTEtMA_ed6ab102-2057-4b34-ab82-2dbd9d6ef745">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2a09f1a4ea2c46e6b142985640accc45_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtNi0xLTEtMA_97befcaa-041c-48db-b91c-37853c9e34ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><ix:nonFraction unitRef="usd" contextRef="if1382ae0806f411facc9962211302f96_D20190701-20190929" xsi:nil="true" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtNy0xLTEtMA_7696e653-5ea3-4501-a0c0-956ed5b6ab8b"></ix:nonFraction></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifca93b84479747ca8e694826d35cf5f8_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtOC0xLTEtMA_081e124b-e61b-42c7-84a4-2f343828467d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i59bb85378baf48b8aad7ccdddb9509d9_D20190701-20190929" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtOS0xLTEtMA_d03acbb1-a0e4-4b3a-be1e-3736a4154ca7">89</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i901027a3abc14517a3a903a087117d8c_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtMTAtMS0xLTA_556f1b16-3def-47f7-b326-1351f57a3259">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i622f3878a0cb45db81deff9052aa0056_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctMS0xLTEtMA_f157ba42-5df3-4d2d-b60c-ed4b89a2eace">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8b7b0c17478b4846abf9b2e8b4cc1801_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctMi0xLTEtMA_012d44b0-90d8-4dab-9431-91c8774404d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idc70d684244d4d12a5436ed3961b9126_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctMy0xLTEtMA_c33655b5-b2c4-46f3-94d2-4165b116e16c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6882d65422ca4fe5ba1de209627b9d21_D20200629-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctNC0xLTEtMA_5f3c4d9d-b34e-47f0-98d7-0778c4b803d2">65</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic9e976af5cc446eebaf01b985dbc4a42_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctNS0xLTEtMA_e08b52bc-2bf6-4e88-973f-1a087477eba3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2a09f1a4ea2c46e6b142985640accc45_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctNi0xLTEtMA_c4f02f51-b20d-44a5-86c4-c05e6874efa9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if1382ae0806f411facc9962211302f96_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctNy0xLTEtMA_07191ec4-5063-4bb9-9c4c-3e9f19ecadc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifca93b84479747ca8e694826d35cf5f8_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctOC0xLTEtMA_c00dc4b0-7408-4a29-99a7-288e3e62ce26">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i59bb85378baf48b8aad7ccdddb9509d9_D20190701-20190929" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctOS0xLTEtMA_7974cc37-f9b8-475e-bd19-976df11ce10b">159</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i901027a3abc14517a3a903a087117d8c_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctMTAtMS0xLTA_938424c2-4f5c-4440-887b-da02149d7b4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><ix:continuation id="i65ace9a586974d5fb60478c9070546a8" continuedAt="i66054b6da2bb4949b01033b84cb6237a"><ix:continuation id="i6f83028b46974a82bf11ee312b7247ee" continuedAt="i5a1acd6d6a6447dd8ae9cdfa338eaa8c"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of the activity related to derivatives and hedges for the fiscal nine months ended in 2020 and 2019, net of tax:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:18.493%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.302%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.882%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.172%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.172%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.172%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.011%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.172%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.592%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.172%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.760%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The effects of fair value, net investment and cash flow hedging:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on net investment hedging relationship:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i29f87aaf8f2a484fafdef882e2e279a3_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtMS0xLTEtMA_510c846b-71ca-4556-9a81-255c68859513">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7428937974c844969210c80b4d1269bb_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtMi0xLTEtMA_ecb86b2c-2e4a-4792-872c-78935443bda1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i758bf9c10aaa4c5b85d3f371f710849d_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtMy0xLTEtMA_dec3933a-5633-4488-9728-fa25d7d027cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6f3e6000257046239c2aa58024508811_D20191230-20200927" decimals="-6" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtNC0xLTEtMA_db77ddec-db14-4c68-b6df-22ee518e8059">118</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i61bf4b75f5dc4a5d90e74e58ea5c592f_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtNS0xLTEtMA_abf74730-18d5-47ef-8427-22c49eaba211">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i639cb007bfcd4af88897696baacb9819_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtNi0xLTEtMA_52d54bea-55a1-4350-9f85-1e0dcab56d0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4251ad0c6ca846ebb628818d56f1251a_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtNy0xLTEtMA_1c4c6600-21f5-4d79-b3e4-0941c4d98385">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia4f491ac1fa844caacdc4e58ecd253f6_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtOC0xLTEtMA_cec6a7a0-b778-4c7a-adbc-d9eff33eed4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i32bc7bed7811453990b8957e62697591_D20181231-20190929" decimals="-6" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtOS0xLTEtMA_7d3a6acb-e125-48e1-97bb-e2cc049d8ccb">117</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i292a1d5f47644ba2864bd3beb562b985_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtMTAtMS0xLTA_4e66075a-ed17-4e81-bbcd-003720ded949">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i29f87aaf8f2a484fafdef882e2e279a3_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtMS0xLTEtMA_07d1d059-fafc-4e1c-9cd1-6be99747e549">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7428937974c844969210c80b4d1269bb_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtMi0xLTEtMA_538867c0-4c36-40a1-853d-34f025c8a686">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i758bf9c10aaa4c5b85d3f371f710849d_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtMy0xLTEtMA_d2aa8dbc-715d-4f0e-af3a-ff914db82580">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6f3e6000257046239c2aa58024508811_D20191230-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtNC0xLTEtMA_f7c98422-4111-4035-b641-4c15c3086352">118</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i61bf4b75f5dc4a5d90e74e58ea5c592f_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtNS0xLTEtMA_03b1909a-5434-4529-a814-96a8d57c01dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i639cb007bfcd4af88897696baacb9819_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtNi0xLTEtMA_2699b6c1-f74e-4e26-b8c7-d8ca0cb293cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4251ad0c6ca846ebb628818d56f1251a_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtNy0xLTEtMA_885d2cac-7404-4548-ab9f-ddac65207092">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia4f491ac1fa844caacdc4e58ecd253f6_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtOC0xLTEtMA_8227005e-c1f4-4473-b75c-43cc2f300a2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i32bc7bed7811453990b8957e62697591_D20181231-20190929" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtOS0xLTEtMA_1ebb3460-1a80-4658-8069-cc3726dcd8b7">117</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i292a1d5f47644ba2864bd3beb562b985_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtMTAtMS0xLTA_e31c73a6-6262-46ed-b2e1-1d47f964829e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on cash flow hedging relationship:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i01029a1173314478b27e2a88c1698d60_D20191230-20200927" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtMS0xLTEtMA_faa14828-cefe-44d6-a125-372bf3d922c5">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie0ba4e704712428ca90c45899f493ec2_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtMi0xLTEtMA_30f07bba-d30c-4a27-a01e-459bb314c330">316</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0e6b13cc13d249cea0793a26e097bf2b_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtMy0xLTEtMA_1ef49e45-a444-4f79-ae6e-c9a2c77cd494">121</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idb79bc61a7fd4785baa0abe8babcf4e9_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtNC0xLTEtMA_29d305a4-2d87-4ece-8920-42d7c7efce3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i192bf62c991e495aacd95b6a130d406f_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtNS0xLTEtMA_f9db04bd-077b-489a-a1b0-56bd1100b843">10</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ice1f7153b23149e6b9bdf5779859e8cf_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtNi0xLTEtMA_bb4e5381-e97b-4175-90df-2280e09eef14">43</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i2f095d9205a94f68b57c820821576001_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtNy0xLTEtMA_89b51181-32fc-4364-b83e-7f6bbb463606">213</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4ec08d548cc34c89bc05df02e4c29100_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtOC0xLTEtMA_1afc100c-c3bf-423b-9539-d6ca2cfd961d">1,808</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d1186e0f9dd4e6cbaa910c65af648f8_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtOS0xLTEtMA_63df4a8c-aa1d-4620-8a75-25438530d6b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i350db5668e464af6b375c3b4bbd5f0e8_D20181231-20190929" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtMTAtMS0xLTA_cfc52244-197a-4a79-9c4a-e9ec4bdfee63">9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i01029a1173314478b27e2a88c1698d60_D20191230-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItMS0xLTEtMA_c049f020-0828-4d26-b352-c0cc04b74c0e">25</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie0ba4e704712428ca90c45899f493ec2_D20191230-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItMi0xLTEtMA_5a52e211-501d-4909-8ec4-8d6185c9c27e">330</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0e6b13cc13d249cea0793a26e097bf2b_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItMy0xLTEtMA_7bf428c7-e7c3-4fb7-86d2-d948734d0d0f">156</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idb79bc61a7fd4785baa0abe8babcf4e9_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItNC0xLTEtMA_6190fce5-ff46-45a2-875d-31f9b615d828">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i192bf62c991e495aacd95b6a130d406f_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItNS0xLTEtMA_53e4028b-f495-4aae-b324-97db4f284f67">55</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ice1f7153b23149e6b9bdf5779859e8cf_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItNi0xLTEtMA_330ed7ad-5735-490f-8b34-ae2485959cc6">29</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i2f095d9205a94f68b57c820821576001_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItNy0xLTEtMA_30e30eb7-a918-428b-9bc0-e71a80e91591">543</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4ec08d548cc34c89bc05df02e4c29100_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItOC0xLTEtMA_2cac8936-2af3-4bbd-8f12-ccc440348c25">1,847</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d1186e0f9dd4e6cbaa910c65af648f8_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItOS0xLTEtMA_6f0e6aeb-5423-4704-bca7-62f8a8e61aae">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i350db5668e464af6b375c3b4bbd5f0e8_D20181231-20190929" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItMTAtMS0xLTA_7ef021e7-aa90-4f78-af76-a902f0567fc7">15</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaac6fa6375624cbf89f14f995817172f_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtMS0xLTEtMA_bba7bbba-e1c5-46af-ba75-669c1ed9519a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1d932d154b6049149af36416558320a0_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtMi0xLTEtMA_b7519e58-6293-4a57-b026-9e301babafce">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6e091eab1cd14f03b93bd9d094df209a_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtMy0xLTEtMA_9be76cb0-a2af-45f5-b3df-d28d60a4dc07">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i372abf170594420094ccb2d5bcf0ec43_D20191230-20200927" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtNC0xLTEtMA_2ece6a7b-59a7-4605-aa83-b55c44624cf2">265</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2e53d4b575e548578cb08588b7acfcac_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtNS0xLTEtMA_d0205e95-e4f5-45ee-925f-6ce86e88c0e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1c3a289ef5b14159b92eb7f4023a3e8d_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtNi0xLTEtMA_3d47fbcc-48e0-4871-a1f8-871094dad237">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i54d1f30235984b0d92230944638bbefc_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtNy0xLTEtMA_16c26425-5964-4235-b930-5c3e68b402fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a1e39c45d4d40a5aeeb99e4ac32a934_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtOC0xLTEtMA_3c68598a-9679-4d86-8af9-4905279a243c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8d23a00fc837488e8322cd4fa9f6eb80_D20181231-20190929" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtOS0xLTEtMA_5a8093ac-8e56-4697-b11a-ef787c7ffc45">207</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9954b9535f4046ada0661eb9c93f272f_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtMTAtMS0xLTA_01523deb-d6d8-4eaf-9dad-305f6bead28a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaac6fa6375624cbf89f14f995817172f_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctMS0xLTEtMA_f6a973b6-faac-412a-a711-86b720ea0739">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1d932d154b6049149af36416558320a0_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctMi0xLTEtMA_1c47b04d-a32c-414b-856b-c521afd3b3e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6e091eab1cd14f03b93bd9d094df209a_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctMy0xLTEtMA_184effa2-c488-42bf-821b-d59a17781c49">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i372abf170594420094ccb2d5bcf0ec43_D20191230-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctNC0xLTEtMA_2feb36ff-95b8-4635-8ced-151a49e500b2">790</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2e53d4b575e548578cb08588b7acfcac_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctNS0xLTEtMA_a3dab2bf-2825-4539-ada3-8fa8d4e7b028">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1c3a289ef5b14159b92eb7f4023a3e8d_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctNi0xLTEtMA_003d896f-feb6-4242-971b-1f348b97a412">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i54d1f30235984b0d92230944638bbefc_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctNy0xLTEtMA_bdcb4c1e-b3d0-40be-8a79-1ca91392d025">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a1e39c45d4d40a5aeeb99e4ac32a934_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctOC0xLTEtMA_ac413291-2135-4d58-96a9-8b5d6be06f1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8d23a00fc837488e8322cd4fa9f6eb80_D20181231-20190929" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctOS0xLTEtMA_9c336211-1769-46df-8d65-a4145bf4e4b6">299</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9954b9535f4046ada0661eb9c93f272f_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctMTAtMS0xLTA_b3a99f24-1501-402f-bd8e-98bb62a377a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div></ix:continuation><div style="margin-top:5pt;margin-bottom:12pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:29.455%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.823%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:14.689%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.969%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:14.689%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.992%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:14.835%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.700%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:14.548%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" xsi:nil="true" name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIwNTM_30c78f66-7084-46f8-b0d7-748973caa048" escape="true"></ix:nonNumeric>The following table is the effect of derivatives not designated as hedging instruments for the fiscal third quarters and fiscal nine months ended in 2020 and 2019: </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIwNDQ_0c75a326-b0eb-41b5-a90d-5c1433905c16" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:27.160%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:2.698%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:16.871%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.959%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.494%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.814%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.494%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.494%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:2.118%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.498%;"></td><td style="width:0.1%;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Income on Derivative</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Income on Derivative</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain /(Loss) Recognized in Income on Derivative</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idbc5ce6f7f184806bd9942142222b820_D20200629-20200927" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjU2ZDkxNDFhMDYzNTQ0OTM5NmU4Y2QyMjgwMGNkOGM3L3RhYmxlcmFuZ2U6NTZkOTE0MWEwNjM1NDQ5Mzk2ZThjZDIyODAwY2Q4YzdfNC00LTEtMS0w_e313a9ba-fe3c-4551-be94-d4ef2c205cbc">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1c0ed7d0f118415182ad2034719558ca_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjU2ZDkxNDFhMDYzNTQ0OTM5NmU4Y2QyMjgwMGNkOGM3L3RhYmxlcmFuZ2U6NTZkOTE0MWEwNjM1NDQ5Mzk2ZThjZDIyODAwY2Q4YzdfNC02LTEtMS0w_3fea878b-76a4-449e-b101-21493aa5647d">13</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia4f1f0010d2342a8967ad0c59c55d4ec_D20191230-20200927" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjU2ZDkxNDFhMDYzNTQ0OTM5NmU4Y2QyMjgwMGNkOGM3L3RhYmxlcmFuZ2U6NTZkOTE0MWEwNjM1NDQ5Mzk2ZThjZDIyODAwY2Q4YzdfNC03LTEtMS0w_397ac1e7-adbf-47ac-804a-695015faebc3">66</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i227f787e18a34f9bb38cccba24d02a79_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjU2ZDkxNDFhMDYzNTQ0OTM5NmU4Y2QyMjgwMGNkOGM3L3RhYmxlcmFuZ2U6NTZkOTE0MWEwNjM1NDQ5Mzk2ZThjZDIyODAwY2Q4YzdfNC05LTEtMS0w_5d3d718f-e78f-40eb-b6c7-55eb8c7492f9">101</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><ix:continuation id="i66054b6da2bb4949b01033b84cb6237a" continuedAt="ib240372776664cd592c1331f50ee0a2c"><ix:continuation id="i5a1acd6d6a6447dd8ae9cdfa338eaa8c"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is the effect of net investment hedges for the fiscal third quarters ended in 2020 and 2019</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:21.363%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.524%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.769%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.524%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.769%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.814%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:28.610%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.959%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.769%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.524%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.775%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Accumulated<br/>OCI</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From<br/>Accumulated OCI<br/>Into Income</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjc4M2FmOWU3YWY2ZTQ0YjNhYTdhNDYwNjJjN2NkMzQ4L3RhYmxlcmFuZ2U6NzgzYWY5ZTdhZjZlNDRiM2FhN2E0NjA2MmM3Y2QzNDhfMy0yLTEtMS0w_0d1b17de-a9e2-4e12-8268-218f02403d8b">169</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjc4M2FmOWU3YWY2ZTQ0YjNhYTdhNDYwNjJjN2NkMzQ4L3RhYmxlcmFuZ2U6NzgzYWY5ZTdhZjZlNDRiM2FhN2E0NjA2MmM3Y2QzNDhfMy00LTEtMS0w_7c082343-23e7-4fe8-8a9b-94f1bf130501">162</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7af68fed7c3b4b4c8cd6739097abf04a_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjc4M2FmOWU3YWY2ZTQ0YjNhYTdhNDYwNjJjN2NkMzQ4L3RhYmxlcmFuZ2U6NzgzYWY5ZTdhZjZlNDRiM2FhN2E0NjA2MmM3Y2QzNDhfMy04LTEtMS0w_035ab332-3ec8-480e-8b7e-24f9750452f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5a666010da7f4d2eb9c1b6cf6bd24a16_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjc4M2FmOWU3YWY2ZTQ0YjNhYTdhNDYwNjJjN2NkMzQ4L3RhYmxlcmFuZ2U6NzgzYWY5ZTdhZjZlNDRiM2FhN2E0NjA2MmM3Y2QzNDhfMy0xMC0xLTEtMA_6c0a5f10-548d-4c3f-b0f0-827bcf7495e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross Currency interest rate swaps</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i468e8ec1c58344b5a45790f5c51e8c09_D20200629-20200927" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjc4M2FmOWU3YWY2ZTQ0YjNhYTdhNDYwNjJjN2NkMzQ4L3RhYmxlcmFuZ2U6NzgzYWY5ZTdhZjZlNDRiM2FhN2E0NjA2MmM3Y2QzNDhfNC0yLTEtMS0w_0621337a-48b4-4684-a286-73d38d78d166">234</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4ab4dfe0a05c498895f727f1d1cdb016_D20190701-20190929" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjc4M2FmOWU3YWY2ZTQ0YjNhYTdhNDYwNjJjN2NkMzQ4L3RhYmxlcmFuZ2U6NzgzYWY5ZTdhZjZlNDRiM2FhN2E0NjA2MmM3Y2QzNDhfNC00LTEtMS0w_170b950a-17e2-4bd5-82f8-094fd06b4be9">152</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ida55a615e74b412f9e17f752df014784_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjc4M2FmOWU3YWY2ZTQ0YjNhYTdhNDYwNjJjN2NkMzQ4L3RhYmxlcmFuZ2U6NzgzYWY5ZTdhZjZlNDRiM2FhN2E0NjA2MmM3Y2QzNDhfNC04LTEtMS0w_b307eb60-26c3-4e98-87f6-fc306e9ae764">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia08c2e302e194315ab73624c233b25e5_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjc4M2FmOWU3YWY2ZTQ0YjNhYTdhNDYwNjJjN2NkMzQ4L3RhYmxlcmFuZ2U6NzgzYWY5ZTdhZjZlNDRiM2FhN2E0NjA2MmM3Y2QzNDhfNC0xMC0xLTEtMA_50e2dd3a-c1d4-423b-a0d1-158c2d0e0a47">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is the effect of net investment hedges for the fiscal nine months ended in 2020 and 2019</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:21.396%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.525%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.075%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.525%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.785%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.815%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:28.072%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.961%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.930%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.525%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.791%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="33" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Accumulated OCI</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From<br/>Accumulated OCI<br/>Into Income</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmU0MWFjOTljNTRlOTQ0M2JhOGNjYzc3OThjNzkxYTU5L3RhYmxlcmFuZ2U6ZTQxYWM5OWM1NGU5NDQzYmE4Y2NjNzc5OGM3OTFhNTlfNC0yLTEtMS0w_28371a27-07a2-4555-976f-42091ba1b400">217</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmU0MWFjOTljNTRlOTQ0M2JhOGNjYzc3OThjNzkxYTU5L3RhYmxlcmFuZ2U6ZTQxYWM5OWM1NGU5NDQzYmE4Y2NjNzc5OGM3OTFhNTlfNC00LTEtMS0w_09a37aa3-2a19-4e42-a876-85eb686b3e5f">176</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia6e8354567bd4a978607e65d30a26741_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmU0MWFjOTljNTRlOTQ0M2JhOGNjYzc3OThjNzkxYTU5L3RhYmxlcmFuZ2U6ZTQxYWM5OWM1NGU5NDQzYmE4Y2NjNzc5OGM3OTFhNTlfNC04LTEtMS0w_5aad3d32-d7ce-4416-bc93-e15eb641691f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i43f2992b3ca941c3ad80001e95066a6b_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmU0MWFjOTljNTRlOTQ0M2JhOGNjYzc3OThjNzkxYTU5L3RhYmxlcmFuZ2U6ZTQxYWM5OWM1NGU5NDQzYmE4Y2NjNzc5OGM3OTFhNTlfNC0xMC0xLTEtMA_cbf705f9-738b-4cb2-be19-bbc80e677489">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross Currency interest rate swaps</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5173f4423f0449ce945bc91eb4676e98_D20191230-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmU0MWFjOTljNTRlOTQ0M2JhOGNjYzc3OThjNzkxYTU5L3RhYmxlcmFuZ2U6ZTQxYWM5OWM1NGU5NDQzYmE4Y2NjNzc5OGM3OTFhNTlfNS0yLTEtMS0w_513ed814-cb90-436d-b295-c49ae9e62d40">407</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8abc68185a784fcca778998cec6761df_D20181231-20190929" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmU0MWFjOTljNTRlOTQ0M2JhOGNjYzc3OThjNzkxYTU5L3RhYmxlcmFuZ2U6ZTQxYWM5OWM1NGU5NDQzYmE4Y2NjNzc5OGM3OTFhNTlfNS00LTEtMS0w_5056c7a5-c5fe-4e0f-9ed4-c2a049f66424">465</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i095e59b2969f4ed8b53a10dc8c2219bc_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmU0MWFjOTljNTRlOTQ0M2JhOGNjYzc3OThjNzkxYTU5L3RhYmxlcmFuZ2U6ZTQxYWM5OWM1NGU5NDQzYmE4Y2NjNzc5OGM3OTFhNTlfNS04LTEtMS0w_2f59b140-9c12-4a25-8dd7-36f9bfb3e8b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4e85a98890fd4f78b3493cdc6bbec1d5_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmU0MWFjOTljNTRlOTQ0M2JhOGNjYzc3OThjNzkxYTU5L3RhYmxlcmFuZ2U6ZTQxYWM5OWM1NGU5NDQzYmE4Y2NjNzc5OGM3OTFhNTlfNS0xMC0xLTEtMA_6c129029-1ead-42c0-bb13-87c5627cfd74">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr></table></div></ix:continuation><div style="margin-bottom:7pt;"><span><br/></span></div><div style="margin-bottom:7pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company holds equity investments with readily determinable fair values and equity investments without readily determinable fair values.  The Company has elected to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.</span></div><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIwMzM_9704a77d-ff02-44f2-9f94-1c3097a582c6" escape="true"><div style="margin-bottom:7pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of the activity related to equity investments:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:25.476%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.001%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:14.365%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.851%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.464%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.550%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.963%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.851%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.662%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.550%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.667%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Changes in Fair Value Reflected in Net Income </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Sales/ Purchases/Other </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non Current Other Assets</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity Investments with readily determinable value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8c27b77222684cf6918b97cd45fc5ace_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfMi0yLTEtMS0w_d0578b79-c266-4802-8e25-65214f4a1ec8">1,148</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if0c4a4ae70f84c9bbbc600bb0718afe2_D20191230-20200927" decimals="-6" name="us-gaap:EquityFairValueAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfMi00LTEtMS0w_5ab3f1d6-631a-4687-9701-da40105b18fe">161</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if0c4a4ae70f84c9bbbc600bb0718afe2_D20191230-20200927" decimals="-6" sign="-" name="jnj:EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfMi02LTEtMS0w_fb5fd23d-a820-4386-929e-ae2958159b42">169</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i24df639c9fc04ceeb8bd2cfaeedf32ae_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfMi04LTEtMS0w_c2551938-2861-4ae9-9a03-770cb8ed56e8">1,140</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i24df639c9fc04ceeb8bd2cfaeedf32ae_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfMi0xMC0xLTEtMA_c0acf3f7-3669-4f19-a7d1-fd51fd26438c">1,140</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity Investments without readily determinable value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0439badcd60b4553a7b6551b725bd8d8_I20191229" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfNC0yLTEtMS0w_4922b710-a12b-44ab-8f0f-50e8e67e7257">712</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i8128a659f3a049a29db2519c8d080e12_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:EquityFairValueAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfNC00LTEtMS0w_3b21393d-7035-45df-bcab-4fdada1d70a6">36</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8128a659f3a049a29db2519c8d080e12_D20191230-20200927" decimals="-6" name="jnj:EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfNC02LTEtMS0w_3f1da12c-1de8-4a55-8487-880c1723f5a9">66</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia3f03d1d353d4af1b97302c91561ce50_I20200927" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfNC04LTEtMS0w_bb2ae7f5-1bf0-4c8a-a605-e5ae8de64a82">742</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia3f03d1d353d4af1b97302c91561ce50_I20200927" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfNC0xMC0xLTEtMA_916680b2-1202-4302-a9f4-d1513d32b0c6">742</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Recorded in Other Income/Expense</span></div><div style="text-indent:-36pt;padding-left:36pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> (2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Other includes impact of currency</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For equity investments without readily determinable market values, $<ix:nonFraction unitRef="usd" contextRef="i8128a659f3a049a29db2519c8d080e12_D20191230-20200927" decimals="-6" sign="-" format="ixt:numdotdecimal" name="jnj:EquityFairValueAdjustmentImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfNjUxMg_7feea5d4-ad9b-4874-bfca-49bf018f96f3">48</ix:nonFraction> million of the decrease in the fair value reflected in net income were the result of impairments.  There were $<ix:nonFraction unitRef="usd" contextRef="i8128a659f3a049a29db2519c8d080e12_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="jnj:EquityFairValueAdjustmentChangeInObservablePrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfNjYxNw_55ec054c-ebf6-46f7-80c0-7c596f0ef35c">12</ix:nonFraction> million of increase in fair value reflected in net income due to changes in observable prices.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fair value is the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement determined using assumptions that market participants would use in pricing an asset or liability. In accordance with ASC 820, a three-level hierarchy was established to prioritize the inputs used in measuring fair value. The levels within the hierarchy are described below with Level 1 inputs having the highest priority and Level 3 inputs having the lowest.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of a derivative financial instrument (i.e., forward foreign exchange contracts, interest rate contracts) is the aggregation by currency of all future cash flows discounted to its present value at the prevailing market interest rates and </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><ix:continuation id="ib240372776664cd592c1331f50ee0a2c" continuedAt="i34996b9b7a93481babb8b572a4c6769a"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">subsequently converted to the U.S. Dollar at the current spot foreign exchange rate. The Company does not believe that fair values of these derivative instruments materially differ from the amounts that could be realized upon settlement or maturity, or that the changes in fair value will have a material effect on the Company&#8217;s results of operations, cash flows or financial position. The Company also holds equity investments which are classified as Level 1 and debt securities which are classified as Level 2. The Company holds acquisition related contingent liabilities based upon certain regulatory and commercial events, which are classified as Level 3, whose values are determined using discounted cash flow methodologies or similar techniques for which the determination of fair value requires significant judgment or estimations.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following three levels of inputs are used to measure fair value:</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 1 &#8212; Quoted prices in active markets for identical assets and liabilities.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 2 &#8212; Significant other observable inputs.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 3 &#8212; Significant unobservable inputs.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIwOTc_d78d8092-0376-4fb5-b40a-84e1d1361c3b" continuedAt="i5db525cd214d442788193adc4f53f02a" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#8217;s significant financial assets and liabilities measured at fair value as of September&#160;27, 2020 and December&#160;29, 2019 were as follows:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:48.229%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.545%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.245%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.545%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.202%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.545%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.904%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.545%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.245%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.545%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:14.850%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Total</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3ed67e743095488a967574c1fa9c061f_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNC0yLTEtMS0w_669767be-f2d1-48d6-aa0d-243d1281ff7d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia9ed98fbd4de41809e2bbc7eb1afd160_I20200927" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNC00LTEtMS0w_b0c6f3bf-bb22-455d-81ca-d9cb41f8e405">612</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic041dfb9d11749aea360ec6976d75398_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNC02LTEtMS0w_97f9e81f-f4a6-433a-aee2-b0e73fc91664">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i602f0b572b2642298407a8c186b700b3_I20200927" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNC04LTEtMS0w_be93ac3e-cca2-4226-92f3-61f12e3d2ba9">612</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i075b4e0d383b4d769029c92ebf7473f2_I20191229" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNC0xMC0xLTEtMA_d36e41e9-e5ee-4c5c-b839-a629b19ea306">209</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Interest rate contracts </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)(3)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6b7b583681fa4180bb4ba14738b78ba9_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNS0yLTEtMS0w_9001a5b7-f0f5-4d71-b9b4-8c5a62382d65">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i26a4a5bdc75a469cbac1c40a5b7f4419_I20200927" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNS00LTEtMS0w_a50745f7-e845-4c4a-aeea-73a0bde83ff2">635</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf7ba8da4a85439f9212ec5c6c3cdbbc_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNS02LTEtMS0w_184d8c59-4a5e-4bb3-9e0c-032284b1ddc0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4f6fc756c33f4aefbaa09c8db437ba3d_I20200927" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNS04LTEtMS0w_e0d4bee1-2d3e-46d8-8a3a-f1275e85432a">635</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id0c4a50667354367b5d5bc0ba2591ec7_I20191229" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNS0xMC0xLTEtMA_56ff1f22-c466-423e-8637-b4807e534e55">693</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia1132e994a254a868feebb3f706ca20f_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNy0yLTEtMS0w_86190e26-b888-4e9b-9d0e-f6ec18ac3de8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i49bd4ba56a684b248e46d6b51af825e4_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNy00LTEtMS0w_3b960c7e-a507-4296-b6ce-49da0fd92458">1,247</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id07a8860c7464a1e83cd897bd0e82400_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNy02LTEtMS0w_8fb63092-0569-42ba-bc32-4d8f04518a5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNy04LTEtMS0w_7879f8c9-98d6-4091-b74a-40e6f770cc58">1,247</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i075f06ffede94a0786d62da3dcbb7230_I20191229" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNy0xMC0xLTEtMA_de89169a-60e2-4197-8950-a9242ee67081">902</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3ed67e743095488a967574c1fa9c061f_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfOS0yLTEtMS0w_376b61db-fba6-4a08-9022-43deedb30c01">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia9ed98fbd4de41809e2bbc7eb1afd160_I20200927" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfOS00LTEtMS0w_1eb31d81-72a7-4c1d-b720-d289bdbe0b30">327</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic041dfb9d11749aea360ec6976d75398_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfOS02LTEtMS0w_0f222164-fdec-476f-acd4-006627117fed">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i602f0b572b2642298407a8c186b700b3_I20200927" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfOS04LTEtMS0w_65a59861-585a-4e23-afb7-7e0fb855e503">327</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i075b4e0d383b4d769029c92ebf7473f2_I20191229" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfOS0xMC0xLTEtMA_2ef01c56-a7f7-4b04-bea4-62ca425fab1e">426</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Interest rate contracts </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3) </sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6b7b583681fa4180bb4ba14738b78ba9_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTAtMi0xLTEtMA_35363de1-48c3-4f06-a2c3-79ab3d755bd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i26a4a5bdc75a469cbac1c40a5b7f4419_I20200927" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTAtNC0xLTEtMA_1491402e-c8a1-4d20-b0d3-8d99b0bd0e53">382</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf7ba8da4a85439f9212ec5c6c3cdbbc_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTAtNi0xLTEtMA_a8c03fbf-aea4-4c2e-99b5-eb82d33709b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4f6fc756c33f4aefbaa09c8db437ba3d_I20200927" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTAtOC0xLTEtMA_3c4fd053-22d8-4b2f-bf89-3557a4f33b0e">382</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id0c4a50667354367b5d5bc0ba2591ec7_I20191229" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTAtMTAtMS0xLTA_8e705702-d4f6-4d0b-9c40-817574a6e064">193</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia1132e994a254a868feebb3f706ca20f_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTItMi0xLTEtMA_6d9ce200-9dfe-443b-911a-755a963ea86c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i49bd4ba56a684b248e46d6b51af825e4_I20200927" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTItNC0xLTEtMA_cae65bd7-af9d-4d47-b30f-51adb8420bbf">709</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id07a8860c7464a1e83cd897bd0e82400_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTItNi0xLTEtMA_9c11c423-21e0-4eec-94f1-2ebdf6be038d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTItOC0xLTEtMA_c5604f73-ed32-45dd-85c4-d81fffe5ca61">709</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i075f06ffede94a0786d62da3dcbb7230_I20191229" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTItMTAtMS0xLTA_031127f7-128e-46ba-bbb0-4eb08644833f">619</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3ed67e743095488a967574c1fa9c061f_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTUtMi0xLTEtMA_80957ecd-40b6-4e98-8fb8-34e989b032f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia9ed98fbd4de41809e2bbc7eb1afd160_I20200927" decimals="-6" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTUtNC0xLTEtMA_4f1a2c70-abcb-4cd3-bc0c-3cd616cbfe35">64</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic041dfb9d11749aea360ec6976d75398_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTUtNi0xLTEtMA_b9185d1b-2b23-4ec7-a9b4-c85a65d7e9f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i602f0b572b2642298407a8c186b700b3_I20200927" decimals="-6" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTUtOC0xLTEtMA_a48113da-aacd-4fdd-a4c7-c680f7e09adf">64</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i075b4e0d383b4d769029c92ebf7473f2_I20191229" decimals="-6" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTUtMTAtMS0xLTA_ab2e9f39-0246-48ba-a8f8-f51ba03c692e">23</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3ed67e743095488a967574c1fa9c061f_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTctMi0xLTEtMA_4be806cc-26ef-4b6e-999c-93a589150d3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia9ed98fbd4de41809e2bbc7eb1afd160_I20200927" decimals="-6" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTctNC0xLTEtMA_75be9506-a478-4d60-a077-3edcf52bc0df">56</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic041dfb9d11749aea360ec6976d75398_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTctNi0xLTEtMA_9d6d8faa-d789-48da-a462-df975604db69">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i602f0b572b2642298407a8c186b700b3_I20200927" decimals="-6" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTctOC0xLTEtMA_3482bf06-0bc2-429d-a2dd-6608e09f35d7">56</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i075b4e0d383b4d769029c92ebf7473f2_I20191229" decimals="-6" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTctMTAtMS0xLTA_fc64319d-5a03-49a7-ae1d-968de6e2477e">33</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Investments:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Equity investments </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(4)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia1132e994a254a868feebb3f706ca20f_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTktMi0xLTEtMA_e30ceda7-2b07-47c5-8dcf-f55e6b5724dd">1,140</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i49bd4ba56a684b248e46d6b51af825e4_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTktNC0xLTEtMA_9a349981-7501-4490-b6e9-aaa3bf8584b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id07a8860c7464a1e83cd897bd0e82400_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTktNi0xLTEtMA_86065327-d02e-418b-9111-50f46a9f3226">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTktOC0xLTEtMA_690baf6a-9d43-45f7-83cb-97ed53f5c714">1,140</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTktMTAtMS0xLTA_f45bd870-38d4-4f36-9e81-8e8133ed6dc6">1,148</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Debt securities</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(5)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia1132e994a254a868feebb3f706ca20f_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjAtMi0xLTEtMA_9588f08f-ba56-4ce2-b343-7e4b2f5d496c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i49bd4ba56a684b248e46d6b51af825e4_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjAtNC0xLTEtMA_4e6041af-4767-4599-ada6-2feb28fb8de7">13,391</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id07a8860c7464a1e83cd897bd0e82400_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjAtNi0xLTEtMA_5cf82142-eecd-4321-98f4-934109aa3895">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjAtOC0xLTEtMA_acc40250-f2c3-4b1e-994f-65227f254de9">13,391</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjAtMTAtMS0xLTA_bc166e05-9f5a-4694-8c7a-1a1ad02dec85">4,368</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Contingent consideration </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(6)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia1132e994a254a868feebb3f706ca20f_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjItMi0xLTEtMzk3Nw_b6d47828-e769-4bad-80d1-41ae1ffcf600">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i49bd4ba56a684b248e46d6b51af825e4_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjItNC0xLTEtMzk3OQ_2d2e7bd1-782d-4398-b15b-9533f3c8e0a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id07a8860c7464a1e83cd897bd0e82400_I20200927" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjItNi0xLTEtMA_b1d6485f-abb1-4471-8e45-df2d5f11dd5e">636</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjItOC0xLTEtMA_2c0f8ffe-8e6d-4c4d-bc3b-9658d03aa694">636</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjItMTAtMS0xLTA_6c920fc9-c658-4ea2-89a2-e37c283983f8">1,715</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:42.905%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.992%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:20.098%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.087%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:23.318%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross to Net Derivative Reconciliation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Gross Assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfMi0yLTEtMS0w_909d5528-6cdd-4633-9cd1-98f18fb2d831">1,311</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfMi00LTEtMS0w_b11e0859-0ed7-415e-a7f0-281e094f8173">925</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Credit Support Agreement (CSA)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetFairValueGrossLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfMy0yLTEtMS0w_008c0924-e782-49da-a2e6-a8d3fa399d77">1,117</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfMy00LTEtMS0w_778ba00f-f8f4-4edf-8f9a-7e6d88e0a2ae">841</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Net Asset</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfNC0yLTEtMS0w_0869e518-7e79-47f9-8eb9-9b524f910650">194</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfNC00LTEtMS0w_7c33e922-bb97-4811-aac2-032f5cf3bc01">84</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Gross Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfNi0yLTEtMS0w_adbeff2e-41b1-42dc-a475-48815a4b0228">765</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfNi00LTEtMS0w_303ece42-91ba-4977-804d-2b4a4ce251cb">652</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Credit Support Agreement (CSA)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfNy0yLTEtMS0w_9569d3d4-b2c3-4671-a4fd-db2a1555fbfe">737</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfNy00LTEtMS0w_57dc94a1-6e34-43d8-825e-fcbcc6383b91">586</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Net Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfOC0yLTEtMS0w_3c0ffdd2-72c3-4b4b-8f0d-e77ece71d16c">28</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfOC00LTEtMS0w_15e0c5ae-8b77-4937-b8f8-7620a04f0e7b">66</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><ix:continuation id="i34996b9b7a93481babb8b572a4c6769a" continuedAt="i5710f50860c04168b9f06fe0a15cc22d"><ix:continuation id="i5db525cd214d442788193adc4f53f02a"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Summarized information about changes in liabilities for contingent consideration is as follows:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:74.774%;"><tr><td style="width:1.0%;"></td><td style="width:41.269%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:2.410%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:25.606%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.406%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:25.609%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Beginning Balance</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfMy0yLTEtMS0w_c20f0a9c-b623-4d9a-9679-90edb257d366">1,715</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id0a2a626a2c244b9a56b493374930da0_I20181230" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfMy00LTEtMS0w_b35490de-beca-4fe2-a44b-ef6c689620ff">397</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Changes in estimated fair value </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(7) </sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" sign="-" format="ixt:numdotdecimal" name="jnj:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfNC0yLTEtMS0w_04156088-9a00-4f90-aeb4-aaec1d1d04c3">1,088</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="jnj:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfNC00LTEtMS0w_0879376f-61a4-4e54-b03c-17c3a9965d1b">117</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additions</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfNS0yLTEtMS0w_94952d06-5fae-4736-b016-272ea1d05439">107</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfNS00LTEtMS0w_48368534-877c-42a4-9f56-8a12da3817c5">1,133</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Payments</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfNi0yLTEtMS0w_34e2fcba-c6e4-4ed0-a6d8-57787701ed73">98</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfNi00LTEtMS0w_cc09ada1-6ccf-4d3e-8948-76ba67d239d4">9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ending Balance</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfNy0yLTEtMS0w_be1dfbdf-24b3-4b65-b490-1f146fbc1778">636</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7973ae70802a4ed0a4cd812adebb0210_I20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfNy00LTEtMS0w_17973def-51d0-4278-9de1-c995d6a8d3c7">1,638</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;">December 30, 2019 assets and liabilities are all classified as Level 2 with the exception of equity investments of $<ix:nonFraction unitRef="usd" contextRef="i5c550e4021f14358b75cb96f31b7315e_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfODg4Ng_241919ef-cd22-402a-b7ef-29332a1229fa">1,148</ix:nonFraction> million, which are classified as Level 1 and contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i7f95053789564fc7ab821eb34ad95a92_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfODk1NA_2f25da2d-eb61-4549-9417-ff3dfcd98c7f">1,715</ix:nonFraction> million, classified as Level 3.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;">Includes $<ix:nonFraction unitRef="usd" contextRef="icc1339831aaa4cbb833e93308c747d53_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfODk5OA_92ff2fbf-f4ef-4292-be0f-1f926261dbc0">1</ix:nonFraction> million of non-current other assets as of December&#160;29, 2019.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(3)     </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Includes cross currency interest rate swaps and interest rate swaps.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">           (4)&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Classified as non-current other assets. </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(5)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;Classified within cash equivalents and current marketable securities.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(6)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;Includes $<ix:nonFraction unitRef="usd" contextRef="i3463d9cf730744ada323be8c796f5190_I20200927" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfOTI2MA_5d2f594e-7373-41c9-9b32-d709b8385dba">608</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia9134ec591ce4337a548a5cdf634d5d0_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfOTI3NQ_292566f7-b17d-45fc-b4e4-8240e90ee552">1,631</ix:nonFraction> million (primarily related to Auris Health at December 29, 2019), classified as non-current other liabilities as of September&#160;27, 2020 and December&#160;29, 2019, respectively.  Includes $<ix:nonFraction unitRef="usd" contextRef="i1a53e8456ab744c7beec3f2ef4378d29_I20200927" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfOTQwOA_6c40ada4-5066-4d94-94b1-5d9bad5f855c">28</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id49a521ff2d04c15901e39f520471d2b_I20191229" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfOTQyMw_1e9585fa-7361-427c-9e75-b176b7b8a40a">84</ix:nonFraction> million classified as current liabilities as of September&#160;27, 2020 and December&#160;29, 2019, respectively.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">           (7)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">    Ongoing fair value adjustment amounts are primarily recorded in Research and Development expense. </span></div><div style="padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company recorded a contingent consideration reversal of $<ix:nonFraction unitRef="usd" contextRef="i3da82ce120b1479b8130fc2f67172a04_D20191230-20200927" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfOTcxNw_52760b1f-928e-461d-b42c-f051a23da7c7">1,148</ix:nonFraction> million related to the timing of certain developmental milestones associated with the Auris Health acquisition. The reversal of the contingent consideration was recorded in Other income and expense. For additional details see Note 10 </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">t</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">o the Consolidated Financial Statements.</span></div></ix:continuation></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span><br/></span></div><ix:continuation id="i5710f50860c04168b9f06fe0a15cc22d" continuedAt="i90ee81ee546c4775aa875e83e32f623e"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIxMDc_698f4943-3d0c-43f2-afed-e9ade7fa7115" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company's cash, cash equivalents and current marketable securities as of September&#160;27, 2020 comprised:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.849%;"><tr><td style="width:1.0%;"></td><td style="width:22.208%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.727%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.153%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.531%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.153%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.381%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.153%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.727%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.454%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.478%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.153%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.182%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrecognized Gain</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrecognized Loss</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash &amp; Cash Equivalents</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current Marketable Securities</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if1a4bb7f18ff46a49d5c2a061670c81f_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMS0xLTEtMS0w_0fce78ed-e4c5-4cb3-ac7d-90129c6c3fc4">2,231</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if1a4bb7f18ff46a49d5c2a061670c81f_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMS0zLTEtMS0w_4223a5e4-0ccd-43b9-a392-6cde4bc2d487">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if1a4bb7f18ff46a49d5c2a061670c81f_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMS01LTEtMS0w_9e80ad7d-41a9-4d3b-8f2e-9964e894917d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if1a4bb7f18ff46a49d5c2a061670c81f_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMS03LTEtMS0w_b745c97d-cf51-4419-a38b-35e5843ba56b">2,231</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if1a4bb7f18ff46a49d5c2a061670c81f_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMS05LTEtMS0w_368b2743-9ddf-4b99-917a-6d5fc6e57d42">2,231</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Non-U.S. sovereign securities</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie37a55c0ed28487097c8fd0b33e77426_I20200927" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMy0xLTEtMS0w_0163b111-de79-4c14-9de1-ec4b53c54781">647</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie37a55c0ed28487097c8fd0b33e77426_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMy0zLTEtMS0w_44388b9e-69ec-4657-834c-f96383c26547">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie37a55c0ed28487097c8fd0b33e77426_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMy01LTEtMS0w_fdaace19-ade4-4cbd-a606-fc04f8218a79">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie37a55c0ed28487097c8fd0b33e77426_I20200927" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMy03LTEtMS0w_35af3061-f685-4006-952d-0697f719177c">647</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie37a55c0ed28487097c8fd0b33e77426_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMy05LTEtMS0w_c7bde271-5262-4e6b-9df9-f1b6df42bbf5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie37a55c0ed28487097c8fd0b33e77426_I20200927" decimals="-6" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMy0xMS0xLTEtMA_008a64e1-959f-4481-82d0-f51228e1ee2a">647</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. reverse repurchase agreements</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic8a100e64514437c862f0d1cd3d7ab0d_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNC0xLTEtMS0w_41104e61-1652-48a6-a9e6-9fabbe57eac2">3,094</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic8a100e64514437c862f0d1cd3d7ab0d_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNC0zLTEtMS0w_d974bdc4-0e19-4a55-bb15-e31f017486fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic8a100e64514437c862f0d1cd3d7ab0d_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNC01LTEtMS0w_c1eae612-d251-4444-a49d-80c4878b34fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic8a100e64514437c862f0d1cd3d7ab0d_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNC03LTEtMS0w_12482149-9884-481d-aef9-63a6454645f2">3,094</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic8a100e64514437c862f0d1cd3d7ab0d_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNC05LTEtMS0w_6ada3e61-0c90-4b32-b362-977fd1b08294">3,094</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic8a100e64514437c862f0d1cd3d7ab0d_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNC0xMS0xLTEtMA_d20df36a-e55d-4b20-8d01-4642be56f6b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other reverse repurchase agreements</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iac96af33cfc442a5917405a3caa3be5c_I20200927" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNS0xLTEtMS0w_1bc4d07b-3535-48a3-b0e7-a7705a5f70bc">430</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iac96af33cfc442a5917405a3caa3be5c_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNS0zLTEtMS0w_6ff86e4a-d5b6-4e55-b214-685ae269b72b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iac96af33cfc442a5917405a3caa3be5c_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNS01LTEtMS0w_fa9b8dd8-1ef5-47ef-9d82-0f1be02f7b66">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iac96af33cfc442a5917405a3caa3be5c_I20200927" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNS03LTEtMS0w_f4a41f7d-6559-488e-b289-17c424bd28f5">430</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iac96af33cfc442a5917405a3caa3be5c_I20200927" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNS05LTEtMS0w_f6f5029e-5d04-48aa-b774-ab75cb6f62b6">430</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Corporate debt securities</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib6d334f7d7524737a5a1e0b9b48367dd_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNi0xLTEtMS0w_52c65d7b-5c61-4542-93ed-6c0bfd8b63e5">1,843</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib6d334f7d7524737a5a1e0b9b48367dd_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNi0zLTEtMS0w_21853a91-7497-42a5-ae99-1b053c836817">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib6d334f7d7524737a5a1e0b9b48367dd_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNi01LTEtMS0w_cf208744-1f7a-46d8-9bcb-2c70c55855b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib6d334f7d7524737a5a1e0b9b48367dd_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNi03LTEtMS0w_cbd0a6bd-ca67-457f-a512-e4dd63252d1a">1,843</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib6d334f7d7524737a5a1e0b9b48367dd_I20200927" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNi05LTEtMS0w_df0a9da3-b00e-40b5-a158-cfcea9a8c697">571</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib6d334f7d7524737a5a1e0b9b48367dd_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNi0xMS0xLTEtMA_f3a1f828-18a5-4804-970a-76b4428b6649">1,272</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e99c71717f340a685ff09c95429db3f_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNy0xLTEtMS0w_bacb3b40-5b0e-42fa-a226-80e00df4dc6b">8,485</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e99c71717f340a685ff09c95429db3f_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNy0zLTEtMS0w_589d685a-9611-45a0-b648-07a7ed4bfa07">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e99c71717f340a685ff09c95429db3f_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNy01LTEtMS0w_578c5070-4a6c-407d-9d06-ef18cce2cc13">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e99c71717f340a685ff09c95429db3f_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNy03LTEtMS0w_fe896c86-36e5-4621-966a-7a4c5b85cf49">8,485</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e99c71717f340a685ff09c95429db3f_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNy05LTEtMS0w_5a568059-66cd-45ee-81da-fac9acf44afd">8,485</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Time deposits</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2a2ca294220e4bf68ba6b1a11fa1739a_I20200927" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOC0xLTEtMS0w_99bbf28e-1b19-479a-a6f4-cb05da8be76d">660</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2a2ca294220e4bf68ba6b1a11fa1739a_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOC0zLTEtMS0w_9b6f72de-2c5c-4a82-b065-45304c80b601">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2a2ca294220e4bf68ba6b1a11fa1739a_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOC01LTEtMS0w_26e0a0ec-6442-4f32-b218-48da9e9eefbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2a2ca294220e4bf68ba6b1a11fa1739a_I20200927" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOC03LTEtMS0w_ba88e142-0471-4971-ab01-7f357870b32e">660</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2a2ca294220e4bf68ba6b1a11fa1739a_I20200927" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOC05LTEtMS0w_8e0cce1d-cce7-49b3-8472-db4750295b02">660</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Subtotal </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7828932564cc42808d3bc1319ed98668_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOS0xLTEtMS0w_a89e6a66-2e94-4770-8346-43f0e2d62c22">17,390</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7828932564cc42808d3bc1319ed98668_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOS0zLTEtMS0w_3c8d809c-ef62-42fc-aaf0-e3fe1d234168">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7828932564cc42808d3bc1319ed98668_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOS01LTEtMS0w_a2435e70-e2bd-49dd-8e58-a0e2aa1d39aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7828932564cc42808d3bc1319ed98668_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOS03LTEtMS0w_36adad4a-5d77-43de-8bc5-e2c05ffd22f8">17,390</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7828932564cc42808d3bc1319ed98668_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOS05LTEtMS0w_b3690da2-a0e1-4c71-a4fb-cda1e3f756e4">15,471</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7828932564cc42808d3bc1319ed98668_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOS0xMS0xLTEtMA_6cc04b7c-2d4c-41b5-b9ba-6ca76900cab0">1,919</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized Gain</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized Loss</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. Gov't securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1ff57a4b24ad4de3bb98f30bf0dbc693_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTItMS0xLTEtMA_37a3f6e8-cf2f-4db3-9462-c0f013fe0277">13,133</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1ff57a4b24ad4de3bb98f30bf0dbc693_I20200927" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTItMy0xLTEtMA_070ed120-749d-40e6-880a-c4028b4a9a4a">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1ff57a4b24ad4de3bb98f30bf0dbc693_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTItNS0xLTEtMA_f9b8aaca-e376-44a2-a7b2-5fb3741cd174">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1ff57a4b24ad4de3bb98f30bf0dbc693_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTItNy0xLTEtMA_0c741243-2512-44c3-9b8e-1cd5d3523bc6">13,134</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1ff57a4b24ad4de3bb98f30bf0dbc693_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTItOS0xLTEtMA_9687cc0c-09d8-471d-99a9-d56ade70d22a">3,483</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1ff57a4b24ad4de3bb98f30bf0dbc693_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTItMTEtMS0xLTA_c0d0ddba-e4d0-4d3d-a5a6-632a5fc0d363">9,651</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other sovereign securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2280350b15814286becfc035a03921a3_I20200927" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTMtMS0xLTEtMA_46872f54-e206-4152-93f7-3f553c8ad5f1">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2280350b15814286becfc035a03921a3_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTMtMy0xLTEtMA_aecdc94a-4eb6-4bb4-929a-ee81d22b3b2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2280350b15814286becfc035a03921a3_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTMtNS0xLTEtMA_58a313ce-6ca1-4261-b9f2-c9d16b9b7d6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2280350b15814286becfc035a03921a3_I20200927" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTMtNy0xLTEtMA_e9364a89-621c-41b6-a945-282fd7566af4">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2280350b15814286becfc035a03921a3_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTMtOS0xLTEtMA_a1f1a9a7-df72-462b-b5d0-6b89a201d6e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2280350b15814286becfc035a03921a3_I20200927" decimals="-6" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTMtMTEtMS0xLTA_5009a4d7-7946-45bf-ac5e-763da238f40f"><ix:nonFraction unitRef="usd" contextRef="i2280350b15814286becfc035a03921a3_I20200927" decimals="-6" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTMtMTEtMS0xLTA_dbe98eab-a59b-4aaa-b165-5f4a1c411a0e">10</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate debt securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id5f928f37d1542b3bf86cc736479d215_I20200927" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTQtMS0xLTEtMA_012e2431-b1a1-45f2-9883-4d24f4c7fc8c">247</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id5f928f37d1542b3bf86cc736479d215_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTQtMy0xLTEtMA_95e8938c-dc25-4099-a0a2-4f0ce9a75635">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id5f928f37d1542b3bf86cc736479d215_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTQtNS0xLTEtMA_5ecad952-1203-4927-9c1c-c7cace471ede">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id5f928f37d1542b3bf86cc736479d215_I20200927" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTQtNy0xLTEtMA_f86fa7f5-c7f2-4bad-aa31-e2863684c59d">247</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id5f928f37d1542b3bf86cc736479d215_I20200927" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTQtOS0xLTEtMA_52049649-cd89-487e-a940-1993a7f8fedd">11</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id5f928f37d1542b3bf86cc736479d215_I20200927" decimals="-6" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTQtMTEtMS0xLTA_5a38bb4f-d689-4545-964f-95d73efa6a7d">236</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;Subtotal available for sale debt</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ffd52d1e0664f24b3f3822ede7a0cd1_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTUtMS0xLTEtMA_be543530-9915-4e4f-91bc-3f1e307286b4">13,390</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ffd52d1e0664f24b3f3822ede7a0cd1_I20200927" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTUtMy0xLTEtMA_e956b70c-f633-4195-b5aa-157be2a3938c">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ffd52d1e0664f24b3f3822ede7a0cd1_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTUtNS0xLTEtMA_3323cdff-ffc9-41f5-9fd0-bcfca248879f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ffd52d1e0664f24b3f3822ede7a0cd1_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTUtNy0xLTEtMA_b6866e9c-4da8-4dbe-8cfe-0109cd8930a9">13,391</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ffd52d1e0664f24b3f3822ede7a0cd1_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTUtOS0xLTEtMA_4dd61ea6-347e-4b60-8e55-a5161afc3ef0">3,494</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ffd52d1e0664f24b3f3822ede7a0cd1_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTUtMTEtMS0xLTA_975a2b34-33b3-4bd6-8bdc-1eedec26b307">9,897</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total cash, cash equivalents and current marketable securities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTYtMS0xLTEtMA_1db4ddd1-ac01-4d39-8479-64819eda314d">30,780</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" name="jnj:CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTYtMy0xLTEtMA_ee0eea39-42a5-47a2-8073-f648be5eba84">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:zerodash" name="jnj:CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTYtNS0xLTEtMA_5786552f-0ec3-4646-bc60-908f5243c980">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="jnj:CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTYtNy0xLTEtMA_f4b2cb8b-2ad0-42aa-ad6f-833dc33c3b18">30,781</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTYtOS0xLTEtMA_75f9ae33-9503-4b9c-8aa8-2e3f7aeb0abd">18,965</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTYtMTEtMS0xLTA_03adcb4a-0d61-43d0-9e2e-badd75196b80">11,816</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Held to maturity investments are reported at amortized cost and gains or losses are reported in earnings. </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Available for sale debt securities are reported at fair value with unrealized gains and losses reported net of taxes in other comprehensive income.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the fiscal year ended December&#160;29, 2019 the carrying amount was the same as the estimated fair value.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fair value of government securities and obligations and corporate debt securities was estimated using quoted broker prices and significant other observable inputs.</span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIxMDk_308b51b3-921c-4e07-af46-ead2fc07f749" escape="true">The Company classifies all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months from the date of purchase as current marketable securities. Available for sale securities with stated maturities of greater than one year from the date of purchase are available to fund current operations and are classified as cash equivalents and current marketable securities.</ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIwNjg_95f1d9b0-a273-4651-b8d2-9fee428890dc" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The contractual maturities of the available for sale securities as of September&#160;27, 2020 are as follows:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:76.426%;"><tr><td style="width:1.0%;"></td><td style="width:43.104%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:2.829%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:22.279%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:2.157%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:25.031%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost Basis</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Due within one year</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjgxNTAzMmM1ODNiZTRjNDE4MDBmNDU4NmQ1MDU5NDRhL3RhYmxlcmFuZ2U6ODE1MDMyYzU4M2JlNGM0MTgwMGY0NTg2ZDUwNTk0NGFfMS0yLTEtMS0w_1d329857-fdd6-4574-9dda-8f77ba66663f">13,368</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjgxNTAzMmM1ODNiZTRjNDE4MDBmNDU4NmQ1MDU5NDRhL3RhYmxlcmFuZ2U6ODE1MDMyYzU4M2JlNGM0MTgwMGY0NTg2ZDUwNTk0NGFfMS00LTEtMS0w_23fa0567-1994-4efd-82a4-d3f82fc26f45">13,369</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Due after one year through five years</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjgxNTAzMmM1ODNiZTRjNDE4MDBmNDU4NmQ1MDU5NDRhL3RhYmxlcmFuZ2U6ODE1MDMyYzU4M2JlNGM0MTgwMGY0NTg2ZDUwNTk0NGFfMi0yLTEtMS0w_f2b62543-7726-43a1-9f99-0f5567b0e32d">22</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjgxNTAzMmM1ODNiZTRjNDE4MDBmNDU4NmQ1MDU5NDRhL3RhYmxlcmFuZ2U6ODE1MDMyYzU4M2JlNGM0MTgwMGY0NTg2ZDUwNTk0NGFfMi00LTEtMS0w_0c524f55-2e9b-423b-9927-f13f638ed356">22</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Due after five years through ten years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjgxNTAzMmM1ODNiZTRjNDE4MDBmNDU4NmQ1MDU5NDRhL3RhYmxlcmFuZ2U6ODE1MDMyYzU4M2JlNGM0MTgwMGY0NTg2ZDUwNTk0NGFfMy0yLTEtMS0w_aef7b77c-57d7-4c2f-b797-19f8f728a955">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjgxNTAzMmM1ODNiZTRjNDE4MDBmNDU4NmQ1MDU5NDRhL3RhYmxlcmFuZ2U6ODE1MDMyYzU4M2JlNGM0MTgwMGY0NTg2ZDUwNTk0NGFfMy00LTEtMS0w_74484454-4401-4ab3-bbd7-bb2633ebc18f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjgxNTAzMmM1ODNiZTRjNDE4MDBmNDU4NmQ1MDU5NDRhL3RhYmxlcmFuZ2U6ODE1MDMyYzU4M2JlNGM0MTgwMGY0NTg2ZDUwNTk0NGFfNC0yLTEtMS0w_21414077-3bce-440b-b70c-971aa7d7fec3">13,390</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjgxNTAzMmM1ODNiZTRjNDE4MDBmNDU4NmQ1MDU5NDRhL3RhYmxlcmFuZ2U6ODE1MDMyYzU4M2JlNGM0MTgwMGY0NTg2ZDUwNTk0NGFfNC00LTEtMS0w_d860dc0f-7ce2-429f-b0d1-3b995936bed9">13,391</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span><br/></span></div><ix:continuation id="i90ee81ee546c4775aa875e83e32f623e" continuedAt="iabf5559e6c224d3db40699b5a25cdaba"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIwOTk_b8c5c877-4372-4894-a779-8d3f8f500570" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Financial Instruments not measured at Fair Value:</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following financial liabilities are held at carrying amount on the consolidated balance sheet as of September&#160;27, 2020:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:79.838%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.533%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.137%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.533%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.259%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Financial Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current Debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idce2d47fd1804a3f98973754ffded2a3_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNC0yLTEtMS0w_094e22be-a15e-4ef4-b843-f8c4a51a829c">5,078</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i935d5ef44a4142eb80b98b85c665cdae_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNC00LTEtMS0w_4649d700-5f06-4b4f-9479-363ccff41ec8">5,093</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-Current Debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="ic1916a7de9304cc59832dd469de21cc9_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNy0wLTEtMS0wL3RleHRyZWdpb246ODI4MWVkZjI3YTUwNDg4YTg3ODhmNTAxOWIxYjllM2RfMTA0NDUzNjA0NjM5MDE_70f21d37-dc12-4723-9274-571dec54c7aa">2.45</ix:nonFraction>% Notes due 2021</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if11c31b2d6a44925b98b6b61c64e2daa_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNy0yLTEtMS0w_09c024c7-46cf-408c-b4a3-102aa0ad71c5">350</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1647f236f4204443831bf07df847e56f_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNy00LTEtMS0w_1a4cd578-1b2d-48df-995f-681b515c9256">358</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i0fe7d6eeef6547a081274e2ede3f5ff9_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfOS0wLTEtMS0wL3RleHRyZWdpb246NWRkYjUxYWE1N2I4NGVhMjkzNjQ4ZDYyYzBkMGMzYzVfMTA0NDUzNjA0NjM5MjA_885be458-a295-4a8e-b475-b32659466514">0.250</ix:nonFraction>% Notes due 2022 (1B Euro 1.1641)</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib9b43d320de345feb114bcda4919416f_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfOS0yLTEtMS0w_b327da5b-694f-4fdb-8b95-64fbba35eb9f">1,163</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1538e33ce6b24f88a81816a950b4b247_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfOS00LTEtMS0w_7d3750b2-4960-44ba-b5c7-d08c7f85da20">1,172</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i056990540d404780b0b73129befbc636_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOmIxMTBhM2U3YzMwNzQ2YzFhYjNlNzU4YTQ2NDA0YmFiXzEwNDQ1MzYwNDYzOTAx_2f7be948-f6d5-4531-a782-b733b8fd6730">2.25</ix:nonFraction>% Notes due 2022</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19d6e666640143e29c89b138db0f6d22_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTAtMi0xLTEtMA_735762cd-1efb-4180-b331-97f6181914a4">998</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ica2fd4caec424e239a481a2bcaf79e6b_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTAtNC0xLTEtMA_ad08627d-407b-4043-b6ce-785fb76dd0d6">1,025</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="iafefab750a92478c87896b310434e7fe_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjIxNTRkNTUwMjg2ODQ4OWJiYTQzYjdlMGE4N2I5ZGFhXzEwNDQ1MzYwNDYzOTA2_ba89ab9a-7759-4711-8be6-af19600fca73">6.73</ix:nonFraction>% Debentures due 2023</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2e92a5dbc9214a8d9f87742c76176ff2_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTEtMi0xLTEtMA_faf04f1d-eaea-42d8-b702-b85973a618e4">250</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieea3231abf62476ea5bcf5de0b5578f9_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTEtNC0xLTEtMA_56a9b66e-ecbd-45e9-9ed5-21ea1ab1d81b">299</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i02e32328220f4303a40455ed4b2da979_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTItMC0xLTEtMC90ZXh0cmVnaW9uOmI1MmVhYjE0YTVjOTQwODZhYWMxNWRjOTJjYjQzMDhhXzEwNDQ1MzYwNDYzOTAz_59498193-24d2-45c3-98c1-9a9fb4455564">3.375</ix:nonFraction>% Notes due 2023</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if268019a4de94135a6b62c5f0e256440_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTItMi0xLTEtMA_71b37674-c148-4dc1-acdb-56cf1cebda61">803</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i13cce8a254e449e083f46c20c1bbe797_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTItNC0xLTEtMA_2d1ece77-9e8e-4728-84de-73cabf2095ea">881</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="ieef980882cf74f48864a6d1029945cef_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjNhNTZjNDEzN2VhMjQ2MjRiMjZmOWVhYTY2ZGY5NTFjXzEwNDQ1MzYwNDYzOTAx_05d19f64-6805-4eb1-a34a-68098e714ac3">2.05</ix:nonFraction>% Notes due 2023</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i536828fe3d9e41f894d6e23d6416769c_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTMtMi0xLTEtMA_7e729916-74a8-484b-8b8d-d8d00230df75">499</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie7c53e72904247ce8947b14425657966_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTMtNC0xLTEtMA_969ce178-5921-46f9-8f8b-ff0aa0423634">518</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="id1ca9536dcaf404e8afcb2da4501ac6a_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOmEwOWNhNmE2MDc2NjRlZWE5NWU3YjRhMzgzN2RmNjY2XzEwNDQ1MzYwNDYzOTIz_1a75b076-53f9-427c-8894-a9c852ce9fef">0.650</ix:nonFraction>% Notes due 2024 (750MM Euro 1.1641)</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie2e2c07a5d624a8598c2fdc999a47461_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTQtMi0xLTEtMA_14cc922f-e5e1-4511-92ea-39bbfad5a493">870</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i01dae954e6b6449b91fb72ad27b9bc51_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTQtNC0xLTEtMA_a2b384b2-a9f9-4eb5-b95a-0be24f286dd9">899</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i136b1f0e6fd14acaa8a68b132e09a0a6_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjIwZDI3OTM5MTJjMTRhMTBiY2I4YWYyYTQzMzNjOGYzXzEwNDQ1MzYwNDYzOTIx_4c9c3301-63e2-4220-b282-a0d90aed5368">5.50</ix:nonFraction>% Notes due 2024 (500 MM GBP 1.2757)</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i645cefa2669b4e44b397f9618653aa80_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTUtMi0xLTEtMA_9a4779df-a9c7-4a46-ad14-15d0d72fa1b4">634</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3150eb2704984084ac3204e1f7084267_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTUtNC0xLTEtMA_2ee29772-b03f-4be9-bb16-62292ec76317">768</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i6f424501f76142b7a914b49ea7286203_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjMyNDFhMzg1YTdkNTQ1MzRhNmFhYTQyOGNhZmMwNGEwXzEwNDQ1MzYwNDYzOTAz_1d22be4f-cf2b-489f-93b2-b0183431f0e0">2.625</ix:nonFraction>% Notes due 2025</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i76b7bfb69eb9403b99deb7e7eef8d40a_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTYtMi0xLTEtMA_7fb76537-4629-40d8-ba5e-18aea4ad82fe">748</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i52179e2f9d674e078511c80f498c6c0a_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTYtNC0xLTEtMA_6d19d24f-7887-4a2e-bb63-e7205cd2445a">813</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="idbc85d394a774ed9868d5b95e674664e_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTgtMC0xLTEtMzA0Ni90ZXh0cmVnaW9uOmVmYzdkYWY2YmU4ZTRhZjNiNmIyMzMxYWQ2OTY1NmMyXzEwNDQ1MzYwNDYzOTA3_bb97c625-ea6f-4091-b91b-9ab3d7dd8dfc">0.55</ix:nonFraction>% Notes due 2025</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id4dbf413e19e4cef9e7278a102ee7157_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTgtMi0xLTEtMzA0Ng_f4fe77d8-5a31-4ffb-b322-c058cede098d">996</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i078e08bd46af4e3f9e215207cc204105_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTgtNC0xLTEtMzA0Ng_e84a3044-ae5c-4333-a04a-70a806f37ee8">990</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i159981f414cb4bb18af0fbaee7927deb_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjkzZTg4YWZlZmQwZTRkYWVhMjg3M2UzMjQ0YWUwMjRjXzEwNDQ1MzYwNDYzOTAx_c9f9b340-ce4a-49e6-b9d6-070665c2816c">2.45</ix:nonFraction>% Notes due 2026</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i668b41dcf7f44976bf86a2f9db667fb5_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTctMi0xLTEtMA_442bba35-c2ac-4876-a639-5f7bad6ba51a">1,994</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if1eeb605be014548afd510c0c8aa8eb3_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTctNC0xLTEtMA_d9160354-794b-4bf6-835d-d0883cc1067f">2,180</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i165c4f1ce2ed4d76ab34c44c41db1255_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmU1YzEwMjRiYjk0YzQwZjFiMjk5MzU3MTcxY2E0YmI5XzEwNDQ1MzYwNDYzOTAx_6dfcb6da-ab1c-4f8a-bc7f-22305c5b1841">2.95</ix:nonFraction>% Notes due 2027</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib2686d72e0c343febe8ff2bd5ac5e63a_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTgtMi0xLTEtMA_d2a82e25-5241-4093-8132-4497b9aa5b5d">997</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iab1049268d7f4fe8b4d96cce87cafc93_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTgtNC0xLTEtMA_83cf8cb1-b40b-43d6-84c8-160be4956adc">1,119</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i6059fa37b091494880a716afab863d00_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjItMC0xLTEtMzA1Ny90ZXh0cmVnaW9uOmRhYTFlZWY4MmZhNzRlMTE4MWE1YzFjYzZlNGRhZDdmXzEwNDQ1MzYwNDYzOTA0_02bce687-ab83-4ad6-b565-2289f42a33bb">0.95</ix:nonFraction>% Notes due 2027</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifd980a324e5844119be04d1bb8b21864_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjItMi0xLTEtMzA1Nw_cd322b4b-16b3-44e1-97c3-985f28c8932e">1,494</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic8948fc5022044e38940be61c4706a21_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjItNC0xLTEtMzA1Nw_4625e772-2252-4236-a468-723e938786c7">1,510</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="iae91b5c8065840b89f68ae84c662b898_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjNmMWEyYjVlZDM1OTRkYWI4MDQ4NTU5NmFkYmExNTUyXzEwNDQ1MzYwNDYzOTAx_e8dce0d5-07f8-4b18-8604-05120107348e">2.90</ix:nonFraction>%&#160;Notes due 2028</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia36b73a057224ba4affcfc6bb3cea2e1_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTktMi0xLTEtMA_c70a32fb-f461-4af5-a6f4-f8c588a50524">1,494</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6e79dc01a22a42a1b246532434f100c4_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTktNC0xLTEtMA_56f967c8-1796-4cb1-9c2d-76eff00ffaf9">1,680</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="if7a2d03254ee4d5f9a357de70108e5b0_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjVkOTdhYzQwYjU1NzQwZTFiN2VlMjdiNzdhOTBkYWVhXzEwNDQ1MzYwNDYzOTIz_a3b78b2e-01ca-48ca-b576-edabe72c46d6">1.150</ix:nonFraction>% Notes due 2028 (750MM Euro 1.1641)</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i21be7fdecb314fed8cd5a7cb7f876fdf_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjAtMi0xLTEtMA_62ef1028-4e8f-4459-9095-c314c9a6514e">867</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i51f2a2865858445bb19a36565773cc28_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjAtNC0xLTEtMA_44bdc4e1-a0f6-4025-b467-0011bf43dcf6">960</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i9acb3bf537f748f9b2c3359991790afe_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjUwMDcxY2I4MjAwMzQzMWQ4OGFmMTYwYWY2MjFmZWFmXzEwNDQ1MzYwNDYzOTAx_5bf489a1-fa61-4cec-90f7-74d3ef1268f8">6.95</ix:nonFraction>% Notes due 2029</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i35c7685f5dd046aeb031adc37a8ca784_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjEtMi0xLTEtMA_058b229a-e6ff-42c5-8ee9-9f66638668fd">297</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1333214536b64c51ab1dacec5ddd05c6_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjEtNC0xLTEtMA_2a49a1a0-0079-41b2-99c3-6df6335bea65">441</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i1245a84acd304e199ac2b7dc8d467d7e_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjctMC0xLTEtMzA4Ny90ZXh0cmVnaW9uOjE2ZDNkOTg1OGZiNDRkNjlhZmI3NGYyZTU4ZjEyMDU5XzEwNDQ1MzYwNDYzOTA0_aa085b08-7a0c-48b6-92b2-b5e83caa98e8">1.30</ix:nonFraction>% Notes due 2030</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icca8ff318ac34efc92f4216ddfb91fb2_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjctMi0xLTEtMzA4Nw_1b0b2814-e74f-4b8a-bc5c-f351541a13b5">1,743</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ea632070b0e40e898b52619bced26b7_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjctNC0xLTEtMzA4Nw_24f448af-5085-4cd8-9d28-7b322c60f84d">1,739</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="ia1378408d96d46e39591826c2abb98dc_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjItMC0xLTEtMC90ZXh0cmVnaW9uOjhjMGFjYjM5ZWE0NTQ2YmI5ZWU5OTY5MTgzZTJlNDQ5XzEwNDQ1MzYwNDYzOTA2_441e3d26-40bd-4b90-a7eb-7544b9488670">4.95</ix:nonFraction>% Debentures due 2033</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id5f87b6d74d749babe28b84569bdf760_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjItMi0xLTEtMA_63436fc9-d0e6-4214-97a4-8881da79588a">498</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i995150be58c746e482284b146887f7d3_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjItNC0xLTEtMA_6d247f31-4524-418b-b329-dd6c29752f1c">690</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i2622b7e579a8492eb15ec639424f7c89_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOjNlOGM2YTM4NzU4MTQ0ZDk5YjJlZmVlNjA3YjBlMGM5XzEwNDQ1MzYwNDYzOTAz_1b1637bf-f499-41da-808f-93315c24aa22">4.375</ix:nonFraction>% Notes due 2033</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id36151c33f4848bbbcff81875e541568_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjMtMi0xLTEtMA_95297b06-bc2f-4586-8c6c-f44d7aba3198">855</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7e0d64b50fd84e3a8c7f405b55ccc1c7_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjMtNC0xLTEtMA_f818188a-0536-47d7-b38c-8e28c7c62233">1,128</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="id41e1a92e44e4a829be6caa81c1fccec_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjQtMC0xLTEtMC90ZXh0cmVnaW9uOjU2MmU1YmFlNmJiODRlOTBhN2IzOTc5ZGRhNmRhMzI5XzEwNDQ1MzYwNDYzOTIy_cfa340a4-de15-4e25-bb46-85685dbb45d4">1.650</ix:nonFraction>% Notes due 2035 (1.5B Euro 1.1641)</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib7803914447c4a189138f7ee1b3e91b1_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjQtMi0xLTEtMA_6b38264d-3c9c-47d9-8770-ed5025ec20cd">1,731</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i256f4cdb5243490987a08f155c79ea6b_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjQtNC0xLTEtMA_2ab6f982-e68d-4efa-aef2-03aed6ccedc3">2,101</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i62ebec4387da4562b9e6654db09a6b96_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjU4YmZjYmFkMGY5ZDQxNDQ5NDg0NmVlZWQ3Yjk3NDZlXzEwNDQ1MzYwNDYzOTAx_1175cf9d-7b85-4da0-ba69-27358d4f8461">3.55</ix:nonFraction>% Notes due 2036</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i69ab97fe3bda4a55b6837fd20fb4462a_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjUtMi0xLTEtMA_5cc142f2-bac6-43b4-bc73-94f0a9a1a643">989</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i480827ff0c054590abd0ec468b49c4e6_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjUtNC0xLTEtMA_0aad9a54-c109-470a-a045-48d6587e4272">1,197</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="ia5536eadd4c94ef6a5ab2937cc959359_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjQ0Nzc5ODQzOGZmYTRmNWJiZjViYjEwZjc5ODVlMDM1XzEwNDQ1MzYwNDYzOTAx_8cea5ef2-c876-4e36-92cc-d2a26a9d38bc">5.95</ix:nonFraction>% Notes due 2037</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if1b4030a20b24ff0a711318c1a843cce_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjYtMi0xLTEtMA_16be318a-4603-4927-a79e-52e480db5f7f">992</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1da6151136fb464ca1c2c5796b81d7fc_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjYtNC0xLTEtMA_3a31d47f-a8b7-4c1e-8d1f-a24b310d837c">1,536</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="ic8ef119f549949d08c1ae0df1c64dac7_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmU1MzQwYzY0MDE2YjQ3NmE5ZmMyOTA1NDU0MTc4MzM1XzEwNDQ1MzYwNDYzOTAz_32cc5f77-9db9-46ff-9d01-ba7cc73913be">3.625</ix:nonFraction>% Notes due 2037</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i86d6509ed13b4aaf912a2823edcb1029_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjctMi0xLTEtMA_8d43c12e-d643-4a6c-918c-7e88b2edcc58">1,488</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie8a5b10c02c54e47ab7d11d7d166c538_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjctNC0xLTEtMA_a09ba856-893b-493d-ae81-0e4ec62e7e71">1,819</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i9aa446f74b2d40f4aedc83ea2ea53439_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOmU1ZGNhMjRkODRhNzQ1ODZhMzNlNTFlZWM1ZGM3YWEzXzEwNDQ1MzYwNDYzOTAx_e4c9e294-56b3-4392-a6dd-e7154e5dc455">3.40</ix:nonFraction>%&#160;Notes due 2038</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4f66b72f3c7f424b8a380c66e8da7d27_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjgtMi0xLTEtMA_13b48c7a-a896-477e-94f6-7022a57c6c46">991</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i48a1bd53e02644e6b26acc106519b804_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjgtNC0xLTEtMA_e6911a13-521e-4325-9ecd-54fba535226e">1,176</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="ic49fdd1ce30c46f8badb4ff4bd1017bd_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjYzMjFhYzlmM2UzYTRiZDFhNzJiODI2YmMzYjBlYmZhXzEwNDQ1MzYwNDYzOTA2_1372ff01-468e-4bf2-820e-46ceb2a575c8">5.85</ix:nonFraction>% Debentures due 2038</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibd0f7065260a48cda35109d9ae5386a1_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjktMi0xLTEtMA_c277bdb9-2e87-40bc-8253-7610fc1eece6">696</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5951d9504b1a4dff8f25e5796b4c0a9a_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjktNC0xLTEtMA_376805f2-613a-40d3-a8f1-0380610ccf8d">1,094</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i387cbe08835047789169cf51f45ee5fe_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjA5ZmJkOWFhYmIzODQ5ZGE4NmRhYmI5NzVmYjE1NWIxXzEwNDQ1MzYwNDYzOTA2_61908b7d-429f-4114-9ba2-7d6390aa523a">4.50</ix:nonFraction>% Debentures due 2040</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ide6e5e064d024312addc5538bdaa7c85_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzAtMi0xLTEtMA_e9d4d4fe-f959-4801-80a4-fe9f6d6259e2">539</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib69bdfb1b7b94a449af780c7ad54b9da_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzAtNC0xLTEtMA_fdf6f7aa-c708-423a-9a54-ef690e3cadaa">737</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="idcd460ebbac7457b8cb0a76ce59423a5_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzgtMC0xLTEtMzA5OS90ZXh0cmVnaW9uOjIyMDk1MTFiYjNiYzQ2NDU5NGNkMTBjZWVlNTE0MjhkXzEwNDQ1MzYwNDYzOTA0_115dac3e-0828-4cc7-a61f-62669978c077">2.10</ix:nonFraction>% Notes due 2040</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0c89e14a0fa3403581aa0e9723a4286c_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzgtMi0xLTEtMzA5OQ_ee836d60-4573-42d1-a005-bc8213f29567">986</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i98dd15586d034500902f9f3c99a576a5_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzgtNC0xLTEtMzA5OQ_105f9cb9-65fc-48bb-b89a-d20fc6163da8">991</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i324a2081f5854fad8130ebd189647549_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmMxNTc3YjA5NzZhYTRhNjE5OGJhYjY1MjYxNzMzYzk2XzEwNDQ1MzYwNDYzOTAx_55e7ad9f-6e3d-426a-9b56-1121f9e644ab">4.85</ix:nonFraction>% Notes due 2041</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1eb3f36ba8a74f5480d62d0a81bbc354_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzEtMi0xLTEtMA_11904038-cef4-4d7f-87b4-743c79af6187">297</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b41d3fa848d4b0ea4f78009aec60a63_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzEtNC0xLTEtMA_b920c882-9e20-4842-9696-441b7c5d53b6">421</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i5bdf805eaea4472d81e2786f92535e75_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmU2YzVmODQxZjdjNDQ3NmFiNDM2Mjk3NzBiOTA1NmQ3XzEwNDQ1MzYwNDYzOTAx_01240cfe-fd5d-4ecc-9039-8121aa536bc8">4.50</ix:nonFraction>% Notes due 2043</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i24b0208298044a269325b9653684ec98_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzItMi0xLTEtMA_d7bbfdfb-d595-4fc2-b5ed-b7b35242f091">495</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id4ff4a9f1fb34cd2b7cbea524a570fba_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzItNC0xLTEtMA_e814f1d2-14d5-4911-87b5-f2215f303399">689</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="if02c9f9f84d64647b122e66b2b1a6f36_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjY1MDQwM2FiMDViNTRiMmM5NTRlMDlmMzYyOTNhMTE2XzEwNDQ1MzYwNDYzOTAx_2add1e05-d9f8-4609-bd13-6de074c7e8c8">3.70</ix:nonFraction>% Notes due 2046</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i171dded75a42462f8691992184163a6a_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzMtMi0xLTEtMA_d0b37678-e338-4698-a030-585fd40c4c42">1,974</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4e60bc8e3f0942bd832fc02168754abe_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzMtNC0xLTEtMA_2acfb1fc-ce8d-4811-b7f7-43ec0cbb391d">2,478</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="ib3acfd6e023d48c49956f11aca1794a8_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjhjNTcxNTVkZTBlNDRjNTc5MmJjMDY5ODcxYzNmNjNiXzEwNDQ1MzYwNDYzOTAx_9bfc7b7c-89ef-4fe5-afa1-85466dc8340c">3.75</ix:nonFraction>% Notes due 2047</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia8fdd90a9a534e91a456c1d33c226809_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzQtMi0xLTEtMA_3507d67b-ea5a-47e5-909b-cea6dc65d078">991</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if3dc5cdf91884ac5a55987be998ef035_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzQtNC0xLTEtMA_8c02c8f0-a03c-49ba-8b12-ef4488beb795">1,258</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i2dc08c035fa24dcca70c9fdd3ca863ed_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjQwZGE3YjExOWEwZDQwNDM5MzY1OGJkNjhmNGNhOTc1XzEwNDQ1MzYwNDYzOTAx_cb42592b-e991-4939-a4b4-27ade8aab230">3.50</ix:nonFraction>% Notes due 2048</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i43d605e8071140abb14e4a1b5c23edad_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzUtMi0xLTEtMA_b4dba26f-9e99-4a23-a3dd-9ef27d8d8825">742</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id5c0678f2622446789e384e30ddb3b34_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzUtNC0xLTEtMA_fb36f06a-ab97-48f5-a20d-27a45b7abeeb">921</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="ib1da88ade9134203bd9ab5f43e40ea74_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNDAtMC0xLTEtNjMwL3RleHRyZWdpb246OWM5MjZmNzc5ZGZhNGQ0NjliNmNiZjcyNDkzZGI4MDlfMTA0NDUzNjA0NjM5MDQ_c6e42356-3756-4f97-b994-adb29a3192be">2.25</ix:nonFraction>% Notes due 2050</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id9d8b34477a34cff93a83812f0c68017_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNDAtMi0xLTEtNjIz_80ce1eed-a633-42cb-9fa2-e127eef58f35">984</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5044fde7f5e441ac9def46cca0d955d7_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNDAtNC0xLTEtNjI3_d9daf664-c72a-42a9-8757-479b7f867a02">984</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"><ix:nonFraction unitRef="number" contextRef="i37cb21206af94c5da0e8b41d9ff52e60_I20200927" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNDEtMC0xLTEtNjMwL3RleHRyZWdpb246ZjljMjNmZWE5NzExNDc2NWI1NmJmODVkMWQwMjE3MzdfMTA0NDUzNjA0NjM5MDQ_c7a1e690-a068-4b48-88a3-bf788fc4b7fd">2.45</ix:nonFraction>% Notes due 2060</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i930c3d7cca544f488362ecf22d4ba011_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNDEtMi0xLTEtNjIz_b6b0bbfc-c57e-46e3-bc40-360b0d38d184">1,228</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6ecc4cdda5b24f6c8a06cf84bffb3461_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNDEtNC0xLTEtNjI3_aae6153e-03fc-4327-80df-547bdab11436">1,230</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i709d0243b3794243b831d6b6a562bf4b_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzYtMi0xLTEtMA_686d75ac-4799-47cc-ac1d-27a9ca43bf4e">7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i278399ba66af46a19d5e0d9c2a66430e_I20200927" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzYtNC0xLTEtMA_8531e604-1058-46d1-86a7-4662cc845584">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Non-Current Debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idce2d47fd1804a3f98973754ffded2a3_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzctMi0xLTEtMA_c705f792-d736-44e7-ba87-f28e096a2f45">32,680</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i935d5ef44a4142eb80b98b85c665cdae_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzctNC0xLTEtMA_4ffc7f1d-ed38-4e29-aa85-91726f7e72ce">37,812</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><ix:continuation id="iabf5559e6c224d3db40699b5a25cdaba"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The weighted average effective interest rate on non-current debt is <ix:nonFraction unitRef="number" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTE1Mzc_470d2827-9718-40dc-b205-679de21cc008">2.85</ix:nonFraction>%.</span></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The excess of the estimated fair value over the carrying value of debt was $<ix:nonFraction unitRef="usd" contextRef="i719d92c03acf4660873bf7164fbd0cdf_D20181231-20191229" decimals="-8" format="ixt:numdotdecimal" name="jnj:ExcessOfFairValueOverCarryingValueOfDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTE2MTc_e01edbeb-4943-4465-93c6-3de6538a6137">3.0</ix:nonFraction> billion at December 29, 2019.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Current Debt balance as of September 27, 2020 includes $<ix:nonFraction unitRef="usd" contextRef="ib12c2507851947309a7a823e9e3770dc_I20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTE2OTc_0868aca1-fe4f-41de-b683-80dd1b6d2f2c">3.0</ix:nonFraction>&#160;billion of commercial paper which has a weighted average interest rate of <ix:nonFraction unitRef="number" contextRef="ib12c2507851947309a7a823e9e3770dc_I20200927" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTE3NjY_1e743d74-7544-4c1a-a84f-f9d21a0aefce">0.15</ix:nonFraction>% and a weighted average maturity of 1.2 months. There was no commercial paper as of December 29, 2019.</span></div><div><span><br/></span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:107%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">In the fiscal third quarter of 2020, the Company issued senior unsecured notes for a total of $<ix:nonFraction unitRef="usd" contextRef="i7f434199d52940ed909adbee7e2ad0a8_I20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTA0NDUzNjA0Nzc5NDc_0f5aa49b-0ad1-4138-b2af-2fa800bac6e8">7.5</ix:nonFraction>&#160;billion.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fair value of the non-current debt was estimated using market prices, which were corroborated by quoted broker prices and significant other observable inputs.</span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">18</span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 5 &#8212; <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMTA5OTUxMTYyODk4NDE_8a542836-1f83-4d23-b9b4-5b4d5cea2362" continuedAt="i2d4abc79960944b1b3ace2de5c92e01e" escape="true">INCOME TAXES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2d4abc79960944b1b3ace2de5c92e01e"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">The worldwide effective income tax rates for the fiscal nine months of 2020 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">2019 were <ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMTE1_cc5f95fc-878d-4c05-b08f-657a04716ebb">12.6</ix:nonFraction>% an</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">d <ix:nonFraction unitRef="number" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMTIy_f289ce05-9184-4822-b953-3a543becc459">15.3</ix:nonFraction>%, respectively. In the fiscal third quarter of 2019, Switzerland enacted the Federal Act on Tax Reform and AHV Financing (TRAF), which became effective on January 1, 2020. More information on the provisions of TRAF, including the step-up transitional provisions, can be found in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. During the fiscal first quarter of 2020, the final canton where the Company maintains significant operations enacted TRAF legislation and, accordingly, the Company recorded an estimated deferred tax benefit of approximately $<ix:nonFraction unitRef="usd" contextRef="ic847fc16c1a54fb78d5fe18b8a9bd17b_D20191230-20200329" decimals="-8" format="ixt:numdotdecimal" name="jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfNjk5_3ea8a5e9-f85b-4017-8854-a85064239f44">0.3</ix:nonFraction> billion for the remeasurement of existing deferred tax liabilities offset by a related $<ix:nonFraction unitRef="usd" contextRef="ic847fc16c1a54fb78d5fe18b8a9bd17b_D20191230-20200329" decimals="-8" format="ixt:numdotdecimal" name="jnj:FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfNzgx_50ae430c-2711-4aec-b194-169af17adf4f">0.2</ix:nonFraction> billion increase in U.S. GILTI deferred taxes. During the second fiscal quarter of 2020, the Company received rulings from the Swiss Federal and cantonal tax authorities in the remaining jurisdictions where it has significant operations. These rulings resulted in the Company revising its estimate on the tax basis adjustment (i.e., &#8220;step-up&#8221;) for its assets. As a result, the Company recorded additional deferred tax benefits in the second fiscal quarter of 2020 to recognize this step-up. Consequently, the benefit recorded related to Swiss Tax reform in the first nine months of fiscal 2020 was approximately $<ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-8" format="ixt:numdotdecimal" name="jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMTM4OA_e9bd5391-12b2-4374-8e3e-2628b59a75b3">0.4</ix:nonFraction>&#160;billion, or <ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" name="jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMTM5NQ_99f73bf2-50d7-4909-a80b-af5e2564eb99">2.7</ix:nonFraction>% benefit to the Company&#8217;s fiscal nine months effective tax rate, inclusive of the impact of U.S. GILTI deferred taxes. Comparatively, in the fiscal third quarter of 2019, the Company recorded a tax benefit from the enactment of Swiss tax reform which reduced the effective rate for the fiscal nine months of 2019 by <ix:nonFraction unitRef="number" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="2" name="jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfODc5NjA5MzAyNzMwNQ_3aa520d0-8307-4f56-b772-2d6cb2d2f509">3.0</ix:nonFraction>%.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">The Company does not expect to receive future rulings regarding the transitional provisions of TRAF.   </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">In the fiscal third quarter of 2019, the Company recorded additional unrecognized tax benefit liabilities which increased the effective tax rate for the fiscal nine months of 2019 by approximately <ix:nonFraction unitRef="number" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="3" name="jnj:EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMTkwMg_3722e9e4-a976-401d-8ed9-e8617ca7efdd">2.0</ix:nonFraction>%. In the fiscal third quarter of 2020, the Company recorded additional net unrecognized tax benefit liabilities which increased the effective tax rate for the fiscal nine months of 2020 by approximately <ix:nonFraction unitRef="number" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="3" name="jnj:EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMjE3Mg_ea46c5df-ceb2-42d7-b88b-7b0d60000b54">1.1</ix:nonFraction>%.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">Additionally, the following items impacted the Company's effective tax rate as compared to the same period in the prior fiscal year:</span></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;">the impact of the agreement in principle to settle opioid litigation (see Note 21 to the Consolidated Financial Statements) in the fiscal third quarter of 2019, which was recorded in the U.S., at an effective tax rate of <ix:nonFraction unitRef="number" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="3" name="jnj:EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMzI5ODUzNDg5NTM1NA_493848f0-e52d-495e-9cce-c8aec91de088">23.0</ix:nonFraction>%. In the fiscal third quarter of 2020, the Company reduced the effective tax rate of this agreement in principle to <ix:nonFraction unitRef="number" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="3" name="jnj:EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfODc5NjA5MzAzMTczNg_1adb3dd8-26e5-4a74-9620-8f63d76c085a">21.4</ix:nonFraction>%. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;">the reduced income in lower tax jurisdictions due to the ongoing COVID-19 pandemic</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;">the 2019 divestiture gain related to Advanced Sterilization Products (ASP) which was primarily taxed in the U.S.</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;">the accrual of additional legal costs, including an additional $<ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-8" format="ixt:numdotdecimal" name="jnj:AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfODc5NjA5MzAzMTc1Mg_d0056736-f6bd-4390-a9cd-7b224582370d">1.0</ix:nonFraction>&#160;billion associated with a revised agreement in principle to settle opioid litigation at an effective tax rate of <ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" name="jnj:EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfODc5NjA5MzAzMTc0Mw_0606d355-d043-4bfa-8fec-d0a717469960">21.4</ix:nonFraction>%, in fiscal nine months of 2020 (see Notes 9 and 11 to the Consolidated Financial Statements for more details). </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company also generated additional tax benefits from stock-based compensation that were either exercised or vested; reduction of a contingent consideration liability related to the 2019 Auris Health acquisition; and reversal of some of its international unrecognized tax benefits due to the completion of several years of tax examinations in certain jurisdictions during the first fiscal three quarters of 2020.</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of September&#160;27, 2020, the Company had approximately $<ix:nonFraction unitRef="usd" contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMzA1Ng_340534c1-225c-4482-9f72-942fe280eca0">3.3</ix:nonFraction> billion of liabilities from unrecognized tax benefits. The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of jurisdictions. With respect to the United States, the IRS has completed its audit for the tax years through 2009 and is currently auditing the tax years 2010 through 2012. The Company currently expects completion of this audit in the fiscal year 2020. As of September&#160;27, 2020, the Company has classified unrecognized tax benefits and related interest of approximately $<ix:nonFraction unitRef="usd" contextRef="ibf5f634dad614276bd22344f56a80048_I20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMzY0Ng_8a278a51-fa8b-40c2-a445-9f325c7c257a">0.1</ix:nonFraction> billion as a current liability on the &#8220;Accrued taxes on Income&#8221; line of the Consolidated Balance Sheet. This is the amount expected to be paid over the next 12 months with respect to the IRS audit. During the first fiscal quarter of 2020, the Company made a payment of approximately $<ix:nonFraction unitRef="usd" contextRef="ib105bdc301f94aa0bdad8883c084fba1_D20191230-20200329" decimals="-8" format="ixt:numdotdecimal" name="jnj:UnrecognizedTaxBenefitLiabilityPayment" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMzkyNA_36dacc3a-df81-42fe-80bb-61365b909186">0.6</ix:nonFraction> billion to the U.S. Treasury with respect to the 2010-2012 tax audit in anticipation of a final settlement. The completion of this tax audit may result in additional adjustments to the Company&#8217;s unrecognized tax benefit liability. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">In other major jurisdictions where the Company conducts business, the years that remain open to tax audit go back to the year 2006. The Company believes it is possible that tax audits may be completed over the next twelve months by taxing authorities in some jurisdictions outside of the United States. However, the Company is not able to provide a reasonably reliable estimate of the timing of any other future tax payments relating to uncertain tax positions.</span></div></ix:continuation><div style="margin-bottom:8pt;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div style="margin-bottom:8pt;"><span><br/></span></div><div id="ief97c24c8c144887ab2ad376fc457d4d_76"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 6 &#8212; <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RleHRyZWdpb246YzlkOTNmOTU4NzQyNDUyMjhiOGRmZjcxOWIxOGQ2YTFfOTQ3_f65ccc86-c368-4a25-9a08-1bb835314526" continuedAt="i7c32f294c9bd4bbd8aefddb8b2fb2b91" escape="true">PENSIONS AND OTHER BENEFIT PLANS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7c32f294c9bd4bbd8aefddb8b2fb2b91"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Components of Net Periodic Benefit Cost</span></div><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RleHRyZWdpb246YzlkOTNmOTU4NzQyNDUyMjhiOGRmZjcxOWIxOGQ2YTFfOTQz_7701fac5-bfc5-479e-8d9f-a549940100ef" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net periodic benefit costs for the Company&#8217;s defined benefit retirement plans and other benefit plans for the fiscal third quarters and fiscal nine months of 2020 and 2019 include the following components:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%;"><tr><td style="width:1.0%;"></td><td style="width:25.331%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.534%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.270%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.534%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.270%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.534%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.270%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.534%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.270%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.827%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.270%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.534%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.270%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.534%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.270%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.534%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.714%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retirement Plans</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Benefit Plans</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retirement Plans</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Benefit Plans</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Service cost</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i76991a953ea2430ab905037bfcac327d_D20200629-20200927" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMy0yLTEtMS0w_fc153d63-ea9d-44c3-9529-1629bddf9e5e">330</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i97db63a5b1bf481bbea39077a0761ca9_D20190701-20190929" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMy00LTEtMS0w_b60a75a6-459b-443f-80bd-20c637bceffc">275</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4dbd3aef0b5a4bbc9dc149f14c7e3d3b_D20200629-20200927" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMy02LTEtMS0w_277e3ffb-9720-4d5e-8034-f3de142c4709">72</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ac819dd65a24ccea1e79d719e0d1cff_D20190701-20190929" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMy04LTEtMS0w_c38641ee-e367-4815-bf83-63baf1bff97d">68</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i32b2b3e0644f45ff8702ea89bf54ad06_D20191230-20200927" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMy0xMC0xLTEtMA_1b319509-c613-4679-9fe9-14cf79e54ba9">979</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3a18f6b9ab22475b952191fef9a136c7_D20181231-20190929" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMy0xMi0xLTEtMA_0b034814-9a6b-41ae-92fc-151ddf42593f">828</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i62d4b60ec8e44411a7c22519b07bcb56_D20191230-20200927" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMy0xNC0xLTEtMA_6eca764c-1817-4bec-b7d0-8e51f6c262a8">216</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id7d38e2b061c40569b6a15416f6b0063_D20181231-20190929" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMy0xNi0xLTEtMA_e42465de-1d96-4f02-9e79-3e0e8ce9b45c">205</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i76991a953ea2430ab905037bfcac327d_D20200629-20200927" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNC0yLTEtMS0w_474d8b01-3cac-4e5d-9905-49141d03bd1e">238</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i97db63a5b1bf481bbea39077a0761ca9_D20190701-20190929" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNC00LTEtMS0w_111ffaeb-9621-44e2-8ddd-6914620897e7">273</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4dbd3aef0b5a4bbc9dc149f14c7e3d3b_D20200629-20200927" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNC02LTEtMS0w_fa67faee-7721-419d-8dfc-fd175c3720a1">33</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ac819dd65a24ccea1e79d719e0d1cff_D20190701-20190929" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNC04LTEtMS0w_622682c9-1f39-40ba-b3f0-299903ab72e1">46</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i32b2b3e0644f45ff8702ea89bf54ad06_D20191230-20200927" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNC0xMC0xLTEtMA_95574fc1-086e-498e-84ad-98b38c1c75a4">715</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3a18f6b9ab22475b952191fef9a136c7_D20181231-20190929" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNC0xMi0xLTEtMA_351f06b1-cf31-4964-a83f-1e8304c59f90">822</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i62d4b60ec8e44411a7c22519b07bcb56_D20191230-20200927" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNC0xNC0xLTEtMA_80ec41a9-f2e2-4f6a-b0fa-8f108ebac008">99</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id7d38e2b061c40569b6a15416f6b0063_D20181231-20190929" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNC0xNi0xLTEtMA_fec36576-ad5b-43eb-8542-9016b86f30c5">138</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i76991a953ea2430ab905037bfcac327d_D20200629-20200927" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNS0yLTEtMS0w_a75836b3-b21d-42ce-b30f-7c086ac94475">617</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i97db63a5b1bf481bbea39077a0761ca9_D20190701-20190929" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNS00LTEtMS0w_e5b948ab-2693-45f5-a818-fe508d527a79">578</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4dbd3aef0b5a4bbc9dc149f14c7e3d3b_D20200629-20200927" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNS02LTEtMS0w_5297cbd6-a25a-4ec8-8712-693a91086ffa">2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0ac819dd65a24ccea1e79d719e0d1cff_D20190701-20190929" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNS04LTEtMS0w_2521fdcb-ec2e-40a3-8ecf-6312b51fda54">2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i32b2b3e0644f45ff8702ea89bf54ad06_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNS0xMC0xLTEtMA_57e14574-4638-4756-9a85-b6a6579b595f">1,839</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3a18f6b9ab22475b952191fef9a136c7_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNS0xMi0xLTEtMA_1f1de846-f036-4a59-9f9e-7128a2ee4034">1,742</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i62d4b60ec8e44411a7c22519b07bcb56_D20191230-20200927" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNS0xNC0xLTEtMA_9649e119-8f7c-4465-966a-5335d906d354">5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="id7d38e2b061c40569b6a15416f6b0063_D20181231-20190929" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNS0xNi0xLTEtMA_39186def-60db-4919-abfa-aef4782e269a">5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of prior service cost/(credit)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i76991a953ea2430ab905037bfcac327d_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNi0yLTEtMS0w_32b76205-c32b-4919-b385-14a65de8c2df">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i97db63a5b1bf481bbea39077a0761ca9_D20190701-20190929" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNi00LTEtMS0w_5c417bd0-a4d5-47c7-b482-aad14767d2f4">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4dbd3aef0b5a4bbc9dc149f14c7e3d3b_D20200629-20200927" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNi02LTEtMS0w_48eb9976-3669-4dd7-8feb-840df4daab20">7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0ac819dd65a24ccea1e79d719e0d1cff_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNi04LTEtMS0w_4f62ebe3-d42e-4b1c-8e54-27c101ba257f">7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i32b2b3e0644f45ff8702ea89bf54ad06_D20191230-20200927" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNi0xMC0xLTEtMA_09b5275f-a392-41c0-bdaa-7c39c92e4d11">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3a18f6b9ab22475b952191fef9a136c7_D20181231-20190929" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNi0xMi0xLTEtMA_f4495f5a-175f-44a2-ad6c-35db2039df6c">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i62d4b60ec8e44411a7c22519b07bcb56_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNi0xNC0xLTEtMA_0360df2f-d5ea-4208-9c79-2c217f39008a">23</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="id7d38e2b061c40569b6a15416f6b0063_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNi0xNi0xLTEtMA_7befcbc8-cb79-466b-a276-7b5bc2312290">23</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Recognized actuarial losses</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i76991a953ea2430ab905037bfcac327d_D20200629-20200927" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOC0yLTEtMS0w_48097b22-4b6b-4197-a484-7553b02f73a1">224</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i97db63a5b1bf481bbea39077a0761ca9_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOC00LTEtMS0w_61bd1c4c-ce32-498b-99fb-7cb934fdd306">145</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4dbd3aef0b5a4bbc9dc149f14c7e3d3b_D20200629-20200927" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOC02LTEtMS0w_c34c0629-7f49-4be3-ad7f-167a8d0a56fe">36</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ac819dd65a24ccea1e79d719e0d1cff_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOC04LTEtMS0w_79fa4630-ec87-4c3c-be5c-c72f90656721">32</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i32b2b3e0644f45ff8702ea89bf54ad06_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOC0xMC0xLTEtMA_f8e29a15-097c-4228-b208-318e82d7eb52">669</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3a18f6b9ab22475b952191fef9a136c7_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOC0xMi0xLTEtMA_9387a98f-01ad-455e-a22d-0df739755735">435</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i62d4b60ec8e44411a7c22519b07bcb56_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOC0xNC0xLTEtMA_74d69438-9498-4df9-97d7-58358da7bf99">107</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id7d38e2b061c40569b6a15416f6b0063_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOC0xNi0xLTEtMA_7cf7b418-8c27-4e52-a4a5-fd966077fb16">97</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Curtailments and settlements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i76991a953ea2430ab905037bfcac327d_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOS0yLTEtMS0w_2243a626-d020-453a-aa17-2c29ceae16b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i97db63a5b1bf481bbea39077a0761ca9_D20190701-20190929" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOS00LTEtMS0w_43bace1b-8708-482f-923c-5b2ab08de4a1">4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4dbd3aef0b5a4bbc9dc149f14c7e3d3b_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOS02LTEtMS0w_91677bc1-743a-4cfe-9ccc-71ab0baaec17">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ac819dd65a24ccea1e79d719e0d1cff_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOS04LTEtMS0w_cacb8f44-dac8-44bf-8fff-1ee10dbfaec5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i32b2b3e0644f45ff8702ea89bf54ad06_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOS0xMC0xLTEtMA_eb912b07-7211-4960-ae1a-59f30a9313f9">19</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3a18f6b9ab22475b952191fef9a136c7_D20181231-20190929" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOS0xMi0xLTEtMA_c30c38fa-51e1-478c-b13d-05f1b34a94fc">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i62d4b60ec8e44411a7c22519b07bcb56_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOS0xNC0xLTEtMA_324fd2e6-ff15-41f6-bf44-1a88efd52f38">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id7d38e2b061c40569b6a15416f6b0063_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOS0xNi0xLTEtMA_2a7a558e-b347-431c-8820-476b09bbb5cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net periodic benefit cost</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i76991a953ea2430ab905037bfcac327d_D20200629-20200927" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMTAtMi0xLTEtMA_4430fec3-2d73-4d39-8727-31562765dda5">175</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i97db63a5b1bf481bbea39077a0761ca9_D20190701-20190929" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMTAtNC0xLTEtMA_6010e13d-ddfa-4189-a115-d2fcc2afec7c">112</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4dbd3aef0b5a4bbc9dc149f14c7e3d3b_D20200629-20200927" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMTAtNi0xLTEtMA_5ad7508b-5666-4cd1-b7aa-f0e9e0a60575">132</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ac819dd65a24ccea1e79d719e0d1cff_D20190701-20190929" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMTAtOC0xLTEtMA_5bcb262e-8910-40df-84c6-0b1ec763db1c">137</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i32b2b3e0644f45ff8702ea89bf54ad06_D20191230-20200927" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMTAtMTAtMS0xLTA_8cd3dd0c-0b04-4abd-b5fb-73855dec45c0">544</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3a18f6b9ab22475b952191fef9a136c7_D20181231-20190929" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMTAtMTItMS0xLTA_e5de6bd1-c243-4e87-b42c-cc093d1f7369">349</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i62d4b60ec8e44411a7c22519b07bcb56_D20191230-20200927" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMTAtMTQtMS0xLTA_165ef793-b663-440f-9d8a-039bacf015e3">394</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id7d38e2b061c40569b6a15416f6b0063_D20181231-20190929" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMTAtMTYtMS0xLTA_204e3487-38ae-4915-b10d-b54bb8c1c586">412</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The service cost component of net periodic benefit cost is presented in the same line items on the Consolidated Statement of Earnings where other employee compensation costs are reported. All other components of net periodic benefit cost are presented as part of Other (income) expense, net on the Consolidated Statement of Earnings.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Company Contributions</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the fiscal nine months ended September&#160;27, 2020, the Company contributed $<ix:nonFraction unitRef="usd" contextRef="iba89a9d0fc0d402d9b56774badd78c07_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PensionContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RleHRyZWdpb246YzlkOTNmOTU4NzQyNDUyMjhiOGRmZjcxOWIxOGQ2YTFfNjcx_639f7f6e-66ee-4b44-b742-0fda6dcb315c">364</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7aca824b885d4113af57a768e99be46f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PensionContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RleHRyZWdpb246YzlkOTNmOTU4NzQyNDUyMjhiOGRmZjcxOWIxOGQ2YTFfNjc4_43c84cdb-b8b7-4bf3-9c78-f5e3cbd7d7dc">27</ix:nonFraction> million to its U.S. and international retirement plans, respectively. The Company plans to continue to fund its U.S. defined benefit plans to comply with the Pension Protection Act of 2006. International plans are funded in accordance with local regulations.</span></div></ix:continuation><div><span><br/></span></div><div id="ief97c24c8c144887ab2ad376fc457d4d_79"></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 7 &#8212; <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RleHRyZWdpb246MWQxMjJiYjAzNDIzNDQ0ZmI2M2VlN2ViZGM5ODMyMzBfOTIx_cfadae39-08b4-4ac5-8124-d03687915956" continuedAt="i77e9ee6fc255419a985205d6fe9fabae" escape="true">ACCUMULATED OTHER COMPREHENSIVE INCOME</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i77e9ee6fc255419a985205d6fe9fabae"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RleHRyZWdpb246MWQxMjJiYjAzNDIzNDQ0ZmI2M2VlN2ViZGM5ODMyMzBfOTI4_068c7195-9e8c-4c52-b99e-22a363202ac6" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Components of other comprehensive income (loss) consist of the following:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%;"><tr><td style="width:1.0%;"></td><td style="width:34.774%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.547%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.914%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.547%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.662%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.846%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.719%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.547%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.306%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.547%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:16.991%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Accumulated</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">On</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefit</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">On Derivatives</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Comprehensive</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Translation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Securities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Plans</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&amp; Hedges</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income (Loss)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idee3ed30241e424493acca72e673afcd_I20191229" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNC0yLTEtMS0w_6eb1a208-e9bb-4f7d-a457-a39e4ff34206">8,705</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iad56cf144ec847a8a16206fa418498c9_I20191229" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNC00LTEtMS0w_6d554f12-d07a-407e-a9e7-4c01d68f0645">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iebebc2fd778f40798d1314b14d68d59c_I20191229" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNC02LTEtMS0w_726537b0-ca53-4e1d-aff3-7747eb4a5900">6,891</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib49a989cb90342ab8cacece521c7d896_I20191229" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNC04LTEtMS0w_f86e9013-1f9e-40f5-ad67-dc0ea29b9a25">295</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4dff82851aa243f2a42e09821411d92e_I20191229" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNC0xMC0xLTEtMA_12b7f8b0-f1a6-4a68-9572-e2657878b704">15,891</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1a657cd2705e49199faed73d18529a9f_D20191230-20200927" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNS0yLTEtMS0w_e51e939b-768b-46f4-9320-c345dce00f9a">741</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i686763308513427ab8b79b989e11e0b5_D20191230-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNS00LTEtMS0w_7093f5b4-c2a8-4fa4-a98e-c7ba0c67bf8d">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7b2070364dbe40199c021a5f19b0d7cd_D20191230-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNS02LTEtMS0w_eff5ed47-4250-40c7-b982-bfd36bd3430b">587</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i240092c4b65b491c93381937b17173a3_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNS04LTEtMS0w_a0829c13-d65d-4572-98a0-045c5c1a5b3c">1,106</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3494e72aac944cd896896e8cc599429d_D20191230-20200927" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNS0xMC0xLTEtMA_e4cbc9fd-7e2c-4ae7-a107-e8904b5ef6c3">953</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i33664fe4d1f148e7bd9e8ade82e1790b_I20200927" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNy0yLTEtMS0w_a2228727-fbf0-4d9f-a78f-fa638bd0e1d9">9,446</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9b60bad991094d70b3aa1309c7d2f70c_I20200927" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNy00LTEtMS0w_6750c319-c309-4046-b0d2-14c8f924f252">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0247279f84684992bafc7f3bcd811a4c_I20200927" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNy02LTEtMS0w_c2255170-132b-4b69-82ae-d2f2e18e77e4">6,304</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i258eab55a2d94c38a37a02b6761520fb_I20200927" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNy04LTEtMS0w_ce641a43-cf55-408b-891d-27b04ebf582a">811</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7b3f9043c47442aea143141642e7e123_I20200927" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNy0xMC0xLTEtMA_cf860933-981d-4838-96d1-7d0fac29a02c">14,938</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Amounts in accumulated other comprehensive income are presented net of the related tax impact.  Foreign currency translation is not adjusted for income taxes where it relates to permanent investments in international subsidiaries.  For additional details on comprehensive income see the Consolidated Statements of Comprehensive Income. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Details on reclassifications out of Accumulated Other Comprehensive Income:</span></div><div style="padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Gain/(Loss) On Securities - reclassifications released to Other (income) expense, net.</span></div><div style="padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Employee Benefit Plans - reclassifications are included in net periodic benefit cost. See Note 6 for additional details.</span></div><div style="padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Gain/(Loss) On Derivatives &amp; Hedges - reclassifications to earnings are recorded in the same account as the underlying transaction. See Note 4 for additional details.</span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">20</span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 8 &#8212; <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RleHRyZWdpb246YWViNzAzOWQ2OTFiNDVkOThlMDdjMzFiYTgwNGRmMjdfMTQ2NA_98aa9888-2285-4f43-b741-3a21e8140efd" continuedAt="i0bb27d5b3b6c4e6e93072c17cbbc6cfa" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0bb27d5b3b6c4e6e93072c17cbbc6cfa"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RleHRyZWdpb246YWViNzAzOWQ2OTFiNDVkOThlMDdjMzFiYTgwNGRmMjdfMTQ2MA_18f4f0db-4b38-44b0-838a-483afecc4844" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following is a reconciliation of basic net earnings per share to diluted net earnings per share for the fiscal third quarters and fiscal nine months ended September&#160;27, 2020 and September&#160;29, 2019:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:48.325%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.805%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.400%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.380%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.974%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.518%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.532%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.518%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.248%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Shares in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic net earnings per share </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfMi0yLTEtMS0w_a979223c-8b60-4573-ac6c-2e0766f6bc07">1.35</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfMi00LTEtMS0w_696b7f98-8ab7-455a-9e35-eca7fe1558a9">0.67</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfMi02LTEtMS0w_f786c935-fdeb-4e41-86b7-9d423fcbfbf3">4.93</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfMi04LTEtMS0w_cef7d7de-e048-432d-9c0b-b4ade9d77f60">4.19</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Average shares outstanding &#8212; basic</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfMy0yLTEtMS0w_8d5a1fc7-5510-44bd-8d1b-44507e24fe04">2,632.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfMy00LTEtMS0w_21ddec9d-bcba-4fd0-9f3b-afe1633e1e6e">2,635.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfMy02LTEtMS0w_5e8a55d6-76eb-4727-ad88-ab0611765f73">2,633.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfMy04LTEtMS0w_70ea1c3e-22c7-46e9-a7b7-1e5a5899d263">2,649.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Potential shares exercisable under stock option plans</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNC0yLTEtMS0w_c390326c-5ce5-4714-a3b2-0b5835f0e0a9">115.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNC00LTEtMS0w_bea68b3b-afa6-4bef-897c-f952faeacb02">117.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNC02LTEtMS0w_5e0d066e-2424-4b36-a542-52cbae733d0c">120.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNC04LTEtMS0w_b6f5ab66-5a6e-4e04-8046-b2e3afb9ebe0">137.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: shares which could be repurchased under treasury stock method</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-5" name="jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNS0yLTEtMS0w_01f24b6e-4d92-4d0d-b841-172bb5473866">78.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-5" name="jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNS00LTEtMS0w_1e5e4a96-7077-408a-beea-04e5d712a27b">83.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-5" name="jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNS02LTEtMS0w_8cd9f03a-8054-4ac3-8e00-312372565c16">82.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-5" name="jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNS04LTEtMS0w_30e03efe-3978-4a3c-8878-d93115eb49d1">99.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Convertible debt shares</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-5" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNi0yLTEtMS0w_60e3e3bb-69ab-4b7a-a81a-c74079461700">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNi00LTEtMS0w_90b19f8f-5d5d-4ac8-b516-d4443fb2815f">0.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-5" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNi02LTEtMS0w_9c252e2c-4ea3-4a58-8c1e-9879e9d2764f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNi04LTEtMS0w_aefb8bab-5fe9-4585-a610-45f0347b9d39">0.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Average shares outstanding &#8212; diluted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNy0yLTEtMS0w_d7f43867-63ca-4913-903d-46f90e3338ad">2,669.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNy00LTEtMS0w_932c1a32-57c4-4a18-b271-1bda79bcdd2c">2,669.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNy02LTEtMS0w_4a9065ef-01db-4f1f-b894-7aaaba0097d6">2,670.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNy04LTEtMS0w_d2f7983f-f91a-4c80-ad89-f92de263d158">2,688.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted net earnings per share</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfOC0yLTEtMS0w_6d488999-dbb9-4975-ac30-fced36975eaf">1.33</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfOC00LTEtMS0w_8c57ff5d-5c83-442e-9358-7f3f5c4d32f7">0.66</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfOC02LTEtMS0w_c54306ee-1dca-4fd2-8c00-196acc6b6fbb">4.86</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfOC04LTEtMS0w_b41f3d8e-369f-45e2-b977-f44a6f239419">4.13</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The diluted net earnings per share calculation for the fiscal third quarter ended September&#160;27, 2020 excluded <ix:nonFraction unitRef="shares" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RleHRyZWdpb246YWViNzAzOWQ2OTFiNDVkOThlMDdjMzFiYTgwNGRmMjdfNDg3_a07d7d73-49f0-4eee-95a4-ec9f05429d7d">20</ix:nonFraction> million shares related to stock options, as the exercise price of these options was greater than their average market value. In the fiscal third quarter ended September 27, 2020 the Company did not have convertible debt.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The diluted net earnings per share calculation for the fiscal third quarter ended September&#160;29, 2019 excluded <ix:nonFraction unitRef="shares" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RleHRyZWdpb246YWViNzAzOWQ2OTFiNDVkOThlMDdjMzFiYTgwNGRmMjdfMTA5OTUxMTYyOTMwMA_53094e74-079c-414b-a76f-2cef91e53fa8">19</ix:nonFraction>&#160;million shares related to stock options, as the exercise price of these options was greater than their average market value. The diluted net earnings per share calculation for the fiscal third quarter ended September&#160;29, 2019 included the dilutive effect of convertible debt that was offset by the related reduction in interest expense. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The diluted net earnings per share calculation for the fiscal nine months ended September&#160;27, 2020 excluded <ix:nonFraction unitRef="shares" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RleHRyZWdpb246YWViNzAzOWQ2OTFiNDVkOThlMDdjMzFiYTgwNGRmMjdfMTEwOQ_23b6cf12-8269-4677-a1eb-2e72800c3897">17</ix:nonFraction>&#160;million shares related to stock options, as the exercise price of these options was greater than their average market value. In the fiscal nine months ended September 27, 2020 the Company did not have convertible debt.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The diluted net earnings per share calculation for the fiscal nine months ended September&#160;29, 2019 excluded an insignificant number of shares related to stock options, as the exercise price of these options was greater than their average market value. The diluted net earnings per share calculation for the fiscal nine months ended September&#160;29, 2019 included the dilutive effect of convertible debt that was offset by the related reduction in interest expense.</span></div></ix:continuation><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:57.327%;"><tr><td style="width:1.0%;"></td><td style="width:32.233%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:32.233%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:32.234%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">21</span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 9 &#8212; <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTA5OTUxMTYyODcxMTA_cbebb887-4218-4bec-a504-959649310bad" continuedAt="i656d59972188405a99e22bda71b0fc9a" escape="true">SEGMENTS OF BUSINESS AND GEOGRAPHIC AREAS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i656d59972188405a99e22bda71b0fc9a" continuedAt="i21c421b3505748faa336f0c98dfbe9e9"><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="jnj:SalesBySegmentOfBusinessTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMzM0NA_61652f19-e9b7-4793-858e-e9733c266f09" continuedAt="i47209320cc6c4008be0a943e0ddc4b6f" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">SALES BY SEGMENT OF BUSINESS </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"></td><td style="width:35.144%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.525%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.525%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.633%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.234%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.234%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.643%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent Change</span></td></tr><tr><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consumer Health*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">OTC</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d95454e2f2b47bba671c0f16ef3678d_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNS0yLTEtMS0w_727d99e7-3871-4a78-8f43-ba3ce8f67cb8">601</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i55c350243936480182afafc99c54f755_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNS00LTEtMS0w_5408856d-4869-4dc0-a089-acaded9385d3">477</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i6d95454e2f2b47bba671c0f16ef3678d_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNS02LTEtMS0w_abc4d10b-70d1-4b3f-9169-cc4d92ebe3be">26.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8b916937f8b4417f970a191c21a50d7b_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNS04LTEtMS0w_bf6e7cec-5ad8-4814-8297-bbcb85b304af">1,917</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icbdf62a6d4e04d9497cf6a3f7fe73fcc_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNS0xMC0xLTEtMA_aa3fd878-cc24-4d7e-8d67-ffa775533943">1,468</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i8b916937f8b4417f970a191c21a50d7b_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNS0xMi0xLTEtMA_5658b929-c77f-4466-87ca-028ceab6c30d">30.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38c6793cfc6744c19666a02341ec9b31_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNi0yLTEtMS0w_6fb5b9ff-8119-4aa0-97fe-13dc1f41c62c">541</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieeebc720734846059822e5b88d5728d4_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNi00LTEtMS0w_4724dafb-0df3-441c-8771-0ae36066b56b">621</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i38c6793cfc6744c19666a02341ec9b31_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNi02LTEtMS0w_17070885-2ea1-49e0-9913-c5e133a7bd8c">12.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic3b1c962253f40358196e13a8dba4ab4_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNi04LTEtMS0w_1a38645e-af1a-4df1-93fd-7f5ccc6d7a7b">1,722</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2da046285a854cbfba8fbfe14771ce6a_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNi0xMC0xLTEtMA_81cad5a5-e577-4b25-8b47-077b8b2a365b">1,781</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ic3b1c962253f40358196e13a8dba4ab4_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNi0xMi0xLTEtMA_888d55f1-a03f-4acd-8fc1-7033b8f838fc">3.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia9b2fae840754a6ea4f68f1acc7268f9_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNy0yLTEtMS0w_50cb0e58-c5ec-44a4-9b2f-59caf059d55f">1,142</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id933df11eed64928a3b3481a8a126bb8_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNy00LTEtMS0w_b3d8d279-51d4-4187-9b16-a4ba5743f8ac">1,098</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ia9b2fae840754a6ea4f68f1acc7268f9_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNy02LTEtMS0w_80a73f33-1e65-4c9d-85e7-7c27ea4864fe">4.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9ffccfe4dfab435e94684d4fcf3d976f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNy04LTEtMS0w_4d09ef2e-03c2-43d6-9d64-d94135b2a9ec">3,639</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie757ee9c942f4859aab86954bd239d38_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNy0xMC0xLTEtMA_d6049b6e-46a1-4a7d-957e-5afc00132d5a">3,249</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9ffccfe4dfab435e94684d4fcf3d976f_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNy0xMi0xLTEtMA_ce86ba12-3aa8-4483-951f-eb324e9b60e6">12.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Skin Health/Beauty</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i735a40d88d7e46dc9295f42c61e9310a_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOS0yLTEtMS0w_a92fde9f-a785-4973-86d8-c095cca7e858">572</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib4183cb021584ec6b8420859ed1b2c0d_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOS00LTEtMS0w_676a812c-5a49-49f6-aa18-cd492226150c">559</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i735a40d88d7e46dc9295f42c61e9310a_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOS02LTEtMS0w_c7ccd5c1-5575-498b-a1e7-0906fa8aed04">2.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9db0932464f74a4a8916179795da088d_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOS04LTEtMS0w_68536cd5-1ad4-44c5-a2c8-314ba79d5c42">1,767</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic8013563982e4faf92e1d4712047488c_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOS0xMC0xLTEtMA_2b9164fb-4947-43e9-928d-fc0ac0f70231">1,810</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9db0932464f74a4a8916179795da088d_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOS0xMi0xLTEtMA_886b97d8-fde6-4a8a-b0df-9e02536ff560">2.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ice288e8c219a4507ad03507ff5dd2f25_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAtMi0xLTEtMA_311584f6-2543-49c6-8f42-ec4879593f01">577</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6167e7598a3a497a987f9d52e44c47c0_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAtNC0xLTEtMA_b13055aa-108b-4cff-8dd9-c6d13b905f96">592</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ice288e8c219a4507ad03507ff5dd2f25_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAtNi0xLTEtMA_89769b5e-d8ad-4d83-bb1e-7b60185b52ed">2.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ife45c684b85a4e89bfaae65632c76bed_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAtOC0xLTEtMA_0acd2edf-3dab-4371-9101-d3d45eeac7c8">1,506</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2317353ffc6a4b6699b4670f8065adb7_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAtMTAtMS0xLTA_532dc4b4-7f33-4042-b60c-630352b314aa">1,633</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ife45c684b85a4e89bfaae65632c76bed_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAtMTItMS0xLTA_7f3f9b26-12b0-4558-a9ac-42ea0541758d">7.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3cf576db9a634f2bbe83401cc15ae8ad_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEtMi0xLTEtMA_6c5df7c6-7a55-4e12-8cf8-b7200e63a438">1,149</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if5501bef72d543db9d17b8fb2870aa8f_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEtNC0xLTEtMA_7fdef7ab-3f67-4bbf-8f41-90e01a7988ae">1,151</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i3cf576db9a634f2bbe83401cc15ae8ad_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEtNi0xLTEtMA_3989ff95-df78-4bd4-8495-6be480303b55">0.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d0c5dfa391d4390b7907e241d878e21_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEtOC0xLTEtMA_e61f5432-b233-4038-8fb0-ead08fae6389">3,273</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7b497129d20c4ad3a9e5f5c96133de85_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEtMTAtMS0xLTA_2bb3acc1-20b3-4402-a626-9b92009809a3">3,443</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i6d0c5dfa391d4390b7907e241d878e21_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEtMTItMS0xLTA_de238902-3740-4527-bdd9-b3e6db9679dc">5.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oral Care</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib88a939963264141828fb4d58e203838_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMtMi0xLTEtMA_59ce40e0-7e48-414c-aab1-224aad208e5e">164</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iccf1e8f3a0074a97b0f52772a56a8633_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMtNC0xLTEtMA_6a59cff3-ba7d-44ca-b755-38e2276bf953">156</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ib88a939963264141828fb4d58e203838_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMtNi0xLTEtMA_8869bebe-7f71-4a97-b610-383733d56588">5.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9bb84639aa354224b5d50732c027f3ca_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMtOC0xLTEtMA_dd3e4ecf-abbd-4133-9ae9-2651bc408bae">510</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i72078429833b482abb75ff2f963b1c95_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMtMTAtMS0xLTA_c4b36296-ccf8-4910-b115-37fc3b72315c">462</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9bb84639aa354224b5d50732c027f3ca_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMtMTItMS0xLTA_1b68506a-82e9-4c1a-a94b-2fcda7ada22e">10.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1a72efbbc13f4a9899424dc34768f292_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQtMi0xLTEtMA_0db0a5d2-a5fb-4a1d-b68b-f69741e5887c">248</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4d8fa9621c1a4788aeed3179569fe294_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQtNC0xLTEtMA_56901577-b88f-4003-be37-484ec3fba7d0">223</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1a72efbbc13f4a9899424dc34768f292_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQtNi0xLTEtMA_f87fa9c6-ce49-42c3-aa05-0316a8fd64c1">10.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a9f94d741d04069bba045fd793e2102_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQtOC0xLTEtMA_3bc23450-ce6e-41fd-b241-f6a2f55f56c9">694</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i282eb35f5a6f4308a0133f28f9e9fe51_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQtMTAtMS0xLTA_3d1d1986-30b5-4751-a3b0-7ee42a7a8557">673</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7a9f94d741d04069bba045fd793e2102_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQtMTItMS0xLTA_ff02c864-ba96-4bb2-8059-f902d679f4b8">3.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i86ef51c7d032407cb30caef60d2e438e_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUtMi0xLTEtMA_b91e2bda-c34b-4c50-ae31-94cb797274e5">412</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fc5a0ba168445cf92dcf88ef880150d_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUtNC0xLTEtMA_54fa346a-61a9-4d64-89f4-dcdf61e0a631">379</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i86ef51c7d032407cb30caef60d2e438e_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUtNi0xLTEtMA_d4af2685-831a-4555-94be-d2d76ef091d0">8.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3d63809b7b464394a1928e0d87c2b8e9_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUtOC0xLTEtMA_6256343a-23da-49c2-b1e4-b655dd083b3c">1,204</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id1d3e97e875047218ce5d543119f6e23_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUtMTAtMS0xLTA_72fd6458-4ad2-475d-a98e-efc76d1ba335">1,135</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3d63809b7b464394a1928e0d87c2b8e9_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUtMTItMS0xLTA_609acff0-8da9-4604-a8b7-726de2af5947">6.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Baby Care</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e589fe2a250489bae1d93a267c01624_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTctMi0xLTEtMA_4cfc0c5e-9fc1-4a3b-811f-281e9127b803">91</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibc8fefdc8c3146ef985668dfce568821_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTctNC0xLTEtMA_44143392-f06b-4125-8b13-434b5c82bef2">91</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9e589fe2a250489bae1d93a267c01624_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTctNi0xLTEtMA_7b117333-17bf-4ca7-adc3-d78c39f0c2ee">1.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id0e7b1947201413e85946bcaada77275_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTctOC0xLTEtMA_ab468d4c-323f-488c-aa37-fae12dc54028">279</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i14fbc68dbd2745caa0dcaf30d0e59cd9_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTctMTAtMS0xLTA_f96d2bd9-44ca-4d15-b2de-8fe7a5aeb7b7">277</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="id0e7b1947201413e85946bcaada77275_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTctMTItMS0xLTA_080a783c-fbd1-4562-a236-d3e18d70744d">0.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iee45030c44e44d0aaff586a9a06e0532_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgtMi0xLTEtMA_0875c8a0-4555-4d9e-82d6-209c76896674">302</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i61637434781b4c8998469b74ad8a39e4_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgtNC0xLTEtMA_10299d3e-6738-457a-a320-876e1b35c624">326</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="iee45030c44e44d0aaff586a9a06e0532_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgtNi0xLTEtMA_d00919bd-b9ba-486e-86bd-907bb9ea4224">7.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63c4e377a3ae40f4bcb7d5a4e5f8b84b_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgtOC0xLTEtMA_6ad34abd-1387-4716-bacf-abb7b3909d56">831</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i61b21fa64d6040eb9fbae0bbae8c3b11_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgtMTAtMS0xLTA_f878c01a-019c-47d8-83a9-426cea9cb961">977</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i63c4e377a3ae40f4bcb7d5a4e5f8b84b_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgtMTItMS0xLTA_d6e11cb5-722e-497e-be9c-d2f75e9fae90">14.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58e8bc1a90394483be831705847d06fd_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTktMi0xLTEtMA_a71bd14c-3dd6-4a5f-8678-9b6ef7774a40">393</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia03a4e20bbbf43c28052fd90303aab5e_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTktNC0xLTEtMA_71a08f9c-6ad5-4ac8-a58d-9a99f5bcd92d">417</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i58e8bc1a90394483be831705847d06fd_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTktNi0xLTEtMA_d132d79b-73d5-4533-845e-c41232b465d4">5.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifc43c3a1acde44b7a8a4d40d89e4efd5_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTktOC0xLTEtMA_ec334b3e-d45f-434c-b4a2-d9430d478636">1,110</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id798043e75334798bf5217fb399c1997_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTktMTAtMS0xLTA_957ebc11-c498-4d9f-8723-dca5ca0cb74f">1,254</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ifc43c3a1acde44b7a8a4d40d89e4efd5_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTktMTItMS0xLTA_3df92172-ebeb-4b50-83ce-238cf19e1767">11.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Women's Health</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib4cf6ca49a8e404cbbfb2fcf0ee82a44_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEtMi0xLTEtMA_9b6c8b2f-fb7f-4090-9dbe-c2550173a404">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4d496bd90754417ebede4d9829a52df5_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEtNC0xLTEtMA_bb032b1f-37e3-4ef4-ba1f-201d07ddda6a">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib4cf6ca49a8e404cbbfb2fcf0ee82a44_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEtNi0xLTEtMA_9bd5ac5e-2096-4c21-834c-49fbdee2bada">6.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib0d8e990787d47c0b75a6b3923da8b2b_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEtOC0xLTEtMA_5cbf3441-1ba9-4851-84f3-e73d159cb9b0">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4ae786e5f2804cd8b49c7613a74391d2_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEtMTAtMS0xLTA_2ca675c7-1773-4f85-86be-adb557f50969">9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ib0d8e990787d47c0b75a6b3923da8b2b_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEtMTItMS0xLTA_b4c6698e-2cb4-481e-9ea3-79ac2db34fc6">7.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5751770904eb4b40aae931e43968e339_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjItMi0xLTEtMA_6cdd421a-1c92-4c42-a553-c28dbdd0143c">227</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if752582ef2ea49b69e87bafa1de27a77_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjItNC0xLTEtMA_8d99dde9-8634-4c2c-8849-57bac5425c3b">252</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i5751770904eb4b40aae931e43968e339_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjItNi0xLTEtMA_83353576-924c-4b94-a568-8579aa70f4b4">9.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie724f8c70c1e47fa9a3509c07877098c_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjItOC0xLTEtMA_ba6f578b-c74d-4926-8b1d-b828691dedde">654</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib4c4a17d7588422db6a82c1ac5960f10_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjItMTAtMS0xLTA_03648b64-5098-4bc1-9dd3-3c4aefa7a297">724</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ie724f8c70c1e47fa9a3509c07877098c_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjItMTItMS0xLTA_4be1daa7-0fd0-47f9-9f4c-179cb5f6cc48">9.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4360908e63cc43f4afd75a1169c42e6a_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMtMi0xLTEtMA_5778d179-da36-47c9-81ba-2f609357aeeb">230</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i585883c87d6f468ebbe4454a07b867aa_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMtNC0xLTEtMA_f1b5c7cd-e458-48a1-9f00-26003f33099e">255</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i4360908e63cc43f4afd75a1169c42e6a_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMtNi0xLTEtMA_252a1e0a-08af-41c9-9fb0-e5a57d40e267">9.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iae3a3a38435f49649638b494f6bccee6_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMtOC0xLTEtMA_759f52ca-1a6f-45a7-9803-4964d3094acf">664</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iede096f8f0704067b69be6dae6af81dc_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMtMTAtMS0xLTA_98e01d98-2dc0-46df-bd18-d34c909b5e93">733</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="iae3a3a38435f49649638b494f6bccee6_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMtMTItMS0xLTA_2df32704-9b21-4870-8f18-8e33849340f1">9.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Wound Care/Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia7c75ec32bd0476981aaefd378fca34c_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjUtMi0xLTEtMA_9cc1a9e1-a980-46dd-947d-930cd5370949">125</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic7eb47e278e24b51ba738fd66bd6e91e_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjUtNC0xLTEtMA_2eaee0ce-6c3b-4140-a4cf-6c6d9875fe5e">109</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ia7c75ec32bd0476981aaefd378fca34c_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjUtNi0xLTEtMA_b3b9d341-12cc-4e9f-849d-0f2b7a7ba6df">15.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i95d2bc3ef16c46d9b02250368f6f79fe_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjUtOC0xLTEtMA_39b64e6d-2ed0-4b0e-b044-b1a7a1995fd6">370</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19f91fce38e74e8abff653dd29e4e05b_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjUtMTAtMS0xLTA_b028a6d9-26dd-4d02-a00e-5674e7538387">343</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i95d2bc3ef16c46d9b02250368f6f79fe_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjUtMTItMS0xLTA_cf6b20c3-8e7d-429d-ad92-3a4aad456a89">8.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i08464ba4d52a4eb3914d1d9e020164be_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjYtMi0xLTEtMA_d8fabea5-b1de-49db-92c9-0408c991c8c5">64</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i33b4445ad1ea4e698cc11d61facc127b_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjYtNC0xLTEtMA_bba5fa02-ca03-4665-9f2a-6af8ee750650">59</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i08464ba4d52a4eb3914d1d9e020164be_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjYtNi0xLTEtMA_db45a4c7-21df-43a2-8056-a4abac870d34">7.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i077f80fe22fa40258a7a8564873d966a_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjYtOC0xLTEtMA_76383be8-3e9b-4385-b013-e2b9c1626564">175</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2ddf71a7398d40838d9e518d97fe48b0_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjYtMTAtMS0xLTA_61deae16-7ad8-4bae-8928-d3b2771cb7c1">173</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i077f80fe22fa40258a7a8564873d966a_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjYtMTItMS0xLTA_6667fe63-b4d9-49cb-b4bf-8aad9d036fdb">1.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2686d4d38b79478aa2b6dcfb62ab0339_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjctMi0xLTEtMA_0366fb34-79df-41bc-a9e2-e7c7004d586a">189</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if59b92da44574ef0b138a6fef376b519_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjctNC0xLTEtMA_c21c75a2-3c23-4ee8-9d68-79df4e3fac8b">168</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i2686d4d38b79478aa2b6dcfb62ab0339_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjctNi0xLTEtMA_0120a0bc-3f25-4188-bf73-251ae533e0e2">12.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie69aec39506048e693f8810a2bec2f05_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjctOC0xLTEtMA_ac92b66d-337a-49bd-8c0b-cb7c24fdc31d">545</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i99ad086b9b774548b75e48c3ae0dd0a6_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjctMTAtMS0xLTA_0f2c8790-8f3b-4b51-81ca-d123a046662c">516</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ie69aec39506048e693f8810a2bec2f05_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjctMTItMS0xLTA_3ac699f4-ee59-4dd8-a8db-e29c6e1a9ef6">5.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">TOTAL </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Consumer Health</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8fd225a39cf14e8fb13dbb1438b30e84_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjktMi0xLTEtMA_517e1906-ca50-4405-a098-17f10d0a2ea9">1,556</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0494a1212b6c4384ad100f4b232c73a5_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjktNC0xLTEtMA_70815ddf-9f10-46f8-83b0-9d4788b3b3f3">1,394</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i8fd225a39cf14e8fb13dbb1438b30e84_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjktNi0xLTEtMA_afc61fb7-2b6d-4047-a1e6-5dc63ada0b15">11.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4a475264ce8941ce924ce89da6c1b1f8_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjktOC0xLTEtMA_4ae02f90-2c3b-4123-afe7-6466c864f139">4,853</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i62a183893e91467983b0dbd1d2467359_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjktMTAtMS0xLTA_39c26e8d-da75-4353-8036-fcc6675d642f">4,369</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i4a475264ce8941ce924ce89da6c1b1f8_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjktMTItMS0xLTA_27e6aaa5-db9e-473a-b860-210727426a9c">11.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7721a842d6e04cd68272b2ceb8cd492d_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzAtMi0xLTEtMA_012a4f9b-95fe-4fe9-a90d-164828272161">1,958</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie377154beabf45b18b5f586329899114_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzAtNC0xLTEtMA_a554a69e-11a6-4bfb-885b-2602e65d5d6e">2,075</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i7721a842d6e04cd68272b2ceb8cd492d_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzAtNi0xLTEtMA_3a7df013-cea8-437d-81c0-7a0dc4238cb1">5.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iae10ea720f56417c9b64a77097323def_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzAtOC0xLTEtMA_7b4c5e6a-5ffa-4809-8a54-39dab63e2532">5,582</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic7d047e2d661467cbcc58d9b0a2b8f87_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzAtMTAtMS0xLTA_c953d3cb-ef58-4a45-ac36-bbeabfeb75d0">5,962</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="iae10ea720f56417c9b64a77097323def_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzAtMTItMS0xLTA_ec20e509-bbd4-4ec1-bacd-d91afd0869c0">6.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5a3e920df42c47f494f7fad0bdd00892_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzEtMi0xLTEtMA_1a6d1608-62fb-4d71-bd6e-fc7bab462798">3,514</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if1f5496c4f57420a9c9179ba0ecf286a_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzEtNC0xLTEtMA_53e4bf7e-04c4-4a2c-93bc-e2340c613514">3,469</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5a3e920df42c47f494f7fad0bdd00892_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzEtNi0xLTEtMA_186206c4-8148-49c2-b796-d7bbffcbe0f4">1.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i498b81f2554f4e868dce4daa5736066a_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzEtOC0xLTEtMA_f0066b71-8f0f-4362-8610-cbbe344447ae">10,435</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i80fc979b7821412b9354bc3c8c18f543_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzEtMTAtMS0xLTA_b7d6e28f-4ff8-47f7-a8b8-feed5a78b166">10,331</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i498b81f2554f4e868dce4daa5736066a_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzEtMTItMS0xLTA_51d42475-d5ea-4a1a-b9f2-5f520c83ad76">1.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">* Previously referred to as Consumer</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div style="margin-top:5pt;margin-bottom:5pt;"><ix:continuation id="i21c421b3505748faa336f0c98dfbe9e9" continuedAt="ib1d74340ef2549cb8a4eded891fc21af"><ix:continuation id="i47209320cc6c4008be0a943e0ddc4b6f" continuedAt="i85b0f9db090e4de58da5e3b1aa76ac8d"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"></td><td style="width:35.144%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.525%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.525%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.633%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.234%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.234%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.643%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PHARMACEUTICAL</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Immunology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0580a0f80a854712a683ccfae2bc01c7_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzYtMi0xLTEtMA_9193bd3a-2905-4bcf-9538-016150a8f324">2,558</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i20a3b648a6b14250804ce2ee299db44a_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzYtNC0xLTEtMA_ad0a40bd-8b34-4cc3-94b2-0ead0002cf99">2,582</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i0580a0f80a854712a683ccfae2bc01c7_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzYtNi0xLTEtMA_0cd7ae87-266e-452a-b11e-96a3415dc181">0.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4377262270cc41a59014888c45de668a_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzYtOC0xLTEtMA_2e945b40-60d0-4352-b9b1-14abd7066a32">7,330</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id1ac04085de547c09d5d0c96ced99ebf_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzYtMTAtMS0xLTA_b3d0170f-b239-4640-b053-9858f7a8ccfa">7,124</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i4377262270cc41a59014888c45de668a_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzYtMTItMS0xLTA_1f9e17f9-5cdb-4343-ae34-4e882e6c023d">2.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i08189f8df3194c738e0366b591e994da_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzctMi0xLTEtMA_6b5d4a40-bbb5-4142-b44f-0da46468cb43">1,230</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a49b61963434f44bc5c32db3f151981_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzctNC0xLTEtMA_0b922529-90e9-449e-974c-955cbbf6be99">1,129</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i08189f8df3194c738e0366b591e994da_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzctNi0xLTEtMA_e179fed7-48f6-4db8-8c26-df3407c26766">9.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4107f09a348348f5836beb164c41a295_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzctOC0xLTEtMA_62743cb2-5a0f-417f-bad2-182bea695709">3,619</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia54c27d99b0c4b6e8967c1db2422520a_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzctMTAtMS0xLTA_ae8a90f3-0ceb-46bb-812b-05bd7e8c0de3">3,304</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i4107f09a348348f5836beb164c41a295_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzctMTItMS0xLTA_4128ec6e-0968-4662-9916-9b66dff52680">9.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i28a313fee6cc48c980ee757740247668_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzgtMi0xLTEtMA_80a4da5a-28ec-4428-9316-0ad9924d0780">3,789</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i57b326234b5040d2924a11d5a5d2f80a_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzgtNC0xLTEtMA_1ee317af-cd3f-4e63-a47b-9b23fb56a4bf">3,711</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i28a313fee6cc48c980ee757740247668_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzgtNi0xLTEtMA_8fad4b43-46d4-4530-87db-9d32d781685b">2.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib1cced7a8930436b8bb62f6c2b776b00_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzgtOC0xLTEtMA_8e670e53-1a43-443a-846d-f6ece257d2b7">10,950</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i49584bdd90da4200830477e258a1f18a_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzgtMTAtMS0xLTA_018d015a-eea5-423e-ac5a-9e8a46e3aae6">10,428</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ib1cced7a8930436b8bb62f6c2b776b00_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzgtMTItMS0xLTA_a5092ba4-55c3-4e5e-b90c-9efdf9c1ef9f">5.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i71de0a16958d4a86a067f40d027e87df_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDAtMi0xLTEtMA_7ba9f29d-581c-4831-8185-0bc942dd8286">634</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5991575feed545c4b92cb368006afbca_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDAtNC0xLTEtMA_54603e55-9f73-4afd-bd9c-3f18ff9b4d64">749</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i71de0a16958d4a86a067f40d027e87df_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDAtNi0xLTEtMA_94efead5-39d3-4214-a49d-c99df98484fa">15.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ice0ca647d51147ab8d51aff745fcf585_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDAtOC0xLTEtMA_2fd1adc1-012a-472d-9d77-04099e508162">1,852</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d625ffa896248a38279e2b4a29f3219_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDAtMTAtMS0xLTA_ea5d492b-05eb-448e-8e5b-208b98f0a85d">2,324</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ice0ca647d51147ab8d51aff745fcf585_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDAtMTItMS0xLTA_2561d055-3cde-43ad-bc0d-cf01aa12421a">20.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S. Exports</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38b3cd6b638a4e2096aef80289a086d8_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDEtMi0xLTEtMA_e6655086-39a2-458a-b6cf-a02806a169e8">78</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6ed049d22c86487cbbb24c08237cf4b6_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDEtNC0xLTEtMA_3dcc631f-0124-4004-b51d-f6224ffb42ab">88</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i38b3cd6b638a4e2096aef80289a086d8_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDEtNi0xLTEtMA_9fba681c-d98e-406f-8e3b-6ea8030b6416">11.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic4bef45a84dc4c01abdc1d98d90dcf34_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDEtOC0xLTEtMA_affd248d-21d2-4ab0-9d2a-e536d858759a">321</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i600cf308c1784241b70b032c5d68bd00_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDEtMTAtMS0xLTA_7067648f-a49f-46cd-90fe-17e3dd328abb">226</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic4bef45a84dc4c01abdc1d98d90dcf34_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDEtMTItMS0xLTA_8ce77c1c-cffc-4627-a670-ed9bd39f469e">42.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63fb4ada15044f6c8fa99130ea93d6ab_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDItMi0xLTEtMA_7eb1a9e4-f589-4ed5-bd2e-24e10689e2c0">209</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i79355bad3e5e445082550bcd9d3f6dcf_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDItNC0xLTEtMA_9f760448-2eb7-45ba-b439-44cb95dad2f7">299</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i63fb4ada15044f6c8fa99130ea93d6ab_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDItNi0xLTEtMA_b9586037-0840-4b3b-a804-013b97491ae6">30.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i898fcee3d0f945379eea001f50fec410_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDItOC0xLTEtMA_e487c4ea-6fd7-4ec5-a5cb-1b932d388b55">673</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia77eb74fc24d4dee978633e876eeed4c_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDItMTAtMS0xLTA_53cf7a55-50ac-43c8-8d87-814ee865c4f0">795</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i898fcee3d0f945379eea001f50fec410_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDItMTItMS0xLTA_9b02b5d9-850b-4788-9bbb-f1d20d443da1">15.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibd37483bbf104452b66657df9eec0a8e_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDMtMi0xLTEtMA_c0dd4f36-c611-4d54-a7cf-56643f24c4be">921</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idb87e2b919d04ce0890e77ecba398e3c_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDMtNC0xLTEtMA_2b36393a-77ab-4212-a897-3fd951100c40">1,136</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ibd37483bbf104452b66657df9eec0a8e_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDMtNi0xLTEtMA_e75be110-9980-4a70-82a8-86d0ff402ccb">18.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id7fe0e4ddc03461a8b43fc91268211aa_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDMtOC0xLTEtMA_a8c2c32c-fd0c-432e-8982-b86a445736a6">2,846</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id4219375293b47b3b667294bccd3f0d2_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDMtMTAtMS0xLTA_065b6568-1b5d-4eaa-8b85-bc3a4c0e3c7e">3,345</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="id7fe0e4ddc03461a8b43fc91268211aa_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDMtMTItMS0xLTA_e9bcf6ea-725b-42ef-957c-c2b9c1913a24">14.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">SIMPONI / SIMPONI ARIA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie2a1050013c34d03af84c0a422360167_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDUtMi0xLTEtMA_bc775d02-cf3b-45d3-97e8-e1efd1ee56eb">312</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic3e62d93a7b248c084cbe02d4097ea9b_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDUtNC0xLTEtMA_c5d1e4a1-5600-4f72-b5c1-7b991c250d64">313</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ie2a1050013c34d03af84c0a422360167_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDUtNi0xLTEtMA_fc98b186-67d0-4ee8-a20b-b2b1cde33953">0.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i41d2ba995c114bea8112dc3f01a44747_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDUtOC0xLTEtMA_218f016c-6229-4b08-aa31-296acad49d53">840</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic1735f2c1b584a5387b7afb371b2cced_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDUtMTAtMS0xLTA_2c2e5c46-6a5f-4591-ab0c-9a87a4dd1109">857</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i41d2ba995c114bea8112dc3f01a44747_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDUtMTItMS0xLTA_8de9efab-27e7-4ca4-869b-498508b7efc2">2.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia3f96f7c0ee0405d828605b25d8ad883_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDYtMi0xLTEtMA_932c1857-4b98-48d9-bf36-17c10113500c">280</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic017a6711bd74dc0bfa3467c9d21905e_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDYtNC0xLTEtMA_19b4aeb5-0cba-40cb-8b1d-102291271443">273</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ia3f96f7c0ee0405d828605b25d8ad883_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDYtNi0xLTEtMA_eb77629c-2ccf-417a-bdbd-eefc84f2ad3c">2.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6f8cb419ecd94801b4d8467fb355264b_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDYtOC0xLTEtMA_4d74b81d-062e-4e52-b068-8d5602fd758c">827</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia794884513314c399f7a15b03dabd0e8_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDYtMTAtMS0xLTA_aecf5a75-13d3-49f6-b154-14ed3b4b2992">816</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i6f8cb419ecd94801b4d8467fb355264b_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDYtMTItMS0xLTA_dee81578-c400-49d4-bb00-81df0942f50c">1.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iab4590d1e9a54db1808fa18df4d4b0e7_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDctMi0xLTEtMA_cb5f1ca0-32b1-4a9e-91be-c74497be3b57">592</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3dc4de912284470885b7eab6009487a0_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDctNC0xLTEtMA_60e0f9f0-7b03-4648-b2f8-d03c5f2f46b4">586</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iab4590d1e9a54db1808fa18df4d4b0e7_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDctNi0xLTEtMA_8929710f-18cf-4555-be37-82d65051ca02">0.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8a91bcb926e849978bced69fbb28f834_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDctOC0xLTEtMA_40b44fbf-49cb-45b6-a9f3-6a2342064ac2">1,667</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2550784b68a94c5e9a6680ddeb5a5dd9_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDctMTAtMS0xLTA_63e5c077-7b39-44a0-b24b-7cd83e9f3b85">1,673</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i8a91bcb926e849978bced69fbb28f834_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDctMTItMS0xLTA_9378faf7-4585-48b8-b20b-884d86e72a1b">0.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">STELARA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id05fcdc5a97449168a9c27235f88a4a3_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDktMi0xLTEtMA_06f6009c-19f0-45e2-a415-5396eca2fbc0">1,313</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iae663d548ab040e1b558e27622a655de_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDktNC0xLTEtMA_9488581b-f0d5-445f-b71e-3f1fa071aef0">1,212</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="id05fcdc5a97449168a9c27235f88a4a3_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDktNi0xLTEtMA_668281cf-f4a3-4bc6-aa3d-a226aa39740d">8.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6a44552997a1438b8dd35f1ec093c504_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDktOC0xLTEtMA_ed435b99-e52f-4a0d-9e7c-89da123f0283">3,668</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2a72154c44cf41628c31a554960fb0ef_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDktMTAtMS0xLTA_1e6a0c03-2309-4f1e-a679-9f167b0cc470">3,152</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i6a44552997a1438b8dd35f1ec093c504_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDktMTItMS0xLTA_83a5a20f-4b3c-407e-8d9d-971dd62013fc">16.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1e256d64e1f14cda9becb9ce95293d74_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTAtMi0xLTEtMA_7258354e-a191-4cba-b5db-46e5a16be750">634</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if9f32d7f981b49809c5a26d11cfd4bef_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTAtNC0xLTEtMA_3ff7adf6-bac3-42bb-88a2-f3277ae4b275">487</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1e256d64e1f14cda9becb9ce95293d74_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTAtNi0xLTEtMA_11af1dcf-c513-40a4-a8a0-68ec5ffc1d95">30.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib1fa30f3e8d749dcb44364f361265101_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTAtOC0xLTEtMA_046c0113-c9bf-42c1-816c-93a6f7a2dc01">1,795</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib09c328bd9b9495b850d67bcb81cf0e9_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTAtMTAtMS0xLTA_644a6ea8-6873-4e8f-94fa-cf53b2b9aa3d">1,509</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ib1fa30f3e8d749dcb44364f361265101_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTAtMTItMS0xLTA_9f389a16-e6eb-474e-b374-e8eb5de09135">19.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7dc3572916fc412292b0f22a60e8ffa9_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTEtMi0xLTEtMA_2f89fb80-a662-4fd7-be4b-7825c7d0e739">1,947</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibfb0a635e286413fa05216c24bd242a7_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTEtNC0xLTEtMA_030fbf1c-9f61-4765-92a0-9f78dc848c05">1,698</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7dc3572916fc412292b0f22a60e8ffa9_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTEtNi0xLTEtMA_42f1747f-3de1-4139-b4f8-94ad0f8faeab">14.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idc83cb6294cb49adb420c6d0d9a84038_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTEtOC0xLTEtMA_7b6d9a69-71d3-411b-a1f3-8cf75a5964af">5,463</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i24c66572a6274c88bc620e4593e2bee7_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTEtMTAtMS0xLTA_0ef29d08-f513-45e6-b329-366eda2bc734">4,661</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idc83cb6294cb49adb420c6d0d9a84038_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTEtMTItMS0xLTA_a3eb7245-4d45-4af5-bbe9-6c74a259981e">17.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">TREMFYA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i833f6bdd0ed74fd890f7d87af9bf634b_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTMtMi0xLTEtMA_51306f98-ae36-4377-8157-4dadd881b344">222</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3d16336042034ca19612e535c7203721_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTMtNC0xLTEtMA_3c604d11-b8e4-4b0c-ab73-5c051a2159e8">221</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i833f6bdd0ed74fd890f7d87af9bf634b_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTMtNi0xLTEtMA_13685dca-56ea-4054-bc2d-85c2a7651e31">0.4</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7f0843036b964e08a45d950a3620e639_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTMtOC0xLTEtMA_a3abbfcd-2fc2-492b-873c-be951b7f709e">650</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic56e7a163c104637a12666dccee0cccf_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTMtMTAtMS0xLTA_18c3079a-e649-4dbc-b092-c5c745945975">565</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7f0843036b964e08a45d950a3620e639_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTMtMTItMS0xLTA_a8a59c3e-6c89-4615-9136-7115ce6ceefb">15.0</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if0b694b680c54fd3954e2c9de825640c_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTQtMi0xLTEtMA_47e4f4b8-660e-4db2-bcb1-e42f63694860">105</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i71cf25bbc69049d7a04ce269ab9edbfc_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTQtNC0xLTEtMA_a4787c54-fee9-40b9-98b4-255b78f10671">69</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="if0b694b680c54fd3954e2c9de825640c_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTQtNi0xLTEtMA_48fe275d-0a1b-4c2d-8073-90a60d0678ea">54.4</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie9c6b2cd97644d858ea79595de3d0fb8_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTQtOC0xLTEtMA_c2c6ca8d-b4f2-4c33-92ea-143a81d372cb">316</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie7d0e75dc93a4714a87669d7c1755832_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTQtMTAtMS0xLTA_b9fe9194-7006-4095-b509-4f8bea4aad9f">177</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ie9c6b2cd97644d858ea79595de3d0fb8_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTQtMTItMS0xLTA_b81c4793-6cd0-4539-afc8-0d0a748e329c">78.7</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib59aee6a72054b5cb1cbd5bddc82a106_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTUtMi0xLTEtMA_5739e68a-6802-4cab-87c0-2aec3f18b2cb">327</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6e3f978416814668818a1ac3d0016e08_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTUtNC0xLTEtMA_aac1a686-26f2-459b-b094-3bcb0cac9eca">290</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ib59aee6a72054b5cb1cbd5bddc82a106_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTUtNi0xLTEtMA_481d2512-cb51-40a5-9f55-da0c575b3c1f">13.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id5ccf929f2094fa7b1f560a94aef5455_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTUtOC0xLTEtMA_e11d4f2e-7b42-4c8d-b482-a010ccdaa179">965</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie48cd916e4a74a618757c125457112d0_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTUtMTAtMS0xLTA_3fa35d02-478e-4591-9834-a223ba2f2dd9">742</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="id5ccf929f2094fa7b1f560a94aef5455_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTUtMTItMS0xLTA_1acb2122-e8b7-4b9e-8390-53401efd9f3d">30.2</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER IMMUNOLOGY</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i31dea148331149cca5a80f720044788b_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTctMi0xLTEtMA_c14a4e50-ad33-4d7a-b7d5-d07c56bb2a98">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iecdff515762e495ab6fc8d22e512e250_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTctNC0xLTEtMA_1de43011-3f19-4342-b36a-b9ede38cdd8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i31dea148331149cca5a80f720044788b_D20200629-20200927" decimals="3" format="ixt:zerodash" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTctNi0xLTEtMA_a3fd018e-141a-4468-8e9e-63b6a3cc97ee">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1be2f593ae2b4c93ac28c4879f064560_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTctOC0xLTEtMA_ce569cfe-a01d-410c-a384-0d29586e0128">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5d8ceba2b66d44b3a34e55b430bf0cd0_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTctMTAtMS0xLTA_608a5637-a2e2-47d8-bdcf-676f11f52c1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1be2f593ae2b4c93ac28c4879f064560_D20191230-20200927" decimals="3" format="ixt:zerodash" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTctMTItMS0xLTA_346b8333-39b6-4935-9604-4d346b1a9ee8">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie11aec75a6e74827a118fcb88d74e00f_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTgtMi0xLTEtMA_1d7c7cd5-0fa4-44e3-96d9-6e4e26a49d10">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i97c1b4ea6d1a4ecb97e3016e1eee457b_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTgtNC0xLTEtMA_20c6249f-75ee-4803-bdb2-67a0bac67ee8">2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ie11aec75a6e74827a118fcb88d74e00f_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTgtNi0xLTEtMA_d7f6c23c-50e4-4c7f-af02-bc115ac7648b">35.6</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5d39e83bc807453883a50f25b55fa036_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTgtOC0xLTEtMA_d9da2e93-f24e-4332-b9f5-87b318af95ae">9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i04e9c913340f4fd9bd58f8191b92c901_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTgtMTAtMS0xLTA_c02f8350-1269-42af-b779-2c86b279a6e0">8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5d39e83bc807453883a50f25b55fa036_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTgtMTItMS0xLTA_dbd46207-b623-48ec-a267-ff4f91e74a25">12.4</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i27a5631c2fb54ff69c55c3cfd8c73d66_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTktMi0xLTEtMA_09df019d-58c5-4f3b-9327-e9dbff41b9c0">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7577089dcd244daaab8e65459409715a_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTktNC0xLTEtMA_8527a6ac-7bf3-4224-a76c-d7c0dae0e29d">2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i27a5631c2fb54ff69c55c3cfd8c73d66_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTktNi0xLTEtMA_32af84e3-6f4e-4a3c-a452-279b5174fb19">35.6</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7e213faa318546279e9fd452570893b7_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTktOC0xLTEtMA_c219b32a-ad9e-4b12-800b-5fe023c5d20d">9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib040cfc0c5614b24b802c847b9882e83_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTktMTAtMS0xLTA_f8b877ca-7fc5-4d1d-9d2e-dd36709dabd7">8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7e213faa318546279e9fd452570893b7_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTktMTItMS0xLTA_3356bef2-127d-44da-8e8b-2bf2845e5bda">12.4</ix:nonFraction></span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Infectious Diseases</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibb1464cedac54631af9b25c35805ce37_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjItMi0xLTEtMA_f5d16986-cbea-4766-8350-c99bc94784fa">413</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0d6bb0f027f641e382fb220073c0b43f_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjItNC0xLTEtMA_f17e452d-5d7c-4515-b733-ad0f0c46baea">418</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ibb1464cedac54631af9b25c35805ce37_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjItNi0xLTEtMA_5b3c442f-317b-48fc-8637-ef436b1883d7">1.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9f59ef10b8cc46cda0b50f4338e55776_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjItOC0xLTEtMA_4c499dd4-4ddf-4e05-ae1a-bb243486ef15">1,265</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4e29ce41396f48e889d97e03233e6707_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjItMTAtMS0xLTA_752cbaec-4bfd-4265-8fa2-ea63597b829e">1,162</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9f59ef10b8cc46cda0b50f4338e55776_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjItMTItMS0xLTA_5e40081c-ff03-4bf8-9f95-f6bf06cd644d">8.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idd7af9434c1d463397ad836760e61d27_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjMtMi0xLTEtMA_40bc992d-d6a3-4e98-91f6-7c7e8b237ff6">451</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic8bc6696056e49588142a93df17780a2_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjMtNC0xLTEtMA_d05a2d6a-d084-4267-bfdd-6bd4c49417d1">421</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idd7af9434c1d463397ad836760e61d27_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjMtNi0xLTEtMA_f3b055e9-f95f-45ed-969e-95998181226e">7.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie776bdb04f934182825e29d6f3d24312_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjMtOC0xLTEtMA_5e6438c3-6347-40d9-830f-867ee612ad51">1,397</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id50261a61f02491c979c43c1a7e12622_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjMtMTAtMS0xLTA_a22b7d4e-d4d3-4705-b867-c9c83e1447b5">1,385</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ie776bdb04f934182825e29d6f3d24312_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjMtMTItMS0xLTA_dadaf239-118a-4b75-b1a7-a25e598b57d9">0.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8a00e22875b445d8a301f09f4917837d_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjQtMi0xLTEtMA_391302d0-da9d-436a-8e26-b4858189f516">864</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i86d495dddd6e45b0b86fb85e4b21a2dd_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjQtNC0xLTEtMA_ddfd4e6b-299d-4512-882f-e203e94da44b">839</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i8a00e22875b445d8a301f09f4917837d_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjQtNi0xLTEtMA_985d7b0b-578d-439c-b954-12024bda68f1">3.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7387eb05ef5c4fdb842526c456bbe3c5_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjQtOC0xLTEtMA_b3ca52e3-27f6-4575-9fcc-e48d6570cbdc">2,662</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i313ef0d43b1b446cba4d11086db5cb51_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjQtMTAtMS0xLTA_c6e86073-1911-4799-8c88-ec223198a213">2,547</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7387eb05ef5c4fdb842526c456bbe3c5_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjQtMTItMS0xLTA_43cc5c30-fedc-4730-b3db-7f2ec4b8486d">4.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">EDURANT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / rilpivirine</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib77203578b1e4210a44754b41d738e9c_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjYtMi0xLTEtMA_43bb51a7-d4f4-443e-b405-faea92671961">11</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1173e423785c44f1b4f1120ba26ad0c8_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjYtNC0xLTEtMA_a655ff34-635b-4a4d-ba01-ac4935e7802c">12</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib77203578b1e4210a44754b41d738e9c_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjYtNi0xLTEtMA_bd91a17d-d5f4-4de8-8d71-ce76bd2712fd">12.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i73165b608c644bd1908c9df7d2a34b56_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjYtOC0xLTEtMA_84c4efac-040e-42a2-a0fc-d043a9fb8c94">33</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2d0350d7f7b0426fae4ab3e96ce6a2d0_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjYtMTAtMS0xLTA_6923fae0-4b7b-4c4c-97df-d02f5badbf60">36</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i73165b608c644bd1908c9df7d2a34b56_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjYtMTItMS0xLTA_5e1daaab-ea4b-4ae7-a770-ccfa14d660ff">8.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idab010351da041bdb2cbf40ef950465c_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjctMi0xLTEtMA_71f5811e-9f33-45a5-8ad0-415e83d0b3cf">226</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1ede8c86463a4ca1900b7e1fd0a2b799_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjctNC0xLTEtMA_0924b0af-4484-418d-a163-e3899b2503f2">206</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idab010351da041bdb2cbf40ef950465c_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjctNi0xLTEtMA_243864bc-6bb2-4d3c-9f27-b89163ae3692">9.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia0bb26554dca476f8295e07cd23d1a30_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjctOC0xLTEtMA_4eb8ca09-603e-464e-a2c7-935544130c37">684</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3ab4cc6bdbc94b5cbf46487897a3b4c1_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjctMTAtMS0xLTA_f055f164-163b-4bf2-bb02-72013b99386e">603</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ia0bb26554dca476f8295e07cd23d1a30_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjctMTItMS0xLTA_3ce90bd7-6d1f-4881-84b7-f76dc6f6a601">13.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2f63caca7fb446d981bd3f55e5f83321_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjgtMi0xLTEtMA_62c8d1ed-d524-4c07-b0ab-a2cf23a3221d">236</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58ab3c81d40b4648b33db3b797bc2e2e_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjgtNC0xLTEtMA_e1a0904c-7d45-4d05-a675-41a34112c078">218</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i2f63caca7fb446d981bd3f55e5f83321_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjgtNi0xLTEtMA_1581681f-6162-4a2a-90ec-84b99b3db4c7">8.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i42d8379119de4f56aacbfe9fb385c84a_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjgtOC0xLTEtMA_5d254e7c-1fed-445b-82a2-b0cc66e3d986">716</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie267eb4c95db4a2490afebd4e223298d_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjgtMTAtMS0xLTA_fe75b590-7665-46fd-bbe8-8e92e084d4e7">639</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i42d8379119de4f56aacbfe9fb385c84a_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjgtMTItMS0xLTA_3ff1c6c1-e376-427b-83a5-e2343c495de5">12.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / PREZCOBIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> /  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">                         </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">                     REZOLSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / SYMTUZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie025a2f5e9ec4234a5ed0d872620533d_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzAtMi0xLTEtMA_e8511915-74b1-4370-a09a-c802699da71a">379</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i022b92c911e04342ae67e207f4d0515e_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzAtNC0xLTEtMA_457a897a-95fe-47ab-a3ea-8b7992c67b77">373</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ie025a2f5e9ec4234a5ed0d872620533d_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzAtNi0xLTEtMA_ed510fd5-f0df-4e0f-b356-649aca32a0ee">1.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2e38b2e1ebc14377b3723fca5ed4fc49_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzAtOC0xLTEtMA_83095e3b-193b-47f2-9d0b-30b58bf1fa9c">1,154</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i836e6925162d4ab1800fa82a7ab90e71_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzAtMTAtMS0xLTA_283a5adb-b6cd-4913-8bdf-5dd82b0005a4">1,032</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i2e38b2e1ebc14377b3723fca5ed4fc49_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzAtMTItMS0xLTA_e925b23d-b2b4-4b31-b513-f14f4ec37fb0">11.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iccc032099418444abc0b942948f6db9c_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzEtMi0xLTEtMA_fc806402-f365-4b48-963c-3c8057e837e9">147</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7969cdb22dd40dcad77977375507b7c_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzEtNC0xLTEtMA_5f9c8860-5e4f-486e-8d5f-d8a79ae7ab37">135</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iccc032099418444abc0b942948f6db9c_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzEtNi0xLTEtMA_c94a811f-95bb-4dd5-a10f-aa35b8da1bdf">9.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib23a110014b24e3e9dee37ef5d241637_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzEtOC0xLTEtMA_c30db1f2-deb7-4109-b0b6-d57ae3be3392">461</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i400fe3ea80954d2fa120c009dd823c28_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzEtMTAtMS0xLTA_a944977c-a4b2-4de4-92f6-e043afea9690">534</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib23a110014b24e3e9dee37ef5d241637_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzEtMTItMS0xLTA_8ed4bcf0-183e-4e02-aed4-a667c2f2777b">13.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibb55b5529292435b9665dbde03853a33_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzItMi0xLTEtMA_9c226a55-a438-4442-91ba-dc35f74a1d03">526</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i760f73e5eac14ceaa22fe96b46943bbb_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzItNC0xLTEtMA_47aa01a1-a91e-4b5e-9df3-cc0e7c55baa0">508</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ibb55b5529292435b9665dbde03853a33_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzItNi0xLTEtMA_583043a3-75a3-41b7-ace2-69f34b290b00">3.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie059b332397c41f9a9a476949ab0f9db_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzItOC0xLTEtMA_ce9e2ca6-6d21-4ac4-a845-3c4638930e69">1,615</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i77166f2077334d64bae7a52b781efe80_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzItMTAtMS0xLTA_c400c5f0-f7cf-41a5-8da7-82b8dbce1345">1,566</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ie059b332397c41f9a9a476949ab0f9db_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzItMTItMS0xLTA_a81b5ca1-9955-4373-9a1d-b9265eedc048">3.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER INFECTIOUS DISEASES</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia076593d3cf644b2a4c230fb8aa33f2b_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzQtMi0xLTEtMA_c879bff6-492b-48be-bfcd-8d556ea004e2">24</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5cbc3463e1ae4fa096e2ee9db46c6632_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzQtNC0xLTEtMA_fec94e39-517e-40bd-8fd7-93fbe3f9341d">33</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ia076593d3cf644b2a4c230fb8aa33f2b_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzQtNi0xLTEtMA_4f7cc8d3-5f2d-48b4-97a4-a83913be135e">26.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic670fa5873324341b652814d7990b6ae_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzQtOC0xLTEtMA_af5974fd-929d-44c5-9b01-943476ee6581">79</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i39d249731b8e4bafa48866d9284ba875_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzQtMTAtMS0xLTA_a21f40cd-0341-4f88-84b9-05a2d42467cf">94</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ic670fa5873324341b652814d7990b6ae_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzQtMTItMS0xLTA_d7708874-1d3f-4e9c-8172-94f26517539c">16.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i74965ae98cf74a79a669cab97dcec19d_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzUtMi0xLTEtMA_43e06feb-ed2a-46de-b1ac-e5e12d059ad0">78</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i37b6d89c8f7649f59cd7ed840dc6187b_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzUtNC0xLTEtMA_38580c0e-1f30-437c-89ef-f0dde914788e">80</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i74965ae98cf74a79a669cab97dcec19d_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzUtNi0xLTEtMA_a5c9df37-b3a5-4293-b6a4-f74d7a6113b4">2.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i03e4b6fa743e46aba9b64898e02d6610_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzUtOC0xLTEtMA_78c016e8-cc66-4a60-8cb1-ee5c73f4d7c4">252</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i864fefcfe9ef4b1f8253371aa4da89d9_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzUtMTAtMS0xLTA_5ab99b93-5faa-4c5a-b2ac-104cb6d748bb">248</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i03e4b6fa743e46aba9b64898e02d6610_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzUtMTItMS0xLTA_db37388d-83c8-495b-b4fe-7006f9270b19">1.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c99f12082bc4cb2903b1862521cb302_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzYtMi0xLTEtMA_7112eb81-f645-4156-ac16-6d0d06bc0b14">102</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i75a1d3c0a8c34a149a347f13a9e28320_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzYtNC0xLTEtMA_a7fd1f5a-cb6e-46e4-a1bb-e477889141fd">113</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i4c99f12082bc4cb2903b1862521cb302_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzYtNi0xLTEtMA_ac346676-dde1-41eb-94df-498e0c77990f">9.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idc9abc58a71044878c2aa7ae09ff8f8c_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzYtOC0xLTEtMA_b9e6de5b-52d3-4dfe-ac8f-12470f24296a">331</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia105d1087fa6441a9079ac5df861898e_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzYtMTAtMS0xLTA_6cfccbf7-4105-4842-a9f3-0d5ecce7c3c1">342</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="idc9abc58a71044878c2aa7ae09ff8f8c_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzYtMTItMS0xLTA_bb1dce30-59cd-4f03-a705-ede0f56f8483">3.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></ix:continuation></ix:continuation></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div style="margin-top:5pt;margin-bottom:5pt;"><ix:continuation id="ib1d74340ef2549cb8a4eded891fc21af" continuedAt="ie916a957265e472290d2e644e60dbef5"><ix:continuation id="i85b0f9db090e4de58da5e3b1aa76ac8d" continuedAt="i5cdd8e927e5c42a9b1e227093c914e6d"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"></td><td style="width:35.144%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.525%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.525%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.633%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.234%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.234%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.643%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Neuroscience</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iacb6b77961a1479ebecb82fdc6fe00d7_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzktMi0xLTEtMA_34592acb-a827-43b2-94f3-d3676c5e7f72">759</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2c08f4679ad1446eb19be39cc3bbf8cb_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzktNC0xLTEtMA_657bf99b-0937-4cd3-ad1b-10485e5def7b">785</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="iacb6b77961a1479ebecb82fdc6fe00d7_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzktNi0xLTEtMA_0632ccc1-2eb6-4940-95dc-690780913e0e">3.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie0c2f0fa25124f8b90b673fc8d30c977_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzktOC0xLTEtMA_f1027337-6e60-4b2e-888e-65f575302c87">2,285</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia3b86ebc40de4d02b5a15198e05e4dd2_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzktMTAtMS0xLTA_9fae2b05-5033-4477-a03d-18e407f56132">2,172</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ie0c2f0fa25124f8b90b673fc8d30c977_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzktMTItMS0xLTA_2162512f-7339-4885-85d3-6157c53f36c9">5.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i04d10f41995549958614dc5d62ead9fa_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODAtMi0xLTEtMA_1350b910-516f-41de-b93f-55c5a5330b11">846</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i15bd82bcfc384cd1be06ff3479f7fe56_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODAtNC0xLTEtMA_1035b7a4-017c-4d4f-8d03-231c4fa1f3e6">810</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i04d10f41995549958614dc5d62ead9fa_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODAtNi0xLTEtMA_101d0041-c52c-44fe-ba99-61bcc2590928">4.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i77bd07ae97df45fe8f18bc29a8766b16_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODAtOC0xLTEtMA_d350c1cc-6860-4f22-980f-ad7fde708d1c">2,565</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaf7cf5a1f5484ad28076d05cc5bf5456_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODAtMTAtMS0xLTA_7ddc3c05-69f7-4694-a1c4-191a1735ea62">2,590</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i77bd07ae97df45fe8f18bc29a8766b16_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODAtMTItMS0xLTA_699e10b5-3b2d-4b4c-922d-411c88295ee1">1.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idb272bfc6aa14c8d833db65bd2d89c9f_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODEtMi0xLTEtMA_5c079367-4adb-41fa-8194-9990747cd66e">1,605</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i024b31141065487eb47c8f27eacf8b94_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODEtNC0xLTEtMA_2676d7a2-058a-4a9f-b6b3-ae7ee5f78b6f">1,595</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idb272bfc6aa14c8d833db65bd2d89c9f_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODEtNi0xLTEtMA_f2cdee96-ae81-4ae3-9cca-bf7bef85b3b3">0.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i26d2bebfc5134ffea7bebf182f6bfe88_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODEtOC0xLTEtMA_4e3a44d4-6bfe-48be-9e7f-e3b75397a099">4,850</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i09fc122a66fd43d987b35c926766da1e_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODEtMTAtMS0xLTA_71e8f6bd-d74d-44e4-a610-1b3907fd3e46">4,762</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i26d2bebfc5134ffea7bebf182f6bfe88_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODEtMTItMS0xLTA_9cdd5dcc-36a7-463a-b20b-edf32b4223d2">1.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">CONCERTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / methylphenidate</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i838fec96a85e490a91abbe0f423852cd_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODMtMi0xLTEtMA_3546a6a7-40d3-4db4-ad0d-083f7326d584">43</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i205f53eb2b4844e4b0c11273e65d1efa_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODMtNC0xLTEtMA_bbe952bd-c660-4ac5-af07-05e9edca3691">84</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i838fec96a85e490a91abbe0f423852cd_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODMtNi0xLTEtMA_402542fc-fcde-4bef-94dc-d81ced49ebff">49.2</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i49d169f73b2a460ba9c3d0d74492a3fb_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODMtOC0xLTEtMA_7ceb3ff9-db45-4c53-b184-8334e33f90be">150</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idc2604a22a5446d1b2baa44602c72c6b_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODMtMTAtMS0xLTA_b68bd9aa-f257-4f69-8d19-88eb95499a8e">196</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i49d169f73b2a460ba9c3d0d74492a3fb_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODMtMTItMS0xLTA_fe5acf98-2cb7-4e8a-bbef-2cdfe90466eb">23.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4603cfe6fe1046c6af473d0b35dc1e66_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODQtMi0xLTEtMA_4802d09a-204f-4ab2-9e82-b9e12a9eb9f9">107</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4f7c241d8ff946ad9a3f1e8650b6d548_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODQtNC0xLTEtMA_4f9b5662-f3fe-4d9f-be59-66323c7ff17c">109</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i4603cfe6fe1046c6af473d0b35dc1e66_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODQtNi0xLTEtMA_c632aa32-3b34-495b-90ae-b8a83ec1722c">2.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3e5b1f4897dc44e3889d6a11570ac3c3_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODQtOC0xLTEtMA_2686a450-33b2-4878-8b89-529b5ff3aac0">319</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idcd6dab96cbe45f7959c3a93eca497ca_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODQtMTAtMS0xLTA_58dd518e-69ce-445e-8c00-f98cc6c6bd21">348</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i3e5b1f4897dc44e3889d6a11570ac3c3_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODQtMTItMS0xLTA_cadace7b-2312-455c-8135-4cffa9d93924">8.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i54ccc3c917cf4242a4f575583368ce21_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODUtMi0xLTEtMA_59e9f334-ab16-47cc-8260-a0a0ee4c999c">149</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5377031ce1bd478a865faa89ac9e836d_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODUtNC0xLTEtMA_8c567a2f-842f-498a-9058-a40ae8d2a766">193</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i54ccc3c917cf4242a4f575583368ce21_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODUtNi0xLTEtMA_71e9119e-d143-4215-8d78-6917526c41ee">22.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ief1076e1d3ec4608a9c69b0854bd5c3d_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODUtOC0xLTEtMA_f5c83774-df09-4bdf-aac7-4eed458b9e40">469</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2d0623be30d649bdb8c119d1fb380cf5_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODUtMTAtMS0xLTA_a712d731-3d9d-4dfe-a69f-9e2250377b0e">544</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ief1076e1d3ec4608a9c69b0854bd5c3d_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODUtMTItMS0xLTA_c1bf17c5-4ef0-4bee-bfaa-8fc31f0ac972">13.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / XEPLION</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / INVEGA   TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / TREVICTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie5493cd95e9040eca88efc765e25c90b_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODctMi0xLTEtMA_cae8ae1e-4879-4c24-82c2-89725f41fd22">585</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib8154cbc3358471d81b6c9e0cfca602b_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODctNC0xLTEtMA_2b343834-f064-4b22-a014-df7e5a9e5007">554</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ie5493cd95e9040eca88efc765e25c90b_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODctNi0xLTEtMA_6d0cd26a-d128-459b-b539-079b3a0288b4">5.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia65c328603194766a57c17632de4fa37_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODctOC0xLTEtMA_d9f37035-7ca9-4259-bcb7-4b687a80cabe">1,704</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5abf17b6cb264cb197714b4eaa2858f6_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODctMTAtMS0xLTA_8a05f004-624a-4509-99ff-56bfd07e8e7a">1,543</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ia65c328603194766a57c17632de4fa37_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODctMTItMS0xLTA_f846e6df-83fe-47b6-b00e-3f8fc9155184">10.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iebb810100f164a6f90ad8126497b2fee_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODgtMi0xLTEtMA_4c6c563b-cbaa-43a7-8538-5a92249f0d46">341</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id795ffd344cd44f3ae87465d76b3b61d_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODgtNC0xLTEtMA_b70b095d-d469-4a8b-b2a0-e2f3ac25adb5">297</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iebb810100f164a6f90ad8126497b2fee_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODgtNi0xLTEtMA_d4ab0bb8-ddcf-4f1f-a488-b459f489510d">14.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i020804ccc75241b39a2537441aa2abb8_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODgtOC0xLTEtMA_3d3c8f2e-ed43-4a9a-a96a-4e63bfa10436">983</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i466ad16e878648bfa865eeba3f05858e_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODgtMTAtMS0xLTA_b8e8ec74-27cf-45b9-bb82-718ececca8c8">916</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i020804ccc75241b39a2537441aa2abb8_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODgtMTItMS0xLTA_04695bc3-52bf-404e-9583-92d4ed0a8b6a">7.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i702c3ba78f294a499d08adca2c3e05d3_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODktMi0xLTEtMA_e04e2988-5fe1-4b6c-88ad-938164eb590f">926</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8d5788dcb82e4eee98bd8058fbf39537_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODktNC0xLTEtMA_e2697c0e-332f-46e9-a322-64a150b77224">851</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i702c3ba78f294a499d08adca2c3e05d3_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODktNi0xLTEtMA_2762d273-b55e-4543-a747-953112cb22e1">8.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa520d7163634d8fae3b61f2452fa6a9_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODktOC0xLTEtMA_5ef3740e-5f78-440e-a740-3fe3adb811d7">2,688</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3397044102204bdea03afee12e1ddbe8_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODktMTAtMS0xLTA_bd341b65-2184-4092-adc4-2db6ca101115">2,459</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ifa520d7163634d8fae3b61f2452fa6a9_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODktMTItMS0xLTA_3a679471-3755-4722-b188-464bd19c5e51">9.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;RISPERDAL CONSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i230206d0e0be406ea6ed74138f698967_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTEtMi0xLTEtMA_00336bea-aaff-4d56-bb62-ee6990619950">70</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8af9975ac5e84f31902e2dc3297b1c31_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTEtNC0xLTEtMA_adbb135f-4010-42f7-9998-bef6fdc80514">79</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i230206d0e0be406ea6ed74138f698967_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTEtNi0xLTEtMA_61eba95f-9c55-4f19-b292-cdab1ddadf00">11.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifc11f05a7e144bb8a612662099fd1476_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTEtOC0xLTEtMA_295725d2-5b65-417b-b800-8e1ce94f94f6">220</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iec74f00dc144400fbf71837c3f85d010_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTEtMTAtMS0xLTA_1250390c-4c57-4599-a2c1-8a09d500daf8">237</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ifc11f05a7e144bb8a612662099fd1476_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTEtMTItMS0xLTA_0a0f449a-afcc-44d2-bdc1-4266d9036ef6">6.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i88615927a6634ebe93715f2ce1c8ffed_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTItMi0xLTEtMA_5d04f67b-b853-4ac5-9404-47fe6943e6a4">81</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i542156a6acd14373931ce4b7ccae05f5_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTItNC0xLTEtMA_90fe8255-f05e-40ff-9e6a-56de9ac8687f">89</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i88615927a6634ebe93715f2ce1c8ffed_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTItNi0xLTEtMA_94b3f172-d998-475a-afde-b87ce0f7cc45">7.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4492bef684ea46c1a3ae25b9fe930f14_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTItOC0xLTEtMA_44944fe9-0b72-4a86-83d9-d61bce85c945">254</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i721706f8e045481c86dc8e07627a8f0c_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTItMTAtMS0xLTA_0c76f9c2-1fe9-41a9-999a-390f620fc702">292</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i4492bef684ea46c1a3ae25b9fe930f14_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTItMTItMS0xLTA_1153d387-03ff-4455-8956-f1b9ef684206">12.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i69abd303a0a949469442142f029642f9_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTMtMi0xLTEtMA_22335350-ffc9-4708-a235-609f44fe12dc">152</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iba3f0ee0c4f3486faa522e60acb01051_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTMtNC0xLTEtMA_9b882c8d-7933-4332-9c1c-7ccdb9b7cf18">167</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i69abd303a0a949469442142f029642f9_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTMtNi0xLTEtMA_9130e858-8805-41d1-a0af-041b30dd988b">9.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if4a66bae60fa4ef0af457100fe8a6b2b_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTMtOC0xLTEtMA_657b3298-e95e-4aa6-829f-4c9af448a972">475</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b81e17f99cf4307aca1954a29ad581c_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTMtMTAtMS0xLTA_43383ce2-57fd-4568-8de8-202bb2f5e795">528</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="if4a66bae60fa4ef0af457100fe8a6b2b_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTMtMTItMS0xLTA_b5d823f1-4e9c-4e02-9a93-3dd2db4794b0">10.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER NEUROSCIENCE</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3c1f3898bb4b45dda42e758bda36a669_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTUtMi0xLTEtMA_35823277-a107-438c-8b65-3c378e439ce8">60</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5054190d146a4cd188e4ff52a2ac195c_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTUtNC0xLTEtMA_291a9ce1-81a0-4213-87d4-92efe55ea29b">68</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i3c1f3898bb4b45dda42e758bda36a669_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTUtNi0xLTEtMA_d850e2af-5b91-4f90-b581-3a1e5638b55a">11.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia396ef4400a04721bcb9eb751d28c14c_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTUtOC0xLTEtMA_c4d29c51-76ec-4ead-b614-1d123afcb9f1">210</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4e196f60c8f84d0e863995c395467711_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTUtMTAtMS0xLTA_e0747f8b-08ae-4ca2-bf5b-909bd4a16b3e">196</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ia396ef4400a04721bcb9eb751d28c14c_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTUtMTItMS0xLTA_0a7799ad-59b4-4d08-9549-d0d9b89d93eb">7.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7fe837c300e64a599158923b9a3e0ccb_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTYtMi0xLTEtMA_f857955f-1062-4460-8544-d35cd9eb7162">317</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i73c197aa1c3f4a2983242ba4675beaa2_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTYtNC0xLTEtMA_b84bc8c6-884d-4e52-b9b4-11fa67714146">316</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7fe837c300e64a599158923b9a3e0ccb_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTYtNi0xLTEtMA_558deeeb-bd2c-408b-891f-0c1ad2ce46a5">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic939d8552fd24ed6815d0c7676ad9233_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTYtOC0xLTEtMA_138e5e43-ea5e-41cf-b61f-0bd1d9a42ed3">1,008</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2a78f12a5dbb4fbfba94b0044e46b502_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTYtMTAtMS0xLTA_a01b72ca-61e2-44f1-b62f-775a3c2ae474">1,035</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ic939d8552fd24ed6815d0c7676ad9233_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTYtMTItMS0xLTA_8c50e204-94e0-494c-ba33-bda513d70afb">2.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8646c210ca8d446ebfb79435ca8cbfcd_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTctMi0xLTEtMA_1d0d393d-4cf4-4eb7-93b8-9d655b9f19b2">377</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9bb13790d6ad4aad86f8fce7a1c50f3b_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTctNC0xLTEtMA_3dd13e41-b4dd-4379-8ada-229d6438b364">384</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i8646c210ca8d446ebfb79435ca8cbfcd_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTctNi0xLTEtMA_4aa13b3a-15b0-40f6-a1bc-87cba897efb2">1.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie9d9bffedef249fdb93057aafdd09a8a_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTctOC0xLTEtMA_a6305373-e826-4b71-b535-9950319950a6">1,218</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibbaf2076fc654fa1a5fe9210a7f4452c_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTctMTAtMS0xLTA_7681619c-3334-43f7-9fa5-b31d1f0b0acb">1,231</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ie9d9bffedef249fdb93057aafdd09a8a_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTctMTItMS0xLTA_d8fb90bd-5b25-4390-84bd-055e7bd4d69c">1.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2778860e516341fdac7a99b7214a99dc_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAwLTItMS0xLTA_e4110e04-0b41-45b3-b558-124cb856334b">1,267</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6dd83f9144404cd69bdacd864d641631_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAwLTQtMS0xLTA_ca048f89-0786-40a9-a794-5be759bc1149">1,171</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i2778860e516341fdac7a99b7214a99dc_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAwLTYtMS0xLTA_65dc7588-b4c4-481e-90fb-2b32f1e629c3">8.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i752cd2edd61e4f58b473965cea3aafd4_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAwLTgtMS0xLTA_648176ac-a806-4bb4-9842-249a97f19511">3,623</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic26bca171f714ec08510fa419cbd9f78_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAwLTEwLTEtMS0w_3ef9d008-d0ed-4d5f-ac4d-1bd274a4b012">3,146</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i752cd2edd61e4f58b473965cea3aafd4_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAwLTEyLTEtMS0w_61cfce41-a835-46d2-9e63-c4b16422026c">15.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idfe3e7487808413aa0811c36064223df_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAxLTItMS0xLTA_9ba09e84-7aa6-4508-a46c-06d862175c29">1,862</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieec92b888fc2475ba4b45585fa0376f8_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAxLTQtMS0xLTA_86f63094-8504-404c-a282-4e3a8398237e">1,590</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idfe3e7487808413aa0811c36064223df_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAxLTYtMS0xLTA_9f71c7dc-6c5a-48e8-bbf1-0784a71850f2">17.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1205be94e68d4cda8b85bdc70cf76ba2_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAxLTgtMS0xLTA_d87f4707-734a-4833-bcda-1db6ede9a701">5,310</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie4cb44ddf8cc45cf985f507e2ad63eed_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAxLTEwLTEtMS0w_905c8d00-df17-4278-9540-251ab8147014">4,830</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1205be94e68d4cda8b85bdc70cf76ba2_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAxLTEyLTEtMS0w_56ab9f51-0ada-494f-84ca-b0221083c233">9.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1d9559b960f641bb99edabc691773a8a_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAyLTItMS0xLTA_f5b2957d-e7a9-4989-825d-c50f7ebcc12c">3,129</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4b155857af2742ec98b26f0e8bd6f63c_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAyLTQtMS0xLTA_1c1394f2-e0c7-4f9a-90c2-91c1cec4790a">2,761</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1d9559b960f641bb99edabc691773a8a_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAyLTYtMS0xLTA_3e20a026-96e4-4df8-a30b-f3ff9fe5fac0">13.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i02575caf89d44152bc3372011aef005e_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAyLTgtMS0xLTA_1ec7fdf6-979f-4698-8be8-b2989299614f">8,933</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i425fac1e024e4a3985d9c88eadccb208_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAyLTEwLTEtMS0w_40313351-6afc-44ea-8b5f-36cf3c32ea55">7,976</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i02575caf89d44152bc3372011aef005e_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAyLTEyLTEtMS0w_fee9935c-c6dd-466c-ba3d-f1ec5a662b44">12.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">DARZALEX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8ea9ee18248c41a0990af9a8bd2d9634_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA0LTItMS0xLTA_b8feee55-9b03-4b0c-969f-47622ce9f624">585</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c4aac1ba6bb45aab22decf4191b4c08_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA0LTQtMS0xLTA_158cb70f-cd8c-48cd-b6c9-3bd40f7e26e1">402</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i8ea9ee18248c41a0990af9a8bd2d9634_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA0LTYtMS0xLTA_a4cd1b51-57fc-4a51-8d6a-058684781785">46.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i97b82273e4234a9a905cbcb65c575356_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA0LTgtMS0xLTA_1afeb25a-9839-4018-84b5-6d3c09bd3bfa">1,540</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6ddb0f73dd2a4c0a8d3fcfa0f7522b98_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA0LTEwLTEtMS0w_b45ca6dc-7298-4749-9c6a-7184c51a37f9">1,123</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i97b82273e4234a9a905cbcb65c575356_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA0LTEyLTEtMS0w_765c2628-43dc-44b2-bd62-0d907e4bd042">37.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5381d639283543639418c19ee2938e11_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA1LTItMS0xLTA_e160dc8a-df44-4e96-871b-79af166ef486">514</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1910340b47b743deb6e4133b4aa1b30c_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA1LTQtMS0xLTA_b3db6e66-ef73-45f5-a85e-eaefcd155ed3">363</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5381d639283543639418c19ee2938e11_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA1LTYtMS0xLTA_22c9ad37-4959-42d1-8d86-622c5b1632cd">41.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i40dc71d902444824a22852a9b082d005_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA1LTgtMS0xLTA_ddf145e0-0d37-4117-8fce-0a1619f45dcc">1,397</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8cf7bb68342d478abe812d2082348d36_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA1LTEwLTEtMS0w_e484c340-26d9-4906-919a-79c189cc364e">1,045</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i40dc71d902444824a22852a9b082d005_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA1LTEyLTEtMS0w_53b81de1-e346-4452-8704-4bf08a55d12f">33.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i705ab2d26ecf4df3a64a2a7de556d9ba_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA2LTItMS0xLTA_c0544147-4163-462f-b33e-40f794926bd1">1,099</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9749eeca9e1e4d8db5458ec220a2454c_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA2LTQtMS0xLTA_8c365315-a2f3-43ed-b2ba-4e2dd39cbbcd">765</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i705ab2d26ecf4df3a64a2a7de556d9ba_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA2LTYtMS0xLTA_5b11a21c-5052-4a21-84eb-3599fbb13de6">43.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5920e241198f48f38ebd20ae56e19795_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA2LTgtMS0xLTA_201a84b2-d969-49a4-9f74-c84dde6fa451">2,937</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibfe72bbf690841b18512fbf1d62a9972_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA2LTEwLTEtMS0w_f967805d-a748-436a-8f11-de9e74995b6b">2,168</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5920e241198f48f38ebd20ae56e19795_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA2LTEyLTEtMS0w_e6d0b0f4-1431-4799-b5de-961431aa5a1f">35.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">ERLEADA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"> </span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iff059545ae6e4221920a372b17db3e2f_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA4LTItMS0xLTA_5ab2ed0d-6776-49dc-9c94-02e29de64a73">152</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic9675c62f8e7451998e302272f33726b_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA4LTQtMS0xLTA_e1588570-d0b5-4a72-b37a-1bf9e7aa81e7">74</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6b963caee0e54df9b30e44510c6584c3_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA4LTgtMS0xLTA_df3c7648-aae2-448d-a095-5b49fdd5d8dc">407</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibc13c87f32fe44c191a0a792e991354a_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA4LTEwLTEtMS0w_75b018fb-9c66-462f-86d2-45d44ba85872">194</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i81b57ee3c6154482a279f76aead7f4af_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA5LTItMS0xLTA_60bd0331-56c3-4444-85fb-ac647eec8297">55</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib57a13d3edd943ca817dd9ead9e296ae_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA5LTQtMS0xLTA_2eac2fc8-bee4-43e4-9256-9779e83af041">12</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4ca84dcf326c430cbe701477a9c57a9e_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA5LTgtMS0xLTA_ae4eec7d-e326-4f07-b9c9-47b4e62d902d">112</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i77adc61bfc404ed98cdd17cd48df3b1c_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA5LTEwLTEtMS0w_9c97a6e9-a0ba-45e5-8842-5f6845ba8808">22</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i372932b60c2c4cedac8377b6bac57e40_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEwLTItMS0xLTA_91bfa0b7-0f81-4acd-8b29-f87ce4105cde">206</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifc0025ae94a8482b889201ee8f579b2a_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEwLTQtMS0xLTA_29a1de8e-2fc0-4ac7-b24d-02d8888759ce">86</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e76cc62521e4a5b9a91e983d896f049_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEwLTgtMS0xLTA_f0b90a9c-9aca-4718-8448-0fbb0e58da28">519</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5ee09d3943c845e39af6dba238d48fe3_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEwLTEwLTEtMS0w_2a727308-5826-438a-8cee-9f6a4e052173">216</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i34735177370944c4801a9842bf884fbd_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEyLTItMS0xLTA_8eca85fa-2e41-4d6f-ade4-5140260e918f">450</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i796fcef4d74540e6bf307cbf351c2bed_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEyLTQtMS0xLTA_21ce4cf9-7c6f-45ff-9117-64b9bcb42e86">447</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i34735177370944c4801a9842bf884fbd_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEyLTYtMS0xLTA_420b8578-8096-4050-8bed-0af9b8307a22">0.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6b57e3ca4ff34279b822c3d9d12fc1e1_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEyLTgtMS0xLTA_26cc99ba-65f8-474e-bb4f-0baeb6031c85">1,329</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id9465452a2864f51a42faf1511d0fd43_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEyLTEwLTEtMS0w_ed29d1fc-f922-4ee2-a4c2-5dfaaf5d9305">1,163</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i6b57e3ca4ff34279b822c3d9d12fc1e1_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEyLTEyLTEtMS0w_81fc03bd-3b86-4fe2-bb87-0596692a97de">14.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i72c72074c6ba43788b7c9742c486d2df_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEzLTItMS0xLTA_5901cc6e-4139-424d-b63b-abfc78a93d4e">581</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5ba0577bcdd34b8d86faec42ec29417e_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEzLTQtMS0xLTA_44697a48-38c3-4817-bf17-0b1d87434295">475</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i72c72074c6ba43788b7c9742c486d2df_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEzLTYtMS0xLTA_db6c792f-322c-4564-ab95-614e5b051171">22.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia0693b80dea945c2978dab63fda27374_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEzLTgtMS0xLTA_79b3d7cd-4ff6-45ac-b762-05e6d2c53b5c">1,682</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1e3e511ff0b44224b63d2ea86eadb7e7_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEzLTEwLTEtMS0w_a9dbd8f3-dca2-4a04-9b95-1ffa80f5c150">1,373</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ia0693b80dea945c2978dab63fda27374_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEzLTEyLTEtMS0w_6424ba37-5528-44fe-9d9b-887d5d24e592">22.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i45dfcb3ffb3e4a97a4cd1f22832657d1_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE0LTItMS0xLTA_b9386978-a5bb-41c4-8cf9-58c0b7fa065f">1,031</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idf94b5c46b474da196e27de4e267114a_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE0LTQtMS0xLTA_2bd56c9f-3ed2-41a1-a775-657cf87b7c43">921</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i45dfcb3ffb3e4a97a4cd1f22832657d1_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE0LTYtMS0xLTA_7a086808-d77e-4179-af35-3587cedabd3d">11.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i62b6d2dac7db484986c41d5f29e1baf5_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE0LTgtMS0xLTA_bc10ffb8-e34c-47da-a1ed-dd3a64077c4e">3,011</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5446e8f0ab454edea3b3c38dd20556eb_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE0LTEwLTEtMS0w_a8ce0533-2c2b-483d-9807-0d0ba2f09c41">2,536</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i62b6d2dac7db484986c41d5f29e1baf5_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE0LTEyLTEtMS0w_6a95a962-a0e2-4672-b148-785143e0db0e">18.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">VELCADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67ccf902b8ca4f778d40454a90bd5dd6_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE2LTItMS0xLTA_c89a713c-ea70-4bd0-aa29-2baa80ba9b3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4109c4932c754685876797c6af614e62_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE2LTQtMS0xLTA_34af6a3f-7fb4-4504-9a67-fc082834ca56">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i67ccf902b8ca4f778d40454a90bd5dd6_D20200629-20200927" decimals="3" format="ixt:zerodash" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE2LTYtMS0xLTA_759c82f9-ee5a-4990-a75e-d6fe208a8eab">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i330bc9af1877499b8065d4b7b3fa2e01_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE2LTgtMS0xLTA_9e8b020c-4347-4d8d-8148-0e99a2cd66ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if3c3b9971d0b4acc9e1042b91d15ebe2_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE2LTEwLTEtMS0w_540a6909-804a-44c1-99af-3deeeba41437">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i330bc9af1877499b8065d4b7b3fa2e01_D20191230-20200927" decimals="3" format="ixt:zerodash" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE2LTEyLTEtMS0w_e1f59d83-9cb4-440d-b1ab-e2fa362a3899">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic4955df2646f4d2db40aeaab35a9f11e_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE3LTItMS0xLTA_7438fb38-53a2-4e3f-b44d-ca74f9827fa9">105</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e0a71362e3743e4b1f4d0012e92b109_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE3LTQtMS0xLTA_e450928e-0836-421b-b614-601cfb5e8f67">149</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ic4955df2646f4d2db40aeaab35a9f11e_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE3LTYtMS0xLTA_c7510752-3a2a-447b-b3b4-9e6a422a3ee2">30.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53f5011996b74418b2ae013de7b25fe8_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE3LTgtMS0xLTA_bee61e4b-008a-4a76-8cdd-99df042be6ba">311</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iabef23428a1c4d3b94722d03cb22cc1f_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE3LTEwLTEtMS0w_ae1cbda4-a54a-4f75-9e4e-a1cc4b6c1191">636</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i53f5011996b74418b2ae013de7b25fe8_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE3LTEyLTEtMS0w_8910f9eb-8a1d-43fb-adb9-8125f9e9d483">51.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i09245da0ca9744d097847bbacddaaba3_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE4LTItMS0xLTA_96b50f34-a87b-4ffc-af28-74d6b2f8c686">105</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0c8552621f43462f820822d0db06546b_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE4LTQtMS0xLTA_99e1f854-a739-4d91-884a-ef6accebd407">149</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i09245da0ca9744d097847bbacddaaba3_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE4LTYtMS0xLTA_98ba851c-06fb-40a6-9be6-ad1b8ccb9ef0">30.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i268dbe75625d4f94821b1992136466b5_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE4LTgtMS0xLTA_3a4da4a9-07ef-4c96-8004-f489c17cd39f">311</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i54921a8e1bae412499c1ed6066b7babb_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE4LTEwLTEtMS0w_c00809a2-e41f-4e54-bdd8-81a4cbc88dab">636</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i268dbe75625d4f94821b1992136466b5_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE4LTEyLTEtMS0w_2d06b06e-21f8-48b1-93b3-ecaeee89166a">51.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"> / </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">abiraterone acetate</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i00b989b237614d92886abe9728179769_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIwLTItMS0xLTA_304d8450-61ba-44f0-a551-3adffe5d56cf">58</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i18c083bcea8740cb90e264a1f6f78d34_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIwLTQtMS0xLTA_00d09980-14ad-4514-8e0a-6bb8cdaa3863">233</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i00b989b237614d92886abe9728179769_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIwLTYtMS0xLTA_a52076a7-772c-4d17-b8c1-78ac1a7a3084">75.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ica56f357873048e8b05d7f37a64550b7_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIwLTgtMS0xLTA_3aa42d75-b5af-4df0-9561-d2430c1449cd">284</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icd88bb111cfc4697a30d5ec9e6455e68_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIwLTEwLTEtMS0w_a3904400-7d6c-4e49-a548-08df3700a344">616</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ica56f357873048e8b05d7f37a64550b7_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIwLTEyLTEtMS0w_eaacaab7-5279-4acb-aa6d-64b70d6cc68e">53.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id7c1dfd0ab824a55aa683fc2853c811c_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIxLTItMS0xLTA_d466695a-3953-4920-9838-250c13b6b851">532</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7515a418c4d04e6696b8dea069d6787d_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIxLTQtMS0xLTA_108ed01e-37df-428d-be71-5bcb9a454194">508</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="id7c1dfd0ab824a55aa683fc2853c811c_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIxLTYtMS0xLTA_1c5a09c0-7c7e-4f2f-9f7d-0608d523f9b2">4.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iea069e1f599749b4955a9badba8f5442_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIxLTgtMS0xLTA_c21f34c4-102e-46dc-9759-831a6788a171">1,564</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6c31b8af359a42f99b7d8bce11dc8b0e_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIxLTEwLTEtMS0w_465a990b-2e73-4812-bfe5-e93f194e037b">1,502</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iea069e1f599749b4955a9badba8f5442_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIxLTEyLTEtMS0w_1513702a-a6c8-431f-bea0-715beeab8a3b">4.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if3bad18a87304c4cbc3c2dc4d1ce3cb1_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIyLTItMS0xLTA_89dc1683-12b0-417c-b983-f943c72cbc1d">590</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa05f30dbe0343b0b935c997aa17c4a3_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIyLTQtMS0xLTA_20bb77a0-9ef3-43c7-8cf4-6e4c3b189c81">741</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="if3bad18a87304c4cbc3c2dc4d1ce3cb1_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIyLTYtMS0xLTA_655424df-56f4-4a24-8e45-fd49b7104b55">20.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icfb336e5668642d095d254e92dbd3662_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIyLTgtMS0xLTA_5b0175b0-4203-40f3-9aa5-ebd80dfcae3e">1,848</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if54134f7c5b24e07917d778ac41dce41_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIyLTEwLTEtMS0w_dd903eb8-3ffc-4c18-b0a5-e1616eb50f4f">2,118</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="icfb336e5668642d095d254e92dbd3662_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIyLTEyLTEtMS0w_ff06a169-d63b-475d-bbe9-28495d546118">12.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></ix:continuation></ix:continuation></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div style="margin-top:5pt;margin-bottom:5pt;"><ix:continuation id="ie916a957265e472290d2e644e60dbef5" continuedAt="i6316a3c81fd248a889c2d590619c83f5"><ix:continuation id="i5cdd8e927e5c42a9b1e227093c914e6d" continuedAt="i2b84aeb775d5436ab58e82c06bc3a660"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"></td><td style="width:35.144%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.525%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.525%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.633%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.234%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.234%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.643%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER ONCOLOGY</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id920a9ae68314dba941e6bd37d23c794_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI1LTItMS0xLTA_c4ef052f-c813-43ee-8604-edb2ae8a379a">21</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i99dbd0f9ca734810b3b3cebdf13dccf7_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI1LTQtMS0xLTA_a9aa9d49-bdf9-41c6-ad9d-93830cfd7aa4">17</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="id920a9ae68314dba941e6bd37d23c794_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI1LTYtMS0xLTA_31833767-6009-4395-8abc-4397ff964303">35.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib5ea83560e2c4220bda25b528dac795f_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI1LTgtMS0xLTA_71125675-5b52-403d-8edd-e24fc538096d">63</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icc48547d5c2d45b18b0cffc58b8418d0_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI1LTEwLTEtMS0w_c134a758-6538-4596-a50c-84dc6c283a6b">51</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ib5ea83560e2c4220bda25b528dac795f_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI1LTEyLTEtMS0w_c3b9fe27-a56c-42e2-8eab-267e0b9dc6f6">25.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2930e4636157460e97c87253a644ebee_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI2LTItMS0xLTA_ede4be9b-bb29-4740-8a7b-197303db68fb">76</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idde0b706304b45b88a9d831118eea942_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI2LTQtMS0xLTA_e7e2f7bd-ed6a-4d5f-ac3c-2a44502a872d">83</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i2930e4636157460e97c87253a644ebee_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI2LTYtMS0xLTA_e81fabce-0eb1-4066-bcfc-8634e90b9d7d">8.8</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3555c8eb101047b7b3e6f5fd9a92fdfa_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI2LTgtMS0xLTA_35108503-fb95-4d8b-bd70-c5423652ff47">244</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5c8089c225324cd2bee3241e1f84f5e1_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI2LTEwLTEtMS0w_9a0764f2-4619-4008-91e1-342ab0733572">252</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i3555c8eb101047b7b3e6f5fd9a92fdfa_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI2LTEyLTEtMS0w_68c00e91-df24-4c47-96a9-3438d3663d30">3.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf2f109a663b489da13497ab8eee8ac3_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI3LTItMS0xLTA_9148490c-9f3d-42df-a790-bc831bd1c043">98</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i32579ea231594ff8ac2d8f4ae4ce03a9_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI3LTQtMS0xLTA_7161b942-8b4f-48b2-9ffa-24876456e6cf">100</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="icf2f109a663b489da13497ab8eee8ac3_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI3LTYtMS0xLTA_73419643-d235-494b-8fd1-9234d38bb223">1.7</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i121970d9573c4f7ead61761fc53904c1_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI3LTgtMS0xLTA_86315c70-2d3b-4502-b479-0f8837aff41e">308</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie5ea45ba97f246528bda5b3f66a608de_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI3LTEwLTEtMS0w_1a0dcc8f-406d-48a2-83af-df2006ad3283">303</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i121970d9573c4f7ead61761fc53904c1_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI3LTEyLTEtMS0w_bab589b6-9451-4fa1-aa76-afa7591918cb">1.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pulmonary Hypertension</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i398b379cf9824522a2ced7cf59facc66_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMwLTItMS0xLTA_8b564168-b052-4471-bdcf-b6bdd819d063">510</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia701d7201ccb4861bb77be7093c08db4_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMwLTQtMS0xLTA_c959090a-eff2-473f-af8f-60fa8721dc58">427</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i398b379cf9824522a2ced7cf59facc66_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMwLTYtMS0xLTA_806da948-5c6c-47ae-be66-162c59a7f845">19.4</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8263c917767241278ccdb61c3e4e2803_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMwLTgtMS0xLTA_9d352cfd-2f70-439c-a160-86d052ce9a25">1,541</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4175bbda9cfe43b6be2edab57371b4ab_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMwLTEwLTEtMS0w_999067d1-107f-427c-95f1-6e95a70c9842">1,296</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i8263c917767241278ccdb61c3e4e2803_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMwLTEyLTEtMS0w_189e72a6-06f4-4e8b-89bf-7721e2a11023">18.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib373300898e546d283fc33d0388ff705_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMxLTItMS0xLTA_adc0e009-3d23-49e2-af70-326ef0afabe0">239</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1044002d40e647fd8326e72b1451460f_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMxLTQtMS0xLTA_d3a4586a-0047-47c1-8b75-2599e593dad3">227</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ib373300898e546d283fc33d0388ff705_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMxLTYtMS0xLTA_485366e4-b887-40c0-acba-d238b271723f">5.2</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i42c60d3862824ccd828e4b74762f6418_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMxLTgtMS0xLTA_cfc3e054-a191-4c07-9192-af075fb80ead">742</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if420f4bfc54a4c239ff4a7c3b49fa4b8_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMxLTEwLTEtMS0w_78fa3baa-740c-46eb-a5a2-93c305eadaa4">704</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i42c60d3862824ccd828e4b74762f6418_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMxLTEyLTEtMS0w_785423e8-f92a-4a65-ab08-7772c0ef9399">5.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i16cf6062a6ae470696458b6461568e25_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMyLTItMS0xLTA_30ce0d17-8d7e-4363-9df9-b33f92cfa0cd">749</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d4fcfc7f7e247ac9b236ab2cc9b7610_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMyLTQtMS0xLTA_ce8a6f57-823f-4f32-ab3f-969a37f274f9">654</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i16cf6062a6ae470696458b6461568e25_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMyLTYtMS0xLTA_5c3315f2-04ba-4e46-bc1e-5d07822dcbac">14.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i191ce2e499304831a66740e08cdd128a_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMyLTgtMS0xLTA_a1de8c61-32c0-40ba-8ef5-e918681be31f">2,283</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i37e02e11e60a431296858d46dcb92eb9_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMyLTEwLTEtMS0w_de33134c-6c08-45df-8c2b-89eaabab2364">2,000</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i191ce2e499304831a66740e08cdd128a_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMyLTEyLTEtMS0w_8a6161cf-85f6-4ff4-ad6e-9065c7d59ffc">14.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i37fe03909d0c42c2a5d1a9b179769776_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM0LTItMS0xLTA_031acb9f-20ef-4f0b-bc0c-6d42586e4a5f">244</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic80413ba702646b38fbb6b8bcb646200_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM0LTQtMS0xLTA_48578c98-eef2-4c3f-8348-a94192f7a5c1">206</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i37fe03909d0c42c2a5d1a9b179769776_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM0LTYtMS0xLTA_3fae3edb-dc66-47e3-a462-87d013eb277d">18.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if047c787f50d450e8de9249ed46afe73_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM0LTgtMS0xLTA_9acef53f-e50f-4287-adcf-5a886eedc23e">729</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic9a361df298440088f461b4343dc1a17_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM0LTEwLTEtMS0w_56d4b408-134b-4e3b-89a9-344c4f7c57d5">581</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="if047c787f50d450e8de9249ed46afe73_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM0LTEyLTEtMS0w_ee074bfd-844c-4fa7-9c56-146ed9035b06">25.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i94465a7eb96141d99ff73e62a319bfb8_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM1LTItMS0xLTA_1e1b4984-26a2-4491-9fb1-72919a93d841">148</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0698ee2dd7914e2abe8fa68b898a1a28_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM1LTQtMS0xLTA_494c5ab4-e42a-4b75-88a3-1ad44abc9ece">140</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i94465a7eb96141d99ff73e62a319bfb8_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM1LTYtMS0xLTA_e306f309-6b21-4e1a-bf80-1193ca5a8432">5.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if08abe1920f04bf98dd739839be93b65_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM1LTgtMS0xLTA_e429fa43-3e31-495a-8cb1-525deadc7729">458</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i217e2c9aa29f4999bafbb343189c1d78_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM1LTEwLTEtMS0w_d94acd3f-13f6-4359-9539-253f51e97867">419</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="if08abe1920f04bf98dd739839be93b65_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM1LTEyLTEtMS0w_41b4756f-5e5e-4933-8cd6-8361db70fb74">9.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic56fe73198cf4b13a4b507b21a942116_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM2LTItMS0xLTA_f52c3119-ed00-412b-8c43-6f2da5c99052">392</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i318c310c110a410ebd87a7483d92e09c_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM2LTQtMS0xLTA_cdf1d360-5bd1-4657-9755-833b8860ff27">347</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic56fe73198cf4b13a4b507b21a942116_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM2LTYtMS0xLTA_80add949-ba18-45a0-b0ef-48e36bfc9717">13.0</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2be36e5216d54100a37a610a312db40a_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM2LTgtMS0xLTA_482735a4-de3f-4a53-aaa2-897b54e95521">1,187</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3e63c1418afa4562877a6c19653bb704_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM2LTEwLTEtMS0w_d1e92a51-17c2-46d8-bb5d-2b7e5fc40ed8">1,001</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i2be36e5216d54100a37a610a312db40a_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM2LTEyLTEtMS0w_43f0c6ff-79cc-4edd-9f32-7ef43492a009">18.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i73eb95bb08bd41cb8d99dd2c4a0b8742_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM4LTItMS0xLTA_ee1c6f44-180e-4fc8-a01d-fa2471c7c262">226</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3aa4dd5cd6a94deb9b074d8cc077c127_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM4LTQtMS0xLTA_1c98e9b0-411f-4923-8339-68e1362708c7">185</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i73eb95bb08bd41cb8d99dd2c4a0b8742_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM4LTYtMS0xLTA_51806c86-989e-4461-baa7-eac44de5e18f">22.4</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia179bce14d4544eda2428c53ec509422_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM4LTgtMS0xLTA_419ab4fe-0082-476c-8a2c-de8c794775b8">692</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1a8eaf42923c495eb5579fd7097cba34_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM4LTEwLTEtMS0w_ce3104a1-3ef5-42a9-806f-58bf0b23d640">536</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ia179bce14d4544eda2428c53ec509422_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM4LTEyLTEtMS0w_b7679d1c-2100-482a-8ca6-d9e4ab5f4f03">29.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i010426648d814b3aa129307a75a78d2a_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM5LTItMS0xLTA_d2ea6dad-7012-49c0-a1d4-adc33a28e6d5">34</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id454beb1da294c5abf1642ce831df07b_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM5LTQtMS0xLTA_d29e1acd-7591-4b01-af06-db67c0cf7bd4">25</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i010426648d814b3aa129307a75a78d2a_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM5LTYtMS0xLTA_32e1b69f-1363-48bf-9732-1b0d656e4bfb">32.3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie15c767fe2ab4976b0a06babdc79238d_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM5LTgtMS0xLTA_b853c707-9c9d-4020-a472-6694f21c5859">100</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id44c86afd635403a91e902792dfb4c5c_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM5LTEwLTEtMS0w_d5a474ed-9be7-4d8e-a84b-20c764b6a325">75</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ie15c767fe2ab4976b0a06babdc79238d_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM5LTEyLTEtMS0w_2fe08fa0-fbff-4bca-933a-8a0cd6ca693b">33.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e2e06db53a2451dbf125d3629e771b6_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQwLTItMS0xLTA_145320ea-80d9-4d6d-a066-5520a31a8dab">260</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9cd752a9056749c1b4ecc334a21ed7c3_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQwLTQtMS0xLTA_06f88380-33ad-400a-b784-b180100026f1">210</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0e2e06db53a2451dbf125d3629e771b6_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQwLTYtMS0xLTA_f02ed27a-baa9-43d5-9cd1-310d3b72462d">23.6</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8257d323d64145da8c90884eb259a7d2_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQwLTgtMS0xLTA_68091055-0c11-4c07-a1ab-bc42d8000e3a">792</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8c2832df4f35417caf2fffb8cb822af6_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQwLTEwLTEtMS0w_0f458a6e-ff9c-4803-b619-ebd67c4b7e9f">611</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i8257d323d64145da8c90884eb259a7d2_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQwLTEyLTEtMS0w_924e69e4-f173-4611-9ce5-e69aa769274d">29.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER PULMONARY HYPERTENSION</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5075a6f43b343338c5062f76a48e067_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQyLTItMS0xLTA_5d566d67-5481-48e3-a954-8b7aa9b1f80a">40</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i01d88a3108764d0bb869889f44b14203_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQyLTQtMS0xLTA_a57c20eb-194f-4590-966d-0a2f56a6e6d7">36</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic5075a6f43b343338c5062f76a48e067_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQyLTYtMS0xLTA_6dca144f-3208-4450-9e62-c719d9e37ed1">11.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id644fa2e713f49e1a5ae05b7fc4e4f1c_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQyLTgtMS0xLTA_60c88a79-ab7f-42d4-bec4-9a53fb545b86">121</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5ed3772815cc4a3faa703e73bf58e0a1_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQyLTEwLTEtMS0w_294ea7ae-bb3e-4be5-bbc0-731d66b5d80f">179</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="id644fa2e713f49e1a5ae05b7fc4e4f1c_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQyLTEyLTEtMS0w_6c180928-56f7-4e92-9c54-88b5d2e3d872">32.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iba2b4531ff2140fabce85ea3fb293461_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQzLTItMS0xLTA_91c3505c-f480-4efa-9e0e-83ac26b8bc32">57</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63eb447b40dd454fb968053fddf79121_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQzLTQtMS0xLTA_038466e2-0232-4ba4-b5e6-5251fc791902">61</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="iba2b4531ff2140fabce85ea3fb293461_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQzLTYtMS0xLTA_66655ae1-d4af-47b7-a2d0-36a70281f316">6.7</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i013947f80a9443098796115f97595392_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQzLTgtMS0xLTA_c48db382-ad80-498c-864a-6ea5569dbe5d">183</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1a0434c21b524a9bb6ea856dd5969c76_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQzLTEwLTEtMS0w_e7a841be-e902-458d-a5eb-d69b4f4cac1f">210</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i013947f80a9443098796115f97595392_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQzLTEyLTEtMS0w_2543b31f-38f0-4938-b50f-2b25af1dbf37">12.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i80e3dc1f3fb94925ba1c451b2ab83aee_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ0LTItMS0xLTA_29e5be81-9db8-4c2c-9790-f620396cda56">97</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id389da37c3cb472483e3c18b6f953869_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ0LTQtMS0xLTA_6413098a-88af-48ba-8871-0124434c5cc8">96</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i80e3dc1f3fb94925ba1c451b2ab83aee_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ0LTYtMS0xLTA_795da8ca-473d-4e53-86b1-fdc4575bd904">0.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i00da0f84c86847d7a8655fdf18a81a3d_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ0LTgtMS0xLTA_cb29361e-420c-441a-9917-8e600d85f1ad">304</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i41759335282246b889e936ec23f879ff_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ0LTEwLTEtMS0w_b791faa6-1bd8-4357-9078-8c323ea7d359">388</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i00da0f84c86847d7a8655fdf18a81a3d_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ0LTEyLTEtMS0w_a6beecaa-5a81-44f6-9a0b-ad15ba8fcab2">21.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cardiovascular / Metabolism / Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i43ecfa483f6c4bd19953e3fdca33dd8d_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ3LTItMS0xLTA_d29935ba-4a03-40c6-af4a-4f981d005f90">931</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia9f66f37ff7a44b583b3c5e7100eff8d_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ3LTQtMS0xLTA_614eb7f2-799c-445f-b69f-6fc7e53ec6ff">955</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i43ecfa483f6c4bd19953e3fdca33dd8d_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ3LTYtMS0xLTA_924557ae-152f-4f89-b1ed-1e8bd0f7e18f">2.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i57a9bf838edd4528ace0d2c9eba6e86d_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ3LTgtMS0xLTA_7a5cf93a-0e20-4b1b-a012-5dc203f74e6e">2,574</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d744e86513440f39ebc068eda44b32b_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ3LTEwLTEtMS0w_77f9ba2f-e094-47bc-b399-39c9ced1b611">2,804</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i57a9bf838edd4528ace0d2c9eba6e86d_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ3LTEyLTEtMS0w_60dbb741-cc7d-41df-b9a9-57d78743a46a">8.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i95265ffca9d34d798871d9fa7c192928_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ4LTItMS0xLTA_a2fbe11a-32e7-455c-86dd-cd689cef5940">351</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i861817aea75241f3a7830b21a7873c16_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ4LTQtMS0xLTA_6c9cbfd7-23e6-42c8-ba82-395cc4437f74">360</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i95265ffca9d34d798871d9fa7c192928_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ4LTYtMS0xLTA_c82eb521-0402-4370-b893-3e7a2bfe4c5d">2.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i57cdedd2e4924130b9f973dccbf1425f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ4LTgtMS0xLTA_102380bc-ae3c-4a25-8012-9d31b979223d">1,052</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i966b90600060495180cde77fff0831e5_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ4LTEwLTEtMS0w_cd1e8239-2d66-4eea-98a8-6a65020f3839">1,131</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i57cdedd2e4924130b9f973dccbf1425f_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ4LTEyLTEtMS0w_9a5e0293-46f5-4aef-a8a8-f4fd259bd50d">7.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i33cef8db85f6459a8f53ef7046c5bfa7_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ5LTItMS0xLTA_35b0a64f-3e3d-4b9c-a4b8-2fe6459fd85a">1,281</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i21c25d970b094401ac14010054e1f3ca_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ5LTQtMS0xLTA_ca1467eb-0780-4af1-b9a2-cf2df68a82c3">1,316</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i33cef8db85f6459a8f53ef7046c5bfa7_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ5LTYtMS0xLTA_d99d2d31-737b-4cb9-bf41-91491d29466f">2.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if8c574d380a348e68b4cc617a801ea6e_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ5LTgtMS0xLTA_fc1a9212-7ae4-4106-8f23-581dd2990e6d">3,625</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id37ad7cfc12b41428d45ab46b67de2b0_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ5LTEwLTEtMS0w_d4b9492a-4769-4af0-813c-eef466fb83ca">3,936</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="if8c574d380a348e68b4cc617a801ea6e_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ5LTEyLTEtMS0w_05db078e-8a36-4d63-a379-30aae56be882">7.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i892fd133b58a4cadb07bdf935bc6af34_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUxLTItMS0xLTA_7fabd7b0-0407-4db4-810d-981a3770fdd6">630</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id9a6429a54d841c1bcde5ff62985a777_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUxLTQtMS0xLTA_3b611100-3b56-44e8-837b-031cf6983ca1">613</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i892fd133b58a4cadb07bdf935bc6af34_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUxLTYtMS0xLTA_e55b9a8c-2cff-4890-bfd2-f1186be2763a">2.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id21567f828814171bae17a473a89e0af_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUxLTgtMS0xLTA_9ed200b2-eae2-4e97-84f2-bff7a1f70220">1,716</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i96d11501e2ac4574bacde0ae4de62fd8_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUxLTEwLTEtMS0w_889e3f0b-22b2-441f-b009-eee85ad93bf3">1,704</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="id21567f828814171bae17a473a89e0af_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUxLTEyLTEtMS0w_589f1bec-a68d-45b1-b2cf-5a24fd004d75">0.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i762b4c937c7f46559a1d1ebdea00839f_D20200629-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUyLTItMS0xLTA_c86173a5-bf1a-49cb-8dbb-8fed08a457b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2ca2df401f3e4b03a03bb594e14680e5_D20190701-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUyLTQtMS0xLTA_b83ac249-defe-4852-a587-340a82a9a0d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i762b4c937c7f46559a1d1ebdea00839f_D20200629-20200927" decimals="3" format="ixt:zerodash" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUyLTYtMS0xLTA_c6e21927-7b1d-44bd-a21a-40c0f68e2d2b">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0242667ce51c4802826573ff14607be2_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUyLTgtMS0xLTA_3bd36a10-1c82-4c3b-97be-903d42f6cd41">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8a3f0f519f304581a495ee44fa8e215e_D20181231-20190929" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUyLTEwLTEtMS0w_9d798f4c-51fa-4fae-8a53-b322553e2174">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0242667ce51c4802826573ff14607be2_D20191230-20200927" decimals="3" format="ixt:zerodash" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUyLTEyLTEtMS0w_9b29fc43-3985-42b1-8ed7-353fea61fb69">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4d38ab9af5db42ec82566d7e0b60d483_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUzLTItMS0xLTA_a27ab660-5f64-400b-b726-6b03972e9ecd">630</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id7d07f6f95354ba9ad6ec0fd6afb8f1d_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUzLTQtMS0xLTA_1aed4cb4-103e-4734-abd3-51cf89633ae2">613</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i4d38ab9af5db42ec82566d7e0b60d483_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUzLTYtMS0xLTA_ad120679-c18b-4f24-b87f-373d8ad3c5f1">2.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic78f1097f5d748cb869eb5b503824ebe_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUzLTgtMS0xLTA_f79c3c96-02d1-4ce7-9549-45c099253b20">1,716</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6563c54cfc0a46558fb408ed4e9fd465_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUzLTEwLTEtMS0w_5458b9d7-de80-441e-97a7-2a10f0538264">1,704</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic78f1097f5d748cb869eb5b503824ebe_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUzLTEyLTEtMS0w_a565b388-d83a-4e99-b648-5317f34d2280">0.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1bb45cec18df4abb9e67780a9955c6f4_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU1LTItMS0xLTA_4184c6f9-73a0-4883-bc90-6e30c8fee8c7">156</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6c8d711197c44ef8aa825b062094402b_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU1LTQtMS0xLTA_721b8036-43d1-4ce0-9414-f284d52a1966">125</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1bb45cec18df4abb9e67780a9955c6f4_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU1LTYtMS0xLTA_3870cc16-4765-4196-8748-1ed098c21330">24.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0f4b21e1fd1a4652b30fc4578fce9c11_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU1LTgtMS0xLTA_da435413-c275-4cd0-9d01-77cda847207c">405</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a3a40f9c30840b1927ebacddcf845ac_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU1LTEwLTEtMS0w_53ed8abc-0e79-4b12-92c9-641579a84c2c">411</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i0f4b21e1fd1a4652b30fc4578fce9c11_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU1LTEyLTEtMS0w_17045783-6d7f-44ac-a855-0b309a25b0b2">1.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3694631e7fff4ce1b73ec6332f8f1114_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU2LTItMS0xLTA_d29b5279-a10e-4b68-9c2f-285583f8344c">68</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic32d7dcacf84400d91757b36f9215e72_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU2LTQtMS0xLTA_a447fcf1-5a14-44a3-bbc0-e28f54347894">55</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3694631e7fff4ce1b73ec6332f8f1114_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU2LTYtMS0xLTA_f8e7cdf1-d53f-4017-b7ea-78b0dfadf447">24.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9a75613a853b432d954dc4de396f1b7b_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU2LTgtMS0xLTA_5ba1051e-f99f-438c-9911-e8d0d0a364a9">173</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ff9e6b244664dcc8c57f0d6c1e416d0_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU2LTEwLTEtMS0w_e59b293e-1dd8-47b6-987e-4191d4c52ea6">147</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9a75613a853b432d954dc4de396f1b7b_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU2LTEyLTEtMS0w_902eecfc-d08a-425a-80de-458b90ca74d2">18.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia756fd0cfb2e474196776e501a411735_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU3LTItMS0xLTA_357cc481-3a45-43ea-9216-e9521a44b408">224</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i31cd8eb3320a41a397704a1328b8854c_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU3LTQtMS0xLTA_fac0cbd8-7ab6-4764-96e0-c35f13bc7f73">179</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ia756fd0cfb2e474196776e501a411735_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU3LTYtMS0xLTA_a96edcf5-22b7-4c69-afd2-b04d0fc47f51">24.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7fd6606fa19d4019bc87ef7e6ba6eb73_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU3LTgtMS0xLTA_c7dbdb61-2b22-4a79-bfc2-dbac02b12c1d">578</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i34aaafb86ca14d2d9716c717162ad440_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU3LTEwLTEtMS0w_f603af30-7150-4d33-b4f0-6a7ba2750e7d">558</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7fd6606fa19d4019bc87ef7e6ba6eb73_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU3LTEyLTEtMS0w_16ba9b5e-4d72-4bc0-bc60-fc801e8ec19e">3.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;PROCRIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / EPREX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia7fe0b9644764d87866372cd691decb6_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU5LTItMS0xLTA_6a4de73a-aa32-4ddf-9e3a-f7edd9948ba6">69</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia85d0ddfb054423a9895f28c3b06f8cf_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU5LTQtMS0xLTA_5f2f2893-b813-453b-974b-e0adfdecd445">126</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ia7fe0b9644764d87866372cd691decb6_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU5LTYtMS0xLTA_a71cf3a3-5bde-4ca5-9767-1e6303aaca0c">45.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic4763443528342868e35179cf61ecdde_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU5LTgtMS0xLTA_3820c9eb-85eb-439b-b0b0-060107338da4">215</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i333c0de72c3a4698981d349cac512c7e_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU5LTEwLTEtMS0w_36a5b643-c11c-410b-a710-47215c4710cc">387</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ic4763443528342868e35179cf61ecdde_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU5LTEyLTEtMS0w_4fcd87da-20ee-4714-ad50-4f4058b490c2">44.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id724502ba8f2486cac318bef4c54fd96_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYwLTItMS0xLTA_d2d7c8bf-2380-438a-9a90-8569622d76a7">63</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i69ceed544ddc4d9b88e01a94fdf9e5a1_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYwLTQtMS0xLTA_4eafb480-4c36-4216-97d7-072449e96c3c">72</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="id724502ba8f2486cac318bef4c54fd96_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYwLTYtMS0xLTA_bc26c856-d2e0-49b6-9c48-1a38a7c2945f">12.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i392f000005e74b13ae8ec4fd2245bab8_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYwLTgtMS0xLTA_e597c079-2994-4087-a26f-8fca7d13bc15">208</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id0ebe2acbb28427fb07907d3d7cc84c8_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYwLTEwLTEtMS0w_4c150528-877d-48fb-bc1a-6dd055aaf324">220</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i392f000005e74b13ae8ec4fd2245bab8_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYwLTEyLTEtMS0w_a8a7957d-fff2-45ff-aa21-310bac073e11">5.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2d4f2c99a1f249c49d42d6f746af5a57_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYxLTItMS0xLTA_e9b42dcc-55d6-4c66-ab21-6ad3a0eacd5c">132</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic8603b809d89437c8397bde709854409_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYxLTQtMS0xLTA_3ceadd37-fb3e-42b2-82fe-844d00ac5fed">198</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i2d4f2c99a1f249c49d42d6f746af5a57_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYxLTYtMS0xLTA_359f59e0-f02a-4abf-ace0-bb9edeaad131">33.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9f2972e6f6484e36b1d2a91c5cc8c877_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYxLTgtMS0xLTA_2989231b-e32f-49bf-91aa-3dd05136b5de">423</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2c5a38578aa04cd7a11950dd9aea6179_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYxLTEwLTEtMS0w_1ea94b63-d214-4578-8a3c-d625529e1c0f">607</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9f2972e6f6484e36b1d2a91c5cc8c877_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYxLTEyLTEtMS0w_afabd479-4f5c-49e2-b1c1-c7ecf1672220">30.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic8308cb00a64487ca422779891052509_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYzLTItMS0xLTA_045db9a0-8fc7-4c8d-8ed7-6db1dccc5b39">75</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i72b87b179f8b450ca58c7e90f207c8cf_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYzLTQtMS0xLTA_5646c779-3193-414f-ba1e-fb03256d511b">91</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ic8308cb00a64487ca422779891052509_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYzLTYtMS0xLTA_ee7d7320-496f-47b0-8377-c679f3f00945">17.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5882b17221ff476797f83dbe3709f9f7_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYzLTgtMS0xLTA_bc8f27e8-5aa3-4696-9d28-39b75e6f2f1b">238</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1276e4c945994ec68e5b1a60f0f2e568_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYzLTEwLTEtMS0w_d7f228b1-d1ed-4d92-b19c-f4b00dd50ae3">302</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i5882b17221ff476797f83dbe3709f9f7_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYzLTEyLTEtMS0w_166a034d-e802-40df-864d-1d455d0cba47">21.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iebff1eb342264ce2915080aaeaaff91f_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY0LTItMS0xLTA_caca0e67-9135-458c-80de-4361fe4c64b3">219</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9141ca3c0a1c484a869bed176ba77cae_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY0LTQtMS0xLTA_815aa94b-7133-4e31-aa06-695ecad3a1f2">234</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="iebff1eb342264ce2915080aaeaaff91f_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY0LTYtMS0xLTA_f0173d46-7b46-4693-83a3-143a8a41faf7">6.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1e756c09a365446ba32b0f4451a03c98_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY0LTgtMS0xLTA_5a24df37-7f5e-4db8-90f5-06a835f8cbd7">670</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id74229a2d6f0451fb97e2c96709af358_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY0LTEwLTEtMS0w_33f65ea0-793d-4062-ab78-07f6bd87835b">765</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1e756c09a365446ba32b0f4451a03c98_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY0LTEyLTEtMS0w_21ec0e4c-4161-4e2e-8ecc-b73b7fa8ecd8">12.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i18dad1ee5f9340d5a35c3c37e4cec4ab_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY1LTItMS0xLTA_64521778-69fd-4678-97fc-55c14edb0565">294</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ideea0ce4a35c49a0a45ee282bf1b4beb_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY1LTQtMS0xLTA_aabd849a-563d-474d-8e84-8914c50feae3">325</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i18dad1ee5f9340d5a35c3c37e4cec4ab_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY1LTYtMS0xLTA_3c05a80d-094f-4df6-974c-aa1a66fed56c">9.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id554573e94b84b8cab2eb20188d60570_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY1LTgtMS0xLTA_2c42dfdf-97c8-4693-96dd-02ad2db2bc69">908</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i49cd0b4d91974b7da8bf40cd67d178c1_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY1LTEwLTEtMS0w_7da3a3e7-e001-4d9f-854e-f870d8806231">1,067</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i49cd0b4d91974b7da8bf40cd67d178c1_D20181231-20190929" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY1LTEyLTEtMS0w_56a34d37-b72f-4c1d-9d1b-8cccf1d20b22">14.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TOTAL PHARMACEUTICAL</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53b2c0aad4df4af0b03896d334176f20_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY4LTItMS0xLTA_b544bffb-d269-46ab-9a3e-4eab65ccee8f">6,438</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2badccfe6cf04b1c9d7f2fa0fc294693_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY4LTQtMS0xLTA_ff518b70-1759-4ab6-9254-fe08cd040b8f">6,340</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i53b2c0aad4df4af0b03896d334176f20_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY4LTYtMS0xLTA_6fa3efba-3e1c-45af-b1d7-778d1d35e004">1.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3d5c80efe6b1469391e9a4a07886a5a9_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY4LTgtMS0xLTA_2a5ca937-5b03-4e59-ae1e-d6c961f92391">18,619</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idff7cfe33b4c4b039394833c97daf9f1_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY4LTEwLTEtMS0w_68e741e1-3e45-4fd4-ba53-877633537b07">17,705</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3d5c80efe6b1469391e9a4a07886a5a9_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY4LTEyLTEtMS0w_9baa54af-91af-487c-a9b8-0ab05f1aeccc">5.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibe12ceed34eb4a389dbacc45771bab50_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY5LTItMS0xLTA_adc3324f-15ce-4b77-8c83-0bb6ef0f37a2">4,980</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaec3c39feb634238a2be7772b9926fde_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY5LTQtMS0xLTA_70ef72cf-9091-4fa4-8b93-d317b3cf8646">4,537</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ibe12ceed34eb4a389dbacc45771bab50_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY5LTYtMS0xLTA_ec489a50-2afa-4438-b7c4-b9213c3fd17c">9.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i73fa6421e055482c920a5e447a1f8675_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY5LTgtMS0xLTA_7be79c91-89b0-4b7c-bb4c-d86bfa56f2ff">14,685</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if9b7a1c7831f4541b7d5fbf0ef0a1e55_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY5LTEwLTEtMS0w_47395ad6-beae-4048-96c8-80ab9b450db4">13,945</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i73fa6421e055482c920a5e447a1f8675_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY5LTEyLTEtMS0w_9113bbaa-20af-436a-9c60-3a7153a1affb">5.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7db38f4a02ec46bd9364e821dfd12084_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTcwLTItMS0xLTA_ac395b38-010f-4dfa-8f48-fb720e85025b">11,418</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i08b63855cabe4bbdbeb0a69f02efd745_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTcwLTQtMS0xLTA_7fe8f8f0-4a94-4bf5-9910-6a21b53942c3">10,877</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7db38f4a02ec46bd9364e821dfd12084_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTcwLTYtMS0xLTA_ad115a67-909c-4b90-87de-3ae0e5524553">5.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i31c5bebe5faa45388656d1dcb0238be9_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTcwLTgtMS0xLTA_bc5b3f05-6106-41ac-bb28-1e9a582b50e3">33,304</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie736ef5792a9408d9d187416e6bf80ae_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTcwLTEwLTEtMS0w_816ac62d-f61e-4922-977a-8820c8b2efdc">31,650</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i31c5bebe5faa45388656d1dcb0238be9_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTcwLTEyLTEtMS0w_4061685f-e519-4447-93a0-79163e1779f7">5.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></ix:continuation></ix:continuation></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div style="margin-top:5pt;margin-bottom:5pt;"><ix:continuation id="i6316a3c81fd248a889c2d590619c83f5" continuedAt="idc7c3e31a36d455a927c91d1a28b40bd"><ix:continuation id="i2b84aeb775d5436ab58e82c06bc3a660" continuedAt="i2995f5693b2c43d49206739139c05676"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"></td><td style="width:35.144%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.525%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.525%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.633%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.234%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.234%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.643%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MEDICAL DEVICES</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interventional Solutions</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id1666eaae52c4401935f050f08c6ad04_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgyLTItMS0xLTA_d959252b-8ad7-4640-95db-912274a00c44">399</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icff6620acad14e70ba4ae22cb2b1c5ab_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgyLTQtMS0xLTA_7c7980cf-c4e1-479e-b478-ede63c2ac4f9">357</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="id1666eaae52c4401935f050f08c6ad04_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgyLTYtMS0xLTA_f58c9245-4a83-4ddb-8f30-66c8e71718be">11.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8dcb3df9a1d84367b2ad2572e6f5d507_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgyLTgtMS0xLTA_a48a52af-743d-4901-ac72-d552af3854e8">1,019</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ide630ed019df43bb97fc9e366da29198_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgyLTEwLTEtMS0w_7495063e-5833-437b-bbf7-05b1634fa636">1,066</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i8dcb3df9a1d84367b2ad2572e6f5d507_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgyLTEyLTEtMS0w_5485c29e-1508-4ebd-9c81-952f3fc537f6">4.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1940a237e8c44075af2c9cefe451512d_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgzLTItMS0xLTA_14a4d9e3-576a-4e48-81d4-55fb252e9edc">437</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1111a41f19b54df1a08a52959ba8a81a_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgzLTQtMS0xLTA_19586fb1-f71f-4f6c-a632-c68b0d40da2a">382</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1940a237e8c44075af2c9cefe451512d_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgzLTYtMS0xLTA_7419aadf-db86-46a5-82fd-5826e88d09ab">14.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if89b08d6774845f39dbd843c88a623e4_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgzLTgtMS0xLTA_d444e71f-6c91-47ac-882f-dea1f8887c99">1,134</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ab8b554e029447da97b0eeb058f7784_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgzLTEwLTEtMS0w_24183536-6d72-4dea-be8d-7d7f1dbac220">1,156</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="if89b08d6774845f39dbd843c88a623e4_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgzLTEyLTEtMS0w_a5ca7138-27b3-4917-9598-2c0d030c580a">2.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i362aa1da8517434aa7ec7cdae445543f_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg0LTItMS0xLTA_a5cd398f-56b6-4aa1-86c2-0ff1d70b3649">836</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6ef01fc2d1d144f591e77eb42bf26fa1_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg0LTQtMS0xLTA_64ca95a5-4d44-40d3-8008-c383bf45bd75">741</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i362aa1da8517434aa7ec7cdae445543f_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg0LTYtMS0xLTA_7001cd5e-3810-4cb3-9bc1-f969eb4a52bf">12.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6a7520101a8347d8b81b529c44f5e031_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg0LTgtMS0xLTA_38a1091e-b1f0-49e9-9e8f-b6c7d0975975">2,153</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7455b437e0ee48eb9473a4538a82626d_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg0LTEwLTEtMS0w_0f2a2f1d-54d4-4342-b5ee-1f7747eebc42">2,223</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i6a7520101a8347d8b81b529c44f5e031_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg0LTEyLTEtMS0w_2497badd-a3b5-44c8-8ab5-367cb6cb0248">3.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Orthopaedics</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i331b2defbc4b495580cbf5071b32f36e_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg2LTItMS0xLTA_10c59487-7529-41f4-a5f4-8549ba3df043">1,308</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i700c383f769a4f039b3dadd10d216a66_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg2LTQtMS0xLTA_14c507e6-85fc-4a7e-b51c-cfcda6c8c2aa">1,301</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i331b2defbc4b495580cbf5071b32f36e_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg2LTYtMS0xLTA_c4392862-75a5-4c86-b75b-cb119f780045">0.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9a16cc194cf149e188ec098d494aa4eb_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg2LTgtMS0xLTA_cc1ab3f2-ccb8-400a-9d39-9578e247ef0d">3,427</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i61e9bd42de204e38b485cae7266baf3f_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg2LTEwLTEtMS0w_3d114266-b19b-46ed-be1e-48bbe4b7efb0">3,950</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9a16cc194cf149e188ec098d494aa4eb_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg2LTEyLTEtMS0w_c607f067-a702-430d-9352-e2b570fa43a0">13.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9ebcff1d99364d61b75d91cd03f2edbd_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg3LTItMS0xLTA_a91088fd-2e83-4f76-be93-da1540370972">774</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5f5862c1f9554aeaad6ec3149da92dcd_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg3LTQtMS0xLTA_4a1f700f-ac23-4911-ba36-fea07124b02f">837</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9ebcff1d99364d61b75d91cd03f2edbd_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg3LTYtMS0xLTA_26a288cd-832e-458c-85df-fb263c41d9fc">7.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56570f28521e4309bb5acfbc1d861206_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg3LTgtMS0xLTA_9bd24084-21ec-464e-bbf4-6ca8a54ec4a0">2,145</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4772bb2f70594c609f15d55b5b840ce3_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg3LTEwLTEtMS0w_0627e584-eb37-4376-a176-0d6f25d4b21d">2,616</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i56570f28521e4309bb5acfbc1d861206_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg3LTEyLTEtMS0w_71e8068e-c181-4223-93ec-f78e54e49c13">18.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i96b312422bef422894f64737926c8653_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg4LTItMS0xLTA_03c78e08-39dc-4d6b-a63e-2faba5670d23">2,083</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i94c1dc95b63b47a19b2b55e786fda0a6_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg4LTQtMS0xLTA_4b149d77-32f3-433d-822a-a458d96252bb">2,138</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i96b312422bef422894f64737926c8653_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg4LTYtMS0xLTA_f6308c93-a37a-4a9a-ac4a-34bdfe8aebab">2.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i620ad18d8b8e4ee4b483bbd4fc7e9e5a_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg4LTgtMS0xLTA_d7930c62-6b5c-4d23-b04b-385ecc1c5eb6">5,572</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i79e0912ed4304749a55e7ac7a0fe0ec5_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg4LTEwLTEtMS0w_4ea7d097-97a9-41e3-b7ad-9defb9d4a486">6,566</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i620ad18d8b8e4ee4b483bbd4fc7e9e5a_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg4LTEyLTEtMS0w_8f32c422-0452-408b-bf0d-85bc3c4cb204">15.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">HIPS</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibc0fcc5f2a24455490a6a544350ae618_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkwLTItMS0xLTA_3d79c5c3-eafc-4f61-9ffc-c8c52dba573c">221</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i86a18dd116e24e96b3485a5f6169baf3_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkwLTQtMS0xLTA_92a23f23-bddf-425f-bfd9-361c4791de2d">204</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ibc0fcc5f2a24455490a6a544350ae618_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkwLTYtMS0xLTA_e3eca164-203b-402d-bd13-fb354943e5d1">8.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9b766c43eb6240ba8bbdaa57b4a094d3_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkwLTgtMS0xLTA_0a2345f0-0531-40ba-9dfa-ee3678371ca4">564</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i228a88e232a3439ba7508d3f89efab11_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkwLTEwLTEtMS0w_12a87224-c85a-4013-880e-e62547edb00e">633</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9b766c43eb6240ba8bbdaa57b4a094d3_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkwLTEyLTEtMS0w_2c14ff86-776c-4534-a88c-c6d31fee1dd9">10.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic8e0f6bad1de4c50a2da26602cdee485_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkxLTItMS0xLTA_8cbd0e67-9766-4895-93a1-e9e3018a9f23">124</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5478e07cbf10492b94c7f95ded249535_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkxLTQtMS0xLTA_1913ea83-beda-4d61-9963-66d00f535a3c">133</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ic8e0f6bad1de4c50a2da26602cdee485_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkxLTYtMS0xLTA_36d6cc9b-2547-4c1a-8637-e470756ca67f">7.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifd8aa81948f24b89a510f6d5974fe76b_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkxLTgtMS0xLTA_23e540e9-0710-4d94-a7f3-841d4861d03a">344</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5470093de4834bc093bb3471c8a0d68a_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkxLTEwLTEtMS0w_ed70cde3-6395-4264-bd30-d4668474251c">428</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ifd8aa81948f24b89a510f6d5974fe76b_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkxLTEyLTEtMS0w_a23e5c96-e72e-4a17-bd96-2bc907844683">19.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia9e844cd7770412489bfc37a68ec0c16_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkyLTItMS0xLTA_5e60f27f-ba07-4886-80b1-40a1cabba9e3">345</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1801a6a1406d4302bae15df4fc5e6e72_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkyLTQtMS0xLTA_c18450d4-3b69-4371-ae4c-7909f32425c4">336</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ia9e844cd7770412489bfc37a68ec0c16_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkyLTYtMS0xLTA_5340904a-7859-4028-b552-302921a83c91">2.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia35085eaa6c748a5bfddc85e2da15d60_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkyLTgtMS0xLTA_afa1c3cb-686c-441b-8e9c-ba36d935898f">908</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if25d735005cc4622a33272df76697e88_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkyLTEwLTEtMS0w_61224774-43c8-42f7-a79e-7b2179f494ef">1,061</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ia35085eaa6c748a5bfddc85e2da15d60_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkyLTEyLTEtMS0w_505ec258-fd9a-49ce-a8e9-7244d44b79c3">14.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">KNEES</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5faf7b6f7a9d42c58b9a332270703b95_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk0LTItMS0xLTA_785c772b-5264-4fee-9090-615753e174f0">205</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i59e7895988ef4dae840116b8f041c33c_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk0LTQtMS0xLTA_bb9a40be-822c-4d5a-b292-cef360c1ee28">209</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i5faf7b6f7a9d42c58b9a332270703b95_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk0LTYtMS0xLTA_0eb849de-7ab6-4177-9ec3-40b9bf79cd05">1.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic339811f8c7445d4af842ec97e4900dc_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk0LTgtMS0xLTA_50075dc8-db0d-4ea1-a744-924656c0c41b">527</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8e17bddbdca5483e9fb788af9d2d8cd4_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk0LTEwLTEtMS0w_1e1bb852-c2e8-4dba-8b76-e19269b829e9">650</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ic339811f8c7445d4af842ec97e4900dc_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk0LTEyLTEtMS0w_839ed226-c487-4eab-9f63-a34f335a1617">19.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i83d80cb8b62742239c836bc6aed6077c_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk1LTItMS0xLTA_329d9e2c-b55a-4a08-aa77-5c26629783f4">102</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaf702c0dd8c14d8a908386735f728ab2_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk1LTQtMS0xLTA_1b6489e6-79df-46f7-a8a4-da03370753b4">136</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i83d80cb8b62742239c836bc6aed6077c_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk1LTYtMS0xLTA_c90e53e9-876e-480d-b65f-e3128e30283a">24.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i06f5aba171ac42868d1d0f93dc180a43_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk1LTgtMS0xLTA_66aff24a-33e4-4c1f-9dfe-b7a2a64bd564">298</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i62ede8edf37b48389570fe7528e37670_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk1LTEwLTEtMS0w_f442c215-c9b2-40d4-80e0-3f0770e980fc">435</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i06f5aba171ac42868d1d0f93dc180a43_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk1LTEyLTEtMS0w_ecdb5df7-9fd8-4363-90c4-33ced16aaa2d">31.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia4eb2ce198ed40b7b248f09b87ca97ce_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk2LTItMS0xLTA_4f9f29f7-1ec7-404f-b052-71fcc67d1efa">308</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic63cd8e33f3e404aa8678a6a0bd21989_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk2LTQtMS0xLTA_8ad22c73-baaf-48e1-b9a5-ed4763e31fbb">344</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ia4eb2ce198ed40b7b248f09b87ca97ce_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk2LTYtMS0xLTA_e79d7f57-d758-41ab-b783-ee174cb9ad7b">10.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifd0f4a74ca2f4dac9fb438dfe7c99571_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk2LTgtMS0xLTA_1622e895-b414-4451-a2a2-bfad3bb7a969">825</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i257430a4bde64ea48d158e7205d2c483_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk2LTEwLTEtMS0w_0c9d5312-f1a0-4352-b67b-fa7867b5cb07">1,085</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ifd0f4a74ca2f4dac9fb438dfe7c99571_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk2LTEyLTEtMS0w_cdf7717d-2acd-4e6f-a4c8-8082f97102ad">24.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">TRAUMA</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8ec3b3d8e35c4d95bf1c4fbbecbbe0dd_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk4LTItMS0xLTA_9cb193a7-9ee3-4faf-ba82-651d9ec034d8">433</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id2e2712a0d5049f5a4531ceefce9f03a_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk4LTQtMS0xLTA_5ed3812d-c02c-4c0f-a6a8-aabbd893812e">415</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i8ec3b3d8e35c4d95bf1c4fbbecbbe0dd_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk4LTYtMS0xLTA_8ec3b87f-aade-4b85-a466-f26605f7f02d">4.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i80bf15618213433798636c636144fd62_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk4LTgtMS0xLTA_0e785b12-6400-450e-8b8d-ed51de44fdb2">1,194</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i680358c8ea674cb9ad8f59a84f3e2968_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk4LTEwLTEtMS0w_39aaee49-5d69-42dc-9584-79654135efc7">1,239</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i80bf15618213433798636c636144fd62_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk4LTEyLTEtMS0w_54511a72-46aa-439a-a47b-9bd2ce266bba">3.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i506f1906854848fab0375dee9395568d_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk5LTItMS0xLTA_5de39a7e-4b29-40b0-b810-a381920bdc3d">253</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic59c453b839243f1910be25d60212165_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk5LTQtMS0xLTA_54873a02-3f5e-4c20-bd7f-f2f0965de27b">262</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i506f1906854848fab0375dee9395568d_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk5LTYtMS0xLTA_a79ad8d0-dbcd-497f-9c50-45393aa846a2">3.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i92e00f4cd50544f1a6fc1c21b5eff033_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk5LTgtMS0xLTA_a80ed276-d10a-40c1-903b-d82f956d5c9f">698</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id9a73c4de08348d0aebe04a72f25b265_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk5LTEwLTEtMS0w_5401d589-2232-46f0-8962-76f4e11b8a7c">795</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i92e00f4cd50544f1a6fc1c21b5eff033_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk5LTEyLTEtMS0w_c2c57e41-b14a-4439-9d7b-9b26434bf64c">12.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaa548762232c4bf1ab0a3a867110e217_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAwLTItMS0xLTA_c3e16b4c-cfc2-4d3e-83d7-ef54e3674b4a">685</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i80e7c2e2168a439eb1b8ec9732ba396f_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAwLTQtMS0xLTA_eee1f156-b891-400e-895c-50728a84ed2f">677</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iaa548762232c4bf1ab0a3a867110e217_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAwLTYtMS0xLTA_fe408291-5444-495f-a855-a3175cb40483">1.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i159a3081cf544186938c908e8fa7c674_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAwLTgtMS0xLTA_05e41478-113a-4e75-ba1f-19c39ad9246e">1,892</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i126743cd6a3047e9838e7e77686dec4f_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAwLTEwLTEtMS0w_fd151b86-c1c8-471a-b40e-d327974959a2">2,034</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i159a3081cf544186938c908e8fa7c674_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAwLTEyLTEtMS0w_0793c981-ea06-41e3-a4d2-896f57e2b110">7.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">SPINE, SPORTS &amp; OTHER</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9f7d40b1ae56403c89c4041e353c5f2d_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAyLTItMS0xLTA_9445607b-c182-4dad-b748-e6758da39ef0">449</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i279d140c5f3b4e169fdb57f7f0df5aa2_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAyLTQtMS0xLTA_4f60ae31-c0ce-47d5-84f5-7ae2e990dfbf">472</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9f7d40b1ae56403c89c4041e353c5f2d_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAyLTYtMS0xLTA_716031f1-7edb-449f-91d8-843f7e6ad51d">4.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id82df2ce137f4d92afc976d33692c8bf_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAyLTgtMS0xLTA_730af72b-673b-4b9f-93ca-f613a6082bd9">1,142</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8b733e335d8e4c1fb383d893bb64d6c6_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAyLTEwLTEtMS0w_3196b863-8827-4f3b-a2bd-936ddbd753ef">1,427</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="id82df2ce137f4d92afc976d33692c8bf_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAyLTEyLTEtMS0w_f902bf2f-e339-4c45-940e-9d706f2f3b55">20.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i078e82fb2a1e41d6810522efa7753a85_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAzLTItMS0xLTA_443be0ca-6d05-4460-ae02-c471ebd46425">295</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic3b18e1cdfb2424b8ef0500cab9b37e1_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAzLTQtMS0xLTA_7bb863a4-5345-4b67-bdae-7a83fc40dbdf">306</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i078e82fb2a1e41d6810522efa7753a85_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAzLTYtMS0xLTA_fe22d945-d0e1-4dd1-967c-e173a4076b8f">3.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i549bc38f2f2e4815adbcbdca90f24d9e_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAzLTgtMS0xLTA_f21063f9-a349-4620-91bd-2a0f12414e44">805</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i46022c7e16be41ff96edd7e762e38dc9_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAzLTEwLTEtMS0w_b94e3e82-c158-4433-b932-83a98dfbcc47">957</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i549bc38f2f2e4815adbcbdca90f24d9e_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAzLTEyLTEtMS0w_5b7e9e77-781c-4e71-a05c-85cfe496ad3d">15.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iafa8ab4bd43341708edcefb67a5354af_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA0LTItMS0xLTA_69e13a75-02b9-4eb1-a100-52a02333518c">745</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i445e1d6a7f2f49918827c8cb78f49926_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA0LTQtMS0xLTA_ae6169b8-40e8-4a5b-b28e-a20f9983fe3d">778</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="iafa8ab4bd43341708edcefb67a5354af_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA0LTYtMS0xLTA_6c05694f-7c8d-4380-978c-0b3f8092753b">4.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5c6117a9799b4fe0b16e620b0cb21f30_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA0LTgtMS0xLTA_c379b399-b22a-4e1e-9314-97af1f2e13ef">1,947</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie3f23ca283834dfca4b73d913c0b495a_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA0LTEwLTEtMS0w_34e21ad4-9cff-4546-9dec-4ec7485f20a9">2,384</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i5c6117a9799b4fe0b16e620b0cb21f30_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA0LTEyLTEtMS0w_15d0e2ca-db33-453f-a25b-8f81be3c7555">18.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Surgery</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i662c0af4be474f6287c7693841b01f99_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA2LTItMS0xLTA_8457b936-c20a-42c8-acab-c71e0dde5e48">913</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if783cccc272c4ee5b8d37788be2343c1_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA2LTQtMS0xLTA_1980ee5f-0cd8-4806-bfd1-afe7538f8d87">940</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i662c0af4be474f6287c7693841b01f99_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA2LTYtMS0xLTA_4f65c667-ba7f-495f-9623-8d32bbec6238">3.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib233b0caa2d24cce930843ce9532eb98_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA2LTgtMS0xLTA_1f7fbfcf-9a39-454c-8283-6c6d59119992">2,247</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e809c62413f4b6eaf0f1f74674cd8a3_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA2LTEwLTEtMS0w_e9372207-23e0-41e7-82b8-a9b5f1c9c16c">2,867</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib233b0caa2d24cce930843ce9532eb98_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA2LTEyLTEtMS0w_fcd965dc-52ec-4c00-b728-21603fa66e2e">21.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0c35c71d39d448d08df9def2add49a90_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA3LTItMS0xLTA_6a193412-a474-461c-8c3d-972b32cde473">1,239</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1321854500714d2386badf8f4f85c1b7_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA3LTQtMS0xLTA_68ef949f-8d16-4cda-a0b1-b52acf829103">1,371</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i0c35c71d39d448d08df9def2add49a90_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA3LTYtMS0xLTA_e2defaa6-36a2-4c1d-b369-ade395284c64">9.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i08939ac29dae4ffeb1039b346ac2884e_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA3LTgtMS0xLTA_a6787604-fa43-4314-bb15-9f9aaee0b90b">3,556</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i61d23b7f2d4241a38597ec38811725dd_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA3LTEwLTEtMS0w_6a1a2efd-4b60-4aaf-bb35-53ae05cff276">4,192</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i08939ac29dae4ffeb1039b346ac2884e_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA3LTEyLTEtMS0w_152569b3-ff13-4716-a389-6c50c756109c">15.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e5acb865e574efe9eca9f998ed83da8_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA4LTItMS0xLTA_a9da1b71-1a60-41dd-be04-9c02c5a9ebd6">2,152</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i421903ae07dc46e8b1403cf39867c316_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA4LTQtMS0xLTA_2cb5f36f-2a89-4498-a3be-8d78accc7376">2,311</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i0e5acb865e574efe9eca9f998ed83da8_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA4LTYtMS0xLTA_2bd621d6-0758-48aa-b6b7-85cf40dd7616">6.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i97a2b98ae57b4c268d8ebab5c60642d4_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA4LTgtMS0xLTA_454d553d-9be7-4c5f-a763-14f9660e1257">5,803</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i35f618e2b32f4a35bc3855d06290605d_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA4LTEwLTEtMS0w_c45ff5e2-784c-4a44-b50c-42426dc11dcc">7,059</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i97a2b98ae57b4c268d8ebab5c60642d4_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA4LTEyLTEtMS0w_4e1d44dc-7370-454d-8484-db22e2c059e2">17.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">ADVANCED</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7b15a4efca2e45b29ee3e92ad084572f_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEwLTItMS0xLTA_f4c7993d-8631-4acb-ada0-cb88eba42771">421</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i656d3fc14e6a4325bd24b770e013526b_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEwLTQtMS0xLTA_572827af-d226-4972-b627-2d51be08d218">409</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7b15a4efca2e45b29ee3e92ad084572f_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEwLTYtMS0xLTA_52e66283-1621-47f3-96da-692fd6bde580">3.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8258fdc417094593a4a129bf9b40a2af_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEwLTgtMS0xLTA_ebde7b0d-0796-441b-a6e9-756da753d937">1,079</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i52d7cf57476d45a5ad57d74c0085b847_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEwLTEwLTEtMS0w_442b30b4-908b-43ba-8a91-5212f2f26abf">1,209</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i8258fdc417094593a4a129bf9b40a2af_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEwLTEyLTEtMS0w_49af79e2-c0dc-4827-94ba-158d9097f972">10.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3d714fa9dc89438e93a39c79621b1d01_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjExLTItMS0xLTA_fffcdd01-91e0-4a02-80b0-cb0b7af03ac7">579</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1851455e464849f5bd9f21eb2518567d_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjExLTQtMS0xLTA_ce5e406f-e0d7-4f59-95d6-f9c3678ac533">602</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i3d714fa9dc89438e93a39c79621b1d01_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjExLTYtMS0xLTA_fea1b556-cea6-473a-8205-f35117d40a15">3.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i66ae8fc90597499185a5d9eff2fa78f6_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjExLTgtMS0xLTA_b8fe2620-b1de-4b69-b844-1c444a6fac4c">1,644</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4ef142f0f71444aab8fd23edf4a5fc2d_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjExLTEwLTEtMS0w_e72e9710-96a4-4b1d-b7d3-6d0c6a60df76">1,811</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i66ae8fc90597499185a5d9eff2fa78f6_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjExLTEyLTEtMS0w_44562c92-a3f2-4810-a702-4b778269f929">9.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib11b611985894d70b30457565b4d7fa7_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEyLTItMS0xLTA_17cef861-d54d-42cc-bc2d-0b42a19f11ae">1,000</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8de79cd48b68455aa26dbbe51313f2ee_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEyLTQtMS0xLTA_a1e8b664-c196-45da-a175-d968a9a8c54b">1,010</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib11b611985894d70b30457565b4d7fa7_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEyLTYtMS0xLTA_5ef2341f-0d0e-4017-b3a2-8396f4d5f365">1.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1531b5603bb54e4c933c82c142112323_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEyLTgtMS0xLTA_8f12775e-f92b-496b-aca6-476803799c9d">2,723</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i39a68f7975ed486181d4f5f3f67d31c7_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEyLTEwLTEtMS0w_9b27138b-c7d7-4a44-b081-bec02ec76a83">3,019</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1531b5603bb54e4c933c82c142112323_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEyLTEyLTEtMS0w_eacccb98-ae6c-4ac2-9579-4aa948057392">9.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#160;&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">GENERAL</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if8fb64d50c40401c93c4477200e096b0_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE0LTItMS0xLTA_5117e591-e9e2-49cf-8243-a1217785addb">492</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6aa2716ac6604a51a4a3c42da27fccb4_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE0LTQtMS0xLTA_09f01973-5406-45b7-8029-bc36238e794b">531</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="if8fb64d50c40401c93c4477200e096b0_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE0LTYtMS0xLTA_65846c11-f3b8-4aa8-9c8d-2b1256863caa">7.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56e42d0e762d48c888f6a1c64e9490e6_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE0LTgtMS0xLTA_834041ba-93f3-4466-a2dd-c513fe601e29">1,168</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iea38e5177c29474eb554d7141dcd0f68_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE0LTEwLTEtMS0w_aa842f03-8085-4d7c-a251-f021153e3815">1,658</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i56e42d0e762d48c888f6a1c64e9490e6_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE0LTEyLTEtMS0w_a9eb7fd3-222e-4189-b8b5-f449b97d661c">29.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5049c06813234998b24265d8cb35cedc_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE1LTItMS0xLTA_57f0a68e-960f-42fe-b4d4-76173fb3f624">660</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie31d7e3dc1b64e3eb43c6b2090aa773e_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE1LTQtMS0xLTA_daa9e22f-d9a2-4a2c-b2dc-375aadba012d">769</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i5049c06813234998b24265d8cb35cedc_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE1LTYtMS0xLTA_b6c5fa3e-acd0-48ba-bf15-e667ef8e93cc">14.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i59920036dbf249039599856c49398657_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE1LTgtMS0xLTA_1527f507-b9c4-43b8-8316-598bcc2ae5aa">1,912</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i84b634865f474f6b8bc070ee303b8b91_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE1LTEwLTEtMS0w_8ffc1e4c-fa3c-47a0-84c0-69b0a73ce7ae">2,381</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i59920036dbf249039599856c49398657_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE1LTEyLTEtMS0w_10f493a6-b9b9-4d96-be50-bc5b893d0b55">19.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaffa1a11347d4888924b6e99e98c8764_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE2LTItMS0xLTA_8746e0bd-7b9c-4440-b887-25892b2f8f47">1,152</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib7042183f12643f98389d82808fc723d_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE2LTQtMS0xLTA_2cf350a1-0d44-4061-96d1-f0fc4f0690e4">1,301</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="iaffa1a11347d4888924b6e99e98c8764_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE2LTYtMS0xLTA_ae7940b8-5d2d-432f-97a1-59c717a65ad8">11.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i75a76bf8abad43c5960ec48d79f04f36_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE2LTgtMS0xLTA_c731ff32-c5c2-4cf8-b01c-1380d223d81b">3,080</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if38c2f57b46d452f93dafc3b162a0fde_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE2LTEwLTEtMS0w_9f0b14bf-1284-412a-9810-d06c99d312aa">4,040</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i75a76bf8abad43c5960ec48d79f04f36_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE2LTEyLTEtMS0w_789e945a-b0a3-4757-b4c8-72e420e3ae23">23.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vision</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i296b0e556e1b48a3bf64b25710ec956e_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE4LTItMS0xLTA_35b4645a-1575-44f5-b22b-2011b1bb91cc">473</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i260e88f62d2843a188e4c53283699a2e_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE4LTQtMS0xLTA_6c2b8a5e-9d4c-4941-9d84-a66b7be89853">459</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i296b0e556e1b48a3bf64b25710ec956e_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE4LTYtMS0xLTA_4543026a-ef15-464f-b2dc-7547d3f786d9">3.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie77c8050b8fd472e8e5678efee8c7de9_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE4LTgtMS0xLTA_ec5b8773-477b-4a89-b336-dc9910eeffa9">1,160</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4444b1a6e50447f2aad3784749794afb_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE4LTEwLTEtMS0w_8bfa696d-1b10-40a1-b9f3-f9ea6eec7d89">1,366</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ie77c8050b8fd472e8e5678efee8c7de9_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE4LTEyLTEtMS0w_267bd593-9ed1-4413-a13e-8543104a6990">15.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i625fb1ccccb948cba7bfb675b72f1fc5_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE5LTItMS0xLTA_dd6fd5aa-d7ae-442a-ade0-5d0452e9a4f5">608</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iab8d758e1db8401fbac59a2421221ac2_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE5LTQtMS0xLTA_651ad6f2-747e-4840-bdc9-adaa54c7e8ba">734</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i625fb1ccccb948cba7bfb675b72f1fc5_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE5LTYtMS0xLTA_3718128b-ad0d-4b25-b6d5-6919a09e3ca8">17.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3f6c0b9d80c34d16ae17316c585ff15c_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE5LTgtMS0xLTA_c25cf7b9-0908-4ce9-bbd7-f0cc824a2826">1,683</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2e71fdd99cd04db297741c300cd7ab55_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE5LTEwLTEtMS0w_1ad52a07-1e6d-45fc-929f-ec83480907af">2,117</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i3f6c0b9d80c34d16ae17316c585ff15c_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE5LTEyLTEtMS0w_13ac2b75-e477-4d1b-9e73-a26b6d2d3167">20.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i963e0700cb4d4671b572343d69b2232f_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIwLTItMS0xLTA_7f9a1e6b-609c-41fc-ab65-51e9caea5b04">1,081</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibc4c63f509c84cbe8f5ff6e2c6ca1ebb_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIwLTQtMS0xLTA_189461d0-efcb-4545-a880-f091c6c32d89">1,193</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i963e0700cb4d4671b572343d69b2232f_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIwLTYtMS0xLTA_aa8ebbdb-295c-40ed-8bea-3b652f332dd7">9.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67aaaec919ba4dc6be289f8f6538f686_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIwLTgtMS0xLTA_b0e060a6-df7b-4712-b6c5-0b52eacb393b">2,843</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9886d032efa5433a993723420ebb6645_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIwLTEwLTEtMS0w_82459ebd-c178-4017-bbae-8fbd940503c9">3,483</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i67aaaec919ba4dc6be289f8f6538f686_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIwLTEyLTEtMS0w_8c17a416-25de-46ab-9fca-4d3e21a7aa96">18.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#160;&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">CONTACT LENSES / OTHER</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i01334be3ea4e40c3b74d0c4ce690baf7_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIyLTItMS0xLTA_2c1b9139-e486-4d1e-a1dc-78aec601e030">375</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i66d42047ed1546a99c98157dc227337c_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIyLTQtMS0xLTA_7fcefa17-43a9-42f2-82b5-652365c36351">339</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i01334be3ea4e40c3b74d0c4ce690baf7_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIyLTYtMS0xLTA_8b664a20-f0a8-4f2a-97c5-5e9261bf9a56">10.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1029f059b6514bd2b972b5ccf27ad129_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIyLTgtMS0xLTA_7bd78a0a-14d9-44f2-9782-83a9386e44c6">924</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3a6480a1e04142e5bd0b115b8b7beda4_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIyLTEwLTEtMS0w_96a19754-36e5-4eba-b705-7914bcc964ba">993</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1029f059b6514bd2b972b5ccf27ad129_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIyLTEyLTEtMS0w_2ee10f7a-977b-4db7-bfd1-f8e5554b4de8">6.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ied4375401e354a6bbb3e8ac51c6e0bf0_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIzLTItMS0xLTA_8dd2264f-e922-423f-9b70-d241470b2da0">455</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2b2e30c0de694d49b6f122976eebf086_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIzLTQtMS0xLTA_6f64c792-14b2-4c1e-9174-869940529d6f">555</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ied4375401e354a6bbb3e8ac51c6e0bf0_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIzLTYtMS0xLTA_afc58ad2-f5ae-41c1-a247-c9ae7077d736">18.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i17aa526e89604821b23f94ff90695ac7_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIzLTgtMS0xLTA_adfda639-b9ec-43e7-b581-00c6ea2f1e6f">1,274</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5a837853bdd94ee2b05b75ff02e99532_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIzLTEwLTEtMS0w_e18923ea-477c-4ffc-9131-45da02264ab0">1,566</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i17aa526e89604821b23f94ff90695ac7_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIzLTEyLTEtMS0w_fd432289-dcf3-43b7-9bc0-08cb0d489e5a">18.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iac6c465d42c648babbe737db5a107e69_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI0LTItMS0xLTA_c4d40a3b-4186-4f5d-a655-34d542209709">830</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if61ce55cf8dc49728545a3f242ea36bf_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI0LTQtMS0xLTA_c9c1b959-0e06-4113-aeb1-d2937c67c342">893</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="iac6c465d42c648babbe737db5a107e69_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI0LTYtMS0xLTA_bb3119b4-4516-4e05-aed0-665c7f42b571">7.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i708a5f3cd9c14d6b90cc957a086ad592_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI0LTgtMS0xLTA_6e1de135-5df7-4ebc-97ac-7c3a66c89a8d">2,198</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9958a497e25348dbb14e5c5271ce2fb9_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI0LTEwLTEtMS0w_62c41319-08b9-4eb6-a928-5abd0a8539ce">2,559</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i708a5f3cd9c14d6b90cc957a086ad592_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI0LTEyLTEtMS0w_1230db39-a88c-4c83-830a-f1e78d881417">14.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></ix:continuation></ix:continuation></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><ix:continuation id="idc7c3e31a36d455a927c91d1a28b40bd" continuedAt="i2c8aca81014f43688a1e815210d6f3fb"><ix:continuation id="i2995f5693b2c43d49206739139c05676"><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"></td><td style="width:35.144%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.525%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.525%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.633%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.234%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.234%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.643%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#160;&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">SURGICAL</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i245a692de7db476e92675c28db36afcb_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI3LTItMS0xLTA_c081b738-2a7c-4d20-b547-d3d580dfdf9b">98</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2abfd02ddda74dfb962822b218cefdb2_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI3LTQtMS0xLTA_258f1b38-3231-4e14-9915-47a410a1a5db">120</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i245a692de7db476e92675c28db36afcb_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI3LTYtMS0xLTA_000e6b2e-2786-49a2-a23d-c07597af0536">18.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7338276873e1496e803482ff1f8104cd_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI3LTgtMS0xLTA_d0473bd4-232b-460f-a73b-fbcf9be20e6e">236</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib7bcddb586564ee4905b520cba578975_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI3LTEwLTEtMS0w_2fce1add-0f93-409d-bf9e-5a2839cd384c">373</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i7338276873e1496e803482ff1f8104cd_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI3LTEyLTEtMS0w_10c1b2ba-bf6e-47b9-90a4-8b25fe64c933">36.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1d02bf81fd4147c3961e6b66bf6df83c_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI4LTItMS0xLTA_95a9b3fc-435a-495c-9a1e-6aac3ad1fcf9">153</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d33df78c2d74a9794b67f99c431b4c4_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI4LTQtMS0xLTA_661935cb-1e77-47a8-ad82-bac9c41f4fb1">180</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1d02bf81fd4147c3961e6b66bf6df83c_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI4LTYtMS0xLTA_28c7ba8c-3e1d-4005-9ffd-8dcc1f0bee0e">14.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e88a966742642f7beacda981f64e553_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI4LTgtMS0xLTA_4504a4c9-a442-4616-a6ef-86e2135b65b7">409</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie0fbb6beed0b4039960cc5369a53a72b_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI4LTEwLTEtMS0w_73bf9a51-9753-4365-aecc-4e7a180d2a55">551</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9e88a966742642f7beacda981f64e553_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI4LTEyLTEtMS0w_0094ef8c-c749-45c0-8604-1264ed91242f">25.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib5a04b866c0148a38d04d0efd708709f_D20200629-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI5LTItMS0xLTA_a23d40ed-af23-4ae7-86f9-b70c60afc805">251</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4593bade2d004b69994c70585546ce89_D20190701-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI5LTQtMS0xLTA_62c6ef58-c1b2-41dc-beaf-c1b1b417c39a">299</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib5a04b866c0148a38d04d0efd708709f_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI5LTYtMS0xLTA_78b29b8f-456f-4c59-b6a2-81992528a0ba">16.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8b89d826ccd04092ab54bd782548a003_D20191230-20200927" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI5LTgtMS0xLTA_aad4bd96-5bf0-4dff-8d59-c46884d86433">645</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i453c063241274887b6d6b9fd8f525a52_D20181231-20190929" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI5LTEwLTEtMS0w_1e08b280-9f41-4e1c-ad37-a2a96d2e64be">923</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i8b89d826ccd04092ab54bd782548a003_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI5LTEyLTEtMS0w_07197dbc-9378-49b4-8b88-cad1f4a6ea12">30.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TOTAL MEDICAL DEVICES</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iea21a9f89725422d8afcbf963b29af87_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMyLTItMS0xLTA_5ce02491-cf38-4d08-88f8-3cd9673d4b0a">3,092</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2cbcdfd43e8f485799e205dfb983107b_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMyLTQtMS0xLTA_e40d86a1-f89a-4d4d-9990-049a403e9462">3,057</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iea21a9f89725422d8afcbf963b29af87_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMyLTYtMS0xLTA_d379d1eb-b704-42fb-b6a9-9f08b757b19c">1.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9a1e0fd24f2240dfbfc672acac04a0c6_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMyLTgtMS0xLTA_d568f364-ee75-498a-9443-2718754d5cc6">7,852</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i120a34db825e4d07a1e15b8566101ff7_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMyLTEwLTEtMS0w_d38b9e4b-5e61-4f15-85bf-cf88306d1a1b">9,249</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9a1e0fd24f2240dfbfc672acac04a0c6_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMyLTEyLTEtMS0w_d40a289f-9dd3-40fa-a6a0-575425598cfa">15.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7b6741314c5f4ad1b9cf58499b18ac5b_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMzLTItMS0xLTA_20537dbd-f139-4c30-89a8-66dad69a5580">3,058</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8fbd398566b04e5496711b52c150ddcf_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMzLTQtMS0xLTA_632658bd-080c-420d-b131-8b24f41dede7">3,326</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i7b6741314c5f4ad1b9cf58499b18ac5b_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMzLTYtMS0xLTA_b1eb6c53-1e39-4933-bf3f-88f33d57403d">8.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i52a54bb5fdd2493ab00d5b1e8462304f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMzLTgtMS0xLTA_5ca9b0bc-94ee-4510-ab3d-f3f3b0e6b54c">8,518</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie84d5ea9d4f740178ee2bd661a5b76bb_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMzLTEwLTEtMS0w_ef40fd52-c17d-45cd-83bc-4f1a90743f3c">10,082</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i52a54bb5fdd2493ab00d5b1e8462304f_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMzLTEyLTEtMS0w_44c9c493-abf1-42ef-bf84-29c7c00cd74a">15.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2ef0bd79dd674186aa6f73f88e7a8163_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM0LTItMS0xLTA_d0544df4-4d72-4f98-98d5-c2ec22b3c41c">6,150</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i444727e6684545a7a9f22d74975fa1b6_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM0LTQtMS0xLTA_a94d41aa-a1a8-48b6-8b84-1d51e54121d3">6,383</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i2ef0bd79dd674186aa6f73f88e7a8163_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM0LTYtMS0xLTA_8a3e43f9-eff5-4491-84ba-f02e649c6eed">3.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic80539fe5fa44b869a360326b6dee52a_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM0LTgtMS0xLTA_61ecf50d-d76b-458f-80e0-43a700876003">16,370</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i33ce4e97b0f24651ad32677d55f5fc93_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM0LTEwLTEtMS0w_cef6cdc8-8487-4964-9950-0da6cb01c9ad">19,331</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ic80539fe5fa44b869a360326b6dee52a_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM0LTEyLTEtMS0w_04451196-0cb1-4c40-b573-21d8cf082f49">15.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">WORLDWIDE</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c18e167d7fe4b04a6ac423556324888_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM3LTItMS0xLTA_d62cbfaa-99ee-4ddc-9afe-7e5ceac7f77a">11,086</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i708014e4e6e44faf8244b75bda858331_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM3LTQtMS0xLTA_06646a01-5b22-41c7-8181-d53c1658c16f">10,791</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i4c18e167d7fe4b04a6ac423556324888_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM3LTYtMS0xLTA_9c3b38ba-51ad-4d39-9d91-4645c1a2166b">2.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie499303b87b94c58b5bfac0841a99079_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM3LTgtMS0xLTA_6a48a770-891c-4ed9-afca-cd520a9365a8">31,324</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia7c244381d0c4963b4d71699e772e533_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM3LTEwLTEtMS0w_6c7c420d-0f5a-4824-b233-4e403df74cff">31,323</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ie499303b87b94c58b5bfac0841a99079_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM3LTEyLTEtMS0w_d90749b5-aad7-423f-a806-59a5fcb5054e">0.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8e8ec55bd4294e1d97f2c5160d99527e_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM4LTItMS0xLTA_367256c8-492c-4d5d-93df-1102a60933e7">9,996</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1168ff1f8da940379fbadf2e0fb141f7_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM4LTQtMS0xLTA_6b4938e9-3111-4195-9380-cedbd1357b00">9,938</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i8e8ec55bd4294e1d97f2c5160d99527e_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM4LTYtMS0xLTA_fe022263-d020-4e41-b017-88d782bc6dc9">0.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i28eeee657bbb42488adc0e5f6326d3e0_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM4LTgtMS0xLTA_8ed76b9d-e1df-4a35-8776-fed4c159421d">28,785</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i52821a5a2b214804b0a20989602dc348_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM4LTEwLTEtMS0w_0848a56f-e3e3-4798-98c4-112bd5273b93">29,989</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i28eeee657bbb42488adc0e5f6326d3e0_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM4LTEyLTEtMS0w_a500c0e9-53ef-44b4-a81c-1a3fac4c85b8">4.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM5LTItMS0xLTA_e23e01c6-173a-4743-857a-7d26e2a655fd">21,082</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM5LTQtMS0xLTA_a858fcc5-9eb1-40dc-b847-c4038094dd9f">20,729</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM5LTYtMS0xLTA_71d956cc-730a-4b13-9967-17ffc7580d64">1.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM5LTgtMS0xLTA_8baa2b60-827d-4a1b-881d-2207da4f23c0">60,109</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM5LTEwLTEtMS0w_19d03080-80e5-4592-a23f-1c888eeb797b">61,312</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM5LTEyLTEtMS0w_95b0041b-028c-482d-a8e4-85240aeee5d6">2.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">*Percentage greater than 100% or not meaningful</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTA5OTUxMTYyODcxMTE_515cdefa-a213-4424-8a12-fd092570f55c" continuedAt="i85a43e9193374d1481744a9e7eced0c5" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">EARNINGS BEFORE PROVISION FOR TAXES BY SEGMENT  </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.710%;"><tr><td style="width:1.0%;"></td><td style="width:36.109%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.526%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.365%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.526%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.219%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.526%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.475%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.526%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.365%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.526%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.219%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.526%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.192%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29,<br/>2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>Change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29,<br/>2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Consumer Health </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib9afc9d0e42b478ea02c980b18106ca2_D20200629-20200927" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMi0yLTEtMS0w_656fba7b-90d2-4233-b186-abb49c4e7939">191</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i938f7adae1b841d3aa77845e6f04e5bf_D20190701-20190929" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMi00LTEtMS0w_18bc31d3-fdf8-4806-bbb4-1ccf74435f33">653</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib9afc9d0e42b478ea02c980b18106ca2_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInOperatingIncomeLoss" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMi02LTEtMS0w_53c549de-bd96-4d66-a83f-dc170ec7c693">70.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ife1a6848c3604397bdf131dedd495ada_D20191230-20200927" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMi04LTEtMS0w_f9ef2832-f19f-48a0-abec-a31a5f688cf5">993</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1ae290a5603746f8b45d01b27ea9d896_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMi0xMC0xLTEtMA_a4419b1a-3bec-4f4c-a58c-31793394c7bf">1,800</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ife1a6848c3604397bdf131dedd495ada_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInOperatingIncomeLoss" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMi0xMi0xLTEtMA_6e9aa34f-5788-476b-a332-11fb6ea08b7d">44.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Pharmaceutical</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i52dbcdb545674f538361e9912a01a050_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMy0yLTEtMS0w_bfbbd8b3-ffb2-4b9c-bc97-f8fa1fc5212c">3,439</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i080887d60f0940a59368f26c445c633c_D20190701-20190929" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMy00LTEtMS0w_90d00965-e821-4e2f-a369-a304b885f944">222</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia7d6c21b42a6409195bfc194bb649b2d_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMy04LTEtMS0w_b2211ef9-4026-4015-95bb-ce6a76b85016">11,787</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5bdc0915d2ea4d4ebcf9bd0941e693ad_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMy0xMC0xLTEtMA_463a7308-e2dd-4da1-bb09-2a05ef61acc1">5,786</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Medical Devices</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i091d9a98d2f448dda83641c2c3ce380a_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNC0yLTEtMS0w_2761c1b1-2b00-4a67-ae66-585898a2f228">1,010</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if32c09ac0b5647a1ad0e4dc7ce139472_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNC00LTEtMS0w_9a146f6e-25fb-4a67-8424-95166e7412b3">1,392</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i091d9a98d2f448dda83641c2c3ce380a_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInOperatingIncomeLoss" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNC02LTEtMS0w_d6cdbd1c-5f1c-4a13-88fa-09dfdcb0b1c8">27.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4126d8e6b9664efda5bedc99ff1ad067_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNC04LTEtMS0w_87608bdd-3f1b-4f07-bf5b-b05d3e2bed69">2,681</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1e561884e759475b9165f1413e1beae5_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNC0xMC0xLTEtMA_a91ee15f-35aa-48fc-b443-d4936edc8bdd">6,078</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i4126d8e6b9664efda5bedc99ff1ad067_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInOperatingIncomeLoss" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNC0xMi0xLTEtMA_5f6ca18a-b2c4-417c-ad21-0b203e262ce2">55.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment earnings before provision for taxes</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i74d121d1b483489e95a357c286e4c8ac_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNS0yLTEtMS0w_9151aaf6-e0a0-4393-a20d-1a5f64d7eb48">4,640</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2bdb1c21f8014a99a12c45d0019dd537_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNS00LTEtMS0w_66edc548-1366-4a9e-8b11-00e2ebd77dfa">1,823</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4e4204b60fad4fc7a1648e3538b6dc63_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNS04LTEtMS0w_c3591dc0-5a9b-43d8-98ad-0df6510c172a">15,461</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5dbb3222fd984af2a17fc6f092a9ae02_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNS0xMC0xLTEtMA_63e30e67-3a37-4ab4-b987-4eddc3e4a663">13,664</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i4e4204b60fad4fc7a1648e3538b6dc63_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInOperatingIncomeLoss" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNS0xMi0xLTEtMA_be483e99-de9b-481d-b3da-4cae9438b9f2">13.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Less: Expense not allocated to segments</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"> (4)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i66b302567e9241048a2995dae38b25c6_D20200629-20200927" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNi0yLTEtMS0w_382779af-c2d2-4094-b5ec-6497823168b7">239</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4150ce8a62e645fb8abfee3ebb12c773_D20190701-20190929" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNi00LTEtMS0w_f5580388-eb48-4c30-a4e2-2acbb86b830f">176</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1b18393bc5c64f7b83e0397afdb39c21_D20191230-20200927" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNi04LTEtMS0w_58d6c6fc-43eb-452f-a41e-03c7eca8b6a8">611</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4ae77b0256144a08b4e114c88ef9700d_D20181231-20190929" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNi0xMC0xLTEtMA_6f2195a7-ad70-4a63-866d-dd6017d229b3">554</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Worldwide income before tax</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNy0yLTEtMS0w_e5fc939e-1edc-4a8f-b703-a57e3de337ab">4,401</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNy00LTEtMS0w_0e3f835f-b05b-461f-b949-77d6557ed865">1,647</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNy04LTEtMS0w_311e2dec-a4ba-43d7-8b63-9441acdf53e3">14,850</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNy0xMC0xLTEtMA_a5d20945-aa94-4d17-9f75-f13b37f051d7">13,110</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInOperatingIncomeLoss" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNy0xMi0xLTEtMA_1d13abe4-c8db-4482-b85b-6e3db918a152">13.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">*Percentage greater than 100% or not meaningful</span></div><div><span><br/></span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Consumer Health</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a gain of $<ix:nonFraction unitRef="usd" contextRef="i4067541252a744ed90386e112cdd837b_D20181231-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfEquityInvestments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMjYy_411b7fee-d88c-4cb2-819b-13819fd80a2d">0.3</ix:nonFraction> billion related to the Company's previously held equity investment in Ci:z Holdings Co., Ltd. (DR. CI: LABO) in the fiscal nine months of 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt;">Includes litigation expense of $<ix:nonFraction unitRef="usd" contextRef="i5a3e920df42c47f494f7fad0bdd00892_D20200629-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNDMx_93d8ddd9-d9b9-4822-ba4c-87778ae0d729">0.5</ix:nonFraction>&#160;billion in the fiscal third quarter of 2020, primarily talc related costs, including certain settlements. Includes litigation expense of $<ix:nonFraction unitRef="usd" contextRef="i498b81f2554f4e868dce4daa5736066a_D20191230-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNTY5_fc5d3fba-e258-4cca-8a0e-99bb85c90385">1.2</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i80fc979b7821412b9354bc3c8c18f543_D20181231-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNTc2_0aef883f-c108-43e5-a391-0e4f21be22c9">0.2</ix:nonFraction>&#160;billion in both the fiscal nine months of 2020 and 2019, primarily talc related costs, including certain settlements. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i938f7adae1b841d3aa77845e6f04e5bf_D20190701-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzA0_1ea4be71-b37c-42f3-9c4d-ea4cc02203f3"><ix:nonFraction unitRef="usd" contextRef="ib9afc9d0e42b478ea02c980b18106ca2_D20200629-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzA0_ebd9edd2-5b62-4015-9ab9-3d8adfe3e50d">0.1</ix:nonFraction></ix:nonFraction> billion in both the fiscal third quarters of 2020 and 2019, respectively and $<ix:nonFraction unitRef="usd" contextRef="ife1a6848c3604397bdf131dedd495ada_D20191230-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzc3_79755341-9470-4e4b-bbf7-ef399eb6f9b5"><ix:nonFraction unitRef="usd" contextRef="i1ae290a5603746f8b45d01b27ea9d896_D20181231-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzc3_c2d0b1da-78b0-413d-836f-47975e2f7302">0.3</ix:nonFraction></ix:nonFraction>&#160;billion in both the fiscal nine months of 2020 and 2019, respectively.</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a restructuring related charge of $<ix:nonFraction unitRef="usd" contextRef="i498b81f2554f4e868dce4daa5736066a_D20191230-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzY5NjU4MTM5OTk0NQ_48486e1b-0daa-4774-a55e-dac8c354c568"><ix:nonFraction unitRef="usd" contextRef="i80fc979b7821412b9354bc3c8c18f543_D20181231-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzY5NjU4MTM5OTk0NQ_79772533-83b3-4233-9331-e1b9fd4268e6">0.1</ix:nonFraction></ix:nonFraction>&#160;billion in both the fiscal nine months of 2020 and 2019, respectively.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Pharmaceutical</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes an in-process research and development expense of $<ix:nonFraction unitRef="usd" contextRef="ie736ef5792a9408d9d187416e6bf80ae_D20181231-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfOTA5_c1aacf02-760e-4888-a5c6-ed9340318e13">0.9</ix:nonFraction> billion related to the Alios asset in the fiscal nine months of 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes litigation expense of $<ix:nonFraction unitRef="usd" contextRef="i7db38f4a02ec46bd9364e821dfd12084_D20200629-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzY5NjU4MTQwMDIwMQ_70235eed-f8cb-4fec-8f4a-55cd15b59772">1.0</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i08b63855cabe4bbdbeb0a69f02efd745_D20190701-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzY5NjU4MTQwMDIxNQ_f8db08ad-d774-4c1e-87dc-9c658804a7ef">4.0</ix:nonFraction>&#160;billion in the fiscal third quarters of 2020 and 2019 and $<ix:nonFraction unitRef="usd" contextRef="i31c5bebe5faa45388656d1dcb0238be9_D20191230-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzY5NjU4MTM5ODU4NQ_7a3a78be-16a6-42f2-bdd4-3dbed84921e0">1.0</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="ie736ef5792a9408d9d187416e6bf80ae_D20181231-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTAwNA_bb4ec229-b821-4a93-9ddf-fc2687cc3ba7">4.3</ix:nonFraction> billion in the fiscal nine months of 2020 and 2019, respectively. Litigation expense in all periods is primarily related to the agreement in principle to settle opioid litigation. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes an unrealized loss on securities of $<ix:nonFraction unitRef="usd" contextRef="i080887d60f0940a59368f26c445c633c_D20190701-20190929" decimals="-8" sign="-" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnSecurities" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTA5Mw_1c666174-c64d-47b1-82fd-2fce68bba144">0.1</ix:nonFraction>&#160;billion in the fiscal third quarter of 2019. Includes an unrealized gain on securities of $<ix:nonFraction unitRef="usd" contextRef="i5bdc0915d2ea4d4ebcf9bd0941e693ad_D20181231-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnSecurities" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTIwMg_6a2707ac-2d80-4413-8d6f-a56ddfe16360"><ix:nonFraction unitRef="usd" contextRef="ia7d6c21b42a6409195bfc194bb649b2d_D20191230-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnSecurities" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTIwMg_8b1cb51e-16d4-4aa4-91f2-30e40da3a000">0.2</ix:nonFraction></ix:nonFraction>&#160;billion in both the fiscal nine months of 2020 and 2019, respectively. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a research and development expense of $<ix:nonFraction unitRef="usd" contextRef="ie736ef5792a9408d9d187416e6bf80ae_D20181231-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTM2MA_9c1c44af-855d-47cf-84ef-b63665923b82">0.3</ix:nonFraction> billion in the fiscal nine months of 2019, for an upfront payment related to argenx. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i080887d60f0940a59368f26c445c633c_D20190701-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTQzOA_0b3d6f8e-9674-4ff9-8345-3f7fc948bacd"><ix:nonFraction unitRef="usd" contextRef="i52dbcdb545674f538361e9912a01a050_D20200629-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTQzOA_523ccaea-9edb-47fc-ad54-4fb60a59be9f">0.8</ix:nonFraction></ix:nonFraction> billion in both the fiscal third quarters of 2020 and 2019. Includes amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i5bdc0915d2ea4d4ebcf9bd0941e693ad_D20181231-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTUyNw_3d1b6f6e-0e70-4dd5-bab4-d50c7cb27b04"><ix:nonFraction unitRef="usd" contextRef="ia7d6c21b42a6409195bfc194bb649b2d_D20191230-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTUyNw_f9ad5edc-5d44-4267-b9b3-f713731720da">2.4</ix:nonFraction></ix:nonFraction>&#160;billion in both the fiscal nine months of 2020 and 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a restructuring related charge of $<ix:nonFraction unitRef="usd" contextRef="i5bdc0915d2ea4d4ebcf9bd0941e693ad_D20181231-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzY5NjU4MTM5OTcwNA_0c2d5d88-578b-4c5e-bf12-29d716cdf2d4"><ix:nonFraction unitRef="usd" contextRef="ia7d6c21b42a6409195bfc194bb649b2d_D20191230-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzY5NjU4MTM5OTcwNA_6ca0fdb0-dd35-49bf-9fe2-be7af8ef12d0">0.1</ix:nonFraction></ix:nonFraction>&#160;billion in both the fiscal nine months of 2020 and 2019, respectively. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes Actelion acquisition related costs of $<ix:nonFraction unitRef="usd" contextRef="i5bdc0915d2ea4d4ebcf9bd0941e693ad_D20181231-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AcquisitionCosts" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzY5NjU4MTM5OTg1MA_88ae87ab-b669-44dc-9d81-033e3d7f1b5c">0.1</ix:nonFraction>&#160;billion in the fiscal nine months of 2019. </span></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><ix:continuation id="i2c8aca81014f43688a1e815210d6f3fb"><ix:continuation id="i85a43e9193374d1481744a9e7eced0c5" continuedAt="i2ffe8651c746489c96c63aaa6a2c3432"><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">In the fiscal second and third quarters of 2020, the Company entered into a series of contract manufacturing arrangements for vaccine production with third party contract manufacturing organizations. These arrangements provide the Company with future supplemental commercial capacity for vaccine production and potentially transferable rights to such production if capacity is not required. Amounts paid and contractually obligated to be paid to these contract manufacturing organizations of approximately $<ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-8" format="ixt:numdotdecimal" name="jnj:AmountPrepaidAndDueToManufacturers" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTA5OTUxMTYyODcwOTc_5d446118-e0af-44f1-aa17-1ef20e9312d6">0.8</ix:nonFraction>&#160;billion are reflected in the prepaid expenses and other, other assets, accrued liabilities and other liabilities accounts in the Company's consolidated balance sheet upon execution of each agreement. Additionally, the Company has entered into certain vaccine development cost sharing arrangements with government related organizations. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:96%;"> </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(3) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Medical Devices </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a contingent consideration reversal of $<ix:nonFraction unitRef="usd" contextRef="iaa10b3392f3547b5aa32d11feeed9344_D20200629-20200927" decimals="-8" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfODI0NjMzNzIxNTA1NA_a6229bdf-a6c4-4e13-9234-6764a4ff6e77">0.2</ix:nonFraction>&#160;billion in the fiscal third quarter of 2020 and $<ix:nonFraction unitRef="usd" contextRef="i47a7c165a7d648d29d77c01df838e0c8_D20191230-20200927" decimals="-8" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMjU1Nw_814151fd-277f-4a75-a314-11f57f0d3973">1.1</ix:nonFraction> billion in the fiscal nine months of 2020 related to the timing of certain developmental milestones associated with the Auris Health acquisition. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a gain of $<ix:nonFraction unitRef="usd" contextRef="i93f441a7dbae4cb0928cf691ada790e5_D20181231-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMjcxNg_4b6e1146-1855-487e-b2f9-d2eafbd32d13">2.0</ix:nonFraction>&#160;billion from the divestiture of the ASP business in the fiscal nine months of 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes litigation expense of $<ix:nonFraction unitRef="usd" contextRef="i33ce4e97b0f24651ad32677d55f5fc93_D20181231-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMjg1MQ_7406fc34-9177-442f-8665-43aaef4e80dd">0.3</ix:nonFraction>&#160;billion in the fiscal nine months of 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a restructuring related charge of $<ix:nonFraction unitRef="usd" contextRef="i2ef0bd79dd674186aa6f73f88e7a8163_D20200629-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMjk3MQ_38ad1241-a6ca-4520-aa30-7d9cae141deb"><ix:nonFraction unitRef="usd" contextRef="i444727e6684545a7a9f22d74975fa1b6_D20190701-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMjk3MQ_982a76cd-1c3e-43e4-9bfd-6580d77e658a">0.1</ix:nonFraction></ix:nonFraction> billion and amortization expense of $<ix:nonFraction unitRef="usd" contextRef="if32c09ac0b5647a1ad0e4dc7ce139472_D20190701-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMzAwMg_00ebe624-4714-4044-9858-6902d85afcc2"><ix:nonFraction unitRef="usd" contextRef="i091d9a98d2f448dda83641c2c3ce380a_D20200629-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMzAwMg_a7c63789-14a6-4800-8eaa-11ca2db25c3d">0.2</ix:nonFraction></ix:nonFraction> billion in both the fiscal third quarters of 2020 and 2019.  </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a restructuring related charge of $<ix:nonFraction unitRef="usd" contextRef="i33ce4e97b0f24651ad32677d55f5fc93_D20181231-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMzEwMg_3271b35b-9caa-4ca4-87c2-b3c71ea69ced"><ix:nonFraction unitRef="usd" contextRef="ic80539fe5fa44b869a360326b6dee52a_D20191230-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMzEwMg_df2919d6-a673-4ca6-890e-933f51016077">0.2</ix:nonFraction></ix:nonFraction>&#160;billion and amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i4126d8e6b9664efda5bedc99ff1ad067_D20191230-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMzEzMw_2b27b13a-deb8-4f6c-926c-59013802541a"><ix:nonFraction unitRef="usd" contextRef="i1e561884e759475b9165f1413e1beae5_D20181231-20190929" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMzEzMw_3866195c-b2f7-43b7-bd12-c0ad61beabbc">0.7</ix:nonFraction></ix:nonFraction>&#160;billion in both the fiscal nine months of 2020 and 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes an in-process research and development expense of $<ix:nonFraction unitRef="usd" contextRef="i091d9a98d2f448dda83641c2c3ce380a_D20200629-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfODI0NjMzNzIxNDg2Ng_bdd5a229-432c-4948-bf61-9a6e4383ec1e"><ix:nonFraction unitRef="usd" contextRef="i4126d8e6b9664efda5bedc99ff1ad067_D20191230-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfODI0NjMzNzIxNDg2Ng_c9868d55-9b48-4223-9565-ab639001cf9f">0.1</ix:nonFraction></ix:nonFraction>&#160;billion in the fiscal third quarter of 2020 and fiscal nine months of 2020. </span></div></ix:continuation><div><span><br/></span></div><div style="margin-bottom:10pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"><ix:continuation id="i2ffe8651c746489c96c63aaa6a2c3432" continuedAt="i483800e1c18147e898572a240adc8105">(4)</ix:continuation></sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i483800e1c18147e898572a240adc8105"> Amounts not allocated to segments include interest income/expense and general corporate income/expense.</ix:continuation> </span></div><div style="margin-bottom:10pt;"><span><br/></span></div><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMzM0MQ_2aa1a20e-c75b-40f1-9763-b5fc5b21e7b8" escape="true"><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">SALES BY GEOGRAPHIC AREA</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.275%;"><tr><td style="width:1.0%;"></td><td style="width:32.038%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.529%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.994%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.529%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.410%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.529%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.243%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.821%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.994%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.821%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.410%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.529%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.253%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c18e167d7fe4b04a6ac423556324888_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMi0yLTEtMS0w_047b5a0c-15f4-485e-9d8f-b6e3c2f34f5d">11,086</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i708014e4e6e44faf8244b75bda858331_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMi00LTEtMS0w_a208bdd2-7039-4d82-905e-0fcc5ad79924">10,791</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i4c18e167d7fe4b04a6ac423556324888_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMi02LTEtMS0w_515d08f5-70eb-4d50-88d4-18e6ba241d35">2.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie499303b87b94c58b5bfac0841a99079_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMi04LTEtMS0w_885da1c6-0444-485b-8250-12273ebafa1a">31,324</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia7c244381d0c4963b4d71699e772e533_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMi0xMC0xLTEtMA_65ccd5ac-c16b-4670-8da6-6f9a17d2b5be">31,323</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ie499303b87b94c58b5bfac0841a99079_D20191230-20200927" decimals="3" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMi0xMi0xLTEtMA_f7b695e3-f1ee-4d1d-896d-b1bf2acdc4c9">0.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Europe</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4048e18828d34f3daefe8f21a5eb3078_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMy0yLTEtMS0w_f29870c0-10ff-48d8-91ba-3c8f25b4681c">4,819</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i390edd640d8a484e89238123183ad634_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMy00LTEtMS0w_7ebfc64d-5665-41e7-8e4c-8943804e9b11">4,461</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i4048e18828d34f3daefe8f21a5eb3078_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMy02LTEtMS0w_6d84b352-deb6-4532-8411-7d8ec490b600">8.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic337c3dd3159462ebc2978ca7661b3b5_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMy04LTEtMS0w_25f7499a-8aad-4bc5-8808-f114c4464c76">13,709</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5e8913d91dfd40939075cfdac19606a5_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMy0xMC0xLTEtMA_bd356a8c-cf95-42ac-887d-bd675221ffcc">13,803</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ic337c3dd3159462ebc2978ca7661b3b5_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMy0xMi0xLTEtMA_13cf1370-f128-4c6e-ad74-edf8d36b2993">0.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Western Hemisphere, excluding U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i02c1a908c32b4cb8a265199c069d86b6_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNC0yLTEtMS0w_22c9ed9a-7e33-4b4a-8f5e-c4f43b3299c5">1,296</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia292ce2a3c634451b0fd283ea27bc5cc_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNC00LTEtMS0w_5b1a3652-8b9f-462c-82fe-57da41d16838">1,488</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i02c1a908c32b4cb8a265199c069d86b6_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNC02LTEtMS0w_34085a0c-e2db-4bed-b779-a14dd317be38">12.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id25c49104c0e46f0bbff08ef9bf0330f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNC04LTEtMS0w_5430bcda-e96b-4f35-b9a9-6feb21317d25">3,931</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i875527922e5949c8a80b0260e40653b8_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNC0xMC0xLTEtMA_2908ce43-69ee-4ae1-906c-ef943ecab9fa">4,446</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="id25c49104c0e46f0bbff08ef9bf0330f_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNC0xMi0xLTEtMA_32bb3ce5-2a3c-469a-8a3a-aaf948bfbb11">11.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asia-Pacific, Africa</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67ea74e368284b5383248520a5e39f2a_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNS0yLTEtMS0w_e625ef33-3e49-49a6-80eb-036d9811b32f">3,881</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifb167b63c624424bb3e66daffa308d4b_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNS00LTEtMS0w_04fb4677-e459-4954-aa57-2c824e52ab05">3,989</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i67ea74e368284b5383248520a5e39f2a_D20200629-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNS02LTEtMS0w_bc483051-f3c4-4a7e-9c68-901f17172992">2.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i557d36686f0d404b8f74fbd282b65bac_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNS04LTEtMS0w_2c888768-25ff-4c26-acd6-5fe3e1f8839b">11,145</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2e7337ef99574e5ab6458deb6e8bb89b_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNS0xMC0xLTEtMA_c6bacb8c-e0ba-4ef2-8945-ec90ab73f432">11,740</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i557d36686f0d404b8f74fbd282b65bac_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNS0xMi0xLTEtMA_31a118dc-b224-4683-9bee-038adbe4352e">5.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNi0yLTEtMS0w_c7d3af79-2961-485f-83aa-3a7480ddde4c">21,082</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNi00LTEtMS0w_13f7d125-ce04-4765-8ba2-ad36a6894d12">20,729</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927" decimals="3" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNi02LTEtMS0w_214da28d-d331-48d3-8822-2597acf85ec6">1.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNi04LTEtMS0w_51ae2da1-2ed8-49b9-b1ab-418fbc70b634">60,109</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNi0xMC0xLTEtMA_375ec43c-065c-43bd-8cf9-5fc55c099859">61,312</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" decimals="3" sign="-" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNi0xMi0xLTEtMA_ca31902e-aa4e-41db-92dd-482bb8972f8c">2.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">28</span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 10&#8212; <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNjA1Nw_8750c616-8ec3-4b60-afa2-3c1db7d067b2" continuedAt="i9b5cea4ba5b74460b1d10e56acace1a5" escape="true">BUSINESS COMBINATIONS AND DIVESTITURES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i9b5cea4ba5b74460b1d10e56acace1a5" continuedAt="i68aed858695948e6a3b63f0c595c32ca"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Subsequent to the fiscal third quarter, on October 1, 2020, the Company completed the acquisition of Momenta Pharmaceuticals, Inc. (Momenta) a company that discovers and develops novel therapies for immune-mediated diseases, for a purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="ia0178d1d89bd4d1a9069a8e871ea628f_D20201001-20201001" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTY0OTI2NzQ0OTQ5Ng_5587fdec-3669-4dab-86a6-8f3742e07a49">6.5</ix:nonFraction>&#160;billion, primarily allocated to IPR&amp;D. In the fiscal fourth quarter of 2020, the transaction will be accounted for as a business combination and included in the Pharmaceutical segment. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the fiscal third quarter of  2020, the Company sold <ix:nonFraction unitRef="shares" contextRef="i5e557174a06c44d49bfcc86bb2b3d0fd_D20200629-20200927" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTE1_07b5448d-7f9e-4614-8cf7-5ff17af66700">11.8</ix:nonFraction>&#160;million shares of Idorsia LTD (Idorsia), or its <ix:nonFraction unitRef="number" contextRef="i5e557174a06c44d49bfcc86bb2b3d0fd_D20200629-20200927" decimals="3" name="us-gaap:SaleOfStockPercentageOfOwnershipBeforeTransaction" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTYw_2e6bc028-c1f0-42bd-8e83-7bc9b14b2ea4">8.3</ix:nonFraction>% ownership in the company. The transaction resulted in gross proceeds of approximately CHF<ix:nonFraction unitRef="chf" contextRef="i5e557174a06c44d49bfcc86bb2b3d0fd_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjkx_16082f2b-647f-40cb-8d05-1162a09af1ae">337</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="i5e557174a06c44d49bfcc86bb2b3d0fd_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjk1_7b864360-eaea-4059-bfc4-76289325a536">357</ix:nonFraction>&#160;million) based on a sales price of CHF <ix:nonFraction unitRef="chfPerShare" contextRef="i88a026e754eb416abcce4c71f9725a45_I20200927" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMzI5_028b7a93-866b-4fb4-9c43-4f8545f165b7">28.55</ix:nonFraction>/share and an immaterial net loss. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company currently has rights to at least an additional <ix:nonFraction unitRef="shares" contextRef="i5e557174a06c44d49bfcc86bb2b3d0fd_D20200629-20200927" decimals="-5" format="ixt:numdotdecimal" name="jnj:EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDAw_b16cf9e9-0504-42a2-9396-25cd4f4f23a8">38.7</ix:nonFraction>&#160;million shares (or approximately <ix:nonFraction unitRef="number" contextRef="i5e557174a06c44d49bfcc86bb2b3d0fd_D20200629-20200927" decimals="2" name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDI4_efb431af-a31f-4ed9-80e9-b5f91f10b87b">20</ix:nonFraction>% of Idorsia equity) through a convertible loan with a principal amount of CHF <ix:nonFraction unitRef="chf" contextRef="ifb9d663934dc4e77a2227f263e7e9b90_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNTA4_0c3f424b-acbc-4528-aec0-a022156c3e5d">445</ix:nonFraction>&#160;million (due June 2027). Idorsia also has access to an approximate CHF <ix:nonFraction unitRef="chf" contextRef="i39abb4a782c7412fb74f873a3b89e52c_I20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNTc0_6ce42720-0c16-4c9b-8ddf-7d6a459d399d">243</ix:nonFraction>&#160;million credit facility with the Company. As of September 27, 2020, Idorsia has not made any draw-downs under the credit facility.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the fiscal first quarter of 2020, the Company completed the acquisition of all rights to the investigational compound bermekimab, which has multiple dermatological indications, along with certain employees from XBiotech Inc., for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i1cc26d706e3948b0839e40d3e0521660_D20191230-20200329" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfOTU1_9ed8e14d-1565-494b-9ebe-986b82a99db3">0.8</ix:nonFraction> billion. The fair value of the acquisition was allocated primarily to non-amortizable intangible assets, primarily IPR&amp;D, for $<ix:nonFraction unitRef="usd" contextRef="i514e624a05cb4ac3b06eb3d5591e1ae9_I20200329" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTA3Ng_98a01361-4213-4752-a60e-4c3c79ded5a5">0.8</ix:nonFraction> billion. XBiotech may be eligible to receive additional payments upon the receipt of certain commercialization authorizations. The transaction was accounted for as a business combination and included in the Pharmaceutical segment. Additionally, the Company completed the acquisition of all outstanding shares in Verb Surgical Inc., a company with world-class robotics and data science capabilities, including those shares previously held by Verily. The transaction was accounted for as a business combination and included in the Medical Devices segment. The fair value of the acquisition was allocated primarily to non-amortizable intangible assets, primarily IPR&amp;D, for $<ix:nonFraction unitRef="usd" contextRef="i6fe29d550e3c4c2ba9f8054b3e1472ce_I20200329" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTc0Mg_30ca3f08-888e-4c49-a687-49d7d666a970">0.4</ix:nonFraction> billion, goodwill for $<ix:nonFraction unitRef="usd" contextRef="i6fe29d550e3c4c2ba9f8054b3e1472ce_I20200329" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTc1OQ_391d2ca7-5a20-49f4-942d-3d92f7b78fe1">0.2</ix:nonFraction> billion, other assets of $<ix:nonFraction unitRef="usd" contextRef="i6fe29d550e3c4c2ba9f8054b3e1472ce_I20200329" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTc3OQ_fad5dc04-39aa-4736-bc9c-2ed1b8daff91">0.2</ix:nonFraction> billion and liabilities assumed of $<ix:nonFraction unitRef="usd" contextRef="i6fe29d550e3c4c2ba9f8054b3e1472ce_I20200329" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTgwOQ_3f997196-3e04-46ba-9dfc-027c69bce35a">0.3</ix:nonFraction> billion. The fair value of the Company's previously held equity investment in Verb Surgical Inc. was $<ix:nonFraction unitRef="usd" contextRef="i6fe29d550e3c4c2ba9f8054b3e1472ce_I20200329" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTkwNQ_28c5af0f-cfaf-42f4-9cb8-3590ff819f09">0.4</ix:nonFraction> billion. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On April 1, 2019, the Company completed the divestiture of its ASP business to Fortive Corporation for an aggregate value of approximately $<ix:nonFraction unitRef="usd" contextRef="i80809b7f6de042b2930962754b585f17_I20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjA1MA_1fcf42cf-1aa2-498c-8087-faba4dc5243f">2.8</ix:nonFraction>&#160;billion, consisting of $<ix:nonFraction unitRef="usd" contextRef="i80809b7f6de042b2930962754b585f17_I20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCash" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjA2OA_b1ebdc84-a8dc-4a7b-8da2-f5bc8b309908">2.7</ix:nonFraction>&#160;billion of cash proceeds and $<ix:nonFraction unitRef="usd" contextRef="i80809b7f6de042b2930962754b585f17_I20190401" decimals="-8" format="ixt:numdotdecimal" name="jnj:DisposalGroupIncludingDiscontinuedOperationReceivablesRetained" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjA5Mg_a4eee08d-461b-42e7-8f05-8b4a1f011308">0.1</ix:nonFraction>&#160;billion of retained net receivables.  The Company recognized a pre-tax gain recorded in Other (income) expense, net, of approximately $<ix:nonFraction unitRef="usd" contextRef="i6f42cd49f093497bb053a9863a95db49_D20190401-20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjIyMQ_63574175-35cb-415c-b92b-b83af06742a3">2.0</ix:nonFraction>&#160;billion.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On April 1, 2019, the Company&#160;completed the acquisition of Auris Health, Inc. for approximately $<ix:nonFraction unitRef="usd" contextRef="i88ab1a165c864c2099402645c6315d0f_D20190401-20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjMyMg_5193f922-f695-4494-a6c1-eddd5aa6570e">3.4</ix:nonFraction> billion, net of cash acquired. Additional contingent payments of up to $<ix:nonFraction unitRef="usd" contextRef="ie7bbcc036f7349cb94794a2287751afb_I20190401" decimals="-7" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjM4OA_871cfb66-dd56-406d-8ce1-8d017974cff3">2.35</ix:nonFraction> billion, in the aggregate, may be payable upon reaching certain predetermined milestones. Auris Health was a privately held developer of robotic technologies, initially focused in lung cancer, with an FDA-cleared platform currently used in bronchoscopic diagnostic and therapeutic procedures. The Company treated this transaction as a business combination and included it in the Medical Devices segment. The fair value of the acquisition was allocated primarily to amortizable and non-amortizable intangible assets, primarily IPR&amp;D, for $<ix:nonFraction unitRef="usd" contextRef="ie7bbcc036f7349cb94794a2287751afb_I20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjkyMA_7ceea8c5-a3a1-4aa9-9469-e3eccd3f7428">3.0</ix:nonFraction> billion, goodwill for $<ix:nonFraction unitRef="usd" contextRef="ie7bbcc036f7349cb94794a2287751afb_I20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjkzNw_23c02392-05f0-49c6-89f6-762fbc77c0de">2.0</ix:nonFraction> billion, marketable securities of $<ix:nonFraction unitRef="usd" contextRef="ie7bbcc036f7349cb94794a2287751afb_I20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjk2Ng_58a02c04-93ed-4222-86b9-ec190a2109fc">0.2</ix:nonFraction> billion and liabilities assumed of $<ix:nonFraction unitRef="usd" contextRef="ie7bbcc036f7349cb94794a2287751afb_I20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjk5Ng_aee7732b-6b2b-41c1-8e77-c8d7206d2fef">1.8</ix:nonFraction> billion, which includes the fair value of the contingent payments mentioned above. During the fiscal second quarter of 2020, the Company finalized the purchase price allocation.  During the fiscal nine months of 2020, the Company recorded Other income of approximately $<ix:nonFraction unitRef="usd" contextRef="ibf3d6533ad0042b69ef23b269adffb17_D20191230-20200927" decimals="-8" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMzMyNQ_a6d30a48-855d-4a75-bd24-2906409803c9">1.1</ix:nonFraction> billion for the reversal of all of the contingent consideration related to the timing of certain developmental and commercial milestones, which are not expected to be met based on the Company&#8217;s current timelines. During the fiscal third quarter of 2020, the Company recorded a partial IPR&amp;D impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i24e7ef5b16d34adf9098ddac81e8905a_D20200629-20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTA5OTUxMTYyODU4NTE_86d938da-316f-4839-b876-d7b092bed54b">0.1</ix:nonFraction>&#160;billion related to timing and progression of the digital surgery platforms.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 17, 2019, the Company acquired DR. CI:LABO, a Japanese company focused on the marketing, development and distribution of a broad range of dermocosmetic, cosmetic and skincare products for a total purchase price of approximately &#165;<ix:nonFraction unitRef="jpy" contextRef="ic5e8b6d3c30e45ffaa54a4a9227592ed_D20190117-20190117" decimals="-9" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDA0Nw_9e0e4029-8fc7-4ec1-9afe-47467b9a5ea6">230</ix:nonFraction> billion, which equates to approximately $<ix:nonFraction unitRef="usd" contextRef="ic5e8b6d3c30e45ffaa54a4a9227592ed_D20190117-20190117" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDA4Mg_0d5377fd-b341-46e2-b3a3-cbe75b152bd1">2.1</ix:nonFraction> billion, using the exchange rate of <ix:nonFraction unitRef="number" contextRef="ia0d30897acc34d6aa8fc665dca7ddd1c_I20190116" decimals="2" name="us-gaap:ForeignCurrencyExchangeRateTranslation1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDExMw_5356f26d-1e86-4e30-84ec-13536a3cd1d2">109.06</ix:nonFraction> Japanese Yen to each U.S. Dollar on January 16, 2019. Additionally, in the fiscal first quarter of 2019, the Company recognized a pre-tax gain recorded in Other (income) expense, net, of approximately $<ix:nonFraction unitRef="usd" contextRef="i273f8b995c6b4f499a8b328d60523fbe_D20181231-20190331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDMxNw_258d9de8-9c1d-4ab3-98a6-df8bdca6347d">0.3</ix:nonFraction> billion related to the Company's previously held equity investment in DR. CI:LABO. </span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company treated this transaction as a business combination and included it in the Consumer Health segment. During the fiscal first quarter of 2020, the Company finalized the purchase price allocation. The fair value of the acquisition was allocated primarily to amortizable intangible assets for $<ix:nonFraction unitRef="usd" contextRef="ia56f405e259a45239a2888912d6a9972_I20200329" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDY5Nw_53bfb8c9-db46-4673-920d-2d552ae2f594">1.5</ix:nonFraction> billion, goodwill for $<ix:nonFraction unitRef="usd" contextRef="ia56f405e259a45239a2888912d6a9972_I20200329" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDcxNA_d8124d6b-21ad-49dc-8056-3396481bc02d">1.2</ix:nonFraction> billion and liabilities assumed of $<ix:nonFraction unitRef="usd" contextRef="ia56f405e259a45239a2888912d6a9972_I20200329" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDc0NA_8cec488d-1321-4fef-9240-91650c69ec91">0.4</ix:nonFraction> billion. The adjustments made since the date of acquisition were $<ix:nonFraction unitRef="usd" contextRef="ia56f405e259a45239a2888912d6a9972_I20200329" decimals="-8" format="ixt:numdotdecimal" name="jnj:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDgwNA_3f04864b-ee13-4ed8-adc6-8e534df744c5">0.1</ix:nonFraction> billion to intangible assets, accrued liabilities, deferred taxes on income and property, plant and equipment with the offset to goodwill. The amortizable intangible assets were comprised of brand/trademarks and customer relationships with a weighted average life of <ix:nonNumeric contextRef="i0ba1319bb59843d6a0cf051fb471834a_D20191230-20200329" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNTA2Ng_0f649a3e-be01-40d1-baf4-130f425ee752">15.3</ix:nonNumeric> years. The goodwill is primarily attributable to synergies expected to arise from the business acquisition and is not expected to be deductible for tax purposes.</span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i68aed858695948e6a3b63f0c595c32ca">During the fiscal third quarter of 2018, the Company accepted a binding offer to form a strategic collaboration with Jabil Inc., one of the world&#8217;s leading manufacturing services providers for health care products and technology products.&#160;The Company is expanding a 12-year relationship with Jabil Inc. to produce a range of products within the Ethicon Endo-Surgery and DePuy Synthes businesses. This transaction includes the transfer of certain employees and manufacturing sites. The majority of the transfers were completed in 2019 with a minor amount remaining in 2020.&#160;As of September 27, 2020, the assets held for sale on the Consolidated Balance Sheet were $<ix:nonFraction unitRef="usd" contextRef="ia2b1e0bfe69940ce9a25d129f9820402_I20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNTg4NA_c2b3a384-f07b-4d3a-9a1c-2a535e497774">0.1</ix:nonFraction> billion of inventory and property, plant and equipment, net. For additional details on the global supply chain restructuring see Note 12 to the Consolidated Financial Statements.</ix:continuation></span></div><div><span><br/></span></div><div id="ief97c24c8c144887ab2ad376fc457d4d_91"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 11 &#8212; <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfODg3MTQ_6b968899-f294-4475-a814-d38efadcdaae" continuedAt="ic4794c924d60427c906511895237ad54" escape="true">LEGAL PROCEEDINGS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ic4794c924d60427c906511895237ad54" continuedAt="i998e2e3f7468453a908bc2e4783a24fe"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Johnson &amp; Johnson and certain of its subsidiaries are involved in various lawsuits and claims regarding product liability; intellectual property; commercial; supplier indemnification and other matters; governmental investigations; and other legal proceedings that arise from time to time in the ordinary course of their business. Due to the ongoing impacts of the COVID-19 pandemic, certain trials have been rescheduled or delayed.  The Company continues to monitor its legal proceedings as the situation evolves.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred, and the amount of the loss can be reasonably estimated. As of September&#160;27, 2020, the Company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated. The Company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with ASC 450-20-25. For these and other litigation and regulatory matters discussed below for which a loss is probable or reasonably possible, the Company is unable to estimate the possible loss or range of loss beyond the amounts already accrued. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions including timing of related payments. The ability to make such estimates and judgments can be affected by various factors including, among other things, whether damages sought in the proceedings are unsubstantiated or indeterminate; scientific and legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; procedural or jurisdictional issues; the uncertainty and unpredictability of the number of potential claims; ability to achieve comprehensive multi-party settlements;  complexity of related cross-claims and counterclaims; and/or there are numerous parties involved. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's balance sheet, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of, or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company's results of operations and cash flows for that period.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">PRODUCT LIABILITY</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Johnson &amp; Johnson and certain of its subsidiaries are involved in numerous product liability claims and lawsuits involving multiple products. Claimants in these cases seek substantial compensatory and, where available, punitive damages. While the Company believes it has substantial defenses, it is not feasible to predict the ultimate outcome of litigation. From time to time, even if it has substantial defenses, the Company considers isolated settlements based on a variety of circumstances. The Company has established accruals for product liability claims and lawsuits in compliance with ASC 450-20 based on currently available information, which in some cases may be limited. The Company accrues an estimate of the legal defense costs needed to defend each matter when those costs are probable and can be reasonably estimated. For certain of these matters, the Company has accrued additional amounts such as estimated costs associated with settlements, damages and other losses. Product liability accruals can represent projected product liability for thousands of claims around the world, each in different litigation environments and with different fact patterns. Changes to the accruals may be required in the future as additional information becomes available.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The most significant of these cases include: the DePuy ASR&#8482; XL Acetabular System and DePuy ASR&#8482; Hip Resurfacing System; the PINNACLE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Acetabular Cup System; pelvic meshes; RISPERDAL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; body powders containing talc, primarily JOHNSONS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Baby Powder; INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; and ETHICON PHYSIOMESH</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Flexible Composite Mesh. As of September&#160;27, 2020, in the United States there were approximately <ix:nonFraction unitRef="claimant" contextRef="i0b429fd585e64f27b994198388c6251a_I20200927" decimals="INF" name="jnj:ProductLiabilityContingencyNumberOfClaimant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNDQ2MA_21bc8713-07b9-4214-8bc6-f17f21b1d018">600</ix:nonFraction> plaintiffs with direct claims in pending lawsuits regarding injuries allegedly due to the DePuy ASR&#8482; XL Acetabular System and DePuy ASR&#8482; Hip Resurfacing System; <ix:nonFraction unitRef="claimant" contextRef="i0930560d9bb641e1bf17cd07a2da8aca_I20200927" decimals="INF" format="ixt:numdotdecimal" name="jnj:ProductLiabilityContingencyNumberOfClaimant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNDYyNA_38be2a8e-4fb3-4ec2-845b-5fe6e0e8cdab">8,200</ix:nonFraction> with respect to the PINNACLE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Acetabular Cup System; <ix:nonFraction unitRef="claimant" contextRef="i5f0486c287ba4a878933882831daf68c_I20200927" decimals="INF" format="ixt:numdotdecimal" name="jnj:ProductLiabilityContingencyNumberOfClaimant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNDY4MA_46438e25-03dc-4102-b8c4-dce0504c4095">15,400</ix:nonFraction> with respect to pelvic meshes; <ix:nonFraction unitRef="claimant" contextRef="icd9edb018cc04c2d919c3af6e6effdc2_I20200927" decimals="INF" format="ixt:numdotdecimal" name="jnj:ProductLiabilityContingencyNumberOfClaimant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNDcxNA_71881eae-1e54-4289-90da-78ac203dec78">10,400</ix:nonFraction> with respect to </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><ix:continuation id="i998e2e3f7468453a908bc2e4783a24fe" continuedAt="i25f630cd608f4fd1a3ab80644474a37b"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">RISPERDAL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; <ix:nonFraction unitRef="claimant" contextRef="ib10ac8fdffb7462695332fde36b80854_I20200927" decimals="INF" format="ixt:numdotdecimal" name="jnj:ProductLiabilityContingencyNumberOfClaimant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNDc0NQ_15b8aa80-8dac-432b-bbfa-cf800ff58528">15,000</ix:nonFraction> with respect to XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; <ix:nonFraction unitRef="claimant" contextRef="ic41bf8ae137a4af1b760ea9606804331_I20200927" decimals="INF" format="ixt:numdotdecimal" name="jnj:ProductLiabilityContingencyNumberOfClaimant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNDc3NA_4d49e4db-72d7-44a7-a487-4478073c44a7">21,800</ix:nonFraction> with respect to body powders containing talc; <ix:nonFraction unitRef="claimant" contextRef="i6c15628b0bdb4b959f8610f3fd7e5d48_I20200927" decimals="INF" name="jnj:ProductLiabilityContingencyNumberOfClaimant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNDgyMw_ecfaf879-0ba1-4c71-a85a-87df29ff36b3">300</ix:nonFraction> with respect to INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">;</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and <ix:nonFraction unitRef="claimant" contextRef="id21618e853834a89ac8ad0c7b9c482b7_I20200927" decimals="INF" format="ixt:numdotdecimal" name="jnj:ProductLiabilityContingencyNumberOfClaimant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNDg1OA_bed9eb92-8ea7-4565-a371-e44ff0469e7f">4,000</ix:nonFraction> with respect to ETHICON PHYSIOMESH</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Flexible Composite Mesh.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2010, DePuy Orthopaedics, Inc. (DePuy) announced a worldwide voluntary recall of its ASR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#8482;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> XL Acetabular System and DePuy ASR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#8482;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Hip Resurfacing System used in hip replacement surgery. Claims for personal injury have been made against DePuy and Johnson &amp; Johnson. The number of pending lawsuits is expected to fluctuate as certain lawsuits are settled or dismissed and additional lawsuits are filed. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Ohio. Litigation has also been filed in countries outside of the United States, primarily in the United Kingdom, Canada, Australia, Ireland, Germany, India and Italy. In November 2013, DePuy reached an agreement with a Court-appointed committee of lawyers representing ASR Hip System plaintiffs to establish a program to settle claims with eligible ASR Hip patients in the United States who had surgery to replace their ASR Hips, known as revision surgery, as of August 31, 2013. DePuy reached additional agreements in February 2015 and March 2017, which further extended the settlement program to include ASR Hip patients who had revision surgeries after August 31, 2013 and prior to February 15, 2017. This settlement program has resolved more than <ix:nonFraction unitRef="patient" contextRef="icb6f889e341146e590594ffb796f5067_I20200927" decimals="0" format="ixt:numdotdecimal" name="jnj:Numberofpatientsinsettlement" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNjI0OA_adbe63e7-3da8-4b58-becf-c7551d576d7c">10,000</ix:nonFraction> claims, therefore bringing to resolution significant ASR Hip litigation activity in the United States. However, lawsuits in the United States remain, and the settlement program does not address litigation outside of the United States. In Australia, a class action settlement was reached that resolved the claims of the majority of ASR Hip patients in that country. In Canada, the Company has reached agreements to settle two pending class actions which have been approved by the Qu&#233;bec Superior Court and the Supreme Court of British Columbia. The Company continues to receive information with respect to potential additional costs associated with this recall on a worldwide basis. The Company has established accruals for the costs associated with the United States settlement program and DePuy ASR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#8482;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Hip-related product liability litigation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Claims for personal injury have also been made against DePuy Orthopaedics, Inc. and Johnson &amp; Johnson (collectively, DePuy) relating to the PINNACLE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Acetabular Cup System used in hip replacement surgery.  Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Texas. Litigation has also been filed in some state courts and in countries outside of the United States.  Several adverse verdicts have been rendered against DePuy, one of which was reversed on appeal and remanded for retrial.  During the first quarter of 2019, DePuy established a United States settlement program to resolve these cases. As part of the settlement program, adverse verdicts have been settled. The Company has established an accrual for product liability litigation associated with the PINNACLE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Acetabular Cup System and the related settlement program.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Claims for personal injury have been made against Ethicon, Inc. (Ethicon) and Johnson &amp; Johnson arising out of Ethicon's pelvic mesh devices used to treat stress urinary incontinence and pelvic organ prolapse. The Company continues to receive information with respect to potential costs and additional cases. Cases filed in federal courts in the United States had been organized as a multi-district litigation (MDL) in the United States District Court for the Southern District of West Virginia. The MDL Court is remanding cases for trial to the jurisdictions where the case was originally filed and additional pelvic mesh lawsuits have been filed, and remain, outside of the MDL.  The Company has settled or otherwise resolved a majority of the United States cases and the estimated costs associated with these settlements and the remaining cases are reflected in the Company's accruals. In addition, class actions and individual personal injury cases or claims have been commenced in various countries outside of the United States, including claims and cases in the United Kingdom, the Netherlands, and class actions in Israel, Australia and Canada, seeking damages for alleged injury resulting from Ethicon's pelvic mesh devices.  In November 2019, the Federal Court of Australia issued a judgment regarding its findings with respect to liability in relation to the three Lead Applicants and generally in relation to the design, manufacture, pre and post-market assessments and testing, and supply and promotion of the devices in Australia used to treat stress urinary incontinence and pelvic organ prolapse. In March 2020, the Court entered damages awards to the three Lead Applicants. The Company is appealing the decision. With respect to other group members, there will be an individual case assessment process which will require proof of use and causally related loss.  The class actions in Canada are expected to be discontinued in 2020 as a result of a settlement of a group of cases. The Company has established accruals with respect to product liability litigation associated with Ethicon's pelvic mesh product</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">s. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Following a June 2016 worldwide market withdrawal of ETHICON PHYSIOMESH</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Flexible Composite Mesh, claims for personal injury have been made against Ethicon, Inc. and Johnson &amp; Johnson alleging personal injury arising out of the use of this hernia mesh device.&#160; Cases filed in federal courts in the United States have been organized as a multi-district litigation (MDL) in the United States District Court for the Northern District of Georgia. A multi-county litigation (MCL) has also been formed in New Jersey state court and assigned to Atlantic County for cases pending in New Jersey.  In addition to the matters in the MDL and MCL, there are additional lawsuits pending in the United States District Court for the Southern District of Ohio, which are part of the MDL for polypropylene mesh devices manufactured by C.R. Bard, Inc., and lawsuits pending outside the United States.   </span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><ix:continuation id="i25f630cd608f4fd1a3ab80644474a37b" continuedAt="i3c5fc616aa1c40398e179d2555eb9ecf"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">Claims have also been filed against Ethicon and Johnson &amp; Johnson alleging personal injuries arising from the PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> Mesh and PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> Ventral Patch hernia mesh products.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In March 2019, the New Jersey Supreme Court entered an order consolidating these cases pending in New Jersey as an MCL in Atlantic County Superior Court.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">Additional cases have been filed in various federal and state courts in the US, and in jurisdictions outside the US.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> The Company has established accruals with respect to product liability litigation associated with ETHICON PHYSIOMESH</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">Flexible Composite Mesh, PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> Mesh and PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> Ventral Patch products. In September 2019, plaintiffs&#8217; attorney filed an application with the New Jersey Supreme Court seeking centralized management of 107 PROLENE&#8482; Polypropylene Hernia System (&#8220;PHS&#8221;) cases.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">The New Jersey Supreme Court granted plaintiffs application in January 2020 and those cases have also been transferred to an MCL in Atlantic County Superior Court.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Claims for personal injury have been made against Janssen Pharmaceuticals, Inc. and Johnson &amp; Johnson arising out of the use of RISPERDAL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, and related compounds, indicated for the treatment of schizophrenia, acute manic or mixed episodes associated with bipolar I disorder and irritability associated with autism. Lawsuits have been primarily filed in state courts in Pennsylvania, California, and Missouri. Other actions are pending in various courts in the United States and Canada. Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has successfully defended a number of these cases but there have been verdicts against the Company, including a recent verdict in October 2019 of $<ix:nonFraction unitRef="usd" contextRef="iea72f2ed06994c33932765fa19c03cd3_D20190930-20191229" decimals="-9" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfMTMxNzc_817d00a8-f78e-4343-a7e5-5cfdab850ceb">8</ix:nonFraction> billion of punitive damages related to one single plaintiff which was subsequently reduced in January 2020 to $<ix:nonFraction unitRef="usd" contextRef="i488a067b9a194c0186abeac5734fa68b_D20191230-20200329" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfMTMyODI_e078e981-17fb-4b4d-92e5-9eb73b5560a7">6.8</ix:nonFraction> million by the trial judge. The Company and plaintiff are each appealing this judgment. The Company has settled or otherwise resolved many of the United States cases and the costs associated with these settlements are reflected in the Company's accruals.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Claims for personal injury arising out of the use of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, an oral anticoagulant, have been made against Janssen Pharmaceuticals, Inc. (JPI); Johnson &amp; Johnson (J&amp;J); and JPI&#8217;s collaboration partner for XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, Bayer AG and certain of its affiliates. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Eastern District of Louisiana. In addition, cases have been filed in state courts across the United States. Many of these cases have been consolidated into a state mass tort litigation in Philadelphia, Pennsylvania and in a coordinated proceeding in Los Angeles, California. Class action lawsuits also have been filed in Canada. In March 2019, JPI and J&amp;J announced an agreement in principle to the settle the XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> cases in the United States; the settlement agreement was executed in May 2019, the settlement became final in December 2019, and the settlement was funded in January 2020.  This resolved the majority of cases pending in the United States. The Company has established accruals for its costs associated with the United States settlement program and XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> related product liability litigation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Personal injury claims alleging that talc causes cancer have been made against Johnson &amp; Johnson Consumer Inc. and Johnson &amp; Johnson arising out of the use of body powders containing talc, primarily JOHNSON&#8217;S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Baby Powder.  The number of pending personal injury lawsuits continues to increase, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Lawsuits have been primarily filed in state courts in Missouri, New Jersey and California, and suits have also been filed outside the United States. The majority of cases are pending in federal court, organized into a multi-district litigation in the United States District Court for the District of New Jersey. In the multi-district litigation, the parties have sought to exclude experts, through Daubert motions.  In April 2020, the Court issued rulings that limit the scope of testimony, including some theories and testing methods, for certain plaintiff expert witnesses and denied  plaintiffs&#8217; attempt to limit the scope of testimony of certain of the Company&#8217;s witnesses.  With this ruling made, case-specific discovery has begun, per the court&#8217;s directive to proceed.  In talc cases that have previously gone to trial, the Company has obtained defense verdicts in a number of these cases but there have also been verdicts against the Company, many of which have been reversed on appeal.  Most recently, in June 2020, the Missouri Court of Appeals reversed in part and affirmed in part a July 2018 verdict of $<ix:nonFraction unitRef="usd" contextRef="i6ae80716a299488b87b2be5a3f4dbfb5_D20180701-20180731" decimals="-6" format="ixt:numdotdecimal" name="jnj:LossContingencyPreviousDamagesAwardedAndRevisedValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfMTYyNTA_735e856a-5e88-4833-a01f-20ae41197baf">4.7</ix:nonFraction>&#160;billion, reducing the overall award to $<ix:nonFraction unitRef="usd" contextRef="i06c65d19de8543ca8bdc65646de599c7_D20200601-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfMTYyODQ_6daa8a06-53e2-40c5-9bd5-7661f3d59516">2.1</ix:nonFraction>&#160;billion. The Company has filed an application for transfer of the case to the Missouri Supreme Court.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company continues to believe that it has strong grounds for the appeal of this verdict, as well as other verdicts that it has appealed. Notwithstanding the Company&#8217;s confidence in the safety of its talc products, in certain circumstances the Company has and may settle cases.  The Company has established an accrual for defense costs and reserves for settlement of certain cases and claims in connection with product liability litigation associated with body powders containing talc.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In February 2019, the Company&#8217;s talc supplier, Imerys Talc America, Inc. and two of its affiliates, Imerys Talc Vermont, Inc. and Imerys Talc Canada, Inc. (collectively, Imerys) filed a voluntary chapter 11 petition commencing a reorganization under the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (Imerys Bankruptcy).  The Imerys Bankruptcy relates to Imerys&#8217; potential liability for personal injury from exposure to talcum powder sold by Imerys (Talc Claims).  In its bankruptcy filing, Imerys noted certain claims it alleges it has against the Company for indemnification and rights to joint insurance proceeds.  Based on such claims as well as indemnity and insurance claims the Company has against Imerys, the Company petitioned the United States District Court for the District of Delaware to establish federal jurisdiction of the state court talc lawsuits under the Bankruptcy Code.  The Company's petition was denied and the state court talc lawsuits that have been removed to federal court on such basis have been remanded.  The Company previously proposed to resolve Imerys' (and the Company&#8217;s) obligations arising out of the Talc Claims by agreeing to assume the defense of litigation </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><ix:continuation id="i3c5fc616aa1c40398e179d2555eb9ecf" continuedAt="ic8f3974b3cf745429c3fc9526d577ca7"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">of all Talc Claims involving the Company's products, waiving the Company&#8217;s indemnification claims against Imerys, and lifting the automatic stay to enable the Talc Claims to proceed outside the bankruptcy forum with the Company agreeing to settle or pay any judgment against Imerys. In May 2020, Imerys and the asbestos claimants&#8217; committee filed their Plan of Reorganization and the Disclosure Statement related thereto agreeing to put its North American operations up for auction which was subsequently amended.  The Company has objected to the Disclosure Statement and intends to object to the Plan of Reorganization as currently structured. Additionally, in June 2020, Cyprus Mines Corporation and its parent filed an adversary proceeding against the Company as well as Imerys seeking a declaration of indemnity under certain contractual agreements.  The Company denies such indemnification is owed and filed a motion to dismiss the adversary complaint arguing, among other things, that the Court does not have subject matter jurisdiction over Cyprus&#8217;s claims against the Company.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">In February 2018, a securities class action lawsuit was filed against Johnson &amp; Johnson and certain named officers in the United States District Court for the District of New Jersey, alleging that Johnson &amp; Johnson violated the federal securities laws by failing to disclose alleged asbestos contamination in body powders containing talc, primarily JOHNSON'S&#174; Baby Powder, and that purchasers of Johnson &amp; Johnson&#8217;s shares suffered losses as a result.  Plaintiff is seeking damages. In April 2019, the Company moved to dismiss the complaint and briefing on the motion was complete as of August 2019.  In December 2019, the Court denied, in part, the motion to dismiss.  In March 2020, Defendants answered the complaint. Discovery is underway.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">In June 2019, a shareholder filed a complaint initiating a summary proceeding in New Jersey state court for a books and records inspection. In August 2019, Johnson &amp; Johnson responded to the books and records complaint and filed a cross motion to dismiss. In September 2019, Plaintiff replied and the Court heard oral argument. The Court has not yet ruled in the books and records action. In October 2019, December 2019, and January 2020, four shareholders filed four separate derivative lawsuits against Johnson &amp; Johnson as the nominal defendant and its current directors and certain officers as defendants in the United States District Court for the District of New Jersey, alleging a breach of fiduciary duties related to the alleged asbestos contamination in body powders containing talc, primarily JOHNSON&#8217;S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:99%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">Baby Powder, and that Johnson &amp; Johnson has suffered damages as a result of those alleged breaches. In February 2020, the four cases were consolidated into a single action under the caption </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:99%;">In re Johnson &amp; Johnson Talc Stockholder Derivative Litigation</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In July 2020, a report was delivered to the Company&#8217;s Board of Directors by independent counsel retained by the Board to investigate the allegations in the derivative lawsuits and in a series of shareholder letters that the Board received raising similar issues.  The independent counsel recommended that the Company reject the shareholder demands and take the steps that are necessary or appropriate to secure dismissal of the derivative lawsuits.  The Board unanimously adopted the recommendations of the independent counsel&#8217;s report.  Four of the shareholders who had sent demands are plaintiffs in th</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">e </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:103%;">In re Johnson &amp; Johnson Talc Stockholder Derivative Litigation</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">In January 2019, two ERISA class action lawsuits were filed by participants in the Johnson &amp; Johnson Savings Plan against Johnson &amp; Johnson, its Pension and Benefits Committee, and certain named officers in the United States District Court for the District of New Jersey, alleging that the defendants breached their fiduciary duties by offering Johnson &amp; Johnson stock as a Johnson &amp; Johnson Savings Plan investment option when it was imprudent to do so because of failures to disclose alleged asbestos contamination in body powders containing talc, primarily JOHNSON&#8217;S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> Baby Powder.  Plaintiffs are seeking damages and injunctive relief. In September 2019, Defendants filed a motion to dismiss. In April 2020, the Court granted Defendants&#8217; motion but granted leave to amend.  In June 2020, Plaintiffs filed an amended complaint, and in July 2020, Defendants moved to dismiss the amended complaint.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">A lawsuit is pending in the Superior Court of California for the County of San Diego alleging violations of California&#8217;s Consumer Legal Remedies Act relating to JOHNSON&#8217;S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> Baby Powder.  In that lawsuit, the plaintiffs allege that Johnson &amp; Johnson violated the CLRA by failing to provide required Proposition 65 warnings.  In July 2019, the Company filed a notice of removal to the United States District Court for the Southern District of California and plaintiffs filed a second amended complaint shortly thereafter.  In October 2019, the Company moved to dismiss the second amended complaint for failure to state a claim upon which relief may be granted.  In response to those motions, plaintiffs filed a third amended complaint.  In December 2019, the Company moved to dismiss the third amended complaint for failure to state a claim upon which relief may be granted.  In April 2020, the Court granted the motion to dismiss but granted leave to amend. In May 2020, plaintiffs filed a Fourth Amended Complaint but indicated that they would be filing a motion for leave to file a fifth amended complaint. Plaintiffs filed a Fifth Amended Complaint in August 2020. The Company moved to dismiss the Fifth Amended Complaint for failure to state a claim upon which relief may be granted.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In January 2020, the Abtahi Law Group filed an action under Proposition 65 against Johnson &amp; Johnson and Johnson &amp; Johnson Consumer Inc. as well as a number of other alleged talcum powder manufacturers and distributors, including one California company.  In that action, the plaintiff alleges contamination of talcum powder products with unsafe levels of arsenic, hexavalent chromium and lead.  The plaintiff seeks civil penalties and injunctive relief. The case has been stayed by the court pending an initial status conference.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In addition, the Company has received preliminary inquiries and subpoenas to produce documents regarding these matters from Senator Murray, a member of the Senate Committee on Health, Education, Labor and Pensions, the Department of Justice, the Securities and Exchange Commission and the U.S. Congressional Subcommittee on Economic and Consumer Policy.  The Company is cooperating with government inquiries and continues to produce documents as required in response. </span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><ix:continuation id="ic8f3974b3cf745429c3fc9526d577ca7" continuedAt="ifdd51813360c48bc8faf86d668b4f3b6"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Claims for personal injury have been made against a number of Johnson &amp; Johnson companies, including Janssen Pharmaceuticals, Inc. and Johnson &amp; Johnson, arising out of the use of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, a prescription medication indicated to improve glycemic control in adults with Type 2 diabetes. Lawsuits filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the District of New Jersey. Cases have also been filed in state courts. Class action lawsuits have been filed in Canada. Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has settled or otherwise resolved many of the cases and claims in the United States and the costs associated with these settlements are reflected in the Company's accruals.</span></div><div style="margin-bottom:10pt;"><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">INTELLECTUAL PROPERTY</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certain subsidiaries of Johnson &amp; Johnson are subject, from time to time, to legal proceedings and claims related to patent, trademark and other intellectual property matters arising out of their businesses. Many of these matters involve challenges to the coverage and/or validity of the patents on various products and allegations that certain of the Company&#8217;s products infringe the patents of third parties. Although these subsidiaries believe that they have substantial defenses to these challenges and allegations with respect to all significant patents, there can be no assurance as to the outcome of these matters. A loss in any of these cases could adversely affect the ability of these subsidiaries to sell their products, result in loss of sales due to loss of market exclusivity, require the payment of past damages and future royalties, and may result in a non-cash impairment charge for any associated intangible asset. The most significant of these matters are described below.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Medical Devices</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2016, MedIdea, L.L.C. (MedIdea) filed a patent infringement lawsuit against DePuy Orthopaedics, Inc. in the United States District Court for the Northern District of Illinois alleging infringement by the ATTUNE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Knee System. In April 2017, MedIdea filed an amended complaint adding DePuy Synthes Products, Inc. and DePuy Synthes Sales, Inc. as named defendants (collectively, DePuy).  MedIdea alleges infringement of United States Patent Nos. 6,558,426 (&#8217;426); 8,273,132 (&#8217;132); 8,721,730 (&#8217;730)   and 9,492,280 (&#8217;280) relating to posterior stabilized knee systems. Specifically, MedIdea alleges that the SOFCAM</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">TM</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Contact feature of the ATTUNE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> posterior stabilized knee products infringes the patents-in-suit. MedIdea is seeking monetary damages and injunctive relief. In June 2017, the case was transferred to the United States District Court for the District of Massachusetts.  A claim construction hearing was held in October 2018, and a claim construction order was issued in November 2018. In December 2018, MedIdea stipulated to non-infringement of the &#8217;132, &#8217;730 and &#8217;280 patents, based on the district court&#8217;s claim construction and reserving its right to appeal that construction, leaving only the &#8217;426 patent at issue before the district court. In May 2019, DePuy filed a motion for summary judgment of non-infringement of the claims of the &#8217;426 patent. In November 2019, judgment was entered in favor of DePuy.  In December 2019, MedIdea filed a notice of appeal and the appeal is fully briefed.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In December 2016, Ethicon Endo-Surgery, Inc. and Ethicon Endo-Surgery, LLC (now known as Ethicon LLC) sued Covidien, Inc. in the United States District Court for the District of Massachusetts seeking a declaration that United States Patent Nos. 6,585,735 (&#8217;735); 7,118,587; 7,473,253; 8,070,748 and 8,241,284 (&#8217;284), are either invalid or not infringed by Ethicon&#8217;s ENSEAL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> X1 Large Jaw Tissue Sealer product. In April 2017, Covidien LP, Covidien Sales LLC, and Covidien AG (collectively, Covidien) answered and counterclaimed, denying the allegations, asserting willful infringement of the &#8217;735 patent, the &#8217;284 patent and United States Patent Nos. 8,323,310 (&#8217;310); 9,084,608; 9,241,759 (&#8217;759) and 9,113,882, and seeking damages and an injunction. In June 2020, after a bench trial, the district court entered judgment in Ethicon&#8217;s favor.  In July 2020, Covidien filed a notice of appeal, and Ethicon filed a cross appeal.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In August 2020, the parties agreed to dismiss their respective appeals.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2016, Dr. Ford Albritton sued Acclarent, Inc. (Acclarent) in United States District Court for the Northern District of Texas alleging that Acclarent&#8217;s RELIEVA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Spin and RELIEVEA SpinPlus</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> products infringe U.S. Patent No. 9,011,412 (&#8217;412).  Dr. Albritton also alleges breach of contract, fraud and that he is the true owner of Acclarent&#8217;s U.S. Patent No. 8,414,473. Trial is scheduled to begin in March 2021.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2017, Board of Regents, The University of Texas System and TissueGen, Inc. (collectively, UT) filed a lawsuit in the United States District Court for the Western District of Texas against Ethicon, Inc. and Ethicon US, LLC (collectively, Ethicon) alleging the manufacture and sale of VICRYL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures, MONOCRYL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures, PDS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures, STRATAFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> PDS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Antibacterial Sutures and STRATAFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> MONOCRYL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Plus Antibacterial Sutures infringe plaintiffs&#8217; United States Patent Nos. 6,596,296 (&#8217;296) and 7,033,603 (&#8217;603) directed to implantable polymer drug releasing biodegradable fibers containing a therapeutic agent.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">UT is seeking damages and an injunction.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2018, Ethicon filed petitions with the United States Patent and Trademark Office (USPTO), seeking </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><ix:continuation id="ifdd51813360c48bc8faf86d668b4f3b6" continuedAt="i9a38d5bd33f6485884ee26f0e3308436"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Inter Partes Review (IPR) of both asserted patents. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2020, the USPTO denied institution of the &#8217;296 patent IPR and granted institution of the &#8217;603 patent IPR.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">UT dismissed the &#8217;603 patent from the suit and no longer accuses PDS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures or STRATAFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> PDS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures of infringement. The previously scheduled district court trial has been postponed.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> In August 2018, Intuitive Surgical, Inc. and Intuitive Surgical Operations, Inc. (collectively, Intuitive) filed a patent infringement suit against Auris Health, Inc. (Auris) in United States District Court for the District of Delaware.  In the suit, Intuitive alleges willful infringement of U.S. Patent Nos. 6,246,200 (&#8217;200); 6,491,701 (&#8217;701); 6,522,906 (&#8217;906); 6,800,056 (&#8217;056); 8,142,447 (&#8217;447); 8,620,473 (&#8217;473); 8,801,601 (&#8217;601); and 9,452,276 (&#8217;276) based on Auris&#8217; Monarch&#8482; Platform.  Auris filed IPR Petitions with the USPTO regarding the &#8217;200, &#8217;056, &#8217;601 &#8217;701, &#8217;447, &#8217;276 and &#8217;906 patents.   Intuitive subsequently dropped the &#8217;200, &#8217;473 and &#8217;701 patents from the suit.  In December 2019, the USPTO instituted review of the &#8217;601 patent and denied review of the &#8217;056 patent.  In February and March 2020, the USPTO instituted review of the &#8217;200, &#8217;447, &#8217;701 and &#8217;906 patents and denied review of the &#8217;276 patent.   The district court trial is scheduled to begin in June 2021.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In August 2019, RSB Spine LLC (RSB Spine) filed a patent infringement suit against DePuy Synthes, Inc. in United States District Court for the District of Delaware.  In October 2019, RSB Spine amended the complaint to change the named defendants to DePuy Synthes Sales, Inc. and DePuy Synthes Products, Inc.  In the suit, RSB Spine alleges willful infringement of United States Patent Nos. 6,984,234 and 9,713, 537 by one or more of the following products:  ZERO-P-VA&#8482; Spacer, ZERO-P</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Spacer, ZERO-P NATURAL&#8482; Plate, SYNFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> LR Spacer and SYNFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Evolution System.  RSB Spine seeks monetary damages and injunctive relief. In November 2019, the suit was consolidated for pre-trial purposes with other patent infringement suits brought by RSB Spine in the United States District Court for the District of Delaware against Life Spine, Inc., Medacta USA, Inc., Precision Spine, Inc., and Xtant Medical Holdings, Inc. In June 2020, the case was stayed pending IPR proceedings involving the asserted patents. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In March 2020, Osteoplastics, LLC filed a patent infringement suit against DePuy Synthes, Inc., DePuy Synthes Products, Inc., Medical Device Business Services, Inc., and Synthes, Inc. (collectively, DePuy Synthes)  in the United States District Court for the District of Delaware.  In the suit, Osteoplastics alleges willful infringement of U.S. Patent Nos. 8,781,557; 9,929,920; 9,330,206; 9,626,756; 9,672,617; 9,672,302; and 9,275,191 based on the PROPLAN CMF</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Virtual Surgical Planning Services and the TruMatch</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> CMF Personalize Solutions.  In April 2020, Osteoplastics filed an amended complaint to substitute U.S. Patent No. 9,292,920 for U.S. Patent No. 9,929,920.  Osteoplastics seeks monetary damages and injunctive relief. In June 2020, DePuy Synthes filed a motion to dismiss the complaint. </span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Pharmaceutical</span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Litigation Against Filers of Abbreviated New Drug Applications (ANDAs)</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following summarizes lawsuits pending against generic companies that have filed ANDAs with the FDA or undertaken similar regulatory processes outside of the United States, seeking to market generic forms of products sold by various subsidiaries of Johnson &amp; Johnson prior to expiration of the applicable patents covering those products. These ANDAs typically include allegations of non-infringement and invalidity of the applicable patents. In the event the subsidiaries are not successful in an action, or the automatic statutory stay of the ANDAs expires before the United States District Court rulings are obtained, the third-party companies involved would have the ability, upon approval of the FDA, to introduce generic versions of their products to the market, resulting in the potential for substantial market share and revenue losses for the applicable products, and which may result in a non-cash impairment charge in any associated intangible asset. In addition, from time to time, subsidiaries may settle these types of actions and such settlements can involve the introduction of generic versions of the products at issue to the market prior to the expiration of the relevant patents. The IPR process with the USPTO, created under the 2011 America Invents Act, is also being used at times by generic companies in conjunction with ANDAs and lawsuits, to challenge the applicable patents.</span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2017, Janssen initiated a Notice of Application under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex Inc. (Apotex) and the Minister of Health in Canada in response to Apotex&#8217;s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of Canadian Patent No. 2,661,422 (the &#8217;422).  The final hearing concluded in May 2019.  In October 2019, the court issued an order prohibiting the Canadian Minister of Health from approving Apotex&#8217;s ANDS until the expiration of the &#8217;422 patent.  In November 2019, Apotex filed an appeal.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex in Canada in response to Apotex&#8217;s filing of an Abbreviated New Drug Submission (ANDS) seeking </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><ix:continuation id="i9a38d5bd33f6485884ee26f0e3308436" continuedAt="i31b028497434403fbe75ee2d53058f4e"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">approval to market a film-coated generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;422 patent. The final hearing is scheduled to begin in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Pharmascience Inc. (Pharmascience) in Canada in response to Pharmascience&#8217;s filing of an ANDS seeking approval to market a generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;  </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">250 mg,</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of the  &#8217;422 patent. The final hearing is scheduled to begin in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Pharmascience in Canada in response to Pharmascience&#8217;s filing of an ANDS seeking approval to market a generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, 500 mg, before the expiration of the &#8217;422 patent.  The final hearing is scheduled to begin in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories, Inc. (collectively, DRL) in Canada in response to DRL's filing of an ANDS seeking approval to market a generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;422 patent. The final hearing is scheduled to begin in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In August 2020, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against JAMP Pharma Corporation (Jamp) in Canada in response to Jamp&#8217;s filing of an ANDS seeking approval to market a generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> before the expiration of the &#8217;422 patent.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of these Canadian actions, Janssen is seeking an order enjoining the defendants from marketing their generic versions of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;422 patent.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In June 2017, Janssen Pharmaceuticals, Inc. (JPI) and Bayer Pharma AG and Bayer Intellectual Property GmbH (collectively, Bayer) filed a patent infringement lawsuit in the United States District Court for the District of Delaware against InvaGen Pharmaceuticals Inc. (InvaGen) who filed an ANDA seeking approval to market generic versions of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> before expiration of Bayer AG&#8217;s United States Patent No. 9,539,218 (&#8217;218) relating to XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">. JPI is the exclusive sublicensee of the asserted patent. In August 2020, JPI and Bayer AG entered into a settlement agreement with InvaGen. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;">In May 2020, JPI and Bayer AG filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Unichem Inc. (a/k/a Unichem Laboratories, Ltd.) and Unichem Pharmaceuticals (USA), Inc.(collectively, Unichem) who filed an ANDA seeking approval to market a generic version of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:88%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;"> before expiration of </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:88%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;">the &#8217;218 patent and United States Patent No. 7,157,456 relating</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:88%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;">to XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:88%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;">. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:88%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:88%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;">In September 2020, JPI and Bayer entered into a settlement agreement with Unichem.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;">In August 2020, JPI and Bayer filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Dr. Reddy&#8217;s Laboratories, Inc. and Dr. Reddy&#8217;s Laboratories, Ltd. (collectively, DRL) who filed an ANDA seeking approval to market a generic version of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:88%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;"> before expiration of </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:88%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;">the &#8217;218 patent.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:88%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;">In this lawsuit, JPI is seeking an order enjoining DRL from marketing their generic versions of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:88%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;"> before the expiration of the relevant patents.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">/INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">/INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span><br/></span></div><ix:continuation id="i31b028497434403fbe75ee2d53058f4e" continuedAt="i9fa400a50f1c421eab4dfa0eb1910389"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">Beginning in July 2017, Janssen Pharmaceuticals, Inc., Janssen Research &amp; Development, LLC, Cilag GmbH International and Janssen Pharmaceutica NV (collectively, Janssen) and Mitsubishi Tanabe Pharma Corporation (MTPC) filed patent infringement lawsuits in the United States District Court for the District of New Jersey against a number of generic companies who filed ANDAs seeking approval to market generic versions of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> and/or INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> XR before expiration of MTPC&#8217;s United States Patent Nos. 7,943,582 (&#8217;582) and/or 8,513,202 (&#8217;202) relating to INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> and/or INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> XR. Janssen is the exclusive licensee of the asserted patents. The following generic companies were named as defendants:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">Dr. Reddy&#8217;s Laboratories, Inc. and Dr. Reddy&#8217;s Laboratories Ltd (DRL); MSN Laboratories Private Ltd. and MSN Pharmaceuticals, Inc. (MSN); Zydus Pharmaceuticals (USA) Inc. (Zydus); Sandoz, Inc. (Sandoz); and Lupin Ltd. and Lupin Pharmaceuticals, Inc. (Lupin).</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">These cases were consolidated into one action (Polymorph Main Action), which has been scheduled for trial starting in February 2021.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">In July 2017, Janssen and MTPC filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus who filed an ANDA seeking approval to market generic versions of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> and/or INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">before expiration of MTPC&#8217;s United States Patent No. 7,943,788 (&#8217;788), 8,222,219 (&#8217;219) and/or 8,785,403 (&#8217;403) relating to INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">and/or INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> XR (Compounds Main Action). Janssen is the exclusive licensee of the asserted patents. Trial began in September 2020 and will conclude in October or November 2020.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%;">  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">In July 2019, Janssen and MTPC filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against MSN, who filed an ANDA seeking approval to market a generic version of INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> before expiration of the &#8217;582 patent and &#8217;202 patent relating to INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">In October 2019, Janssen and MTPC initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against MSN, who filed ANDAs seeking approval to market generic versions of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> and INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> before expiration of the &#8217;788 patent.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">In October 2019, Janssen and MTPC initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against DRL, who filed an ANDA seeking approval to market a generic version of INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> before expiration of the &#8217;788 patent.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">These lawsuits have not been consolidated with the Main Actions.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In each of these lawsuits, Janssen and MTPC are seeking an order enjoining the defendants from marketing their generic versions of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> and/or, INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">before the expiration of the relevant patents.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In January 2018, Actelion Pharmaceuticals Ltd (Actelion) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus Pharmaceuticals (USA) Inc. (Zydus) who filed an ANDA seeking approval to market a generic version of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">before the expiration of United States Patent No. 7,094,781 (&#8217;781).  In the lawsuit, Actelion was seeking an order enjoining Zydus from marketing generic versions of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> before the expiration of the patent. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In September 2020, Actelion and Zydus entered into a settlement agreement.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">I</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">n October 2020, Actelion initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Laurus Labs Limited and PharmaQ, Inc. (collectively, Laurus), who filed an ANDA seeking approval to market generic versions of OPSUMIT&#174; before the expiration of U.S. Patent No. 7,094,781 (&#8217;781).  Actelion is seeking an order enjoining Laurus from marketing generic versions of OPSUMIT&#174; before the expiration of the &#8217;781 patent.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In May 2020, Janssen Inc. (Janssen) and Actelion initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Sandoz Canada Inc. (Sandoz) in Canada in response to Sandoz&#8217;s filing of an ANDS seeking approval to market a generic version of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;  </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">10 mg,</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">before the expiration of Canadian Patent No. 2,659,770 (&#8217;770). Trial is scheduled to begin in January 2022.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2020, Janssen and Actelion initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex Inc. (Apotex) in Canada in response to Apotex&#8217;s filing of an ANDS seeking approval to market a generic version of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">10 mg,</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of the &#8217;770 patent. Trial is scheduled to begin in February 2022.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In July 2020, Janssen and Actelion initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against JAMP Pharma Corporation (JAMP) in Canada in response to JAMP&#8217;s filing of an ANDS seeking approval to market a generic version of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> 10 mg before the expiration of the &#8217;770 patent and Canadian Patent No. 2,621,273 (&#8217;273).  Trial is scheduled to begin in April 2022.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of these Canadian actions, Janssen and Actelion are seeking an order enjoining the defendants from marketing their generic versions of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the relevant patents.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><ix:continuation id="i9fa400a50f1c421eab4dfa0eb1910389" continuedAt="i887c13cb655f4d50817ebd2492473a2c"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2018, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Teva Pharmaceuticals USA, Inc. (Teva), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of United States Patent No. 9,439,906 (&#8217;906).  Trial commenced in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In August 2019, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Mylan Laboratories Limited (Mylan), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> before the expiration of the &#8217;906 patent.  In February 2020, Mylan filed a Petition for Inter Partes Review with the USPTO seeking to invalidate the &#8217;906 patent. The USPTO denied the Petition in September 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Courts for the Districts of New Jersey and Delaware against Pharmascience Inc., Mallinckrodt PLC and Specgx LLC (collectively, Pharmascience), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;906 patent.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2018, Janssen Inc. and Janssen Pharmaceutica NV (collectively, Janssen) initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Teva Canada Limited (Teva)  in response to Teva's filing of an ANDS seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of Canadian Patent Nos. 2,309,629 (&#8217;629) and 2,655,335 (&#8217;335).  Janssen subsequently discontinued the portion of the lawsuit relating to the &#8217;629 patent.  In  May 2020, the Canadian Federal Court issued a Public Judgment and Reasons declaring that Teva&#8217;s generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, if approved, would infringe claims of the &#8217;335 patent and that the claims of the &#8217;335 patent are not invalid for obviousness. Teva appealed the court&#8217;s decision.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In April 2020, Janssen Inc. and Janssen Pharmaceutica NV (together, Janssen) initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Pharmascience Inc. (Pharmascience)  in response to Pharmascience's filing of an ANDS seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> before the expiration of the &#8217;335 patent.  In September 2020, Pharmascience withdrew its ANDS and Janssen discontinued the lawsuit.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of these lawsuits, Janssen is seeking an order enjoining the defendant from marketing a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the relevant patents.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">Beginning in January 2018, Pharmacyclics LLC (Pharmacyclics) and Janssen Biotech, Inc. (JBI) filed patent infringement lawsuits in the United States District Court for the District of Delaware against a number of generic companies who filed ANDAs seeking approval to market generic versions of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> 140 mg capsules before expiration of Pharmacyclics&#8217;  United States Patent Nos. 8,008,309, 7,514,444, 8,697,711, 8,735,403, 8,957,079, 9,181,257, 8,754,091, 8,497,277, 8,925,015, 8,476,284, 8,754,090, 8,999,999, 9,125,889, 9,801,881, 9,801,883, 9,814,721, 9,795,604, 9,296,753, 9,540,382, 9,713,617 and/or 9,725,455 relating to IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">. JBI is the exclusive licensee of the asserted patents. The named defendants include the following generic companies: Cipla Limited and Cipla USA Inc. (collectively, Cipla); Sandoz Inc. and Lek Pharmaceuticals d.d. (collectively, Sandoz); and Zydus Worldwide DMCC and Cadila Healthcare Limited (collectively, Zydus).  The trial commenced in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2019, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Zydus, who filed an ANDA seeking approval to market a generic version of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> 70 mg before the expiration of U.S. Patent Nos. 7,514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753, 9,540,382, 9,713,617, 9,725,455, 10,106,548, and 10,125,140. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2019, Pharmacyclics and JBI amended their complaint against Cipla to allege infringement of United States Patent Nos. 10,106,548, and 10,125,140.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2019, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Alvogen Pine Brook LLC and Natco Pharma Ltd. (collectively, Alvogen), who filed an ANDA seeking approval to market generic versions of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> tablets, asserting infringement of United States Patent Nos. 7,514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753,  9,655,857, 9,725,455, 10,010,507, 10,106,548, and 10,125,140.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><ix:continuation id="i887c13cb655f4d50817ebd2492473a2c" continuedAt="i32a35b941b464e57b4925f664374d244"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2019, Pharmacyclics and JBI amended their complaint against Cipla to further allege infringement of United States Patent No. 10,016,435.  In June 2019, Pharmacyclics and JBI amended their complaint against Alvogen to further allege infringement of United States Patent No. 10,213,386.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2019, Pharmacyclics and JBI amended their complaints against Cipla and Sandoz to further allege infringement of U.S. Patent Nos. 10,294,231 and 10,294,232.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In March 2019, Sandoz filed an</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">IPR Petition with</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">the USPTO, seeking to invalidate United States Patent No. 9,795,604.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In September 2020, the USPTO issued a final decision in the IPR invalidating certain claims of the &#8217;604 patent and upholding the validity of certain claims in the &#8217;604 patent.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In March 2020, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Alvogen, Zydus and Sandoz asserting infringement of United States Patent No. 10,478,439.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In April 2020, Pharmacyclics and JBI amended their complaint against Sandoz to further allege infringement of U.S. Patent No. 10,463,668. In October 2020, Pharmacyclics and JBI amended their complaint against Sandoz to further allege infringement of U.S. Patent Nos. 10,752,634 and 10,695,350, amended their complaint against Zydus to further allege infringement of U.S. Patent Nos.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">10,752,634 and 10,653,696, and amended their complaint against Alvogen to further allege infringement of U.S. Patent No. 10,653,696.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Zydus, who filed an ANDA seeking approval to market generic versions of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> tablets, asserting infringement of United States Patent Nos. 7,514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753,  9,655,857, 9,725,455, 10,010,507, 10,106,548, 10,125,140, 10,213,286 and 10,478,439.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In October 2020, Pharmacyclics and JBI entered into a settlement agreement with Zydus.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of the lawsuits, Pharmacyclics and JBI are seeking an order enjoining the defendants from marketing generic versions of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of the relevant patents.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, Actelion Pharmaceuticals Ltd and Nippon Shinyaku Co., Ltd. initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against a number of generic companies who filed ANDAs seeking approval to market generic versions of UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before expiration of Nippon Shinyaku&#8217;s United States Patent Nos. 7,205,302; 8,791,122; and 9,284,280 relating to UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Actelion is the exclusive licensee of the asserted patents. The following generics are named defendants in the complaint: Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals Inc. (Alembic); MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. (MSN); Aizant Drug Research Solutions Private Limited (Aizant); VGYAAN Pharmaceuticals LLC (VGYAAN); and Zydus Pharmaceuticals (USA), Inc. and Zydus Worldwide DMCC (Zydus). In June 2020, the court entered a joint stipulation dismissing Aizant from suit.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Actelion and Nippon Shinyaku are seeking an order enjoining the defendants from marketing generic versions of UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of the relevant patents.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">INVEGA TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In September 2020, Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica NV, and Janssen Research &amp; Development, LCC (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., and Mylan Institutional LLC (collectively, Mylan). Mylan filed an ANDA seeking approval to market generic versions of INVEGA TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">before expiration of United States Patent No. 10,143,693 relating to INVEGA TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">. Janssen is seeking an order enjoining Mylan from marketing a generic version of INVEGA TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> before the expiration of the relevant patent.</span></div><div style="margin-top:12pt;margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">GOVERNMENT PROCEEDINGS</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Like other companies in the pharmaceutical, consumer and medical devices industries, Johnson &amp; Johnson and certain of its subsidiaries are subject to extensive regulation by national, state and local government agencies in the United States and other countries in which they operate. As a result, interaction with government agencies is ongoing. The most significant litigation brought by, and investigations conducted by, government agencies are listed below. It is possible that criminal charges and substantial fines and/or civil penalties or damages could result from government investigations or litigation.</span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span><br/></span></div><ix:continuation id="i32a35b941b464e57b4925f664374d244" continuedAt="i009bf26614f94870b53366d87a2d6585"><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Average Wholesale Price (AWP) Litigation</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Johnson &amp; Johnson and several of its pharmaceutical subsidiaries (the J&amp;J AWP Defendants), along with numerous other pharmaceutical companies, were named as defendants in a series of lawsuits in state and federal courts involving allegations that the pricing and marketing of certain pharmaceutical products amounted to fraudulent and otherwise actionable conduct because, among other things, the companies allegedly reported an inflated Average Wholesale Price (AWP) for the drugs at issue. Payors alleged that they used those AWPs in calculating provider reimbursement levels. The plaintiffs in these cases included three classes of private persons or entities that paid for any portion of the purchase of the drugs at issue based on AWP, and state government entities that made Medicaid payments for the drugs at issue based on AWP. Many of these cases, both federal actions and state actions removed to federal court, were consolidated for pre-trial purposes in a multi-district litigation in the United States District Court for the District of Massachusetts, where all claims against the J&amp;J AWP Defendants were ultimately dismissed. The J&amp;J AWP Defendants also prevailed in a case brought by the Commonwealth of Pennsylvania. Other AWP cases have been resolved through court order or settlement. The case brought by Illinois was settled after trial.  In New Jersey, a putative class action based upon AWP allegations is pending against Centocor, Inc. and Ortho Biotech Inc. (both now Janssen Biotech, Inc.), Johnson &amp; Johnson and ALZA Corporation. All other cases have been resolved.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Opioid Litigation</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Beginning in 2014 and continuing to the present, Johnson &amp; Johnson and Janssen Pharmaceuticals, Inc. (JPI), along with other pharmaceutical companies, have been named in more than <ix:nonFraction unitRef="claimant" contextRef="ic4f17482cf3c41e598a0357f6aaae45c_I20191229" decimals="0" format="ixt:numdotdecimal" name="jnj:ProductLiabilityContingencyNumberOfClaimant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNTkzMjc_6e78d94e-a9c8-4c7c-9a45-99f7e88c40ba">3,100</ix:nonFraction> lawsuits related to the marketing of opioids, including DURAGESIC</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, NUCYNTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and NUCYNTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> ER.  The suits also raise allegations related to previously owned active pharmaceutical ingredient supplier subsidiaries, Tasmanian Alkaloids Pty, Ltd. and Noramco, Inc. (both subsidiaries were divested in 2016). The majority of the cases have been filed by state and local governments. Similar lawsuits have also been filed by private plaintiffs and organizations, including but not limited to the following: individual plaintiffs on behalf of children suffering from Neonatal Abstinence Syndrome; hospitals; and health insurers/payors. To date, complaints against pharmaceutical companies, including Johnson &amp; Johnson and JPI, have been filed by the state Attorneys General in Arkansas, Florida, Idaho, Illinois, Kentucky, Louisiana, Mississippi, Missouri, New Hampshire, New Jersey, New Mexico, New York, Ohio, Oklahoma, South Dakota, Texas, Washington and West Virginia. Complaints against the manufacturers also have been filed in state or federal court by city, county and local government agencies in the following states: Alabama, Arizona, Arkansas, California, Connecticut, Florida, Georgia, Illinois, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Mississippi, Missouri, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina; Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia and Wisconsin. The Government of Puerto Rico filed suit in Superior Court of San Juan. There are more than 370 cases pending in various state&#160;courts. There are over 2,700 federal cases coordinated in a federal Multi-District Litigation (MDL) pending in the U.S. District Court for the Northern District of Ohio (MDL No. 2804).&#160;In addition, the Province of British Columbia filed suit in Canada.  In October 2019, an anti-trust complaint was filed by private plaintiffs in federal court in Tennessee and is pending transfer to the MDL. These actions allege a variety of claims related to opioid marketing practices, including false advertising, unfair competition, public nuisance, consumer fraud violations, deceptive acts and practices, false claims and unjust enrichment. The suits generally seek penalties and/or injunctive and monetary relief and, in some of the suits, the plaintiffs are seeking joint and several liability among the defendants. An adverse judgment in any of these lawsuits could result in the imposition of large monetary penalties and significant damages including, punitive damages, cost of abatement, substantial fines, equitable remedies and other sanctions.</span><span style="background-color:rgb(255,255,255, 0.0);color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The trial in the matter filed by the Oklahoma Attorney General resulted in a judgment against Johnson &amp; Johnson and JPI in the amount of $<ix:nonFraction unitRef="usd" contextRef="i8b7242888eaf4e6d93abf906006a26fe_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNjIxNDc_a0137513-123c-45fa-ba8c-e367588a8780">572</ix:nonFraction> million, subject to a final order to be issued by the court.&#160; The court issued a final judgment reducing the amount to $<ix:nonFraction unitRef="usd" contextRef="i63a02018e9aa4b8fab85aa8bf8d518c8_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNjIyNjE_1d339bab-067e-416f-8084-f74426838fe2">465</ix:nonFraction> million. Johnson &amp; Johnson and JPI have appealed the judgment. The Company believes that it has strong grounds to overturn this judgment.&#160; In October 2019 Johnson &amp; Johnson and JPI announced a settlement of the first case set for trial in the MDL with two counties in Ohio. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Johnson &amp; Johnson, JPI and other pharmaceutical companies have also received subpoenas or requests for information related to opioids marketing practices from the following state Attorneys General: Alaska, Indiana, Montana, New Hampshire, South Carolina, Tennessee, Texas and Washington. In September 2017, Johnson &amp; Johnson and JPI were contacted by the Texas and Colorado Attorney General&#8217;s Offices on behalf of approximately 38 states regarding a multi-state Attorney General investigation. In October 2019, the Company announced a proposed agreement in principle that would include the Company paying $<ix:nonFraction unitRef="usd" contextRef="i4957f58a493d49f5bef49186ecf1dbf7_I20191031" decimals="-9" format="ixt:numdotdecimal" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNjMxMzc_fb476e26-2ac9-49a5-97e1-34e35b0a0b49">4</ix:nonFraction> billion as settlement of these lawsuits.  In October 2020, the Company agreed to contribute up to an additional $<ix:nonFraction unitRef="usd" contextRef="ia877cf56320947748ba1727613e928d1_I20201031" decimals="-9" format="ixt:numdotdecimal" name="jnj:LossContingencyEstimateOfAdditionalPossibleLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfMTA5OTUxMTY0NDg2ODM_c20e4520-40b7-4ccd-8aec-4f7cc1d64463">1</ix:nonFraction>&#160;billion to an all-in settlement amount that would resolve opioid lawsuits filed and future claims by states, cities, counties and tribal governments, for a total of $<ix:nonFraction unitRef="usd" contextRef="ia877cf56320947748ba1727613e928d1_I20201031" decimals="-9" format="ixt:numdotdecimal" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfMTA5OTUxMTY0NDg2OTU_70d700c3-09ad-4262-9499-0c669a94132a">5</ix:nonFraction>&#160;billion, subject to various conditions and an agreement being finalized. This agreement in </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><ix:continuation id="i009bf26614f94870b53366d87a2d6585" continuedAt="ided872c630a544cf9002d29884f17e31"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">principle is not an admission of liability or wrong-doing and would resolve opioid lawsuits filed and future claims by states, cities and counties.  The Company cannot predict if or when the agreement will be finalized and individual cases are ongoing. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> In August 2019, Johnson &amp; Johnson received a grand jury subpoena from the United States Attorney&#8217;s Office for the Eastern District of New York for documents related to the Company&#8217;s anti-diversion policies and procedures and distribution of its opioid medications, in what the Company understands to be part of a broader investigation into manufacturers&#8217; and distributors&#8217; monitoring programs and reporting under the Controlled Substances Act.&#160; In September 2019, Johnson &amp; Johnson received subpoenas from the New York State Department of Financial Services (NYDFS) as part of an industry-wide inquiry into the effect of opioid prescriptions on New York health insurance premiums.&#160;In September 2020, the Company learned that NYDFS filed a statement of charges related to this investigation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In November 2019, a shareholder filed a derivative complaint against Johnson &amp; Johnson as the nominal defendant and certain current and former directors and officers as defendants in the Superior Court of New Jersey.  The complaint alleges breaches of fiduciary duties related to the marketing of opioids, and that Johnson &amp; Johnson has suffered damages as a result of those alleged breaches.  In December 2019, two additional shareholders filed two separate derivative complaints making similar allegations against Johnson &amp; Johnson as the nominal defendant and certain current and former directors and officers as defendants in the United States District for the District of New Jersey. In April 2020,  the two federal cases were consolidated into a single action captioned</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"> In re Johnson &amp; Johnson Opioid Stockholder Derivative Litigation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.  Pursuant to an agreed stipulation entered by the Court, the shareholders have until July 2020 to file a consolidated complaint or identify a previously filed complaint as the operative complaint. In July 2020, an additional shareholder filed a derivative complaint in the United States District Court for the District of New Jersey making similar allegations against the same defendants named in the consolidated action.  Pursuant to an order in the consolidated action, the newly-filed case will be consolidated into the consolidated action.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, a report was delivered to the Company&#8217;s Board of Directors by independent counsel retained by the Board to investigate the allegations in the derivative lawsuits and in a series of shareholder letters that the Board received raising similar issues.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The independent counsel recommended that the Company reject the shareholder demands and take the steps that are necessary or appropriate to secure dismissal of the derivative litigation. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Board unanimously adopted the recommendations of the independent counsel&#8217;s report.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Other</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In August 2012, DePuy Orthopaedics, Inc., DePuy, Inc. (now known as DePuy Synthes, Inc.), and Johnson &amp; Johnson Services, Inc. (collectively DePuy) received an informal request from the United States Attorney's Office for the District of Massachusetts and the Civil Division of the United States Department of Justice (the United States) for the production of materials relating to the DePuy ASR&#8482; XL Hip device. In July 2014, the United States notified the United States District Court for the District of Massachusetts that it had declined to intervene in a </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> case filed pursuant to the False Claims Act against the companies. In February 2016, the district court granted the companies&#8217; motion to dismiss with prejudice, unsealed the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> complaint, and denied the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> relators&#8217; request for leave to file a further amended complaint. The </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> relators appealed the case to the United States Court of Appeals for the First Circuit. In July 2017, the First Circuit affirmed the district court&#8217;s dismissal in part, reversed in part, and affirmed the decision to deny the relators&#8217; request to file a third amended complaint. The relators&#8217; remaining claims are now pending before the district court. In July 2020, the Court ordered the relators to complete discovery by August 2020; the Relators have requested an extension of the August 2020 deadline that DePuy opposed and additional discovery-related motions have been filed by both parties. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In October 2012, Johnson &amp; Johnson was contacted by the California Attorney General's office regarding a multi-state Attorney General investigation of the marketing of surgical mesh products for hernia and urogynecological purposes by Johnson &amp; Johnson's subsidiary, Ethicon, Inc. (Ethicon). In May 2016, California and Washington filed civil complaints against Johnson &amp; Johnson, Ethicon and Ethicon US, LLC alleging violations of their consumer protection statutes. Similar complaints were filed against the companies by the following states:  Kentucky, Mississippi, West Virginia and Oregon. In April 2019, Johnson &amp; Johnson and Ethicon settled the Washington case.  The California case started trial in July 2019 and concluded in September 2019. The trial date for the Kentucky case was scheduled for September 2019 but has been adjourned and no new trial date has been scheduled. The trial date for the Mississippi case is scheduled for April 2021. In October 2019, Johnson &amp; Johnson and Ethicon settled the multi-state investigation with 41 other states and the District of Columbia. In January 2020, the Court in California issued a statement of decision, finding in favor of the State of California, and awarded civil penalties in the amount of $<ix:nonFraction unitRef="usd" contextRef="i12cbe2e6652048f1abbf81f0d8f8b6cc_D20200101-20200131" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNjg3OTk_7d46a908-98a7-4f0c-bb97-3b30c047476a">344</ix:nonFraction> million. In April 2020, the Court in California denied the Company's motion for a new trial. In August 2020, the Court entered judgment with respect to the penalties of $<ix:nonFraction unitRef="usd" contextRef="ibb5dd3fead9e4921a49ec475665dfe71_D20200401-20200430" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfMTA5OTUxMTY0NDc1NjM_a253a3a3-f143-4c05-b667-40dccb6c8b0a">344</ix:nonFraction>&#160;million, but denied the Attorney General&#8217;s request for injunctive relief. The Company is appealing the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">penalty judgment. In April 2020, the Company settled the West Virginia case. In June 2020 the Court in Oregon denied the Company's motion to dismiss. Trial in Oregon is set for February 2022. The Attorney General of </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><ix:continuation id="ided872c630a544cf9002d29884f17e31" continuedAt="i0660d06cb9c04c7c82e5b0a5badc7ec3"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Mississippi filed a second amended complaint in April 2020 and the Company filed a motion to dismiss in May 2020. The motion to dismiss argument was heard in August 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In December 2012, Therakos, Inc. (Therakos), formerly a subsidiary of Johnson &amp; Johnson and part of the Ortho-Clinical Diagnostics, Inc. (OCD) franchise, received a letter from the civil division of the United States Attorney's Office for the Eastern District of Pennsylvania informing Therakos that the United States Attorney's Office was investigating the sales and marketing of Uvadex</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> (methoxsalen) and the Uvar Xts</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> and Cellex</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Systems during the period 2000 to the present. The United States Attorney's Office requested that OCD and Johnson &amp; Johnson preserve documents that could relate to the investigation. Therakos was subsequently acquired by an affiliate of Gores Capital Partners III, L.P. in January 2013, and OCD was divested in June 2014. Following the divestiture of OCD, Johnson &amp; Johnson retains OCD&#8217;s portion of any liability that may result from the investigation for activity that occurred prior to the sale of Therakos. In March 2014 and March 2016, the United States Attorney&#8217;s Office requested that Johnson &amp; Johnson produce certain documents, and Johnson &amp; Johnson is cooperating with those requests.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2014, the Mississippi Attorney General filed a complaint in Chancery Court of The First Judicial District of Hinds County, Mississippi against Johnson &amp; Johnson and Johnson &amp; Johnson Consumer Companies, Inc. (now known as Johnson &amp; Johnson Consumer Inc.) (JJCI).&#160;The complaint alleges that defendants violated the Mississippi Consumer Protection Act by </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">failing to disclose alleged health risks associated with female consumers' use of talc contained in JOHNSON'S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Baby Powder and JOHNSON'S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Shower to Shower (a product divested in 2012) and seeks injunctive and monetary relief.  The matter is stayed pending interlocutory appeal of a December 2018 denial of Johnson &amp; Johnson and JJCI's motion for summary judgment. The Mississippi Supreme Court granted J&amp;J and JJCI's request to file an interlocutory appeal of the denial of the motion for summary judgment in late 2019. Briefing is complete.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In January 2020, the State of New Mexico filed a consumer protection case alleging that the Company deceptively marketed and sold its talcum powder products by making misrepresentations about the safety of the products and the presence of carcinogens, including asbestos.  The State of New Mexico filed an Amended Complaint in March 2020. The Company has moved to dismiss certain of the claims in the Amended Complaint, which was granted, but the State of New Mexico was given leave to amend its complaint. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Forty-one states have commenced a joint investigation into the Company&#8217;s marketing of its talcum powder products. At this time, the multi-state group has not asserted any claims against the Company. Several states have issued Civil Investigative Demands seeking documents and other information. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2016, Janssen Pharmaceuticals, Inc. (JPI) received a Civil Investigative Demand from the United States Attorney&#8217;s Office for the Southern District of New York related to JPI&#8217;s contractual relationships with pharmacy benefit managers over the period from January 1, 2006 to the present with regard to certain of JPI's pharmaceutical products.  The demand was issued in connection with an investigation under the False Claims Act.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2016, Johnson &amp; Johnson and Janssen Products LP were served with a </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> complaint pursuant to the False Claims Act filed in the United States District Court for the District of New Jersey alleging the off-label promotion of two HIV products, PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and INTELENCE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, and anti-kickback violations in connection with the promotion of these products.&#160; The complaint was filed under seal in December 2012.&#160; The federal and state governments have declined to intervene, and the lawsuit is being prosecuted by the relators.&#160; </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2017, Janssen Biotech, Inc. received a Civil Investigative Demand from the United States Department of Justice regarding a False Claims Act investigation concerning management and advisory services provided to rheumatology and gastroenterology practices that purchased REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> or SIMPONI ARIA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. In August 2019, the Unites States Department of Justice notified Janssen Biotech, Inc. that it was closing the investigation. Subsequently, the United States District Court for the District of Massachusetts unsealed a qui tam False Claims Act complaint, which was served on the Company.  The Department of Justice had declined to intervene in the qui tam lawsuit in August 2019.  The Company has filed a motion to dismiss the relator&#8217;s complaint. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April and September 2017, Johnson &amp; Johnson received subpoenas from the United States Attorney for the District of Massachusetts seeking documents broadly relating to pharmaceutical copayment support programs for DARZALEX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, OLYSIO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, SIMPONI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, STELARA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">and ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.&#160;The subpoenas also seek documents relating to&#160;Average Manufacturer Price and Best Price reporting to the Center for Medicare and Medicaid Services related to those products, as well as rebate payments to state Medicaid agencies. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2017, Johnson &amp; Johnson received a subpoena from the United States Attorney's Office for the District of Massachusetts seeking information regarding practices pertaining to the sterilization of DePuy Synthes, Inc. spinal implants at </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><ix:continuation id="i0660d06cb9c04c7c82e5b0a5badc7ec3" continuedAt="i74928caf086946c8b1fe4f74f8506158"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">three hospitals in Boston as well as interactions of employees of Company subsidiaries with physicians at these hospitals. Johnson &amp; Johnson and DePuy Synthes, Inc. have produced documents in response to the subpoena and are fully cooperating with the government&#8217;s investigation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2018 the Public Prosecution Service in Rio de Janeiro and representatives from the Brazilian antitrust authority CADE inspected the offices of more than 30 companies including Johnson &amp; Johnson do Brasil Ind&#250;stria e Com&#233;rcio de Produtos para Sa&#250;de Ltda. The authorities appear to be investigating allegations of possible anti-competitive behavior and possible improper payments in the medical device industry.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We continue to actively respond to inquiries regarding the Foreign Corrupt Practices Act from the United States Department of Justice and the United States Securities and Exchange Commission. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">From time to time, the Company has received requests from a variety of United States Congressional Committees to produce information relevant to ongoing congressional inquiries. It is the policy of Johnson &amp; Johnson to cooperate with these inquiries by producing the requested information.</span></div><div style="margin-top:12pt;margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">GENERAL LITIGATION</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In May 2014, two purported class actions were filed in federal court, one in the United States District Court for the Central District of California and one in the United States District Court for the Southern District of Illinois, against Johnson &amp; Johnson and Johnson &amp; Johnson Consumer Companies, Inc. (now known as Johnson &amp; Johnson Consumer Inc.) (JJCI) alleging violations of state consumer fraud statutes based on nondisclosure of alleged health risks associated with talc contained in JOHNSON'S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Baby Powder and JOHNSON'S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Shower to Shower (a product no longer sold by JJCI). Both cases seek injunctive relief and monetary damages; neither includes a claim for personal injuries. In October 2016, both cases were transferred to the United States District Court for the District Court of New Jersey as part of a newly created federal multi-district litigation. In July 2017, the district court granted Johnson &amp; Johnson's and JJCI&#8217;s motion to dismiss one of the cases.  In September 2018, the United States Court of Appeals for the Third Circuit affirmed this dismissal.  In September 2017, the plaintiff in the second case voluntarily dismissed the complaint.  In March 2018, the plaintiff in the second case refiled in Illinois State Court. Following motion practice to remove the case to United States District Court, as of September 2020 the case will remain in Illinois State Court. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In August 2014, United States Customs and Border Protection (US CBP) issued a Penalty Notice against Janssen Ortho LLC (Janssen Ortho), assessing penalties for the alleged improper classification of darunavir ethanolate (the active pharmaceutical ingredient in PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">) in connection with its importation into the United States. In October 2014, Janssen Ortho submitted a Petition for Relief in response to the Penalty Notice. In May 2015, US CBP issued an Amended Penalty Notice assessing substantial penalties and Janssen Ortho filed a Petition for Relief in July 2015. In May 2019, US CBP issued its Mitigation Decision and determined that Janssen Ortho had negligently misrepresented that darunavir ethanolate is entitled to duty free treatment.  In June 2019, Janssen Ortho filed a Supplemental Petition for Relief. The Penalties Proceeding will be impacted by the related Classification Litigation pending in the United States Court of International Trade. The Classification Litigation will determine whether darunavir ethanolate was properly classified as exempt from duties upon importation into the United States. The trial in the Classification Litigation was held in July 2019. In February 2020, the Court ruled that darunavir ethanolate is eligible for duty free treatment. In April 2020, the United States filed a Notice of Appeal to the United States Court of Appeals for the Federal Circuit. In August 2020, Janssen Ortho received notice that Janssen's Supplemental Petition for Relief from the Amended Penalty Notice was denied. In October 2020, USCBP agreed to hold the enforcement of penalties in abeyance pending resolution of the Classification litigation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In September 2020, Genmab A/S brought an arbitration against Janssen Biotech, Inc. pursuant to a 2012 License Agreement between the parties.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The arbitration relates to royalties for certain Janssen daratumumab products.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In March and April 2015, over 30 putative class action complaints were filed by contact lens patients in a number of courts around the United States against Johnson &amp; Johnson Vision Care, Inc. (JJVCI) and other contact lens manufacturers, distributors, and retailers, alleging vertical and horizontal conspiracies to fix the retail prices of contact lenses. The complaints allege that the manufacturers reached agreements with each other and certain distributors and retailers concerning the prices at which some contact lenses could be sold to consumers. The plaintiffs are seeking damages and injunctive relief. All of the class action cases were transferred to the United States District Court for the Middle District of Florida in June 2015. The plaintiffs filed a consolidated class action complaint in November 2015. In December 2018, the district court granted the plaintiffs' motion for class certification. Defendants filed two motions for interlocutory appeal of class certification to the United States Court of Appeals for the Eleventh Circuit. Both motions were denied. Defendants' motions for summary judgment were denied in November 2019. The parties await a trial date. </span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2015, two third-party payors filed a purported class action in the United States District Court for the Eastern District of Louisiana against Janssen Research &amp; Development, LLC, Janssen Ortho LLC, Janssen Pharmaceuticals, Inc., Ortho-</span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><ix:continuation id="i74928caf086946c8b1fe4f74f8506158" continuedAt="i80be4b57d73d4d309c7394a6ee8f7bc1"><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">McNeil-Janssen Pharmaceuticals, Inc. and Johnson &amp; Johnson (as well as certain Bayer entities), alleging that the defendants improperly marketed and promoted XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> as safer and more effective than less expensive alternative medications while failing to fully disclose its risks.  The complaint seeks damages.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In September 2017, Pfizer, Inc. (Pfizer) filed an antitrust complaint against Johnson &amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) in United States District Court for the Eastern District of Pennsylvania.  Pfizer alleges that Janssen has violated federal antitrust laws through its contracting strategies for REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  The complaint seeks damages and injunctive relief. Discovery is ongoing. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Beginning in September 2017, multiple purported class actions of direct and indirect purchasers were filed against Johnson &amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) alleging that Janssen&#8217;s REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> contracting strategies violated federal and state antitrust and consumer laws and seeking damages and injunctive relief.  In November 2017, the cases were consolidated for pre-trial purposes in United States District Court for the Eastern District of Pennsylvania as In re Remicade Antitrust Litigation. Motions to dismiss were denied in both the direct and indirect purchaser cases.  A motion to compel arbitration of the direct purchaser case was denied by the district court. The United States Court of Appeals for the Third Circuit reversed the district court's ruling.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2018, Walgreen Co. and Kroger Co, filed an antitrust complaint against Johnson &amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) in the United States District Court for the Eastern District of Pennsylvania.  The complaint alleges that Janssen has violated federal antitrust laws through its contracting strategies for REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  The complaint seeks damages and injunctive relief. In March 2019, summary judgment was granted in favor of Janssen. In February 2020, the United States Court of Appeals for the Third Circuit reversed the District Court&#8217;s decision.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2019, the United States Federal Trade Commission (FTC) issued a Civil Investigative Demand to Johnson &amp; Johnson in connection with its investigation of whether Janssen&#8217;s REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> contracting practices violate federal antitrust laws. The Company has produced documents and information responsive to the Civil Investigative Demand.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In October 2017, certain United States service members and their families brought a complaint against a number of pharmaceutical and medical devices companies, including Johnson &amp; Johnson and certain of its subsidiaries, alleging that the defendants violated the United States Anti-Terrorism Act.&#160; The complaint alleges that the defendants provided funding for terrorist organizations through their sales practices pursuant to pharmaceutical and medical device contracts with the Iraqi Ministry of Health. In January 2020, plaintiffs filed a Third Amended Complaint adding further plaintiffs to the lawsuit. In July 2020, the District Court dismissed the Third Amended Complaint.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In October 2018, two separate putative class actions were filed against Actelion Pharmaceutical Ltd., Actelion Pharmaceuticals US, Inc., and Actelion Clinical Research, Inc. (collectively Actelion) in United States District Court for the District of Maryland and United States District Court for the District of Columbia.&#160; The complaints allege that Actelion violated state and federal antitrust and unfair competition laws by allegedly refusing to supply generic pharmaceutical manufacturers with samples of TRACLEER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.&#160; TRACLEER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> is subject to a Risk Evaluation and Mitigation Strategy, which imposes restrictions on distribution of the product.&#160; In January 2019, the plaintiffs dismissed the District of Columbia case and filed a consolidated complaint in the United States District Court for the District of Maryland.&#160; In October 2019, the Court granted Actelion&#8217;s motion to dismiss the amended complaint. Plaintiffs have appealed the decision.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2018, Janssen Biotech, Inc., Janssen Oncology, Inc, Janssen Research &amp; Development, LLC, and Johnson &amp; Johnson (collectively, Janssen) were served with a </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> complaint filed on behalf of the United States, 28 states, and the District of Columbia.&#160; The complaint, which was filed in December 2017 in United States District Court for the Northern District of California, alleges that Janssen violated the federal False Claims Act and state law when providing pricing information for ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> to the government in connection with direct government sales and government-funded drug reimbursement programs.&#160; At this time, the federal and state governments have declined to intervene. The case has been transferred to United States District Court for the District of New Jersey. In September 2019, Janssen moved to dismiss the complaint. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2019, Blue Cross &amp; Blue Shield of Louisiana and HMO Louisiana, Inc. filed a class action complaint against Janssen Biotech, Inc, Janssen Oncology, Inc, Janssen Research &amp; Development, LLC and BTG International Limited in the United States District Court for the Eastern District of Virginia on behalf of indirect purchasers of ZYTIGA&#174;. Several additional complaints were filed thereafter in Virginia and New Jersey.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The indirect purchaser complaints generally allege that the defendants violated the antitrust and consumer protections laws of several states and the Sherman Act by pursuing patent litigation relating to ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in order to delay generic entry and seek damages. The Virginia cases have been transferred to </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><ix:continuation id="i80be4b57d73d4d309c7394a6ee8f7bc1"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">the United States District Court for the District of New Jersey and consolidated with the New Jersey case for pretrial purposes.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2020, a class action complaint was filed against Janssen Biotech Inc., Janssen Oncology, Inc., Janssen Research &amp; Development LLC and BTG International Limited in the United States District Court for the District of New Jersey, on behalf of direct purchasers of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The direct purchaser complaint alleges that defendants violated the Sherman Act by pursuing patent litigation relating to ZYTIGA&#174; in order to delay generic entry, and seek damages and injunctive relief. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In May 2019, a class action antitrust complaint was filed against Janssen R&amp;D Ireland (Janssen) and Johnson &amp; Johnson in the United States District Court for the Northern District of California.  The complaint alleges that Janssen violated federal and state antitrust and consumer protection laws by agreeing to exclusivity provisions in its agreements with Gilead concerning the development and marketing of combination antiretroviral therapies (cART) to treat HIV.  The complaint also alleges that Gilead entered into similar agreements with Bristol-Myers-Squibb and Japan Tobacco.  In March 2020, the Court granted in part and denied in part defendants&#8217; motions to dismiss.  Plaintiffs filed an amended complaint in April 2020. Defendants moved to dismiss the amended complaint.  In July 2020, the court granted in part and denied in part the renewed motion to dismiss.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In October 2019, Innovative Health, LLC filed a complaint against Biosense Webster, Inc. (BWI) in the United States District Court for the Middle District of California.  The complaint alleges that certain of BWI&#8217;s&#160;business practices and contractual terms violate the antitrust laws of the United States and the State of California by restricting competition in the sale of High Density Mapping Catheters and Ultrasound Catheters. In January 2020, BWI filed a motion to dismiss the complaint. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In August 2020, the court granted in part and denied in part BWI&#8217;s motion to dismiss.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2019, Johnson &amp; Johnson received a demand for indemnification from Pfizer Inc., pursuant to the 2006 Stock and Asset Purchase Agreement between the Company and Pfizer.  Also in November 2019, Johnson &amp; Johnson, Inc. received a demand for indemnification from Sanofi Consumer Health, Inc., pursuant to the 2016 Asset Purchase Agreement between J&amp;J, Inc. and Sanofi.  In January 2020, Johnson &amp; Johnson received a demand for indemnification from Boehringer Ingelheim Pharmaceuticals, Inc., pursuant to the 2006 Asset Purchase Agreement among the Company, Pfizer, and Boehringer Ingelheim.  The notices seek indemnification for legal claims related to over-the-counter Zantac (ranitidine) products. Plaintiffs in the underlying actions allege that Zantac and other over-the-counter ranitidine medications contain unsafe levels of NDMA (N-nitrosodimethylamine) and can cause and/or have caused various cancers in patients using the products, and seek injunctive and monetary relief.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In October 2020, Fortis Advisors LLC (Fortis), in its capacity as representative of the former stockholders of Auris Health Inc. (Auris), filed a complaint against Johnson &amp; Johnson, Ethicon Inc., and certain named officers and employees (collectively, Ethicon) in the Court of Chancery of the State of Delaware.   The complaint alleges breach of contract, fraud, and other causes of action against Ethicon in connection with Ethicon&#8217;s acquisition of Auris in 2019.  The complaint seeks damages and other relief.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Johnson &amp; Johnson or its subsidiaries are also parties to a number of proceedings brought under the Comprehensive Environmental Response, Compensation, and Liability Act, commonly known as Superfund, and comparable state, local or foreign laws in which the primary relief sought is the cost of past and/or future remediation.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span><br/></span></div><div id="ief97c24c8c144887ab2ad376fc457d4d_94"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 12&#8212; <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMjg0Mg_55fd2a7f-2e04-459a-9f56-601d6b87fe01" continuedAt="ife31228608244ec78e092ca34f3da58e" escape="true">RESTRUCTURING</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ife31228608244ec78e092ca34f3da58e"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company announced plans to implement a series of actions across its Global Supply Chain that are intended to focus resources and increase investments in the critical capabilities, technologies and solutions necessary to manufacture and supply its product portfolio, enhance agility and drive growth. The Global Supply Chain actions will include expanding the use of strategic collaborations and bolstering initiatives to reduce complexity, improve cost-competitiveness, enhance capabilities and optimize the Supply Chain network. For additional details on the Global Supply Chain restructuring strategic collaborations see Note 10 to the Consolidated Financial Statements. In the fiscal third quarter of 2020, the Company recorded a pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="i09487d9b040c41f5b1f1ac6a4eb69ecb_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfNzg1_263bac29-9ed0-4b9e-8f8f-3ec7721818ee">130</ix:nonFraction> million, which is included on the following lines of the Consolidated Statement of Earnings, $<ix:nonFraction unitRef="usd" contextRef="i5110f18fd4f34d9986fb039d56af95c6_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfODcz_a49343f3-2230-4b58-bbc4-705da9bd1954">68</ix:nonFraction> million in restructuring, $<ix:nonFraction unitRef="usd" contextRef="ic998353501c74da5afda8d2b3ead50c5_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfODk0_68660d53-9423-4356-ab6a-517a79fcd3af">32</ix:nonFraction> million in cost of products sold and $<ix:nonFraction unitRef="usd" contextRef="i023474a55b284cd99429e03503a8a901_D20200629-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfOTI2_d1628a25-a5b0-4e91-a703-55975e972d8e">30</ix:nonFraction> million in other (income) expense. In the fiscal nine months of 2020, the Company recorded a pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="i82b8a8526a0b4f7c9f84a00039d7fa45_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTAzNw_99e06efe-2edb-4fb0-b644-bf244daca471">363</ix:nonFraction>&#160;million, which is included on the following lines of the Consolidated Statement of Earnings, $<ix:nonFraction unitRef="usd" contextRef="i2a9ec615fd2b43679132d3c41485de92_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTEyNQ_a9a15f3a-204c-4c92-91d4-05a92b5bbbd2">187</ix:nonFraction>&#160;million in restructuring, $<ix:nonFraction unitRef="usd" contextRef="i98f8797e4aa74fdd9e5fa8711131743e_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTE0Ng_244ffc7c-ebbc-4db0-955d-2e4034fb5fd2">69</ix:nonFraction>&#160;million in cost of products sold and $<ix:nonFraction unitRef="usd" contextRef="i82ffccf862f04217ba5474adbd9d48c9_D20191230-20200927" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTE3OA_7493087f-38a9-4263-b11a-664600decd27">107</ix:nonFraction>&#160;million in other (income) expense. Total project costs of approximately $<ix:nonFraction unitRef="usd" contextRef="i867dc8a2a19c4423b9b7ee18ce1d36b5_I20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTI0NA_b64a350a-ec4e-4378-9ef8-3c878892ae98">1.2</ix:nonFraction> billion have been recorded since the restructuring was announced. See the following table for additional details on the restructuring program. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In total, the Company expects the Global Supply Chain actions to generate approximately $<ix:nonFraction unitRef="usd" contextRef="i405860c539564ee5b8e0b222554dba38_I20200927" decimals="-8" format="ixt:numdotdecimal" name="jnj:RestructuringandRelatedCostExpectedFutureSavings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTQ3Mg_32dc013a-a61e-4dbf-86ca-c0337d4ace18">0.6</ix:nonFraction> billion to $<ix:nonFraction unitRef="usd" contextRef="i410f9ae233db4a80981d7bcef1e0749a_I20200927" decimals="-8" format="ixt:numdotdecimal" name="jnj:RestructuringandRelatedCostExpectedFutureSavings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTQ3OA_343cb7f6-62a2-4202-9681-2e1c6768ec28">0.8</ix:nonFraction> billion in annual pre-tax cost savings that will be substantially delivered by 2022. The Company expects to record pre-tax restructuring charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i405860c539564ee5b8e0b222554dba38_I20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTYzNQ_50b84ffd-e393-4a9c-94d6-c61526cea2c2">1.9</ix:nonFraction> billion to $<ix:nonFraction unitRef="usd" contextRef="i410f9ae233db4a80981d7bcef1e0749a_I20200927" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTY0MQ_eb876a05-be2e-411e-84a1-28eff367f59b">2.3</ix:nonFraction> billion, over the <ix:nonNumeric contextRef="i9c3e80cad55d41f6a3525d636c512e88_D20191230-20200927" format="ixt-sec:duryear" name="jnj:RestructuringandRelatedCostDurationofRestructuringPlan" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTY1NA_370bab07-8597-4e86-9e41-81289ace5ac1">4</ix:nonNumeric> to <ix:nonNumeric contextRef="ib2a9ba204bdd4530ae30c6d71d30d92f_D20191230-20200927" format="ixt-sec:duryear" name="jnj:RestructuringandRelatedCostDurationofRestructuringPlan" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTY2MA_29a77cac-b3a0-484e-a358-bd845f0476e2">5</ix:nonNumeric> year period of this activity. These costs are associated with network optimizations, exit costs and accelerated depreciation and amortization.&#160; &#160;</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMjg0MA_a0bef5cb-2970-4455-9ed2-67d50f3a912d" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the severance related reserves and the associated restructuring expenses through the fiscal nine months of 2020:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%;"><tr><td style="width:1.0%;"></td><td style="width:33.603%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:14.272%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:14.881%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:14.272%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:2.400%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.972%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Severance</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset Write-offs</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Other</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Reserve balance, December 29, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6cd238e746ca494b962a8cdfec78532f_I20191229" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfMS0xLTEtMS0w_7f66c1e7-a3b7-4998-a6bc-2ae637ae8399">164</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib5ccab87c7704f459a110126f42d578f_I20191229" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfMS0yLTEtMS0w_13fee103-2586-4ee0-a28e-c7b0179965cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib44160c8cfcb4364a86afc1ebf7ea5db_I20191229" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfMS0zLTEtMS0w_3cdfdbfd-6293-4fb6-bb95-667b209ce4e1">16</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7153539e0f5345cc86253ed5aadc3d3c_I20191229" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfMS01LTEtMS0w_16d02fc3-8718-4553-a545-6ad21a84e073">180</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current year activity:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Charges  </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic763bc82f42c427fa881f68d00497d2c_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNC0xLTEtMS0w_1a70efa6-5ac5-471b-8be8-4d6285a957f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id36fda814d6046bfa30b6bdd0fe5d257_D20191230-20200927" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNC0yLTEtMS0w_e5507b75-1317-44e0-8b8c-53ab4a1d8d25">55</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i254209b7e3f54f69a129c76d5b0d3e93_D20191230-20200927" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNC0zLTEtMS0w_6a1ff226-f185-4b6a-8de5-2b1a292bfcd6">308</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7392cf4986564b5e9e2afd38679fb669_D20191230-20200927" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNC01LTEtMS0w_f74b0dab-1972-4d3f-bdcd-a23e6c8e4bac">363</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Cash payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic763bc82f42c427fa881f68d00497d2c_D20191230-20200927" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNS0xLTEtMS0w_9ac01fe3-b45c-4de8-a3e4-148991cb3ddf">18</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id36fda814d6046bfa30b6bdd0fe5d257_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNS0yLTEtMS0w_81705a88-bb88-4459-b571-1f4ccb915f30">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i254209b7e3f54f69a129c76d5b0d3e93_D20191230-20200927" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNS0zLTEtMS0w_99a74814-f632-4270-bf54-917ebe18baeb">297</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7392cf4986564b5e9e2afd38679fb669_D20191230-20200927" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNS01LTEtMS0w_20abdb1b-5eb0-4697-a46b-5ab168e25a21">315</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Settled non cash </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic763bc82f42c427fa881f68d00497d2c_D20191230-20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNi0xLTEtMS0w_471d4423-7532-4e33-b7df-93d901d9515c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="id36fda814d6046bfa30b6bdd0fe5d257_D20191230-20200927" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNi0yLTEtMS0w_cd9c635d-dbab-49e2-a134-58ba26808929">55</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i254209b7e3f54f69a129c76d5b0d3e93_D20191230-20200927" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNi0zLTEtMS0w_7b81ecdd-48c0-4731-a88b-1ba587e290b5">17</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7392cf4986564b5e9e2afd38679fb669_D20191230-20200927" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNi01LTEtMS0w_1be2085f-a659-4d28-a8cd-08a3f5aeddf5">72</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Reserve balance, September 27, 2020</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i61bba3fc154c46aba1e0aeb8dc224242_I20200927" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfOS0xLTEtMS0w_edbcb6ce-e92f-4670-af63-c0bca2b2c706">146</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0c0bc17c52f34567b49e094ed620eb73_I20200927" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfOS0yLTEtMS0w_9fbb3fad-349e-4052-bcf4-01df570dc446">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id5b06f3dcb1c4d1f94c7dbe9b3ce5ef1_I20200927" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfOS0zLTEtMS0w_027431eb-0636-4fe2-9a60-d6cd05140f77">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib046be1bad564ea69c1c677f161cf688_I20200927" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfOS01LTEtMS0w_925f93b6-5727-4f73-8cde-f47865746031">156</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Cash outlays for severance are expected to be substantially paid out over the next <ix:nonNumeric contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927" format="ixt-sec:duryear" name="jnj:RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid" id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMjAyNw_43f1c5ee-cc4a-473d-bc69-c8e2189f8a85">2</ix:nonNumeric> years in accordance with the Company's plans and local laws. </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"> Other includes project expense such as salaries for employees supporting these initiatives and consulting expenses.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(3) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Relates to pension related actuarial losses associated with the transfer of employees to Jabil Inc. as part of the strategic collaboration.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company continuously reevaluates its severance reserves related to restructuring and the timing of payments due to the planned release of associates regarding several longer-term projects. The Company believes that the existing severance reserves are sufficient to cover the Global Supply Chain plans given the period over which the actions will take place. The Company will continue to assess and make adjustments as necessary if additional amounts become probable and estimable.</span></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">46</span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div style="text-indent:-54pt;padding-left:54pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 1A.&#160;&#160;&#160;&#160;RISK FACTORS</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company faces a number of uncertainties and risks that are difficult to predict and many of which are outside of the Company's control.&#160;For a detailed discussion of the risks that affect our business, please refer to Part I, Item IA, &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended December 29, 2019.&#160;There have been no material changes to the risk factors as previously disclosed in the Company's Annual Report on Form 10-K, except as follows:</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Global health crises and pandemics, such as the global outbreak of the novel coronavirus (COVID-19), could cause disruptions in our business.</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The recent global outbreak of COVID-19 could cause disruptions to the Company's business and have a negative impact on the Company's revenues and operating results. While the Company has robust business continuity plans in place across its global supply chain network to help mitigate the impact of COVID-19, these efforts may not completely prevent its business from being adversely affected. The extent to which COVID-19 impacts the Company's operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the outbreak and any prolonged restrictive measures implemented in order to control the spread of the disease. In particular, the continued global spread of COVID-19 could adversely impact the Company's operations, including, among other things, its manufacturing operations, supply chain, sales and marketing and clinical trial operations. Any of these factors could adversely affect the Company's business, operating results or financial condition.</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">47</span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_100"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div style="text-indent:-40.5pt;padding-left:40.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Item&#160;2 &#8212; MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Sales to Customers</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Analysis of Consolidated Sales</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the fiscal nine months of 2020, worldwide sales were $60.1 billion, a total decrease of 2.0%, including an operational decline of 0.8% as compared to 2019 fiscal nine months sales of $61.3 billion. Currency fluctuations had a negative impact of 1.2% for the fiscal nine months of 2020. In the fiscal nine months of 2020, the net impact of acquisitions and divestitures on worldwide operational sales growth was a negative 0.4%.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Sales by U.S. companies were $31.3 billion in the fiscal nine months of 2020, which was flat as compared to the prior year. In the fiscal nine months of 2020, the net impact of acquisitions and divestitures on the U.S. operational sales growth was a negative 0.4%.  Sales by international companies were $28.8 billion, a decrease of 4.0%, including an operational decline of 1.7%, and a negative currency impact of 2.3% as compared to the fiscal nine months sales of 2019. In the fiscal nine months of 2020, the net impact of acquisitions and divestitures on the international operational sales growth was a negative 0.4%.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the fiscal nine months of 2020, sales by companies in Europe experienced a decline of 0.7%, which included an operational increase of 0.1% and a negative currency impact of 0.8%. Sales by companies in the Western Hemisphere, excluding the U.S., experienced a decline of 11.6%, which included an operational decline of 0.4%, and a negative currency impact of 11.2%. Sales by companies in the Asia-Pacific, Africa region experienced a decline of 5.1%, including an operational decline of 4.3% and a negative currency impact of 0.8%.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center;"><img src="jnj-20200927_g1.jpg" alt="jnj-20200927_g1.jpg" style="height:293px;width:324px;"/><img src="jnj-20200927_g2.jpg" alt="jnj-20200927_g2.jpg" style="height:293px;width:324px;"/></div><div><span><br/></span></div><div style="padding-left:180pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">Note: values may have been rounded</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the fiscal third quarter of 2020, worldwide sales were $21.1 billion, a total increase of 1.7%, and operational increase of 1.7% as compared to 2019 fiscal third quarter sales of $20.7 billion. In the fiscal third quarter of 2020, the net impact of acquisitions and divestitures on worldwide operational sales growth was a negative 0.3%. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Sales by U.S. companies were $11.1 billion in the fiscal third quarter of 2020, which represented an increase of 2.7% as compared to the prior year. In the fiscal third quarter of 2020, the net impact of acquisitions and divestitures on the U.S. operational sales growth was a negative 0.1%.  Sales by international companies were $10.0 billion, a total increase of 0.6%, and an operational increase of 0.6%. In the fiscal third quarter of 2020, the net impact of acquisitions and divestitures on the international operational sales growth was a negative 0.5%. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the fiscal third quarter of 2020, sales by companies in Europe achieved growth of 8.0%, which included operational growth of 4.6% and a positive currency impact of 3.4%. Sales by companies in the Western Hemisphere, excluding the U.S., experienced a decline of 12.9%, which included an operational decline of 1.2%, and a negative currency impact of 11.7%. Sales by companies in the Asia-Pacific, Africa region experienced a decline of 2.7%, including an operational decline of 3.2% and a positive currency impact of 0.5%.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:18pt;text-align:center;"><span><br/></span></div><div style="text-align:center;"><img src="jnj-20200927_g3.jpg" alt="jnj-20200927_g3.jpg" style="height:293px;width:324px;"/><img src="jnj-20200927_g4.jpg" alt="jnj-20200927_g4.jpg" style="height:293px;width:324px;"/></div><div style="padding-left:180pt;"><span><br/></span></div><div style="padding-left:180pt;"><span><br/></span></div><div style="padding-left:180pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">Note: values may have been rounded</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div style="padding-left:180pt;"><span><br/></span></div><div style="padding-left:180pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Analysis of Sales by Business Segments</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Consumer Health* </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consumer Health segment sales in the fiscal nine months of 2020 were $10.4 billion, an increase of 1.0% as compared to the same period a year ago, including operational growth of 3.4% and a negative currency impact of 2.4%. U.S. Consumer Health segment sales increased by 11.1%.  International Consumer Health segment sales decreased by 6.4%, including an operational decline of 2.2% and a negative currency impact of 4.2%.  In the fiscal nine months of 2020, the net impact of acquisitions and divestitures on the Consumer Health segment operational sales growth was a negligible. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Major Consumer Health* Franchise Sales &#8212; Fiscal Nine Months Ended</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.492%;"><tr><td style="width:1.0%;"></td><td style="width:42.470%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.556%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.397%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.556%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.397%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.556%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.036%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.556%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.582%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.556%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.738%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operations<br/>Change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency<br/>Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">OTC</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,639&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,249&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Skin Health/Beauty**</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,273&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,443&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oral Care</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,204&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,135&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Baby Care</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,110&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,254&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Women&#8217;s Health</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">664&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">733&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Wound Care/Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">545&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">516&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Consumer Health* Sales</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,435</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,331</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.4</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">* Previously referred to as Consumer</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">** Previously referred to as Beauty</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consumer Health segment sales in the fiscal third quarter of 2020 were $3.5 billion, an increase of 1.3% as compared to the same period a year ago, including operational growth of 3.0% and a negative currency impact of 1.7%. U.S. Consumer Health segment sales increased by 11.6%. International Consumer Health segment sales decreased by 5.6%, including an operational decline of 2.7% and a negative currency impact of 2.9%. In the fiscal third quarter of 2020, the net impact of acquisitions and divestitures on the Consumer Health segment operational sales growth was a negative 0.1%. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Major Consumer Health* Franchise Sales &#8212; Fiscal Third Quarter Ended</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.640%;"><tr><td style="width:1.0%;"></td><td style="width:43.159%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.555%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.380%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.555%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.380%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.555%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.416%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.555%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.567%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.555%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.723%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operations<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency<br/>Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">OTC</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,142&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,098&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Skin Health/Beauty**</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,151&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oral Care</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">412&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">379&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Baby Care</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">393&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">417&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Women&#8217;s Health</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">230&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">255&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Wound Care/Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">189&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">168&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Consumer Health* Sales</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,514</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,469</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">* Previously referred to as Consumer</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">** Previously referred to as Beauty</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The OTC franchise achieved operational growth of 4.0% as compared to the prior year fiscal third quarter. Growth was primarily attributable to sales from TYLENOL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> driven by COVID-19 stocking demand, digestive health products in the U.S. and ZARBEES</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Naturals. International sales were negatively impacted by COVID-19.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Skin Health/Beauty franchise achieved operational growth of 0.9% as compared to the prior year fiscal third quarter. Growth was primarily attributable to OGX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and DR. CI:LABO products partially offset by negative COVID-19 related impacts in the U.S., Asia Pacific and Latin America regions and competitive pressure. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Oral Care franchise achieved operational growth of 10.8% as compared to the prior year fiscal third quarter primarily due to sales of LISTERINE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">mouthwash related to COVID-19 stocking demand globally and new product launches in Asia Pacific.</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Baby Care franchise experienced an operational decline of 0.7% as compared to the prior year fiscal third quarter. The decline was primarily due to COVID-19 related impacts and the Baby Center divestiture in the U.S. partially offset by strength in AVEENO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">baby. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Women&#8217;s Health franchise experienced an operational decline of 4.1% as compared to the prior year fiscal third quarter primarily driven by price reductions and COVID-19 impacts. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Wound Care/Other franchise achieved operational growth of 13.5% as compared to the prior year fiscal third quarter. Growth was due to strong performance of BAND-AID</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Brand Adhesive Bandages in the U.S. and COVID-19 related demand in the Asia Pacific region.</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Pharmaceutical</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pharmaceutical segment sales in the fiscal nine months of 2020 were $33.3 billion, an increase of 5.2% as compared to the same period a year ago, with an operational increase of 6.1% and a negative currency impact of 0.9%. U.S. Pharmaceutical sales increased 5.2% as compared to the same period a year ago. International Pharmaceutical sales increased by 5.3%, including operational growth of 7.4% and a negative currency impact of 2.1%.  In the fiscal nine months of 2020, the net impact of acquisitions and divestitures on the Pharmaceutical segment operational sales growth was a negative 0.2%. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Major Pharmaceutical Therapeutic Area Sales** &#8212; Fiscal Nine Months Ended</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:48.457%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.519%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.371%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.749%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.602%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.017%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operations<br/>Change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency<br/>Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Immunology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,950</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,428</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.0</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.7</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,846&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,345&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;SIMPONI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/ SIMPONI ARIA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,667&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,673&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;STELARA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,463&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,661&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;TREMFYA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">965&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">742&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other Immunology</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Infectious Diseases</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,662</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,547</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.5</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.1</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;EDURANT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/rilpivirine</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">716&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">639&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ PREZCOBIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ REZOLSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ SYMTUZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,615&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,566&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other Infectious Diseases</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">331&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">342&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:12pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Neuroscience</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,850</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,762</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;CONCERTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/methylphenidate</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">469&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">544&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ XEPLION</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ INVEGA TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ TREVICTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,688&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,459&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;RISPERDAL CONSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">475&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">528&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other Neuroscience</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,218&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,231&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,933</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,976</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.0</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.1</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;DARZALEX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,937&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,168&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;ERLEADA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">519</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">216</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,011&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,536&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;VELCADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">311&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">636&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(51.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(50.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/ abiraterone acetate</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,848&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,118&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other Oncology</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">308&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">303&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pulmonary Hypertension</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,283</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,000</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.1</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.6</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,187&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,001&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">792&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">611&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;Other Pulmonary Hypertension</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">304&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">388&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cardiovascular / Metabolism / Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,625</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,936</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,716&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,704&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/ INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">578&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">558&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;PROCRIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/EPREX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">423&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">607&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">908&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,067&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Pharmaceutical Sales</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,304</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,650</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.2</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.1</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">* Percentage greater than 100% or not meaningful</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">**Certain prior year amounts have been reclassified to conform to current year presentation</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Previously included in Other Oncology</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Inclusive of TRACLEER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">which was previously disclosed separately</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pharmaceutical segment sales in the fiscal third quarter of 2020 were $11.4 billion, an increase of 5.0% as compared to the same period a year ago, with an operational increase of 4.6% and a positive currency impact of 0.4%. U.S. Pharmaceutical sales increased 1.5% as compared to the same period a year ago. International Pharmaceutical sales increased by 9.7%, including operational growth of 8.8% and a positive currency impact of 0.9%. In the fiscal third quarter of 2020, the net impact of acquisitions and divestitures on the Pharmaceutical segment operational sales growth was a negative 0.1%.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Major Pharmaceutical Therapeutic Area Sales** &#8212; Fiscal Third Quarter Ended</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:47.572%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.961%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.961%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.307%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.602%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.312%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operations<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency<br/>Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Immunology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,789</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,711</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">921&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,136&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;SIMPONI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/ SIMPONI ARIA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">592&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">586&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;STELARA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,947&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,698&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;TREMFYA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">327&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">290&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other Immunology</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;Infectious Diseases</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">864</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">839</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;EDURANT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/rilpivirine</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">236&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">218&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ PREZCOBIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ REZOLSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">SYMTUZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">526&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">508&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other Infectious Diseases</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">102&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">113&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;Neuroscience</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,605</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,595</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;CONCERTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/ methylphenidate</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">193&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ XEPLION</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ INVEGA TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">TREVICTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">926&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">851&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;RISPERDAL CONSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">167&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other Neuroscience</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">377&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">384&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;Oncology</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,129</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,761</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.3</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.4</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;DARZALEX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,099&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">765&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;ERLEADA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">206&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">86&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,031&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">921&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;VELCADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">105&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/ abiraterone acetate</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">590&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other Oncology</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">98&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;Pulmonary Hypertension</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">749</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">654</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.5</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.9</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">392&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">347&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">260&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;Other Pulmonary Hypertension</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">97&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">96&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;Cardiovascular / Metabolism / Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,281</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,316</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">630&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">613&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/ INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">224&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">179&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;PROCRIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/ EPREX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">198&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">294&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">325&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Pharmaceutical Sales</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,418</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,877</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.0</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.6</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">* Percentage greater than 100% or not meaningful</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">**Certain prior year amounts have been reclassified to conform to current year presentation</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Previously included in Other Oncology</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Inclusive of TRACLEER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">which was previously disclosed separately</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Immunology products achieved operational growth of 1.9% as compared to the same period a year ago driven by strong uptake of STELARA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (ustekinumab) in Crohn's disease and Ulcerative Colitis and strength in TREMFYA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(guselkumab) in Psoriasis. This was partially offset by COVID-19 related demand and lower sales of REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(infliximab) due to increased discounts/rebates and biosimilar competition. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The patents for REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(infliximab)</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in certain countries in Europe expired in February 2015. Biosimilar versions of REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> have been introduced in certain markets outside the United States, resulting in a reduction in sales of REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> in those markets.  Additional biosimilar competition will likely result in a further reduction in REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> sales in markets outside the United States.&#160;In the United States, a biosimilar version of REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> was introduced in 2016, and additional competitors continue to enter the market. Continued infliximab biosimilar competition in the U.S. market will result in a further reduction in U.S. sales of REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Infectious disease products achieved operational growth of 2.6% as compared to the same period a year ago primarily due to strong sales of SYMTUZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in the U.S. and the launch uptake of </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">JULUCA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> This was partially offset by lower sales of PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">and PREZCOBIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">/REZOLSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> due to increased competition and loss of exclusivity of PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in certain countries outside the U.S. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Neuroscience products achieved operational sales growth of 0.4% as compared to the same period a year ago. Paliperidone long-acting injectables growth driven by sales of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">/XEPLION</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (paliperidone palmitate) and INVEGA TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">/TREVICTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> from new patient starts and persistence. The growth was partially offset by cannibalization of RISPERDAL CONSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(risperidone), declines in U.S. CONCERTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(methylphenidate) due to competitive entrants and the negative impact of COVID-19. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Oncology products achieved strong operational sales growth of 12.4% as compared to the same period a year ago. Contributors to the growth were strong sales of DARZALEX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (daratumumab) driven by patient uptake in all lines of therapy,  IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (ibrutinib) due to increased patient uptake globally partially offset by a one-time sales return in the prior year and the continued global launch uptake of ERLEADA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (apalutamide). Additionally, the growth was negatively impacted declining sales of  ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(abiraterone acetate) and VELCADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(bortezomib) due to generic competition.   </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pulmonary Hypertension achieved operational sales growth of 13.9% as compared to the same period a year ago. Sales growth of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (macitentan) and UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (selexipag) were due to continued share gains, market growth and payer mix, partially offset by the impact of COVID-19.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cardiovascular / Metabolism / Other products experienced an operational decline of 2.5% as compared to the same period a year ago. Sales growth of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">/INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (canagliflozin) were due to market growth and favorable channel mix dynamics in the U.S. and strength in the European region. The growth of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(rivaroxaban) included a one-time pricing adjustment in 2020 and demand growth partially offset by higher rebates. Lower sales of PROCRIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">/ EPREX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(epoetin alfa) were due to biosimilar competition. </span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Medical Devices</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Medical Devices segment sales in the fiscal nine months of 2020 were $16.4 billion, a decrease of 15.3% as compared to the same period a year ago, with an operational decline of 14.6% and a negative currency impact of 0.7%. U.S. Medical Devices sales decreased 15.1%. International Medical Devices sales decreased by 15.5%, including an operational decline of 14.1% and a negative currency impact of 1.4%. In the fiscal nine months of 2020, the net impact of acquisitions and divestitures on the Medical Devices segment operational sales growth was a negative 0.9% primarily due to the divestiture of the ASP business. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Major Medical Devices Franchise Sales* &#8212; Fiscal Nine Months Ended</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:496.50pt;"><tr><td style="width:1.0pt;"></td><td style="width:228.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:55.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:54.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:43.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:42.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:42.25pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operations<br/>Change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency<br/>Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Surgery</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,803</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,059</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Advanced</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,723&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,019&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;General</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,080&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,040&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Orthopaedics</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,572</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,566</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Hips</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">908&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,061&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Knees</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">825&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,085&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Trauma</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,892&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,034&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;Spine, Sports &amp; Other</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,947&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,384&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vision</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,843</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,483</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Contact Lenses/Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,198&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,559&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Surgical</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">645&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">923&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interventional Solutions</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,153</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,223</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Medical Devices Sales</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,370</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,331</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">*Certain prior year amounts have been reclassified to conform to current year presentation</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Includes</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Specialty Surgery which was previously disclosed separately</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Previously referred to as Spine &amp; Other</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Medical Devices segment sales in the fiscal third quarter of 2020 were $6.2 billion, a decrease of 3.6% as compared to the same period a year ago, with an operational decline of 3.9% and a positive currency impact of 0.3%. U.S. Medical Devices sales increased 1.2%. International Medical Devices sales decreased by 8.1%, including an operational decline of 8.5% partially offset by a positive currency impact of 0.4%. In the fiscal third quarter of 2020, the net impact of acquisitions and divestitures on the Medical Devices segment operational sales growth was a negative 0.6%. While results in the fiscal third quarter were net negatively impacted by COVID-19, primarily related to reduced procedures, the Company did see improvement throughout the quarter as countries and states began to gradually re-open. For example, sales in the U.S. returned to gradual growth in the fiscal third quarter. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">However, the ultimate COVID-19 impact on Medical Devices fiscal year sales remains highly fluid and will continue to evolve with geographical re-openings and virus waves. </span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Major Medical Devices Franchise Sales* &#8212; Fiscal Third Quarter Ended</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:507.75pt;"><tr><td style="width:1.0pt;"></td><td style="width:235.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:55.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:52.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:46.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:43.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:45.25pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operations<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency<br/>Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Surgery</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,152</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,311</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Advanced</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,010&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;General</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,301&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Orthopaedics</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,083</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,138</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Hips</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">345&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">336&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Knees</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">308&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">344&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Trauma</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">685&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">677&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;Spine, Sports &amp; Other</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">745&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">778&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vision</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,081</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,193</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Contact Lenses/Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">830&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">893&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Surgical</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">251&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">299&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interventional Solutions</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">836</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.9</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.4</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Medical Devices Sales</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,150</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,383</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3</span><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">*Certain prior year amounts have been reclassified to conform to current year presentation</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Includes</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Specialty Surgery which was previously disclosed separately</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Previously referred to as Spine &amp; Other</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">    </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Surgery franchise experienced an operational sales decline of 6.9% as compared to the prior year fiscal third quarter. The operational decline in Advanced Surgery was primarily driven by the negative impact of COVID-19 and competitive pressures in the U.S. This was partially offset by global growth in Biosurgery led by share gains from SURGIFLO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">which was positively impacted due to the recovery of an isolated supply disruption in the prior year. The operational decline in General Surgery was primarily driven by the negative impact of COVID-19.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Orthopaedics franchise experienced an operational sales decline of 3.1% as compared to the prior year fiscal third quarter. The operational growth in hips was driven by market procedure recovery as well as our leadership in the Anterior approach, strong market demand for the ACTIS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> stem and enabling technologies &#8211; KINCISE&#8482; and VELYS&#8482; Hip Navigation. The operational decline in knees was driven by the negative impact of COVID-19. The operational growth in Trauma was driven by procedures rebounding and strength from new products. The operational decline in Spine, Sports &amp; Other was driven by the negative impact of COVID-19 partially offset by the uptake of the SYMPHONY</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#8482;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Occipito-Cervico-Thoracic (OCT) System in Spine.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Vision franchise experienced an operational sales decline of 9.5% as compared to the prior year fiscal third quarter. The  Contact Lenses/Other operational decline was due to the negative impact of COVID-19 which was partially offset by growth in the U.S. driven by higher level of stocking. The Surgical operational decline was primarily driven by the negative impact of COVID-19 and competitive pressures in the U.S.     </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Interventional Solutions franchise achieved operational growth of 12.4% as compared to the prior year fiscal third quarter driven by atrial fibrillation procedure growth coupled with strength from new products.  </span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">ANALYSIS OF CONSOLIDATED EARNINGS BEFORE PROVISION FOR TAXES ON INCOME </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated earnings before provision for taxes on income for the fiscal nine months of 2020 was $14.9 billion representing 24.7% of sales as compared to $13.1 billion in the fiscal nine months of 2019, representing 21.4% of sales.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated earnings before provision for taxes on income for the fiscal third quarter of 2020 was $4.4 billion representing 20.9% of sales as compared to $1.6 billion in the fiscal third quarter of 2019, representing 7.9% of sales. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cost of Products Sold </span></div><div style="text-align:center;"><img src="jnj-20200927_g5.jpg" alt="jnj-20200927_g5.jpg" style="height:190px;width:250px;"/><img src="jnj-20200927_g6.jpg" alt="jnj-20200927_g6.jpg" style="height:130px;width:240px;"/></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">(Dollars in billions. Percentages in chart are as a percent to total sales)</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Fiscal Nine months Q3 2020 versus Fiscal Nine months Q3 2019</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cost of products sold increased as a percent to sales driven by:</span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt;">Medical Device idle capacity costs associated with COVID-19 related production slow downs and fixed cost deleveraging.</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">Establishment of obsolescence reserves associated with the impact of COVID-19 in the Medical Devices business </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The intangible asset amortization expense included in cost of products sold for the fiscal nine months of 2020 and 2019 was $3.4 billion and $3.3 billion, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Q3 2020 versus Q3 2019</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cost of products sold remained flat as a percent to sales driven by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt;">Medical Device idle capacity costs associated with COVID-19 related production slow downs and fixed cost deleveraging. </span></div><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">partially offset by:</span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">Favorable mix within the Pharmaceutical and Consumer businesses.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The intangible asset amortization expense included in cost of products sold for the fiscal third quarters of 2020 and 2019 was $1.2 billion and $1.1 billion, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Selling, Marketing and Administrative Expenses</span></div><div><span><br/></span></div><div style="text-align:center;"><img src="jnj-20200927_g7.jpg" alt="jnj-20200927_g7.jpg" style="height:190px;width:250px;"/><img src="jnj-20200927_g8.jpg" alt="jnj-20200927_g8.jpg" style="height:155px;width:250px;"/></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">(Dollars in billions. Percentages in chart are as a percent to total sales)</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Fiscal Nine months Q3 2020 versus Fiscal Nine months Q3 2019</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Selling, Marketing and Administrative Expenses decreased as a percent to sales driven by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Leveraging in the Pharmaceutical business </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Planned prioritization and reduced brand marketing expense in the Consumer Health business</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Favorable product mix with a higher percentage of sales coming from the Pharmaceutical business</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;partially offset by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Deleveraging in the Medical Devices business resulting from the COVID-19 impact on sales  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Q3 2020 versus Q3 2019</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Selling, Marketing and Administrative Expenses decreased as a percent to sales driven by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Expense leveraging in the Pharmaceutical business </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Favorable segment mix with a higher percentage of sales coming from the Pharmaceutical business</span></div><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">partially offset by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Deleveraging in the Medical Devices business resulting from the COVID-19 impact on sales </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Increased brand marketing expense in the Consumer Health business</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Research and Development Expense</span></div><div style="text-align:center;"><img src="jnj-20200927_g9.jpg" alt="jnj-20200927_g9.jpg" style="height:200px;width:254px;"/><img src="jnj-20200927_g10.jpg" alt="jnj-20200927_g10.jpg" style="height:170px;width:254px;"/></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">(Dollars in billions. Percentages in chart are as a percent to total sales)</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Fiscal Nine months Q3 2020 versus Fiscal Nine months Q3 2019</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Research and Development increased slightly as a percent to sales driven by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Higher upfront/milestone payments in the fiscal nine months of 2019, primarily related to the argenx collaboration</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;partially offset by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The negative COVID-19 impact on Medical Devices sales</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Increased investment in the Medical Devices business related to robotics and digital programs </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Q3 2020 versus Q3 2019</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Research and Development increased as a percent to sales driven by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">Portfolio progression including the COVID-19 vaccine in the Pharmaceutical business</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The negative COVID-19 impact on Medical Devices sales</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Increased investment in the Medical Devices business related to robotics and digital programs </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Segment mix with a higher percentage of sales coming from the Pharmaceutical business</span></div><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">partially offset by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Lower upfront/milestone payments in the fiscal third quarter of 2020</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Research and Development costs for the remainder of the fiscal year will include incremental investment spending associated with vaccines and the recently completed Momenta Pharmaceuticals acquisition to advance the pipeline.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">In-Process Research and Development (IPR&amp;D)</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the fiscal third quarter and fiscal nine months of 2020, the Company recorded a partial IPR&amp;D charge of $0.1 billion related to timing and progression of the digital surgery platforms acquired with the Auris Health acquisition. In the fiscal first quarter of 2019, the Company recorded an IPR&amp;D charge of $0.9 billion for the remaining intangible asset value related to the development program of AL-8176, an investigational drug for the treatment of Respiratory Syncytial Virus (RSV) and human metapneumovirus (hMPV) acquired with the 2014 acquisition of Alios Biopharma Inc. The impairment charge was based on </span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">additional information, including clinical data, which became available and led to the Company's decision to abandon the development of AL-8176. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Interest (Income) Expense</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Interest (Income) Expense in the fiscal nine months of 2020 was a net interest expense of $16 million as compared to income of $43 million in same period a year ago. This was primarily due to reduced interest income resulting from lower rates of interest earned on cash balances and a higher average debt balance. Interest (Income) Expense in the fiscal third quarter of 2020 was a net interest expense of $32 million as compared to income of $41 million in the same period a year ago. This was primarily due to reduced interest income resulting from lower rates of interest earned on cash balances and a higher average debt balance. The balance of cash, cash equivalents and current marketable securities was $30.8&#160;billion at the end of the fiscal third quarter of 2020 as compared to $17.9 billion at the end of the fiscal third quarter of 2019. The Company&#8217;s debt position was $37.8 billion as of September 27, 2020 as compared to $29.2 billion the same period a year ago. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Other (Income) Expense, Net</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Fiscal Nine months Q3 2020 versus Fiscal Nine months Q3 2019</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other (income)&#160;expense, net for the fiscal nine months of 2020 was favorable by $2.0 billion as compared to the prior year primarily due to the following:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.377%;"><tr><td style="width:1.0%;"></td><td style="width:49.274%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:2.648%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.243%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:2.648%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.693%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:2.348%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.146%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Billions)(Income)/Expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Litigation expense</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Acquisition and Integration related</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized (gains)/losses on securities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity step-up gain related to DR. CI:LABO </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Divestiture Gains</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restructuring related</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Other (Income) Expense, Net</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">2019 included higher litigation expense primarily related to the agreement in principle to settle opioid litigation </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">2020 is primarily driven by a contingent consideration reversal of approximately $1.1 billion related to the timing of certain developmental milestones associated with the Auris Health acquisition.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(3) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">2019 included the divestiture of ASP  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Q3 2020 versus Q3 2019</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other (income)&#160;expense, net for the fiscal third quarter of 2020 was favorable by $3.0 billion as compared to the prior year primarily due to the following:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.377%;"><tr><td style="width:1.0%;"></td><td style="width:49.274%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:2.648%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.243%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:2.648%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.693%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:2.348%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.146%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Billions)(Income)/Expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Litigation expense</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisition and Integration related</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized (gains)/losses on securities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Other (Income) Expense, Net</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">2019 included higher litigation expense primarily related to the agreement in principle to settle opioid litigation</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">  </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"> </span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> EARNINGS BEFORE PROVISION FOR TAXES BY SEGMENT</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Income before tax by segment of business for the fiscal nine months were as follows:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.525%;"><tr><td style="width:1.0%;"></td><td style="width:24.498%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.398%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.726%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.398%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.277%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.398%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.426%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.398%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.726%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.398%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.726%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.398%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.333%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income Before Tax</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment Sales</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent of Segment Sales</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consumer Health</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">993&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,800&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,435&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,331&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharmaceutical</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,787&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,786&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,304&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,650&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Medical Devices</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,681&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,078&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,370&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,331&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment earnings before tax</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,461&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,664&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60,109&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61,312&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Less: Expenses not allocated to segments </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">611&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">554&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Worldwide income before tax</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,850&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,110&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60,109&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61,312&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Income before tax by segment of business for the fiscal third quarters were as follows:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:23.678%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.846%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.551%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.551%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.846%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.256%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.150%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income Before Tax</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment Sales</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent of Segment Sales</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consumer Health</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">191&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">653&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,514&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,469&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharmaceutical</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,439&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(222)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,418&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,877&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Medical Devices</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,010&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,392&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,150&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,383&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment earnings before tax</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,640&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,823&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,082&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,729&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Less: Expenses not allocated to segments </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">239&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">176&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Worldwide income before tax</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,401&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,647&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,082&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,729&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Amounts not allocated to segments include interest (income) expense and general corporate (income) expense. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Consumer Health Segment</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Consumer Health segment income before tax as a percent of sales in the fiscal nine months of 2020 was 9.5% versus 17.4% for the same period a year ago. The decrease in the income before tax as a percent of sales in the fiscal nine months of 2020 as compared to the prior year was primarily driven by the following:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt;">Higher litigation expense of $1.2 billion in 2020 vs. $0.2 billion in 2019 (primarily associated with talc related costs, including certain settlements) </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The fiscal nine months of 2019 included a gain of $0.3 billion related to the Company's previously held equity investment in DR. CI:LABO </span></div><div style="padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">partially offset by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Planned prioritization and reduced brand marketing expense in the fiscal nine months of 2020</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Consumer Health segment income before tax as a percent of sales in the fiscal third quarter of 2020 was 5.4% versus 18.8% for the same period a year ago. The decrease in the income before tax as a percent of sales in the fiscal third quarter of 2020 as compared to the prior year was primarily driven by the following:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt;">Higher litigation expense of $0.5 billion in 2020 vs. $0.0 billion in 2019 (primarily associated with talc related costs, including certain settlements)</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Increased brand marketing expense</span></div><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">partially offset by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Favorable product mix </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Pharmaceutical Segment</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Pharmaceutical segment income before tax as a percent of sales in the fiscal nine months of 2020 was 35.4% versus 18.3% for the same period a year ago. The increase in the income before tax as a percent of sales for the fiscal nine months of 2020 as compared to the prior year was primarily driven by the following:</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div style="text-indent:-18pt;padding-left:36pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#8226;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:15.73pt;">Lower litigation expense of $1.0 billion in 2020 vs. $4.3 billion in 2019 (primarily related to the agreement in principle to settle opioid litigation, $4.0 billion in 2019 and $1.0 billion in 2020)</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">An in-process research and development charge of $0.9 billion in the fiscal nine months of 2019 related to Alios</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Lower research and development expense in 2020. The fiscal nine months of 2019 included a $0.3 billion upfront payment to argenx</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Lower acquisition and integration related costs in 2020</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Leveraging in selling, marketing and administrative expense</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Pharmaceutical segment income before tax as a percent of sales in the fiscal third quarter of 2020 was 30.1% versus (2.0)% for the same period a year ago. The increase in the income before tax as a percent of sales for the fiscal third quarter of 2020 as compared to the prior year was primarily driven by the following:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;vertical-align:top;">&#8226;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.44pt;">Lower litigation expense of $1.0 billion in 2020 vs. $4.0 billion in 2019 (primarily related to the agreement in principle to settle opioid litigation)</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Leveraging in selling, marketing and administrative expense</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Favorable product mix</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Medical Devices Segment</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Medical Devices segment income before tax as a percent of sales in the fiscal nine months of 2020 was 16.4% versus 31.4% for the same period a year ago. The decrease in the income before tax as a percent of sales for the fiscal nine months was primarily driven by the following:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">A gain of $2.0 billion related to the ASP divestiture recorded in the fiscal nine months of 2019</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">COVID-19 period costs and fixed costs deleveraging and idle capacity charges in Cost of Products Sold in the fiscal nine months of 2020</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The negative impact of COVID-19 on sales in the fiscal nine months of 2020</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">An in-process research and development charge of $0.1 billion in 2020 related to the Auris Health acquisition</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">   &#160;&#160;&#160;&#160;partially offset by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">A contingent consideration reversal of approximately $1.1 billion in the fiscal nine months of 2020 related to the timing of certain developmental milestones associated with the Auris Health acquisition</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Litigation expense was insignificant in 2020 vs. $0.3 billion in 2019 </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Medical Devices segment income before tax as a percent of sales in the fiscal third quarter of 2020 was 16.4% versus 21.8% for the same period a year ago. The decrease in the income before tax as a percent of sales for the fiscal third quarter was primarily driven by the following:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">COVID-19 period costs and fixed costs deleveraging and idle capacity charges in Cost of Products Sold in the fiscal third quarter of 2020</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The negative impact of COVID-19 on sales in the fiscal third quarter of 2020</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">An in-process research and development charge of $0.1 billion in 2020 related to the Auris Health acquisition</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">   &#160;&#160;&#160;&#160;partially offset by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">A contingent consideration reversal of approximately $0.2 billion in the fiscal third quarter of 2020 related to the timing of certain developmental milestones associated with the Auris Health acquisition </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Restructuring</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the second quarter of 2018, the Company announced plans to implement actions across its global supply chain that are intended to enable the Company to focus resources and increase investments in critical capabilities, technologies and solutions necessary to manufacture and supply its product portfolio of the future, enhance agility and drive growth. The Company expects these supply chain actions will include expanding its use of strategic collaborations, and bolstering its initiatives to reduce complexity, improving cost-competitiveness, enhancing capabilities and optimizing its network.&#160;Discussions regarding specific future actions are ongoing and are subject to all relevant consultation requirements before they are finalized. In total, the Company expects these actions to generate approximately $0.6 to $0.8 billion in annual pre-tax cost savings that will be substantially delivered by 2022. The Company expects to record pre-tax restructuring charges of approximately $1.9 to $2.3 billion. In the fiscal nine months of 2020, the Company recorded a pre-tax charge of $363 million, which is included on the following lines of the Consolidated Statement of Earnings, $187 million in restructuring, $69 million in cost of products sold and $107 million in other (income) expense. In the fiscal third quarter of 2020, the Company recorded a pre-tax charge of $130 million, which is included on the following lines of the Consolidated Statement of Earnings, $68 million in restructuring, $32 million in cost of products sold and $30 million in other (income) expense. In the fiscal nine months of 2019, the Company recorded a pre-tax charge of $360 million, which is included on the following lines of the Consolidated Statement of Earnings, $162 million in restructuring, $81 million in cost of products sold and $117 million in other (income) expense. In the </span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">fiscal third quarter of 2019, the Company recorded a pre-tax charge of $128 million, which is included on the following lines of the Consolidated Statement of Earnings, $69 million in restructuring, $20 million in cost of products sold and $39 million in other (income) expense.  Restructuring charges of approximately $1.2 billion have been recorded since the restructuring was announced.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See Note&#160;12 to the Consolidated Financial Statements for additional details related to the restructuring.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Provision for Taxes on Income</span></div><div><span><br/></span></div><div style="padding-right:2.25pt;margin-top:2.7pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For discussion related to the fiscal nine months of 2020 provision for taxes refer to Note&#160;5 to the Consolidated Financial Statements. </span></div><div style="padding-right:2.25pt;margin-top:2.7pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">During the second quarter of 2020, the Internal Revenue Service proposed regulations that may, if issued in their current form, limit the tax deductibility of the payments under the agreement in principle to settle opioid litigation that was initially accrued for in fiscal 2019 for $4.0 billion and an additional $1.0 billion in the fiscal third quarter of 2020 at an effective rate of 21.4%</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;"> </span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(for more information see Note 21 in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019). The financial impact of these regulations may be material to the Company&#8217;s financial results in the period in which they are finalized which could be later in fiscal 2020.</span></div><div style="margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">LIQUIDITY AND CAPITAL RESOURCES </span></div><div><span><br/></span></div><div style="text-align:center;"><img src="jnj-20200927_g11.jpg" alt="jnj-20200927_g11.jpg" style="height:184px;width:193px;"/><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">    </span><img src="jnj-20200927_g12.jpg" alt="jnj-20200927_g12.jpg" style="height:184px;width:200px;"/><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">    </span><img src="jnj-20200927_g13.jpg" alt="jnj-20200927_g13.jpg" style="height:184px;width:193px;"/></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cash Flows</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cash and cash equivalents were $19.0&#160;billion at the end of the fiscal third quarter of 2020 as compared with $17.3&#160;billion at the end of fiscal year 2019. The primary sources and uses of cash that contributed to the $1.7&#160;billion increase were:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.542%;"><tr><td style="width:1.0%;"></td><td style="width:21.364%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:76.436%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars In Billions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Q4 2019 Cash and cash equivalents balance</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">cash generated from operating activities</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">net cash used by investing activities</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">net cash used by financing activities</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">effect of exchange rate and rounding</span></td></tr><tr><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:1pt solid #000;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Q3 2020 Cash and cash equivalents balance</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, the Company had $11.8 billion in marketable securities at the end of the fiscal third quarter of 2020 and $2.0 billion at the end of fiscal year 2019.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cash flow from operations of $15.2&#160;billion was the result of:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.575%;"><tr><td style="width:1.0%;"></td><td style="width:19.424%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:78.376%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars In Billions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Earnings</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">non-cash expenses and other adjustments primarily for depreciation and amortization, stock-based compensation, asset write-downs and credit losses and accounts receivable allowances partially offset by the deferred tax provision and net gain on sale of assets/businesses  </span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">decrease in accounts payable and accrued liabilities</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">an increase in accounts receivable, inventories and other current and non-current liabilities and other current and non-current assets</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">contingent consideration reversal (related to the timing of certain developmental milestones associated with the Auris Health acquisition) and rounding</span></td></tr><tr><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:1pt solid #000;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash Flow from operations</span></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Investing activities use of $12.9 billion of cash was primarily used for:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.575%;"><tr><td style="width:1.0%;"></td><td style="width:19.424%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:78.376%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars In Billions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">primarily related to the acquisitions of bermekimab and related assets from XBiotech Inc. as well as the acquisition of all outstanding shares in Verb Surgical Inc.</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">additions to property, plant and equipment</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">net purchases of investments</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">other (primarily licenses and milestones)</span></td></tr><tr><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-bottom:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-bottom:1pt solid #000;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash used for investing activities</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Financing activities use of $0.5 billion of cash was primarily used for: </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.575%;"><tr><td style="width:1.0%;"></td><td style="width:19.424%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:78.376%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars In Billions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">dividends to shareholders </span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">repurchase of common stock</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">net proceeds from short and long term debt</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">proceeds from stock options exercised/employee withholding tax on stock awards, net</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">other</span></td></tr><tr><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:1pt solid #000;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash used for financing activities</span></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has access to substantial sources of funds at numerous banks worldwide. In September 2020, the Company secured a new 364-day Credit Facility. Total credit available to the Company approximates $10&#160;billion, which expires on September&#160;9, 2021.  Interest charged on borrowings under the credit line agreement is based on either bids provided by banks, the prime rate, London Interbank Offered Rates (LIBOR), or other applicable market rates as allowed under the terms of the agreement, plus applicable margins. Commitment fees under the agreement are not material.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In the fiscal third quarter of 2020, the Company's notes payable and long-term debt was in excess of cash, cash equivalents and marketable securities. As of September 27, 2020, the net debt position was $7.0 billion as compared to the prior year of $11.3 billion. Considering recent market conditions and the on-going COVID-19 crisis, the Company has re-evaluated its operating cash flows and liquidity profile and does not foresee any significant incremental risk. The Company anticipates that operating cash flows, the ability to raise funds from external sources, borrowing capacity from existing committed credit facilities and access to the commercial paper markets will continue to provide sufficient resources to fund operating needs, including the agreement in principle to settle opioid litigation of which the majority may be paid over the next two to three years. In addition, the Company monitors the global capital markets on an ongoing basis and from time to time may raise capital when market conditions are favorable. In the fiscal third quarter of 2020, the Company issued approximately $5.0 billion of commercial paper, with approximately $3.0 billion outstanding at quarter end which had a weighted average interest rate of 0.15% and a weighted average maturity of 1.2 months. In the fiscal third quarter of 2020, the Company issued senior unsecured notes for a total of $7.5 billion at favorable rates. The net proceeds from this offering were used to fund the </span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Momenta Pharmaceuticals, Inc. acquisition on October 1, 2020 and for general corporate purposes</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Additionally, as a result of the Tax Cuts and Jobs Act (TCJA), the Company has access to its cash outside the U.S. at a significantly reduced cost.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the fiscal second quarter of 2020, the Company paid approximately $1.3 billion to the U.S. Treasury related to the normal estimated tax payment for the fiscal first and second quarters of 2020 and the current installment due on foreign undistributed earnings as part of the TCJA (see Note 8 to the Consolidated Financial Statements as contained in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019).</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Dividends</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On July 20, 2020, the Board of Directors declared a regular cash dividend of $1.01 per share, payable on September 8, 2020 to shareholders of record as of August 25, 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On October 22, 2020, the Board of Directors declared a regular cash dividend of $1.01 per share, payable on December 8, 2020 to shareholders of record as of November 24, 2020. The Company expects to continue the practice of paying regular quarterly cash dividends.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">OTHER INFORMATION</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">New Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Refer to Note 1 to the Consolidated Financial Statements for new accounting pronouncements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Economic and Market Factors</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">COVID-19 considerations and business continuity </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has considered various internal and external factors in assessing the potential impact of COVID-19 on its business and financial results based upon information available at this time, as follows:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt;">Operating Model: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has a diversified business model across the healthcare industry with flexibility designed into its manufacturing, research and development clinical operations and commercial capabilities. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt;">Supply Chain: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company continues to leverage its global manufacturing footprint and dual-source capabilities while closely monitoring and maintaining critical inventory at major distribution centers away from high-risk areas to ensure adequate and effective distribution. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt;">Business Continuity: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The robust, active business continuity plans across the Company's network have been instrumental in preparing the Company for events like COVID-19 and the ability to meet the majority of patient and consumer needs remains uninterrupted.  </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt;">Workforce: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has put procedures in place to protect its essential workforce in manufacturing, distribution, commercial and research operations while ensuring appropriate remote working protocols have been established for other employees  </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:12.03pt;">Liquidity:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> The Company's high-quality credit rating allows the Company superior access to the financial capital markets for the foreseeable future. In the fiscal third quarter of 2020, the Company issued approximately $5.0 billion of commercial paper, with approximately $3.0 billion outstanding at quarter end, for additional liquidity at favorable interest rates. Additionally, in the fiscal third quarter of 2020, the Company issued senior unsecured notes for a total of $7.5 billion at favorable rates. The net proceeds from this offering were used to fund the Momenta Pharmaceuticals, Inc. acquisition on October 1, 2020 and for general corporate purposes.</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt;">Domestic and Foreign Legislation: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company will continue to assess and evaluate the on-going global legislative efforts to combat the COVID-19 impact on economies and the sectors in which it participates. Currently, the recent legislative acts put in place are not expected to have a material impact on the Company&#8217;s operations. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In the fiscal second and third quarters of 2020, the Company entered into a series of contract manufacturing arrangements for vaccine production with third party contract manufacturing organizations. These arrangements provide the Company with future supplemental commercial capacity for vaccine production and potentially transferable rights to such production if capacity is not required. Amounts paid and contractually obligated to be paid to these contract manufacturing organizations of approximately $0.8 billion are reflected in the prepaid expenses and other, other assets, accrued liabilities and other liabilities accounts in the Company's consolidated balance sheet upon execution of each agreement. Additionally, the Company has entered into certain vaccine development cost sharing arrangements with government related organizations. </span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company operates in certain countries where the economic conditions continue to present significant challenges. The Company continues to monitor these situations and take appropriate actions. Inflation rates and currency exchange rates continue to have an effect on worldwide economies and, consequently, on the way the Company operates. The Company has accounted for operations in Venezuela and Argentina as highly inflationary, as the prior three-year cumulative inflation rate surpassed 100%. This did not have a material impact on the Company's results in the period. In the face of increasing costs, the Company strives to maintain its profit margins through cost reduction programs, productivity improvements and periodic price increases.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2016, the United Kingdom (U.K.) held a referendum in which voters approved an exit from the European Union (E.U.), commonly referred to as &#8220;Brexit&#8221; and on January 31, 2020, the U.K. formally exited the E.U. Given the lack of comparable precedent, it is unclear what the ultimate financial, trade, regulatory and legal implications the withdrawal of the U.K. from the E.U. will have. Brexit creates global political and economic uncertainty, which may cause, among other consequences, volatility in exchange rates and interest rates, additional cost containment by third-party payors and changes in regulations.&#160; However, the Company currently does not believe that these and other related effects will have a material impact on the Company&#8217;s consolidated financial position or operating results. As of September 27, 2020 and for the fiscal nine months, the business of the Company&#8217;s U.K. subsidiaries represented less than 3% of both the Company&#8217;s consolidated assets and fiscal nine months revenues, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Governments around the world consider various proposals to make changes to tax laws and regulations, which may include increasing or decreasing existing statutory tax rates. A change in statutory tax rate in any country would result in the revaluation of the Company&#8217;s deferred tax assets and liabilities related to that particular jurisdiction in the period in which the new tax law is enacted.&#160; This change would result in an expense or benefit recorded to the Company&#8217;s Consolidated Statement of Earnings.&#160; The Company closely monitors these proposals as they arise in the countries where it operates. Changes to the statutory tax rate may occur at any time, and any related expense or benefit recorded may be material to the fiscal quarter and year in which the law change is enacted. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company faces various worldwide health care changes that may continue to result in pricing pressures that include health care cost containment and government legislation relating to sales, promotions and reimbursement of health care products.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Changes in the behavior and spending patterns of purchasers of health care products and services, including delaying medical procedures, rationing prescription medications, reducing the frequency of physician visits and foregoing health care insurance coverage, may continue to impact the Company&#8217;s businesses.</span></div><div style="text-indent:18pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company also operates in an environment increasingly hostile to intellectual property rights. Firms have filed Abbreviated New Drug Applications or Biosimilar Biological Product Applications with the FDA, initiated Inter Partes Review proceedings in the United States Patent and Trademark Office, or otherwise challenged the coverage and/or validity of the Company's patents, seeking to market generic or biosimilar forms of many of the Company&#8217;s key pharmaceutical products prior to expiration of the applicable patents covering those products. In the event the Company is not successful in defending the patent claims challenged in these actions, generic or biosimilar versions of the products at issue may be introduced to the market, resulting in the potential for substantial market share and revenue losses for those products, and which may result in a non-cash impairment charge in any associated intangible asset. There is also a risk that one or more competitors could launch a generic or biosimilar version of the product at issue following regulatory approval even though one or more valid patents are in place. For further information, see the discussion on &#8220;Litigation Against Filers of Abbreviated New Drug Applications&#8221; in Note&#160;11 to the Consolidated Financial Statements.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">65</span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Item&#160;3 &#8212; QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There has been no material change in the Company&#8217;s assessment of its sensitivity to market risk since its presentation set forth in Item&#160;7A, &#8220;Quantitative and Qualitative Disclosures About Market Risk,&#8221; in its Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019.</span></div><div><span><br/></span></div><div id="ief97c24c8c144887ab2ad376fc457d4d_106"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Item&#160;4 &#8212; CONTROLS AND PROCEDURES</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Disclosure controls and procedures. At the end of the period covered by this report, the Company evaluated the effectiveness of the design and operation of its disclosure controls and procedures. The Company&#8217;s disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act is accumulated and communicated to the Company&#8217;s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Alex Gorsky, Chairman and Chief Executive Officer, and Joseph J. Wolk, Executive Vice President, Chief Financial Officer, reviewed and participated in this evaluation. Based on this evaluation, Messrs.&#160;Gorsky and Wolk concluded that, as of the end of the period covered by this report, the Company&#8217;s disclosure controls and procedures were effective.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Internal control. During the period covered by this report, there were no changes in the Company&#8217;s internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting. The Company has not experienced any material impact to its internal controls over financial reporting despite the fact that most of its employees are working remotely due to the COVID-19 pandemic. The Company proactively took actions to re-evaluate and refine its financial reporting process through additional monitoring controls to provide reasonable assurance that the financial results are reported accurately and timely. The Company continues to monitor and assess the effectiveness of the design and operation of its disclosure controls and procedures. </span></div><div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company is implementing a multi-year, enterprise-wide initiative to integrate, simplify and standardize processes and systems for the human resources, information technology, procurement, supply chain and finance functions. These are enhancements to support the growth of the Company&#8217;s financial shared service capabilities and standardize financial systems. This initiative is not in response to any identified deficiency or weakness in the Company&#8217;s internal control over financial reporting. In conjunction with this initiative, the Company has and will continue to align and streamline the design and operation of its financial control environment.</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">66</span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Part II &#8212; OTHER INFORMATION</span></div><div><span><br/></span></div><div id="ief97c24c8c144887ab2ad376fc457d4d_112"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Item&#160;1 &#8212; LEGAL PROCEEDINGS</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The information called for by this item is incorporated herein by reference to Note 11 included in Part&#160;I, Item&#160;1, Financial Statements (unaudited) &#8212; Notes to Consolidated Financial Statements.</span></div><div><span><br/></span></div><div id="ief97c24c8c144887ab2ad376fc457d4d_115"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Item&#160;2 &#8212; UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(c)&#160;Purchases of Equity Securities by the Issuer and Affiliated Purchasers.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table provides information with respect to Common Stock purchases by the Company during the fiscal third quarter of 2020. Common stock purchases on the open market are made as part of a systematic plan to meet the needs of the Company's compensation programs. The repurchases below also include the stock-for-stock option exercises that settled in the fiscal third quarter.</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:497.25pt;"><tr><td style="width:1.0pt;"></td><td style="width:210.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:58.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:52.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:67.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:84.25pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Month Period</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Total Number</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">of Shares Purchased</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Avg. Price<br/>Per Share</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 29, 2020 through July 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">531,900&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">149.95&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">July 27, 2020 through August 23, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,385,930&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">147.74&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">August 24, 2020 through September 27, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,320,104&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150.00&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,237,934&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> &#160;&#160;&#160;&#160;During the fiscal third quarter of 2020, the Company repurchased an aggregate of 3,237,934 shares of Johnson &amp; Johnson Common Stock in open-market transactions, all of which were purchased as part of a systematic plan to meet the needs of the Company&#8217;s compensation programs.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">67</span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div><span><br/></span></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Item&#160;6 &#8212; EXHIBITS</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;-sec-extract:exhibit;" href="a202010-q3qexhibit311c.htm">Exhibit&#160;31.1 </a><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;-sec-extract:exhibit;" href="a202010-q3qexhibit311c.htm"> </a></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certification of Chief Executive Officer under Rule&#160;13a-14(a) of the Securities Exchange Act pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002 &#8212; Filed with this document.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;-sec-extract:exhibit;" href="a202010-q3qexhibit312c.htm">Exhibit&#160;31.2 </a></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certification of Chief Financial Officer under Rule&#160;13a-14(a) of the Securities Exchange Act pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002 &#8212; Filed with this document.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;-sec-extract:exhibit;" href="a202010-q3qexhibit321c.htm">Exhibit&#160;32.1 </a></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certification of Chief Executive Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 &#8212; Furnished with this document.</span></div><div style="text-indent:11.25pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;-sec-extract:exhibit;" href="a202010-q3qexhibit322c.htm">Exhibit&#160;32.2</a></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Certification of Chief Financial Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 &#8212; Furnished with this document.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Exhibit 101: </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:15.859%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:2.723%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:79.018%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">EX-101.INS</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Instance Document - the instance document does not appear in the Interactive Data File because its                XBRL tags are embedded within the Inline XBRL document</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">EX-101.SCH</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Schema</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">EX-101.CAL</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Calculation Linkbase</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">EX-101.LAB</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Label Linkbase</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">EX-101.PRE</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Presentation Linkbase</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">EX-101.DEF</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Definition Document</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exhibit 104:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cover Page Interactive Data File&#8211;&#8211;the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">68</span></div></div></div><div id="ief97c24c8c144887ab2ad376fc457d4d_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#ief97c24c8c144887ab2ad376fc457d4d_10">Table of Content</a></span></div></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">SIGNATURES</span></div><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.076%;"><tr><td style="width:1.0%;"></td><td style="width:51.460%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:46.340%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">JOHNSON &amp; JOHNSON<br/>(Registrant)&#160;</span></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Date: October 23, 2020</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">By /s/ J. J. WOLK</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">J. J. WOLK</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Executive Vice President, Chief Financial Officer (Principal Financial Officer)&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Date: October 23, 2020</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">By /s/&#160;R. J. DECKER Jr.</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R. J. DECKER Jr.</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Controller (Principal Accounting Officer)&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">69</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>a202010-q3qexhibit311c.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i09dcb7c672bd445ba05dfb9d674ea2f2_1"></div><div style="min-height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Exhibit 31.1</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT </font></div><div style="text-align:center;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">I, Alex Gorsky, certify that&#58;</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> &#160;&#160;&#160;&#160;</font></div><div style="text-indent:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">1. I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended September&#160;27, 2020 (the &#8220;report&#8221;) of Johnson &#38; Johnson (the &#34;Company&#34;)&#59; </font></div><div style="text-indent:36pt;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report&#59; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">4. The Company's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the Company and have&#58; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">c)  Evaluated the effectiveness of the Company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">d)  Disclosed in this report any change in the Company's internal control over financial reporting that occurred during the Company's most recent fiscal quarter (the Company's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting&#59; and</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;5.  The Company's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company's auditors and the audit committee of the Company's board of directors (or persons performing the equivalent functions)&#58; </font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company's internal control over financial reporting.</font></div><div style="padding-left:288pt;"><font><br></font></div><div style="padding-left:288pt;"><font><br></font></div><div style="padding-left:288pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#47;s&#47; Alex Gorsky</font></div><div style="padding-left:288pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#7d7d7d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">__________________________</font></div><div style="text-indent:36pt;padding-left:252pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Alex Gorsky</font></div><div style="text-indent:36pt;padding-left:252pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Chief Executive Officer</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Date&#58;   October&#160;23, 2020</font></div><div><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>a202010-q3qexhibit312c.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="iead7b7d413b94b34a64adce397518200_1"></div><div style="min-height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Exhibit 31.2</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT </font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">I, Joseph J. Wolk, certify that&#58;</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> &#160;&#160;&#160;&#160;</font></div><div style="text-indent:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">1. I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended September&#160;27, 2020 (the &#8220;report&#8221;) of Johnson &#38; Johnson (the &#34;Company&#34;)&#59; </font></div><div style="text-indent:36pt;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report&#59; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">4. The Company's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the Company and have&#58; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">c)  Evaluated the effectiveness of the Company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">d)  Disclosed in this report any change in the Company's internal control over financial reporting that occurred during the Company's most recent fiscal quarter (the Company's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting&#59; and</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;5.  The Company's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company's auditors and the audit committee of the Company's board of directors (or persons performing the equivalent functions)&#58; </font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company's internal control over financial reporting.</font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-indent:36pt;padding-left:252pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:252pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:252pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#47;s&#47; Joseph J. Wolk</font></div><div style="text-indent:36pt;padding-left:252pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">______________________________</font></div><div style="text-indent:36pt;padding-left:252pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Joseph J. Wolk</font></div><div style="text-indent:36pt;padding-left:252pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Chief Financial Officer</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Date&#58; October&#160;23, 2020</font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%;"><div><font><br></font></div></div><div><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>a202010-q3qexhibit321c.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i98c72d54833b4a188ac8bb81d2fcc46e_1"></div><div style="min-height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="padding-right:38.25pt;text-align:right;margin-top:18pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Exhibit 32.1</font></div><div style="padding-right:38.25pt;text-align:center;margin-top:18pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="padding-right:38.25pt;text-align:center;margin-top:18pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT</font></div><div style="padding-right:38.25pt;text-align:center;margin-top:18pt;"><font><br></font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;text-align:justify;margin-top:6pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The undersigned, Alex Gorsky, the Chief Executive Officer of Johnson &#38; Johnson, a New Jersey corporation (the &#8220;Company&#8221;), pursuant to 18 U.S.C. 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, hereby certifies that, to the best of my knowledge&#58;</font></div><div style="padding-left:22.5pt;padding-right:38.25pt;text-align:center;margin-top:11pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.327%;"><tr><td style="width:1.0%;"></td><td style="width:2.827%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.137%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.109%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:20.667%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:2.664%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:2.664%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:40.962%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.070%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1)</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:justify;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">the Company's Quarterly Report on Form 10-Q for the quarterly period ended September 27, 2020 (the&#8220;Report&#8221;) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934&#59; and</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="21" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:justify;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#47;s&#47; Alex Gorsky</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Alex Gorsky&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chief Executive Officer&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="24" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="padding-left:22.5pt;padding-right:38.25pt;margin-top:6pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Dated&#58;  October&#160;23, 2020</font></div><div style="padding-left:22.5pt;padding-right:38.25pt;margin-top:6pt;"><font><br></font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;text-align:justify;margin-top:6pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This certification is being furnished to the SEC with this Report pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section.</font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;text-align:center;margin-top:11.25pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> &#160; </font></div><div><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>a202010-q3qexhibit322c.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ib20ea3db4e894e3ab32428916aef1656_1"></div><div style="min-height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="padding-right:38.25pt;text-align:right;margin-top:18pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Exhibit 32.2</font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;text-align:center;margin-top:18pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;text-align:center;margin-top:18pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT</font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;text-align:center;margin-top:18pt;"><font><br></font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;text-align:justify;margin-top:6pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The undersigned, Joseph J. Wolk, the Chief Financial Officer of Johnson &#38; Johnson, a New Jersey corporation (the &#8220;Company&#8221;), pursuant to 18 U.S.C. 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, hereby certifies that, to the best of my knowledge&#58;</font></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.327%;"><tr><td style="width:1.0%;"></td><td style="width:2.827%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:4.137%;"></td><td style="width:0.1%;"></td><td style="width:0.1%;"></td><td style="width:1.109%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:20.667%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:2.664%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:2.664%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:40.962%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.070%;"></td><td style="width:0.1%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1)</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:justify;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">the Company's Quarterly Report on Form 10-Q for the quarterly period ended September 27, 2020 (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934&#59; and</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="21" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:justify;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="12" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#47;s&#47; Joseph J. Wolk</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Joseph J. Wolk&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chief Financial Officer&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="24" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;margin-top:6pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;Dated&#58;  October&#160;23, 2020</font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;margin-top:6pt;"><font><br></font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;text-align:justify;margin-top:6pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This certification is being furnished to the SEC with this Report pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section.</font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;text-align:center;margin-top:11.25pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> &#160; </font></div><div><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>jnj-20200927.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:fc2d7a08-4b3d-4935-bed1-d6009b2c298f,g:489318f6-0cc0-48fd-9e8b-f08139bc7aae-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:jnj="http://www.jnj.com/20200927" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.jnj.com/20200927">
  <xs:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jnj-20200927_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jnj-20200927_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jnj-20200927_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jnj-20200927_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.jnj.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.jnj.com/role/ConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEarnings" roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEarnings">
        <link:definition>1003004 - Statement - Consolidated Statements of Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>1004005 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEquity" roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEquity">
        <link:definition>1005006 - Statement - Consolidated Statements of Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEquityParenthetical" roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical">
        <link:definition>1006007 - Statement - Consolidated Statements of Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.jnj.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1007008 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.jnj.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.jnj.com/role/Inventories">
        <link:definition>2103102 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.jnj.com/role/InventoriesTables">
        <link:definition>2304301 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://www.jnj.com/role/InventoriesDetails">
        <link:definition>2405401 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwill" roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwill">
        <link:definition>2106103 - Disclosure - Intangible Assets and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillTables" roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillTables">
        <link:definition>2307302 - Disclosure - Intangible Assets and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillDetails" roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails">
        <link:definition>2408402 - Disclosure - Intangible Assets and Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillGoodwillBySegmentDetails" roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails">
        <link:definition>2409403 - Disclosure - Intangible Assets and Goodwill - Goodwill By Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillNarrativeDetails" roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails">
        <link:definition>2410404 - Disclosure - Intangible Assets and Goodwill - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails" roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails">
        <link:definition>2411405 - Disclosure - Intangible Assets and Goodwill - Intangible Asset Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.jnj.com/role/FairValueMeasurements">
        <link:definition>2112104 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsPolicies" roleURI="http://www.jnj.com/role/FairValueMeasurementsPolicies">
        <link:definition>2213202 - Disclosure - Fair Value Measurements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.jnj.com/role/FairValueMeasurementsTables">
        <link:definition>2314303 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2415406 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsSummaryofDerivativeActivityDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails">
        <link:definition>2416407 - Disclosure - Fair Value Measurements - Summary of Derivative Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails">
        <link:definition>2417408 - Disclosure - Fair Value Measurements - Schedule of Derivatives Recorded in Consolidated Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails">
        <link:definition>2418409 - Disclosure - Fair Value Measurements - Schedule of Effect of Derivatives not Designated as Hedging Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails">
        <link:definition>2419410 - Disclosure - Fair Value Measurements - Schedule of Effect of Net Investment Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails">
        <link:definition>2420411 - Disclosure - Fair Value Measurements - Summary of Activity Related to Equity Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails">
        <link:definition>2421412 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails">
        <link:definition>2422413 - Disclosure - Fair Value Measurements - Cash, Cash Equivalents and Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails">
        <link:definition>2423414 - Disclosure - Fair Value Measurements - Schedule of Available for Sale Securities Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails">
        <link:definition>2424415 - Disclosure - Fair Value Measurements - Financial Liabilities not Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.jnj.com/role/IncomeTaxes">
        <link:definition>2125105 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.jnj.com/role/IncomeTaxesDetails">
        <link:definition>2426416 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandOtherBenefitPlans" roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlans">
        <link:definition>2127106 - Disclosure - Pensions and Other Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandOtherBenefitPlansTables" roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansTables">
        <link:definition>2328304 - Disclosure - Pensions and Other Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails" roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails">
        <link:definition>2429417 - Disclosure - Pensions and Other Benefit Plans - Components of Net Periodic Benefit Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandOtherBenefitPlansDetails" roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails">
        <link:definition>2430418 - Disclosure - Pensions and Other Benefit Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncome" roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome">
        <link:definition>2131107 - Disclosure - Accumulated Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeTables" roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables">
        <link:definition>2332305 - Disclosure - Accumulated Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>2433419 - Disclosure - Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.jnj.com/role/EarningsPerShare">
        <link:definition>2134108 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.jnj.com/role/EarningsPerShareTables">
        <link:definition>2335306 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareDetails" roleURI="http://www.jnj.com/role/EarningsPerShareDetails">
        <link:definition>2436420 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessandGeographicAreas" roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas">
        <link:definition>2137109 - Disclosure - Segments of Business and Geographic Areas</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessandGeographicAreasTables" roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables">
        <link:definition>2338307 - Disclosure - Segments of Business and Geographic Areas (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails" roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails">
        <link:definition>2439421 - Disclosure - Segments of Business and Geographic Areas - Sales By Segment Of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails" roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails">
        <link:definition>2440422 - Disclosure - Segments of Business and Geographic Areas - Operating Profit by Segment of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails" roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails">
        <link:definition>2441423 - Disclosure - Segments of Business and Geographic Areas - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandDivestitures" roleURI="http://www.jnj.com/role/BusinessCombinationsandDivestitures">
        <link:definition>2142110 - Disclosure - Business Combinations and Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandDivestituresNarrativeDetails" roleURI="http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails">
        <link:definition>2443424 - Disclosure - Business Combinations and Divestitures - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LegalProceedings" roleURI="http://www.jnj.com/role/LegalProceedings">
        <link:definition>2144111 - Disclosure - Legal Proceedings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LegalProceedingsDetails" roleURI="http://www.jnj.com/role/LegalProceedingsDetails">
        <link:definition>2445425 - Disclosure - Legal Proceedings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Restructuring" roleURI="http://www.jnj.com/role/Restructuring">
        <link:definition>2146112 - Disclosure - Restructuring</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringTables" roleURI="http://www.jnj.com/role/RestructuringTables">
        <link:definition>2347308 - Disclosure - Restructuring (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringNarrativeDetails" roleURI="http://www.jnj.com/role/RestructuringNarrativeDetails">
        <link:definition>2448426 - Disclosure - Restructuring - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringScheduleofRestructuringReserveDetails" roleURI="http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails">
        <link:definition>2449427 - Disclosure - Restructuring - Schedule of Restructuring Reserve (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="jnj_A2.45Notesdue2026Member" abstract="true" name="A2.45Notesdue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A3.400Notesdue2038Member" abstract="true" name="A3.400Notesdue2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_PercentageChangeInOperatingIncomeLoss" abstract="false" name="PercentageChangeInOperatingIncomeLoss" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_A6.95Notesdue2029Member" abstract="true" name="A6.95Notesdue2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_InterventionalSolutionsMember" abstract="true" name="InterventionalSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ConsumerMember" abstract="true" name="ConsumerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_UNITEDSTATESExportsMember" abstract="true" name="UNITEDSTATESExportsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_WoundCareandOtherMember" abstract="true" name="WoundCareandOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_LegalProceedingTextualsAbstract" abstract="true" name="LegalProceedingTextualsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" abstract="false" name="FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_PhysiomeshMember" abstract="true" name="PhysiomeshMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_SurgeryMember" abstract="true" name="SurgeryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_A2.25Notesdue2022Member" abstract="true" name="A2.25Notesdue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" abstract="false" name="SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="jnj_VerbSurgicalInc.Member" abstract="true" name="VerbSurgicalInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_Numberofpatientsinsettlement" abstract="false" name="Numberofpatientsinsettlement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="jnj_XareltoMember" abstract="true" name="XareltoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OtherNonOperatingIncomeExpensePercentToSales" abstract="false" name="OtherNonOperatingIncomeExpensePercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_PercentageChangeInSalesByGeographicArea" abstract="false" name="PercentageChangeInSalesByGeographicArea" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" abstract="false" name="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_PelvicMeshesMember" abstract="false" name="PelvicMeshesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OtherOncologyMember" abstract="true" name="OtherOncologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember" abstract="true" name="OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ResearchAndDevelopmentInProcessPercentToSales" abstract="false" name="ResearchAndDevelopmentInProcessPercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_OTHERNEUROSCIENCEMember" abstract="true" name="OTHERNEUROSCIENCEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_EquityInvestmentswithReadilyDeterminableValueMember" abstract="true" name="EquityInvestmentswithReadilyDeterminableValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A0.250NotesDue2022Member" abstract="true" name="A0.250NotesDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_AccruedTaxesOnIncomeMember" abstract="true" name="AccruedTaxesOnIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OPSUMITMember" abstract="true" name="OPSUMITMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue" abstract="false" name="CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" abstract="false" name="FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_AsrMember" abstract="false" name="AsrMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ProductLiabilityContingencyNumberOfClaimant" abstract="false" name="ProductLiabilityContingencyNumberOfClaimant" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="jnj_VisionMember" abstract="true" name="VisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_RisperdalMember" abstract="true" name="RisperdalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_TalcMember" abstract="true" name="TalcMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_BeautyMember" abstract="true" name="BeautyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_WesternHemisphereExcludingUSMember" abstract="true" name="WesternHemisphereExcludingUSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OtherReverseRepurchaseAgreementsMember" abstract="true" name="OtherReverseRepurchaseAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A5.95Notesdue2037Member" abstract="true" name="A5.95Notesdue2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OtherIncomeExpenseNetMember" abstract="true" name="OtherIncomeExpenseNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" abstract="true" name="DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jnj_IncomeTaxTextualsAbstract" abstract="true" name="IncomeTaxTextualsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jnj_KNEESMember" abstract="true" name="KNEESMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_RISPERDALCONSTAMember" abstract="true" name="RISPERDALCONSTAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_INVOKANAINVOKAMETMember" abstract="true" name="INVOKANAINVOKAMETMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_CostOfGoodsSoldPercentToSales" abstract="false" name="CostOfGoodsSoldPercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_InvestmentIncomeInterestPercentToSales" abstract="false" name="InvestmentIncomeInterestPercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_NotesDuePeriodFifteenMember" abstract="true" name="NotesDuePeriodFifteenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_InterestExpensePercentToSales" abstract="false" name="InterestExpensePercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_InterestIncomeExpenseNetMember" abstract="true" name="InterestIncomeExpenseNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_UnrecognizedTaxBenefitLiabilityPayment" abstract="false" name="UnrecognizedTaxBenefitLiabilityPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_SimponiSimponiAriaMember" abstract="true" name="SimponiSimponiAriaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_PatentsAndTrademarksMember" abstract="true" name="PatentsAndTrademarksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A2.900Notesdue2028Member" abstract="true" name="A2.900Notesdue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_PurchasedInProcessResearchAndDevelopmentMember" abstract="true" name="PurchasedInProcessResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember" abstract="true" name="PREZISTAPREZCOBIXREZOLSTASYMTUZAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember" abstract="true" name="INVEGASUSTENNAXEPLIONTRINZATREVICTAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A5.85Debenturesdue2038Member" abstract="true" name="A5.85Debenturesdue2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_SalesRevenueGoodsNetPercentToSales" abstract="false" name="SalesRevenueGoodsNetPercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_CONCERTAMethylphenidateMember" abstract="true" name="CONCERTAMethylphenidateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_SURGICALMember" abstract="true" name="SURGICALMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_LitigationSettlementByCompaniesAxis" abstract="true" name="LitigationSettlementByCompaniesAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="jnj_Proceedsfromcreditsupportagreements" abstract="false" name="Proceedsfromcreditsupportagreements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_UPTRAVIMember" abstract="true" name="UPTRAVIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" abstract="false" name="ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement" abstract="false" name="AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_A4.85Notesdue2041Member" abstract="true" name="A4.85Notesdue2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_BermekimabMember" abstract="true" name="BermekimabMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_EquityFairValueAdjustmentChangeInObservablePrice" abstract="false" name="EquityFairValueAdjustmentChangeInObservablePrice" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid" abstract="false" name="RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" abstract="false" name="EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_OTCMember" abstract="true" name="OTCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A3.75Notesdue2047Member" abstract="true" name="A3.75Notesdue2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_CardiovascularMetabolismOtherMember" abstract="true" name="CardiovascularMetabolismOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares" abstract="false" name="EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="jnj_A6.73Debenturesdue2023Member" abstract="true" name="A6.73Debenturesdue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue" abstract="false" name="LossContingencyPreviousDamagesAwardedAndRevisedValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" abstract="false" name="OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_SellingGeneralAndAdministrativeExpensePercentToSales" abstract="false" name="SellingGeneralAndAdministrativeExpensePercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_ZYTIGAMember" abstract="true" name="ZYTIGAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_PROCRITEPREXMember" abstract="true" name="PROCRITEPREXMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_PinnacleAcetabularCupSystemMember" abstract="false" name="PinnacleAcetabularCupSystemMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_TremfyaMember" abstract="true" name="TremfyaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A1.650NotesDue2035Member" abstract="true" name="A1.650NotesDue2035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_AurisHealthMember" abstract="true" name="AurisHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_SalesBySegmentOfBusinessTableTextBlock" abstract="false" name="SalesBySegmentOfBusinessTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="jnj_IncomeTaxExpenseBenefitPercentToSales" abstract="false" name="IncomeTaxExpenseBenefitPercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_InfectiousDiseasesMember" abstract="true" name="InfectiousDiseasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A2.45Notesdue2021Member" abstract="true" name="A2.45Notesdue2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_EquityInvestmentswithoutReadilyDeterminableValueMember" abstract="true" name="EquityInvestmentswithoutReadilyDeterminableValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_PharmaceuticalMember" abstract="true" name="PharmaceuticalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A2250NotesDue2050Member" abstract="true" name="A2250NotesDue2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_SupplyChainMember" abstract="true" name="SupplyChainMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A4.95Debenturesdue2033Member" abstract="true" name="A4.95Debenturesdue2033Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_LossContingencyEstimateOfAdditionalPossibleLoss" abstract="false" name="LossContingencyEstimateOfAdditionalPossibleLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_DePuyASRU.S.Member" abstract="true" name="DePuyASRU.S.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ImmunologyMember" abstract="true" name="ImmunologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_CizHoldingsCo.Ltd.Member" abstract="true" name="CizHoldingsCo.Ltd.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_StelaraMember" abstract="true" name="StelaraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A3.55Notesdue2036Member" abstract="true" name="A3.55Notesdue2036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_HIPSMember" abstract="true" name="HIPSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_AsiaPacificAfricaMember" abstract="true" name="AsiaPacificAfricaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_PercentageChangeInSalesBySegmentOfBusiness" abstract="false" name="PercentageChangeInSalesBySegmentOfBusiness" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_ERLEADAMember" abstract="true" name="ERLEADAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_MedicalDevicesMember" abstract="true" name="MedicalDevicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationReceivablesRetained" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_MomentaMember" abstract="true" name="MomentaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OtherImmunologyMember" abstract="true" name="OtherImmunologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_SPINEOTHERMember" abstract="true" name="SPINEOTHERMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jnj_OrthopaedicsMember" abstract="true" name="OrthopaedicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_AdvancedSterilizationProductsMember" abstract="true" name="AdvancedSterilizationProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock" abstract="false" name="ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="jnj_Restructuringchargepercenttosales" abstract="false" name="Restructuringchargepercenttosales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_A4.375Notesdue2033Member" abstract="true" name="A4.375Notesdue2033Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_DARZALEXMember" abstract="true" name="DARZALEXMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_AmountPrepaidAndDueToManufacturers" abstract="false" name="AmountPrepaidAndDueToManufacturers" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_AssetWriteoffMember" abstract="true" name="AssetWriteoffMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A0.650NotesDue2024Member" abstract="true" name="A0.650NotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_BabyPowderMember" abstract="true" name="BabyPowderMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_AccruedRebatesReturnsAndPromotions" abstract="false" name="AccruedRebatesReturnsAndPromotions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_OpioidMember" abstract="true" name="OpioidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A1.150NotesDue2028Member" abstract="true" name="A1.150NotesDue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A095NotesDue2027Member" abstract="true" name="A095NotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A2450NotesDue2060Member" abstract="true" name="A2450NotesDue2060Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_RestructuringandRelatedCostDurationofRestructuringPlan" abstract="false" name="RestructuringandRelatedCostDurationofRestructuringPlan" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_A0550NotesDue2025Member" abstract="true" name="A0550NotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_CONTACTLENSESOTHERMember" abstract="true" name="CONTACTLENSESOTHERMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_IMBRUVICAMember" abstract="true" name="IMBRUVICAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A130NotesDue2030Member" abstract="true" name="A130NotesDue2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A3.625Notesdue2037Member" abstract="true" name="A3.625Notesdue2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A5.50NotesDue2024Member" abstract="true" name="A5.50NotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A4.50Notesdue2043Member" abstract="true" name="A4.50Notesdue2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" abstract="true" name="ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="jnj_PulmonaryHypertensionMember" abstract="true" name="PulmonaryHypertensionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A225NotesDue2050Member" abstract="true" name="A225NotesDue2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_NeuroscienceMember" abstract="true" name="NeuroscienceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OncologyMember" abstract="true" name="OncologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A3.375Notesdue2023Member" abstract="true" name="A3.375Notesdue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ADVANCEDMember" abstract="true" name="ADVANCEDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A2.95Notesdue2027Member" abstract="true" name="A2.95Notesdue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A4.50Debenturesdue2040Member" abstract="true" name="A4.50Debenturesdue2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_TRAUMAMember" abstract="true" name="TRAUMAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A055NotesDue2025Member" abstract="true" name="A055NotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_EquityFairValueAdjustmentImpairmentLoss" abstract="false" name="EquityFairValueAdjustmentImpairmentLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_A1300NotesDue2030Member" abstract="true" name="A1300NotesDue2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_IntangibleAssetsAndGoodwillTextualsAbstract" abstract="true" name="IntangibleAssetsAndGoodwillTextualsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jnj_OralCareMember" abstract="true" name="OralCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_InvokanaMember" abstract="true" name="InvokanaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A210NotesDue2040Member" abstract="true" name="A210NotesDue2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_NetIncomeAttributableToParentPercentToSales" abstract="false" name="NetIncomeAttributableToParentPercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_GrossProfitPercentToSales" abstract="false" name="GrossProfitPercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_GENERALMember" abstract="true" name="GENERALMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement" abstract="false" name="EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_ExcessOfFairValueOverCarryingValueOfDebt" abstract="false" name="ExcessOfFairValueOverCarryingValueOfDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_A3.70Notesdue2046Member" abstract="true" name="A3.70Notesdue2046Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_RestructuringandRelatedCostExpectedFutureSavings" abstract="false" name="RestructuringandRelatedCostExpectedFutureSavings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_A2.625Notesdue2025Member" abstract="true" name="A2.625Notesdue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_VELCADEMember" abstract="true" name="VELCADEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" abstract="false" name="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" abstract="false" name="OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_A3.500Notesdue2048Member" abstract="true" name="A3.500Notesdue2048Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_EquityInvestmentRollForward" abstract="true" name="EquityInvestmentRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jnj_WomensHealthMember" abstract="true" name="WomensHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit" abstract="false" name="FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_OtherInfectiousDiseasesMember" abstract="true" name="OtherInfectiousDiseasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_LitigationSettlementByCompaniesDomain" abstract="true" name="LitigationSettlementByCompaniesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A2.05Notesdue2023Member" abstract="true" name="A2.05Notesdue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_IdorsiaLTDMember" abstract="true" name="IdorsiaLTDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_BabyCareMember" abstract="true" name="BabyCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_RemicadeMember" abstract="true" name="RemicadeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" abstract="false" name="FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain" abstract="false" name="CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss" abstract="false" name="CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_EDURANTrilpivirineMember" abstract="true" name="EDURANTrilpivirineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>jnj-20200927_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:fc2d7a08-4b3d-4935-bed1-d6009b2c298f,g:489318f6-0cc0-48fd-9e8b-f08139bc7aae-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.jnj.com/role/Cover" xlink:type="simple" xlink:href="jnj-20200927.xsd#Cover"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/Cover" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ad1363b2-e476-4972-bfd4-d10737adab70" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5a99fe19-f252-4e35-85b1-c29a2c51d6bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ad1363b2-e476-4972-bfd4-d10737adab70" xlink:to="loc_us-gaap_AssetsCurrent_5a99fe19-f252-4e35-85b1-c29a2c51d6bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5af5a382-9113-42f2-998d-694976fc14af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ad1363b2-e476-4972-bfd4-d10737adab70" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_5af5a382-9113-42f2-998d-694976fc14af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_611e634b-685d-4945-87bf-499d1add3385" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ad1363b2-e476-4972-bfd4-d10737adab70" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_611e634b-685d-4945-87bf-499d1add3385" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_88070142-9975-4506-a17a-d0a71b76092e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ad1363b2-e476-4972-bfd4-d10737adab70" xlink:to="loc_us-gaap_Goodwill_88070142-9975-4506-a17a-d0a71b76092e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_8d8fec53-b429-41c6-9834-c9157d258dc9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ad1363b2-e476-4972-bfd4-d10737adab70" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_8d8fec53-b429-41c6-9834-c9157d258dc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_6960afa9-094b-4dc1-8660-244f1b4e022d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ad1363b2-e476-4972-bfd4-d10737adab70" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_6960afa9-094b-4dc1-8660-244f1b4e022d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b20bc781-42bb-4112-9bcd-28a053f1dad7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_fde8ab89-e7fd-4652-9848-375a80b8facc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b20bc781-42bb-4112-9bcd-28a053f1dad7" xlink:to="loc_us-gaap_ShortTermBorrowings_fde8ab89-e7fd-4652-9848-375a80b8facc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_6bac46ad-53f2-4770-814f-ddac963ed5f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b20bc781-42bb-4112-9bcd-28a053f1dad7" xlink:to="loc_us-gaap_AccountsPayableCurrent_6bac46ad-53f2-4770-814f-ddac963ed5f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_29f40f3b-15a2-441d-b27d-47bbbee893d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b20bc781-42bb-4112-9bcd-28a053f1dad7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_29f40f3b-15a2-441d-b27d-47bbbee893d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AccruedRebatesReturnsAndPromotions_e77226c7-866a-458d-8010-610d63fdb624" xlink:href="jnj-20200927.xsd#jnj_AccruedRebatesReturnsAndPromotions"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b20bc781-42bb-4112-9bcd-28a053f1dad7" xlink:to="loc_jnj_AccruedRebatesReturnsAndPromotions_e77226c7-866a-458d-8010-610d63fdb624" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7712ef75-c8e7-4e60-b322-afe7cd4e2d5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b20bc781-42bb-4112-9bcd-28a053f1dad7" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7712ef75-c8e7-4e60-b322-afe7cd4e2d5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_2e5e1f26-9a3b-4f3c-a9cd-49c66f42204c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b20bc781-42bb-4112-9bcd-28a053f1dad7" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_2e5e1f26-9a3b-4f3c-a9cd-49c66f42204c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_57f27b5b-5f1f-4b79-8826-7b35f9509fe6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f6eaa0bf-d413-47f7-9202-edc3bb2ac643" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_57f27b5b-5f1f-4b79-8826-7b35f9509fe6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f6eaa0bf-d413-47f7-9202-edc3bb2ac643" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d12a8620-b1f7-4938-8a08-4e587e96d7db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_57f27b5b-5f1f-4b79-8826-7b35f9509fe6" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d12a8620-b1f7-4938-8a08-4e587e96d7db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_e5635110-81ca-472b-8020-b044348d1386" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_57f27b5b-5f1f-4b79-8826-7b35f9509fe6" xlink:to="loc_us-gaap_CommonStockValue_e5635110-81ca-472b-8020-b044348d1386" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_dafc9feb-a3bc-4954-8b95-0d669a09c7bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_57f27b5b-5f1f-4b79-8826-7b35f9509fe6" xlink:to="loc_us-gaap_TreasuryStockValue_dafc9feb-a3bc-4954-8b95-0d669a09c7bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d49cd151-d544-4b05-915f-e8ac93d36e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d8476d06-39c1-4106-9c49-1d8ef348f50f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d49cd151-d544-4b05-915f-e8ac93d36e7b" xlink:to="loc_us-gaap_LiabilitiesCurrent_d8476d06-39c1-4106-9c49-1d8ef348f50f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_4f4742d3-7d33-4bd8-a03e-253d0fc62ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d49cd151-d544-4b05-915f-e8ac93d36e7b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_4f4742d3-7d33-4bd8-a03e-253d0fc62ed1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9ca9fbb8-bdd8-43b0-a095-fccb66a2ac0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d49cd151-d544-4b05-915f-e8ac93d36e7b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_9ca9fbb8-bdd8-43b0-a095-fccb66a2ac0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_e8312c4b-a903-4a8c-ba4c-4839628f84b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d49cd151-d544-4b05-915f-e8ac93d36e7b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_e8312c4b-a903-4a8c-ba4c-4839628f84b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_00415541-a28b-413f-8d85-1301112b7b03" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d49cd151-d544-4b05-915f-e8ac93d36e7b" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_00415541-a28b-413f-8d85-1301112b7b03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a0ff31b3-395e-4b25-b4dd-7ef776712f9b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d49cd151-d544-4b05-915f-e8ac93d36e7b" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a0ff31b3-395e-4b25-b4dd-7ef776712f9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_bbd8ff4b-9dbe-489d-9661-15af29f63f89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ecb57e0e-97d4-4bbb-b2cf-960952507a78" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bbd8ff4b-9dbe-489d-9661-15af29f63f89" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ecb57e0e-97d4-4bbb-b2cf-960952507a78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_3967f15f-b1aa-4e0c-85ed-ab13bb45c3d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bbd8ff4b-9dbe-489d-9661-15af29f63f89" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_3967f15f-b1aa-4e0c-85ed-ab13bb45c3d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_3183de12-d9ab-4315-afa4-d4520d468ef2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bbd8ff4b-9dbe-489d-9661-15af29f63f89" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_3183de12-d9ab-4315-afa4-d4520d468ef2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e4105bf4-a0ed-476e-a6a6-7c0c2b614723" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bbd8ff4b-9dbe-489d-9661-15af29f63f89" xlink:to="loc_us-gaap_InventoryNet_e4105bf4-a0ed-476e-a6a6-7c0c2b614723" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_95bfb5b1-04d7-4cb7-a2e0-b6b11d621fb0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bbd8ff4b-9dbe-489d-9661-15af29f63f89" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_95bfb5b1-04d7-4cb7-a2e0-b6b11d621fb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther_f394292d-e9e6-4d35-816b-26db04f380d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bbd8ff4b-9dbe-489d-9661-15af29f63f89" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther_f394292d-e9e6-4d35-816b-26db04f380d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_578c7503-83f1-430d-9a3e-e58c4b8e00ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_76652998-1096-43d1-ae0c-7e07562c3b11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_578c7503-83f1-430d-9a3e-e58c4b8e00ca" xlink:to="loc_us-gaap_Liabilities_76652998-1096-43d1-ae0c-7e07562c3b11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_811d2830-85d1-4393-8046-35978a9529ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_578c7503-83f1-430d-9a3e-e58c4b8e00ca" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_811d2830-85d1-4393-8046-35978a9529ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_750c3ec2-3d03-4440-8f2c-3948bf094c68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_578c7503-83f1-430d-9a3e-e58c4b8e00ca" xlink:to="loc_us-gaap_CommitmentsAndContingencies_750c3ec2-3d03-4440-8f2c-3948bf094c68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_be56368c-57b3-421d-a000-91963e3d5ef6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_4ac17406-c57c-416e-b782-3af52019d6d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_be56368c-57b3-421d-a000-91963e3d5ef6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_4ac17406-c57c-416e-b782-3af52019d6d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6e60871e-a14c-4846-9cea-6f37ff16ee32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_be56368c-57b3-421d-a000-91963e3d5ef6" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6e60871e-a14c-4846-9cea-6f37ff16ee32" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEarnings" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedStatementsofEarnings"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5bed2175-802f-47b6-89d6-b5124a60bb94" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_64d51ba0-cb67-418d-a098-883b31f50037" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5bed2175-802f-47b6-89d6-b5124a60bb94" xlink:to="loc_us-gaap_GrossProfit_64d51ba0-cb67-418d-a098-883b31f50037" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_909dc60b-2635-40ac-a1e2-ae63168b309e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5bed2175-802f-47b6-89d6-b5124a60bb94" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_909dc60b-2635-40ac-a1e2-ae63168b309e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_cd772254-6425-4a0b-9bf9-adc2346b205b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5bed2175-802f-47b6-89d6-b5124a60bb94" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_cd772254-6425-4a0b-9bf9-adc2346b205b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_066d185e-61c6-47af-914a-4b11fb1436d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5bed2175-802f-47b6-89d6-b5124a60bb94" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_066d185e-61c6-47af-914a-4b11fb1436d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_09dd6d66-88ba-42f3-ad71-862aba3e4af6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5bed2175-802f-47b6-89d6-b5124a60bb94" xlink:to="loc_us-gaap_InvestmentIncomeInterest_09dd6d66-88ba-42f3-ad71-862aba3e4af6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8ea2a8b4-6378-4b8d-a871-af4a6320d209" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5bed2175-802f-47b6-89d6-b5124a60bb94" xlink:to="loc_us-gaap_InterestExpense_8ea2a8b4-6378-4b8d-a871-af4a6320d209" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_c8dba822-69db-4827-a681-bf042063ba60" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5bed2175-802f-47b6-89d6-b5124a60bb94" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_c8dba822-69db-4827-a681-bf042063ba60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_fb61b003-70a0-4ac0-9c8b-04328e3a0776" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5bed2175-802f-47b6-89d6-b5124a60bb94" xlink:to="loc_us-gaap_RestructuringCharges_fb61b003-70a0-4ac0-9c8b-04328e3a0776" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_96c250b3-2e43-4bc4-afab-b7d3ce59b982" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_67d99ae9-5472-4e6f-928c-237f9e202ff5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_96c250b3-2e43-4bc4-afab-b7d3ce59b982" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_67d99ae9-5472-4e6f-928c-237f9e202ff5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8fa58712-8929-4f61-8b69-f2b3c2d58b3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_96c250b3-2e43-4bc4-afab-b7d3ce59b982" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8fa58712-8929-4f61-8b69-f2b3c2d58b3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_NetIncomeAttributableToParentPercentToSales_53ddd40f-bd07-4af2-ab9a-8b3abcd9684f" xlink:href="jnj-20200927.xsd#jnj_NetIncomeAttributableToParentPercentToSales"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_9f4e3fee-c946-4749-ab8b-84647e8222b3" xlink:href="jnj-20200927.xsd#jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_NetIncomeAttributableToParentPercentToSales_53ddd40f-bd07-4af2-ab9a-8b3abcd9684f" xlink:to="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_9f4e3fee-c946-4749-ab8b-84647e8222b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeTaxExpenseBenefitPercentToSales_c261c3fa-c9d0-4431-b2f6-bd5b232f8a8b" xlink:href="jnj-20200927.xsd#jnj_IncomeTaxExpenseBenefitPercentToSales"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_NetIncomeAttributableToParentPercentToSales_53ddd40f-bd07-4af2-ab9a-8b3abcd9684f" xlink:to="loc_jnj_IncomeTaxExpenseBenefitPercentToSales_c261c3fa-c9d0-4431-b2f6-bd5b232f8a8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_GrossProfitPercentToSales_d8d6d996-b1a6-4fd5-b608-59bdd7507906" xlink:href="jnj-20200927.xsd#jnj_GrossProfitPercentToSales"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SalesRevenueGoodsNetPercentToSales_8a0c34e5-780f-41e0-9c54-e47c5b7813b0" xlink:href="jnj-20200927.xsd#jnj_SalesRevenueGoodsNetPercentToSales"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_GrossProfitPercentToSales_d8d6d996-b1a6-4fd5-b608-59bdd7507906" xlink:to="loc_jnj_SalesRevenueGoodsNetPercentToSales_8a0c34e5-780f-41e0-9c54-e47c5b7813b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CostOfGoodsSoldPercentToSales_afa2d0e4-ab8b-4130-9946-c78832eca6a9" xlink:href="jnj-20200927.xsd#jnj_CostOfGoodsSoldPercentToSales"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_GrossProfitPercentToSales_d8d6d996-b1a6-4fd5-b608-59bdd7507906" xlink:to="loc_jnj_CostOfGoodsSoldPercentToSales_afa2d0e4-ab8b-4130-9946-c78832eca6a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4ba4cf69-e4f6-4565-87bb-be2cb802b1ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1a51e9ea-10f4-4d70-9252-bfc109980370" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4ba4cf69-e4f6-4565-87bb-be2cb802b1ca" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1a51e9ea-10f4-4d70-9252-bfc109980370" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b0047ba4-a360-4450-90e3-157ffca304bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_4ba4cf69-e4f6-4565-87bb-be2cb802b1ca" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b0047ba4-a360-4450-90e3-157ffca304bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_94184f06-eb57-4f6a-8c85-994408972cb1" xlink:href="jnj-20200927.xsd#jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_GrossProfitPercentToSales_f4ec12a9-4b6c-49c0-a8be-8ec8bf88394a" xlink:href="jnj-20200927.xsd#jnj_GrossProfitPercentToSales"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_94184f06-eb57-4f6a-8c85-994408972cb1" xlink:to="loc_jnj_GrossProfitPercentToSales_f4ec12a9-4b6c-49c0-a8be-8ec8bf88394a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SellingGeneralAndAdministrativeExpensePercentToSales_8ce9124c-8054-47d6-aea6-d84db3b3864e" xlink:href="jnj-20200927.xsd#jnj_SellingGeneralAndAdministrativeExpensePercentToSales"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_94184f06-eb57-4f6a-8c85-994408972cb1" xlink:to="loc_jnj_SellingGeneralAndAdministrativeExpensePercentToSales_8ce9124c-8054-47d6-aea6-d84db3b3864e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales_23946052-1750-42a1-853f-ecf1cd9c0369" xlink:href="jnj-20200927.xsd#jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_94184f06-eb57-4f6a-8c85-994408972cb1" xlink:to="loc_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales_23946052-1750-42a1-853f-ecf1cd9c0369" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InvestmentIncomeInterestPercentToSales_bd2737a6-e759-4905-ab77-c299a19b132f" xlink:href="jnj-20200927.xsd#jnj_InvestmentIncomeInterestPercentToSales"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_94184f06-eb57-4f6a-8c85-994408972cb1" xlink:to="loc_jnj_InvestmentIncomeInterestPercentToSales_bd2737a6-e759-4905-ab77-c299a19b132f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterestExpensePercentToSales_a08f0388-aef1-4453-8822-411bb6065075" xlink:href="jnj-20200927.xsd#jnj_InterestExpensePercentToSales"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_94184f06-eb57-4f6a-8c85-994408972cb1" xlink:to="loc_jnj_InterestExpensePercentToSales_a08f0388-aef1-4453-8822-411bb6065075" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherNonOperatingIncomeExpensePercentToSales_e93c27a6-62ca-452c-84f1-a4a329625da4" xlink:href="jnj-20200927.xsd#jnj_OtherNonOperatingIncomeExpensePercentToSales"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_94184f06-eb57-4f6a-8c85-994408972cb1" xlink:to="loc_jnj_OtherNonOperatingIncomeExpensePercentToSales_e93c27a6-62ca-452c-84f1-a4a329625da4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Restructuringchargepercenttosales_6e736c64-ad8a-4a11-b7ff-87e8b517d2b1" xlink:href="jnj-20200927.xsd#jnj_Restructuringchargepercenttosales"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_94184f06-eb57-4f6a-8c85-994408972cb1" xlink:to="loc_jnj_Restructuringchargepercenttosales_6e736c64-ad8a-4a11-b7ff-87e8b517d2b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ResearchAndDevelopmentInProcessPercentToSales_290bcb17-c291-4912-bc0c-fbac1d9ae448" xlink:href="jnj-20200927.xsd#jnj_ResearchAndDevelopmentInProcessPercentToSales"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_94184f06-eb57-4f6a-8c85-994408972cb1" xlink:to="loc_jnj_ResearchAndDevelopmentInProcessPercentToSales_290bcb17-c291-4912-bc0c-fbac1d9ae448" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_86333edc-f025-4c00-86b8-c646dd64a569" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_5af93647-51a4-443b-b51b-842be3fadf00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_86333edc-f025-4c00-86b8-c646dd64a569" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_5af93647-51a4-443b-b51b-842be3fadf00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_5caea8c5-c661-41f6-af28-bb66990584dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_86333edc-f025-4c00-86b8-c646dd64a569" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_5caea8c5-c661-41f6-af28-bb66990584dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_dbf9470b-9a9c-49aa-8522-0eb90f98fe5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_86333edc-f025-4c00-86b8-c646dd64a569" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_dbf9470b-9a9c-49aa-8522-0eb90f98fe5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cb62cb7c-5fdc-4de1-8f4b-04824c19715d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_86333edc-f025-4c00-86b8-c646dd64a569" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cb62cb7c-5fdc-4de1-8f4b-04824c19715d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ac88ea75-f02a-4212-baaa-fb7e9541b383" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax_15b37285-92a0-4da3-b796-c50262871b95" xlink:href="jnj-20200927.xsd#jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ac88ea75-f02a-4212-baaa-fb7e9541b383" xlink:to="loc_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax_15b37285-92a0-4da3-b796-c50262871b95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax_778627c4-9ada-438a-aef5-1a261a88c9ab" xlink:href="jnj-20200927.xsd#jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ac88ea75-f02a-4212-baaa-fb7e9541b383" xlink:to="loc_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax_778627c4-9ada-438a-aef5-1a261a88c9ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_65527a32-7366-472c-a876-82d1de1fe52c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3507dbec-bdb9-489d-a600-cad5c0641c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_65527a32-7366-472c-a876-82d1de1fe52c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3507dbec-bdb9-489d-a600-cad5c0641c7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e44acae5-9bd2-4144-9b57-ae9b3faa9d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_65527a32-7366-472c-a876-82d1de1fe52c" xlink:to="loc_us-gaap_NetIncomeLoss_e44acae5-9bd2-4144-9b57-ae9b3faa9d4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2e4d48fd-e1ff-4285-9c08-9c22c2b23da0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e5d0bcd3-12e8-4405-b22e-8ea9ed9dd3b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2e4d48fd-e1ff-4285-9c08-9c22c2b23da0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e5d0bcd3-12e8-4405-b22e-8ea9ed9dd3b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_0fa9bc9a-682d-4bd1-8968-b710439ad253" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2e4d48fd-e1ff-4285-9c08-9c22c2b23da0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_0fa9bc9a-682d-4bd1-8968-b710439ad253" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cffd1f05-70d4-4e9d-b54c-578e6b2a9159" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_92e51fc5-0feb-4ec9-85df-e6766edfc355" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cffd1f05-70d4-4e9d-b54c-578e6b2a9159" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_92e51fc5-0feb-4ec9-85df-e6766edfc355" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_440f3558-a6ef-4f71-96b4-f00ba9afab23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_cffd1f05-70d4-4e9d-b54c-578e6b2a9159" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_440f3558-a6ef-4f71-96b4-f00ba9afab23" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedStatementsofEquity"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedStatementsofEquityParenthetical"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8ffeab60-2d4e-4123-8a12-17161fc04d7c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_221118f2-f9d9-4065-be94-9a3bf16cb071" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8ffeab60-2d4e-4123-8a12-17161fc04d7c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_221118f2-f9d9-4065-be94-9a3bf16cb071" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d372b92-a4aa-4d5f-af19-897760f3d186" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8ffeab60-2d4e-4123-8a12-17161fc04d7c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0d372b92-a4aa-4d5f-af19-897760f3d186" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3422614a-f098-404c-975e-f96c5aadaead" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8ffeab60-2d4e-4123-8a12-17161fc04d7c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3422614a-f098-404c-975e-f96c5aadaead" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_f1679145-9676-4650-b307-1eb3b1627629" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8ffeab60-2d4e-4123-8a12-17161fc04d7c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_f1679145-9676-4650-b307-1eb3b1627629" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd5d1e76-3177-44ae-b1cb-c744836b0757" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_d6f34510-218d-4bfa-9d69-ce00a12251a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd5d1e76-3177-44ae-b1cb-c744836b0757" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_d6f34510-218d-4bfa-9d69-ce00a12251a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_50032190-9fc2-4fa2-9b9f-4788cd50ab97" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd5d1e76-3177-44ae-b1cb-c744836b0757" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_50032190-9fc2-4fa2-9b9f-4788cd50ab97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_da641586-f97a-4460-a27a-03add783192c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd5d1e76-3177-44ae-b1cb-c744836b0757" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_da641586-f97a-4460-a27a-03add783192c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ae5b9245-abf9-47f5-9379-1af3e4b4ed0e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd5d1e76-3177-44ae-b1cb-c744836b0757" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ae5b9245-abf9-47f5-9379-1af3e4b4ed0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits_8a064219-b7ff-44ad-8c7a-ef1ae429c7c5" xlink:href="jnj-20200927.xsd#jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd5d1e76-3177-44ae-b1cb-c744836b0757" xlink:to="loc_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits_8a064219-b7ff-44ad-8c7a-ef1ae429c7c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_6f10ecb9-684e-4e4b-a245-f9f55b0c6819" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd5d1e76-3177-44ae-b1cb-c744836b0757" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_6f10ecb9-684e-4e4b-a245-f9f55b0c6819" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_75bf58ae-01f2-4ee8-9001-c8b184580a87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd5d1e76-3177-44ae-b1cb-c744836b0757" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_75bf58ae-01f2-4ee8-9001-c8b184580a87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_5e253514-fffd-4ddb-b793-09b2c4ed8b79" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fd5d1e76-3177-44ae-b1cb-c744836b0757" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_5e253514-fffd-4ddb-b793-09b2c4ed8b79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d7c08c3-e505-4cf5-9384-9c294b9c6271" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4b40f998-927f-43da-8d1f-36465cb56eb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d7c08c3-e505-4cf5-9384-9c294b9c6271" xlink:to="loc_us-gaap_NetIncomeLoss_4b40f998-927f-43da-8d1f-36465cb56eb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_92eb78d7-f92e-424e-9eae-7e000dbce77c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d7c08c3-e505-4cf5-9384-9c294b9c6271" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_92eb78d7-f92e-424e-9eae-7e000dbce77c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_28dbb389-399e-45ee-b9b4-5d578d38cd89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d7c08c3-e505-4cf5-9384-9c294b9c6271" xlink:to="loc_us-gaap_ShareBasedCompensation_28dbb389-399e-45ee-b9b4-5d578d38cd89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_8456898d-9fc8-4908-b407-a8e8f7c821d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d7c08c3-e505-4cf5-9384-9c294b9c6271" xlink:to="loc_us-gaap_AssetImpairmentCharges_8456898d-9fc8-4908-b407-a8e8f7c821d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9a39632b-5f0d-4b27-8f60-e7715f87378d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d7c08c3-e505-4cf5-9384-9c294b9c6271" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9a39632b-5f0d-4b27-8f60-e7715f87378d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_7662631b-d845-45a7-a867-3be0996b98e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d7c08c3-e505-4cf5-9384-9c294b9c6271" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_7662631b-d845-45a7-a867-3be0996b98e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1ae918e1-bae6-4566-b7bb-145d2371ab25" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d7c08c3-e505-4cf5-9384-9c294b9c6271" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1ae918e1-bae6-4566-b7bb-145d2371ab25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_80903268-0400-4d71-9ab1-2d3d586b9ed8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d7c08c3-e505-4cf5-9384-9c294b9c6271" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_80903268-0400-4d71-9ab1-2d3d586b9ed8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_693e9f5e-7b4d-42ca-b3b1-fe0f3afc3ad1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d7c08c3-e505-4cf5-9384-9c294b9c6271" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_693e9f5e-7b4d-42ca-b3b1-fe0f3afc3ad1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_bacf5230-8be5-4a50-af08-ba4a9c612811" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d7c08c3-e505-4cf5-9384-9c294b9c6271" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_bacf5230-8be5-4a50-af08-ba4a9c612811" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ed2dd544-d0ab-4d45-af8e-7b29fab7dfd8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d7c08c3-e505-4cf5-9384-9c294b9c6271" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ed2dd544-d0ab-4d45-af8e-7b29fab7dfd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5ce80385-6fcf-48b2-ab46-7bc524d4b910" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d7c08c3-e505-4cf5-9384-9c294b9c6271" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5ce80385-6fcf-48b2-ab46-7bc524d4b910" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6e72c9ae-e7b7-4cbb-a0a2-fbc1ed2efad5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d7c08c3-e505-4cf5-9384-9c294b9c6271" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6e72c9ae-e7b7-4cbb-a0a2-fbc1ed2efad5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_1349a43d-fc5a-487a-a9a1-006a864a1fa0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_685e3da3-146e-43ad-be29-d438b7c7b2d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_1349a43d-fc5a-487a-a9a1-006a864a1fa0" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_685e3da3-146e-43ad-be29-d438b7c7b2d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_3bb26918-142d-458e-b372-e4f6ba85c2e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_1349a43d-fc5a-487a-a9a1-006a864a1fa0" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_3bb26918-142d-458e-b372-e4f6ba85c2e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b430c659-340e-4576-a359-93d533483d82" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_92fdf2a3-61ad-4532-a00e-bed469875cce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b430c659-340e-4576-a359-93d533483d82" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_92fdf2a3-61ad-4532-a00e-bed469875cce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_15403ba7-b847-4799-ae79-15bcad375553" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b430c659-340e-4576-a359-93d533483d82" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_15403ba7-b847-4799-ae79-15bcad375553" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a211b9da-1c2b-407c-adc5-5c334d293b58" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b430c659-340e-4576-a359-93d533483d82" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a211b9da-1c2b-407c-adc5-5c334d293b58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_2a37f3bd-49cc-458b-87e4-1133115a36e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b430c659-340e-4576-a359-93d533483d82" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_2a37f3bd-49cc-458b-87e4-1133115a36e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_d1e05848-f974-411d-8c26-d2f1f008c872" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b430c659-340e-4576-a359-93d533483d82" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_d1e05848-f974-411d-8c26-d2f1f008c872" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_bf26851f-609f-4cbc-9877-1f7247ca1dd4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b430c659-340e-4576-a359-93d533483d82" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_bf26851f-609f-4cbc-9877-1f7247ca1dd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Proceedsfromcreditsupportagreements_8a2e3784-2a02-482d-9f52-73d188962d4e" xlink:href="jnj-20200927.xsd#jnj_Proceedsfromcreditsupportagreements"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b430c659-340e-4576-a359-93d533483d82" xlink:to="loc_jnj_Proceedsfromcreditsupportagreements_8a2e3784-2a02-482d-9f52-73d188962d4e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="jnj-20200927.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="jnj-20200927.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/Inventories" xlink:type="simple" xlink:href="jnj-20200927.xsd#Inventories"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/Inventories" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/InventoriesTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#InventoriesTables"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/InventoriesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/InventoriesDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_bf284371-4b21-4528-a1a6-17a3678b982b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_f4b3107c-c86d-4006-a119-51d3245edc8b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_bf284371-4b21-4528-a1a6-17a3678b982b" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_f4b3107c-c86d-4006-a119-51d3245edc8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_866d13bb-4f0e-4451-9c9e-234aa8f5c89a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_bf284371-4b21-4528-a1a6-17a3678b982b" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_866d13bb-4f0e-4451-9c9e-234aa8f5c89a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_ab0e4b75-ad3c-4208-8252-e9de29ef83bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_bf284371-4b21-4528-a1a6-17a3678b982b" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_ab0e4b75-ad3c-4208-8252-e9de29ef83bb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="jnj-20200927.xsd#IntangibleAssetsandGoodwill"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwill" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#IntangibleAssetsandGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8d72a472-3f92-4d64-b25b-970750f4a998" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d5e2a7da-f350-44b4-9adb-593f76726154" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8d72a472-3f92-4d64-b25b-970750f4a998" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d5e2a7da-f350-44b4-9adb-593f76726154" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4e19dcc9-1689-4482-bace-c11572dde89a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8d72a472-3f92-4d64-b25b-970750f4a998" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4e19dcc9-1689-4482-bace-c11572dde89a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#IntangibleAssetsandGoodwillGoodwillBySegmentDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#IntangibleAssetsandGoodwillNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsPolicies" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsPolicies"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsSummaryofDerivativeActivityDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_f3e38ad1-e20e-4a6b-8dfe-205244512282" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a196dfe9-1cdb-4d74-8168-8012b0ddab56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssets_f3e38ad1-e20e-4a6b-8dfe-205244512282" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a196dfe9-1cdb-4d74-8168-8012b0ddab56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_233b2ceb-97cd-469d-9cf8-ad3e3e4d33f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssets_f3e38ad1-e20e-4a6b-8dfe-205244512282" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_233b2ceb-97cd-469d-9cf8-ad3e3e4d33f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_d783d93e-9860-430e-ba84-5746d8e0e7e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0be61401-d0f1-415f-b7b9-3f253dc8f88c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilities_d783d93e-9860-430e-ba84-5746d8e0e7e0" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_0be61401-d0f1-415f-b7b9-3f253dc8f88c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_e1dc10f8-dc52-4f85-8d6a-c00c9579226c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilities_d783d93e-9860-430e-ba84-5746d8e0e7e0" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_e1dc10f8-dc52-4f85-8d6a-c00c9579226c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_b9b1c0b9-0605-4210-9cbf-74f518c20ded" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_7deb39ef-4c06-4a4f-811e-796bc7797136" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_b9b1c0b9-0605-4210-9cbf-74f518c20ded" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_7deb39ef-4c06-4a4f-811e-796bc7797136" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_9ea9fcae-ebef-4294-8f88-1208a66f618a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_b9b1c0b9-0605-4210-9cbf-74f518c20ded" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_9ea9fcae-ebef-4294-8f88-1208a66f618a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_4f30ad56-9401-4164-888a-c37e2fd41fe4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_b9b1c0b9-0605-4210-9cbf-74f518c20ded" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_4f30ad56-9401-4164-888a-c37e2fd41fe4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_216e2dee-58ea-4d1f-b4d6-92f9855cf0c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_42d397b6-05f6-4303-a937-59171914b5ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_216e2dee-58ea-4d1f-b4d6-92f9855cf0c3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_42d397b6-05f6-4303-a937-59171914b5ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9a18010f-9a12-4d3a-be41-7d43f8391d5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_216e2dee-58ea-4d1f-b4d6-92f9855cf0c3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_9a18010f-9a12-4d3a-be41-7d43f8391d5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ce820bfa-6bbd-48d1-bc7e-34e045fc2404" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_216e2dee-58ea-4d1f-b4d6-92f9855cf0c3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ce820bfa-6bbd-48d1-bc7e-34e045fc2404" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_41e23b26-a907-4799-b1aa-d4df19bfc274" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_89da9dd6-8828-4200-8386-e8306332a1bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_41e23b26-a907-4799-b1aa-d4df19bfc274" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_89da9dd6-8828-4200-8386-e8306332a1bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_c4d2982d-b508-4ff8-8a24-0bc06aa00a63" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_41e23b26-a907-4799-b1aa-d4df19bfc274" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_c4d2982d-b508-4ff8-8a24-0bc06aa00a63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_cd1aac24-dafc-48d0-b81e-b0efcb152e91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_41e23b26-a907-4799-b1aa-d4df19bfc274" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_cd1aac24-dafc-48d0-b81e-b0efcb152e91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_66ccf41d-283e-4504-837e-9b9c00a3690d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_80929291-259b-48ae-98aa-2aaaa2964554" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_66ccf41d-283e-4504-837e-9b9c00a3690d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_80929291-259b-48ae-98aa-2aaaa2964554" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_cfc70c8b-2ed5-4f2a-b9da-81a50f739d35" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_66ccf41d-283e-4504-837e-9b9c00a3690d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_cfc70c8b-2ed5-4f2a-b9da-81a50f739d35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_f751d6e8-831a-443b-93c0-f9770fda7c04" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_66ccf41d-283e-4504-837e-9b9c00a3690d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_f751d6e8-831a-443b-93c0-f9770fda7c04" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IncomeTaxes" xlink:type="simple" xlink:href="jnj-20200927.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#IncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/IncomeTaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlans" xlink:type="simple" xlink:href="jnj-20200927.xsd#PensionsandOtherBenefitPlans"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#PensionsandOtherBenefitPlansTables"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlansTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_271b7c32-a4ba-4c18-9ff2-3507842cd3f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_57cbb4ee-163b-442d-b478-19ddf36e1d0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_271b7c32-a4ba-4c18-9ff2-3507842cd3f9" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_57cbb4ee-163b-442d-b478-19ddf36e1d0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_c670c8b8-a1a0-4c8d-b52b-941f56552dce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_271b7c32-a4ba-4c18-9ff2-3507842cd3f9" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_c670c8b8-a1a0-4c8d-b52b-941f56552dce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_8f20b7a4-312c-44cf-b02f-e5059ecd9912" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_271b7c32-a4ba-4c18-9ff2-3507842cd3f9" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_8f20b7a4-312c-44cf-b02f-e5059ecd9912" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_563831b2-4291-40f3-bbce-8b6b364960bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_271b7c32-a4ba-4c18-9ff2-3507842cd3f9" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_563831b2-4291-40f3-bbce-8b6b364960bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_6f167b9c-4e62-4938-8da7-b48c915cf233" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_271b7c32-a4ba-4c18-9ff2-3507842cd3f9" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_6f167b9c-4e62-4938-8da7-b48c915cf233" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_193468ca-29d8-4e19-b603-461e50edc252" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_271b7c32-a4ba-4c18-9ff2-3507842cd3f9" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_193468ca-29d8-4e19-b603-461e50edc252" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#PensionsandOtherBenefitPlansDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="simple" xlink:href="jnj-20200927.xsd#AccumulatedOtherComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#AccumulatedOtherComprehensiveIncomeTables"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#AccumulatedOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/EarningsPerShare" xlink:type="simple" xlink:href="jnj-20200927.xsd#EarningsPerShare"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/EarningsPerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#EarningsPerShareTables"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/EarningsPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#EarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3307bd19-fd3a-4ea7-a1d6-a021872d092c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f29b1d3c-fb43-4ef9-bd8c-f0b39a484a02" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3307bd19-fd3a-4ea7-a1d6-a021872d092c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f29b1d3c-fb43-4ef9-bd8c-f0b39a484a02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_158f0b23-e9f7-4d88-a79f-53a46a7eb705" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3307bd19-fd3a-4ea7-a1d6-a021872d092c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_158f0b23-e9f7-4d88-a79f-53a46a7eb705" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_29966580-aabb-44dd-bd2b-8d7c3f6cfcf7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3307bd19-fd3a-4ea7-a1d6-a021872d092c" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_29966580-aabb-44dd-bd2b-8d7c3f6cfcf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod_bfabad8b-47e9-4374-add6-790b16774446" xlink:href="jnj-20200927.xsd#jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3307bd19-fd3a-4ea7-a1d6-a021872d092c" xlink:to="loc_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod_bfabad8b-47e9-4374-add6-790b16774446" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas" xlink:type="simple" xlink:href="jnj-20200927.xsd#SegmentsofBusinessandGeographicAreas"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#SegmentsofBusinessandGeographicAreasTables"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/BusinessCombinationsandDivestitures" xlink:type="simple" xlink:href="jnj-20200927.xsd#BusinessCombinationsandDivestitures"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/BusinessCombinationsandDivestitures" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#BusinessCombinationsandDivestituresNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/LegalProceedings" xlink:type="simple" xlink:href="jnj-20200927.xsd#LegalProceedings"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/LegalProceedings" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/LegalProceedingsDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#LegalProceedingsDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/LegalProceedingsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/Restructuring" xlink:type="simple" xlink:href="jnj-20200927.xsd#Restructuring"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/Restructuring" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/RestructuringTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#RestructuringTables"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/RestructuringTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/RestructuringNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#RestructuringNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/RestructuringNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#RestructuringScheduleofRestructuringReserveDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>jnj-20200927_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:fc2d7a08-4b3d-4935-bed1-d6009b2c298f,g:489318f6-0cc0-48fd-9e8b-f08139bc7aae-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.jnj.com/role/Cover" xlink:type="simple" xlink:href="jnj-20200927.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/Cover" xlink:type="extended" id="iba523150cbda4f9299f29502ea9f6114_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_1396657d-05d6-4451-aaee-600272209ce9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_DocumentType_1396657d-05d6-4451-aaee-600272209ce9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_eefa1da3-0697-4bfd-9f59-4f71c7d1cc33" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_DocumentQuarterlyReport_eefa1da3-0697-4bfd-9f59-4f71c7d1cc33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e40e2222-e8de-45ae-b6d8-2ffa0a0a863d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_DocumentPeriodEndDate_e40e2222-e8de-45ae-b6d8-2ffa0a0a863d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_9bf49e1b-e05f-445c-958d-fa7ed9fddd79" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_DocumentTransitionReport_9bf49e1b-e05f-445c-958d-fa7ed9fddd79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_d8dbf484-6864-47ce-8397-3439e0326ef8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityFileNumber_d8dbf484-6864-47ce-8397-3439e0326ef8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e20b7492-8955-4063-b7a3-6f1d6bdfc6e9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityRegistrantName_e20b7492-8955-4063-b7a3-6f1d6bdfc6e9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_cf8115a8-9bc7-4824-9312-e009151b6c14" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityIncorporationStateCountryCode_cf8115a8-9bc7-4824-9312-e009151b6c14" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_7870fdbf-0428-4840-8fb0-a5db75dec0f6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityTaxIdentificationNumber_7870fdbf-0428-4840-8fb0-a5db75dec0f6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_210bd61a-7dd6-4620-95ee-da58c0b22c89" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityAddressAddressLine1_210bd61a-7dd6-4620-95ee-da58c0b22c89" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_7e1b5435-f878-4181-82ba-434a2466d25d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityAddressCityOrTown_7e1b5435-f878-4181-82ba-434a2466d25d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_18eebe4a-b070-4de7-8f0b-5af39b81215a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityAddressStateOrProvince_18eebe4a-b070-4de7-8f0b-5af39b81215a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2cbef4aa-3a3e-4575-9721-a2857eb8a90f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityAddressPostalZipCode_2cbef4aa-3a3e-4575-9721-a2857eb8a90f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_124ab905-4946-44a9-9257-a639e831b644" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_CityAreaCode_124ab905-4946-44a9-9257-a639e831b644" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2fd0ab39-8a20-403a-ba16-20f90b540898" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_LocalPhoneNumber_2fd0ab39-8a20-403a-ba16-20f90b540898" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_52123fa8-1f05-4c1d-b4a0-ac56dbad1f41" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityCurrentReportingStatus_52123fa8-1f05-4c1d-b4a0-ac56dbad1f41" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_5ef4e772-a593-4e1c-a5f8-2f54c121d07e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityInteractiveDataCurrent_5ef4e772-a593-4e1c-a5f8-2f54c121d07e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_97377478-1f12-436e-9f21-ab9dc6c80bf6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityFilerCategory_97377478-1f12-436e-9f21-ab9dc6c80bf6" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_19e5c160-4475-4393-b3eb-2c2a21d54f80" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntitySmallBusiness_19e5c160-4475-4393-b3eb-2c2a21d54f80" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_34c62e0b-090c-4401-a669-5ffa8fc7fd49" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityEmergingGrowthCompany_34c62e0b-090c-4401-a669-5ffa8fc7fd49" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_cc455153-2f50-4c25-a32c-8bd328c5e947" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityShellCompany_cc455153-2f50-4c25-a32c-8bd328c5e947" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_129b0174-4cd0-46e3-af79-64bd106de838" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_Security12bTitle_129b0174-4cd0-46e3-af79-64bd106de838" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_0f8665cf-e440-40d0-b4f9-768e9ba46399" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_TradingSymbol_0f8665cf-e440-40d0-b4f9-768e9ba46399" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_55299cdf-fbaa-4d85-b78d-1cc38a99b0df" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_SecurityExchangeName_55299cdf-fbaa-4d85-b78d-1cc38a99b0df" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_c2789071-2bdd-489c-b768-7c6093feb2ff" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_c2789071-2bdd-489c-b768-7c6093feb2ff" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_32c10112-6124-46b0-b370-90b4c0a0d1fc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityCentralIndexKey_32c10112-6124-46b0-b370-90b4c0a0d1fc" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c7f7efbb-0b93-46d1-909a-de523a6c0acf" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_CurrentFiscalYearEndDate_c7f7efbb-0b93-46d1-909a-de523a6c0acf" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_eafc5724-d7ce-455b-b5cf-e74e41052ab6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_DocumentFiscalYearFocus_eafc5724-d7ce-455b-b5cf-e74e41052ab6" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_08b973b4-a496-48ae-9a46-6baae229ae6f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_DocumentFiscalPeriodFocus_08b973b4-a496-48ae-9a46-6baae229ae6f" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f3c823a1-1b0c-4b4d-abc3-9fe1f2f0baff" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_AmendmentFlag_f3c823a1-1b0c-4b4d-abc3-9fe1f2f0baff" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_8b0e39bb-5928-4546-b6a6-3108d5932cc4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntitiesTable_8b0e39bb-5928-4546-b6a6-3108d5932cc4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4946a1ec-4139-4c1c-82e0-5ec0bea62d38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_8b0e39bb-5928-4546-b6a6-3108d5932cc4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4946a1ec-4139-4c1c-82e0-5ec0bea62d38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4946a1ec-4139-4c1c-82e0-5ec0bea62d38_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4946a1ec-4139-4c1c-82e0-5ec0bea62d38" xlink:to="loc_us-gaap_ClassOfStockDomain_4946a1ec-4139-4c1c-82e0-5ec0bea62d38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6f643a38-4886-4c17-9b84-082d9a7ecdad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4946a1ec-4139-4c1c-82e0-5ec0bea62d38" xlink:to="loc_us-gaap_ClassOfStockDomain_6f643a38-4886-4c17-9b84-082d9a7ecdad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_377343f7-2441-4c90-992e-823e7de7ddb5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6f643a38-4886-4c17-9b84-082d9a7ecdad" xlink:to="loc_us-gaap_CommonStockMember_377343f7-2441-4c90-992e-823e7de7ddb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.250NotesDue2022Member_2a5ab734-8fc9-4093-9c94-5fa7c7e16881" xlink:href="jnj-20200927.xsd#jnj_A0.250NotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6f643a38-4886-4c17-9b84-082d9a7ecdad" xlink:to="loc_jnj_A0.250NotesDue2022Member_2a5ab734-8fc9-4093-9c94-5fa7c7e16881" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.650NotesDue2024Member_2da8c5ae-1ea5-49c2-bfa2-42fc1965a25c" xlink:href="jnj-20200927.xsd#jnj_A0.650NotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6f643a38-4886-4c17-9b84-082d9a7ecdad" xlink:to="loc_jnj_A0.650NotesDue2024Member_2da8c5ae-1ea5-49c2-bfa2-42fc1965a25c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.50NotesDue2024Member_16f90603-5b2d-4ed0-9273-1545e7b64cc0" xlink:href="jnj-20200927.xsd#jnj_A5.50NotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6f643a38-4886-4c17-9b84-082d9a7ecdad" xlink:to="loc_jnj_A5.50NotesDue2024Member_16f90603-5b2d-4ed0-9273-1545e7b64cc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.150NotesDue2028Member_76f5c913-c2ba-490c-bc09-21e8617e8aad" xlink:href="jnj-20200927.xsd#jnj_A1.150NotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6f643a38-4886-4c17-9b84-082d9a7ecdad" xlink:to="loc_jnj_A1.150NotesDue2028Member_76f5c913-c2ba-490c-bc09-21e8617e8aad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.650NotesDue2035Member_5f9a62e6-e379-4599-95d5-c15c73d41e4a" xlink:href="jnj-20200927.xsd#jnj_A1.650NotesDue2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6f643a38-4886-4c17-9b84-082d9a7ecdad" xlink:to="loc_jnj_A1.650NotesDue2035Member_5f9a62e6-e379-4599-95d5-c15c73d41e4a" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/ConsolidatedBalanceSheets" xlink:type="extended" id="ib9b91e50fd5048ebba26eacb7e592d19_ConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i4cb07cf2464c4161b7c9cf3b36145dc5_ConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEarnings" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedStatementsofEarnings"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofEarnings" xlink:type="extended" id="i6938e84de21f4c3dad14902e07abcb17_ConsolidatedStatementsofEarnings"/>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended" id="i2888cc00c0c845d28382cca31d05a627_ConsolidatedStatementsofComprehensiveIncome"/>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedStatementsofEquity"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofEquity" xlink:type="extended" id="idadebeae28054ba8a1720793089adfa2_ConsolidatedStatementsofEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e01f5fcf-1b20-4040-9328-45ef6dc7b4ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e01f5fcf-1b20-4040-9328-45ef6dc7b4ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b9955eb1-0525-40de-9b27-60f39efbcf6d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:to="loc_us-gaap_NetIncomeLoss_b9955eb1-0525-40de-9b27-60f39efbcf6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_f9f34e10-5143-4acf-aed0-51a1886e53a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:to="loc_us-gaap_DividendsCommonStockCash_f9f34e10-5143-4acf-aed0-51a1886e53a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_f994824d-de10-4a3f-867d-a43be0cf5b27" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_f994824d-de10-4a3f-867d-a43be0cf5b27" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_a658188b-94ac-419a-9cc7-4fcf00ab57b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_a658188b-94ac-419a-9cc7-4fcf00ab57b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_a3558ea9-adc5-4c36-9ab6-8f9e272bed5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:to="loc_us-gaap_StockholdersEquityOther_a3558ea9-adc5-4c36-9ab6-8f9e272bed5c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6894cbe4-0481-467d-bfff-6c55d03743ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6894cbe4-0481-467d-bfff-6c55d03743ab" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90dc1bd0-1d0a-49c4-9092-bfde7ff275d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_bf094620-424d-4669-9804-e4f4620f8eae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:to="loc_us-gaap_RestructuringCharges_bf094620-424d-4669-9804-e4f4620f8eae" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5a0d01b9-fb10-448d-a050-ea9906a83793" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:to="loc_us-gaap_StatementTable_5a0d01b9-fb10-448d-a050-ea9906a83793" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_55e520d0-15ec-489e-87ce-a6b945c790d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5a0d01b9-fb10-448d-a050-ea9906a83793" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_55e520d0-15ec-489e-87ce-a6b945c790d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_55e520d0-15ec-489e-87ce-a6b945c790d8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_55e520d0-15ec-489e-87ce-a6b945c790d8" xlink:to="loc_us-gaap_EquityComponentDomain_55e520d0-15ec-489e-87ce-a6b945c790d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b015af79-0480-4885-bd4c-8ed04a756d67" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_55e520d0-15ec-489e-87ce-a6b945c790d8" xlink:to="loc_us-gaap_EquityComponentDomain_b015af79-0480-4885-bd4c-8ed04a756d67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_87b4d5b4-040f-485e-88e8-d449cde4b8a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b015af79-0480-4885-bd4c-8ed04a756d67" xlink:to="loc_us-gaap_RetainedEarningsMember_87b4d5b4-040f-485e-88e8-d449cde4b8a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b6d5a54e-5e19-4da8-99f8-b5497e3da899" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b015af79-0480-4885-bd4c-8ed04a756d67" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b6d5a54e-5e19-4da8-99f8-b5497e3da899" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0f46f5cd-68d6-4e4c-a91d-7ef9af03a5ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b015af79-0480-4885-bd4c-8ed04a756d67" xlink:to="loc_us-gaap_CommonStockMember_0f46f5cd-68d6-4e4c-a91d-7ef9af03a5ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_5ef06b4b-616c-4181-9b15-abf6029bad8e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b015af79-0480-4885-bd4c-8ed04a756d67" xlink:to="loc_us-gaap_TreasuryStockMember_5ef06b4b-616c-4181-9b15-abf6029bad8e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0b1d61ce-e33a-4c7b-8e96-d58e13f6ffc6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5a0d01b9-fb10-448d-a050-ea9906a83793" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0b1d61ce-e33a-4c7b-8e96-d58e13f6ffc6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0b1d61ce-e33a-4c7b-8e96-d58e13f6ffc6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0b1d61ce-e33a-4c7b-8e96-d58e13f6ffc6" xlink:to="loc_us-gaap_SegmentDomain_0b1d61ce-e33a-4c7b-8e96-d58e13f6ffc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9ea1118d-e533-479c-96b6-b8594a69c1a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0b1d61ce-e33a-4c7b-8e96-d58e13f6ffc6" xlink:to="loc_us-gaap_SegmentDomain_9ea1118d-e533-479c-96b6-b8594a69c1a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_a5ebd47f-2993-4556-8eda-ee4f13d01c9e" xlink:href="jnj-20200927.xsd#jnj_MedicalDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9ea1118d-e533-479c-96b6-b8594a69c1a9" xlink:to="loc_jnj_MedicalDevicesMember_a5ebd47f-2993-4556-8eda-ee4f13d01c9e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedStatementsofEquityParenthetical"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical" xlink:type="extended" id="i537e009acaca486cb23f0ddd3c5c0872_ConsolidatedStatementsofEquityParenthetical"/>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="i36ab857ebaf74f85ad1b0b76026cb17b_ConsolidatedStatementsofCashFlows">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0d4464ab-99f4-4faf-8a62-50e9eef0d259" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0d4464ab-99f4-4faf-8a62-50e9eef0d259" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_af15eb7e-c6eb-4280-806d-7a55a0582a0e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0d4464ab-99f4-4faf-8a62-50e9eef0d259" xlink:to="loc_us-gaap_NetIncomeLoss_af15eb7e-c6eb-4280-806d-7a55a0582a0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8367ca56-1864-4e39-80e3-6c043ddd23c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0d4464ab-99f4-4faf-8a62-50e9eef0d259" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8367ca56-1864-4e39-80e3-6c043ddd23c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_50277553-a12a-4c35-b909-a0d9eb092a05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8367ca56-1864-4e39-80e3-6c043ddd23c3" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_50277553-a12a-4c35-b909-a0d9eb092a05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5b0ec1c7-7467-4d8c-b43c-ef07f84fdc08" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8367ca56-1864-4e39-80e3-6c043ddd23c3" xlink:to="loc_us-gaap_ShareBasedCompensation_5b0ec1c7-7467-4d8c-b43c-ef07f84fdc08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_da164511-0d43-4b84-9c17-4b0742ba95b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8367ca56-1864-4e39-80e3-6c043ddd23c3" xlink:to="loc_us-gaap_AssetImpairmentCharges_da164511-0d43-4b84-9c17-4b0742ba95b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a938562b-518b-48e1-a5f1-ed989aa32447" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8367ca56-1864-4e39-80e3-6c043ddd23c3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a938562b-518b-48e1-a5f1-ed989aa32447" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_58f2f731-2b80-4acc-ac45-3d237fc12d43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8367ca56-1864-4e39-80e3-6c043ddd23c3" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_58f2f731-2b80-4acc-ac45-3d237fc12d43" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_463c62f3-9c90-4cec-842a-7828660b7af9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8367ca56-1864-4e39-80e3-6c043ddd23c3" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_463c62f3-9c90-4cec-842a-7828660b7af9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_79bc49be-78bb-4274-965a-427fa030353b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8367ca56-1864-4e39-80e3-6c043ddd23c3" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_79bc49be-78bb-4274-965a-427fa030353b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39256604-cd4d-4bce-bd6e-c472ada9182e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0d4464ab-99f4-4faf-8a62-50e9eef0d259" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39256604-cd4d-4bce-bd6e-c472ada9182e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c19cda67-5281-47cd-9e6a-e1dd323fb6fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39256604-cd4d-4bce-bd6e-c472ada9182e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c19cda67-5281-47cd-9e6a-e1dd323fb6fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_9f570d75-0680-4e21-81a4-481ec42a8c57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39256604-cd4d-4bce-bd6e-c472ada9182e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_9f570d75-0680-4e21-81a4-481ec42a8c57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_987708d6-7b4d-44cb-b9d4-9a8703e23f7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39256604-cd4d-4bce-bd6e-c472ada9182e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_987708d6-7b4d-44cb-b9d4-9a8703e23f7d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1c9e5e6f-824e-46e6-b810-0f9a81ac64db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39256604-cd4d-4bce-bd6e-c472ada9182e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1c9e5e6f-824e-46e6-b810-0f9a81ac64db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_d1a4435a-9976-41d1-9cfc-9bbcc5e47730" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39256604-cd4d-4bce-bd6e-c472ada9182e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_d1a4435a-9976-41d1-9cfc-9bbcc5e47730" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dee5bc36-c4ad-4d03-98b8-bdeba71cf80d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39256604-cd4d-4bce-bd6e-c472ada9182e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dee5bc36-c4ad-4d03-98b8-bdeba71cf80d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b89c54ef-88f9-42cf-81a2-26b4e773ca11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b89c54ef-88f9-42cf-81a2-26b4e773ca11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_36bdb41b-d454-4b99-b9be-0ef4cea33692" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_36bdb41b-d454-4b99-b9be-0ef4cea33692" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3641fd90-2da3-48a4-ad57-bfbc07a1497d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3641fd90-2da3-48a4-ad57-bfbc07a1497d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_0b790048-1c57-4ad4-a763-7bfaaa600bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_0b790048-1c57-4ad4-a763-7bfaaa600bb8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_a83af65b-230e-4848-8cd6-4fe69f11ef3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_a83af65b-230e-4848-8cd6-4fe69f11ef3d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Proceedsfromcreditsupportagreements_c63c6da6-b1ed-4281-8339-cacba3127f88" xlink:href="jnj-20200927.xsd#jnj_Proceedsfromcreditsupportagreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:to="loc_jnj_Proceedsfromcreditsupportagreements_c63c6da6-b1ed-4281-8339-cacba3127f88" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_a2041fda-7412-48c0-8f36-cd3416cf4c98" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_a2041fda-7412-48c0-8f36-cd3416cf4c98" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5e626143-81a1-4d25-8c0a-ec87e4102e38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5e626143-81a1-4d25-8c0a-ec87e4102e38" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_2c9154e5-11cb-4a49-81a2-e05c7b99f283" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_2c9154e5-11cb-4a49-81a2-e05c7b99f283" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0d9f5abc-3873-4185-b0ef-531e24fc70a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0d9f5abc-3873-4185-b0ef-531e24fc70a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_dae16944-a0a0-49d4-b13c-ef48cfcd528b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_dae16944-a0a0-49d4-b13c-ef48cfcd528b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_5eef4618-8929-4efc-b837-393d2c1fd79d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_5eef4618-8929-4efc-b837-393d2c1fd79d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9cea93d7-cf9f-47df-a36c-adebcb769547" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9cea93d7-cf9f-47df-a36c-adebcb769547" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_9dea6612-da50-4c9e-a9d2-a92c25ac0ceb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_9dea6612-da50-4c9e-a9d2-a92c25ac0ceb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits_0d6dfc07-5d79-4911-9554-82d2986bd4fe" xlink:href="jnj-20200927.xsd#jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:to="loc_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits_0d6dfc07-5d79-4911-9554-82d2986bd4fe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bb4ddeb3-6dbd-4c7f-9442-6df62f93df62" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bb4ddeb3-6dbd-4c7f-9442-6df62f93df62" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b45141fc-ed16-4b9a-aa2c-60419fdfa721" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b45141fc-ed16-4b9a-aa2c-60419fdfa721" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_7cad3b59-6b98-4ea9-9fdf-0a757b8bcbdb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_7cad3b59-6b98-4ea9-9fdf-0a757b8bcbdb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_089e3ff4-0521-4867-ac2a-bf613f44b0de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_089e3ff4-0521-4867-ac2a-bf613f44b0de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bd445b04-b97a-4601-9e93-f4deba29f2a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bd445b04-b97a-4601-9e93-f4deba29f2a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_30337b19-0345-44d7-90c8-2eccbf2af676" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_049df0ae-85c4-4463-bbab-8f2325c3ef31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_049df0ae-85c4-4463-bbab-8f2325c3ef31" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_d3d55a8a-08d1-454f-a7a6-4dfc430cc824" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_049df0ae-85c4-4463-bbab-8f2325c3ef31" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_d3d55a8a-08d1-454f-a7a6-4dfc430cc824" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_c2f79e4d-0e20-4a9f-8d3d-a9c0d266201a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_049df0ae-85c4-4463-bbab-8f2325c3ef31" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_c2f79e4d-0e20-4a9f-8d3d-a9c0d266201a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_aaac417d-ebe5-4f8f-bc18-685425aa5a26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_049df0ae-85c4-4463-bbab-8f2325c3ef31" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_aaac417d-ebe5-4f8f-bc18-685425aa5a26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_24fe9743-e265-4df8-8d78-49ec54d84fd6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:to="loc_us-gaap_StatementTable_24fe9743-e265-4df8-8d78-49ec54d84fd6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2818f1ad-b860-4008-a6b5-7a35df8fcf0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_24fe9743-e265-4df8-8d78-49ec54d84fd6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2818f1ad-b860-4008-a6b5-7a35df8fcf0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2818f1ad-b860-4008-a6b5-7a35df8fcf0d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2818f1ad-b860-4008-a6b5-7a35df8fcf0d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2818f1ad-b860-4008-a6b5-7a35df8fcf0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c26b7053-1646-41cb-837f-db85dfb43d38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2818f1ad-b860-4008-a6b5-7a35df8fcf0d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c26b7053-1646-41cb-837f-db85dfb43d38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AurisHealthMember_c7c78663-eef4-49bd-ab6b-21e94a4614a4" xlink:href="jnj-20200927.xsd#jnj_AurisHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c26b7053-1646-41cb-837f-db85dfb43d38" xlink:to="loc_jnj_AurisHealthMember_c7c78663-eef4-49bd-ab6b-21e94a4614a4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="jnj-20200927.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended" id="i13a30f0eb23b417ea287010dc34bbc0f_SummaryofSignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="jnj-20200927.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended" id="id2a4a0ae55c74e4d89d17d8f345ad433_SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.jnj.com/role/Inventories" xlink:type="simple" xlink:href="jnj-20200927.xsd#Inventories"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/Inventories" xlink:type="extended" id="iea5898fc2ce444fcba928bb25a0f6017_Inventories"/>
  <link:roleRef roleURI="http://www.jnj.com/role/InventoriesTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#InventoriesTables"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/InventoriesTables" xlink:type="extended" id="i49bfca8eb0fd4ca1897c50b4e6ad6036_InventoriesTables"/>
  <link:roleRef roleURI="http://www.jnj.com/role/InventoriesDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#InventoriesDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/InventoriesDetails" xlink:type="extended" id="ie0ccfd06225e4be5b700e4e631e4e0f6_InventoriesDetails"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="jnj-20200927.xsd#IntangibleAssetsandGoodwill"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwill" xlink:type="extended" id="i65f0f17551f541fa9a239442a04e9af8_IntangibleAssetsandGoodwill"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillTables" xlink:type="extended" id="ib76096c161ce40498bf7deddc80fc939_IntangibleAssetsandGoodwillTables"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#IntangibleAssetsandGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails" xlink:type="extended" id="ia8bf39b8f8894ceca1b167b1c6355375_IntangibleAssetsandGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_88076031-0560-4d93-afbb-53c03b56c49b" xlink:href="jnj-20200927.xsd#jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_54839912-0f01-4f2d-a54b-3fc5ccbc3627" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_88076031-0560-4d93-afbb-53c03b56c49b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_54839912-0f01-4f2d-a54b-3fc5ccbc3627" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_977558f1-ae55-4c34-8eba-9bc2365f6e3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_54839912-0f01-4f2d-a54b-3fc5ccbc3627" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_977558f1-ae55-4c34-8eba-9bc2365f6e3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ba81b105-3f08-419b-bc2c-9fd9b91fef1f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_977558f1-ae55-4c34-8eba-9bc2365f6e3f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ba81b105-3f08-419b-bc2c-9fd9b91fef1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_34e43781-9a04-4fea-a4f9-9437420ce845" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_977558f1-ae55-4c34-8eba-9bc2365f6e3f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_34e43781-9a04-4fea-a4f9-9437420ce845" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8cbd107e-cf96-4a72-987c-61edd8800556" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_977558f1-ae55-4c34-8eba-9bc2365f6e3f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8cbd107e-cf96-4a72-987c-61edd8800556" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_f36b861e-950b-4c0e-8510-d87d10952bd2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_54839912-0f01-4f2d-a54b-3fc5ccbc3627" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_f36b861e-950b-4c0e-8510-d87d10952bd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_68e7119e-9f05-44f2-ac9b-2b36ee1fff9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_f36b861e-950b-4c0e-8510-d87d10952bd2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_68e7119e-9f05-44f2-ac9b-2b36ee1fff9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b0b15f08-aa5e-40ff-92fd-03645e5e00b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_f36b861e-950b-4c0e-8510-d87d10952bd2" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b0b15f08-aa5e-40ff-92fd-03645e5e00b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_17428ad5-c591-4d47-9dc8-21810cc8d363" xlink:href="jnj-20200927.xsd#jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_88076031-0560-4d93-afbb-53c03b56c49b" xlink:to="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_17428ad5-c591-4d47-9dc8-21810cc8d363" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8c3f31d6-5694-42d3-8aa0-490ffeb3bb87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_17428ad5-c591-4d47-9dc8-21810cc8d363" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8c3f31d6-5694-42d3-8aa0-490ffeb3bb87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8c3f31d6-5694-42d3-8aa0-490ffeb3bb87_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8c3f31d6-5694-42d3-8aa0-490ffeb3bb87" xlink:to="loc_us-gaap_SegmentDomain_8c3f31d6-5694-42d3-8aa0-490ffeb3bb87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7f1bd537-1199-464a-8625-6813ce8c0a14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8c3f31d6-5694-42d3-8aa0-490ffeb3bb87" xlink:to="loc_us-gaap_SegmentDomain_7f1bd537-1199-464a-8625-6813ce8c0a14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember_28a93bce-cc84-4636-b74b-e91f195c1a7f" xlink:href="jnj-20200927.xsd#jnj_ConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7f1bd537-1199-464a-8625-6813ce8c0a14" xlink:to="loc_jnj_ConsumerMember_28a93bce-cc84-4636-b74b-e91f195c1a7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e9c81718-3fab-45b8-9ff9-0dbdd10bc584" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_17428ad5-c591-4d47-9dc8-21810cc8d363" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e9c81718-3fab-45b8-9ff9-0dbdd10bc584" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e9c81718-3fab-45b8-9ff9-0dbdd10bc584_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e9c81718-3fab-45b8-9ff9-0dbdd10bc584" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e9c81718-3fab-45b8-9ff9-0dbdd10bc584_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_077c0361-75a8-4617-aa85-35c4d02e3157" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e9c81718-3fab-45b8-9ff9-0dbdd10bc584" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_077c0361-75a8-4617-aa85-35c4d02e3157" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PatentsAndTrademarksMember_b0c83538-e02e-4d8a-9295-5f0686d1780c" xlink:href="jnj-20200927.xsd#jnj_PatentsAndTrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_077c0361-75a8-4617-aa85-35c4d02e3157" xlink:to="loc_jnj_PatentsAndTrademarksMember_b0c83538-e02e-4d8a-9295-5f0686d1780c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_f3bcda05-d4e0-4965-b68c-9a363397e466" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_077c0361-75a8-4617-aa85-35c4d02e3157" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_f3bcda05-d4e0-4965-b68c-9a363397e466" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2cd84b81-91e5-47d0-800d-927e3cdd04f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_17428ad5-c591-4d47-9dc8-21810cc8d363" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2cd84b81-91e5-47d0-800d-927e3cdd04f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2cd84b81-91e5-47d0-800d-927e3cdd04f5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2cd84b81-91e5-47d0-800d-927e3cdd04f5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2cd84b81-91e5-47d0-800d-927e3cdd04f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ab88401b-31d4-4500-b64b-766e4bd8f30f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2cd84b81-91e5-47d0-800d-927e3cdd04f5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ab88401b-31d4-4500-b64b-766e4bd8f30f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_d99d8dbc-9b06-48df-ba32-f18538a8b4be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ab88401b-31d4-4500-b64b-766e4bd8f30f" xlink:to="loc_us-gaap_TrademarksMember_d99d8dbc-9b06-48df-ba32-f18538a8b4be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_dad50bf3-a68f-49f4-a09b-fb466b69f2b6" xlink:href="jnj-20200927.xsd#jnj_PurchasedInProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ab88401b-31d4-4500-b64b-766e4bd8f30f" xlink:to="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_dad50bf3-a68f-49f4-a09b-fb466b69f2b6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#IntangibleAssetsandGoodwillGoodwillBySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails" xlink:type="extended" id="ic106619f013341f5a72145653066d619_IntangibleAssetsandGoodwillGoodwillBySegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_02863cbd-0539-4021-bd55-4744df929dc1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_67d6d7e0-5620-4211-bda9-1180881fa8ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_02863cbd-0539-4021-bd55-4744df929dc1" xlink:to="loc_us-gaap_GoodwillRollForward_67d6d7e0-5620-4211-bda9-1180881fa8ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_122701d1-b1fd-4264-880e-e304aeea5f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_67d6d7e0-5620-4211-bda9-1180881fa8ac" xlink:to="loc_us-gaap_Goodwill_122701d1-b1fd-4264-880e-e304aeea5f6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_320c2cf0-11f6-414c-b119-9311debdbf66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_67d6d7e0-5620-4211-bda9-1180881fa8ac" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_320c2cf0-11f6-414c-b119-9311debdbf66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease_d6a45759-97ed-42ee-ad27-206d0b5bc75d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_67d6d7e0-5620-4211-bda9-1180881fa8ac" xlink:to="loc_us-gaap_GoodwillOtherIncreaseDecrease_d6a45759-97ed-42ee-ad27-206d0b5bc75d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_83200a4c-cd91-4223-954d-11428ec0c4b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_87e769ea-c23e-4066-af86-f89e8086c4d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_02863cbd-0539-4021-bd55-4744df929dc1" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_87e769ea-c23e-4066-af86-f89e8086c4d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ad1a4a6c-b231-4844-9a94-b3e902ed7d18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_87e769ea-c23e-4066-af86-f89e8086c4d0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ad1a4a6c-b231-4844-9a94-b3e902ed7d18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ad1a4a6c-b231-4844-9a94-b3e902ed7d18_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ad1a4a6c-b231-4844-9a94-b3e902ed7d18" xlink:to="loc_us-gaap_SegmentDomain_ad1a4a6c-b231-4844-9a94-b3e902ed7d18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_dcc279b6-b8b0-45af-9d86-dd4552825dde" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ad1a4a6c-b231-4844-9a94-b3e902ed7d18" xlink:to="loc_us-gaap_SegmentDomain_dcc279b6-b8b0-45af-9d86-dd4552825dde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember_4bd0423b-afbd-424b-b0bf-4490f048c474" xlink:href="jnj-20200927.xsd#jnj_ConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_dcc279b6-b8b0-45af-9d86-dd4552825dde" xlink:to="loc_jnj_ConsumerMember_4bd0423b-afbd-424b-b0bf-4490f048c474" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PharmaceuticalMember_12d4206a-b20b-4563-aa37-56a861c1eaed" xlink:href="jnj-20200927.xsd#jnj_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_dcc279b6-b8b0-45af-9d86-dd4552825dde" xlink:to="loc_jnj_PharmaceuticalMember_12d4206a-b20b-4563-aa37-56a861c1eaed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_3bb620fe-af08-462f-b878-4bf99e11469d" xlink:href="jnj-20200927.xsd#jnj_MedicalDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_dcc279b6-b8b0-45af-9d86-dd4552825dde" xlink:to="loc_jnj_MedicalDevicesMember_3bb620fe-af08-462f-b878-4bf99e11469d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#IntangibleAssetsandGoodwillNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails" xlink:type="extended" id="i979a1c3d6cf44de690d2c05b108430d5_IntangibleAssetsandGoodwillNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a731192e-7a4f-408d-a00b-1cf287e67e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_77840e6d-ab92-4ad3-825e-dde89a309ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a731192e-7a4f-408d-a00b-1cf287e67e7b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_77840e6d-ab92-4ad3-825e-dde89a309ff4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_8c56fda1-a9e0-4bcd-891b-3ad7931f740b" xlink:href="jnj-20200927.xsd#jnj_IntangibleAssetsAndGoodwillTextualsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a731192e-7a4f-408d-a00b-1cf287e67e7b" xlink:to="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_8c56fda1-a9e0-4bcd-891b-3ad7931f740b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_cf6fad02-d261-4999-bb77-295c858005ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_8c56fda1-a9e0-4bcd-891b-3ad7931f740b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_cf6fad02-d261-4999-bb77-295c858005ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9c1a8277-9cbc-4a1e-8a89-af1776b3f723" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_8c56fda1-a9e0-4bcd-891b-3ad7931f740b" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9c1a8277-9cbc-4a1e-8a89-af1776b3f723" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ec2a592e-c7dd-4629-8b08-0effa29b616c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a731192e-7a4f-408d-a00b-1cf287e67e7b" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ec2a592e-c7dd-4629-8b08-0effa29b616c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9f9dd42c-8d7d-4831-a06a-c0a9e37e78ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ec2a592e-c7dd-4629-8b08-0effa29b616c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9f9dd42c-8d7d-4831-a06a-c0a9e37e78ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9f9dd42c-8d7d-4831-a06a-c0a9e37e78ee_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9f9dd42c-8d7d-4831-a06a-c0a9e37e78ee" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9f9dd42c-8d7d-4831-a06a-c0a9e37e78ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_190ea0f9-b973-48e0-a0a3-0cd1d2793cde" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9f9dd42c-8d7d-4831-a06a-c0a9e37e78ee" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_190ea0f9-b973-48e0-a0a3-0cd1d2793cde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_98297c67-8d46-4b89-92cf-79bd2f1c94ef" xlink:href="jnj-20200927.xsd#jnj_PurchasedInProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_190ea0f9-b973-48e0-a0a3-0cd1d2793cde" xlink:to="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_98297c67-8d46-4b89-92cf-79bd2f1c94ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b2a3bb87-c602-4b7c-b94d-30c733f9b3ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ec2a592e-c7dd-4629-8b08-0effa29b616c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b2a3bb87-c602-4b7c-b94d-30c733f9b3ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b2a3bb87-c602-4b7c-b94d-30c733f9b3ad_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b2a3bb87-c602-4b7c-b94d-30c733f9b3ad" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b2a3bb87-c602-4b7c-b94d-30c733f9b3ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_30d4ca5a-a17e-48e1-ad35-951152cf317b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b2a3bb87-c602-4b7c-b94d-30c733f9b3ad" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_30d4ca5a-a17e-48e1-ad35-951152cf317b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BermekimabMember_02e2a0fb-036c-4c88-b994-95e901f2b1f8" xlink:href="jnj-20200927.xsd#jnj_BermekimabMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_30d4ca5a-a17e-48e1-ad35-951152cf317b" xlink:to="loc_jnj_BermekimabMember_02e2a0fb-036c-4c88-b994-95e901f2b1f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VerbSurgicalInc.Member_d0d8502d-8915-41a7-8d02-6f839e427746" xlink:href="jnj-20200927.xsd#jnj_VerbSurgicalInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_30d4ca5a-a17e-48e1-ad35-951152cf317b" xlink:to="loc_jnj_VerbSurgicalInc.Member_d0d8502d-8915-41a7-8d02-6f839e427746" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08bb603a-9735-4e96-b8ff-46f7d5193b97" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ec2a592e-c7dd-4629-8b08-0effa29b616c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08bb603a-9735-4e96-b8ff-46f7d5193b97" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_08bb603a-9735-4e96-b8ff-46f7d5193b97_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08bb603a-9735-4e96-b8ff-46f7d5193b97" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_08bb603a-9735-4e96-b8ff-46f7d5193b97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e0ad8d60-a130-43d8-9a81-7d985dfc2a7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08bb603a-9735-4e96-b8ff-46f7d5193b97" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e0ad8d60-a130-43d8-9a81-7d985dfc2a7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PatentsAndTrademarksMember_894539d0-469c-4f7d-a749-65cc1f74b660" xlink:href="jnj-20200927.xsd#jnj_PatentsAndTrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e0ad8d60-a130-43d8-9a81-7d985dfc2a7d" xlink:to="loc_jnj_PatentsAndTrademarksMember_894539d0-469c-4f7d-a749-65cc1f74b660" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_4b0fc301-3ed9-4cc5-842a-c765efecb3f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e0ad8d60-a130-43d8-9a81-7d985dfc2a7d" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_4b0fc301-3ed9-4cc5-842a-c765efecb3f1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails" xlink:type="extended" id="ifeb5222dcbe544698d9254475bfb52c4_IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurements" xlink:type="extended" id="i4242c542e11342a4be22a6ad7b4dba13_FairValueMeasurements"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsPolicies" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsPolicies"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsPolicies" xlink:type="extended" id="i55ca57f3598740f9bb77d93fd36aa1b8_FairValueMeasurementsPolicies"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsTables" xlink:type="extended" id="ib8a2c2d39d3b45f395b31c030085c3b5_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="icddfd7ac9d694603846379f27554f64a_FairValueMeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_6a00c639-24c2-40e6-89be-2a05d20df596" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_6a00c639-24c2-40e6-89be-2a05d20df596" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_f11dc014-bed5-4b79-9952-3228903da0a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_f11dc014-bed5-4b79-9952-3228903da0a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_6cb5f48a-33dc-4b78-ad4e-5be7341a947b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CollateralAlreadyPostedAggregateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_6cb5f48a-33dc-4b78-ad4e-5be7341a947b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_2e2a0bc2-be8c-475a-8f7d-125948015958" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_DerivativeNotionalAmount_2e2a0bc2-be8c-475a-8f7d-125948015958" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_113e81d7-88da-429b-a21f-f454f00596c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_113e81d7-88da-429b-a21f-f454f00596c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss_fcc30d45-3e55-426d-b3ea-6b877ebe3d59" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss_fcc30d45-3e55-426d-b3ea-6b877ebe3d59" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_a9cef0c6-7089-46a9-bf5c-fc75c6707c13" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_a9cef0c6-7089-46a9-bf5c-fc75c6707c13" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityFairValueAdjustmentImpairmentLoss_1f357fff-8b42-47de-a3e0-956c0998034a" xlink:href="jnj-20200927.xsd#jnj_EquityFairValueAdjustmentImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_jnj_EquityFairValueAdjustmentImpairmentLoss_1f357fff-8b42-47de-a3e0-956c0998034a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityFairValueAdjustmentChangeInObservablePrice_fcaaff0b-fb24-4f35-a848-9b86fc6412a7" xlink:href="jnj-20200927.xsd#jnj_EquityFairValueAdjustmentChangeInObservablePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_jnj_EquityFairValueAdjustmentChangeInObservablePrice_fcaaff0b-fb24-4f35-a848-9b86fc6412a7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_0cc454b3-eb57-47fc-aed3-6b3a56f55fcc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_0cc454b3-eb57-47fc-aed3-6b3a56f55fcc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_1090f510-761c-4f11-a7e5-5b1c3f435204" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_1090f510-761c-4f11-a7e5-5b1c3f435204" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ExcessOfFairValueOverCarryingValueOfDebt_a6a85524-e7c7-413b-a420-c008abd477a9" xlink:href="jnj-20200927.xsd#jnj_ExcessOfFairValueOverCarryingValueOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_jnj_ExcessOfFairValueOverCarryingValueOfDebt_a6a85524-e7c7-413b-a420-c008abd477a9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_ce46dde4-674a-4b04-b2b0-30572da1d94a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_ShortTermBorrowings_ce46dde4-674a-4b04-b2b0-30572da1d94a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_3de306f7-d463-45a6-9a8b-b50bdc669516" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_3de306f7-d463-45a6-9a8b-b50bdc669516" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_95f12407-17a3-4662-b3f6-622e91f856ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_DebtInstrumentTerm_95f12407-17a3-4662-b3f6-622e91f856ec" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_e765eaf4-c1c2-4409-8e61-588c821a4fa4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_e765eaf4-c1c2-4409-8e61-588c821a4fa4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_33b16ffc-b555-41f8-b33e-74a32a005b5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_33b16ffc-b555-41f8-b33e-74a32a005b5a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_8414b696-5d81-4093-bc40-ab185b0452ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_8414b696-5d81-4093-bc40-ab185b0452ad" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_97fa596c-aaa7-4eef-afb4-56fd42f2c7cf" xlink:href="jnj-20200927.xsd#jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_97fa596c-aaa7-4eef-afb4-56fd42f2c7cf" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityFairValueAdjustmentImpairmentLoss_45b4b17c-f1bf-43d4-9ce4-07c902bb0f31" xlink:href="jnj-20200927.xsd#jnj_EquityFairValueAdjustmentImpairmentLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_fe87ed31-7b7a-482b-818f-1bffa19b522b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_fe87ed31-7b7a-482b-818f-1bffa19b522b" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFairValueAdjustment_9fe25067-0cc2-41c0-9fed-e222aaaca1a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityFairValueAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_EquityFairValueAdjustment_9fe25067-0cc2-41c0-9fed-e222aaaca1a6" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fa647947-7f44-4b29-a62c-f55ce6ca1a34" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fa647947-7f44-4b29-a62c-f55ce6ca1a34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_fa647947-7f44-4b29-a62c-f55ce6ca1a34_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fa647947-7f44-4b29-a62c-f55ce6ca1a34" xlink:to="loc_us-gaap_HedgingRelationshipDomain_fa647947-7f44-4b29-a62c-f55ce6ca1a34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_152007c9-b26b-4f20-9d13-8cfe6f5017cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fa647947-7f44-4b29-a62c-f55ce6ca1a34" xlink:to="loc_us-gaap_HedgingRelationshipDomain_152007c9-b26b-4f20-9d13-8cfe6f5017cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_e1497a7a-5e94-44d4-9b33-c936e3fafb72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_152007c9-b26b-4f20-9d13-8cfe6f5017cc" xlink:to="loc_us-gaap_FairValueHedgingMember_e1497a7a-5e94-44d4-9b33-c936e3fafb72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_110a00e5-6b0e-478f-80f5-2e29183ab632" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_152007c9-b26b-4f20-9d13-8cfe6f5017cc" xlink:to="loc_us-gaap_CashFlowHedgingMember_110a00e5-6b0e-478f-80f5-2e29183ab632" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_40beb981-e0c9-408e-a15e-e86c7df035ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_40beb981-e0c9-408e-a15e-e86c7df035ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_40beb981-e0c9-408e-a15e-e86c7df035ea_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_40beb981-e0c9-408e-a15e-e86c7df035ea" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_40beb981-e0c9-408e-a15e-e86c7df035ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_143145ee-3d89-4e1a-bc3c-a6f930ac70d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_40beb981-e0c9-408e-a15e-e86c7df035ea" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_143145ee-3d89-4e1a-bc3c-a6f930ac70d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_ca14405b-5078-4f7f-94e7-58c9cc1f428d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_143145ee-3d89-4e1a-bc3c-a6f930ac70d8" xlink:to="loc_us-gaap_SalesMember_ca14405b-5078-4f7f-94e7-58c9cc1f428d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_6a2bbc30-de42-477f-b330-f99fe591f734" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_143145ee-3d89-4e1a-bc3c-a6f930ac70d8" xlink:to="loc_us-gaap_CostOfSalesMember_6a2bbc30-de42-477f-b330-f99fe591f734" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5fc3a9bb-4ae1-4ba3-87ec-9c75ccb0e276" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_143145ee-3d89-4e1a-bc3c-a6f930ac70d8" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5fc3a9bb-4ae1-4ba3-87ec-9c75ccb0e276" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterestIncomeExpenseNetMember_44514812-5c0b-4363-98fe-762b16dcc143" xlink:href="jnj-20200927.xsd#jnj_InterestIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_143145ee-3d89-4e1a-bc3c-a6f930ac70d8" xlink:to="loc_jnj_InterestIncomeExpenseNetMember_44514812-5c0b-4363-98fe-762b16dcc143" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_2c0252bd-0bf2-4e4c-8040-8be8bc6d1b1c" xlink:href="jnj-20200927.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_143145ee-3d89-4e1a-bc3c-a6f930ac70d8" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_2c0252bd-0bf2-4e4c-8040-8be8bc6d1b1c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5cbeb476-4cac-430e-b2e3-f29b519fcfb7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5cbeb476-4cac-430e-b2e3-f29b519fcfb7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5cbeb476-4cac-430e-b2e3-f29b519fcfb7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5cbeb476-4cac-430e-b2e3-f29b519fcfb7" xlink:to="loc_us-gaap_EquityComponentDomain_5cbeb476-4cac-430e-b2e3-f29b519fcfb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c16c5609-02c3-4477-b69d-bb0064c32a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5cbeb476-4cac-430e-b2e3-f29b519fcfb7" xlink:to="loc_us-gaap_EquityComponentDomain_c16c5609-02c3-4477-b69d-bb0064c32a1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5b8e382c-e46c-4945-9d1c-839d41a20e38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c16c5609-02c3-4477-b69d-bb0064c32a1d" xlink:to="loc_us-gaap_RetainedEarningsMember_5b8e382c-e46c-4945-9d1c-839d41a20e38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_1bf0d173-0476-44f2-8210-17e8a28424ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_1bf0d173-0476-44f2-8210-17e8a28424ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_1bf0d173-0476-44f2-8210-17e8a28424ba_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_1bf0d173-0476-44f2-8210-17e8a28424ba" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_1bf0d173-0476-44f2-8210-17e8a28424ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_c42b8bb7-d3a3-49dd-bc76-4a112746f363" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_1bf0d173-0476-44f2-8210-17e8a28424ba" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_c42b8bb7-d3a3-49dd-bc76-4a112746f363" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_f7e86fbc-c270-4ad3-bd34-78e897a045fc" xlink:href="jnj-20200927.xsd#jnj_EquityInvestmentswithoutReadilyDeterminableValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_c42b8bb7-d3a3-49dd-bc76-4a112746f363" xlink:to="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_f7e86fbc-c270-4ad3-bd34-78e897a045fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember_8ca53633-2a65-4ed0-82f8-f4e62497edf5" xlink:href="jnj-20200927.xsd#jnj_EquityInvestmentswithReadilyDeterminableValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_c42b8bb7-d3a3-49dd-bc76-4a112746f363" xlink:to="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember_8ca53633-2a65-4ed0-82f8-f4e62497edf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_19e92349-0177-4c8c-bec9-a277370b4e75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_19e92349-0177-4c8c-bec9-a277370b4e75" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_19e92349-0177-4c8c-bec9-a277370b4e75_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_19e92349-0177-4c8c-bec9-a277370b4e75" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_19e92349-0177-4c8c-bec9-a277370b4e75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3246597-3925-45fd-bb8c-d65f2aa48aab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_19e92349-0177-4c8c-bec9-a277370b4e75" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3246597-3925-45fd-bb8c-d65f2aa48aab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_48731171-f1c6-423d-9e77-02c75fe481ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3246597-3925-45fd-bb8c-d65f2aa48aab" xlink:to="loc_us-gaap_EquitySecuritiesMember_48731171-f1c6-423d-9e77-02c75fe481ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_d17761aa-d5b1-404e-bbe8-b22791a63842" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:to="loc_us-gaap_InvestmentTypeAxis_d17761aa-d5b1-404e-bbe8-b22791a63842" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_d17761aa-d5b1-404e-bbe8-b22791a63842_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_d17761aa-d5b1-404e-bbe8-b22791a63842" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_d17761aa-d5b1-404e-bbe8-b22791a63842_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_16a21ee9-e9b2-4468-bd19-d2082b5129c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_d17761aa-d5b1-404e-bbe8-b22791a63842" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_16a21ee9-e9b2-4468-bd19-d2082b5129c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_08ad1e90-3fe9-48f1-b9ca-76c923041641" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_16a21ee9-e9b2-4468-bd19-d2082b5129c0" xlink:to="loc_us-gaap_EquitySecuritiesMember_08ad1e90-3fe9-48f1-b9ca-76c923041641" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f8aa3802-7413-442d-9eab-19ea62afe95d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f8aa3802-7413-442d-9eab-19ea62afe95d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f8aa3802-7413-442d-9eab-19ea62afe95d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f8aa3802-7413-442d-9eab-19ea62afe95d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f8aa3802-7413-442d-9eab-19ea62afe95d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9ac89518-a4e2-427d-8063-4709f50f1357" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f8aa3802-7413-442d-9eab-19ea62afe95d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9ac89518-a4e2-427d-8063-4709f50f1357" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_338d844f-5ff8-414d-81bf-7e5dffb95ec5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9ac89518-a4e2-427d-8063-4709f50f1357" xlink:to="loc_us-gaap_ForeignExchangeContractMember_338d844f-5ff8-414d-81bf-7e5dffb95ec5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_78b41791-f52a-4f2a-aa5b-600ba388226e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9ac89518-a4e2-427d-8063-4709f50f1357" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_78b41791-f52a-4f2a-aa5b-600ba388226e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_a9b88f82-26e5-4cdb-a974-75168dba23f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9ac89518-a4e2-427d-8063-4709f50f1357" xlink:to="loc_us-gaap_InterestRateContractMember_a9b88f82-26e5-4cdb-a974-75168dba23f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_3fbf4b86-8120-4239-9b4a-09a000284172" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_3fbf4b86-8120-4239-9b4a-09a000284172" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_3fbf4b86-8120-4239-9b4a-09a000284172_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_3fbf4b86-8120-4239-9b4a-09a000284172" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_3fbf4b86-8120-4239-9b4a-09a000284172_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_05191900-81bf-41e9-8db7-9ffdec4e0349" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_3fbf4b86-8120-4239-9b4a-09a000284172" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_05191900-81bf-41e9-8db7-9ffdec4e0349" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_4128e3bd-f18e-48f4-81e8-e1dd4a1954dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_05191900-81bf-41e9-8db7-9ffdec4e0349" xlink:to="loc_us-gaap_CommercialPaperMember_4128e3bd-f18e-48f4-81e8-e1dd4a1954dc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsSummaryofDerivativeActivityDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails" xlink:type="extended" id="i031a2d6575c34216bf2b4a8a3c6e2284_FairValueMeasurementsSummaryofDerivativeActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3f6b2041-25fc-4612-b38e-d5014395b22e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3f6b2041-25fc-4612-b38e-d5014395b22e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_7983f80b-dca2-4514-8af5-8d0961260506" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:to="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_7983f80b-dca2-4514-8af5-8d0961260506" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_a8099aae-9c9f-4473-be50-a17c2fb5e2b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_a8099aae-9c9f-4473-be50-a17c2fb5e2b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_b8d4624b-79a1-4706-8d81-dcac79209f25" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CollateralAlreadyPostedAggregateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:to="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_b8d4624b-79a1-4706-8d81-dcac79209f25" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_923bbdd4-258c-438d-a907-991dfc2449e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:to="loc_us-gaap_DerivativeNotionalAmount_923bbdd4-258c-438d-a907-991dfc2449e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_d52e4ec9-c1d7-4061-b492-cb8154732e1f" xlink:href="jnj-20200927.xsd#jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:to="loc_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_d52e4ec9-c1d7-4061-b492-cb8154732e1f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_a716f515-21bd-4090-98f7-dec58137ed4e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_d52e4ec9-c1d7-4061-b492-cb8154732e1f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_a716f515-21bd-4090-98f7-dec58137ed4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_c8d175f6-781e-4cac-aa31-e679c461f3e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_c8d175f6-781e-4cac-aa31-e679c461f3e0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_96681d4b-1ed7-4395-8f92-a4fd82b37881" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_96681d4b-1ed7-4395-8f92-a4fd82b37881" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8950c2f7-c6c4-4c3b-8446-943abb617503" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8950c2f7-c6c4-4c3b-8446-943abb617503" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fb683895-c5f3-4898-bc18-bd8facee45ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8950c2f7-c6c4-4c3b-8446-943abb617503" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fb683895-c5f3-4898-bc18-bd8facee45ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_fb683895-c5f3-4898-bc18-bd8facee45ae_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fb683895-c5f3-4898-bc18-bd8facee45ae" xlink:to="loc_us-gaap_HedgingRelationshipDomain_fb683895-c5f3-4898-bc18-bd8facee45ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_156bc5a8-9ac2-43d8-b852-dfc2aa04fafd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fb683895-c5f3-4898-bc18-bd8facee45ae" xlink:to="loc_us-gaap_HedgingRelationshipDomain_156bc5a8-9ac2-43d8-b852-dfc2aa04fafd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_c27a6ec1-c48e-4f04-8279-2a8239b30e18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_156bc5a8-9ac2-43d8-b852-dfc2aa04fafd" xlink:to="loc_us-gaap_FairValueHedgingMember_c27a6ec1-c48e-4f04-8279-2a8239b30e18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_74a175ed-0f97-4e7f-969a-c88b0fc9a4a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_156bc5a8-9ac2-43d8-b852-dfc2aa04fafd" xlink:to="loc_us-gaap_CashFlowHedgingMember_74a175ed-0f97-4e7f-969a-c88b0fc9a4a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_cd01a4ca-7ace-4979-b06f-cbda6604e358" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8950c2f7-c6c4-4c3b-8446-943abb617503" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_cd01a4ca-7ace-4979-b06f-cbda6604e358" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cd01a4ca-7ace-4979-b06f-cbda6604e358_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cd01a4ca-7ace-4979-b06f-cbda6604e358" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cd01a4ca-7ace-4979-b06f-cbda6604e358_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e32610ac-a22b-45ae-aaf5-e42c18272178" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cd01a4ca-7ace-4979-b06f-cbda6604e358" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e32610ac-a22b-45ae-aaf5-e42c18272178" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_b2fc5528-818e-4478-b273-7c257518216e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e32610ac-a22b-45ae-aaf5-e42c18272178" xlink:to="loc_us-gaap_InterestRateContractMember_b2fc5528-818e-4478-b273-7c257518216e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ffd18a4a-75a2-4a2b-9f48-63a7ca4955fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e32610ac-a22b-45ae-aaf5-e42c18272178" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ffd18a4a-75a2-4a2b-9f48-63a7ca4955fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_d9eb1f87-f041-4e0e-85b2-6cc752922ee5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e32610ac-a22b-45ae-aaf5-e42c18272178" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_d9eb1f87-f041-4e0e-85b2-6cc752922ee5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7ef8168c-69ca-416c-be35-4551524f473a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8950c2f7-c6c4-4c3b-8446-943abb617503" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7ef8168c-69ca-416c-be35-4551524f473a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7ef8168c-69ca-416c-be35-4551524f473a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7ef8168c-69ca-416c-be35-4551524f473a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7ef8168c-69ca-416c-be35-4551524f473a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fb33f637-85a3-493b-a219-a73fe9862c88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7ef8168c-69ca-416c-be35-4551524f473a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fb33f637-85a3-493b-a219-a73fe9862c88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_4710110b-8195-4b34-8bfc-5dda2e1adafd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fb33f637-85a3-493b-a219-a73fe9862c88" xlink:to="loc_us-gaap_SalesMember_4710110b-8195-4b34-8bfc-5dda2e1adafd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_24bf9634-c8a7-4cab-a26a-9601c256e6a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fb33f637-85a3-493b-a219-a73fe9862c88" xlink:to="loc_us-gaap_CostOfSalesMember_24bf9634-c8a7-4cab-a26a-9601c256e6a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f19bb4fd-e64f-4435-9e7b-8c315e9d0190" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fb33f637-85a3-493b-a219-a73fe9862c88" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f19bb4fd-e64f-4435-9e7b-8c315e9d0190" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_3121d55e-9833-42fd-a7bd-051918a791ca" xlink:href="jnj-20200927.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fb33f637-85a3-493b-a219-a73fe9862c88" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_3121d55e-9833-42fd-a7bd-051918a791ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterestIncomeExpenseNetMember_f40211e7-2ffb-4f87-a85c-e5a1fdc217b6" xlink:href="jnj-20200927.xsd#jnj_InterestIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fb33f637-85a3-493b-a219-a73fe9862c88" xlink:to="loc_jnj_InterestIncomeExpenseNetMember_f40211e7-2ffb-4f87-a85c-e5a1fdc217b6" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails" xlink:type="extended" id="i35cdb19bfa95412c88ab11b711625860_FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails" xlink:type="extended" id="i95f8efd2fd7c4408894113a1a115b3e5_FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6daa56e7-3177-42c4-861f-edc20ee33b10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_59b45e86-c7fa-43dd-aa21-8870613117ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6daa56e7-3177-42c4-861f-edc20ee33b10" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_59b45e86-c7fa-43dd-aa21-8870613117ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_7232bf7c-9d7a-46fd-be8e-3231faac4919" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6daa56e7-3177-42c4-861f-edc20ee33b10" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_7232bf7c-9d7a-46fd-be8e-3231faac4919" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_413a8c59-8dde-48b2-9d8f-82b5a3514d0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6daa56e7-3177-42c4-861f-edc20ee33b10" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_413a8c59-8dde-48b2-9d8f-82b5a3514d0d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_3801dc42-cd95-42c5-8601-ce72e2a0845f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_413a8c59-8dde-48b2-9d8f-82b5a3514d0d" xlink:to="loc_us-gaap_HedgingDesignationAxis_3801dc42-cd95-42c5-8601-ce72e2a0845f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3801dc42-cd95-42c5-8601-ce72e2a0845f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_3801dc42-cd95-42c5-8601-ce72e2a0845f" xlink:to="loc_us-gaap_HedgingDesignationDomain_3801dc42-cd95-42c5-8601-ce72e2a0845f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9a32fa99-1c1f-4246-97a1-07d64acc75fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_3801dc42-cd95-42c5-8601-ce72e2a0845f" xlink:to="loc_us-gaap_HedgingDesignationDomain_9a32fa99-1c1f-4246-97a1-07d64acc75fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_fd7b28dd-aa02-4963-8357-8640665dce42" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_9a32fa99-1c1f-4246-97a1-07d64acc75fb" xlink:to="loc_us-gaap_NondesignatedMember_fd7b28dd-aa02-4963-8357-8640665dce42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2689dbb8-091a-43e6-9fc2-a226c494cefc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_413a8c59-8dde-48b2-9d8f-82b5a3514d0d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2689dbb8-091a-43e6-9fc2-a226c494cefc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2689dbb8-091a-43e6-9fc2-a226c494cefc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2689dbb8-091a-43e6-9fc2-a226c494cefc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2689dbb8-091a-43e6-9fc2-a226c494cefc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2b832668-b9c1-4821-83d2-7c6fb1bb0a49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2689dbb8-091a-43e6-9fc2-a226c494cefc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2b832668-b9c1-4821-83d2-7c6fb1bb0a49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_e89ea689-e97d-46d9-93de-280ae7801e68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2b832668-b9c1-4821-83d2-7c6fb1bb0a49" xlink:to="loc_us-gaap_ForeignExchangeContractMember_e89ea689-e97d-46d9-93de-280ae7801e68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4e5f4865-a169-4fbb-8b2b-e07e8fc04f4e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_413a8c59-8dde-48b2-9d8f-82b5a3514d0d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4e5f4865-a169-4fbb-8b2b-e07e8fc04f4e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4e5f4865-a169-4fbb-8b2b-e07e8fc04f4e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4e5f4865-a169-4fbb-8b2b-e07e8fc04f4e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4e5f4865-a169-4fbb-8b2b-e07e8fc04f4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_86987755-4b00-4139-bb63-fde3ce5b5575" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4e5f4865-a169-4fbb-8b2b-e07e8fc04f4e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_86987755-4b00-4139-bb63-fde3ce5b5575" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_d146a4e8-4b71-4ac9-858f-563a239ddece" xlink:href="jnj-20200927.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_86987755-4b00-4139-bb63-fde3ce5b5575" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_d146a4e8-4b71-4ac9-858f-563a239ddece" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails" xlink:type="extended" id="i06b52fba6dff4288b9a81bf400575ba8_FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_172328a7-61a4-4d12-b926-219c8d8220f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c7dc42c1-40f0-4d51-920e-89cacb36342c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_172328a7-61a4-4d12-b926-219c8d8220f8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c7dc42c1-40f0-4d51-920e-89cacb36342c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_74446336-8d81-42d4-90a5-64183a0f07e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_172328a7-61a4-4d12-b926-219c8d8220f8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_74446336-8d81-42d4-90a5-64183a0f07e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_582ade8c-2862-4241-8ccf-e8ca1be9897d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_172328a7-61a4-4d12-b926-219c8d8220f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_582ade8c-2862-4241-8ccf-e8ca1be9897d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_115f261c-70cb-4b8b-b7b9-73a78c4c6f86" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_172328a7-61a4-4d12-b926-219c8d8220f8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_115f261c-70cb-4b8b-b7b9-73a78c4c6f86" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_86258061-e313-4cd8-aad7-37f6a42034c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_115f261c-70cb-4b8b-b7b9-73a78c4c6f86" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_86258061-e313-4cd8-aad7-37f6a42034c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_86258061-e313-4cd8-aad7-37f6a42034c0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_86258061-e313-4cd8-aad7-37f6a42034c0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_86258061-e313-4cd8-aad7-37f6a42034c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ec0d2fc4-2c06-404f-a4b1-6d5424464c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_86258061-e313-4cd8-aad7-37f6a42034c0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ec0d2fc4-2c06-404f-a4b1-6d5424464c7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_3f7fd4f5-723c-450e-91ac-58b3515ca7c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ec0d2fc4-2c06-404f-a4b1-6d5424464c7b" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_3f7fd4f5-723c-450e-91ac-58b3515ca7c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ad9aecbe-1be5-4bec-ae0e-fa1f1170f053" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_115f261c-70cb-4b8b-b7b9-73a78c4c6f86" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ad9aecbe-1be5-4bec-ae0e-fa1f1170f053" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ad9aecbe-1be5-4bec-ae0e-fa1f1170f053_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ad9aecbe-1be5-4bec-ae0e-fa1f1170f053" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ad9aecbe-1be5-4bec-ae0e-fa1f1170f053_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9edcfc2b-9bba-46fa-96fc-2db7c2ef7827" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ad9aecbe-1be5-4bec-ae0e-fa1f1170f053" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9edcfc2b-9bba-46fa-96fc-2db7c2ef7827" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfSubsidiaryGainLossMember_16f7b4fc-ff44-4687-bb56-e3d069f30232" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfSubsidiaryGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9edcfc2b-9bba-46fa-96fc-2db7c2ef7827" xlink:to="loc_us-gaap_SaleOfSubsidiaryGainLossMember_16f7b4fc-ff44-4687-bb56-e3d069f30232" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_cc927594-1f4a-4f39-b6f5-7898dd991692" xlink:href="jnj-20200927.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9edcfc2b-9bba-46fa-96fc-2db7c2ef7827" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_cc927594-1f4a-4f39-b6f5-7898dd991692" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails" xlink:type="extended" id="ieabdad79b18941e786c4b800f20ec8ea_FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_e06679be-e5fc-4823-b83e-b3a3e78c905a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_943bdad6-850e-4346-89cf-4278f4149bbd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_e06679be-e5fc-4823-b83e-b3a3e78c905a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_943bdad6-850e-4346-89cf-4278f4149bbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentRollForward_5099855a-424c-42b4-8db7-4b5fa15d2f24" xlink:href="jnj-20200927.xsd#jnj_EquityInvestmentRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_e06679be-e5fc-4823-b83e-b3a3e78c905a" xlink:to="loc_jnj_EquityInvestmentRollForward_5099855a-424c-42b4-8db7-4b5fa15d2f24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_df94be97-1750-4c6b-8592-53ddf3010c95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_EquityInvestmentRollForward_5099855a-424c-42b4-8db7-4b5fa15d2f24" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_df94be97-1750-4c6b-8592-53ddf3010c95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_72e6d35a-3566-4c13-8683-2f1e34e43292" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_EquityInvestmentRollForward_5099855a-424c-42b4-8db7-4b5fa15d2f24" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_72e6d35a-3566-4c13-8683-2f1e34e43292" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFairValueAdjustment_4cf01bec-c1b7-4a65-a95a-716b5c3d2c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityFairValueAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_EquityInvestmentRollForward_5099855a-424c-42b4-8db7-4b5fa15d2f24" xlink:to="loc_us-gaap_EquityFairValueAdjustment_4cf01bec-c1b7-4a65-a95a-716b5c3d2c6a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod_8f7d90db-9076-4410-8f73-c9e67778669c" xlink:href="jnj-20200927.xsd#jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_EquityInvestmentRollForward_5099855a-424c-42b4-8db7-4b5fa15d2f24" xlink:to="loc_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod_8f7d90db-9076-4410-8f73-c9e67778669c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_25ebca0d-74c0-4992-a095-fd2369bc817f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_6852af97-6f2b-48db-9dc8-6ba35e6630ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d8bcdc0e-6e34-46e4-83e7-c66722e5fbe6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_EquityInvestmentRollForward_5099855a-424c-42b4-8db7-4b5fa15d2f24" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d8bcdc0e-6e34-46e4-83e7-c66722e5fbe6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable_b1f00146-6c14-4483-b558-bce640006345" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_e06679be-e5fc-4823-b83e-b3a3e78c905a" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable_b1f00146-6c14-4483-b558-bce640006345" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_cd5a8b7f-c6c3-4667-a7dd-d285cdeed5ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable_b1f00146-6c14-4483-b558-bce640006345" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_cd5a8b7f-c6c3-4667-a7dd-d285cdeed5ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cd5a8b7f-c6c3-4667-a7dd-d285cdeed5ed_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_cd5a8b7f-c6c3-4667-a7dd-d285cdeed5ed" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cd5a8b7f-c6c3-4667-a7dd-d285cdeed5ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_932e9d74-8fd0-4039-bb88-25bd3e0906b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_cd5a8b7f-c6c3-4667-a7dd-d285cdeed5ed" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_932e9d74-8fd0-4039-bb88-25bd3e0906b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_d6ab7ef3-a46b-480f-9b7d-1c7355922a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_932e9d74-8fd0-4039-bb88-25bd3e0906b6" xlink:to="loc_us-gaap_EquitySecuritiesMember_d6ab7ef3-a46b-480f-9b7d-1c7355922a1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_853fc4d5-e9c2-4f8e-91be-8da0fedb83cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable_b1f00146-6c14-4483-b558-bce640006345" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_853fc4d5-e9c2-4f8e-91be-8da0fedb83cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_853fc4d5-e9c2-4f8e-91be-8da0fedb83cc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_853fc4d5-e9c2-4f8e-91be-8da0fedb83cc" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_853fc4d5-e9c2-4f8e-91be-8da0fedb83cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_0c9a17fd-1df2-457a-8aa7-a3d761d07642" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_853fc4d5-e9c2-4f8e-91be-8da0fedb83cc" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_0c9a17fd-1df2-457a-8aa7-a3d761d07642" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember_e2747e33-548e-4f59-88a6-066cf8d88dae" xlink:href="jnj-20200927.xsd#jnj_EquityInvestmentswithReadilyDeterminableValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_0c9a17fd-1df2-457a-8aa7-a3d761d07642" xlink:to="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember_e2747e33-548e-4f59-88a6-066cf8d88dae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_fddca239-8b9a-4427-a487-f13f07878401" xlink:href="jnj-20200927.xsd#jnj_EquityInvestmentswithoutReadilyDeterminableValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_0c9a17fd-1df2-457a-8aa7-a3d761d07642" xlink:to="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_fddca239-8b9a-4427-a487-f13f07878401" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails" xlink:type="extended" id="i42182a00a6ff41c6854517efa9f3328b_FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentDetailAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_6497f8ef-11b5-4265-9cf5-9969f53c80e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:to="loc_us-gaap_DerivativeNotionalAmount_6497f8ef-11b5-4265-9cf5-9969f53c80e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_52062632-13a0-4cb4-ba70-ba63dda67bca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_52062632-13a0-4cb4-ba70-ba63dda67bca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_f87364db-b9b1-41a8-8426-96324f7ebe16" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_f87364db-b9b1-41a8-8426-96324f7ebe16" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_ab7c3976-f112-4aa0-a180-5d1ac389742a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:to="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_ab7c3976-f112-4aa0-a180-5d1ac389742a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_be52fee4-c7d7-4cf4-804e-449ea857c8b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:to="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_be52fee4-c7d7-4cf4-804e-449ea857c8b0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_b9597854-5df8-481f-a623-875ca3f3296f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_b9597854-5df8-481f-a623-875ca3f3296f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d21ff4ad-2b6e-4449-b7cc-a0158be07299" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d21ff4ad-2b6e-4449-b7cc-a0158be07299" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_dc5e1f58-520e-40e5-b5f3-7abc6cbbfabe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_dc5e1f58-520e-40e5-b5f3-7abc6cbbfabe" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_b02a1b28-b605-45f4-88ca-c04b151db87d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_b02a1b28-b605-45f4-88ca-c04b151db87d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_6c9ea167-699e-4c9a-ba62-572beff60ff7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_6c9ea167-699e-4c9a-ba62-572beff60ff7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_94dac566-f8e4-4254-90a5-8afe5fff6d51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_DerivativeAssets_94dac566-f8e4-4254-90a5-8afe5fff6d51" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_84df9798-ef78-43df-bfbc-aefd075753fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_84df9798-ef78-43df-bfbc-aefd075753fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_f9602e36-26e4-4092-9c13-1aa331abf8c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_f9602e36-26e4-4092-9c13-1aa331abf8c6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_78975f20-3ddc-4174-856f-0e858fe24be2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_DerivativeLiabilities_78975f20-3ddc-4174-856f-0e858fe24be2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_391aa5d1-7161-48f8-aafe-e4f9e5106abb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_391aa5d1-7161-48f8-aafe-e4f9e5106abb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_1c919b7a-d94a-4b4a-afc4-b165327b61ca" xlink:href="jnj-20200927.xsd#jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_1c919b7a-d94a-4b4a-afc4-b165327b61ca" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_1a77810c-7930-44d0-8586-a329a768d527" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_1a77810c-7930-44d0-8586-a329a768d527" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_f155e3f4-d5d4-443d-8aba-9fefe2be7b56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_f155e3f4-d5d4-443d-8aba-9fefe2be7b56" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_8caf417e-f121-4d73-8e19-12eb76b0d0d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c0835426-20f9-4f58-99a3-46f7d01562be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c0835426-20f9-4f58-99a3-46f7d01562be" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bb6f0f8c-4681-4c21-8afd-77c2494532e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bb6f0f8c-4681-4c21-8afd-77c2494532e4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c83f1205-7824-498a-b322-03d1998a2f53" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c83f1205-7824-498a-b322-03d1998a2f53" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fd7a78dd-9e03-45fa-b8c6-bc10b79d6a29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c83f1205-7824-498a-b322-03d1998a2f53" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fd7a78dd-9e03-45fa-b8c6-bc10b79d6a29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_fd7a78dd-9e03-45fa-b8c6-bc10b79d6a29_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fd7a78dd-9e03-45fa-b8c6-bc10b79d6a29" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_fd7a78dd-9e03-45fa-b8c6-bc10b79d6a29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e4bfa40e-2c5f-4069-9135-34d4ffb9a9ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fd7a78dd-9e03-45fa-b8c6-bc10b79d6a29" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e4bfa40e-2c5f-4069-9135-34d4ffb9a9ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_0f303db3-149d-4499-b2d1-0ab120c6f898" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e4bfa40e-2c5f-4069-9135-34d4ffb9a9ad" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_0f303db3-149d-4499-b2d1-0ab120c6f898" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_9d334a05-b311-4531-a5f9-22938df1ca5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e4bfa40e-2c5f-4069-9135-34d4ffb9a9ad" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_9d334a05-b311-4531-a5f9-22938df1ca5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a5a88d17-e637-4317-b122-802a1b562826" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c83f1205-7824-498a-b322-03d1998a2f53" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a5a88d17-e637-4317-b122-802a1b562826" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a5a88d17-e637-4317-b122-802a1b562826_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a5a88d17-e637-4317-b122-802a1b562826" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a5a88d17-e637-4317-b122-802a1b562826_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_805683dd-066e-4457-84aa-a3d3c1531ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a5a88d17-e637-4317-b122-802a1b562826" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_805683dd-066e-4457-84aa-a3d3c1531ee3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AurisHealthMember_c82eee7f-7840-4968-a73a-c881bf1537f9" xlink:href="jnj-20200927.xsd#jnj_AurisHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_805683dd-066e-4457-84aa-a3d3c1531ee3" xlink:to="loc_jnj_AurisHealthMember_c82eee7f-7840-4968-a73a-c881bf1537f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_968135b2-5b9a-4c0b-b177-ce2a10d0312b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c83f1205-7824-498a-b322-03d1998a2f53" xlink:to="loc_us-gaap_InvestmentTypeAxis_968135b2-5b9a-4c0b-b177-ce2a10d0312b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_968135b2-5b9a-4c0b-b177-ce2a10d0312b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_968135b2-5b9a-4c0b-b177-ce2a10d0312b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_968135b2-5b9a-4c0b-b177-ce2a10d0312b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_198b61ae-5729-4858-871c-c6965cd104a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_968135b2-5b9a-4c0b-b177-ce2a10d0312b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_198b61ae-5729-4858-871c-c6965cd104a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_0cbc0439-5225-4bb5-8525-da337f7516a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_198b61ae-5729-4858-871c-c6965cd104a0" xlink:to="loc_us-gaap_EquitySecuritiesMember_0cbc0439-5225-4bb5-8525-da337f7516a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_81603a6d-2b89-43c3-b0b9-1e8621436b18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c83f1205-7824-498a-b322-03d1998a2f53" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_81603a6d-2b89-43c3-b0b9-1e8621436b18" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_81603a6d-2b89-43c3-b0b9-1e8621436b18_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_81603a6d-2b89-43c3-b0b9-1e8621436b18" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_81603a6d-2b89-43c3-b0b9-1e8621436b18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ac53d7f9-0d10-4968-b4a8-645de12fd347" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_81603a6d-2b89-43c3-b0b9-1e8621436b18" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ac53d7f9-0d10-4968-b4a8-645de12fd347" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_e94b3b21-4d6b-4747-9056-1c0a8bc919e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ac53d7f9-0d10-4968-b4a8-645de12fd347" xlink:to="loc_us-gaap_InterestRateContractMember_e94b3b21-4d6b-4747-9056-1c0a8bc919e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_24a28003-7814-49ab-b9d3-8213fc962596" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ac53d7f9-0d10-4968-b4a8-645de12fd347" xlink:to="loc_us-gaap_ForeignExchangeContractMember_24a28003-7814-49ab-b9d3-8213fc962596" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_1d665468-0993-4277-8bee-d00b5ff7c106" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ac53d7f9-0d10-4968-b4a8-645de12fd347" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_1d665468-0993-4277-8bee-d00b5ff7c106" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bd1f0c7e-a2e3-4271-939f-91e424c0abb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c83f1205-7824-498a-b322-03d1998a2f53" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bd1f0c7e-a2e3-4271-939f-91e424c0abb1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bd1f0c7e-a2e3-4271-939f-91e424c0abb1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bd1f0c7e-a2e3-4271-939f-91e424c0abb1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bd1f0c7e-a2e3-4271-939f-91e424c0abb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c2c1d72-e275-4d04-b6b4-7231db584888" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bd1f0c7e-a2e3-4271-939f-91e424c0abb1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c2c1d72-e275-4d04-b6b4-7231db584888" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_85aa8c8e-a853-467e-8ab9-1535c573c5db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c2c1d72-e275-4d04-b6b4-7231db584888" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_85aa8c8e-a853-467e-8ab9-1535c573c5db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_136866ef-0c51-4d20-9dd6-fe8f7e5493c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c2c1d72-e275-4d04-b6b4-7231db584888" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_136866ef-0c51-4d20-9dd6-fe8f7e5493c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_24516ce7-905b-4d60-9d78-f775bf9ceb3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c2c1d72-e275-4d04-b6b4-7231db584888" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_24516ce7-905b-4d60-9d78-f775bf9ceb3a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails" xlink:type="extended" id="i68906b0a994f413799fc782fff92f40c_FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_ac606367-2cf5-4db5-bd4c-63468a03822b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_53032192-6f1a-445e-a450-f1a2b1e8a091" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesClassifiedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_ac606367-2cf5-4db5-bd4c-63468a03822b" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_53032192-6f1a-445e-a450-f1a2b1e8a091" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_282159c6-fdbf-49a0-a935-75f2082924d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_53032192-6f1a-445e-a450-f1a2b1e8a091" xlink:to="loc_us-gaap_HeldToMaturitySecurities_282159c6-fdbf-49a0-a935-75f2082924d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_eadeca3e-3d98-4e11-ab8f-e48500056754" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_53032192-6f1a-445e-a450-f1a2b1e8a091" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_eadeca3e-3d98-4e11-ab8f-e48500056754" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_819d4069-3783-494c-b7a6-ad34e7d56df5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_53032192-6f1a-445e-a450-f1a2b1e8a091" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_819d4069-3783-494c-b7a6-ad34e7d56df5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_12290ca0-ce5f-44f1-99c5-d515ef4e79c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_53032192-6f1a-445e-a450-f1a2b1e8a091" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_12290ca0-ce5f-44f1-99c5-d515ef4e79c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_64a986b8-b951-49d1-9740-a28a0a8d0699" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_ac606367-2cf5-4db5-bd4c-63468a03822b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_64a986b8-b951-49d1-9740-a28a0a8d0699" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8b924c52-b272-4a8a-a3e4-dee10851ff5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_64a986b8-b951-49d1-9740-a28a0a8d0699" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8b924c52-b272-4a8a-a3e4-dee10851ff5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a7232c28-3807-4c42-b6d3-37ef0c889d50" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_64a986b8-b951-49d1-9740-a28a0a8d0699" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a7232c28-3807-4c42-b6d3-37ef0c889d50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4084b04d-86cb-4135-b06b-413aaf887dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_64a986b8-b951-49d1-9740-a28a0a8d0699" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4084b04d-86cb-4135-b06b-413aaf887dd1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1f626665-6c1b-4644-bb78-7225ce31e01e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_64a986b8-b951-49d1-9740-a28a0a8d0699" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1f626665-6c1b-4644-bb78-7225ce31e01e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_7cb99a57-3fa0-47ce-8a7f-31b53a960f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_ac606367-2cf5-4db5-bd4c-63468a03822b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_7cb99a57-3fa0-47ce-8a7f-31b53a960f6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_07dd7d5c-fe29-4046-920d-df7928e76a2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_7cb99a57-3fa0-47ce-8a7f-31b53a960f6b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_07dd7d5c-fe29-4046-920d-df7928e76a2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_e5b130d0-a030-4ccc-8b0b-ce1afc773a49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_7cb99a57-3fa0-47ce-8a7f-31b53a960f6b" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_e5b130d0-a030-4ccc-8b0b-ce1afc773a49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_787e9441-ac0e-467d-9dc6-bdc27981674e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_7cb99a57-3fa0-47ce-8a7f-31b53a960f6b" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_787e9441-ac0e-467d-9dc6-bdc27981674e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain_9f3bffa0-3501-44ce-b53c-9e245d180efd" xlink:href="jnj-20200927.xsd#jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_7cb99a57-3fa0-47ce-8a7f-31b53a960f6b" xlink:to="loc_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain_9f3bffa0-3501-44ce-b53c-9e245d180efd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss_75b1e042-002c-4a40-92e0-8d4599ece09f" xlink:href="jnj-20200927.xsd#jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_7cb99a57-3fa0-47ce-8a7f-31b53a960f6b" xlink:to="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss_75b1e042-002c-4a40-92e0-8d4599ece09f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue_3cb3f6bf-a251-47ca-8656-dc5e946bb1f1" xlink:href="jnj-20200927.xsd#jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_7cb99a57-3fa0-47ce-8a7f-31b53a960f6b" xlink:to="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue_3cb3f6bf-a251-47ca-8656-dc5e946bb1f1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_e8b3198c-6099-4265-9518-7bfccf7ae1f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_ac606367-2cf5-4db5-bd4c-63468a03822b" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_e8b3198c-6099-4265-9518-7bfccf7ae1f0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_d7a4412d-4822-4a78-8f69-4db61e9e517b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_e8b3198c-6099-4265-9518-7bfccf7ae1f0" xlink:to="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_d7a4412d-4822-4a78-8f69-4db61e9e517b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_d7a4412d-4822-4a78-8f69-4db61e9e517b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_d7a4412d-4822-4a78-8f69-4db61e9e517b" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_d7a4412d-4822-4a78-8f69-4db61e9e517b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_5bd22eb2-32a6-4d5c-a5a8-85348fa4980e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_d7a4412d-4822-4a78-8f69-4db61e9e517b" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_5bd22eb2-32a6-4d5c-a5a8-85348fa4980e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesMember_0aeb6c4a-19f0-441c-a2df-ff65d93f77ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldtomaturitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_5bd22eb2-32a6-4d5c-a5a8-85348fa4980e" xlink:to="loc_us-gaap_HeldtomaturitySecuritiesMember_0aeb6c4a-19f0-441c-a2df-ff65d93f77ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_d1c894cb-8e87-4092-9c50-beff94008cb3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_5bd22eb2-32a6-4d5c-a5a8-85348fa4980e" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_d1c894cb-8e87-4092-9c50-beff94008cb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ef16e063-2838-456f-8663-f3d4d8009273" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_e8b3198c-6099-4265-9518-7bfccf7ae1f0" xlink:to="loc_us-gaap_InvestmentTypeAxis_ef16e063-2838-456f-8663-f3d4d8009273" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ef16e063-2838-456f-8663-f3d4d8009273_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_ef16e063-2838-456f-8663-f3d4d8009273" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ef16e063-2838-456f-8663-f3d4d8009273_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_ef16e063-2838-456f-8663-f3d4d8009273" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_834c72ac-5abd-4a98-bd52-45f5a56b0747" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:to="loc_us-gaap_CashMember_834c72ac-5abd-4a98-bd52-45f5a56b0747" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtSecuritiesMember_cec58bac-9797-4f6b-ab2a-04ec61b16421" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SovereignDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:to="loc_us-gaap_SovereignDebtSecuritiesMember_cec58bac-9797-4f6b-ab2a-04ec61b16421" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember_f974b3fc-5a99-4510-8c74-47786d3200df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:to="loc_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember_f974b3fc-5a99-4510-8c74-47786d3200df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherReverseRepurchaseAgreementsMember_19ee98e8-6acf-4005-990a-89a69a67ce05" xlink:href="jnj-20200927.xsd#jnj_OtherReverseRepurchaseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:to="loc_jnj_OtherReverseRepurchaseAgreementsMember_19ee98e8-6acf-4005-990a-89a69a67ce05" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_374cfddc-82a8-47d1-9418-3273581e987c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_374cfddc-82a8-47d1-9418-3273581e987c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_ba5ad51c-2480-4bca-91d4-930d1d3819ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:to="loc_us-gaap_MoneyMarketFundsMember_ba5ad51c-2480-4bca-91d4-930d1d3819ac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_e5f3c628-a486-4aa5-a211-390377487b21" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:to="loc_us-gaap_BankTimeDepositsMember_e5f3c628-a486-4aa5-a211-390377487b21" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_bfc51728-2d16-40e6-97bb-ae561bc603ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_bfc51728-2d16-40e6-97bb-ae561bc603ad" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails" xlink:type="extended" id="iebce01f65ee34546b462dcf715cfe891_FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails" xlink:type="extended" id="i0cafda80d3754238ac0b8960783563fc_FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6cfa6cbd-c907-41cc-9cf2-9aa25be83c66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_12a11bb1-e9ba-4fbf-9b2e-dcda0a9836ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6cfa6cbd-c907-41cc-9cf2-9aa25be83c66" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_12a11bb1-e9ba-4fbf-9b2e-dcda0a9836ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_a1612dab-baeb-4152-a294-823efcadecb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_12a11bb1-e9ba-4fbf-9b2e-dcda0a9836ea" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_a1612dab-baeb-4152-a294-823efcadecb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_328d5f35-46c6-49a1-bd79-b3e9f6e83c5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_a1612dab-baeb-4152-a294-823efcadecb1" xlink:to="loc_us-gaap_ShortTermBorrowings_328d5f35-46c6-49a1-bd79-b3e9f6e83c5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrentAbstract_b82a7830-31a5-4b82-9150-d2b5202564ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_12a11bb1-e9ba-4fbf-9b2e-dcda0a9836ea" xlink:to="loc_us-gaap_LongTermDebtNoncurrentAbstract_b82a7830-31a5-4b82-9150-d2b5202564ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ad599a32-e402-424b-a8d0-9f3c0f35d22e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_b82a7830-31a5-4b82-9150-d2b5202564ed" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ad599a32-e402-424b-a8d0-9f3c0f35d22e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cef6d96a-32a9-4c79-9224-9be8addb6800" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_12a11bb1-e9ba-4fbf-9b2e-dcda0a9836ea" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cef6d96a-32a9-4c79-9224-9be8addb6800" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c2c1d1-8572-49b9-8743-7b2b2dc8651b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6cfa6cbd-c907-41cc-9cf2-9aa25be83c66" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c2c1d1-8572-49b9-8743-7b2b2dc8651b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d5a26d2f-2982-4602-9143-4d14118f9172" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c2c1d1-8572-49b9-8743-7b2b2dc8651b" xlink:to="loc_us-gaap_DebtInstrumentAxis_d5a26d2f-2982-4602-9143-4d14118f9172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d5a26d2f-2982-4602-9143-4d14118f9172_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d5a26d2f-2982-4602-9143-4d14118f9172" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d5a26d2f-2982-4602-9143-4d14118f9172_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d5a26d2f-2982-4602-9143-4d14118f9172" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.45Notesdue2021Member_54d982e5-9886-4d48-a827-5e31462253b9" xlink:href="jnj-20200927.xsd#jnj_A2.45Notesdue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A2.45Notesdue2021Member_54d982e5-9886-4d48-a827-5e31462253b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.250NotesDue2022Member_c010a2f8-6221-4de7-b1d4-4d1db69860c0" xlink:href="jnj-20200927.xsd#jnj_A0.250NotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A0.250NotesDue2022Member_c010a2f8-6221-4de7-b1d4-4d1db69860c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.25Notesdue2022Member_3c1120b8-1f29-437e-ab20-6a15cc84cc78" xlink:href="jnj-20200927.xsd#jnj_A2.25Notesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A2.25Notesdue2022Member_3c1120b8-1f29-437e-ab20-6a15cc84cc78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A6.73Debenturesdue2023Member_7eafbdbc-2547-4597-bd31-b3fed0a28241" xlink:href="jnj-20200927.xsd#jnj_A6.73Debenturesdue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A6.73Debenturesdue2023Member_7eafbdbc-2547-4597-bd31-b3fed0a28241" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.375Notesdue2023Member_be195c65-7832-4ab5-b460-802af36d68e2" xlink:href="jnj-20200927.xsd#jnj_A3.375Notesdue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A3.375Notesdue2023Member_be195c65-7832-4ab5-b460-802af36d68e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.05Notesdue2023Member_ebab4142-43f9-455b-8025-3b1d594457a8" xlink:href="jnj-20200927.xsd#jnj_A2.05Notesdue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A2.05Notesdue2023Member_ebab4142-43f9-455b-8025-3b1d594457a8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.650NotesDue2024Member_14dab88b-5256-463c-9d94-e707aadad57e" xlink:href="jnj-20200927.xsd#jnj_A0.650NotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A0.650NotesDue2024Member_14dab88b-5256-463c-9d94-e707aadad57e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.50NotesDue2024Member_387e55d6-0e35-4025-9947-29e710031bc1" xlink:href="jnj-20200927.xsd#jnj_A5.50NotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A5.50NotesDue2024Member_387e55d6-0e35-4025-9947-29e710031bc1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.625Notesdue2025Member_0f4d8030-37bb-4f6b-944e-941296ffeb7f" xlink:href="jnj-20200927.xsd#jnj_A2.625Notesdue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A2.625Notesdue2025Member_0f4d8030-37bb-4f6b-944e-941296ffeb7f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0550NotesDue2025Member_c58ae444-9c77-42fa-8194-9a11e67632d5" xlink:href="jnj-20200927.xsd#jnj_A0550NotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A0550NotesDue2025Member_c58ae444-9c77-42fa-8194-9a11e67632d5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A055NotesDue2025Member_af4856ce-c5c0-480e-9fa8-8a5a144c8024" xlink:href="jnj-20200927.xsd#jnj_A055NotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A055NotesDue2025Member_af4856ce-c5c0-480e-9fa8-8a5a144c8024" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.45Notesdue2026Member_ffee4186-c211-4367-8fd2-8f858762dda7" xlink:href="jnj-20200927.xsd#jnj_A2.45Notesdue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A2.45Notesdue2026Member_ffee4186-c211-4367-8fd2-8f858762dda7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.95Notesdue2027Member_0f769cd3-1f68-4d90-b620-dbb4f4186c73" xlink:href="jnj-20200927.xsd#jnj_A2.95Notesdue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A2.95Notesdue2027Member_0f769cd3-1f68-4d90-b620-dbb4f4186c73" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A095NotesDue2027Member_b1a27422-5356-4547-867d-40f5d5dc393b" xlink:href="jnj-20200927.xsd#jnj_A095NotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A095NotesDue2027Member_b1a27422-5356-4547-867d-40f5d5dc393b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.900Notesdue2028Member_fc5c19e1-5662-4b24-80c1-eb144ada3332" xlink:href="jnj-20200927.xsd#jnj_A2.900Notesdue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A2.900Notesdue2028Member_fc5c19e1-5662-4b24-80c1-eb144ada3332" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.150NotesDue2028Member_300b71fe-332c-4022-bbc6-f508d587311e" xlink:href="jnj-20200927.xsd#jnj_A1.150NotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A1.150NotesDue2028Member_300b71fe-332c-4022-bbc6-f508d587311e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A6.95Notesdue2029Member_ea298d53-0697-4a24-9c68-b1140a74f5cc" xlink:href="jnj-20200927.xsd#jnj_A6.95Notesdue2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A6.95Notesdue2029Member_ea298d53-0697-4a24-9c68-b1140a74f5cc" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1300NotesDue2030Member_559d9d09-4693-4708-b671-f5934024dae3" xlink:href="jnj-20200927.xsd#jnj_A1300NotesDue2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A1300NotesDue2030Member_559d9d09-4693-4708-b671-f5934024dae3" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.95Debenturesdue2033Member_4deba0aa-0dae-4fdf-a700-0ca6616f7157" xlink:href="jnj-20200927.xsd#jnj_A4.95Debenturesdue2033Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A4.95Debenturesdue2033Member_4deba0aa-0dae-4fdf-a700-0ca6616f7157" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.375Notesdue2033Member_06ce1562-b7ed-4ea4-a543-ce9509dae5c6" xlink:href="jnj-20200927.xsd#jnj_A4.375Notesdue2033Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A4.375Notesdue2033Member_06ce1562-b7ed-4ea4-a543-ce9509dae5c6" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.650NotesDue2035Member_d24c3940-baac-4525-85bc-81ce60eab80e" xlink:href="jnj-20200927.xsd#jnj_A1.650NotesDue2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A1.650NotesDue2035Member_d24c3940-baac-4525-85bc-81ce60eab80e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.55Notesdue2036Member_b14a4068-b0d3-424e-999d-36fc6ce3662a" xlink:href="jnj-20200927.xsd#jnj_A3.55Notesdue2036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A3.55Notesdue2036Member_b14a4068-b0d3-424e-999d-36fc6ce3662a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.95Notesdue2037Member_ed7ba873-33fb-449f-8c75-9f9802136551" xlink:href="jnj-20200927.xsd#jnj_A5.95Notesdue2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A5.95Notesdue2037Member_ed7ba873-33fb-449f-8c75-9f9802136551" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.625Notesdue2037Member_b556c031-f04f-4fb4-a89c-d97168430fee" xlink:href="jnj-20200927.xsd#jnj_A3.625Notesdue2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A3.625Notesdue2037Member_b556c031-f04f-4fb4-a89c-d97168430fee" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.400Notesdue2038Member_12d8b490-4b94-4fd2-93db-ae0d39ee3181" xlink:href="jnj-20200927.xsd#jnj_A3.400Notesdue2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A3.400Notesdue2038Member_12d8b490-4b94-4fd2-93db-ae0d39ee3181" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.85Debenturesdue2038Member_ed1e06f5-f2b6-42dd-b77a-40345e4cde2a" xlink:href="jnj-20200927.xsd#jnj_A5.85Debenturesdue2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A5.85Debenturesdue2038Member_ed1e06f5-f2b6-42dd-b77a-40345e4cde2a" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.50Debenturesdue2040Member_b330af53-3f2a-42e6-a759-e8774c1fd463" xlink:href="jnj-20200927.xsd#jnj_A4.50Debenturesdue2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A4.50Debenturesdue2040Member_b330af53-3f2a-42e6-a759-e8774c1fd463" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A210NotesDue2040Member_6c61f251-7a4e-409a-b501-aea5efc06dc4" xlink:href="jnj-20200927.xsd#jnj_A210NotesDue2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A210NotesDue2040Member_6c61f251-7a4e-409a-b501-aea5efc06dc4" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.85Notesdue2041Member_bd0f37e9-f5de-4f20-b9d1-f458a23fd185" xlink:href="jnj-20200927.xsd#jnj_A4.85Notesdue2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A4.85Notesdue2041Member_bd0f37e9-f5de-4f20-b9d1-f458a23fd185" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.50Notesdue2043Member_8e0783af-a0e4-4aca-84a0-2d1d1763f4b3" xlink:href="jnj-20200927.xsd#jnj_A4.50Notesdue2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A4.50Notesdue2043Member_8e0783af-a0e4-4aca-84a0-2d1d1763f4b3" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.70Notesdue2046Member_0bb2781e-b6e9-4398-be7b-aabc22a03a9c" xlink:href="jnj-20200927.xsd#jnj_A3.70Notesdue2046Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A3.70Notesdue2046Member_0bb2781e-b6e9-4398-be7b-aabc22a03a9c" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.75Notesdue2047Member_b6373d59-1f20-4ce1-a6df-3619d5e98c63" xlink:href="jnj-20200927.xsd#jnj_A3.75Notesdue2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A3.75Notesdue2047Member_b6373d59-1f20-4ce1-a6df-3619d5e98c63" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.500Notesdue2048Member_9694f82e-bfac-42c9-b465-d766f1bac7bf" xlink:href="jnj-20200927.xsd#jnj_A3.500Notesdue2048Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A3.500Notesdue2048Member_9694f82e-bfac-42c9-b465-d766f1bac7bf" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2250NotesDue2050Member_c7aa134b-f787-4261-86f4-241d76c3cb11" xlink:href="jnj-20200927.xsd#jnj_A2250NotesDue2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A2250NotesDue2050Member_c7aa134b-f787-4261-86f4-241d76c3cb11" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2450NotesDue2060Member_f540e3e4-3b1b-493f-bcdf-f5dfbd6debbb" xlink:href="jnj-20200927.xsd#jnj_A2450NotesDue2060Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A2450NotesDue2060Member_f540e3e4-3b1b-493f-bcdf-f5dfbd6debbb" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_NotesDuePeriodFifteenMember_be4f3f75-fb79-42fe-bcc3-bb78e3d40502" xlink:href="jnj-20200927.xsd#jnj_NotesDuePeriodFifteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_NotesDuePeriodFifteenMember_be4f3f75-fb79-42fe-bcc3-bb78e3d40502" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A130NotesDue2030Member_fcabcc21-a6f4-4ff4-8625-7aa2e9b54ab2" xlink:href="jnj-20200927.xsd#jnj_A130NotesDue2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A130NotesDue2030Member_fcabcc21-a6f4-4ff4-8625-7aa2e9b54ab2" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A225NotesDue2050Member_00525e2c-165b-45f4-9fd3-0b513667fa50" xlink:href="jnj-20200927.xsd#jnj_A225NotesDue2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A225NotesDue2050Member_00525e2c-165b-45f4-9fd3-0b513667fa50" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_53a146f1-fad1-4e12-aaf2-74e1fd1ba02d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c2c1d1-8572-49b9-8743-7b2b2dc8651b" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_53a146f1-fad1-4e12-aaf2-74e1fd1ba02d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_53a146f1-fad1-4e12-aaf2-74e1fd1ba02d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_53a146f1-fad1-4e12-aaf2-74e1fd1ba02d" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_53a146f1-fad1-4e12-aaf2-74e1fd1ba02d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7359f297-75e1-4c31-92e0-8d374fab25cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_53a146f1-fad1-4e12-aaf2-74e1fd1ba02d" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7359f297-75e1-4c31-92e0-8d374fab25cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8bf9ad2d-45be-4041-8f01-62a97f73b209" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7359f297-75e1-4c31-92e0-8d374fab25cd" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8bf9ad2d-45be-4041-8f01-62a97f73b209" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_a3db9b3e-f019-4673-909c-eb01aa5d2356" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8bf9ad2d-45be-4041-8f01-62a97f73b209" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_a3db9b3e-f019-4673-909c-eb01aa5d2356" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_d9213abc-71f9-413b-9da8-7b5ab5551d04" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8bf9ad2d-45be-4041-8f01-62a97f73b209" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_d9213abc-71f9-413b-9da8-7b5ab5551d04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_bbf9859c-9de5-4e48-acb4-c656e8805899" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c2c1d1-8572-49b9-8743-7b2b2dc8651b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_bbf9859c-9de5-4e48-acb4-c656e8805899" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bbf9859c-9de5-4e48-acb4-c656e8805899_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bbf9859c-9de5-4e48-acb4-c656e8805899" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bbf9859c-9de5-4e48-acb4-c656e8805899_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_89995515-52a1-4914-9144-0eda7a0c88ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bbf9859c-9de5-4e48-acb4-c656e8805899" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_89995515-52a1-4914-9144-0eda7a0c88ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_09e6bcc8-76ee-401f-a88a-7b76b62eb73e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_89995515-52a1-4914-9144-0eda7a0c88ab" xlink:to="loc_us-gaap_SeniorNotesMember_09e6bcc8-76ee-401f-a88a-7b76b62eb73e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IncomeTaxes" xlink:type="simple" xlink:href="jnj-20200927.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/IncomeTaxes" xlink:type="extended" id="iab71a531d4e545aa89c744f539b044ec_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/IncomeTaxesDetails" xlink:type="extended" id="i789f2c2bfa78403796496f9cc3df32eb_IncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_c81e5d19-a816-4c0c-9509-7478b245d087" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:href="jnj-20200927.xsd#jnj_IncomeTaxTextualsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c81e5d19-a816-4c0c-9509-7478b245d087" xlink:to="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2d1b3679-454b-4475-a22d-1f3dff363f25" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2d1b3679-454b-4475-a22d-1f3dff363f25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset_5b394267-214a-4c4b-98de-90a47e95a328" xlink:href="jnj-20200927.xsd#jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset_5b394267-214a-4c4b-98de-90a47e95a328" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit_e53d3bd3-3da6-401d-9db4-b87fd640f4cf" xlink:href="jnj-20200927.xsd#jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit_e53d3bd3-3da6-401d-9db4-b87fd640f4cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent_8d6c8d4f-8b99-4a78-8451-beedf0b4c3e3" xlink:href="jnj-20200927.xsd#jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent_8d6c8d4f-8b99-4a78-8451-beedf0b4c3e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent_189e18db-4717-4a92-9855-9d4d644daf5f" xlink:href="jnj-20200927.xsd#jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent_189e18db-4717-4a92-9855-9d4d644daf5f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent_e9f92267-de54-4e84-981e-e947290e3586" xlink:href="jnj-20200927.xsd#jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent_e9f92267-de54-4e84-981e-e947290e3586" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement_1c700ae9-c9f4-436f-b3b3-e646d67406fc" xlink:href="jnj-20200927.xsd#jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement_1c700ae9-c9f4-436f-b3b3-e646d67406fc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement_846af210-efbe-4f21-b86c-f6c51d4ddbb5" xlink:href="jnj-20200927.xsd#jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement_846af210-efbe-4f21-b86c-f6c51d4ddbb5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_635d4aa3-353a-43a6-b8c0-1ccd6b92155a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_635d4aa3-353a-43a6-b8c0-1ccd6b92155a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_UnrecognizedTaxBenefitLiabilityPayment_2bf013bc-9afb-43ad-9ade-53b2583bfc8e" xlink:href="jnj-20200927.xsd#jnj_UnrecognizedTaxBenefitLiabilityPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_jnj_UnrecognizedTaxBenefitLiabilityPayment_2bf013bc-9afb-43ad-9ade-53b2583bfc8e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_844ab0b8-e2fe-487a-bb86-184646a2459e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c81e5d19-a816-4c0c-9509-7478b245d087" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_844ab0b8-e2fe-487a-bb86-184646a2459e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_67c11ac4-9214-4adf-9271-1b620ad33ffe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_844ab0b8-e2fe-487a-bb86-184646a2459e" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_67c11ac4-9214-4adf-9271-1b620ad33ffe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_67c11ac4-9214-4adf-9271-1b620ad33ffe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_67c11ac4-9214-4adf-9271-1b620ad33ffe" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_67c11ac4-9214-4adf-9271-1b620ad33ffe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_d4dba34f-bb01-4693-9f09-b1bb114f077e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_67c11ac4-9214-4adf-9271-1b620ad33ffe" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_d4dba34f-bb01-4693-9f09-b1bb114f077e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_adcb76d8-d1bd-45cc-89e0-1a9ba8858c97" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_d4dba34f-bb01-4693-9f09-b1bb114f077e" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_adcb76d8-d1bd-45cc-89e0-1a9ba8858c97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d5e43b46-11e9-4a11-b86b-4bf754db3fd5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_844ab0b8-e2fe-487a-bb86-184646a2459e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d5e43b46-11e9-4a11-b86b-4bf754db3fd5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d5e43b46-11e9-4a11-b86b-4bf754db3fd5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d5e43b46-11e9-4a11-b86b-4bf754db3fd5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d5e43b46-11e9-4a11-b86b-4bf754db3fd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4adf3942-e9a3-4e37-9a03-7315e4599d01" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d5e43b46-11e9-4a11-b86b-4bf754db3fd5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4adf3942-e9a3-4e37-9a03-7315e4599d01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AccruedTaxesOnIncomeMember_8bf6fdb8-f30e-47f6-861a-41bb0694c843" xlink:href="jnj-20200927.xsd#jnj_AccruedTaxesOnIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4adf3942-e9a3-4e37-9a03-7315e4599d01" xlink:to="loc_jnj_AccruedTaxesOnIncomeMember_8bf6fdb8-f30e-47f6-861a-41bb0694c843" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_bd86dbda-0cb2-4d95-97a9-b03dad48ccdd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_844ab0b8-e2fe-487a-bb86-184646a2459e" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_bd86dbda-0cb2-4d95-97a9-b03dad48ccdd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_bd86dbda-0cb2-4d95-97a9-b03dad48ccdd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_bd86dbda-0cb2-4d95-97a9-b03dad48ccdd" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_bd86dbda-0cb2-4d95-97a9-b03dad48ccdd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_5fdf83c4-8386-4b34-b5f4-c95f9cb491f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_bd86dbda-0cb2-4d95-97a9-b03dad48ccdd" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_5fdf83c4-8386-4b34-b5f4-c95f9cb491f9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlans" xlink:type="simple" xlink:href="jnj-20200927.xsd#PensionsandOtherBenefitPlans"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlans" xlink:type="extended" id="i9be0e03ea3eb48ef8e47b7984b40063e_PensionsandOtherBenefitPlans"/>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#PensionsandOtherBenefitPlansTables"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlansTables" xlink:type="extended" id="i5f5ae541b8ec49819710b53a0fbdccc4_PensionsandOtherBenefitPlansTables"/>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended" id="i896b88af497846869afe3018dd4c332a_PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f9706d0a-1645-46c8-9c74-1718c8be5b15" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_aa10489d-558e-466c-afdd-a36232bb4fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f9706d0a-1645-46c8-9c74-1718c8be5b15" xlink:to="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_aa10489d-558e-466c-afdd-a36232bb4fdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_0e2a3105-bd76-4395-a52a-1545006a57f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_aa10489d-558e-466c-afdd-a36232bb4fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_0e2a3105-bd76-4395-a52a-1545006a57f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_a2408451-dd8a-40a6-a115-4c5df24d5751" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_aa10489d-558e-466c-afdd-a36232bb4fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_a2408451-dd8a-40a6-a115-4c5df24d5751" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_36119294-2290-485d-be78-ecfcd5fddf32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_aa10489d-558e-466c-afdd-a36232bb4fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_36119294-2290-485d-be78-ecfcd5fddf32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_405e8f83-0128-4593-9434-96be9a48a5dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_aa10489d-558e-466c-afdd-a36232bb4fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_405e8f83-0128-4593-9434-96be9a48a5dd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_e1a42df1-8664-406b-ae6d-df7f915c9b3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_aa10489d-558e-466c-afdd-a36232bb4fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_e1a42df1-8664-406b-ae6d-df7f915c9b3a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_c69f18c6-97ab-4e0e-a81c-c7127355fe4a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_aa10489d-558e-466c-afdd-a36232bb4fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_c69f18c6-97ab-4e0e-a81c-c7127355fe4a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_da09becf-9ee0-4836-9ffa-5768e7244343" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_aa10489d-558e-466c-afdd-a36232bb4fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_da09becf-9ee0-4836-9ffa-5768e7244343" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8759a2e4-193f-44fc-9b50-63b1378bb777" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f9706d0a-1645-46c8-9c74-1718c8be5b15" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8759a2e4-193f-44fc-9b50-63b1378bb777" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_2504eea0-0ec0-41aa-8834-891e83649713" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8759a2e4-193f-44fc-9b50-63b1378bb777" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_2504eea0-0ec0-41aa-8834-891e83649713" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_2504eea0-0ec0-41aa-8834-891e83649713_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_2504eea0-0ec0-41aa-8834-891e83649713" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_2504eea0-0ec0-41aa-8834-891e83649713_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_71523ccd-6340-4141-9506-6e9a1034c756" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_2504eea0-0ec0-41aa-8834-891e83649713" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_71523ccd-6340-4141-9506-6e9a1034c756" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_61e4eacb-2b65-41cf-8e84-80211ad049d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_71523ccd-6340-4141-9506-6e9a1034c756" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_61e4eacb-2b65-41cf-8e84-80211ad049d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_7b704b18-ce01-4380-9f86-86cb560e50da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_71523ccd-6340-4141-9506-6e9a1034c756" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_7b704b18-ce01-4380-9f86-86cb560e50da" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#PensionsandOtherBenefitPlansDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails" xlink:type="extended" id="id5388d23528f43c2b858160a5955fe94_PensionsandOtherBenefitPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4e71b11f-35bb-459e-a822-d3b47c0db91d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionContributions_d2992e60-9ab3-4234-9bd7-76c24192a255" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4e71b11f-35bb-459e-a822-d3b47c0db91d" xlink:to="loc_us-gaap_PensionContributions_d2992e60-9ab3-4234-9bd7-76c24192a255" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4db64eb1-98a5-4451-b557-556ecd50d571" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4e71b11f-35bb-459e-a822-d3b47c0db91d" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4db64eb1-98a5-4451-b557-556ecd50d571" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_df404580-30c8-47c3-865b-114263903d0f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4db64eb1-98a5-4451-b557-556ecd50d571" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_df404580-30c8-47c3-865b-114263903d0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_df404580-30c8-47c3-865b-114263903d0f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_df404580-30c8-47c3-865b-114263903d0f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_df404580-30c8-47c3-865b-114263903d0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_9d600b4f-a86a-4bf9-9b4b-d4682dcc86c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_df404580-30c8-47c3-865b-114263903d0f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_9d600b4f-a86a-4bf9-9b4b-d4682dcc86c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4a7e41ce-0b67-4ac8-99ae-7fb0d0e75539" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_9d600b4f-a86a-4bf9-9b4b-d4682dcc86c4" xlink:to="loc_country_US_4a7e41ce-0b67-4ac8-99ae-7fb0d0e75539" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_163a7ac2-603d-4946-9465-ae28f33e5f49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_9d600b4f-a86a-4bf9-9b4b-d4682dcc86c4" xlink:to="loc_us-gaap_ForeignPlanMember_163a7ac2-603d-4946-9465-ae28f33e5f49" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="simple" xlink:href="jnj-20200927.xsd#AccumulatedOtherComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="extended" id="i256d96ff3f6648878a6eeb6d063e1f7e_AccumulatedOtherComprehensiveIncome"/>
  <link:roleRef roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#AccumulatedOtherComprehensiveIncomeTables"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="extended" id="i7eee7c56dfad4ab1a335eb9c1789277c_AccumulatedOtherComprehensiveIncomeTables"/>
  <link:roleRef roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#AccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" id="i646ac82014a941b3869a8b5554f76a2e_AccumulatedOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f880e53-e101-4e37-82ad-2aa15aa4f201" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_62b616c0-90ba-4f86-9978-553aa6309a05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f880e53-e101-4e37-82ad-2aa15aa4f201" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_62b616c0-90ba-4f86-9978-553aa6309a05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fbbc82fb-fa46-4291-91ff-a02279310a84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_62b616c0-90ba-4f86-9978-553aa6309a05" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fbbc82fb-fa46-4291-91ff-a02279310a84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_62510757-86ba-4aa3-a86c-0b8942091625" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_62b616c0-90ba-4f86-9978-553aa6309a05" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_62510757-86ba-4aa3-a86c-0b8942091625" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5b143b80-7572-4bdc-9a33-04a9359fab95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7565c857-c15a-4ef0-831e-d44c9fb7210e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f880e53-e101-4e37-82ad-2aa15aa4f201" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7565c857-c15a-4ef0-831e-d44c9fb7210e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_75d2c051-eea6-436e-a034-0f48f0ef872a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7565c857-c15a-4ef0-831e-d44c9fb7210e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_75d2c051-eea6-436e-a034-0f48f0ef872a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_75d2c051-eea6-436e-a034-0f48f0ef872a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_75d2c051-eea6-436e-a034-0f48f0ef872a" xlink:to="loc_us-gaap_EquityComponentDomain_75d2c051-eea6-436e-a034-0f48f0ef872a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ecd971d0-6168-491a-b8ce-e51ed730e85a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_75d2c051-eea6-436e-a034-0f48f0ef872a" xlink:to="loc_us-gaap_EquityComponentDomain_ecd971d0-6168-491a-b8ce-e51ed730e85a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_34cdc712-e441-43d0-9657-de553cb3a9e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ecd971d0-6168-491a-b8ce-e51ed730e85a" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_34cdc712-e441-43d0-9657-de553cb3a9e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_110883b9-d4cc-47e7-8e1d-0d02f85ee1e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ecd971d0-6168-491a-b8ce-e51ed730e85a" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_110883b9-d4cc-47e7-8e1d-0d02f85ee1e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_6a139faf-3b11-41d4-81ea-5403615b2480" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ecd971d0-6168-491a-b8ce-e51ed730e85a" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_6a139faf-3b11-41d4-81ea-5403615b2480" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_47e6e713-1c58-4195-96c2-3444a4b9f568" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ecd971d0-6168-491a-b8ce-e51ed730e85a" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_47e6e713-1c58-4195-96c2-3444a4b9f568" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c1dd5253-32b9-421d-91ce-68d6b07c213c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ecd971d0-6168-491a-b8ce-e51ed730e85a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c1dd5253-32b9-421d-91ce-68d6b07c213c" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/EarningsPerShare" xlink:type="simple" xlink:href="jnj-20200927.xsd#EarningsPerShare"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/EarningsPerShare" xlink:type="extended" id="idb1efe5fe2644c32ad0f4fcd733f01c7_EarningsPerShare"/>
  <link:roleRef roleURI="http://www.jnj.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#EarningsPerShareTables"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/EarningsPerShareTables" xlink:type="extended" id="i431bf5e9e45a4f09aebd25b45d41a5a8_EarningsPerShareTables"/>
  <link:roleRef roleURI="http://www.jnj.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#EarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/EarningsPerShareDetails" xlink:type="extended" id="i84938ba3c682441587441c709545a7f8_EarningsPerShareDetails"/>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas" xlink:type="simple" xlink:href="jnj-20200927.xsd#SegmentsofBusinessandGeographicAreas"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas" xlink:type="extended" id="i6ca8e0bfec2f4cc187ffd3cbbb651903_SegmentsofBusinessandGeographicAreas"/>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#SegmentsofBusinessandGeographicAreasTables"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables" xlink:type="extended" id="i0659b260e9bf420e8de3f09660579ca5_SegmentsofBusinessandGeographicAreasTables"/>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails" xlink:type="extended" id="i48abb5e66ec444d6841ec1eb025a6a78_SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f7305c4d-2734-4d8f-a850-3fdc5f7f4753" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract_05b0bcb6-060b-403d-b772-0c71e33ff58d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f7305c4d-2734-4d8f-a850-3fdc5f7f4753" xlink:to="loc_us-gaap_SegmentReportingInformationRevenueAbstract_05b0bcb6-060b-403d-b772-0c71e33ff58d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4ba11b89-0256-4ef5-8da0-966c993333a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_05b0bcb6-060b-403d-b772-0c71e33ff58d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4ba11b89-0256-4ef5-8da0-966c993333a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInSalesBySegmentOfBusiness_07992b7e-d298-48c8-8043-fb5d11885784" xlink:href="jnj-20200927.xsd#jnj_PercentageChangeInSalesBySegmentOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_05b0bcb6-060b-403d-b772-0c71e33ff58d" xlink:to="loc_jnj_PercentageChangeInSalesBySegmentOfBusiness_07992b7e-d298-48c8-8043-fb5d11885784" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d99da0a-f9c3-4b22-a40d-069a51bec173" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f7305c4d-2734-4d8f-a850-3fdc5f7f4753" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d99da0a-f9c3-4b22-a40d-069a51bec173" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e64c6115-f36c-4877-a613-2af2a9061369" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d99da0a-f9c3-4b22-a40d-069a51bec173" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e64c6115-f36c-4877-a613-2af2a9061369" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e64c6115-f36c-4877-a613-2af2a9061369_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e64c6115-f36c-4877-a613-2af2a9061369" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e64c6115-f36c-4877-a613-2af2a9061369_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9987f813-0a7f-4b75-9d5a-6cfff4260025" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e64c6115-f36c-4877-a613-2af2a9061369" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9987f813-0a7f-4b75-9d5a-6cfff4260025" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e718049b-410c-4623-a6d4-702a22cd4e53" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d99da0a-f9c3-4b22-a40d-069a51bec173" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e718049b-410c-4623-a6d4-702a22cd4e53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e718049b-410c-4623-a6d4-702a22cd4e53_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e718049b-410c-4623-a6d4-702a22cd4e53" xlink:to="loc_us-gaap_SegmentDomain_e718049b-410c-4623-a6d4-702a22cd4e53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c5ec1551-2bed-425b-b5cc-b45893077a9d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e718049b-410c-4623-a6d4-702a22cd4e53" xlink:to="loc_us-gaap_SegmentDomain_c5ec1551-2bed-425b-b5cc-b45893077a9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember_f1c51b22-141d-4f05-99cd-c89a4ffcd1e5" xlink:href="jnj-20200927.xsd#jnj_ConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c5ec1551-2bed-425b-b5cc-b45893077a9d" xlink:to="loc_jnj_ConsumerMember_f1c51b22-141d-4f05-99cd-c89a4ffcd1e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PharmaceuticalMember_94f28bd7-72b6-4dc1-9704-cac64e9c0df5" xlink:href="jnj-20200927.xsd#jnj_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c5ec1551-2bed-425b-b5cc-b45893077a9d" xlink:to="loc_jnj_PharmaceuticalMember_94f28bd7-72b6-4dc1-9704-cac64e9c0df5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_33e01713-1962-4ae5-adc8-7b5684eea560" xlink:href="jnj-20200927.xsd#jnj_MedicalDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c5ec1551-2bed-425b-b5cc-b45893077a9d" xlink:to="loc_jnj_MedicalDevicesMember_33e01713-1962-4ae5-adc8-7b5684eea560" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_aeeea4d8-aed2-4d8a-8ea4-6f8a0e62e8a5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d99da0a-f9c3-4b22-a40d-069a51bec173" xlink:to="loc_us-gaap_SubsegmentsAxis_aeeea4d8-aed2-4d8a-8ea4-6f8a0e62e8a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_aeeea4d8-aed2-4d8a-8ea4-6f8a0e62e8a5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_aeeea4d8-aed2-4d8a-8ea4-6f8a0e62e8a5" xlink:to="loc_us-gaap_SubsegmentsDomain_aeeea4d8-aed2-4d8a-8ea4-6f8a0e62e8a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_aeeea4d8-aed2-4d8a-8ea4-6f8a0e62e8a5" xlink:to="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ImmunologyMember_44a54c99-2d13-4d16-be71-f73d1ff6d838" xlink:href="jnj-20200927.xsd#jnj_ImmunologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_ImmunologyMember_44a54c99-2d13-4d16-be71-f73d1ff6d838" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InfectiousDiseasesMember_0effe44d-d53f-4af4-b52e-d3314bc97164" xlink:href="jnj-20200927.xsd#jnj_InfectiousDiseasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_InfectiousDiseasesMember_0effe44d-d53f-4af4-b52e-d3314bc97164" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_NeuroscienceMember_7932fa17-2dd4-4ac3-a0ea-8d0195e29c1f" xlink:href="jnj-20200927.xsd#jnj_NeuroscienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_NeuroscienceMember_7932fa17-2dd4-4ac3-a0ea-8d0195e29c1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OncologyMember_6b1212ce-8705-471f-9c20-d09ec6c445da" xlink:href="jnj-20200927.xsd#jnj_OncologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_OncologyMember_6b1212ce-8705-471f-9c20-d09ec6c445da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PulmonaryHypertensionMember_0bd63585-b47e-4429-873e-0e04dbab5be5" xlink:href="jnj-20200927.xsd#jnj_PulmonaryHypertensionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_PulmonaryHypertensionMember_0bd63585-b47e-4429-873e-0e04dbab5be5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CardiovascularMetabolismOtherMember_bb591c73-121d-4622-b584-21de2985e7fb" xlink:href="jnj-20200927.xsd#jnj_CardiovascularMetabolismOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_CardiovascularMetabolismOtherMember_bb591c73-121d-4622-b584-21de2985e7fb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterventionalSolutionsMember_7da7f468-c86b-4add-984f-09f0d699057f" xlink:href="jnj-20200927.xsd#jnj_InterventionalSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_InterventionalSolutionsMember_7da7f468-c86b-4add-984f-09f0d699057f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OrthopaedicsMember_193b6fe3-b810-4266-b42e-9e2d052c164f" xlink:href="jnj-20200927.xsd#jnj_OrthopaedicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_OrthopaedicsMember_193b6fe3-b810-4266-b42e-9e2d052c164f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SurgeryMember_f66fcb28-21fe-4c28-95cf-b2eb18578f8a" xlink:href="jnj-20200927.xsd#jnj_SurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_SurgeryMember_f66fcb28-21fe-4c28-95cf-b2eb18578f8a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VisionMember_20e0e084-2c64-4f27-913d-45f153aec2cf" xlink:href="jnj-20200927.xsd#jnj_VisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_VisionMember_20e0e084-2c64-4f27-913d-45f153aec2cf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_36448e5f-8808-4cf2-aeb8-22a1c5ee8c00" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d99da0a-f9c3-4b22-a40d-069a51bec173" xlink:to="loc_srt_ProductOrServiceAxis_36448e5f-8808-4cf2-aeb8-22a1c5ee8c00" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_36448e5f-8808-4cf2-aeb8-22a1c5ee8c00_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_36448e5f-8808-4cf2-aeb8-22a1c5ee8c00" xlink:to="loc_srt_ProductsAndServicesDomain_36448e5f-8808-4cf2-aeb8-22a1c5ee8c00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_36448e5f-8808-4cf2-aeb8-22a1c5ee8c00" xlink:to="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OTCMember_26495998-5151-4463-8148-c3d0e3858808" xlink:href="jnj-20200927.xsd#jnj_OTCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_OTCMember_26495998-5151-4463-8148-c3d0e3858808" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BeautyMember_3363042c-be4a-4ab5-be55-c2bfe394e324" xlink:href="jnj-20200927.xsd#jnj_BeautyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_BeautyMember_3363042c-be4a-4ab5-be55-c2bfe394e324" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OralCareMember_e81c257e-201a-46eb-8b55-69574ea9018c" xlink:href="jnj-20200927.xsd#jnj_OralCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_OralCareMember_e81c257e-201a-46eb-8b55-69574ea9018c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BabyCareMember_cead7f4d-b499-4dff-9b92-26f08a3b8852" xlink:href="jnj-20200927.xsd#jnj_BabyCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_BabyCareMember_cead7f4d-b499-4dff-9b92-26f08a3b8852" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WomensHealthMember_049f5fdd-18e5-4b6d-8368-5697e99157e3" xlink:href="jnj-20200927.xsd#jnj_WomensHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_WomensHealthMember_049f5fdd-18e5-4b6d-8368-5697e99157e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WoundCareandOtherMember_946eb6a2-ce13-4b69-aae5-f5a4d42aa10c" xlink:href="jnj-20200927.xsd#jnj_WoundCareandOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_WoundCareandOtherMember_946eb6a2-ce13-4b69-aae5-f5a4d42aa10c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RemicadeMember_e91b361d-2c48-4a83-b324-fa3e81de2eec" xlink:href="jnj-20200927.xsd#jnj_RemicadeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_RemicadeMember_e91b361d-2c48-4a83-b324-fa3e81de2eec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SimponiSimponiAriaMember_60306258-021e-4171-945c-61867cf64cb4" xlink:href="jnj-20200927.xsd#jnj_SimponiSimponiAriaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_SimponiSimponiAriaMember_60306258-021e-4171-945c-61867cf64cb4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_StelaraMember_10abf238-498e-427c-9262-be19673a4045" xlink:href="jnj-20200927.xsd#jnj_StelaraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_StelaraMember_10abf238-498e-427c-9262-be19673a4045" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_TremfyaMember_ececfc1b-2b83-4469-ace5-c1d6f27cfeea" xlink:href="jnj-20200927.xsd#jnj_TremfyaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_TremfyaMember_ececfc1b-2b83-4469-ace5-c1d6f27cfeea" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherImmunologyMember_01b2defb-fa58-4d2a-860a-e401e134b196" xlink:href="jnj-20200927.xsd#jnj_OtherImmunologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_OtherImmunologyMember_01b2defb-fa58-4d2a-860a-e401e134b196" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EDURANTrilpivirineMember_d50ae8d7-34d0-49b5-8d32-7e5708d961d6" xlink:href="jnj-20200927.xsd#jnj_EDURANTrilpivirineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_EDURANTrilpivirineMember_d50ae8d7-34d0-49b5-8d32-7e5708d961d6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember_e03c7cf5-caf1-4866-a86a-e765482e5e56" xlink:href="jnj-20200927.xsd#jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember_e03c7cf5-caf1-4866-a86a-e765482e5e56" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherInfectiousDiseasesMember_8fc21fba-3232-4b16-be0c-ca6898d08586" xlink:href="jnj-20200927.xsd#jnj_OtherInfectiousDiseasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_OtherInfectiousDiseasesMember_8fc21fba-3232-4b16-be0c-ca6898d08586" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CONCERTAMethylphenidateMember_27f3f2e1-cb39-40de-aa4d-a55d401e775b" xlink:href="jnj-20200927.xsd#jnj_CONCERTAMethylphenidateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_CONCERTAMethylphenidateMember_27f3f2e1-cb39-40de-aa4d-a55d401e775b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember_f9e126d0-3c2f-4947-b79d-a4414cd10050" xlink:href="jnj-20200927.xsd#jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember_f9e126d0-3c2f-4947-b79d-a4414cd10050" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RISPERDALCONSTAMember_343e4a23-d2b5-4586-a8a4-0758e93afa47" xlink:href="jnj-20200927.xsd#jnj_RISPERDALCONSTAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_RISPERDALCONSTAMember_343e4a23-d2b5-4586-a8a4-0758e93afa47" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OTHERNEUROSCIENCEMember_76ca9366-cdeb-4c3e-8887-ee2ddad37465" xlink:href="jnj-20200927.xsd#jnj_OTHERNEUROSCIENCEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_OTHERNEUROSCIENCEMember_76ca9366-cdeb-4c3e-8887-ee2ddad37465" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DARZALEXMember_28bcffa2-b7bb-40bf-9adb-abfc479439fb" xlink:href="jnj-20200927.xsd#jnj_DARZALEXMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_DARZALEXMember_28bcffa2-b7bb-40bf-9adb-abfc479439fb" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ERLEADAMember_c857ca59-d98f-4d36-aef8-98447cc4bbc3" xlink:href="jnj-20200927.xsd#jnj_ERLEADAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_ERLEADAMember_c857ca59-d98f-4d36-aef8-98447cc4bbc3" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IMBRUVICAMember_75573760-4e32-4ff9-b3ad-d987fd75ce5e" xlink:href="jnj-20200927.xsd#jnj_IMBRUVICAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_IMBRUVICAMember_75573760-4e32-4ff9-b3ad-d987fd75ce5e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VELCADEMember_2174c673-da7d-4ec8-bd39-55e3c7900739" xlink:href="jnj-20200927.xsd#jnj_VELCADEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_VELCADEMember_2174c673-da7d-4ec8-bd39-55e3c7900739" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ZYTIGAMember_8cad077e-4212-4f2b-a8c7-448a6994e6f3" xlink:href="jnj-20200927.xsd#jnj_ZYTIGAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_ZYTIGAMember_8cad077e-4212-4f2b-a8c7-448a6994e6f3" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherOncologyMember_f679b1c9-fc23-4b97-a3f5-84124704a615" xlink:href="jnj-20200927.xsd#jnj_OtherOncologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_OtherOncologyMember_f679b1c9-fc23-4b97-a3f5-84124704a615" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OPSUMITMember_c3f4e067-959e-4201-8fb9-7ddfba46def2" xlink:href="jnj-20200927.xsd#jnj_OPSUMITMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_OPSUMITMember_c3f4e067-959e-4201-8fb9-7ddfba46def2" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_UPTRAVIMember_78380360-5e93-45dc-85e5-e069dc983360" xlink:href="jnj-20200927.xsd#jnj_UPTRAVIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_UPTRAVIMember_78380360-5e93-45dc-85e5-e069dc983360" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_XareltoMember_097d86b7-a554-4c15-b45a-ea2cb96cfc85" xlink:href="jnj-20200927.xsd#jnj_XareltoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_XareltoMember_097d86b7-a554-4c15-b45a-ea2cb96cfc85" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_INVOKANAINVOKAMETMember_7b61dc26-50c6-4446-81cb-dae195653d53" xlink:href="jnj-20200927.xsd#jnj_INVOKANAINVOKAMETMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_INVOKANAINVOKAMETMember_7b61dc26-50c6-4446-81cb-dae195653d53" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PROCRITEPREXMember_1ecc4a5b-c3d7-4068-aa49-9dca000f3502" xlink:href="jnj-20200927.xsd#jnj_PROCRITEPREXMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_PROCRITEPREXMember_1ecc4a5b-c3d7-4068-aa49-9dca000f3502" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherMember_9bd01508-7667-4e17-a9bd-3461b7125da0" xlink:href="jnj-20200927.xsd#jnj_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_OtherMember_9bd01508-7667-4e17-a9bd-3461b7125da0" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_HIPSMember_dd1dd7b1-1803-4dd2-bd99-c2be3e0a757a" xlink:href="jnj-20200927.xsd#jnj_HIPSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_HIPSMember_dd1dd7b1-1803-4dd2-bd99-c2be3e0a757a" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_KNEESMember_2d1eaaba-3fd4-4b2c-90d4-5709f6b54dc2" xlink:href="jnj-20200927.xsd#jnj_KNEESMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_KNEESMember_2d1eaaba-3fd4-4b2c-90d4-5709f6b54dc2" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_TRAUMAMember_e74283b4-963b-4ab6-b4e8-539c6693dfb3" xlink:href="jnj-20200927.xsd#jnj_TRAUMAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_TRAUMAMember_e74283b4-963b-4ab6-b4e8-539c6693dfb3" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SPINEOTHERMember_1f944bcd-84d4-4c4a-b872-c1368053789b" xlink:href="jnj-20200927.xsd#jnj_SPINEOTHERMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_SPINEOTHERMember_1f944bcd-84d4-4c4a-b872-c1368053789b" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ADVANCEDMember_c8c0190c-a124-4a4d-bfe3-4cadad1c6e48" xlink:href="jnj-20200927.xsd#jnj_ADVANCEDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_ADVANCEDMember_c8c0190c-a124-4a4d-bfe3-4cadad1c6e48" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_GENERALMember_a0241e40-d8e0-4f37-8f5c-73af3f242b23" xlink:href="jnj-20200927.xsd#jnj_GENERALMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_GENERALMember_a0241e40-d8e0-4f37-8f5c-73af3f242b23" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CONTACTLENSESOTHERMember_9157f411-ad64-44b2-93be-75bfa2bd42af" xlink:href="jnj-20200927.xsd#jnj_CONTACTLENSESOTHERMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_CONTACTLENSESOTHERMember_9157f411-ad64-44b2-93be-75bfa2bd42af" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SURGICALMember_9027c4ed-4cce-4252-a0f1-e85588df82da" xlink:href="jnj-20200927.xsd#jnj_SURGICALMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_SURGICALMember_9027c4ed-4cce-4252-a0f1-e85588df82da" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_af031964-b6cb-42e5-991a-5ac8b38c47c3" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d99da0a-f9c3-4b22-a40d-069a51bec173" xlink:to="loc_srt_StatementGeographicalAxis_af031964-b6cb-42e5-991a-5ac8b38c47c3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_af031964-b6cb-42e5-991a-5ac8b38c47c3_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_af031964-b6cb-42e5-991a-5ac8b38c47c3" xlink:to="loc_srt_SegmentGeographicalDomain_af031964-b6cb-42e5-991a-5ac8b38c47c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5b3db68a-0071-4ddd-a48b-85f8f5784241" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_af031964-b6cb-42e5-991a-5ac8b38c47c3" xlink:to="loc_srt_SegmentGeographicalDomain_5b3db68a-0071-4ddd-a48b-85f8f5784241" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_01fb1c78-0879-4d29-919a-36da76c045d4" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5b3db68a-0071-4ddd-a48b-85f8f5784241" xlink:to="loc_country_US_01fb1c78-0879-4d29-919a-36da76c045d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_UNITEDSTATESExportsMember_56d9df08-068f-4c5b-beae-dad18156551e" xlink:href="jnj-20200927.xsd#jnj_UNITEDSTATESExportsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5b3db68a-0071-4ddd-a48b-85f8f5784241" xlink:to="loc_jnj_UNITEDSTATESExportsMember_56d9df08-068f-4c5b-beae-dad18156551e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_d4908b6c-d716-4d98-86d7-5b6fb1fe60d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_5b3db68a-0071-4ddd-a48b-85f8f5784241" xlink:to="loc_us-gaap_NonUsMember_d4908b6c-d716-4d98-86d7-5b6fb1fe60d9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails" xlink:type="extended" id="if394b48ab6904bafab6dfa3eda04db95_SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInSalesByGeographicArea_f71e90c2-8217-46c7-ba7c-30a54aead506" xlink:href="jnj-20200927.xsd#jnj_PercentageChangeInSalesByGeographicArea"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_jnj_PercentageChangeInSalesByGeographicArea_f71e90c2-8217-46c7-ba7c-30a54aead506" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3eae0626-7561-4a84-a820-b0033590dfe6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3eae0626-7561-4a84-a820-b0033590dfe6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_eb2dc456-da31-4367-8963-7ed2040a40f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_OperatingIncomeLoss_eb2dc456-da31-4367-8963-7ed2040a40f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInOperatingIncomeLoss_f4f3c7b9-bb1b-45ac-8765-fe96b74bd4bc" xlink:href="jnj-20200927.xsd#jnj_PercentageChangeInOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_jnj_PercentageChangeInOperatingIncomeLoss_f4f3c7b9-bb1b-45ac-8765-fe96b74bd4bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_485fea6a-07c3-4e33-81a9-96c695cc0b02" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_485fea6a-07c3-4e33-81a9-96c695cc0b02" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_0fa480ff-ec97-46ce-a526-0e648c3c70e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_AdjustmentForAmortization_0fa480ff-ec97-46ce-a526-0e648c3c70e0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_0c1cda14-5bab-41c2-8801-d4d834d95d44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_0c1cda14-5bab-41c2-8801-d4d834d95d44" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_97f78770-12c5-468d-8303-a32a4823e6bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_97f78770-12c5-468d-8303-a32a4823e6bd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfEquityInvestments_ee79ada8-05a7-4aac-97f6-156cb5195be1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfEquityInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_GainLossOnSaleOfEquityInvestments_ee79ada8-05a7-4aac-97f6-156cb5195be1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_66346da4-dd2b-4780-9f4c-0a4834adf58e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_RestructuringCharges_66346da4-dd2b-4780-9f4c-0a4834adf58e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_91f6caf1-3132-432e-8d55-183bc8b93337" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_LitigationSettlementExpense_91f6caf1-3132-432e-8d55-183bc8b93337" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnSecurities_39c2b705-9559-4fa7-9bee-7c8db350b04c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_UnrealizedGainLossOnSecurities_39c2b705-9559-4fa7-9bee-7c8db350b04c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_efce4ecd-2f85-4296-a4dc-7b774496a53d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_efce4ecd-2f85-4296-a4dc-7b774496a53d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_fc09667b-0a33-44ed-88a7-0a5ae779b173" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_fc09667b-0a33-44ed-88a7-0a5ae779b173" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCosts_b0aa5348-f688-4e0b-b38d-c1e296438119" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquisitionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_AcquisitionCosts_b0aa5348-f688-4e0b-b38d-c1e296438119" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d68a5fe8-2f05-464b-a739-509be19d4926" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d68a5fe8-2f05-464b-a739-509be19d4926" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8c2b190d-7299-428d-b10b-e8e3087ae3cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d68a5fe8-2f05-464b-a739-509be19d4926" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8c2b190d-7299-428d-b10b-e8e3087ae3cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8c2b190d-7299-428d-b10b-e8e3087ae3cf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8c2b190d-7299-428d-b10b-e8e3087ae3cf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8c2b190d-7299-428d-b10b-e8e3087ae3cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dc9c2a9f-7937-4d91-b03b-8f9cb38d2499" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8c2b190d-7299-428d-b10b-e8e3087ae3cf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dc9c2a9f-7937-4d91-b03b-8f9cb38d2499" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_d5e14b1b-964d-42a9-88bd-128b3a0ea1e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dc9c2a9f-7937-4d91-b03b-8f9cb38d2499" xlink:to="loc_us-gaap_OtherIncomeMember_d5e14b1b-964d-42a9-88bd-128b3a0ea1e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aac7f5d7-83c7-46ae-892f-9feab491b6ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d68a5fe8-2f05-464b-a739-509be19d4926" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aac7f5d7-83c7-46ae-892f-9feab491b6ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aac7f5d7-83c7-46ae-892f-9feab491b6ea_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aac7f5d7-83c7-46ae-892f-9feab491b6ea" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_aac7f5d7-83c7-46ae-892f-9feab491b6ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8eba38e7-9be2-4b8b-a745-f53b9f0bb61e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aac7f5d7-83c7-46ae-892f-9feab491b6ea" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8eba38e7-9be2-4b8b-a745-f53b9f0bb61e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AdvancedSterilizationProductsMember_bc7d3ab4-4de3-4a33-8d10-3f4f3fc0c392" xlink:href="jnj-20200927.xsd#jnj_AdvancedSterilizationProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8eba38e7-9be2-4b8b-a745-f53b9f0bb61e" xlink:to="loc_jnj_AdvancedSterilizationProductsMember_bc7d3ab4-4de3-4a33-8d10-3f4f3fc0c392" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_cb353c56-2343-4b4a-9dec-e3311ffd4175" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d68a5fe8-2f05-464b-a739-509be19d4926" xlink:to="loc_srt_StatementGeographicalAxis_cb353c56-2343-4b4a-9dec-e3311ffd4175" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_cb353c56-2343-4b4a-9dec-e3311ffd4175_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_cb353c56-2343-4b4a-9dec-e3311ffd4175" xlink:to="loc_srt_SegmentGeographicalDomain_cb353c56-2343-4b4a-9dec-e3311ffd4175_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f559ace1-34e4-4baf-9f96-ac9e740b9efe" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_cb353c56-2343-4b4a-9dec-e3311ffd4175" xlink:to="loc_srt_SegmentGeographicalDomain_f559ace1-34e4-4baf-9f96-ac9e740b9efe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_608fd9a2-0055-4662-bc97-70f0c373419f" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f559ace1-34e4-4baf-9f96-ac9e740b9efe" xlink:to="loc_country_US_608fd9a2-0055-4662-bc97-70f0c373419f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_4936486f-ab48-45ed-a451-d371d2966b09" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f559ace1-34e4-4baf-9f96-ac9e740b9efe" xlink:to="loc_srt_EuropeMember_4936486f-ab48-45ed-a451-d371d2966b09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WesternHemisphereExcludingUSMember_5e76c44e-fe41-4422-80d2-3a10ec6505e1" xlink:href="jnj-20200927.xsd#jnj_WesternHemisphereExcludingUSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f559ace1-34e4-4baf-9f96-ac9e740b9efe" xlink:to="loc_jnj_WesternHemisphereExcludingUSMember_5e76c44e-fe41-4422-80d2-3a10ec6505e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AsiaPacificAfricaMember_46bed0a7-0e53-46f8-9b28-18f1cb918ae2" xlink:href="jnj-20200927.xsd#jnj_AsiaPacificAfricaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f559ace1-34e4-4baf-9f96-ac9e740b9efe" xlink:to="loc_jnj_AsiaPacificAfricaMember_46bed0a7-0e53-46f8-9b28-18f1cb918ae2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a76fa2cc-a567-4560-9404-31d6500f1892" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d68a5fe8-2f05-464b-a739-509be19d4926" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a76fa2cc-a567-4560-9404-31d6500f1892" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a76fa2cc-a567-4560-9404-31d6500f1892_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a76fa2cc-a567-4560-9404-31d6500f1892" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a76fa2cc-a567-4560-9404-31d6500f1892_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a8101745-a0fd-4576-b39d-fbc31cc1f3c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a76fa2cc-a567-4560-9404-31d6500f1892" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a8101745-a0fd-4576-b39d-fbc31cc1f3c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CizHoldingsCo.Ltd.Member_7bb4b2e4-f331-46e7-b3ae-e1fbe2dbefb1" xlink:href="jnj-20200927.xsd#jnj_CizHoldingsCo.Ltd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a8101745-a0fd-4576-b39d-fbc31cc1f3c9" xlink:to="loc_jnj_CizHoldingsCo.Ltd.Member_7bb4b2e4-f331-46e7-b3ae-e1fbe2dbefb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AurisHealthMember_e1528741-01bd-4667-a919-d37a818b29fb" xlink:href="jnj-20200927.xsd#jnj_AurisHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a8101745-a0fd-4576-b39d-fbc31cc1f3c9" xlink:to="loc_jnj_AurisHealthMember_e1528741-01bd-4667-a919-d37a818b29fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a94cb02a-5ff9-443d-9b5e-d82ad867160f" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d68a5fe8-2f05-464b-a739-509be19d4926" xlink:to="loc_srt_ConsolidationItemsAxis_a94cb02a-5ff9-443d-9b5e-d82ad867160f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a94cb02a-5ff9-443d-9b5e-d82ad867160f_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_a94cb02a-5ff9-443d-9b5e-d82ad867160f" xlink:to="loc_srt_ConsolidationItemsDomain_a94cb02a-5ff9-443d-9b5e-d82ad867160f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f3bcfb81-9155-4538-8c86-9bcf9657f9f8" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_a94cb02a-5ff9-443d-9b5e-d82ad867160f" xlink:to="loc_srt_ConsolidationItemsDomain_f3bcfb81-9155-4538-8c86-9bcf9657f9f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_c94a6885-a29b-4ec1-84e9-200548e810e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_f3bcfb81-9155-4538-8c86-9bcf9657f9f8" xlink:to="loc_us-gaap_OperatingSegmentsMember_c94a6885-a29b-4ec1-84e9-200548e810e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_1ca74a05-1860-41e0-8a62-96342fe4e012" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_f3bcfb81-9155-4538-8c86-9bcf9657f9f8" xlink:to="loc_us-gaap_CorporateNonSegmentMember_1ca74a05-1860-41e0-8a62-96342fe4e012" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b6ba0127-92bb-41f2-bca1-2342ef31cc17" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d68a5fe8-2f05-464b-a739-509be19d4926" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b6ba0127-92bb-41f2-bca1-2342ef31cc17" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b6ba0127-92bb-41f2-bca1-2342ef31cc17_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b6ba0127-92bb-41f2-bca1-2342ef31cc17" xlink:to="loc_us-gaap_SegmentDomain_b6ba0127-92bb-41f2-bca1-2342ef31cc17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cfa77bac-6493-4f74-ba0e-f217ce15ae81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b6ba0127-92bb-41f2-bca1-2342ef31cc17" xlink:to="loc_us-gaap_SegmentDomain_cfa77bac-6493-4f74-ba0e-f217ce15ae81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember_dd72049a-8392-436a-88fe-6ae7f102b038" xlink:href="jnj-20200927.xsd#jnj_ConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cfa77bac-6493-4f74-ba0e-f217ce15ae81" xlink:to="loc_jnj_ConsumerMember_dd72049a-8392-436a-88fe-6ae7f102b038" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PharmaceuticalMember_5f3663d4-08ba-4e60-a966-5425388841bf" xlink:href="jnj-20200927.xsd#jnj_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cfa77bac-6493-4f74-ba0e-f217ce15ae81" xlink:to="loc_jnj_PharmaceuticalMember_5f3663d4-08ba-4e60-a966-5425388841bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_21527d34-ad9e-4c0c-bf8f-91cb5b8d4b75" xlink:href="jnj-20200927.xsd#jnj_MedicalDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cfa77bac-6493-4f74-ba0e-f217ce15ae81" xlink:to="loc_jnj_MedicalDevicesMember_21527d34-ad9e-4c0c-bf8f-91cb5b8d4b75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_fe41de3e-c7c3-4056-96c9-85e25040417b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_45bca440-66f4-43fa-930e-e00a88937cb4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_fe41de3e-c7c3-4056-96c9-85e25040417b" xlink:to="loc_us-gaap_LitigationSettlementExpense_45bca440-66f4-43fa-930e-e00a88937cb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e5fb8455-6091-4e1a-9dc1-6a7c8b3ff837" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_fe41de3e-c7c3-4056-96c9-85e25040417b" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e5fb8455-6091-4e1a-9dc1-6a7c8b3ff837" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a697f0d7-9861-40f8-b722-3854457525db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e5fb8455-6091-4e1a-9dc1-6a7c8b3ff837" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a697f0d7-9861-40f8-b722-3854457525db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a697f0d7-9861-40f8-b722-3854457525db_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ef404349-2e44-4005-9f36-b78eae6e1f00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember_5c9fdfb1-a34b-4d1e-945f-3ba442d43197" xlink:href="jnj-20200927.xsd#jnj_ConsumerMember"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails" xlink:type="extended" id="i9b072f09f57e47e18dab592ff05e8b76_SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_973acbf8-53a5-4faa-89aa-78c59424ae61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentsGeographicalAreasAbstract_128090d0-25c6-411c-bb78-7a90ccebc62e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentsGeographicalAreasAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_973acbf8-53a5-4faa-89aa-78c59424ae61" xlink:to="loc_us-gaap_SegmentsGeographicalAreasAbstract_128090d0-25c6-411c-bb78-7a90ccebc62e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_39bd4bb9-dcf4-4e62-8a68-13b8babf0b40" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentsGeographicalAreasAbstract_128090d0-25c6-411c-bb78-7a90ccebc62e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_39bd4bb9-dcf4-4e62-8a68-13b8babf0b40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInSalesByGeographicArea_13956820-3d92-4880-a206-1f6389cff362" xlink:href="jnj-20200927.xsd#jnj_PercentageChangeInSalesByGeographicArea"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentsGeographicalAreasAbstract_128090d0-25c6-411c-bb78-7a90ccebc62e" xlink:to="loc_jnj_PercentageChangeInSalesByGeographicArea_13956820-3d92-4880-a206-1f6389cff362" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_bd33877f-85e0-456c-b83b-e7c75b263cc9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_973acbf8-53a5-4faa-89aa-78c59424ae61" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_bd33877f-85e0-456c-b83b-e7c75b263cc9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_fc4c8bd0-8c96-4020-b4e7-b4ffb4f0d801" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_bd33877f-85e0-456c-b83b-e7c75b263cc9" xlink:to="loc_srt_StatementGeographicalAxis_fc4c8bd0-8c96-4020-b4e7-b4ffb4f0d801" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_fc4c8bd0-8c96-4020-b4e7-b4ffb4f0d801_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_fc4c8bd0-8c96-4020-b4e7-b4ffb4f0d801" xlink:to="loc_srt_SegmentGeographicalDomain_fc4c8bd0-8c96-4020-b4e7-b4ffb4f0d801_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d5d28fa6-6f05-4e50-a929-ceba0f67ae79" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_fc4c8bd0-8c96-4020-b4e7-b4ffb4f0d801" xlink:to="loc_srt_SegmentGeographicalDomain_d5d28fa6-6f05-4e50-a929-ceba0f67ae79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_3051dce5-f8b2-41a0-9ec6-849e1d0a5d3b" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d5d28fa6-6f05-4e50-a929-ceba0f67ae79" xlink:to="loc_country_US_3051dce5-f8b2-41a0-9ec6-849e1d0a5d3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_ba89ee80-43ba-443a-b458-9790b06558ce" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d5d28fa6-6f05-4e50-a929-ceba0f67ae79" xlink:to="loc_srt_EuropeMember_ba89ee80-43ba-443a-b458-9790b06558ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WesternHemisphereExcludingUSMember_8caf5b54-578e-45d5-a376-03465ce6aadd" xlink:href="jnj-20200927.xsd#jnj_WesternHemisphereExcludingUSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d5d28fa6-6f05-4e50-a929-ceba0f67ae79" xlink:to="loc_jnj_WesternHemisphereExcludingUSMember_8caf5b54-578e-45d5-a376-03465ce6aadd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AsiaPacificAfricaMember_aba5f62e-1f98-4e02-82ff-0c4167cbf5f2" xlink:href="jnj-20200927.xsd#jnj_AsiaPacificAfricaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d5d28fa6-6f05-4e50-a929-ceba0f67ae79" xlink:to="loc_jnj_AsiaPacificAfricaMember_aba5f62e-1f98-4e02-82ff-0c4167cbf5f2" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/BusinessCombinationsandDivestitures" xlink:type="simple" xlink:href="jnj-20200927.xsd#BusinessCombinationsandDivestitures"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/BusinessCombinationsandDivestitures" xlink:type="extended" id="i54442dc6ab934599a803d7577832435b_BusinessCombinationsandDivestitures"/>
  <link:roleRef roleURI="http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#BusinessCombinationsandDivestituresNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails" xlink:type="extended" id="i27db20f769544b7996989112c51aab94_BusinessCombinationsandDivestituresNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8f5ce313-3775-4d2c-9468-4c2903d66a46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8f5ce313-3775-4d2c-9468-4c2903d66a46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_45112cbb-a83f-441e-b143-ee23248821a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_45112cbb-a83f-441e-b143-ee23248821a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction_0cbff6c5-f574-4d16-8549-fbb2c02a83d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction_0cbff6c5-f574-4d16-8549-fbb2c02a83d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_bda8cf08-be69-4b82-be1f-3360c565c494" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_bda8cf08-be69-4b82-be1f-3360c565c494" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_5440005d-434e-4661-99cc-e3bb7df6f870" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_5440005d-434e-4661-99cc-e3bb7df6f870" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares_e020441d-21ff-42b4-8808-3ea46f9855fc" xlink:href="jnj-20200927.xsd#jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares_e020441d-21ff-42b4-8808-3ea46f9855fc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_05738e40-6d4f-47de-a33c-681c75e036c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_05738e40-6d4f-47de-a33c-681c75e036c1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_84c0821a-c3a5-47d8-9c2e-b58ab47bab6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_LongTermDebt_84c0821a-c3a5-47d8-9c2e-b58ab47bab6b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d05dde04-cb88-4c9a-b47a-1eb1990fc985" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d05dde04-cb88-4c9a-b47a-1eb1990fc985" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_af201415-f6fb-494e-b373-d960b6cb04ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_af201415-f6fb-494e-b373-d960b6cb04ec" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5310d8a5-0f5c-4506-a493-241b323310c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_Goodwill_5310d8a5-0f5c-4506-a493-241b323310c5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_d1c866b3-a4e8-4c23-9de5-852b7951005a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_d1c866b3-a4e8-4c23-9de5-852b7951005a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_7a5be1e7-e73c-4bd5-8a6f-91d7dd126b99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_7a5be1e7-e73c-4bd5-8a6f-91d7dd126b99" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_88771cf5-7711-432b-aa16-f92b26669029" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_88771cf5-7711-432b-aa16-f92b26669029" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_532b5d9b-6da7-4024-95f0-a251bb07ff21" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_532b5d9b-6da7-4024-95f0-a251bb07ff21" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained_545ba186-ffbc-427a-8c7c-31cc91abb89e" xlink:href="jnj-20200927.xsd#jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained_545ba186-ffbc-427a-8c7c-31cc91abb89e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_bc25547d-586f-4c81-861a-7c2515920331" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_bc25547d-586f-4c81-861a-7c2515920331" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_25e21315-f472-407b-ad2d-8e8a41364e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_25e21315-f472-407b-ad2d-8e8a41364e6c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_450e2bd3-d309-49ab-9fbc-e6773e01d9eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_450e2bd3-d309-49ab-9fbc-e6773e01d9eb" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_04730e90-2fd0-4daa-9cc4-f49bb7680261" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_04730e90-2fd0-4daa-9cc4-f49bb7680261" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_0e62de33-92a5-4e28-9a38-0bd29753d2d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_0e62de33-92a5-4e28-9a38-0bd29753d2d0" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_4c9fb466-191e-4916-baaf-8dcd2c953de1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_AssetImpairmentCharges_4c9fb466-191e-4916-baaf-8dcd2c953de1" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyExchangeRateTranslation1_47e0b671-0381-4254-90c3-967dda248ca5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_ForeignCurrencyExchangeRateTranslation1_47e0b671-0381-4254-90c3-967dda248ca5" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b3ad83eb-a0f0-4c16-b575-504432f27461" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b3ad83eb-a0f0-4c16-b575-504432f27461" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill_f5cbae68-c74f-41dd-976b-553130728df3" xlink:href="jnj-20200927.xsd#jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill_f5cbae68-c74f-41dd-976b-553130728df3" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_fc3d4d26-139f-449b-b710-21cc677da9ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_fc3d4d26-139f-449b-b710-21cc677da9ac" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_a8c2ad4d-ce73-4ddd-ac06-24393cda259e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_a8c2ad4d-ce73-4ddd-ac06-24393cda259e" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_059257c0-df25-4b2b-b839-5467349c436a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_059257c0-df25-4b2b-b839-5467349c436a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_059257c0-df25-4b2b-b839-5467349c436a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_059257c0-df25-4b2b-b839-5467349c436a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_059257c0-df25-4b2b-b839-5467349c436a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_139fe3d3-da9f-4173-9490-3dc99f150432" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_059257c0-df25-4b2b-b839-5467349c436a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_139fe3d3-da9f-4173-9490-3dc99f150432" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_c17f51a1-592e-4a79-81af-606b5ffe7639" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_139fe3d3-da9f-4173-9490-3dc99f150432" xlink:to="loc_us-gaap_OtherIncomeMember_c17f51a1-592e-4a79-81af-606b5ffe7639" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_473932e8-04b0-4c68-a43c-586ddfb19c36" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_473932e8-04b0-4c68-a43c-586ddfb19c36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_473932e8-04b0-4c68-a43c-586ddfb19c36_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_473932e8-04b0-4c68-a43c-586ddfb19c36" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_473932e8-04b0-4c68-a43c-586ddfb19c36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c62c3708-059e-463c-8d30-32157fd19af9" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_473932e8-04b0-4c68-a43c-586ddfb19c36" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c62c3708-059e-463c-8d30-32157fd19af9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IdorsiaLTDMember_49a02527-74c2-424c-bfc3-ad23ed0e667e" xlink:href="jnj-20200927.xsd#jnj_IdorsiaLTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c62c3708-059e-463c-8d30-32157fd19af9" xlink:to="loc_jnj_IdorsiaLTDMember_49a02527-74c2-424c-bfc3-ad23ed0e667e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4cc65fa2-51e7-4f88-9131-b833cb0170b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4cc65fa2-51e7-4f88-9131-b833cb0170b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_4cc65fa2-51e7-4f88-9131-b833cb0170b8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4cc65fa2-51e7-4f88-9131-b833cb0170b8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_4cc65fa2-51e7-4f88-9131-b833cb0170b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_30361a48-46e2-421e-a6bc-ac79b861a0fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4cc65fa2-51e7-4f88-9131-b833cb0170b8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_30361a48-46e2-421e-a6bc-ac79b861a0fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_709b9c39-476c-4b90-8744-18058671459a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_30361a48-46e2-421e-a6bc-ac79b861a0fc" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_709b9c39-476c-4b90-8744-18058671459a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_24780729-c3ca-4210-a896-2978bfd82416" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_24780729-c3ca-4210-a896-2978bfd82416" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_24780729-c3ca-4210-a896-2978bfd82416_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_24780729-c3ca-4210-a896-2978bfd82416" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_24780729-c3ca-4210-a896-2978bfd82416_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_130a0473-9f8a-4d71-8aed-a2ddad0df78a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_24780729-c3ca-4210-a896-2978bfd82416" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_130a0473-9f8a-4d71-8aed-a2ddad0df78a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SupplyChainMember_d4433eae-874f-4585-888b-e7ee2d779c1f" xlink:href="jnj-20200927.xsd#jnj_SupplyChainMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_130a0473-9f8a-4d71-8aed-a2ddad0df78a" xlink:to="loc_jnj_SupplyChainMember_d4433eae-874f-4585-888b-e7ee2d779c1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AdvancedSterilizationProductsMember_87f607a8-bfec-495b-9011-3ce9621a49f6" xlink:href="jnj-20200927.xsd#jnj_AdvancedSterilizationProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_130a0473-9f8a-4d71-8aed-a2ddad0df78a" xlink:to="loc_jnj_AdvancedSterilizationProductsMember_87f607a8-bfec-495b-9011-3ce9621a49f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IdorsiaLTDMember_3c7a90ec-bb3f-44aa-b19d-d01d6f50daf1" xlink:href="jnj-20200927.xsd#jnj_IdorsiaLTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_130a0473-9f8a-4d71-8aed-a2ddad0df78a" xlink:to="loc_jnj_IdorsiaLTDMember_3c7a90ec-bb3f-44aa-b19d-d01d6f50daf1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_fe133872-cd39-4074-9372-f458d2897153" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_dei_LegalEntityAxis_fe133872-cd39-4074-9372-f458d2897153" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fe133872-cd39-4074-9372-f458d2897153_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_fe133872-cd39-4074-9372-f458d2897153" xlink:to="loc_dei_EntityDomain_fe133872-cd39-4074-9372-f458d2897153_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d4cbe684-5471-4693-aed8-49f4b18f339e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_fe133872-cd39-4074-9372-f458d2897153" xlink:to="loc_dei_EntityDomain_d4cbe684-5471-4693-aed8-49f4b18f339e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IdorsiaLTDMember_1436766e-cade-4f65-b049-20d83b2d302b" xlink:href="jnj-20200927.xsd#jnj_IdorsiaLTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_d4cbe684-5471-4693-aed8-49f4b18f339e" xlink:to="loc_jnj_IdorsiaLTDMember_1436766e-cade-4f65-b049-20d83b2d302b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9f4ea741-7c73-4791-9632-22ddc26217cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9f4ea741-7c73-4791-9632-22ddc26217cf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9f4ea741-7c73-4791-9632-22ddc26217cf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9f4ea741-7c73-4791-9632-22ddc26217cf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9f4ea741-7c73-4791-9632-22ddc26217cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4502b14b-8ad1-4aeb-b40b-2d73ee886ff3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9f4ea741-7c73-4791-9632-22ddc26217cf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4502b14b-8ad1-4aeb-b40b-2d73ee886ff3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BermekimabMember_ca8f6772-8dfa-4a5b-bcfb-e357de375162" xlink:href="jnj-20200927.xsd#jnj_BermekimabMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4502b14b-8ad1-4aeb-b40b-2d73ee886ff3" xlink:to="loc_jnj_BermekimabMember_ca8f6772-8dfa-4a5b-bcfb-e357de375162" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VerbSurgicalInc.Member_347a15da-a438-4b79-8ad8-679dfd7b7a32" xlink:href="jnj-20200927.xsd#jnj_VerbSurgicalInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4502b14b-8ad1-4aeb-b40b-2d73ee886ff3" xlink:to="loc_jnj_VerbSurgicalInc.Member_347a15da-a438-4b79-8ad8-679dfd7b7a32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AurisHealthMember_35c1e169-ff0b-4a4c-b709-a265a743cef4" xlink:href="jnj-20200927.xsd#jnj_AurisHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4502b14b-8ad1-4aeb-b40b-2d73ee886ff3" xlink:to="loc_jnj_AurisHealthMember_35c1e169-ff0b-4a4c-b709-a265a743cef4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CizHoldingsCo.Ltd.Member_aa920e37-7611-4ad6-9fa2-6f673856fa13" xlink:href="jnj-20200927.xsd#jnj_CizHoldingsCo.Ltd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4502b14b-8ad1-4aeb-b40b-2d73ee886ff3" xlink:to="loc_jnj_CizHoldingsCo.Ltd.Member_aa920e37-7611-4ad6-9fa2-6f673856fa13" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MomentaMember_2f921c41-afc9-418c-9a92-455e1b764d1a" xlink:href="jnj-20200927.xsd#jnj_MomentaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4502b14b-8ad1-4aeb-b40b-2d73ee886ff3" xlink:to="loc_jnj_MomentaMember_2f921c41-afc9-418c-9a92-455e1b764d1a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_46dabebc-fe21-4327-a982-9575e5505373" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_46dabebc-fe21-4327-a982-9575e5505373" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_46dabebc-fe21-4327-a982-9575e5505373_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_46dabebc-fe21-4327-a982-9575e5505373" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_46dabebc-fe21-4327-a982-9575e5505373_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a2004f91-6533-45ce-9d0f-1db500723240" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_46dabebc-fe21-4327-a982-9575e5505373" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a2004f91-6533-45ce-9d0f-1db500723240" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_e5ee038e-e7b8-44c4-a6a8-fdcb23134c1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a2004f91-6533-45ce-9d0f-1db500723240" xlink:to="loc_us-gaap_ConvertibleDebtMember_e5ee038e-e7b8-44c4-a6a8-fdcb23134c1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_25dcd922-e412-46fa-9879-458da7a3b7b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a2004f91-6533-45ce-9d0f-1db500723240" xlink:to="loc_us-gaap_LineOfCreditMember_25dcd922-e412-46fa-9879-458da7a3b7b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4baacbb7-6399-48ad-923e-8c907125db90" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_CreditFacilityAxis_4baacbb7-6399-48ad-923e-8c907125db90" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4baacbb7-6399-48ad-923e-8c907125db90_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_4baacbb7-6399-48ad-923e-8c907125db90" xlink:to="loc_us-gaap_CreditFacilityDomain_4baacbb7-6399-48ad-923e-8c907125db90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a5bc0b33-ffb2-464b-baf4-ea9b48e6820f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_4baacbb7-6399-48ad-923e-8c907125db90" xlink:to="loc_us-gaap_CreditFacilityDomain_a5bc0b33-ffb2-464b-baf4-ea9b48e6820f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_13f34516-4538-4d60-a5ac-6622452d0b52" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a5bc0b33-ffb2-464b-baf4-ea9b48e6820f" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_13f34516-4538-4d60-a5ac-6622452d0b52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_dc2f674d-e6cc-4427-99ab-45e7118188fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_dc2f674d-e6cc-4427-99ab-45e7118188fd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_dc2f674d-e6cc-4427-99ab-45e7118188fd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_dc2f674d-e6cc-4427-99ab-45e7118188fd" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_dc2f674d-e6cc-4427-99ab-45e7118188fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_7a48a489-5754-4950-9387-19a3d8b73467" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_dc2f674d-e6cc-4427-99ab-45e7118188fd" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_7a48a489-5754-4950-9387-19a3d8b73467" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IdorsiaLTDMember_6edf82e9-c6f6-4b90-b769-e39f5724673e" xlink:href="jnj-20200927.xsd#jnj_IdorsiaLTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_7a48a489-5754-4950-9387-19a3d8b73467" xlink:to="loc_jnj_IdorsiaLTDMember_6edf82e9-c6f6-4b90-b769-e39f5724673e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_98690ba5-c5b1-4b84-90bc-a73f0f4a0e2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_98690ba5-c5b1-4b84-90bc-a73f0f4a0e2c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_98690ba5-c5b1-4b84-90bc-a73f0f4a0e2c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_98690ba5-c5b1-4b84-90bc-a73f0f4a0e2c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_98690ba5-c5b1-4b84-90bc-a73f0f4a0e2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e4eb3129-f242-4929-9e3f-9cf455827932" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_98690ba5-c5b1-4b84-90bc-a73f0f4a0e2c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e4eb3129-f242-4929-9e3f-9cf455827932" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_34900e96-45a2-4c9f-b4ad-db01b9ca2f6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e4eb3129-f242-4929-9e3f-9cf455827932" xlink:to="loc_us-gaap_SubsequentEventMember_34900e96-45a2-4c9f-b4ad-db01b9ca2f6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_419ff33e-a289-4696-8451-1bcc4965f7dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_419ff33e-a289-4696-8451-1bcc4965f7dc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_419ff33e-a289-4696-8451-1bcc4965f7dc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_419ff33e-a289-4696-8451-1bcc4965f7dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_419ff33e-a289-4696-8451-1bcc4965f7dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03517ab6-cd30-443b-9ee0-cff4453b2353" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_419ff33e-a289-4696-8451-1bcc4965f7dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03517ab6-cd30-443b-9ee0-cff4453b2353" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_4ac3b67a-c84c-4af1-877a-7aded7314ad0" xlink:href="jnj-20200927.xsd#jnj_PurchasedInProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03517ab6-cd30-443b-9ee0-cff4453b2353" xlink:to="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_4ac3b67a-c84c-4af1-877a-7aded7314ad0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/LegalProceedings" xlink:type="simple" xlink:href="jnj-20200927.xsd#LegalProceedings"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/LegalProceedings" xlink:type="extended" id="icfa572aa434b4a4183241ca7c9872500_LegalProceedings"/>
  <link:roleRef roleURI="http://www.jnj.com/role/LegalProceedingsDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#LegalProceedingsDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/LegalProceedingsDetails" xlink:type="extended" id="i3e42a76f692149d8a6d647184c6f30bb_LegalProceedingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_07887ec4-8469-4a2d-ae44-6a987121dcfc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LegalProceedingTextualsAbstract_3ef5f4ef-bf84-4354-9722-446772908cd6" xlink:href="jnj-20200927.xsd#jnj_LegalProceedingTextualsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_07887ec4-8469-4a2d-ae44-6a987121dcfc" xlink:to="loc_jnj_LegalProceedingTextualsAbstract_3ef5f4ef-bf84-4354-9722-446772908cd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ProductLiabilityContingencyNumberOfClaimant_98d34ad6-7f07-49ba-ac94-6181d5caba54" xlink:href="jnj-20200927.xsd#jnj_ProductLiabilityContingencyNumberOfClaimant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_3ef5f4ef-bf84-4354-9722-446772908cd6" xlink:to="loc_jnj_ProductLiabilityContingencyNumberOfClaimant_98d34ad6-7f07-49ba-ac94-6181d5caba54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Numberofpatientsinsettlement_d0838d26-1968-49d8-8677-8c16c78751c2" xlink:href="jnj-20200927.xsd#jnj_Numberofpatientsinsettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_3ef5f4ef-bf84-4354-9722-446772908cd6" xlink:to="loc_jnj_Numberofpatientsinsettlement_d0838d26-1968-49d8-8677-8c16c78751c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_12f0ba6f-aee4-4c60-bac4-7587ec019196" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_3ef5f4ef-bf84-4354-9722-446772908cd6" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_12f0ba6f-aee4-4c60-bac4-7587ec019196" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue_449a6129-f384-4249-9cb3-4db6ea2273e5" xlink:href="jnj-20200927.xsd#jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_3ef5f4ef-bf84-4354-9722-446772908cd6" xlink:to="loc_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue_449a6129-f384-4249-9cb3-4db6ea2273e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_71e20e78-6309-4811-9cb4-7f248eacc3ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_3ef5f4ef-bf84-4354-9722-446772908cd6" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_71e20e78-6309-4811-9cb4-7f248eacc3ee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LossContingencyEstimateOfAdditionalPossibleLoss_4b6c771a-291e-41f4-8747-8a0181be1489" xlink:href="jnj-20200927.xsd#jnj_LossContingencyEstimateOfAdditionalPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_3ef5f4ef-bf84-4354-9722-446772908cd6" xlink:to="loc_jnj_LossContingencyEstimateOfAdditionalPossibleLoss_4b6c771a-291e-41f4-8747-8a0181be1489" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8fadc69a-2daf-4e51-9ecb-97eaa8e157c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_07887ec4-8469-4a2d-ae44-6a987121dcfc" xlink:to="loc_us-gaap_LossContingenciesTable_8fadc69a-2daf-4e51-9ecb-97eaa8e157c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_0db71c43-7554-482d-ac9e-b90825214eb0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8fadc69a-2daf-4e51-9ecb-97eaa8e157c5" xlink:to="loc_srt_LitigationCaseAxis_0db71c43-7554-482d-ac9e-b90825214eb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_0db71c43-7554-482d-ac9e-b90825214eb0_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_0db71c43-7554-482d-ac9e-b90825214eb0" xlink:to="loc_srt_LitigationCaseTypeDomain_0db71c43-7554-482d-ac9e-b90825214eb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_4eba9c36-5eae-4c7b-9223-471282fcc823" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_0db71c43-7554-482d-ac9e-b90825214eb0" xlink:to="loc_srt_LitigationCaseTypeDomain_4eba9c36-5eae-4c7b-9223-471282fcc823" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DePuyASRU.S.Member_97f80214-6418-489e-b84c-46df89e28794" xlink:href="jnj-20200927.xsd#jnj_DePuyASRU.S.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_4eba9c36-5eae-4c7b-9223-471282fcc823" xlink:to="loc_jnj_DePuyASRU.S.Member_97f80214-6418-489e-b84c-46df89e28794" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RisperdalMember_984df9d2-6bc9-48e1-a701-43c594d25036" xlink:href="jnj-20200927.xsd#jnj_RisperdalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_4eba9c36-5eae-4c7b-9223-471282fcc823" xlink:to="loc_jnj_RisperdalMember_984df9d2-6bc9-48e1-a701-43c594d25036" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BabyPowderMember_ab293c2f-7517-445c-908e-d2c269c43d57" xlink:href="jnj-20200927.xsd#jnj_BabyPowderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_4eba9c36-5eae-4c7b-9223-471282fcc823" xlink:to="loc_jnj_BabyPowderMember_ab293c2f-7517-445c-908e-d2c269c43d57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember_de2cb9b5-e082-4870-bed1-a40ebfbd592e" xlink:href="jnj-20200927.xsd#jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_4eba9c36-5eae-4c7b-9223-471282fcc823" xlink:to="loc_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember_de2cb9b5-e082-4870-bed1-a40ebfbd592e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_fea4a04f-7194-4536-aae1-b00a555ad3c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8fadc69a-2daf-4e51-9ecb-97eaa8e157c5" xlink:to="loc_us-gaap_LitigationStatusAxis_fea4a04f-7194-4536-aae1-b00a555ad3c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_fea4a04f-7194-4536-aae1-b00a555ad3c1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_fea4a04f-7194-4536-aae1-b00a555ad3c1" xlink:to="loc_us-gaap_LitigationStatusDomain_fea4a04f-7194-4536-aae1-b00a555ad3c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_580f91f9-c046-444f-8b59-d348b82cbd4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_fea4a04f-7194-4536-aae1-b00a555ad3c1" xlink:to="loc_us-gaap_LitigationStatusDomain_580f91f9-c046-444f-8b59-d348b82cbd4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_01dd1a6c-fb73-472c-998c-27490a2cfbcd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_580f91f9-c046-444f-8b59-d348b82cbd4f" xlink:to="loc_us-gaap_SettledLitigationMember_01dd1a6c-fb73-472c-998c-27490a2cfbcd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_JudicialRulingMember_67107b41-15f0-4f85-9d2e-e80e1903468e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_JudicialRulingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_580f91f9-c046-444f-8b59-d348b82cbd4f" xlink:to="loc_us-gaap_JudicialRulingMember_67107b41-15f0-4f85-9d2e-e80e1903468e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_878dc93e-604e-4760-9dd0-afdc15a61097" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_580f91f9-c046-444f-8b59-d348b82cbd4f" xlink:to="loc_us-gaap_PendingLitigationMember_878dc93e-604e-4760-9dd0-afdc15a61097" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b59780de-ab7b-47f4-8c2c-8386c8b47bfc" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8fadc69a-2daf-4e51-9ecb-97eaa8e157c5" xlink:to="loc_srt_ProductOrServiceAxis_b59780de-ab7b-47f4-8c2c-8386c8b47bfc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b59780de-ab7b-47f4-8c2c-8386c8b47bfc_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b59780de-ab7b-47f4-8c2c-8386c8b47bfc" xlink:to="loc_srt_ProductsAndServicesDomain_b59780de-ab7b-47f4-8c2c-8386c8b47bfc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b59780de-ab7b-47f4-8c2c-8386c8b47bfc" xlink:to="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AsrMember_4d76e34e-abb8-458c-a06b-bd8e3d2c4048" xlink:href="jnj-20200927.xsd#jnj_AsrMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:to="loc_jnj_AsrMember_4d76e34e-abb8-458c-a06b-bd8e3d2c4048" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PinnacleAcetabularCupSystemMember_193764bd-f344-429b-9ae1-e0c79bcffdc7" xlink:href="jnj-20200927.xsd#jnj_PinnacleAcetabularCupSystemMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:to="loc_jnj_PinnacleAcetabularCupSystemMember_193764bd-f344-429b-9ae1-e0c79bcffdc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PelvicMeshesMember_157a1a6c-1c41-42fa-9f9a-6c029a8a264d" xlink:href="jnj-20200927.xsd#jnj_PelvicMeshesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:to="loc_jnj_PelvicMeshesMember_157a1a6c-1c41-42fa-9f9a-6c029a8a264d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RisperdalMember_90249c4c-2810-4e9d-9567-485735ee54d3" xlink:href="jnj-20200927.xsd#jnj_RisperdalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:to="loc_jnj_RisperdalMember_90249c4c-2810-4e9d-9567-485735ee54d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_XareltoMember_d073926a-8eb6-4dc0-8425-362eef1e139e" xlink:href="jnj-20200927.xsd#jnj_XareltoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:to="loc_jnj_XareltoMember_d073926a-8eb6-4dc0-8425-362eef1e139e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_TalcMember_88180d05-a3a1-4f88-8466-22d71aefc00f" xlink:href="jnj-20200927.xsd#jnj_TalcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:to="loc_jnj_TalcMember_88180d05-a3a1-4f88-8466-22d71aefc00f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InvokanaMember_21058f74-9c75-49ac-90bb-d7a7c8aa77e7" xlink:href="jnj-20200927.xsd#jnj_InvokanaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:to="loc_jnj_InvokanaMember_21058f74-9c75-49ac-90bb-d7a7c8aa77e7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PhysiomeshMember_485101d7-efea-4cf9-a855-1ad71aaa6418" xlink:href="jnj-20200927.xsd#jnj_PhysiomeshMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:to="loc_jnj_PhysiomeshMember_485101d7-efea-4cf9-a855-1ad71aaa6418" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OpioidMember_a930bf72-fdc0-4709-b8c6-051a9d0243ca" xlink:href="jnj-20200927.xsd#jnj_OpioidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:to="loc_jnj_OpioidMember_a930bf72-fdc0-4709-b8c6-051a9d0243ca" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LitigationSettlementByCompaniesAxis_081d8387-0c0e-461d-a619-8fc02bbea3fd" xlink:href="jnj-20200927.xsd#jnj_LitigationSettlementByCompaniesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8fadc69a-2daf-4e51-9ecb-97eaa8e157c5" xlink:to="loc_jnj_LitigationSettlementByCompaniesAxis_081d8387-0c0e-461d-a619-8fc02bbea3fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LitigationSettlementByCompaniesDomain_081d8387-0c0e-461d-a619-8fc02bbea3fd_default" xlink:href="jnj-20200927.xsd#jnj_LitigationSettlementByCompaniesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_jnj_LitigationSettlementByCompaniesAxis_081d8387-0c0e-461d-a619-8fc02bbea3fd" xlink:to="loc_jnj_LitigationSettlementByCompaniesDomain_081d8387-0c0e-461d-a619-8fc02bbea3fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LitigationSettlementByCompaniesDomain_de73685d-e529-4fdf-bacb-adbafdd7acaf" xlink:href="jnj-20200927.xsd#jnj_LitigationSettlementByCompaniesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_jnj_LitigationSettlementByCompaniesAxis_081d8387-0c0e-461d-a619-8fc02bbea3fd" xlink:to="loc_jnj_LitigationSettlementByCompaniesDomain_de73685d-e529-4fdf-bacb-adbafdd7acaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RisperdalMember_f543a173-775b-454a-8ccf-e4f57ba3ab11" xlink:href="jnj-20200927.xsd#jnj_RisperdalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_LitigationSettlementByCompaniesDomain_de73685d-e529-4fdf-bacb-adbafdd7acaf" xlink:to="loc_jnj_RisperdalMember_f543a173-775b-454a-8ccf-e4f57ba3ab11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b92340fb-7215-4690-bd47-6435ce5e6d98" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_8fadc69a-2daf-4e51-9ecb-97eaa8e157c5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b92340fb-7215-4690-bd47-6435ce5e6d98" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b92340fb-7215-4690-bd47-6435ce5e6d98_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b92340fb-7215-4690-bd47-6435ce5e6d98" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b92340fb-7215-4690-bd47-6435ce5e6d98_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c9d1f13c-881f-40f5-8e16-d546ef604d67" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b92340fb-7215-4690-bd47-6435ce5e6d98" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c9d1f13c-881f-40f5-8e16-d546ef604d67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_41c5d9e9-b23e-4be9-9802-b5e43a47a50c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c9d1f13c-881f-40f5-8e16-d546ef604d67" xlink:to="loc_us-gaap_SubsequentEventMember_41c5d9e9-b23e-4be9-9802-b5e43a47a50c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/Restructuring" xlink:type="simple" xlink:href="jnj-20200927.xsd#Restructuring"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/Restructuring" xlink:type="extended" id="i4b28329884b3490fb6e4f7aee20f6e5b_Restructuring"/>
  <link:roleRef roleURI="http://www.jnj.com/role/RestructuringTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#RestructuringTables"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/RestructuringTables" xlink:type="extended" id="ia0befd9b28a144068cbfd805135fd63e_RestructuringTables"/>
  <link:roleRef roleURI="http://www.jnj.com/role/RestructuringNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#RestructuringNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/RestructuringNarrativeDetails" xlink:type="extended" id="id3bf77af8ea743fa990d4f5b28bab9f8_RestructuringNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_2df0d92d-28bc-4583-b4b0-a38aa67c9ff5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c99a7ab0-4e7a-4b91-a617-8b907b05e59e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2df0d92d-28bc-4583-b4b0-a38aa67c9ff5" xlink:to="loc_us-gaap_RestructuringCharges_c99a7ab0-4e7a-4b91-a617-8b907b05e59e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_3a07e1af-d28f-408c-b4ea-1a68f3939e84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2df0d92d-28bc-4583-b4b0-a38aa67c9ff5" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_3a07e1af-d28f-408c-b4ea-1a68f3939e84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_3aa4140e-8a8a-4ce3-99db-32429a18a5c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2df0d92d-28bc-4583-b4b0-a38aa67c9ff5" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_3aa4140e-8a8a-4ce3-99db-32429a18a5c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RestructuringandRelatedCostExpectedFutureSavings_dbfc5ea7-4b00-4f0e-96d9-264bd93b9fc4" xlink:href="jnj-20200927.xsd#jnj_RestructuringandRelatedCostExpectedFutureSavings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2df0d92d-28bc-4583-b4b0-a38aa67c9ff5" xlink:to="loc_jnj_RestructuringandRelatedCostExpectedFutureSavings_dbfc5ea7-4b00-4f0e-96d9-264bd93b9fc4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RestructuringandRelatedCostDurationofRestructuringPlan_ec528149-f76c-4876-a20e-14ebb874768c" xlink:href="jnj-20200927.xsd#jnj_RestructuringandRelatedCostDurationofRestructuringPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2df0d92d-28bc-4583-b4b0-a38aa67c9ff5" xlink:to="loc_jnj_RestructuringandRelatedCostDurationofRestructuringPlan_ec528149-f76c-4876-a20e-14ebb874768c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76dd166c-0750-44d9-8461-9f56b51a8d5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2df0d92d-28bc-4583-b4b0-a38aa67c9ff5" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76dd166c-0750-44d9-8461-9f56b51a8d5b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_04b63a37-1e2f-4408-a434-772c5680ba43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76dd166c-0750-44d9-8461-9f56b51a8d5b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_04b63a37-1e2f-4408-a434-772c5680ba43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_04b63a37-1e2f-4408-a434-772c5680ba43_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_04b63a37-1e2f-4408-a434-772c5680ba43" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_04b63a37-1e2f-4408-a434-772c5680ba43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4685cf57-9fe9-4717-af23-0efa6d77e32c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_04b63a37-1e2f-4408-a434-772c5680ba43" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4685cf57-9fe9-4717-af23-0efa6d77e32c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SupplyChainMember_3aa2fdd5-3037-4b46-aafa-66c8170c1af4" xlink:href="jnj-20200927.xsd#jnj_SupplyChainMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4685cf57-9fe9-4717-af23-0efa6d77e32c" xlink:to="loc_jnj_SupplyChainMember_3aa2fdd5-3037-4b46-aafa-66c8170c1af4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_70d44dd9-89f9-4a8f-8d83-79698b5bbf91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76dd166c-0750-44d9-8461-9f56b51a8d5b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_70d44dd9-89f9-4a8f-8d83-79698b5bbf91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_70d44dd9-89f9-4a8f-8d83-79698b5bbf91_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_70d44dd9-89f9-4a8f-8d83-79698b5bbf91" xlink:to="loc_us-gaap_SegmentDomain_70d44dd9-89f9-4a8f-8d83-79698b5bbf91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a1871d6c-e4a7-4802-a5f3-5eff2e5e727a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_70d44dd9-89f9-4a8f-8d83-79698b5bbf91" xlink:to="loc_us-gaap_SegmentDomain_a1871d6c-e4a7-4802-a5f3-5eff2e5e727a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_5139ef12-0508-45e8-9bdc-0066d1edbe0b" xlink:href="jnj-20200927.xsd#jnj_MedicalDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a1871d6c-e4a7-4802-a5f3-5eff2e5e727a" xlink:to="loc_jnj_MedicalDevicesMember_5139ef12-0508-45e8-9bdc-0066d1edbe0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_dadd26ce-c447-4eec-8564-7092aa4c7e66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76dd166c-0750-44d9-8461-9f56b51a8d5b" xlink:to="loc_us-gaap_RestructuringPlanAxis_dadd26ce-c447-4eec-8564-7092aa4c7e66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_dadd26ce-c447-4eec-8564-7092aa4c7e66_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_dadd26ce-c447-4eec-8564-7092aa4c7e66" xlink:to="loc_us-gaap_RestructuringPlanDomain_dadd26ce-c447-4eec-8564-7092aa4c7e66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_840a3929-97d7-40a4-9cae-e6a08f374a2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_dadd26ce-c447-4eec-8564-7092aa4c7e66" xlink:to="loc_us-gaap_RestructuringPlanDomain_840a3929-97d7-40a4-9cae-e6a08f374a2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SupplyChainMember_7c682773-da6a-49b8-ad9a-a7794874e5fe" xlink:href="jnj-20200927.xsd#jnj_SupplyChainMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_840a3929-97d7-40a4-9cae-e6a08f374a2c" xlink:to="loc_jnj_SupplyChainMember_7c682773-da6a-49b8-ad9a-a7794874e5fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_9b183e60-b3c5-4785-af17-1b659db32990" xlink:href="jnj-20200927.xsd#jnj_MedicalDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_840a3929-97d7-40a4-9cae-e6a08f374a2c" xlink:to="loc_jnj_MedicalDevicesMember_9b183e60-b3c5-4785-af17-1b659db32990" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_71af02cd-ba63-40b4-8383-75b6a1753cf0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76dd166c-0750-44d9-8461-9f56b51a8d5b" xlink:to="loc_srt_RangeAxis_71af02cd-ba63-40b4-8383-75b6a1753cf0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_71af02cd-ba63-40b4-8383-75b6a1753cf0_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_71af02cd-ba63-40b4-8383-75b6a1753cf0" xlink:to="loc_srt_RangeMember_71af02cd-ba63-40b4-8383-75b6a1753cf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_370186f1-fa74-401d-bff9-55aa1bc6e4b4" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_71af02cd-ba63-40b4-8383-75b6a1753cf0" xlink:to="loc_srt_RangeMember_370186f1-fa74-401d-bff9-55aa1bc6e4b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9ad4d81f-31f8-4aca-bbb7-c00f45e6b0f1" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_370186f1-fa74-401d-bff9-55aa1bc6e4b4" xlink:to="loc_srt_MinimumMember_9ad4d81f-31f8-4aca-bbb7-c00f45e6b0f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_23cc102e-f98f-4a47-9358-f05fee2e256b" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_370186f1-fa74-401d-bff9-55aa1bc6e4b4" xlink:to="loc_srt_MaximumMember_23cc102e-f98f-4a47-9358-f05fee2e256b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9373a375-9f13-48d8-8758-933fea70b35e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76dd166c-0750-44d9-8461-9f56b51a8d5b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9373a375-9f13-48d8-8758-933fea70b35e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9373a375-9f13-48d8-8758-933fea70b35e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9373a375-9f13-48d8-8758-933fea70b35e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9373a375-9f13-48d8-8758-933fea70b35e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_156a0381-fa75-45a2-91ef-e930add349f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9373a375-9f13-48d8-8758-933fea70b35e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_156a0381-fa75-45a2-91ef-e930add349f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_ee356ae2-48db-457d-a68b-3a5958c02bf7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_156a0381-fa75-45a2-91ef-e930add349f8" xlink:to="loc_us-gaap_RestructuringChargesMember_ee356ae2-48db-457d-a68b-3a5958c02bf7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_9d41aef4-b6c4-44ea-ace4-73fd8f731ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_156a0381-fa75-45a2-91ef-e930add349f8" xlink:to="loc_us-gaap_CostOfSalesMember_9d41aef4-b6c4-44ea-ace4-73fd8f731ec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_38d1814e-4372-4af2-a675-422de52f3587" xlink:href="jnj-20200927.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_156a0381-fa75-45a2-91ef-e930add349f8" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_38d1814e-4372-4af2-a675-422de52f3587" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#RestructuringScheduleofRestructuringReserveDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails" xlink:type="extended" id="i32caf6649cc5476aa800603f7dad962f_RestructuringScheduleofRestructuringReserveDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_e11b4dad-9272-472e-9c2f-1316d870288c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_70a6bbdf-f013-40de-94bd-7bddfb81d4ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e11b4dad-9272-472e-9c2f-1316d870288c" xlink:to="loc_us-gaap_RestructuringReserveRollForward_70a6bbdf-f013-40de-94bd-7bddfb81d4ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_74ae618b-aefa-4708-864d-97fddc57b042" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_70a6bbdf-f013-40de-94bd-7bddfb81d4ba" xlink:to="loc_us-gaap_RestructuringReserve_74ae618b-aefa-4708-864d-97fddc57b042" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_8981926b-cf4d-4dcf-aabc-89e06194b4b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_70a6bbdf-f013-40de-94bd-7bddfb81d4ba" xlink:to="loc_us-gaap_RestructuringCharges_8981926b-cf4d-4dcf-aabc-89e06194b4b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_4e19fcb1-114a-4c43-954b-51961d5672fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_70a6bbdf-f013-40de-94bd-7bddfb81d4ba" xlink:to="loc_us-gaap_PaymentsForRestructuring_4e19fcb1-114a-4c43-954b-51961d5672fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_84005d09-efa8-4907-837b-645c5475b053" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_70a6bbdf-f013-40de-94bd-7bddfb81d4ba" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_84005d09-efa8-4907-837b-645c5475b053" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_4417caac-39fa-40a5-8628-801508d27a5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid_855ea31a-dc18-49bf-8e6f-4f89115e9407" xlink:href="jnj-20200927.xsd#jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e11b4dad-9272-472e-9c2f-1316d870288c" xlink:to="loc_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid_855ea31a-dc18-49bf-8e6f-4f89115e9407" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee232807-7741-4265-a635-826e85154803" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e11b4dad-9272-472e-9c2f-1316d870288c" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee232807-7741-4265-a635-826e85154803" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_519fe635-7268-4052-b2a5-0f2677f84af3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee232807-7741-4265-a635-826e85154803" xlink:to="loc_us-gaap_RestructuringPlanAxis_519fe635-7268-4052-b2a5-0f2677f84af3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_519fe635-7268-4052-b2a5-0f2677f84af3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_519fe635-7268-4052-b2a5-0f2677f84af3" xlink:to="loc_us-gaap_RestructuringPlanDomain_519fe635-7268-4052-b2a5-0f2677f84af3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_597204f9-e844-4726-96bd-d937c4e5cd05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_519fe635-7268-4052-b2a5-0f2677f84af3" xlink:to="loc_us-gaap_RestructuringPlanDomain_597204f9-e844-4726-96bd-d937c4e5cd05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_1c049a3e-f891-4e7c-a6c5-494c050ddfb6" xlink:href="jnj-20200927.xsd#jnj_MedicalDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_597204f9-e844-4726-96bd-d937c4e5cd05" xlink:to="loc_jnj_MedicalDevicesMember_1c049a3e-f891-4e7c-a6c5-494c050ddfb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_e2f40bc6-ae76-4d75-94a7-561ec6170fb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee232807-7741-4265-a635-826e85154803" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_e2f40bc6-ae76-4d75-94a7-561ec6170fb8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_e2f40bc6-ae76-4d75-94a7-561ec6170fb8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_e2f40bc6-ae76-4d75-94a7-561ec6170fb8" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_e2f40bc6-ae76-4d75-94a7-561ec6170fb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_c67f4c15-ed8a-4156-b143-074a9402265b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_e2f40bc6-ae76-4d75-94a7-561ec6170fb8" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_c67f4c15-ed8a-4156-b143-074a9402265b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_7fb15557-cc5a-49f3-a123-c682bbde9c1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c67f4c15-ed8a-4156-b143-074a9402265b" xlink:to="loc_us-gaap_EmployeeSeveranceMember_7fb15557-cc5a-49f3-a123-c682bbde9c1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AssetWriteoffMember_2f58b2e3-48f4-4d4f-bc8d-cda1fa386fa4" xlink:href="jnj-20200927.xsd#jnj_AssetWriteoffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c67f4c15-ed8a-4156-b143-074a9402265b" xlink:to="loc_jnj_AssetWriteoffMember_2f58b2e3-48f4-4d4f-bc8d-cda1fa386fa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_a1cc7a54-6ee2-4aaf-9433-e6d6db2ca778" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c67f4c15-ed8a-4156-b143-074a9402265b" xlink:to="loc_us-gaap_OtherRestructuringMember_a1cc7a54-6ee2-4aaf-9433-e6d6db2ca778" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>jnj-20200927_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:fc2d7a08-4b3d-4935-bed1-d6009b2c298f,g:489318f6-0cc0-48fd-9e8b-f08139bc7aae-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b48aca71-01f2-4ab5-ba96-24ca369ee532_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_10f6b616-bdf3-4fd7-b6ed-50e217072e49_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_074a1753-96d6-41fb-b667-d7795d84c0d9_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_87c2bc29-76fe-4fb5-870e-2d0c5f29add4_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant unobservable inputs Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember_9f2dacf7-e1d5-4145-90dd-de0e7862e977_terseLabel_en-US" xlink:label="lab_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oklahoma Attorney General vs. Johnson &amp; Johnson and JPI</link:label>
    <link:label id="lab_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember_label_en-US" xlink:label="lab_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oklahoma Attorney General VS. Johnson And Johnson And JPI [Member]</link:label>
    <link:label id="lab_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember_documentation_en-US" xlink:label="lab_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oklahoma Attorney General VS. Johnson And Johnson And JPI [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember" xlink:href="jnj-20200927.xsd#jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember" xlink:to="lab_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_BabyPowderMember_530a7cb3-e0e4-4774-aa8d-0fedba37a5b2_terseLabel_en-US" xlink:label="lab_jnj_BabyPowderMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baby Powder</link:label>
    <link:label id="lab_jnj_BabyPowderMember_label_en-US" xlink:label="lab_jnj_BabyPowderMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baby Powder [Member]</link:label>
    <link:label id="lab_jnj_BabyPowderMember_documentation_en-US" xlink:label="lab_jnj_BabyPowderMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baby Powder [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BabyPowderMember" xlink:href="jnj-20200927.xsd#jnj_BabyPowderMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_BabyPowderMember" xlink:to="lab_jnj_BabyPowderMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_641743bf-c3d1-4257-864b-6c9a7b694f12_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration reversal</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b70492ce-f9ca-4fa0-aea3-8d2037ad0ccf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_3c996e0b-3e4f-4a86-9d15-1a8f9ede4897_negatedTerseLabel_en-US" xlink:label="lab_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of contingent consideration</link:label>
    <link:label id="lab_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_22d5ff18-ec19-4bae-bbd0-7d497a069357_terseLabel_en-US" xlink:label="lab_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in estimated fair value (7)</link:label>
    <link:label id="lab_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_label_en-US" xlink:label="lab_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Change In Estimated Fair Value</link:label>
    <link:label id="lab_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_documentation_en-US" xlink:label="lab_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Change In Estimated Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" xlink:href="jnj-20200927.xsd#jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" xlink:to="lab_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_4ad8850f-daf9-436d-9b52-70c745c5c2ce_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_4c9eb6bb-9130-4668-b083-d4e97c814eec_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_RestructuringandRelatedCostDurationofRestructuringPlan_f946c3a1-da2a-42bc-86d3-42b12145407f_terseLabel_en-US" xlink:label="lab_jnj_RestructuringandRelatedCostDurationofRestructuringPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period for activity</link:label>
    <link:label id="lab_jnj_RestructuringandRelatedCostDurationofRestructuringPlan_label_en-US" xlink:label="lab_jnj_RestructuringandRelatedCostDurationofRestructuringPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Duration of Restructuring Plan</link:label>
    <link:label id="lab_jnj_RestructuringandRelatedCostDurationofRestructuringPlan_documentation_en-US" xlink:label="lab_jnj_RestructuringandRelatedCostDurationofRestructuringPlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Duration of Restructuring Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RestructuringandRelatedCostDurationofRestructuringPlan" xlink:href="jnj-20200927.xsd#jnj_RestructuringandRelatedCostDurationofRestructuringPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_RestructuringandRelatedCostDurationofRestructuringPlan" xlink:to="lab_jnj_RestructuringandRelatedCostDurationofRestructuringPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_280434c8-0fc5-4c14-863c-ad36ea07c19a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ConsumerMember_34ec7617-859e-4c9e-be2a-745bd66a509b_terseLabel_en-US" xlink:label="lab_jnj_ConsumerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Health*</link:label>
    <link:label id="lab_jnj_ConsumerMember_label_en-US" xlink:label="lab_jnj_ConsumerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer [Member]</link:label>
    <link:label id="lab_jnj_ConsumerMember_documentation_en-US" xlink:label="lab_jnj_ConsumerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember" xlink:href="jnj-20200927.xsd#jnj_ConsumerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ConsumerMember" xlink:to="lab_jnj_ConsumerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_DARZALEXMember_8b1ef226-6122-4482-8ec0-f2c39ccc34a4_terseLabel_en-US" xlink:label="lab_jnj_DARZALEXMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DARZALEX&#174;</link:label>
    <link:label id="lab_jnj_DARZALEXMember_label_en-US" xlink:label="lab_jnj_DARZALEXMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DARZALEX [Member]</link:label>
    <link:label id="lab_jnj_DARZALEXMember_documentation_en-US" xlink:label="lab_jnj_DARZALEXMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DARZALEX [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DARZALEXMember" xlink:href="jnj-20200927.xsd#jnj_DARZALEXMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_DARZALEXMember" xlink:to="lab_jnj_DARZALEXMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_5f8f382b-5a37-4899-ba66-75d8f1f41672_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-to-maturity Securities - Carrying Amount</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecurities" xlink:to="lab_us-gaap_HeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_64babc69-3b8a-4332-acdb-ad453ab06037_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from divestiture of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SovereignDebtSecuritiesMember_30643c6e-a79e-4093-9683-d2f9a8b494fc_terseLabel_en-US" xlink:label="lab_us-gaap_SovereignDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. sovereign securities(1)</link:label>
    <link:label id="lab_us-gaap_SovereignDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_SovereignDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sovereign Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SovereignDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SovereignDebtSecuritiesMember" xlink:to="lab_us-gaap_SovereignDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_69271bf0-78a9-4e07-a7b1-88e45882f431_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_f05deed8-faa9-4309-a3ed-3c0389a5718b_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ADVANCEDMember_b77507ee-ff96-4eca-b425-bccfe2dda4a3_terseLabel_en-US" xlink:label="lab_jnj_ADVANCEDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADVANCED</link:label>
    <link:label id="lab_jnj_ADVANCEDMember_label_en-US" xlink:label="lab_jnj_ADVANCEDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADVANCED [Member]</link:label>
    <link:label id="lab_jnj_ADVANCEDMember_documentation_en-US" xlink:label="lab_jnj_ADVANCEDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADVANCED [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ADVANCEDMember" xlink:href="jnj-20200927.xsd#jnj_ADVANCEDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ADVANCEDMember" xlink:to="lab_jnj_ADVANCEDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_f6412411-b459-47cd-9089-aeb2cff8bfa5_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_c0058fe1-af3e-47c6-b31f-85395bff9664_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_b0ceee16-7eac-4223-81ae-e6f102e62654_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, related to acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_6249cc97-fd65-4b45-9e1c-a38f5ed20649_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_48d75982-400d-4645-9d08-673c0609ad54_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as hedging instruments : Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Assets, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_52c230ae-a4f8-441d-b75d-dbe9e2a0da7c_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PercentageChangeInOperatingIncomeLoss_ffd6adbe-ab55-416c-9817-7ac95b99940f_terseLabel_en-US" xlink:label="lab_jnj_PercentageChangeInOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Change in Operating Income Loss</link:label>
    <link:label id="lab_jnj_PercentageChangeInOperatingIncomeLoss_label_en-US" xlink:label="lab_jnj_PercentageChangeInOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Change in Operating Income Loss</link:label>
    <link:label id="lab_jnj_PercentageChangeInOperatingIncomeLoss_documentation_en-US" xlink:label="lab_jnj_PercentageChangeInOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage change in operating income loss.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInOperatingIncomeLoss" xlink:href="jnj-20200927.xsd#jnj_PercentageChangeInOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PercentageChangeInOperatingIncomeLoss" xlink:to="lab_jnj_PercentageChangeInOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2d2cee20-1fd4-4fad-bb3f-edfbe4946380_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards Recently Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_a966ef2c-f795-4b62-8b5a-5df5b64001e0_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_063c1593-68bc-4819-a5b0-0647840d2386_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_03c8a106-3935-4b7d-88fc-9500f967bb01_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_68875769-4844-45c3-a39d-2ca6dabbac3c_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_d90ccdee-4ae5-44a5-9341-8f2cd375c6f3_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_e9e3d8c9-00a1-4161-a2a6-b62078472052_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A3.75Notesdue2047Member_28eed46f-af29-48f3-9670-880c4a1ea0dd_terseLabel_en-US" xlink:label="lab_jnj_A3.75Notesdue2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% Notes due 2047</link:label>
    <link:label id="lab_jnj_A3.75Notesdue2047Member_label_en-US" xlink:label="lab_jnj_A3.75Notesdue2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% Notes due 2047 [Member]</link:label>
    <link:label id="lab_jnj_A3.75Notesdue2047Member_documentation_en-US" xlink:label="lab_jnj_A3.75Notesdue2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% Notes due 2047 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.75Notesdue2047Member" xlink:href="jnj-20200927.xsd#jnj_A3.75Notesdue2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A3.75Notesdue2047Member" xlink:to="lab_jnj_A3.75Notesdue2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_3077f321-2303-4198-a6a6-86967720cae6_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3ea9e7bb-bc4c-4a8a-a7b9-d1c798556bf9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7f017ef3-58ca-4997-883d-0cfb178592cf_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average shares outstanding &#8212; diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_91507139-cda4-4288-9912-e404516be21a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_3a65e45c-71d0-4ab9-91ce-74825efb92ad_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="lab_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_4cdef2ef-58c0-4f46-9ecd-15f98e02dfe4_verboseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_c67fb32a-2807-4cdf-95ce-bf746ec84831_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_CONTACTLENSESOTHERMember_2f9e4d03-4828-4c50-9221-49b143337c0e_terseLabel_en-US" xlink:label="lab_jnj_CONTACTLENSESOTHERMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTACT LENSES / OTHER</link:label>
    <link:label id="lab_jnj_CONTACTLENSESOTHERMember_label_en-US" xlink:label="lab_jnj_CONTACTLENSESOTHERMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTACT LENSES/OTHER [Member]</link:label>
    <link:label id="lab_jnj_CONTACTLENSESOTHERMember_documentation_en-US" xlink:label="lab_jnj_CONTACTLENSESOTHERMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTACT LENSES/OTHER [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CONTACTLENSESOTHERMember" xlink:href="jnj-20200927.xsd#jnj_CONTACTLENSESOTHERMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_CONTACTLENSESOTHERMember" xlink:to="lab_jnj_CONTACTLENSESOTHERMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_23142e4c-37bf-46d6-bc95-77c5be26cd06_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available for Sale Securities Maturities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fe3131da-865d-4c19-b622-2457ac352cfc_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss_03db12c3-7a5f-400f-92ef-6eeb849e979a_negatedTerseLabel_en-US" xlink:label="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and current marketable securities, Unrecognized Loss</link:label>
    <link:label id="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss_label_en-US" xlink:label="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, And Short-Term Investments, Accumulated Gross Unrealized Loss</link:label>
    <link:label id="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss_documentation_en-US" xlink:label="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, And Short-Term Investments, Accumulated Gross Unrealized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss" xlink:href="jnj-20200927.xsd#jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss" xlink:to="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod_3e0fd27c-93b2-4136-9fab-41ad0b06fad8_negatedTerseLabel_en-US" xlink:label="lab_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: shares which could be repurchased under treasury stock method</link:label>
    <link:label id="lab_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod_label_en-US" xlink:label="lab_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Which Could Be Repurchased Under Treasury Stock Method</link:label>
    <link:label id="lab_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod_documentation_en-US" xlink:label="lab_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock assumed to be purchased using the proceeds that could be obtained upon exercise of potential shares exercisable under stock option plans, at the average market price during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" xlink:href="jnj-20200927.xsd#jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" xlink:to="lab_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_3bef2f5f-c79a-4c88-a9c4-944c27e61f29_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_HIPSMember_bb2df35e-ef8f-46c3-b051-05aca4228bee_terseLabel_en-US" xlink:label="lab_jnj_HIPSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIPS</link:label>
    <link:label id="lab_jnj_HIPSMember_label_en-US" xlink:label="lab_jnj_HIPSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIPS [Member]</link:label>
    <link:label id="lab_jnj_HIPSMember_documentation_en-US" xlink:label="lab_jnj_HIPSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIPS [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_HIPSMember" xlink:href="jnj-20200927.xsd#jnj_HIPSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_HIPSMember" xlink:to="lab_jnj_HIPSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2923ef3d-77d3-47af-99eb-70103b5ea706_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_86f08e99-278c-45fc-9aae-13ed00225e5b_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_602f9bb9-663e-4a78-b2dc-73dd0b021ca4_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_666075c4-cfb2-482e-939d-69cb34edbb70_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward foreign exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_ff81aaf3-011a-4bac-a00b-47138d14f384_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_a0fc2d48-a8f2-477d-8fcb-99cd73065948_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives &amp; Hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_80b1b521-aef6-4ed1-a471-80552636779c_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_dafa4e0b-3fb1-473e-a42d-a840dff685cc_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_f4bbcad2-674e-4e26-8344-7ac6c01d6c7e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_cfe4d338-cc46-4bac-8cb8-cfac06e75bd8_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0d20a657-a22c-4a9f-855a-96c8c3ec8278_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities, Unrecognized Loss</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_281facf2-f469-4858-af4d-ea1efa6da8ad_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A1.650NotesDue2035Member_04dd039f-1026-48a7-97da-3088cf1a8b13_verboseLabel_en-US" xlink:label="lab_jnj_A1.650NotesDue2035Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.650% Notes Due May 2035</link:label>
    <link:label id="lab_jnj_A1.650NotesDue2035Member_47b17c6f-a51d-41a8-b574-4c970bf8d9f8_terseLabel_en-US" xlink:label="lab_jnj_A1.650NotesDue2035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.650% Notes due 2035 (1.5B Euro 1.1641)</link:label>
    <link:label id="lab_jnj_A1.650NotesDue2035Member_label_en-US" xlink:label="lab_jnj_A1.650NotesDue2035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.650% Notes Due 2035 [Member]</link:label>
    <link:label id="lab_jnj_A1.650NotesDue2035Member_documentation_en-US" xlink:label="lab_jnj_A1.650NotesDue2035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.650% Notes Due 2035 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.650NotesDue2035Member" xlink:href="jnj-20200927.xsd#jnj_A1.650NotesDue2035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A1.650NotesDue2035Member" xlink:to="lab_jnj_A1.650NotesDue2035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_79870478-d090-434f-bea3-bea978b3fb7d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_6d9b4d18-d3a9-4d5b-84d5-0ce161c02511_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_c4cb21f5-6a94-457d-bfa3-98646cb94ca2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_9f753eaa-3b4b-468d-a168-542c9bee8b2c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of basic net earnings per share to diluted net earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_12c53862-87db-400e-93a2-31d849c8e2fe_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_6ccddee6-a79c-4a45-9c92-ebd8a4cb5d15_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EquityInvestmentRollForward_0462a2f9-1b39-4b3c-9355-1b70d982d3e3_terseLabel_en-US" xlink:label="lab_jnj_EquityInvestmentRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investment [Roll Forward]</link:label>
    <link:label id="lab_jnj_EquityInvestmentRollForward_label_en-US" xlink:label="lab_jnj_EquityInvestmentRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investment [Roll Forward]</link:label>
    <link:label id="lab_jnj_EquityInvestmentRollForward_documentation_en-US" xlink:label="lab_jnj_EquityInvestmentRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investment [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentRollForward" xlink:href="jnj-20200927.xsd#jnj_EquityInvestmentRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EquityInvestmentRollForward" xlink:to="lab_jnj_EquityInvestmentRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_370192b4-535d-4b36-ae1d-09c3215035f6_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages awarded</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_4364a57e-4f9b-4216-a804-908549c0f642_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued taxes on income (Note 5)</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OTHERNEUROSCIENCEMember_555939e8-35b4-4a4a-af65-c9126c92ed98_terseLabel_en-US" xlink:label="lab_jnj_OTHERNEUROSCIENCEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER NEUROSCIENCE</link:label>
    <link:label id="lab_jnj_OTHERNEUROSCIENCEMember_label_en-US" xlink:label="lab_jnj_OTHERNEUROSCIENCEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER NEUROSCIENCE [Member]</link:label>
    <link:label id="lab_jnj_OTHERNEUROSCIENCEMember_documentation_en-US" xlink:label="lab_jnj_OTHERNEUROSCIENCEMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER NEUROSCIENCE [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OTHERNEUROSCIENCEMember" xlink:href="jnj-20200927.xsd#jnj_OTHERNEUROSCIENCEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OTHERNEUROSCIENCEMember" xlink:to="lab_jnj_OTHERNEUROSCIENCEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_c87282fa-523b-49c7-9bd9-09d68e17014d_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International retirement plans</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_0a5708d5-b678-4993-a526-2bb9cb1efa9e_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_49418d4e-a807-44d1-810d-34244bbe95aa_negatedLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of liabilities assumed and noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Value of Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_9c6ab3c3-7eb1-4a48-8613-1d101eabe7e7_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_96c2de58-64e7-4e02-8903-b70921037e55_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term taxes payable (Note 5)</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_f7301754-a6c6-48e3-a65d-f1d079bc34e5_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A130NotesDue2030Member_44260b5f-e71e-409a-89e0-5b67c69ff824_terseLabel_en-US" xlink:label="lab_jnj_A130NotesDue2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Notes due 2030</link:label>
    <link:label id="lab_jnj_A130NotesDue2030Member_label_en-US" xlink:label="lab_jnj_A130NotesDue2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Notes due 2030 [Member]</link:label>
    <link:label id="lab_jnj_A130NotesDue2030Member_documentation_en-US" xlink:label="lab_jnj_A130NotesDue2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.30% Notes due 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A130NotesDue2030Member" xlink:href="jnj-20200927.xsd#jnj_A130NotesDue2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A130NotesDue2030Member" xlink:to="lab_jnj_A130NotesDue2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_900d9580-5a3f-481d-801d-6bd7783880f1_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_Proceedsfromcreditsupportagreements_42a6e3fc-c0b0-4b91-98d9-2bea79aebb0b_terseLabel_en-US" xlink:label="lab_jnj_Proceedsfromcreditsupportagreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from credit support agreements, net</link:label>
    <link:label id="lab_jnj_Proceedsfromcreditsupportagreements_label_en-US" xlink:label="lab_jnj_Proceedsfromcreditsupportagreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from credit support agreements</link:label>
    <link:label id="lab_jnj_Proceedsfromcreditsupportagreements_documentation_en-US" xlink:label="lab_jnj_Proceedsfromcreditsupportagreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from credit support agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Proceedsfromcreditsupportagreements" xlink:href="jnj-20200927.xsd#jnj_Proceedsfromcreditsupportagreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_Proceedsfromcreditsupportagreements" xlink:to="lab_jnj_Proceedsfromcreditsupportagreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentDetailAbstract_20adafdf-a0e1-4a1c-8b10-27a47de6b63b_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentDetailAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial assets and liabilities at fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentDetailAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentDetailAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument Detail [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentDetailAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentDetailAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentDetailAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PhysiomeshMember_676bee51-e611-4817-9bbf-4c6a305cdd92_terseLabel_en-US" xlink:label="lab_jnj_PhysiomeshMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physiomesh</link:label>
    <link:label id="lab_jnj_PhysiomeshMember_label_en-US" xlink:label="lab_jnj_PhysiomeshMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physiomesh [Member]</link:label>
    <link:label id="lab_jnj_PhysiomeshMember_documentation_en-US" xlink:label="lab_jnj_PhysiomeshMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physiomesh [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PhysiomeshMember" xlink:href="jnj-20200927.xsd#jnj_PhysiomeshMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PhysiomeshMember" xlink:to="lab_jnj_PhysiomeshMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_089b75b5-e59c-4cee-9085-2d363da9fa8c_verboseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross currency interest rate swaps</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_0977ca9d-1ffe-493a-8ee2-dbd8fbf0f184_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A055NotesDue2025Member_7bdf22fc-b7d6-4aa6-9a7d-62321a50de53_terseLabel_en-US" xlink:label="lab_jnj_A055NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.55% Notes due 2025</link:label>
    <link:label id="lab_jnj_A055NotesDue2025Member_label_en-US" xlink:label="lab_jnj_A055NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.55% Notes due 2025 [Member]</link:label>
    <link:label id="lab_jnj_A055NotesDue2025Member_documentation_en-US" xlink:label="lab_jnj_A055NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.55% Notes due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A055NotesDue2025Member" xlink:href="jnj-20200927.xsd#jnj_A055NotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A055NotesDue2025Member" xlink:to="lab_jnj_A055NotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_Numberofpatientsinsettlement_8ed27d09-ffdc-430f-9877-1b601a730f5d_terseLabel_en-US" xlink:label="lab_jnj_Numberofpatientsinsettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patients in settlement</link:label>
    <link:label id="lab_jnj_Numberofpatientsinsettlement_label_en-US" xlink:label="lab_jnj_Numberofpatientsinsettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patients in settlement</link:label>
    <link:label id="lab_jnj_Numberofpatientsinsettlement_documentation_en-US" xlink:label="lab_jnj_Numberofpatientsinsettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patients in settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Numberofpatientsinsettlement" xlink:href="jnj-20200927.xsd#jnj_Numberofpatientsinsettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_Numberofpatientsinsettlement" xlink:to="lab_jnj_Numberofpatientsinsettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_2e10e350-9c57-4cb7-a7af-7b439a92fb09_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments of Business and Geographic Areas</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_6afd534e-fdbe-477e-a8d7-0672809bb7d7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableTable_f3122287-02cf-4d59-86f2-c8a9cc9448de_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable [Table]</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableTable_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable" xlink:to="lab_us-gaap_OtherInvestmentNotReadilyMarketableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationRevenueAbstract_c048dc48-bac2-4457-b04e-e64465b5954c_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales by segment of business</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Revenue for Reportable Segment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A6.95Notesdue2029Member_ed1fed21-968f-49af-8c8c-bbef5458a3b0_terseLabel_en-US" xlink:label="lab_jnj_A6.95Notesdue2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.95% Notes due 2029</link:label>
    <link:label id="lab_jnj_A6.95Notesdue2029Member_label_en-US" xlink:label="lab_jnj_A6.95Notesdue2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.95% Notes due 2029 [Member]</link:label>
    <link:label id="lab_jnj_A6.95Notesdue2029Member_documentation_en-US" xlink:label="lab_jnj_A6.95Notesdue2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.95% Notes due 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A6.95Notesdue2029Member" xlink:href="jnj-20200927.xsd#jnj_A6.95Notesdue2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A6.95Notesdue2029Member" xlink:to="lab_jnj_A6.95Notesdue2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_1aa839e8-87b4-4dd7-8727-0fdd900110a4_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_1afed1f9-e270-41ca-82d5-3491f93332ec_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_cf2f54da-2ee8-4fc0-b98d-6b7d499c72c1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) arising during period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_1bb07143-489d-4001-b054-a331f53eeedf_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_6286a992-7726-473f-920b-b80cad305bee_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_fa477132-0174-4572-bb54-de6def0c9383_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_63c91d78-2c35-4700-ad2b-06d38409f2cc_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies (Note 11)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_20a5a8ec-e8cd-4327-9efc-44c382a5d5b4_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_63889ee3-928a-4d37-a43f-054039b6788c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_54b32c94-629a-4f90-8f0d-aff91908048a_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2262287d-bb1c-47da-a24d-1b0b3c27a5a5_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5269eb60-98df-437a-82ff-0c871e0bfd97_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e9aea575-cc01-479d-8001-c14c879744b5_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets with definite lives:</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_InvokanaMember_2b709c9b-0446-4aa9-b20b-bdf433bf0f56_terseLabel_en-US" xlink:label="lab_jnj_InvokanaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Invokana</link:label>
    <link:label id="lab_jnj_InvokanaMember_label_en-US" xlink:label="lab_jnj_InvokanaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Invokana [Member]</link:label>
    <link:label id="lab_jnj_InvokanaMember_documentation_en-US" xlink:label="lab_jnj_InvokanaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Invokana [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InvokanaMember" xlink:href="jnj-20200927.xsd#jnj_InvokanaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_InvokanaMember" xlink:to="lab_jnj_InvokanaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EquityInvestmentswithReadilyDeterminableValueMember_d1c5a984-9429-47c2-96d5-bb9c32bdd535_terseLabel_en-US" xlink:label="lab_jnj_EquityInvestmentswithReadilyDeterminableValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments with readily determinable value</link:label>
    <link:label id="lab_jnj_EquityInvestmentswithReadilyDeterminableValueMember_label_en-US" xlink:label="lab_jnj_EquityInvestmentswithReadilyDeterminableValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments with Readily Determinable Value [Member]</link:label>
    <link:label id="lab_jnj_EquityInvestmentswithReadilyDeterminableValueMember_documentation_en-US" xlink:label="lab_jnj_EquityInvestmentswithReadilyDeterminableValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments with Readily Determinable Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember" xlink:href="jnj-20200927.xsd#jnj_EquityInvestmentswithReadilyDeterminableValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember" xlink:to="lab_jnj_EquityInvestmentswithReadilyDeterminableValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_7d38d09b-4886-4845-bc6a-37530009c3d6_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_a2c2f66c-d15f-416f-9db6-b54d0cf87005_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_WesternHemisphereExcludingUSMember_f02d2b47-f084-4b0b-be53-0881a7e370ae_terseLabel_en-US" xlink:label="lab_jnj_WesternHemisphereExcludingUSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Western Hemisphere, excluding U.S.</link:label>
    <link:label id="lab_jnj_WesternHemisphereExcludingUSMember_label_en-US" xlink:label="lab_jnj_WesternHemisphereExcludingUSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Western Hemisphere, excluding U.S. [Member]</link:label>
    <link:label id="lab_jnj_WesternHemisphereExcludingUSMember_documentation_en-US" xlink:label="lab_jnj_WesternHemisphereExcludingUSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Western Hemisphere, excluding U.S. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WesternHemisphereExcludingUSMember" xlink:href="jnj-20200927.xsd#jnj_WesternHemisphereExcludingUSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_WesternHemisphereExcludingUSMember" xlink:to="lab_jnj_WesternHemisphereExcludingUSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_b3553d88-38dd-484b-8f09-faa356a0e0c9_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_d715fe03-5d2b-4699-8e91-17de07137880_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_4667d4a3-252e-454d-86f4-02a5e50e297e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_81b61e02-e5ce-4cd8-9d4e-1f3c255a6412_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A2.45Notesdue2021Member_6c7a51fd-9725-424d-9a2c-7ca6fc9478d6_terseLabel_en-US" xlink:label="lab_jnj_A2.45Notesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.45% Notes due 2021</link:label>
    <link:label id="lab_jnj_A2.45Notesdue2021Member_label_en-US" xlink:label="lab_jnj_A2.45Notesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.45% Notes due 2021 [Member]</link:label>
    <link:label id="lab_jnj_A2.45Notesdue2021Member_documentation_en-US" xlink:label="lab_jnj_A2.45Notesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.45% Notes due 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.45Notesdue2021Member" xlink:href="jnj-20200927.xsd#jnj_A2.45Notesdue2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A2.45Notesdue2021Member" xlink:to="lab_jnj_A2.45Notesdue2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_699d8c96-d3ee-45c4-9bc0-f338b1d47b23_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_InvestmentIncomeInterestPercentToSales_bed4ea50-1244-4320-b321-c39bbc4b9568_terseLabel_en-US" xlink:label="lab_jnj_InvestmentIncomeInterestPercentToSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income percent to sales</link:label>
    <link:label id="lab_jnj_InvestmentIncomeInterestPercentToSales_label_en-US" xlink:label="lab_jnj_InvestmentIncomeInterestPercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income Interest Percent To Sales</link:label>
    <link:label id="lab_jnj_InvestmentIncomeInterestPercentToSales_documentation_en-US" xlink:label="lab_jnj_InvestmentIncomeInterestPercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income interest percent to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InvestmentIncomeInterestPercentToSales" xlink:href="jnj-20200927.xsd#jnj_InvestmentIncomeInterestPercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_InvestmentIncomeInterestPercentToSales" xlink:to="lab_jnj_InvestmentIncomeInterestPercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_82aaba9f-3e2f-4cab-a39e-f6ee77265043_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_bc1c20d3-298e-44c9-8d01-97452684bb70_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales price per share (in CHF per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_bd2b00ed-e806-4dd5-9edd-d3f180450a5b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill_e60cdc38-09ad-4434-a05c-7c8588da9c38_terseLabel_en-US" xlink:label="lab_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments made to intangible assets</link:label>
    <link:label id="lab_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill_label_en-US" xlink:label="lab_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Adjustments Made To Intangible Assets, Other than Goodwill</link:label>
    <link:label id="lab_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill_documentation_en-US" xlink:label="lab_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Adjustments Made To Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill" xlink:href="jnj-20200927.xsd#jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill" xlink:to="lab_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OtherNonOperatingIncomeExpensePercentToSales_77802d7b-c95d-436b-bdd1-4a299244632f_terseLabel_en-US" xlink:label="lab_jnj_OtherNonOperatingIncomeExpensePercentToSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net percent to sales</link:label>
    <link:label id="lab_jnj_OtherNonOperatingIncomeExpensePercentToSales_label_en-US" xlink:label="lab_jnj_OtherNonOperatingIncomeExpensePercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non Operating Income Expense Percent To Sales</link:label>
    <link:label id="lab_jnj_OtherNonOperatingIncomeExpensePercentToSales_documentation_en-US" xlink:label="lab_jnj_OtherNonOperatingIncomeExpensePercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non operating income expense percent to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherNonOperatingIncomeExpensePercentToSales" xlink:href="jnj-20200927.xsd#jnj_OtherNonOperatingIncomeExpensePercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OtherNonOperatingIncomeExpensePercentToSales" xlink:to="lab_jnj_OtherNonOperatingIncomeExpensePercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EquityFairValueAdjustmentChangeInObservablePrice_618c0d4a-9cd7-4028-8393-912854c679e5_terseLabel_en-US" xlink:label="lab_jnj_EquityFairValueAdjustmentChangeInObservablePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Fair Value Adjustment, Change In Observable Price</link:label>
    <link:label id="lab_jnj_EquityFairValueAdjustmentChangeInObservablePrice_label_en-US" xlink:label="lab_jnj_EquityFairValueAdjustmentChangeInObservablePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Fair Value Adjustment, Change In Observable Price</link:label>
    <link:label id="lab_jnj_EquityFairValueAdjustmentChangeInObservablePrice_documentation_en-US" xlink:label="lab_jnj_EquityFairValueAdjustmentChangeInObservablePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Fair Value Adjustment, Change In Observable Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityFairValueAdjustmentChangeInObservablePrice" xlink:href="jnj-20200927.xsd#jnj_EquityFairValueAdjustmentChangeInObservablePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EquityFairValueAdjustmentChangeInObservablePrice" xlink:to="lab_jnj_EquityFairValueAdjustmentChangeInObservablePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_da361971-2107-4f5b-9604-bd77b0e80e98_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_0998f3a4-a426-4dcc-a084-dbd233be339c_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Amount</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_717c1887-5591-4a2e-9362-017e102f3383_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">settled litigation</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_BeautyMember_7eb7c03e-5d7d-420c-a6df-b59e769236ac_terseLabel_en-US" xlink:label="lab_jnj_BeautyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skin Health/Beauty</link:label>
    <link:label id="lab_jnj_BeautyMember_label_en-US" xlink:label="lab_jnj_BeautyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beauty [Member]</link:label>
    <link:label id="lab_jnj_BeautyMember_documentation_en-US" xlink:label="lab_jnj_BeautyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beauty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BeautyMember" xlink:href="jnj-20200927.xsd#jnj_BeautyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_BeautyMember" xlink:to="lab_jnj_BeautyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent_61018c96-6763-497b-b86f-dc6e1c928b8b_terseLabel_en-US" xlink:label="lab_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net impact to tax rate due to change in contingent consideration liability</link:label>
    <link:label id="lab_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent_label_en-US" xlink:label="lab_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change In Contingent Consideration Liability, Percent</link:label>
    <link:label id="lab_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent_documentation_en-US" xlink:label="lab_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change In Contingent Consideration Liability, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent" xlink:href="jnj-20200927.xsd#jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent" xlink:to="lab_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_22404ad9-f6dd-4ae1-b5b1-437142d235f0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_23833447-be99-40a9-9683-dac202e872a1_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Business Segments</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_1028a618-f72e-4283-bf39-5dc0389eaecf_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as hedging instruments : Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Liabilities, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_85b1509d-dce4-46d5-b681-45d5a0ec0267_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_d4e551ba-29cd-411f-b056-4961cb354cf9_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Abstract]</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_2d7c725c-5705-4e8e-832f-4f0fcc633820_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_5325fc2d-0806-4685-88cf-7af5aa688d23_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications to earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_dc8d8c82-221a-4ae7-9e31-62a940875d27_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: common stock held in treasury, at cost (487,676,000 and 487,336,000 shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_d76ce703-16e7-433b-bdfb-2d5fa41fc471_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_a317d11e-9512-4108-9923-6b7596bb9005_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_14aa1a8f-b9d3-4eb7-bb84-8955e8c0be71_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f07cf8c6-9fd7-4c5d-a58a-91049d1996fb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_a15297f8-5b52-4519-9b73-3be36bc25cd0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Amortization Expense</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_f8db92ae-8701-4af9-8b6f-f4cac5fa1c5c_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentsGeographicalAreasAbstract_8f84ef13-b65f-46cc-a823-382dc89063b4_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentsGeographicalAreasAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales by geographic area</link:label>
    <link:label id="lab_us-gaap_SegmentsGeographicalAreasAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentsGeographicalAreasAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments, Geographical Areas [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentsGeographicalAreasAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentsGeographicalAreasAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentsGeographicalAreasAbstract" xlink:to="lab_us-gaap_SegmentsGeographicalAreasAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_51535c19-ec3a-4a14-bd3e-8a5aa7685ce2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A2.25Notesdue2022Member_6f22bb69-1064-4477-930e-14d49a4941e5_terseLabel_en-US" xlink:label="lab_jnj_A2.25Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.25% Notes due 2022</link:label>
    <link:label id="lab_jnj_A2.25Notesdue2022Member_label_en-US" xlink:label="lab_jnj_A2.25Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.25% Notes due 2022 [Member]</link:label>
    <link:label id="lab_jnj_A2.25Notesdue2022Member_documentation_en-US" xlink:label="lab_jnj_A2.25Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.25% Notes due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.25Notesdue2022Member" xlink:href="jnj-20200927.xsd#jnj_A2.25Notesdue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A2.25Notesdue2022Member" xlink:to="lab_jnj_A2.25Notesdue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_c6ad909a-d8f5-4d6b-91a1-bd5f12c9dbd6_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_50be8ad9-571c-407c-bd77-30cd28494271_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Segment Operating Income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringChargesMember_844f4a81-a36e-4418-ac26-b1cf98890776_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringChargesMember_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesMember" xlink:to="lab_us-gaap_RestructuringChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A3.375Notesdue2023Member_74042e3f-a5f0-4115-8454-41dc30ab8bc3_terseLabel_en-US" xlink:label="lab_jnj_A3.375Notesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% Notes due 2023</link:label>
    <link:label id="lab_jnj_A3.375Notesdue2023Member_label_en-US" xlink:label="lab_jnj_A3.375Notesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% Notes due 2023 [Member]</link:label>
    <link:label id="lab_jnj_A3.375Notesdue2023Member_documentation_en-US" xlink:label="lab_jnj_A3.375Notesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% Notes due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.375Notesdue2023Member" xlink:href="jnj-20200927.xsd#jnj_A3.375Notesdue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A3.375Notesdue2023Member" xlink:to="lab_jnj_A3.375Notesdue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_993d7b20-5fc7-40e8-b458-2ae966bc2882_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill (Note 3)</link:label>
    <link:label id="lab_us-gaap_Goodwill_0b4c9787-4724-4599-af93-8af33738177e_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Beginning of Period</link:label>
    <link:label id="lab_us-gaap_Goodwill_c0c5b8a0-a2eb-46d7-a335-d2d94ef32431_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill End of Period</link:label>
    <link:label id="lab_us-gaap_Goodwill_69f2402b-b81e-4c9e-9620-ae6f06e7394f_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_DePuyASRU.S.Member_1e445f24-2edf-45a5-8c41-4070a8e4c9cb_terseLabel_en-US" xlink:label="lab_jnj_DePuyASRU.S.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DePuy ASR U.S.</link:label>
    <link:label id="lab_jnj_DePuyASRU.S.Member_label_en-US" xlink:label="lab_jnj_DePuyASRU.S.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DePuy ASR U.S. [Member]</link:label>
    <link:label id="lab_jnj_DePuyASRU.S.Member_documentation_en-US" xlink:label="lab_jnj_DePuyASRU.S.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DePuy ASR U.S. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DePuyASRU.S.Member" xlink:href="jnj-20200927.xsd#jnj_DePuyASRU.S.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_DePuyASRU.S.Member" xlink:to="lab_jnj_DePuyASRU.S.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A095NotesDue2027Member_aa44947e-c2a5-4b37-a8d3-564d5b9eb519_terseLabel_en-US" xlink:label="lab_jnj_A095NotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.95% Notes due 2027</link:label>
    <link:label id="lab_jnj_A095NotesDue2027Member_label_en-US" xlink:label="lab_jnj_A095NotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.95% Notes due 2027 [Member]</link:label>
    <link:label id="lab_jnj_A095NotesDue2027Member_documentation_en-US" xlink:label="lab_jnj_A095NotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.95% Notes due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A095NotesDue2027Member" xlink:href="jnj-20200927.xsd#jnj_A095NotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A095NotesDue2027Member" xlink:to="lab_jnj_A095NotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember_f193cabd-6c36-44b4-b67c-f22e473f978a_terseLabel_en-US" xlink:label="lab_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PREZISTA&#174; / PREZCOBIX&#174; / REZOLSTA&#174; / SYMTUZA&#174;</link:label>
    <link:label id="lab_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember_label_en-US" xlink:label="lab_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA [Member]</link:label>
    <link:label id="lab_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember_documentation_en-US" xlink:label="lab_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember" xlink:href="jnj-20200927.xsd#jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember" xlink:to="lab_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_3905afa4-86f7-4174-bfab-0fe730d2cf11_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_ed3dbf7d-fed4-43e9-8b54-8eadc601c8a1_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_25279451-a778-43f2-89e8-53f94e40ba9a_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_8691ad80-3a0a-41fb-a49b-276bb143a667_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e8e8eee8-0371-474a-8e18-7cb4101d7e70_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_20742b1d-a482-4330-937f-51e3d97e0269_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0be73b6c-75da-4f98-b78d-059281f2d833_netLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_378984f5-8ece-4134-b579-ba6e0bd1aa4c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_7abbceec-509b-4b74-a836-32944479a999_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_aaea3c56-1060-452e-8992-d0bcdec4fcf9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ResearchAndDevelopmentInProcessPercentToSales_d0dd15af-af09-4039-8a7e-ac211ea84e4d_terseLabel_en-US" xlink:label="lab_jnj_ResearchAndDevelopmentInProcessPercentToSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development percent to sales</link:label>
    <link:label id="lab_jnj_ResearchAndDevelopmentInProcessPercentToSales_label_en-US" xlink:label="lab_jnj_ResearchAndDevelopmentInProcessPercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development in process percent to sales</link:label>
    <link:label id="lab_jnj_ResearchAndDevelopmentInProcessPercentToSales_documentation_en-US" xlink:label="lab_jnj_ResearchAndDevelopmentInProcessPercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">research and development in process percent to sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ResearchAndDevelopmentInProcessPercentToSales" xlink:href="jnj-20200927.xsd#jnj_ResearchAndDevelopmentInProcessPercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ResearchAndDevelopmentInProcessPercentToSales" xlink:to="lab_jnj_ResearchAndDevelopmentInProcessPercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_f0abd19a-42ab-44cf-aeeb-cf959dcde542_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_04292f12-0470-4eea-855c-7f7efa656e63_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_a6a7d844-c34d-46c8-bae2-20f3783f5482_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_af6c77dc-0a47-4cbc-b089-ef40b6e12bf2_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_SupplyChainMember_73069d51-5e58-40d4-9102-c736fa6aa36a_terseLabel_en-US" xlink:label="lab_jnj_SupplyChainMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Chain</link:label>
    <link:label id="lab_jnj_SupplyChainMember_label_en-US" xlink:label="lab_jnj_SupplyChainMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Chain [Member]</link:label>
    <link:label id="lab_jnj_SupplyChainMember_documentation_en-US" xlink:label="lab_jnj_SupplyChainMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Chain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SupplyChainMember" xlink:href="jnj-20200927.xsd#jnj_SupplyChainMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_SupplyChainMember" xlink:to="lab_jnj_SupplyChainMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_7f04499c-392d-4497-ba90-317ca28fdd90_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract_ee80085e-5679-4c6c-90b5-1c6a5b4890f5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives &amp; hedges:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A4.375Notesdue2033Member_1e140779-a134-421a-b782-a43ca50c25f5_terseLabel_en-US" xlink:label="lab_jnj_A4.375Notesdue2033Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% Notes due 2033</link:label>
    <link:label id="lab_jnj_A4.375Notesdue2033Member_label_en-US" xlink:label="lab_jnj_A4.375Notesdue2033Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% Notes due 2033 [Member]</link:label>
    <link:label id="lab_jnj_A4.375Notesdue2033Member_documentation_en-US" xlink:label="lab_jnj_A4.375Notesdue2033Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% Notes due 2033 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.375Notesdue2033Member" xlink:href="jnj-20200927.xsd#jnj_A4.375Notesdue2033Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A4.375Notesdue2033Member" xlink:to="lab_jnj_A4.375Notesdue2033Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_a1f648e6-547b-491d-ab3a-d362549aaba1_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_bbe7f112-84db-4d0c-987e-f253853ca346_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueGrossLiability_d8fbf7dd-b804-483a-a6d8-316097a8d828_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Support Agreement (CSA)</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueGrossLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:to="lab_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_abbc1a5b-a83c-4358-8640-9b869d634084_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_1e2b6faa-cfc8-4528-8821-b348261d89b7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_23539261-07cf-4c7a-b5a9-e3ce745a851a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_fd76b658-d653-4f5c-a944-06be0a1a94b1_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_3b9cb3b7-0958-4dd3-86fc-cb4918f0bf54_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8ab4b42e-64ac-4b9f-80ea-4eb425588806_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities - Carrying Amount</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c5ab93c4-967b-4bd9-9859-ab7a0d6f5554_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities, net of effects from acquisitions and divestitures:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_76190b77-05ce-4f8e-8213-cd25f6d7debc_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before provision for taxes on income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ca6a5196-1245-44d2-99f1-069c1232a53a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before provision for taxes on income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_0993ed8a-416a-420c-8620-00479e55f7ee_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AVG. SHARES OUTSTANDING</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_d8533eb3-20ab-4483-85d9-c40329df04c7_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_6a523f95-493a-44e9-917a-46a5c1f1a894_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted prices in active markets for identical assets and liabilities Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_4d9e4b0a-cc8f-429c-8a92-b42f167a0d5a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net of portion capitalized</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_fb49290f-ca88-4349-88fb-728891ddb59f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_b1e60a5a-e113-4374-8f13-4ec69e9df633_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue_956ec21e-a972-4c54-a2e9-2c9d7ff33ee9_terseLabel_en-US" xlink:label="lab_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previous damages awarded and revised</link:label>
    <link:label id="lab_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue_label_en-US" xlink:label="lab_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Previous Damages Awarded And Revised, Value</link:label>
    <link:label id="lab_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue_documentation_en-US" xlink:label="lab_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Previous Damages Awarded And Revised, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue" xlink:href="jnj-20200927.xsd#jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue" xlink:to="lab_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A1300NotesDue2030Member_259232dd-754f-4466-8571-7c27ec43dfbe_terseLabel_en-US" xlink:label="lab_jnj_A1300NotesDue2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.300% Notes due 2030</link:label>
    <link:label id="lab_jnj_A1300NotesDue2030Member_label_en-US" xlink:label="lab_jnj_A1300NotesDue2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.300% Notes due 2030 [Member]</link:label>
    <link:label id="lab_jnj_A1300NotesDue2030Member_documentation_en-US" xlink:label="lab_jnj_A1300NotesDue2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.300% Notes due 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1300NotesDue2030Member" xlink:href="jnj-20200927.xsd#jnj_A1300NotesDue2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A1300NotesDue2030Member" xlink:to="lab_jnj_A1300NotesDue2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_45410e40-4f10-4aaa-b15f-cf2e10b0befd_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate on non-current debt</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e842aa8f-a2d2-461f-8f19-26c604059450_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_bb81cae3-c835-49c5-9ea1-01ac998ae5ef_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships and other intangible assets</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction_53205c9f-603c-4afd-82c4-d29f427f5be4_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage ownership before transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Percentage of Ownership before Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction" xlink:to="lab_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_a4170cd7-e10a-444d-99b4-e1ba7e40fa9b_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailments and settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_a40a224f-73fb-4a2a-8321-7df8158c7ed5_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the disposal of assets/businesses, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_87815529-7317-44b5-9786-f07bedf4733b_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, trade, less allowances for doubtful accounts and credit losses $292 (2019, $226)</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_CardiovascularMetabolismOtherMember_797f1193-b9c1-480a-8d03-1590f88ccd1e_terseLabel_en-US" xlink:label="lab_jnj_CardiovascularMetabolismOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular / Metabolism / Other</link:label>
    <link:label id="lab_jnj_CardiovascularMetabolismOtherMember_label_en-US" xlink:label="lab_jnj_CardiovascularMetabolismOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular/Metabolism/Other [Member]</link:label>
    <link:label id="lab_jnj_CardiovascularMetabolismOtherMember_documentation_en-US" xlink:label="lab_jnj_CardiovascularMetabolismOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular/Metabolism/Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CardiovascularMetabolismOtherMember" xlink:href="jnj-20200927.xsd#jnj_CardiovascularMetabolismOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_CardiovascularMetabolismOtherMember" xlink:to="lab_jnj_CardiovascularMetabolismOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_6fd3ffcd-59ae-4d1a-a7e4-61a91487a514_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_aebb3a2e-394f-4804-a6f6-3b1213a7b74f_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_d0a0b574-3fe1-4f89-89f6-d3082f5d738a_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goods in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_9010cae1-c528-4378-83d6-44e842b24827_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfEquityInvestments_4c629524-0891-4af3-8a8d-705525ef3998_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of equity investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfEquityInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Equity Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfEquityInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfEquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfEquityInvestments" xlink:to="lab_us-gaap_GainLossOnSaleOfEquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax_7dc6c732-0659-4beb-a672-41e5e98f12b8_negatedTerseLabel_en-US" xlink:label="lab_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost amortization during period</link:label>
    <link:label id="lab_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax_label_en-US" xlink:label="lab_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit), Net of Amortization, Arising During Period, Net of Tax</link:label>
    <link:label id="lab_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax_documentation_en-US" xlink:label="lab_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit), Net of Amortization, Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" xlink:href="jnj-20200927.xsd#jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" xlink:to="lab_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_LegalProceedingTextualsAbstract_c76b3e39-56ae-4229-9984-ad9c465053cf_terseLabel_en-US" xlink:label="lab_jnj_LegalProceedingTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceeding (Textuals)</link:label>
    <link:label id="lab_jnj_LegalProceedingTextualsAbstract_label_en-US" xlink:label="lab_jnj_LegalProceedingTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceeding (Textuals) [Abstract]</link:label>
    <link:label id="lab_jnj_LegalProceedingTextualsAbstract_documentation_en-US" xlink:label="lab_jnj_LegalProceedingTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceeding Textuals Abstract.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LegalProceedingTextualsAbstract" xlink:href="jnj-20200927.xsd#jnj_LegalProceedingTextualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_LegalProceedingTextualsAbstract" xlink:to="lab_jnj_LegalProceedingTextualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember_512883e8-6714-457d-9988-e7bebb80507d_terseLabel_en-US" xlink:label="lab_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVEGA SUSTENNA&#174; / XEPLION&#174; / INVEGA TRINZA&#174; / TREVICTA&#174;</link:label>
    <link:label id="lab_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember_label_en-US" xlink:label="lab_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVEGA SUSTENNA/XEPLION/TRINZA/TREVICTA [Member]</link:label>
    <link:label id="lab_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember_documentation_en-US" xlink:label="lab_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVEGA SUSTENNA/XEPLION/TRINZA/TREVICTA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember" xlink:href="jnj-20200927.xsd#jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember" xlink:to="lab_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_150b2368-4171-4a4c-9edc-f2dbd9ee8a26_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_AccruedRebatesReturnsAndPromotions_e935b093-f7e5-4a36-9070-e58c537bfd9a_verboseLabel_en-US" xlink:label="lab_jnj_AccruedRebatesReturnsAndPromotions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued rebates, returns and promotions</link:label>
    <link:label id="lab_jnj_AccruedRebatesReturnsAndPromotions_label_en-US" xlink:label="lab_jnj_AccruedRebatesReturnsAndPromotions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates Returns And Promotions</link:label>
    <link:label id="lab_jnj_AccruedRebatesReturnsAndPromotions_documentation_en-US" xlink:label="lab_jnj_AccruedRebatesReturnsAndPromotions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reflects the estimated obligations due within one year for rebates, returns and promotions. Reserves include such items related to Medicaid rebates, product returns due to expiration, product recalls, current portion of coupons and volume-based sales incentives programs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AccruedRebatesReturnsAndPromotions" xlink:href="jnj-20200927.xsd#jnj_AccruedRebatesReturnsAndPromotions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_AccruedRebatesReturnsAndPromotions" xlink:to="lab_jnj_AccruedRebatesReturnsAndPromotions" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PurchasedInProcessResearchAndDevelopmentMember_2f31ac95-42a9-4ce3-92dd-f51b10082b90_terseLabel_en-US" xlink:label="lab_jnj_PurchasedInProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased In-Process Research And Development</link:label>
    <link:label id="lab_jnj_PurchasedInProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_jnj_PurchasedInProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased In-Process Research And Development [Member]</link:label>
    <link:label id="lab_jnj_PurchasedInProcessResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_jnj_PurchasedInProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased In-Process Research And Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember" xlink:href="jnj-20200927.xsd#jnj_PurchasedInProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember" xlink:to="lab_jnj_PurchasedInProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_0fceb1ca-7a72-4d60-9fb7-f0a47e0cc42e_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_BabyCareMember_9e1e2a68-a3b0-4660-b162-57896dee16bd_terseLabel_en-US" xlink:label="lab_jnj_BabyCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baby Care</link:label>
    <link:label id="lab_jnj_BabyCareMember_label_en-US" xlink:label="lab_jnj_BabyCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baby Care [Member]</link:label>
    <link:label id="lab_jnj_BabyCareMember_documentation_en-US" xlink:label="lab_jnj_BabyCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baby Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BabyCareMember" xlink:href="jnj-20200927.xsd#jnj_BabyCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_BabyCareMember" xlink:to="lab_jnj_BabyCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_1d2e8d02-ef47-4369-8359-8118dd870a8b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PinnacleAcetabularCupSystemMember_ec01103d-25fb-41cc-b6c3-e780ac1381dd_terseLabel_en-US" xlink:label="lab_jnj_PinnacleAcetabularCupSystemMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pinnacle Acetabular Cup System</link:label>
    <link:label id="lab_jnj_PinnacleAcetabularCupSystemMember_label_en-US" xlink:label="lab_jnj_PinnacleAcetabularCupSystemMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pinnacle Acetabular Cup System [Member]</link:label>
    <link:label id="lab_jnj_PinnacleAcetabularCupSystemMember_documentation_en-US" xlink:label="lab_jnj_PinnacleAcetabularCupSystemMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pinnacle Acetabular cup system.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PinnacleAcetabularCupSystemMember" xlink:href="jnj-20200927.xsd#jnj_PinnacleAcetabularCupSystemMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PinnacleAcetabularCupSystemMember" xlink:to="lab_jnj_PinnacleAcetabularCupSystemMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_14a349aa-de9e-4faf-a8fd-8b93328c2330_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_68676ff8-e676-4e18-97cc-e2111c082f2c_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_8aecba3a-c37e-4e0d-8ab5-4c3f93ded3c0_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_3b410d2b-8eb2-4c2d-a99b-698d911833f6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_8c1d7878-975c-43c4-b252-fb5a3ed13547_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesClassifiedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f0dce723-386f-4da2-8efd-2d39dfdb4327_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase/(Decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_ee0fa74a-9bb1-43df-8988-4b4cf8437c04_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET EARNINGS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_74af9b61-0a62-483c-bfe9-4dc13db4a5ff_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_1d74dfd3-9869-47c4-81f5-1df9a31e8ddb_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A4.50Debenturesdue2040Member_84bba40f-5bd2-458e-9c9b-72d55ebc3c3f_terseLabel_en-US" xlink:label="lab_jnj_A4.50Debenturesdue2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Debentures due 2040</link:label>
    <link:label id="lab_jnj_A4.50Debenturesdue2040Member_label_en-US" xlink:label="lab_jnj_A4.50Debenturesdue2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Debentures due 2040 [Member]</link:label>
    <link:label id="lab_jnj_A4.50Debenturesdue2040Member_documentation_en-US" xlink:label="lab_jnj_A4.50Debenturesdue2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Debentures due 2040 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.50Debenturesdue2040Member" xlink:href="jnj-20200927.xsd#jnj_A4.50Debenturesdue2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A4.50Debenturesdue2040Member" xlink:to="lab_jnj_A4.50Debenturesdue2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A3.55Notesdue2036Member_78be21c0-425e-4a26-b023-2ba6eb18361c_terseLabel_en-US" xlink:label="lab_jnj_A3.55Notesdue2036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.55% Notes due 2036</link:label>
    <link:label id="lab_jnj_A3.55Notesdue2036Member_label_en-US" xlink:label="lab_jnj_A3.55Notesdue2036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.55% Notes due 2036 [Member]</link:label>
    <link:label id="lab_jnj_A3.55Notesdue2036Member_documentation_en-US" xlink:label="lab_jnj_A3.55Notesdue2036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.55% Notes due 2036 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.55Notesdue2036Member" xlink:href="jnj-20200927.xsd#jnj_A3.55Notesdue2036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A3.55Notesdue2036Member" xlink:to="lab_jnj_A3.55Notesdue2036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_4b01ffe9-044a-44c1-bb30-eb9b252b1a9c_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_4055d5e2-4979-42b2-91b3-4921b6b4fd29_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par Value $1.00</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_d2ad29c2-6556-48e9-8e2a-b0d944899462_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Issued Amount</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8f49d882-df38-4141-8665-e1f66efdc471_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_TalcMember_eb67c512-3d45-43a9-a8d4-4120b4ab79f8_terseLabel_en-US" xlink:label="lab_jnj_TalcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Talc</link:label>
    <link:label id="lab_jnj_TalcMember_label_en-US" xlink:label="lab_jnj_TalcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Talc [Member]</link:label>
    <link:label id="lab_jnj_TalcMember_documentation_en-US" xlink:label="lab_jnj_TalcMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Talc [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_TalcMember" xlink:href="jnj-20200927.xsd#jnj_TalcMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_TalcMember" xlink:to="lab_jnj_TalcMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_72132465-1278-4a1e-8467-b6c5fe8b06c9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_43af8307-ac02-423b-a90a-033387e76d3d_verboseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_30a67b00-3755-40f1-b935-c1dd2d99eec1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and stock option plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Treasury Stock Reissued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnSecurities_d3d262cd-4f25-47ab-8b1c-7192dccdd25a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Securities</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnSecurities_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnSecurities" xlink:to="lab_us-gaap_UnrealizedGainLossOnSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_23da3040-7d0f-43a3-9bce-eb7cd766624e_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities, Equity Securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_3630bbbf-889b-4663-bcc9-ec14f5cc8e2b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain/(Loss) Recognized In Income on Derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3015e259-f5f9-443f-a26a-6b1c6937e366_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A5.85Debenturesdue2038Member_cfe73f7f-8564-4344-bf55-d5fd77b715ac_terseLabel_en-US" xlink:label="lab_jnj_A5.85Debenturesdue2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.85% Debentures due 2038</link:label>
    <link:label id="lab_jnj_A5.85Debenturesdue2038Member_label_en-US" xlink:label="lab_jnj_A5.85Debenturesdue2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.85% Debentures due 2038 [Member]</link:label>
    <link:label id="lab_jnj_A5.85Debenturesdue2038Member_documentation_en-US" xlink:label="lab_jnj_A5.85Debenturesdue2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.85% Debentures due 2038 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.85Debenturesdue2038Member" xlink:href="jnj-20200927.xsd#jnj_A5.85Debenturesdue2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A5.85Debenturesdue2038Member" xlink:to="lab_jnj_A5.85Debenturesdue2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_2fe5307d-5328-4a7e-bccc-9fbcffef5096_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_SimponiSimponiAriaMember_388a9748-6f68-4ef6-905c-b79da4828bc1_terseLabel_en-US" xlink:label="lab_jnj_SimponiSimponiAriaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SIMPONI / SIMPONI ARIA&#174;</link:label>
    <link:label id="lab_jnj_SimponiSimponiAriaMember_label_en-US" xlink:label="lab_jnj_SimponiSimponiAriaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simponi/Simponi Aria [Member]</link:label>
    <link:label id="lab_jnj_SimponiSimponiAriaMember_documentation_en-US" xlink:label="lab_jnj_SimponiSimponiAriaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simponi/Simponi Aria [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SimponiSimponiAriaMember" xlink:href="jnj-20200927.xsd#jnj_SimponiSimponiAriaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_SimponiSimponiAriaMember" xlink:to="lab_jnj_SimponiSimponiAriaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_96ef1fc4-a868-4a98-9176-f9508023dcc3_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PelvicMeshesMember_74259e74-2963-49d8-8c71-46c78b92df2f_terseLabel_en-US" xlink:label="lab_jnj_PelvicMeshesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pelvic Meshes</link:label>
    <link:label id="lab_jnj_PelvicMeshesMember_label_en-US" xlink:label="lab_jnj_PelvicMeshesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pelvic Meshes [Member]</link:label>
    <link:label id="lab_jnj_PelvicMeshesMember_documentation_en-US" xlink:label="lab_jnj_PelvicMeshesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pelvic meshes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PelvicMeshesMember" xlink:href="jnj-20200927.xsd#jnj_PelvicMeshesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PelvicMeshesMember" xlink:to="lab_jnj_PelvicMeshesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_28b561c4-0ba4-4959-be6e-e8f0fd7681b7_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_cf99b4b3-df79-4fa5-8255-a1038129cd34_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_f967a93e-a997-43f6-a653-4e657e8c8450_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_b5749f7a-91d7-413d-8e9f-85479c3cf92b_totalLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash paid for acquisitions</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_XareltoMember_2f33e738-2f7c-4be1-affc-876c8edf7b01_terseLabel_en-US" xlink:label="lab_jnj_XareltoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">XARELTO&#174;</link:label>
    <link:label id="lab_jnj_XareltoMember_label_en-US" xlink:label="lab_jnj_XareltoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xarelto [Member]</link:label>
    <link:label id="lab_jnj_XareltoMember_documentation_en-US" xlink:label="lab_jnj_XareltoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xarelto [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_XareltoMember" xlink:href="jnj-20200927.xsd#jnj_XareltoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_XareltoMember" xlink:to="lab_jnj_XareltoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_96f78c0a-702a-433c-b757-cb3b7ad0928f_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OtherReverseRepurchaseAgreementsMember_f9f6cfdc-dba4-461b-8f1e-7fed3f357e0e_terseLabel_en-US" xlink:label="lab_jnj_OtherReverseRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other reverse repurchase agreements</link:label>
    <link:label id="lab_jnj_OtherReverseRepurchaseAgreementsMember_label_en-US" xlink:label="lab_jnj_OtherReverseRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Reverse Repurchase Agreements [Member]</link:label>
    <link:label id="lab_jnj_OtherReverseRepurchaseAgreementsMember_documentation_en-US" xlink:label="lab_jnj_OtherReverseRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Reverse Repurchase Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherReverseRepurchaseAgreementsMember" xlink:href="jnj-20200927.xsd#jnj_OtherReverseRepurchaseAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OtherReverseRepurchaseAgreementsMember" xlink:to="lab_jnj_OtherReverseRepurchaseAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_fdebb62e-ac2c-4942-ac85-e1e1f6ac9234_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1b9ec1d4-9284-4f32-b2e2-06902a16e32e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_10142373-c2bb-4fbc-aa3b-6eb99c48110b_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_99bbfeea-d913-4979-9d14-c06903b28ec9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_933d1e20-37f2-4d90-b0f9-56185c57c4b5_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Derivative Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A2.45Notesdue2026Member_53896f34-f9ac-4d3e-b2cb-8fa79c60ecfa_terseLabel_en-US" xlink:label="lab_jnj_A2.45Notesdue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.45% Notes due 2026</link:label>
    <link:label id="lab_jnj_A2.45Notesdue2026Member_label_en-US" xlink:label="lab_jnj_A2.45Notesdue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.45% Notes due 2026 [Member]</link:label>
    <link:label id="lab_jnj_A2.45Notesdue2026Member_documentation_en-US" xlink:label="lab_jnj_A2.45Notesdue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.45% Notes due 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.45Notesdue2026Member" xlink:href="jnj-20200927.xsd#jnj_A2.45Notesdue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A2.45Notesdue2026Member" xlink:to="lab_jnj_A2.45Notesdue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_eb87c952-20fa-4112-be4d-9d655b4fe645_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_3a71c4df-56ad-4703-a0d1-e6aee72c31f4_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans and notes payable</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_823c6f19-17ad-4faa-95cf-a6d6dc822966_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A4.50Notesdue2043Member_eae1f211-059e-4c7e-b860-a8ac0eaa202f_terseLabel_en-US" xlink:label="lab_jnj_A4.50Notesdue2043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Notes due 2043</link:label>
    <link:label id="lab_jnj_A4.50Notesdue2043Member_label_en-US" xlink:label="lab_jnj_A4.50Notesdue2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Notes due 2043 [Member]</link:label>
    <link:label id="lab_jnj_A4.50Notesdue2043Member_documentation_en-US" xlink:label="lab_jnj_A4.50Notesdue2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Notes due 2043 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.50Notesdue2043Member" xlink:href="jnj-20200927.xsd#jnj_A4.50Notesdue2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A4.50Notesdue2043Member" xlink:to="lab_jnj_A4.50Notesdue2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_IncomeTaxExpenseBenefitPercentToSales_5983777b-98bd-4572-99b1-3fb232407eb0_terseLabel_en-US" xlink:label="lab_jnj_IncomeTaxExpenseBenefitPercentToSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for (benefit from) taxes on income (Note 5)</link:label>
    <link:label id="lab_jnj_IncomeTaxExpenseBenefitPercentToSales_label_en-US" xlink:label="lab_jnj_IncomeTaxExpenseBenefitPercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense Benefit Percent To Sales</link:label>
    <link:label id="lab_jnj_IncomeTaxExpenseBenefitPercentToSales_documentation_en-US" xlink:label="lab_jnj_IncomeTaxExpenseBenefitPercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense benefit percent to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeTaxExpenseBenefitPercentToSales" xlink:href="jnj-20200927.xsd#jnj_IncomeTaxExpenseBenefitPercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_IncomeTaxExpenseBenefitPercentToSales" xlink:to="lab_jnj_IncomeTaxExpenseBenefitPercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_5aa2f411-5a7c-43b4-9b37-12cb2311d5d2_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_SalesRevenueGoodsNetPercentToSales_191fc9f2-9758-4853-a7c3-176541764626_terseLabel_en-US" xlink:label="lab_jnj_SalesRevenueGoodsNetPercentToSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to customers percent to sales</link:label>
    <link:label id="lab_jnj_SalesRevenueGoodsNetPercentToSales_label_en-US" xlink:label="lab_jnj_SalesRevenueGoodsNetPercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue Goods Net Percent To Sales</link:label>
    <link:label id="lab_jnj_SalesRevenueGoodsNetPercentToSales_documentation_en-US" xlink:label="lab_jnj_SalesRevenueGoodsNetPercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales revenue goods net percentage to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SalesRevenueGoodsNetPercentToSales" xlink:href="jnj-20200927.xsd#jnj_SalesRevenueGoodsNetPercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_SalesRevenueGoodsNetPercentToSales" xlink:to="lab_jnj_SalesRevenueGoodsNetPercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_83836b1f-8516-438a-801f-c97be58cdb97_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities(1)</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_7b48197d-4d86-48ef-b938-efe7b0206048_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_0765aa29-c13a-4cbc-adca-be4511b72c0c_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_b397476e-1552-4869-a079-b0c6278d8394_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfOrdinaryDividends_442cdc1c-734f-43e9-a512-8fc02a2fdef8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends to shareholders</link:label>
    <link:label id="lab_us-gaap_PaymentsOfOrdinaryDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfOrdinaryDividends" xlink:to="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_89cde471-c99c-4021-8703-4d0251dcdfe3_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod_51fb4077-5633-4f92-a7b2-4ce3b87fa781_terseLabel_en-US" xlink:label="lab_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales/ Purchases/Other</link:label>
    <link:label id="lab_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod_label_en-US" xlink:label="lab_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments, Increase (Decrease) from Acquisition (Sale) During Period</link:label>
    <link:label id="lab_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod_documentation_en-US" xlink:label="lab_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments, Increase (Decrease) from Acquisition (Sale) During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" xlink:href="jnj-20200927.xsd#jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" xlink:to="lab_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1a80f1d9-dfa8-4721-a629-5e15768cd823_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_aeb01136-1cad-43f0-a98d-6dccf48b3b20_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities not Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_4334beb1-ea54-4b82-bd9e-3ea4f809341d_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pensions and Other Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement_4f00c699-f3e1-4938-a167-934d4ffab8a6_terseLabel_en-US" xlink:label="lab_jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued legal fees, revised agreement from litigation settlement</link:label>
    <link:label id="lab_jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement_label_en-US" xlink:label="lab_jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Revised Agreement from Litigation Settlement</link:label>
    <link:label id="lab_jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement_documentation_en-US" xlink:label="lab_jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Revised Agreement from Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement" xlink:href="jnj-20200927.xsd#jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement" xlink:to="lab_jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_feaee022-6d06-4525-ba29-7986604fc6d6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount of the Hedged Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_041e8c51-e081-4a11-ace4-21cdd2546c36_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Net Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_6264bb78-51da-485f-bc92-cbe108319361_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale, current</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1104c366-1a47-42b7-b985-2b726778af2e_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Weighted-Average Useful Life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_33ee32a0-b015-43cc-82be-3dd7e4e3f9be_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case Type</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_4027d79d-03bc-4d15-8f6d-6de16e12bd6b_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage ownership after transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Percentage of Ownership after Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:to="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ZYTIGAMember_d0238522-2026-450c-98cd-d00fa6d2f82d_terseLabel_en-US" xlink:label="lab_jnj_ZYTIGAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZYTIGA&#174; / abiraterone acetate</link:label>
    <link:label id="lab_jnj_ZYTIGAMember_label_en-US" xlink:label="lab_jnj_ZYTIGAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZYTIGA [Member]</link:label>
    <link:label id="lab_jnj_ZYTIGAMember_documentation_en-US" xlink:label="lab_jnj_ZYTIGAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZYTIGA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ZYTIGAMember" xlink:href="jnj-20200927.xsd#jnj_ZYTIGAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ZYTIGAMember" xlink:to="lab_jnj_ZYTIGAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock_bdd6c762-bd0b-4ec6-acf5-ba6b6aef0098_verboseLabel_en-US" xlink:label="lab_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill</link:label>
    <link:label id="lab_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock_label_en-US" xlink:label="lab_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite and Indefinite-Lived Intangible Assets Excluding Goodwill by Major Class [Table Text Block]</link:label>
    <link:label id="lab_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock_documentation_en-US" xlink:label="lab_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite and Indefinite-Lived Intangible Assets Excluding Goodwill by Major Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock" xlink:href="jnj-20200927.xsd#jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock" xlink:to="lab_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_a412cc58-670b-45dc-84f8-119457ba3494_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_86a7662f-6feb-4302-bf2d-992d82faf950_verboseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowances for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_365cca9c-bd49-49bf-923e-ff4f69b2097e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain" xlink:to="lab_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_81b4577d-cee2-4996-af82-19fe93b99101_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_304288f6-4688-4840-aea1-bcb950fd7a24_terseLabel_en-US" xlink:label="lab_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments without readily determinable value</link:label>
    <link:label id="lab_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_label_en-US" xlink:label="lab_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments without Readily Determinable Value [Member]</link:label>
    <link:label id="lab_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_documentation_en-US" xlink:label="lab_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments without Readily Determinable Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember" xlink:href="jnj-20200927.xsd#jnj_EquityInvestmentswithoutReadilyDeterminableValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember" xlink:to="lab_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset_e898609c-c5af-4c10-927f-63a89191b36e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Support Agreement (CSA)</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:to="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_26e48bdc-2164-4a48-ae9d-5bb02859cf56_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_0bf03102-7b5a-4c4e-934e-3898d0298438_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_LitigationSettlementByCompaniesAxis_9f67cafe-e69c-4605-847a-99187fa1da33_terseLabel_en-US" xlink:label="lab_jnj_LitigationSettlementByCompaniesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement By Companies</link:label>
    <link:label id="lab_jnj_LitigationSettlementByCompaniesAxis_label_en-US" xlink:label="lab_jnj_LitigationSettlementByCompaniesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement By Companies [Axis]</link:label>
    <link:label id="lab_jnj_LitigationSettlementByCompaniesAxis_documentation_en-US" xlink:label="lab_jnj_LitigationSettlementByCompaniesAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement by companies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LitigationSettlementByCompaniesAxis" xlink:href="jnj-20200927.xsd#jnj_LitigationSettlementByCompaniesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_LitigationSettlementByCompaniesAxis" xlink:to="lab_jnj_LitigationSettlementByCompaniesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_5f6569a6-f124-4c1b-b1af-710b91b55b69_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_91d9f1d9-0e9c-4872-88e3-7899d96f412c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PharmaceuticalMember_7d3303eb-59c8-4c12-baa4-5f3db16f624e_terseLabel_en-US" xlink:label="lab_jnj_PharmaceuticalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PHARMACEUTICAL</link:label>
    <link:label id="lab_jnj_PharmaceuticalMember_label_en-US" xlink:label="lab_jnj_PharmaceuticalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical [Member]</link:label>
    <link:label id="lab_jnj_PharmaceuticalMember_documentation_en-US" xlink:label="lab_jnj_PharmaceuticalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PharmaceuticalMember" xlink:href="jnj-20200927.xsd#jnj_PharmaceuticalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PharmaceuticalMember" xlink:to="lab_jnj_PharmaceuticalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_5c033587-47a1-4c79-a578-f623d55a992a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_784202ae-09dc-43ce-85fb-2f47961f55de_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_a8347eac-8c6e-4060-bc5e-ad85e71f8506_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated as hedging instruments : Liabilities</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Liability at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:to="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3824d6b1-18dd-432e-99b1-051d9b3965a6_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss) (Note 7)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_VerbSurgicalInc.Member_10820185-7343-465e-845c-6b0053d3a46a_terseLabel_en-US" xlink:label="lab_jnj_VerbSurgicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Verb Surgical Inc.</link:label>
    <link:label id="lab_jnj_VerbSurgicalInc.Member_label_en-US" xlink:label="lab_jnj_VerbSurgicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Verb Surgical Inc. [Member]</link:label>
    <link:label id="lab_jnj_VerbSurgicalInc.Member_documentation_en-US" xlink:label="lab_jnj_VerbSurgicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Verb Surgical Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VerbSurgicalInc.Member" xlink:href="jnj-20200927.xsd#jnj_VerbSurgicalInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_VerbSurgicalInc.Member" xlink:to="lab_jnj_VerbSurgicalInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_a19cd84c-7a4f-40fc-ab16-1009283e1e54_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_41dd131f-9a7e-4a24-8ed4-849d77140c49_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_e2a4cdf8-3b10-4ab1-ae3b-7a107e727013_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PercentageChangeInSalesByGeographicArea_4cc1b06d-100e-4277-9b08-9bf183c55011_terseLabel_en-US" xlink:label="lab_jnj_PercentageChangeInSalesByGeographicArea" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Change In Sales By Geographic Area</link:label>
    <link:label id="lab_jnj_PercentageChangeInSalesByGeographicArea_label_en-US" xlink:label="lab_jnj_PercentageChangeInSalesByGeographicArea" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Change In Sales By Geographic Area</link:label>
    <link:label id="lab_jnj_PercentageChangeInSalesByGeographicArea_documentation_en-US" xlink:label="lab_jnj_PercentageChangeInSalesByGeographicArea" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage change in sales by geographic area.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInSalesByGeographicArea" xlink:href="jnj-20200927.xsd#jnj_PercentageChangeInSalesByGeographicArea"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PercentageChangeInSalesByGeographicArea" xlink:to="lab_jnj_PercentageChangeInSalesByGeographicArea" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_SurgeryMember_33f4ab61-7cd4-4c80-ada4-295ab397ab0c_terseLabel_en-US" xlink:label="lab_jnj_SurgeryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgery</link:label>
    <link:label id="lab_jnj_SurgeryMember_label_en-US" xlink:label="lab_jnj_SurgeryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgery [Member]</link:label>
    <link:label id="lab_jnj_SurgeryMember_documentation_en-US" xlink:label="lab_jnj_SurgeryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgery [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SurgeryMember" xlink:href="jnj-20200927.xsd#jnj_SurgeryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_SurgeryMember" xlink:to="lab_jnj_SurgeryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrentAbstract_f779e985-677a-4143-a9ce-71c145cd68d7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Current Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract" xlink:to="lab_us-gaap_LongTermDebtNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_RemicadeMember_736fd925-fa10-4aa7-994e-a0dce0c010de_terseLabel_en-US" xlink:label="lab_jnj_RemicadeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REMICADE&#174;</link:label>
    <link:label id="lab_jnj_RemicadeMember_label_en-US" xlink:label="lab_jnj_RemicadeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remicade [Member]</link:label>
    <link:label id="lab_jnj_RemicadeMember_documentation_en-US" xlink:label="lab_jnj_RemicadeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remicade [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RemicadeMember" xlink:href="jnj-20200927.xsd#jnj_RemicadeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_RemicadeMember" xlink:to="lab_jnj_RemicadeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_7406a9b0-420e-4310-9787-87442cc28483_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_6a0c3abc-1e75-4f16-a9a2-1e2b2c883a76_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_f53f0ecc-8364-4381-afa2-01cec9d57ef3_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_cdfec08d-7284-4dc5-aace-38f88ca0d38d_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_TremfyaMember_27feef80-a283-405d-b133-18cc7e0b8619_terseLabel_en-US" xlink:label="lab_jnj_TremfyaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TREMFYA&#174;</link:label>
    <link:label id="lab_jnj_TremfyaMember_label_en-US" xlink:label="lab_jnj_TremfyaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tremfya [Member]</link:label>
    <link:label id="lab_jnj_TremfyaMember_documentation_en-US" xlink:label="lab_jnj_TremfyaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tremfaya</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_TremfyaMember" xlink:href="jnj-20200927.xsd#jnj_TremfyaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_TremfyaMember" xlink:to="lab_jnj_TremfyaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_14eaaed2-1b63-44f5-a60e-9ff8e08afe66_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_NeuroscienceMember_00ba7072-315f-4fe3-a628-991816f350bf_terseLabel_en-US" xlink:label="lab_jnj_NeuroscienceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuroscience</link:label>
    <link:label id="lab_jnj_NeuroscienceMember_label_en-US" xlink:label="lab_jnj_NeuroscienceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuroscience [Member]</link:label>
    <link:label id="lab_jnj_NeuroscienceMember_documentation_en-US" xlink:label="lab_jnj_NeuroscienceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuroscience [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_NeuroscienceMember" xlink:href="jnj-20200927.xsd#jnj_NeuroscienceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_NeuroscienceMember" xlink:to="lab_jnj_NeuroscienceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_be732579-1809-46a0-9fd3-9eecb8f96178_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityFairValueAdjustment_43b4fa74-7f78-4b93-8c89-0025da432f9f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Fair Value Reflected in Net Income</link:label>
    <link:label id="lab_us-gaap_EquityFairValueAdjustment_label_en-US" xlink:label="lab_us-gaap_EquityFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Fair Value Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFairValueAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityFairValueAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityFairValueAdjustment" xlink:to="lab_us-gaap_EquityFairValueAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ff1d5565-115e-475f-bf75-fd4ef4d4f338_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_977af278-62cc-4655-bce3-ada538e8af9d_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_c69a978c-03bc-4c33-8319-381d93b738ee_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_49b7b21b-87d6-45fb-bec6-649bb32df2b7_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_bfc55b7c-57ea-44d2-aba8-ea398cdd1bfb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_label_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:to="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_c3da8459-c162-469a-b414-39cf22206a72_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_af851bbf-5b40-49dd-853c-47daa6f90fc7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_364d0b4a-8acd-4a9a-8ec3-421c26f9b98e_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities - Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_8cb210f4-1daa-4661-80e7-d3286dde2598_verboseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_VisionMember_b5036c26-f353-4cf3-9d51-e917846bccd3_terseLabel_en-US" xlink:label="lab_jnj_VisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vision</link:label>
    <link:label id="lab_jnj_VisionMember_label_en-US" xlink:label="lab_jnj_VisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vision [Member]</link:label>
    <link:label id="lab_jnj_VisionMember_documentation_en-US" xlink:label="lab_jnj_VisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vision[Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VisionMember" xlink:href="jnj-20200927.xsd#jnj_VisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_VisionMember" xlink:to="lab_jnj_VisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0c94a0bf-f7a8-43b0-8d77-ecbf4ea23c53_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_4415b5b8-5783-4dce-a64f-2f820a397e61_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_AccruedTaxesOnIncomeMember_2ae1da55-011c-4d82-aa59-60ab61ca0a26_terseLabel_en-US" xlink:label="lab_jnj_AccruedTaxesOnIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Taxes On Income [Member]</link:label>
    <link:label id="lab_jnj_AccruedTaxesOnIncomeMember_label_en-US" xlink:label="lab_jnj_AccruedTaxesOnIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Taxes On Income [Member]</link:label>
    <link:label id="lab_jnj_AccruedTaxesOnIncomeMember_documentation_en-US" xlink:label="lab_jnj_AccruedTaxesOnIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Taxes On Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AccruedTaxesOnIncomeMember" xlink:href="jnj-20200927.xsd#jnj_AccruedTaxesOnIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_AccruedTaxesOnIncomeMember" xlink:to="lab_jnj_AccruedTaxesOnIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_730399d1-4afe-45e5-8805-260614f4111d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesMember_b41c950d-3100-4641-b755-81683cc0f644_terseLabel_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:label id="lab_us-gaap_SalesMember_4851c0cd-58cb-4133-b9ad-177dbbde705e_verboseLabel_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to customers</link:label>
    <link:label id="lab_us-gaap_SalesMember_label_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesMember" xlink:to="lab_us-gaap_SalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_e0bba935-8ebd-4b36-866c-f25a082c1091_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_2d45552f-ab13-4483-8d3a-52afa10a5a1a_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_9042a1fd-3edd-451b-9f10-b83cf655b483_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_1587acd6-e62d-4b77-82f4-cbd0b4f07fd8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1c1ab711-b647-4073-a767-a36feb057c6b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized holding gain (loss) arising during period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_9d87cd77-7486-48bb-8065-5c66fe5c4f7a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains on equity investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_5853e319-39f1-4737-916c-930929f8cdcd_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_598ff1a7-d95e-4194-9111-b1d51ab17f4b_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_005d8225-8c43-4632-ac9d-a4216cf737fd_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_GENERALMember_cf1f376c-dbe1-44b5-bef6-17f3a747628a_terseLabel_en-US" xlink:label="lab_jnj_GENERALMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GENERAL</link:label>
    <link:label id="lab_jnj_GENERALMember_label_en-US" xlink:label="lab_jnj_GENERALMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GENERAL [Member]</link:label>
    <link:label id="lab_jnj_GENERALMember_documentation_en-US" xlink:label="lab_jnj_GENERALMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GENERAL [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_GENERALMember" xlink:href="jnj-20200927.xsd#jnj_GENERALMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_GENERALMember" xlink:to="lab_jnj_GENERALMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_e9f6980d-63ad-432c-bd53-828a738b1c30_verboseLabel_en-US" xlink:label="lab_jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill (Textuals)</link:label>
    <link:label id="lab_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_label_en-US" xlink:label="lab_jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill (Textuals) [Abstract]</link:label>
    <link:label id="lab_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_documentation_en-US" xlink:label="lab_jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill Textuals Abstract.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:href="jnj-20200927.xsd#jnj_IntangibleAssetsAndGoodwillTextualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:to="lab_jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_6e3e1067-fc31-4b27-bb3a-25206f16b2f4_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_142ff303-ae5c-4312-a7cf-ba91a87df71e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_ecb3b30d-aad8-4efa-9b8d-6eeeeda98c78_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation expense</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_acd960ed-b5a5-40c8-aa3a-10b09223a311_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_60cf17ea-1d3a-4337-97a1-94f30e7c2d01_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A3.500Notesdue2048Member_fa989c46-070e-4dc5-b8fd-fb1b47fb6d92_terseLabel_en-US" xlink:label="lab_jnj_A3.500Notesdue2048Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.50% Notes due 2048</link:label>
    <link:label id="lab_jnj_A3.500Notesdue2048Member_label_en-US" xlink:label="lab_jnj_A3.500Notesdue2048Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% Notes due 2048 [Member]</link:label>
    <link:label id="lab_jnj_A3.500Notesdue2048Member_documentation_en-US" xlink:label="lab_jnj_A3.500Notesdue2048Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% Notes due 2048 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.500Notesdue2048Member" xlink:href="jnj-20200927.xsd#jnj_A3.500Notesdue2048Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A3.500Notesdue2048Member" xlink:to="lab_jnj_A3.500Notesdue2048Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_fd7947ac-0dc5-4e93-9ee5-71134cb19f8c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_8321457e-d147-4897-93c5-9954cbc27dba_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A0550NotesDue2025Member_40b6517a-a385-481f-bec7-14b0c15fdaba_terseLabel_en-US" xlink:label="lab_jnj_A0550NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.550 Notes due 2025</link:label>
    <link:label id="lab_jnj_A0550NotesDue2025Member_label_en-US" xlink:label="lab_jnj_A0550NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.550 Notes due 2025 [Member]</link:label>
    <link:label id="lab_jnj_A0550NotesDue2025Member_documentation_en-US" xlink:label="lab_jnj_A0550NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.550 Notes due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0550NotesDue2025Member" xlink:href="jnj-20200927.xsd#jnj_A0550NotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A0550NotesDue2025Member" xlink:to="lab_jnj_A0550NotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_d32ea421-cde5-485d-8ab2-ed7e5dff226e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_4fd448b5-f13b-44ff-9f02-a85b7f193e1d_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_d1c4e544-aa1c-46f1-bbeb-44faa1e2cf2c_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EquityFairValueAdjustmentImpairmentLoss_75c31cd6-6293-4aba-8937-5428367cce99_terseLabel_en-US" xlink:label="lab_jnj_EquityFairValueAdjustmentImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Fair Value Adjustment, Impairment Loss</link:label>
    <link:label id="lab_jnj_EquityFairValueAdjustmentImpairmentLoss_label_en-US" xlink:label="lab_jnj_EquityFairValueAdjustmentImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Fair Value Adjustment, Impairment Loss</link:label>
    <link:label id="lab_jnj_EquityFairValueAdjustmentImpairmentLoss_documentation_en-US" xlink:label="lab_jnj_EquityFairValueAdjustmentImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Fair Value Adjustment, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityFairValueAdjustmentImpairmentLoss" xlink:href="jnj-20200927.xsd#jnj_EquityFairValueAdjustmentImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EquityFairValueAdjustmentImpairmentLoss" xlink:to="lab_jnj_EquityFairValueAdjustmentImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_17794993-ec71-4a52-a46b-d43c1abd38ca_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_c23d2e2a-3b76-430a-98af-6b663f329015_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_337219f6-6ed6-463a-a08b-69a65864079b_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings to cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_cc9a0a7b-40b2-4b92-8e71-1ed638b843a4_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_Restructuringchargepercenttosales_7a2cf109-4b9b-4dea-ad33-df48800ee59a_terseLabel_en-US" xlink:label="lab_jnj_Restructuringchargepercenttosales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charge percent to sales</link:label>
    <link:label id="lab_jnj_Restructuringchargepercenttosales_label_en-US" xlink:label="lab_jnj_Restructuringchargepercenttosales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charge percent to sales</link:label>
    <link:label id="lab_jnj_Restructuringchargepercenttosales_documentation_en-US" xlink:label="lab_jnj_Restructuringchargepercenttosales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charge percent to sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Restructuringchargepercenttosales" xlink:href="jnj-20200927.xsd#jnj_Restructuringchargepercenttosales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_Restructuringchargepercenttosales" xlink:to="lab_jnj_Restructuringchargepercenttosales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_6d8cf744-8b55-4d04-a175-239a17aab72c_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale or Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale or Disposed of by Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_6fa5ff69-0da5-4021-9ac6-282ccae557b7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET CASH USED BY FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_7c9a49fa-8134-46dd-b4b7-00ca933331c7_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_fafd6da9-a239-4ed8-821f-f83a2bdc520e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1f947e6e-58d9-4683-8c13-63c2f872fbc1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for taxes on income</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_41f1c7c6-0ac3-4e36-a419-ca131491d146_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain on sale of assets/businesses</link:label>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_SPINEOTHERMember_60d3b50a-00f3-41d3-9feb-ce1e1fc34dec_terseLabel_en-US" xlink:label="lab_jnj_SPINEOTHERMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPINE, SPORTS &amp; OTHER</link:label>
    <link:label id="lab_jnj_SPINEOTHERMember_label_en-US" xlink:label="lab_jnj_SPINEOTHERMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPINE &amp; OTHER [Member]</link:label>
    <link:label id="lab_jnj_SPINEOTHERMember_documentation_en-US" xlink:label="lab_jnj_SPINEOTHERMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPINE &amp; OTHER [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SPINEOTHERMember" xlink:href="jnj-20200927.xsd#jnj_SPINEOTHERMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_SPINEOTHERMember" xlink:to="lab_jnj_SPINEOTHERMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_58e7a469-4804-4299-b0c3-5b623da38b9a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Gross Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_f3d51700-8fef-4ebd-b64c-2a4a6576ac21_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax_c7e26c85-2f37-4ba6-b526-085b0737a1fd_negatedTerseLabel_en-US" xlink:label="lab_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) amortization during period</link:label>
    <link:label id="lab_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax_label_en-US" xlink:label="lab_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI Pension and Other Postretirement Benefit Plans for Net Gain Loss, Net of Amortization, Net of Tax</link:label>
    <link:label id="lab_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax_documentation_en-US" xlink:label="lab_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI Pension and Other Postretirement Benefit Plans for Net Gain Loss, Net of Amortization, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" xlink:href="jnj-20200927.xsd#jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" xlink:to="lab_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_CostOfGoodsSoldPercentToSales_af5e1eda-7d65-44c7-b3b3-c7f3d75d40fa_terseLabel_en-US" xlink:label="lab_jnj_CostOfGoodsSoldPercentToSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold percent to sales</link:label>
    <link:label id="lab_jnj_CostOfGoodsSoldPercentToSales_label_en-US" xlink:label="lab_jnj_CostOfGoodsSoldPercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Goods Sold Percent To Sales</link:label>
    <link:label id="lab_jnj_CostOfGoodsSoldPercentToSales_documentation_en-US" xlink:label="lab_jnj_CostOfGoodsSoldPercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold percent to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CostOfGoodsSoldPercentToSales" xlink:href="jnj-20200927.xsd#jnj_CostOfGoodsSoldPercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_CostOfGoodsSoldPercentToSales" xlink:to="lab_jnj_CostOfGoodsSoldPercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_AdvancedSterilizationProductsMember_e653a9c8-d5b0-4a2f-95fd-75f6132c6b34_terseLabel_en-US" xlink:label="lab_jnj_AdvancedSterilizationProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AdvancedSterilizationProducts</link:label>
    <link:label id="lab_jnj_AdvancedSterilizationProductsMember_label_en-US" xlink:label="lab_jnj_AdvancedSterilizationProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AdvancedSterilizationProducts [Member]</link:label>
    <link:label id="lab_jnj_AdvancedSterilizationProductsMember_documentation_en-US" xlink:label="lab_jnj_AdvancedSterilizationProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AdvancedSterilizationProducts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AdvancedSterilizationProductsMember" xlink:href="jnj-20200927.xsd#jnj_AdvancedSterilizationProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_AdvancedSterilizationProductsMember" xlink:to="lab_jnj_AdvancedSterilizationProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_5e344d4c-471b-440f-95f4-232008eb93a6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_e53b7bec-69ee-4b6b-876c-d54bf3e1e3b1_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_ba184071-1d42-48cc-95f1-7b0c9b1870e6_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee related obligations (Note 6)</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_e0ae059a-f815-48b7-aebb-a881c76ea6ae_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net (Note 3)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_ac3df743-795e-4e1b-bf2f-1af3fee8ef63_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible assets - net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_9c405d6c-a7ce-4543-a39d-f8a4a264f432_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ImmunologyMember_570034b7-2def-4d51-9e6d-5d81c07f0469_terseLabel_en-US" xlink:label="lab_jnj_ImmunologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immunology</link:label>
    <link:label id="lab_jnj_ImmunologyMember_label_en-US" xlink:label="lab_jnj_ImmunologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immunology [Member]</link:label>
    <link:label id="lab_jnj_ImmunologyMember_documentation_en-US" xlink:label="lab_jnj_ImmunologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immunology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ImmunologyMember" xlink:href="jnj-20200927.xsd#jnj_ImmunologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ImmunologyMember" xlink:to="lab_jnj_ImmunologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_308ba7c1-92ea-408f-b0d1-2e7c323a8a21_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (primarily licenses and milestones)</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement_fc5fcfb9-07bf-458b-8d2d-eec25f3ea386_terseLabel_en-US" xlink:label="lab_jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate from revised agreement (as a percent)</link:label>
    <link:label id="lab_jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement_label_en-US" xlink:label="lab_jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Percent, Revised Agreement from Litigation Settlement</link:label>
    <link:label id="lab_jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement_documentation_en-US" xlink:label="lab_jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Percent, Revised Agreement from Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement" xlink:href="jnj-20200927.xsd#jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement" xlink:to="lab_jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_bd564317-aa31-4ef1-acd1-b0d493723f73_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollateralAlreadyPostedAggregateFairValue_60b9a486-6ba0-4000-beeb-b56c7ebbda0b_terseLabel_en-US" xlink:label="lab_us-gaap_CollateralAlreadyPostedAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral Already Posted, Aggregate Fair Value</link:label>
    <link:label id="lab_us-gaap_CollateralAlreadyPostedAggregateFairValue_label_en-US" xlink:label="lab_us-gaap_CollateralAlreadyPostedAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral Already Posted, Aggregate Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CollateralAlreadyPostedAggregateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue" xlink:to="lab_us-gaap_CollateralAlreadyPostedAggregateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_bb2e5622-e22c-464f-a82d-5bd8a381778c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_54bd8442-4669-4617-bb53-466f53019140_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_07371ce0-e0fb-4f93-ba20-4d7dbcd00298_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_a85fe62b-3be4-4e5c-9579-b63f74ad051e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableAxis_ff6b64f6-dde4-4ef0-9339-b79f878a782f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableAxis_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis" xlink:to="lab_us-gaap_OtherInvestmentNotReadilyMarketableAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_303ac54c-a80e-4696-a638-8869db4c3197_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Investment Gain (Loss) Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_93e7eb27-bc2e-45d3-a401-49dcf479c39b_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes on income (Note 5)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_28b5a890-62df-4916-840f-db69a18ede54_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_ed58d5e6-2cb2-4ce3-b6e9-1c1785a44f78_terseLabel_en-US" xlink:label="lab_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived And Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived And Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived And Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:href="jnj-20200927.xsd#jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:to="lab_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A1.150NotesDue2028Member_dbc2f76e-da83-450f-b236-d3a232b6bfd6_verboseLabel_en-US" xlink:label="lab_jnj_A1.150NotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.150% Notes Due November 2028</link:label>
    <link:label id="lab_jnj_A1.150NotesDue2028Member_ca34746a-9279-4678-b72c-7ce293b5db14_terseLabel_en-US" xlink:label="lab_jnj_A1.150NotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.150% Notes due 2028 (750MM Euro 1.1641)</link:label>
    <link:label id="lab_jnj_A1.150NotesDue2028Member_label_en-US" xlink:label="lab_jnj_A1.150NotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.150% Notes Due 2028 [Member]</link:label>
    <link:label id="lab_jnj_A1.150NotesDue2028Member_documentation_en-US" xlink:label="lab_jnj_A1.150NotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.150% Notes Due 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.150NotesDue2028Member" xlink:href="jnj-20200927.xsd#jnj_A1.150NotesDue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A1.150NotesDue2028Member" xlink:to="lab_jnj_A1.150NotesDue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_58d4cf75-1d1e-4b48-b7e7-0503d88f838a_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_4b1c3444-95cc-4f59-9eac-ea7806250186_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities, Unrecognized Gain</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_6df563fd-1cce-4cfa-9645-544e2d9ca248_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_8089cfa5-2e80-49a1-990f-d5d7bd728228_verboseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt shares</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EDURANTrilpivirineMember_bccb7710-6ee6-4844-83b3-a6a18e9ff6b7_terseLabel_en-US" xlink:label="lab_jnj_EDURANTrilpivirineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EDURANT&#174; / rilpivirine</link:label>
    <link:label id="lab_jnj_EDURANTrilpivirineMember_label_en-US" xlink:label="lab_jnj_EDURANTrilpivirineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EDURANT/rilpivirine [Member]</link:label>
    <link:label id="lab_jnj_EDURANTrilpivirineMember_documentation_en-US" xlink:label="lab_jnj_EDURANTrilpivirineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EDURANT/rilpivirine [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EDURANTrilpivirineMember" xlink:href="jnj-20200927.xsd#jnj_EDURANTrilpivirineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EDURANTrilpivirineMember" xlink:to="lab_jnj_EDURANTrilpivirineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyExchangeRateTranslation1_44cc74a2-e54f-4047-8b6f-cc4fb4719f0f_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange rate</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyExchangeRateTranslation1_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Exchange Rate, Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:to="lab_us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_a1106cfa-d316-40fa-b41e-90883310abea_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b208c574-67d8-449c-9d98-ba1a17ba1e7c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A0.650NotesDue2024Member_33942024-051b-494c-b7dc-4ec7cfc2fead_verboseLabel_en-US" xlink:label="lab_jnj_A0.650NotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.650% Notes Due May 2024</link:label>
    <link:label id="lab_jnj_A0.650NotesDue2024Member_2d61ba8a-2a09-49a9-85fd-f01433b22fb8_terseLabel_en-US" xlink:label="lab_jnj_A0.650NotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.650% Notes due 2024 (750MM Euro 1.1641)</link:label>
    <link:label id="lab_jnj_A0.650NotesDue2024Member_label_en-US" xlink:label="lab_jnj_A0.650NotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.650% Notes Due 2024 [Member]</link:label>
    <link:label id="lab_jnj_A0.650NotesDue2024Member_documentation_en-US" xlink:label="lab_jnj_A0.650NotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.650% Notes Due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.650NotesDue2024Member" xlink:href="jnj-20200927.xsd#jnj_A0.650NotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A0.650NotesDue2024Member" xlink:to="lab_jnj_A0.650NotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid_7ff5dca3-137b-4607-98ab-0a4bdf766139_terseLabel_en-US" xlink:label="lab_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of cash outlays for severance expected to be paid out</link:label>
    <link:label id="lab_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid_label_en-US" xlink:label="lab_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Cost, Expected Period Of Cash Outlays For Severance Paid</link:label>
    <link:label id="lab_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid_documentation_en-US" xlink:label="lab_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Cost, Expected Period Of Cash Outlays For Severance Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid" xlink:href="jnj-20200927.xsd#jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid" xlink:to="lab_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_LossContingencyEstimateOfAdditionalPossibleLoss_60f7e809-2bd8-480a-bf1c-5a9a0585f36c_terseLabel_en-US" xlink:label="lab_jnj_LossContingencyEstimateOfAdditionalPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Additional Possible Loss</link:label>
    <link:label id="lab_jnj_LossContingencyEstimateOfAdditionalPossibleLoss_label_en-US" xlink:label="lab_jnj_LossContingencyEstimateOfAdditionalPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Additional Possible Loss</link:label>
    <link:label id="lab_jnj_LossContingencyEstimateOfAdditionalPossibleLoss_documentation_en-US" xlink:label="lab_jnj_LossContingencyEstimateOfAdditionalPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Additional Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LossContingencyEstimateOfAdditionalPossibleLoss" xlink:href="jnj-20200927.xsd#jnj_LossContingencyEstimateOfAdditionalPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_LossContingencyEstimateOfAdditionalPossibleLoss" xlink:to="lab_jnj_LossContingencyEstimateOfAdditionalPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f14f22db-b135-4a7f-9b8a-805c81fd68cf_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_6bfec1de-1d84-4c65-b10f-53d575d6c124_totalLabel_en-US" xlink:label="lab_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before provision for taxes on income percent to sales</link:label>
    <link:label id="lab_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_label_en-US" xlink:label="lab_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments Percent To Sales</link:label>
    <link:label id="lab_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_documentation_en-US" xlink:label="lab_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income loss from continuing operations before income taxes minority interest and income loss from equity method investments percent to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" xlink:href="jnj-20200927.xsd#jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" xlink:to="lab_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent_6d20ea9e-3516-4567-b836-b0bd0e770022_terseLabel_en-US" xlink:label="lab_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact to effective tax rate, percent</link:label>
    <link:label id="lab_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent_label_en-US" xlink:label="lab_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Increase (Decrease), Percent</link:label>
    <link:label id="lab_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent_documentation_en-US" xlink:label="lab_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Increase (Decrease), Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent" xlink:href="jnj-20200927.xsd#jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent" xlink:to="lab_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_AmountPrepaidAndDueToManufacturers_55ab285f-4f6c-46f3-8188-06322877e4fd_terseLabel_en-US" xlink:label="lab_jnj_AmountPrepaidAndDueToManufacturers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount prepaid and due to manufacturers</link:label>
    <link:label id="lab_jnj_AmountPrepaidAndDueToManufacturers_label_en-US" xlink:label="lab_jnj_AmountPrepaidAndDueToManufacturers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Prepaid and Due to Manufacturers</link:label>
    <link:label id="lab_jnj_AmountPrepaidAndDueToManufacturers_documentation_en-US" xlink:label="lab_jnj_AmountPrepaidAndDueToManufacturers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Prepaid and Due to Manufacturers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AmountPrepaidAndDueToManufacturers" xlink:href="jnj-20200927.xsd#jnj_AmountPrepaidAndDueToManufacturers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_AmountPrepaidAndDueToManufacturers" xlink:to="lab_jnj_AmountPrepaidAndDueToManufacturers" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_WomensHealthMember_eef1b845-bb97-4596-84ca-0f43e8b37f0e_terseLabel_en-US" xlink:label="lab_jnj_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health</link:label>
    <link:label id="lab_jnj_WomensHealthMember_label_en-US" xlink:label="lab_jnj_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health [Member]</link:label>
    <link:label id="lab_jnj_WomensHealthMember_documentation_en-US" xlink:label="lab_jnj_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WomensHealthMember" xlink:href="jnj-20200927.xsd#jnj_WomensHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_WomensHealthMember" xlink:to="lab_jnj_WomensHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_7847a2df-dae2-4a93-9ee6-02c4f19e7107_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_c55a7049-4c24-49e7-8514-3338aba9709f_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_d337d677-927a-4da1-858a-ce9dac04f8d2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_IMBRUVICAMember_c374fb09-62a1-47ed-b2a2-fcfc963331c7_terseLabel_en-US" xlink:label="lab_jnj_IMBRUVICAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IMBRUVICA&#174;</link:label>
    <link:label id="lab_jnj_IMBRUVICAMember_label_en-US" xlink:label="lab_jnj_IMBRUVICAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IMBRUVICA [Member]</link:label>
    <link:label id="lab_jnj_IMBRUVICAMember_documentation_en-US" xlink:label="lab_jnj_IMBRUVICAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IMBRUVICA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IMBRUVICAMember" xlink:href="jnj-20200927.xsd#jnj_IMBRUVICAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_IMBRUVICAMember" xlink:to="lab_jnj_IMBRUVICAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_98bb13b5-c65d-405e-9b9a-6bc4f45cccda_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_3df8199b-11fa-43f0-a7f7-4b3d30bf72cb_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Profit by Segment of Business</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_beff8a8f-3761-4c2f-8120-0a3781ede9d6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A2250NotesDue2050Member_96a6b6eb-f8cf-448a-ab3a-d039562c20fa_terseLabel_en-US" xlink:label="lab_jnj_A2250NotesDue2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.250% Notes due 2050</link:label>
    <link:label id="lab_jnj_A2250NotesDue2050Member_label_en-US" xlink:label="lab_jnj_A2250NotesDue2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.250% Notes due 2050 [Member]</link:label>
    <link:label id="lab_jnj_A2250NotesDue2050Member_documentation_en-US" xlink:label="lab_jnj_A2250NotesDue2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.250% Notes due 2050</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2250NotesDue2050Member" xlink:href="jnj-20200927.xsd#jnj_A2250NotesDue2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A2250NotesDue2050Member" xlink:to="lab_jnj_A2250NotesDue2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_a6935200-1cf8-4589-a050-333a81adb012_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping, Disclosure Item Amounts</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_b45a3a7c-bd6d-42e3-ad79-d44577e289c1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_25a28520-e20e-41d1-aef9-e98109372fce_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_3ca89e11-3e21-4946-8843-264e2312823c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_948b3884-1897-4fd2-93e5-bdb6fdcaa743_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_102011c1-009f-4955-8293-4c131526a20a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1ad1be6b-c5f3-4817-ba9a-f8748ec5a919_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OralCareMember_0015d7b6-37ae-4d5f-bc5b-f6492bb45982_terseLabel_en-US" xlink:label="lab_jnj_OralCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care</link:label>
    <link:label id="lab_jnj_OralCareMember_label_en-US" xlink:label="lab_jnj_OralCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care [Member]</link:label>
    <link:label id="lab_jnj_OralCareMember_documentation_en-US" xlink:label="lab_jnj_OralCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OralCareMember" xlink:href="jnj-20200927.xsd#jnj_OralCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OralCareMember" xlink:to="lab_jnj_OralCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_80e9793c-6b2f-43d9-8ba0-1a0ff81dd90c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_6e66e501-9908-4688-94cd-4744129ff66c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_08950cad-b487-4d1c-9bfe-43ee08cc677e_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_471081d7-0f2b-40ab-85fb-f9b89e4c7b34_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OPSUMITMember_49e3f539-9e61-457b-9b47-4cc394f3fc0b_terseLabel_en-US" xlink:label="lab_jnj_OPSUMITMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPSUMIT&#174;</link:label>
    <link:label id="lab_jnj_OPSUMITMember_label_en-US" xlink:label="lab_jnj_OPSUMITMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPSUMIT [Member]</link:label>
    <link:label id="lab_jnj_OPSUMITMember_documentation_en-US" xlink:label="lab_jnj_OPSUMITMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPSUMIT [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OPSUMITMember" xlink:href="jnj-20200927.xsd#jnj_OPSUMITMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OPSUMITMember" xlink:to="lab_jnj_OPSUMITMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_3fa1f862-e62f-4804-89aa-d56b373a5e92_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-to-maturity Securities - Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_206938fb-4924-4e70-84c4-c2dc0f3930b0_terseLabel_en-US" xlink:label="lab_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived And Indefinite-Lived Intangible Assets By Major Class [Table]</link:label>
    <link:label id="lab_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_label_en-US" xlink:label="lab_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived And Indefinite-Lived Intangible Assets By Major Class [Table]</link:label>
    <link:label id="lab_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_documentation_en-US" xlink:label="lab_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived And Indefinite-Lived Intangible Assets By Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:href="jnj-20200927.xsd#jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:to="lab_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_365127b9-faff-4b83-9c7f-4332710d02ad_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_620ebe35-da72-442c-b530-43977bf9eea2_verboseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_903b6ce7-8f48-49fb-b79d-6d38d7768848_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</link:label>
    <link:label id="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_a33b6979-ca2a-4237-b9ee-63283ef81cca_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:to="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_e86d9426-0d9b-49a0-9cfb-69cc4c6635e5_negatedLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-to-maturity Securities, Unrecognized Loss</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A0.250NotesDue2022Member_27361814-5e0f-4d4d-a089-a5fb1c640bf2_verboseLabel_en-US" xlink:label="lab_jnj_A0.250NotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.250% Notes Due January 2022</link:label>
    <link:label id="lab_jnj_A0.250NotesDue2022Member_df8765ce-495a-4933-9e51-d05b063c3180_terseLabel_en-US" xlink:label="lab_jnj_A0.250NotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.250% Notes due 2022 (1B Euro 1.1641)</link:label>
    <link:label id="lab_jnj_A0.250NotesDue2022Member_label_en-US" xlink:label="lab_jnj_A0.250NotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.250% Notes Due 2022 [Member]</link:label>
    <link:label id="lab_jnj_A0.250NotesDue2022Member_documentation_en-US" xlink:label="lab_jnj_A0.250NotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.250% Notes Due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.250NotesDue2022Member" xlink:href="jnj-20200927.xsd#jnj_A0.250NotesDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A0.250NotesDue2022Member" xlink:to="lab_jnj_A0.250NotesDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_e6d6a41a-3d31-4afd-ac23-16e832ad44f7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_b6b6aaad-c6f7-49d2-8925-c02027c76cb8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_2250c247-bd1a-4b80-9eec-5ad82608ff09_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A2.900Notesdue2028Member_52456fe0-5cc7-4a0c-a43a-0f9c6787a0d5_terseLabel_en-US" xlink:label="lab_jnj_A2.900Notesdue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.90%&#160;Notes due 2028</link:label>
    <link:label id="lab_jnj_A2.900Notesdue2028Member_label_en-US" xlink:label="lab_jnj_A2.900Notesdue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.900% Notes due 2028 [Member]</link:label>
    <link:label id="lab_jnj_A2.900Notesdue2028Member_documentation_en-US" xlink:label="lab_jnj_A2.900Notesdue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.900% Notes due 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.900Notesdue2028Member" xlink:href="jnj-20200927.xsd#jnj_A2.900Notesdue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A2.900Notesdue2028Member" xlink:to="lab_jnj_A2.900Notesdue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_UNITEDSTATESExportsMember_9e98d162-b3e9-4316-bfbb-934049c3e3d9_terseLabel_en-US" xlink:label="lab_jnj_UNITEDSTATESExportsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Exports</link:label>
    <link:label id="lab_jnj_UNITEDSTATESExportsMember_label_en-US" xlink:label="lab_jnj_UNITEDSTATESExportsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES Exports [Member]</link:label>
    <link:label id="lab_jnj_UNITEDSTATESExportsMember_documentation_en-US" xlink:label="lab_jnj_UNITEDSTATESExportsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES Exports [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_UNITEDSTATESExportsMember" xlink:href="jnj-20200927.xsd#jnj_UNITEDSTATESExportsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_UNITEDSTATESExportsMember" xlink:to="lab_jnj_UNITEDSTATESExportsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_6fb32867-b79b-4edf-abea-dd78f7a566b1_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve balance beginning</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_7a7dec37-b91f-4436-a180-b5a2bfea05ed_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve balance ending</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1a8a3a20-915e-4975-9ad5-38e5c1388c4e_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_AssetWriteoffMember_192371d0-7b0d-47b5-a338-2e35c10cf65e_terseLabel_en-US" xlink:label="lab_jnj_AssetWriteoffMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Write-off</link:label>
    <link:label id="lab_jnj_AssetWriteoffMember_label_en-US" xlink:label="lab_jnj_AssetWriteoffMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Write-off [Member]</link:label>
    <link:label id="lab_jnj_AssetWriteoffMember_documentation_en-US" xlink:label="lab_jnj_AssetWriteoffMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Write-off [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AssetWriteoffMember" xlink:href="jnj-20200927.xsd#jnj_AssetWriteoffMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_AssetWriteoffMember" xlink:to="lab_jnj_AssetWriteoffMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_6c69ce78-bb99-4fff-982f-11148b6af6b2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges recorded to date</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_db8b7cc8-70cc-4345-bd8b-d9332e4c6ab5_terseLabel_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time deposits(1)</link:label>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_label_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Time Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BankTimeDepositsMember" xlink:to="lab_us-gaap_BankTimeDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_aaedfb30-bc48-42e4-8625-28b2029b227e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_05f46034-50b2-493d-a5ea-1c4ed862f37c_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure_31841601-3a40-4104-842e-165141debe1a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of previously held equity investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_731a927c-3857-421d-aa5a-8b0873caa81f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ce05925a-debb-4818-871b-92692d5fcdfa_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_d4b9fd53-208d-4aba-958f-efc9b2a4187d_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_9612bab3-e4f7-4867-bc4c-5f864e84f896_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_0f31b8c7-57b1-4aed-9e00-afbc5a7931f4_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_18a327a6-5bef-47bb-9dda-946a772d8fb9_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_AsrMember_fdfe6245-6693-4265-9eeb-5d80156568e9_terseLabel_en-US" xlink:label="lab_jnj_AsrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR</link:label>
    <link:label id="lab_jnj_AsrMember_label_en-US" xlink:label="lab_jnj_AsrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR [Member]</link:label>
    <link:label id="lab_jnj_AsrMember_documentation_en-US" xlink:label="lab_jnj_AsrMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AsrMember" xlink:href="jnj-20200927.xsd#jnj_AsrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_AsrMember" xlink:to="lab_jnj_AsrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_83437f49-a908-42e2-ad37-dd011cbce31d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_IdorsiaLTDMember_95658e48-a2f6-4dca-b6d6-257cb993097a_terseLabel_en-US" xlink:label="lab_jnj_IdorsiaLTDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Idorsia</link:label>
    <link:label id="lab_jnj_IdorsiaLTDMember_label_en-US" xlink:label="lab_jnj_IdorsiaLTDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Idorsia LTD [Member]</link:label>
    <link:label id="lab_jnj_IdorsiaLTDMember_documentation_en-US" xlink:label="lab_jnj_IdorsiaLTDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Idorsia LTD</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IdorsiaLTDMember" xlink:href="jnj-20200927.xsd#jnj_IdorsiaLTDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_IdorsiaLTDMember" xlink:to="lab_jnj_IdorsiaLTDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ExcessOfFairValueOverCarryingValueOfDebt_894d36c2-c4f4-44ee-ba43-89518d34fc2f_terseLabel_en-US" xlink:label="lab_jnj_ExcessOfFairValueOverCarryingValueOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess of the estimated fair value over the carrying value of debt</link:label>
    <link:label id="lab_jnj_ExcessOfFairValueOverCarryingValueOfDebt_label_en-US" xlink:label="lab_jnj_ExcessOfFairValueOverCarryingValueOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess Of Fair Value Over Carrying Value Of Debt</link:label>
    <link:label id="lab_jnj_ExcessOfFairValueOverCarryingValueOfDebt_documentation_en-US" xlink:label="lab_jnj_ExcessOfFairValueOverCarryingValueOfDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess of fair value over carrying value of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ExcessOfFairValueOverCarryingValueOfDebt" xlink:href="jnj-20200927.xsd#jnj_ExcessOfFairValueOverCarryingValueOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ExcessOfFairValueOverCarryingValueOfDebt" xlink:to="lab_jnj_ExcessOfFairValueOverCarryingValueOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3ce7f115-ed84-4d2d-a938-d9dbcaaecbfb_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_4545e2d1-b395-4d56-bfa3-c566c175e145_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivatives Recorded in Consolidated Balance Sheet</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Liabilities at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_GrossProfitPercentToSales_a2707bfc-550c-4b01-ba6c-b2ac9b43a07f_totalLabel_en-US" xlink:label="lab_jnj_GrossProfitPercentToSales" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit percent to sales</link:label>
    <link:label id="lab_jnj_GrossProfitPercentToSales_label_en-US" xlink:label="lab_jnj_GrossProfitPercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit Percent To Sales</link:label>
    <link:label id="lab_jnj_GrossProfitPercentToSales_documentation_en-US" xlink:label="lab_jnj_GrossProfitPercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit percent to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_GrossProfitPercentToSales" xlink:href="jnj-20200927.xsd#jnj_GrossProfitPercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_GrossProfitPercentToSales" xlink:to="lab_jnj_GrossProfitPercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_b2c2a1b0-b9dd-4d4b-9ba0-f367517bb931_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_b13c8a08-3bb7-4d67-9ec8-fda3e835c57e_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, marketing and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillOtherIncreaseDecrease_3bff01b2-4c5f-444b-a3b5-e0f43bfe6500_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation/Other</link:label>
    <link:label id="lab_us-gaap_GoodwillOtherIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Other Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillOtherIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_767105d4-efe1-43c1-a53c-131f9898b694_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_040dcb8c-4e12-44de-aa0a-43e1253918ee_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A4.95Debenturesdue2033Member_6848bcb0-7d7b-4893-ba55-b0a0a63be1dd_terseLabel_en-US" xlink:label="lab_jnj_A4.95Debenturesdue2033Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.95% Debentures due 2033</link:label>
    <link:label id="lab_jnj_A4.95Debenturesdue2033Member_label_en-US" xlink:label="lab_jnj_A4.95Debenturesdue2033Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.95% Debentures due 2033 [Member]</link:label>
    <link:label id="lab_jnj_A4.95Debenturesdue2033Member_documentation_en-US" xlink:label="lab_jnj_A4.95Debenturesdue2033Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.95% Debentures due 2033 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.95Debenturesdue2033Member" xlink:href="jnj-20200927.xsd#jnj_A4.95Debenturesdue2033Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A4.95Debenturesdue2033Member" xlink:to="lab_jnj_A4.95Debenturesdue2033Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_KNEESMember_e5a44eb0-1d79-402d-9eca-289035199796_terseLabel_en-US" xlink:label="lab_jnj_KNEESMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KNEES</link:label>
    <link:label id="lab_jnj_KNEESMember_label_en-US" xlink:label="lab_jnj_KNEESMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KNEES [Member]</link:label>
    <link:label id="lab_jnj_KNEESMember_documentation_en-US" xlink:label="lab_jnj_KNEESMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KNEES [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_KNEESMember" xlink:href="jnj-20200927.xsd#jnj_KNEESMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_KNEESMember" xlink:to="lab_jnj_KNEESMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_e0ed72ae-dac0-43a0-acec-7d54de04ae0c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_SellingGeneralAndAdministrativeExpensePercentToSales_8851f111-c7e8-4233-9d88-412cba0f067a_terseLabel_en-US" xlink:label="lab_jnj_SellingGeneralAndAdministrativeExpensePercentToSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling marketing and administrative expenses percent to sales</link:label>
    <link:label id="lab_jnj_SellingGeneralAndAdministrativeExpensePercentToSales_label_en-US" xlink:label="lab_jnj_SellingGeneralAndAdministrativeExpensePercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling General And Administrative Expense Percent To Sales</link:label>
    <link:label id="lab_jnj_SellingGeneralAndAdministrativeExpensePercentToSales_documentation_en-US" xlink:label="lab_jnj_SellingGeneralAndAdministrativeExpensePercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling general and administrative expense percent to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SellingGeneralAndAdministrativeExpensePercentToSales" xlink:href="jnj-20200927.xsd#jnj_SellingGeneralAndAdministrativeExpensePercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_SellingGeneralAndAdministrativeExpensePercentToSales" xlink:to="lab_jnj_SellingGeneralAndAdministrativeExpensePercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9b8d9015-18a2-4d19-9d79-817554f3b786_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic Net Earnings per Share to Diluted Net Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_JudicialRulingMember_de8866a6-51e9-4dd6-a5fc-a154be72c784_terseLabel_en-US" xlink:label="lab_us-gaap_JudicialRulingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judicial Ruling</link:label>
    <link:label id="lab_us-gaap_JudicialRulingMember_label_en-US" xlink:label="lab_us-gaap_JudicialRulingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judicial Ruling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_JudicialRulingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_JudicialRulingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_JudicialRulingMember" xlink:to="lab_us-gaap_JudicialRulingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_448ff5b1-cb9b-47c8-a671-165ea6db4c48_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt (Note 4)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_29437e16-6315-491c-be37-1ed0e68256b3_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Current Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_d07c3129-80a8-4c3a-a3b4-4453f637636f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_e07a885d-e84e-4182-9627-f63b0cd1a39f_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_9c0545b0-f8de-4d64-b749-419ed757a0e9_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7877c685-280d-4f50-80e7-190b4e150669_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_aa4477ae-4720-4c63-9a36-d833ff216518_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_242d5b02-dc5e-48b9-9755-7e238803fab5_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and employee related obligations</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_5822112f-97cb-4ca2-95a8-ba6406e596de_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant other observable inputs Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_e510acd6-959a-4ae8-8ae3-60cf2b9b9c85_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_19411f48-f05f-4331-803d-f4a71e4198d5_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials and supplies</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_fbfd7283-1532-46a9-925e-e93b0e523e89_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_IncomeTaxTextualsAbstract_16d9168b-5588-424e-ac13-edea5384c4ca_verboseLabel_en-US" xlink:label="lab_jnj_IncomeTaxTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax (Textuals)</link:label>
    <link:label id="lab_jnj_IncomeTaxTextualsAbstract_label_en-US" xlink:label="lab_jnj_IncomeTaxTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax (Textuals) [Abstract]</link:label>
    <link:label id="lab_jnj_IncomeTaxTextualsAbstract_documentation_en-US" xlink:label="lab_jnj_IncomeTaxTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Textuals Abstract.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeTaxTextualsAbstract" xlink:href="jnj-20200927.xsd#jnj_IncomeTaxTextualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_IncomeTaxTextualsAbstract" xlink:to="lab_jnj_IncomeTaxTextualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_47b6e0e3-1ca6-4823-8a56-73ddc00367d2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_2063fc67-675f-4b9b-94ac-e8b28705f96f_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale, Maturity and Collection of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_eb8b2b24-b6e8-4d6c-98ac-74318d14fad7_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_5bca3a80-b551-407b-b3e5-16ef4147fe33_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Derivatives not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_78bc3b33-570b-4117-81f6-d996ae47b5b4_verboseLabel_en-US" xlink:label="lab_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of designated derivatives</link:label>
    <link:label id="lab_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_label_en-US" xlink:label="lab_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Gain Loss On Statement Of Financial Performance Abstract</link:label>
    <link:label id="lab_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_documentation_en-US" xlink:label="lab_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments gain loss on statement of financial performance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:href="jnj-20200927.xsd#jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:to="lab_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ProductLiabilityContingencyNumberOfClaimant_524bdc2e-184f-4db1-b1b4-fb118a7218db_terseLabel_en-US" xlink:label="lab_jnj_ProductLiabilityContingencyNumberOfClaimant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency Number Of Claimants</link:label>
    <link:label id="lab_jnj_ProductLiabilityContingencyNumberOfClaimant_label_en-US" xlink:label="lab_jnj_ProductLiabilityContingencyNumberOfClaimant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency Number Of Claimant</link:label>
    <link:label id="lab_jnj_ProductLiabilityContingencyNumberOfClaimant_documentation_en-US" xlink:label="lab_jnj_ProductLiabilityContingencyNumberOfClaimant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability contingency number of claimant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ProductLiabilityContingencyNumberOfClaimant" xlink:href="jnj-20200927.xsd#jnj_ProductLiabilityContingencyNumberOfClaimant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ProductLiabilityContingencyNumberOfClaimant" xlink:to="lab_jnj_ProductLiabilityContingencyNumberOfClaimant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_50e22e0c-de25-459c-a5b4-cc5fa22b4982_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development in Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentInProcess" xlink:to="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_33cdd360-8ff8-428f-9134-fa43c8bc9b4c_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfSubsidiaryGainLossMember_89be7088-6a29-470b-b659-6196a50302a4_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfSubsidiaryGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Subsidiary Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_SaleOfSubsidiaryGainLossMember_label_en-US" xlink:label="lab_us-gaap_SaleOfSubsidiaryGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Subsidiary Gain (Loss) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfSubsidiaryGainLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfSubsidiaryGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfSubsidiaryGainLossMember" xlink:to="lab_us-gaap_SaleOfSubsidiaryGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_77788cf6-06e7-438d-8fa0-b976837b4d91_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_d578dfbf-09ba-44e5-a2a8-2283ebbb0bce_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Current Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_2f7bc342-f58f-4074-a7db-dd1ab41688ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_c08d6f40-cc73-463d-aaaf-41023863042f_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets and Goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_INVOKANAINVOKAMETMember_d7a2531b-cdb4-4874-932c-98ad42e5a4cb_terseLabel_en-US" xlink:label="lab_jnj_INVOKANAINVOKAMETMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVOKANA&#174; / INVOKAMET&#174;</link:label>
    <link:label id="lab_jnj_INVOKANAINVOKAMETMember_label_en-US" xlink:label="lab_jnj_INVOKANAINVOKAMETMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVOKANA/INVOKAMET [Member]</link:label>
    <link:label id="lab_jnj_INVOKANAINVOKAMETMember_documentation_en-US" xlink:label="lab_jnj_INVOKANAINVOKAMETMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVOKANA/INVOKAMET [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_INVOKANAINVOKAMETMember" xlink:href="jnj-20200927.xsd#jnj_INVOKANAINVOKAMETMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_INVOKANAINVOKAMETMember" xlink:to="lab_jnj_INVOKANAINVOKAMETMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A3.400Notesdue2038Member_d13440bd-2222-4842-9d31-60675a0f31d0_terseLabel_en-US" xlink:label="lab_jnj_A3.400Notesdue2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.40%&#160;Notes due 2038</link:label>
    <link:label id="lab_jnj_A3.400Notesdue2038Member_label_en-US" xlink:label="lab_jnj_A3.400Notesdue2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.400% Notes due 2038 [Member]</link:label>
    <link:label id="lab_jnj_A3.400Notesdue2038Member_documentation_en-US" xlink:label="lab_jnj_A3.400Notesdue2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.400% Notes due 2038 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.400Notesdue2038Member" xlink:href="jnj-20200927.xsd#jnj_A3.400Notesdue2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A3.400Notesdue2038Member" xlink:to="lab_jnj_A3.400Notesdue2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_a6ce48b9-df6c-4c78-9e88-bee41930838c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c7961180-4cf8-42ed-b193-e39317fcbbbd_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f561633d-9da7-46a5-9520-9ffb4fbfa2a6_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c3250c2d-5c1d-4dfb-94fd-668a1c54e10b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e314ec90-65a3-4a06-a2dd-482e46af1698_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_e3dc5fbd-a5bc-4f53-a11b-4a2e7b412968_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_bb92f3b2-255a-494f-9a79-0e1afe7d8b5c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_d7aa7ad0-070f-4d0e-b22a-3d1b148e39a6_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Decrease)/Increase in accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A2.05Notesdue2023Member_2b52e108-8599-455f-97dd-ce736a39971e_terseLabel_en-US" xlink:label="lab_jnj_A2.05Notesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.05% Notes due 2023</link:label>
    <link:label id="lab_jnj_A2.05Notesdue2023Member_label_en-US" xlink:label="lab_jnj_A2.05Notesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.05% Notes due 2023 [Member]</link:label>
    <link:label id="lab_jnj_A2.05Notesdue2023Member_documentation_en-US" xlink:label="lab_jnj_A2.05Notesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.05% Notes due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.05Notesdue2023Member" xlink:href="jnj-20200927.xsd#jnj_A2.05Notesdue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A2.05Notesdue2023Member" xlink:to="lab_jnj_A2.05Notesdue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_VELCADEMember_69fe3c96-680b-483b-a3e8-4cbe77918461_terseLabel_en-US" xlink:label="lab_jnj_VELCADEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VELCADE&#174;</link:label>
    <link:label id="lab_jnj_VELCADEMember_label_en-US" xlink:label="lab_jnj_VELCADEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VELCADE [Member]</link:label>
    <link:label id="lab_jnj_VELCADEMember_documentation_en-US" xlink:label="lab_jnj_VELCADEMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VELCADE [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VELCADEMember" xlink:href="jnj-20200927.xsd#jnj_VELCADEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_VELCADEMember" xlink:to="lab_jnj_VELCADEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_3f8ab8c8-2745-442b-939e-72e4e24384d8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit_06d97b71-13ff-4e95-8675-045a4a5ab904_terseLabel_en-US" xlink:label="lab_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability related to TRAF</link:label>
    <link:label id="lab_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Act On Tax Reform And AHV Financing, GILTI Remeasurement, Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit_documentation_en-US" xlink:label="lab_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Act On Tax Reform And AHV Financing, GILTI Remeasurement, Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit" xlink:href="jnj-20200927.xsd#jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit" xlink:to="lab_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_db56c9ae-df6a-4600-8580-1bb51d8ed919_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_AurisHealthMember_2aef1257-04b1-4096-93bb-47c73fc101bc_terseLabel_en-US" xlink:label="lab_jnj_AurisHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auris Health</link:label>
    <link:label id="lab_jnj_AurisHealthMember_label_en-US" xlink:label="lab_jnj_AurisHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auris Health [Member]</link:label>
    <link:label id="lab_jnj_AurisHealthMember_documentation_en-US" xlink:label="lab_jnj_AurisHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auris Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AurisHealthMember" xlink:href="jnj-20200927.xsd#jnj_AurisHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_AurisHealthMember" xlink:to="lab_jnj_AurisHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c7e8cb4d-df2a-4268-862c-51c7305a5332_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cccebc60-3a8c-4d45-9f4d-b1901689a3a4_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_651f498a-2931-4605-bfd5-1c93989ab69f_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-to-maturity Securities, Unrecognized Gain</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_41c625a0-be4e-497c-8e59-37c512c9b1b7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_7789c676-8c7e-48d3-90d2-f0e0f8777a83_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_6fa89b13-6d12-4fec-9bef-155e3a028aa7_periodStartLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value, beginning of period</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_47bb689d-66d2-4868-9ddd-a12fc044165a_periodEndLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value, end of period</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_249a9957-a3b5-45df-9f04-4d7b6f4aef69_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_5d93f174-b8ac-48ca-9aa1-77a15f2bb586_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_NotesDuePeriodFifteenMember_cd5d01b0-7323-471f-9e24-d1b8d476f74f_terseLabel_en-US" xlink:label="lab_jnj_NotesDuePeriodFifteenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_jnj_NotesDuePeriodFifteenMember_label_en-US" xlink:label="lab_jnj_NotesDuePeriodFifteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due Period Fifteen Member</link:label>
    <link:label id="lab_jnj_NotesDuePeriodFifteenMember_documentation_en-US" xlink:label="lab_jnj_NotesDuePeriodFifteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes due period fifteen.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_NotesDuePeriodFifteenMember" xlink:href="jnj-20200927.xsd#jnj_NotesDuePeriodFifteenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_NotesDuePeriodFifteenMember" xlink:to="lab_jnj_NotesDuePeriodFifteenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_5537faa8-bf48-446b-beef-865700e7b8ca_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets and Liabilities at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_SalesBySegmentOfBusinessTableTextBlock_2555a5c4-03b8-401b-9e89-b008af126f42_terseLabel_en-US" xlink:label="lab_jnj_SalesBySegmentOfBusinessTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales By Segment Of Business</link:label>
    <link:label id="lab_jnj_SalesBySegmentOfBusinessTableTextBlock_label_en-US" xlink:label="lab_jnj_SalesBySegmentOfBusinessTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales By Segment Of Business [Table Text Block]</link:label>
    <link:label id="lab_jnj_SalesBySegmentOfBusinessTableTextBlock_documentation_en-US" xlink:label="lab_jnj_SalesBySegmentOfBusinessTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales by segment of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SalesBySegmentOfBusinessTableTextBlock" xlink:href="jnj-20200927.xsd#jnj_SalesBySegmentOfBusinessTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_SalesBySegmentOfBusinessTableTextBlock" xlink:to="lab_jnj_SalesBySegmentOfBusinessTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_2d788675-35da-4084-b754-61352362768e_verboseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit losses and accounts receivable allowances</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_b9c5824a-1d8b-42ee-a911-28ae83895cbb_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Net Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_c4dc4087-cfd2-4ad8-9a65-cbca8e85e1f9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A5.50NotesDue2024Member_fdb24206-1244-4b1d-979d-240aadb99f8c_verboseLabel_en-US" xlink:label="lab_jnj_A5.50NotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% Notes Due November 2024</link:label>
    <link:label id="lab_jnj_A5.50NotesDue2024Member_e9b36408-a6d7-4172-a8b9-32f9a33b76f1_terseLabel_en-US" xlink:label="lab_jnj_A5.50NotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% Notes due 2024 (500 MM GBP 1.2757)</link:label>
    <link:label id="lab_jnj_A5.50NotesDue2024Member_label_en-US" xlink:label="lab_jnj_A5.50NotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% Notes Due 2024 [Member]</link:label>
    <link:label id="lab_jnj_A5.50NotesDue2024Member_documentation_en-US" xlink:label="lab_jnj_A5.50NotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% Notes Due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.50NotesDue2024Member" xlink:href="jnj-20200927.xsd#jnj_A5.50NotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A5.50NotesDue2024Member" xlink:to="lab_jnj_A5.50NotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_c1d5c3e2-b400-4397-9a88-a84f04858c5c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsNoncurrent_442a24b0-7168-42e9-b624-cf98a80bff41_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsNoncurrent_0333127f-a859-4bea-bd40-410d32812d58_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsNoncurrent" xlink:to="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent_ef5c9ef7-d6e2-40a6-b5b2-1e9028b9a652_terseLabel_en-US" xlink:label="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax benefit related to TRAF, percent</link:label>
    <link:label id="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent_label_en-US" xlink:label="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset, Percent</link:label>
    <link:label id="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent_documentation_en-US" xlink:label="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" xlink:href="jnj-20200927.xsd#jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" xlink:to="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b386d65b-2cbb-46a6-80c9-be1ed54b9e4b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_RisperdalMember_b951cb8e-95f5-431e-96ea-663553124876_terseLabel_en-US" xlink:label="lab_jnj_RisperdalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risperdal</link:label>
    <link:label id="lab_jnj_RisperdalMember_label_en-US" xlink:label="lab_jnj_RisperdalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risperdal [Member]</link:label>
    <link:label id="lab_jnj_RisperdalMember_documentation_en-US" xlink:label="lab_jnj_RisperdalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risperdal.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RisperdalMember" xlink:href="jnj-20200927.xsd#jnj_RisperdalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_RisperdalMember" xlink:to="lab_jnj_RisperdalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionContributions_e1ff0680-6462-4469-b05c-4cab5617af15_terseLabel_en-US" xlink:label="lab_us-gaap_PensionContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution to pension plans</link:label>
    <link:label id="lab_us-gaap_PensionContributions_label_en-US" xlink:label="lab_us-gaap_PensionContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Pension Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionContributions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionContributions" xlink:to="lab_us-gaap_PensionContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A3.70Notesdue2046Member_e427079a-ce9b-4c18-92f4-18ac1578142f_terseLabel_en-US" xlink:label="lab_jnj_A3.70Notesdue2046Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.70% Notes due 2046</link:label>
    <link:label id="lab_jnj_A3.70Notesdue2046Member_label_en-US" xlink:label="lab_jnj_A3.70Notesdue2046Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.70% Notes due 2046 [Member]</link:label>
    <link:label id="lab_jnj_A3.70Notesdue2046Member_documentation_en-US" xlink:label="lab_jnj_A3.70Notesdue2046Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.70% Notes due 2046 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.70Notesdue2046Member" xlink:href="jnj-20200927.xsd#jnj_A3.70Notesdue2046Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A3.70Notesdue2046Member" xlink:to="lab_jnj_A3.70Notesdue2046Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_48f34556-13f9-4d48-aef6-6b19ff8fc814_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes on income (Note 5)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_a6a962be-888d-44ee-a3e3-a4e5c4b8f897_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_619e96a2-60d4-4a8c-a0a4-bc95eb69d2bc_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_f90c540f-de24-401e-8ff9-c4bdaebf79bf_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_2ffc17e8-e800-44d2-8aed-b7d6600dbcdf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_512a56f7-cab1-48b4-9e75-f94b2883b435_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_MedicalDevicesMember_8374ef48-e316-4ff7-bedc-41bbd4d7c3f0_terseLabel_en-US" xlink:label="lab_jnj_MedicalDevicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MEDICAL DEVICES</link:label>
    <link:label id="lab_jnj_MedicalDevicesMember_99dce4c7-c549-425a-8443-011270028ee5_verboseLabel_en-US" xlink:label="lab_jnj_MedicalDevicesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Devices</link:label>
    <link:label id="lab_jnj_MedicalDevicesMember_label_en-US" xlink:label="lab_jnj_MedicalDevicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Devices [Member]</link:label>
    <link:label id="lab_jnj_MedicalDevicesMember_documentation_en-US" xlink:label="lab_jnj_MedicalDevicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Devices [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember" xlink:href="jnj-20200927.xsd#jnj_MedicalDevicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_MedicalDevicesMember" xlink:to="lab_jnj_MedicalDevicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_d3582ff1-9fa0-4822-b866-6d2eb1d498b8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_9297df53-9f7a-40ed-bc0e-c45ca314bb9b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:to="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain_24386f15-1604-4b50-8e76-27bda8adda17_terseLabel_en-US" xlink:label="lab_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and current marketable securities, Unrecognized Gain</link:label>
    <link:label id="lab_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain_label_en-US" xlink:label="lab_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments, Accumulated Gross Unrealized Gain</link:label>
    <link:label id="lab_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain_documentation_en-US" xlink:label="lab_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments, Accumulated Gross Unrealized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain" xlink:href="jnj-20200927.xsd#jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain" xlink:to="lab_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_ec47a7c4-163c-40a3-988e-a56a67b4435d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss_1f1b3e98-b667-4683-9d19-e9152f08fda9_verboseLabel_en-US" xlink:label="lab_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of foreign exchange contracts into earnings, period</link:label>
    <link:label id="lab_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss_label_en-US" xlink:label="lab_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Reclassification of Cash Flow Hedge Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" xlink:to="lab_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_c09898c9-9aa2-4075-a507-1925d0742d07_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OtherOncologyMember_e343e08d-9953-4376-a24c-e5ffff5a03b1_terseLabel_en-US" xlink:label="lab_jnj_OtherOncologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER ONCOLOGY</link:label>
    <link:label id="lab_jnj_OtherOncologyMember_label_en-US" xlink:label="lab_jnj_OtherOncologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Oncology [Member]</link:label>
    <link:label id="lab_jnj_OtherOncologyMember_documentation_en-US" xlink:label="lab_jnj_OtherOncologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Oncology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherOncologyMember" xlink:href="jnj-20200927.xsd#jnj_OtherOncologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OtherOncologyMember" xlink:to="lab_jnj_OtherOncologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_1ce89d1c-9154-4ca3-8440-44d0c3de65bc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_1d72691d-8d1e-46c8-8406-2e9df1aac190_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_67d7988c-706f-46c2-850f-825c8609026f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income on derivatives, after tax</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_714ea6c8-0831-4cc0-9731-4402a7a83848_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_26b41fff-290b-41a4-be95-bfc63c6260d6_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_96b7b60f-f942-42b8-8f01-421671edaeee_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A6.73Debenturesdue2023Member_11d507ae-c4b7-44f6-a26b-36e457577d40_terseLabel_en-US" xlink:label="lab_jnj_A6.73Debenturesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.73% Debentures due 2023</link:label>
    <link:label id="lab_jnj_A6.73Debenturesdue2023Member_label_en-US" xlink:label="lab_jnj_A6.73Debenturesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.73% Debentures due 2023 [Member]</link:label>
    <link:label id="lab_jnj_A6.73Debenturesdue2023Member_documentation_en-US" xlink:label="lab_jnj_A6.73Debenturesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.73% Debentures due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A6.73Debenturesdue2023Member" xlink:href="jnj-20200927.xsd#jnj_A6.73Debenturesdue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A6.73Debenturesdue2023Member" xlink:to="lab_jnj_A6.73Debenturesdue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_63360a11-dc30-4380-aba7-c127a5ef54c8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_b9b778a0-f218-4b51-b6bc-64ab0fae6d81_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefit Plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_81909bfa-24fb-4872-9f6b-0b9096d4d74c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications to earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_856d0392-0a8b-415b-af31-06887e52fa08_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain/ (Loss) reclassified from Accumulated OCI into income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7117f1a3-61e6-4d1f-b1c0-84ffd65b66b0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_9addb307-180f-4e0b-98d2-e990e96d5080_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_aae6e476-f2f2-486b-b28c-b9ee432a37ac_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ERLEADAMember_7f98792a-6d0c-4161-985f-65f1ebf4d9c2_terseLabel_en-US" xlink:label="lab_jnj_ERLEADAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ERLEADA</link:label>
    <link:label id="lab_jnj_ERLEADAMember_label_en-US" xlink:label="lab_jnj_ERLEADAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ERLEADA [Member]</link:label>
    <link:label id="lab_jnj_ERLEADAMember_documentation_en-US" xlink:label="lab_jnj_ERLEADAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ERLEADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ERLEADAMember" xlink:href="jnj-20200927.xsd#jnj_ERLEADAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ERLEADAMember" xlink:to="lab_jnj_ERLEADAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_91650ab3-a8e4-4737-a31c-8d4c9b994c77_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets with indefinite lives:</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_b1d4be4f-b358-45d2-8009-e5d16ce278fe_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_a151b046-d2d9-454e-ae66-800a93612e2c_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_ec211108-8f0c-4027-972c-0f51e9dbabff_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PatentsAndTrademarksMember_a4bde035-df0a-4f89-9bb8-0428bf5d8ed2_terseLabel_en-US" xlink:label="lab_jnj_PatentsAndTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents And Trademarks</link:label>
    <link:label id="lab_jnj_PatentsAndTrademarksMember_label_en-US" xlink:label="lab_jnj_PatentsAndTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents And Trademarks [Member]</link:label>
    <link:label id="lab_jnj_PatentsAndTrademarksMember_documentation_en-US" xlink:label="lab_jnj_PatentsAndTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents And Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PatentsAndTrademarksMember" xlink:href="jnj-20200927.xsd#jnj_PatentsAndTrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PatentsAndTrademarksMember" xlink:to="lab_jnj_PatentsAndTrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_2f47476a-fcc5-405f-8228-e8b7c1be01f8_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring (Note 12)</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_62226466-a2e2-4ff5-b113-31ffafa52634_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_387b349d-df46-4a1d-960d-3542dee84ae1_verboseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_b8e06ddf-885d-4636-9e26-bc72142f9335_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_89b13415-21ca-428a-97d0-65978b2ad67c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET CASH USED BY INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A3.625Notesdue2037Member_c427cdd3-624a-48e1-9bcf-4a1cfa4fa4bc_terseLabel_en-US" xlink:label="lab_jnj_A3.625Notesdue2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625% Notes due 2037</link:label>
    <link:label id="lab_jnj_A3.625Notesdue2037Member_label_en-US" xlink:label="lab_jnj_A3.625Notesdue2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625% Notes due 2037 [Member]</link:label>
    <link:label id="lab_jnj_A3.625Notesdue2037Member_documentation_en-US" xlink:label="lab_jnj_A3.625Notesdue2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625% Notes due 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.625Notesdue2037Member" xlink:href="jnj-20200927.xsd#jnj_A3.625Notesdue2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A3.625Notesdue2037Member" xlink:to="lab_jnj_A3.625Notesdue2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OtherImmunologyMember_12e4c21f-ff27-4966-966d-eaed5795698e_terseLabel_en-US" xlink:label="lab_jnj_OtherImmunologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER IMMUNOLOGY</link:label>
    <link:label id="lab_jnj_OtherImmunologyMember_label_en-US" xlink:label="lab_jnj_OtherImmunologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Immunology [Member]</link:label>
    <link:label id="lab_jnj_OtherImmunologyMember_documentation_en-US" xlink:label="lab_jnj_OtherImmunologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Immunology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherImmunologyMember" xlink:href="jnj-20200927.xsd#jnj_OtherImmunologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OtherImmunologyMember" xlink:to="lab_jnj_OtherImmunologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_93e7683b-52c6-4ba9-aa52-430e58298c08_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition cost</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_RISPERDALCONSTAMember_44a8cfc0-3f83-4a1b-ab4c-7f9edb0bd0f4_terseLabel_en-US" xlink:label="lab_jnj_RISPERDALCONSTAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RISPERDAL CONSTA&#174;</link:label>
    <link:label id="lab_jnj_RISPERDALCONSTAMember_label_en-US" xlink:label="lab_jnj_RISPERDALCONSTAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RISPERDAL CONSTA [Member]</link:label>
    <link:label id="lab_jnj_RISPERDALCONSTAMember_documentation_en-US" xlink:label="lab_jnj_RISPERDALCONSTAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RISPERDAL CONSTA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RISPERDALCONSTAMember" xlink:href="jnj-20200927.xsd#jnj_RISPERDALCONSTAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_RISPERDALCONSTAMember" xlink:to="lab_jnj_RISPERDALCONSTAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_ed620227-23ba-42d7-94f0-35638089ed04_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and current marketable securities, Carrying Amount</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_BermekimabMember_417f8d42-f8fa-4fae-8366-7ca388e70451_terseLabel_en-US" xlink:label="lab_jnj_BermekimabMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">bermekimab</link:label>
    <link:label id="lab_jnj_BermekimabMember_label_en-US" xlink:label="lab_jnj_BermekimabMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">bermekimab [Member]</link:label>
    <link:label id="lab_jnj_BermekimabMember_documentation_en-US" xlink:label="lab_jnj_BermekimabMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">bermekimab [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BermekimabMember" xlink:href="jnj-20200927.xsd#jnj_BermekimabMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_BermekimabMember" xlink:to="lab_jnj_BermekimabMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_016f595c-0d57-4029-b9f6-d07cfad9412f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_399dfd46-3cad-4b01-a04d-53976af5229e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_cf564507-80bf-4b07-852a-6bd68c3dee34_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) arising during period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_5193efe4-8168-4744-b839-3d62baa18df7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_98e54fc2-e769-44ec-873d-c0be81a89637_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_aa3e0893-1356-404e-a4e1-7a77c855c9ca_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of short-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_2e065bb7-d2cd-4de1-92a4-87e426a589f1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_95dc4db8-b4f6-464d-8f2d-542b34dac468_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares_5c6ae2b1-636a-4dbb-bbcc-0198a074818f_terseLabel_en-US" xlink:label="lab_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest after sale</link:label>
    <link:label id="lab_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares_label_en-US" xlink:label="lab_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment Retained After Disposal, Ownership Interest After Disposal, Shares</link:label>
    <link:label id="lab_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares_documentation_en-US" xlink:label="lab_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment Retained After Disposal, Ownership Interest After Disposal, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares" xlink:href="jnj-20200927.xsd#jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares" xlink:to="lab_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_b8c84b5a-875c-4107-958e-658d862ed75f_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_6140b0c0-4322-448d-8bc9-2cba34e9fc2f_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_94821a15-85da-48b1-835c-adb9230c9dd8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_caaf6fdd-8169-4b12-a9f7-84e27342aece_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_4f0c5507-49c0-464b-a18c-746118ebeb9f_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_40d63244-4ef2-4b34-8828-36d65f6f39af_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_28541a12-a171-4e98-af41-359b7c657aa2_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value per share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_b876a2c9-39ab-4418-861e-f4ec11e10cc5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_f2435c74-93af-47a9-8069-1e7bda736fb3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset write-downs</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_InterventionalSolutionsMember_59cfd4e9-90c2-4b19-aa74-5c56ec194dca_verboseLabel_en-US" xlink:label="lab_jnj_InterventionalSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Solutions</link:label>
    <link:label id="lab_jnj_InterventionalSolutionsMember_label_en-US" xlink:label="lab_jnj_InterventionalSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Solutions [Member]</link:label>
    <link:label id="lab_jnj_InterventionalSolutionsMember_documentation_en-US" xlink:label="lab_jnj_InterventionalSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterventionalSolutionsMember" xlink:href="jnj-20200927.xsd#jnj_InterventionalSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_InterventionalSolutionsMember" xlink:to="lab_jnj_InterventionalSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_43bf2bc2-8109-45ad-83d5-e33ceae9273d_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories (Note 2)</link:label>
    <link:label id="lab_us-gaap_InventoryNet_88b9c8fc-a9b4-4ee6-9442-09ddf91bb39d_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f2c9473f-99e4-41aa-96d9-a9ec644a42fd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_ad830009-a6a7-4c5c-a606-c848c3703c39_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_b0c46f0b-bcfd-4a52-abd7-956fe2713549_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service cost/(credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_InterestExpensePercentToSales_e4bcb046-ee0d-427f-9753-4f1ae82cb7b8_terseLabel_en-US" xlink:label="lab_jnj_InterestExpensePercentToSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net of portion capitalized percent to sales</link:label>
    <link:label id="lab_jnj_InterestExpensePercentToSales_label_en-US" xlink:label="lab_jnj_InterestExpensePercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense Percent To Sales</link:label>
    <link:label id="lab_jnj_InterestExpensePercentToSales_documentation_en-US" xlink:label="lab_jnj_InterestExpensePercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense percent to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterestExpensePercentToSales" xlink:href="jnj-20200927.xsd#jnj_InterestExpensePercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_InterestExpensePercentToSales" xlink:to="lab_jnj_InterestExpensePercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_48d3bc65-2718-453f-b966-eb1ac78c2400_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plans</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_35462537-eb20-452d-b4ff-1ddd5bd61298_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_76bbf547-2208-4208-a56b-9f7e3688abaa_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits_5560d5dc-e3c2-4ec8-bf61-a598ee163aa3_verboseLabel_en-US" xlink:label="lab_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the exercise of stock options/employee withholding tax on stock awards, net</link:label>
    <link:label id="lab_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits_label_en-US" xlink:label="lab_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From The Exercise Of Stock Options And Excess Tax Benefits</link:label>
    <link:label id="lab_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits_documentation_en-US" xlink:label="lab_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From The Exercise Of Stock Options And Excess Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" xlink:href="jnj-20200927.xsd#jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" xlink:to="lab_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_cefeaf00-e23e-436f-829b-7f738b2a1986_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5689f40f-e76a-41b8-bd01-eb7b0ca7dca9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9b0d038f-1e20-47b7-82ca-c83e43de2362_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in other current and non-current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_d684e543-fd13-4dbe-bf80-73077b749957_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A2.95Notesdue2027Member_4caec95c-5ae0-4fd3-a2ab-60bf3d166bb1_terseLabel_en-US" xlink:label="lab_jnj_A2.95Notesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% Notes due 2027</link:label>
    <link:label id="lab_jnj_A2.95Notesdue2027Member_label_en-US" xlink:label="lab_jnj_A2.95Notesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% Notes due 2027 [Member]</link:label>
    <link:label id="lab_jnj_A2.95Notesdue2027Member_documentation_en-US" xlink:label="lab_jnj_A2.95Notesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% Notes due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.95Notesdue2027Member" xlink:href="jnj-20200927.xsd#jnj_A2.95Notesdue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A2.95Notesdue2027Member" xlink:to="lab_jnj_A2.95Notesdue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashMember_436564ee-93ff-4711-abf5-3a89408a19e3_terseLabel_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_CashMember_label_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashMember" xlink:to="lab_us-gaap_CashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_2f662b5d-e3f1-4de6-9c71-b1850039755f_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_127cc303-8793-41f2-88a3-6ee6cc848d84_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_98f1f582-f314-4ba9-99c9-6573bce1c48b_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OpioidMember_c6df792e-fe28-4db4-bdf2-6656c3e2716a_terseLabel_en-US" xlink:label="lab_jnj_OpioidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid</link:label>
    <link:label id="lab_jnj_OpioidMember_label_en-US" xlink:label="lab_jnj_OpioidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">opioid [Member]</link:label>
    <link:label id="lab_jnj_OpioidMember_documentation_en-US" xlink:label="lab_jnj_OpioidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OpioidMember" xlink:href="jnj-20200927.xsd#jnj_OpioidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OpioidMember" xlink:to="lab_jnj_OpioidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_8bb547cd-a652-40d5-b9ac-78a4f76e2273_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_acbcfe5b-1583-41b6-9295-a9db6ca5e5c4_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A2450NotesDue2060Member_20a6ed6e-9f58-4cde-8540-6d57d221c5ca_terseLabel_en-US" xlink:label="lab_jnj_A2450NotesDue2060Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.450% Notes due 2060</link:label>
    <link:label id="lab_jnj_A2450NotesDue2060Member_label_en-US" xlink:label="lab_jnj_A2450NotesDue2060Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.450% Notes due 2060 [Member]</link:label>
    <link:label id="lab_jnj_A2450NotesDue2060Member_documentation_en-US" xlink:label="lab_jnj_A2450NotesDue2060Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.450% Notes due 2060</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2450NotesDue2060Member" xlink:href="jnj-20200927.xsd#jnj_A2450NotesDue2060Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A2450NotesDue2060Member" xlink:to="lab_jnj_A2450NotesDue2060Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_c1f8fd6a-53fa-4b0f-ad61-98363232eb74_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_e3a585f5-dd87-4d23-83b0-a07df59a3991_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableforsaleSecuritiesMember_d113a918-1c26-4977-9c19-c82022f6a3ed_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities</link:label>
    <link:label id="lab_us-gaap_AvailableforsaleSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableforsaleSecuritiesMember" xlink:to="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6ca3c557-236a-40f5-9c8e-90498dbc7b0b_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d219775f-843f-4d78-9c91-7068971ec446_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Worldwide effective income tax rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A4.85Notesdue2041Member_a50d2cf5-8956-4d1e-99c8-e40c306ccb75_terseLabel_en-US" xlink:label="lab_jnj_A4.85Notesdue2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.85% Notes due 2041</link:label>
    <link:label id="lab_jnj_A4.85Notesdue2041Member_label_en-US" xlink:label="lab_jnj_A4.85Notesdue2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.85% Notes due 2041 [Member]</link:label>
    <link:label id="lab_jnj_A4.85Notesdue2041Member_documentation_en-US" xlink:label="lab_jnj_A4.85Notesdue2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.85% Notes due 2041 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.85Notesdue2041Member" xlink:href="jnj-20200927.xsd#jnj_A4.85Notesdue2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A4.85Notesdue2041Member" xlink:to="lab_jnj_A4.85Notesdue2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_01d6439a-9c0f-49e3-9164-038dea8420a6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_cba9f197-bcbb-4825-bcbb-ead92d2e8597_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_eb81fd70-81cf-480d-8fe8-b0d6750cc351_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OtherMember_8d1d5eda-a7e3-4250-a0c1-cc0524da91a0_terseLabel_en-US" xlink:label="lab_jnj_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER PULMONARY HYPERTENSION</link:label>
    <link:label id="lab_jnj_OtherMember_label_en-US" xlink:label="lab_jnj_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_jnj_OtherMember_documentation_en-US" xlink:label="lab_jnj_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherMember" xlink:href="jnj-20200927.xsd#jnj_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OtherMember" xlink:to="lab_jnj_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_aaf4c1ef-26fc-4cc9-aac3-fd73a92eff09_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_52fba43e-9beb-4866-8bf6-390a2559c9cf_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock &#8212; par value $1.00 per share (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_InterestIncomeExpenseNetMember_5be1a571-9dc8-489a-9f0f-11b2ad6c4e52_terseLabel_en-US" xlink:label="lab_jnj_InterestIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income Expense Net Member</link:label>
    <link:label id="lab_jnj_InterestIncomeExpenseNetMember_2219901f-b154-4bdc-9178-c64caf7b21a3_verboseLabel_en-US" xlink:label="lab_jnj_InterestIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest (income)/Interest expense, net</link:label>
    <link:label id="lab_jnj_InterestIncomeExpenseNetMember_label_en-US" xlink:label="lab_jnj_InterestIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income Expense Net Member</link:label>
    <link:label id="lab_jnj_InterestIncomeExpenseNetMember_documentation_en-US" xlink:label="lab_jnj_InterestIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income Expense Net Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterestIncomeExpenseNetMember" xlink:href="jnj-20200927.xsd#jnj_InterestIncomeExpenseNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_InterestIncomeExpenseNetMember" xlink:to="lab_jnj_InterestIncomeExpenseNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_54d19945-119f-4d0e-af10-9a0f132c3e2b_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_504d1446-509c-4660-92a5-7cb102a0a423_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group consideration, cash</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_9953dacf-c8ab-416b-ae8b-873891ee93b3_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquisitionCosts_256bfcaf-0fb3-499d-80c1-f54a09eac946_terseLabel_en-US" xlink:label="lab_us-gaap_AcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Costs, Period Cost</link:label>
    <link:label id="lab_us-gaap_AcquisitionCosts_label_en-US" xlink:label="lab_us-gaap_AcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Costs, Period Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquisitionCosts" xlink:to="lab_us-gaap_AcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_3b4b25cc-9955-4b5c-b6f4-5881d1fed68c_verboseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations and Divestitures</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_TRAUMAMember_b5404479-8374-4953-960c-2a07d22ed5ec_terseLabel_en-US" xlink:label="lab_jnj_TRAUMAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRAUMA</link:label>
    <link:label id="lab_jnj_TRAUMAMember_label_en-US" xlink:label="lab_jnj_TRAUMAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRAUMA [Member]</link:label>
    <link:label id="lab_jnj_TRAUMAMember_documentation_en-US" xlink:label="lab_jnj_TRAUMAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRAUMA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_TRAUMAMember" xlink:href="jnj-20200927.xsd#jnj_TRAUMAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_TRAUMAMember" xlink:to="lab_jnj_TRAUMAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_5e4e6df4-f061-4e71-a7ae-437a2899dd87_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized actuarial losses</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OtherIncomeExpenseNetMember_7c8c1c37-8afa-49fb-8c55-d26bef6e709e_terseLabel_en-US" xlink:label="lab_jnj_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense</link:label>
    <link:label id="lab_jnj_OtherIncomeExpenseNetMember_dedcf47f-905c-4a2b-b081-b83f74bc1470_verboseLabel_en-US" xlink:label="lab_jnj_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income Expense Net</link:label>
    <link:label id="lab_jnj_OtherIncomeExpenseNetMember_label_en-US" xlink:label="lab_jnj_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income Expense Net [Member]</link:label>
    <link:label id="lab_jnj_OtherIncomeExpenseNetMember_documentation_en-US" xlink:label="lab_jnj_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income Expense Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember" xlink:href="jnj-20200927.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OtherIncomeExpenseNetMember" xlink:to="lab_jnj_OtherIncomeExpenseNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fc110c35-1f64-4b3b-99dd-8cd1949413a6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_9aeb651b-9623-4fdd-8e51-b2d64be527e4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_546cb3fd-1a48-4114-b097-64284468774a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_799c5f6b-6416-4064-a4b9-8e55f9957adb_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Basis</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_23fdd0b4-75e9-4fe1-9326-84ba1932c5a2_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3f9ffe89-ac74-4b29-b89c-1df35aaeecc9_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OncologyMember_cd020080-7c52-45af-b1ba-08d90ac14e50_terseLabel_en-US" xlink:label="lab_jnj_OncologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncology</link:label>
    <link:label id="lab_jnj_OncologyMember_label_en-US" xlink:label="lab_jnj_OncologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncology [Member]</link:label>
    <link:label id="lab_jnj_OncologyMember_documentation_en-US" xlink:label="lab_jnj_OncologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OncologyMember" xlink:href="jnj-20200927.xsd#jnj_OncologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OncologyMember" xlink:to="lab_jnj_OncologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_37ceeb8f-9862-4908-9e8d-9ff29ba06f37_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential shares exercisable under stock option plans</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldtomaturitySecuritiesMember_d22cfade-e8e9-42f2-a0f2-a44deaa99fcb_terseLabel_en-US" xlink:label="lab_us-gaap_HeldtomaturitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-to-maturity Securities</link:label>
    <link:label id="lab_us-gaap_HeldtomaturitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_HeldtomaturitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-to-maturity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldtomaturitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldtomaturitySecuritiesMember" xlink:to="lab_us-gaap_HeldtomaturitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_fdec4850-8a58-4e78-8ed5-c0a7c88491cc_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring estimated cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OTCMember_31cba2f4-1526-4164-907c-30833d048d98_terseLabel_en-US" xlink:label="lab_jnj_OTCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTC</link:label>
    <link:label id="lab_jnj_OTCMember_label_en-US" xlink:label="lab_jnj_OTCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTC [Member]</link:label>
    <link:label id="lab_jnj_OTCMember_documentation_en-US" xlink:label="lab_jnj_OTCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OTCMember" xlink:href="jnj-20200927.xsd#jnj_OTCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OTCMember" xlink:to="lab_jnj_OTCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_f295b8bf-3afa-40cd-9826-7d08bbf508df_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_ec1b84c4-4cae-40da-ac26-3802260eff3f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_577bfe04-5f15-46a6-9d53-ab17c5ebbc18_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f7b9b4ed-74a7-4426-9575-74741a190b18_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average shares outstanding &#8212; basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales_ba93c7a2-4178-489c-8492-b6d960acf86a_terseLabel_en-US" xlink:label="lab_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense percent to sales</link:label>
    <link:label id="lab_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales_label_en-US" xlink:label="lab_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Expense Excluding Acquired In Process Cost Percent To Sales</link:label>
    <link:label id="lab_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales_documentation_en-US" xlink:label="lab_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense excluding acquired in process cost percent to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" xlink:href="jnj-20200927.xsd#jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" xlink:to="lab_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A225NotesDue2050Member_3684845a-331c-490e-8f78-ede11fb6b461_terseLabel_en-US" xlink:label="lab_jnj_A225NotesDue2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.25% Notes due 2050</link:label>
    <link:label id="lab_jnj_A225NotesDue2050Member_label_en-US" xlink:label="lab_jnj_A225NotesDue2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.25% Notes due 2050 [Member]</link:label>
    <link:label id="lab_jnj_A225NotesDue2050Member_documentation_en-US" xlink:label="lab_jnj_A225NotesDue2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.25% Notes due 2050</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A225NotesDue2050Member" xlink:href="jnj-20200927.xsd#jnj_A225NotesDue2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A225NotesDue2050Member" xlink:to="lab_jnj_A225NotesDue2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_f997dbd7-57ce-4c85-9d73-c7af6ca5d910_periodStartLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value, beginning of period</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_a66c90e2-6175-4cd2-81ba-95011c0491bc_periodEndLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value, end of period</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:to="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_2cafa2ac-a196-4be0-b4cf-0ed233a81d92_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue_72f57841-1216-4c5b-afcb-7fbde74454c9_terseLabel_en-US" xlink:label="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and current marketable securities, Estimated Fair Value</link:label>
    <link:label id="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue_label_en-US" xlink:label="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, And Short-Term Investments, Estimated Fair Value</link:label>
    <link:label id="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue_documentation_en-US" xlink:label="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments, Estimated Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue" xlink:href="jnj-20200927.xsd#jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue" xlink:to="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A5.95Notesdue2037Member_c5a7d315-eaef-49a5-8e40-78ab78f578c0_terseLabel_en-US" xlink:label="lab_jnj_A5.95Notesdue2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.95% Notes due 2037</link:label>
    <link:label id="lab_jnj_A5.95Notesdue2037Member_label_en-US" xlink:label="lab_jnj_A5.95Notesdue2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.95% Notes due 2037 [Member]</link:label>
    <link:label id="lab_jnj_A5.95Notesdue2037Member_documentation_en-US" xlink:label="lab_jnj_A5.95Notesdue2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.95% Notes due 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.95Notesdue2037Member" xlink:href="jnj-20200927.xsd#jnj_A5.95Notesdue2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A5.95Notesdue2037Member" xlink:to="lab_jnj_A5.95Notesdue2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_UnrecognizedTaxBenefitLiabilityPayment_5457b780-e4c1-42ba-9cd8-8b3ce4c84f77_terseLabel_en-US" xlink:label="lab_jnj_UnrecognizedTaxBenefitLiabilityPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment on unrecognized tax benefit liability</link:label>
    <link:label id="lab_jnj_UnrecognizedTaxBenefitLiabilityPayment_label_en-US" xlink:label="lab_jnj_UnrecognizedTaxBenefitLiabilityPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefit Liability, Payment</link:label>
    <link:label id="lab_jnj_UnrecognizedTaxBenefitLiabilityPayment_documentation_en-US" xlink:label="lab_jnj_UnrecognizedTaxBenefitLiabilityPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefit Liability, Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_UnrecognizedTaxBenefitLiabilityPayment" xlink:href="jnj-20200927.xsd#jnj_UnrecognizedTaxBenefitLiabilityPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_UnrecognizedTaxBenefitLiabilityPayment" xlink:to="lab_jnj_UnrecognizedTaxBenefitLiabilityPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_3a33ad53-c51b-4524-9f37-a7b986818e93_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_2f4ce317-a865-40e6-b28e-6dda7ee452f8_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense of amortizable intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_5619cdc8-53f0-4ad7-9f06-f1918cc2eb0c_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated as hedging instruments : Assets</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:to="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_34bf9cf8-1549-447e-a1f6-6406574a131e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_5564f4bd-22ba-4ea3-832e-112126750779_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in other current and non-current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_664484e9-f277-4add-9653-e1fb538c9383_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis_c70ce205-476c-4c30-8c3f-3d1bd04f5098_terseLabel_en-US" xlink:label="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security Category [Axis]</link:label>
    <link:label id="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis_label_en-US" xlink:label="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:to="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset_ffc533f2-5ccd-4d7e-9617-d8cd56452bda_terseLabel_en-US" xlink:label="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax benefit related to TRAF</link:label>
    <link:label id="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset_label_en-US" xlink:label="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset</link:label>
    <link:label id="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset_documentation_en-US" xlink:label="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" xlink:href="jnj-20200927.xsd#jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" xlink:to="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_3069f96f-3b17-4e3e-95f6-185b16eb4a19_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PROCRITEPREXMember_88a0fdeb-a68a-4c02-83eb-37df8e9d10de_terseLabel_en-US" xlink:label="lab_jnj_PROCRITEPREXMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROCRIT&#174; / EPREX&#174;</link:label>
    <link:label id="lab_jnj_PROCRITEPREXMember_label_en-US" xlink:label="lab_jnj_PROCRITEPREXMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROCRIT/EPREX [Member]</link:label>
    <link:label id="lab_jnj_PROCRITEPREXMember_documentation_en-US" xlink:label="lab_jnj_PROCRITEPREXMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROCRIT/EPREX [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PROCRITEPREXMember" xlink:href="jnj-20200927.xsd#jnj_PROCRITEPREXMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PROCRITEPREXMember" xlink:to="lab_jnj_PROCRITEPREXMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_a81a5231-6f27-4d45-addf-98e9dffbc497_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_1c5d1441-4c64-4200-a1c4-54af4a6c995a_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum length of time for hedge exposure</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time, Foreign Currency Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:to="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_706d4a8c-0ab7-40e0-9599-2a32994e51d0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A210NotesDue2040Member_ca3dc67b-ad33-4bb3-83fa-aabdacb9618d_terseLabel_en-US" xlink:label="lab_jnj_A210NotesDue2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.10% Notes due 2040</link:label>
    <link:label id="lab_jnj_A210NotesDue2040Member_label_en-US" xlink:label="lab_jnj_A210NotesDue2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.10% Notes due 2040 [Member]</link:label>
    <link:label id="lab_jnj_A210NotesDue2040Member_documentation_en-US" xlink:label="lab_jnj_A210NotesDue2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.10% Notes due 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A210NotesDue2040Member" xlink:href="jnj-20200927.xsd#jnj_A210NotesDue2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A210NotesDue2040Member" xlink:to="lab_jnj_A210NotesDue2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_c9c24ca3-8937-44d0-8605-1064ee3081f8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_LitigationSettlementByCompaniesDomain_0e5469a3-c492-4b72-b6c8-7afdf970ae67_terseLabel_en-US" xlink:label="lab_jnj_LitigationSettlementByCompaniesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement By Companies</link:label>
    <link:label id="lab_jnj_LitigationSettlementByCompaniesDomain_label_en-US" xlink:label="lab_jnj_LitigationSettlementByCompaniesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement By Companies [Domain]</link:label>
    <link:label id="lab_jnj_LitigationSettlementByCompaniesDomain_documentation_en-US" xlink:label="lab_jnj_LitigationSettlementByCompaniesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement by companies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LitigationSettlementByCompaniesDomain" xlink:href="jnj-20200927.xsd#jnj_LitigationSettlementByCompaniesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_LitigationSettlementByCompaniesDomain" xlink:to="lab_jnj_LitigationSettlementByCompaniesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_CONCERTAMethylphenidateMember_7a2632a5-644c-4c6d-8f7d-fa68e6f56d33_terseLabel_en-US" xlink:label="lab_jnj_CONCERTAMethylphenidateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONCERTA&#174; / methylphenidate</link:label>
    <link:label id="lab_jnj_CONCERTAMethylphenidateMember_label_en-US" xlink:label="lab_jnj_CONCERTAMethylphenidateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONCERTA/Methylphenidate [Member]</link:label>
    <link:label id="lab_jnj_CONCERTAMethylphenidateMember_documentation_en-US" xlink:label="lab_jnj_CONCERTAMethylphenidateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONCERTA/Methylphenidate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CONCERTAMethylphenidateMember" xlink:href="jnj-20200927.xsd#jnj_CONCERTAMethylphenidateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_CONCERTAMethylphenidateMember" xlink:to="lab_jnj_CONCERTAMethylphenidateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_a591524b-f929-47dd-b0fb-7562f14e96b0_verboseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets acquired</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_StelaraMember_c4850e90-6130-4fb5-a083-1ad1df87daa8_terseLabel_en-US" xlink:label="lab_jnj_StelaraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STELARA&#174;</link:label>
    <link:label id="lab_jnj_StelaraMember_label_en-US" xlink:label="lab_jnj_StelaraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stelara [Member]</link:label>
    <link:label id="lab_jnj_StelaraMember_documentation_en-US" xlink:label="lab_jnj_StelaraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stelara [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_StelaraMember" xlink:href="jnj-20200927.xsd#jnj_StelaraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_StelaraMember" xlink:to="lab_jnj_StelaraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_SURGICALMember_776267ab-92a1-4a0d-9f14-18ff8daf4401_terseLabel_en-US" xlink:label="lab_jnj_SURGICALMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SURGICAL</link:label>
    <link:label id="lab_jnj_SURGICALMember_label_en-US" xlink:label="lab_jnj_SURGICALMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SURGICAL [Member]</link:label>
    <link:label id="lab_jnj_SURGICALMember_documentation_en-US" xlink:label="lab_jnj_SURGICALMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SURGICAL [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SURGICALMember" xlink:href="jnj-20200927.xsd#jnj_SURGICALMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_SURGICALMember" xlink:to="lab_jnj_SURGICALMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained_1bb94af9-9da6-4a77-9fdd-196a7e4ed3b8_terseLabel_en-US" xlink:label="lab_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables retained</link:label>
    <link:label id="lab_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained_label_en-US" xlink:label="lab_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Receivables Retained</link:label>
    <link:label id="lab_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained_documentation_en-US" xlink:label="lab_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Receivables Retained</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained" xlink:href="jnj-20200927.xsd#jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained" xlink:to="lab_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_7f6d25ad-4e04-43de-9c92-3302ec197812_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_94de5840-2bbc-41be-9cc2-d7fae9f726f3_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization of property and intangibles</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OrthopaedicsMember_03d93fb7-0b55-411a-9300-350cc6f8aa64_terseLabel_en-US" xlink:label="lab_jnj_OrthopaedicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopaedics</link:label>
    <link:label id="lab_jnj_OrthopaedicsMember_label_en-US" xlink:label="lab_jnj_OrthopaedicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopaedics [Member]</link:label>
    <link:label id="lab_jnj_OrthopaedicsMember_documentation_en-US" xlink:label="lab_jnj_OrthopaedicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopaedics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OrthopaedicsMember" xlink:href="jnj-20200927.xsd#jnj_OrthopaedicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OrthopaedicsMember" xlink:to="lab_jnj_OrthopaedicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_f20522c4-763d-4014-a49f-f623d32c5727_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds on sale</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received Per Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_8695e5b6-af85-44f6-a1f4-c047dc19fe50_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_1578a849-40ef-48e1-a732-231161133825_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_be530f93-6b78-4d3f-bd1f-f2ccf6ea58bf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_20ae36e2-7c93-44f8-842c-8ce331d88ee0_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_68ac307c-eaf9-4e02-8569-365ed1b76f91_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee benefit plans:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_InfectiousDiseasesMember_27c08783-660f-48ab-8e13-ecb57fe03025_terseLabel_en-US" xlink:label="lab_jnj_InfectiousDiseasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infectious Diseases</link:label>
    <link:label id="lab_jnj_InfectiousDiseasesMember_label_en-US" xlink:label="lab_jnj_InfectiousDiseasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infectious Diseases [Member]</link:label>
    <link:label id="lab_jnj_InfectiousDiseasesMember_documentation_en-US" xlink:label="lab_jnj_InfectiousDiseasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infectious Diseases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InfectiousDiseasesMember" xlink:href="jnj-20200927.xsd#jnj_InfectiousDiseasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_InfectiousDiseasesMember" xlink:to="lab_jnj_InfectiousDiseasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PulmonaryHypertensionMember_c4a67fef-bb29-42d5-8b1f-8485db88b5cb_terseLabel_en-US" xlink:label="lab_jnj_PulmonaryHypertensionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pulmonary Hypertension</link:label>
    <link:label id="lab_jnj_PulmonaryHypertensionMember_label_en-US" xlink:label="lab_jnj_PulmonaryHypertensionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pulmonary Hypertension [Member]</link:label>
    <link:label id="lab_jnj_PulmonaryHypertensionMember_documentation_en-US" xlink:label="lab_jnj_PulmonaryHypertensionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pulmonary Hypertension [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PulmonaryHypertensionMember" xlink:href="jnj-20200927.xsd#jnj_PulmonaryHypertensionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PulmonaryHypertensionMember" xlink:to="lab_jnj_PulmonaryHypertensionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_72fb5e31-a7fb-4425-9505-326a587c22fd_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Benefit Plans</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_acdce117-92ed-435c-9de1-4e280dcf737a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_47db4c82-318b-41b8-89aa-a0cb1b6b33bb_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_91704f5e-35d4-432e-adf1-7b113c090473_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_0cd8da21-64f7-4cae-a650-52f72cd78c32_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_18595133-fa7e-49e8-9c58-ccc30851bb1c_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_2d66814f-7455-4cdf-ab0a-f78d8745f31b_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_NetIncomeAttributableToParentPercentToSales_e1322042-c1a8-40ef-8760-a48db0e217ca_totalLabel_en-US" xlink:label="lab_jnj_NetIncomeAttributableToParentPercentToSales" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings percent to sales</link:label>
    <link:label id="lab_jnj_NetIncomeAttributableToParentPercentToSales_label_en-US" xlink:label="lab_jnj_NetIncomeAttributableToParentPercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Attributable to Parent Percent to Sales</link:label>
    <link:label id="lab_jnj_NetIncomeAttributableToParentPercentToSales_documentation_en-US" xlink:label="lab_jnj_NetIncomeAttributableToParentPercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Attributable to Parent Percent to Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_NetIncomeAttributableToParentPercentToSales" xlink:href="jnj-20200927.xsd#jnj_NetIncomeAttributableToParentPercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_NetIncomeAttributableToParentPercentToSales" xlink:to="lab_jnj_NetIncomeAttributableToParentPercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_MomentaMember_779d1b39-eab6-499d-bef9-b8c4a6f18fa9_terseLabel_en-US" xlink:label="lab_jnj_MomentaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Momenta [Member]</link:label>
    <link:label id="lab_jnj_MomentaMember_label_en-US" xlink:label="lab_jnj_MomentaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Momenta [Member]</link:label>
    <link:label id="lab_jnj_MomentaMember_documentation_en-US" xlink:label="lab_jnj_MomentaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Momenta</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MomentaMember" xlink:href="jnj-20200927.xsd#jnj_MomentaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_MomentaMember" xlink:to="lab_jnj_MomentaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_1899a635-f49d-4c12-b379-c220c87b9768_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems" xlink:to="lab_us-gaap_OtherInvestmentNotReadilyMarketableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1b0adbfd-9f39-457c-a8fe-ac7c04478b81_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_f7842460-d2da-48a1-9572-56f632d0e5e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Activity Related to Equity Investments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_1ae92323-b834-499e-8509-cb59476249a4_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_533b9f20-f938-4849-80ca-830eb15c0fc8_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeMember_c21035ac-780b-44ab-9f3a-f1f496238160_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label>
    <link:label id="lab_us-gaap_OtherIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeMember" xlink:to="lab_us-gaap_OtherIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_ac7f42f8-d83a-40cb-90b6-738bae989d5d_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_3b2bc799-9b45-4de9-89fc-7b61d0a4a171_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_612c9fd9-39a1-4149-8de7-cf53c1487a48_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_52127465-02e9-447b-b233-6fcc41a7b11d_verboseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_988914b5-85a9-444e-b9df-141b36de573b_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PercentageChangeInSalesBySegmentOfBusiness_df152fe4-2288-4936-9817-083f55817531_terseLabel_en-US" xlink:label="lab_jnj_PercentageChangeInSalesBySegmentOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Change (as a percent)</link:label>
    <link:label id="lab_jnj_PercentageChangeInSalesBySegmentOfBusiness_label_en-US" xlink:label="lab_jnj_PercentageChangeInSalesBySegmentOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Change In Sales By Segment Of Business</link:label>
    <link:label id="lab_jnj_PercentageChangeInSalesBySegmentOfBusiness_documentation_en-US" xlink:label="lab_jnj_PercentageChangeInSalesBySegmentOfBusiness" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage change in sales by segment of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInSalesBySegmentOfBusiness" xlink:href="jnj-20200927.xsd#jnj_PercentageChangeInSalesBySegmentOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PercentageChangeInSalesBySegmentOfBusiness" xlink:to="lab_jnj_PercentageChangeInSalesBySegmentOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A2.625Notesdue2025Member_6dafcfc1-56c7-4a88-b940-717da521d9e0_terseLabel_en-US" xlink:label="lab_jnj_A2.625Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625% Notes due 2025</link:label>
    <link:label id="lab_jnj_A2.625Notesdue2025Member_label_en-US" xlink:label="lab_jnj_A2.625Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625 Notes due 2025 [Member]</link:label>
    <link:label id="lab_jnj_A2.625Notesdue2025Member_documentation_en-US" xlink:label="lab_jnj_A2.625Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625 Notes due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.625Notesdue2025Member" xlink:href="jnj-20200927.xsd#jnj_A2.625Notesdue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A2.625Notesdue2025Member" xlink:to="lab_jnj_A2.625Notesdue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_a3ade477-51f2-47c7-bd4f-95ec85723c97_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_88e70c07-0cb4-42ce-afda-4da8a5919ada_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_AsiaPacificAfricaMember_47ff29e5-50b3-4bca-bb4c-2e0b1ce06b4d_terseLabel_en-US" xlink:label="lab_jnj_AsiaPacificAfricaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia-Pacific, Africa</link:label>
    <link:label id="lab_jnj_AsiaPacificAfricaMember_label_en-US" xlink:label="lab_jnj_AsiaPacificAfricaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia-Pacific, Africa [Member]</link:label>
    <link:label id="lab_jnj_AsiaPacificAfricaMember_documentation_en-US" xlink:label="lab_jnj_AsiaPacificAfricaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia-Pacific, Africa [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AsiaPacificAfricaMember" xlink:href="jnj-20200927.xsd#jnj_AsiaPacificAfricaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_AsiaPacificAfricaMember" xlink:to="lab_jnj_AsiaPacificAfricaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther_2e2994b8-5602-4c94-b3b4-551c23399462_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale (Note 10)</link:label>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther_label_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-for-sale, Not Part of Disposal Group, Current, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther" xlink:to="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_38ce4b64-1572-47d6-922e-a82b1b858739_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_UPTRAVIMember_e89b7f8e-70d9-4d9c-9dda-35e7760758ae_terseLabel_en-US" xlink:label="lab_jnj_UPTRAVIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UPTRAVI&#174;</link:label>
    <link:label id="lab_jnj_UPTRAVIMember_label_en-US" xlink:label="lab_jnj_UPTRAVIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UPTRAVI [Member]</link:label>
    <link:label id="lab_jnj_UPTRAVIMember_documentation_en-US" xlink:label="lab_jnj_UPTRAVIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UPTRAVI [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_UPTRAVIMember" xlink:href="jnj-20200927.xsd#jnj_UPTRAVIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_UPTRAVIMember" xlink:to="lab_jnj_UPTRAVIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_dc766388-c598-4213-8bdf-d57c11ae2f01_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_60620951-27ff-4f68-a672-90797c842437_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_WoundCareandOtherMember_729f0e41-7bfa-41e6-b46b-ac2f96983fc9_terseLabel_en-US" xlink:label="lab_jnj_WoundCareandOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wound Care/Other</link:label>
    <link:label id="lab_jnj_WoundCareandOtherMember_label_en-US" xlink:label="lab_jnj_WoundCareandOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wound Care and Other [Member]</link:label>
    <link:label id="lab_jnj_WoundCareandOtherMember_documentation_en-US" xlink:label="lab_jnj_WoundCareandOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wound Care and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WoundCareandOtherMember" xlink:href="jnj-20200927.xsd#jnj_WoundCareandOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_WoundCareandOtherMember" xlink:to="lab_jnj_WoundCareandOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e151827e-bdef-4cab-b043-677bd7fdbc54_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember_47744aca-8dc7-4de5-8d57-cc348f3ea5f7_terseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. reverse repurchase agreements</link:label>
    <link:label id="lab_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember_label_en-US" xlink:label="lab_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Loaned or Sold under Agreements to Repurchase [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember" xlink:to="lab_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OtherInfectiousDiseasesMember_6f84063a-8b4e-47c6-87bb-2d4f0e0159af_terseLabel_en-US" xlink:label="lab_jnj_OtherInfectiousDiseasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER INFECTIOUS DISEASES</link:label>
    <link:label id="lab_jnj_OtherInfectiousDiseasesMember_label_en-US" xlink:label="lab_jnj_OtherInfectiousDiseasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Infectious Diseases [Member]</link:label>
    <link:label id="lab_jnj_OtherInfectiousDiseasesMember_documentation_en-US" xlink:label="lab_jnj_OtherInfectiousDiseasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Infectious Diseases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherInfectiousDiseasesMember" xlink:href="jnj-20200927.xsd#jnj_OtherInfectiousDiseasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OtherInfectiousDiseasesMember" xlink:to="lab_jnj_OtherInfectiousDiseasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_7030d1da-31cd-495a-8918-7a5418a8f1b1_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_RestructuringandRelatedCostExpectedFutureSavings_c395272c-ded3-4ac8-a589-66aa3462b415_terseLabel_en-US" xlink:label="lab_jnj_RestructuringandRelatedCostExpectedFutureSavings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost savings expected</link:label>
    <link:label id="lab_jnj_RestructuringandRelatedCostExpectedFutureSavings_label_en-US" xlink:label="lab_jnj_RestructuringandRelatedCostExpectedFutureSavings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Future Savings</link:label>
    <link:label id="lab_jnj_RestructuringandRelatedCostExpectedFutureSavings_documentation_en-US" xlink:label="lab_jnj_RestructuringandRelatedCostExpectedFutureSavings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Future Savings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RestructuringandRelatedCostExpectedFutureSavings" xlink:href="jnj-20200927.xsd#jnj_RestructuringandRelatedCostExpectedFutureSavings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_RestructuringandRelatedCostExpectedFutureSavings" xlink:to="lab_jnj_RestructuringandRelatedCostExpectedFutureSavings" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_CizHoldingsCo.Ltd.Member_5fddcee9-b2bd-4e47-8dc3-786f954c3c1b_terseLabel_en-US" xlink:label="lab_jnj_CizHoldingsCo.Ltd.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ci:z Holdings Co. Ltd.</link:label>
    <link:label id="lab_jnj_CizHoldingsCo.Ltd.Member_label_en-US" xlink:label="lab_jnj_CizHoldingsCo.Ltd.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ci:z Holdings Co. Ltd. [Member]</link:label>
    <link:label id="lab_jnj_CizHoldingsCo.Ltd.Member_documentation_en-US" xlink:label="lab_jnj_CizHoldingsCo.Ltd.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ci:z Holdings Co. Ltd. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CizHoldingsCo.Ltd.Member" xlink:href="jnj-20200927.xsd#jnj_CizHoldingsCo.Ltd.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_CizHoldingsCo.Ltd.Member" xlink:to="lab_jnj_CizHoldingsCo.Ltd.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_27741622-dadb-4f07-90b6-31b8b98c8a79_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_cb503a31-2c0e-4825-ad0d-7b24f6efc732_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_4c367081-318a-4ea0-b559-3e8c74ffbca8_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_02bc9856-3a00-4610-93e7-1653e25147ef_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_4f6f173f-7da8-4ac6-a49d-1a2a27366291_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Gross Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_0b30ef13-7576-4f71-b334-ddf1367b5456_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_450fe260-7082-4792-9d0a-fa565479083a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>jnj-20200927_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:fc2d7a08-4b3d-4935-bed1-d6009b2c298f,g:489318f6-0cc0-48fd-9e8b-f08139bc7aae-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.jnj.com/role/Cover" xlink:type="simple" xlink:href="jnj-20200927.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_f485fc69-4210-40be-971a-ca0e35681453" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_8b0e39bb-5928-4546-b6a6-3108d5932cc4" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f485fc69-4210-40be-971a-ca0e35681453" xlink:to="loc_dei_EntitiesTable_8b0e39bb-5928-4546-b6a6-3108d5932cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4946a1ec-4139-4c1c-82e0-5ec0bea62d38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_8b0e39bb-5928-4546-b6a6-3108d5932cc4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4946a1ec-4139-4c1c-82e0-5ec0bea62d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6f643a38-4886-4c17-9b84-082d9a7ecdad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4946a1ec-4139-4c1c-82e0-5ec0bea62d38" xlink:to="loc_us-gaap_ClassOfStockDomain_6f643a38-4886-4c17-9b84-082d9a7ecdad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_377343f7-2441-4c90-992e-823e7de7ddb5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6f643a38-4886-4c17-9b84-082d9a7ecdad" xlink:to="loc_us-gaap_CommonStockMember_377343f7-2441-4c90-992e-823e7de7ddb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.250NotesDue2022Member_2a5ab734-8fc9-4093-9c94-5fa7c7e16881" xlink:href="jnj-20200927.xsd#jnj_A0.250NotesDue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6f643a38-4886-4c17-9b84-082d9a7ecdad" xlink:to="loc_jnj_A0.250NotesDue2022Member_2a5ab734-8fc9-4093-9c94-5fa7c7e16881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.650NotesDue2024Member_2da8c5ae-1ea5-49c2-bfa2-42fc1965a25c" xlink:href="jnj-20200927.xsd#jnj_A0.650NotesDue2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6f643a38-4886-4c17-9b84-082d9a7ecdad" xlink:to="loc_jnj_A0.650NotesDue2024Member_2da8c5ae-1ea5-49c2-bfa2-42fc1965a25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.50NotesDue2024Member_16f90603-5b2d-4ed0-9273-1545e7b64cc0" xlink:href="jnj-20200927.xsd#jnj_A5.50NotesDue2024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6f643a38-4886-4c17-9b84-082d9a7ecdad" xlink:to="loc_jnj_A5.50NotesDue2024Member_16f90603-5b2d-4ed0-9273-1545e7b64cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.150NotesDue2028Member_76f5c913-c2ba-490c-bc09-21e8617e8aad" xlink:href="jnj-20200927.xsd#jnj_A1.150NotesDue2028Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6f643a38-4886-4c17-9b84-082d9a7ecdad" xlink:to="loc_jnj_A1.150NotesDue2028Member_76f5c913-c2ba-490c-bc09-21e8617e8aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.650NotesDue2035Member_5f9a62e6-e379-4599-95d5-c15c73d41e4a" xlink:href="jnj-20200927.xsd#jnj_A1.650NotesDue2035Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6f643a38-4886-4c17-9b84-082d9a7ecdad" xlink:to="loc_jnj_A1.650NotesDue2035Member_5f9a62e6-e379-4599-95d5-c15c73d41e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_8b0e39bb-5928-4546-b6a6-3108d5932cc4" xlink:to="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_1396657d-05d6-4451-aaee-600272209ce9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_DocumentType_1396657d-05d6-4451-aaee-600272209ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_eefa1da3-0697-4bfd-9f59-4f71c7d1cc33" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_DocumentQuarterlyReport_eefa1da3-0697-4bfd-9f59-4f71c7d1cc33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e40e2222-e8de-45ae-b6d8-2ffa0a0a863d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_DocumentPeriodEndDate_e40e2222-e8de-45ae-b6d8-2ffa0a0a863d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_9bf49e1b-e05f-445c-958d-fa7ed9fddd79" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_DocumentTransitionReport_9bf49e1b-e05f-445c-958d-fa7ed9fddd79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_d8dbf484-6864-47ce-8397-3439e0326ef8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityFileNumber_d8dbf484-6864-47ce-8397-3439e0326ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e20b7492-8955-4063-b7a3-6f1d6bdfc6e9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityRegistrantName_e20b7492-8955-4063-b7a3-6f1d6bdfc6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_cf8115a8-9bc7-4824-9312-e009151b6c14" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityIncorporationStateCountryCode_cf8115a8-9bc7-4824-9312-e009151b6c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_7870fdbf-0428-4840-8fb0-a5db75dec0f6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityTaxIdentificationNumber_7870fdbf-0428-4840-8fb0-a5db75dec0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_210bd61a-7dd6-4620-95ee-da58c0b22c89" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityAddressAddressLine1_210bd61a-7dd6-4620-95ee-da58c0b22c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_7e1b5435-f878-4181-82ba-434a2466d25d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityAddressCityOrTown_7e1b5435-f878-4181-82ba-434a2466d25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_18eebe4a-b070-4de7-8f0b-5af39b81215a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityAddressStateOrProvince_18eebe4a-b070-4de7-8f0b-5af39b81215a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_2cbef4aa-3a3e-4575-9721-a2857eb8a90f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityAddressPostalZipCode_2cbef4aa-3a3e-4575-9721-a2857eb8a90f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_124ab905-4946-44a9-9257-a639e831b644" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_CityAreaCode_124ab905-4946-44a9-9257-a639e831b644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2fd0ab39-8a20-403a-ba16-20f90b540898" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_LocalPhoneNumber_2fd0ab39-8a20-403a-ba16-20f90b540898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_52123fa8-1f05-4c1d-b4a0-ac56dbad1f41" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityCurrentReportingStatus_52123fa8-1f05-4c1d-b4a0-ac56dbad1f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_5ef4e772-a593-4e1c-a5f8-2f54c121d07e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityInteractiveDataCurrent_5ef4e772-a593-4e1c-a5f8-2f54c121d07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_97377478-1f12-436e-9f21-ab9dc6c80bf6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityFilerCategory_97377478-1f12-436e-9f21-ab9dc6c80bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_19e5c160-4475-4393-b3eb-2c2a21d54f80" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntitySmallBusiness_19e5c160-4475-4393-b3eb-2c2a21d54f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_34c62e0b-090c-4401-a669-5ffa8fc7fd49" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityEmergingGrowthCompany_34c62e0b-090c-4401-a669-5ffa8fc7fd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_cc455153-2f50-4c25-a32c-8bd328c5e947" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityShellCompany_cc455153-2f50-4c25-a32c-8bd328c5e947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_129b0174-4cd0-46e3-af79-64bd106de838" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_Security12bTitle_129b0174-4cd0-46e3-af79-64bd106de838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_0f8665cf-e440-40d0-b4f9-768e9ba46399" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_TradingSymbol_0f8665cf-e440-40d0-b4f9-768e9ba46399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_55299cdf-fbaa-4d85-b78d-1cc38a99b0df" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_SecurityExchangeName_55299cdf-fbaa-4d85-b78d-1cc38a99b0df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_c2789071-2bdd-489c-b768-7c6093feb2ff" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_c2789071-2bdd-489c-b768-7c6093feb2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_32c10112-6124-46b0-b370-90b4c0a0d1fc" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_EntityCentralIndexKey_32c10112-6124-46b0-b370-90b4c0a0d1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c7f7efbb-0b93-46d1-909a-de523a6c0acf" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_CurrentFiscalYearEndDate_c7f7efbb-0b93-46d1-909a-de523a6c0acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_eafc5724-d7ce-455b-b5cf-e74e41052ab6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_DocumentFiscalYearFocus_eafc5724-d7ce-455b-b5cf-e74e41052ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_08b973b4-a496-48ae-9a46-6baae229ae6f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_DocumentFiscalPeriodFocus_08b973b4-a496-48ae-9a46-6baae229ae6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f3c823a1-1b0c-4b4d-abc3-9fe1f2f0baff" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_3515fb4b-4d6d-4b4f-9719-965c6e3f8bb8" xlink:to="loc_dei_AmendmentFlag_f3c823a1-1b0c-4b4d-abc3-9fe1f2f0baff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e323f062-37ab-462d-b418-dafaf86c1422" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_0f5245e8-3779-4bdd-8e93-5ed4083d2a2f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e323f062-37ab-462d-b418-dafaf86c1422" xlink:to="loc_us-gaap_AssetsAbstract_0f5245e8-3779-4bdd-8e93-5ed4083d2a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_e0b68730-fd89-4d87-9e0f-24191557bb76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f5245e8-3779-4bdd-8e93-5ed4083d2a2f" xlink:to="loc_us-gaap_AssetsCurrentAbstract_e0b68730-fd89-4d87-9e0f-24191557bb76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5e0c9558-556e-41ea-9e19-c5df2e50567f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e0b68730-fd89-4d87-9e0f-24191557bb76" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5e0c9558-556e-41ea-9e19-c5df2e50567f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_9c7a7efa-533e-4399-bd7d-9ba15960c88f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e0b68730-fd89-4d87-9e0f-24191557bb76" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_9c7a7efa-533e-4399-bd7d-9ba15960c88f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_3ac15514-c29c-46b1-b662-92525e15f7b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e0b68730-fd89-4d87-9e0f-24191557bb76" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_3ac15514-c29c-46b1-b662-92525e15f7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_579fd2a0-4e7e-473e-be0c-8791dcc5ddd6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e0b68730-fd89-4d87-9e0f-24191557bb76" xlink:to="loc_us-gaap_InventoryNet_579fd2a0-4e7e-473e-be0c-8791dcc5ddd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fb2bf4d7-e4f9-4693-a97c-0dfe5d3cc47b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e0b68730-fd89-4d87-9e0f-24191557bb76" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_fb2bf4d7-e4f9-4693-a97c-0dfe5d3cc47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther_015fa1df-3a00-4572-99b1-2c1a5aa0d6d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e0b68730-fd89-4d87-9e0f-24191557bb76" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther_015fa1df-3a00-4572-99b1-2c1a5aa0d6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_31953194-1e4d-4a2d-9956-9afb31bc7c78" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e0b68730-fd89-4d87-9e0f-24191557bb76" xlink:to="loc_us-gaap_AssetsCurrent_31953194-1e4d-4a2d-9956-9afb31bc7c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_614ed8a1-ea8b-4973-80d2-779ac2ae658a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f5245e8-3779-4bdd-8e93-5ed4083d2a2f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_614ed8a1-ea8b-4973-80d2-779ac2ae658a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_abafccf3-6e92-4e6c-af83-e7b2948368ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f5245e8-3779-4bdd-8e93-5ed4083d2a2f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_abafccf3-6e92-4e6c-af83-e7b2948368ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3730059c-db15-45a1-a1c4-0253116edbe9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f5245e8-3779-4bdd-8e93-5ed4083d2a2f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3730059c-db15-45a1-a1c4-0253116edbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1a2b2ad2-e04b-4b45-9a37-20a33588a0a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f5245e8-3779-4bdd-8e93-5ed4083d2a2f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1a2b2ad2-e04b-4b45-9a37-20a33588a0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e5eefe8b-7322-4fe6-b6d9-4d852a6350d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f5245e8-3779-4bdd-8e93-5ed4083d2a2f" xlink:to="loc_us-gaap_Goodwill_e5eefe8b-7322-4fe6-b6d9-4d852a6350d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_eda321f5-b371-453e-82c7-1be81b93aca0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f5245e8-3779-4bdd-8e93-5ed4083d2a2f" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_eda321f5-b371-453e-82c7-1be81b93aca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b02c521e-423b-494f-9285-d8b9931fe511" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f5245e8-3779-4bdd-8e93-5ed4083d2a2f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b02c521e-423b-494f-9285-d8b9931fe511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4220357c-3e01-451b-8372-cd0a3c3c85ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0f5245e8-3779-4bdd-8e93-5ed4083d2a2f" xlink:to="loc_us-gaap_Assets_4220357c-3e01-451b-8372-cd0a3c3c85ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfe812f2-4ee2-4137-b3f8-9518e4a1a7aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e323f062-37ab-462d-b418-dafaf86c1422" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfe812f2-4ee2-4137-b3f8-9518e4a1a7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_120c6a89-35de-4948-b405-9caecedac4a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfe812f2-4ee2-4137-b3f8-9518e4a1a7aa" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_120c6a89-35de-4948-b405-9caecedac4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_a73903f2-cc12-4c44-bbc6-f53cf8a1c41f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_120c6a89-35de-4948-b405-9caecedac4a0" xlink:to="loc_us-gaap_ShortTermBorrowings_a73903f2-cc12-4c44-bbc6-f53cf8a1c41f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_39f1aeab-2b28-43d1-9fb1-d568e24309ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_120c6a89-35de-4948-b405-9caecedac4a0" xlink:to="loc_us-gaap_AccountsPayableCurrent_39f1aeab-2b28-43d1-9fb1-d568e24309ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a7712d5e-b684-44c8-9d3d-7a6b6e2554de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_120c6a89-35de-4948-b405-9caecedac4a0" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a7712d5e-b684-44c8-9d3d-7a6b6e2554de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AccruedRebatesReturnsAndPromotions_85aee502-80ec-4ccd-b7dc-19155fed8e77" xlink:href="jnj-20200927.xsd#jnj_AccruedRebatesReturnsAndPromotions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_120c6a89-35de-4948-b405-9caecedac4a0" xlink:to="loc_jnj_AccruedRebatesReturnsAndPromotions_85aee502-80ec-4ccd-b7dc-19155fed8e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ebe2aa0f-585c-4871-8bd7-3073ec868043" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_120c6a89-35de-4948-b405-9caecedac4a0" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ebe2aa0f-585c-4871-8bd7-3073ec868043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_3e4c415b-065c-48bd-bcee-7a925561bd3b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_120c6a89-35de-4948-b405-9caecedac4a0" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_3e4c415b-065c-48bd-bcee-7a925561bd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_fd234d60-4a50-493e-8fa7-61c312355e43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_120c6a89-35de-4948-b405-9caecedac4a0" xlink:to="loc_us-gaap_LiabilitiesCurrent_fd234d60-4a50-493e-8fa7-61c312355e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ffe06066-e614-4040-aea0-c539d5b26981" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfe812f2-4ee2-4137-b3f8-9518e4a1a7aa" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ffe06066-e614-4040-aea0-c539d5b26981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_c0331736-0941-40d1-8735-6fe6f1b3603b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfe812f2-4ee2-4137-b3f8-9518e4a1a7aa" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_c0331736-0941-40d1-8735-6fe6f1b3603b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_6c8062ee-e7da-432e-9bb5-e9be07f4c675" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfe812f2-4ee2-4137-b3f8-9518e4a1a7aa" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_6c8062ee-e7da-432e-9bb5-e9be07f4c675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_728e2167-adc8-4a0d-af99-b9e841f8a57f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfe812f2-4ee2-4137-b3f8-9518e4a1a7aa" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_728e2167-adc8-4a0d-af99-b9e841f8a57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_14a1e1d5-218e-4683-8bd0-f188027d0110" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfe812f2-4ee2-4137-b3f8-9518e4a1a7aa" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_14a1e1d5-218e-4683-8bd0-f188027d0110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b8456a9a-1940-48ad-99c6-e49c34a6ff5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfe812f2-4ee2-4137-b3f8-9518e4a1a7aa" xlink:to="loc_us-gaap_Liabilities_b8456a9a-1940-48ad-99c6-e49c34a6ff5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b325dcfd-5d51-4676-bd53-be6e51d06d81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfe812f2-4ee2-4137-b3f8-9518e4a1a7aa" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b325dcfd-5d51-4676-bd53-be6e51d06d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_2a9cd1b9-ae51-43bc-b0b3-05c16579ae1a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfe812f2-4ee2-4137-b3f8-9518e4a1a7aa" xlink:to="loc_us-gaap_StockholdersEquityAbstract_2a9cd1b9-ae51-43bc-b0b3-05c16579ae1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_76a777b4-237a-49cc-8f25-9c345dd7c80c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2a9cd1b9-ae51-43bc-b0b3-05c16579ae1a" xlink:to="loc_us-gaap_CommonStockValue_76a777b4-237a-49cc-8f25-9c345dd7c80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7c6f1db2-b243-4aee-8b7e-22739ec8ac89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2a9cd1b9-ae51-43bc-b0b3-05c16579ae1a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7c6f1db2-b243-4aee-8b7e-22739ec8ac89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f64c3c4a-8dbd-4209-99a1-88033a339724" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2a9cd1b9-ae51-43bc-b0b3-05c16579ae1a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f64c3c4a-8dbd-4209-99a1-88033a339724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_8236270c-c8af-46b9-b3d4-d183e48a9da6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2a9cd1b9-ae51-43bc-b0b3-05c16579ae1a" xlink:to="loc_us-gaap_TreasuryStockValue_8236270c-c8af-46b9-b3d4-d183e48a9da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_124f8d46-e760-4214-a48c-e58fc4f06a4e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_2a9cd1b9-ae51-43bc-b0b3-05c16579ae1a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_124f8d46-e760-4214-a48c-e58fc4f06a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a759ef10-e672-4910-a5cc-fa6e44bb8f1c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bfe812f2-4ee2-4137-b3f8-9518e4a1a7aa" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_a759ef10-e672-4910-a5cc-fa6e44bb8f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_628a07f8-e67a-4fb9-b2dd-850870aebe78" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e323f062-37ab-462d-b418-dafaf86c1422" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_628a07f8-e67a-4fb9-b2dd-850870aebe78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7864e61f-0a8b-4762-959f-fae292383251" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e323f062-37ab-462d-b418-dafaf86c1422" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7864e61f-0a8b-4762-959f-fae292383251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_8ca4844c-b4cf-495d-92f3-311eaff88f3e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e323f062-37ab-462d-b418-dafaf86c1422" xlink:to="loc_us-gaap_CommonStockSharesIssued_8ca4844c-b4cf-495d-92f3-311eaff88f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_65c846c9-554e-44f1-9813-1a25c533ab9f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_fe6af39e-e312-4770-82e8-8ce1becf6806" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_65c846c9-554e-44f1-9813-1a25c533ab9f" xlink:to="loc_us-gaap_AssetsCurrentAbstract_fe6af39e-e312-4770-82e8-8ce1becf6806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7a46819c-2c38-4b72-9e8c-9a5aeb633b9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fe6af39e-e312-4770-82e8-8ce1becf6806" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7a46819c-2c38-4b72-9e8c-9a5aeb633b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_e6e43f49-793d-4386-98bf-3c2a5b6b0950" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_65c846c9-554e-44f1-9813-1a25c533ab9f" xlink:to="loc_us-gaap_StockholdersEquityAbstract_e6e43f49-793d-4386-98bf-3c2a5b6b0950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_bdfb4611-f32b-4420-9757-dd75f091d76e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e6e43f49-793d-4386-98bf-3c2a5b6b0950" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_bdfb4611-f32b-4420-9757-dd75f091d76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b37d811a-e187-4a5b-80f5-1151ecbec9ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e6e43f49-793d-4386-98bf-3c2a5b6b0950" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b37d811a-e187-4a5b-80f5-1151ecbec9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_684ac65b-5d43-4a5b-9a2b-65ce88ae718e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e6e43f49-793d-4386-98bf-3c2a5b6b0950" xlink:to="loc_us-gaap_CommonStockSharesIssued_684ac65b-5d43-4a5b-9a2b-65ce88ae718e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_5ddc61e7-6767-408b-884a-7cc9ead71af0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e6e43f49-793d-4386-98bf-3c2a5b6b0950" xlink:to="loc_us-gaap_TreasuryStockShares_5ddc61e7-6767-408b-884a-7cc9ead71af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEarnings" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedStatementsofEarnings"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_39e5136f-4956-4888-aeb7-4db9d1eeb5cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_39e5136f-4956-4888-aeb7-4db9d1eeb5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SalesRevenueGoodsNetPercentToSales_08686458-6f18-49c9-8b00-5b50cbe9a86c" xlink:href="jnj-20200927.xsd#jnj_SalesRevenueGoodsNetPercentToSales"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_jnj_SalesRevenueGoodsNetPercentToSales_08686458-6f18-49c9-8b00-5b50cbe9a86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_595839fd-246b-42ae-aed7-7e054f9a0ea5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_595839fd-246b-42ae-aed7-7e054f9a0ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CostOfGoodsSoldPercentToSales_bbf2dd8a-a1a6-40f2-988a-f6e9b5339676" xlink:href="jnj-20200927.xsd#jnj_CostOfGoodsSoldPercentToSales"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_jnj_CostOfGoodsSoldPercentToSales_bbf2dd8a-a1a6-40f2-988a-f6e9b5339676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_637d14ff-8c68-4085-96cd-1096605f8d75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_us-gaap_GrossProfit_637d14ff-8c68-4085-96cd-1096605f8d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_GrossProfitPercentToSales_5609f93f-c392-4e69-8f91-f232c6109516" xlink:href="jnj-20200927.xsd#jnj_GrossProfitPercentToSales"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_jnj_GrossProfitPercentToSales_5609f93f-c392-4e69-8f91-f232c6109516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6bc0d548-5cc4-4b14-a1e6-850aa700d099" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6bc0d548-5cc4-4b14-a1e6-850aa700d099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SellingGeneralAndAdministrativeExpensePercentToSales_e1987f22-15c2-47d9-be3a-77eb0c0d89b0" xlink:href="jnj-20200927.xsd#jnj_SellingGeneralAndAdministrativeExpensePercentToSales"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_jnj_SellingGeneralAndAdministrativeExpensePercentToSales_e1987f22-15c2-47d9-be3a-77eb0c0d89b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_99c2abb2-3061-4e5d-a243-fdf902c8e9e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_99c2abb2-3061-4e5d-a243-fdf902c8e9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales_f7f789d4-fcd8-4a4e-b6f0-e2505c351738" xlink:href="jnj-20200927.xsd#jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales_f7f789d4-fcd8-4a4e-b6f0-e2505c351738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_a27b55fa-beb5-4c2a-835f-609bfb904257" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_a27b55fa-beb5-4c2a-835f-609bfb904257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ResearchAndDevelopmentInProcessPercentToSales_49b504c3-4a82-442c-8edb-44fe401661f4" xlink:href="jnj-20200927.xsd#jnj_ResearchAndDevelopmentInProcessPercentToSales"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_jnj_ResearchAndDevelopmentInProcessPercentToSales_49b504c3-4a82-442c-8edb-44fe401661f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_9bd36b45-0bcf-4932-9773-1cce4b8eaad5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_us-gaap_InvestmentIncomeInterest_9bd36b45-0bcf-4932-9773-1cce4b8eaad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InvestmentIncomeInterestPercentToSales_d640bb6c-9d5e-4dca-bcd2-1819d71674eb" xlink:href="jnj-20200927.xsd#jnj_InvestmentIncomeInterestPercentToSales"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_jnj_InvestmentIncomeInterestPercentToSales_d640bb6c-9d5e-4dca-bcd2-1819d71674eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_a31b23ca-6e59-40ad-98b6-d1cf6e3b3e09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_us-gaap_InterestExpense_a31b23ca-6e59-40ad-98b6-d1cf6e3b3e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterestExpensePercentToSales_1d6884ce-9068-48f6-8595-dfe490a15de9" xlink:href="jnj-20200927.xsd#jnj_InterestExpensePercentToSales"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_jnj_InterestExpensePercentToSales_1d6884ce-9068-48f6-8595-dfe490a15de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_bacb892c-baca-4522-966d-fc28c6d80a1a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_bacb892c-baca-4522-966d-fc28c6d80a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherNonOperatingIncomeExpensePercentToSales_8f105ff3-9a3c-4a55-aeed-522e42101f14" xlink:href="jnj-20200927.xsd#jnj_OtherNonOperatingIncomeExpensePercentToSales"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_jnj_OtherNonOperatingIncomeExpensePercentToSales_8f105ff3-9a3c-4a55-aeed-522e42101f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_43c92730-f7cd-457d-a5c7-09c4abfbfb9b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_us-gaap_RestructuringCharges_43c92730-f7cd-457d-a5c7-09c4abfbfb9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Restructuringchargepercenttosales_910ff92d-dd5c-4093-9c5a-a2e4a2fe5a30" xlink:href="jnj-20200927.xsd#jnj_Restructuringchargepercenttosales"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_jnj_Restructuringchargepercenttosales_910ff92d-dd5c-4093-9c5a-a2e4a2fe5a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8ff235cf-e80a-4dbf-b598-70488cee3b30" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8ff235cf-e80a-4dbf-b598-70488cee3b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_22b485de-5eec-4e4f-a905-350f551bf720" xlink:href="jnj-20200927.xsd#jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_22b485de-5eec-4e4f-a905-350f551bf720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_661922d0-54d5-4bb7-9875-c097ca721a78" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_661922d0-54d5-4bb7-9875-c097ca721a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeTaxExpenseBenefitPercentToSales_1bfb9aa3-3b8c-411b-8fde-76a122f61111" xlink:href="jnj-20200927.xsd#jnj_IncomeTaxExpenseBenefitPercentToSales"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_jnj_IncomeTaxExpenseBenefitPercentToSales_1bfb9aa3-3b8c-411b-8fde-76a122f61111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7df9e8fa-29be-4da7-8a15-44677b40cba0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_us-gaap_NetIncomeLoss_7df9e8fa-29be-4da7-8a15-44677b40cba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_NetIncomeAttributableToParentPercentToSales_128cb39a-001a-48ee-9bce-c58ef3e28eaa" xlink:href="jnj-20200927.xsd#jnj_NetIncomeAttributableToParentPercentToSales"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_jnj_NetIncomeAttributableToParentPercentToSales_128cb39a-001a-48ee-9bce-c58ef3e28eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5f78a1a3-4716-445b-a5e9-79895a93a0bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_us-gaap_EarningsPerShareAbstract_5f78a1a3-4716-445b-a5e9-79895a93a0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4199c39e-5a55-49fb-999e-fa65da856fdb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5f78a1a3-4716-445b-a5e9-79895a93a0bb" xlink:to="loc_us-gaap_EarningsPerShareBasic_4199c39e-5a55-49fb-999e-fa65da856fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_aaa45545-7e65-48fe-a48b-177171bfa8ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5f78a1a3-4716-445b-a5e9-79895a93a0bb" xlink:to="loc_us-gaap_EarningsPerShareDiluted_aaa45545-7e65-48fe-a48b-177171bfa8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f8247055-0279-4074-bf71-efaf84fd6ea0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f8247055-0279-4074-bf71-efaf84fd6ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c60f30cf-09f2-4807-9351-c3848d65fc3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f8247055-0279-4074-bf71-efaf84fd6ea0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c60f30cf-09f2-4807-9351-c3848d65fc3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2e32983f-755a-41b1-bb98-c838ad98c4e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_f8247055-0279-4074-bf71-efaf84fd6ea0" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2e32983f-755a-41b1-bb98-c838ad98c4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_86eefd4e-31f2-4526-9396-96e6ed573064" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_23b27b7d-c9c2-45b7-a7e3-0505289e4646" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_86eefd4e-31f2-4526-9396-96e6ed573064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_11219f6c-c1d5-4200-aede-f31085617341" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_16f00871-4dbd-4675-916b-a09b735fb8d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_11219f6c-c1d5-4200-aede-f31085617341" xlink:to="loc_us-gaap_NetIncomeLoss_16f00871-4dbd-4675-916b-a09b735fb8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0e6bbf26-3852-471a-b0f9-7658c6a67582" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_11219f6c-c1d5-4200-aede-f31085617341" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0e6bbf26-3852-471a-b0f9-7658c6a67582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_c14b5a0b-d687-490c-be5c-4a11ad6f3a8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0e6bbf26-3852-471a-b0f9-7658c6a67582" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_c14b5a0b-d687-490c-be5c-4a11ad6f3a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_d17f2ff2-0dc3-4e0a-a10f-0a22995ce625" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0e6bbf26-3852-471a-b0f9-7658c6a67582" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_d17f2ff2-0dc3-4e0a-a10f-0a22995ce625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_d1609dd9-7308-476e-8f4b-efb2397abd58" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_d17f2ff2-0dc3-4e0a-a10f-0a22995ce625" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_d1609dd9-7308-476e-8f4b-efb2397abd58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_d21df5b6-50ae-4f40-a5a5-97042ef7eba6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_d17f2ff2-0dc3-4e0a-a10f-0a22995ce625" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_d21df5b6-50ae-4f40-a5a5-97042ef7eba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_93141da1-ae86-4561-9fcb-73d8008535f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_d17f2ff2-0dc3-4e0a-a10f-0a22995ce625" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_93141da1-ae86-4561-9fcb-73d8008535f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_e88d6d33-63de-4499-bc44-75fed2337b21" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0e6bbf26-3852-471a-b0f9-7658c6a67582" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_e88d6d33-63de-4499-bc44-75fed2337b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax_4af3ae3d-2413-4e4f-9395-52de46c60485" xlink:href="jnj-20200927.xsd#jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_e88d6d33-63de-4499-bc44-75fed2337b21" xlink:to="loc_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax_4af3ae3d-2413-4e4f-9395-52de46c60485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax_3cab02b1-9bf8-4694-af55-e666c5a660a5" xlink:href="jnj-20200927.xsd#jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_e88d6d33-63de-4499-bc44-75fed2337b21" xlink:to="loc_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax_3cab02b1-9bf8-4694-af55-e666c5a660a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f3e69ac0-4b74-47f6-84c5-4267730e2580" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_e88d6d33-63de-4499-bc44-75fed2337b21" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_f3e69ac0-4b74-47f6-84c5-4267730e2580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract_4f2f52ad-76c6-43aa-89d7-849b4bcb70e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0e6bbf26-3852-471a-b0f9-7658c6a67582" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract_4f2f52ad-76c6-43aa-89d7-849b4bcb70e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_cdc6f9b4-73f3-49f8-8b33-3e727a181e7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract_4f2f52ad-76c6-43aa-89d7-849b4bcb70e4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_cdc6f9b4-73f3-49f8-8b33-3e727a181e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_8f2cb78f-c542-407d-aea4-e3d7fc35ecef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract_4f2f52ad-76c6-43aa-89d7-849b4bcb70e4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_8f2cb78f-c542-407d-aea4-e3d7fc35ecef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_35507517-f785-42bc-b5f6-4f685ccdb1a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract_4f2f52ad-76c6-43aa-89d7-849b4bcb70e4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_35507517-f785-42bc-b5f6-4f685ccdb1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0abb680a-5969-4c38-a7ea-6319126c5839" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_11219f6c-c1d5-4200-aede-f31085617341" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0abb680a-5969-4c38-a7ea-6319126c5839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8403dafb-839d-47ff-8d87-872eb205809f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_11219f6c-c1d5-4200-aede-f31085617341" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_8403dafb-839d-47ff-8d87-872eb205809f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_69950a1f-e73d-4d2a-b8a9-42c5a8d121df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_11219f6c-c1d5-4200-aede-f31085617341" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_69950a1f-e73d-4d2a-b8a9-42c5a8d121df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_7a93ea85-6026-4927-a333-65eabf65541f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_11219f6c-c1d5-4200-aede-f31085617341" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_7a93ea85-6026-4927-a333-65eabf65541f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_9164770e-cfbf-43c8-89d3-273c596bd4c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_11219f6c-c1d5-4200-aede-f31085617341" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_9164770e-cfbf-43c8-89d3-273c596bd4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedStatementsofEquity"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a41bde7a-b92e-4d92-b9cc-be5e65cbf39b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5a0d01b9-fb10-448d-a050-ea9906a83793" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a41bde7a-b92e-4d92-b9cc-be5e65cbf39b" xlink:to="loc_us-gaap_StatementTable_5a0d01b9-fb10-448d-a050-ea9906a83793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_55e520d0-15ec-489e-87ce-a6b945c790d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5a0d01b9-fb10-448d-a050-ea9906a83793" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_55e520d0-15ec-489e-87ce-a6b945c790d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b015af79-0480-4885-bd4c-8ed04a756d67" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_55e520d0-15ec-489e-87ce-a6b945c790d8" xlink:to="loc_us-gaap_EquityComponentDomain_b015af79-0480-4885-bd4c-8ed04a756d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_87b4d5b4-040f-485e-88e8-d449cde4b8a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b015af79-0480-4885-bd4c-8ed04a756d67" xlink:to="loc_us-gaap_RetainedEarningsMember_87b4d5b4-040f-485e-88e8-d449cde4b8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b6d5a54e-5e19-4da8-99f8-b5497e3da899" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b015af79-0480-4885-bd4c-8ed04a756d67" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b6d5a54e-5e19-4da8-99f8-b5497e3da899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0f46f5cd-68d6-4e4c-a91d-7ef9af03a5ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b015af79-0480-4885-bd4c-8ed04a756d67" xlink:to="loc_us-gaap_CommonStockMember_0f46f5cd-68d6-4e4c-a91d-7ef9af03a5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_5ef06b4b-616c-4181-9b15-abf6029bad8e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b015af79-0480-4885-bd4c-8ed04a756d67" xlink:to="loc_us-gaap_TreasuryStockMember_5ef06b4b-616c-4181-9b15-abf6029bad8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0b1d61ce-e33a-4c7b-8e96-d58e13f6ffc6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5a0d01b9-fb10-448d-a050-ea9906a83793" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0b1d61ce-e33a-4c7b-8e96-d58e13f6ffc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9ea1118d-e533-479c-96b6-b8594a69c1a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0b1d61ce-e33a-4c7b-8e96-d58e13f6ffc6" xlink:to="loc_us-gaap_SegmentDomain_9ea1118d-e533-479c-96b6-b8594a69c1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_a5ebd47f-2993-4556-8eda-ee4f13d01c9e" xlink:href="jnj-20200927.xsd#jnj_MedicalDevicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9ea1118d-e533-479c-96b6-b8594a69c1a9" xlink:to="loc_jnj_MedicalDevicesMember_a5ebd47f-2993-4556-8eda-ee4f13d01c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5a0d01b9-fb10-448d-a050-ea9906a83793" xlink:to="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e01f5fcf-1b20-4040-9328-45ef6dc7b4ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e01f5fcf-1b20-4040-9328-45ef6dc7b4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b9955eb1-0525-40de-9b27-60f39efbcf6d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:to="loc_us-gaap_NetIncomeLoss_b9955eb1-0525-40de-9b27-60f39efbcf6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_f9f34e10-5143-4acf-aed0-51a1886e53a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:to="loc_us-gaap_DividendsCommonStockCash_f9f34e10-5143-4acf-aed0-51a1886e53a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_f994824d-de10-4a3f-867d-a43be0cf5b27" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_f994824d-de10-4a3f-867d-a43be0cf5b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_a658188b-94ac-419a-9cc7-4fcf00ab57b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_a658188b-94ac-419a-9cc7-4fcf00ab57b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_a3558ea9-adc5-4c36-9ab6-8f9e272bed5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:to="loc_us-gaap_StockholdersEquityOther_a3558ea9-adc5-4c36-9ab6-8f9e272bed5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6894cbe4-0481-467d-bfff-6c55d03743ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6894cbe4-0481-467d-bfff-6c55d03743ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90dc1bd0-1d0a-49c4-9092-bfde7ff275d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_90dc1bd0-1d0a-49c4-9092-bfde7ff275d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_bf094620-424d-4669-9804-e4f4620f8eae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d86853a5-5081-4455-8e54-dbfdd4c79046" xlink:to="loc_us-gaap_RestructuringCharges_bf094620-424d-4669-9804-e4f4620f8eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedStatementsofEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_6aaf7e53-5142-405d-ad34-a6fb23b40bbf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_5e023b6d-bd36-4b79-9233-f08fabddd2ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_6aaf7e53-5142-405d-ad34-a6fb23b40bbf" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_5e023b6d-bd36-4b79-9233-f08fabddd2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="jnj-20200927.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_debbe5fb-5bd0-4ec9-b984-80c07bb72945" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_24fe9743-e265-4df8-8d78-49ec54d84fd6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_debbe5fb-5bd0-4ec9-b984-80c07bb72945" xlink:to="loc_us-gaap_StatementTable_24fe9743-e265-4df8-8d78-49ec54d84fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2818f1ad-b860-4008-a6b5-7a35df8fcf0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_24fe9743-e265-4df8-8d78-49ec54d84fd6" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2818f1ad-b860-4008-a6b5-7a35df8fcf0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c26b7053-1646-41cb-837f-db85dfb43d38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2818f1ad-b860-4008-a6b5-7a35df8fcf0d" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c26b7053-1646-41cb-837f-db85dfb43d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AurisHealthMember_c7c78663-eef4-49bd-ab6b-21e94a4614a4" xlink:href="jnj-20200927.xsd#jnj_AurisHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c26b7053-1646-41cb-837f-db85dfb43d38" xlink:to="loc_jnj_AurisHealthMember_c7c78663-eef4-49bd-ab6b-21e94a4614a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_24fe9743-e265-4df8-8d78-49ec54d84fd6" xlink:to="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0d4464ab-99f4-4faf-8a62-50e9eef0d259" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0d4464ab-99f4-4faf-8a62-50e9eef0d259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_af15eb7e-c6eb-4280-806d-7a55a0582a0e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0d4464ab-99f4-4faf-8a62-50e9eef0d259" xlink:to="loc_us-gaap_NetIncomeLoss_af15eb7e-c6eb-4280-806d-7a55a0582a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8367ca56-1864-4e39-80e3-6c043ddd23c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0d4464ab-99f4-4faf-8a62-50e9eef0d259" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8367ca56-1864-4e39-80e3-6c043ddd23c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_50277553-a12a-4c35-b909-a0d9eb092a05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8367ca56-1864-4e39-80e3-6c043ddd23c3" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_50277553-a12a-4c35-b909-a0d9eb092a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5b0ec1c7-7467-4d8c-b43c-ef07f84fdc08" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8367ca56-1864-4e39-80e3-6c043ddd23c3" xlink:to="loc_us-gaap_ShareBasedCompensation_5b0ec1c7-7467-4d8c-b43c-ef07f84fdc08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_da164511-0d43-4b84-9c17-4b0742ba95b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8367ca56-1864-4e39-80e3-6c043ddd23c3" xlink:to="loc_us-gaap_AssetImpairmentCharges_da164511-0d43-4b84-9c17-4b0742ba95b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a938562b-518b-48e1-a5f1-ed989aa32447" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8367ca56-1864-4e39-80e3-6c043ddd23c3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a938562b-518b-48e1-a5f1-ed989aa32447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_58f2f731-2b80-4acc-ac45-3d237fc12d43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8367ca56-1864-4e39-80e3-6c043ddd23c3" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_58f2f731-2b80-4acc-ac45-3d237fc12d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_463c62f3-9c90-4cec-842a-7828660b7af9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8367ca56-1864-4e39-80e3-6c043ddd23c3" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_463c62f3-9c90-4cec-842a-7828660b7af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_79bc49be-78bb-4274-965a-427fa030353b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_8367ca56-1864-4e39-80e3-6c043ddd23c3" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_79bc49be-78bb-4274-965a-427fa030353b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39256604-cd4d-4bce-bd6e-c472ada9182e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_0d4464ab-99f4-4faf-8a62-50e9eef0d259" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39256604-cd4d-4bce-bd6e-c472ada9182e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c19cda67-5281-47cd-9e6a-e1dd323fb6fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39256604-cd4d-4bce-bd6e-c472ada9182e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c19cda67-5281-47cd-9e6a-e1dd323fb6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_9f570d75-0680-4e21-81a4-481ec42a8c57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39256604-cd4d-4bce-bd6e-c472ada9182e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_9f570d75-0680-4e21-81a4-481ec42a8c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_987708d6-7b4d-44cb-b9d4-9a8703e23f7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39256604-cd4d-4bce-bd6e-c472ada9182e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_987708d6-7b4d-44cb-b9d4-9a8703e23f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1c9e5e6f-824e-46e6-b810-0f9a81ac64db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39256604-cd4d-4bce-bd6e-c472ada9182e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_1c9e5e6f-824e-46e6-b810-0f9a81ac64db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_d1a4435a-9976-41d1-9cfc-9bbcc5e47730" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39256604-cd4d-4bce-bd6e-c472ada9182e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_d1a4435a-9976-41d1-9cfc-9bbcc5e47730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dee5bc36-c4ad-4d03-98b8-bdeba71cf80d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_39256604-cd4d-4bce-bd6e-c472ada9182e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_dee5bc36-c4ad-4d03-98b8-bdeba71cf80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b89c54ef-88f9-42cf-81a2-26b4e773ca11" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b89c54ef-88f9-42cf-81a2-26b4e773ca11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_36bdb41b-d454-4b99-b9be-0ef4cea33692" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_36bdb41b-d454-4b99-b9be-0ef4cea33692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3641fd90-2da3-48a4-ad57-bfbc07a1497d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3641fd90-2da3-48a4-ad57-bfbc07a1497d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_0b790048-1c57-4ad4-a763-7bfaaa600bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_0b790048-1c57-4ad4-a763-7bfaaa600bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_a83af65b-230e-4848-8cd6-4fe69f11ef3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_a83af65b-230e-4848-8cd6-4fe69f11ef3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Proceedsfromcreditsupportagreements_c63c6da6-b1ed-4281-8339-cacba3127f88" xlink:href="jnj-20200927.xsd#jnj_Proceedsfromcreditsupportagreements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:to="loc_jnj_Proceedsfromcreditsupportagreements_c63c6da6-b1ed-4281-8339-cacba3127f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_a2041fda-7412-48c0-8f36-cd3416cf4c98" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_a2041fda-7412-48c0-8f36-cd3416cf4c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5e626143-81a1-4d25-8c0a-ec87e4102e38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_acdff209-8159-4f8b-a703-8eb24d3d172d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5e626143-81a1-4d25-8c0a-ec87e4102e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_2c9154e5-11cb-4a49-81a2-e05c7b99f283" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_2c9154e5-11cb-4a49-81a2-e05c7b99f283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0d9f5abc-3873-4185-b0ef-531e24fc70a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0d9f5abc-3873-4185-b0ef-531e24fc70a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_dae16944-a0a0-49d4-b13c-ef48cfcd528b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_dae16944-a0a0-49d4-b13c-ef48cfcd528b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_5eef4618-8929-4efc-b837-393d2c1fd79d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_5eef4618-8929-4efc-b837-393d2c1fd79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9cea93d7-cf9f-47df-a36c-adebcb769547" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9cea93d7-cf9f-47df-a36c-adebcb769547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_9dea6612-da50-4c9e-a9d2-a92c25ac0ceb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_9dea6612-da50-4c9e-a9d2-a92c25ac0ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits_0d6dfc07-5d79-4911-9554-82d2986bd4fe" xlink:href="jnj-20200927.xsd#jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:to="loc_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits_0d6dfc07-5d79-4911-9554-82d2986bd4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bb4ddeb3-6dbd-4c7f-9442-6df62f93df62" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bb4ddeb3-6dbd-4c7f-9442-6df62f93df62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b45141fc-ed16-4b9a-aa2c-60419fdfa721" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_5ff0c3a5-a5ac-45d4-b0a3-c19ad07b2bad" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b45141fc-ed16-4b9a-aa2c-60419fdfa721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_7cad3b59-6b98-4ea9-9fdf-0a757b8bcbdb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_7cad3b59-6b98-4ea9-9fdf-0a757b8bcbdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_089e3ff4-0521-4867-ac2a-bf613f44b0de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_089e3ff4-0521-4867-ac2a-bf613f44b0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bd445b04-b97a-4601-9e93-f4deba29f2a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bd445b04-b97a-4601-9e93-f4deba29f2a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_30337b19-0345-44d7-90c8-2eccbf2af676" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_30337b19-0345-44d7-90c8-2eccbf2af676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_049df0ae-85c4-4463-bbab-8f2325c3ef31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dc399a9f-af66-4ab4-b0ed-939c2b71cc14" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_049df0ae-85c4-4463-bbab-8f2325c3ef31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_d3d55a8a-08d1-454f-a7a6-4dfc430cc824" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_049df0ae-85c4-4463-bbab-8f2325c3ef31" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_d3d55a8a-08d1-454f-a7a6-4dfc430cc824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_c2f79e4d-0e20-4a9f-8d3d-a9c0d266201a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_049df0ae-85c4-4463-bbab-8f2325c3ef31" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_c2f79e4d-0e20-4a9f-8d3d-a9c0d266201a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_aaac417d-ebe5-4f8f-bc18-685425aa5a26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_049df0ae-85c4-4463-bbab-8f2325c3ef31" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_aaac417d-ebe5-4f8f-bc18-685425aa5a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="jnj-20200927.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_75f7181b-8828-4e81-bd55-ffd254a904ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_8dab0605-55b6-4b8b-8570-007c74486ca0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_75f7181b-8828-4e81-bd55-ffd254a904ce" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_8dab0605-55b6-4b8b-8570-007c74486ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="jnj-20200927.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9c6ab1ea-5d1a-4b91-885c-c4d7df69efc9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_b46e90a6-6fcd-4aef-a63e-0e0f68154341" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9c6ab1ea-5d1a-4b91-885c-c4d7df69efc9" xlink:to="loc_us-gaap_UseOfEstimates_b46e90a6-6fcd-4aef-a63e-0e0f68154341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c6a3ae7e-52d1-4d87-b371-a486ce33c9c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9c6ab1ea-5d1a-4b91-885c-c4d7df69efc9" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c6a3ae7e-52d1-4d87-b371-a486ce33c9c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_7f5bd14b-17fe-4106-a110-8745ec9108a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9c6ab1ea-5d1a-4b91-885c-c4d7df69efc9" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_7f5bd14b-17fe-4106-a110-8745ec9108a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/Inventories" xlink:type="simple" xlink:href="jnj-20200927.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_541eeb50-b3fe-4d85-9b59-6401a4797d92" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_106a0091-84ef-4a02-9a91-0685fc156c13" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_541eeb50-b3fe-4d85-9b59-6401a4797d92" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_106a0091-84ef-4a02-9a91-0685fc156c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/InventoriesTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_cbee0059-ccce-4a52-aa2d-4b34f1d7218c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_d3cdfafd-0c0a-45dc-a48f-dcb397a507cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_cbee0059-ccce-4a52-aa2d-4b34f1d7218c" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_d3cdfafd-0c0a-45dc-a48f-dcb397a507cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/InventoriesDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_2315f2f3-f2bb-485c-ad57-f2f44af1d787" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_1dc85a38-fb72-4313-aa6a-6bf4e7e1e76c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2315f2f3-f2bb-485c-ad57-f2f44af1d787" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_1dc85a38-fb72-4313-aa6a-6bf4e7e1e76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_78933a54-8f15-4958-8739-be1bd20120e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2315f2f3-f2bb-485c-ad57-f2f44af1d787" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_78933a54-8f15-4958-8739-be1bd20120e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_7508ffd8-44af-4f93-9d9a-ff78900a6b6c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2315f2f3-f2bb-485c-ad57-f2f44af1d787" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_7508ffd8-44af-4f93-9d9a-ff78900a6b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_cdb24ec1-c440-4d42-8c23-0256840cd0ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_2315f2f3-f2bb-485c-ad57-f2f44af1d787" xlink:to="loc_us-gaap_InventoryNet_cdb24ec1-c440-4d42-8c23-0256840cd0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="jnj-20200927.xsd#IntangibleAssetsandGoodwill"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_76b98a0f-1a21-4a4d-b617-c2c8d45be027" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_dbd14fd4-2cc4-4808-92ca-6d77c7b2937e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_76b98a0f-1a21-4a4d-b617-c2c8d45be027" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_dbd14fd4-2cc4-4808-92ca-6d77c7b2937e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2ab546b3-b1ad-463e-bbbe-5115a8b97c4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock_9efe31cc-e92e-4c6f-b4da-e071451d68cd" xlink:href="jnj-20200927.xsd#jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2ab546b3-b1ad-463e-bbbe-5115a8b97c4c" xlink:to="loc_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock_9efe31cc-e92e-4c6f-b4da-e071451d68cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_a9c6f4a3-faed-4741-bd62-83eed4b9122d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2ab546b3-b1ad-463e-bbbe-5115a8b97c4c" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_a9c6f4a3-faed-4741-bd62-83eed4b9122d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_9ddd5d83-f59a-45db-a382-95af733e606e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2ab546b3-b1ad-463e-bbbe-5115a8b97c4c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_9ddd5d83-f59a-45db-a382-95af733e606e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#IntangibleAssetsandGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_95d9ff5c-c11f-45fa-87ca-cba452f46071" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_17428ad5-c591-4d47-9dc8-21810cc8d363" xlink:href="jnj-20200927.xsd#jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_95d9ff5c-c11f-45fa-87ca-cba452f46071" xlink:to="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_17428ad5-c591-4d47-9dc8-21810cc8d363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_8c3f31d6-5694-42d3-8aa0-490ffeb3bb87" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_17428ad5-c591-4d47-9dc8-21810cc8d363" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_8c3f31d6-5694-42d3-8aa0-490ffeb3bb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7f1bd537-1199-464a-8625-6813ce8c0a14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_8c3f31d6-5694-42d3-8aa0-490ffeb3bb87" xlink:to="loc_us-gaap_SegmentDomain_7f1bd537-1199-464a-8625-6813ce8c0a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember_28a93bce-cc84-4636-b74b-e91f195c1a7f" xlink:href="jnj-20200927.xsd#jnj_ConsumerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7f1bd537-1199-464a-8625-6813ce8c0a14" xlink:to="loc_jnj_ConsumerMember_28a93bce-cc84-4636-b74b-e91f195c1a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e9c81718-3fab-45b8-9ff9-0dbdd10bc584" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_17428ad5-c591-4d47-9dc8-21810cc8d363" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e9c81718-3fab-45b8-9ff9-0dbdd10bc584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_077c0361-75a8-4617-aa85-35c4d02e3157" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e9c81718-3fab-45b8-9ff9-0dbdd10bc584" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_077c0361-75a8-4617-aa85-35c4d02e3157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PatentsAndTrademarksMember_b0c83538-e02e-4d8a-9295-5f0686d1780c" xlink:href="jnj-20200927.xsd#jnj_PatentsAndTrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_077c0361-75a8-4617-aa85-35c4d02e3157" xlink:to="loc_jnj_PatentsAndTrademarksMember_b0c83538-e02e-4d8a-9295-5f0686d1780c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_f3bcda05-d4e0-4965-b68c-9a363397e466" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_077c0361-75a8-4617-aa85-35c4d02e3157" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_f3bcda05-d4e0-4965-b68c-9a363397e466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2cd84b81-91e5-47d0-800d-927e3cdd04f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_17428ad5-c591-4d47-9dc8-21810cc8d363" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2cd84b81-91e5-47d0-800d-927e3cdd04f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ab88401b-31d4-4500-b64b-766e4bd8f30f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_2cd84b81-91e5-47d0-800d-927e3cdd04f5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ab88401b-31d4-4500-b64b-766e4bd8f30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_d99d8dbc-9b06-48df-ba32-f18538a8b4be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ab88401b-31d4-4500-b64b-766e4bd8f30f" xlink:to="loc_us-gaap_TrademarksMember_d99d8dbc-9b06-48df-ba32-f18538a8b4be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_dad50bf3-a68f-49f4-a09b-fb466b69f2b6" xlink:href="jnj-20200927.xsd#jnj_PurchasedInProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ab88401b-31d4-4500-b64b-766e4bd8f30f" xlink:to="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_dad50bf3-a68f-49f4-a09b-fb466b69f2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_88076031-0560-4d93-afbb-53c03b56c49b" xlink:href="jnj-20200927.xsd#jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_17428ad5-c591-4d47-9dc8-21810cc8d363" xlink:to="loc_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_88076031-0560-4d93-afbb-53c03b56c49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_54839912-0f01-4f2d-a54b-3fc5ccbc3627" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_88076031-0560-4d93-afbb-53c03b56c49b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_54839912-0f01-4f2d-a54b-3fc5ccbc3627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_977558f1-ae55-4c34-8eba-9bc2365f6e3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_54839912-0f01-4f2d-a54b-3fc5ccbc3627" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_977558f1-ae55-4c34-8eba-9bc2365f6e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ba81b105-3f08-419b-bc2c-9fd9b91fef1f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_977558f1-ae55-4c34-8eba-9bc2365f6e3f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ba81b105-3f08-419b-bc2c-9fd9b91fef1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_34e43781-9a04-4fea-a4f9-9437420ce845" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_977558f1-ae55-4c34-8eba-9bc2365f6e3f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_34e43781-9a04-4fea-a4f9-9437420ce845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8cbd107e-cf96-4a72-987c-61edd8800556" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_977558f1-ae55-4c34-8eba-9bc2365f6e3f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8cbd107e-cf96-4a72-987c-61edd8800556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_f36b861e-950b-4c0e-8510-d87d10952bd2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_54839912-0f01-4f2d-a54b-3fc5ccbc3627" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_f36b861e-950b-4c0e-8510-d87d10952bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_68e7119e-9f05-44f2-ac9b-2b36ee1fff9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_f36b861e-950b-4c0e-8510-d87d10952bd2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_68e7119e-9f05-44f2-ac9b-2b36ee1fff9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b0b15f08-aa5e-40ff-92fd-03645e5e00b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_f36b861e-950b-4c0e-8510-d87d10952bd2" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b0b15f08-aa5e-40ff-92fd-03645e5e00b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#IntangibleAssetsandGoodwillGoodwillBySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fdc37f9f-5cfd-42f6-860a-38f9a78c7db4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_87e769ea-c23e-4066-af86-f89e8086c4d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fdc37f9f-5cfd-42f6-860a-38f9a78c7db4" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_87e769ea-c23e-4066-af86-f89e8086c4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ad1a4a6c-b231-4844-9a94-b3e902ed7d18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_87e769ea-c23e-4066-af86-f89e8086c4d0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ad1a4a6c-b231-4844-9a94-b3e902ed7d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_dcc279b6-b8b0-45af-9d86-dd4552825dde" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ad1a4a6c-b231-4844-9a94-b3e902ed7d18" xlink:to="loc_us-gaap_SegmentDomain_dcc279b6-b8b0-45af-9d86-dd4552825dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember_4bd0423b-afbd-424b-b0bf-4490f048c474" xlink:href="jnj-20200927.xsd#jnj_ConsumerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_dcc279b6-b8b0-45af-9d86-dd4552825dde" xlink:to="loc_jnj_ConsumerMember_4bd0423b-afbd-424b-b0bf-4490f048c474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PharmaceuticalMember_12d4206a-b20b-4563-aa37-56a861c1eaed" xlink:href="jnj-20200927.xsd#jnj_PharmaceuticalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_dcc279b6-b8b0-45af-9d86-dd4552825dde" xlink:to="loc_jnj_PharmaceuticalMember_12d4206a-b20b-4563-aa37-56a861c1eaed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_3bb620fe-af08-462f-b878-4bf99e11469d" xlink:href="jnj-20200927.xsd#jnj_MedicalDevicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_dcc279b6-b8b0-45af-9d86-dd4552825dde" xlink:to="loc_jnj_MedicalDevicesMember_3bb620fe-af08-462f-b878-4bf99e11469d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_02863cbd-0539-4021-bd55-4744df929dc1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_87e769ea-c23e-4066-af86-f89e8086c4d0" xlink:to="loc_us-gaap_GoodwillLineItems_02863cbd-0539-4021-bd55-4744df929dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_67d6d7e0-5620-4211-bda9-1180881fa8ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_02863cbd-0539-4021-bd55-4744df929dc1" xlink:to="loc_us-gaap_GoodwillRollForward_67d6d7e0-5620-4211-bda9-1180881fa8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_122701d1-b1fd-4264-880e-e304aeea5f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_67d6d7e0-5620-4211-bda9-1180881fa8ac" xlink:to="loc_us-gaap_Goodwill_122701d1-b1fd-4264-880e-e304aeea5f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_320c2cf0-11f6-414c-b119-9311debdbf66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_67d6d7e0-5620-4211-bda9-1180881fa8ac" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_320c2cf0-11f6-414c-b119-9311debdbf66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease_d6a45759-97ed-42ee-ad27-206d0b5bc75d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_67d6d7e0-5620-4211-bda9-1180881fa8ac" xlink:to="loc_us-gaap_GoodwillOtherIncreaseDecrease_d6a45759-97ed-42ee-ad27-206d0b5bc75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_83200a4c-cd91-4223-954d-11428ec0c4b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_67d6d7e0-5620-4211-bda9-1180881fa8ac" xlink:to="loc_us-gaap_Goodwill_83200a4c-cd91-4223-954d-11428ec0c4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#IntangibleAssetsandGoodwillNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c139f858-2f7a-45d8-8dbd-ce40afe93768" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ec2a592e-c7dd-4629-8b08-0effa29b616c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c139f858-2f7a-45d8-8dbd-ce40afe93768" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ec2a592e-c7dd-4629-8b08-0effa29b616c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9f9dd42c-8d7d-4831-a06a-c0a9e37e78ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ec2a592e-c7dd-4629-8b08-0effa29b616c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9f9dd42c-8d7d-4831-a06a-c0a9e37e78ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_190ea0f9-b973-48e0-a0a3-0cd1d2793cde" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_9f9dd42c-8d7d-4831-a06a-c0a9e37e78ee" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_190ea0f9-b973-48e0-a0a3-0cd1d2793cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_98297c67-8d46-4b89-92cf-79bd2f1c94ef" xlink:href="jnj-20200927.xsd#jnj_PurchasedInProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_190ea0f9-b973-48e0-a0a3-0cd1d2793cde" xlink:to="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_98297c67-8d46-4b89-92cf-79bd2f1c94ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b2a3bb87-c602-4b7c-b94d-30c733f9b3ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ec2a592e-c7dd-4629-8b08-0effa29b616c" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b2a3bb87-c602-4b7c-b94d-30c733f9b3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_30d4ca5a-a17e-48e1-ad35-951152cf317b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b2a3bb87-c602-4b7c-b94d-30c733f9b3ad" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_30d4ca5a-a17e-48e1-ad35-951152cf317b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BermekimabMember_02e2a0fb-036c-4c88-b994-95e901f2b1f8" xlink:href="jnj-20200927.xsd#jnj_BermekimabMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_30d4ca5a-a17e-48e1-ad35-951152cf317b" xlink:to="loc_jnj_BermekimabMember_02e2a0fb-036c-4c88-b994-95e901f2b1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VerbSurgicalInc.Member_d0d8502d-8915-41a7-8d02-6f839e427746" xlink:href="jnj-20200927.xsd#jnj_VerbSurgicalInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_30d4ca5a-a17e-48e1-ad35-951152cf317b" xlink:to="loc_jnj_VerbSurgicalInc.Member_d0d8502d-8915-41a7-8d02-6f839e427746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08bb603a-9735-4e96-b8ff-46f7d5193b97" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ec2a592e-c7dd-4629-8b08-0effa29b616c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08bb603a-9735-4e96-b8ff-46f7d5193b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e0ad8d60-a130-43d8-9a81-7d985dfc2a7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_08bb603a-9735-4e96-b8ff-46f7d5193b97" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e0ad8d60-a130-43d8-9a81-7d985dfc2a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PatentsAndTrademarksMember_894539d0-469c-4f7d-a749-65cc1f74b660" xlink:href="jnj-20200927.xsd#jnj_PatentsAndTrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e0ad8d60-a130-43d8-9a81-7d985dfc2a7d" xlink:to="loc_jnj_PatentsAndTrademarksMember_894539d0-469c-4f7d-a749-65cc1f74b660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_4b0fc301-3ed9-4cc5-842a-c765efecb3f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e0ad8d60-a130-43d8-9a81-7d985dfc2a7d" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_4b0fc301-3ed9-4cc5-842a-c765efecb3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a731192e-7a4f-408d-a00b-1cf287e67e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ec2a592e-c7dd-4629-8b08-0effa29b616c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a731192e-7a4f-408d-a00b-1cf287e67e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_77840e6d-ab92-4ad3-825e-dde89a309ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a731192e-7a4f-408d-a00b-1cf287e67e7b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_77840e6d-ab92-4ad3-825e-dde89a309ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_8c56fda1-a9e0-4bcd-891b-3ad7931f740b" xlink:href="jnj-20200927.xsd#jnj_IntangibleAssetsAndGoodwillTextualsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a731192e-7a4f-408d-a00b-1cf287e67e7b" xlink:to="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_8c56fda1-a9e0-4bcd-891b-3ad7931f740b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_cf6fad02-d261-4999-bb77-295c858005ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_8c56fda1-a9e0-4bcd-891b-3ad7931f740b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_cf6fad02-d261-4999-bb77-295c858005ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_9c1a8277-9cbc-4a1e-8a89-af1776b3f723" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_8c56fda1-a9e0-4bcd-891b-3ad7931f740b" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_9c1a8277-9cbc-4a1e-8a89-af1776b3f723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e7d61601-bb3b-4ac8-a635-b6dd1f2aeeff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7dadbdf5-e1bc-4ab5-8668-26c40d33347e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e7d61601-bb3b-4ac8-a635-b6dd1f2aeeff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_7dadbdf5-e1bc-4ab5-8668-26c40d33347e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3fa6186a-cf0e-4b5a-a98d-0f4161cd2c95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e7d61601-bb3b-4ac8-a635-b6dd1f2aeeff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3fa6186a-cf0e-4b5a-a98d-0f4161cd2c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_fd0e8cc7-ee1f-4667-b87e-afa4c352cc3b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e7d61601-bb3b-4ac8-a635-b6dd1f2aeeff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_fd0e8cc7-ee1f-4667-b87e-afa4c352cc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_11c9a198-802d-4a9f-8626-af06ea74aca2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e7d61601-bb3b-4ac8-a635-b6dd1f2aeeff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_11c9a198-802d-4a9f-8626-af06ea74aca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2e5e79a8-ca94-4416-95ad-5b70cde43277" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e7d61601-bb3b-4ac8-a635-b6dd1f2aeeff" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2e5e79a8-ca94-4416-95ad-5b70cde43277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3b928a5f-0885-4df7-a76a-e26a2d8287a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_f2ab210f-12cc-4d5e-915d-2f99f0682d5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3b928a5f-0885-4df7-a76a-e26a2d8287a9" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_f2ab210f-12cc-4d5e-915d-2f99f0682d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsPolicies" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsPolicies"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_64b476ed-0610-4eec-9804-c75624beca2e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c25e87a6-1135-40f9-8745-d3e37b86d67f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_64b476ed-0610-4eec-9804-c75624beca2e" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c25e87a6-1135-40f9-8745-d3e37b86d67f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1ad53258-3fba-485d-9e90-046eb4a7574d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_c390385c-bd77-4e5a-ba25-4e517f6c9205" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1ad53258-3fba-485d-9e90-046eb4a7574d" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_c390385c-bd77-4e5a-ba25-4e517f6c9205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_29ffc53a-9809-498a-97d4-7686d930a415" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1ad53258-3fba-485d-9e90-046eb4a7574d" xlink:to="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_29ffc53a-9809-498a-97d4-7686d930a415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_664a3aac-e0b9-498f-bdd5-a9db058e0421" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1ad53258-3fba-485d-9e90-046eb4a7574d" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_664a3aac-e0b9-498f-bdd5-a9db058e0421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_66bc9bff-c1da-47d3-9184-5631c00582b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1ad53258-3fba-485d-9e90-046eb4a7574d" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_66bc9bff-c1da-47d3-9184-5631c00582b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2c54847c-ffc7-46b5-a4de-ec3ccbf16432" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1ad53258-3fba-485d-9e90-046eb4a7574d" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_2c54847c-ffc7-46b5-a4de-ec3ccbf16432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_e9debf28-babc-457c-bb03-83505985099b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1ad53258-3fba-485d-9e90-046eb4a7574d" xlink:to="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_e9debf28-babc-457c-bb03-83505985099b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_8177bf91-f2ef-4e88-b92b-2dea4df24b34" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1ad53258-3fba-485d-9e90-046eb4a7574d" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_8177bf91-f2ef-4e88-b92b-2dea4df24b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_dc86d519-12e7-41b1-99c5-f0bbbf18c87b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1ad53258-3fba-485d-9e90-046eb4a7574d" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_dc86d519-12e7-41b1-99c5-f0bbbf18c87b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_533d336a-d97f-4f87-8cf9-34f1b12175fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_533d336a-d97f-4f87-8cf9-34f1b12175fc" xlink:to="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fa647947-7f44-4b29-a62c-f55ce6ca1a34" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fa647947-7f44-4b29-a62c-f55ce6ca1a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_152007c9-b26b-4f20-9d13-8cfe6f5017cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fa647947-7f44-4b29-a62c-f55ce6ca1a34" xlink:to="loc_us-gaap_HedgingRelationshipDomain_152007c9-b26b-4f20-9d13-8cfe6f5017cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_e1497a7a-5e94-44d4-9b33-c936e3fafb72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_152007c9-b26b-4f20-9d13-8cfe6f5017cc" xlink:to="loc_us-gaap_FairValueHedgingMember_e1497a7a-5e94-44d4-9b33-c936e3fafb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_110a00e5-6b0e-478f-80f5-2e29183ab632" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_152007c9-b26b-4f20-9d13-8cfe6f5017cc" xlink:to="loc_us-gaap_CashFlowHedgingMember_110a00e5-6b0e-478f-80f5-2e29183ab632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_40beb981-e0c9-408e-a15e-e86c7df035ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_40beb981-e0c9-408e-a15e-e86c7df035ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_143145ee-3d89-4e1a-bc3c-a6f930ac70d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_40beb981-e0c9-408e-a15e-e86c7df035ea" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_143145ee-3d89-4e1a-bc3c-a6f930ac70d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_ca14405b-5078-4f7f-94e7-58c9cc1f428d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_143145ee-3d89-4e1a-bc3c-a6f930ac70d8" xlink:to="loc_us-gaap_SalesMember_ca14405b-5078-4f7f-94e7-58c9cc1f428d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_6a2bbc30-de42-477f-b330-f99fe591f734" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_143145ee-3d89-4e1a-bc3c-a6f930ac70d8" xlink:to="loc_us-gaap_CostOfSalesMember_6a2bbc30-de42-477f-b330-f99fe591f734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5fc3a9bb-4ae1-4ba3-87ec-9c75ccb0e276" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_143145ee-3d89-4e1a-bc3c-a6f930ac70d8" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5fc3a9bb-4ae1-4ba3-87ec-9c75ccb0e276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterestIncomeExpenseNetMember_44514812-5c0b-4363-98fe-762b16dcc143" xlink:href="jnj-20200927.xsd#jnj_InterestIncomeExpenseNetMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_143145ee-3d89-4e1a-bc3c-a6f930ac70d8" xlink:to="loc_jnj_InterestIncomeExpenseNetMember_44514812-5c0b-4363-98fe-762b16dcc143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_2c0252bd-0bf2-4e4c-8040-8be8bc6d1b1c" xlink:href="jnj-20200927.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_143145ee-3d89-4e1a-bc3c-a6f930ac70d8" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_2c0252bd-0bf2-4e4c-8040-8be8bc6d1b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5cbeb476-4cac-430e-b2e3-f29b519fcfb7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5cbeb476-4cac-430e-b2e3-f29b519fcfb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c16c5609-02c3-4477-b69d-bb0064c32a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5cbeb476-4cac-430e-b2e3-f29b519fcfb7" xlink:to="loc_us-gaap_EquityComponentDomain_c16c5609-02c3-4477-b69d-bb0064c32a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5b8e382c-e46c-4945-9d1c-839d41a20e38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c16c5609-02c3-4477-b69d-bb0064c32a1d" xlink:to="loc_us-gaap_RetainedEarningsMember_5b8e382c-e46c-4945-9d1c-839d41a20e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_1bf0d173-0476-44f2-8210-17e8a28424ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_1bf0d173-0476-44f2-8210-17e8a28424ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_c42b8bb7-d3a3-49dd-bc76-4a112746f363" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_1bf0d173-0476-44f2-8210-17e8a28424ba" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_c42b8bb7-d3a3-49dd-bc76-4a112746f363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_f7e86fbc-c270-4ad3-bd34-78e897a045fc" xlink:href="jnj-20200927.xsd#jnj_EquityInvestmentswithoutReadilyDeterminableValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_c42b8bb7-d3a3-49dd-bc76-4a112746f363" xlink:to="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_f7e86fbc-c270-4ad3-bd34-78e897a045fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember_8ca53633-2a65-4ed0-82f8-f4e62497edf5" xlink:href="jnj-20200927.xsd#jnj_EquityInvestmentswithReadilyDeterminableValueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_c42b8bb7-d3a3-49dd-bc76-4a112746f363" xlink:to="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember_8ca53633-2a65-4ed0-82f8-f4e62497edf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_19e92349-0177-4c8c-bec9-a277370b4e75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_19e92349-0177-4c8c-bec9-a277370b4e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3246597-3925-45fd-bb8c-d65f2aa48aab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_19e92349-0177-4c8c-bec9-a277370b4e75" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3246597-3925-45fd-bb8c-d65f2aa48aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_48731171-f1c6-423d-9e77-02c75fe481ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_a3246597-3925-45fd-bb8c-d65f2aa48aab" xlink:to="loc_us-gaap_EquitySecuritiesMember_48731171-f1c6-423d-9e77-02c75fe481ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_d17761aa-d5b1-404e-bbe8-b22791a63842" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:to="loc_us-gaap_InvestmentTypeAxis_d17761aa-d5b1-404e-bbe8-b22791a63842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_16a21ee9-e9b2-4468-bd19-d2082b5129c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_d17761aa-d5b1-404e-bbe8-b22791a63842" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_16a21ee9-e9b2-4468-bd19-d2082b5129c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_08ad1e90-3fe9-48f1-b9ca-76c923041641" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_16a21ee9-e9b2-4468-bd19-d2082b5129c0" xlink:to="loc_us-gaap_EquitySecuritiesMember_08ad1e90-3fe9-48f1-b9ca-76c923041641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f8aa3802-7413-442d-9eab-19ea62afe95d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f8aa3802-7413-442d-9eab-19ea62afe95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9ac89518-a4e2-427d-8063-4709f50f1357" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f8aa3802-7413-442d-9eab-19ea62afe95d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9ac89518-a4e2-427d-8063-4709f50f1357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_338d844f-5ff8-414d-81bf-7e5dffb95ec5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9ac89518-a4e2-427d-8063-4709f50f1357" xlink:to="loc_us-gaap_ForeignExchangeContractMember_338d844f-5ff8-414d-81bf-7e5dffb95ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_78b41791-f52a-4f2a-aa5b-600ba388226e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9ac89518-a4e2-427d-8063-4709f50f1357" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_78b41791-f52a-4f2a-aa5b-600ba388226e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_a9b88f82-26e5-4cdb-a974-75168dba23f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9ac89518-a4e2-427d-8063-4709f50f1357" xlink:to="loc_us-gaap_InterestRateContractMember_a9b88f82-26e5-4cdb-a974-75168dba23f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_3fbf4b86-8120-4239-9b4a-09a000284172" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_3fbf4b86-8120-4239-9b4a-09a000284172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_05191900-81bf-41e9-8db7-9ffdec4e0349" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_3fbf4b86-8120-4239-9b4a-09a000284172" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_05191900-81bf-41e9-8db7-9ffdec4e0349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_4128e3bd-f18e-48f4-81e8-e1dd4a1954dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_05191900-81bf-41e9-8db7-9ffdec4e0349" xlink:to="loc_us-gaap_CommercialPaperMember_4128e3bd-f18e-48f4-81e8-e1dd4a1954dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_0988e668-6a2b-40a6-a38e-374596bd3fb4" xlink:to="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_6a00c639-24c2-40e6-89be-2a05d20df596" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_6a00c639-24c2-40e6-89be-2a05d20df596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_f11dc014-bed5-4b79-9952-3228903da0a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_f11dc014-bed5-4b79-9952-3228903da0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_6cb5f48a-33dc-4b78-ad4e-5be7341a947b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CollateralAlreadyPostedAggregateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_6cb5f48a-33dc-4b78-ad4e-5be7341a947b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_2e2a0bc2-be8c-475a-8f7d-125948015958" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_DerivativeNotionalAmount_2e2a0bc2-be8c-475a-8f7d-125948015958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_113e81d7-88da-429b-a21f-f454f00596c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_113e81d7-88da-429b-a21f-f454f00596c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss_fcc30d45-3e55-426d-b3ea-6b877ebe3d59" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss_fcc30d45-3e55-426d-b3ea-6b877ebe3d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_a9cef0c6-7089-46a9-bf5c-fc75c6707c13" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_a9cef0c6-7089-46a9-bf5c-fc75c6707c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityFairValueAdjustmentImpairmentLoss_1f357fff-8b42-47de-a3e0-956c0998034a" xlink:href="jnj-20200927.xsd#jnj_EquityFairValueAdjustmentImpairmentLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_jnj_EquityFairValueAdjustmentImpairmentLoss_1f357fff-8b42-47de-a3e0-956c0998034a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityFairValueAdjustmentChangeInObservablePrice_fcaaff0b-fb24-4f35-a848-9b86fc6412a7" xlink:href="jnj-20200927.xsd#jnj_EquityFairValueAdjustmentChangeInObservablePrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_jnj_EquityFairValueAdjustmentChangeInObservablePrice_fcaaff0b-fb24-4f35-a848-9b86fc6412a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_0cc454b3-eb57-47fc-aed3-6b3a56f55fcc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_0cc454b3-eb57-47fc-aed3-6b3a56f55fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_1090f510-761c-4f11-a7e5-5b1c3f435204" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_1090f510-761c-4f11-a7e5-5b1c3f435204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ExcessOfFairValueOverCarryingValueOfDebt_a6a85524-e7c7-413b-a420-c008abd477a9" xlink:href="jnj-20200927.xsd#jnj_ExcessOfFairValueOverCarryingValueOfDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_jnj_ExcessOfFairValueOverCarryingValueOfDebt_a6a85524-e7c7-413b-a420-c008abd477a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_ce46dde4-674a-4b04-b2b0-30572da1d94a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_ShortTermBorrowings_ce46dde4-674a-4b04-b2b0-30572da1d94a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_3de306f7-d463-45a6-9a8b-b50bdc669516" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_3de306f7-d463-45a6-9a8b-b50bdc669516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_95f12407-17a3-4662-b3f6-622e91f856ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_DebtInstrumentTerm_95f12407-17a3-4662-b3f6-622e91f856ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_e765eaf4-c1c2-4409-8e61-588c821a4fa4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_e765eaf4-c1c2-4409-8e61-588c821a4fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_33b16ffc-b555-41f8-b33e-74a32a005b5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_33b16ffc-b555-41f8-b33e-74a32a005b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_8414b696-5d81-4093-bc40-ab185b0452ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_8414b696-5d81-4093-bc40-ab185b0452ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_97fa596c-aaa7-4eef-afb4-56fd42f2c7cf" xlink:href="jnj-20200927.xsd#jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_97fa596c-aaa7-4eef-afb4-56fd42f2c7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityFairValueAdjustmentImpairmentLoss_45b4b17c-f1bf-43d4-9ce4-07c902bb0f31" xlink:href="jnj-20200927.xsd#jnj_EquityFairValueAdjustmentImpairmentLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_fe87ed31-7b7a-482b-818f-1bffa19b522b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_fe87ed31-7b7a-482b-818f-1bffa19b522b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFairValueAdjustment_9fe25067-0cc2-41c0-9fed-e222aaaca1a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityFairValueAdjustment"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_08429b01-693b-4619-b257-565912b6333b" xlink:to="loc_us-gaap_EquityFairValueAdjustment_9fe25067-0cc2-41c0-9fed-e222aaaca1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsSummaryofDerivativeActivityDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_113de178-67e7-4cf5-8f40-7e64fe0429f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8950c2f7-c6c4-4c3b-8446-943abb617503" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_113de178-67e7-4cf5-8f40-7e64fe0429f6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8950c2f7-c6c4-4c3b-8446-943abb617503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fb683895-c5f3-4898-bc18-bd8facee45ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8950c2f7-c6c4-4c3b-8446-943abb617503" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fb683895-c5f3-4898-bc18-bd8facee45ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_156bc5a8-9ac2-43d8-b852-dfc2aa04fafd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_fb683895-c5f3-4898-bc18-bd8facee45ae" xlink:to="loc_us-gaap_HedgingRelationshipDomain_156bc5a8-9ac2-43d8-b852-dfc2aa04fafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_c27a6ec1-c48e-4f04-8279-2a8239b30e18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_156bc5a8-9ac2-43d8-b852-dfc2aa04fafd" xlink:to="loc_us-gaap_FairValueHedgingMember_c27a6ec1-c48e-4f04-8279-2a8239b30e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_74a175ed-0f97-4e7f-969a-c88b0fc9a4a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_156bc5a8-9ac2-43d8-b852-dfc2aa04fafd" xlink:to="loc_us-gaap_CashFlowHedgingMember_74a175ed-0f97-4e7f-969a-c88b0fc9a4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_cd01a4ca-7ace-4979-b06f-cbda6604e358" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8950c2f7-c6c4-4c3b-8446-943abb617503" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_cd01a4ca-7ace-4979-b06f-cbda6604e358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e32610ac-a22b-45ae-aaf5-e42c18272178" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cd01a4ca-7ace-4979-b06f-cbda6604e358" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e32610ac-a22b-45ae-aaf5-e42c18272178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_b2fc5528-818e-4478-b273-7c257518216e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e32610ac-a22b-45ae-aaf5-e42c18272178" xlink:to="loc_us-gaap_InterestRateContractMember_b2fc5528-818e-4478-b273-7c257518216e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_ffd18a4a-75a2-4a2b-9f48-63a7ca4955fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e32610ac-a22b-45ae-aaf5-e42c18272178" xlink:to="loc_us-gaap_ForeignExchangeContractMember_ffd18a4a-75a2-4a2b-9f48-63a7ca4955fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_d9eb1f87-f041-4e0e-85b2-6cc752922ee5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e32610ac-a22b-45ae-aaf5-e42c18272178" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_d9eb1f87-f041-4e0e-85b2-6cc752922ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7ef8168c-69ca-416c-be35-4551524f473a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8950c2f7-c6c4-4c3b-8446-943abb617503" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7ef8168c-69ca-416c-be35-4551524f473a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fb33f637-85a3-493b-a219-a73fe9862c88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7ef8168c-69ca-416c-be35-4551524f473a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fb33f637-85a3-493b-a219-a73fe9862c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_4710110b-8195-4b34-8bfc-5dda2e1adafd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fb33f637-85a3-493b-a219-a73fe9862c88" xlink:to="loc_us-gaap_SalesMember_4710110b-8195-4b34-8bfc-5dda2e1adafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_24bf9634-c8a7-4cab-a26a-9601c256e6a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fb33f637-85a3-493b-a219-a73fe9862c88" xlink:to="loc_us-gaap_CostOfSalesMember_24bf9634-c8a7-4cab-a26a-9601c256e6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f19bb4fd-e64f-4435-9e7b-8c315e9d0190" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fb33f637-85a3-493b-a219-a73fe9862c88" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f19bb4fd-e64f-4435-9e7b-8c315e9d0190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_3121d55e-9833-42fd-a7bd-051918a791ca" xlink:href="jnj-20200927.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fb33f637-85a3-493b-a219-a73fe9862c88" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_3121d55e-9833-42fd-a7bd-051918a791ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterestIncomeExpenseNetMember_f40211e7-2ffb-4f87-a85c-e5a1fdc217b6" xlink:href="jnj-20200927.xsd#jnj_InterestIncomeExpenseNetMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fb33f637-85a3-493b-a219-a73fe9862c88" xlink:to="loc_jnj_InterestIncomeExpenseNetMember_f40211e7-2ffb-4f87-a85c-e5a1fdc217b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_8950c2f7-c6c4-4c3b-8446-943abb617503" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3f6b2041-25fc-4612-b38e-d5014395b22e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3f6b2041-25fc-4612-b38e-d5014395b22e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_7983f80b-dca2-4514-8af5-8d0961260506" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:to="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_7983f80b-dca2-4514-8af5-8d0961260506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_a8099aae-9c9f-4473-be50-a17c2fb5e2b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_a8099aae-9c9f-4473-be50-a17c2fb5e2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_b8d4624b-79a1-4706-8d81-dcac79209f25" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CollateralAlreadyPostedAggregateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:to="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_b8d4624b-79a1-4706-8d81-dcac79209f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_923bbdd4-258c-438d-a907-991dfc2449e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:to="loc_us-gaap_DerivativeNotionalAmount_923bbdd4-258c-438d-a907-991dfc2449e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_d52e4ec9-c1d7-4061-b492-cb8154732e1f" xlink:href="jnj-20200927.xsd#jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:to="loc_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_d52e4ec9-c1d7-4061-b492-cb8154732e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_a716f515-21bd-4090-98f7-dec58137ed4e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_d52e4ec9-c1d7-4061-b492-cb8154732e1f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_a716f515-21bd-4090-98f7-dec58137ed4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_c8d175f6-781e-4cac-aa31-e679c461f3e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_c8d175f6-781e-4cac-aa31-e679c461f3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_96681d4b-1ed7-4395-8f92-a4fd82b37881" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_586e3e3a-891f-41b0-b00b-c670712e15d9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_96681d4b-1ed7-4395-8f92-a4fd82b37881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7a4b191c-749e-459e-a097-d5f72e4cff7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4807eefe-3095-4510-8617-b6920fbeba01" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7a4b191c-749e-459e-a097-d5f72e4cff7b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_4807eefe-3095-4510-8617-b6920fbeba01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_d690231e-4d43-45eb-93e2-b855e46b9bfa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7a4b191c-749e-459e-a097-d5f72e4cff7b" xlink:to="loc_us-gaap_DerivativeLiabilities_d690231e-4d43-45eb-93e2-b855e46b9bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3c736289-8267-4a3b-a9d4-e309d27182eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_413a8c59-8dde-48b2-9d8f-82b5a3514d0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3c736289-8267-4a3b-a9d4-e309d27182eb" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_413a8c59-8dde-48b2-9d8f-82b5a3514d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_3801dc42-cd95-42c5-8601-ce72e2a0845f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_413a8c59-8dde-48b2-9d8f-82b5a3514d0d" xlink:to="loc_us-gaap_HedgingDesignationAxis_3801dc42-cd95-42c5-8601-ce72e2a0845f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_9a32fa99-1c1f-4246-97a1-07d64acc75fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_3801dc42-cd95-42c5-8601-ce72e2a0845f" xlink:to="loc_us-gaap_HedgingDesignationDomain_9a32fa99-1c1f-4246-97a1-07d64acc75fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_fd7b28dd-aa02-4963-8357-8640665dce42" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_9a32fa99-1c1f-4246-97a1-07d64acc75fb" xlink:to="loc_us-gaap_NondesignatedMember_fd7b28dd-aa02-4963-8357-8640665dce42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2689dbb8-091a-43e6-9fc2-a226c494cefc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_413a8c59-8dde-48b2-9d8f-82b5a3514d0d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2689dbb8-091a-43e6-9fc2-a226c494cefc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2b832668-b9c1-4821-83d2-7c6fb1bb0a49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2689dbb8-091a-43e6-9fc2-a226c494cefc" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2b832668-b9c1-4821-83d2-7c6fb1bb0a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_e89ea689-e97d-46d9-93de-280ae7801e68" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2b832668-b9c1-4821-83d2-7c6fb1bb0a49" xlink:to="loc_us-gaap_ForeignExchangeContractMember_e89ea689-e97d-46d9-93de-280ae7801e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4e5f4865-a169-4fbb-8b2b-e07e8fc04f4e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_413a8c59-8dde-48b2-9d8f-82b5a3514d0d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4e5f4865-a169-4fbb-8b2b-e07e8fc04f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_86987755-4b00-4139-bb63-fde3ce5b5575" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4e5f4865-a169-4fbb-8b2b-e07e8fc04f4e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_86987755-4b00-4139-bb63-fde3ce5b5575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_d146a4e8-4b71-4ac9-858f-563a239ddece" xlink:href="jnj-20200927.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_86987755-4b00-4139-bb63-fde3ce5b5575" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_d146a4e8-4b71-4ac9-858f-563a239ddece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6daa56e7-3177-42c4-861f-edc20ee33b10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_413a8c59-8dde-48b2-9d8f-82b5a3514d0d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6daa56e7-3177-42c4-861f-edc20ee33b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_59b45e86-c7fa-43dd-aa21-8870613117ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6daa56e7-3177-42c4-861f-edc20ee33b10" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_59b45e86-c7fa-43dd-aa21-8870613117ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_7232bf7c-9d7a-46fd-be8e-3231faac4919" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6daa56e7-3177-42c4-861f-edc20ee33b10" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_7232bf7c-9d7a-46fd-be8e-3231faac4919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b292c7c1-5dc2-44d9-a60f-387ba2727bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_115f261c-70cb-4b8b-b7b9-73a78c4c6f86" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b292c7c1-5dc2-44d9-a60f-387ba2727bf8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_115f261c-70cb-4b8b-b7b9-73a78c4c6f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_86258061-e313-4cd8-aad7-37f6a42034c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_115f261c-70cb-4b8b-b7b9-73a78c4c6f86" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_86258061-e313-4cd8-aad7-37f6a42034c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ec0d2fc4-2c06-404f-a4b1-6d5424464c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_86258061-e313-4cd8-aad7-37f6a42034c0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ec0d2fc4-2c06-404f-a4b1-6d5424464c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_3f7fd4f5-723c-450e-91ac-58b3515ca7c3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ec0d2fc4-2c06-404f-a4b1-6d5424464c7b" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_3f7fd4f5-723c-450e-91ac-58b3515ca7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ad9aecbe-1be5-4bec-ae0e-fa1f1170f053" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_115f261c-70cb-4b8b-b7b9-73a78c4c6f86" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ad9aecbe-1be5-4bec-ae0e-fa1f1170f053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9edcfc2b-9bba-46fa-96fc-2db7c2ef7827" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ad9aecbe-1be5-4bec-ae0e-fa1f1170f053" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9edcfc2b-9bba-46fa-96fc-2db7c2ef7827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfSubsidiaryGainLossMember_16f7b4fc-ff44-4687-bb56-e3d069f30232" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfSubsidiaryGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9edcfc2b-9bba-46fa-96fc-2db7c2ef7827" xlink:to="loc_us-gaap_SaleOfSubsidiaryGainLossMember_16f7b4fc-ff44-4687-bb56-e3d069f30232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_cc927594-1f4a-4f39-b6f5-7898dd991692" xlink:href="jnj-20200927.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9edcfc2b-9bba-46fa-96fc-2db7c2ef7827" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_cc927594-1f4a-4f39-b6f5-7898dd991692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_172328a7-61a4-4d12-b926-219c8d8220f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_115f261c-70cb-4b8b-b7b9-73a78c4c6f86" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_172328a7-61a4-4d12-b926-219c8d8220f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c7dc42c1-40f0-4d51-920e-89cacb36342c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_172328a7-61a4-4d12-b926-219c8d8220f8" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c7dc42c1-40f0-4d51-920e-89cacb36342c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_74446336-8d81-42d4-90a5-64183a0f07e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_172328a7-61a4-4d12-b926-219c8d8220f8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_74446336-8d81-42d4-90a5-64183a0f07e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_582ade8c-2862-4241-8ccf-e8ca1be9897d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_172328a7-61a4-4d12-b926-219c8d8220f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_582ade8c-2862-4241-8ccf-e8ca1be9897d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5c815427-c76d-4548-a5d2-b17a37ed7994" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable_b1f00146-6c14-4483-b558-bce640006345" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5c815427-c76d-4548-a5d2-b17a37ed7994" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable_b1f00146-6c14-4483-b558-bce640006345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_cd5a8b7f-c6c3-4667-a7dd-d285cdeed5ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable_b1f00146-6c14-4483-b558-bce640006345" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_cd5a8b7f-c6c3-4667-a7dd-d285cdeed5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_932e9d74-8fd0-4039-bb88-25bd3e0906b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_cd5a8b7f-c6c3-4667-a7dd-d285cdeed5ed" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_932e9d74-8fd0-4039-bb88-25bd3e0906b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_d6ab7ef3-a46b-480f-9b7d-1c7355922a1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_932e9d74-8fd0-4039-bb88-25bd3e0906b6" xlink:to="loc_us-gaap_EquitySecuritiesMember_d6ab7ef3-a46b-480f-9b7d-1c7355922a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_853fc4d5-e9c2-4f8e-91be-8da0fedb83cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable_b1f00146-6c14-4483-b558-bce640006345" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_853fc4d5-e9c2-4f8e-91be-8da0fedb83cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_0c9a17fd-1df2-457a-8aa7-a3d761d07642" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_853fc4d5-e9c2-4f8e-91be-8da0fedb83cc" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_0c9a17fd-1df2-457a-8aa7-a3d761d07642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember_e2747e33-548e-4f59-88a6-066cf8d88dae" xlink:href="jnj-20200927.xsd#jnj_EquityInvestmentswithReadilyDeterminableValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_0c9a17fd-1df2-457a-8aa7-a3d761d07642" xlink:to="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember_e2747e33-548e-4f59-88a6-066cf8d88dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_fddca239-8b9a-4427-a487-f13f07878401" xlink:href="jnj-20200927.xsd#jnj_EquityInvestmentswithoutReadilyDeterminableValueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_0c9a17fd-1df2-457a-8aa7-a3d761d07642" xlink:to="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_fddca239-8b9a-4427-a487-f13f07878401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_e06679be-e5fc-4823-b83e-b3a3e78c905a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable_b1f00146-6c14-4483-b558-bce640006345" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_e06679be-e5fc-4823-b83e-b3a3e78c905a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_943bdad6-850e-4346-89cf-4278f4149bbd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_e06679be-e5fc-4823-b83e-b3a3e78c905a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_943bdad6-850e-4346-89cf-4278f4149bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentRollForward_5099855a-424c-42b4-8db7-4b5fa15d2f24" xlink:href="jnj-20200927.xsd#jnj_EquityInvestmentRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_e06679be-e5fc-4823-b83e-b3a3e78c905a" xlink:to="loc_jnj_EquityInvestmentRollForward_5099855a-424c-42b4-8db7-4b5fa15d2f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_df94be97-1750-4c6b-8592-53ddf3010c95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_EquityInvestmentRollForward_5099855a-424c-42b4-8db7-4b5fa15d2f24" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_df94be97-1750-4c6b-8592-53ddf3010c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_72e6d35a-3566-4c13-8683-2f1e34e43292" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_EquityInvestmentRollForward_5099855a-424c-42b4-8db7-4b5fa15d2f24" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_72e6d35a-3566-4c13-8683-2f1e34e43292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFairValueAdjustment_4cf01bec-c1b7-4a65-a95a-716b5c3d2c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityFairValueAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_EquityInvestmentRollForward_5099855a-424c-42b4-8db7-4b5fa15d2f24" xlink:to="loc_us-gaap_EquityFairValueAdjustment_4cf01bec-c1b7-4a65-a95a-716b5c3d2c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod_8f7d90db-9076-4410-8f73-c9e67778669c" xlink:href="jnj-20200927.xsd#jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_EquityInvestmentRollForward_5099855a-424c-42b4-8db7-4b5fa15d2f24" xlink:to="loc_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod_8f7d90db-9076-4410-8f73-c9e67778669c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_25ebca0d-74c0-4992-a095-fd2369bc817f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_EquityInvestmentRollForward_5099855a-424c-42b4-8db7-4b5fa15d2f24" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_25ebca0d-74c0-4992-a095-fd2369bc817f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_6852af97-6f2b-48db-9dc8-6ba35e6630ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_EquityInvestmentRollForward_5099855a-424c-42b4-8db7-4b5fa15d2f24" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_6852af97-6f2b-48db-9dc8-6ba35e6630ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d8bcdc0e-6e34-46e4-83e7-c66722e5fbe6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_EquityInvestmentRollForward_5099855a-424c-42b4-8db7-4b5fa15d2f24" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d8bcdc0e-6e34-46e4-83e7-c66722e5fbe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f695f105-db6b-4fee-9a3f-ac5d59cd30b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c83f1205-7824-498a-b322-03d1998a2f53" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f695f105-db6b-4fee-9a3f-ac5d59cd30b4" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c83f1205-7824-498a-b322-03d1998a2f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fd7a78dd-9e03-45fa-b8c6-bc10b79d6a29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c83f1205-7824-498a-b322-03d1998a2f53" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fd7a78dd-9e03-45fa-b8c6-bc10b79d6a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e4bfa40e-2c5f-4069-9135-34d4ffb9a9ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fd7a78dd-9e03-45fa-b8c6-bc10b79d6a29" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e4bfa40e-2c5f-4069-9135-34d4ffb9a9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_0f303db3-149d-4499-b2d1-0ab120c6f898" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e4bfa40e-2c5f-4069-9135-34d4ffb9a9ad" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_0f303db3-149d-4499-b2d1-0ab120c6f898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_9d334a05-b311-4531-a5f9-22938df1ca5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e4bfa40e-2c5f-4069-9135-34d4ffb9a9ad" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_9d334a05-b311-4531-a5f9-22938df1ca5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a5a88d17-e637-4317-b122-802a1b562826" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c83f1205-7824-498a-b322-03d1998a2f53" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a5a88d17-e637-4317-b122-802a1b562826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_805683dd-066e-4457-84aa-a3d3c1531ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a5a88d17-e637-4317-b122-802a1b562826" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_805683dd-066e-4457-84aa-a3d3c1531ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AurisHealthMember_c82eee7f-7840-4968-a73a-c881bf1537f9" xlink:href="jnj-20200927.xsd#jnj_AurisHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_805683dd-066e-4457-84aa-a3d3c1531ee3" xlink:to="loc_jnj_AurisHealthMember_c82eee7f-7840-4968-a73a-c881bf1537f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_968135b2-5b9a-4c0b-b177-ce2a10d0312b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c83f1205-7824-498a-b322-03d1998a2f53" xlink:to="loc_us-gaap_InvestmentTypeAxis_968135b2-5b9a-4c0b-b177-ce2a10d0312b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_198b61ae-5729-4858-871c-c6965cd104a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_968135b2-5b9a-4c0b-b177-ce2a10d0312b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_198b61ae-5729-4858-871c-c6965cd104a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_0cbc0439-5225-4bb5-8525-da337f7516a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_198b61ae-5729-4858-871c-c6965cd104a0" xlink:to="loc_us-gaap_EquitySecuritiesMember_0cbc0439-5225-4bb5-8525-da337f7516a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_81603a6d-2b89-43c3-b0b9-1e8621436b18" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c83f1205-7824-498a-b322-03d1998a2f53" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_81603a6d-2b89-43c3-b0b9-1e8621436b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ac53d7f9-0d10-4968-b4a8-645de12fd347" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_81603a6d-2b89-43c3-b0b9-1e8621436b18" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ac53d7f9-0d10-4968-b4a8-645de12fd347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_e94b3b21-4d6b-4747-9056-1c0a8bc919e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ac53d7f9-0d10-4968-b4a8-645de12fd347" xlink:to="loc_us-gaap_InterestRateContractMember_e94b3b21-4d6b-4747-9056-1c0a8bc919e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_24a28003-7814-49ab-b9d3-8213fc962596" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ac53d7f9-0d10-4968-b4a8-645de12fd347" xlink:to="loc_us-gaap_ForeignExchangeContractMember_24a28003-7814-49ab-b9d3-8213fc962596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_1d665468-0993-4277-8bee-d00b5ff7c106" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ac53d7f9-0d10-4968-b4a8-645de12fd347" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_1d665468-0993-4277-8bee-d00b5ff7c106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bd1f0c7e-a2e3-4271-939f-91e424c0abb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c83f1205-7824-498a-b322-03d1998a2f53" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bd1f0c7e-a2e3-4271-939f-91e424c0abb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c2c1d72-e275-4d04-b6b4-7231db584888" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bd1f0c7e-a2e3-4271-939f-91e424c0abb1" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c2c1d72-e275-4d04-b6b4-7231db584888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_85aa8c8e-a853-467e-8ab9-1535c573c5db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c2c1d72-e275-4d04-b6b4-7231db584888" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_85aa8c8e-a853-467e-8ab9-1535c573c5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_136866ef-0c51-4d20-9dd6-fe8f7e5493c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c2c1d72-e275-4d04-b6b4-7231db584888" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_136866ef-0c51-4d20-9dd6-fe8f7e5493c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_24516ce7-905b-4d60-9d78-f775bf9ceb3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c2c1d72-e275-4d04-b6b4-7231db584888" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_24516ce7-905b-4d60-9d78-f775bf9ceb3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c83f1205-7824-498a-b322-03d1998a2f53" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentDetailAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_6497f8ef-11b5-4265-9cf5-9969f53c80e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:to="loc_us-gaap_DerivativeNotionalAmount_6497f8ef-11b5-4265-9cf5-9969f53c80e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_52062632-13a0-4cb4-ba70-ba63dda67bca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_52062632-13a0-4cb4-ba70-ba63dda67bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_f87364db-b9b1-41a8-8426-96324f7ebe16" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_f87364db-b9b1-41a8-8426-96324f7ebe16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_ab7c3976-f112-4aa0-a180-5d1ac389742a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:to="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_ab7c3976-f112-4aa0-a180-5d1ac389742a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_be52fee4-c7d7-4cf4-804e-449ea857c8b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:to="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_be52fee4-c7d7-4cf4-804e-449ea857c8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_b9597854-5df8-481f-a623-875ca3f3296f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_b9597854-5df8-481f-a623-875ca3f3296f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d21ff4ad-2b6e-4449-b7cc-a0158be07299" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d21ff4ad-2b6e-4449-b7cc-a0158be07299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_dc5e1f58-520e-40e5-b5f3-7abc6cbbfabe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_146477c9-f759-4a83-ac86-8e117f6d1d4c" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_dc5e1f58-520e-40e5-b5f3-7abc6cbbfabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_b02a1b28-b605-45f4-88ca-c04b151db87d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_b02a1b28-b605-45f4-88ca-c04b151db87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_6c9ea167-699e-4c9a-ba62-572beff60ff7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_6c9ea167-699e-4c9a-ba62-572beff60ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_94dac566-f8e4-4254-90a5-8afe5fff6d51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_DerivativeAssets_94dac566-f8e4-4254-90a5-8afe5fff6d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_84df9798-ef78-43df-bfbc-aefd075753fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_84df9798-ef78-43df-bfbc-aefd075753fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_f9602e36-26e4-4092-9c13-1aa331abf8c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_f9602e36-26e4-4092-9c13-1aa331abf8c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_78975f20-3ddc-4174-856f-0e858fe24be2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_DerivativeLiabilities_78975f20-3ddc-4174-856f-0e858fe24be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_391aa5d1-7161-48f8-aafe-e4f9e5106abb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_391aa5d1-7161-48f8-aafe-e4f9e5106abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_1c919b7a-d94a-4b4a-afc4-b165327b61ca" xlink:href="jnj-20200927.xsd#jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_1c919b7a-d94a-4b4a-afc4-b165327b61ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_1a77810c-7930-44d0-8586-a329a768d527" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_1a77810c-7930-44d0-8586-a329a768d527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_f155e3f4-d5d4-443d-8aba-9fefe2be7b56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_f155e3f4-d5d4-443d-8aba-9fefe2be7b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_8caf417e-f121-4d73-8e19-12eb76b0d0d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_8caf417e-f121-4d73-8e19-12eb76b0d0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c0835426-20f9-4f58-99a3-46f7d01562be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c0835426-20f9-4f58-99a3-46f7d01562be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bb6f0f8c-4681-4c21-8afd-77c2494532e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd5e9eba-df28-4427-bca1-a2561cdd6b6f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_bb6f0f8c-4681-4c21-8afd-77c2494532e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_334a7282-702b-4735-9504-d1747f15b0e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_e8b3198c-6099-4265-9518-7bfccf7ae1f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_334a7282-702b-4735-9504-d1747f15b0e9" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_e8b3198c-6099-4265-9518-7bfccf7ae1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_d7a4412d-4822-4a78-8f69-4db61e9e517b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_e8b3198c-6099-4265-9518-7bfccf7ae1f0" xlink:to="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_d7a4412d-4822-4a78-8f69-4db61e9e517b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_5bd22eb2-32a6-4d5c-a5a8-85348fa4980e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_d7a4412d-4822-4a78-8f69-4db61e9e517b" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_5bd22eb2-32a6-4d5c-a5a8-85348fa4980e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesMember_0aeb6c4a-19f0-441c-a2df-ff65d93f77ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldtomaturitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_5bd22eb2-32a6-4d5c-a5a8-85348fa4980e" xlink:to="loc_us-gaap_HeldtomaturitySecuritiesMember_0aeb6c4a-19f0-441c-a2df-ff65d93f77ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_d1c894cb-8e87-4092-9c50-beff94008cb3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_5bd22eb2-32a6-4d5c-a5a8-85348fa4980e" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_d1c894cb-8e87-4092-9c50-beff94008cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ef16e063-2838-456f-8663-f3d4d8009273" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_e8b3198c-6099-4265-9518-7bfccf7ae1f0" xlink:to="loc_us-gaap_InvestmentTypeAxis_ef16e063-2838-456f-8663-f3d4d8009273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_ef16e063-2838-456f-8663-f3d4d8009273" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_834c72ac-5abd-4a98-bd52-45f5a56b0747" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:to="loc_us-gaap_CashMember_834c72ac-5abd-4a98-bd52-45f5a56b0747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtSecuritiesMember_cec58bac-9797-4f6b-ab2a-04ec61b16421" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SovereignDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:to="loc_us-gaap_SovereignDebtSecuritiesMember_cec58bac-9797-4f6b-ab2a-04ec61b16421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember_f974b3fc-5a99-4510-8c74-47786d3200df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:to="loc_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember_f974b3fc-5a99-4510-8c74-47786d3200df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherReverseRepurchaseAgreementsMember_19ee98e8-6acf-4005-990a-89a69a67ce05" xlink:href="jnj-20200927.xsd#jnj_OtherReverseRepurchaseAgreementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:to="loc_jnj_OtherReverseRepurchaseAgreementsMember_19ee98e8-6acf-4005-990a-89a69a67ce05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_374cfddc-82a8-47d1-9418-3273581e987c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_374cfddc-82a8-47d1-9418-3273581e987c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_ba5ad51c-2480-4bca-91d4-930d1d3819ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:to="loc_us-gaap_MoneyMarketFundsMember_ba5ad51c-2480-4bca-91d4-930d1d3819ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_e5f3c628-a486-4aa5-a211-390377487b21" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:to="loc_us-gaap_BankTimeDepositsMember_e5f3c628-a486-4aa5-a211-390377487b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_bfc51728-2d16-40e6-97bb-ae561bc603ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_a16271ca-7e68-49ee-b51b-0be2879651f1" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_bfc51728-2d16-40e6-97bb-ae561bc603ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_ac606367-2cf5-4db5-bd4c-63468a03822b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_e8b3198c-6099-4265-9518-7bfccf7ae1f0" xlink:to="loc_us-gaap_CashAndCashEquivalentsLineItems_ac606367-2cf5-4db5-bd4c-63468a03822b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_53032192-6f1a-445e-a450-f1a2b1e8a091" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesClassifiedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_ac606367-2cf5-4db5-bd4c-63468a03822b" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_53032192-6f1a-445e-a450-f1a2b1e8a091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_282159c6-fdbf-49a0-a935-75f2082924d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_53032192-6f1a-445e-a450-f1a2b1e8a091" xlink:to="loc_us-gaap_HeldToMaturitySecurities_282159c6-fdbf-49a0-a935-75f2082924d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_eadeca3e-3d98-4e11-ab8f-e48500056754" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_53032192-6f1a-445e-a450-f1a2b1e8a091" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_eadeca3e-3d98-4e11-ab8f-e48500056754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_819d4069-3783-494c-b7a6-ad34e7d56df5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_53032192-6f1a-445e-a450-f1a2b1e8a091" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_819d4069-3783-494c-b7a6-ad34e7d56df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_12290ca0-ce5f-44f1-99c5-d515ef4e79c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_53032192-6f1a-445e-a450-f1a2b1e8a091" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_12290ca0-ce5f-44f1-99c5-d515ef4e79c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_64a986b8-b951-49d1-9740-a28a0a8d0699" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_ac606367-2cf5-4db5-bd4c-63468a03822b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_64a986b8-b951-49d1-9740-a28a0a8d0699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8b924c52-b272-4a8a-a3e4-dee10851ff5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_64a986b8-b951-49d1-9740-a28a0a8d0699" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8b924c52-b272-4a8a-a3e4-dee10851ff5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a7232c28-3807-4c42-b6d3-37ef0c889d50" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_64a986b8-b951-49d1-9740-a28a0a8d0699" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a7232c28-3807-4c42-b6d3-37ef0c889d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4084b04d-86cb-4135-b06b-413aaf887dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_64a986b8-b951-49d1-9740-a28a0a8d0699" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4084b04d-86cb-4135-b06b-413aaf887dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1f626665-6c1b-4644-bb78-7225ce31e01e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_64a986b8-b951-49d1-9740-a28a0a8d0699" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1f626665-6c1b-4644-bb78-7225ce31e01e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_7cb99a57-3fa0-47ce-8a7f-31b53a960f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_ac606367-2cf5-4db5-bd4c-63468a03822b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_7cb99a57-3fa0-47ce-8a7f-31b53a960f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_07dd7d5c-fe29-4046-920d-df7928e76a2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_7cb99a57-3fa0-47ce-8a7f-31b53a960f6b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_07dd7d5c-fe29-4046-920d-df7928e76a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_e5b130d0-a030-4ccc-8b0b-ce1afc773a49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_7cb99a57-3fa0-47ce-8a7f-31b53a960f6b" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_e5b130d0-a030-4ccc-8b0b-ce1afc773a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_787e9441-ac0e-467d-9dc6-bdc27981674e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_7cb99a57-3fa0-47ce-8a7f-31b53a960f6b" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_787e9441-ac0e-467d-9dc6-bdc27981674e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain_9f3bffa0-3501-44ce-b53c-9e245d180efd" xlink:href="jnj-20200927.xsd#jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_7cb99a57-3fa0-47ce-8a7f-31b53a960f6b" xlink:to="loc_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain_9f3bffa0-3501-44ce-b53c-9e245d180efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss_75b1e042-002c-4a40-92e0-8d4599ece09f" xlink:href="jnj-20200927.xsd#jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_7cb99a57-3fa0-47ce-8a7f-31b53a960f6b" xlink:to="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss_75b1e042-002c-4a40-92e0-8d4599ece09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue_3cb3f6bf-a251-47ca-8656-dc5e946bb1f1" xlink:href="jnj-20200927.xsd#jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_7cb99a57-3fa0-47ce-8a7f-31b53a960f6b" xlink:to="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue_3cb3f6bf-a251-47ca-8656-dc5e946bb1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_90c4bf49-f235-49f8-aed0-b5e34b6c459a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_06b8cfad-0d6d-4375-ad3a-43275fa1bc92" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_90c4bf49-f235-49f8-aed0-b5e34b6c459a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_06b8cfad-0d6d-4375-ad3a-43275fa1bc92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_800a2010-45fa-4da4-8bc5-405eafe31dad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_06b8cfad-0d6d-4375-ad3a-43275fa1bc92" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_800a2010-45fa-4da4-8bc5-405eafe31dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_b919e031-2c8d-403a-ab68-75064b0ee13e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_06b8cfad-0d6d-4375-ad3a-43275fa1bc92" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_b919e031-2c8d-403a-ab68-75064b0ee13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_b8b71e17-622c-45a6-8c90-5efa640b9a43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_06b8cfad-0d6d-4375-ad3a-43275fa1bc92" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_b8b71e17-622c-45a6-8c90-5efa640b9a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_21126db1-416d-4ede-9f23-e275faa8845b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_06b8cfad-0d6d-4375-ad3a-43275fa1bc92" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_21126db1-416d-4ede-9f23-e275faa8845b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d6e94c76-eb68-44e3-8410-d7f45a1dfd62" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_90c4bf49-f235-49f8-aed0-b5e34b6c459a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d6e94c76-eb68-44e3-8410-d7f45a1dfd62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_c46a7aab-7116-4aa7-b6f9-252b1a1474fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d6e94c76-eb68-44e3-8410-d7f45a1dfd62" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_c46a7aab-7116-4aa7-b6f9-252b1a1474fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_377ad4fb-aa58-4441-b1b2-497e646c8f82" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d6e94c76-eb68-44e3-8410-d7f45a1dfd62" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_377ad4fb-aa58-4441-b1b2-497e646c8f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_5e95740c-8d86-4963-bcc4-6e86dea11949" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d6e94c76-eb68-44e3-8410-d7f45a1dfd62" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_5e95740c-8d86-4963-bcc4-6e86dea11949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_bd406c2b-8465-4722-b7fb-3b89af287886" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_d6e94c76-eb68-44e3-8410-d7f45a1dfd62" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_bd406c2b-8465-4722-b7fb-3b89af287886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8251c8c4-89a2-4080-a65d-931c9ad0e895" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c2c1d1-8572-49b9-8743-7b2b2dc8651b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8251c8c4-89a2-4080-a65d-931c9ad0e895" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c2c1d1-8572-49b9-8743-7b2b2dc8651b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d5a26d2f-2982-4602-9143-4d14118f9172" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c2c1d1-8572-49b9-8743-7b2b2dc8651b" xlink:to="loc_us-gaap_DebtInstrumentAxis_d5a26d2f-2982-4602-9143-4d14118f9172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d5a26d2f-2982-4602-9143-4d14118f9172" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.45Notesdue2021Member_54d982e5-9886-4d48-a827-5e31462253b9" xlink:href="jnj-20200927.xsd#jnj_A2.45Notesdue2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A2.45Notesdue2021Member_54d982e5-9886-4d48-a827-5e31462253b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.250NotesDue2022Member_c010a2f8-6221-4de7-b1d4-4d1db69860c0" xlink:href="jnj-20200927.xsd#jnj_A0.250NotesDue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A0.250NotesDue2022Member_c010a2f8-6221-4de7-b1d4-4d1db69860c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.25Notesdue2022Member_3c1120b8-1f29-437e-ab20-6a15cc84cc78" xlink:href="jnj-20200927.xsd#jnj_A2.25Notesdue2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A2.25Notesdue2022Member_3c1120b8-1f29-437e-ab20-6a15cc84cc78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A6.73Debenturesdue2023Member_7eafbdbc-2547-4597-bd31-b3fed0a28241" xlink:href="jnj-20200927.xsd#jnj_A6.73Debenturesdue2023Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A6.73Debenturesdue2023Member_7eafbdbc-2547-4597-bd31-b3fed0a28241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.375Notesdue2023Member_be195c65-7832-4ab5-b460-802af36d68e2" xlink:href="jnj-20200927.xsd#jnj_A3.375Notesdue2023Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A3.375Notesdue2023Member_be195c65-7832-4ab5-b460-802af36d68e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.05Notesdue2023Member_ebab4142-43f9-455b-8025-3b1d594457a8" xlink:href="jnj-20200927.xsd#jnj_A2.05Notesdue2023Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A2.05Notesdue2023Member_ebab4142-43f9-455b-8025-3b1d594457a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.650NotesDue2024Member_14dab88b-5256-463c-9d94-e707aadad57e" xlink:href="jnj-20200927.xsd#jnj_A0.650NotesDue2024Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A0.650NotesDue2024Member_14dab88b-5256-463c-9d94-e707aadad57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.50NotesDue2024Member_387e55d6-0e35-4025-9947-29e710031bc1" xlink:href="jnj-20200927.xsd#jnj_A5.50NotesDue2024Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A5.50NotesDue2024Member_387e55d6-0e35-4025-9947-29e710031bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.625Notesdue2025Member_0f4d8030-37bb-4f6b-944e-941296ffeb7f" xlink:href="jnj-20200927.xsd#jnj_A2.625Notesdue2025Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A2.625Notesdue2025Member_0f4d8030-37bb-4f6b-944e-941296ffeb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0550NotesDue2025Member_c58ae444-9c77-42fa-8194-9a11e67632d5" xlink:href="jnj-20200927.xsd#jnj_A0550NotesDue2025Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A0550NotesDue2025Member_c58ae444-9c77-42fa-8194-9a11e67632d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A055NotesDue2025Member_af4856ce-c5c0-480e-9fa8-8a5a144c8024" xlink:href="jnj-20200927.xsd#jnj_A055NotesDue2025Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A055NotesDue2025Member_af4856ce-c5c0-480e-9fa8-8a5a144c8024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.45Notesdue2026Member_ffee4186-c211-4367-8fd2-8f858762dda7" xlink:href="jnj-20200927.xsd#jnj_A2.45Notesdue2026Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A2.45Notesdue2026Member_ffee4186-c211-4367-8fd2-8f858762dda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.95Notesdue2027Member_0f769cd3-1f68-4d90-b620-dbb4f4186c73" xlink:href="jnj-20200927.xsd#jnj_A2.95Notesdue2027Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A2.95Notesdue2027Member_0f769cd3-1f68-4d90-b620-dbb4f4186c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A095NotesDue2027Member_b1a27422-5356-4547-867d-40f5d5dc393b" xlink:href="jnj-20200927.xsd#jnj_A095NotesDue2027Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A095NotesDue2027Member_b1a27422-5356-4547-867d-40f5d5dc393b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.900Notesdue2028Member_fc5c19e1-5662-4b24-80c1-eb144ada3332" xlink:href="jnj-20200927.xsd#jnj_A2.900Notesdue2028Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A2.900Notesdue2028Member_fc5c19e1-5662-4b24-80c1-eb144ada3332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.150NotesDue2028Member_300b71fe-332c-4022-bbc6-f508d587311e" xlink:href="jnj-20200927.xsd#jnj_A1.150NotesDue2028Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A1.150NotesDue2028Member_300b71fe-332c-4022-bbc6-f508d587311e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A6.95Notesdue2029Member_ea298d53-0697-4a24-9c68-b1140a74f5cc" xlink:href="jnj-20200927.xsd#jnj_A6.95Notesdue2029Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A6.95Notesdue2029Member_ea298d53-0697-4a24-9c68-b1140a74f5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1300NotesDue2030Member_559d9d09-4693-4708-b671-f5934024dae3" xlink:href="jnj-20200927.xsd#jnj_A1300NotesDue2030Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A1300NotesDue2030Member_559d9d09-4693-4708-b671-f5934024dae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.95Debenturesdue2033Member_4deba0aa-0dae-4fdf-a700-0ca6616f7157" xlink:href="jnj-20200927.xsd#jnj_A4.95Debenturesdue2033Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A4.95Debenturesdue2033Member_4deba0aa-0dae-4fdf-a700-0ca6616f7157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.375Notesdue2033Member_06ce1562-b7ed-4ea4-a543-ce9509dae5c6" xlink:href="jnj-20200927.xsd#jnj_A4.375Notesdue2033Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A4.375Notesdue2033Member_06ce1562-b7ed-4ea4-a543-ce9509dae5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.650NotesDue2035Member_d24c3940-baac-4525-85bc-81ce60eab80e" xlink:href="jnj-20200927.xsd#jnj_A1.650NotesDue2035Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A1.650NotesDue2035Member_d24c3940-baac-4525-85bc-81ce60eab80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.55Notesdue2036Member_b14a4068-b0d3-424e-999d-36fc6ce3662a" xlink:href="jnj-20200927.xsd#jnj_A3.55Notesdue2036Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A3.55Notesdue2036Member_b14a4068-b0d3-424e-999d-36fc6ce3662a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.95Notesdue2037Member_ed7ba873-33fb-449f-8c75-9f9802136551" xlink:href="jnj-20200927.xsd#jnj_A5.95Notesdue2037Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A5.95Notesdue2037Member_ed7ba873-33fb-449f-8c75-9f9802136551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.625Notesdue2037Member_b556c031-f04f-4fb4-a89c-d97168430fee" xlink:href="jnj-20200927.xsd#jnj_A3.625Notesdue2037Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A3.625Notesdue2037Member_b556c031-f04f-4fb4-a89c-d97168430fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.400Notesdue2038Member_12d8b490-4b94-4fd2-93db-ae0d39ee3181" xlink:href="jnj-20200927.xsd#jnj_A3.400Notesdue2038Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A3.400Notesdue2038Member_12d8b490-4b94-4fd2-93db-ae0d39ee3181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.85Debenturesdue2038Member_ed1e06f5-f2b6-42dd-b77a-40345e4cde2a" xlink:href="jnj-20200927.xsd#jnj_A5.85Debenturesdue2038Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A5.85Debenturesdue2038Member_ed1e06f5-f2b6-42dd-b77a-40345e4cde2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.50Debenturesdue2040Member_b330af53-3f2a-42e6-a759-e8774c1fd463" xlink:href="jnj-20200927.xsd#jnj_A4.50Debenturesdue2040Member"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A4.50Debenturesdue2040Member_b330af53-3f2a-42e6-a759-e8774c1fd463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A210NotesDue2040Member_6c61f251-7a4e-409a-b501-aea5efc06dc4" xlink:href="jnj-20200927.xsd#jnj_A210NotesDue2040Member"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A210NotesDue2040Member_6c61f251-7a4e-409a-b501-aea5efc06dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.85Notesdue2041Member_bd0f37e9-f5de-4f20-b9d1-f458a23fd185" xlink:href="jnj-20200927.xsd#jnj_A4.85Notesdue2041Member"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A4.85Notesdue2041Member_bd0f37e9-f5de-4f20-b9d1-f458a23fd185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.50Notesdue2043Member_8e0783af-a0e4-4aca-84a0-2d1d1763f4b3" xlink:href="jnj-20200927.xsd#jnj_A4.50Notesdue2043Member"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A4.50Notesdue2043Member_8e0783af-a0e4-4aca-84a0-2d1d1763f4b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.70Notesdue2046Member_0bb2781e-b6e9-4398-be7b-aabc22a03a9c" xlink:href="jnj-20200927.xsd#jnj_A3.70Notesdue2046Member"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A3.70Notesdue2046Member_0bb2781e-b6e9-4398-be7b-aabc22a03a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.75Notesdue2047Member_b6373d59-1f20-4ce1-a6df-3619d5e98c63" xlink:href="jnj-20200927.xsd#jnj_A3.75Notesdue2047Member"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A3.75Notesdue2047Member_b6373d59-1f20-4ce1-a6df-3619d5e98c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.500Notesdue2048Member_9694f82e-bfac-42c9-b465-d766f1bac7bf" xlink:href="jnj-20200927.xsd#jnj_A3.500Notesdue2048Member"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A3.500Notesdue2048Member_9694f82e-bfac-42c9-b465-d766f1bac7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2250NotesDue2050Member_c7aa134b-f787-4261-86f4-241d76c3cb11" xlink:href="jnj-20200927.xsd#jnj_A2250NotesDue2050Member"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A2250NotesDue2050Member_c7aa134b-f787-4261-86f4-241d76c3cb11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2450NotesDue2060Member_f540e3e4-3b1b-493f-bcdf-f5dfbd6debbb" xlink:href="jnj-20200927.xsd#jnj_A2450NotesDue2060Member"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A2450NotesDue2060Member_f540e3e4-3b1b-493f-bcdf-f5dfbd6debbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_NotesDuePeriodFifteenMember_be4f3f75-fb79-42fe-bcc3-bb78e3d40502" xlink:href="jnj-20200927.xsd#jnj_NotesDuePeriodFifteenMember"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_NotesDuePeriodFifteenMember_be4f3f75-fb79-42fe-bcc3-bb78e3d40502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A130NotesDue2030Member_fcabcc21-a6f4-4ff4-8625-7aa2e9b54ab2" xlink:href="jnj-20200927.xsd#jnj_A130NotesDue2030Member"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A130NotesDue2030Member_fcabcc21-a6f4-4ff4-8625-7aa2e9b54ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A225NotesDue2050Member_00525e2c-165b-45f4-9fd3-0b513667fa50" xlink:href="jnj-20200927.xsd#jnj_A225NotesDue2050Member"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7d15cd2c-89fc-47dc-bdb6-d827c820d397" xlink:to="loc_jnj_A225NotesDue2050Member_00525e2c-165b-45f4-9fd3-0b513667fa50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_53a146f1-fad1-4e12-aaf2-74e1fd1ba02d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c2c1d1-8572-49b9-8743-7b2b2dc8651b" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_53a146f1-fad1-4e12-aaf2-74e1fd1ba02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7359f297-75e1-4c31-92e0-8d374fab25cd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_53a146f1-fad1-4e12-aaf2-74e1fd1ba02d" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7359f297-75e1-4c31-92e0-8d374fab25cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8bf9ad2d-45be-4041-8f01-62a97f73b209" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_7359f297-75e1-4c31-92e0-8d374fab25cd" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8bf9ad2d-45be-4041-8f01-62a97f73b209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_a3db9b3e-f019-4673-909c-eb01aa5d2356" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8bf9ad2d-45be-4041-8f01-62a97f73b209" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_a3db9b3e-f019-4673-909c-eb01aa5d2356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_d9213abc-71f9-413b-9da8-7b5ab5551d04" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_8bf9ad2d-45be-4041-8f01-62a97f73b209" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_d9213abc-71f9-413b-9da8-7b5ab5551d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_bbf9859c-9de5-4e48-acb4-c656e8805899" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c2c1d1-8572-49b9-8743-7b2b2dc8651b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_bbf9859c-9de5-4e48-acb4-c656e8805899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_89995515-52a1-4914-9144-0eda7a0c88ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bbf9859c-9de5-4e48-acb4-c656e8805899" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_89995515-52a1-4914-9144-0eda7a0c88ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_09e6bcc8-76ee-401f-a88a-7b76b62eb73e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_89995515-52a1-4914-9144-0eda7a0c88ab" xlink:to="loc_us-gaap_SeniorNotesMember_09e6bcc8-76ee-401f-a88a-7b76b62eb73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6cfa6cbd-c907-41cc-9cf2-9aa25be83c66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_20c2c1d1-8572-49b9-8743-7b2b2dc8651b" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6cfa6cbd-c907-41cc-9cf2-9aa25be83c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_12a11bb1-e9ba-4fbf-9b2e-dcda0a9836ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_6cfa6cbd-c907-41cc-9cf2-9aa25be83c66" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_12a11bb1-e9ba-4fbf-9b2e-dcda0a9836ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_a1612dab-baeb-4152-a294-823efcadecb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_12a11bb1-e9ba-4fbf-9b2e-dcda0a9836ea" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_a1612dab-baeb-4152-a294-823efcadecb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_328d5f35-46c6-49a1-bd79-b3e9f6e83c5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_a1612dab-baeb-4152-a294-823efcadecb1" xlink:to="loc_us-gaap_ShortTermBorrowings_328d5f35-46c6-49a1-bd79-b3e9f6e83c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrentAbstract_b82a7830-31a5-4b82-9150-d2b5202564ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_12a11bb1-e9ba-4fbf-9b2e-dcda0a9836ea" xlink:to="loc_us-gaap_LongTermDebtNoncurrentAbstract_b82a7830-31a5-4b82-9150-d2b5202564ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ad599a32-e402-424b-a8d0-9f3c0f35d22e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_b82a7830-31a5-4b82-9150-d2b5202564ed" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ad599a32-e402-424b-a8d0-9f3c0f35d22e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cef6d96a-32a9-4c79-9224-9be8addb6800" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_12a11bb1-e9ba-4fbf-9b2e-dcda0a9836ea" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cef6d96a-32a9-4c79-9224-9be8addb6800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IncomeTaxes" xlink:type="simple" xlink:href="jnj-20200927.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_40761ff4-2250-43e1-8d95-f3e7f2ffcc3e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_9933e45a-6921-4ce3-aa4d-7fc35c4307b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_40761ff4-2250-43e1-8d95-f3e7f2ffcc3e" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_9933e45a-6921-4ce3-aa4d-7fc35c4307b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_786a3931-23ec-4577-a5e5-601037aa2d8f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_844ab0b8-e2fe-487a-bb86-184646a2459e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_786a3931-23ec-4577-a5e5-601037aa2d8f" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_844ab0b8-e2fe-487a-bb86-184646a2459e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_67c11ac4-9214-4adf-9271-1b620ad33ffe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_844ab0b8-e2fe-487a-bb86-184646a2459e" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_67c11ac4-9214-4adf-9271-1b620ad33ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_d4dba34f-bb01-4693-9f09-b1bb114f077e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_67c11ac4-9214-4adf-9271-1b620ad33ffe" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_d4dba34f-bb01-4693-9f09-b1bb114f077e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_adcb76d8-d1bd-45cc-89e0-1a9ba8858c97" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_d4dba34f-bb01-4693-9f09-b1bb114f077e" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_adcb76d8-d1bd-45cc-89e0-1a9ba8858c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d5e43b46-11e9-4a11-b86b-4bf754db3fd5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_844ab0b8-e2fe-487a-bb86-184646a2459e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d5e43b46-11e9-4a11-b86b-4bf754db3fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4adf3942-e9a3-4e37-9a03-7315e4599d01" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d5e43b46-11e9-4a11-b86b-4bf754db3fd5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4adf3942-e9a3-4e37-9a03-7315e4599d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AccruedTaxesOnIncomeMember_8bf6fdb8-f30e-47f6-861a-41bb0694c843" xlink:href="jnj-20200927.xsd#jnj_AccruedTaxesOnIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4adf3942-e9a3-4e37-9a03-7315e4599d01" xlink:to="loc_jnj_AccruedTaxesOnIncomeMember_8bf6fdb8-f30e-47f6-861a-41bb0694c843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_bd86dbda-0cb2-4d95-97a9-b03dad48ccdd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_844ab0b8-e2fe-487a-bb86-184646a2459e" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_bd86dbda-0cb2-4d95-97a9-b03dad48ccdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_5fdf83c4-8386-4b34-b5f4-c95f9cb491f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_bd86dbda-0cb2-4d95-97a9-b03dad48ccdd" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_5fdf83c4-8386-4b34-b5f4-c95f9cb491f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_c81e5d19-a816-4c0c-9509-7478b245d087" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_844ab0b8-e2fe-487a-bb86-184646a2459e" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_c81e5d19-a816-4c0c-9509-7478b245d087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:href="jnj-20200927.xsd#jnj_IncomeTaxTextualsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_c81e5d19-a816-4c0c-9509-7478b245d087" xlink:to="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2d1b3679-454b-4475-a22d-1f3dff363f25" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_2d1b3679-454b-4475-a22d-1f3dff363f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset_5b394267-214a-4c4b-98de-90a47e95a328" xlink:href="jnj-20200927.xsd#jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset_5b394267-214a-4c4b-98de-90a47e95a328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit_e53d3bd3-3da6-401d-9db4-b87fd640f4cf" xlink:href="jnj-20200927.xsd#jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit_e53d3bd3-3da6-401d-9db4-b87fd640f4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent_8d6c8d4f-8b99-4a78-8451-beedf0b4c3e3" xlink:href="jnj-20200927.xsd#jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent_8d6c8d4f-8b99-4a78-8451-beedf0b4c3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent_189e18db-4717-4a92-9855-9d4d644daf5f" xlink:href="jnj-20200927.xsd#jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent_189e18db-4717-4a92-9855-9d4d644daf5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent_e9f92267-de54-4e84-981e-e947290e3586" xlink:href="jnj-20200927.xsd#jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent_e9f92267-de54-4e84-981e-e947290e3586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement_1c700ae9-c9f4-436f-b3b3-e646d67406fc" xlink:href="jnj-20200927.xsd#jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement_1c700ae9-c9f4-436f-b3b3-e646d67406fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement_846af210-efbe-4f21-b86c-f6c51d4ddbb5" xlink:href="jnj-20200927.xsd#jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement_846af210-efbe-4f21-b86c-f6c51d4ddbb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_635d4aa3-353a-43a6-b8c0-1ccd6b92155a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_635d4aa3-353a-43a6-b8c0-1ccd6b92155a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_UnrecognizedTaxBenefitLiabilityPayment_2bf013bc-9afb-43ad-9ade-53b2583bfc8e" xlink:href="jnj-20200927.xsd#jnj_UnrecognizedTaxBenefitLiabilityPayment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2a230598-56ce-45f4-be39-2a5fc19ed20e" xlink:to="loc_jnj_UnrecognizedTaxBenefitLiabilityPayment_2bf013bc-9afb-43ad-9ade-53b2583bfc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlans" xlink:type="simple" xlink:href="jnj-20200927.xsd#PensionsandOtherBenefitPlans"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_830641ac-80bd-4353-918d-afd14d2a1a1a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_31375479-4103-45c9-819d-a169797971ae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_830641ac-80bd-4353-918d-afd14d2a1a1a" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_31375479-4103-45c9-819d-a169797971ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#PensionsandOtherBenefitPlansTables"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_39d14350-c3f1-46e1-9431-e452227518d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_208ce583-478e-458d-ad4f-f14e8f8f4a09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_39d14350-c3f1-46e1-9431-e452227518d7" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_208ce583-478e-458d-ad4f-f14e8f8f4a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_96b7601b-acc3-4b30-bc0f-c0c10daf69b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8759a2e4-193f-44fc-9b50-63b1378bb777" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_96b7601b-acc3-4b30-bc0f-c0c10daf69b7" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8759a2e4-193f-44fc-9b50-63b1378bb777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_2504eea0-0ec0-41aa-8834-891e83649713" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8759a2e4-193f-44fc-9b50-63b1378bb777" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_2504eea0-0ec0-41aa-8834-891e83649713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_71523ccd-6340-4141-9506-6e9a1034c756" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_2504eea0-0ec0-41aa-8834-891e83649713" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_71523ccd-6340-4141-9506-6e9a1034c756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_61e4eacb-2b65-41cf-8e84-80211ad049d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_71523ccd-6340-4141-9506-6e9a1034c756" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_61e4eacb-2b65-41cf-8e84-80211ad049d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_7b704b18-ce01-4380-9f86-86cb560e50da" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_71523ccd-6340-4141-9506-6e9a1034c756" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_7b704b18-ce01-4380-9f86-86cb560e50da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f9706d0a-1645-46c8-9c74-1718c8be5b15" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8759a2e4-193f-44fc-9b50-63b1378bb777" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f9706d0a-1645-46c8-9c74-1718c8be5b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_aa10489d-558e-466c-afdd-a36232bb4fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f9706d0a-1645-46c8-9c74-1718c8be5b15" xlink:to="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_aa10489d-558e-466c-afdd-a36232bb4fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_0e2a3105-bd76-4395-a52a-1545006a57f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_aa10489d-558e-466c-afdd-a36232bb4fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_0e2a3105-bd76-4395-a52a-1545006a57f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_a2408451-dd8a-40a6-a115-4c5df24d5751" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_aa10489d-558e-466c-afdd-a36232bb4fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_a2408451-dd8a-40a6-a115-4c5df24d5751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_36119294-2290-485d-be78-ecfcd5fddf32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_aa10489d-558e-466c-afdd-a36232bb4fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_36119294-2290-485d-be78-ecfcd5fddf32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_405e8f83-0128-4593-9434-96be9a48a5dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_aa10489d-558e-466c-afdd-a36232bb4fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_405e8f83-0128-4593-9434-96be9a48a5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_e1a42df1-8664-406b-ae6d-df7f915c9b3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_aa10489d-558e-466c-afdd-a36232bb4fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_e1a42df1-8664-406b-ae6d-df7f915c9b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_c69f18c6-97ab-4e0e-a81c-c7127355fe4a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_aa10489d-558e-466c-afdd-a36232bb4fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_c69f18c6-97ab-4e0e-a81c-c7127355fe4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_da09becf-9ee0-4836-9ffa-5768e7244343" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_aa10489d-558e-466c-afdd-a36232bb4fdf" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_da09becf-9ee0-4836-9ffa-5768e7244343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#PensionsandOtherBenefitPlansDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_97ff9a4e-f736-4126-aa9b-452a352e938c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4db64eb1-98a5-4451-b557-556ecd50d571" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_97ff9a4e-f736-4126-aa9b-452a352e938c" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4db64eb1-98a5-4451-b557-556ecd50d571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_df404580-30c8-47c3-865b-114263903d0f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4db64eb1-98a5-4451-b557-556ecd50d571" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_df404580-30c8-47c3-865b-114263903d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_9d600b4f-a86a-4bf9-9b4b-d4682dcc86c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_df404580-30c8-47c3-865b-114263903d0f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_9d600b4f-a86a-4bf9-9b4b-d4682dcc86c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4a7e41ce-0b67-4ac8-99ae-7fb0d0e75539" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_9d600b4f-a86a-4bf9-9b4b-d4682dcc86c4" xlink:to="loc_country_US_4a7e41ce-0b67-4ac8-99ae-7fb0d0e75539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_163a7ac2-603d-4946-9465-ae28f33e5f49" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_9d600b4f-a86a-4bf9-9b4b-d4682dcc86c4" xlink:to="loc_us-gaap_ForeignPlanMember_163a7ac2-603d-4946-9465-ae28f33e5f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4e71b11f-35bb-459e-a822-d3b47c0db91d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4db64eb1-98a5-4451-b557-556ecd50d571" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4e71b11f-35bb-459e-a822-d3b47c0db91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionContributions_d2992e60-9ab3-4234-9bd7-76c24192a255" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionContributions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4e71b11f-35bb-459e-a822-d3b47c0db91d" xlink:to="loc_us-gaap_PensionContributions_d2992e60-9ab3-4234-9bd7-76c24192a255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="simple" xlink:href="jnj-20200927.xsd#AccumulatedOtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8d6dc71b-a996-4294-bab1-f16d7a566506" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_6be0cce4-b841-4145-8ef2-894fede1488f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8d6dc71b-a996-4294-bab1-f16d7a566506" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_6be0cce4-b841-4145-8ef2-894fede1488f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#AccumulatedOtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_dff1c025-0bb4-4b80-ad82-940ea988e91b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7c4853c5-bd2c-4038-b2c3-5138b863d288" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_dff1c025-0bb4-4b80-ad82-940ea988e91b" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_7c4853c5-bd2c-4038-b2c3-5138b863d288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#AccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d2810ce3-b540-48a8-8afb-474a3ebce054" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7565c857-c15a-4ef0-831e-d44c9fb7210e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d2810ce3-b540-48a8-8afb-474a3ebce054" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7565c857-c15a-4ef0-831e-d44c9fb7210e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_75d2c051-eea6-436e-a034-0f48f0ef872a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7565c857-c15a-4ef0-831e-d44c9fb7210e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_75d2c051-eea6-436e-a034-0f48f0ef872a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ecd971d0-6168-491a-b8ce-e51ed730e85a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_75d2c051-eea6-436e-a034-0f48f0ef872a" xlink:to="loc_us-gaap_EquityComponentDomain_ecd971d0-6168-491a-b8ce-e51ed730e85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_34cdc712-e441-43d0-9657-de553cb3a9e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ecd971d0-6168-491a-b8ce-e51ed730e85a" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_34cdc712-e441-43d0-9657-de553cb3a9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_110883b9-d4cc-47e7-8e1d-0d02f85ee1e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ecd971d0-6168-491a-b8ce-e51ed730e85a" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_110883b9-d4cc-47e7-8e1d-0d02f85ee1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_6a139faf-3b11-41d4-81ea-5403615b2480" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ecd971d0-6168-491a-b8ce-e51ed730e85a" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_6a139faf-3b11-41d4-81ea-5403615b2480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_47e6e713-1c58-4195-96c2-3444a4b9f568" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ecd971d0-6168-491a-b8ce-e51ed730e85a" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_47e6e713-1c58-4195-96c2-3444a4b9f568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c1dd5253-32b9-421d-91ce-68d6b07c213c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ecd971d0-6168-491a-b8ce-e51ed730e85a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c1dd5253-32b9-421d-91ce-68d6b07c213c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f880e53-e101-4e37-82ad-2aa15aa4f201" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7565c857-c15a-4ef0-831e-d44c9fb7210e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f880e53-e101-4e37-82ad-2aa15aa4f201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_62b616c0-90ba-4f86-9978-553aa6309a05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_6f880e53-e101-4e37-82ad-2aa15aa4f201" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_62b616c0-90ba-4f86-9978-553aa6309a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fbbc82fb-fa46-4291-91ff-a02279310a84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_62b616c0-90ba-4f86-9978-553aa6309a05" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_fbbc82fb-fa46-4291-91ff-a02279310a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_62510757-86ba-4aa3-a86c-0b8942091625" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_62b616c0-90ba-4f86-9978-553aa6309a05" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_62510757-86ba-4aa3-a86c-0b8942091625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5b143b80-7572-4bdc-9a33-04a9359fab95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_62b616c0-90ba-4f86-9978-553aa6309a05" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5b143b80-7572-4bdc-9a33-04a9359fab95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/EarningsPerShare" xlink:type="simple" xlink:href="jnj-20200927.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ab0b7cea-343f-4766-982e-5879bf5f9a67" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_1207ef9a-01eb-4f2a-a4da-7b8b6368e9b6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ab0b7cea-343f-4766-982e-5879bf5f9a67" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_1207ef9a-01eb-4f2a-a4da-7b8b6368e9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_376d0ec1-191d-4462-bfcc-668c1c6c36d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7b953bac-a005-4175-9268-40a1cd900e74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_376d0ec1-191d-4462-bfcc-668c1c6c36d7" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_7b953bac-a005-4175-9268-40a1cd900e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#EarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f65ec541-483a-4b78-827b-f208059a9fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_34935874-cb66-4f58-bd74-e1b62611fa57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f65ec541-483a-4b78-827b-f208059a9fc2" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_34935874-cb66-4f58-bd74-e1b62611fa57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_3fb68e80-0013-473d-88e3-be2ec759b9ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_34935874-cb66-4f58-bd74-e1b62611fa57" xlink:to="loc_us-gaap_EarningsPerShareBasic_3fb68e80-0013-473d-88e3-be2ec759b9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3d2ca11d-8d00-46c1-b9d6-f524bf83d3ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_34935874-cb66-4f58-bd74-e1b62611fa57" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3d2ca11d-8d00-46c1-b9d6-f524bf83d3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_98daf6a8-48cc-469d-8be3-ca6fc1a7b0f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_34935874-cb66-4f58-bd74-e1b62611fa57" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_98daf6a8-48cc-469d-8be3-ca6fc1a7b0f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod_f617f9ce-2fe6-4448-8f36-da6eba35786f" xlink:href="jnj-20200927.xsd#jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_34935874-cb66-4f58-bd74-e1b62611fa57" xlink:to="loc_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod_f617f9ce-2fe6-4448-8f36-da6eba35786f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_b963b288-3a9f-4fa9-a7d0-c6210becb204" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_34935874-cb66-4f58-bd74-e1b62611fa57" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_b963b288-3a9f-4fa9-a7d0-c6210becb204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_03a0edf1-2722-4f5d-a567-c28ddfa8a8a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_34935874-cb66-4f58-bd74-e1b62611fa57" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_03a0edf1-2722-4f5d-a567-c28ddfa8a8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_02db17d8-d3e9-47f0-8ddb-6ad7c6433768" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_34935874-cb66-4f58-bd74-e1b62611fa57" xlink:to="loc_us-gaap_EarningsPerShareDiluted_02db17d8-d3e9-47f0-8ddb-6ad7c6433768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fbba3eab-617a-4ed7-9455-4b25863d5764" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_34935874-cb66-4f58-bd74-e1b62611fa57" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fbba3eab-617a-4ed7-9455-4b25863d5764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas" xlink:type="simple" xlink:href="jnj-20200927.xsd#SegmentsofBusinessandGeographicAreas"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_096eb55a-04f3-41c7-9925-6c69c4f5fd74" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_0a68ca24-0f56-4fa1-b47d-bb2df406a1ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_096eb55a-04f3-41c7-9925-6c69c4f5fd74" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_0a68ca24-0f56-4fa1-b47d-bb2df406a1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#SegmentsofBusinessandGeographicAreasTables"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_df7bf6cb-bf53-4397-9292-253ebac81b7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SalesBySegmentOfBusinessTableTextBlock_eef3348a-2ff2-462e-8f49-fe50f3125791" xlink:href="jnj-20200927.xsd#jnj_SalesBySegmentOfBusinessTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_df7bf6cb-bf53-4397-9292-253ebac81b7d" xlink:to="loc_jnj_SalesBySegmentOfBusinessTableTextBlock_eef3348a-2ff2-462e-8f49-fe50f3125791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b991bae7-486f-42ff-9b03-2b1a74d6efa4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_df7bf6cb-bf53-4397-9292-253ebac81b7d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b991bae7-486f-42ff-9b03-2b1a74d6efa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_c9e28d16-b788-4549-bcdd-802bf7261c04" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_df7bf6cb-bf53-4397-9292-253ebac81b7d" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_c9e28d16-b788-4549-bcdd-802bf7261c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d0716f09-1837-4ab1-a457-d8ccfb4b4459" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d99da0a-f9c3-4b22-a40d-069a51bec173" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d0716f09-1837-4ab1-a457-d8ccfb4b4459" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d99da0a-f9c3-4b22-a40d-069a51bec173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e64c6115-f36c-4877-a613-2af2a9061369" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d99da0a-f9c3-4b22-a40d-069a51bec173" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e64c6115-f36c-4877-a613-2af2a9061369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9987f813-0a7f-4b75-9d5a-6cfff4260025" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e64c6115-f36c-4877-a613-2af2a9061369" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9987f813-0a7f-4b75-9d5a-6cfff4260025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e718049b-410c-4623-a6d4-702a22cd4e53" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d99da0a-f9c3-4b22-a40d-069a51bec173" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e718049b-410c-4623-a6d4-702a22cd4e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c5ec1551-2bed-425b-b5cc-b45893077a9d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e718049b-410c-4623-a6d4-702a22cd4e53" xlink:to="loc_us-gaap_SegmentDomain_c5ec1551-2bed-425b-b5cc-b45893077a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember_f1c51b22-141d-4f05-99cd-c89a4ffcd1e5" xlink:href="jnj-20200927.xsd#jnj_ConsumerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c5ec1551-2bed-425b-b5cc-b45893077a9d" xlink:to="loc_jnj_ConsumerMember_f1c51b22-141d-4f05-99cd-c89a4ffcd1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PharmaceuticalMember_94f28bd7-72b6-4dc1-9704-cac64e9c0df5" xlink:href="jnj-20200927.xsd#jnj_PharmaceuticalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c5ec1551-2bed-425b-b5cc-b45893077a9d" xlink:to="loc_jnj_PharmaceuticalMember_94f28bd7-72b6-4dc1-9704-cac64e9c0df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_33e01713-1962-4ae5-adc8-7b5684eea560" xlink:href="jnj-20200927.xsd#jnj_MedicalDevicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c5ec1551-2bed-425b-b5cc-b45893077a9d" xlink:to="loc_jnj_MedicalDevicesMember_33e01713-1962-4ae5-adc8-7b5684eea560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_aeeea4d8-aed2-4d8a-8ea4-6f8a0e62e8a5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d99da0a-f9c3-4b22-a40d-069a51bec173" xlink:to="loc_us-gaap_SubsegmentsAxis_aeeea4d8-aed2-4d8a-8ea4-6f8a0e62e8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_aeeea4d8-aed2-4d8a-8ea4-6f8a0e62e8a5" xlink:to="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ImmunologyMember_44a54c99-2d13-4d16-be71-f73d1ff6d838" xlink:href="jnj-20200927.xsd#jnj_ImmunologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_ImmunologyMember_44a54c99-2d13-4d16-be71-f73d1ff6d838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InfectiousDiseasesMember_0effe44d-d53f-4af4-b52e-d3314bc97164" xlink:href="jnj-20200927.xsd#jnj_InfectiousDiseasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_InfectiousDiseasesMember_0effe44d-d53f-4af4-b52e-d3314bc97164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_NeuroscienceMember_7932fa17-2dd4-4ac3-a0ea-8d0195e29c1f" xlink:href="jnj-20200927.xsd#jnj_NeuroscienceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_NeuroscienceMember_7932fa17-2dd4-4ac3-a0ea-8d0195e29c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OncologyMember_6b1212ce-8705-471f-9c20-d09ec6c445da" xlink:href="jnj-20200927.xsd#jnj_OncologyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_OncologyMember_6b1212ce-8705-471f-9c20-d09ec6c445da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PulmonaryHypertensionMember_0bd63585-b47e-4429-873e-0e04dbab5be5" xlink:href="jnj-20200927.xsd#jnj_PulmonaryHypertensionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_PulmonaryHypertensionMember_0bd63585-b47e-4429-873e-0e04dbab5be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CardiovascularMetabolismOtherMember_bb591c73-121d-4622-b584-21de2985e7fb" xlink:href="jnj-20200927.xsd#jnj_CardiovascularMetabolismOtherMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_CardiovascularMetabolismOtherMember_bb591c73-121d-4622-b584-21de2985e7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterventionalSolutionsMember_7da7f468-c86b-4add-984f-09f0d699057f" xlink:href="jnj-20200927.xsd#jnj_InterventionalSolutionsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_InterventionalSolutionsMember_7da7f468-c86b-4add-984f-09f0d699057f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OrthopaedicsMember_193b6fe3-b810-4266-b42e-9e2d052c164f" xlink:href="jnj-20200927.xsd#jnj_OrthopaedicsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_OrthopaedicsMember_193b6fe3-b810-4266-b42e-9e2d052c164f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SurgeryMember_f66fcb28-21fe-4c28-95cf-b2eb18578f8a" xlink:href="jnj-20200927.xsd#jnj_SurgeryMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_SurgeryMember_f66fcb28-21fe-4c28-95cf-b2eb18578f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VisionMember_20e0e084-2c64-4f27-913d-45f153aec2cf" xlink:href="jnj-20200927.xsd#jnj_VisionMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_638c9f63-bfeb-41a3-8a69-44921e89c95e" xlink:to="loc_jnj_VisionMember_20e0e084-2c64-4f27-913d-45f153aec2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_36448e5f-8808-4cf2-aeb8-22a1c5ee8c00" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d99da0a-f9c3-4b22-a40d-069a51bec173" xlink:to="loc_srt_ProductOrServiceAxis_36448e5f-8808-4cf2-aeb8-22a1c5ee8c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_36448e5f-8808-4cf2-aeb8-22a1c5ee8c00" xlink:to="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OTCMember_26495998-5151-4463-8148-c3d0e3858808" xlink:href="jnj-20200927.xsd#jnj_OTCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_OTCMember_26495998-5151-4463-8148-c3d0e3858808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BeautyMember_3363042c-be4a-4ab5-be55-c2bfe394e324" xlink:href="jnj-20200927.xsd#jnj_BeautyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_BeautyMember_3363042c-be4a-4ab5-be55-c2bfe394e324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OralCareMember_e81c257e-201a-46eb-8b55-69574ea9018c" xlink:href="jnj-20200927.xsd#jnj_OralCareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_OralCareMember_e81c257e-201a-46eb-8b55-69574ea9018c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BabyCareMember_cead7f4d-b499-4dff-9b92-26f08a3b8852" xlink:href="jnj-20200927.xsd#jnj_BabyCareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_BabyCareMember_cead7f4d-b499-4dff-9b92-26f08a3b8852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WomensHealthMember_049f5fdd-18e5-4b6d-8368-5697e99157e3" xlink:href="jnj-20200927.xsd#jnj_WomensHealthMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_WomensHealthMember_049f5fdd-18e5-4b6d-8368-5697e99157e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WoundCareandOtherMember_946eb6a2-ce13-4b69-aae5-f5a4d42aa10c" xlink:href="jnj-20200927.xsd#jnj_WoundCareandOtherMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_WoundCareandOtherMember_946eb6a2-ce13-4b69-aae5-f5a4d42aa10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RemicadeMember_e91b361d-2c48-4a83-b324-fa3e81de2eec" xlink:href="jnj-20200927.xsd#jnj_RemicadeMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_RemicadeMember_e91b361d-2c48-4a83-b324-fa3e81de2eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SimponiSimponiAriaMember_60306258-021e-4171-945c-61867cf64cb4" xlink:href="jnj-20200927.xsd#jnj_SimponiSimponiAriaMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_SimponiSimponiAriaMember_60306258-021e-4171-945c-61867cf64cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_StelaraMember_10abf238-498e-427c-9262-be19673a4045" xlink:href="jnj-20200927.xsd#jnj_StelaraMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_StelaraMember_10abf238-498e-427c-9262-be19673a4045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_TremfyaMember_ececfc1b-2b83-4469-ace5-c1d6f27cfeea" xlink:href="jnj-20200927.xsd#jnj_TremfyaMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_TremfyaMember_ececfc1b-2b83-4469-ace5-c1d6f27cfeea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherImmunologyMember_01b2defb-fa58-4d2a-860a-e401e134b196" xlink:href="jnj-20200927.xsd#jnj_OtherImmunologyMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_OtherImmunologyMember_01b2defb-fa58-4d2a-860a-e401e134b196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EDURANTrilpivirineMember_d50ae8d7-34d0-49b5-8d32-7e5708d961d6" xlink:href="jnj-20200927.xsd#jnj_EDURANTrilpivirineMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_EDURANTrilpivirineMember_d50ae8d7-34d0-49b5-8d32-7e5708d961d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember_e03c7cf5-caf1-4866-a86a-e765482e5e56" xlink:href="jnj-20200927.xsd#jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember_e03c7cf5-caf1-4866-a86a-e765482e5e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherInfectiousDiseasesMember_8fc21fba-3232-4b16-be0c-ca6898d08586" xlink:href="jnj-20200927.xsd#jnj_OtherInfectiousDiseasesMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_OtherInfectiousDiseasesMember_8fc21fba-3232-4b16-be0c-ca6898d08586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CONCERTAMethylphenidateMember_27f3f2e1-cb39-40de-aa4d-a55d401e775b" xlink:href="jnj-20200927.xsd#jnj_CONCERTAMethylphenidateMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_CONCERTAMethylphenidateMember_27f3f2e1-cb39-40de-aa4d-a55d401e775b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember_f9e126d0-3c2f-4947-b79d-a4414cd10050" xlink:href="jnj-20200927.xsd#jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember_f9e126d0-3c2f-4947-b79d-a4414cd10050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RISPERDALCONSTAMember_343e4a23-d2b5-4586-a8a4-0758e93afa47" xlink:href="jnj-20200927.xsd#jnj_RISPERDALCONSTAMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_RISPERDALCONSTAMember_343e4a23-d2b5-4586-a8a4-0758e93afa47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OTHERNEUROSCIENCEMember_76ca9366-cdeb-4c3e-8887-ee2ddad37465" xlink:href="jnj-20200927.xsd#jnj_OTHERNEUROSCIENCEMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_OTHERNEUROSCIENCEMember_76ca9366-cdeb-4c3e-8887-ee2ddad37465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DARZALEXMember_28bcffa2-b7bb-40bf-9adb-abfc479439fb" xlink:href="jnj-20200927.xsd#jnj_DARZALEXMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_DARZALEXMember_28bcffa2-b7bb-40bf-9adb-abfc479439fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ERLEADAMember_c857ca59-d98f-4d36-aef8-98447cc4bbc3" xlink:href="jnj-20200927.xsd#jnj_ERLEADAMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_ERLEADAMember_c857ca59-d98f-4d36-aef8-98447cc4bbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IMBRUVICAMember_75573760-4e32-4ff9-b3ad-d987fd75ce5e" xlink:href="jnj-20200927.xsd#jnj_IMBRUVICAMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_IMBRUVICAMember_75573760-4e32-4ff9-b3ad-d987fd75ce5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VELCADEMember_2174c673-da7d-4ec8-bd39-55e3c7900739" xlink:href="jnj-20200927.xsd#jnj_VELCADEMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_VELCADEMember_2174c673-da7d-4ec8-bd39-55e3c7900739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ZYTIGAMember_8cad077e-4212-4f2b-a8c7-448a6994e6f3" xlink:href="jnj-20200927.xsd#jnj_ZYTIGAMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_ZYTIGAMember_8cad077e-4212-4f2b-a8c7-448a6994e6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherOncologyMember_f679b1c9-fc23-4b97-a3f5-84124704a615" xlink:href="jnj-20200927.xsd#jnj_OtherOncologyMember"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_OtherOncologyMember_f679b1c9-fc23-4b97-a3f5-84124704a615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OPSUMITMember_c3f4e067-959e-4201-8fb9-7ddfba46def2" xlink:href="jnj-20200927.xsd#jnj_OPSUMITMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_OPSUMITMember_c3f4e067-959e-4201-8fb9-7ddfba46def2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_UPTRAVIMember_78380360-5e93-45dc-85e5-e069dc983360" xlink:href="jnj-20200927.xsd#jnj_UPTRAVIMember"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_UPTRAVIMember_78380360-5e93-45dc-85e5-e069dc983360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_XareltoMember_097d86b7-a554-4c15-b45a-ea2cb96cfc85" xlink:href="jnj-20200927.xsd#jnj_XareltoMember"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_XareltoMember_097d86b7-a554-4c15-b45a-ea2cb96cfc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_INVOKANAINVOKAMETMember_7b61dc26-50c6-4446-81cb-dae195653d53" xlink:href="jnj-20200927.xsd#jnj_INVOKANAINVOKAMETMember"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_INVOKANAINVOKAMETMember_7b61dc26-50c6-4446-81cb-dae195653d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PROCRITEPREXMember_1ecc4a5b-c3d7-4068-aa49-9dca000f3502" xlink:href="jnj-20200927.xsd#jnj_PROCRITEPREXMember"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_PROCRITEPREXMember_1ecc4a5b-c3d7-4068-aa49-9dca000f3502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherMember_9bd01508-7667-4e17-a9bd-3461b7125da0" xlink:href="jnj-20200927.xsd#jnj_OtherMember"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_OtherMember_9bd01508-7667-4e17-a9bd-3461b7125da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_HIPSMember_dd1dd7b1-1803-4dd2-bd99-c2be3e0a757a" xlink:href="jnj-20200927.xsd#jnj_HIPSMember"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_HIPSMember_dd1dd7b1-1803-4dd2-bd99-c2be3e0a757a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_KNEESMember_2d1eaaba-3fd4-4b2c-90d4-5709f6b54dc2" xlink:href="jnj-20200927.xsd#jnj_KNEESMember"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_KNEESMember_2d1eaaba-3fd4-4b2c-90d4-5709f6b54dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_TRAUMAMember_e74283b4-963b-4ab6-b4e8-539c6693dfb3" xlink:href="jnj-20200927.xsd#jnj_TRAUMAMember"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_TRAUMAMember_e74283b4-963b-4ab6-b4e8-539c6693dfb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SPINEOTHERMember_1f944bcd-84d4-4c4a-b872-c1368053789b" xlink:href="jnj-20200927.xsd#jnj_SPINEOTHERMember"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_SPINEOTHERMember_1f944bcd-84d4-4c4a-b872-c1368053789b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ADVANCEDMember_c8c0190c-a124-4a4d-bfe3-4cadad1c6e48" xlink:href="jnj-20200927.xsd#jnj_ADVANCEDMember"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_ADVANCEDMember_c8c0190c-a124-4a4d-bfe3-4cadad1c6e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_GENERALMember_a0241e40-d8e0-4f37-8f5c-73af3f242b23" xlink:href="jnj-20200927.xsd#jnj_GENERALMember"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_GENERALMember_a0241e40-d8e0-4f37-8f5c-73af3f242b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CONTACTLENSESOTHERMember_9157f411-ad64-44b2-93be-75bfa2bd42af" xlink:href="jnj-20200927.xsd#jnj_CONTACTLENSESOTHERMember"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_CONTACTLENSESOTHERMember_9157f411-ad64-44b2-93be-75bfa2bd42af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SURGICALMember_9027c4ed-4cce-4252-a0f1-e85588df82da" xlink:href="jnj-20200927.xsd#jnj_SURGICALMember"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5cb5c875-73b9-4ae3-9710-59535c4cd1ed" xlink:to="loc_jnj_SURGICALMember_9027c4ed-4cce-4252-a0f1-e85588df82da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_af031964-b6cb-42e5-991a-5ac8b38c47c3" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d99da0a-f9c3-4b22-a40d-069a51bec173" xlink:to="loc_srt_StatementGeographicalAxis_af031964-b6cb-42e5-991a-5ac8b38c47c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5b3db68a-0071-4ddd-a48b-85f8f5784241" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_af031964-b6cb-42e5-991a-5ac8b38c47c3" xlink:to="loc_srt_SegmentGeographicalDomain_5b3db68a-0071-4ddd-a48b-85f8f5784241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_01fb1c78-0879-4d29-919a-36da76c045d4" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5b3db68a-0071-4ddd-a48b-85f8f5784241" xlink:to="loc_country_US_01fb1c78-0879-4d29-919a-36da76c045d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_UNITEDSTATESExportsMember_56d9df08-068f-4c5b-beae-dad18156551e" xlink:href="jnj-20200927.xsd#jnj_UNITEDSTATESExportsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5b3db68a-0071-4ddd-a48b-85f8f5784241" xlink:to="loc_jnj_UNITEDSTATESExportsMember_56d9df08-068f-4c5b-beae-dad18156551e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_d4908b6c-d716-4d98-86d7-5b6fb1fe60d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_5b3db68a-0071-4ddd-a48b-85f8f5784241" xlink:to="loc_us-gaap_NonUsMember_d4908b6c-d716-4d98-86d7-5b6fb1fe60d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_f7305c4d-2734-4d8f-a850-3fdc5f7f4753" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d99da0a-f9c3-4b22-a40d-069a51bec173" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_f7305c4d-2734-4d8f-a850-3fdc5f7f4753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract_05b0bcb6-060b-403d-b772-0c71e33ff58d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_f7305c4d-2734-4d8f-a850-3fdc5f7f4753" xlink:to="loc_us-gaap_SegmentReportingInformationRevenueAbstract_05b0bcb6-060b-403d-b772-0c71e33ff58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4ba11b89-0256-4ef5-8da0-966c993333a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_05b0bcb6-060b-403d-b772-0c71e33ff58d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4ba11b89-0256-4ef5-8da0-966c993333a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInSalesBySegmentOfBusiness_07992b7e-d298-48c8-8043-fb5d11885784" xlink:href="jnj-20200927.xsd#jnj_PercentageChangeInSalesBySegmentOfBusiness"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_05b0bcb6-060b-403d-b772-0c71e33ff58d" xlink:to="loc_jnj_PercentageChangeInSalesBySegmentOfBusiness_07992b7e-d298-48c8-8043-fb5d11885784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_2c7d2e62-48f3-4ab1-a11a-1f3785f09c10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d0716f09-1837-4ab1-a457-d8ccfb4b4459" xlink:to="loc_us-gaap_AdjustmentForAmortization_2c7d2e62-48f3-4ab1-a11a-1f3785f09c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_9d6828da-baf7-4eed-8f63-804f42dd1fe9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d68a5fe8-2f05-464b-a739-509be19d4926" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9d6828da-baf7-4eed-8f63-804f42dd1fe9" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d68a5fe8-2f05-464b-a739-509be19d4926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8c2b190d-7299-428d-b10b-e8e3087ae3cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d68a5fe8-2f05-464b-a739-509be19d4926" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8c2b190d-7299-428d-b10b-e8e3087ae3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dc9c2a9f-7937-4d91-b03b-8f9cb38d2499" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8c2b190d-7299-428d-b10b-e8e3087ae3cf" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dc9c2a9f-7937-4d91-b03b-8f9cb38d2499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_d5e14b1b-964d-42a9-88bd-128b3a0ea1e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_dc9c2a9f-7937-4d91-b03b-8f9cb38d2499" xlink:to="loc_us-gaap_OtherIncomeMember_d5e14b1b-964d-42a9-88bd-128b3a0ea1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aac7f5d7-83c7-46ae-892f-9feab491b6ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d68a5fe8-2f05-464b-a739-509be19d4926" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aac7f5d7-83c7-46ae-892f-9feab491b6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8eba38e7-9be2-4b8b-a745-f53b9f0bb61e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_aac7f5d7-83c7-46ae-892f-9feab491b6ea" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8eba38e7-9be2-4b8b-a745-f53b9f0bb61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AdvancedSterilizationProductsMember_bc7d3ab4-4de3-4a33-8d10-3f4f3fc0c392" xlink:href="jnj-20200927.xsd#jnj_AdvancedSterilizationProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8eba38e7-9be2-4b8b-a745-f53b9f0bb61e" xlink:to="loc_jnj_AdvancedSterilizationProductsMember_bc7d3ab4-4de3-4a33-8d10-3f4f3fc0c392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_cb353c56-2343-4b4a-9dec-e3311ffd4175" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d68a5fe8-2f05-464b-a739-509be19d4926" xlink:to="loc_srt_StatementGeographicalAxis_cb353c56-2343-4b4a-9dec-e3311ffd4175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f559ace1-34e4-4baf-9f96-ac9e740b9efe" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_cb353c56-2343-4b4a-9dec-e3311ffd4175" xlink:to="loc_srt_SegmentGeographicalDomain_f559ace1-34e4-4baf-9f96-ac9e740b9efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_608fd9a2-0055-4662-bc97-70f0c373419f" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f559ace1-34e4-4baf-9f96-ac9e740b9efe" xlink:to="loc_country_US_608fd9a2-0055-4662-bc97-70f0c373419f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_4936486f-ab48-45ed-a451-d371d2966b09" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f559ace1-34e4-4baf-9f96-ac9e740b9efe" xlink:to="loc_srt_EuropeMember_4936486f-ab48-45ed-a451-d371d2966b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WesternHemisphereExcludingUSMember_5e76c44e-fe41-4422-80d2-3a10ec6505e1" xlink:href="jnj-20200927.xsd#jnj_WesternHemisphereExcludingUSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f559ace1-34e4-4baf-9f96-ac9e740b9efe" xlink:to="loc_jnj_WesternHemisphereExcludingUSMember_5e76c44e-fe41-4422-80d2-3a10ec6505e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AsiaPacificAfricaMember_46bed0a7-0e53-46f8-9b28-18f1cb918ae2" xlink:href="jnj-20200927.xsd#jnj_AsiaPacificAfricaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f559ace1-34e4-4baf-9f96-ac9e740b9efe" xlink:to="loc_jnj_AsiaPacificAfricaMember_46bed0a7-0e53-46f8-9b28-18f1cb918ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a76fa2cc-a567-4560-9404-31d6500f1892" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d68a5fe8-2f05-464b-a739-509be19d4926" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a76fa2cc-a567-4560-9404-31d6500f1892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a8101745-a0fd-4576-b39d-fbc31cc1f3c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a76fa2cc-a567-4560-9404-31d6500f1892" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a8101745-a0fd-4576-b39d-fbc31cc1f3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CizHoldingsCo.Ltd.Member_7bb4b2e4-f331-46e7-b3ae-e1fbe2dbefb1" xlink:href="jnj-20200927.xsd#jnj_CizHoldingsCo.Ltd.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a8101745-a0fd-4576-b39d-fbc31cc1f3c9" xlink:to="loc_jnj_CizHoldingsCo.Ltd.Member_7bb4b2e4-f331-46e7-b3ae-e1fbe2dbefb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AurisHealthMember_e1528741-01bd-4667-a919-d37a818b29fb" xlink:href="jnj-20200927.xsd#jnj_AurisHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a8101745-a0fd-4576-b39d-fbc31cc1f3c9" xlink:to="loc_jnj_AurisHealthMember_e1528741-01bd-4667-a919-d37a818b29fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_a94cb02a-5ff9-443d-9b5e-d82ad867160f" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d68a5fe8-2f05-464b-a739-509be19d4926" xlink:to="loc_srt_ConsolidationItemsAxis_a94cb02a-5ff9-443d-9b5e-d82ad867160f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_f3bcfb81-9155-4538-8c86-9bcf9657f9f8" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_a94cb02a-5ff9-443d-9b5e-d82ad867160f" xlink:to="loc_srt_ConsolidationItemsDomain_f3bcfb81-9155-4538-8c86-9bcf9657f9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_c94a6885-a29b-4ec1-84e9-200548e810e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_f3bcfb81-9155-4538-8c86-9bcf9657f9f8" xlink:to="loc_us-gaap_OperatingSegmentsMember_c94a6885-a29b-4ec1-84e9-200548e810e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_1ca74a05-1860-41e0-8a62-96342fe4e012" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_f3bcfb81-9155-4538-8c86-9bcf9657f9f8" xlink:to="loc_us-gaap_CorporateNonSegmentMember_1ca74a05-1860-41e0-8a62-96342fe4e012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b6ba0127-92bb-41f2-bca1-2342ef31cc17" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d68a5fe8-2f05-464b-a739-509be19d4926" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b6ba0127-92bb-41f2-bca1-2342ef31cc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cfa77bac-6493-4f74-ba0e-f217ce15ae81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b6ba0127-92bb-41f2-bca1-2342ef31cc17" xlink:to="loc_us-gaap_SegmentDomain_cfa77bac-6493-4f74-ba0e-f217ce15ae81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember_dd72049a-8392-436a-88fe-6ae7f102b038" xlink:href="jnj-20200927.xsd#jnj_ConsumerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cfa77bac-6493-4f74-ba0e-f217ce15ae81" xlink:to="loc_jnj_ConsumerMember_dd72049a-8392-436a-88fe-6ae7f102b038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PharmaceuticalMember_5f3663d4-08ba-4e60-a966-5425388841bf" xlink:href="jnj-20200927.xsd#jnj_PharmaceuticalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cfa77bac-6493-4f74-ba0e-f217ce15ae81" xlink:to="loc_jnj_PharmaceuticalMember_5f3663d4-08ba-4e60-a966-5425388841bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_21527d34-ad9e-4c0c-bf8f-91cb5b8d4b75" xlink:href="jnj-20200927.xsd#jnj_MedicalDevicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cfa77bac-6493-4f74-ba0e-f217ce15ae81" xlink:to="loc_jnj_MedicalDevicesMember_21527d34-ad9e-4c0c-bf8f-91cb5b8d4b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d68a5fe8-2f05-464b-a739-509be19d4926" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInSalesByGeographicArea_f71e90c2-8217-46c7-ba7c-30a54aead506" xlink:href="jnj-20200927.xsd#jnj_PercentageChangeInSalesByGeographicArea"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_jnj_PercentageChangeInSalesByGeographicArea_f71e90c2-8217-46c7-ba7c-30a54aead506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3eae0626-7561-4a84-a820-b0033590dfe6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3eae0626-7561-4a84-a820-b0033590dfe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_eb2dc456-da31-4367-8963-7ed2040a40f0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_OperatingIncomeLoss_eb2dc456-da31-4367-8963-7ed2040a40f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInOperatingIncomeLoss_f4f3c7b9-bb1b-45ac-8765-fe96b74bd4bc" xlink:href="jnj-20200927.xsd#jnj_PercentageChangeInOperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_jnj_PercentageChangeInOperatingIncomeLoss_f4f3c7b9-bb1b-45ac-8765-fe96b74bd4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_485fea6a-07c3-4e33-81a9-96c695cc0b02" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_485fea6a-07c3-4e33-81a9-96c695cc0b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_0fa480ff-ec97-46ce-a526-0e648c3c70e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_AdjustmentForAmortization_0fa480ff-ec97-46ce-a526-0e648c3c70e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_0c1cda14-5bab-41c2-8801-d4d834d95d44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_0c1cda14-5bab-41c2-8801-d4d834d95d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_97f78770-12c5-468d-8303-a32a4823e6bd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_97f78770-12c5-468d-8303-a32a4823e6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfEquityInvestments_ee79ada8-05a7-4aac-97f6-156cb5195be1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfEquityInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_GainLossOnSaleOfEquityInvestments_ee79ada8-05a7-4aac-97f6-156cb5195be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_66346da4-dd2b-4780-9f4c-0a4834adf58e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_RestructuringCharges_66346da4-dd2b-4780-9f4c-0a4834adf58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_91f6caf1-3132-432e-8d55-183bc8b93337" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_LitigationSettlementExpense_91f6caf1-3132-432e-8d55-183bc8b93337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnSecurities_39c2b705-9559-4fa7-9bee-7c8db350b04c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnSecurities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_UnrealizedGainLossOnSecurities_39c2b705-9559-4fa7-9bee-7c8db350b04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_efce4ecd-2f85-4296-a4dc-7b774496a53d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_efce4ecd-2f85-4296-a4dc-7b774496a53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_fc09667b-0a33-44ed-88a7-0a5ae779b173" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_fc09667b-0a33-44ed-88a7-0a5ae779b173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCosts_b0aa5348-f688-4e0b-b38d-c1e296438119" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquisitionCosts"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61b2dd74-2283-4454-b865-8c47b9684a4c" xlink:to="loc_us-gaap_AcquisitionCosts_b0aa5348-f688-4e0b-b38d-c1e296438119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e5fb8455-6091-4e1a-9dc1-6a7c8b3ff837" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9d6828da-baf7-4eed-8f63-804f42dd1fe9" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e5fb8455-6091-4e1a-9dc1-6a7c8b3ff837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a697f0d7-9861-40f8-b722-3854457525db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e5fb8455-6091-4e1a-9dc1-6a7c8b3ff837" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a697f0d7-9861-40f8-b722-3854457525db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ef404349-2e44-4005-9f36-b78eae6e1f00" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember_5c9fdfb1-a34b-4d1e-945f-3ba442d43197" xlink:href="jnj-20200927.xsd#jnj_ConsumerMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_fe41de3e-c7c3-4056-96c9-85e25040417b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_e5fb8455-6091-4e1a-9dc1-6a7c8b3ff837" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_fe41de3e-c7c3-4056-96c9-85e25040417b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_45bca440-66f4-43fa-930e-e00a88937cb4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_fe41de3e-c7c3-4056-96c9-85e25040417b" xlink:to="loc_us-gaap_LitigationSettlementExpense_45bca440-66f4-43fa-930e-e00a88937cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AmountPrepaidAndDueToManufacturers_41cae83e-f72d-46d9-a9f3-2498470b0488" xlink:href="jnj-20200927.xsd#jnj_AmountPrepaidAndDueToManufacturers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9d6828da-baf7-4eed-8f63-804f42dd1fe9" xlink:to="loc_jnj_AmountPrepaidAndDueToManufacturers_41cae83e-f72d-46d9-a9f3-2498470b0488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4c0f8c04-e85f-4536-bc63-996e9570dc39" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_bd33877f-85e0-456c-b83b-e7c75b263cc9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4c0f8c04-e85f-4536-bc63-996e9570dc39" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_bd33877f-85e0-456c-b83b-e7c75b263cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_fc4c8bd0-8c96-4020-b4e7-b4ffb4f0d801" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_bd33877f-85e0-456c-b83b-e7c75b263cc9" xlink:to="loc_srt_StatementGeographicalAxis_fc4c8bd0-8c96-4020-b4e7-b4ffb4f0d801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d5d28fa6-6f05-4e50-a929-ceba0f67ae79" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_fc4c8bd0-8c96-4020-b4e7-b4ffb4f0d801" xlink:to="loc_srt_SegmentGeographicalDomain_d5d28fa6-6f05-4e50-a929-ceba0f67ae79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_3051dce5-f8b2-41a0-9ec6-849e1d0a5d3b" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d5d28fa6-6f05-4e50-a929-ceba0f67ae79" xlink:to="loc_country_US_3051dce5-f8b2-41a0-9ec6-849e1d0a5d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_ba89ee80-43ba-443a-b458-9790b06558ce" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d5d28fa6-6f05-4e50-a929-ceba0f67ae79" xlink:to="loc_srt_EuropeMember_ba89ee80-43ba-443a-b458-9790b06558ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WesternHemisphereExcludingUSMember_8caf5b54-578e-45d5-a376-03465ce6aadd" xlink:href="jnj-20200927.xsd#jnj_WesternHemisphereExcludingUSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d5d28fa6-6f05-4e50-a929-ceba0f67ae79" xlink:to="loc_jnj_WesternHemisphereExcludingUSMember_8caf5b54-578e-45d5-a376-03465ce6aadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AsiaPacificAfricaMember_aba5f62e-1f98-4e02-82ff-0c4167cbf5f2" xlink:href="jnj-20200927.xsd#jnj_AsiaPacificAfricaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d5d28fa6-6f05-4e50-a929-ceba0f67ae79" xlink:to="loc_jnj_AsiaPacificAfricaMember_aba5f62e-1f98-4e02-82ff-0c4167cbf5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_973acbf8-53a5-4faa-89aa-78c59424ae61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_bd33877f-85e0-456c-b83b-e7c75b263cc9" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_973acbf8-53a5-4faa-89aa-78c59424ae61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentsGeographicalAreasAbstract_128090d0-25c6-411c-bb78-7a90ccebc62e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentsGeographicalAreasAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_973acbf8-53a5-4faa-89aa-78c59424ae61" xlink:to="loc_us-gaap_SegmentsGeographicalAreasAbstract_128090d0-25c6-411c-bb78-7a90ccebc62e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_39bd4bb9-dcf4-4e62-8a68-13b8babf0b40" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentsGeographicalAreasAbstract_128090d0-25c6-411c-bb78-7a90ccebc62e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_39bd4bb9-dcf4-4e62-8a68-13b8babf0b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInSalesByGeographicArea_13956820-3d92-4880-a206-1f6389cff362" xlink:href="jnj-20200927.xsd#jnj_PercentageChangeInSalesByGeographicArea"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentsGeographicalAreasAbstract_128090d0-25c6-411c-bb78-7a90ccebc62e" xlink:to="loc_jnj_PercentageChangeInSalesByGeographicArea_13956820-3d92-4880-a206-1f6389cff362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/BusinessCombinationsandDivestitures" xlink:type="simple" xlink:href="jnj-20200927.xsd#BusinessCombinationsandDivestitures"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/BusinessCombinationsandDivestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_935776f0-aa3f-44ab-bc09-a4813b8765fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_c9099aab-8c80-4175-9b45-c1bc477a770f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_935776f0-aa3f-44ab-bc09-a4813b8765fb" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_c9099aab-8c80-4175-9b45-c1bc477a770f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#BusinessCombinationsandDivestituresNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_240fffc1-602d-4904-932e-3e6167ff5f10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_240fffc1-602d-4904-932e-3e6167ff5f10" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_059257c0-df25-4b2b-b839-5467349c436a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_059257c0-df25-4b2b-b839-5467349c436a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_139fe3d3-da9f-4173-9490-3dc99f150432" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_059257c0-df25-4b2b-b839-5467349c436a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_139fe3d3-da9f-4173-9490-3dc99f150432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_c17f51a1-592e-4a79-81af-606b5ffe7639" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_139fe3d3-da9f-4173-9490-3dc99f150432" xlink:to="loc_us-gaap_OtherIncomeMember_c17f51a1-592e-4a79-81af-606b5ffe7639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_473932e8-04b0-4c68-a43c-586ddfb19c36" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_473932e8-04b0-4c68-a43c-586ddfb19c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c62c3708-059e-463c-8d30-32157fd19af9" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_473932e8-04b0-4c68-a43c-586ddfb19c36" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c62c3708-059e-463c-8d30-32157fd19af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IdorsiaLTDMember_49a02527-74c2-424c-bfc3-ad23ed0e667e" xlink:href="jnj-20200927.xsd#jnj_IdorsiaLTDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c62c3708-059e-463c-8d30-32157fd19af9" xlink:to="loc_jnj_IdorsiaLTDMember_49a02527-74c2-424c-bfc3-ad23ed0e667e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_4cc65fa2-51e7-4f88-9131-b833cb0170b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_4cc65fa2-51e7-4f88-9131-b833cb0170b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_30361a48-46e2-421e-a6bc-ac79b861a0fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_4cc65fa2-51e7-4f88-9131-b833cb0170b8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_30361a48-46e2-421e-a6bc-ac79b861a0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_709b9c39-476c-4b90-8744-18058671459a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_30361a48-46e2-421e-a6bc-ac79b861a0fc" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_709b9c39-476c-4b90-8744-18058671459a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_24780729-c3ca-4210-a896-2978bfd82416" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_24780729-c3ca-4210-a896-2978bfd82416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_130a0473-9f8a-4d71-8aed-a2ddad0df78a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_24780729-c3ca-4210-a896-2978bfd82416" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_130a0473-9f8a-4d71-8aed-a2ddad0df78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SupplyChainMember_d4433eae-874f-4585-888b-e7ee2d779c1f" xlink:href="jnj-20200927.xsd#jnj_SupplyChainMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_130a0473-9f8a-4d71-8aed-a2ddad0df78a" xlink:to="loc_jnj_SupplyChainMember_d4433eae-874f-4585-888b-e7ee2d779c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AdvancedSterilizationProductsMember_87f607a8-bfec-495b-9011-3ce9621a49f6" xlink:href="jnj-20200927.xsd#jnj_AdvancedSterilizationProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_130a0473-9f8a-4d71-8aed-a2ddad0df78a" xlink:to="loc_jnj_AdvancedSterilizationProductsMember_87f607a8-bfec-495b-9011-3ce9621a49f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IdorsiaLTDMember_3c7a90ec-bb3f-44aa-b19d-d01d6f50daf1" xlink:href="jnj-20200927.xsd#jnj_IdorsiaLTDMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_130a0473-9f8a-4d71-8aed-a2ddad0df78a" xlink:to="loc_jnj_IdorsiaLTDMember_3c7a90ec-bb3f-44aa-b19d-d01d6f50daf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_fe133872-cd39-4074-9372-f458d2897153" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_dei_LegalEntityAxis_fe133872-cd39-4074-9372-f458d2897153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d4cbe684-5471-4693-aed8-49f4b18f339e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_fe133872-cd39-4074-9372-f458d2897153" xlink:to="loc_dei_EntityDomain_d4cbe684-5471-4693-aed8-49f4b18f339e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IdorsiaLTDMember_1436766e-cade-4f65-b049-20d83b2d302b" xlink:href="jnj-20200927.xsd#jnj_IdorsiaLTDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_d4cbe684-5471-4693-aed8-49f4b18f339e" xlink:to="loc_jnj_IdorsiaLTDMember_1436766e-cade-4f65-b049-20d83b2d302b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9f4ea741-7c73-4791-9632-22ddc26217cf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9f4ea741-7c73-4791-9632-22ddc26217cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4502b14b-8ad1-4aeb-b40b-2d73ee886ff3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9f4ea741-7c73-4791-9632-22ddc26217cf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4502b14b-8ad1-4aeb-b40b-2d73ee886ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BermekimabMember_ca8f6772-8dfa-4a5b-bcfb-e357de375162" xlink:href="jnj-20200927.xsd#jnj_BermekimabMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4502b14b-8ad1-4aeb-b40b-2d73ee886ff3" xlink:to="loc_jnj_BermekimabMember_ca8f6772-8dfa-4a5b-bcfb-e357de375162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VerbSurgicalInc.Member_347a15da-a438-4b79-8ad8-679dfd7b7a32" xlink:href="jnj-20200927.xsd#jnj_VerbSurgicalInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4502b14b-8ad1-4aeb-b40b-2d73ee886ff3" xlink:to="loc_jnj_VerbSurgicalInc.Member_347a15da-a438-4b79-8ad8-679dfd7b7a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AurisHealthMember_35c1e169-ff0b-4a4c-b709-a265a743cef4" xlink:href="jnj-20200927.xsd#jnj_AurisHealthMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4502b14b-8ad1-4aeb-b40b-2d73ee886ff3" xlink:to="loc_jnj_AurisHealthMember_35c1e169-ff0b-4a4c-b709-a265a743cef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CizHoldingsCo.Ltd.Member_aa920e37-7611-4ad6-9fa2-6f673856fa13" xlink:href="jnj-20200927.xsd#jnj_CizHoldingsCo.Ltd.Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4502b14b-8ad1-4aeb-b40b-2d73ee886ff3" xlink:to="loc_jnj_CizHoldingsCo.Ltd.Member_aa920e37-7611-4ad6-9fa2-6f673856fa13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MomentaMember_2f921c41-afc9-418c-9a92-455e1b764d1a" xlink:href="jnj-20200927.xsd#jnj_MomentaMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4502b14b-8ad1-4aeb-b40b-2d73ee886ff3" xlink:to="loc_jnj_MomentaMember_2f921c41-afc9-418c-9a92-455e1b764d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_46dabebc-fe21-4327-a982-9575e5505373" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_46dabebc-fe21-4327-a982-9575e5505373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a2004f91-6533-45ce-9d0f-1db500723240" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_46dabebc-fe21-4327-a982-9575e5505373" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a2004f91-6533-45ce-9d0f-1db500723240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_e5ee038e-e7b8-44c4-a6a8-fdcb23134c1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a2004f91-6533-45ce-9d0f-1db500723240" xlink:to="loc_us-gaap_ConvertibleDebtMember_e5ee038e-e7b8-44c4-a6a8-fdcb23134c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_25dcd922-e412-46fa-9879-458da7a3b7b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a2004f91-6533-45ce-9d0f-1db500723240" xlink:to="loc_us-gaap_LineOfCreditMember_25dcd922-e412-46fa-9879-458da7a3b7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_4baacbb7-6399-48ad-923e-8c907125db90" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_CreditFacilityAxis_4baacbb7-6399-48ad-923e-8c907125db90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a5bc0b33-ffb2-464b-baf4-ea9b48e6820f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_4baacbb7-6399-48ad-923e-8c907125db90" xlink:to="loc_us-gaap_CreditFacilityDomain_a5bc0b33-ffb2-464b-baf4-ea9b48e6820f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_13f34516-4538-4d60-a5ac-6622452d0b52" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a5bc0b33-ffb2-464b-baf4-ea9b48e6820f" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_13f34516-4538-4d60-a5ac-6622452d0b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_dc2f674d-e6cc-4427-99ab-45e7118188fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_dc2f674d-e6cc-4427-99ab-45e7118188fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_7a48a489-5754-4950-9387-19a3d8b73467" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_dc2f674d-e6cc-4427-99ab-45e7118188fd" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_7a48a489-5754-4950-9387-19a3d8b73467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IdorsiaLTDMember_6edf82e9-c6f6-4b90-b769-e39f5724673e" xlink:href="jnj-20200927.xsd#jnj_IdorsiaLTDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_7a48a489-5754-4950-9387-19a3d8b73467" xlink:to="loc_jnj_IdorsiaLTDMember_6edf82e9-c6f6-4b90-b769-e39f5724673e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_98690ba5-c5b1-4b84-90bc-a73f0f4a0e2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_98690ba5-c5b1-4b84-90bc-a73f0f4a0e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e4eb3129-f242-4929-9e3f-9cf455827932" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_98690ba5-c5b1-4b84-90bc-a73f0f4a0e2c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e4eb3129-f242-4929-9e3f-9cf455827932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_34900e96-45a2-4c9f-b4ad-db01b9ca2f6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e4eb3129-f242-4929-9e3f-9cf455827932" xlink:to="loc_us-gaap_SubsequentEventMember_34900e96-45a2-4c9f-b4ad-db01b9ca2f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_419ff33e-a289-4696-8451-1bcc4965f7dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_419ff33e-a289-4696-8451-1bcc4965f7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03517ab6-cd30-443b-9ee0-cff4453b2353" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_419ff33e-a289-4696-8451-1bcc4965f7dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03517ab6-cd30-443b-9ee0-cff4453b2353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_4ac3b67a-c84c-4af1-877a-7aded7314ad0" xlink:href="jnj-20200927.xsd#jnj_PurchasedInProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_03517ab6-cd30-443b-9ee0-cff4453b2353" xlink:to="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_4ac3b67a-c84c-4af1-877a-7aded7314ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f44d5a9d-0d39-4a6b-af6e-dedfd162120d" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8f5ce313-3775-4d2c-9468-4c2903d66a46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8f5ce313-3775-4d2c-9468-4c2903d66a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_45112cbb-a83f-441e-b143-ee23248821a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_45112cbb-a83f-441e-b143-ee23248821a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction_0cbff6c5-f574-4d16-8549-fbb2c02a83d1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction_0cbff6c5-f574-4d16-8549-fbb2c02a83d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_bda8cf08-be69-4b82-be1f-3360c565c494" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_bda8cf08-be69-4b82-be1f-3360c565c494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_5440005d-434e-4661-99cc-e3bb7df6f870" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_5440005d-434e-4661-99cc-e3bb7df6f870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares_e020441d-21ff-42b4-8808-3ea46f9855fc" xlink:href="jnj-20200927.xsd#jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares_e020441d-21ff-42b4-8808-3ea46f9855fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_05738e40-6d4f-47de-a33c-681c75e036c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_05738e40-6d4f-47de-a33c-681c75e036c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_84c0821a-c3a5-47d8-9c2e-b58ab47bab6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_LongTermDebt_84c0821a-c3a5-47d8-9c2e-b58ab47bab6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d05dde04-cb88-4c9a-b47a-1eb1990fc985" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d05dde04-cb88-4c9a-b47a-1eb1990fc985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_af201415-f6fb-494e-b373-d960b6cb04ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_af201415-f6fb-494e-b373-d960b6cb04ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5310d8a5-0f5c-4506-a493-241b323310c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_Goodwill_5310d8a5-0f5c-4506-a493-241b323310c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_d1c866b3-a4e8-4c23-9de5-852b7951005a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_d1c866b3-a4e8-4c23-9de5-852b7951005a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_7a5be1e7-e73c-4bd5-8a6f-91d7dd126b99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_7a5be1e7-e73c-4bd5-8a6f-91d7dd126b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_88771cf5-7711-432b-aa16-f92b26669029" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_88771cf5-7711-432b-aa16-f92b26669029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_532b5d9b-6da7-4024-95f0-a251bb07ff21" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_532b5d9b-6da7-4024-95f0-a251bb07ff21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained_545ba186-ffbc-427a-8c7c-31cc91abb89e" xlink:href="jnj-20200927.xsd#jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained_545ba186-ffbc-427a-8c7c-31cc91abb89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_bc25547d-586f-4c81-861a-7c2515920331" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_bc25547d-586f-4c81-861a-7c2515920331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_25e21315-f472-407b-ad2d-8e8a41364e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_25e21315-f472-407b-ad2d-8e8a41364e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_450e2bd3-d309-49ab-9fbc-e6773e01d9eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_450e2bd3-d309-49ab-9fbc-e6773e01d9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_04730e90-2fd0-4daa-9cc4-f49bb7680261" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_04730e90-2fd0-4daa-9cc4-f49bb7680261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_0e62de33-92a5-4e28-9a38-0bd29753d2d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_0e62de33-92a5-4e28-9a38-0bd29753d2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_4c9fb466-191e-4916-baaf-8dcd2c953de1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_AssetImpairmentCharges_4c9fb466-191e-4916-baaf-8dcd2c953de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyExchangeRateTranslation1_47e0b671-0381-4254-90c3-967dda248ca5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_ForeignCurrencyExchangeRateTranslation1_47e0b671-0381-4254-90c3-967dda248ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b3ad83eb-a0f0-4c16-b575-504432f27461" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b3ad83eb-a0f0-4c16-b575-504432f27461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill_f5cbae68-c74f-41dd-976b-553130728df3" xlink:href="jnj-20200927.xsd#jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill_f5cbae68-c74f-41dd-976b-553130728df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_fc3d4d26-139f-449b-b710-21cc677da9ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_fc3d4d26-139f-449b-b710-21cc677da9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_a8c2ad4d-ce73-4ddd-ac06-24393cda259e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_65c9c009-749e-4c72-8998-62d33c6bf154" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_a8c2ad4d-ce73-4ddd-ac06-24393cda259e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/LegalProceedings" xlink:type="simple" xlink:href="jnj-20200927.xsd#LegalProceedings"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/LegalProceedings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f91fe1db-a666-4da6-b079-c218fd702a06" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_4cb7338c-1db2-437f-b064-a1cee43ff10a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f91fe1db-a666-4da6-b079-c218fd702a06" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_4cb7338c-1db2-437f-b064-a1cee43ff10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/LegalProceedingsDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#LegalProceedingsDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/LegalProceedingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2339f480-ee07-4bcc-8497-ae56f49219c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_8fadc69a-2daf-4e51-9ecb-97eaa8e157c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2339f480-ee07-4bcc-8497-ae56f49219c4" xlink:to="loc_us-gaap_LossContingenciesTable_8fadc69a-2daf-4e51-9ecb-97eaa8e157c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_0db71c43-7554-482d-ac9e-b90825214eb0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8fadc69a-2daf-4e51-9ecb-97eaa8e157c5" xlink:to="loc_srt_LitigationCaseAxis_0db71c43-7554-482d-ac9e-b90825214eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_4eba9c36-5eae-4c7b-9223-471282fcc823" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_0db71c43-7554-482d-ac9e-b90825214eb0" xlink:to="loc_srt_LitigationCaseTypeDomain_4eba9c36-5eae-4c7b-9223-471282fcc823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DePuyASRU.S.Member_97f80214-6418-489e-b84c-46df89e28794" xlink:href="jnj-20200927.xsd#jnj_DePuyASRU.S.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_4eba9c36-5eae-4c7b-9223-471282fcc823" xlink:to="loc_jnj_DePuyASRU.S.Member_97f80214-6418-489e-b84c-46df89e28794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RisperdalMember_984df9d2-6bc9-48e1-a701-43c594d25036" xlink:href="jnj-20200927.xsd#jnj_RisperdalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_4eba9c36-5eae-4c7b-9223-471282fcc823" xlink:to="loc_jnj_RisperdalMember_984df9d2-6bc9-48e1-a701-43c594d25036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BabyPowderMember_ab293c2f-7517-445c-908e-d2c269c43d57" xlink:href="jnj-20200927.xsd#jnj_BabyPowderMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_4eba9c36-5eae-4c7b-9223-471282fcc823" xlink:to="loc_jnj_BabyPowderMember_ab293c2f-7517-445c-908e-d2c269c43d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember_de2cb9b5-e082-4870-bed1-a40ebfbd592e" xlink:href="jnj-20200927.xsd#jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_4eba9c36-5eae-4c7b-9223-471282fcc823" xlink:to="loc_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember_de2cb9b5-e082-4870-bed1-a40ebfbd592e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_fea4a04f-7194-4536-aae1-b00a555ad3c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8fadc69a-2daf-4e51-9ecb-97eaa8e157c5" xlink:to="loc_us-gaap_LitigationStatusAxis_fea4a04f-7194-4536-aae1-b00a555ad3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_580f91f9-c046-444f-8b59-d348b82cbd4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_fea4a04f-7194-4536-aae1-b00a555ad3c1" xlink:to="loc_us-gaap_LitigationStatusDomain_580f91f9-c046-444f-8b59-d348b82cbd4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_01dd1a6c-fb73-472c-998c-27490a2cfbcd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_580f91f9-c046-444f-8b59-d348b82cbd4f" xlink:to="loc_us-gaap_SettledLitigationMember_01dd1a6c-fb73-472c-998c-27490a2cfbcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_JudicialRulingMember_67107b41-15f0-4f85-9d2e-e80e1903468e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_JudicialRulingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_580f91f9-c046-444f-8b59-d348b82cbd4f" xlink:to="loc_us-gaap_JudicialRulingMember_67107b41-15f0-4f85-9d2e-e80e1903468e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_878dc93e-604e-4760-9dd0-afdc15a61097" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_580f91f9-c046-444f-8b59-d348b82cbd4f" xlink:to="loc_us-gaap_PendingLitigationMember_878dc93e-604e-4760-9dd0-afdc15a61097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b59780de-ab7b-47f4-8c2c-8386c8b47bfc" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8fadc69a-2daf-4e51-9ecb-97eaa8e157c5" xlink:to="loc_srt_ProductOrServiceAxis_b59780de-ab7b-47f4-8c2c-8386c8b47bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b59780de-ab7b-47f4-8c2c-8386c8b47bfc" xlink:to="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AsrMember_4d76e34e-abb8-458c-a06b-bd8e3d2c4048" xlink:href="jnj-20200927.xsd#jnj_AsrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:to="loc_jnj_AsrMember_4d76e34e-abb8-458c-a06b-bd8e3d2c4048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PinnacleAcetabularCupSystemMember_193764bd-f344-429b-9ae1-e0c79bcffdc7" xlink:href="jnj-20200927.xsd#jnj_PinnacleAcetabularCupSystemMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:to="loc_jnj_PinnacleAcetabularCupSystemMember_193764bd-f344-429b-9ae1-e0c79bcffdc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PelvicMeshesMember_157a1a6c-1c41-42fa-9f9a-6c029a8a264d" xlink:href="jnj-20200927.xsd#jnj_PelvicMeshesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:to="loc_jnj_PelvicMeshesMember_157a1a6c-1c41-42fa-9f9a-6c029a8a264d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RisperdalMember_90249c4c-2810-4e9d-9567-485735ee54d3" xlink:href="jnj-20200927.xsd#jnj_RisperdalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:to="loc_jnj_RisperdalMember_90249c4c-2810-4e9d-9567-485735ee54d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_XareltoMember_d073926a-8eb6-4dc0-8425-362eef1e139e" xlink:href="jnj-20200927.xsd#jnj_XareltoMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:to="loc_jnj_XareltoMember_d073926a-8eb6-4dc0-8425-362eef1e139e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_TalcMember_88180d05-a3a1-4f88-8466-22d71aefc00f" xlink:href="jnj-20200927.xsd#jnj_TalcMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:to="loc_jnj_TalcMember_88180d05-a3a1-4f88-8466-22d71aefc00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InvokanaMember_21058f74-9c75-49ac-90bb-d7a7c8aa77e7" xlink:href="jnj-20200927.xsd#jnj_InvokanaMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:to="loc_jnj_InvokanaMember_21058f74-9c75-49ac-90bb-d7a7c8aa77e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PhysiomeshMember_485101d7-efea-4cf9-a855-1ad71aaa6418" xlink:href="jnj-20200927.xsd#jnj_PhysiomeshMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:to="loc_jnj_PhysiomeshMember_485101d7-efea-4cf9-a855-1ad71aaa6418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OpioidMember_a930bf72-fdc0-4709-b8c6-051a9d0243ca" xlink:href="jnj-20200927.xsd#jnj_OpioidMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_64676108-533c-453d-8337-1ed2e99c5ed9" xlink:to="loc_jnj_OpioidMember_a930bf72-fdc0-4709-b8c6-051a9d0243ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LitigationSettlementByCompaniesAxis_081d8387-0c0e-461d-a619-8fc02bbea3fd" xlink:href="jnj-20200927.xsd#jnj_LitigationSettlementByCompaniesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8fadc69a-2daf-4e51-9ecb-97eaa8e157c5" xlink:to="loc_jnj_LitigationSettlementByCompaniesAxis_081d8387-0c0e-461d-a619-8fc02bbea3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LitigationSettlementByCompaniesDomain_de73685d-e529-4fdf-bacb-adbafdd7acaf" xlink:href="jnj-20200927.xsd#jnj_LitigationSettlementByCompaniesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_LitigationSettlementByCompaniesAxis_081d8387-0c0e-461d-a619-8fc02bbea3fd" xlink:to="loc_jnj_LitigationSettlementByCompaniesDomain_de73685d-e529-4fdf-bacb-adbafdd7acaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RisperdalMember_f543a173-775b-454a-8ccf-e4f57ba3ab11" xlink:href="jnj-20200927.xsd#jnj_RisperdalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_LitigationSettlementByCompaniesDomain_de73685d-e529-4fdf-bacb-adbafdd7acaf" xlink:to="loc_jnj_RisperdalMember_f543a173-775b-454a-8ccf-e4f57ba3ab11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b92340fb-7215-4690-bd47-6435ce5e6d98" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8fadc69a-2daf-4e51-9ecb-97eaa8e157c5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b92340fb-7215-4690-bd47-6435ce5e6d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c9d1f13c-881f-40f5-8e16-d546ef604d67" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b92340fb-7215-4690-bd47-6435ce5e6d98" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c9d1f13c-881f-40f5-8e16-d546ef604d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_41c5d9e9-b23e-4be9-9802-b5e43a47a50c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c9d1f13c-881f-40f5-8e16-d546ef604d67" xlink:to="loc_us-gaap_SubsequentEventMember_41c5d9e9-b23e-4be9-9802-b5e43a47a50c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_07887ec4-8469-4a2d-ae44-6a987121dcfc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_8fadc69a-2daf-4e51-9ecb-97eaa8e157c5" xlink:to="loc_us-gaap_LossContingenciesLineItems_07887ec4-8469-4a2d-ae44-6a987121dcfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LegalProceedingTextualsAbstract_3ef5f4ef-bf84-4354-9722-446772908cd6" xlink:href="jnj-20200927.xsd#jnj_LegalProceedingTextualsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_07887ec4-8469-4a2d-ae44-6a987121dcfc" xlink:to="loc_jnj_LegalProceedingTextualsAbstract_3ef5f4ef-bf84-4354-9722-446772908cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ProductLiabilityContingencyNumberOfClaimant_98d34ad6-7f07-49ba-ac94-6181d5caba54" xlink:href="jnj-20200927.xsd#jnj_ProductLiabilityContingencyNumberOfClaimant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_3ef5f4ef-bf84-4354-9722-446772908cd6" xlink:to="loc_jnj_ProductLiabilityContingencyNumberOfClaimant_98d34ad6-7f07-49ba-ac94-6181d5caba54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Numberofpatientsinsettlement_d0838d26-1968-49d8-8677-8c16c78751c2" xlink:href="jnj-20200927.xsd#jnj_Numberofpatientsinsettlement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_3ef5f4ef-bf84-4354-9722-446772908cd6" xlink:to="loc_jnj_Numberofpatientsinsettlement_d0838d26-1968-49d8-8677-8c16c78751c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_12f0ba6f-aee4-4c60-bac4-7587ec019196" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_3ef5f4ef-bf84-4354-9722-446772908cd6" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_12f0ba6f-aee4-4c60-bac4-7587ec019196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue_449a6129-f384-4249-9cb3-4db6ea2273e5" xlink:href="jnj-20200927.xsd#jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_3ef5f4ef-bf84-4354-9722-446772908cd6" xlink:to="loc_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue_449a6129-f384-4249-9cb3-4db6ea2273e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_71e20e78-6309-4811-9cb4-7f248eacc3ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_3ef5f4ef-bf84-4354-9722-446772908cd6" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_71e20e78-6309-4811-9cb4-7f248eacc3ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LossContingencyEstimateOfAdditionalPossibleLoss_4b6c771a-291e-41f4-8747-8a0181be1489" xlink:href="jnj-20200927.xsd#jnj_LossContingencyEstimateOfAdditionalPossibleLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_3ef5f4ef-bf84-4354-9722-446772908cd6" xlink:to="loc_jnj_LossContingencyEstimateOfAdditionalPossibleLoss_4b6c771a-291e-41f4-8747-8a0181be1489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/Restructuring" xlink:type="simple" xlink:href="jnj-20200927.xsd#Restructuring"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/Restructuring" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f7b26e57-6e10-4c70-bf52-0739c2a0d02d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_b21d4646-ebe3-441c-8bbf-43db058aeea0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f7b26e57-6e10-4c70-bf52-0739c2a0d02d" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_b21d4646-ebe3-441c-8bbf-43db058aeea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/RestructuringTables" xlink:type="simple" xlink:href="jnj-20200927.xsd#RestructuringTables"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/RestructuringTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4eba28bf-3082-487c-a7f4-3591b7ce5f84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_fd052000-3c6c-4e18-9920-1d09e0f32862" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_4eba28bf-3082-487c-a7f4-3591b7ce5f84" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_fd052000-3c6c-4e18-9920-1d09e0f32862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/RestructuringNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#RestructuringNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/RestructuringNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_70a740e8-f50d-4178-a164-32d6f05208ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76dd166c-0750-44d9-8461-9f56b51a8d5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_70a740e8-f50d-4178-a164-32d6f05208ef" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76dd166c-0750-44d9-8461-9f56b51a8d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_04b63a37-1e2f-4408-a434-772c5680ba43" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76dd166c-0750-44d9-8461-9f56b51a8d5b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_04b63a37-1e2f-4408-a434-772c5680ba43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4685cf57-9fe9-4717-af23-0efa6d77e32c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_04b63a37-1e2f-4408-a434-772c5680ba43" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4685cf57-9fe9-4717-af23-0efa6d77e32c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SupplyChainMember_3aa2fdd5-3037-4b46-aafa-66c8170c1af4" xlink:href="jnj-20200927.xsd#jnj_SupplyChainMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_4685cf57-9fe9-4717-af23-0efa6d77e32c" xlink:to="loc_jnj_SupplyChainMember_3aa2fdd5-3037-4b46-aafa-66c8170c1af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_70d44dd9-89f9-4a8f-8d83-79698b5bbf91" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76dd166c-0750-44d9-8461-9f56b51a8d5b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_70d44dd9-89f9-4a8f-8d83-79698b5bbf91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a1871d6c-e4a7-4802-a5f3-5eff2e5e727a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_70d44dd9-89f9-4a8f-8d83-79698b5bbf91" xlink:to="loc_us-gaap_SegmentDomain_a1871d6c-e4a7-4802-a5f3-5eff2e5e727a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_5139ef12-0508-45e8-9bdc-0066d1edbe0b" xlink:href="jnj-20200927.xsd#jnj_MedicalDevicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a1871d6c-e4a7-4802-a5f3-5eff2e5e727a" xlink:to="loc_jnj_MedicalDevicesMember_5139ef12-0508-45e8-9bdc-0066d1edbe0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_dadd26ce-c447-4eec-8564-7092aa4c7e66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76dd166c-0750-44d9-8461-9f56b51a8d5b" xlink:to="loc_us-gaap_RestructuringPlanAxis_dadd26ce-c447-4eec-8564-7092aa4c7e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_840a3929-97d7-40a4-9cae-e6a08f374a2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_dadd26ce-c447-4eec-8564-7092aa4c7e66" xlink:to="loc_us-gaap_RestructuringPlanDomain_840a3929-97d7-40a4-9cae-e6a08f374a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SupplyChainMember_7c682773-da6a-49b8-ad9a-a7794874e5fe" xlink:href="jnj-20200927.xsd#jnj_SupplyChainMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_840a3929-97d7-40a4-9cae-e6a08f374a2c" xlink:to="loc_jnj_SupplyChainMember_7c682773-da6a-49b8-ad9a-a7794874e5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_9b183e60-b3c5-4785-af17-1b659db32990" xlink:href="jnj-20200927.xsd#jnj_MedicalDevicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_840a3929-97d7-40a4-9cae-e6a08f374a2c" xlink:to="loc_jnj_MedicalDevicesMember_9b183e60-b3c5-4785-af17-1b659db32990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_71af02cd-ba63-40b4-8383-75b6a1753cf0" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76dd166c-0750-44d9-8461-9f56b51a8d5b" xlink:to="loc_srt_RangeAxis_71af02cd-ba63-40b4-8383-75b6a1753cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_370186f1-fa74-401d-bff9-55aa1bc6e4b4" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_71af02cd-ba63-40b4-8383-75b6a1753cf0" xlink:to="loc_srt_RangeMember_370186f1-fa74-401d-bff9-55aa1bc6e4b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9ad4d81f-31f8-4aca-bbb7-c00f45e6b0f1" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_370186f1-fa74-401d-bff9-55aa1bc6e4b4" xlink:to="loc_srt_MinimumMember_9ad4d81f-31f8-4aca-bbb7-c00f45e6b0f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_23cc102e-f98f-4a47-9358-f05fee2e256b" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_370186f1-fa74-401d-bff9-55aa1bc6e4b4" xlink:to="loc_srt_MaximumMember_23cc102e-f98f-4a47-9358-f05fee2e256b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_9373a375-9f13-48d8-8758-933fea70b35e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76dd166c-0750-44d9-8461-9f56b51a8d5b" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_9373a375-9f13-48d8-8758-933fea70b35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_156a0381-fa75-45a2-91ef-e930add349f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_9373a375-9f13-48d8-8758-933fea70b35e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_156a0381-fa75-45a2-91ef-e930add349f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_ee356ae2-48db-457d-a68b-3a5958c02bf7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_156a0381-fa75-45a2-91ef-e930add349f8" xlink:to="loc_us-gaap_RestructuringChargesMember_ee356ae2-48db-457d-a68b-3a5958c02bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_9d41aef4-b6c4-44ea-ace4-73fd8f731ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_156a0381-fa75-45a2-91ef-e930add349f8" xlink:to="loc_us-gaap_CostOfSalesMember_9d41aef4-b6c4-44ea-ace4-73fd8f731ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_38d1814e-4372-4af2-a675-422de52f3587" xlink:href="jnj-20200927.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_156a0381-fa75-45a2-91ef-e930add349f8" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_38d1814e-4372-4af2-a675-422de52f3587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_2df0d92d-28bc-4583-b4b0-a38aa67c9ff5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_76dd166c-0750-44d9-8461-9f56b51a8d5b" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_2df0d92d-28bc-4583-b4b0-a38aa67c9ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c99a7ab0-4e7a-4b91-a617-8b907b05e59e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2df0d92d-28bc-4583-b4b0-a38aa67c9ff5" xlink:to="loc_us-gaap_RestructuringCharges_c99a7ab0-4e7a-4b91-a617-8b907b05e59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_3a07e1af-d28f-408c-b4ea-1a68f3939e84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2df0d92d-28bc-4583-b4b0-a38aa67c9ff5" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_3a07e1af-d28f-408c-b4ea-1a68f3939e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_3aa4140e-8a8a-4ce3-99db-32429a18a5c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2df0d92d-28bc-4583-b4b0-a38aa67c9ff5" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_3aa4140e-8a8a-4ce3-99db-32429a18a5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RestructuringandRelatedCostExpectedFutureSavings_dbfc5ea7-4b00-4f0e-96d9-264bd93b9fc4" xlink:href="jnj-20200927.xsd#jnj_RestructuringandRelatedCostExpectedFutureSavings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2df0d92d-28bc-4583-b4b0-a38aa67c9ff5" xlink:to="loc_jnj_RestructuringandRelatedCostExpectedFutureSavings_dbfc5ea7-4b00-4f0e-96d9-264bd93b9fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RestructuringandRelatedCostDurationofRestructuringPlan_ec528149-f76c-4876-a20e-14ebb874768c" xlink:href="jnj-20200927.xsd#jnj_RestructuringandRelatedCostDurationofRestructuringPlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_2df0d92d-28bc-4583-b4b0-a38aa67c9ff5" xlink:to="loc_jnj_RestructuringandRelatedCostDurationofRestructuringPlan_ec528149-f76c-4876-a20e-14ebb874768c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails" xlink:type="simple" xlink:href="jnj-20200927.xsd#RestructuringScheduleofRestructuringReserveDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_19c6f8b2-a7f2-46d9-b2ea-6a6f397b99e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee232807-7741-4265-a635-826e85154803" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_19c6f8b2-a7f2-46d9-b2ea-6a6f397b99e2" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee232807-7741-4265-a635-826e85154803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_519fe635-7268-4052-b2a5-0f2677f84af3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee232807-7741-4265-a635-826e85154803" xlink:to="loc_us-gaap_RestructuringPlanAxis_519fe635-7268-4052-b2a5-0f2677f84af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_597204f9-e844-4726-96bd-d937c4e5cd05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_519fe635-7268-4052-b2a5-0f2677f84af3" xlink:to="loc_us-gaap_RestructuringPlanDomain_597204f9-e844-4726-96bd-d937c4e5cd05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_1c049a3e-f891-4e7c-a6c5-494c050ddfb6" xlink:href="jnj-20200927.xsd#jnj_MedicalDevicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_597204f9-e844-4726-96bd-d937c4e5cd05" xlink:to="loc_jnj_MedicalDevicesMember_1c049a3e-f891-4e7c-a6c5-494c050ddfb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_e2f40bc6-ae76-4d75-94a7-561ec6170fb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee232807-7741-4265-a635-826e85154803" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_e2f40bc6-ae76-4d75-94a7-561ec6170fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_c67f4c15-ed8a-4156-b143-074a9402265b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_e2f40bc6-ae76-4d75-94a7-561ec6170fb8" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_c67f4c15-ed8a-4156-b143-074a9402265b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_7fb15557-cc5a-49f3-a123-c682bbde9c1d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c67f4c15-ed8a-4156-b143-074a9402265b" xlink:to="loc_us-gaap_EmployeeSeveranceMember_7fb15557-cc5a-49f3-a123-c682bbde9c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AssetWriteoffMember_2f58b2e3-48f4-4d4f-bc8d-cda1fa386fa4" xlink:href="jnj-20200927.xsd#jnj_AssetWriteoffMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c67f4c15-ed8a-4156-b143-074a9402265b" xlink:to="loc_jnj_AssetWriteoffMember_2f58b2e3-48f4-4d4f-bc8d-cda1fa386fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_a1cc7a54-6ee2-4aaf-9433-e6d6db2ca778" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_c67f4c15-ed8a-4156-b143-074a9402265b" xlink:to="loc_us-gaap_OtherRestructuringMember_a1cc7a54-6ee2-4aaf-9433-e6d6db2ca778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_e11b4dad-9272-472e-9c2f-1316d870288c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_ee232807-7741-4265-a635-826e85154803" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_e11b4dad-9272-472e-9c2f-1316d870288c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_70a6bbdf-f013-40de-94bd-7bddfb81d4ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e11b4dad-9272-472e-9c2f-1316d870288c" xlink:to="loc_us-gaap_RestructuringReserveRollForward_70a6bbdf-f013-40de-94bd-7bddfb81d4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_74ae618b-aefa-4708-864d-97fddc57b042" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_70a6bbdf-f013-40de-94bd-7bddfb81d4ba" xlink:to="loc_us-gaap_RestructuringReserve_74ae618b-aefa-4708-864d-97fddc57b042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_8981926b-cf4d-4dcf-aabc-89e06194b4b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_70a6bbdf-f013-40de-94bd-7bddfb81d4ba" xlink:to="loc_us-gaap_RestructuringCharges_8981926b-cf4d-4dcf-aabc-89e06194b4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_4e19fcb1-114a-4c43-954b-51961d5672fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_70a6bbdf-f013-40de-94bd-7bddfb81d4ba" xlink:to="loc_us-gaap_PaymentsForRestructuring_4e19fcb1-114a-4c43-954b-51961d5672fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_84005d09-efa8-4907-837b-645c5475b053" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_70a6bbdf-f013-40de-94bd-7bddfb81d4ba" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_84005d09-efa8-4907-837b-645c5475b053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_4417caac-39fa-40a5-8628-801508d27a5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_70a6bbdf-f013-40de-94bd-7bddfb81d4ba" xlink:to="loc_us-gaap_RestructuringReserve_4417caac-39fa-40a5-8628-801508d27a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid_855ea31a-dc18-49bf-8e6f-4f89115e9407" xlink:href="jnj-20200927.xsd#jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_e11b4dad-9272-472e-9c2f-1316d870288c" xlink:to="loc_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid_855ea31a-dc18-49bf-8e6f-4f89115e9407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>jnj-20200927_g1.jpg
<TEXT>
begin 644 jnj-20200927_g1.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDOEPK,+I[R(09"Y61&?R\NJ 'U117YU>%_\ @NQX[\.?M(_LY_!O]IG]B_\
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M4]TW]BF27]G;2?B OAR75V\>!?%,UJ;B.V_M1-+-E]F\OSY4B\DWH?.3D 4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %><?'#]KO\ 9H_9OUC2?#/Q
MK^,NC:%K&NJ[Z)H4LS3:A?HGWY(;2$/-(B_Q.J%5XR1FO1Z_ O\ ;<_X**_'
M[_@B3_P<*_$K]J/]I;X#ZCXV^&GQ;\*:;I?AC5[5A'/;:/;PVQ:/399/W8>&
MX27SK0M&)&=969-Z.P!^W'PB_:B_9R^/S1Q_!+XW^&/%<DEK-<-!H.L17,D*
M12)%+YJ(Q:%DD=49'"L&RI&00.\KXJ_X)W_&#_@G1^W]^T5JW_!2S]AGXB:9
M<:_K/@-?#/Q,T 6/V/5/-6YAGLIK^W)#++&L=S")L.LJ% DC+#7C'Q!_X.-[
M75OV</C+^V5^RG^S9HGCCX;? KQI:Z!XP.O?$2;1]<OEGN(+=+ZTLETVXB^S
M/)-^[:6X21Q%(3&A4*P!^@GQV_::_9W_ &7O#EMXP_:0^-_A7P)I-Y<_9[75
M/%NN0:?;RS8SY:R3,JEL<XSFNB\!^/?!'Q2\%Z7\1_AKXNT[7_#^MV4=YH^M
M:1>)<6M[;R+N26*5"5D1@00P)!%?E1_P7W_:G^'/[<'_  ;4W_[6'PKL[R#0
MO&TWAK4;&UU*-5N+1O[8@CEADVDKOCD62,E202I()!KT#X ?\%)OA3_P33_X
M(6?LM^/_ !MX9OO$_B7Q?X"\-^'OA_X(TF=(KG7M4FM8PD7F."L$2\%YF!"@
MJ K,RJP!^EM%?('PJ_X*J0V7[;GBS_@GS^U_\+M*^'_C[0/A^GC71[_P]XJD
MUG2-;T<1EK@QRRV=K-'/ 5E!B,1WK"[JV!MKS']DG_@N%\1/VT/ACI'[2?P1
M_9(T35_AMJWQ>TSP3?FP^* F\2^&(+S5H+"/5=5TO[ (X(2DWG[([F5E4H3E
M#)+$ ?H5<7$%I;R7=S*J1Q(7D=C@*H&23^%>;_!C]LW]DC]HSQCJ_P //@'^
MTOX&\9Z_H$;/KNB^&?$]K>W>GJLGE,9XHG9XL2?(=P&&XZUZ77\_G_!*CXA?
M'_X=?\%]OV]+G]F;]G:W^(OB:X\1^(_(TO4O%L.AV,"KXB9B\]T\<K@L<*BQ
MPN69OF,:AI% /Z Z*^!OV _^"X@_X*%?LO\ Q6\??"3]E:_M?C'\&V=/%OP4
MU#Q0JS7$B^:56TO5MB)#)]GN(T5H4(FB\M]BLLIM?\$P?^"W6A_\%.OV5/BG
M^TWX.^"&F>#V^&-Q+%=>'->\>%Y95CL_M1N)Y4L<6MNR[U23;(2T$V54("P!
M]WU1\2^)O#?@SP_>>+/&'B"QTG2M.MVN-0U/4KM(+>UB49:221R%10.2Q( K
MDOV9/BAX_P#C;\!/"GQ?^)OPH'@?5_$VB6^IR^%&UC[=+IJ3QB2.&:7R8AYP
M1@'4+A6RH9L9/X??\'#?[3GQ&_;=_P""RGP;_P""+=IXLO=+^&'_  EOA>#Q
M[IMC=&(ZM=ZC<0RO)*5(WK!9RQF)#P)'=N3L*@'ZY:9_P5N_X)JZRCWNE_MF
M^")],CNS;2>(4U,_V0LH8+@ZAM^R@;B!GS<9.,U[1\._BY\+OB[;:E>_"OXA
MZ-XCM](U!;'4KG1-1CNHK>Y:V@NEB9XR5W&"YMY,9^[,A[U-X6^&?P[\$?#R
MR^$GA#P1I6G>%].TM=-L?#UI8HEG#9JGEBW6(#;Y>SY=N,$5X#^S+^RM^S-_
MP2%^#GQP\7^'=4L?"OPNU+QUJ7Q(N+%(2MOX;M3I&GQ7<"*N28Q+83RQH@^5
M9DB4':,@'TU17YQP?\' =KH/P'^%O[=7Q8_9=/AG]GGXN?$>7PCX?\8R^,A-
MK>F#S+F.WU._TT6@BAM9&LKDL([J1XT16Q(7"UZU^TK_ ,%7[+X?_P#!03P;
M_P $N_V:OA19>/?BYXFTF;5];.M>)FTG1_#.GI;R7 >ZN(K6ZE>9XXLK"D/2
M2(LRAQ0!]A45\8?L<_\ !:GX"_M%:%\==*^,OAM_AIXT_9JN]3C^+_ARXU,:
MC;VEM8M<+-?65RD<;7EMFVE&?*CD!"@H-Z%O!Q_P<9>/M0_8%\0?\%3_  ]^
MP<EQ\$]&\=?\([;"Z^)'D^(KF(RQP+J#6BZ>]M'&;B6.$Q_:F8$LV2% 8 _4
M>BOST_:]_P""Z_B/]CW_ ()R_#G_ (*.>-?V-?MV@?$36[:RL]!LOB5;27$5
MO=VLUW8WB30VLD4L<L,#EE)22,LBE6);9N_LX?\ !9+XL_M,_M<_#OX0^$/^
M"<WQ$L/A)X_\#RZ_#\==3>1=)A:.Q>Y8(HMMCVYE06R3/+&TK2QR)&8G1W /
MNZBORT\9_P#!RC%JO['WC?\ X*(_LV_LLZ5XS^#GP\^(4'A;Q$^J_$272_$;
MB62"..^33_[,FA2!S<PE ]UO8,=RQE6 ]D_;D_X+<^#_ -DS_@G/\//^"FOP
M_P#@/=>._ ?C_P#LTII\OB-=+U&P%];M-#N0V\\;E3&\<@#C:VW;O!)4 ^YZ
M\Q^,W[:O[(7[.GC'3/A[\??VG/ G@O7=:56T?2/%/BBUL;B^#.$!ACF=6DRQ
M"_*#R0.]?!_QJ_X.*?'G[,GA/X*?M*_M'?\ !/'6_"WP)^--O9'3_'G_  G=
MO=:GI;SVR7 DFTR.WYB,;/)'^^$DD,;.41_W-?,/_!XWXATUOBS^Q-XMTPOJ
M-H?$7B2[MVTU/.:ZB\_PXZ^4%_UA88V@=<C'6@#]W*\XD_:__9=B_:4C_8ZD
M^/'AA?BE+I1U*/P*=53^T6M@ADW^5G.?+!DV?>\L%\;?FKY!^%G_  7$\:3_
M /!5K2O^"6_[4?[$.I?"[5_&&AG5/ NMS>.+357N8OLT]Q&EY#;1^7;.Z6TZ
M$1SS!)8]F65A)7DEG\=/V+IO^#HVW^$'BO\ 8.-K\>!X=GAL?B_9?$*>XLVM
M!X>EN(YSI[01JMRUB#:,<G8&(#. &(!^L%%? 7Q^_P""W>IZ5XZ_:%\(_L:_
MLV6?Q1M/V6O#0U7XOZUJGC1](A6X!F,FFV"Q6-TUS/'':W9=Y/*16MG3+<&O
MI;_@GO\ MK^ /^"B?['O@K]L3X9^'-2T?2O&-G.XTG5E'GV=Q;W,MK<1%E^6
M15F@D"N,!U"MA<[0 7_CC^WA^Q7^S)X@B\*?M&?M6_#[P)J4Z%K>Q\7>++73
MY95"JQ*+.ZE@ Z$XSC</6L?P_P#\%,O^"=/BGQ)9^#= _;M^$-SJ^H[/[.TQ
M?B)IHN+O<<+Y49F#2$]@H.:_*[_@][MX&_9?^!MTT*F1/'NI(DA7E5-DI(!]
M"57\AZ5G_P#!P3^TE^P[\=O^"+OPK^ /@+XE>#OB#\8;D>%T\#^'?!^IV^K:
MQ83);1K=L8K9GEA0PB2(@@;G9%P2O !^Z-%?"W[%OQ\\6?\ !,;_ ((2^ /C
M;_P4SU35]/U?X??#^-_$EK>KYNIA7N733=.V.P)NO)DL[;8Y!5P0Y7:Q%?P-
M_P %H=?T/XG_ +.7A?\ :P_9FL_A_P"'_P!JK2&N?A5K>F^.#JLUG=LMM);6
M.J0-96XMI9X[RTVM$\P66;RSPC24 ?>-9?CCQOX/^&?@W5?B)\0O$]CHN@Z%
MI\U_K.KZG<K#;V5K$A>2:61B B*JEB3P *^(=*_X+0>(OC]^V[\6_P!BO]A?
M]FW3/'=U\#]#N[KQSXF\5>.GT2UN-0MY?)?2[)(K&[>63S@\1FD\N-6ADX90
MK/YA\._^"S'A7_@IY_P2P^/W[26M?L#_ &[X6^$_"6IVGB[P_J_Q/@CFU>"*
MT,M_:+]GMS-;2K:NDD;E5#EQMD5E) !^AWP"_:'^!_[4WPOL/C3^SM\4-'\8
M>%=3>5++7-#NQ-!(\;E)$R.5964@J0"/2NSK\OO^"9'_  41_P"">7[''_!"
M#_AMGX=_ 35?A;\+M UG4XX?!I\0-K6J:GJ9O/("K<2A#-//+M W;5C0<E8X
MR1V#?\%W=:^#-A^SW\2OVV_V7-/^'WP\_:6M(IO!7BG0O'[:O-H+3I;RVJZO
M;RV%J(%DANH9#)#),(_W@883<0#]$:*^!/\ @H7_ ,%R9?\ @GW^WU\-OV&M
M9_9!U?QQ<?%&/3G\-ZMX6\51"Z?[5>-9^2;.>W1/.$R,%4W 1E*%I(\L$7]B
MK_@MEXK_ &@/^"F7CW_@EI^TK^Q]<?"GX@>$M).IZ:\'C:'7+>^@\FWN DCQ
M01+%(UM=0S+M,BD;U)5E&\ ^^J*** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *^!]._;0_8P_:^^-?QT_P"";_\ P47T'PI-#X8^(TMA
MX0M_B+IL$&E^(+!K*WG1+.YF58VOK9YI5*HPG5/+D4GYRGWQ67K?@CP9XFT:
MX\.>(_".EZAIUY(9+NPOK".6&=R<EG1E*L2><D4 ?B?_ ,$J/^"=7@/]F/\
MX.&O'7BO_@FUXQO=8_9[\,_#V>#QCJ=KJ9OM.M=3NU4KX>BO02MY)%*D-S@L
M[Q*FR1MXR_R+\9_V\[/_ (*)_L6?MHQ^)?AGKW@'Q%I.J6.H>$O@C\-_ 5U8
M:38P)JD#ZAK7B&XL8%2[OTB@:-WU&0(C@F&+>5\O^G/0M T+POI,&@>&=%M-
M.L+9-EM96%LL,,2]<*B *H]@*DATK2[?[1]GTVW3[6Y>ZV0J/.8C!+X'S'
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M^V:XO[1M*N(V%T(E^9K>6TC2%F4?NC%N<A7RO[BT4 ? G_!1W_@H-^Q)\?\
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MZQJ 4B2^01W$,UG%*^7$45CB$,$1&"B@#EO^#IG3OV;?A/\ \$)O@?\  _\
M9T\=Z+J'A/3O'GA^T\ M8:[#>G4M*L]&U&$7,4L;$7*@-%OF7*EI5)(+C/ZD
M_L'>-?!G_#N3X3>+/AM-;Z]I.F?!_1?L4'AV9+@3?9],A4V\6PD%P4,>W.0P
MP<&N>_X)(?L&ZG_P37_8/\'_ +)6N^-X]?U'19K^\U&\M'D-K%/=W<MRT%MY
M@#F&,R[ S!2Y5I"J%RH^E* /Y9_C+^W%H_\ P4'_ ."6/[4WB;Q%X$U?PCXH
MTGQWI5YX:^#'PN\"7>G>%/#&EG4K%KC6-3FLH$M[N_E(E@>:_9I%,:F&- [;
M/H/_ (*%^._"WCO_ (,^_@;)X5U%[I-)U?PUI=](;66-5NH([E944NH$@5CM
M+)N7<K+G*L!_09'HNCPV]S:1:3;+%>.[W<2P*%G9QAV<8PQ;N3U[U\#_ /!Q
M7^P[^TY_P4 _8+TW]E#]D3X66NK:M/XRL=3N;B\UJTT^RT^TM8YAL)ED5F=F
ME0*J(5"JY9EPH8 _-;_@LG^T5\(/VOO^")W[%G["G[,WBBU\:_%Z]O?""-X
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7+ZO\
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M7^+7PND_X/4?B;XBC^(VAMI^H>%XM)L;]=4B,-Q?1^%]*A>U1]VUI5EAEC*
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M[_@V*_9=_8K^">HQ>)_BYJ'Q2M]$7X:Z3*LNMPW=K)K"SI+9@^;$$9X<EU4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^ :V*=)*M'$1ASZWY7"3MNUOV2OUN>T:SJ$NE:5<:C!IT]Y)#"SQVELH,DS
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M***\@]@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX8(8UCAAB0*D: 8"J!P  , "I***^,;;9]\DDK(**** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%?AQ^[!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(Z?&]98U8#1-/(##/(U6S(/X$ UT5I2A2E*.Z39RX>$*E>,);-I?>>Z?L/\
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M**Z:$5:CJU'-[MW.Q^$]WA[RP8]0LBC\P?YBNSKS/P+J@TOQ) [MA)OW3_\
M NGZXKTROG,UIN&*YNZ_X!];DM55,$H]8MK]0HHHKS3UPHHHH **** "BBB@
M HHHH **** "BBB@#\L/^#C3XB6=SXF^&'PFM;C_ $BSL-1U>]BS_!,\,,#?
MG!<"OS.KZ/\ ^"L7QTLOCY^W3XSU_1+[[1I6B3QZ%I<@;*E+1?+E*GH5:?SV
M!'4,#7SA7]K\"99+*.$<'AYJTN3F?DYMS:?IS6^1_#_'V:0SCC#&8F#O'GY5
MV:@E!->O+?YA1117UI\>%%%% !1110 4444 =E^SIH!\5_M!^!/"X3=_:7C+
M2[7;Z^9=Q)C]:_I.K^?;_@F-X*;Q_P#M]_"S0UB+_9_%,6I8 Z?8T>[S^'D9
M_"OZ":_FSQQQ"EFV$H?RPE+_ ,"E;_VT_IKP)P[CE&,K])5(Q_\  8W_ /;@
MHHHK\./W8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M \\^)EJ8/$GG[>)X%;/J1\O]!7/5W'Q6L=]C:ZBJ\QRF-C[,,C_T']:X>OK,
MOJ>TPD?+3[CX?-*7LL=-=]?O"BBBNP\\**** "BBB@ HHHH  2I#*<$="*]3
M\+:VFOZ-%?9'F ;)E]''7\^OXUY/>WMGIMJ]]J%W'!#$N9)9G"JH]R>!7.^"
M/VK/"VB^/X-!6%SHUV_E7>IRDJ(WY"N%(SL!QDG!P3QQSCB,IQ>9T)2H0<G#
M7_->O9;LZ\#F^%RO$J->:BIZ?Y/T75[(^BZ*165U#HP((R"#P12U\:?>A111
M0 4444 %%%% !1110 4444 %>&_\%%/VI]._9&_95\1_$A-26'7;RV;3/"D6
M?GDU&9&$; =Q& TQ]HB.I%>W7EY::=:2ZAJ%U'!;P1M)//,X5(T499F8\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC\W\7^),?!T\)&-!/JO>E]\M/NBGYG7_ !>^.WQ3^.NN#7OB9XKGOWCR+:V
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M<?=)*CSZO3IU(U8\T3S*E.5*7+(***^M_P#@DG^P)=_M@_&E/&_CK2F/P_\
M"%U'/K32I\FIW(PT=BI[@\-)CI'QP9%->?G&;8+(\MJ8[%2M""N^[[)>;>B\
MST,FRC&Y]F=+ X2-YS=EV7=OR2U?D?<?_!$3]B&7X!?!>3]H;Q_I1B\5>/+-
M&L89DP]AI&0\2>S3$+*W^R(1P0U?<U)'&D2"*) JJ %51@ >E+7\39]G6+XA
MS:KC\0_>F]NB6RBO)+3\=S^Y.'\DPG#N44LOPR]V"M?JWNY/S;N_+;8****\
M<]D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M."BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1%YY&=HY'+C<=A,NPTL1B9J$([MZ+_A^RW>R.O X'&9EBHX;"P<YRT22N_\
MAN[>BW9S'PP^%GCGXQ>+[;P/\/M"EO[^X.2%X2%.\DC=$0=R?8#)(!_2[]E3
M]E?PC^S-X+%A:"*]U^^C4ZUK.SF5NOE1YY6)3T'4GYCSP-SX"_L]?#G]G?P@
MOA;P)IO[V4*VHZI. ;B]D ^\[>@R<*/E7)P,DD]S7\S\<^(&(XDD\)A+PPR?
MSG;K+LNT?F];6_I_@/P[PW#,5C,7:>):^4+](]WWE\EI=LHHHK\U/TX****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *J:[H.B^)]*FT/Q!ID-Y:7"[9K>= RL/Z'T/4'I5N
MBJC*4)*479HF48SBXR5T^A\1?M9?\$Y/&LNIW7Q$^"FHR:Q;LN9/#URP%Q;H
MHX6!N!*H'\)P_N[$FOC[4=.U#2+Z;2]6L9K6YMY#'/;W$122-P<%65L$$>AK
M]GJ\U^._[)WP8_:&MS-XW\.^3JBQ[8-<TYA%=(,< M@B0#LKA@.V*_8N%/%;
M$8"$<+FL>>FM%./Q)>:T4EYZ/_$S\8XM\)<-F$Y8O*)>SJ/5PDWRM^3U<7Y:
MK_"C\I:*^B?CM_P3=^-7PM$VM>!%'B[2$RQ;3X2MY$O^U!DEOK&6/? KYYN+
M>XM)WM;J!XI8V*R1R*596'!!!Z&OW3*LZRK.\/[; U54CY;KU3U3]4C\%S;)
M,VR/$>QQU&5.72ZT?HUHUZ-C****]0\H**** . _:&^$GC+XM>&]'C^'7Q+_
M .$3U[P]XB@UC2M5;3!>1F2..6-H98MZ;HY$F=&PP.":\,UC]A;XJ?M"^,_$
MEE^U#XCT./PG<_$73_$DNF>'-,=3KTMOHME9J/,EG=K6WW12H\94R,0Q#JI4
MGZRHKQ\=D>7YC4YJZ;5TVN9\LK)I7C>VSUM:^B=UH>S@,^S'+:7)AVD[-*7*
MN:-VF[2M?=:7O;5QL]3QG]MS]EGQ5^V!\'KCX*:?\4['PQI=[=6\U[._AI[Z
M=S#)YBJI%U"J@L%SE3T/KQ'\/OV7?B/X$_9"/[+=M\?9+>\M- .EZ'XRT#0W
ML+NR4%MDFW[3)N8 J,HT9P"002"/:J*TGDN75,=/&.+]I.'(WS2^#M;FLN]T
MDT]4R(9WF5/ 0P<9+V4)^T2Y8?'WORW>BLTVTUHT?..@?LI?M/\ C#X*S_LZ
M_M*?M):3XF\-W2);ZEJMAX<EAUF_M%<,8'N'N#&NX*%:7RGD*EOFW'>'?MK?
ML(:O^TWX%\#> ?A;\8+GX?6'@J]4V]IIUL[0M L<<<6U4D0J\*Q_NSG WMTS
MFOHRBN>IP[E5;!SPU6,I1DE%MSDY.,7=+FOS63UWUZW-Z?$F;4<9#$TI1C*,
MI224(**E)6;Y;<MVM-5ITL<5\>?ASXO^)?P&\2?"GP1XO32]4US0I=,AUJ]B
M,GDK*GER2$(02^PO@C&&(/:M;X4_#S1OA)\,?#WPN\.J!8^'M&MM.MCMP76&
M)4#'W.W)]236_17J+"T%BOK%O?Y>6_E>_P">_>R[(\MXNN\+]6O[G,Y6MU:2
MW]-ETN[;L***ELK*\U*[CL-.M)9YYG"10PQEG=CT  Y)]A6[:2NSG2;=D15/
MINF:EK-_#I6CZ?/=W5Q($@MK:(R22,>BJJ@DD^@KZ#^"/_!-?XX?$OR=6\=J
MGA'2WPQ.H1E[QU_V8 05_P"VA4CT-?:GP(_98^#O[/6GJG@;PXLFHM'MN=;O
M\27<WJ-^ $4_W4"CU!/-?G7$?B7D&21=/#R]O5[1?NK_ !2U7R5WWL?I'#7A
MAQ!GDE4Q$?84>\E[S7]V&C^;LNUSY=_9B_X)EZ[KTT'C']H=)-.L!AX?#D$N
M+B?O^^=?]4O^R#O]2A%?;7AOPUX?\'Z);>&O"NBVVGZ?:1A+:SM(1''&OH /
MS]SS5ZBOY\XBXISCB;$>TQD_=7PP6D8^B[^;N_.Q_1?#G"F3<+X;V>"A[S^*
M;UE+U?;R5EY7"BBBOG#Z0**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *XGXJ_LZ?!7XU0,OQ&^'UA?3E=JZ@L?E72>F)H\/@>A)'M7;45T8;%XK!5E
M5P\W"2V<6T_O1SXK"87&T71Q%-3@]U))K[GH?%OQ5_X)-,TLE_\ !;XCJJG)
M73?$2'CV$\2\^@!C^IKY_P#B)^Q=^TO\,M\VN_"R_NK9,G[9HZB\CV_WCY6Y
MD'^\!7ZI45^BY5XK\3X!*&(Y:T5_,K2_\"C;[VF?FV;>$G"V8-SPZE0D_P"5
MWC_X#*_W)H_%V:&:WE:"XB9'1BKHZX*D=00>E-K]B/%?PR^''CI&3QKX!T;5
M@PP3J6F13'\W4D5YCXL_X)\?LI>*RTP^'!TR9NLNDZA-#CZ)N*#_ +YK[S!>
M,N45++%8:<'_ '6I+\>5_@? 8WP5SBE=X3$PFO[RE!_AS+\3\Q:*_0/6/^"4
M/P%N\OHWC7Q59L?X9+FWE0?AY(/ZUS5Y_P $B= >8MI_QSO(H^RS: DC?F)E
M_E7T%'Q2X-JKWJTH^L)?^VIGSU;PHXTI/W:,9>DX_P#MS1\0T5]K3?\ !(2V
M8#[/^T!(I[[_  L&_E<BK6F_\$BO#<6/[8^.%]/Z_9M#2+_T*5ZVEXG<%*-U
MB;_]N5/_ )$QCX6\<.5GA4O/VE/_ .3/A^BOT"TG_@E!\!K619-7\;>*KO:>
M8TN;>)6^N(2?R(KN_"__  3]_90\+E9%^&"W\J_\M=4U">;/U0OL_P#':\O$
M^+G"M%?NU4F_**7_ *4T>IA?![BRN_WKITUYR;_])3_,_,:UM;J^N$M+*VDF
MED;;'%$A9F/H .37I_@#]BO]IOXC>7+HOPGU&UMWP?M6L 6:!?[P\XJS#_=!
MK]-?"'PS^'/P_C,7@7P'H^CAAAO[,TV* L/<HH)_&MRODLQ\9L5-..!PJCYS
M;E^"Y?S9]AEO@IA(6EC\4Y>4$H_^32YO_24?&7PJ_P""3=I%Y>H?&CXCM*>"
M^F>'H]JY]#/*N2/4!![&OI?X4?LY_!7X)Q#_ (5OX LK&XV;7U!E,MRX[@RR
M$O@^@('M7;45^:YQQ?Q%GMXXO$2<7]E>['_P%63^=V?IN3<'<-Y!:6#P\5-?
M:?O2_P# G=KY604445\V?3!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO^!_"?[2-WX*\&?$KQEK>E>.;5M/TAH98+31KB^A99[VUD>!C-"L9(< JY
M;!K,\>?M3?$G7O\ @L/\*?V;_A+^U+]I^'GB7X7Z]X@\1^&]$@T:\B-Y83VD
M4*?:#:R7$:.L[LZ^:"2HVE0"* /M2BO';_\ ;T_9CTKXB^'_ (;ZIXSO[:;Q
M9X@N] \+:U/X<OETG5M7MA*9=.M[_P G[/)<#R)PJ!_WC0R)&7=&4<5%_P %
M>?V"Y+73M8D^*>M0:1J'CF;P=+XAO? 6LV^FZ9K<5RUJ;*_NI;18M/D,ZF-1
M<M&22#]U@Q /I>BOGC4/V_?V9/BC\+/C'#HOQ0\9^#[GX8Z S^-[NZ^'>JV6
MM>&[6YMIGM]6AL;RQ,TT6R.6:.4021G[.Y8%585IZ%^V5\!_AQ\%_"&IZO\
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ML-1NHH 0B23V\<K!<\X!8X]J\E^*'_!+W]BOXN>)=8\3>*/AA?6O_"1?#Q/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
4B@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>jnj-20200927_g10.jpg
<TEXT>
begin 644 jnj-20200927_g10.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *^-/VOO^2]:O_UPM?\ T0E?9=?&G[7W_)>M7_ZX6O\
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M#;4EA>9R9XP>[Y+'"X3<&'N/[ 7[96L_M<> =>L?B5\-Y?!OQ"\!ZZ^A>/\
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MOB%^US^Q)X5^+WQ9BB_X2;S;O3=;N8(5C2[FM;AX?/"K\JEU52P4!=^[: ,
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M1117S)].%%%% !1110 4444 %?G=J7_(1N/^N[_S-?HC7YW:E_R$;C_KN_\
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M1110!])_L"_\@[Q/_P!=[3^4M?0M?/7[ O\ R#O$_P#UWM/Y2U]"U^$\8?\
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M\A&X_P"N[_S-?HC7YW:E_P A&X_Z[O\ S-?IGAS\>)_[<_\ ;C\N\2OAPO\
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M(W'_ %W?^9K]$:_.[4O^0C<?]=W_ )FOTSPY^/$_]N?^W'Y=XE?#A?\ M_\
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MV./V?-;^#F@>*/B'\1H;<>.OB9XHG\2>,%M9?,BLI) $M]/B?^..V@5(@_\
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M70/#NI^.M)T#XC_#235)KK3M5L[ZZ2V6:%9F9UG1Y!MR6P7!7:%9'^H/B_\
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M_P#D=3_Z]O\ ]*B?!^(?_(CA_P!?%_Z3(\RHHHK]C/Q<**** "BBB@ HHHH
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M%%%?J!^6!1110 4444 %%%% !1110 4444 %%%% !1110!]L_LM_\D%\/?\
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MLM_\D%\/?]<)O_1\E=_7 ?LM_P#)!?#W_7";_P!'R5W]?SKG'_(WQ'_7R?\
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M)ZV_^(H \L_X>D?\$^?^CK/"O_@1)_\ $5\S?M'?MC?LK^/?BYJ/B?PG\?\
MPK=V,\4 BG_M>./<5B13\KD$<@CI7W9_PHSX)?\ 1'?"O_A/6W_Q%'_"C/@E
M_P!$=\*_^$];?_$5ZN3YQB<DQ3KT$FVG'WKM6;3Z-=CR<YR;"YYA5AZ[:BFI
M>[9.Z375/N?FU_PTK^SU_P!%M\*_^#V#_P"*H_X:5_9Z_P"BV^%?_![!_P#%
M5^DO_"C/@E_T1WPK_P"$];?_ !%'_"C/@E_T1WPK_P"$];?_ !%?3?\ $0<Z
M_P"?=/[I?_)GR_\ Q#K)/^?E3[X__('YM?\ #2O[/7_1;?"O_@]@_P#BJ/\
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MO^BV^%?_  >P?_%5^DO_  HSX)?]$=\*_P#A/6W_ ,11_P *,^"7_1'?"O\
MX3UM_P#$4?\ $0<Z_P"?=/[I?_)A_P 0ZR3_ )^5/OC_ /('YM?\-*_L]?\
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M=<=:]E_X>D?\$^?^CK/"O_@1)_\ $5ZG_P *,^"7_1'?"O\ X3UM_P#$4?\
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M/_R!^;7_  TK^SU_T6WPK_X/8/\ XJC_ (:5_9Z_Z+;X5_\ ![!_\57Z2_\
M"C/@E_T1WPK_ .$];?\ Q%'_  HSX)?]$=\*_P#A/6W_ ,11_P 1!SK_ )]T
M_NE_\F'_ !#K)/\ GY4^^/\ \@?FU_PTK^SU_P!%M\*_^#V#_P"*H_X:5_9Z
M_P"BV^%?_![!_P#%5^DO_"C/@E_T1WPK_P"$];?_ !%'_"C/@E_T1WPK_P"$
M];?_ !%'_$0<Z_Y]T_NE_P#)A_Q#K)/^?E3[X_\ R!^;7_#2O[/7_1;?"O\
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MV4LC7DGD&4JDJ6\:HQ=B@]/_ ."T?[0NB_M*_LC^(O\ @G=^Q7KVD_$?XO\
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MC&WPW\1_9SM_M+0M:\B.6"8#_6I%(BSQJV0L@W#!YK&_X*<7$?[2_@']D?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
910 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>jnj-20200927_g11.jpg
<TEXT>
begin 644 jnj-20200927_g11.jpg
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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MS 'W_4&GZIIFK1//I6HP7*13R02/;S*X26-BCH2#PRL"I'4$$'D5^=/[>O\
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M1U6)E#(%(!H ^??V$?B[_P $^OV_/^"8GP2_:K^.7A[X<>(+7X:^%]-:\O\
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MV5/#EAKMG-J%C;FXO;**Y5I8(IM5M1%(Z@Y57\J3:3PWEMCH:[W_ (/@O^2
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M=>*-1M]/AT_2O&TM]/>7"QQV\<7BRS,CNS$!54 DL3@#DFOUU_9#_P""-_\
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M_P"">\/_  4Z_8%\9?LHV6OV^D:[?BWU'PEJUX&,-KJEK()8?-V@D1R /"[
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MWX$2_#>\O=?^'!TGPK?ZY;W^H06/_"5S;'O6MBT$4[2><?*BDE54\O+[RZ(
M>B?\'DFI:M\+_P!I_P#9^\6?#76[_P /ZCXDTO5$\07>B7\MJVHBWN;%8#-Y
M; 2%%E=0S9(4[<X  /\ @Z\U'5OAC_P4Z_9TUSX<:YJ&@7/BBPMF\1R:-?RV
MPU-H=4BBB>=8V E=8R(]S ML55SA5 ^BO^#K3_@EE^UW^W;HGP?^.?['WPV;
MQGJ?PYN-4MM?\-6EU&EW);W36DD,\*2.HE5'MG5U4E_WJ$*0K$>'_P#!8O\
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M_P!B;X6R_"_X+Z3='^T=6N-8\3^(=8N?M.J>(]6N&WW.HW]P0#/<2MR6P%4
M*BJBJH]3HH **** "BBB@ HHHH **** "BBB@ KY _X+\?\ *&S]H3_LG\W_
M *.BKZ_KY _X+\?\H;/VA/\ LG\W_HZ*@#^,*BBB@#]_O^#3;_E*9^UW_P!O
M'_I\GK]_J_ '_@TV_P"4IG[7?_;Q_P"GR>OW^H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** /"?^"@W[4?B;]F7X+65O\)]2\(Q_$KQYK]OX8^&4'CK46M=).JSJ\AN+
MQT.\6UO;Q3W,@3YW$/EIEY$!Y3]A;3?^"R,/CW5KS_@I#XJ_9SN/"W]C@:!:
M_!>TULWKWQE0[YY-1VHL*QAQM169F<'*A<-U_P"V[_P3<_8O_P""C/AK2_"O
M[8OP8B\7VVA"Y.AL^KWEI)I[SA!+)$UM-&0Y\J/DY^[CH2#\G?\ !+;X2?&W
M_@FS_P %&?'G_!*;_A;FO^.O@I<?"B#XB_"2Y\477VB]\+1#4AI\^D&7 RA=
MC(J@! L0955GER ?I'7R+\'?VU?C%_P4(^+'BG2/V)KS1_#_ ,'_  +KDVAZ
MW\8M9TPZA-XGU:''VBUT*V\Q(A! 2%>_G\V-W)2*!P#*.M_X*]_$?QS\(_\
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ME,_:[_[>/_3Y/7[_ %?@#_P:;?\ *4S]KO\ [>/_ $^3U^_U !1110 4444
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MF-I[FZF:221M[\LS$DGZU[C7@_\ P3!_Y,!^%?\ V*T?_HQZ]XK^/C^RPKY
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M=%7U_7R!_P %^/\ E#9^T)_V3^;_ -'14 ?QA4444 ?O]_P:;?\ *4S]KO\
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MCTG2H=5FUV'3+=+ZYMXH+B\6%1++%&TC1QL^,LJM+*54G ,CD8W'(!8HHHH
M*XKXU?M%_!#]G32[+6OC?\2=-\-VNI7#06,^HNRK-(J[BHP#R!S7:U^;_P#P
M<@$CX%_#P@X/_"37?(_Z]A77@,*\=CJ6&3MSRC&_;F:5_P 3DQ^*6!P-7$M7
MY(RE;ORINWX'U/\ \//_ -@'_HZ?PO\ ]_Y/_B*/^'G_ .P#_P!'3^%_^_\
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M[ZH\Z7_GJW_?5'_$%L5_T&K_ , ?_P D'_$;L+_T!2_\#7_R)_13_P //_V
M?^CI_"__ '_D_P#B*/\ AY_^P#_T=/X7_P"_\G_Q%?SK>=+_ ,]6_P"^J/.E
M_P">K?\ ?5'_ !!;%?\ 0:O_  !__)!_Q&["_P#0%+_P-?\ R)_13_P\_P#V
M ?\ HZ?PO_W_ )/_ (BO4_A-\8_AA\=O!Z>/_A#XTLM?T:2XD@34;!B8S(AP
MR\@<@U_,'YTO_/5O^^J_=?\ X(/<_P#!/S3"?^AFU+_T-:^+XQX'J\(4Z,YU
MU4]HY+2-K<MO-]S[;@OCNEQC5K0A0=/V:B]9<U^:_DNQ]ET445\(??'Y%_\
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M'#W_  3\_P"A8\3?^%(__P 37[C_ ,1IPO\ T!/_ ,#7_P B?@__ !!'%?\
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M<5_T&Q_\ ?\ \D?A-17[L_\ #A[_ ()^?]"QXF_\*1__ (FC_AP]_P $_/\
MH6/$W_A2/_\ $T?\1IPO_0$__ U_\B'_ !!'%?\ 0;'_ , ?_P D?A-7[L_\
M$'O^4?>F?]C-J7_H:T?\.'O^"?G_ $+'B;_PI'_^)KZ,_9J_9J^%_P"R?\+X
MOA#\(;2\AT:&\FNHX[^\,\GF2D%OF('&1TKX3CCCBEQ?2H0A0=/V;D]97OS6
M\EV/ON!.!*O!U:O.==5/:**TCRVY;^;[G?T445^>GZ,?D7_P<D_\E=^'/_8L
M77_I2*_,^OZ,OVL?^">7[-W[:/B#2?$WQQTK5KBZT6R>UL3IVJM;J(W?><@
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M!/\ \#7_ ,B'_$$<5_T&Q_\  '_\D?A-17[L_P##A[_@GY_T+'B;_P *1_\
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MUA\'S? ;7KGX<?;OEMW\63W4\=T8RWRFX&GV\<:_Q 7!4?ZS! /N/X)?M%_
MS]I#0KWQ%\#/BEH_B:VTN_:QU==-N@TVG7:C+6]S"<26\H!!\N15;!!Q@@UO
M^-_'7@[X:^%[OQMX_P#$UEH^D6$>^]U+4;@10P+D#<[MPHR1R:_.OXF^+9O@
M;_P=$?#;PS\,9C;6_P ;?V?;V+XF:9:N!%=RZ:][-8ZA,@ZS*L MUD/(C)4<
M%L_I30!Q/P(_:4_9Y_:C\)W/CS]FWXX>%/'NB6=^UC=ZMX0U^WU&WANE1':%
MY('95D"21L5)SAU/0BNB\;>-_!WPU\':I\0_B'XJT_0]!T.PEOM9UG5KQ+>U
ML;:)"\DTLKD+&BJ"Q9B  "37X?\ _!&[5+__ ();?M[> /!.KWTEO\(?VT_"
MEQ<:"TS$6^E^---NYXC;J2<+YT94 #EGO8$'$0K[1_X+X:UJ_P ;/V<_%O[$
MW@_4IX+?_A4GB7XB_$RZM)2CVVAZ/9326%H6&-IO=66U7&?GM[&^7!&< 'V;
M\#_VDOV?_P!ICP[)XP_9X^,_AGQOI,3!9-4\+:S#?6P)9UQYD+,I.Z-QP>JD
M=J[:OSS_ ."/G[1_P@_8[_X-W?A1^TI\<O$ TCPGX0^'EQ?ZO=)%O=LZA<*D
M4:#'F2RRND:)U:211WKT?X[?\%1_B5^QWX3\(?';]M#]D&7P3\)_%FK6>G7_
M (MTSQLNJ:AX/ENR!;OK=@+2)+:/<0DCVUS=B-_E^8E=P!]BT5\D?M'?\%5E
M_9__ &YO 7[#]K^R7XX\4:A\1/#>IZMX:U_1;_3WAU3[);M*(;6-9F.6<(CR
MW1M8HE<R,YC4M1^R=_P4S^(_Q]^/'Q:_9"^+/['FH_#GXN_##0;36[3PE<^-
M+34[37]/ND)MYH;^&-8XR7V(X*L(S(.6*NJ@'T]\0OB)X#^$W@O4?B/\3_&.
MF^'] TBW,^IZQK%ZEO;6L>0-SR.0JY) '/)( Y(K _9O_:2^"/[77P;TK]H+
M]G/Q[!XH\&ZY->1:1KMK;311W36MW-:3E5F1'*K/!*@;;M8+N4LI5C\1?\$9
MOVT?VS/VR/ /QL\;?M"_"'2HM/?XO^*-.N-6L?&'G0Z*UE:VEK%I5O:-"&DB
M18AF?<HD=WD* N:^:_\ @D+_ ,%%/B_^PU_P;W_"OXM^!OV&?%'Q)\&^!;7Q
M'>_$/Q);^);328]-M#XFU-Y'LXK@-+J+11.))/+58ESM\TNDJ1@'[4T5\^?$
M?_@H!X/L)?@EX9^"?A^S\3^(_P!H/3Y]2^'%GKFN'2+*73X-.34)[FXN!!<2
M1X@EA"QQPRNSR@;0JNZ==^S)\>_B7\9M1\>>%?BY\##X%USP%XL31+BWA\0#
M4[35$?3[2]2]M9Q#"7@9;H(-\:.&B<,J,"H /5:*** "BBB@ HHHH XGXS?M
M'? W]GJVTZ?XR_$S3-"DUF:2'1K*XD+W>HO&N^1;>WC#2SE$^9O+5MJ\G YK
M0^$/QG^$OQ_\!VGQ0^"/Q'T;Q7X>OF=;76-!U".Y@=T8J\99"=KHP*LAPRL"
M& ((KX._9T^+UQJ__!RM^T5\+_C#=JFHZ7\%/#$/P=BOOE+:*4BN=4^R[NN^
M^G^?;RWV89R(N,W]ACQ;-\+/^#B?]K;]ESX=S&+P5XD\"Z#X]U/1[=Q]FL/$
M+164%Q,B#B.6Y6X,LIZNR*3]U< 'Z!?%SXU?"+X!>#IOB'\;OB5HGA/0;<XN
M=:\0ZC':6L/!/SRR$*HP"<DCI3_A'\8_A+\?OA_8_%?X'?$O0O&'AC5#*-.\
M0>&M5BO;.Y,<C12!)H69&VR(Z'!X92#R*Y#]NBTMK_\ 8E^,5C>P)+#-\*_$
M,<L4BY5U.FW (([@@U^:7_! O7M9_P""=G[7GBS_ ())_$#59_\ A%/B%X-T
MWXL_ :YO9"1+;W=I&=2T]&8DL8W1MJ^EE<2'F2@#]6OB_P#&CX1?L^_#^]^*
M_P =?B=H/@[PQIK1+J'B#Q-JT5E9VYDD6*,/-,RHI:1T0 GEF ')IWPI^,/P
MK^.G@Z#XA?!GXAZ/XIT&ZQ]EUG0K]+JUFRBN"DD9*N"KJP()!# U^4'_  =*
M:SK'[1/[*GQ6^&7A_4IX_"GP"\,:+XF\7R6TI5;SQ+JNJ6MGIE@^,;A!I\M_
M=R(<_-=V#<<5]O>'_P!K;X9?L6_\$U_@M\1/'FGWVHW.L>$?"'AOP;X6T1(S
M?>(-;OK.WAL].M5D9$\R1LG+,JHB.[$!30!]2T5\H>-?^"E'C#]FG]H;X<?
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M_@TV_P"4IG[7?_;Q_P"GR>OW^K\ ?^#3;_E*9^UW_P!O'_I\GK]_J "BBB@
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M-$\96=TNE1.6"R7!CD/DJ2C?,V!\I]*^-/\ @KXJI_P6B_X)N(B@ >+_ !V
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MIL%Y:7,9CN;6ZA62.5",%65@0P/H: /R0_;8_P""<?[&W[6%])_P3N_X)B?
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-Y>@]: /PMHHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>jnj-20200927_g12.jpg
<TEXT>
begin 644 jnj-20200927_g12.jpg
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M5^(/_![S_P FL_ __LH&H_\ I"* //\ _@TV_P"4IG[7?_;Q_P"GR>OW^K\
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MBO88H3]HA:,K-$T2A=\;(\BOD?L#^W!_P58\ ?\ !.7P%\!_AB? T'BKQ_\
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M[T]+6=+>X$RW=O%L>.:1(V0G>&.,<''T!7\W?_!.#XU>)?@#_P '.O[6^O\
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M\$A4[9%*R(Z2+PRN,A6#HH!]$T444 %%%% !1110 4444 %?B#_P>\_\FL_
M_P#[*!J/_I"*_;ZOQ!_X/>?^36?@?_V4#4?_ $A% 'G_ /P:;?\ *4S]KO\
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M^":_B*[\<_LP_!:2W\2W=O);-XF\0:O/J-[!;N07A@:9BMNK8&[RE4O@!RP
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M_:%_90_X)O\ Q _:M_9E^,-SX4\4^ K2UO+6/^Q;"^M-066_M;=X[B.[@D;
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M^T+\9-8AU#Q3XO\  MGJ6NWL%G';I-<R*2S".,!$!]% % 'OU%%% !17PO\
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M?2JKF-+G=BXCA:&0;C;UM?\ !>'1O$.B_P#!RK^SW\*/A)\1=?\  =MX_O/
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M_P""[W[8WQ)_:$_X+-?LY_\ !(BQ\37]A\)M8\3>&+OXF:3IU[);?\)0M_J
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M5RL$.JVUS&B7=CYKD+#(_DV[H[D)N@"L5#ET^</^"E_[$G[=O_!;KP;^S/\
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M %%%% !1110 5^(/_![S_P FL_ __LH&H_\ I"*_;ZOQ!_X/>?\ DUGX'_\
M90-1_P#2$4 >?_\ !IM_RE,_:[_[>/\ T^3U^_U?@#_P:;?\I3/VN_\ MX_]
M/D]?O]0 4444 %%%% !1110 4444 %%%% !1110 445!'J>FRZE+H\6H0-=P
M01S3VJR@R1QR%U1V7.0K&.0 G@F-@/NG !/1110 45\T^/O^"O'[ ?PK\/\
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M K\0?^#WG_DUGX'_ /90-1_](17[?5^(/_![S_R:S\#_ /LH&H_^D(H \_\
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M#OB$2L+6>Z:U<O9BV,IE22.3$49D,B[-IW,47\__ /@LY_RMG?LN?]A#X?\
M_I^N*/\ @Z*_Y3E_LE?]@_P]_P"I--0!]Q#_ (.(-4^'G_!3'P3_ ,$\?VL/
M^"?/B_X3I\2WL!X%\3Z[XPLKR[N4OYWMK"2YL+5'2U66XC:%E^TR/$X(=!AL
M?1?_  4*_P""H_PQ_81\7_#GX%:?X(O/'?Q:^+WB"'2/AW\/M,OTM3<N\R1&
MZN[EU<6=JKR*#+L=B=VU&"2%/R2_X.(?^5G']C[_ +!_P^_]334JH?\ !P]X
MOU?X _\ !QO^SW\>?BQX[U[PGX)7PYX>2V\8Z(8A-I%FNIWL5[+"T\4L7F0^
M>TS*8W^613M^9: /UH_9@_X*FZ?\5/VYO&__  35_:*^$5M\._C%X/TB'6;*
MPTKQ2=:T?Q#I<D44GGV5Z]K:2-(BS)OADMXV&&*EPCE?(?A!_P %WO&?[5'@
M;XO_ +0/[&G[%"?$CX8?![6[O3=3OK/XFPVOB;6%@M_/:\LM&:R97M77)C:2
M[264*X2)Y$:(=?X+_P""8/[%W@7_ (*&_#C_ (*#>(_VJ?B/XU^+^K:==6?@
MN]UOQ'87-OK-B-+N$D)AL;&)'MTMIF8395 [P#>6>-6_&_\ ;$_X)[?M/?\
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MZ+088K&YNHK[2[IAO2QN%M98&@(4+(P^6-UD5OU;_9#_ ."R'_!/+]NGX_\
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M2V@GOOBOKL%E#-.JO<2B&"4H@)R["-'<@9.U&/0$T ?JO1110 4444 %%%%
M!7X@_P#![S_R:S\#_P#LH&H_^D(K]OJ_$'_@]Y_Y-9^!_P#V4#4?_2$4 >?_
M /!IM_RE,_:[_P"WC_T^3U^_U?@#_P &FW_*4S]KO_MX_P#3Y/7[_4 %%%%
M!1110 4444 ?-W[<_P#P2/\ ^"?W_!2'Q/X:\9_MA? 6+Q1JOA2-H-)OX=:O
M;"4VS/O:VE>TFC,L6_+!6)VEF*E=[;N3\=?\$&O^"37Q"^*G@[XP:U^QQX?M
M=4\"Z=;V&@VFC75S86'V>!F>%)[2WE2"YVL[$F1&,FXB0N.*^O:* /G;XI?\
M$O/V7?B;\;/$/[2MC=>._!WQ#\4V5O8:YXP^'WQ%U31;JZLH;>.".T=+:=87
MB58U(W1EE;YE93@A]K_P2J_8.L/V)Y/^">.G_ BVM_A)<WEK=ZCX:@U.Z1[^
M>"^@OA+/="3[1+(\]O$7<R;F5=F=N /H:B@#YP^%W_!*W]D[X9?'3P]^T9=Q
M>-/&/BKP5ITUAX!O?B+X_P!2U]?"UM*NV1+%;V:01LR@*96WR[0%WXXK'_X*
M!?\ !&'_ ()Z?\%--<TWQE^U5\%FOO$FDV@M++Q3HFJS:??BU#,PMY)(6 FC
M#,Q59%;86;;MW-GZGHH \H_8]_8B_9E_8,^%I^$'[+WPTA\/:5-=?:M1FDNY
MKN\U*YV*GGW-S.SRSOM55&YB%50JA5  \M^!'_!%/_@FE^S1^T;J/[4WP3_9
MLMM#\5:C??;FC@UR^?3;>ZRS":'3WF-K&ZL[,A$?[HDF+RZ^J:* /DOQA_P1
M2_89\6IXWT^WL?B!H>D_$_Q%?ZU\3O#GAOXI:S8Z9XKN;RYDN+C[7:QW(BVL
MTA0^4L9,86,DHH6O3_#?[!/[,W@WXV> ?CIX1\$-IE_\+O -QX/\ :/8S^7I
MFBZ;.T1E\FW PLK)#'&9,YV#'?->RT4 >9_M9?LA? +]M[X3CX&?M+>"_P#A
M(O"C:U9:G=:,UW)#'=2VLPFB20QLK-'O4;DR PX.02#X?X@_X(<_\$^?$OAL
M?"R_\%>*HOAF/$)UP?!RS\>ZE!X2%^9/-,BZ;',(TC\TF3[.I6#>Q/E\U]>4
M4 <_K?PH^&?B+X6W7P0UGP'I,W@^]T%]$N?#/V%%L7TYX3 UIY*@*(O*.S8
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M"[1-6U#QCX]O(KGQMX[\6Z]<:KK6M/$NR)9KJX9F$<:X5(DVQJ!PN>:]HHH
M^&_CW_P;F?\ !)G]HK]H2Z_:9\;?L]WNG^)=3U!K[7!X7\57VEVNIW+DF266
M*WE4([DDNT/EER69B69B?=/C7_P3B_8W^/WP0\$_LW^/O@]'!X)^'.M6NK>"
MM"\-ZK=Z.ND7EM:W%K;S026,L4L;1)=2LI5P0^U_O*#7N%% '@W[/O\ P3A_
M9J_9W^-^J?M-:1#XH\5?$C5=%31I/'7Q"\77FN:G;:6C;UL8);IV\B'=\Q"
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M8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_$'_@]
MY_Y-9^!__90-1_\ 2$5^WU?B#_P>\_\ )K/P/_[*!J/_ *0B@#S_ /X--O\
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M"(F&T#YA]&T %%%% !1110 4444 %%%% !7X@_\ ![S_ ,FL_ __ +*!J/\
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M=_BC%\6?^"E3?M$7-YX3\+/:--I&G6,GA]%N=<!!BTX"#;.3PW^L)MV#<!*
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M_P#!!;?_ !%=110!R_\ PI#X+?\ 1(?"_P#X(+;_ .(H_P"%(?!;_HD/A?\
M\$%M_P#$5U%% '+_ /"D/@M_T2'PO_X(+;_XBC_A2'P6_P"B0^%__!!;?_$5
MU%% '+_\*0^"W_1(?"__ ((+;_XBC_A2'P6_Z)#X7_\ !!;?_$5U%% '+_\
M"D/@M_T2'PO_ .""V_\ B*/^%(?!;_HD/A?_ ,$%M_\ $5U%% '+_P#"D/@M
M_P!$A\+_ /@@MO\ XBK&E_"7X5:)J$6K:+\,_#UG=0/N@N;718(Y(V]594!!
M^E=!10 4444 %?B#_P 'O/\ R:S\#_\ LH&H_P#I"*_;ZOQ!_P"#WG_DUGX'
M_P#90-1_](10!Y__ ,&FW_*4S]KO_MX_]/D]?O\ 5^ /_!IM_P I3/VN_P#M
MX_\ 3Y/7[_4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFO7DG?1[#RD:&4,(9)@_DAXV9Q^J=U=6MC:R7U]<QPPPQEYII7"JB@9+$G@
M#DDU)10!^>OPD\+_ +*?_!230OV[OV.KOXK>&M;M/'?QCEM_+TS5K>ZGMU7P
M;X8MHM0BC5R7$%]9R%7^[YMHRDY4BN!_X(-^'/VGM4^'4/Q6_P""C"6FA-^S
M'I&I?!_P5=:M>^7#,UM?;=2UAY)0JX,-OIFGQRYR5LKEMW^D,*_4BB@#\5?^
M"%Y\*?M3?L#_ +>G[,'PE^+>@#Q;\1OBU\0(O#"0ZQ'YI@U/28[:TOT56WF
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MQ!KMXP%GH>D^/].FO+@DX'EP+,9'R>/E4\\5['7C?[='["/[.G_!0OX ZS\
M/VB? MEJ5IJ%G*ND:PUJAOM"NRN([VSE/S0RHVUN" X!1PR,RGY%_P"#8_\
M;!^-W[2G[#7B/X0?M'^)KC7O&'P1^(-[X*N/$-W.TTVI6<"1O;O+(W,DB;I(
M=QR62&-F)9F) /O?XQ_&OX0_L\_#S4/BU\=?B9H?A#PQI2!M0UWQ%J<=I:P;
MB%4&20@;F8A54<LQ  )(%<I^S!^VY^R-^VEHE_X@_93_ &B?"GCRWTN58]47
MP]JR32V3-G9YT61)$&P=I90&VG&<&KOQH_9;^#W[0_C7PCXI^-7A2S\36/@N
M6\N](\-:W:1W.G'49EBCCOW@D!5YX(EGCB9@0@NY2!NVLOP]8?LB^ / /_!R
M#X:^)/[(G@RQ\*V=C\ KZ\^/%KX:LTM=/NC=73P:2D\<0""ZFDA:;& S)8!S
MTR0#[F^-G[5/[.W[.=SI^G_&SXNZ/X?O-5BEET[3[N<M=7$,0!FG6",-(88]
MR^9+MV1[EW,N1GK/#?CGP5XR\&V?Q%\(^+],U3P_J-@E]8:YIU_'-9W-JR;U
MGCF0E'C*_,'!((YSBOSV_P""-?Q U/\ :C_X*(?MP?M4>-Y3>:AH?Q8B^&7A
M5IQDZ9HFBFX0009_U232L+B11C=)\QY%<I_P2L\+Z+\7?B)^W/\ \$J/%VH7
M?_"N/ /QTBO='T:UF*1V^A:U=3WMQH:8QLLY#:7$+QK@[+R8 @L#0!]I?!;_
M (*>_P#!/']HOXM3? KX&?MF_#OQ3XNB:0)H6C^)H)9KDQ@E_L^&Q<[0"3Y1
M? !/0$UZI\5?B[\+_@=X*N?B/\8?'VE>&M"LW1)]4UF]2"(2.P2.,%B-TCN5
M1$7+.S!5!) K\YO^"ZG[!7P)U7P%\ ;']E3X->'/!WQI3X\>'=/^%.J>"]#@
ML+JTC1WN+PM]G13]DM[6"2Y?(VQ^0IXSAM[]JGX@:G\;_P#@XX_9U_9)U^4S
M^$OAE\)]7^)O]E2C,%UK<[7>G6T[H>'>V5/,B8_<:5BN"30!]W?!OX^?!K]H
M/0+KQ-\&/B-IGB&UL+YK+4Q8S_O;"Z559K>XB8"2WE"LC>7(JMM=3C# GKZ_
M.;XN?$'4/V=/^#E_X4^&?"%RUMI?[1/P+U'3/&&F1$B*]U#1?MM[:7\BC@SI
M!&UNKGI&Q6OT9H **** "BBB@#FOBW\9?A-\!/!%S\2_C;\2-%\)^';(@7FN
M>(=1CM+2#/3?+(0J9QU)%8/P&_:W_9=_:EM+N_\ V:_V@_!WCVWL'*7MSX0\
M0V^H1P,-I*N\#L%;#*<$Y^8>M=SKFB:-XFT6\\-^(])MK_3]0M9+:_L;R!98
M;F&12KQR(P(=&4D%2"""0:_)#]D7QQX?_P"#>W_@H+XL_P""?/QU\2PZ)^S/
M\8Y;_P :_ WQEK%QMMO#U_'&K7^CW$S]%"(@4L2<K;GE[E]H!^E&M?MM_L?>
M'/C+'^SMK_[3?@:S\?3.%A\%W/B6V35)"<XVVI?S6'!Y"XX/I7)Z_P#\%5/^
M"9_A;6]4\->)?V^_@_8:AHE[+9ZS97?Q#T^.6QN(W*212J9<QNK*RE6P001V
MK*_8E^%VJ?$OQWX@_P""C/QE\$MIGC/XDZ5;Z;X.TO4;39=^&/!<$DDVGV$@
M8;HKBX>:2^NEX*RW*0G(M4->4?\ !8_X+_#SX ?\$*_CU\,_ACH,-AIEMX%O
M;AQ'$BO<W,]VDT]S*450TLLKO([8&68F@#W3PA_P4^_X)Q?$#Q?HWP_\#?MV
M?"75]<\17L5GH.D:=X^L)KG4;B5@L<4$:REI79F4*J@DD@#K3?%7_!47_@F_
MX%\67'@+QM^W7\)]'UVT8+=:+JGCRQM[N$E0X#0R2AURI#<CH0>E<W^Q/\$_
MAW\<?^"8W[,FD?$/08KQ= ^'/P^\1:/.T,;2VE_I]GI]W!+&SJVP[X0C%<$Q
MNZY&[-?+/P;AA'_!W%\67$2[C^R%;-G;SG^U=&&?KCCZ4 ??WP3_ &N?V5/V
ME)KFU_9W_:6\ ^.IK)2U[;^$/%]EJ,ML <'S$@D9H^3CY@.:]#K\V/\ @X]_
M9"\+G]D'5O\ @I/\#,>"OCM\"YK3Q!X8^(7A]5MK^XM4N(XKBRN9%Q]HA,,C
MNJ2;@&39PDLJM]E_L#_M(7?[8'[%/PK_ &G]3TN.QO?'7@33=7U*R@!\N"[E
MMT:=$SSL$N\*3R5 H E_:@_;G_8]_8KT[3M3_:M_:.\)^ TUAV728?$&K)#-
M>;<;S%%S)(JY7<RJ57<,D9%=I\)OC!\*OCS\/].^*WP3^(VB>+/#.KQ&33->
M\/:E%=VERH)!VR1L5)# J1G*D$$ @BN+U']BC]F[Q7\7O%7QQ^*/PIT'QEXB
M\46UM8F]\6:+;WYT[3(;=8UTZV$R,(K<RFXN&0??DNI"Q("!?SR_X)V:3)_P
M3M_9K_X*$?M(_L_6#6OP@\,>.?%&K?!K0CEK(7.D:=.+Y[53E6M3>QK:JP^4
MBR(R=N: /T3\0_ML?LE>%/BK_P *2\1_M">%[/Q.NHP:?-IDVJ(/L]]. 8+.
M:3_5PW,H93'!(RRR;UVJ=PSZ;=75K8VLE]?7,<,,,9>::5PJHH&2Q)X  Y)-
M?F;^PM^SKX;^)_\ P;*W?A7X@@:KJ?Q1^$?B7Q7XIUN^/F7-_K6H&[OEU":0
MY+SQRF!ED.2#;Q_W0*]V_P"",'QKNOV^_P#@C[\&_BA^T!I]IXJN]<\+-IWB
M/^WK1+I-3N--OIK!KB=)05D=Y+(2DD<N=WI0!])_!WX\_!;]H7P]>^+O@5\4
MM"\7Z3I^KSZ7=ZKX=U*.[MDO(=OFPB6,E&9-R@[2<$XZ@BL/XV_M@?LR_LXZ
MI#H7QK^,^BZ#J$VGOJ"Z=<3F2Y2R1MKWCQ1AGCME;Y6G<"-3P6!KXO\ ^#8K
M1-*\-?L%>._#FA6,=K8Z?^T+XPMK.VA4*D,4=S$J(H'0!0 ![4[_ ((N_%NX
M^(W[=/[>6@?%J^#_ !%TO]H*2U-O>KBY'A.")[;1%4$Y-N(HI64 8S.6/,G(
M!^@O@WQGX0^(OA73_'?P_P#%6G:YHFK6B76E:QI%['<VMY XRDL4L9*2(P.0
MRD@BM*OS8_X(!>*YO#'QL_;._9#\(WHD^'WPM_:)O_\ A K*/_4Z3!?RW,D^
MGP#HD,4L!*H. TCGJQS^D] !1110 5^(/_![S_R:S\#_ /LH&H_^D(K]OJ_$
M'_@]Y_Y-9^!__90-1_\ 2$4 >?\ _!IM_P I3/VN_P#MX_\ 3Y/7[_5^ /\
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M^"_!.G^#=;NSX1TN5E=K&!EL?+FU"Z9(C=3JVPLD4,;F*$22^A_M@>#K_P"
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M.!FRM/L=O-LU.=&^5G 6UC)F.9!#%)O_  &_:5_X)R?\%2_V4?B9_P $]?\
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M&""#C K]!/\ B-Y_99_Z,>^('_A16/\ A0!^WU%?B#_Q&\_LL_\ 1CWQ _\
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M%8_X4 ?M]17X@_\ $;S^RS_T8]\0/_"BL?\ "C_B-Y_99_Z,>^('_A16/^%
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M !&\_LL_]&/?$#_PHK'_  H_XC>?V6?^C'OB!_X45C_A0!^WU?B#_P 'O/\
MR:S\#_\ LH&H_P#I"*/^(WG]EG_HQ[X@?^%%8_X5\!_\%]/^"^GPB_X+"?"+
GP!\-_AO\ ?$G@Z?P=XDNM2N;G7-3MYTN$EMQ$$41#(((SDT ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>jnj-20200927_g13.jpg
<TEXT>
begin 644 jnj-20200927_g13.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@!
M< &" P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ ^/?V'_V'_P!N3_@KK^W)\=_A1\*/V[O$'@C_ (0CQ!J%^[ZM
MX@U.6*6)]3FA6*-891MVX^F.*^P/^(3;_@J9_P!)=O\ RH:Y_P#'J/\ @TV_
MY2F?M=_]O'_I\GK]_J /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_T
MEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O
M_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH
M:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?
M_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZ
MOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_
MJ* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@
M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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MY3^)_P#P4ZN/V1OV+_%G[8__  45_9NU3X-P>'-4%EIGA,>+--UZ^UYY(XS
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M_!1GXDV_QG_:/^"4[>,88(H)O$_AO6[C3;N\ACP$2X\E@DY50%5W4R*H"A@
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M44 ?O]_P:;?\I3/VN_\ MX_]/D]?O]7X _\ !IM_RE,_:[_[>/\ T^3U^_U
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MK\8OC'J'Q#\)>,_"HL[Q]NH6UO%+HE[!//');FV-N%BD(:W:*3F2-@4KM_\
M@DA^Q/K?[#OP \8^%=;\-6OAH>._BYXA\;:?X%L+I)X/"-C?S)]ETA)(R8V,
M,$,6_P HF,2/(J,Z@.P!]34444 %%%% !1110 4444 %%%% !1110 4444 ?
M,7[<_BK_ (*HZA\1/#GPU_X)J^$OA3:0PZ5-J/C?QA\:(M1.G+OD\NTLK);
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M["Y\LD@>9;SJLD39!^5U!]JZJ@ HHHH **** "BBB@ KY _X+\?\H;/VA/\
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M]!D?_ 9__(G[DT5^&W_#_?\ ;Y_Z#?AG_P )N/\ ^*H_X?[_ +?/_0;\,_\
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M:'^.O_18/$W_ (/KC_XNC_AH?XZ_]%@\3?\ @^N/_BZXVBC_ %.X5_Z J?\
MX @_UTXM_P"@ZK_X&SLO^&A_CK_T6#Q-_P"#ZX_^+H_X:'^.O_18/$W_ (/K
MC_XNN-HH_P!3N%?^@*G_ . (/]=.+?\ H.J_^!L[+_AH?XZ_]%@\3?\ @^N/
M_BZ6/]H7XZ-(JGXP>)L$@?\ (>N?_BZXRG0_ZU?]X5CB>#^%HX>;6"IW2?V%
MV-L-QEQ7+$PB\;5LVOMON?T8_P#!-75=4UO]A'X8ZMK6I7%Y=3^&8VGN;J9I
M))&WORS,22?K7N->#_\ !,'_ ),!^%?_ &*T?_HQZ]XK^/C^RPKY _X+\?\
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M_P!X5ABO]UJ?X7^1T83_ 'NG_B7YG]%7_!,'_DP'X5_]BM'_ .C'KWBO!_\
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MOAEM9T[Q%\5[6T\"Z2+"]D2_UQK*\6."62S7=#$T33,S.R1Y1"S8&* /,?\
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M=4,?+*4R?O@4 ?:%%%% !7YO_P#!R#_R0KX>?]C-=_\ I,*_2"OS?_X.0?\
MDA7P\_[&:[_])A7KY!_R/<)_U]I_^E(\CB#_ )$.+_Z]5/\ TAGX]T445_:I
M_#P4444 %%%% !1110 4444 %%%% !1110 5^[/_  0>_P"4?>F?]C-J7_H:
MU^$U?NS_ ,$'O^4?>F?]C-J7_H:U^(>-/^[8+UG^43]T\$?][QO^&'YR/LNB
MBBOP(_H0_(O_ (.2?^2N_#G_ +%BZ_\ 2D5^9]?IA_P<D_\ )7?AS_V+%U_Z
M4BOS/K^F_"+_ ))27_7R7Y1/Y<\8O^2MC_UZC^<@HHHK]1/RH**** "BBB@
MHHHH **** "BBB@ IT/^M7_>%-IT/^M7_>%88K_=:G^%_D=&$_WNG_B7YG]%
M7_!,'_DP'X5_]BM'_P"C'KWBO!_^"8/_ "8#\*_^Q6C_ /1CU[Q7\-']X!7R
M!_P7X_Y0V?M"?]D_F_\ 1T5?7]?('_!?C_E#9^T)_P!D_F_]'14 ?QA4444
M?O\ ?\&FW_*4S]KO_MX_]/D]?O\ 5^ /_!IM_P I3/VN_P#MX_\ 3Y/7[_4
M%-DAAE='EB5FC;=&67)4X(R/0X)'T)IU% %>^U;2]+"G4]2M[??G9Y\RINQU
MQD\]:S-%\<^ -?\ &&I>%?#_ (CTZ\UK3=.L[G5;6UF5YH+:=[A;9I-O16:"
MYV@]T?\ '\AOVS7_ ."/EM_P4Z^.D/\ P4F_9^^(OQ;\2M/H$OA^YB\$:_J=
MIX<L&TBW']F0+9GR%0R(UV)4'SM>.C8:%BWTA_P16O?^"7\_QA^,MK_P32_9
MS\2_#NTC\-^$F\7VVO>'M0TJ.\E:XU[[.T5O?_O-RJLP:13L8-&HY1L@'Z"4
M444 %?F__P '(/\ R0KX>?\ 8S7?_I,*_2"OS?\ ^#D'_DA7P\_[&:[_ /28
M5Z^0?\CW"?\ 7VG_ .E(\CB#_D0XO_KU4_\ 2&?CW1117]JG\/!1110 4444
M %%%% !1110 4444 %%%% !7[L_\$'O^4?>F?]C-J7_H:U^$U?NS_P $'O\
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MZ(_'JBIO[/O?^?=J/[/O?^?=J_L+^W\B_P"@JG_X,C_F?QG_ *OY]_T"5?\
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MS_R(:*F_L^]_Y]VH_L^]_P"?=J/[?R+_ *"J?_@R/^8?ZOY]_P! E7_P7/\
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M_1T5 '\85%%% '[_ '_!IM_RE,_:[_[>/_3Y/7[_ %?@#_P:;?\ *4S]KO\
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M6_Z)#X7_ /!!;?\ Q%'_  I#X+?]$A\+_P#@@MO_ (BNHHH Y?\ X4A\%O\
MHD/A?_P06W_Q%'_"D/@M_P!$A\+_ /@@MO\ XBNHHH Y?_A2'P6_Z)#X7_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQLNJ:AX/ENR!;OK=@+2)+:/<0DCVUS=B-_E^8E=P!]BT5\D?M'?\%5E_9_\
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ME'_!NYX6U']EWQUI^J?$WX2&7QO\.[[P_?1S7EAK%A?W<PM\(2T<LT(E1$;
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MB_XFZU/J>O>'1?>&K[4KIRTES'8W+Q6S,QY9A:_9U9B2692Q.37W;0 4444
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MG]D[XB?L??MI^ W%AJOAO]HS3O!=^;4;#=>']9M+@:A9, ,-&R62%5.0KJC
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MWQ _\**Q_P * /V^HK\0?^(WG]EG_HQ[X@?^%%8_X4?\1O/[+/\ T8]\0/\
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MWQ _\**Q_P * /V^HK\0?^(WG]EG_HQ[X@?^%%8_X4?\1O/[+/\ T8]\0/\
MPHK'_"@#]OJ*_$'_ (C>?V6?^C'OB!_X45C_ (4?\1O/[+/_ $8]\0/_  HK
M'_"@#]OJ*_$'_B-Y_99_Z,>^('_A16/^%'_$;S^RS_T8]\0/_"BL?\* /V^K
MY _X+\?\H;/VA/\ LG\W_HZ*O@#_ (C>?V6?^C'OB!_X45C_ (5XG_P4<_X.
MTOV>/VW/V'?B5^R?X6_9(\::'J'CKPV^FVFK:AKEI)#:NSHV]U0;B/EZ#UH
(_"VBBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>jnj-20200927_g2.jpg
<TEXT>
begin 644 jnj-20200927_g2.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDOEPK,+I[R(09"Y61&?R\NJ 'U117YU>%_\ @NQX[\.?M(_LY_!O]IG]B_\
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M4]TW]BF27]G;2?B OAR75V\>!?%,UJ;B.V_M1-+-E]F\OSY4B\DWH?.3D 4
M?IM17P=_P5 _X+G_  __ ."=_P"RS\+_ -LWP7\&T^*7@#XJ2P)H6H:9XJ_L
MZ<">S:\@D\N2UD#(T2-G+*Z-A2G4CBM3_P"#@'QE\./V\O@K^R?^T/\ L#:Y
MX$\+_'VUT]OA_P",+[QM:W5\TE],+>V^TZ?#$1;AIWB1D:?S$65'90VZ)0#]
M)6=$&YV &0,D]R<"O,OB[^VM^R#^S_X\TSX7?'/]ISP)X/\ $FMB,Z/H7B7Q
M1:V5W?;W\M/)BF=6DRY"C:#R<=:_+W_@LE_P4?\ VWO"/_!9']G#]@;X<_"&
MS3PK)XMTCQ78Z4OBN.WF\=2K=316\=S,$=;*WCGMY"L;!RSHDKX(14\8_P"#
MK#QAXYN?CS^PMX[^*'PQDT'7UUO5[K5O"NDZBNJR6\B:AHC&"*9$07#$#Y<*
MN2V,4 ?OO17Y^?!/_@N!XUU[_@J[!_P2L_:C_8EO_A;XA\1:(^J>"-6;QU:Z
MN;R,6DMXJ74=O$([=VA@G'[N:8++&8\L")#IQ_\ !9GQ3\5?VOOC?^RA^R/^
MSGX?\<ZG\!;=#XBTK6?B5_8^N>);@+)]IBT6Q^P3I<BW>/RG>6:%3))&/E#J
MQ /O"O+?VG_VW/V1OV+=$L/$'[5G[1/A3P';ZK*T>EKXAU9(9;UEQN\F+)DE
M"Y7<54A=PR1D5U/P.^(\GQC^"G@_XNS:(=-?Q5X6T_6&TXRF0VIN;:.8Q;BJ
MEMN_;DJN<9P.E?-?[:?_  1W_P"">G[7NI^/_CC^VEX)D\2ZIJV@?9X?%&K:
MO/$W@_3+:UPJ:>(W5+=4D$UVS%6+RS2;RR;8U /ICX1?&3X3?'_X>Z=\6?@?
M\2-$\6^&=6C+Z;KWA[4H[NUN "58+)&2I*L"K+U5@00""*XG5_V]?V,= ^+;
M? K6OVF?!]MXJ35XM(FTN;68QY.I2+NCT^27/EQW;KRMLS"9@00AR*_'#_@W
M$U7]H#]B?_@A%^U!^V=J-Q?6^A"TUK7?A99WT)"2W=AI<D;WR(<CRY;E8(2>
M1FS?KMY\0^$UC-XD_P"#-SXV?$#5IFN]9N/CC!K&I:K>2M)<W%X^MZ) UPTC
M99I2KX+$Y()YH _HV^+/Q@^%7P&^'^H_%;XV?$;1/"?AG2(A)J>O>(=2BM+2
MV4D ;I)&"@EB% SEB0 "2!7'?LO_ +</[(7[:FD:AK?[*7[1?A3QY#I,BIJJ
M>'M62::R+9V&:+B2,-M;:S* VTX)P:^1OV"/@?\ !S_@LU_P2U_9I^,G[<^D
M77CVST?P=,MYX:U:^E%CJVLVTATUM5O%1E:XN%6UN-FYM@-Y,Q4ML*?%O_!)
MW]A/2?V<O^#H;XZ>&OV)X;_3?@O\,O#3V_B.-+J26UAFU&QLY4T?S7+-(8[U
MIG17)8+8,"25RP!^RGQV_;'_ &7/V9-2LM$^//QS\/\ AF_U"RFO;33M0O?]
M)>TB_P!==F% SK;Q_P <[ 1I_$PKN_"?B[PIX^\,6'C;P+XFT_6M&U6T2ZTO
M5M)O$N+:\@=0R2Q2QDK(C @AE)!!X-?BK_P1X^,>M_ME_P#!PA^W%XZ\=R_V
MD;7PUJGA'P^E^2R6VCVNKQV45NJGA$=+:-W4#!=G8Y+$G9_X,K/VD/&'Q%_8
MP^)_[.7B;6+B\L_AQXSM;O01<2%OL=IJ<,C-;IGA8Q/:3RA1_%.Y[T ?M#11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %/
MQ#XAT#PCH-[XJ\5ZY9Z9I>FVLEUJ.I:A<I#;VL$:EGEDD<A415!8LQ  !)->
M*^'/^"G'_!/[Q4HFTG]K;P6L$ME->6-Y?:L+6WU"WA4O)+:33!([Q552Q,#.
M-HW=.:^;O^#GWX/?M)?&S_@D/XV\+?LTZ;J>HW=GK&G:EXJT;1D9[G4-%@D+
MW$:(GS2!'\F=E')2!^#C!^4_V9O^"\W_  32_P""S7[)EW_P3B_;]\*:5\*?
M%OBOPZNAV+ZG:HWAZ34?*\NVN["XX%C-'*%DCBFV!"%C660G! /VPM[B&[MX
M[JVD#QRH'C<=&4C(-.=UC0R.P 49)/85\G?MV_\ !3SX:?\ !.OQ%\%OV<_$
M.DP^(?B'\8=<A\/>#[6_U%M,TM94:W@DNKV[2"X:VA\VXA4!(97+2?=VJS+R
M'[$?_!8N[_:(_P""A_Q1_P""7OQ\^ -KX'^)WPVLFOX[SP[XK?6M(UBT7[,6
M:.:2TM989-MW P1XR""^64KM(!])_"#]M3]D+]H'X@ZK\)O@;^TWX%\7>*="
M@EFUOPYX=\46MW?6$<<JPR--!&Y>(+*Z(VX##, >3BO3J_##_@B<53_@Z2_;
M8)( &G^*"3_W,>G5];>(?^"_MIKOP.^+W[:O[.W[,B>./@/\$O&MOX<\3^,6
M\9?8]4UMS);I=W.E6/V22.:&!;NWD!GN(#,DA(V8Y /T9HKX;_:#_P""W'PE
M\'_'7X!?LW?LZZ;X7\2^(OVA/"B>*/"NM>.O&3^'=$M-*FAD>S,MREI=2-<W
M4D;P10+%GS!M8@E5;Z,_9$_:!^)?[0?A#Q+?_%_X"W/PX\1>%O&=YX?U'P[<
M:RNH!C!%!(EU%<+%&)89DF62-@HS&RD@$E0 7OC[^V7^R7^RK/I]M^TS^TIX
M(^'[ZJC-I@\8^)K;3OM84X;RS.Z[\=\9Q7HUE>6FHV<6H6%S'-!/$LD,T3!E
MD1AD,".H(((-?BK_ ,'N'_)EWP<_[*A/_P"FZ:OH/X@_\%RO'?["?QA^"'P=
M_;D_8EG\ _#CXMZ;!9^$OB+;^/[?4KBRDC6VC;^T;&*W"6VTW$#2".YF"))N
M5I2K*H!^E=%? '[9O_!<#Q#^Q-_P4;^'W[ 7Q/\ V142T^*.I:?!X-^),_Q
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M/_\ !/CXO_LC>'O^"5O_  4^^$=GX$@TSPE;^"KO4-3T\/X<U6V@B6V3[6H
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MK+^QRW_"(?VM:Q66@'XD6SW5[8SW45B+F.2&VD5)$O)'@DMY1&R^1(V3\JD
M_0RBOR<^-O\ P<U?$/X(?LQ_"#]NCQ/_ ,$S?$%M\&_B?J2:?+XBO?B):1ZA
M!<%9'?[+9+;LT\82&<QR2M;^<86 "(8Y7[[XV_\ !P)XH_9S_;"^"OP9^-G[
M".M^&_AE\>KV&#P'\0]2\96XU%HI9X8$NKG24A8VJ;KFV=HI)Q,L4P9D$BM
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA:YN[SPSX4TW3IK^7S+Z6PL8X6N'Y.Z0H 7/)Y.3R: /S9_X.JOV#+O]JO\
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M^R'\;]!\6>"+.;0[+PKXAL_$EK>GQ!>'Q%;WEY(DD+%)93(;F5XX_P#5A6&
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M+R!">2D=S%,BD\D*">:]JH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?K4%??X'P3RBFD\7BIS?]U1@OQYV?GN.\<LXJ-K!X6$%_><IO\.1'[+>)?\
M@X5_8VTO?%X=^'GQ!U20?<<:7:01-^+W6X?]\UQ.H_\ !QY\-8I2-)_9=UR=
M,\-<>(X8CCZ+$_\ .OR?HKZ*CX3<%TE[U*4O6<O_ &UH^;K>+O&]5WC6C'TA
M'_VY,_4]O^#D70@Y"?LA797/!/CA02/I]CK3T_\ X.._AA)_R%/V8->AZ_\
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M9\.V\=?%O7LW5PK+HOA^S96O=3E ^[$A/"C(W2-A5R,G)4'\0OVUOV_OCO\
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M"J,^I-#:2NQI-NR.N^!'PID^*7C!8;^.0:1I^V;5ID!&5S\L(;LTA! [A0[
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M=7^PL++16=5KJ]XP^6DGYV71A1117[R?@(4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0<_,&/-7K/X$C2_"7BFST;QG=V7B/Q=(\^I^*+.+RY4F(PGE(&RD:#(5=VX
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MZ1J)_P#@4;?^VA1117XT?M04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!_+[J-PEYJ$]W$"%EF9U#=<$D\U#4VHV4NFZA/ITV=\$S1
MOD8Y4D'CMTJ&O[[C;E5C_/B5^9W"BBBF(**** "BBB@ HHHH _8S_@W=TDV_
M[(OB[6V3!NOB+/$"1U6.PLCGZ9D/Y&OORO@3_@W?UU;S]D7Q9X>8_/8_$.>7
M_@$MC9@?K&U??=?QIX@<W^N>-YOY_P!%;\#^U?#SE_U*P/+_ "?J[_B%%%%?
M''V84444 %%%% !1110 4444 %%%% !1110!\L_\%9; 2? WP]J?>'Q8D7_?
M=M<'_P!DKX!K[^_X*R7J1_ SP_IQDPTOBR.0)ZA+6X!/X;Q^=? -?U+X5<W^
MI]._\T[??_F?REXM<O\ KE4M_)"_W?Y'DG[1WP1_9T_:Y%W^SM\8]$6[U&QT
MF+5K*>)A%=V,<TDL(GMI>2"'@(=<%#F,,&! KX1_X)A7G[0O[,'[4'PZ^!E[
MXI?5_ _Q:\!KXFATY&9HK%9+.6<2A6_U,JRPF)B#MD5U)!;:%_0KXF_LT_"[
MXJ>.--^*&M1ZQIWB?2+-K/3_ !!X?U^ZL+F.V9B[0,89%62,L<E75A6-^S1^
MQ_\ "_\ 9LT33)=*BEUCQ-9^&[31;KQ7J<TLEQ+;0(JK%$LDCBU@RN[R8B$!
MY.3S7?F7#N,Q_$.'QT(QIRIR;=2,FG*%X^Y)6UNN:.[26M_LOS\KXDP67\.8
MG 3E*I&K%)4Y13C&=I>_&5W:SY9;)MZ6^TOD;_@LFRC]JW]GC+#C6V)Y_P"G
MZRKO_P#@NYH7B75OV+K'4-$CD>TTSQQ97.L>6#A8#!<Q*S'^[YTL0^K+Z5[K
M\8_V%?V8?V@/%UIX[^+_ (%U+6M5T\?\2^YE\7ZK$+3Y]_[I(KE4B^;!^4#H
M/05Z)JOP^\(>(/!%S\.?$VCC5M%O+1[:\LM8F>\%Q$V=RR-,S,_7JQ)'&.@J
M*_"^.QDLUC5E&,<6H\K3;:Y8<OO+E6[5]&]-"Z'%>!P<<HE2C*4L(Y<Z:24N
M:?-[KYGLG;5+74_,']OKP9H'A3]G/]ESXX?L_P"@VVE>*YM+L(=/O-#M4BN+
MJ<VEK+%N* %W68,.<G=(P/4U^CLO[2?P0LOC-:_LYZG\2M,C\=75D+E/#P9_
M,*^69,!MNT-L!<(6WE1NQCFN<\!_L-_LZ_#W4_#NHZ5X9U"]C\'232>#M/UK
M6[F]M=#:5@[M;13.RJV0,,VYEP-I%:-_^R!^S]J7[1]O^UA>>!@_CBUM1#%J
M?VR79D1&$2&+=L+B(E Q' QW (O*<CSG*L34Q%%4TZKHJ4;RY5&$.6<HV2]^
M3VNK62OKHHS?/<DS;#4L-6=1JE&LXRM'F<JD^:$97;]R*WL[W;MIJ_@[]I#X
MA_M[Z3^S#\3=*^+G[&*6-KXJ=KGQ;X[F\10O(B"9!"%A5R5BBC6.*.,9P,L<
MLSLWT9_P1B\1^/M9_8CT/2/%?@A=,TO2[FYA\.:D+D.=5MVN9I))BHYCVS-)
M'@]=F>]?2?Q/^&/@?XS> =3^&'Q)T3^TM#UB 0ZC8_:98?.0,&QOB977E0<J
MP/%1?"3X2_#[X%_#S3?A3\*_#_\ 9>@:2LBZ?8?:Y9_*#RO*WSS.[MEW8\L>
MN!P *>6\*XW+N)(XYXF52FJ3A[W+S7<^:SY8)./VF[\SEO=7%F?%F!S+AF6
M6%C3JNJI^[S<J2ARW7-.34OLVMR*.UG8Z_P[>2:=X@L-0B^_!>12+@]U<$?R
MK]F*_&SPC;?;/%FEV@!/FZC G SUD4=.]?LG7YYXU6]K@>]JG_MA^C>""E['
M'/I>G_[>%%%%?AI^\!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$DDDTC332,[NQ+,QR23U)--HHK^MMC^/]PHHHH **** "BBB@ HHHH ^E?\
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M+2P.#IX:E\,(J*](JR_!!1117,=(4444 %%%% !1110 4444 %%%% !1110
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MKP=X<>*S">;U5[M+W8><VM7_ -NQ?WR78LT445_/!_1P4444 %%%% !1110
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MB!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU?'CXU^%?V?OAE??$GQ5;75YY+Q6VEZ/IT8DO-7OYG$5K8VR$C?/-*R1H,@
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M>):-63E5B[O?9_Y'T<N&*U*"C1FFEHKW7^9XO17JMS\"?#,A)MM4O8\]F9&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@GU+X0_%_P '_M-?!NS^*7PKU3Q!IVEZVES%976J>'+C2]1M9(9Y+>0M9ZC
MLD3K+$X EBP0 V&4@D [6BO@#]@/]L_XC?%7_@FOXL^*OQZ_;:AD^(T>J^+[
M6QU"XCT"RN-.&EZK?VEIY=JMHL3&2.VB9O-CDW%R5V@C'I/_  3>_;!\2^*_
M^";WP4_:"_:C^*&K>*_&WQ0\.P7J0V?AV%KN_O9('G>"UM--MD_=I'$[DE#L
M52SN ,T ?6U%>&^'?^"C?[)7C/P?X=\5^"?'][K%QXK\2ZEX=T/PU8^'KTZS
M+J^GI+)J%C)8-$L]M-;)!*THF1 @"Y/SIN\B_:V_;4N?''PZ_9D^/O['WQTU
M"+PG\0OVD?#_ (9UH6NE1Q+J^G2W%W#>6=Q'>6_VBVDCGM&C95,3JRR(^>@
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M1:+<^=9W]K'<VDVQE\R)U#*V& (R"#@@'UK^8&OZ8/@?_P D5\'_ /8K:?\
M^DT=<OB-P/E/"%'#3P<YR=1R3YW%_"HVMRQCW\SJ\-N.\WXQKXF&-A3BJ:BU
MR*2^)RO?FE+MY'44445^6'ZP%%%% !17Q?\ ';Q]^TSK'_!6KPU^RAX._:Z\
M4>#/ VO? 76/%UQ9:-X?\/S/;:E9ZI96B,)K[3IW\DQW3%D)SN12&49!^=?A
M+_P5'_:B^)7PI_9W^,GQ*^*0T_3[G]K#7?AQXJU7PIH41TSXAZ+8Z?JSV^IV
M\(BFN TLUI$BQ6LI$DJ.JJVY$4 _5JBO#/"O_!1[]DKQ=\);SXQZ?XZU2UL-
M/\>Q^"+S2-6\)ZC9ZQ%XCDEBBBTHZ;/ MT+F0SP,J>7RDJN<)EA5U[_@IQ^Q
MKX2^$&K?''QA\2-0TG0/#OCU?!7B634/"FHI+HNO-)#$+*\C\@M;9:YM\328
MA*S1L)"KJ2 >^T5\Y:9_P58_8VU7Q#IG@N'7/'$.OZW;:Q/HOAR\^$OB*WU'
M4%TN98;Q;>VDL5EGD1Y(_P!TBM)M<-MVAB&>#_\ @K+^PYX[M/ VJ^&OB-KD
MNG_$'Q"OA[1M7E\!ZQ%96>M-</;)I5_<O:B+3KYKB-HA;7+1REBGR[9$9@#Z
M0HKQ;6_^"@G[+'A_XDCX8ZAX[O#<K\0+;P+/JT&@7DNF6_B:XBCE@TF2\2(P
MI<.LL0P6VAY$C9A(P0R_%3]OC]ESX+Z_<:-\0_'US:6VG>);'P]KFOPZ'=SZ
M5H^JWIB%K9WE['$T%O*YG@R'<>7]HA,GEB5"P![)17CWQ5_;P_9E^"FNMI7Q
M'\:WMC96WB:T\/:MXD30+R;2-)U2Z,0M[6\OHXF@MG=IX5S(X5&FC5V0R(&S
M_%7_  4?_8]\$_#KXF?%?Q1\2-5M-#^#FM#2?B5<MX&UEI=#NC!#<8D@6T,L
MD?DSPR>=&CQ[9 =_6@#W&BO!K7]O/P1/^V[XK_8PE\!>+DO/"/@2P\1WNM0^
M#]1N;>Y%U)>!8XF@@<;52QD =L"65O*BWNK+6=^S-^UI\!;3]D[X?_$#3?VC
M_%/Q1LO&6HW]CX/\1:MX<D_MSQ3<1W-VSQI8VUK"_P"Z2"8$^0@2&W\R0@!G
MH ^BJ*\-T'_@HW^R5XO\(^'/%/@KQ_>ZS/XM\2:GX>T#P[IOAZ\?5[C5M.69
M]0LFLC$)H9+98)3+YJHJ +\W[R/=Y%^US^VC=>-_AY^S%\?OV/OCMJ$7A+XA
M?M'^'O#6LBUTJ.)-8TV:>[AN[2XCO+?[3;21SVC1LJF)U99$<'H #[/HHHH
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M^:_-;^[&UK>9T<">'_\ J56KS^L^U]JHKX.6W+?^_*][^04445^>'Z,%%%%
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M !-K>N1ZYKFGV'B[4H=$U/6(R&34[C2DN!93W2LJN)7B)$BB7_6 /6/\1/\
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-%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>jnj-20200927_g3.jpg
<TEXT>
begin 644 jnj-20200927_g3.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "O$OB+_P %(/V%_A7X_P!2^%/C']IW
MPLOB;18C)KF@:9>-?WFEH.INHK59&M?^VH6OF?\ X.9OV\/BI^P+_P $N]7\
M9?!'7;C1_%?COQ19^#M(UZS8K/I8N8+FXGGB8<I+]GLYT1Q@HTBNI#**B_X-
M@/V;_!/P+_X)#?#WQUI.CQ#Q)\33>>)O%VLL@-QJ$\MW,EOO<_,P2V2)0"2
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M::SXBT#QI>+I?A3PC L<&HW&L?OA+83DEDMS";><R29=0L8*>9OC#\9\<O\
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M!^N%([K&AD=@ HR2>PK\N/'G_!R7>_#?X$?##]NKQ1^Q+>I^SW\5OB!>^&=
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M-%\1>&Y]4%\D4PBCFCFAN!''YD;QRC[R*RLKK@@!V /KZBBB@ HHHH ****
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M8M-O!JVMS1QSL6Q#(/-MW"M@XDC/\0S^C?\ P7D_:ROOV-/^"87C_P"-6E?
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M&>.4KF/C)!()&1WP2/>J%OX-\(6GB.;QC:^%--BU>XC\NXU6.QC6YE3@;6E
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M[:'5HOB%:WLFF"X7SUMWL8T68QYW;"Z,N[&,J17[>44 %%%% !1110 4444
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MA^6[5;N6R\PQFXCC)#21JXVLR@A2RAL;ES\9WG_!9#Q#\2/VYOBY^Q!^R5\
M/#GC;7O@KI4-SX@L?$'Q+&B:IXDN&4M<6NBVAL9TN6M\!)'FF@3S'1<JK"6N
M:_X+ >(?%?QO_P"",6E_\%#OAK8WG@3XH?#[PWH/Q3\"7J29O/#MVT=O+=V;
M.54R1O:7%S;RQ,H23C>A VT ?H=17BO_  3H_:]TK]O;]A[X:?M=:5I\5FWC
M;PS%=:E8V[%H[34(V:"\@0GDI'<Q3(I/)"@GFO:J "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5P_[1/[0_PN_9<^%.I?&'XMZ\MEI>GQXCB4@SWLY!*6\"$C?*
MY& .@ +,0JLPN?'#XU?#_P#9X^%6L_&/XGZP++1M#M#-<N,%Y6SA(HU)&Z1W
M*HJ]V8=.M?@S^W/^W/\ %/\ ;C^*;^,O&4K6&A6#/'X9\,PS%H=.A)ZGIYDS
M8!>0C)(  "JJC] X#X%Q7%^-YYWCAH/WY=6]^6/F^KVBM7T3_/./^/,)P=@N
M2%IXF:]R/1+;FEY+HMY/1:7:A_;>_;>^*O[<'Q5D\=>.IVLM(LF>+PWX;@F+
M0:9 3^&^5L O(0"Q   555?%Z**_KG X'"9;A(87"P4*<%9);)?UN]V]7J?Q
M[C\?C,SQD\5BIN=2;NV]V_ZV6R6BT"BBBNLY HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#U[]C7]M'XO_ +$_Q0C^
M(/PSO_/LKDI'K_AZYE(M=4@!/R.!]UUR2D@&Y"3U4LK?N]^R[^T[\+?VN/A%
MI_Q@^%&J^=:70\N^L9B!<:==  O;S*.CKD<]&!#*2"#7\X=>U?L,_MN?$S]A
M[XO1>/?!\CWNC7I2'Q/X<DEVPZE;@G_OB5,DI)C*DD'*LRG\Q\0O#^AQ1AGB
M\(E'%16CV4TOLR\_Y9=-GIM^I>'/B'B.%<4L)BVY82;U6[IM_:CY?S1Z[K7?
M^A:BN6^"WQE^'W[0/PPT?XO?"[7$U#1-;M1-:S#AD/1HI%_@D1@593T92*ZF
MOY-K4:N'JRI58N,HMIIZ--:--=T?UU1K4L11C5I24HR2::U33U33[,****S-
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;
M++%!$TTTBHB*6=V. H'4D]A3J_.O_@M[_P %"Y/AMX=G_8Y^$6L-'K^M6:MX
MTU"W?#6%C(NY;12.DDRD%O2(@<^;E?<X<R#&\2YM3P&&6LMWTC%;R?DOQ=EN
MSP>).(,#PQE%3'XIZ1T2ZRD]HKS?X*[V1\M?\%>?^"A4G[6WQ5_X57\,]79O
MA[X2O'6SDB?Y-8O1E'O#CJ@&Y(O]DL__ "TP/CBBBO[4R7)\%D.64\#A(VA!
M6\V^K?FWJ_\ (_B+.\YQW$&:5,?BY7G-W\DNB79):+_,****]0\H**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YKQI\4_#?@O6]-\)RP76
MH:WJ^\Z;HNFQJT\RH,NY+LJ1H!U9V4=@2:P_AA^T1X;^(]SI&D7?AK5]$U'6
M]'74],MM1MPT=U 55F:*:,LC8#+D,589&5'2O._VP/@[\99O'>B_M&_ F\DE
MUGP_I_V6?38E#220AY'RB'B7(E=63J1C;DU5_8I_:'^&_P 4]#\._#+5M(-E
MXG\*:2(-,:5]RW,21"-WC88^8J 6C([9&=N5_/I\28^EQ9_9F)DJ*;_=\T?<
MJQ]SX9[^TUGI=)/D5FVS]$I\,X"KPC_:F&BZS2_><LO?I2_>?%#;V>E/6S;7
M.[I6MZ!\3/VMOA)\-/%-CX%N+VYU'6-0O(K>.TL("5C+R"/<\C83 .<A2S C
M&*]%UG6])\.Z;+J^MW\=M;0C,DLAX'H!W)/0 <D]*^7/V_E4?&_X4L%&3J)!
M./\ IYMZ^K:]7)<US+'9UF6$K2C:A*"A:+7Q0YM?>;;U5]5MI8\K.\IRW 9'
MEF,HQE>O&HYWDG\,^71\J26CMH]];GG7P@_:;^'7QR\7:QX7^'RWL\>C01R3
M:A<6_E1REF9<(K?/QMZL%^E>BU\I?L(JJ_M$_%A54 #49  !T_TN>OJVKX-S
M;&YWD4<7BVN=RJ)V5E[LY15E=]%U;?F9\:91@<CSZ6$PB:@H4VN9W?O0C)W=
MEU?1)>1YA\:_VMOA)\$)ETK7+VYO]4E8K#IVG0%SN!P=TAPBX)&1G</[M>GU
M\I?\%054V/@1RHR-1NP#CV@KZMJ<GS7'XOB7,<#7:<*'L>2RM\<92=]7=[+H
MM-D5G.4Y?A.&<MQU!24Z_MN>[O\ !*,5:R5EN^KUW84445]6?)'UO_P2C_X*
M(ZG^QK\4U\"^/M2EE^'7BB\1=8B8EAI5P<*M]&.P P)5'WD /+(HK]Q;.\M-
M0M(K^PNHYX)XUDAFA<,DB,,AE(X(((((ZU_,'7ZQ_P#!#3]OU_'/AY/V,_BM
MK)?5]&M6E\#WMP^6NK)!E[(D\EX1EDZYB##@1#/X1XN<$QQ%%YY@H>_'^*EU
MCTGZQVEY:]'?]]\'^.)8>LLBQT_<E_";Z2ZP]);Q_O:?:5OT=HHHK^<C^DPH
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH I>(-
M9AT'2I=1EP2HQ&A_B8]!_GM7RQ^U)^R%\$_VN]&>U^*_AP'5%1A8^(K'$=]:
M$DGY9,'<F2?W;ADYS@'!'N7Q'UUM2UC^S89,PVGRX!X+]S^'3\#7.U]=D;Q.
M6..)HR<*FZ:=FOZZ_<SX;B&6'S5RPU:*G36C35TWU_X'WH_&7]KW_@G+\<OV
M4;B?Q!+9GQ'X1#_NO$NF0'$*DX N8LDP'IR24.0 ^3@?/M?T,W%O!=P/:W4"
M2Q2H4DCD4,KJ1@@@\$$=J^*/VQ?^"/?@'XE"Z\>?LU26OAC76W23>'Y<KIMX
MW7$>.;9CZ &/H-J<M7[QPUXF4JW+A\V]V6RJ):/_ !+IZK3R2/P3B7PTJT>;
M$93[T>M-O5?X7U]'KYMGY>T5T'Q-^%?Q$^#7BZX\"?%#PA>Z)JUJ?WEI>Q;2
M5R0'1AE9$.#AU)4]B:Y^OUNG4IUJ:G3:<7JFM4UY,_)JE.I1J.%1-26C3T:?
MF@HHHJR HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .)\6>)?B5X
M3^),5Y8>!;_7/#%WI*1W#:9/"9K*[660[_*D="Z,CJ"5R1L7BO%OV;?@/JGB
M'X@> OCH/"QT/3M#\#6EO))*\8EUB[-LT7FA$8E4"2 ;GPS;%&W'-?3]%?-X
MSAK#YAF%+$8BI*4:<N>,7RV4KQDK.U[)QO:]];7Y?=?TV"XGQ&79?6PV'I1C
M*K%0E)<VL;2B[QOR\S4K7M;2]N;WE\W?M??"?XR_%3XJ>#?$7@+X87=[9>&;
M@S74[ZG91>=^^C?"!YPW2/N!]X5]#?VE>?V2-1_L"[\[;G[!OA\W.>F?,\O/
M?[]6Z*Z<!D=#+\PQ6,IU).6(<7*_+9.*Y5RVBGMW;.7'Y]B,QR["X*I3@H8=
M24;<UVI/F?->36_9(^;OV3/A/\9?AG\:/&?BSQU\,;NRT_Q/<O+:W"ZG92^3
MFX>0!U2<M]U_X0?NUWNH:M^TVO[3]KI5AHMF?AT;+,]T5BW;O*))+9\P2>;A
M0H&W;@XZD>J45QX#A>CEF74L'A\15485/:7O%.7O.3A*T4G"3;NK7\SMQ_%5
M?,\QJXW$8>E*4Z?L[<LFHVBHJ<;R;4XI*SO;R/G']NWX1?&'XV2^&].^&GPX
MN+Y-'N+B:YNI=2LX4;?Y04*'F#'[C9RHQQ^'T+I-]=:C81W=[H]Q82.,M:W3
MQLZ'T)C=U_)C5FBNW!9'A\#FV)S"$Y.>(Y.9/EY5R+ECRVBFM'K=NYPX[/<1
MC\HPN73IQ4,/S\K7-S/G:E+FO)IZK2R5@HHHKVCQ K:^'/Q!\6_"?Q[H_P 2
M_ >K/8ZSH6H17NG74?5)8V##(_B4XP5/!!(/!K%HJ*E.%6#A-735FGLT]TRZ
M=2=*HIP=I)W36Z:V:/Z,OV/?VF_"7[7G[/V@_&[PILB:_@\K5]/5]QL+Z/ G
M@/?AN5)Y9&1OXJ].K\9?^"&'[78^"O[0\WP!\7:MY7A[XA,D-EYK_);ZN@Q
M1Z>:N83C[S&'/"U^S5?Q?QUPS+A;B&IA8K]U+WJ;_NOIZQ=X_*_4_MG@+BB/
M%?#M/%3?[V/NU%_>77TDK2^=N@4445\<?:!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8YEL;WJ?DDP-K8!.QPK@#.,8-?J!_P $8/\ @G<OP!\!1_M,?%W00OC3Q-9
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MAGBCX<TLPH3SC+(6K1NZD5]M=9)?SK=_S+^]O^/5%%%?TL?S$%%%% !1110
M4444 %%%% !7=_LP_&G4?V=?VA/!_P ;--,A/AW78+JYCB^]-;;ML\0_WX6D
M3_@5<)16.(P]+%X>="JKQFG%KNFK-?<;8;$5L)B(5Z3M*#4D^S3NG]Y_3QI.
MJZ=KNE6VN:/>)<6EY;I/:W$1RLL;J&5A[$$'\:L5\W?\$E?C'_PN?]@KP+J5
MU=>;?:!9OH-^"<E6M&\J($]R8! W_ J^D:_A'-<!4RK,ZV#GO3G*/_@+:O\
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M **** "BBB@ HHHH \<<AG+#N:2E=2C%3V.*2ON#\W"BOQ#^.W_!2N/]HO\
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MTVSW[?-OX4W8SC+@9K^G&OYZ\=;>TR_TJ_\ N,_HOP%O[/,/6E_[D"BBBOP
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:DHQ;7\NB]W7MU\S\@XEQ\<9FM6%*?-3C*2B_P";7XOGT\@HHHKWSYX****
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M*CQE3(Q#$.JE2?I[5O!OAC6(Y_M?A^P>6>-E:>2R1FR1C))&36I17%@LHP.
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MJK!1117YT?I(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4=  . *?117QS;;NS[1))604444AA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[.7PR\<^,/AMXU\8ZG::UX#\#Q^,/%%DGA'5)OL^AO))$+V-XK9DND#PRAA
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M+[2I]0TAI1%]NMA=PQB>)92J/MRT;,@=4WIN /4Z*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** *^KZMI^@Z3=:YJUQY5K96[SW,NPM
MLC12S-@ DX )P 37 _\ #6?[/W_0_P#_ )2KO_XU72_%W_DD_B?_ +%V]_\
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M\2?%'C!)OA=9^*I=9M_"EU?:E=:*+>/_ (F]Y;V5OF(RD[BBQJ6?S0D>(W"
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M/[-EQH$OCGX72ZOIYN=0MD\/R:+J'V65;AK26Z@6>2:$&95D4.H=690?(O\
M@JE\!O'UM^SQ^V-^W'X@\$:AX>L?B!X:^'N@>'_"^I2P+>WBZ3K$;27UPL4C
MI&9'O!#$KOO5;=F8*'4#]./A)\3= ^,_PRT+XL>%M.U>TTWQ#ID5_96NO://
MI][%'(H95FMKA5DA?!Y5E!%9/[17[./P>_:O^%-_\$/CSX9N-9\+ZI+!)J&E
MV^M7E@+@PRI-&&DM)8I"!(B-MW8)49!Q0!\;_MQ_L)?&?_@HA\4/&7Q$\)>#
M[SX=L/V8?$?@#1;_ ,4FW2?5-8U:ZMITAE2WDF(L[86961R2KM?'RQ(J.3Z+
M^PAHWCOQQXWTSXA?%O\ X)->%O@3XM\.^'IM/\0>+9(-"N+B]N9#&'M=(GTZ
M1YOL3LK2O)/Y0^6)%CE+-)%Z'XU_X*&_LB_!?XIZG^SCXJ\7^+AXI\+>&DUK
M6-,MOASXCU1[32=[1+?RW,-E*K6^^-U-PTA4E&RV0:]:^%_Q2^''QL^'ND?%
MCX1>-],\2>&M?LEN]&US1[M9[:\A;HZ.I(/(((Z@@@X((H WJ**Y?Q[\6O#G
MPZ\3>$_"FMZ1KMS<>,M;?2M,ETG0+F\@MYEMIKDO=2PHRVL6R!P))2J[BHSS
M0!U%%>-_M ?MW_L_?LVZCJ6G>/[KQ#>G0$TZ3Q2_A;PK>ZO_ &%%?S/#9R72
MVD<CH)7C< *K,  [!496/H?PE^)F@_&;X9:#\5_"^FZO9Z=XBTN&_LK77]'G
MT^]BCD4,JS6TZK)"^#RK $4 =#1110 45ROPY^-OPJ^+>N^+?#7PW\;66KWW
M@7Q(= \606CDG3M1%M!=&W<D8+"*YA)*Y +%2=R,HYG]H/\ :]^#W[-@EMO'
M+:WJ.H6WAVZ\07FC>%M N-4O;?2+9XTN+YX+=6<1(TJ#@%W);8K['V@'J%%<
M?XQ^./@?P=\#+W]HAHM7U7PY9^'/[<1=!T.YO+VZM/)$RF&TC0S2.R$$1A=W
M/(&#CJM.OH=4T^#4K>.9([B%942X@:*10P! 9' 9&YY4@$'@C- $U%%% !11
M10 4444 %%%% !1110!SWQ=_Y)/XG_[%V]_]$/7P17V]^U#XR\2?#K]F?XB?
M$'P;J7V/5]"\"ZOJ.E7?DI)Y%S!92R12;'#*VUU4X8$'&"".*_%G_A\U_P %
M*/\ HY#_ ,L_1O\ Y#K]C\,LISC,<#B)8.--I25^><HN]NG+3G?[T?C'BAFV
M39=CL/'&RJ)N+MR0C)6OUYJD+?<S[(K[U^#O_)(_"W_8N67_ *(2OQ"_X?-?
M\%*/^CD/_+/T;_Y#K]HOV5/&OB;XD_LP?#GXB>-=3^VZQKW@72=1U:\\E(_/
MN9K.*2639&JHN79CA0 ,X  XH\3,JSC+L!AY8R--)R=N2<I.]NO-3A;[V+PO
MS;)LQQ^(C@I5&U%-\\(Q5K].6I._W([ZBBBOQP_: HHHH ^=?^"K?[+GBW]K
MK]A/QO\ #+X79C\>:9!!XD^&MW&ZI);^(M,G2^T\H[$!"\T"Q%CP%F;/%>"?
M%K_@EY\9=4^+W[-?Q)\(:Q9I?I8ZIX9_:<O+90(]>T?49O\ A(-0&UFR89]8
MMI8=@W,JZLW968?6WC3]L?\ 9]^'O[1'AW]E+Q7XHU:#Q[XLL9[SP[HD'A#5
M+A+ZW@"F>5+F*V:W"1[TWL9 $+*&P2*VO$O[0GPO\)?&/0?@'KE[K">*/$UE
M=7>BV=OX5U&>">"V,(GE-U%;M;Q+&;B ,7D7!E0'DB@#YF_X*)_![XY:5^UC
M\*?VPOAQ^R9:_'CPOH'A;7/"?CKX<F73A?VEO?W%A=0ZKIZZBZ02RI+8B*1#
M(C&.48/!*\?\<OV+E^(_A+X?3>%_V.?%GP.UO2K'Q#J_A'Q/^SWJ>EV&I^ =
M2NIK5EL;V""YCMM1%^J&2Y54FMO,M_+:7!6X?[/^,WQW^&'P"T&PU_XFZ[/;
M#5]5CTO1-/T[2[B_OM4O9%=UMK6TM8Y)[B39')(5C1ML<4DC;41F&7\%?VI?
M@S^T!XD\1^"_ASK.J?VWX16S/B?1-<\,W^E7FFFZ$IMQ+#>P1.-ZPR,I (*[
M6!*LI(!\D^ /V>/VZ;?]JWX/_%[X]?#3^U=1UW]DB;X=?$OQ1X+O]/M[;PWX
MAEO[&[FN7A>:(F'9'-L^R1R#S4"A$1@RYO\ P3>^!?QH^&?ACX<_L]_M#_\
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M/2?%VM^+TT](]5^)>FI/=G4A]CO+A8GU"VDN@R'86EBC W8POKUWX"\9ZO\
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M &=_PE/AB_TC^T/L_G?9?M-O)#YOE[EW[=^[;N7.,9&<U^<W_$-W_P!7F?\
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7 HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>jnj-20200927_g4.jpg
<TEXT>
begin 644 jnj-20200927_g4.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@"
M2@*( P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!&944N[
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MJ5LF86BU.V*^;93GI*S(\9??([0YP #]X?!OC/PI\0_"]CXV\"^(;35M'U*
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MH2LB,""&!((K\]O^#L#_ )0E?$;_ +&#P[_Z=K:O"/@/_P %DOC5_P $OO\
M@E!^RS\5_C!^P/?:A\$]0\):%X;O/'5EX^MO[7AF-D66Y72U@=3!(L,K1%[E
M&<* XA9D5@#]EJ*_/;_@J9_P7FL_^":7A_X8?%VV_9<D^(OPO^+6FQ7/A?X@
MZ1XS^R0(SQ1SJD\+64A0/!*LT;!F+JLF%!0BOI_QQ^T]\2- ^/?PC^"_@OX0
MZ'XDM/B5I%_JFJ>(+/QLR1Z'964=N]Q=+']B;[7 6N[6*-PT9>2XB#+&K%P
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M'QX_X)R^!_$?QT^&0NM(U>3Q5K ^*EUXQBN+OQ!J=QXHU"6=)-/6%6M\22W
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MY_9TE^)'AGXPB<>'M<\->+1%,C0FT+'[.;5Q*KQWD+1%)"7(<$)A2^1\.O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !14=W=VMA:R7M]<QPPPH7EFE<*J*!DL2>  .]?,
M/[1'_!83]A[]GSS],_X65_PF&L0Y']D^#$6\PP[-<;E@7!X(\PL.?E/2O0R[
M*<SS>M[+!495)?W4W;UZ)>;/.S+-\KR>C[7&UHTX]Y-*_IU;\E=GU%17Y"?&
MS_@X;^/WB@S:=\"OA)H/A2V;*I?:M*^I78'9E&(XD/?#)(!TR>M?)/Q<_;G_
M &O_ (Z3S/\ $_\ :)\4W\,_^LT^#4VM;,_]NUOLB'_?-?IF5^#G$N,2EBYP
MHKLWS2^Z/N_^3'YAFOC1PS@VXX.$Z[[I<D?OE[W_ )*?OO\ $[]I_P#9R^#&
M]/BM\=/"GA^6/K:ZGKT$4Y/H(BV]C[ $UXCXU_X+1_\ !.WP;OBA^-L^LSIU
M@T3P]>RY^DCQ+&?P:OP?)+$LQR3U)HK[C!^"F1TTOK6)J3?]WE@ON:D_Q/A,
M;XX9[5;^JX:G!?WN:;^]."_ _8[7_P#@X?\ V1+%WB\/?"GXA7Y4X62:QLH$
M?W!^U,V/JH/M7':S_P ''OP\@8CP]^RSK-TN>#>^)X8#_P".P25^45%>_2\)
M^"J?Q492]9R_1H^>K>+O'%3X:T8^D(_JF?J=_P 1(VB_]&@W7_A<K_\ (5:.
MC_\ !QY\.)\?V_\ LN:W;>OV/Q+#/C_OJ&.OR@HK:7A7P/)66&:_[B5/UD8Q
M\6..XN[Q2?\ W#I_I%'['>'/^#AW]D749E@\2?"SX@:;NZRQV-G.B_7%RK8^
MBFO4O!G_  6C_P""=GC#9%-\;YM'G?I!K/AZ]BQ]76)HQ_WU7X/T5YN)\'>$
M:Z_=NI#TDG_Z5&1Z>&\9^,*#_>*G4]8-?^DRB?TH?#/]IC]G?XRK&/A3\<?"
MGB"20#%MI6O033#/9HE;>I]B :[BOY>%9E8,K$$'((/2O6/@_P#MV_M@_ >:
M-OA?^T/XGL8(L;-/N=0-W:#'_3O<;XO_ !VOD\P\$:B3E@<8GV4XV_\ )HM_
M^DGUV7>.E-M1Q^#:[N$K_P#DLDO_ $H_HOHK\AO@I_P<._'GPTT&G_';X0Z#
MXHME(66^T:5].NR.[$'S(G/L%C!Z9'6OMO\ 9Y_X*^_L._M""#3H?B>/"6KS
M8']D>,T6R.X\86?<8'R> !)N/'RBOSC./#[BS)4YUL.Y07VH>^OG;5+U2/TO
M)O$3A'/&H4<2H3?V9^X_17]UOR39]/44RVNK:]MH[RSN$FAE0/%+$X974C((
M(X(/K3Z^+V/MDTT%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%?)
M/[=/_!7K]G[]D-;OP/X3FB\:^.HMT9T/3;H?9]/DZ?Z7.,A"#UB7=)Q@A 0U
M>EE649EG>+6&P-)SF^BZ>;>R7FVD>9FV<99D>#>*QU54X+J^ODENWY)-GU3X
MD\2^'/!VA77BCQ=K]EI>F6,)EO=0U&Z2""",=6=W(50/4FO@;]K+_@OO\&/A
MM/=>$?V8/"C>-]5BRG]O7[/;:5$_J@XEN0#P<>6IZJ["OS8_:E_;B_:3_;#U
MXZI\:?B#/<6,<QDL?#UCF#3K/T\N '!8#C>Y9R.K&O)*_?N&?!W 85*MG$_:
MS_DBVH+U>DI?@O4_GOB?QGS#%MT,FA[*'\\DG-^BUC'_ ,F?H>O_ +2_[=W[
M4O[6M](_QE^*E]<Z:9-\/AZP;[-IT//&((\*Y'9WW/\ [1KR"BBOV/"8+"8"
M@J.&IJ$%LHI)?<C\8QF-QF88AU\54E.;W<FV_O84445TG*%%%% !1110 444
M4 %%%% !1110 4444 >Q_LS?M\_M5?LDW<:_!WXJ7D.EK)NE\.:F?M6G2\Y(
M\A^(R>[1E'_VJ_5']AW_ (+#>#_VB?#*O\=?!$?@N^6Z^R)JUM=&;3KN4*K.
M0"/,MP-Z#Y]Z\_?X./Q6T+1-2\2ZW9^'=&M_.N[ZY2WM8MP7?([!5&3P.2.3
MP*^R_#'AK3?!GAJP\(:/)OMM-MA#'*01YK9+/)@DE=[L[[<\;\#@5\1Q-P5P
M[Q#_ !Z*C5?VX^[+Y])?]O)Z7L?=<+\<<2<.+]Q6<J2^Q+WH_*^L?^W6M;7/
MVLT_4+#5K&+4]*OH;FVGC#P7%O*'213R&5AP0?45-7Y1_ C]JOXR?L]7RGP1
MXB,NFM)NN-#O\RVDOJ0N08V/]Y"I]<CBONO]F_\ ;Q^$GQ^EM_#5XY\/^))0
M%72;^4%+A_2"7@2?[I"OUP"!FOY\XG\.<[X>4JU->VHK[45JE_>CJUZJZ[M'
M]$\+>)61<1.-"H_8UW]F3T;_ +LM$_1V?9,]QHHHK\]/T4**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *Q_'OQ \$_"WPA?^/OB+XILM%T73(#-?:EJ$XCBA4>I/4DX  Y
M)( !) KF/VD_VF_@]^R?\,KKXJ_&?Q0FGV$&4M;9,/<W\^"5@@CR#)(<>P R
MS%5!8?AS^WM_P42^,/[=7C;S_$4KZ/X1TZX9M \)VLY,4'4":8\>=.5."Y&%
M!(4*"<_=\&<"9CQ;B.?^'AXOWIVW_NQ[O\%UZ)_!<;<?9;PAA^3^)B)+W87V
M_O2[1_%].K7OW_!1#_@MGXW^-37WPB_91O+[PUX2;=#?>)>8=1U9>A$>/FM8
M3Z#]XPZE 62OS_9F9BS,22<DD]:2BOZHR/(,JX=P2PN!I\L>K^U)]Y/J_P %
MLDEH?R=GO$.;<28YXK'U'*71?9BNT5T7XO=MO4****]D\4**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBK.CZ1J.OZO:Z#I%L9[N]N4M[6%2 9)'8*J
M\\<D@4FTE=C2;=D>R?L?_#\7%[>_%#4(ODLRUCI?/6=T'G/P?X8G"X(P?/R#
ME*]WK/\ "?A;3? _ABP\'Z3()(-.MA$)@"/.?):27!Y&]V=@#]T,%Z 5H5Y_
M,YMS?7\NG]=[GH64$H+I^?7^NU@I8Y)(I%EB<JRD%64X(([BDHIB/K;]E#_@
MI)K'A/[-X!_:!N9]1TP;8[7Q$%+W-J.@$P',R?[0^<<YW]ON/0=?T3Q3H]OX
MA\-ZM;WUC=Q"2UN[2821RJ>ZL.#7XS5ZU^RS^UQX[_9J\2*+6674?#EU*#J>
MAR2_*<XS+%GB.4#OT;HW8C\?XS\,,+F,98S*4H5=W#:,_3^67_DK\M6?LO!7
MBGBLME#!9NW.CLI[RAZ_S1_\F7GHC]2J*Y_X8?%#P3\8?!MKX[\ :TE[I]TO
M##AXG'WHY%ZHX[@_49!!/05_/%:C6P]65*K%QE%V::LTUT:/Z.HUZ.)HQJTI
M*49*Z:=TT]FF%%%%9&H4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:_#>)CA,7)RPLGKU<&_M1\OYE\UKO^K%%9/@;QQX7^)'A*Q\<>#-6CO=-U&
M2VMQ&>H[@CJK Y!4\@@@\BM:OY?J4ZE&HZ=1-23LT]&FMTS^J*=2G6IJI3:<
M6KIK5-/9I]F%%%%06%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<R." -PW?*I(SL5 >E<^(EIR=_R.G#QUY^WY_P!?H;-%%%<YN%%%% !1110
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M?;]%%%?S$?U*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%#\GFS-$)%VAE?>2,G ^;/V(_P!K3X8_!S0+?]K+]LC0_&%WXK^*6M3V]O\
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MT>T&_P#P*5O_ &T_HWP3H<N48JM_--+_ ,!C?_VX****_&3]K"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#\._\ @NE\.Y/!'_!0'6/$'E%8O%?A
M_3=5BXX^6'[&V/\ @5JQ/N:^.Z_43_@XY^&3D?#+XR6EJ=H^WZ+?S8Z']W/;
MKG_P)/X5^7=?V5X?8[^T.#<'4OK&/(_^W&X_DD?Q9XBX#^SN-,93MI*?.O\
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M%]W,_P 9,_K+PJP'U+@ZE-K6K*4W]_*OPB@HHHK\\/T8**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /F#_@L/\&?^%S?L"^,H[6U\V^\+I%XAL.,[
M#:L3.W_@,]P/QK\%J_I[\1^'])\6>'K_ ,*Z_9K<6&IV4MI>V[])89$*.I]B
MI(_&OYMOVAO@]K/[/WQR\5_!;7MS7'AK7+BQ$KKCSXD<^5,!Z/&4<>S"OZ*\
M%,V53 XG+9/6$E./I)6?W-+_ ,"/YO\ '#*'3Q^&S**TG%PEZQ=XW]4W_P"
MG&T445^Y'X.%%%% !1110 4444 %%%% !7[.?\$:?^"CFE_M"?#JS_9J^+7B
M#;X]\-67EZ7<7<GS:[81CY65B?FGB48=?O,JB3YOWFW\8ZTO"'B_Q/X \4Z?
MXV\%:[<Z9JVE7:76G:A9RE);>9#E74CH017RO%_"N$XLRIX6K[LUK"7\LO\
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M%]<FOW>'][UF[J*^6LODNYV]%%%?S"?U,%%%% !1110 4444 %%%% !1110
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M;#5%.#V<6FOO1^,XO!XO 5W1Q-.4)K=233^YA11170<QZ/\ LA> S\3/VG_
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M#->G>#_A9H/A=DO9_P#3+Q>1-*ORH?\ 97M]3D_2NEAAAMXE@MXE1$&%1%P
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* *6N^(M'\,VBW^MWGD1/((U?RV;+$$XPH)Z UD_\+:^'W_0P?\ DI+_ /$5
MG?'7_D4;;_L))_Z+DKR>OHLMRC#8S"JI-M.[VM_D?-YGG&*P6+=*"35EO?\
MS1[;9_$_P-J%Y%86FN;Y9Y%CB3[-*-S$X R5P.36_7@O@[_D;M*_["4'_HQ:
M]ZKCS; 4<!4C&FV[KK_PR.W*,?6Q].4JB2L^E_U;"BBBO)/7"BBB@ HKY _9
M4_:!^,7_  4:^(_Q7\>>"_C%JW@#X7?#KXD:AX$\*6?A?3]/>_\ $=[IPC6^
MU2ZGO;:X"VYG?R[>&%8SMA=Y6?S%1/4O"/CKQ[^S!X>\4WO[8'QM'B.ROOB)
M!I_PSOXM"C&I:C97%A9+!9&TL(A]HO/M:WY/E1C<BF39'&-J 'MM%>!^*O\
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M44 %%%% !1110 4444 %%%% !1110 4444 <7\=?^11MO^PDG_HN2O)ZUO\
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M?L<^(;[Q98Z!XG\;7P\":U/I'C.[L_@]XHEM=$OH55YH+FX733%"R(Z.VY@
MCJQ.U@3[!\*OBS\,/CG\/M+^+'P:^(&D>*?#.M6_GZ3KN@ZA'=6MTF2I*21D
MJ<,&4C.592" 010!\1_\$^OV+?B%\,?^":7BKX7_ !__ &*H+3XD2ZMXSNK/
M2[Y] O;J_&I:I?W=GY=U'=R0@B*YB4^;+'M*D#@ GR[P+^QS^VA\$OV-OV-_
M%6L_L21^/M;^ OAS4O#7Q/\ @MJNLZ+-<W]G?VT$37]A*UQ+92S6\MI$Z(\B
ML\<LBC82<?J=67XW\6Z=X!\%ZOXZUBTOKBTT72[B_NH-+L)+JYDCAC:1EA@B
M#232$*0L: LS$  D@4 ?$7B?X?\ [17AV]^$VO?!O_@G*G@;P#K_ (ZU[5OB
M3X(^%\N@:3XITUKC3X8K*YN;N*ZAACDN+A9FO);*Y\[REMHS*X699/*O@_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
@B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>jnj-20200927_g5.jpg
<TEXT>
begin 644 jnj-20200927_g5.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MOF+]H?\ :'^,/@7XPZQX6\*^+_LMA:_9_(@_L^W?;NMXW;YGC+'+,3R>]<5_
MPUG^T#_T/_\ Y2K3_P"-5]GA>!LVQ>%A7A.%II25W*]FKJ_NGQ.+X\RC!XJI
M0G3J-PDXNRC:Z=G;WMC[2HKXM_X:S_:!_P"A_P#_ "E6G_QJC_AK/]H'_H?_
M /RE6G_QJNC_ (A]G7_/RG]\O_D#G_XB+DG_ #[J?='_ .3/M*BOBW_AK/\
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M_P!H'_H?_P#RE6G_ ,:H_P"&L_V@?^A__P#*5:?_ !JC_B'V=?\ /RG]\O\
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MW#_TE!1117EGJA1110 4444 %%%% !1110 4444 %%%% !1110!\6_M:?\G
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MYD_'#XL^+?V%_P!M;QA9_M.^$KJ+P+\5OB]X:\3>&OBLD9EM+.*SDA#Z?=L
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MOD__ $IA1117IGEA1110 4444 %%%% !1110 4444 %%%% !7T9^P#_S-O\
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M_MP_]N*^8XR_Y)NO_P!N_P#I<3ZG@K_DIJ'_ &]_Z1(^C****_"C]["BBB@
MHHHH **** "BBB@ K\YZ_1BOSGK].\./^8K_ +<_]O/RWQ*_YA?^XG_M@444
M5^G'Y:%%%% !1110 4444 %%%% !1110 4444 %%%% 'VE^R7_R;]X?_ .WO
M_P!*YJ]&KSG]DO\ Y-^\/_\ ;W_Z5S5Z-7\[YW_R.L3_ -?)_P#I3/Z/R/\
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MOB5_S"_]Q/\ VP****_3C\M"BBB@ HHHH ***P?^%H?#S_A8?_"I?^$RT_\
MX27^S_MW]B?:!]H^SYQYFWT]NN.<8YH WJ*** "BBB@ HHHH **** /M+]DO
M_DW[P_\ ]O?_ *5S5Z-7G/[)?_)OWA__ +>__2N:O1J_G?._^1UB?^OD_P#T
MIG]'Y'_R),+_ ->X?^DH****\L]4**** "BBB@ HHHH **** "BBB@ HHHH
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M&_:T_P"3@?$'_;I_Z20UYS7]$Y)_R)<-_P!>X?\ I*/YOSS_ )'>*_Z^3_\
M2F%%%%>F>6%%%% !1110 4444 %%%% !1110 4444 %?1G[ /_,V_P#;A_[<
M5\YU]&?L _\ ,V_]N'_MQ7S'&7_)-U_^W?\ TN)]3P5_R4U#_M[_ -(D?1E%
M%%?A1^]A1110 4444 %%%% !1110 5^<]?HQ7YSU^G>''_,5_P!N?^WGY;XE
M?\PO_<3_ -L"BBBOTX_+0HHHH **** "N=_X5)\-/^%E_P#"X_\ A"=/_P"$
MH_L_[#_;?D#S_(S]W/KVW?>V_+G'%=%10 4444 %%%% !1110 4444 ?:7[)
M?_)OWA__ +>__2N:O1J\Y_9+_P"3?O#_ /V]_P#I7-7HU?SOG?\ R.L3_P!?
M)_\ I3/Z/R/_ )$F%_Z]P_\ 24%%%%>6>J%%%% !1110 4444 %%%% !1110
M 4444 %%%% 'Q;^UI_R<#X@_[=/_ $DAKSFO1OVM/^3@?$'_ &Z?^DD-><U_
M1.2?\B7#?]>X?^DH_F_//^1WBO\ KY/_ -*84445Z9Y9!J=Y)I^FW%_#83W3
MP0/(MK;!3),5!(1-Q W'&!D@9/)%?%?[6/[0O_!2W]D/2]+_ &H/%S?#G7?
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M@ HHHH **** "BBB@#XM_:T_Y.!\0?\ ;I_Z20UYS7HW[6G_ "<#X@_[=/\
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M1.2?\B7#?]>X?^DH_F_//^1WBO\ KY/_ -*84445Z9Y84444 %%%% !1110
M4444 %%%% !1110 5]&?L _\S;_VX?\ MQ7SG7T9^P#_ ,S;_P!N'_MQ7S'&
M7_)-U_\ MW_TN)]3P5_R4U#_ +>_](D?1E%%%?A1^]A1110 4444 %%%% !1
M110 5^<]?HQ7YSU^G>''_,5_VY_[>?EOB5_S"_\ <3_VP****_3C\M"BBB@
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M'_R11_P[S_;Q_P"BZ_"S_P )C4/_ )(H_P"(@Y+_ ,^ZGW1_^3#_ (AUG?\
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MH_X5/_P5R_Z.T^%G_A!R_P#Q= 'U-17RS_PJ?_@KE_T=I\+/_"#E_P#BZ/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7D7[=/[:OP5_X)[?LO^)_VKOCYJ4\6@^&[92MG9*&NM1NI
M&$<%I I(#2R2,JC)"J-SL5568>NU^37_  >!6&L_\,$?"OQ1=6DUQX4T3X_:
M-=>,8HE)5;8V=\BO(!_!N8ISQNE3N10!]:_!S2/^"IG[0WPCT[XV^.OCMX+^
M#NL>(]/34='^&]A\.CK<>A0RJ)(;?4KNXNXI+RX"D"7R%M55MRKG;O+?^"??
M_!1W7OVBOC5\3/V&_P!IOP3I?A#X\_!RYB_X2K1]$N9)-,UW3)E1K;6=-,O[
MT6\J2PEHI,O"9HPS,6X^KK2[M;^TBOK&YCF@FC62&:)PRNA&0P(X((.0:_)_
M3-(U77_^#P+4M5^&ZR&UT+]FV/\ X6#)#]Q?,"K"DA ZDR6#!3R=H(X7@ ]$
M_P""CG[3/_!:C]D3X*Z__P %"_"5Q\&X_A_X.EBO]7^".IZ+=2ZL=%:=(R\V
MJI/Y9O@DBN\<2"&(AE1[G8#-^A'P[\7?\+ ^'^A>//[$N],_MO1[6_\ [-U"
M/;/:>=$LGE2+V==VUAV(-?&G_!<?X!?MY_%K]F*_\=_LC_'?PO867P_\KQ7J
MGPR\0^!H[Z#QE_9KB]%G<7,LK#9N@5EA$*K(ZJKN 0R_0_[!'[3-S^V9^Q=\
M,/VJ+_PTNC77COP98ZO?:5&6,=K<2Q RQQEN6C$F[8QY*[3WH ^:_P#@N7^U
MC_P4N_8%^ 3?M=_L9V/P_P#$O@[P_<PIX^\/^(_!UY>:AI=DY"G4898+^%98
MD<@21E 4#A]VQ7*_1^B_M+>!-8_8@B_:SM/C_H$OAN?P.?$:?$(:(PL19^29
M_M!M//+C:GRF'S=^X%>&XKU+Q3X7\.>-_#.H^"_&&B6NIZ1J]A-9:IIM[")(
M;NVE0QRQ2(W#(R,RE3P02*_'3_@F=^SMXQ^%O_!3/XM_\$2M6^);ZU^SY\#_
M !'8_%'PGX>OHWDN9C=K:WECH\\C,0]E;75U'=E,?O+FT1S\LDB$ ^S/A/XP
M_P""ROB;]B30OB%X[E^%6G_&+QKJND_8?#Y\ ZC'IWA+3KBZC:XEU!!J3RW%
MQ'9>:S1H\2I,5CWL%WMY1^T;^V-_P5&_9_\ ^"DW[/\ _P $^C^T#\&=73XV
MZ;K=S<>+/^%(ZC;G2#I]I)<86V_X2%_.$ACV\RIMSGYL5^DM?F#_ ,%&O^5D
M+]@O_L7_ !M_Z:[F@#Z4LM9_X*=> HOC#I?Q=^*7POU*V\/^#+'7?AEXTT'X
M87]G;W,^S4_MUE?6DNJS;FC:"P93%<+E)F. 3A?%?^"5G[47_!5S_@I1^P9X
M8_;4A_:"^!GA:]\3SZFEGX5N/@EJMY!$;2^GM )+E?$43D.8"V5C&S>!A\<_
M<O[0G_) _''_ &)^I_\ I+)7P_\ \&K'_*#GX1?]A#Q)_P"G^_H [7]BS_@J
MI\1O&O[:7B/_ ()B_M[?!?2OAW\;]$TDZQX=NO#>J276@>-M*&2;S3GF598V
M"AV,#[F BERP:*1%^QO'/BNU\!^"M8\<7VFWMY!HVEW%]-9Z9;&:YG2&-I#'
M%&.9)&"X51R20.]?E-_P4RMSXU_X.;OV)_#7PN7S?%.@^%]4U+Q4]H?GMM&(
MO"/.8?=0JEXH#8R9<?QBOUMH _,+]L_]I[_@O_\ L:_"#4?^"@OBCPW\"-6\
M ^'/+U+Q?\#M+M[Y]3TK1BZ[\:JS!;BZB1AYLB((@59DCD5=I^A?VO\ _@J%
MIGPB_9/^#_Q;^ WA6WUKQK^T;K/AW1/@WX?\0,T4!O-9CCEBN;X1'>MO;PR>
M9*$()(6,,GF!UTO^"CF@:K^V)X4N_P#@FC\,M0DBNO'UG ?BIX@ML%?"WA-I
MO](9CR/M=\L4EI;1'D[IYR-EL^?F'_@L!X$TWX??\%)/^":6B^'-)BT[P3X=
M^)NKZ-;VD8(@MIOLVEQZ="!ZA8953Z4 ?0NK_M;_ !R_8U_;1^$O[+7[6?Q"
MT?QKX;^.EM?V/A#QOI_AH:3-I/B2SCCE;3[B%)I(WMKJ.0"W8?O4DC9':4.'
M3+_:9UO_ (+2_&CQ7XGUC]@K4_A#\/\ PEX5O[BP\/P?$O1[R\U3QE=VQ*7$
MC>65CT^S:=7AA;#R2"/SLK'(E>0?\' ]OJFL_M+?L$>&?"H8ZU-^UGHMW:F(
M?,EM!+"]P_KL5"&;M@<U]V?M-_'P? 3X?K?>'O#,GB3QEKUS_9?@'P;:RA)]
M=U9T9HX Q_U4*!6EGG/RP012RMPG(!\T_L&?\%@])^.__!,CQG^W;^U3\/QX
M&UCX07FMZ3\6=!T\F2.#5-*17GCM [$MYBR1!(V8D22>7O?:';C_ !3^W[^W
M+\%?V /#?_!7'XP0>&KKP7J<&D^(?%GP9TC0&%UHGA34IHDAEMM1:;?<:C;P
MW$%Q,)(UAD FC6.$A9*\P_X*F_L0ZU^QI_P;1?&?X(^'=<&N^,+T6OBCXB>(
M[2$QC6-6N_$=C>ZO=*O58MGFHBGD0Q("202?6/\ @H_K'ABU_P"#;3QAJ5O+
M"VF3_LX:8E@Z@;&$ME:I!MSZLZ8[].] 'WIX6\3^'_&_AC3?&?A/58;_ $K5
M["&]TR^MVS'<6\J"2.13W5E8$>QJ_7@W_!++1O$WA[_@F9^SSH7C-95U6S^"
M7A:&^CG_ -9'(NDVP*-G^)?NGW!ZU[S0 4444 %%%% !1110 4444 ?+?_!1
M'_@HO-^R7XM^'/[,?P0\#6OC7XX_&?66TWX=>$[V[:"RMHHP&NM5U&2,%X[.
MWCW2,$!DDV,J8VNZ1_$_P3_P5>^%OPSN_BM\-_VCOA_\2/%6D63WUU\-K_X:
M-I.G:YL7<]E9745[)<64K %8I)C<+O*AUP2R_'W[3D=_X;_X.\/V>-?\?*ZZ
M3K/P%U&Q\&74W$*WB0ZX9HE)X\S:[9'4B>,=P*_6F@#YI_9%_P""C'A__@H/
M^P?;?M>?L=>"/[6UR_5M.'@S7=16V.D:XKI%+:WTP4E(H6D69Y$1G:WP\<;L
MRQGP&\_:J_X*Q_L9?\%!?@K\#_VP/$/PO^*/PZ^/FLWVBV5W\/O"5WI-_P"%
M=2@MFN1A);B;S[4)DL[LS;(Y&)C* 2>7_P#!JMI&JG0/VL/&OA]9!X"UC]I+
M5?\ A#6'$4GE[C*\? !!BDM%W#CY,?PD#I?^"EVN?M^_L,?M]?!G_@H9K/Q2
M\*_$KX27GC.U^'M_\/V\#I9W?A"WUJXBB>_LI_-EDEG?RHT:7>A)"1;#'*VP
M _3^OS:_:X_X*"_\%#?V)/\ @J!\)?V?/CQXV^%]C^S[\8M3DT_0?B8GP_O1
M=Z?J?EN(M+NV.I^3%(\Q@ G*A&28ML'ER;/TEKPS_@H_^P=\*_\ @I'^R%XK
M_93^*J+!'K-MY^@ZTL6Z71=5B!:UOH^ARCG#*"-\;R1D@.: ,K_@I+\<?VC/
M@Q\']#L/V/=5\*R?%7QAXOL-!\#>'?%NBS7MKJT\TH:Y,GD7$+PPVUG'=W<L
MP+!8[9OE8E5-3QMI7_!4&[\<^"/AO\._C+\*["TB\,7M]\1O'>K_  JU"[@G
MO_-MDM+2PLDU>'R@5^UN[27,A 6/Y3GGY>_X-Q?B#\8_VYOV<M+_ &X?VMO&
MD7B7QCX*L[CX:>$'$3;;.RM#"]YJ#EB3)?7KBV6>;C*6,( !:3=^FE 'YL?L
MC_MC?\%2OVJ?VY_VDOV+T_:!^"^A?\*#OM&M;7Q&?@EJ5S_;1OX9Y-SP?\)"
MGV<(80,"1]V[JN.6?\%(OV__ /@I[_P3X_X)6-^V!XQE^%Q^)?AKQM/H7B;1
M7\$:@=(U6V;6KNTM+VTW:@DT"R68LY\,T@RSCC(VY?\ P2)_Y3G?\%%O^Q@\
M&_\ I)?5H?\ !VQ_RA;\8_\ 8X>'_P#TN2@#Z!\9Z3_P60\)?"X>/_A;\:/@
M'\1==BT];K_A"M3^%>J^'EU([ Y@@U!==NE@D/*J9860DC<4&6J__P $L_\
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M_P#LU:_\)_V?OA)::5-\2_CEXY'AOP;+KT+RV.EPQ1^??:G<11O&]PEO#C;
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ME;1V=G;I%#$@2**) JHH& H X  XQ3Z** "BBB@ HHHH **** "BBB@#P/\
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MPOGT_P"P?8Q*MNMM<G5IND<S*Q>-MQ 8;>E;?_!7_P#X)O\ CK_@JA^RS/\
MLFZ1^T-I?P]T/4=6L[[5=0G\"R:Q=2M;2&1$B(U"U2(%MF<JYPI QGCZNHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
/"BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>jnj-20200927_g6.jpg
<TEXT>
begin 644 jnj-20200927_g6.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^T4?\-_?]4F_\KW_ -HKYSHH_P!3>&_^?'_DT_\ Y(/]=>)O^?\ _P"2P_\
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M[X*_Y)FA_P!O?^ER"BBBOF#ZD**** "BBB@ HHHH *^<_P!O[_F4O^W_ /\
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M"QL;6/;'%&.@ _4D\DDDY)K1H **** "BBB@ HHHH _1BBBBOYC/ZD"BBB@
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MS'"J2)C5I3ASQDFN]]"I4JL)\DHM/M;4TZ***T,PHHHH ^C/V ?^9M_[</\
MVXKZ,KYS_8!_YFW_ +</_;BOHROPKC+_ )*2O_V[_P"D1/WO@K_DF:'_ &]_
MZ7(****^8/J0HHHH **** "BBB@ KYS_ &_O^92_[?\ _P!MZ^C*^<_V_O\
MF4O^W_\ ]MZ^GX-_Y*2A_P!O?^D2/EN-?^29K_\ ;O\ Z7$^<Z***_=3\$"B
MBJFNZ[HGA?1;OQ)XEUFUT[3K"W>XOK^^N%BAMXD4L\DCN0J*H!)8D  9-)M)
M78TFW9%NBO-_@?\ MA?LN_M*:K?Z%\!OCOX:\57VEIYE]9:1J:2311[MOF;/
MO&/<0-X!7) SR*N?'3]J#]GG]F73+/5_C]\8M \)PZC*T>GC6+]8WNF7&[RT
M^\X7*[B 0NX9QD5BL5AG1]KSKD[W5OOV-GA<4JWL7!\_:SO]VYWE%9'@+Q_X
M'^*7A"Q\?_#;Q=IVO:'J</FZ?JVDWB3V]PF2"5="0<$$'T((."#6O6T91E%-
M.Z9C*,HR<9*S045SGAKXO?"WQGXVUOX<>$/B#I&J:]X:2%O$.E:??I--IOG&
M01K.J$^4S>4^%;#87.,$9H_%#]H'X+_!>>&U^*/Q'TW1II[.:\6&ZE)=;2(J
M)KIU4$QP1EE#S-B--PW,,BH=:BH<[DK=[Z=M_70T5&LY\BB[]K._?;TU.QHJ
M*RO;/4K.'4=.NXKBWN(ED@G@D#I(C#*LK#@@@@@C@@U1\,^,_"WC/^T#X6UN
M&^72M3ETZ_>W)*Q746/-BW="R$[6QG:P93AE8"^:-TK[F?+*S=MC3HHHIB"B
MBB@#]&****_F,_J0**** "BBB@ HHHH **** "BBB@ HHHH **** /SGHHHK
M^G#^6PHHHH ^</VY]6_8G_9R_9_\>^.OVB_#6B3P^+;.Y_M"+4+'[5?:W<M%
MY<4*DJTF$_=1H>$A 0@H!FG_ /!/GX*_#JW_ ."<'P_^"R_$>Q\?>'9O#'E7
MNL:7=.;744EGDEGMU/RN859WMRCA240HZJ=RCI+_ /;F_88\4:QXN^$?B?X^
M^#C?^';N?2O%/AOQ#<K;R&128Y81!<A3=*3E/W0D5B0!DD ^5_L%Z'X/_P""
M?/[#/B+Q]\;+JZ\'>"F\;ZMK^E66JV<[3Z'HMW>K%80S0HK2(Y3RG9-NY#,0
MX5@V/!YJ#S-58N#I\DTVOLV:;YG>S3\[6L_,^@Y<1_9?LI*:J<\&D_M734>5
M6NFEVO>Z\CB/VK[W]B+X@?\ !0?X _!/PIX[\*>%/'7@;Q;_ &O<75A9BW:2
MVA3;#HB2QH(VDN)]@$1<;4BE&-[JC_>=?%'[?,O[/7_!0[X5>"O '[-_COP[
MXS\;R>-M'U+PSK'AB^BNYO#UJETCWE[<21$M:0K;K*"LA4O*(T :3:!]*_%+
M]J/X,?!KXM>!/@C\0/$<]IXB^(]W<VWA2UCT^:5+B2!4:0,Z*5C_ -8@!8C)
M;T!(O U*='$XB<G'DDXM26B=URJ.[5U9;/7F6G0C'4ZE?#8>$5+GBIIQ>K5G
MS.2T3Y7=Z-:<KU>Y\[?\%Z_!GA'5_P#@F7\0_%VJ^%]/N=5TDZ.=+U.>S1KB
MTWZS8QOY<A&Y-R.ZD C(8YKUG]O+X>_$GXK_ /!/_P"(?PZ^$,$TWB+5O DT
M&G6ELV)+O]V"]NGJTL8>,#N7QWKRG_@O7XK\,:1_P3$^(?AK5?$5C;:CJSZ.
MFEV$]VB37C)K-C(XB0G<^U%9CM!P%)-?5WPZ\4>&O&?@?2_$GA#Q#8ZKI]S9
M1M;WVG7:3PRC:!E70E3^!J72I5\VQ-%NW-2@G;?5U5]]FOP&JM;#Y1AJR5^6
MK4:OMHJ37RNG^)\=_!ZY7XG_ +<GP:^)'PCCDC\-^"?V?[BQ\>:@L)BAL6G,
M M]+N&( 2XCDB:1K=L/&(RS!<C/MOPRUO1OBWXW3]KCXA:O:Z=X7MU?3?A-!
MJ=PL,;VTWRRZN=Y \V\P%A!^9;55(P;F5:N?&J>?]H'XA?\ #*V@SN- M8(K
MWXJWT+$ V,F3!HRL.DEW@M*.J6JL#M-S$U>3?%K3]%OO^"KF@>'?CE8:>WP[
MM_V=-6E\*VFLQI_9PU(:C$NHE5?Y1*MAL#<<0EN@S6:B\)M[R<UY+F=H^=E&
MWSGVL:N2QFGPM0?G+E5Y>5W*_E:'>Y]?=>E%?,__  1[U/XB:O\ \$Y_AO>_
M$N:^ENC97::9-J>[SY-,6]G6Q9MW./LPAV'O'L/>OIBO9PF(6+PM.NE;FBG;
MM=7L>)C,.\)BZE"]^235^]G:X4445T'.?1G[ /\ S-O_ &X?^W%?1E?.?[ /
M_,V_]N'_ +<5]&5^%<9?\E)7_P"W?_2(G[WP5_R3-#_M[_TN04445\P?4A11
M10 4444 %%%% !7SG^W]_P RE_V__P#MO7T97SG^W]_S*7_;_P#^V]?3\&_\
ME)0_[>_](D?+<:_\DS7_ .W?_2XGSG1117[J?@@5B>/?A[X,^)FBQ^'O'VB0
MZGID5[%=R:==C=;SO$V^/S8S\LJJX5PK KN16QE16W7$?'O]H_X)_LO^#[7Q
M_P#'KQ_;>&]%O-6ATV#4KR"5XOM,JNR(QC1M@(C<[VPHQR16=:5&%)RJM*/6
M^WSN:T8UIU4J2;ETMO?RMJ?)6@:_^QK\9_\ @LAX;UOX)_$KPWIGB?X?>!M2
MMM?L=,@,#^)[FX4I';QD(L=R+6'S9G968_/$%W"-S']-_'D_LL_!O1/$/[0G
M[0UEH<5J^EK:ZKJNO60O&-G&K$6D4;*[%#F1_)C4[F=V())->$_M$^&/@]^V
M/^UG\!/'W[-OB/1/$FN^ _&!UGQ/XR\+WD5U;V&A);NS6EQ=0$J7GF,"Q0EB
MVUIG"A [5[EXF_;=_9$\'_%S5O@%X]_: \,:#XJT>TBN-2TCQ%?BQ BEC61"
MLEQLBFRC!B$9B >0,&O$PCITE7]HX*\[QE]EMQ71O=+1V>MF]'<]S&*I5E0=
M-3=J=I1^U%*3ZI;-NZNM+I:JQX__ ,$7?#7PIT3]CRYUWX,^/+'5]"\2^.M7
MUNUTNPE9E\.1W$BF+2F# ,DD,*Q%P0!OD8J64J[?65Q;P74#VMU"DD4B%)(Y
M%!5E(P00>H([5\K_ /!.;X(:1\+_ !Y\=?C+X%T)]$^'WC_QW%J'@K3#:- C
MV\%J%N;Z*$@;()[AYC%\HW1Q(RC8R$^U?LU_M/\ P:_:V^%,7QI^!_B2;4?#
M\UY<6JW=U82VK"2%]K@I*JL!T.<8P?7('3E,XTL#2HSM&5G9+JHNW,D];/1^
M2:.7.(3JX^K7A>4;IMOHY*_*VM+K5>;3/FS]AGPIX8\$?\%6?VN_#?@WP[9:
M5IT-OX'>&PTZU2&&-I-)>1RJ( !N=V8X')8GO4?QN67X1_MP?&?XC_&>"4^&
M_&7P!AT[P5=2P-)%=RV[3BYTF'@[[F2259%MQEY!)E0V&Q6_8L^*'PUUW_@K
MM^U<FB_$'1+LZQ;>#%T@6VJ1/]N-OI!CN!#AOWOEO\K[<[3P<5]B_$KXB>%?
MA-X$U3XC^-KYK?3-(M3/<M'&9)'Z!8HT',DKN51(URSNZJH)(%<."P]+$9>[
M245"K5=]U\=1:K32SO\ <SOQN(JX;,5>#DYTJ*MLW^[IO1V>MU;;NCYE_9LF
M^.GP>_86^#7[*9DFLOBSKWA".U'VR,22>&=/C"^??SHW&;2&6&%(VX>X>&(_
M*79?H[X1^'?AI\/_  A;_"CX8ZA:O:>&8Q:3VT5\L\\4ARS-<-DL9I&+2.S_
M #.SLQR237CWB+P%\<M'_9D^+/QV@L98OC'XO\#ZC/I%G:2>9)H@BM)SIFDV
M[+P6A9]S,.)+F:9Q\K(%^<OV<7TG2?BA^PJWP!6$7.K_  BUA_B0=-4;[FP_
MLRU>22_*<DC5-^"__+P9 #DL*N&(> G3IN+>D4K[J+E&"]7KS2VMHO,B>&68
M0JU%)+WI2=MG)1E-_+3EAO=W?6Q^BU%%%?0GS@4444 ?HQ1117\QG]2!1110
M 4444 %%%% !1110 4444 %%%% !1110!^<]%%%?TX?RV%%%% % ^%O#)US_
M (28^'; ZELV_P!H?8T\_;C&/,QNQCMFKEQ;P7<#VMU DL4B%9(Y%#*RD8((
M/4'TI]%))+8;;93T3P]H'AJS_L_PYH=GI]ON+>196R1)D]3M4 9J6XTW3KN[
M@O[JP@EGM68VLTD09X2PVL5)&5R#@XZCBIZ*+)*P7;=PHHHIB*NG:)HVCRW<
M^D:1:VKW]T;F^>VMU0W$Q54,LA4#>^U$7<<G"*.@%4O&GP^\!?$C3$T3XA^"
M-(UZRBG6:*TUK38KJ))5SM<)*K ,,G!QD9K7HJ7&+CRM:%*4E+F3U&PPQ6\2
MP01*B(H5$1<!0.  !T%.HHJB0HHHH ^C/V ?^9M_[</_ &XKZ,KYS_8!_P"9
MM_[</_;BOHROPKC+_DI*_P#V[_Z1$_>^"O\ DF:'_;W_ *7(****^8/J0HHH
MH **** "BBB@ KYS_;^_YE+_ +?_ /VWKZ,KYS_;^_YE+_M__P#;>OI^#?\
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MHH **** "BBB@ HHHH **** /HS]@'_F;?\ MP_]N*^C*^<_V ?^9M_[</\
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ML/)/^@6G_P" 1_R/A/\ X=Y_MX_]%U^%G_A,:A_\D4?\.\_V\?\ HNOPL_\
M"8U#_P"2*^[**/[;SK_H)J?^!R_S#^P\D_Z!:?\ X!'_ "/A/_AWG^WC_P!%
MU^%G_A,:A_\ )%'_  [S_;Q_Z+K\+/\ PF-0_P#DBONRBC^V\Z_Z":G_ ('+
M_,/[#R3_ *!:?_@$?\CX3_X=Y_MX_P#1=?A9_P"$QJ'_ ,D4?\.\_P!O'_HN
MOPL_\)C4/_DBONRBC^V\Z_Z":G_@<O\ ,/[#R3_H%I_^ 1_R/A/_ (=Y_MX_
M]%U^%G_A,:A_\D4?\.\_V\?^BZ_"S_PF-0_^2*^[**/[;SK_ *":G_@<O\P_
ML/)/^@6G_P" 1_R/C;P!^R;_ ,%,OA=]K_X03]I7X66/V[R_M7_%&W<N_9NV
M_P"LE;&-[=,=:Z/_ (5/_P %<O\ H[3X6?\ A!R__%U]345P5J];$U74JR<I
M/=MMM]-V>A0H4,-25.C%1BMDDDEUV6FY\L_\*G_X*Y?]':?"S_P@Y?\ XNC_
M (5/_P %<O\ H[3X6?\ A!R__%U]345D:GRS_P *G_X*Y?\ 1VGPL_\ "#E_
M^+H_X5/_ ,%<O^CM/A9_X0<O_P 77U-10!\L_P#"I_\ @KE_T=I\+/\ P@Y?
M_BZ/^%3_ /!7+_H[3X6?^$'+_P#%U]344 ?+/_"I_P#@KE_T=I\+/_"#E_\
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M:%IF@>%)M/F\4:[:0M#9:GJSRW4R_N0[R_9H0J/.WF,VQ5A  S_@M[%>0?\
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MRQ+0R-AQ](T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
:HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>jnj-20200927_g7.jpg
<TEXT>
begin 644 jnj-20200927_g7.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS_\ _)8?_(GT9_PW]_U2;_RO?_:*/^&_O^J3?^5[_P"T5\YT4?ZF\-_\^/\
MR:?_ ,D'^NO$W_/_ /\ )8?_ ")]&?\ #?W_ %2;_P KW_VBC_AO[_JDW_E>
M_P#M%?.=%'^IO#?_ #X_\FG_ /)!_KKQ-_S_ /\ R6'_ ,B?1G_#?W_5)O\
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M^1/HS_AO[_JDW_E>_P#M%'_#?W_5)O\ RO?_ &BOG.BC_4WAO_GQ_P"33_\
MD@_UUXF_Y_\ _DL/_D3Z,_X;^_ZI-_Y7O_M%'_#?W_5)O_*]_P#:*^<Z*/\
M4WAO_GQ_Y-/_ .2#_77B;_G_ /\ DL/_ )$^I?A]^VC_ ,)WXUTSP?\ \*U^
MR_VC=K#]I_MG?Y>>^WR1GZ9%>YU\,?L^_P#):_#7_85CK[GK\ZXRRK 95C:=
M/"PY4XW>K>MWW;/TC@K-LPS? U*F+GS-2LM$M+)]$@HHHKX\^S"BBB@ HHHH
M **** "BBB@ HHHH **** "O)/VU?^2*-_V%;?\ ]FKUNO)/VU?^2*-_V%;?
M_P!FKV>'?^1[AO\ ''\SQ.)/^1#B?\#_ "/D*BBBOZ#/YV"BBB@ KFOBI\8?
MAC\$O##>+_BIXVT[1+$OY<$E_=I&US+M+"&)6(,LA .$7+'!XKI:^'?^"HFJ
M?&']GKX_^ ?VW],^&6H>-?A]X7\):UH/BW3=)4276@_;E4?VI%&>,;55'?@!
M(RK,H<,.',<7+!81UDKVM?1NR;LY-+5I+5G=EN$CCL6J+=KWMJE=I744WHFW
MHCZG^"/[3'P,_:)TE-2^$?Q)TK5IA90W5YI4-ZGVVQ25%=//@SOB)##[PP>Q
M-;'C+XO?"WX>:]HGA7QQ\0=(TK5/$E\MEX?TR]OT2XU&=C@)#&3ND/KM! [X
MKQ_]ABZ^ OQP^%OPW_:5^%'BC3-7U#2OAC#X4U&]TXJ9%PMG(]M<='1X9;=M
MJ. 1Y[D</D^5_P#!2GP9X0L_VQOV4O&]GX7T^'6;OXPB"[U6*S1;B>,6ZX1Y
M -S@;%P"3C:,5S3QU>EERQ'NR;<=5LU)I7Z]^YU4\!AZN9/#^]%)2T>Z<4W9
M[=NQ]KUY?;?MM_L=WOCU/A;9_M1^ )O$LFK?V7'H,7BRT:\:]\SROLPB$FXR
M^9\FS&=W&,UI?M13_'&']GWQ8G[-6B07_CN?2)+?PS%=7L=O'%<R803EY#M'
ME!C( ?O% O>OC']AWXB_L]> /VA/#7[+_P"U)_P34\)?!CXO0V8?P5XH&AV%
MZGB!X8\/+#JBQ>8;HJ&);S)"[;MTF]@C5C<?/#XJG1C9*762E;5V44UIS/LV
MNEMQ8'+Z>)PE2M*[<?LQ<>;17<FF[N*[I/K>UC]#*SO%OC#PEX \.W7C#QUX
MHT[1=)L8_,O=4U:]CM[>W3.-SR2$*HR0,D]ZT:_/#0?VDXOVJ?VW/B+\5/&G
MPI\<>.?A]\!M9.B^!/!_A/PZU[;W&LPEA>:Q,'9(9[B,KMMX]S2*DH=(PV6.
MV.QT,'R1^U-V7R5VWY)?>[+J88# 3QO/+:,%=_-V27FV_DKOI8^]O _C[PK\
M1]%_X2/P;?RW=@S[8KM[*:&.88!WQF1%\U"#PZ94\X/!K9K@OV;/VE_@[^UI
M\*;/XR_ _P 4?VIHUW*\$GF0M%/:7$>!);SQ-AHY%R,J>H96!*LI/>UUT:D:
MU*,XR4DU>ZV?IN<E:G*C6E"47%IVL]UY/;\@HHHK0R"BBB@#] _ O_(D:-_V
M"K?_ -%+6K65X%_Y$C1O^P5;_P#HI:U:_FG$?QY^K_,_IW#?[M#T7Y!1116)
MN%%%% !1110 4444 ?+W[>7_ ".^A_\ 8*?_ -&FO"*]W_;R_P"1WT/_ +!3
M_P#HTUX17[WPI_R3V']'^;/Y^XN_Y*/$>J_])04445]"?.!1110!YS\:OVLO
MV?\ ]G[4[#0OBC\2-/L=2U&YMXX=*299+I8YI1$MP\*G>L(8\R$8X.,GBNL\
M _$;X??%7PU#XS^&/CC2?$.D7!*PZGHFHQW4#L.JAXV*Y'<9R.]?G'\</BSX
MM_87_;6\86?[3OA*ZB\"_%;XO>&O$WAKXK)&9;2SBLY(0^GW; %HQ%%&P1>J
M[68*5<LOZ#?"#P)\.O"MOKOB_P"%]S8S:9XXUT^(VFTMD:VFEFM;>)IHVC)5
MQ+Y E+C[S2LW.<UX^!S"MB\54@[+D;3CJI+5V?FFDGHK:Z-V/9Q^74<'A:=1
M7?.DU+1Q>BNO)IMK5WTU2N7=,^+WPMUOXC7WPAT7X@Z1>>*-+L1>ZGH-K?I)
M=6<!8*KRQJ28P20!NP3VKHZ^*/V>O!GA#P-_P6K^,&E^"_"^GZ1:S?![19Y+
M73+-((VD,Z OM0 9(49..<5)_P %0_VB/%5W\7OAC^P#\/-2\06,OQ*N)K_Q
MWJ'A2TFFU*+P];[C);6WD@O&]R8Y8O-X5%0[B%9B!9K[/!U*]6.L9N"2ZOFY
M8[]WOV!Y3[3&TZ%*6DH*;;Z+EYI:+LMEUV/JGPM\;OA1XZ\47?@[P-XWL];O
MM/E>+41HVZZALY4^]%--$&BAD'_/-V#9XQ755X/^RU^U%^S?J_C&Y_8V^'WP
M_P!7^'7B'P5H\4MKX \1:$NGR#3N%6XMA&[Q3Q9(!9')R23U)KWBN_"UUB*7
M,I)]';HUNN]UYV]$>?BZ#P];D<6NJONT]GII9^5_5G.+\7OA;)\3O^%*P_$'
M2)/%PTM]2?PW%?HU[':*T:&=X@=R)NE0!F !W<9P<='7Q1IG@SPCX,_X+VQQ
M>$/"^GZ6FH?LOO>7R:=9I"+BX;Q R-*X0 ,Y5$!8\D*/2OM>L\%B:F)53G27
M+)QT\K&N.PM/"NGR-OF@I:^=PHHHKM.$**** .Q_9]_Y+7X:_P"PK'7W/7PQ
M^S[_ ,EK\-?]A6.ON>OR3Q#_ .1E1_P?JS]@\.?^196_Q_\ MJ"BBBOSX_1
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M\3#&XJ>-Q4JTE:_Z*R_!;A11172<H4444 ?H'X%_Y$C1O^P5;_\ HI:U:RO
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MHHK$W"BBB@ HHHH **** /E[]O+_ )'?0_\ L%/_ .C37A%>[_MY?\COH?\
MV"G_ /1IKPBOWOA3_DGL/Z/\V?S]Q=_R4>(]5_Z2@HHHKZ$^<"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#L?V??^2U^&O\ L*QU]SU\,?L^_P#):_#7
M_85CK[GK\D\0_P#D94?\'ZL_8/#G_D65O\?_ +:@HHHK\^/T0**** "BBB@
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#] _ O\ R)&C?]@JW_\
M12UJUE>!?^1(T;_L%6__ **6M6OYIQ'\>?J_S/Z=PW^[0]%^04445B;A1110
M 4444 %%%% 'R]^WE_R.^A_]@I__ $::\(KW?]O+_D=]#_[!3_\ HTUX17[W
MPI_R3V']'^;/Y^XN_P"2CQ'JO_24%%%%?0GS@4444 %%%% !1110 4444 %%
M%% !1110 4444 =C^S[_ ,EK\-?]A6.ON>OAC]GW_DM?AK_L*QU]SU^2>(?_
M ",J/^#]6?L'AS_R+*W^/_VU!1117Y\?H@4444 %%%% !1110 4444 %%%%
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M0 4444 =C^S[_P EK\-?]A6.ON>OAC]GW_DM?AK_ +"L=?<]?DGB'_R,J/\
M@_5G[!X<_P#(LK?X_P#VU!1117Y\?H@4444 %%%% !1110 4444 %%%% !11
M10 5Y)^VK_R11O\ L*V__LU>MUY)^VK_ ,D4;_L*V_\ [-7L\._\CW#?XX_F
M>)Q)_P B'$_X'^1\A4445_09_.P4444 %%0:IJ>G:)IMQK.L7T5K:6D#S75S
M/($2*-%+,[,> H ))/0"OD/QW_P6"\(_"Z\L?&GQ)_9*^+6A_"[4;Z.UM/BC
MJ7AU8[,B1L1W+VY;SX[=\AD9U#LI&(R3MKDQ6.PN"2=:7+?U^]VV7F]#KPN
MQ>-;5"/,UZ?<K[OR6I]AT50?Q1X:B\,GQK-X@LDT=;'[:VJR72+;K;;/,\XR
M$[1'L^;<3C'.<5YY\'/VF/\ AH:6/Q'\'/AOJ5WX*>=DM_'&LS+8VNIHI(:6
MQA(:>XCR,"1TBC?JCN.:VE7I0FHMZO9;OUTZ>>QC&A5G!S2T6[V7IKU\MSU*
MBBO!=;_;OT)H?&GBSX<?"+Q#XM\'?#C4)[+QGXKTB:V5(I[=0]VEG#)()+W[
M,IS*5"C*LL?FN"M*MB*.'2]H[7^>V^W;J^A5'#5L0W[-7M\M]%OWZ+J>]45Y
M1\3/VP/A;X(\#^!O%_A2=O%4GQ/U:ST[X?V>CS(!JTES&94E\QR!% D0:620
M\JJX"LY5#I?L\?M'>'/V@;?Q/IMKH=UHVO\ @GQ//H'BO0KV1'>TNXPK!D=#
MB6&2-TDCDP-RM@JK*RB5B\-*JJ:DFW_E??:]M;;VUV*EA,3&BZKBU%?YVVWM
M?2^U]-ST6BN2\/\ Q:T[Q9\6M=^%_AS2)KJ+PS9PG7M:60"WMKZ8!X[ =WF$
M!$SXXC66'.3)QUM;0G&:O%^7W;F,X3IM*2[/[]@HHHJB HHHH _0/P+_ ,B1
MHW_8*M__ $4M:M97@7_D2-&_[!5O_P"BEK5K^:<1_'GZO\S^G<-_NT/1?D%%
M%%8FX4444 %%%% !1110!\O?MY?\COH?_8*?_P!&FO"*]W_;R_Y'?0_^P4__
M *-->$5^]\*?\D]A_1_FS^?N+O\ DH\1ZK_TE!1117T)\X%%%</^T!XQ^*_A
M/P/%:? SP?8:QXNUK4$T[0DUJ62/3K25D>1[J\>,%Q!''%(Q5?FD8)&I#2 B
M*DU3@Y/IVU9=.FZLU%=>^B^;.XHKXGL_VG_V^OV3OVK/AY\'OVS9O _C+P9\
M6-5;2-#\4>"]+GLI](U3 *02Q2,P>-BR@$Y)7+;OD*-[Q^U5^UEI_P"SY<^&
M?ASX0\)OXK^(WC[4'L? W@Z"Z$/VIT7=-=7$N&^SVD*?/)+M8@<!2<XXJ>9X
M:=*<YIQY'9IK5-VMHKWO=6M>][;G=5RO$PJPA&TN=73B]&E>^KM:UG>]K6N]
M#V"BN2^%GAWXOZ79'4_C'\1[#5]3N(AYMAH.BBSTZT;J1$)&DG?'W=SRX;KL
M7.!H?$G5O'&B^"[V]^&OABWUC7BJ1:797MUY%OYKNJ"2:0 E88]QD?:&<HC!
M%9BJGL53]WSM->77\+G$Z?[SD4D_/I^-C=HKXYL?CW^WU^SM^VE\-O@?^TGK
M/@CQUX1^+3ZC;:;J7A'P_/IUUH=Y:VYN&4QO-+YD&W RS%L;F)79A^I^+W[3
M7QG\3?M*?$+]GKX'ZYIF@GX9_"]/$E[J.HZ5]K.HZG<>8UK:,I90EJ(XB9"O
M[QC( K1[#OX%FE!P;<9*2ER\K2O>W-WM\.N_XZ'H/*:ZFDI1<7'FYDW:W-R]
MK_%I:V_EJ?3M%>0? +]KKP=\5?V+_#O[8WC)$T'2]1\*+JVL0G=(+6105FCC
M &Z3]ZK*@ W/E0!E@*[#X'ZC\4]=\")XJ^+^GQZ=JFL74M[!H*1J&T:T<CR+
M.5U)$DR1A3*^2/-:0+\BK792Q-*LHN#NI+F7H]F_7I\^S..KA:U'F516<7RO
MU6Z7IU^7='7T445N<X4444 =C^S[_P EK\-?]A6.ON>OAC]GW_DM?AK_ +"L
M=?<]?DGB'_R,J/\ @_5G[!X<_P#(LK?X_P#VU!1117Y\?H@4444 %%%% !11
M10 4444 %%%% !1110 5Y)^VK_R11O\ L*V__LU>MUY)^VK_ ,D4;_L*V_\
M[-7L\._\CW#?XX_F>)Q)_P B'$_X'^1\A4445_09_.P4444 5=;T72?$NBWG
MAS7].BN[#4+62VO;2=-R30NI5T8'JI4D$>AKP/\ X*::9<?$O]E_4_V8/"FG
M0ZAXJ^*DL>@>'-/E7<L>9$DN+Z3'*0VL*O.S]F6-1\TB ^Y^,]:UKPYX3U'7
M?#?@^\\0:A:6CRV>B6%S!#-?2 ?+$CW$D<2%CQN=U4>M?%_P]^,?_!3[PWXK
MU7XH>-?^"3EQKWBO55:W&H_\+OT"&'3[ .6BL;6,EC%$.&D8L7FD^=CA8XX_
M+S.M3C3="49>^FFXPE*RV?PQ>NNE_7U];*Z%6555XRC^[::4IQC=[KXI+336
MWIYK'_X*K6GBGP]\-OV>?^";GPMN6DL?B+XDL]"U9KC4&M3?:/I<=L);:29$
M=HED\R(LRHQQ&1M8$J?3=7_:V^-?[*/[3?PU_9O_ &@_AQX,3P1\27.C>!_$
M/@87,"Z3?Q!%BL;B"8L"C!XD1T*=<[ %(4_:C_9R_:*^/?PS^#W[1L'A32;;
MXQ?"SQ)!XG'@^+4$%K<QR[3>Z*MRQ*"3R@D:W!/EL\.?E5\KI_%KX1^,?VT?
MCK\'_%FM_"_7/"7A3X7>)&\5ZA-XE^SQ7=[J<<86TLX8H9I#M20F265L(0B+
M&9-S%/+G1Q<,54JT>92;I<BMIR*R<7II;WF^JNF>I"M@YX2E2K<KBE5YW?7G
M=W&2UUO:"3U3LT>Z_&GQ+JO@SX.>+/&&A F^TKPS?WEF N<RQ6[NG'?YE%?,
MO_!$CPUI-Y_P2I\!0:J!<KKL>MS:O),<FX:75+Q'+D]3L 4D]<5[GX/\?_&W
MQA\?O'GPH^('[/B:9\/]*TZS_P"$:\:2:S%,NOM-$#<1&V W1A&+)S_<Y^^*
M\#^ GPG_ &D?V)_V<?%G[&'PX^$&J^*!;:AJP^$?BBUO[1-/2ROWDFB%^\LR
MR6[VTTTIEQ&WF* 8@[,4';7D_P"T88GE;@HU(?"[\W-'I:]GRM)[/2VZ.&A%
M++IX;F2FY4Y_$K<O++K>UUS)M;K6ZT9\_P#_  3(^$'Q1^._[ G[/?QD\*+_
M &GJOP5^*>J7-KHUS<K$VIZ3+)+'<0PR2$()D$VZ/>RH?+V%E!!'TA\,_!OQ
M5_9MUOXG?$>?2+)/B9^T#\12_@GPD]PLZ:7;0VPABN;UHB5*P0K)<W'ELR?<
MA1V>1-WL7[%O[,^A_L7_ +*OA+]GO2;\WP\-:6W]HW\,#$W=W([SW,JJ,MAI
M9'VKR0NU><4[X"^#?%'BCQ/J7[2WQ6T2?3]>U^V^Q^'-#O5Q)X>T,/OBMV7^
M"YG8+<7&.0_E0DL+9&/-@<K>&PU",KJHHJ_9-04&_7E]U:VZVT9U8_-8XG$X
MB<;.DY.W=IS<U'TYO>>E^E]4<EX#_:%_9A_9JL9_@N/&6I7B>'=?M],\;>-K
MC3I)+1/$&H.LA^WW:KL6XN)IU9R/W<33(C&+*+7T%7YR_%_]E#X^K^SY^T7^
MQ5H_PUU?4];^,GQS;Q-X1\3QV;-I8TN^N["YEN+JZ&4@>U%I*C1N5D<B/RD<
M-D?HK8VSV=E#:27+S-%$J--(<LY QN/N>M=V68C$5)2IU(<L8I6T:L[R7+YV
M2B[]>:^S1P9GA\-3C&I3GS2DW?5:JT7S>5VY*W3EMNF2T445ZQY 4444 ?H'
MX%_Y$C1O^P5;_P#HI:U:RO O_(D:-_V"K?\ ]%+6K7\TXC^//U?YG].X;_=H
M>B_(****Q-PHHHH **** "BBB@#Y>_;R_P"1WT/_ +!3_P#HTUX17N_[>7_(
M[Z'_ -@I_P#T::\(K][X4_Y)[#^C_-G\_<7?\E'B/5?^DH****^A/G HHKR_
M]KCX-?&GX^?".Y^&'P5_:"C^&]SJ3B/5-?3PR=2N'M<?-#"/M, A+]&?YCM)
M"[2=PSK3G3I.4(N36R5DWY:M+[V:480J55&<E%/=N[2\]$W]R.+U'P1:_M<?
MM3>%OBI)$)/ /P=O+V30KHCY->\22*;=YH^S6]D@D02#A[B1P#B EO ]*^'N
MJ?M"_P#!<CXJQ>+?'?B#1[?P!\*]*L/#O]AW:6\S6]VD$\WERE&>$>9+,"\1
M1^2N_:2#ZAX/_8E_;ZTDZ+X7\5?\%/([GP;I\]K%?^&?#WP3TS1FN=/B9=UE
M#<V]P7M%:-?+#QC* \=*]&^*W[*>JZE^TEHO[7WP0\6V6@>-K'0I- U^WU2P
M>XL/$6DLXE6"=8W1XI8I0'CG4DC&UE=<!? J86OBH1G.E)-5(SDFXWEHXZ<L
MFK1T:3=W;J]_H:>*P^%G*$*T9)TY0BTI6CJI:\T8N\O>3:32OT6WDO['OQ*^
M-_PK_P""A'Q/_8+^(WQ.UCQMX8T[PI:^+_ ^N^)+@3ZE96TLL44MG-. #,!)
M*0A?+!8LY^; ^Q*\J^#O[-DG@7XG^,?V@O&_B6WU?Q[XU@MK2[U*ST\P6NFV
M%LA%O96T3N[!%9FD=V<F61BQ"*$1.:\+_ K]MSP]^RG)\,;G]M&UOOB<NJO<
MV_Q#O?!%O)#]G-QO%J]IN"D&/*;\[EW<?=%=V#6)P=%PE"4M9M:IM*_NQNWN
MT].BM9M:'!C7AL974XSC%V@GHTF[>]*RCLFM>KO=)GB?[7.K_M<?LJ_MK_"_
M]J7Q#X[T#QQ\/?$GBBV\"S>&_P#A%TM;GPPNIS(/M%K+YDCNSM$A=RR[_+2,
MKM*E/>OB_P#L<Q^.?BGKWQD^&_Q(F\):[XN\#/X3\53KI:W:7=CN9HIXE,B>
M5=Q;Y%24[TVOAHWVKAVE?L[?%[XG:SX3\0_M;?$?PWKP\&:K%K&DZ%X0\-S:
M?9RZK$C+#>7#3W,[RF+>SQQKY:*Y#MYA5-OHGQ?T/XA^*/A_?^&?A=XFM]$U
M;40ELNMS*6?3H'<+-<0KM(>=(BYB#?)Y@0ME00<Z."TJRJ1DXR:DHMWDG:SL
M[Z7V2OIKLF:UL=K1C3E%2BG&4DK1:O=75K.V[=M='JU<^>=$T3X2> O XTO2
MX9[?X%?LTZ/),Y)$K:]K.FQ-)(Y/ F2R*,Q[27S'[K6G.K\&_P!N_P 5^)_&
MOP>T+XN?#?3M#L_CWX6O-:\!/INIO<2V+06T5X+.\WHH+O:S+()$P ZM'L.
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M_P D4;_L*V__ +-7L\._\CW#?XX_F>)Q)_R(<3_@?Y'R%1117]!G\[!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?H'X%_Y$C1O^P5;_P#HI:U:
MRO O_(D:-_V"K?\ ]%+6K7\TXC^//U?YG].X;_=H>B_(****Q-PHHHH ****
M "BBB@#Y>_;R_P"1WT/_ +!3_P#HTUX17N_[>7_([Z'_ -@I_P#T::\(K][X
M4_Y)[#^C_-G\_<7?\E'B/5?^DH****^A/G HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH [']GW_DM?AK_ +"L=?<]?#'[/O\ R6OPU_V%8Z^YZ_)/$/\
MY&5'_!^K/V#PY_Y%E;_'_P"VH****_/C]$"BBB@ HHHH **** "BBB@ HHHH
M **** "O)/VU?^2*-_V%;?\ ]FKUNO)/VU?^2*-_V%;?_P!FKV>'?^1[AO\
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M_P!A6.ON>OAC]GW_ )+7X:_["L=?<]?DGB'_ ,C*C_@_5G[!X<_\BRM_C_\
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M\BRM_C_]M04445^?'Z(%%%% !1110 4444 %%%% !1110 4444 %>2?MJ_\
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MHH **** "BBB@ HHHH **** "BBB@#] _ O_ ")&C?\ 8*M__12UJUE>!?\
MD2-&_P"P5;_^BEK5K^:<1_'GZO\ ,_IW#?[M#T7Y!1116)N%%%% !1110 44
M44 ?+W[>7_([Z'_V"G_]&FO"*]W_ &\O^1WT/_L%/_Z-->$5^]\*?\D]A_1_
MFS^?N+O^2CQ'JO\ TE!1117T)\X%%%% !1110 4444 %%%% !1110 4444 %
M%%% '8_L^_\ ):_#7_85CK[GKX8_9]_Y+7X:_P"PK'7W/7Y)XA_\C*C_ (/U
M9^P>'/\ R+*W^/\ ]M04445^?'Z(%%%% !1110 4444 %%%% !1110 4444
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M.BNL_P"'>?[>/_1=?A9_X3&H?_)%'_#O/]O'_HNOPL_\)C4/_DBC_B(.2_\
M/NI]T?\ Y,/^(=9W_P _*?WR_P#D#DZ*ZS_AWG^WC_T77X6?^$QJ'_R11_P[
MS_;Q_P"BZ_"S_P )C4/_ )(H_P"(@Y+_ ,^ZGW1_^3#_ (AUG?\ S\I_?+_Y
M Y.BNL_X=Y_MX_\ 1=?A9_X3&H?_ "11_P .\_V\?^BZ_"S_ ,)C4/\ Y(H_
MXB#DO_/NI]T?_DP_XAUG?_/RG]\O_D#DZ*ZS_AWG^WC_ -%U^%G_ (3&H?\
MR11_P[S_ &\?^BZ_"S_PF-0_^2*/^(@Y+_S[J?='_P"3#_B'6=_\_*?WR_\
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M_P"BZ_"S_P )C4/_ )(H_P"'>?[>/_1=?A9_X3&H?_)%'_$0<E_Y]U/NC_\
M)A_Q#K._^?E/[Y?_ "!R=%=9_P .\_V\?^BZ_"S_ ,)C4/\ Y(H_X=Y_MX_]
M%U^%G_A,:A_\D4?\1!R7_GW4^Z/_ ,F'_$.L[_Y^4_OE_P#(')T5UG_#O/\
M;Q_Z+K\+/_"8U#_Y(H_X=Y_MX_\ 1=?A9_X3&H?_ "11_P 1!R7_ )]U/NC_
M /)A_P 0ZSO_ )^4_OE_\@<G176?\.\_V\?^BZ_"S_PF-0_^2*/^'>?[>/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5Y%^W3^VK\%?^">W[+_B?]J[X^:E/%H/A
MNV4K9V2AKK4;J1A'!:0*2 TLDC*HR0JC<[%55F'KM?DU_P '@5AK/_#!'PK\
M475I-<>%-$^/VC77C&*)256V-G?(KR ?P;F*<\;I4[D4 ?6OP<TC_@J9^T-\
M(].^-OCKX[>"_@[K'B/3TU'1_AO8?#HZW'H4,JB2&WU*[N+N*2\N I E\A;5
M5;<JYV[RW_@GW_P4=U[]HKXU?$S]AO\ :;\$Z7X0^//P<N8O^$JT?1+F233-
M=TR94:VUG33+^]%O*DL):*3+PF:,,S%N/JZTN[6_M(KZQN8YH)HUDAFB<,KH
M1D,".""#D&OR?TS2-5U__@\"U+5?ANLAM="_9MC_ .%@R0_<7S JPI(0.I,E
M@P4\G:".%X /1/\ @HY^TS_P6H_9$^"NO_\ !0OPE<?!N/X?^#I8K_5_@CJ>
MBW4NK'16G2,O-JJ3^6;X)(KO'$@AB(94>YV S?H1\._%W_"P/A_H7CS^Q+O3
M/[;T>UO_ .S=0CVSVGG1+)Y4B]G7=M8=B#7QI_P7'^ 7[>?Q:_9BO_'?[(_Q
MW\+V%E\/_*\5ZI\,O$/@:.^@\9?V:XO19W%S+*PV;H%981"JR.JJ[@$,OT/^
MP1^TS<_MF?L7?##]JB_\-+HUUX[\&6.KWVE1EC':W$L0,L<9;EHQ)NV,>2NT
M]Z /FO\ X+E_M8_\%+OV!?@$W[7?[&=C\/\ Q+X.\/W,*>/O#_B/P=>7FH:7
M9.0IU&&6"_A66)'($D90% X?=L5ROT?HO[2W@36/V((OVL[3X_Z!+X;G\#GQ
M&GQ"&B,+$6?DF?[0;3SRXVI\IA\W?N!7AN*]2\4^%_#GC?PSJ/@OQAHEKJ>D
M:O8366J:;>PB2&[MI4,<L4B-PR,C,I4\$$BOQT_X)G?L[>,?A;_P4S^+?_!$
MK5OB6^M?L^? _P 1V/Q1\)^'KZ-Y+F8W:VMY8Z//(S$/96UU=1W93'[RYM$<
M_+)(A /LSX3^,/\ @LKXF_8DT+XA>.Y?A5I_QB\:ZKI/V'P^? .HQZ=X2TZX
MNHVN)=00:D\MQ<1V7FLT:/$J3%8][!=[>4?M&_MC?\%1OV?_ /@I-^S_ /\
M!/H_M _!G5T^-NFZW<W'BS_A2.HVYT@Z?:27&%MO^$A?SA(8]O,J;<Y^;%?I
M+7Y@_P#!1K_E9"_8+_[%_P ;?^FNYH ^E++6?^"G7@*+XPZ7\7?BE\+]2MO#
M_@RQUWX9>--!^&%_9V]S/LU/[=97UI+JLVYHV@L&4Q7"Y29C@$X7Q7_@E9^U
M%_P5<_X*4?L&>&/VU(?V@O@9X6O?$\^II9^%;CX):K>01&TOI[0"2Y7Q%$Y#
MF ME8QLW@8?'/W+^T)_R0/QQ_P!B?J?_ *2R5\/_ /!JQ_R@Y^$7_80\2?\
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MVT?A+^RU^UG\0M'\:^&_CI;7]CX0\;Z?X:&DS:3XDLXXY6T^XA2:2-[:ZCD
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M]G+2_P!N']K;QI%XE\8^"K.X^&GA!Q$VVSLK0PO>:@Y8DR7UZXMEGFXREC"
M 6DW?II0!^;'[(_[8W_!4K]JG]N?]I+]B]/V@?@OH7_"@[[1K6U\1GX):E<_
MVT;^&>3<\'_"0I]G"&$# D?=NZKCEG_!2+]O_P#X*>_\$^/^"5C?M@>,9?A<
M?B7X:\;3Z%XFT5_!&H'2-5MFUJ[M+2]M-VH)- LEF+.?#-(,LXXR-N7_ ,$B
M?^4YW_!1;_L8/!O_ *27U:'_  =L?\H6_&/_ &.'A_\ ]+DH ^@?&>D_\%D/
M"7PN'C_X6_&CX!_$778M/6Z_X0K4_A7JOAY=2.P.8(-077;I8)#RJF6%D)(W
M%!EJO_\ !+/_ (*>?#G_ (*<?!S6_%FE>!=1\$>.? VOR:!\3/AUK4PDN_#V
MJ1E@T9<*OFQ,4<)(50DQR*55D8#Z.\)?\BKIG_8/A_\ 0!7Y1?\ !%"W/BC_
M (+I_P#!0/XE_#-=W@?_ (2BPTV\NK8_Z-<:RD]P)=I'RNZR1WA8@\>;DXWB
M@#](OVK?B+\<?A_\+TMOV9_AWIWB7Q_XAU2+2?"MKK\\L.DV<\BO(][J$L0+
MI:P0Q32L$&^5D2%"'E4CX<;]MS_@K#^P!^W!\'_@E_P47N?A=\1OAE\>?%"^
M&- \9?#?0[G3+OP[KLN!;VTL,TC"2%V90"<L5WOO!C,;_I=7R1XJ^&=C_P %
M!/VW/ OQ4DA$WPH_9TUV_OM(OF&8O%/C4QM:[X#_ !VNF(9U,HX>\E:,$_99
M 0"Q\>?VS/B;XU_X*"Z!_P $ROV6=;TO1O$47@*?QQ\3O'&IZ9]O_P"$?T<7
M"6UK:VMN71)+VXGD4YE)2*$;_+E+@+?_ &+?VU?&OC_]IWXO?L _M$MIC_$K
MX0RV%];:[H]DUK:^*O#U_"LMIJ"6[.Y@FC+?9[B,,4$H#)A9 B?-G['5CJ6F
M?\'0'[7S>),J^I?"'PA=>'!+U>P6STZ*8I_LBY1P?]JE^$UOJFK?\'7_ ,4M
M4T$,-/TG]DRPM-?D0?)]IEU.PE@1L?QE 6&>=J-VZ@'L/Q:_;C_:R^'W_!97
MX,?L+:AX2\$V7PT^(OA3Q%K']HV5Q<W>K73V%M,R)(SK%';+N\ERB+(3DCS,
M Y]!_P""@/[:NO\ [-6O_"?]G[X26FE3?$OXY>.1X;\&RZ]"\MCI<,4?GWVI
MW$4;QO<);PXVP+)&9))8UWHNYAX#^V%_RL8_L>?]DO\ 'G_I'7<?\%@?V%?V
MCOVDM<^"'[6/[&][H\_Q2_9[\>/X@T+PSXBOC:V7B*QN%A2]L&G (ADD2"-5
M=AM +@E20P +/B;]L;X_?L5?MX_"K]E3]JSQMI'C;P/\>([ZQ\">.[/P^NEW
MVC>(;1$D.G7D<<CPS07"2(()45'63<CAQ\X^S:_(W]N[QO\ M)?MM?\ !6K]
MB7]F#Q1^SU:^!-5\$^+9_BGXJTI?&$&L7NEZ;8/#LENC:Q>1!#+-#)!$RRNT
MCL RQ?+N_7*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *XG]H[]G;X
M/?M9?!#Q)^SK\?/!EOK_ (1\5Z<UGK.F7!(WH2&5T88:.1'5)$D4AD=%8$$
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M5M'D  %VD?+GVZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
9HH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>jnj-20200927_g8.jpg
<TEXT>
begin 644 jnj-20200927_g8.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS_\ _)8?_(GT9_PW]_U2;_RO?_:*/^&_O^J3?^5[_P"T5\YT4?ZF\-_\^/\
MR:?_ ,D'^NO$W_/_ /\ )8?_ ")]&?\ #?W_ %2;_P KW_VBC_AO[_JDW_E>
M_P#M%?.=%'^IO#?_ #X_\FG_ /)!_KKQ-_S_ /\ R6'_ ,B?1G_#?W_5)O\
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M^1/HS_AO[_JDW_E>_P#M%'_#?W_5)O\ RO?_ &BOG.BC_4WAO_GQ_P"33_\
MD@_UUXF_Y_\ _DL/_D3Z,_X;^_ZI-_Y7O_M%'_#?W_5)O_*]_P#:*^<Z*/\
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M$_X'^1\A4445_09_.P4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'Z!^!?\ D2-&_P"P5;_^BEK5K*\"_P#(D:-_V"K?_P!%+6K7\TXC^//U?YG]
M.X;_ ':'HOR"BBBL3<**** "BBB@ HHHH ^7OV\O^1WT/_L%/_Z-->$5[O\
MMY?\COH?_8*?_P!&FO"*_>^%/^2>P_H_S9_/W%W_ "4>(]5_Z2@HHHKZ$^<"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#L?V??\ DM?AK_L*QU]SU\,?
ML^_\EK\-?]A6.ON>OR3Q#_Y&5'_!^K/V#PY_Y%E;_'_[:@HHHK\^/T0****
M"BBB@ HHHH **** "BBB@ HHHH *\D_;5_Y(HW_85M__ &:O6Z\D_;5_Y(HW
M_85M_P#V:O9X=_Y'N&_QQ_,\3B3_ )$.)_P/\CY"HHHK^@S^=@HHHH ****
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M?SL%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^@?@7_ )$C1O\
ML%6__HI:U:RO O\ R)&C?]@JW_\ 12UJU_-.(_CS]7^9_3N&_P!VAZ+\@HHH
MK$W"BBB@ HHHH **** /E[]O+_D=]#_[!3_^C37A%>[_ +>7_([Z'_V"G_\
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M@NW76;S7=8\5,]CJVV1?.MFL0!!%"0S".%!L'RH0XK]":\,\?:%8_MJ>(X/
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M4EKU=_5RT445Z9Y84444 ?H'X%_Y$C1O^P5;_P#HI:U:RO O_(D:-_V"K?\
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M4O%OQAU71HKG1+2827.@VT%S#=WUQ>P@[[=+5H/+D\P*1(53[S '["\3^)O
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M/#O_ "/<-_CC^9XG$G_(AQ/^!_D?(5%%%?T&?SL%%%% !1110 4444 %%%%
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M444 %%%% !1110 4444 %%%% !1110!^@?@7_D2-&_[!5O\ ^BEK5K*\"_\
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M6'_R(?ZE<,_\^/\ R:?_ ,D?F;L_:9_Z,:^*?_@OLO\ Y)HV?M,_]&-?%/\
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M31L_:9_Z,:^*?_@OLO\ Y)K],J*/]<N)/^?_ /Y+#_Y$/]2N&?\ GQ_Y-/\
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MM4L9M,U*SBN+:XB:*XMYXPR2HPPRLIX(()!!Z@U^3_\ P:C:YKFC_![]HO\
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M6T>/4]2C)QK5Y;O/.TA0X-I"Y40G]^Z&?R?LWJNF_#S]JK_@I[^Q[\8O@/\
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M[0/_  2CU3XU? [X5?LS>(?B7X&\:_$&_P#&_P ')_#%_811V%QJ$48N-#U
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X_\
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/ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>jnj-20200927_g9.jpg
<TEXT>
begin 644 jnj-20200927_g9.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *^-/VOO^2]:O_UPM?\ T0E?9=?&G[7W_)>M7_ZX6O\
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M(Y+_ ,B;#?\ 7N'_ *2@HHHKS3TPHHHH **** "BBB@ HHHH **** "BBB@
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M /7"U_\ 1"5]EU\:?M??\EZU?_KA:_\ HA*^Y\/_ /D=3_Z]O_TJ)\'XA_\
M(CA_U\7_ *3(\RHHHK]C/Q<**** "BBB@ KQ+]J']O3X)?LJ^(M'\)>-;BXO
MM3U.X0W=EI@#R:?:$X-S*/3T0?,V#CI3?V]OVIM>_92^"S>,/"OA"XU+5-1N
M/L6GW;0%K2PD*Y$L[#_QU/XV&,@ U^/_ (N\7>)O'OB:^\9>,M;N-2U34KAI
M[Z^NI-SRN>I)_0 <   8 H _>#POXH\.^-?#MEXM\):S;ZCIFHVZSV5[:R!X
MYHV&0P(_R*OU^3G_  3J_;<^)/P"\:VWPH_L'4O%'AK7+O9%H%@AEN;:Y;I)
M;+[G[Z="/FX(Y_4/PWXWU'7/AM#X^OO NKZ==2Z:UT_AZ[A'VV-@I/DE0<>8
M<8 SU(H Z"BN?\.>.;W7/AM#\0;[P/K.G3RZ:UV_A^[MA]NC(4MY)C!(\PXP
M%SU(%'ASQY-KWPVA^(MSX(UW3GETUKQM OK';J,>%+>280Q_>G& F>I H Z"
MBN?\.>/U\0?#:'XDR^#=?TU9M-:];0]3T[R]1B 4MY3P!CB4XP$SU(%'AWXA
M6OB'X;0_$P^%];L(9M,:].DZCIYCOXU"EO+:$$D28'W,YR0* .@HKG_#OQ$T
M[Q%\-H?B>NA:O9VLVF-??V??V!CO8T"EBC0Y)$F!]WKD@4>'?B-I/B3X;0_%
M"VTG5+>RFTQKY;.[L&2[6,*6VF'[P? ^[US@4 ?6?[ O_(.\3_\ 7>T_E+7T
M+7RI_P $\?BIX=U3X+^*/C'%8:G'I8TV#4C;S:>ZW8A2*=R/)^]OPIPG4G Z
MU[UX+^./@[QQ\#;;]H+3[#5[30KK0GU=8-1TN2*]2W5&<AK<@N'VJ?DQNZ#&
M:_#.+Z=27$->26EXKY\D=#]ZX.J4X\.X>+>MI/Y<\M3L:*XWP9\=? ?CGX&V
MW[0^DG48?#EUH3ZPC7NF2Q7*VJ(SDM 1Y@;:I.S&[MC-+X,^/'PX\=_ VV_:
M+T/4;M?"MUH+ZS'=W6G313"S5&D9V@9?,!VJ3LV[NV,U\VZ%97O%Z.WS[>I]
M*J]&5K26JO\ +OZ'8T5QW@WX^?"SQY\#;;]I#P[XAE?P?=:"^LQ:I/I\\3?8
MDC:1I3"Z"4852=I7=QTS2^"_CY\)?B'\#[7]I#PAXM%UX+O=";6;;6FLIX@U
MBJ-(TQBD195 52=I0-QTH="M&]XO1VVZ]O7R!5Z$K6DM5=:K;OZ>>QV%%<CX
M/^._PG\>_!6V_:)\)^+DN_!EWH;ZQ;ZW]EFC5[)4:1IO+=!( %4G!7=QTI_A
M3XX?"KQO\&[?]H+PMXPAN_!UUHC:O!KB0R+&]DJ&1IMK*'P%4G&W/'2DZ-97
MO%Z.VW7MZ^0*M1E:TEJK[K;OZ>>QU=%<KX3^-OPL\<_!ZV^/WA7QC;W?@^[T
M5M7M]<6.18VLE0R&;:RAP JDX*YXZ4_PK\9_A?XV^$EO\=_"WC*UO/"%UH[:
MK;ZZ@987LU0N9OF 8*%4GD9P*'1JJ]XO1VVZ]O7R&JU%VM):J^_3OZ>9T]?G
M=J7_ "$;C_KN_P#,U]V^&?B_\,O&7PK@^-_ACQI97GA*ZTEM4@UZ*0_9WLU0
MN9\D#Y0H)SZ"OS[M_'G@WQ'X<;XC:'XDM+G0KBW>]AU6*4&![?EO-#=-N 3G
MTK]*\.X3A/%*2M\"^?O'YAXD3A.&%<7?XW\O<-"BLS2O&GA+7/"4?CS2/$EE
M<:+-9F[CU6*X4P-  6,F_.-N 3GI@4[3/&'A36O"\?C?2?$MA<Z-+:&ZCU6&
M[1K9H "3*) =NS )W9Q@5^G'Y<:-%9^G^+/"NK>&D\9Z7XFT^YT>2U-S'JUO
M>H]LT !)E$H.PI@$[LXP.M.L/%'AG5/#J>+],\16-SI,EL;F/5(+M'MVA SY
M@D!VE, G=G&* +U%4K#Q+X<U70$\5Z7K]E<Z7);FXCU*WND>W:+&?,$@.TK@
M9W9Q3K+Q!H.I:*GB73M;M+C3I(/.COX+E7@:+&=X<':5QSG.* +=8/\ PM#X
M>?\ "P_^%2_\)EI__"2_V?\ ;O[$^T#[1]GSCS-OI[=<<XQS7A7[<G_!0GP/
M^S7X*CTKX>ZI8:YXOUFT\S2(()EF@M(FX%U,5."O]Q,_.1_=!-?EI_PMOXF?
M\+,_X7)_PFVH?\)1_:'V[^V_//G^?G[V?3MM^[M^7&.* /W>HKYR_8)_;V\,
M_M6^&5\*^*I+?3?'.FVX.H:>IVI?H.#<P ]O[R=4)[J0:^C: "BBB@ HHHH
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MB/\  CXCVB_"?0M0\1>&/$6H+;Z$UM$99[:=S\MK-CO_ '9. P'."#7ZR44
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M*** "BBB@ HHHH **** "OC3]K[_ )+UJ_\ UPM?_1"5]EU\:?M??\EZU?\
MZX6O_HA*^Y\/_P#D=3_Z]O\ ]*B?!^(?_(CA_P!?%_Z3(\RHHHK]C/Q<****
M /COXZ?\IJ/@7_V2[Q'_ %KZ^U&/4);">+2;J&"Z:)A;S7$!E2-\?*S(&4L
M<$@,N?4=:\%^(O['GQ-\<?MN>#_VQ+'XWZ'8Q^#="O=(LO#,O@B:8SP76[S&
M>Y&H)\XRN"(P!M.5.>.S_:+\$_M3^*+CP[JW[,7QRT#PG+I=Y*^NZ5XE\*?V
ME::U"P0)&SI+'+!L*N<QL"V_DC:,^5AHU\.\1.5-OFG=)-7:Y8JZU\GNTSU\
M5*AB5AX1J)<L+-M2LGS2=GIYK9-7W/FSX':Y^U1^S#_P4^O/@E^T!XPT7Q[H
MWQOT6ZUCP_XQL_#T>G7EC+ID0'V!U0M^XBB;"H6<;IQ("&DF#?<%>7?#_P"
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M7_T0E?9=?&G[7W_)>M7_ .N%K_Z(2ON?#_\ Y'4_^O;_ /2HGP?B'_R(X?\
M7Q?^DR/,J***_8S\7"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Z3_8%
M_P"0=XG_ .N]I_*6OH6OGK]@7_D'>)_^N]I_*6OH6OPGC#_DHZ__ &[_ .D1
M/WW@W_DFL/\ ]O?^ER"BBBOF3Z<**** "BBB@ HHHH *_.[4O^0C<?\ 7=_Y
MFOT1K\[M2_Y"-Q_UW?\ F:_3/#GX\3_VY_[<?EWB5\.%_P"W_P#VP@HHHK]0
M/RP**** "BBB@ HHHH **** "BBB@ HHHH **** /MG]EO\ Y(+X>_ZX3?\
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MBBBOU _+ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^V?V6_^2"^'O\
MKA-_Z/DKOZX#]EO_ )(+X>_ZX3?^CY*[^OYUSC_D;XC_ *^3_P#2F?TCDO\
MR)L-_P!>X?\ I*"BBBO-/3"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKXT_:^_Y+UJ__7"U_P#1"5]EU\:?M??\EZU?_KA:_P#HA*^Y\/\ _D=3_P"O
M;_\ 2HGP?B'_ ,B.'_7Q?^DR/,J***_8S\7"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@#Z3_ &!?^0=XG_Z[VG\I:^A:^>OV!?\ D'>)_P#KO:?REKZ%
MK\)XP_Y*.O\ ]N_^D1/WW@W_ ))K#_\ ;W_I<@HHHKYD^G"BBB@ HHHH ***
M* "OSNU+_D(W'_7=_P"9K]$:_.[4O^0C<?\ 7=_YFOTSPY^/$_\ ;G_MQ^7>
M)7PX7_M__P!L(****_4#\L"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#
M[9_9;_Y(+X>_ZX3?^CY*[^N _9;_ .2"^'O^N$W_ */DKOZ_G7./^1OB/^OD
M_P#TIG](Y+_R)L-_U[A_Z2@HHHKS3TPHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *^-/VOO^2]:O_P!<+7_T0E?9=?&G[7W_ "7K5_\ KA:_^B$K[GP_
M_P"1U/\ Z]O_ -*B?!^(?_(CA_U\7_I,CS*BBBOV,_%PHHHH **** "BBB@
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MC_KY/_TIG](Y+_R)L-_U[A_Z2@HHHKS3TPHHHH **** "BBB@ HHHH ****
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M%<O^CM/A9_X0<O\ \77U-161J?+/_"I_^"N7_1VGPL_\(.7_ .+H_P"%3_\
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M4_\  Y?YA_8>2?\ 0+3_ / (_P"1\)_\.\_V\?\ HNOPL_\ "8U#_P"2*/\
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MDW.;NWJV]V^[/3A"%*"A!62T26B271'RS_PJ?_@KE_T=I\+/_"#E_P#BZ/\
MA4__  5R_P"CM/A9_P"$'+_\77U-14E'RS_PJ?\ X*Y?]':?"S_P@Y?_ (NO
M2?V;O!O[:'AG6]2G_:A^,WA#Q/82VJ+I<'AOPZ]D\$V[+,[,3N!7C'K7KM%
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M/+WOM#L ?;E%?GGXI_;]_;E^"O[ 'AO_ (*X_&"#PU=>"]3@TGQ#XL^#.D:
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MC;P/\>([ZQ\">.[/P^NEWVC>(;1$D.G7D<<CPS07"2(()45'63<CAQ\X^S:
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M_P $J?V?M2_9OUG]I/2OB+H=UXEO-;L[N'P!)HUW;W%R(0Z,W]HW*21@Q,0
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M@\+^-;SXD>&/A;X>TWQ#J18ZEKFGZ-#!=WA.,F:5%#R]!]XGI72T44 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M0ZEING:QI\^DZO80W5K<Q-%<VUS$'CE1AAE96!# C@@\&IJ* ,#X>_"KX8_"
M32I-!^%?P\T3PU82R>8]AH.EQ6<!?&-WEQ*J@^X'-;]%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
A110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>jnj-20200927_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2017-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:jnj="http://www.jnj.com/20200927"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2019-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="jnj-20200927.xsd" xlink:type="simple"/>
    <context id="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i740dc05b85c94cbd8b1e84ec97346f67_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ica954f234b4c423aabac439f22fd6daf_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A0.250NotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i95ced2b952ea496781eca3d5a59848c3_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A0.650NotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i7eeea2693d75423da856f563c79a259d_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A5.50NotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i93ee65cdd19a4436bcecdbb64e5cca1c_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A1.150NotesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2f968c9419a148cfbb615118ff18f037_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A1.650NotesDue2035Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ide9df46b8f0d4705b774d10707a6d751_I20201019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <instant>2020-10-19</instant>
        </period>
    </context>
    <context id="i19e7a320a15a49fc9131f6215c942e21_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5b511957d9f045e087992edabfe78505_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i0cf38c3475e441fb8f8267516f5f6e04_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="if6c8c63ebbdd45008cb5ac80e7d4a988_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i1f90ce64276d4c29ad4a8c7f4dbd288f_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i06b919224a104e2480ce4da569369152_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="id0b01ffae8c54eaaaf665643769f3f44_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ieca44093d50140b480558060c22367cb_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i381677b70c5d4be996221d9099a8ee95_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4ccc8ddbfa5a467ca8eaf499f719d902_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ib840c9f8515640ed990015d6449203d6_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i7b3f9043c47442aea143141642e7e123_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ie2de08cb9d744bf28bfcab44717ebd79_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ifb8ed1a3c397427ca991016ed24db8d2_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i71bc7ed79cf044f986c36306dd76232b_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i4dff82851aa243f2a42e09821411d92e_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="iac644cecdd17481eae30c88e9f63b87d_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="ia7b18211b77c4d9eb325dfecb4003ccc_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i5c31dab756544c419618439f97c12092_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i8c15ea54ac1647959505ff89d74c73c7_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i3494e72aac944cd896896e8cc599429d_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i9918090831a94bfa90e6639a0e7860b0_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i80a9937f67434d319d5d9d0009f19170_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ie369dd88ecfb42bfbd08a15bc21a6097_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i8623b760505a465db7f09f7ad1d524db_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i7d1eb0b5e3974db0ba19099436b2cc65_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i110288df68f94473b99fed3695503e08_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i6a6ecd40aacc418a87faf0c09967e825_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i7e3164724e36436c908b66cd22c3a21a_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i7973ae70802a4ed0a4cd812adebb0210_I20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <instant>2019-09-29</instant>
        </period>
    </context>
    <context id="i0f437ae6f74d4fa69aa4dac8e499093a_I20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-29</instant>
        </period>
    </context>
    <context id="ic23a7f58f6e14cc1977521f182c06612_I20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-29</instant>
        </period>
    </context>
    <context id="i400557913e3646cfba478852d03d7924_I20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-29</instant>
        </period>
    </context>
    <context id="i018cbb188f0842968a546fe435cdf833_I20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-29</instant>
        </period>
    </context>
    <context id="id0a2a626a2c244b9a56b493374930da0_I20181230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <instant>2018-12-30</instant>
        </period>
    </context>
    <context id="i140bd62410d04a73af76e67490f68df5_I20181230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-30</instant>
        </period>
    </context>
    <context id="idf518ea8aaf64e96abb8d9041f120b48_I20181230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-30</instant>
        </period>
    </context>
    <context id="i1caf669d3c9842f4b9c8d11879c80aec_I20181230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-30</instant>
        </period>
    </context>
    <context id="iad718c4ff9e7438d82af65c75127f1f7_I20181230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-30</instant>
        </period>
    </context>
    <context id="i35bcfc36a3ac40618bf4b3ef88484093_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="icd34e4a6c9104502985d3b5bd4a98c8e_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia9597fec02bb4c31b44fbbd09919bb16_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i8998fcc3526244dcad040549c8bdf899_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i146724b9ab654ac3b05e3567213370a2_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PatentsAndTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="if455a0c82eec4663ab4937953a47b1a0_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PatentsAndTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="ifeaa5dc31fed4356a01542e92bc1b4ac_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i0ec1428acbd748a3ac5a614e4bca5b5b_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i68c2ad5bd3504e018130bc2faeb63dfc_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i7d2f1f6cd2a34b9fb4eb1093a33dc1ae_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i9f84e8435dc0421d8a89f9ea0bce9608_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PurchasedInProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i99b4dc37a244428f8b6a328e6563293f_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PurchasedInProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="ia9cdf38955a64506988afbdd28653b69_I20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:BermekimabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PurchasedInProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-29</instant>
        </period>
    </context>
    <context id="i1db1cbb21378478cbff6ba1c2021c6dc_I20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:VerbSurgicalInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PurchasedInProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-29</instant>
        </period>
    </context>
    <context id="i478b4ff4ed674722bb2570839bc53e96_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i31bf8455628944da8b015d8b789a9fc4_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i87651ba4e20740f0bd2d7665498709be_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i498b81f2554f4e868dce4daa5736066a_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i31c5bebe5faa45388656d1dcb0238be9_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic80539fe5fa44b869a360326b6dee52a_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i3e833bc35e3f438d8cfbc47be4f35753_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i5e4dc688e2e648e983fbdf67f462f0a2_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i11ef6f75bfcc45848502de0139e92200_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="if53c990c748f468ba05775d5cf223ac0_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PatentsAndTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1b287ab5933f41b09d0eeee590ddb648_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i602f0b572b2642298407a8c186b700b3_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i2e99b66377d146a5bc59616148618bc1_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i757aee8078ce429aba0fb497a4a57b0f_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i6caa54ad7b144dcca2cb08b4b3dab964_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i5ca4ea76af704d238626f606c2f2e2e8_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i83cd1045196f4066b8afc93059b316f1_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i48769359a9544223b2b381ebae848550_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="idaae72c759e44c0aa87a7f502152047c_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ie75c8583c4cb4e56a35e19da1d9c0fd3_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4cdbac75c4d1489bad27bcb720ec8453_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i050dea3d0ebc4bb39fdec4f937d89696_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i284822c0f6cd4ad4a13ee1cb4f3bbce6_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="id52cfbe2faf44e1db50daba2fb27ff4a_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i617cd2e5232f4d6481542c77f053e8a4_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i1025e2524ffe4b48931a58f4b78c7f2d_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i9bb6927b7d714bc09b33449c20da1770_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i6b83b2d252c447a2ba19f24dd30e3a65_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i3e39ee9dee804ae5bee2adb6bb8d7288_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic36d3ae76596417b9c30e054d1545171_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i47fda4f228854b19a6da483cbeb232ad_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ie01d8f5ff2bc4b4682da0fc787c482ec_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia68d65479ce04918b459702f999497d0_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ic909e487ce0146d4a1a529a11bf4b714_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ifcb888be82354cb9a97b576afd3ebbf7_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i622f3878a0cb45db81deff9052aa0056_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i8b7b0c17478b4846abf9b2e8b4cc1801_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="idc70d684244d4d12a5436ed3961b9126_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i6882d65422ca4fe5ba1de209627b9d21_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic9e976af5cc446eebaf01b985dbc4a42_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2a09f1a4ea2c46e6b142985640accc45_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="if1382ae0806f411facc9962211302f96_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ifca93b84479747ca8e694826d35cf5f8_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i59bb85378baf48b8aad7ccdddb9509d9_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i901027a3abc14517a3a903a087117d8c_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i29f87aaf8f2a484fafdef882e2e279a3_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i7428937974c844969210c80b4d1269bb_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i758bf9c10aaa4c5b85d3f371f710849d_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i6f3e6000257046239c2aa58024508811_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i61bf4b75f5dc4a5d90e74e58ea5c592f_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i639cb007bfcd4af88897696baacb9819_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i4251ad0c6ca846ebb628818d56f1251a_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia4f491ac1fa844caacdc4e58ecd253f6_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i32bc7bed7811453990b8957e62697591_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i292a1d5f47644ba2864bd3beb562b985_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i01029a1173314478b27e2a88c1698d60_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ie0ba4e704712428ca90c45899f493ec2_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i0e6b13cc13d249cea0793a26e097bf2b_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="idb79bc61a7fd4785baa0abe8babcf4e9_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i192bf62c991e495aacd95b6a130d406f_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ice1f7153b23149e6b9bdf5779859e8cf_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i2f095d9205a94f68b57c820821576001_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i4ec08d548cc34c89bc05df02e4c29100_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i6d1186e0f9dd4e6cbaa910c65af648f8_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i350db5668e464af6b375c3b4bbd5f0e8_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iaac6fa6375624cbf89f14f995817172f_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1d932d154b6049149af36416558320a0_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i6e091eab1cd14f03b93bd9d094df209a_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i372abf170594420094ccb2d5bcf0ec43_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2e53d4b575e548578cb08588b7acfcac_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1c3a289ef5b14159b92eb7f4023a3e8d_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i54d1f30235984b0d92230944638bbefc_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i7a1e39c45d4d40a5aeeb99e4ac32a934_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i8d23a00fc837488e8322cd4fa9f6eb80_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i9954b9535f4046ada0661eb9c93f272f_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="idbc5ce6f7f184806bd9942142222b820_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1c0ed7d0f118415182ad2034719558ca_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia4f1f0010d2342a8967ad0c59c55d4ec_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i227f787e18a34f9bb38cccba24d02a79_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i7af68fed7c3b4b4c8cd6739097abf04a_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SaleOfSubsidiaryGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5a666010da7f4d2eb9c1b6cf6bd24a16_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SaleOfSubsidiaryGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i468e8ec1c58344b5a45790f5c51e8c09_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4ab4dfe0a05c498895f727f1d1cdb016_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ida55a615e74b412f9e17f752df014784_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ia08c2e302e194315ab73624c233b25e5_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia6e8354567bd4a978607e65d30a26741_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SaleOfSubsidiaryGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i43f2992b3ca941c3ad80001e95066a6b_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SaleOfSubsidiaryGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i5173f4423f0449ce945bc91eb4676e98_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i8abc68185a784fcca778998cec6761df_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i095e59b2969f4ed8b53a10dc8c2219bc_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4e85a98890fd4f78b3493cdc6bbec1d5_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i8c27b77222684cf6918b97cd45fc5ace_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithReadilyDeterminableValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="if0c4a4ae70f84c9bbbc600bb0718afe2_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithReadilyDeterminableValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i24df639c9fc04ceeb8bd2cfaeedf32ae_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithReadilyDeterminableValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i0439badcd60b4553a7b6551b725bd8d8_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithoutReadilyDeterminableValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i8128a659f3a049a29db2519c8d080e12_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithoutReadilyDeterminableValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ia3f03d1d353d4af1b97302c91561ce50_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithoutReadilyDeterminableValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i3ed67e743095488a967574c1fa9c061f_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ia9ed98fbd4de41809e2bbc7eb1afd160_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ic041dfb9d11749aea360ec6976d75398_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i075b4e0d383b4d769029c92ebf7473f2_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i6b7b583681fa4180bb4ba14738b78ba9_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i26a4a5bdc75a469cbac1c40a5b7f4419_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="icf7ba8da4a85439f9212ec5c6c3cdbbc_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i4f6fc756c33f4aefbaa09c8db437ba3d_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="id0c4a50667354367b5d5bc0ba2591ec7_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="ia1132e994a254a868feebb3f706ca20f_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i49bd4ba56a684b248e46d6b51af825e4_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="id07a8860c7464a1e83cd897bd0e82400_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i075f06ffede94a0786d62da3dcbb7230_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i5c550e4021f14358b75cb96f31b7315e_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i7f95053789564fc7ab821eb34ad95a92_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="icc1339831aaa4cbb833e93308c747d53_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i3463d9cf730744ada323be8c796f5190_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ia9134ec591ce4337a548a5cdf634d5d0_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i1a53e8456ab744c7beec3f2ef4378d29_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="id49a521ff2d04c15901e39f520471d2b_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i3da82ce120b1479b8130fc2f67172a04_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="if1a4bb7f18ff46a49d5c2a061670c81f_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ie37a55c0ed28487097c8fd0b33e77426_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ic8a100e64514437c862f0d1cd3d7ab0d_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="iac96af33cfc442a5917405a3caa3be5c_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">jnj:OtherReverseRepurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ib6d334f7d7524737a5a1e0b9b48367dd_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i9e99c71717f340a685ff09c95429db3f_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i2a2ca294220e4bf68ba6b1a11fa1739a_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i7828932564cc42808d3bc1319ed98668_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i1ff57a4b24ad4de3bb98f30bf0dbc693_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i2280350b15814286becfc035a03921a3_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="id5f928f37d1542b3bf86cc736479d215_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i0ffd52d1e0664f24b3f3822ede7a0cd1_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="idce2d47fd1804a3f98973754ffded2a3_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i935d5ef44a4142eb80b98b85c665cdae_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ic1916a7de9304cc59832dd469de21cc9_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="if11c31b2d6a44925b98b6b61c64e2daa_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i1647f236f4204443831bf07df847e56f_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i0fe7d6eeef6547a081274e2ede3f5ff9_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.250NotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ib9b43d320de345feb114bcda4919416f_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.250NotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i1538e33ce6b24f88a81816a950b4b247_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.250NotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i056990540d404780b0b73129befbc636_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.25Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i19d6e666640143e29c89b138db0f6d22_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.25Notesdue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ica2fd4caec424e239a481a2bcaf79e6b_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.25Notesdue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="iafefab750a92478c87896b310434e7fe_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.73Debenturesdue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i2e92a5dbc9214a8d9f87742c76176ff2_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.73Debenturesdue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ieea3231abf62476ea5bcf5de0b5578f9_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.73Debenturesdue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i02e32328220f4303a40455ed4b2da979_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.375Notesdue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="if268019a4de94135a6b62c5f0e256440_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.375Notesdue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i13cce8a254e449e083f46c20c1bbe797_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.375Notesdue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ieef980882cf74f48864a6d1029945cef_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.05Notesdue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i536828fe3d9e41f894d6e23d6416769c_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.05Notesdue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ie7c53e72904247ce8947b14425657966_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.05Notesdue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="id1ca9536dcaf404e8afcb2da4501ac6a_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.650NotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ie2e2c07a5d624a8598c2fdc999a47461_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.650NotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i01dae954e6b6449b91fb72ad27b9bc51_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.650NotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i136b1f0e6fd14acaa8a68b132e09a0a6_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.50NotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i645cefa2669b4e44b397f9618653aa80_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.50NotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i3150eb2704984084ac3204e1f7084267_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.50NotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i6f424501f76142b7a914b49ea7286203_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.625Notesdue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i76b7bfb69eb9403b99deb7e7eef8d40a_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.625Notesdue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i52179e2f9d674e078511c80f498c6c0a_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.625Notesdue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="idbc85d394a774ed9868d5b95e674664e_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0550NotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="id4dbf413e19e4cef9e7278a102ee7157_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A055NotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i078e08bd46af4e3f9e215207cc204105_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A055NotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i159981f414cb4bb18af0fbaee7927deb_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i668b41dcf7f44976bf86a2f9db667fb5_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="if1eeb605be014548afd510c0c8aa8eb3_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i165c4f1ce2ed4d76ab34c44c41db1255_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.95Notesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ib2686d72e0c343febe8ff2bd5ac5e63a_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.95Notesdue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="iab1049268d7f4fe8b4d96cce87cafc93_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.95Notesdue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i6059fa37b091494880a716afab863d00_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A095NotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ifd980a324e5844119be04d1bb8b21864_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A095NotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ic8948fc5022044e38940be61c4706a21_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A095NotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="iae91b5c8065840b89f68ae84c662b898_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.900Notesdue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ia36b73a057224ba4affcfc6bb3cea2e1_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.900Notesdue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i6e79dc01a22a42a1b246532434f100c4_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.900Notesdue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="if7a2d03254ee4d5f9a357de70108e5b0_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.150NotesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i21be7fdecb314fed8cd5a7cb7f876fdf_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.150NotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i51f2a2865858445bb19a36565773cc28_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.150NotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i9acb3bf537f748f9b2c3359991790afe_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.95Notesdue2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i35c7685f5dd046aeb031adc37a8ca784_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.95Notesdue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i1333214536b64c51ab1dacec5ddd05c6_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.95Notesdue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i1245a84acd304e199ac2b7dc8d467d7e_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1300NotesDue2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="icca8ff318ac34efc92f4216ddfb91fb2_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A130NotesDue2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i0ea632070b0e40e898b52619bced26b7_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A130NotesDue2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ia1378408d96d46e39591826c2abb98dc_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.95Debenturesdue2033Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="id5f87b6d74d749babe28b84569bdf760_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.95Debenturesdue2033Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i995150be58c746e482284b146887f7d3_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.95Debenturesdue2033Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i2622b7e579a8492eb15ec639424f7c89_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.375Notesdue2033Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="id36151c33f4848bbbcff81875e541568_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.375Notesdue2033Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i7e0d64b50fd84e3a8c7f405b55ccc1c7_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.375Notesdue2033Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="id41e1a92e44e4a829be6caa81c1fccec_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.650NotesDue2035Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ib7803914447c4a189138f7ee1b3e91b1_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.650NotesDue2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i256f4cdb5243490987a08f155c79ea6b_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.650NotesDue2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i62ebec4387da4562b9e6654db09a6b96_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.55Notesdue2036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i69ab97fe3bda4a55b6837fd20fb4462a_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.55Notesdue2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i480827ff0c054590abd0ec468b49c4e6_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.55Notesdue2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ia5536eadd4c94ef6a5ab2937cc959359_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.95Notesdue2037Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="if1b4030a20b24ff0a711318c1a843cce_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.95Notesdue2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i1da6151136fb464ca1c2c5796b81d7fc_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.95Notesdue2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ic8ef119f549949d08c1ae0df1c64dac7_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.625Notesdue2037Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i86d6509ed13b4aaf912a2823edcb1029_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.625Notesdue2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ie8a5b10c02c54e47ab7d11d7d166c538_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.625Notesdue2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i9aa446f74b2d40f4aedc83ea2ea53439_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.400Notesdue2038Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i4f66b72f3c7f424b8a380c66e8da7d27_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.400Notesdue2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i48a1bd53e02644e6b26acc106519b804_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.400Notesdue2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ic49fdd1ce30c46f8badb4ff4bd1017bd_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.85Debenturesdue2038Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ibd0f7065260a48cda35109d9ae5386a1_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.85Debenturesdue2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i5951d9504b1a4dff8f25e5796b4c0a9a_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.85Debenturesdue2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i387cbe08835047789169cf51f45ee5fe_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Debenturesdue2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ide6e5e064d024312addc5538bdaa7c85_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Debenturesdue2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ib69bdfb1b7b94a449af780c7ad54b9da_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Debenturesdue2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="idcd460ebbac7457b8cb0a76ce59423a5_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A210NotesDue2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i0c89e14a0fa3403581aa0e9723a4286c_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A210NotesDue2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i98dd15586d034500902f9f3c99a576a5_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A210NotesDue2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i324a2081f5854fad8130ebd189647549_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.85Notesdue2041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i1eb3f36ba8a74f5480d62d0a81bbc354_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.85Notesdue2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i1b41d3fa848d4b0ea4f78009aec60a63_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.85Notesdue2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i5bdf805eaea4472d81e2786f92535e75_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Notesdue2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i24b0208298044a269325b9653684ec98_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Notesdue2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="id4ff4a9f1fb34cd2b7cbea524a570fba_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Notesdue2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="if02c9f9f84d64647b122e66b2b1a6f36_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.70Notesdue2046Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i171dded75a42462f8691992184163a6a_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.70Notesdue2046Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i4e60bc8e3f0942bd832fc02168754abe_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.70Notesdue2046Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ib3acfd6e023d48c49956f11aca1794a8_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.75Notesdue2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ia8fdd90a9a534e91a456c1d33c226809_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.75Notesdue2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="if3dc5cdf91884ac5a55987be998ef035_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.75Notesdue2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i2dc08c035fa24dcca70c9fdd3ca863ed_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.500Notesdue2048Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i43d605e8071140abb14e4a1b5c23edad_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.500Notesdue2048Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="id5c0678f2622446789e384e30ddb3b34_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.500Notesdue2048Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ib1da88ade9134203bd9ab5f43e40ea74_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2250NotesDue2050Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="id9d8b34477a34cff93a83812f0c68017_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A225NotesDue2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i5044fde7f5e441ac9def46cca0d955d7_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A225NotesDue2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i37cb21206af94c5da0e8b41d9ff52e60_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2450NotesDue2060Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i930c3d7cca544f488362ecf22d4ba011_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2450NotesDue2060Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i6ecc4cdda5b24f6c8a06cf84bffb3461_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2450NotesDue2060Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i709d0243b3794243b831d6b6a562bf4b_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:NotesDuePeriodFifteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i278399ba66af46a19d5e0d9c2a66430e_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:NotesDuePeriodFifteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i719d92c03acf4660873bf7164fbd0cdf_D20181231-20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-12-29</endDate>
        </period>
    </context>
    <context id="ib12c2507851947309a7a823e9e3770dc_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i7f434199d52940ed909adbee7e2ad0a8_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i4ae18f8aab5b4bd6b80b50402d6ad212_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic847fc16c1a54fb78d5fe18b8a9bd17b_D20191230-20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-03-29</endDate>
        </period>
    </context>
    <context id="ibf5f634dad614276bd22344f56a80048_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">jnj:AccruedTaxesOnIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ib105bdc301f94aa0bdad8883c084fba1_D20191230-20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-03-29</endDate>
        </period>
    </context>
    <context id="i76991a953ea2430ab905037bfcac327d_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i97db63a5b1bf481bbea39077a0761ca9_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i4dbd3aef0b5a4bbc9dc149f14c7e3d3b_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i0ac819dd65a24ccea1e79d719e0d1cff_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i32b2b3e0644f45ff8702ea89bf54ad06_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i3a18f6b9ab22475b952191fef9a136c7_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i62d4b60ec8e44411a7c22519b07bcb56_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id7d38e2b061c40569b6a15416f6b0063_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iba89a9d0fc0d402d9b56774badd78c07_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i7aca824b885d4113af57a768e99be46f_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="idee3ed30241e424493acca72e673afcd_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="iad56cf144ec847a8a16206fa418498c9_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="iebebc2fd778f40798d1314b14d68d59c_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="ib49a989cb90342ab8cacece521c7d896_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i1a657cd2705e49199faed73d18529a9f_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i686763308513427ab8b79b989e11e0b5_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i7b2070364dbe40199c021a5f19b0d7cd_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i240092c4b65b491c93381937b17173a3_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i33664fe4d1f148e7bd9e8ade82e1790b_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i9b60bad991094d70b3aa1309c7d2f70c_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i0247279f84684992bafc7f3bcd811a4c_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i258eab55a2d94c38a37a02b6761520fb_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i6d95454e2f2b47bba671c0f16ef3678d_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i55c350243936480182afafc99c54f755_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i8b916937f8b4417f970a191c21a50d7b_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="icbdf62a6d4e04d9497cf6a3f7fe73fcc_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i38c6793cfc6744c19666a02341ec9b31_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ieeebc720734846059822e5b88d5728d4_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ic3b1c962253f40358196e13a8dba4ab4_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2da046285a854cbfba8fbfe14771ce6a_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia9b2fae840754a6ea4f68f1acc7268f9_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id933df11eed64928a3b3481a8a126bb8_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i9ffccfe4dfab435e94684d4fcf3d976f_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ie757ee9c942f4859aab86954bd239d38_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i735a40d88d7e46dc9295f42c61e9310a_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ib4183cb021584ec6b8420859ed1b2c0d_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i9db0932464f74a4a8916179795da088d_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic8013563982e4faf92e1d4712047488c_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ice288e8c219a4507ad03507ff5dd2f25_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i6167e7598a3a497a987f9d52e44c47c0_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ife45c684b85a4e89bfaae65632c76bed_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2317353ffc6a4b6699b4670f8065adb7_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i3cf576db9a634f2bbe83401cc15ae8ad_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="if5501bef72d543db9d17b8fb2870aa8f_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i6d0c5dfa391d4390b7907e241d878e21_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i7b497129d20c4ad3a9e5f5c96133de85_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ib88a939963264141828fb4d58e203838_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="iccf1e8f3a0074a97b0f52772a56a8633_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i9bb84639aa354224b5d50732c027f3ca_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i72078429833b482abb75ff2f963b1c95_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i1a72efbbc13f4a9899424dc34768f292_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4d8fa9621c1a4788aeed3179569fe294_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i7a9f94d741d04069bba045fd793e2102_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i282eb35f5a6f4308a0133f28f9e9fe51_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i86ef51c7d032407cb30caef60d2e438e_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1fc5a0ba168445cf92dcf88ef880150d_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i3d63809b7b464394a1928e0d87c2b8e9_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id1d3e97e875047218ce5d543119f6e23_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i9e589fe2a250489bae1d93a267c01624_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ibc8fefdc8c3146ef985668dfce568821_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="id0e7b1947201413e85946bcaada77275_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i14fbc68dbd2745caa0dcaf30d0e59cd9_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iee45030c44e44d0aaff586a9a06e0532_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i61637434781b4c8998469b74ad8a39e4_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i63c4e377a3ae40f4bcb7d5a4e5f8b84b_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i61b21fa64d6040eb9fbae0bbae8c3b11_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i58e8bc1a90394483be831705847d06fd_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ia03a4e20bbbf43c28052fd90303aab5e_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ifc43c3a1acde44b7a8a4d40d89e4efd5_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id798043e75334798bf5217fb399c1997_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ib4cf6ca49a8e404cbbfb2fcf0ee82a44_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4d496bd90754417ebede4d9829a52df5_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ib0d8e990787d47c0b75a6b3923da8b2b_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4ae786e5f2804cd8b49c7613a74391d2_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i5751770904eb4b40aae931e43968e339_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="if752582ef2ea49b69e87bafa1de27a77_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ie724f8c70c1e47fa9a3509c07877098c_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ib4c4a17d7588422db6a82c1ac5960f10_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i4360908e63cc43f4afd75a1169c42e6a_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i585883c87d6f468ebbe4454a07b867aa_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iae3a3a38435f49649638b494f6bccee6_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="iede096f8f0704067b69be6dae6af81dc_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia7c75ec32bd0476981aaefd378fca34c_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic7eb47e278e24b51ba738fd66bd6e91e_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i95d2bc3ef16c46d9b02250368f6f79fe_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i19f91fce38e74e8abff653dd29e4e05b_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i08464ba4d52a4eb3914d1d9e020164be_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i33b4445ad1ea4e698cc11d61facc127b_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i077f80fe22fa40258a7a8564873d966a_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2ddf71a7398d40838d9e518d97fe48b0_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i2686d4d38b79478aa2b6dcfb62ab0339_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="if59b92da44574ef0b138a6fef376b519_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ie69aec39506048e693f8810a2bec2f05_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i99ad086b9b774548b75e48c3ae0dd0a6_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i8fd225a39cf14e8fb13dbb1438b30e84_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i0494a1212b6c4384ad100f4b232c73a5_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i4a475264ce8941ce924ce89da6c1b1f8_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i62a183893e91467983b0dbd1d2467359_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i7721a842d6e04cd68272b2ceb8cd492d_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ie377154beabf45b18b5f586329899114_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iae10ea720f56417c9b64a77097323def_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic7d047e2d661467cbcc58d9b0a2b8f87_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i5a3e920df42c47f494f7fad0bdd00892_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="if1f5496c4f57420a9c9179ba0ecf286a_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i80fc979b7821412b9354bc3c8c18f543_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i0580a0f80a854712a683ccfae2bc01c7_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i20a3b648a6b14250804ce2ee299db44a_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i4377262270cc41a59014888c45de668a_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id1ac04085de547c09d5d0c96ced99ebf_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i08189f8df3194c738e0366b591e994da_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i7a49b61963434f44bc5c32db3f151981_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i4107f09a348348f5836beb164c41a295_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ia54c27d99b0c4b6e8967c1db2422520a_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i28a313fee6cc48c980ee757740247668_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i57b326234b5040d2924a11d5a5d2f80a_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ib1cced7a8930436b8bb62f6c2b776b00_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i49584bdd90da4200830477e258a1f18a_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i71de0a16958d4a86a067f40d027e87df_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5991575feed545c4b92cb368006afbca_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ice0ca647d51147ab8d51aff745fcf585_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i6d625ffa896248a38279e2b4a29f3219_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i38b3cd6b638a4e2096aef80289a086d8_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:UNITEDSTATESExportsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i6ed049d22c86487cbbb24c08237cf4b6_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:UNITEDSTATESExportsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ic4bef45a84dc4c01abdc1d98d90dcf34_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:UNITEDSTATESExportsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i600cf308c1784241b70b032c5d68bd00_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:UNITEDSTATESExportsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i63fb4ada15044f6c8fa99130ea93d6ab_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i79355bad3e5e445082550bcd9d3f6dcf_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i898fcee3d0f945379eea001f50fec410_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ia77eb74fc24d4dee978633e876eeed4c_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ibd37483bbf104452b66657df9eec0a8e_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="idb87e2b919d04ce0890e77ecba398e3c_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="id7fe0e4ddc03461a8b43fc91268211aa_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id4219375293b47b3b667294bccd3f0d2_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ie2a1050013c34d03af84c0a422360167_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic3e62d93a7b248c084cbe02d4097ea9b_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i41d2ba995c114bea8112dc3f01a44747_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic1735f2c1b584a5387b7afb371b2cced_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia3f96f7c0ee0405d828605b25d8ad883_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic017a6711bd74dc0bfa3467c9d21905e_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i6f8cb419ecd94801b4d8467fb355264b_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ia794884513314c399f7a15b03dabd0e8_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iab4590d1e9a54db1808fa18df4d4b0e7_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i3dc4de912284470885b7eab6009487a0_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i8a91bcb926e849978bced69fbb28f834_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2550784b68a94c5e9a6680ddeb5a5dd9_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="id05fcdc5a97449168a9c27235f88a4a3_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="iae663d548ab040e1b558e27622a655de_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i6a44552997a1438b8dd35f1ec093c504_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2a72154c44cf41628c31a554960fb0ef_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i1e256d64e1f14cda9becb9ce95293d74_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="if9f32d7f981b49809c5a26d11cfd4bef_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ib1fa30f3e8d749dcb44364f361265101_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ib09c328bd9b9495b850d67bcb81cf0e9_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i7dc3572916fc412292b0f22a60e8ffa9_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ibfb0a635e286413fa05216c24bd242a7_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="idc83cb6294cb49adb420c6d0d9a84038_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i24c66572a6274c88bc620e4593e2bee7_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i833f6bdd0ed74fd890f7d87af9bf634b_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i3d16336042034ca19612e535c7203721_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i7f0843036b964e08a45d950a3620e639_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic56e7a163c104637a12666dccee0cccf_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="if0b694b680c54fd3954e2c9de825640c_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i71cf25bbc69049d7a04ce269ab9edbfc_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ie9c6b2cd97644d858ea79595de3d0fb8_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ie7d0e75dc93a4714a87669d7c1755832_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ib59aee6a72054b5cb1cbd5bddc82a106_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i6e3f978416814668818a1ac3d0016e08_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="id5ccf929f2094fa7b1f560a94aef5455_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ie48cd916e4a74a618757c125457112d0_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i31dea148331149cca5a80f720044788b_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="iecdff515762e495ab6fc8d22e512e250_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i1be2f593ae2b4c93ac28c4879f064560_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5d8ceba2b66d44b3a34e55b430bf0cd0_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ie11aec75a6e74827a118fcb88d74e00f_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i97c1b4ea6d1a4ecb97e3016e1eee457b_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i5d39e83bc807453883a50f25b55fa036_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i04e9c913340f4fd9bd58f8191b92c901_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i27a5631c2fb54ff69c55c3cfd8c73d66_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i7577089dcd244daaab8e65459409715a_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i7e213faa318546279e9fd452570893b7_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ib040cfc0c5614b24b802c847b9882e83_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ibb1464cedac54631af9b25c35805ce37_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i0d6bb0f027f641e382fb220073c0b43f_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i9f59ef10b8cc46cda0b50f4338e55776_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4e29ce41396f48e889d97e03233e6707_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="idd7af9434c1d463397ad836760e61d27_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic8bc6696056e49588142a93df17780a2_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ie776bdb04f934182825e29d6f3d24312_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id50261a61f02491c979c43c1a7e12622_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i8a00e22875b445d8a301f09f4917837d_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i86d495dddd6e45b0b86fb85e4b21a2dd_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i7387eb05ef5c4fdb842526c456bbe3c5_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i313ef0d43b1b446cba4d11086db5cb51_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ib77203578b1e4210a44754b41d738e9c_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1173e423785c44f1b4f1120ba26ad0c8_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i73165b608c644bd1908c9df7d2a34b56_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2d0350d7f7b0426fae4ab3e96ce6a2d0_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="idab010351da041bdb2cbf40ef950465c_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1ede8c86463a4ca1900b7e1fd0a2b799_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia0bb26554dca476f8295e07cd23d1a30_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i3ab4cc6bdbc94b5cbf46487897a3b4c1_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i2f63caca7fb446d981bd3f55e5f83321_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i58ab3c81d40b4648b33db3b797bc2e2e_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i42d8379119de4f56aacbfe9fb385c84a_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ie267eb4c95db4a2490afebd4e223298d_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ie025a2f5e9ec4234a5ed0d872620533d_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i022b92c911e04342ae67e207f4d0515e_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i2e38b2e1ebc14377b3723fca5ed4fc49_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i836e6925162d4ab1800fa82a7ab90e71_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iccc032099418444abc0b942948f6db9c_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="if7969cdb22dd40dcad77977375507b7c_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ib23a110014b24e3e9dee37ef5d241637_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i400fe3ea80954d2fa120c009dd823c28_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ibb55b5529292435b9665dbde03853a33_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i760f73e5eac14ceaa22fe96b46943bbb_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ie059b332397c41f9a9a476949ab0f9db_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i77166f2077334d64bae7a52b781efe80_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia076593d3cf644b2a4c230fb8aa33f2b_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5cbc3463e1ae4fa096e2ee9db46c6632_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ic670fa5873324341b652814d7990b6ae_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i39d249731b8e4bafa48866d9284ba875_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i74965ae98cf74a79a669cab97dcec19d_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i37b6d89c8f7649f59cd7ed840dc6187b_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i03e4b6fa743e46aba9b64898e02d6610_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i864fefcfe9ef4b1f8253371aa4da89d9_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i4c99f12082bc4cb2903b1862521cb302_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i75a1d3c0a8c34a149a347f13a9e28320_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="idc9abc58a71044878c2aa7ae09ff8f8c_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ia105d1087fa6441a9079ac5df861898e_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iacb6b77961a1479ebecb82fdc6fe00d7_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2c08f4679ad1446eb19be39cc3bbf8cb_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ie0c2f0fa25124f8b90b673fc8d30c977_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ia3b86ebc40de4d02b5a15198e05e4dd2_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i04d10f41995549958614dc5d62ead9fa_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i15bd82bcfc384cd1be06ff3479f7fe56_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i77bd07ae97df45fe8f18bc29a8766b16_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="iaf7cf5a1f5484ad28076d05cc5bf5456_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="idb272bfc6aa14c8d833db65bd2d89c9f_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i024b31141065487eb47c8f27eacf8b94_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i26d2bebfc5134ffea7bebf182f6bfe88_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i09fc122a66fd43d987b35c926766da1e_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i838fec96a85e490a91abbe0f423852cd_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i205f53eb2b4844e4b0c11273e65d1efa_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i49d169f73b2a460ba9c3d0d74492a3fb_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="idc2604a22a5446d1b2baa44602c72c6b_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i4603cfe6fe1046c6af473d0b35dc1e66_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4f7c241d8ff946ad9a3f1e8650b6d548_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i3e5b1f4897dc44e3889d6a11570ac3c3_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="idcd6dab96cbe45f7959c3a93eca497ca_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i54ccc3c917cf4242a4f575583368ce21_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5377031ce1bd478a865faa89ac9e836d_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ief1076e1d3ec4608a9c69b0854bd5c3d_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2d0623be30d649bdb8c119d1fb380cf5_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ie5493cd95e9040eca88efc765e25c90b_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ib8154cbc3358471d81b6c9e0cfca602b_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia65c328603194766a57c17632de4fa37_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5abf17b6cb264cb197714b4eaa2858f6_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iebb810100f164a6f90ad8126497b2fee_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id795ffd344cd44f3ae87465d76b3b61d_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i020804ccc75241b39a2537441aa2abb8_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i466ad16e878648bfa865eeba3f05858e_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i702c3ba78f294a499d08adca2c3e05d3_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i8d5788dcb82e4eee98bd8058fbf39537_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ifa520d7163634d8fae3b61f2452fa6a9_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i3397044102204bdea03afee12e1ddbe8_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i230206d0e0be406ea6ed74138f698967_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i8af9975ac5e84f31902e2dc3297b1c31_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ifc11f05a7e144bb8a612662099fd1476_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="iec74f00dc144400fbf71837c3f85d010_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i88615927a6634ebe93715f2ce1c8ffed_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i542156a6acd14373931ce4b7ccae05f5_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i4492bef684ea46c1a3ae25b9fe930f14_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i721706f8e045481c86dc8e07627a8f0c_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i69abd303a0a949469442142f029642f9_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="iba3f0ee0c4f3486faa522e60acb01051_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="if4a66bae60fa4ef0af457100fe8a6b2b_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1b81e17f99cf4307aca1954a29ad581c_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i3c1f3898bb4b45dda42e758bda36a669_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5054190d146a4cd188e4ff52a2ac195c_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia396ef4400a04721bcb9eb751d28c14c_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4e196f60c8f84d0e863995c395467711_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i7fe837c300e64a599158923b9a3e0ccb_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i73c197aa1c3f4a2983242ba4675beaa2_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ic939d8552fd24ed6815d0c7676ad9233_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2a78f12a5dbb4fbfba94b0044e46b502_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i8646c210ca8d446ebfb79435ca8cbfcd_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i9bb13790d6ad4aad86f8fce7a1c50f3b_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ie9d9bffedef249fdb93057aafdd09a8a_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ibbaf2076fc654fa1a5fe9210a7f4452c_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i2778860e516341fdac7a99b7214a99dc_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i6dd83f9144404cd69bdacd864d641631_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i752cd2edd61e4f58b473965cea3aafd4_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic26bca171f714ec08510fa419cbd9f78_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="idfe3e7487808413aa0811c36064223df_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ieec92b888fc2475ba4b45585fa0376f8_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i1205be94e68d4cda8b85bdc70cf76ba2_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ie4cb44ddf8cc45cf985f507e2ad63eed_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i1d9559b960f641bb99edabc691773a8a_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4b155857af2742ec98b26f0e8bd6f63c_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i02575caf89d44152bc3372011aef005e_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i425fac1e024e4a3985d9c88eadccb208_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i8ea9ee18248c41a0990af9a8bd2d9634_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4c4aac1ba6bb45aab22decf4191b4c08_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i97b82273e4234a9a905cbcb65c575356_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i6ddb0f73dd2a4c0a8d3fcfa0f7522b98_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i5381d639283543639418c19ee2938e11_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1910340b47b743deb6e4133b4aa1b30c_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i40dc71d902444824a22852a9b082d005_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i8cf7bb68342d478abe812d2082348d36_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i705ab2d26ecf4df3a64a2a7de556d9ba_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i9749eeca9e1e4d8db5458ec220a2454c_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i5920e241198f48f38ebd20ae56e19795_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ibfe72bbf690841b18512fbf1d62a9972_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iff059545ae6e4221920a372b17db3e2f_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic9675c62f8e7451998e302272f33726b_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i6b963caee0e54df9b30e44510c6584c3_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ibc13c87f32fe44c191a0a792e991354a_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i81b57ee3c6154482a279f76aead7f4af_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ib57a13d3edd943ca817dd9ead9e296ae_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i4ca84dcf326c430cbe701477a9c57a9e_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i77adc61bfc404ed98cdd17cd48df3b1c_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i372932b60c2c4cedac8377b6bac57e40_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ifc0025ae94a8482b889201ee8f579b2a_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i0e76cc62521e4a5b9a91e983d896f049_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5ee09d3943c845e39af6dba238d48fe3_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i34735177370944c4801a9842bf884fbd_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i796fcef4d74540e6bf307cbf351c2bed_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i6b57e3ca4ff34279b822c3d9d12fc1e1_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id9465452a2864f51a42faf1511d0fd43_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i72c72074c6ba43788b7c9742c486d2df_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5ba0577bcdd34b8d86faec42ec29417e_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia0693b80dea945c2978dab63fda27374_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1e3e511ff0b44224b63d2ea86eadb7e7_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i45dfcb3ffb3e4a97a4cd1f22832657d1_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="idf94b5c46b474da196e27de4e267114a_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i62b6d2dac7db484986c41d5f29e1baf5_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5446e8f0ab454edea3b3c38dd20556eb_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i67ccf902b8ca4f778d40454a90bd5dd6_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4109c4932c754685876797c6af614e62_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i330bc9af1877499b8065d4b7b3fa2e01_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="if3c3b9971d0b4acc9e1042b91d15ebe2_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ic4955df2646f4d2db40aeaab35a9f11e_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i9e0a71362e3743e4b1f4d0012e92b109_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i53f5011996b74418b2ae013de7b25fe8_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="iabef23428a1c4d3b94722d03cb22cc1f_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i09245da0ca9744d097847bbacddaaba3_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i0c8552621f43462f820822d0db06546b_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i268dbe75625d4f94821b1992136466b5_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i54921a8e1bae412499c1ed6066b7babb_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i00b989b237614d92886abe9728179769_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i18c083bcea8740cb90e264a1f6f78d34_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ica56f357873048e8b05d7f37a64550b7_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="icd88bb111cfc4697a30d5ec9e6455e68_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="id7c1dfd0ab824a55aa683fc2853c811c_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i7515a418c4d04e6696b8dea069d6787d_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iea069e1f599749b4955a9badba8f5442_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i6c31b8af359a42f99b7d8bce11dc8b0e_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="if3bad18a87304c4cbc3c2dc4d1ce3cb1_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ifa05f30dbe0343b0b935c997aa17c4a3_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="icfb336e5668642d095d254e92dbd3662_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="if54134f7c5b24e07917d778ac41dce41_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="id920a9ae68314dba941e6bd37d23c794_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i99dbd0f9ca734810b3b3cebdf13dccf7_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ib5ea83560e2c4220bda25b528dac795f_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="icc48547d5c2d45b18b0cffc58b8418d0_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i2930e4636157460e97c87253a644ebee_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="idde0b706304b45b88a9d831118eea942_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i3555c8eb101047b7b3e6f5fd9a92fdfa_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5c8089c225324cd2bee3241e1f84f5e1_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="icf2f109a663b489da13497ab8eee8ac3_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i32579ea231594ff8ac2d8f4ae4ce03a9_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i121970d9573c4f7ead61761fc53904c1_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ie5ea45ba97f246528bda5b3f66a608de_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i398b379cf9824522a2ced7cf59facc66_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ia701d7201ccb4861bb77be7093c08db4_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i8263c917767241278ccdb61c3e4e2803_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4175bbda9cfe43b6be2edab57371b4ab_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ib373300898e546d283fc33d0388ff705_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1044002d40e647fd8326e72b1451460f_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i42c60d3862824ccd828e4b74762f6418_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="if420f4bfc54a4c239ff4a7c3b49fa4b8_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i16cf6062a6ae470696458b6461568e25_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i9d4fcfc7f7e247ac9b236ab2cc9b7610_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i191ce2e499304831a66740e08cdd128a_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i37e02e11e60a431296858d46dcb92eb9_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i37fe03909d0c42c2a5d1a9b179769776_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic80413ba702646b38fbb6b8bcb646200_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="if047c787f50d450e8de9249ed46afe73_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic9a361df298440088f461b4343dc1a17_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i94465a7eb96141d99ff73e62a319bfb8_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i0698ee2dd7914e2abe8fa68b898a1a28_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="if08abe1920f04bf98dd739839be93b65_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i217e2c9aa29f4999bafbb343189c1d78_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ic56fe73198cf4b13a4b507b21a942116_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i318c310c110a410ebd87a7483d92e09c_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i2be36e5216d54100a37a610a312db40a_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i3e63c1418afa4562877a6c19653bb704_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i73eb95bb08bd41cb8d99dd2c4a0b8742_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i3aa4dd5cd6a94deb9b074d8cc077c127_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia179bce14d4544eda2428c53ec509422_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1a8eaf42923c495eb5579fd7097cba34_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i010426648d814b3aa129307a75a78d2a_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id454beb1da294c5abf1642ce831df07b_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ie15c767fe2ab4976b0a06babdc79238d_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id44c86afd635403a91e902792dfb4c5c_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i0e2e06db53a2451dbf125d3629e771b6_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i9cd752a9056749c1b4ecc334a21ed7c3_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i8257d323d64145da8c90884eb259a7d2_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i8c2832df4f35417caf2fffb8cb822af6_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ic5075a6f43b343338c5062f76a48e067_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i01d88a3108764d0bb869889f44b14203_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="id644fa2e713f49e1a5ae05b7fc4e4f1c_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5ed3772815cc4a3faa703e73bf58e0a1_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iba2b4531ff2140fabce85ea3fb293461_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i63eb447b40dd454fb968053fddf79121_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i013947f80a9443098796115f97595392_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1a0434c21b524a9bb6ea856dd5969c76_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i80e3dc1f3fb94925ba1c451b2ab83aee_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id389da37c3cb472483e3c18b6f953869_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i00da0f84c86847d7a8655fdf18a81a3d_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i41759335282246b889e936ec23f879ff_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i43ecfa483f6c4bd19953e3fdca33dd8d_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ia9f66f37ff7a44b583b3c5e7100eff8d_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i57a9bf838edd4528ace0d2c9eba6e86d_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i9d744e86513440f39ebc068eda44b32b_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i95265ffca9d34d798871d9fa7c192928_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i861817aea75241f3a7830b21a7873c16_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i57cdedd2e4924130b9f973dccbf1425f_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i966b90600060495180cde77fff0831e5_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i33cef8db85f6459a8f53ef7046c5bfa7_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i21c25d970b094401ac14010054e1f3ca_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="if8c574d380a348e68b4cc617a801ea6e_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id37ad7cfc12b41428d45ab46b67de2b0_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i892fd133b58a4cadb07bdf935bc6af34_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id9a6429a54d841c1bcde5ff62985a777_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="id21567f828814171bae17a473a89e0af_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i96d11501e2ac4574bacde0ae4de62fd8_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i762b4c937c7f46559a1d1ebdea00839f_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2ca2df401f3e4b03a03bb594e14680e5_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i0242667ce51c4802826573ff14607be2_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i8a3f0f519f304581a495ee44fa8e215e_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i4d38ab9af5db42ec82566d7e0b60d483_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id7d07f6f95354ba9ad6ec0fd6afb8f1d_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ic78f1097f5d748cb869eb5b503824ebe_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i6563c54cfc0a46558fb408ed4e9fd465_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i1bb45cec18df4abb9e67780a9955c6f4_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i6c8d711197c44ef8aa825b062094402b_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i0f4b21e1fd1a4652b30fc4578fce9c11_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i7a3a40f9c30840b1927ebacddcf845ac_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i3694631e7fff4ce1b73ec6332f8f1114_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic32d7dcacf84400d91757b36f9215e72_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i9a75613a853b432d954dc4de396f1b7b_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i0ff9e6b244664dcc8c57f0d6c1e416d0_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia756fd0cfb2e474196776e501a411735_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i31cd8eb3320a41a397704a1328b8854c_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i7fd6606fa19d4019bc87ef7e6ba6eb73_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i34aaafb86ca14d2d9716c717162ad440_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia7fe0b9644764d87866372cd691decb6_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ia85d0ddfb054423a9895f28c3b06f8cf_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ic4763443528342868e35179cf61ecdde_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i333c0de72c3a4698981d349cac512c7e_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="id724502ba8f2486cac318bef4c54fd96_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i69ceed544ddc4d9b88e01a94fdf9e5a1_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i392f000005e74b13ae8ec4fd2245bab8_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id0ebe2acbb28427fb07907d3d7cc84c8_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i2d4f2c99a1f249c49d42d6f746af5a57_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic8603b809d89437c8397bde709854409_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i9f2972e6f6484e36b1d2a91c5cc8c877_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2c5a38578aa04cd7a11950dd9aea6179_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ic8308cb00a64487ca422779891052509_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i72b87b179f8b450ca58c7e90f207c8cf_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i5882b17221ff476797f83dbe3709f9f7_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1276e4c945994ec68e5b1a60f0f2e568_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iebff1eb342264ce2915080aaeaaff91f_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i9141ca3c0a1c484a869bed176ba77cae_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i1e756c09a365446ba32b0f4451a03c98_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id74229a2d6f0451fb97e2c96709af358_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i18dad1ee5f9340d5a35c3c37e4cec4ab_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ideea0ce4a35c49a0a45ee282bf1b4beb_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="id554573e94b84b8cab2eb20188d60570_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i49cd0b4d91974b7da8bf40cd67d178c1_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i53b2c0aad4df4af0b03896d334176f20_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2badccfe6cf04b1c9d7f2fa0fc294693_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i3d5c80efe6b1469391e9a4a07886a5a9_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="idff7cfe33b4c4b039394833c97daf9f1_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ibe12ceed34eb4a389dbacc45771bab50_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="iaec3c39feb634238a2be7772b9926fde_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i73fa6421e055482c920a5e447a1f8675_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="if9b7a1c7831f4541b7d5fbf0ef0a1e55_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i7db38f4a02ec46bd9364e821dfd12084_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i08b63855cabe4bbdbeb0a69f02efd745_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ie736ef5792a9408d9d187416e6bf80ae_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="id1666eaae52c4401935f050f08c6ad04_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="icff6620acad14e70ba4ae22cb2b1c5ab_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i8dcb3df9a1d84367b2ad2572e6f5d507_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ide630ed019df43bb97fc9e366da29198_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i1940a237e8c44075af2c9cefe451512d_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1111a41f19b54df1a08a52959ba8a81a_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="if89b08d6774845f39dbd843c88a623e4_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i7ab8b554e029447da97b0eeb058f7784_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i362aa1da8517434aa7ec7cdae445543f_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i6ef01fc2d1d144f591e77eb42bf26fa1_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i6a7520101a8347d8b81b529c44f5e031_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i7455b437e0ee48eb9473a4538a82626d_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i331b2defbc4b495580cbf5071b32f36e_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i700c383f769a4f039b3dadd10d216a66_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i9a16cc194cf149e188ec098d494aa4eb_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i61e9bd42de204e38b485cae7266baf3f_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i9ebcff1d99364d61b75d91cd03f2edbd_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5f5862c1f9554aeaad6ec3149da92dcd_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i56570f28521e4309bb5acfbc1d861206_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4772bb2f70594c609f15d55b5b840ce3_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i96b312422bef422894f64737926c8653_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i94c1dc95b63b47a19b2b55e786fda0a6_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i620ad18d8b8e4ee4b483bbd4fc7e9e5a_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i79e0912ed4304749a55e7ac7a0fe0ec5_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ibc0fcc5f2a24455490a6a544350ae618_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i86a18dd116e24e96b3485a5f6169baf3_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i9b766c43eb6240ba8bbdaa57b4a094d3_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i228a88e232a3439ba7508d3f89efab11_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ic8e0f6bad1de4c50a2da26602cdee485_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5478e07cbf10492b94c7f95ded249535_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ifd8aa81948f24b89a510f6d5974fe76b_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5470093de4834bc093bb3471c8a0d68a_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia9e844cd7770412489bfc37a68ec0c16_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1801a6a1406d4302bae15df4fc5e6e72_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia35085eaa6c748a5bfddc85e2da15d60_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="if25d735005cc4622a33272df76697e88_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i5faf7b6f7a9d42c58b9a332270703b95_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i59e7895988ef4dae840116b8f041c33c_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ic339811f8c7445d4af842ec97e4900dc_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i8e17bddbdca5483e9fb788af9d2d8cd4_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i83d80cb8b62742239c836bc6aed6077c_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="iaf702c0dd8c14d8a908386735f728ab2_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i06f5aba171ac42868d1d0f93dc180a43_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i62ede8edf37b48389570fe7528e37670_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia4eb2ce198ed40b7b248f09b87ca97ce_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic63cd8e33f3e404aa8678a6a0bd21989_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ifd0f4a74ca2f4dac9fb438dfe7c99571_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i257430a4bde64ea48d158e7205d2c483_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i8ec3b3d8e35c4d95bf1c4fbbecbbe0dd_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id2e2712a0d5049f5a4531ceefce9f03a_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i80bf15618213433798636c636144fd62_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i680358c8ea674cb9ad8f59a84f3e2968_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i506f1906854848fab0375dee9395568d_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic59c453b839243f1910be25d60212165_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i92e00f4cd50544f1a6fc1c21b5eff033_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id9a73c4de08348d0aebe04a72f25b265_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iaa548762232c4bf1ab0a3a867110e217_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i80e7c2e2168a439eb1b8ec9732ba396f_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i159a3081cf544186938c908e8fa7c674_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i126743cd6a3047e9838e7e77686dec4f_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i9f7d40b1ae56403c89c4041e353c5f2d_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i279d140c5f3b4e169fdb57f7f0df5aa2_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="id82df2ce137f4d92afc976d33692c8bf_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i8b733e335d8e4c1fb383d893bb64d6c6_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i078e82fb2a1e41d6810522efa7753a85_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic3b18e1cdfb2424b8ef0500cab9b37e1_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i549bc38f2f2e4815adbcbdca90f24d9e_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i46022c7e16be41ff96edd7e762e38dc9_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iafa8ab4bd43341708edcefb67a5354af_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i445e1d6a7f2f49918827c8cb78f49926_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i5c6117a9799b4fe0b16e620b0cb21f30_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ie3f23ca283834dfca4b73d913c0b495a_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i662c0af4be474f6287c7693841b01f99_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="if783cccc272c4ee5b8d37788be2343c1_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ib233b0caa2d24cce930843ce9532eb98_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i0e809c62413f4b6eaf0f1f74674cd8a3_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i0c35c71d39d448d08df9def2add49a90_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1321854500714d2386badf8f4f85c1b7_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i08939ac29dae4ffeb1039b346ac2884e_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i61d23b7f2d4241a38597ec38811725dd_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i0e5acb865e574efe9eca9f998ed83da8_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i421903ae07dc46e8b1403cf39867c316_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i97a2b98ae57b4c268d8ebab5c60642d4_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i35f618e2b32f4a35bc3855d06290605d_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i7b15a4efca2e45b29ee3e92ad084572f_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i656d3fc14e6a4325bd24b770e013526b_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i8258fdc417094593a4a129bf9b40a2af_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i52d7cf57476d45a5ad57d74c0085b847_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i3d714fa9dc89438e93a39c79621b1d01_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1851455e464849f5bd9f21eb2518567d_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i66ae8fc90597499185a5d9eff2fa78f6_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4ef142f0f71444aab8fd23edf4a5fc2d_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ib11b611985894d70b30457565b4d7fa7_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i8de79cd48b68455aa26dbbe51313f2ee_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i1531b5603bb54e4c933c82c142112323_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i39a68f7975ed486181d4f5f3f67d31c7_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="if8fb64d50c40401c93c4477200e096b0_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i6aa2716ac6604a51a4a3c42da27fccb4_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i56e42d0e762d48c888f6a1c64e9490e6_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="iea38e5177c29474eb554d7141dcd0f68_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i5049c06813234998b24265d8cb35cedc_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ie31d7e3dc1b64e3eb43c6b2090aa773e_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i59920036dbf249039599856c49398657_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i84b634865f474f6b8bc070ee303b8b91_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iaffa1a11347d4888924b6e99e98c8764_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ib7042183f12643f98389d82808fc723d_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i75a76bf8abad43c5960ec48d79f04f36_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="if38c2f57b46d452f93dafc3b162a0fde_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i296b0e556e1b48a3bf64b25710ec956e_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i260e88f62d2843a188e4c53283699a2e_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ie77c8050b8fd472e8e5678efee8c7de9_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4444b1a6e50447f2aad3784749794afb_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i625fb1ccccb948cba7bfb675b72f1fc5_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="iab8d758e1db8401fbac59a2421221ac2_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i3f6c0b9d80c34d16ae17316c585ff15c_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2e71fdd99cd04db297741c300cd7ab55_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i963e0700cb4d4671b572343d69b2232f_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ibc4c63f509c84cbe8f5ff6e2c6ca1ebb_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i67aaaec919ba4dc6be289f8f6538f686_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i9886d032efa5433a993723420ebb6645_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i01334be3ea4e40c3b74d0c4ce690baf7_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i66d42047ed1546a99c98157dc227337c_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i1029f059b6514bd2b972b5ccf27ad129_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i3a6480a1e04142e5bd0b115b8b7beda4_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ied4375401e354a6bbb3e8ac51c6e0bf0_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2b2e30c0de694d49b6f122976eebf086_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i17aa526e89604821b23f94ff90695ac7_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5a837853bdd94ee2b05b75ff02e99532_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iac6c465d42c648babbe737db5a107e69_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="if61ce55cf8dc49728545a3f242ea36bf_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i708a5f3cd9c14d6b90cc957a086ad592_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i9958a497e25348dbb14e5c5271ce2fb9_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i245a692de7db476e92675c28db36afcb_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2abfd02ddda74dfb962822b218cefdb2_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i7338276873e1496e803482ff1f8104cd_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ib7bcddb586564ee4905b520cba578975_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i1d02bf81fd4147c3961e6b66bf6df83c_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i9d33df78c2d74a9794b67f99c431b4c4_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i9e88a966742642f7beacda981f64e553_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ie0fbb6beed0b4039960cc5369a53a72b_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ib5a04b866c0148a38d04d0efd708709f_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4593bade2d004b69994c70585546ce89_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i8b89d826ccd04092ab54bd782548a003_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i453c063241274887b6d6b9fd8f525a52_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iea21a9f89725422d8afcbf963b29af87_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2cbcdfd43e8f485799e205dfb983107b_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i9a1e0fd24f2240dfbfc672acac04a0c6_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i120a34db825e4d07a1e15b8566101ff7_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i7b6741314c5f4ad1b9cf58499b18ac5b_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i8fbd398566b04e5496711b52c150ddcf_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i52a54bb5fdd2493ab00d5b1e8462304f_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ie84d5ea9d4f740178ee2bd661a5b76bb_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i2ef0bd79dd674186aa6f73f88e7a8163_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i444727e6684545a7a9f22d74975fa1b6_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i33ce4e97b0f24651ad32677d55f5fc93_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i4c18e167d7fe4b04a6ac423556324888_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i708014e4e6e44faf8244b75bda858331_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ie499303b87b94c58b5bfac0841a99079_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ia7c244381d0c4963b4d71699e772e533_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i8e8ec55bd4294e1d97f2c5160d99527e_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1168ff1f8da940379fbadf2e0fb141f7_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i28eeee657bbb42488adc0e5f6326d3e0_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i52821a5a2b214804b0a20989602dc348_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ib9afc9d0e42b478ea02c980b18106ca2_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i938f7adae1b841d3aa77845e6f04e5bf_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ife1a6848c3604397bdf131dedd495ada_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1ae290a5603746f8b45d01b27ea9d896_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i52dbcdb545674f538361e9912a01a050_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i080887d60f0940a59368f26c445c633c_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia7d6c21b42a6409195bfc194bb649b2d_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5bdc0915d2ea4d4ebcf9bd0941e693ad_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i091d9a98d2f448dda83641c2c3ce380a_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="if32c09ac0b5647a1ad0e4dc7ce139472_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i4126d8e6b9664efda5bedc99ff1ad067_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i1e561884e759475b9165f1413e1beae5_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i74d121d1b483489e95a357c286e4c8ac_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2bdb1c21f8014a99a12c45d0019dd537_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i4e4204b60fad4fc7a1648e3538b6dc63_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5dbb3222fd984af2a17fc6f092a9ae02_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i66b302567e9241048a2995dae38b25c6_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4150ce8a62e645fb8abfee3ebb12c773_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i1b18393bc5c64f7b83e0397afdb39c21_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4ae77b0256144a08b4e114c88ef9700d_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i4067541252a744ed90386e112cdd837b_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="iaa10b3392f3547b5aa32d11feeed9344_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i47a7c165a7d648d29d77c01df838e0c8_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i93f441a7dbae4cb0928cf691ada790e5_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jnj:AdvancedSterilizationProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i4048e18828d34f3daefe8f21a5eb3078_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i390edd640d8a484e89238123183ad634_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ic337c3dd3159462ebc2978ca7661b3b5_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5e8913d91dfd40939075cfdac19606a5_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i02c1a908c32b4cb8a265199c069d86b6_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:WesternHemisphereExcludingUSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ia292ce2a3c634451b0fd283ea27bc5cc_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:WesternHemisphereExcludingUSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="id25c49104c0e46f0bbff08ef9bf0330f_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:WesternHemisphereExcludingUSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i875527922e5949c8a80b0260e40653b8_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:WesternHemisphereExcludingUSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i67ea74e368284b5383248520a5e39f2a_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:AsiaPacificAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ifb167b63c624424bb3e66daffa308d4b_D20190701-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:AsiaPacificAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="i557d36686f0d404b8f74fbd282b65bac_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:AsiaPacificAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2e7337ef99574e5ab6458deb6e8bb89b_D20181231-20190929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:AsiaPacificAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-09-29</endDate>
        </period>
    </context>
    <context id="ia0178d1d89bd4d1a9069a8e871ea628f_D20201001-20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:MomentaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="i5e557174a06c44d49bfcc86bb2b3d0fd_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i88a026e754eb416abcce4c71f9725a45_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ifb9d663934dc4e77a2227f263e7e9b90_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i39abb4a782c7412fb74f873a3b89e52c_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i1cc26d706e3948b0839e40d3e0521660_D20191230-20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:BermekimabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-03-29</endDate>
        </period>
    </context>
    <context id="i514e624a05cb4ac3b06eb3d5591e1ae9_I20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:BermekimabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-29</instant>
        </period>
    </context>
    <context id="i6fe29d550e3c4c2ba9f8054b3e1472ce_I20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:VerbSurgicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-29</instant>
        </period>
    </context>
    <context id="i80809b7f6de042b2930962754b585f17_I20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jnj:AdvancedSterilizationProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-01</instant>
        </period>
    </context>
    <context id="i6f42cd49f093497bb053a9863a95db49_D20190401-20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jnj:AdvancedSterilizationProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-01</endDate>
        </period>
    </context>
    <context id="i88ab1a165c864c2099402645c6315d0f_D20190401-20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-01</endDate>
        </period>
    </context>
    <context id="ie7bbcc036f7349cb94794a2287751afb_I20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-01</instant>
        </period>
    </context>
    <context id="ibf3d6533ad0042b69ef23b269adffb17_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i24e7ef5b16d34adf9098ddac81e8905a_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PurchasedInProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic5e8b6d3c30e45ffaa54a4a9227592ed_D20190117-20190117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-17</startDate>
            <endDate>2019-01-17</endDate>
        </period>
    </context>
    <context id="ia0d30897acc34d6aa8fc665dca7ddd1c_I20190116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-16</instant>
        </period>
    </context>
    <context id="i273f8b995c6b4f499a8b328d60523fbe_D20181231-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="ia56f405e259a45239a2888912d6a9972_I20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-29</instant>
        </period>
    </context>
    <context id="i0ba1319bb59843d6a0cf051fb471834a_D20191230-20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-03-29</endDate>
        </period>
    </context>
    <context id="ia2b1e0bfe69940ce9a25d129f9820402_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i0b429fd585e64f27b994198388c6251a_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:AsrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i0930560d9bb641e1bf17cd07a2da8aca_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PinnacleAcetabularCupSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i5f0486c287ba4a878933882831daf68c_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PelvicMeshesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="icd9edb018cc04c2d919c3af6e6effdc2_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RisperdalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ib10ac8fdffb7462695332fde36b80854_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ic41bf8ae137a4af1b760ea9606804331_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TalcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i6c15628b0bdb4b959f8610f3fd7e5d48_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:InvokanaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="id21618e853834a89ac8ad0c7b9c482b7_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PhysiomeshMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="icb6f889e341146e590594ffb796f5067_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:DePuyASRU.S.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="iea72f2ed06994c33932765fa19c03cd3_D20190930-20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-30</startDate>
            <endDate>2019-12-29</endDate>
        </period>
    </context>
    <context id="i488a067b9a194c0186abeac5734fa68b_D20191230-20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-03-29</endDate>
        </period>
    </context>
    <context id="i6ae80716a299488b87b2be5a3f4dbfb5_D20180701-20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:BabyPowderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-07-31</endDate>
        </period>
    </context>
    <context id="i06c65d19de8543ca8bdc65646de599c7_D20200601-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:BabyPowderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic4f17482cf3c41e598a0357f6aaae45c_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OpioidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i8b7242888eaf4e6d93abf906006a26fe_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i63a02018e9aa4b8fab85aa8bf8d518c8_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i4957f58a493d49f5bef49186ecf1dbf7_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="ia877cf56320947748ba1727613e928d1_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i12cbe2e6652048f1abbf81f0d8f8b6cc_D20200101-20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-31</endDate>
        </period>
    </context>
    <context id="ibb5dd3fead9e4921a49ec475665dfe71_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i09487d9b040c41f5b1f1ac6a4eb69ecb_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i5110f18fd4f34d9986fb039d56af95c6_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ic998353501c74da5afda8d2b3ead50c5_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i023474a55b284cd99429e03503a8a901_D20200629-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i82b8a8526a0b4f7c9f84a00039d7fa45_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i2a9ec615fd2b43679132d3c41485de92_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i98f8797e4aa74fdd9e5fa8711131743e_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i82ffccf862f04217ba5474adbd9d48c9_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i867dc8a2a19c4423b9b7ee18ce1d36b5_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i405860c539564ee5b8e0b222554dba38_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i410f9ae233db4a80981d7bcef1e0749a_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i9c3e80cad55d41f6a3525d636c512e88_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="ib2a9ba204bdd4530ae30c6d71d30d92f_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i6cd238e746ca494b962a8cdfec78532f_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="ib5ccab87c7704f459a110126f42d578f_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">jnj:AssetWriteoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="ib44160c8cfcb4364a86afc1ebf7ea5db_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i7153539e0f5345cc86253ed5aadc3d3c_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="ic763bc82f42c427fa881f68d00497d2c_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="id36fda814d6046bfa30b6bdd0fe5d257_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">jnj:AssetWriteoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i254209b7e3f54f69a129c76d5b0d3e93_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i7392cf4986564b5e9e2afd38679fb669_D20191230-20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-09-27</endDate>
        </period>
    </context>
    <context id="i61bba3fc154c46aba1e0aeb8dc224242_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="i0c0bc17c52f34567b49e094ed620eb73_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">jnj:AssetWriteoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="id5b06f3dcb1c4d1f94c7dbe9b3ce5ef1_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <context id="ib046be1bad564ea69c1c677f161cf688_I20200927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-27</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="chf">
        <measure>iso4217:CHF</measure>
    </unit>
    <unit id="chfPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:CHF</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="jpy">
        <measure>iso4217:JPY</measure>
    </unit>
    <unit id="claimant">
        <measure>jnj:claimant</measure>
    </unit>
    <unit id="patient">
        <measure>jnj:patient</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83L2ZyYWc6YzQwZjI5NDRiYmEyNDliNWIzYTIwZmFlODI5NWFkYWMvdGFibGU6ZGM4ZGUxMzAyOGQ3NDIyY2E3MzM5MzVjZGFlNDI5MDEvdGFibGVyYW5nZTpkYzhkZTEzMDI4ZDc0MjJjYTczMzkzNWNkYWU0MjkwMV80LTEtMS0xLTA_36d75e0e-efb5-4dab-81d4-50554b9ce723">0000200406</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83L2ZyYWc6YzQwZjI5NDRiYmEyNDliNWIzYTIwZmFlODI5NWFkYWMvdGFibGU6ZGM4ZGUxMzAyOGQ3NDIyY2E3MzM5MzVjZGFlNDI5MDEvdGFibGVyYW5nZTpkYzhkZTEzMDI4ZDc0MjJjYTczMzkzNWNkYWU0MjkwMV81LTEtMS0xLTA_2c261340-9709-4124-9062-9c8a2975533b">--01-03</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83L2ZyYWc6YzQwZjI5NDRiYmEyNDliNWIzYTIwZmFlODI5NWFkYWMvdGFibGU6ZGM4ZGUxMzAyOGQ3NDIyY2E3MzM5MzVjZGFlNDI5MDEvdGFibGVyYW5nZTpkYzhkZTEzMDI4ZDc0MjJjYTczMzkzNWNkYWU0MjkwMV85LTEtMS0xLTA_2659e3cf-7a78-4a25-bb8f-7cd71b606897">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83L2ZyYWc6YzQwZjI5NDRiYmEyNDliNWIzYTIwZmFlODI5NWFkYWMvdGFibGU6ZGM4ZGUxMzAyOGQ3NDIyY2E3MzM5MzVjZGFlNDI5MDEvdGFibGVyYW5nZTpkYzhkZTEzMDI4ZDc0MjJjYTczMzkzNWNkYWU0MjkwMV8xMC0xLTEtMS0w_d6ac164f-b79b-46c4-95d9-86c851d03ead">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83L2ZyYWc6YzQwZjI5NDRiYmEyNDliNWIzYTIwZmFlODI5NWFkYWMvdGFibGU6ZGM4ZGUxMzAyOGQ3NDIyY2E3MzM5MzVjZGFlNDI5MDEvdGFibGVyYW5nZTpkYzhkZTEzMDI4ZDc0MjJjYTczMzkzNWNkYWU0MjkwMV8xMS0xLTEtMS0w_61145116-6d4f-4288-8744-e6929ccfc923">false</dei:AmendmentFlag>
    <us-gaap:DebtInstrumentTerm
      contextRef="i4ae18f8aab5b4bd6b80b50402d6ad212_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xMDM1L2ZyYWc6MTUwYzNmOTI5ZjNmNDQzOThhZDQ4Nzg1OGUxNjIyYzAvdGV4dHJlZ2lvbjoxNTBjM2Y5MjlmM2Y0NDM5OGFkNDg3ODU4ZTE2MjJjMF8xMDQ0NTM2MDQ2MzkyMw_ce166846-b503-4139-b5f5-f14f5ea2d0f8">P1M6D</us-gaap:DebtInstrumentTerm>
    <dei:DocumentType
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDY1_d80e5d91-10bc-4fd6-bae9-71adb38abe96">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6N2NmMzJkNjU5Mzg0NGE2ZDgxMDNhZGNiNDc1Yzg5MDYvdGFibGVyYW5nZTo3Y2YzMmQ2NTkzODQ0YTZkODEwM2FkY2I0NzVjODkwNl8xLTAtMS0xLTA_430d0d31-0c21-4d72-b5d8-c2b9f1b11d07">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8xMjI_3c9cd2c8-5ca0-4cf0-842f-c176f97afd9c">2020-09-27</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6ODVlNGVlNTQ1ZWQ4NDI3YmFmY2M4MGVlZjQ0YjQ3ZjQvdGFibGVyYW5nZTo4NWU0ZWU1NDVlZDg0MjdiYWZjYzgwZWVmNDRiNDdmNF8xLTAtMS0xLTA_f722f032-d00c-48bc-9fa5-531badd9768e">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDY2_74c42b04-a550-48c0-909f-dc0d84e31600">1-3215</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDY5_c6373354-f728-405d-b335-0eb8b1c9ef36">Johnson &amp; Johnson</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6YjI2NTEyMDMzZTUzNDdiYzlhMjQyZjBiNjA1NGMyYmYvdGFibGVyYW5nZTpiMjY1MTIwMzNlNTM0N2JjOWEyNDJmMGI2MDU0YzJiZl8wLTAtMS0xLTA_a2bc52b6-cc98-403f-9e8c-69c3c07a4ef2">NJ</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6YjI2NTEyMDMzZTUzNDdiYzlhMjQyZjBiNjA1NGMyYmYvdGFibGVyYW5nZTpiMjY1MTIwMzNlNTM0N2JjOWEyNDJmMGI2MDU0YzJiZl8wLTItMS0xLTA_d439bb62-f021-45e7-93e2-7f33072e4d05">22-1024240</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDU5_fc79d604-0377-4788-80b8-e941ab81e810">One Johnson &amp; Johnson Plaza</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDcw_b98860c5-5d50-48da-b439-e728463f2e0f">New Brunswick</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDYw_e41f52c3-bd5a-420a-a88b-5d8ec1d56d59">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDYx_5f16fbbf-9a2f-4191-b89b-22af0e3d53d3">08933</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDYy_6601a897-2929-416f-bd45-23d2c1695929">732</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDYz_b2925baa-a64e-4e9b-9b0c-e1f40149bda3">524-0400</dei:LocalPhoneNumber>
    <dei:EntityCurrentReportingStatus
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDY0_a0dba964-f1bc-460e-9748-6c9f3c5c2c76">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDY3_7fcb7cdd-3038-4663-96b6-b0ed79d2e4a5">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6ZGQ4ZDM4MTg5OWFkNDZjYzkyOTRlYzE4ODAxNTNjYzkvdGFibGVyYW5nZTpkZDhkMzgxODk5YWQ0NmNjOTI5NGVjMTg4MDE1M2NjOV8wLTEtMS0xLTA_3fffc9d5-186b-4b4e-805e-5d6bd27ce03b">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6ZGQ4ZDM4MTg5OWFkNDZjYzkyOTRlYzE4ODAxNTNjYzkvdGFibGVyYW5nZTpkZDhkMzgxODk5YWQ0NmNjOTI5NGVjMTg4MDE1M2NjOV8xLTQtMS0xLTA_fef8a347-56df-403c-8329-8585a565b99d">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6ZGQ4ZDM4MTg5OWFkNDZjYzkyOTRlYzE4ODAxNTNjYzkvdGFibGVyYW5nZTpkZDhkMzgxODk5YWQ0NmNjOTI5NGVjMTg4MDE1M2NjOV8yLTItMS0xLTA_0d0ca6a2-37b6-4a6f-8cad-d8fcc791baac">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8yMDY4_9c99668e-7f2e-4f13-b171-d5ba5463a384">false</dei:EntityShellCompany>
    <dei:Security12bTitle
      contextRef="i740dc05b85c94cbd8b1e84ec97346f67_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM18xLTAtMS0xLTA_1d82deb1-772b-45b8-a4cf-447f225708ba">Common Stock, Par Value $1.00</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i740dc05b85c94cbd8b1e84ec97346f67_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM18xLTEtMS0xLTA_81d3d079-aedc-43e1-85f4-67256d929286">JNJ</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i740dc05b85c94cbd8b1e84ec97346f67_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM18xLTItMS0xLTA_cd878712-181a-484d-a3a2-41437927be54">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ica954f234b4c423aabac439f22fd6daf_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM18yLTAtMS0xLTA_a1f00778-e60c-468e-b4c4-eaf3e3116427">0.250% Notes Due January 2022</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ica954f234b4c423aabac439f22fd6daf_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM18yLTEtMS0xLTA_5c9a7bfa-e046-48cc-9f31-7514badc9cbb">JNJ22</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ica954f234b4c423aabac439f22fd6daf_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM18yLTItMS0xLTA_590514af-7a4b-4fa8-8f00-050cd7e8a866">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i95ced2b952ea496781eca3d5a59848c3_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM18zLTAtMS0xLTA_2408a962-893d-4733-8a5c-0b1461033801">0.650% Notes Due May 2024</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i95ced2b952ea496781eca3d5a59848c3_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM18zLTEtMS0xLTA_750d24e7-1530-4be4-86a0-86c86f838d65">JNJ24</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i95ced2b952ea496781eca3d5a59848c3_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM18zLTItMS0xLTA_b0466538-08f3-4c67-bb4d-09ff79fe34d9">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i7eeea2693d75423da856f563c79a259d_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM180LTAtMS0xLTA_6b4bd982-9876-4705-b49e-c76c7d6ee92e">5.50% Notes Due November 2024</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i7eeea2693d75423da856f563c79a259d_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM180LTEtMS0xLTA_b71d9596-3011-4823-b651-0e3890d99e20">JNJ24BP</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i7eeea2693d75423da856f563c79a259d_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM180LTItMS0xLTA_88f3f2ab-3382-4b6d-9c10-2e801e1316d3">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i93ee65cdd19a4436bcecdbb64e5cca1c_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM181LTAtMS0xLTA_2eb657d3-273e-4c79-ab5a-c69e11bb7847">1.150% Notes Due November 2028</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i93ee65cdd19a4436bcecdbb64e5cca1c_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM181LTEtMS0xLTA_d41d0e10-b7a0-4e77-8ad3-de202cca685d">JNJ28</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i93ee65cdd19a4436bcecdbb64e5cca1c_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM181LTItMS0xLTA_4f23c3b8-0b0d-4ef6-8981-f9338d372a49">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i2f968c9419a148cfbb615118ff18f037_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM182LTAtMS0xLTA_bf195739-eea7-49b3-921c-00c442e89bfb">1.650% Notes Due May 2035</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i2f968c9419a148cfbb615118ff18f037_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM182LTEtMS0xLTA_d8cf6aa4-0d56-44be-b4cc-61254dc70b0b">JNJ35</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i2f968c9419a148cfbb615118ff18f037_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGFibGU6OTg0YzRmZDc1NjFkNDcyZmFiYWViMWU0MWE0ZjdkYTMvdGFibGVyYW5nZTo5ODRjNGZkNzU2MWQ0NzJmYWJhZWIxZTQxYTRmN2RhM182LTItMS0xLTA_6609451b-9c7f-4059-aec4-409e64bfff12">NYSE</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ide9df46b8f0d4705b774d10707a6d751_I20201019"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8xL2ZyYWc6NWJmNjViY2IyNDEzNDVlYWE0MDlhNTBlMzYyMTNmMzQvdGV4dHJlZ2lvbjo1YmY2NWJjYjI0MTM0NWVhYTQwOWE1MGUzNjIxM2YzNF8xOTk4_5cd0bb14-6b95-42b8-a709-b2d64beb0b6d"
      unitRef="shares">2632542672</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMy0yLTEtMS0w_44602f05-ded9-4bde-9ffe-c85186d4d832"
      unitRef="usd">18965000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMy00LTEtMS0w_b7ae095f-691f-4ef0-a627-d35b1648e17e"
      unitRef="usd">17305000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNC0yLTEtMS0w_5a765319-9078-40f9-9ba7-61b4b073554d"
      unitRef="usd">11816000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNC00LTEtMS0w_e0b2f7db-73cc-45b0-b4e3-65e4a432daa9"
      unitRef="usd">1982000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNS0wLTEtMS0wL3RleHRyZWdpb246MjE3NjI2NDgzYTcyNDQwOGIzYmEyY2NlYjk0NGZkZmVfMTA0NDUzNjA0NjM5ODE_c24da1e6-b023-4f9a-9efc-86c79c2643ef"
      unitRef="usd">292000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNS0wLTEtMS0wL3RleHRyZWdpb246MjE3NjI2NDgzYTcyNDQwOGIzYmEyY2NlYjk0NGZkZmVfMTA0NDUzNjA0NjM5ODg_4c400fec-d1d8-47e2-8d9b-64dd411df410"
      unitRef="usd">226000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNS0yLTEtMS0w_4d2bfcc5-871c-44a3-a803-40abca796688"
      unitRef="usd">14579000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNS00LTEtMS0w_55507c6b-a75e-43a7-860c-e136887cca2b"
      unitRef="usd">14481000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNi0yLTEtMS0w_8df49b90-f4d9-450e-b81b-3672c537c51a"
      unitRef="usd">9599000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNi00LTEtMS0w_cac03f7e-d689-4047-be77-d85ffb2ec5d2"
      unitRef="usd">9020000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNy0yLTEtMS0w_e8e09e19-715b-4dfb-ae3e-1d482a1d3d32"
      unitRef="usd">2528000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNy00LTEtMS0w_0a7cc2ba-20e5-450c-bb2f-701435a4a32e"
      unitRef="usd">2392000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfOC0yLTEtMS0w_1a342349-ae61-4dc9-b026-cdbbd8077ee0"
      unitRef="usd">91000000</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfOC00LTEtMS0w_fc5cbe6e-35c1-41b1-9c70-20b901673302"
      unitRef="usd">94000000</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther>
    <us-gaap:AssetsCurrent
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfOS0yLTEtMS0w_7f9a5949-addd-402e-b0bf-b45b6c5511f9"
      unitRef="usd">57578000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfOS00LTEtMS0w_00cb0a3e-721b-46c9-803d-ee53a32cc146"
      unitRef="usd">45274000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTAtMi0xLTEtMA_6209de32-6f1d-4424-b4a3-fa719f16ebae"
      unitRef="usd">45162000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTAtNC0xLTEtMA_00080521-6ec4-49d6-ac40-8ab73ca23043"
      unitRef="usd">43332000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTEtMi0xLTEtMA_56269715-35f3-469e-9fdf-0ecc485d262b"
      unitRef="usd">27307000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTEtNC0xLTEtMA_eb5d8118-af90-4ecd-808c-18ef7af67bad"
      unitRef="usd">25674000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTItMi0xLTEtMA_d434514e-818b-490c-83fd-2837b9a2d29d"
      unitRef="usd">17855000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTItNC0xLTEtMA_4bea2553-27f6-4474-a148-81cb39bf3848"
      unitRef="usd">17658000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTMtMi0xLTEtMA_c19db8ec-8166-49e3-b85e-6900acde88e9"
      unitRef="usd">47006000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTMtNC0xLTEtMA_bcd445e5-07e3-4f10-978a-47835e365360"
      unitRef="usd">47643000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTQtMi0xLTEtMA_28c8e653-54c8-4fd4-aab7-9254e71dc511"
      unitRef="usd">34307000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTQtNC0xLTEtMA_4fa02e9c-6564-4c76-b4df-600e95faf865"
      unitRef="usd">33639000000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTUtMi0xLTEtMA_865c67bf-95dc-40ff-8547-c4ea20fd0e4a"
      unitRef="usd">7816000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTUtNC0xLTEtMA_ea668e76-534a-49ab-9d82-d2101c3db9db"
      unitRef="usd">7819000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTYtMi0xLTEtMA_2a58d66b-c761-47db-90ee-e1fbe85c8a26"
      unitRef="usd">6131000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTYtNC0xLTEtMA_9c680ba2-0ae7-4eab-9655-f300ef22b977"
      unitRef="usd">5695000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTctMi0xLTEtMA_959e5866-858a-4169-a21f-5bd9a6d2858b"
      unitRef="usd">170693000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMTctNC0xLTEtMA_bc9b11d5-25d9-4afd-ad04-56007d6fa6cb"
      unitRef="usd">157728000000</us-gaap:Assets>
    <us-gaap:ShortTermBorrowings
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjAtMi0xLTEtMA_722bdd65-e3a1-42bb-a64a-6fa8c2afbdbd"
      unitRef="usd">5078000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjAtNC0xLTEtMA_cc9f9a92-d3e9-46f3-af9d-b6d80c02c4d7"
      unitRef="usd">1202000000</us-gaap:ShortTermBorrowings>
    <us-gaap:AccountsPayableCurrent
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjEtMi0xLTEtMA_673e2a61-c444-45e1-b13b-929741f574d6"
      unitRef="usd">7044000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjEtNC0xLTEtMA_3b475664-d6e9-40e6-9f28-9aa34ac1de6a"
      unitRef="usd">8544000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjItMi0xLTEtMA_2261a590-f6f8-4c50-bf8a-3fe48bdf300e"
      unitRef="usd">9629000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjItNC0xLTEtMA_8538ab96-0518-478d-91a3-bec172cca1c4"
      unitRef="usd">9715000000</us-gaap:AccruedLiabilitiesCurrent>
    <jnj:AccruedRebatesReturnsAndPromotions
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjMtMi0xLTEtMA_8a206d7d-92c4-4a83-af3b-d5613501f627"
      unitRef="usd">12418000000</jnj:AccruedRebatesReturnsAndPromotions>
    <jnj:AccruedRebatesReturnsAndPromotions
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjMtNC0xLTEtMA_1f3f6150-2977-4c21-bfd2-9ed22e8ca8e8"
      unitRef="usd">10883000000</jnj:AccruedRebatesReturnsAndPromotions>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjQtMi0xLTEtMA_22117b9a-1ab7-467c-906d-c8ff2b81a7ac"
      unitRef="usd">3012000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjQtNC0xLTEtMA_cd696b0f-dfab-4fb0-9389-9829d0532fd1"
      unitRef="usd">3354000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjUtMi0xLTEtMA_0169df65-7c15-4d6b-98f6-8bf61412e9f1"
      unitRef="usd">1666000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjUtNC0xLTEtMA_f4950a90-1388-488d-97cb-3baae77c8d57"
      unitRef="usd">2266000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjYtMi0xLTEtMA_74bc7451-8fa1-42ea-b87f-3db60f13950e"
      unitRef="usd">38847000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjYtNC0xLTEtMA_06755a17-9993-4e79-8460-7a0c2a7ab808"
      unitRef="usd">35964000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjctMi0xLTEtMA_45745bcd-886d-4221-a106-a477490b5e49"
      unitRef="usd">32680000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjctNC0xLTEtMA_f64fe4b4-a8ed-421d-9307-2192c414a898"
      unitRef="usd">26494000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjgtMi0xLTEtMA_ffbf5b86-cd47-4bd0-b373-cf0dbc97f37a"
      unitRef="usd">5615000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjgtNC0xLTEtMA_62370745-ebd9-48aa-bea1-1ad7c2ad8259"
      unitRef="usd">5958000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjktMi0xLTEtMA_f8802e12-8bc7-4249-90c6-f1fb383ec9e4"
      unitRef="usd">10184000000</us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMjktNC0xLTEtMA_d3c7a060-85dc-4bc0-b49b-d7681dc1e30f"
      unitRef="usd">10663000000</us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzAtMi0xLTEtMA_4d3534e9-8615-40e7-9430-4a45d74f991e"
      unitRef="usd">6745000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzAtNC0xLTEtMA_9f39c925-ec8a-4f92-95fb-22b82bf2e851"
      unitRef="usd">7444000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzEtMi0xLTEtMA_24f3f943-dfe2-492a-b395-e449a2aae625"
      unitRef="usd">12149000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzEtNC0xLTEtMA_4ca5a183-803e-4eec-ac4f-9bc5413bfa4c"
      unitRef="usd">11734000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzItMi0xLTEtMA_fab4febd-5887-44e3-a305-e171a72f1d45"
      unitRef="usd">106220000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzItNC0xLTEtMA_a08d603e-428e-4659-9e66-dc4b7c961148"
      unitRef="usd">98257000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzMtMi0xLTEtMA_7f64ce59-2b70-4224-a994-daf3bcc1457a"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzMtNC0xLTEtMA_c74fb250-7c25-426f-9b7c-7aeb06a10b4f"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjM1ZmVmOWVkNzU1YzRmYmJhMzEwYjhlMzIzZmE3MDFmXzEwNDQ1MzYwNDYzOTg0_56db7bfe-478a-490b-b9e7-36bfbd8df038"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjM1ZmVmOWVkNzU1YzRmYmJhMzEwYjhlMzIzZmE3MDFmXzEwNDQ1MzYwNDYzOTg0_631aaff1-0bf3-460b-b2b1-cb8e1c70b37d"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjM1ZmVmOWVkNzU1YzRmYmJhMzEwYjhlMzIzZmE3MDFmXzEwNDQ1MzYwNDY0MDAw_0cb682e2-22a1-4ea0-a42d-dc42e5f879a7"
      unitRef="shares">4320000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjM1ZmVmOWVkNzU1YzRmYmJhMzEwYjhlMzIzZmE3MDFmXzEwNDQ1MzYwNDY0MDAw_c79997e3-c1ad-4504-a3ef-fdd723b30988"
      unitRef="shares">4320000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjM1ZmVmOWVkNzU1YzRmYmJhMzEwYjhlMzIzZmE3MDFmXzEwNDQ1MzYwNDY0MDE2_01c5ebc8-3ef0-4a1f-8550-4e043182ccc3"
      unitRef="shares">3119843000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjM1ZmVmOWVkNzU1YzRmYmJhMzEwYjhlMzIzZmE3MDFmXzEwNDQ1MzYwNDY0MDE2_bb835870-cfe7-4e5c-b84c-54d3d3d8b4c6"
      unitRef="shares">3119843000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzUtMi0xLTEtMA_39fd2a15-cdec-4070-a125-1474b8b690f4"
      unitRef="usd">3120000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzUtNC0xLTEtMA_9c44d6dc-b223-4387-bda4-3b3d4c52c12a"
      unitRef="usd">3120000000</us-gaap:CommonStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzYtMi0xLTEtMA_524089c8-7ff7-4988-b1f0-2426c8367151"
      unitRef="usd">-14938000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzYtNC0xLTEtMA_118756e5-1c0f-4730-b435-4b5f433b8abd"
      unitRef="usd">-15891000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzctMi0xLTEtMA_cf360d12-98f9-455e-be6d-f22711868d95"
      unitRef="usd">114831000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzctNC0xLTEtMA_1e78b947-65b5-4ad8-86e1-4f9edfe670e2"
      unitRef="usd">110659000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjMyY2VlNjgxOWZlMTQwNDM4YTUzOTcxODAwM2RkYjViXzEwNDQ1MzYwNDYzOTY4_3613c73e-7f3b-413c-bf6e-3f55c491cf41"
      unitRef="shares">487676000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjMyY2VlNjgxOWZlMTQwNDM4YTUzOTcxODAwM2RkYjViXzEwNDQ1MzYwNDYzOTgy_74ffcc46-20c0-4648-ba65-21cb1b28f68d"
      unitRef="shares">487336000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzgtMi0xLTEtMA_b15d1275-3d87-4587-974d-fb690df92633"
      unitRef="usd">38540000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzgtNC0xLTEtMA_9f8df658-c522-467f-ba38-6d1564a1e262"
      unitRef="usd">38417000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzktMi0xLTEtMA_8a0add02-0b2d-47b7-9f10-db1b91040a6a"
      unitRef="usd">64473000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfMzktNC0xLTEtMA_35119ec2-23e6-4908-af6b-5e3c3233d1e2"
      unitRef="usd">59471000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNDAtMi0xLTEtMA_e6ac8678-f8a6-4021-9bdb-00a85999d9b8"
      unitRef="usd">170693000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yMi9mcmFnOjQ0MjE4NGI0YmMxMzQ5ZDE5NWJkNWEyMDljMTBjNDAyL3RhYmxlOjkxOTQwOGNmZGRiZDQyNWI4MTlmOTBiOTZkZDVjOTViL3RhYmxlcmFuZ2U6OTE5NDA4Y2ZkZGJkNDI1YjgxOWY5MGI5NmRkNWM5NWJfNDAtNC0xLTEtMA_cb85b7be-3b7a-49cd-aa6d-b832f9796308"
      unitRef="usd">157728000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMi0yLTEtMS0w_f7d100d0-b0e6-4de8-9811-19ff6e815cbf"
      unitRef="usd">21082000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:SalesRevenueGoodsNetPercentToSales
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMi00LTEtMS0w_44a99801-e141-410f-aed9-7c0462f7f4fe"
      unitRef="number">1.000</jnj:SalesRevenueGoodsNetPercentToSales>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMi02LTEtMS0w_21d704f8-aa05-4ac6-a1b3-23ef7f7e838f"
      unitRef="usd">20729000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:SalesRevenueGoodsNetPercentToSales
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMi04LTEtMS0w_4bcf5bf5-8bdb-47e3-8559-05d9b2a57551"
      unitRef="number">1.000</jnj:SalesRevenueGoodsNetPercentToSales>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMy0yLTEtMS0w_eabd3b66-a297-4a5f-91e2-d4b6b521880d"
      unitRef="usd">6972000000</us-gaap:CostOfGoodsAndServicesSold>
    <jnj:CostOfGoodsSoldPercentToSales
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMy00LTEtMS0w_4a1d2f9b-dda5-462f-a245-9c27ed9b39d8"
      unitRef="number">0.331</jnj:CostOfGoodsSoldPercentToSales>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMy02LTEtMS0w_34dab90e-85cf-4dfd-97fb-f08cbd5c0d39"
      unitRef="usd">6867000000</us-gaap:CostOfGoodsAndServicesSold>
    <jnj:CostOfGoodsSoldPercentToSales
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMy04LTEtMS0w_81955a0f-cd1b-407d-a610-161b6b9f5dec"
      unitRef="number">0.331</jnj:CostOfGoodsSoldPercentToSales>
    <us-gaap:GrossProfit
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNC0yLTEtMS0w_65f758d4-f912-45df-8813-35a79524a6c8"
      unitRef="usd">14110000000</us-gaap:GrossProfit>
    <jnj:GrossProfitPercentToSales
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNC00LTEtMS0w_cb5cd405-c33a-47d7-9610-11e38a0c43dd"
      unitRef="number">0.669</jnj:GrossProfitPercentToSales>
    <us-gaap:GrossProfit
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNC02LTEtMS0w_3f6d9f23-0d3d-40cc-8108-1214dd80a63e"
      unitRef="usd">13862000000</us-gaap:GrossProfit>
    <jnj:GrossProfitPercentToSales
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNC04LTEtMS0w_2d26f8c3-2ea8-4fbc-aa4f-cbdbd2e021cd"
      unitRef="number">0.669</jnj:GrossProfitPercentToSales>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNS0yLTEtMS0w_983ebabe-b022-4334-ad49-c0345d4bbec0"
      unitRef="usd">5431000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <jnj:SellingGeneralAndAdministrativeExpensePercentToSales
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNS00LTEtMS0w_f9f96c11-d042-408c-ae8f-b837d4773f63"
      unitRef="number">0.258</jnj:SellingGeneralAndAdministrativeExpensePercentToSales>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNS02LTEtMS0w_1b762672-cb64-4093-9704-d50a9f188242"
      unitRef="usd">5374000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <jnj:SellingGeneralAndAdministrativeExpensePercentToSales
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNS04LTEtMS0w_98626f97-668d-4f7e-8379-c099fe79920f"
      unitRef="number">0.260</jnj:SellingGeneralAndAdministrativeExpensePercentToSales>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNi0yLTEtMS0w_7e6f1daa-fd45-4667-8665-3aebd78b3a12"
      unitRef="usd">2840000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNi00LTEtMS0w_eb3cabb7-6d3d-4648-906f-1a57e14af258"
      unitRef="number">0.135</jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNi02LTEtMS0w_aab00d74-cf57-4110-bb70-c0888e37bb50"
      unitRef="usd">2599000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNi04LTEtMS0w_af8a2d3f-0930-4948-b49e-8d071b90132a"
      unitRef="number">0.125</jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNy0yLTEtMS0w_af7f7377-d0a5-4776-a4fc-83135e921064"
      unitRef="usd">138000000</us-gaap:ResearchAndDevelopmentInProcess>
    <jnj:ResearchAndDevelopmentInProcessPercentToSales
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNy00LTEtMS0w_6c49b1ed-1b45-486b-9efc-b869d3c19de6"
      unitRef="number">0.006</jnj:ResearchAndDevelopmentInProcessPercentToSales>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNy02LTEtMS0w_2bc4a921-5392-4086-88bd-68633200521a"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <jnj:ResearchAndDevelopmentInProcessPercentToSales
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfNy04LTEtMS0w_bdfbc936-4306-462c-bb97-0ed3298c2035"
      unitRef="number">0</jnj:ResearchAndDevelopmentInProcessPercentToSales>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfOC0yLTEtMS0w_9bf10956-354d-4f23-827d-c0f0ae826c36"
      unitRef="usd">12000000</us-gaap:InvestmentIncomeInterest>
    <jnj:InvestmentIncomeInterestPercentToSales
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfOC00LTEtMS0w_486ff22f-807e-4592-a9bc-f429e0e4a79b"
      unitRef="number">-0.001</jnj:InvestmentIncomeInterestPercentToSales>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfOC02LTEtMS0w_27a930e7-bac9-43d4-9712-cd86095bbfa9"
      unitRef="usd">89000000</us-gaap:InvestmentIncomeInterest>
    <jnj:InvestmentIncomeInterestPercentToSales
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfOC04LTEtMS0w_62752186-ca11-4d0b-83ea-68192ad8df72"
      unitRef="number">-0.004</jnj:InvestmentIncomeInterestPercentToSales>
    <us-gaap:InterestExpense
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfOS0yLTEtMS0w_61ceabc5-71fc-4b3d-9bb0-5afceb4ce109"
      unitRef="usd">44000000</us-gaap:InterestExpense>
    <jnj:InterestExpensePercentToSales
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfOS00LTEtMS0w_4b967d75-f867-432e-9d79-aee58db6935f"
      unitRef="number">0.002</jnj:InterestExpensePercentToSales>
    <us-gaap:InterestExpense
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfOS02LTEtMS0w_5f048eb3-9e9c-450a-a47b-ec57bb2d0542"
      unitRef="usd">48000000</us-gaap:InterestExpense>
    <jnj:InterestExpensePercentToSales
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfOS04LTEtMS0w_5a4404f8-29a6-4084-90ca-c86b1004f4e9"
      unitRef="number">0.002</jnj:InterestExpensePercentToSales>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTAtMi0xLTEtMA_1ced99e9-77bc-4dea-9351-e5a490b92250"
      unitRef="usd">-1200000000</us-gaap:OtherNonoperatingIncomeExpense>
    <jnj:OtherNonOperatingIncomeExpensePercentToSales
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTAtNC0xLTEtMA_dceab8c0-03b6-426e-8c76-9b584bbab189"
      unitRef="number">0.057</jnj:OtherNonOperatingIncomeExpensePercentToSales>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTAtNi0xLTEtMA_06712c1e-6da4-4182-a39e-decb35ff827b"
      unitRef="usd">-4214000000</us-gaap:OtherNonoperatingIncomeExpense>
    <jnj:OtherNonOperatingIncomeExpensePercentToSales
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTAtOC0xLTEtMA_236852e5-3489-45d6-837c-e63ace9af09c"
      unitRef="number">0.203</jnj:OtherNonOperatingIncomeExpensePercentToSales>
    <us-gaap:RestructuringCharges
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTEtMi0xLTEtMA_c4140ec0-9f69-4c28-9cdc-874ec093d3f8"
      unitRef="usd">68000000</us-gaap:RestructuringCharges>
    <jnj:Restructuringchargepercenttosales
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTEtNC0xLTEtMA_859a7b0e-4fdb-4c78-be29-ed8f4ac839bc"
      unitRef="number">0.003</jnj:Restructuringchargepercenttosales>
    <us-gaap:RestructuringCharges
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTEtNi0xLTEtMA_0f5970f1-475e-4869-bf56-1a71713543bd"
      unitRef="usd">69000000</us-gaap:RestructuringCharges>
    <jnj:Restructuringchargepercenttosales
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTEtOC0xLTEtMA_50283d42-15a3-4334-b2af-91e06b7b9646"
      unitRef="number">0.004</jnj:Restructuringchargepercenttosales>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTItMi0xLTEtMA_6db34a2f-1191-440a-8f0b-569728d2a33c"
      unitRef="usd">4401000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTItNC0xLTEtMA_7e40e63d-62a3-46d7-8cbe-b497a216a3d2"
      unitRef="number">0.209</jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTItNi0xLTEtMA_ccd3366b-8684-4b7d-8d76-da02165e94c3"
      unitRef="usd">1647000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTItOC0xLTEtMA_d4f7ab64-d1cd-4a43-b3cb-dabcddace10f"
      unitRef="number">0.079</jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTMtMi0xLTEtMA_fc09a00a-c0d5-4375-af40-6b49ce9827e9"
      unitRef="usd">847000000</us-gaap:IncomeTaxExpenseBenefit>
    <jnj:IncomeTaxExpenseBenefitPercentToSales
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTMtNC0xLTEtMA_3630e514-0e9c-4a61-8eae-68eacbb3e955"
      unitRef="number">0.040</jnj:IncomeTaxExpenseBenefitPercentToSales>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTMtNi0xLTEtMA_6a92b807-76d1-4dfe-b75f-9bf54fe1a4b9"
      unitRef="usd">-106000000</us-gaap:IncomeTaxExpenseBenefit>
    <jnj:IncomeTaxExpenseBenefitPercentToSales
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTMtOC0xLTEtMA_324713fb-41ba-4b43-b208-6dc79c397f4c"
      unitRef="number">-0.006</jnj:IncomeTaxExpenseBenefitPercentToSales>
    <us-gaap:NetIncomeLoss
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTQtMi0xLTEtMA_a1da807a-f7b4-4c05-b7c2-09fb6ad45d05"
      unitRef="usd">3554000000</us-gaap:NetIncomeLoss>
    <jnj:NetIncomeAttributableToParentPercentToSales
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTQtNC0xLTEtMA_aac1b3f7-0a3c-4ec1-a980-90de3416ee5d"
      unitRef="number">0.169</jnj:NetIncomeAttributableToParentPercentToSales>
    <us-gaap:NetIncomeLoss
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTQtNi0xLTEtMA_f4ec7529-89f2-48a9-a68e-c7b0db6e8eb7"
      unitRef="usd">1753000000</us-gaap:NetIncomeLoss>
    <jnj:NetIncomeAttributableToParentPercentToSales
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTQtOC0xLTEtMA_09dd3b55-ecb1-4089-b7fa-c96269f17b88"
      unitRef="number">0.085</jnj:NetIncomeAttributableToParentPercentToSales>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTctMi0xLTEtMA_64f74664-eb79-414a-a500-c54b7c5650eb"
      unitRef="usdPerShare">1.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTctNi0xLTEtMA_86eec0ab-8694-47ab-bc44-b15f59ab714c"
      unitRef="usdPerShare">0.67</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTgtMi0xLTEtMA_c4606401-bff4-4fa8-8353-f2481740f075"
      unitRef="usdPerShare">1.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMTgtNi0xLTEtMA_8ecf556b-b8fa-4ffd-a19a-314efd711ddf"
      unitRef="usdPerShare">0.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMjEtMi0xLTEtMA_b99f5a97-38b0-4727-9077-db79e9b0eaab"
      unitRef="shares">2632500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMjEtNi0xLTEtMA_0c4811ec-099f-4f73-9536-15d12d5a25d7"
      unitRef="shares">2635200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMjItMi0xLTEtMA_6e4a8162-1c34-42dc-98e3-a751068eada7"
      unitRef="shares">2669300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8yOC9mcmFnOjBjYTAwYmU2ZTg1ZjQ2ZGI4MTk2MDAzNTUyMGM1NTYyL3RhYmxlOmRmNTZiZjQyZjNmYjQ3M2ZhOGM1NjUyNmFiMThjYjY3L3RhYmxlcmFuZ2U6ZGY1NmJmNDJmM2ZiNDczZmE4YzU2NTI2YWIxOGNiNjdfMjItNi0xLTEtMA_07f7582d-685c-4f28-9a4e-ee4a3508429c"
      unitRef="shares">2669900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMi0yLTEtMS0w_d5afe357-e0cb-4af0-8e07-e605ffd6335e"
      unitRef="usd">60109000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:SalesRevenueGoodsNetPercentToSales
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMi00LTEtMS0w_80fa9018-1582-4b37-aa0c-09cf22c8b08b"
      unitRef="number">1.000</jnj:SalesRevenueGoodsNetPercentToSales>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMi02LTEtMS0w_8a9de1d4-8ba8-4b03-880e-0cad29cd68d3"
      unitRef="usd">61312000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:SalesRevenueGoodsNetPercentToSales
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMi04LTEtMS0w_6aefbe73-d733-4a89-8eac-822db74266ab"
      unitRef="number">1.000</jnj:SalesRevenueGoodsNetPercentToSales>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMy0yLTEtMS0w_e4f821ab-751d-47c0-8c25-4e07c2039066"
      unitRef="usd">20613000000</us-gaap:CostOfGoodsAndServicesSold>
    <jnj:CostOfGoodsSoldPercentToSales
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMy00LTEtMS0w_55ab2821-5f0f-44d3-82af-277de8077815"
      unitRef="number">0.343</jnj:CostOfGoodsSoldPercentToSales>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMy02LTEtMS0w_4a5172e3-f1b6-4087-a8fb-fddc597723c6"
      unitRef="usd">20422000000</us-gaap:CostOfGoodsAndServicesSold>
    <jnj:CostOfGoodsSoldPercentToSales
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMy04LTEtMS0w_b2112631-3627-418b-b35b-c76323dd39d4"
      unitRef="number">0.333</jnj:CostOfGoodsSoldPercentToSales>
    <us-gaap:GrossProfit
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNC0yLTEtMS0w_66929c6f-48a8-4d9c-ada6-8a5a3accadc7"
      unitRef="usd">39496000000</us-gaap:GrossProfit>
    <jnj:GrossProfitPercentToSales
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNC00LTEtMS0w_5fd479c8-5a1a-4ca9-a880-9a7ba147bca4"
      unitRef="number">0.657</jnj:GrossProfitPercentToSales>
    <us-gaap:GrossProfit
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNC02LTEtMS0w_45d28164-a896-4142-8a0a-2f06eee2afdf"
      unitRef="usd">40890000000</us-gaap:GrossProfit>
    <jnj:GrossProfitPercentToSales
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNC04LTEtMS0w_3cbafe15-bf9b-4358-a042-5b5eb981012b"
      unitRef="number">0.667</jnj:GrossProfitPercentToSales>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNS0yLTEtMS0w_ec572a9b-95bc-4593-bc6c-5fc50bd26cd7"
      unitRef="usd">15627000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <jnj:SellingGeneralAndAdministrativeExpensePercentToSales
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNS00LTEtMS0w_e7f529a4-617d-419b-acdb-faf0312a9f97"
      unitRef="number">0.260</jnj:SellingGeneralAndAdministrativeExpensePercentToSales>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNS02LTEtMS0w_7a61b751-5cdd-48f7-9d3b-acca2f315f7b"
      unitRef="usd">16139000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <jnj:SellingGeneralAndAdministrativeExpensePercentToSales
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNS04LTEtMS0w_159bc9f1-3f76-496f-b83b-f95e5b1fcf85"
      unitRef="number">0.263</jnj:SellingGeneralAndAdministrativeExpensePercentToSales>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNi0yLTEtMS0w_2d39ff17-8fe7-45a6-8733-18c1eec17f8d"
      unitRef="usd">8127000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNi00LTEtMS0w_8c8f6a35-f0ac-4eba-bcf0-075e1474be83"
      unitRef="number">0.135</jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNi02LTEtMS0w_01a0d875-1255-453b-a622-f440ecacec15"
      unitRef="usd">8123000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNi04LTEtMS0w_16f7a6ef-ece3-4332-a9e2-e1a09bc7b345"
      unitRef="number">0.133</jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNy0yLTEtMS0w_2d5787a1-65cd-4952-8700-6ff996b0208c"
      unitRef="usd">144000000</us-gaap:ResearchAndDevelopmentInProcess>
    <jnj:ResearchAndDevelopmentInProcessPercentToSales
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNy00LTEtMS0w_37cc5bbf-5261-420b-8892-378cc3f88991"
      unitRef="number">0.003</jnj:ResearchAndDevelopmentInProcessPercentToSales>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNy02LTEtMS0w_51f81a40-9952-4d33-9067-c59e03f5887d"
      unitRef="usd">890000000</us-gaap:ResearchAndDevelopmentInProcess>
    <jnj:ResearchAndDevelopmentInProcessPercentToSales
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfNy04LTEtMS0w_bf92866f-c6f7-4502-b569-46367b61ff64"
      unitRef="number">0.014</jnj:ResearchAndDevelopmentInProcessPercentToSales>
    <us-gaap:InvestmentIncomeInterest
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfOC0yLTEtMS0w_ae83485c-f45c-4aa6-97c6-01f6ce9b55ce"
      unitRef="usd">98000000</us-gaap:InvestmentIncomeInterest>
    <jnj:InvestmentIncomeInterestPercentToSales
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfOC00LTEtMS0w_517ce4be-9ffd-44d6-940d-e2c59d3f3b0d"
      unitRef="number">-0.002</jnj:InvestmentIncomeInterestPercentToSales>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfOC02LTEtMS0w_41b701f3-777b-46d0-a4fc-a3fde4bfdc39"
      unitRef="usd">276000000</us-gaap:InvestmentIncomeInterest>
    <jnj:InvestmentIncomeInterestPercentToSales
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfOC04LTEtMS0w_5114496e-b74c-404f-a249-be6754f524a5"
      unitRef="number">-0.005</jnj:InvestmentIncomeInterestPercentToSales>
    <us-gaap:InterestExpense
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfOS0yLTEtMS0w_c75c35b9-b85d-4942-ac4c-b700e7fa1d1a"
      unitRef="usd">114000000</us-gaap:InterestExpense>
    <jnj:InterestExpensePercentToSales
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfOS00LTEtMS0w_ccb25316-16ce-4a43-ae95-529b221b0b9a"
      unitRef="number">0.002</jnj:InterestExpensePercentToSales>
    <us-gaap:InterestExpense
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfOS02LTEtMS0w_5fce77db-9d04-40a6-b648-649b1025d39f"
      unitRef="usd">233000000</us-gaap:InterestExpense>
    <jnj:InterestExpensePercentToSales
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfOS04LTEtMS0w_181bd5ed-f849-488d-9df6-5732fd436c29"
      unitRef="number">0.004</jnj:InterestExpensePercentToSales>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTAtMi0xLTEtMA_53c57836-188a-452e-a064-3c64792f2372"
      unitRef="usd">-545000000</us-gaap:OtherNonoperatingIncomeExpense>
    <jnj:OtherNonOperatingIncomeExpensePercentToSales
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTAtNC0xLTEtMA_3e9566d2-7b6e-46f6-8926-503811adebfb"
      unitRef="number">0.009</jnj:OtherNonOperatingIncomeExpensePercentToSales>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTAtNi0xLTEtMA_27a34e34-4ae8-43c1-8a9f-88b01fa0023b"
      unitRef="usd">-2509000000</us-gaap:OtherNonoperatingIncomeExpense>
    <jnj:OtherNonOperatingIncomeExpensePercentToSales
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTAtOC0xLTEtMA_4470cc65-6385-44cc-b5b7-d767b3ec1203"
      unitRef="number">0.041</jnj:OtherNonOperatingIncomeExpensePercentToSales>
    <us-gaap:RestructuringCharges
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTEtMi0xLTEtMA_dfc7dd34-b35c-480f-aa2b-03012324f294"
      unitRef="usd">187000000</us-gaap:RestructuringCharges>
    <jnj:Restructuringchargepercenttosales
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTEtNC0xLTEtMA_240da3b2-2266-4fb2-8237-1a760b837aac"
      unitRef="number">0.003</jnj:Restructuringchargepercenttosales>
    <us-gaap:RestructuringCharges
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTEtNi0xLTEtMA_fb4993aa-4226-4282-96af-8285f41efec7"
      unitRef="usd">162000000</us-gaap:RestructuringCharges>
    <jnj:Restructuringchargepercenttosales
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTEtOC0xLTEtMA_946c2707-4609-483e-a124-d81e5590c032"
      unitRef="number">0.003</jnj:Restructuringchargepercenttosales>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTItMi0xLTEtMA_f198fda5-5561-4c9a-9f31-b79073f3f7f8"
      unitRef="usd">14850000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTItNC0xLTEtMA_884f3084-2f38-4838-a198-4f9ad40c99ae"
      unitRef="number">0.247</jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTItNi0xLTEtMA_81d2fe3a-0314-439d-a29b-957f29be3605"
      unitRef="usd">13110000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTItOC0xLTEtMA_f0986608-378a-4beb-bc23-1e1e78aea17e"
      unitRef="number">0.214</jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTMtMi0xLTEtMA_1b8b5d3a-894b-4f99-99ee-a8cd4101ce31"
      unitRef="usd">1874000000</us-gaap:IncomeTaxExpenseBenefit>
    <jnj:IncomeTaxExpenseBenefitPercentToSales
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTMtNC0xLTEtMA_26c4bb50-f328-479b-af5f-4a555488f018"
      unitRef="number">0.031</jnj:IncomeTaxExpenseBenefitPercentToSales>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTMtNi0xLTEtMA_93cb3dfb-98ea-41dc-bb92-278e30645143"
      unitRef="usd">2001000000</us-gaap:IncomeTaxExpenseBenefit>
    <jnj:IncomeTaxExpenseBenefitPercentToSales
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTMtOC0xLTEtMA_284972d4-22a2-462c-aa96-80527af96ad5"
      unitRef="number">0.033</jnj:IncomeTaxExpenseBenefitPercentToSales>
    <us-gaap:NetIncomeLoss
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTQtMi0xLTEtMA_469e83d5-eefb-439b-8d25-d9abeeffa946"
      unitRef="usd">12976000000</us-gaap:NetIncomeLoss>
    <jnj:NetIncomeAttributableToParentPercentToSales
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTQtNC0xLTEtMA_dfb48363-4c19-4a0e-9407-93109c015a06"
      unitRef="number">0.216</jnj:NetIncomeAttributableToParentPercentToSales>
    <us-gaap:NetIncomeLoss
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTQtNi0xLTEtMA_8d5ee663-ce7e-4579-b29f-9940816d0149"
      unitRef="usd">11109000000</us-gaap:NetIncomeLoss>
    <jnj:NetIncomeAttributableToParentPercentToSales
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTQtOC0xLTEtMA_c4c51db2-9159-42b5-8ce8-ef49c1147a9e"
      unitRef="number">0.181</jnj:NetIncomeAttributableToParentPercentToSales>
    <us-gaap:EarningsPerShareBasic
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTctMi0xLTEtMA_940638ea-92d8-4e50-ab7d-eac026ea269f"
      unitRef="usdPerShare">4.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTctNi0xLTEtMA_216b171e-e94b-4976-8247-cee866917b2f"
      unitRef="usdPerShare">4.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTgtMi0xLTEtMA_22027dbd-e80d-4115-aca4-7f2a019c974e"
      unitRef="usdPerShare">4.86</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMTgtNi0xLTEtMA_d3eee002-4de6-4337-acc5-0b9f6d50af31"
      unitRef="usdPerShare">4.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMjEtMi0xLTEtMA_a15889c6-9dfe-47d3-8d06-ea95e56f27e4"
      unitRef="shares">2633000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMjEtNi0xLTEtMA_cbd078f9-bf2e-4b56-a5a5-9fa77f56a927"
      unitRef="shares">2649500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMjItMi0xLTEtMA_527255fb-164e-4a19-9a09-6ce25da63540"
      unitRef="shares">2670800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zMS9mcmFnOjQ0OTQ1ZWExYmJmODRjNDg4MWM1ZmVhMTBmNmRlMjNkL3RhYmxlOmQ1NTA4NzEzMDczMzRkMGM5NWZmZTQzYjNhYzc1ZWI1L3RhYmxlcmFuZ2U6ZDU1MDg3MTMwNzMzNGQwYzk1ZmZlNDNiM2FjNzVlYjVfMjItNi0xLTEtMA_d2101681-b078-423f-8e37-a1b18fb57350"
      unitRef="shares">2688100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMy0xLTEtMS0w_4325d983-8e43-426f-85b1-a4614737048d"
      unitRef="usd">3554000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMy0zLTEtMS0w_d2b03559-5f86-44da-8393-c8c785720b2b"
      unitRef="usd">1753000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMy01LTEtMS0w_6493c957-83ae-43c1-92e5-71950760377d"
      unitRef="usd">12976000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMy03LTEtMS0w_9214b60b-5e58-4a46-ae74-f4e0caa9aee7"
      unitRef="usd">11109000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfNi0xLTEtMS0w_91b82478-7eef-4aca-ab18-78a85ef6559a"
      unitRef="usd">222000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfNi0zLTEtMS0w_fcc6394e-ce82-4017-9b01-2467476aed71"
      unitRef="usd">-667000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfNi01LTEtMS0w_3a33330c-19de-4b8c-b9c7-da5c30cb295f"
      unitRef="usd">-741000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfNi03LTEtMS0w_425691ca-bf8c-419e-ac78-7e57812dca3d"
      unitRef="usd">-575000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfOS0xLTEtMS0w_8b2eb160-48b0-46d1-b175-ec1529628a90"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfOS0zLTEtMS0w_817952cc-51c9-4135-b140-75d28bb12d61"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfOS01LTEtMS0w_eff20fe4-f0c0-4d08-bb33-ea166c5a9c08"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfOS03LTEtMS0w_5c02907f-e5b2-4be8-a4dc-8c80212e67a7"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTAtMS0xLTEtMA_0f939a8d-726c-424a-984f-346016c91778"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTAtMy0xLTEtMA_4a452cf2-51bd-4e30-a34d-a2730e8084b6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTAtNS0xLTEtMA_dac9a723-2363-4240-84f3-e97bfe5e546a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTAtNy0xLTEtMA_3a031ab1-5b14-47d1-91db-06e31940fb58"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTItMS0xLTEtMA_2a7edfe3-0fba-4428-a753-5892d5965b49"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTItMy0xLTEtMA_59978200-9eb6-445e-8a44-bd3953c0dc69"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTItNS0xLTEtMA_7c3257ae-3602-48b6-a6e5-a4d83b368762"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTItNy0xLTEtMA_ffc4dc77-7866-4658-9de4-250126e253ec"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTUtMS0xLTEtMA_9450f8b1-2bbf-41a6-9eda-03e12a0485f0"
      unitRef="usd">6000000</jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax>
    <jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTUtMy0xLTEtMA_58af5337-e3ca-4f84-9f24-604553f25c32"
      unitRef="usd">6000000</jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax>
    <jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTUtNS0xLTEtMA_011a0f14-10a6-459f-b1f0-a2cb3fe12c57"
      unitRef="usd">17000000</jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax>
    <jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTUtNy0xLTEtMA_3c577f16-fceb-437c-b2ef-8992ec528e17"
      unitRef="usd">18000000</jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax>
    <jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTYtMS0xLTEtMA_58816430-9e31-452b-8a65-e55c6e2a16dd"
      unitRef="usd">-203000000</jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax>
    <jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTYtMy0xLTEtMA_b91b3cc7-1656-41a3-9a0e-55efb5de88cf"
      unitRef="usd">-142000000</jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax>
    <jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTYtNS0xLTEtMA_4a300a31-aebf-486b-8e48-7b352108bd7e"
      unitRef="usd">-604000000</jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax>
    <jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTYtNy0xLTEtMA_edb1a134-94c6-454d-b820-19eafd892593"
      unitRef="usd">-460000000</jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTgtMS0xLTEtMA_423d3d10-4c6f-4c4e-a66e-5ff51aa4445d"
      unitRef="usd">-197000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTgtMy0xLTEtMA_229b53ef-1a10-44da-9fc0-ab2f64a80b89"
      unitRef="usd">-136000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTgtNS0xLTEtMA_b1ac8fbb-7292-44eb-aeac-db98948cef65"
      unitRef="usd">-587000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMTgtNy0xLTEtMA_07f5e0b0-08b6-48c3-9f1f-372a4c76b932"
      unitRef="usd">-442000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjEtMS0xLTEtMA_66fc24e5-7f7f-470c-832d-a639c81e7264"
      unitRef="usd">199000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjEtMy0xLTEtMA_68a387de-24da-4631-ae96-475639aff3ff"
      unitRef="usd">1922000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjEtNS0xLTEtMA_5bbe15c1-7125-4a64-b3a9-f1221e85cc44"
      unitRef="usd">1052000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjEtNy0xLTEtMA_943bfff7-db50-410b-bb15-9eafd03c1149"
      unitRef="usd">1706000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjItMS0xLTEtMA_a6492a58-6131-4cee-9c78-9a4f921363b7"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjItMy0xLTEtMA_f8f1eb24-02a6-4e44-9631-6ee91bd238c7"
      unitRef="usd">1955000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjItNS0xLTEtMA_167e0cc4-aa9b-4c28-bc72-aa33524792f1"
      unitRef="usd">-54000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjItNy0xLTEtMA_440f2aee-dc0c-4094-a7ad-e9c474bebe57"
      unitRef="usd">1885000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjMtMS0xLTEtMA_d038a438-8b0e-4e63-af9b-8a4e9c3a9390"
      unitRef="usd">175000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjMtMy0xLTEtMA_ef09d1c8-a25e-4ebf-bbd1-6f8da8faf264"
      unitRef="usd">-33000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjMtNS0xLTEtMA_5403bdc4-5b09-42b6-948d-c16abc7b03b6"
      unitRef="usd">1106000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjMtNy0xLTEtMA_0da64223-4c43-4a49-ab65-4e45a810350f"
      unitRef="usd">-179000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjUtMS0xLTEtMA_7821426b-c8a6-43b8-87bd-bcf3229afefa"
      unitRef="usd">595000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjUtMy0xLTEtMA_a07fccd8-0acc-4e14-b23d-1e6387acbe5a"
      unitRef="usd">-564000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjUtNS0xLTEtMA_0140894a-e812-4443-8a0d-9beafa18aac4"
      unitRef="usd">953000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjUtNy0xLTEtMA_d5f7290e-e7aa-471b-b21b-99e12227d0b8"
      unitRef="usd">-311000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjctMS0xLTEtMA_6c710068-2c6e-4e01-a5da-498d713bb67b"
      unitRef="usd">4149000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjctMy0xLTEtMA_f7715b1e-6920-4a36-9687-746b25206734"
      unitRef="usd">1189000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjctNS0xLTEtMA_6203fea8-fbea-4ae9-8b20-eb2a28322e59"
      unitRef="usd">13929000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOmM4OWZjNjBiMTExNzQ1MTlhZTY3ZGM1ZTMwZDU2N2UwL3RhYmxlcmFuZ2U6Yzg5ZmM2MGIxMTE3NDUxOWFlNjdkYzVlMzBkNTY3ZTBfMjctNy0xLTEtMA_98be30fb-26ce-4565-837b-e3ba80df617a"
      unitRef="usd">10798000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMC0wLTEtMS0zODY5L3RleHRyZWdpb246NzMzZjU0YTI2NmU1NDYzOGE4YjUxYjhiMDJiMmYyYmZfMTA0NDUzNjA0NjQxNjU_6305954c-85da-493e-a81f-cf5516c35e1e"
      unitRef="usd">139000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMC0wLTEtMS0zODY5L3RleHRyZWdpb246NzMzZjU0YTI2NmU1NDYzOGE4YjUxYjhiMDJiMmYyYmZfMTA0NDUzNjA0NjQxODY_9723b399-0e5e-414d-b9ca-e51f72942438"
      unitRef="usd">-94000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMC0wLTEtMS0zODY5L3RleHRyZWdpb246NzMzZjU0YTI2NmU1NDYzOGE4YjUxYjhiMDJiMmYyYmZfMTA0NDUzNjA0NjQxOTE_e64dc264-3cd4-48e4-925e-da882e750d89"
      unitRef="usd">-56000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMC0wLTEtMS0zODY5L3RleHRyZWdpb246NzMzZjU0YTI2NmU1NDYzOGE4YjUxYjhiMDJiMmYyYmZfMTA0NDUzNjA0NjQxOTY_f0bf5490-13a3-4568-a4cc-d7effc7f1ea8"
      unitRef="usd">-34000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMC0wLTEtMS0zODY5L3RleHRyZWdpb246NzMzZjU0YTI2NmU1NDYzOGE4YjUxYjhiMDJiMmYyYmZfMTA0NDUzNjA0NjQxODE_c67476e3-0060-4817-beb1-a85e490d7dd6"
      unitRef="usd">47000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMC0wLTEtMS0zODY5L3RleHRyZWdpb246NzMzZjU0YTI2NmU1NDYzOGE4YjUxYjhiMDJiMmYyYmZfMTA0NDUzNjA0NjQyMDA_6bc8f72a-be28-43eb-9100-44b446ae1292"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMi0wLTEtMS00MDMxL3RleHRyZWdpb246ZDE2ZmQwNGQ0ZjRmNDRkZjkzZTlkZjI0YmI2YThjNGZfMTA0NDUzNjA0NjQxNjY_f09cc489-e297-48b5-86d3-e0ccd4f041da"
      unitRef="usd">207000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMi0wLTEtMS00MDMxL3RleHRyZWdpb246ZDE2ZmQwNGQ0ZjRmNDRkZjkzZTlkZjI0YmI2YThjNGZfMTA0NDUzNjA0NjQxNzc_f8091cbc-584b-473e-8f91-959e333aea3b"
      unitRef="usd">-50000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMi0wLTEtMS00MDMxL3RleHRyZWdpb246ZDE2ZmQwNGQ0ZjRmNDRkZjkzZTlkZjI0YmI2YThjNGZfMTA0NDUzNjA0NjQxODM_bdbea3ea-fe85-4409-8366-1ec4cb82d2bc"
      unitRef="usd">-167000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMi0wLTEtMS00MDMxL3RleHRyZWdpb246ZDE2ZmQwNGQ0ZjRmNDRkZjkzZTlkZjI0YmI2YThjNGZfMTA0NDUzNjA0NjQxODg_88eb769d-aaeb-41ec-982d-3a9d040c9705"
      unitRef="usd">-69000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMi0wLTEtMS00MDMxL3RleHRyZWdpb246ZDE2ZmQwNGQ0ZjRmNDRkZjkzZTlkZjI0YmI2YThjNGZfMTA0NDUzNjA0NjQxNzI_a26872b6-3567-4c5a-b0b9-668348e04e04"
      unitRef="usd">293000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF8zNC9mcmFnOmY4Y2ZiYWYxODgyOTRlYjQ5MjY3ODNmMjU1MjcwYjY4L3RhYmxlOjFiYWQ4MDMyNGY4YzQ2ZGY4ODFkOTBhMTIwYTRjZjNjL3RhYmxlcmFuZ2U6MWJhZDgwMzI0ZjhjNDZkZjg4MWQ5MGExMjBhNGNmM2NfMi0wLTEtMS00MDMxL3RleHRyZWdpb246ZDE2ZmQwNGQ0ZjRmNDRkZjkzZTlkZjI0YmI2YThjNGZfMTA0NDUzNjA0NjQxOTM_39324909-e8b2-4f25-b440-c224b53da0fb"
      unitRef="usd">-48000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0cf38c3475e441fb8f8267516f5f6e04_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMS0xLTEtMS0w_ff9f399a-38f2-45f9-9ba3-5433a6ee374a"
      unitRef="usd">62978000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if6c8c63ebbdd45008cb5ac80e7d4a988_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMS0zLTEtMS0w_b6410c71-444b-492b-a051-a0c46705608f"
      unitRef="usd">113898000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1f90ce64276d4c29ad4a8c7f4dbd288f_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMS01LTEtMS0w_b6267a6c-526e-4980-b9b4-1afb7f312855"
      unitRef="usd">-15533000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i06b919224a104e2480ce4da569369152_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMS03LTEtMS0w_e03cd917-fb85-4129-828e-de60a97463c7"
      unitRef="usd">3120000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id0b01ffae8c54eaaaf665643769f3f44_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMS05LTEtMS0w_0ca0198c-8530-423b-a54a-3329224937a7"
      unitRef="usd">-38507000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMi0xLTEtMS0w_a5b3e34d-ea63-4e66-a12e-805d923cd58d"
      unitRef="usd">3554000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ieca44093d50140b480558060c22367cb_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMi0zLTEtMS0w_27cec79d-15f1-4962-b5b8-20aa6566c9f3"
      unitRef="usd">3554000000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMy0wLTEtMS00MDQzL3RleHRyZWdpb246Njc4NTFjYTE5YWRjNDAxY2JlNDg3YjEzMjVlZTRlNDZfMTA0NDUzNjA0NjM5MTc_c5e744ca-21d1-4bb5-87cc-168bfce4f289"
      unitRef="usdPerShare">1.01</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMy0xLTEtMS0w_bd57f065-0bd3-47b1-9451-4f2dfcc61d49"
      unitRef="usd">2659000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ieca44093d50140b480558060c22367cb_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfMy0zLTEtMS0w_3135c3cb-f109-43d0-b22d-e942b2b246b3"
      unitRef="usd">2659000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfNC0xLTEtMS0w_364a0467-90eb-474c-8d43-bcf2df9877c1"
      unitRef="usd">559000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="ieca44093d50140b480558060c22367cb_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfNC0zLTEtMS0w_86a1ce3c-7384-49d6-b3d1-d5cd78e219cf"
      unitRef="usd">109000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="i381677b70c5d4be996221d9099a8ee95_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfNC05LTEtMS0w_5902bb4a-b458-428c-866a-475bde303b9a"
      unitRef="usd">450000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfNS0xLTEtMS0w_7204d9b5-6ba5-4349-9d6a-776be62bf926"
      unitRef="usd">483000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i381677b70c5d4be996221d9099a8ee95_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfNS05LTEtMS0w_3f70a68c-1737-4eec-a984-58519d29dd3d"
      unitRef="usd">483000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityOther
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfNi0xLTEtMS0w_a1fe1221-9608-491e-92dc-cf8d6900640a"
      unitRef="usd">71000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ieca44093d50140b480558060c22367cb_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfNi0zLTEtMS0w_462ab206-1a82-43ed-a382-70e0db2fda02"
      unitRef="usd">71000000</us-gaap:StockholdersEquityOther>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfNy0xLTEtMS0w_a1619b40-d2c6-4fca-b444-5c07f0f333b6"
      unitRef="usd">595000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4ccc8ddbfa5a467ca8eaf499f719d902_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfNy01LTEtMS0w_ded25dd3-5902-46b8-98cb-3b514716e7d3"
      unitRef="usd">595000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfOC0xLTEtMS0w_0e4c7263-8330-4b3b-926a-7eaf3694ec80"
      unitRef="usd">64473000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib840c9f8515640ed990015d6449203d6_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfOC0zLTEtMS0w_ceaad7ce-8ae9-45db-910d-6d7ef2e7013d"
      unitRef="usd">114831000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b3f9043c47442aea143141642e7e123_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfOC01LTEtMS0w_3030ca3e-92b4-4dd7-8e0a-c583815c1397"
      unitRef="usd">-14938000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie2de08cb9d744bf28bfcab44717ebd79_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfOC03LTEtMS0w_32ef2d5e-8adb-422f-962b-90b110bf10cb"
      unitRef="usd">3120000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifb8ed1a3c397427ca991016ed24db8d2_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjBjZjc5MDIxYmY2MjQ2MDg5ZTU3NzhlNDA0MGIxNzQwL3RhYmxlcmFuZ2U6MGNmNzkwMjFiZjYyNDYwODllNTc3OGU0MDQwYjE3NDBfOC05LTEtMS0w_59982943-ab65-436f-ba26-8b8212ba21f3"
      unitRef="usd">-38540000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMS0xLTEtMS0w_f4cba539-4e39-4fbf-b1a7-26191ca7bad4"
      unitRef="usd">59471000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i71bc7ed79cf044f986c36306dd76232b_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMS0zLTEtMS0w_8a8ffe6c-9f0a-40c8-834f-6a79c00986b0"
      unitRef="usd">110659000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4dff82851aa243f2a42e09821411d92e_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMS01LTEtMS0w_0d2a3da8-cf1b-42fb-8a8a-e6b64c2f42f8"
      unitRef="usd">-15891000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iac644cecdd17481eae30c88e9f63b87d_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMS03LTEtMS0w_38a27bbe-4bd6-463c-8405-1f9b262df9fc"
      unitRef="usd">3120000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia7b18211b77c4d9eb325dfecb4003ccc_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMS05LTEtMS0w_57d7a6cb-124a-48a2-8a44-f1f183f2be09"
      unitRef="usd">-38417000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMi0xLTEtMS0w_471f90de-a2e3-493b-9547-7c970e2e4b0c"
      unitRef="usd">12976000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5c31dab756544c419618439f97c12092_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMi0zLTEtMS0w_e5fa1d34-06b1-4413-b1c7-325c26007330"
      unitRef="usd">12976000000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMy0wLTEtMS00MDQ3L3RleHRyZWdpb246Yjg5NTc0MmVmN2I4NGUzMGJhYjM3NGQ1ODM1OWQyNzlfMTA0NDUzNjA0NjM5MTc_248343fa-35f1-4f39-afbd-ac33309c27ae"
      unitRef="usdPerShare">2.97</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMy0xLTEtMS0w_96144096-0d77-4f90-b77c-e3526fed2918"
      unitRef="usd">7823000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i5c31dab756544c419618439f97c12092_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfMy0zLTEtMS0w_08c3b7d3-be2c-4093-ae78-d69baeebfa90"
      unitRef="usd">7823000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfNC0xLTEtMS0w_6895de2e-3750-4e23-be99-c7f1dbe747d0"
      unitRef="usd">1866000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="i5c31dab756544c419618439f97c12092_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfNC0zLTEtMS0w_89779ff4-09ba-4099-ac02-30e8c00f7e3b"
      unitRef="usd">-911000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="i8c15ea54ac1647959505ff89d74c73c7_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfNC05LTEtMS0w_e55334d9-ca26-47de-ad38-f36752d04c2d"
      unitRef="usd">2777000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfNS0xLTEtMS0w_18d10667-40c3-401a-a8b5-df400f58a6e8"
      unitRef="usd">2900000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i8c15ea54ac1647959505ff89d74c73c7_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfNS05LTEtMS0w_66119b36-db60-428a-812f-3a1f9ce58cc2"
      unitRef="usd">2900000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityOther
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfNi0xLTEtMS0w_3c1eeced-f18f-4552-b2db-2c900af6e368"
      unitRef="usd">70000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i5c31dab756544c419618439f97c12092_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfNi0zLTEtMS0w_02415cbc-34dc-4b9d-bf0a-0fbcf66f5b0b"
      unitRef="usd">70000000</us-gaap:StockholdersEquityOther>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfNy0xLTEtMS0w_0117366e-4ee2-42fb-a8b5-cb5a0918e4b5"
      unitRef="usd">953000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3494e72aac944cd896896e8cc599429d_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfNy01LTEtMS0w_f08be09a-2578-4410-bc83-be55e66195ba"
      unitRef="usd">953000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfOC0xLTEtMS0w_5e1f9fb7-889c-4969-87e2-34bf0c48c597"
      unitRef="usd">64473000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib840c9f8515640ed990015d6449203d6_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfOC0zLTEtMS0w_ee1cbe29-a841-4f13-b0d1-1f4b4c550dc7"
      unitRef="usd">114831000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b3f9043c47442aea143141642e7e123_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfOC01LTEtMS0w_7b79ee06-7b93-43d4-a556-8662ddbe7052"
      unitRef="usd">-14938000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie2de08cb9d744bf28bfcab44717ebd79_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfOC03LTEtMS0w_e8ce8f07-72ab-4756-ac21-aabf96d67372"
      unitRef="usd">3120000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifb8ed1a3c397427ca991016ed24db8d2_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVmY2JjNjBlMTI2ZDQ5YzdiOTBhMjMxNmUyM2EyYTRiL3RhYmxlcmFuZ2U6ZWZjYmM2MGUxMjZkNDljN2I5MGEyMzE2ZTIzYTJhNGJfOC05LTEtMS0w_e9303d1f-ffa9-4fc2-a8e9-bc9007b01167"
      unitRef="usd">-38540000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9918090831a94bfa90e6639a0e7860b0_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfMS0xLTEtMS0w_3a6810aa-8498-4d1f-a2ce-e27e52473db0"
      unitRef="usd">60785000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80a9937f67434d319d5d9d0009f19170_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfMS0zLTEtMS0w_64613661-e930-4e8a-8713-17f4da3716c4"
      unitRef="usd">109809000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie369dd88ecfb42bfbd08a15bc21a6097_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfMS01LTEtMS0w_05edf793-98e4-4b7a-9a04-f021c6224e53"
      unitRef="usd">-14969000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8623b760505a465db7f09f7ad1d524db_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfMS03LTEtMS0w_e06813e9-c990-434d-8e33-3e4afdf0bcae"
      unitRef="usd">3120000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d1eb0b5e3974db0ba19099436b2cc65_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfMS05LTEtMS0w_4e3ad379-ee27-4cf2-8695-63d5721e41ca"
      unitRef="usd">-37175000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfMy0xLTEtMS0w_4fe568ce-5f9a-4f70-8aa7-539143a054ed"
      unitRef="usd">1753000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i110288df68f94473b99fed3695503e08_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfMy0zLTEtMS0w_58ff3722-08ff-4e56-ac3b-4bfd793dad56"
      unitRef="usd">1753000000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfNC0wLTEtMS00MDUxL3RleHRyZWdpb246ODg5ZjBiNjc3NWI5NDIwNzhjYzg1Nzk5OTZkMWMzMjdfMTA0NDUzNjA0NjM5MTc_e356dc83-1c53-4d7b-97ff-e88a59b7d490"
      unitRef="usdPerShare">0.95</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfNC0xLTEtMS0w_94a69ddb-d117-4660-9543-cb88867c34fd"
      unitRef="usd">2499000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i110288df68f94473b99fed3695503e08_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfNC0zLTEtMS0w_c3de2405-0176-4155-9778-c108e4632f4b"
      unitRef="usd">2499000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfNS0xLTEtMS0w_399fab99-87b6-4cf0-b9a2-bed65bd3f82c"
      unitRef="usd">363000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="i110288df68f94473b99fed3695503e08_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfNS0zLTEtMS0w_2778e7c3-e0d8-46e4-b8f0-7ac3c207e6db"
      unitRef="usd">179000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="i6a6ecd40aacc418a87faf0c09967e825_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfNS05LTEtMS0w_913b721f-bac4-4ce6-9f54-0c9adfdeb97d"
      unitRef="usd">184000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfNi0xLTEtMS0w_ded3f35e-130c-499b-9610-3a68f997d85d"
      unitRef="usd">1628000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i6a6ecd40aacc418a87faf0c09967e825_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfNi05LTEtMS0w_8d0b618c-91a9-4186-86e1-924a0b11fb8f"
      unitRef="usd">1628000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfOC0xLTEtMS0w_7f522029-5e70-426f-bc3e-89ae6973cf0a"
      unitRef="usd">-564000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7e3164724e36436c908b66cd22c3a21a_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfOC01LTEtMS0w_8d83c160-6ba3-41c8-9cea-8c3ceca9654a"
      unitRef="usd">-564000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7973ae70802a4ed0a4cd812adebb0210_I20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfOS0xLTEtMS0w_241d4205-27ef-4fa5-bd8d-e1332d61a88b"
      unitRef="usd">58210000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0f437ae6f74d4fa69aa4dac8e499093a_I20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfOS0zLTEtMS0w_5f99dcc7-5ef1-4b33-addf-cb3382fc16bc"
      unitRef="usd">109242000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic23a7f58f6e14cc1977521f182c06612_I20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfOS01LTEtMS0w_132a4b3a-46a7-47e5-982d-0eaf259789fb"
      unitRef="usd">-15533000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i400557913e3646cfba478852d03d7924_I20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfOS03LTEtMS0w_5fcdd670-933b-4f8c-a794-d92ff1782acd"
      unitRef="usd">3120000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i018cbb188f0842968a546fe435cdf833_I20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOjhkYWQ0OTA1ODcwYjQ4NDJhYTIwOWNhNmM3Mzc5Nzc3L3RhYmxlcmFuZ2U6OGRhZDQ5MDU4NzBiNDg0MmFhMjA5Y2E2YzczNzk3NzdfOS05LTEtMS0w_bd8110eb-e603-425d-a492-77272edd0aab"
      unitRef="usd">-38619000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id0a2a626a2c244b9a56b493374930da0_I20181230"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfMS0xLTEtMS0w_6e215857-e091-4e83-b3fa-c0ea2a0ea3e2"
      unitRef="usd">59752000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i140bd62410d04a73af76e67490f68df5_I20181230"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfMS0zLTEtMS0w_d473cadf-5586-44d4-8c3f-5d2083f75a90"
      unitRef="usd">106216000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idf518ea8aaf64e96abb8d9041f120b48_I20181230"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfMS01LTEtMS0w_0ec39cbc-5ece-4b3d-bbcb-2bbdd37f5732"
      unitRef="usd">-15222000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1caf669d3c9842f4b9c8d11879c80aec_I20181230"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfMS03LTEtMS0w_b0d0ea7e-64ad-4cd1-a523-5a3777c5555b"
      unitRef="usd">3120000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iad718c4ff9e7438d82af65c75127f1f7_I20181230"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfMS05LTEtMS0w_77e970fe-1a81-4243-a815-af4230b7979f"
      unitRef="usd">-34362000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfMy0xLTEtMS0w_31d130a7-d41f-4399-b88d-7ca8793578aa"
      unitRef="usd">11109000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i35bcfc36a3ac40618bf4b3ef88484093_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfMy0zLTEtMS0w_ca019b91-6f7e-4b70-8e71-fff6d2aa4058"
      unitRef="usd">11109000000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfNC0wLTEtMS00MDU1L3RleHRyZWdpb246ODc2YmNmM2E3YzFlNDI2MWE4MzMzY2E2YzFmNDQzZTZfMTA0NDUzNjA0NjM5MTc_f12dc2f0-69f9-43d5-8c15-34e1c189a904"
      unitRef="usdPerShare">2.80</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfNC0xLTEtMS0w_d3c90068-890d-4931-811c-1c3d354fcde8"
      unitRef="usd">7417000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i35bcfc36a3ac40618bf4b3ef88484093_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfNC0zLTEtMS0w_e569848a-b11c-4ce4-a4cf-8e6d764701b6"
      unitRef="usd">7417000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfNS0xLTEtMS0w_1804b026-ef32-4ff9-a754-e565beca7612"
      unitRef="usd">1397000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="i35bcfc36a3ac40618bf4b3ef88484093_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfNS0zLTEtMS0w_1069b611-6e0b-42b9-bcf4-de3364b2ea26"
      unitRef="usd">-666000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="icd34e4a6c9104502985d3b5bd4a98c8e_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfNS05LTEtMS0w_b572a2a7-f892-4133-937d-27765d9eacf7"
      unitRef="usd">2063000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfNi0xLTEtMS0w_8d90fb14-2795-4ad9-9089-93acf1d99ba7"
      unitRef="usd">6320000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="icd34e4a6c9104502985d3b5bd4a98c8e_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfNi05LTEtMS0w_6ae905fd-30b0-4af1-a528-bcabc30bdcf0"
      unitRef="usd">6320000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfOC0xLTEtMS0w_b91de991-2245-4e90-924e-3aa4f6a1da63"
      unitRef="usd">-311000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia9597fec02bb4c31b44fbbd09919bb16_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfOC01LTEtMS0w_8b8cb256-1d0f-450b-9622-8be3873b6d7d"
      unitRef="usd">-311000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7973ae70802a4ed0a4cd812adebb0210_I20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfOS0xLTEtMS0w_6f09dcb6-7e34-47bc-bb74-60faaa34007e"
      unitRef="usd">58210000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0f437ae6f74d4fa69aa4dac8e499093a_I20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfOS0zLTEtMS0w_649c7194-ef95-4322-ad1a-ab603cf33013"
      unitRef="usd">109242000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic23a7f58f6e14cc1977521f182c06612_I20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfOS01LTEtMS0w_d806509e-213b-43b3-8b35-9444b61cb431"
      unitRef="usd">-15533000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i400557913e3646cfba478852d03d7924_I20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfOS03LTEtMS0w_b030e400-ca58-4e96-8498-850cd9c65bb6"
      unitRef="usd">3120000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i018cbb188f0842968a546fe435cdf833_I20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80MC9mcmFnOmU4MDg1ZDZlMjNhOTQ0NzRhZjY2ODcxMjU1NDMxNDZlL3RhYmxlOmVkYTg5YmQwOTg1YjQwYjI5Nzk4NzYxMmJmMjlkNzE5L3RhYmxlcmFuZ2U6ZWRhODliZDA5ODViNDBiMjk3OTg3NjEyYmYyOWQ3MTlfOS05LTEtMS0w_70a50cc7-8f62-4eb6-a9c2-37860f3773c0"
      unitRef="usd">-38619000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMy0yLTEtMS0w_fc1f329b-2239-4984-8629-8d22fbd17493"
      unitRef="usd">12976000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMy00LTEtMS0w_052a2729-8667-4fad-8121-ced4b3c71d70"
      unitRef="usd">11109000000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNS0yLTEtMS0w_c24360db-a8d1-44be-88b2-7311f6d4722f"
      unitRef="usd">5291000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNS00LTEtMS0w_9d56e844-6de1-4041-b6cc-77ebf044a498"
      unitRef="usd">5193000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNi0yLTEtMS0w_9246888a-bb5c-4e00-ac30-f2bc6573aec3"
      unitRef="usd">845000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNi00LTEtMS0w_9c5016a4-a5e5-4210-ac44-8c9ac8c91e64"
      unitRef="usd">817000000</us-gaap:ShareBasedCompensation>
    <us-gaap:AssetImpairmentCharges
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfOS0yLTEtMS0w_5d20722b-382b-4ff9-8052-2c3240ec6be5"
      unitRef="usd">198000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfOS00LTEtMS0w_d0eb4418-d9c4-443f-b68e-82cc38a82651"
      unitRef="usd">1019000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTAtMi0xLTEtMA_3d328b25-ce53-4b52-9d07-e972c0c203f5"
      unitRef="usd">-1148000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTAtNC0xLTEtMA_adbc3f88-2ae0-47c5-a914-7e62bec0d9fa"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTEtMi0xLTEtMA_362c3556-e33d-4645-ace7-7ab9d75ba39b"
      unitRef="usd">60000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTEtNC0xLTEtMA_69387a68-3a13-41c6-a92a-eef827f9a473"
      unitRef="usd">2125000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTMtMi0xLTEtMA_4555fdee-23e1-4d70-8a22-13901610902e"
      unitRef="usd">-238000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTMtNC0xLTEtMA_7acb118a-4b5b-4fae-b366-5d5f43e98866"
      unitRef="usd">-2126000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTQtMi0xLTEtMA_a164a749-11d4-441b-b575-8dadca16838d"
      unitRef="usd">74000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTQtNC0xLTEtMA_0ac48b04-0d4a-491c-a65d-34fe2a2964e6"
      unitRef="usd">-15000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTYtMi0xLTEtMA_2a3bc301-99d5-4bcd-bd85-40eee6eb12a4"
      unitRef="usd">440000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTYtNC0xLTEtMA_b4b7e102-ab48-4beb-8c89-595b83df06e4"
      unitRef="usd">665000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTctMi0xLTEtMA_cde0f789-4368-496f-b2aa-939031809f99"
      unitRef="usd">784000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTctNC0xLTEtMA_12e8443f-9581-4ae1-9007-e880f030bb9f"
      unitRef="usd">424000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTgtMi0xLTEtMA_bef0440f-49be-479a-95fe-7176c6ec6ea3"
      unitRef="usd">-119000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTgtNC0xLTEtMA_7036adde-0530-4d2f-a0b9-b3d11ba8f639"
      unitRef="usd">2273000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTktMi0xLTEtMA_5cf3ce4e-fe42-49aa-9236-23541aeda1ef"
      unitRef="usd">1983000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMTktNC0xLTEtMA_8a51888a-fba2-41a2-af51-0140b20ec4c8"
      unitRef="usd">81000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjAtMi0xLTEtMA_b6498dd5-c643-4e7e-9194-e4cec50e3b10"
      unitRef="usd">581000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjAtNC0xLTEtMA_902a2e50-2b3e-4f51-be10-5feb572631db"
      unitRef="usd">2043000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjItMi0xLTEtMA_2d41f361-0619-4edd-9e44-24c0a007fb67"
      unitRef="usd">15193000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjItNC0xLTEtMA_142a9eac-a8c9-478a-8767-610ed48715ad"
      unitRef="usd">17018000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjUtMi0xLTEtMA_cb03d7e9-0924-434c-b965-d5b45d2e6ccd"
      unitRef="usd">2024000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjUtNC0xLTEtMA_ab82f27f-9dc9-4659-9cda-c0739c182ab2"
      unitRef="usd">2238000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjYtMi0xLTEtMA_1eb1dc60-bd9a-4031-b494-62bf43ee69f4"
      unitRef="usd">100000000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjYtNC0xLTEtMA_f203c7e7-ea06-4790-ad65-c97cba3d28fa"
      unitRef="usd">3103000000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjctMi0xLTEtMA_d85803c8-9e0e-4e42-8145-10681ab2ad1d"
      unitRef="usd">949000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjctNC0xLTEtMA_3706ae77-b533-41e3-a176-a2aff7eb1022"
      unitRef="usd">5562000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjgtMi0xLTEtMA_600026f9-4ba5-4d4c-9638-b4af77e593ad"
      unitRef="usd">16243000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjgtNC0xLTEtMA_8335ab2e-e0a1-4a15-bc4c-4e24cf5b24a6"
      unitRef="usd">2684000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjktMi0xLTEtMA_0e5704e9-b372-4b91-8a7e-f9b877fe58eb"
      unitRef="usd">6585000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMjktNC0xLTEtMA_034f5acc-31cc-4c35-9dd6-fca807b11c5d"
      unitRef="usd">2459000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <jnj:Proceedsfromcreditsupportagreements
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzAtMi0xLTEtMA_8c91018b-f846-498b-937d-97dd9097d6bf"
      unitRef="usd">125000000</jnj:Proceedsfromcreditsupportagreements>
    <jnj:Proceedsfromcreditsupportagreements
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzAtNC0xLTEtMA_3e971918-6091-4ef6-9adb-fc7f378b086b"
      unitRef="usd">0</jnj:Proceedsfromcreditsupportagreements>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzEtMi0xLTEtMA_843f34ba-4ccc-49b0-be8a-437bba6d1867"
      unitRef="usd">516000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzEtNC0xLTEtMA_36d9bb26-09e6-4b81-b73d-c69376ed3ade"
      unitRef="usd">-72000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzMtMi0xLTEtMA_5edb2395-f75c-47bb-83fa-25e30b51e85b"
      unitRef="usd">-12922000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzMtNC0xLTEtMA_61118061-d8a9-4c55-a894-744974c81db0"
      unitRef="usd">-4850000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfOrdinaryDividends
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzYtMi0xLTEtMA_d92debfe-7066-4978-b072-0c62266e0c2d"
      unitRef="usd">7823000000</us-gaap:PaymentsOfOrdinaryDividends>
    <us-gaap:PaymentsOfOrdinaryDividends
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzYtNC0xLTEtMA_2aa661c9-3bdb-4181-8ee4-e0d9def919a1"
      unitRef="usd">7417000000</us-gaap:PaymentsOfOrdinaryDividends>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzctMi0xLTEtMA_96754261-9351-4969-95fc-1a324072dd35"
      unitRef="usd">2900000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzctNC0xLTEtMA_4398e625-5c35-4012-b414-33ee9d4879c4"
      unitRef="usd">6320000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzgtMi0xLTEtMA_04a503a4-146a-4897-9435-83e1b3ff0c7e"
      unitRef="usd">3335000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzgtNC0xLTEtMA_757930dd-3adf-4e13-93cf-c00c80cbf3d6"
      unitRef="usd">148000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzktMi0xLTEtMA_b8450636-79f3-4b23-b701-f01999de0b1b"
      unitRef="usd">310000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfMzktNC0xLTEtMA_7a714b34-9204-41db-8157-778720a9977e"
      unitRef="usd">87000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDAtMi0xLTEtMA_a059d1a3-9430-41a0-8a83-caf3eb5fe8e2"
      unitRef="usd">7431000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDAtNC0xLTEtMA_72284f30-b84f-445b-a932-8eda657fe932"
      unitRef="usd">1000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDEtMi0xLTEtMA_0ee16d2b-1cb1-4f6f-9e0a-c35a30361fca"
      unitRef="usd">562000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDEtNC0xLTEtMA_a62087b8-80c9-4ca6-9050-3552c1e9344f"
      unitRef="usd">1008000000</us-gaap:RepaymentsOfLongTermDebt>
    <jnj:ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDItMi0xLTEtMA_be4e47b1-ae10-4d79-bdc4-b455586d4060"
      unitRef="usd">922000000</jnj:ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits>
    <jnj:ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDItNC0xLTEtMA_54c96273-3ca8-4608-9446-ae76712e1c23"
      unitRef="usd">580000000</jnj:ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDMtMi0xLTEtMA_88f2beef-033e-4274-8a49-e2169f09d4f1"
      unitRef="usd">-569000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDMtNC0xLTEtMA_ff099ebf-a5f2-45de-beb6-69d57bde4e70"
      unitRef="usd">160000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDUtMi0xLTEtMA_ca79e4b4-965c-43d8-bd6c-9f1e68494532"
      unitRef="usd">-476000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDUtNC0xLTEtMA_3b374b1f-160d-41a8-8463-0a831723fb70"
      unitRef="usd">-13943000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDctMi0xLTEtMA_154773b0-08c6-4fad-ab7f-6717f234a2bb"
      unitRef="usd">-135000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDctNC0xLTEtMA_51c9f43a-8ce3-4b2a-a489-86f4619851b9"
      unitRef="usd">-83000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDgtMi0xLTEtMA_dd78edf2-6a4a-49ee-9b50-e7057b794884"
      unitRef="usd">1660000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDgtNC0xLTEtMA_3a3e3676-a3b0-45c7-90d6-cf2e691ce69b"
      unitRef="usd">-1858000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDktMi0xLTEtMA_e4a1a820-cf8c-4e74-9701-78bb4f603e2e"
      unitRef="usd">17305000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id0a2a626a2c244b9a56b493374930da0_I20181230"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNDktNC0xLTEtMA_9cdde73a-d323-48a4-945f-6a3647c3e4ce"
      unitRef="usd">18107000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNTAtMi0xLTEtMA_ef45e464-37bf-4bac-916d-a4c9aab5c652"
      unitRef="usd">18965000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7973ae70802a4ed0a4cd812adebb0210_I20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNTAtNC0xLTEtMA_7dd2938e-2717-46e4-8182-c59e267f9b35"
      unitRef="usd">16249000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNTctMi0xLTEtMA_80e6eb80-1dc1-432c-b656-b327d8dd2b2a"
      unitRef="usd">1173000000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNTctNC0xLTEtMA_295bbfef-238c-4a82-8558-a757c59bc245"
      unitRef="usd">6861000000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNTgtMi0xLTEtMA_c9e83071-6d41-4db4-b2ce-7cc7986e8cdf"
      unitRef="usd">224000000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNTgtNC0xLTEtMA_0363410b-99eb-4d20-a87b-e3181d416433"
      unitRef="usd">1299000000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNTktMi0xLTEtMA_35de148c-77e1-4589-bfeb-90c1b2c1a555"
      unitRef="usd">949000000</us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF80Ni9mcmFnOjBlMGQ1NDNhYTU1MTRiMGM5MDYxODExNmQxNmRhNmYwL3RhYmxlOmJkMmUzOTRlMDNjMzRhYmU4ODI2MzYxZjQzZDkzN2ZiL3RhYmxlcmFuZ2U6YmQyZTM5NGUwM2MzNGFiZTg4MjYzNjFmNDNkOTM3ZmJfNTktNC0xLTEtMA_6c9f7782-7c98-4a00-b3ac-f5746f81ea00"
      unitRef="usd">5562000000</us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81Mi9mcmFnOmI0OTgwM2YxYzg4MzQzMGZhNzc2ZTM4ZDhjMmNmNGZjL3RleHRyZWdpb246YjQ5ODAzZjFjODgzNDMwZmE3NzZlMzhkOGMyY2Y0ZmNfMjc3MA_59fbad18-9410-490f-b82a-b270efaf42ae">The accompanying unaudited interim consolidated financial statements and related notes should be read in conjunction with the audited Consolidated Financial Statements of Johnson &amp;amp; Johnson and its subsidiaries (the Company) and related notes as contained in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. The unaudited interim financial statements include all adjustments (consisting only of normal recurring adjustments) and accruals necessary in the judgment of management for a fair statement of the results for the periods presented.&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Columns and rows within tables may not add due to rounding. Percentages have been calculated using actual, non-rounded figures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The extent to which COVID-19 impacts the Company&#x2019;s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts COVID-19 as of September 27, 2020 and through the date of this report. The accounting matters assessed included, but were not limited to, the Company&#x2019;s allowance for doubtful accounts and credit losses, inventory and related reserves, accrued rebates and associated reserves, and the carrying value of the goodwill and other long-lived assets. While there was not a material impact to the Company&#x2019;s consolidated financial statements as of and for the quarter ended September 27, 2020, the Company&#x2019;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the Company&#x2019;s consolidated financial statements in future reporting periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;New Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company assesses the adoption impacts of recently issued accounting standards by the Financial Accounting Standards Board on the Company's financial statements as well as material updates to previous assessments, if any, from the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. There were no new material accounting standards issued in the fiscal third quarter of 2020 that impacted the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;There were no new accounting standards adopted in the fiscal third quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Reclassification&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Certain prior period amounts have been reclassified to conform to current year presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81Mi9mcmFnOmI0OTgwM2YxYzg4MzQzMGZhNzc2ZTM4ZDhjMmNmNGZjL3RleHRyZWdpb246YjQ5ODAzZjFjODgzNDMwZmE3NzZlMzhkOGMyY2Y0ZmNfMjc2Nw_cd54a57b-270f-4a94-9687-b66c3c99387e">&lt;div style="margin-top:3pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The extent to which COVID-19 impacts the Company&#x2019;s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts COVID-19 as of September 27, 2020 and through the date of this report. The accounting matters assessed included, but were not limited to, the Company&#x2019;s allowance for doubtful accounts and credit losses, inventory and related reserves, accrued rebates and associated reserves, and the carrying value of the goodwill and other long-lived assets. While there was not a material impact to the Company&#x2019;s consolidated financial statements as of and for the quarter ended September 27, 2020, the Company&#x2019;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the Company&#x2019;s consolidated financial statements in future reporting periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81Mi9mcmFnOmI0OTgwM2YxYzg4MzQzMGZhNzc2ZTM4ZDhjMmNmNGZjL3RleHRyZWdpb246YjQ5ODAzZjFjODgzNDMwZmE3NzZlMzhkOGMyY2Y0ZmNfMjc2OA_9f020f7e-0e64-4e21-b92e-393398de2b89">&lt;div style="margin-top:3pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;New Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company assesses the adoption impacts of recently issued accounting standards by the Financial Accounting Standards Board on the Company's financial statements as well as material updates to previous assessments, if any, from the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. There were no new material accounting standards issued in the fiscal third quarter of 2020 that impacted the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;There were no new accounting standards adopted in the fiscal third quarter of 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i8998fcc3526244dcad040549c8bdf899_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81Mi9mcmFnOmI0OTgwM2YxYzg4MzQzMGZhNzc2ZTM4ZDhjMmNmNGZjL3RleHRyZWdpb246YjQ5ODAzZjFjODgzNDMwZmE3NzZlMzhkOGMyY2Y0ZmNfMjc2OQ_6fe4b6ba-e094-4bef-bce3-3857a640d1bd">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Reclassification&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Certain prior period amounts have been reclassified to conform to current year presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RleHRyZWdpb246YmJlMzUzM2RlZTMxNDYwM2IwOTBiM2QwNmU2MTQ4OWZfMTYy_e856db3c-6b70-4971-9507-c1838c35a31f">INVENTORIES &lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.070%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.896%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.736%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:20.622%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.736%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:22.310%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Raw materials and supplies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goods in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Total inventories &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"&gt; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;See Note 10 to the Consolidated Financial Statements for details on assets held for sale and the related divestitures.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RleHRyZWdpb246YmJlMzUzM2RlZTMxNDYwM2IwOTBiM2QwNmU2MTQ4OWZfMTY0_11e4bb24-7ba7-4264-b2cb-62a7bf02e9a2">&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.070%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:51.896%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.736%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:20.622%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.736%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:22.310%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Raw materials and supplies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goods in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Total inventories &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"&gt; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;See Note 10 to the Consolidated Financial Statements for details on assets held for sale and the related divestitures.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RhYmxlOjA0ZDliMGI2Y2UwODRhYWViYzUzOGE2MGI3NjFhMTIyL3RhYmxlcmFuZ2U6MDRkOWIwYjZjZTA4NGFhZWJjNTM4YTYwYjc2MWExMjJfMS0yLTEtMS0w_d55221f6-c471-4702-a6b4-2939d871a33b"
      unitRef="usd">1363000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RhYmxlOjA0ZDliMGI2Y2UwODRhYWViYzUzOGE2MGI3NjFhMTIyL3RhYmxlcmFuZ2U6MDRkOWIwYjZjZTA4NGFhZWJjNTM4YTYwYjc2MWExMjJfMS00LTEtMS0w_958c513d-f5cb-41cf-967b-5384c871c9d9"
      unitRef="usd">1117000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RhYmxlOjA0ZDliMGI2Y2UwODRhYWViYzUzOGE2MGI3NjFhMTIyL3RhYmxlcmFuZ2U6MDRkOWIwYjZjZTA4NGFhZWJjNTM4YTYwYjc2MWExMjJfMi0yLTEtMS0w_8c5faeb2-8678-40c1-b878-c627f6cab269"
      unitRef="usd">1916000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RhYmxlOjA0ZDliMGI2Y2UwODRhYWViYzUzOGE2MGI3NjFhMTIyL3RhYmxlcmFuZ2U6MDRkOWIwYjZjZTA4NGFhZWJjNTM4YTYwYjc2MWExMjJfMi00LTEtMS0w_af6d8693-1c7a-4802-baa9-6290cb3b43a6"
      unitRef="usd">1832000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RhYmxlOjA0ZDliMGI2Y2UwODRhYWViYzUzOGE2MGI3NjFhMTIyL3RhYmxlcmFuZ2U6MDRkOWIwYjZjZTA4NGFhZWJjNTM4YTYwYjc2MWExMjJfMy0yLTEtMS0w_7d261c1b-fed3-49d5-9e3d-da3a6eb05e89"
      unitRef="usd">6320000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RhYmxlOjA0ZDliMGI2Y2UwODRhYWViYzUzOGE2MGI3NjFhMTIyL3RhYmxlcmFuZ2U6MDRkOWIwYjZjZTA4NGFhZWJjNTM4YTYwYjc2MWExMjJfMy00LTEtMS0w_19e7c27c-de62-4de5-88b7-4c499a1bf949"
      unitRef="usd">6071000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RhYmxlOjA0ZDliMGI2Y2UwODRhYWViYzUzOGE2MGI3NjFhMTIyL3RhYmxlcmFuZ2U6MDRkOWIwYjZjZTA4NGFhZWJjNTM4YTYwYjc2MWExMjJfNC0yLTEtMS0w_120c7fbb-1357-45ec-b915-45ca25689e38"
      unitRef="usd">9599000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF81OC9mcmFnOmJiZTM1MzNkZWUzMTQ2MDNiMDkwYjNkMDZlNjE0ODlmL3RhYmxlOjA0ZDliMGI2Y2UwODRhYWViYzUzOGE2MGI3NjFhMTIyL3RhYmxlcmFuZ2U6MDRkOWIwYjZjZTA4NGFhZWJjNTM4YTYwYjc2MWExMjJfNC00LTEtMS0w_9547fc98-55d3-4d22-b636-5d41e4162930"
      unitRef="usd">9020000000</us-gaap:InventoryNet>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfMTY3Mg_efe49d53-e6df-4ae0-861a-f91509985405">INTANGIBLE ASSETS AND GOODWILL&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Intangible assets that have finite useful lives are amortized over their estimated useful lives. The latest annual impairment assessment of goodwill and indefinite lived intangible assets was completed in the fiscal fourth quarter of 2019. Future impairment tests for goodwill and indefinite lived intangible assets will be performed annually in the fiscal fourth quarter, or sooner, if warranted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:61.104%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.587%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.325%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.587%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.697%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intangible assets with definite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents and trademarks &#x2014; gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;36,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents and trademarks &#x2014; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer relationships and other intangibles &#x2014; gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer relationships and other intangibles&#160;&#x2014; net*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intangible assets with indefinite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Purchased in-process research and development &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total intangible assets with indefinite lives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total intangible assets &#x2014; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;47,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;47,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;*The majority is comprised of customer relationships&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;In the fiscal first quarter of 2020, the Company completed the acquisition of bermekimab and certain related assets from XBiotech Inc., as well as the acquisition of all outstanding shares in Verb Surgical Inc. and recorded in-process research and development intangible assets of $0.8 billion and $0.4 billion, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Goodwill as of September&#160;27, 2020 was allocated by segment of business as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.859%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:40.177%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.578%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.205%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.447%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.984%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.292%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.361%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.447%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.209%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Consumer Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Medical Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill at December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill, related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Currency translation/Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill at September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The weighted average amortization period for patents and trademarks is 12 years. The weighted average amortization period for customer relationships and other intangible assets is 21 years. The amortization expense of amortizable intangible assets included in cost of products sold was $1.2 billion and $1.1&#160;billion for the fiscal third quarters ended September&#160;27, 2020 and September&#160;29, 2019, respectively. The amortization expense of amortizable intangible assets included in cost of products sold was $3.4 billion and $3.3&#160;billion for the fiscal nine months ended September&#160;27, 2020 and September&#160;29, 2019, respectively. Intangible asset write-downs are included in Other (income) expense, net. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The estimated amortization expense for approved products, before tax, for the five succeeding years is approximately:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:18.528%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.833%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:18.114%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.833%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.908%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.833%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.908%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.833%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.910%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="margin-top:13pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$4,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,900&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; See Note 10 to the Consolidated Financial Statements for additional details related to acquisitions and divestitures.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <jnj:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfMTY2NA_de3b1998-f240-4bdb-b092-4688527ca6c0">&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:61.104%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.587%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.325%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.587%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.697%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intangible assets with definite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents and trademarks &#x2014; gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;36,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents and trademarks &#x2014; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer relationships and other intangibles &#x2014; gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer relationships and other intangibles&#160;&#x2014; net*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intangible assets with indefinite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Purchased in-process research and development &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total intangible assets with indefinite lives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total intangible assets &#x2014; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;47,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;47,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;*The majority is comprised of customer relationships&lt;/span&gt;&lt;/div&gt;(1) In the fiscal first quarter of 2020, the Company completed the acquisition of bermekimab and certain related assets from XBiotech Inc., as well as the acquisition of all outstanding shares in Verb Surgical Inc. and recorded in-process research and development intangible assets of $0.8 billion and $0.4 billion, respectively.</jnj:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i146724b9ab654ac3b05e3567213370a2_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMi0yLTEtMS0w_6c1ce250-a8ef-4cb1-9d05-9cf2d5bc3e6e"
      unitRef="usd">38381000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if455a0c82eec4663ab4937953a47b1a0_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMi00LTEtMS0w_f8de8994-7031-457e-87b0-41ccb6b9475a"
      unitRef="usd">36634000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i146724b9ab654ac3b05e3567213370a2_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMy0yLTEtMS0w_ed83e089-d183-4949-bdb1-8570adc58b96"
      unitRef="usd">16098000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if455a0c82eec4663ab4937953a47b1a0_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMy00LTEtMS0w_b3f8056f-c832-4d19-a329-99083b5e325a"
      unitRef="usd">13154000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i146724b9ab654ac3b05e3567213370a2_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfNC0yLTEtMS0w_a2f01e5a-3fc8-4afb-aabd-bfd87c47ff0e"
      unitRef="usd">22283000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if455a0c82eec4663ab4937953a47b1a0_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfNC00LTEtMS0w_082efd03-df04-4fe2-b32c-57ad358dc5f8"
      unitRef="usd">23480000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ifeaa5dc31fed4356a01542e92bc1b4ac_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfNS0yLTEtMS0w_d32266b4-b40c-4f68-a5bc-81e9854338e2"
      unitRef="usd">22455000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0ec1428acbd748a3ac5a614e4bca5b5b_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfNS00LTEtMS0w_fc52839f-769c-47c6-ba4e-cadc8587a8d6"
      unitRef="usd">22056000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifeaa5dc31fed4356a01542e92bc1b4ac_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfNi0yLTEtMS0w_801c1806-3ccb-46cf-8ac4-e265c7bf9e7d"
      unitRef="usd">10427000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0ec1428acbd748a3ac5a614e4bca5b5b_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfNi00LTEtMS0w_30354650-17d9-41e7-b6b9-bfc98f8c5b74"
      unitRef="usd">9462000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ifeaa5dc31fed4356a01542e92bc1b4ac_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfNy0yLTEtMS0w_79ef8944-f597-407b-8544-6c9cdbd60db4"
      unitRef="usd">12028000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0ec1428acbd748a3ac5a614e4bca5b5b_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfNy00LTEtMS0w_8debf9f5-0805-462e-bbdc-3dcf31eb3ded"
      unitRef="usd">12594000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i68c2ad5bd3504e018130bc2faeb63dfc_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfOS0yLTEtMS0w_1282cc7b-5227-4e66-82dc-48d1416012a4"
      unitRef="usd">6995000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i7d2f1f6cd2a34b9fb4eb1093a33dc1ae_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfOS00LTEtMS0w_8c0f62fd-ac45-434c-af7d-4dd47ba64d4a"
      unitRef="usd">6922000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i9f84e8435dc0421d8a89f9ea0bce9608_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMTAtMi0xLTEtMA_6b1bf4e6-df4f-4ee9-aa63-ac986ea28bdf"
      unitRef="usd">5700000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i99b4dc37a244428f8b6a328e6563293f_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMTAtNC0xLTEtMA_ee7c3e66-b67d-465d-8479-34e934e38bb7"
      unitRef="usd">4647000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMTEtMi0xLTEtMA_b9de1e1c-a982-4c59-a629-63322ce4653a"
      unitRef="usd">12695000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMTEtNC0xLTEtMA_441d8f1a-7a9a-42de-8f8b-ac926b52490e"
      unitRef="usd">11569000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMTItMi0xLTEtMA_b6aefd27-e84a-4fab-a202-46d3bf60e8b8"
      unitRef="usd">47006000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjlhOGYyYWY2Y2I4NzRmODQ5NGUxNTI4YWJmMTgwMDUzL3RhYmxlcmFuZ2U6OWE4ZjJhZjZjYjg3NGY4NDk0ZTE1MjhhYmYxODAwNTNfMTItNC0xLTEtMA_461e965a-ba2e-4f78-b708-00cbfdbf5f93"
      unitRef="usd">47643000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ia9cdf38955a64506988afbdd28653b69_I20200329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfNzgz_b51ccb51-5db6-489e-a002-5b2c71fef426"
      unitRef="usd">800000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i1db1cbb21378478cbff6ba1c2021c6dc_I20200329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfNzkw_7c9fe85f-08bc-4528-afc5-afe79432dd7a"
      unitRef="usd">400000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfMTY3MQ_071aea31-00a7-4aee-a7a1-6f73f9493a51">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Goodwill as of September&#160;27, 2020 was allocated by segment of business as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.859%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:40.177%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.578%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.205%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.447%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.984%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.292%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.361%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.447%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.209%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Consumer Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Medical Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill at December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill, related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Currency translation/Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill at September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i478b4ff4ed674722bb2570839bc53e96_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfMS0yLTEtMS0w_16af8e1a-0344-457e-9cbf-457b2a8704ba"
      unitRef="usd">9736000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i31bf8455628944da8b015d8b789a9fc4_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfMS00LTEtMS0w_ebdd338c-669d-476d-92dd-0c90ec5bad90"
      unitRef="usd">9169000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i87651ba4e20740f0bd2d7665498709be_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfMS02LTEtMS0w_26e5b592-4e6e-4e18-8f62-d724f93b9ee0"
      unitRef="usd">14734000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfMS04LTEtMS0w_82234fe0-47b6-4435-b99a-7a1b4a8852e6"
      unitRef="usd">33639000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i498b81f2554f4e868dce4daa5736066a_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfMi0yLTEtMS0w_5bf3965d-7282-4288-84e7-5b8da106936f"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i31c5bebe5faa45388656d1dcb0238be9_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfMi00LTEtMS0w_e1de5385-1dcf-466e-a4c5-da39b0889fdd"
      unitRef="usd">1000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic80539fe5fa44b869a360326b6dee52a_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfMi02LTEtMS0w_8622f181-9b9a-42d3-ad70-4c4d7595164a"
      unitRef="usd">183000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfMi04LTEtMS0w_f6ce72dd-ba5a-43b7-bf96-eeb7d5d95b69"
      unitRef="usd">184000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i498b81f2554f4e868dce4daa5736066a_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfNC0yLTEtMS0w_7aaaf092-582c-4b44-8b95-5b4bed5694e8"
      unitRef="usd">171000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i31c5bebe5faa45388656d1dcb0238be9_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfNC00LTEtMS0w_e8d6c34c-7c81-497d-b204-df6cf766cbe3"
      unitRef="usd">280000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="ic80539fe5fa44b869a360326b6dee52a_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfNC02LTEtMS0w_5c219464-2354-465d-a655-48e7f1c17535"
      unitRef="usd">33000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfNC04LTEtMS0w_14c5ef29-6d66-461e-8da4-a06c6dc37eed"
      unitRef="usd">484000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:Goodwill
      contextRef="i3e833bc35e3f438d8cfbc47be4f35753_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfNS0yLTEtMS0w_6d8f27e1-d112-45ad-a624-7349b8bae62c"
      unitRef="usd">9907000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5e4dc688e2e648e983fbdf67f462f0a2_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfNS00LTEtMS0w_15ab8aa3-ba68-4e45-a289-6e0566cd6afa"
      unitRef="usd">9450000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i11ef6f75bfcc45848502de0139e92200_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfNS02LTEtMS0w_0a7cf8c1-09da-4293-ace3-7300c213325c"
      unitRef="usd">14950000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjg0MjgzMzY4ODkyZTQwNWQ4ZDA1MzdjYmUyN2MxM2I0L3RhYmxlcmFuZ2U6ODQyODMzNjg4OTJlNDA1ZDhkMDUzN2NiZTI3YzEzYjRfNS04LTEtMS0w_57772442-ff01-4e23-9522-04024dcb207a"
      unitRef="usd">34307000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if53c990c748f468ba05775d5cf223ac0_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfOTUz_3378d790-83db-427d-9d63-4f729fbb7884">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i1b287ab5933f41b09d0eeee590ddb648_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfMTA2Mg_8a62b1c1-03a0-47c5-ab1a-2f1109a8b820">P21Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfMTE2OA_051dc47c-a7c2-4741-baf5-f8914a9b38a6"
      unitRef="usd">1200000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfNzY5NjU4MTM5NjEzMQ_03c089aa-a6d3-4515-bb1a-b7bc7e84f512"
      unitRef="usd">1100000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfMTI5Nw_bf6dec43-8053-44a1-a52d-437758c2a47d"
      unitRef="usd">3400000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfNzY5NjU4MTM5NjIwMQ_bfefb6f8-d156-4ed8-a17a-c5f83ceef340"
      unitRef="usd">3300000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RleHRyZWdpb246MGNiMjYzZDkzMWNhNDZiNDk4NmEwZTU4MWRjN2U1YjlfMTY1MA_13b61952-28b1-45e5-b864-6118b8d6eb70">&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The estimated amortization expense for approved products, before tax, for the five succeeding years is approximately:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:18.528%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.833%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:18.114%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.833%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.908%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.833%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.908%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.833%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.910%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="margin-top:13pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$4,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,900&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjIyMTg5ZDM1NzI5YTQ4YTdhOWJkYWMyOTc3MTY2N2M5L3RhYmxlcmFuZ2U6MjIxODlkMzU3MjlhNDhhN2E5YmRhYzI5NzcxNjY3YzlfMi0wLTEtMS0w_a70321dd-faa3-498d-8c56-247664d91717"
      unitRef="usd">4500000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjIyMTg5ZDM1NzI5YTQ4YTdhOWJkYWMyOTc3MTY2N2M5L3RhYmxlcmFuZ2U6MjIxODlkMzU3MjlhNDhhN2E5YmRhYzI5NzcxNjY3YzlfMi0yLTEtMS0w_9302a872-5b30-4c95-b6c5-f20db9b537c3"
      unitRef="usd">4300000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjIyMTg5ZDM1NzI5YTQ4YTdhOWJkYWMyOTc3MTY2N2M5L3RhYmxlcmFuZ2U6MjIxODlkMzU3MjlhNDhhN2E5YmRhYzI5NzcxNjY3YzlfMi00LTEtMS0w_49003649-cd05-4073-8e63-89c3a6ea89b2"
      unitRef="usd">4100000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjIyMTg5ZDM1NzI5YTQ4YTdhOWJkYWMyOTc3MTY2N2M5L3RhYmxlcmFuZ2U6MjIxODlkMzU3MjlhNDhhN2E5YmRhYzI5NzcxNjY3YzlfMi02LTEtMS0w_cb20eb4a-f787-4f2a-8791-c55414b0e3ac"
      unitRef="usd">4100000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82MS9mcmFnOjBjYjI2M2Q5MzFjYTQ2YjQ5ODZhMGU1ODFkYzdlNWI5L3RhYmxlOjIyMTg5ZDM1NzI5YTQ4YTdhOWJkYWMyOTc3MTY2N2M5L3RhYmxlcmFuZ2U6MjIxODlkMzU3MjlhNDhhN2E5YmRhYzI5NzcxNjY3YzlfMi04LTEtMS0w_abe9afdb-c699-4256-a64d-49739ae83b5b"
      unitRef="usd">3900000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIxMTk_afb31473-cbd9-44c0-8c97-cca1b1e5ac66">FAIR VALUE MEASUREMENTS&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company uses forward foreign exchange contracts to manage its exposure to the variability of cash flows, primarily related to the foreign exchange rate changes of future intercompany product and third-party purchases of materials denominated in a foreign currency. The Company uses cross currency interest rate swaps to manage currency risk primarily related to borrowings. Both types of derivatives are designated as cash flow hedges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Additionally, the Company uses interest rate swaps as an instrument to manage interest rate risk related to fixed rate borrowings.  These derivatives are designated as fair value hedges. The Company uses cross currency interest rate swaps and forward foreign exchange contracts designated as net investment hedges.  Additionally, the Company uses forward foreign exchange contracts to offset its exposure to certain foreign currency assets and liabilities. These forward foreign exchange contracts are not designated as hedges, and therefore, changes in the fair values of these derivatives are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company does not enter into derivative financial instruments for trading or speculative purposes, or that contain credit risk related contingent features. The Company maintains credit support agreements (CSA) with certain derivative counterparties establishing collateral thresholds based on respective credit ratings and netting agreements. As of September&#160;27, 2020, the total amount of cash collateral held by the Company under the CSA amounted to $380 million, net. On an ongoing basis, the Company monitors counter-party credit ratings. The Company considers credit non-performance risk to be low, because the Company primarily enters into agreements with commercial institutions that have at least an investment grade credit rating.  Refer to the table on significant financial assets and liabilities measured at fair value contained in this footnote for receivables and payables with these commercial institutions. As of September&#160;27, 2020, the Company had notional amounts outstanding for forward foreign exchange contracts and cross currency interest rate swaps of $43.6&#160;billion and $26.5&#160;billion, respectively.  As of December&#160;29, 2019, the Company had notional amounts outstanding for forward foreign exchange contracts and cross currency interest rate swaps of $45.3 billion and $20.1 billion, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;All derivative instruments are recorded on the balance sheet at fair value. Changes in the fair value of derivatives are recorded each period in current earnings or other comprehensive income, depending on whether the derivative is designated as part of a hedge transaction, and if so, the type of hedge transaction.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The designation as a cash flow hedge is made at the entrance date of the derivative contract. At inception, all derivatives are expected to be highly effective. Foreign exchange contracts designated as cash flow hedges are accounted for under the forward method and all gains/losses associated with these contracts will be recognized in the income statement when the hedged item impacts earnings. Changes in the fair value of these derivatives are recorded in accumulated other comprehensive income until the underlying transaction affects earnings and are then reclassified to earnings in the same account as the hedged transaction. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Gains and losses associated with interest rate swaps and changes in fair value of hedged debt attributable to changes in interest rates are recorded to interest expense in the period in which they occur.  Gains and losses on net investment hedges are accounted for through the currency translation account within accumulated other comprehensive income. The portion excluded from effectiveness testing is recorded through interest (income) expense using the spot method. On an ongoing basis, the Company assesses whether each derivative continues to be highly effective in offsetting changes of hedged items. If and when a derivative is no longer expected to be highly effective, hedge accounting is discontinued. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company designated its Euro denominated notes issued in May 2016 with due dates ranging from 2022 to 2035 as a net investment hedge of the Company's investments in certain of its international subsidiaries that use the Euro as their functional currency in order to reduce the volatility caused by changes in exchange rates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of September&#160;27, 2020, the balance of deferred net gain on derivatives included in accumulated other comprehensive income was $811&#160;million after-tax. For additional information, see the Consolidated Statements of Comprehensive Income and Note 7. The Company expects that substantially all of the amounts related to forward foreign exchange contracts will be reclassified into earnings over the next 12 months as a result of transactions that are expected to occur over that period. The maximum length of time over which the Company is hedging transaction exposure is 18 months, excluding interest rate contracts and &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;net investment hedge&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; contracts. The amount ultimately realized in earnings may differ as foreign exchange rates change. Realized gains and losses are ultimately determined by actual exchange rates at maturity of the derivative.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is a summary of the activity related to derivatives and hedges for the fiscal third quarters ended in 2020 and 2019, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:19.102%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.259%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.836%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.547%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.413%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.125%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.970%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.836%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.836%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.413%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.563%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of Products Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;R&amp;amp;D Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (Income) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (Income)  Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of Products Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;R&amp;amp;D Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (Income) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (Income)  Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;The effects of fair value, net investment and cash flow hedging:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain (Loss) on net investment hedging relationship:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross currency interest rate swaps contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain (Loss) on cash flow hedging relationship:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross currency interest rate swaps contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is a summary of the activity related to derivatives and hedges for the fiscal nine months ended in 2020 and 2019, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:18.493%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.302%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.882%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.172%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.172%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.172%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.011%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.172%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.592%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.172%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.760%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of Products Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;R&amp;amp;D Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (Income) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (Income)  Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of Products Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;R&amp;amp;D Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (Income) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (Income)  Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;The effects of fair value, net investment and cash flow hedging:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain (Loss) on net investment hedging relationship:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross currency interest rate swaps contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain (Loss) on cash flow hedging relationship:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(316)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(156)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(543)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross currency interest rate swaps contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:12pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:29.455%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.823%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.689%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.969%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.689%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.992%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.835%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.700%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.548%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is the effect of derivatives not designated as hedging instruments for the fiscal third quarters and fiscal nine months ended in 2020 and 2019: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:27.160%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.698%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.871%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.959%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.494%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.814%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.494%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.494%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.118%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.498%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;br/&gt;Recognized In&lt;br/&gt;Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;br/&gt;Recognized In&lt;br/&gt;Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location of Gain /(Loss) Recognized in Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Third Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign Exchange Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is the effect of net investment hedges for the fiscal third quarters ended in 2020 and 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:21.363%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.524%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.769%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.524%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.769%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.814%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:28.610%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.959%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.769%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.524%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.775%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;br/&gt;Recognized In&lt;br/&gt;Accumulated&lt;br/&gt;OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From&lt;br/&gt;Accumulated OCI&lt;br/&gt;Into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross Currency interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is the effect of net investment hedges for the fiscal nine months ended in 2020 and 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:21.396%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.075%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.785%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.815%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:28.072%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.961%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.930%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.791%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;br/&gt;Recognized In&lt;br/&gt;Accumulated OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From&lt;br/&gt;Accumulated OCI&lt;br/&gt;Into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross Currency interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company holds equity investments with readily determinable fair values and equity investments without readily determinable fair values.  The Company has elected to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is a summary of the activity related to equity investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:25.476%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.001%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.365%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.851%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.464%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.550%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.963%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.851%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.662%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.550%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.667%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;"&gt;Changes in Fair Value Reflected in Net Income &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;"&gt;Sales/ Purchases/Other &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non Current Other Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Equity Investments with readily determinable value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Equity Investments without readily determinable value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;Recorded in Other Income/Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt;padding-left:36pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt; (2)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;Other includes impact of currency&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;For equity investments without readily determinable market values, $48 million of the decrease in the fair value reflected in net income were the result of impairments.  There were $12 million of increase in fair value reflected in net income due to changes in observable prices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Fair value is the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement determined using assumptions that market participants would use in pricing an asset or liability. In accordance with ASC 820, a three-level hierarchy was established to prioritize the inputs used in measuring fair value. The levels within the hierarchy are described below with Level 1 inputs having the highest priority and Level 3 inputs having the lowest.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The fair value of a derivative financial instrument (i.e., forward foreign exchange contracts, interest rate contracts) is the aggregation by currency of all future cash flows discounted to its present value at the prevailing market interest rates and &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;subsequently converted to the U.S. Dollar at the current spot foreign exchange rate. The Company does not believe that fair values of these derivative instruments materially differ from the amounts that could be realized upon settlement or maturity, or that the changes in fair value will have a material effect on the Company&#x2019;s results of operations, cash flows or financial position. The Company also holds equity investments which are classified as Level 1 and debt securities which are classified as Level 2. The Company holds acquisition related contingent liabilities based upon certain regulatory and commercial events, which are classified as Level 3, whose values are determined using discounted cash flow methodologies or similar techniques for which the determination of fair value requires significant judgment or estimations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following three levels of inputs are used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Level 1 &#x2014; Quoted prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Level 2 &#x2014; Significant other observable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Level 3 &#x2014; Significant unobservable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company&#x2019;s significant financial assets and liabilities measured at fair value as of September&#160;27, 2020 and December&#160;29, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:48.229%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.245%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.202%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.904%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.245%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.850%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;"&gt;Total&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Interest rate contracts &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(2)(3)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Interest rate contracts &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(3) &lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Equity investments &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(4)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Debt securities&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(5)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Contingent consideration &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(6)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:42.905%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.992%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:20.098%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.087%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:23.318%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross to Net Derivative Reconciliation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Gross Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Credit Support Agreement (CSA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,117)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(841)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Net Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Gross Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Credit Support Agreement (CSA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(737)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(586)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Net Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Summarized information about changes in liabilities for contingent consideration is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:74.774%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:41.269%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.410%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:25.606%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.406%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:25.609%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Changes in estimated fair value &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(7) &lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:18pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;"&gt;December 30, 2019 assets and liabilities are all classified as Level 2 with the exception of equity investments of $1,148 million, which are classified as Level 1 and contingent consideration of $1,715 million, classified as Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:18pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;"&gt;Includes $1 million of non-current other assets as of December&#160;29, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(3)     &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Includes cross currency interest rate swaps and interest rate swaps.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;           (4)&#160;&#160;&#160;&#160;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Classified as non-current other assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(5)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;Classified within cash equivalents and current marketable securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:18pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(6)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;Includes $608 million and $1,631 million (primarily related to Auris Health at December 29, 2019), classified as non-current other liabilities as of September&#160;27, 2020 and December&#160;29, 2019, respectively.  Includes $28 million and $84 million classified as current liabilities as of September&#160;27, 2020 and December&#160;29, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;           (7)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;    Ongoing fair value adjustment amounts are primarily recorded in Research and Development expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company recorded a contingent consideration reversal of $1,148 million related to the timing of certain developmental milestones associated with the Auris Health acquisition. The reversal of the contingent consideration was recorded in Other income and expense. For additional details see Note 10 &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;t&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;o the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company's cash, cash equivalents and current marketable securities as of September&#160;27, 2020 comprised:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.849%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:22.208%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.727%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.153%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.531%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.153%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.381%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.153%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.727%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.454%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.478%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.153%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.182%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrecognized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrecognized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash &amp;amp; Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Current Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Non-U.S. sovereign securities&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. reverse repurchase agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other reverse repurchase agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Corporate debt securities&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Time deposits&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Subtotal &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. Gov't securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other sovereign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;Subtotal available for sale debt&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total cash, cash equivalents and current marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Held to maturity investments are reported at amortized cost and gains or losses are reported in earnings. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(2) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Available for sale debt securities are reported at fair value with unrealized gains and losses reported net of taxes in other comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In the fiscal year ended December&#160;29, 2019 the carrying amount was the same as the estimated fair value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Fair value of government securities and obligations and corporate debt securities was estimated using quoted broker prices and significant other observable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company classifies all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months from the date of purchase as current marketable securities. Available for sale securities with stated maturities of greater than one year from the date of purchase are available to fund current operations and are classified as cash equivalents and current marketable securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The contractual maturities of the available for sale securities as of September&#160;27, 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:76.426%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:43.104%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:2.829%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:22.279%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.157%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:25.031%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost Basis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Financial Instruments not measured at Fair Value:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following financial liabilities are held at carrying amount on the consolidated balance sheet as of September&#160;27, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:79.838%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.533%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.137%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.533%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.259%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Current Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-Current Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.45% Notes due 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;0.250% Notes due 2022 (1B Euro 1.1641)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.25% Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;6.73% Debentures due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3.375% Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.05% Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;0.650% Notes due 2024 (750MM Euro 1.1641)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5.50% Notes due 2024 (500 MM GBP 1.2757)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.625% Notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;0.55% Notes due 2025&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.45% Notes due 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.95% Notes due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;0.95% Notes due 2027&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.90%&#160;Notes due 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;1.150% Notes due 2028 (750MM Euro 1.1641)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;6.95% Notes due 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;1.30% Notes due 2030&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;4.95% Debentures due 2033&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;4.375% Notes due 2033&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;1.650% Notes due 2035 (1.5B Euro 1.1641)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3.55% Notes due 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5.95% Notes due 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3.625% Notes due 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3.40%&#160;Notes due 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5.85% Debentures due 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;4.50% Debentures due 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.10% Notes due 2040&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;4.85% Notes due 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;4.50% Notes due 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3.70% Notes due 2046&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3.75% Notes due 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3.50% Notes due 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.25% Notes due 2050&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.45% Notes due 2060&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Non-Current Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The weighted average effective interest rate on non-current debt is 2.85%.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:18pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The excess of the estimated fair value over the carrying value of debt was $3.0 billion at December 29, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:18pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The Current Debt balance as of September 27, 2020 includes $3.0&#160;billion of commercial paper which has a weighted average interest rate of 0.15% and a weighted average maturity of 1.2 months. There was no commercial paper as of December 29, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:107%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;In the fiscal third quarter of 2020, the Company issued senior unsecured notes for a total of $7.5&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Fair value of the non-current debt was estimated using market prices, which were corroborated by quoted broker prices and significant other observable inputs.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:CollateralAlreadyPostedAggregateFairValue
      contextRef="i602f0b572b2642298407a8c186b700b3_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTY3Mg_7e190cf0-e6eb-4faf-b5b9-19b8de4b0330"
      unitRef="usd">380000000</us-gaap:CollateralAlreadyPostedAggregateFairValue>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i602f0b572b2642298407a8c186b700b3_I20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMjI2OQ_c32dd89e-83c0-400f-a11b-a610a24a06dd"
      unitRef="usd">43600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2e99b66377d146a5bc59616148618bc1_I20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMjI3Ng_52631cc2-9aef-4b4b-9300-6478a3f17c38"
      unitRef="usd">26500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i757aee8078ce429aba0fb497a4a57b0f_I20191229"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMjQzMQ_e326afe5-1e3e-4f46-b5ae-74149d68da7a"
      unitRef="usd">45300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6caa54ad7b144dcca2cb08b4b3dab964_I20191229"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMjQzOA_12beea9b-36c9-4400-96f6-761f29b8ac99"
      unitRef="usd">20100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfNDU2OQ_1c6eb287-b186-4c46-99c3-a9660f45da6a"
      unitRef="usd">-811000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:DescriptionOfReclassificationOfCashFlowHedgeGainLoss
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfNDgyNw_c90b8a4c-a369-44b3-9624-93856d2819f3">next 12 months</us-gaap:DescriptionOfReclassificationOfCashFlowHedgeGainLoss>
    <us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfNDk4OA_9e8cc91f-06aa-4014-8d8b-f61fe22a61d9">P18M</us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIwMzE_2474f013-6a7f-4499-8511-b58d18c437b5">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is a summary of the activity related to derivatives and hedges for the fiscal third quarters ended in 2020 and 2019, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:19.102%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.259%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.836%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.547%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.413%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.125%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.970%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.836%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.836%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.413%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.563%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of Products Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;R&amp;amp;D Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (Income) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (Income)  Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of Products Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;R&amp;amp;D Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (Income) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (Income)  Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;The effects of fair value, net investment and cash flow hedging:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain (Loss) on net investment hedging relationship:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross currency interest rate swaps contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain (Loss) on cash flow hedging relationship:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross currency interest rate swaps contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is a summary of the activity related to derivatives and hedges for the fiscal nine months ended in 2020 and 2019, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:18.493%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.302%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.882%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.172%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.172%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.172%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.011%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.172%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.592%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.172%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.760%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of Products Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;R&amp;amp;D Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (Income) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (Income)  Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of Products Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;R&amp;amp;D Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (Income) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (Income)  Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;The effects of fair value, net investment and cash flow hedging:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain (Loss) on net investment hedging relationship:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross currency interest rate swaps contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain (Loss) on cash flow hedging relationship:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(316)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(156)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(543)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross currency interest rate swaps contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is the effect of net investment hedges for the fiscal third quarters ended in 2020 and 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:21.363%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.524%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.769%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.524%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.769%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.814%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:28.610%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.959%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.769%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.524%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.775%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;br/&gt;Recognized In&lt;br/&gt;Accumulated&lt;br/&gt;OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From&lt;br/&gt;Accumulated OCI&lt;br/&gt;Into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross Currency interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is the effect of net investment hedges for the fiscal nine months ended in 2020 and 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:21.396%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.075%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.785%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.815%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:28.072%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.961%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.930%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.791%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;br/&gt;Recognized In&lt;br/&gt;Accumulated OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From&lt;br/&gt;Accumulated OCI&lt;br/&gt;Into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross Currency interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i5ca4ea76af704d238626f606c2f2e2e8_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtMS0xLTEtMA_55b909a3-ed5c-42ad-b882-c0b65d298803"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i83cd1045196f4066b8afc93059b316f1_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtMi0xLTEtMA_7dcd781e-a0e6-41c7-bc96-78266768f345"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i48769359a9544223b2b381ebae848550_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtMy0xLTEtMA_64e44393-3ce7-44d9-a120-074b3b1cb220"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="idaae72c759e44c0aa87a7f502152047c_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtNC0xLTEtMA_3c3514ef-e55b-477b-8078-7ec46027367a"
      unitRef="usd">39000000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="ie75c8583c4cb4e56a35e19da1d9c0fd3_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtNS0xLTEtMA_6f94a20b-d20c-49eb-b5a8-9e6b0f9048a1"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i4cdbac75c4d1489bad27bcb720ec8453_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtNi0xLTEtMA_18037f1d-cdd7-4f28-aad7-222225645381"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i050dea3d0ebc4bb39fdec4f937d89696_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtNy0xLTEtMA_8935aa74-95a1-4a91-80a9-714a78e42e1c"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i284822c0f6cd4ad4a13ee1cb4f3bbce6_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtOC0xLTEtMA_5b329035-60f0-4a27-a4d1-7cc91e2da303"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="id52cfbe2faf44e1db50daba2fb27ff4a_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtOS0xLTEtMA_369e038e-05e7-429d-a42e-ec286f5e23ce"
      unitRef="usd">39000000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i617cd2e5232f4d6481542c77f053e8a4_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTMtMTAtMS0xLTA_4b204f45-2d5c-4004-96b9-a1542247e13d"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i5ca4ea76af704d238626f606c2f2e2e8_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtMS0xLTEtMA_d3251f99-7ccc-4081-97b9-5c091dfc738b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i83cd1045196f4066b8afc93059b316f1_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtMi0xLTEtMA_dc421062-56a5-421e-9311-86adffabec81"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i48769359a9544223b2b381ebae848550_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtMy0xLTEtMA_9ff383aa-6b27-46f6-878d-45e76440e341"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="idaae72c759e44c0aa87a7f502152047c_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtNC0xLTEtMA_67c6bb92-bbf6-4dbe-9907-0a425acfde25"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ie75c8583c4cb4e56a35e19da1d9c0fd3_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtNS0xLTEtMA_25e695f5-b068-4307-b0c1-f16bb875d44b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i4cdbac75c4d1489bad27bcb720ec8453_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtNi0xLTEtMA_5c55071a-6819-499e-a96f-c2ac5e2c0c5d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i050dea3d0ebc4bb39fdec4f937d89696_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtNy0xLTEtMA_54536791-e788-4fb1-bc9a-dc2aa3003df6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i284822c0f6cd4ad4a13ee1cb4f3bbce6_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtOC0xLTEtMA_510e8a51-a06d-46d0-85c7-902d6bcb23d1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="id52cfbe2faf44e1db50daba2fb27ff4a_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtOS0xLTEtMA_e0174639-706e-45a8-bb64-1e492125f822"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i617cd2e5232f4d6481542c77f053e8a4_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTQtMTAtMS0xLTA_8ac6a81a-cf6b-49c3-80df-9ab8736a8e8b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i1025e2524ffe4b48931a58f4b78c7f2d_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtMS0xLTEtMA_62b14444-3a89-4a1c-b5f1-2e6a8212aae4"
      unitRef="usd">3000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i9bb6927b7d714bc09b33449c20da1770_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtMi0xLTEtMA_d8e0f745-94ee-4881-8dab-151b8e513318"
      unitRef="usd">-81000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i6b83b2d252c447a2ba19f24dd30e3a65_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtMy0xLTEtMA_70f22e30-67fe-4ffa-86f9-bd19af6cb730"
      unitRef="usd">-13000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i3e39ee9dee804ae5bee2adb6bb8d7288_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtNC0xLTEtMA_164a3344-72b3-4ba6-be19-46ba1ab46468"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ic36d3ae76596417b9c30e054d1545171_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtNS0xLTEtMA_45a7cdfa-1f69-4a1c-8466-d2a08f533e07"
      unitRef="usd">-8000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i47fda4f228854b19a6da483cbeb232ad_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtNi0xLTEtMA_15d5d3e8-9a95-4b1c-9790-1132087f3c38"
      unitRef="usd">-8000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ie01d8f5ff2bc4b4682da0fc787c482ec_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtNy0xLTEtMA_90788a46-bdac-49af-ac3c-c4fd4a3320d2"
      unitRef="usd">-77000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ia68d65479ce04918b459702f999497d0_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtOC0xLTEtMA_fc46901b-a24d-4cd0-9735-12ffb2bb5fb2"
      unitRef="usd">1911000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ic909e487ce0146d4a1a529a11bf4b714_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtOS0xLTEtMA_f3cf1c08-bc24-44d3-99b5-a61bdf13989c"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ifcb888be82354cb9a97b576afd3ebbf7_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMTgtMTAtMS0xLTA_fec63794-746f-44d4-8ef5-d2b764cff547"
      unitRef="usd">1000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i1025e2524ffe4b48931a58f4b78c7f2d_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItMS0xLTEtMA_4613a4b6-7acd-4b71-be25-1ac34404e6cb"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i9bb6927b7d714bc09b33449c20da1770_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItMi0xLTEtMA_b017949e-5253-45c0-81c6-81323e623484"
      unitRef="usd">156000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i6b83b2d252c447a2ba19f24dd30e3a65_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItMy0xLTEtMA_8fcc55d2-c57f-4116-adec-5633d847653c"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i3e39ee9dee804ae5bee2adb6bb8d7288_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItNC0xLTEtMA_d04bebcb-6f15-40c9-848f-971c70196cd6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ic36d3ae76596417b9c30e054d1545171_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItNS0xLTEtMA_a2e00250-08aa-400c-89d0-c6a5bb64a8b9"
      unitRef="usd">-41000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i47fda4f228854b19a6da483cbeb232ad_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItNi0xLTEtMA_9c852968-98a1-41ca-9aaf-6d45773caef6"
      unitRef="usd">-23000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ie01d8f5ff2bc4b4682da0fc787c482ec_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItNy0xLTEtMA_a25148e2-f12a-4d6e-95c3-4c68da7f791f"
      unitRef="usd">-197000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ia68d65479ce04918b459702f999497d0_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItOC0xLTEtMA_7adfd155-23dc-4daa-98aa-c09d7aa7c751"
      unitRef="usd">1939000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ic909e487ce0146d4a1a529a11bf4b714_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItOS0xLTEtMA_3d484468-6e6a-43ef-92b2-6accaf82723b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ifcb888be82354cb9a97b576afd3ebbf7_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjItMTAtMS0xLTA_359e7f42-dd3e-4c30-9432-c6aaeba30ca7"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i622f3878a0cb45db81deff9052aa0056_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtMS0xLTEtMA_ce68361a-65ac-4dd8-882e-d39ff1966bdc"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i8b7b0c17478b4846abf9b2e8b4cc1801_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtMi0xLTEtMA_6358ec84-c6da-46d1-ae53-42f112be377a"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="idc70d684244d4d12a5436ed3961b9126_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtMy0xLTEtMA_a4190cb7-35f0-49be-9844-ed91c4703f1b"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i6882d65422ca4fe5ba1de209627b9d21_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtNC0xLTEtMA_df0a51cb-3d2c-4198-9403-0b322eefed5d"
      unitRef="usd">84000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ic9e976af5cc446eebaf01b985dbc4a42_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtNS0xLTEtMA_ed6ab102-2057-4b34-ab82-2dbd9d6ef745"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i2a09f1a4ea2c46e6b142985640accc45_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtNi0xLTEtMA_97befcaa-041c-48db-b91c-37853c9e34ff"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="if1382ae0806f411facc9962211302f96_D20190701-20190929"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtNy0xLTEtMA_7696e653-5ea3-4501-a0c0-956ed5b6ab8b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ifca93b84479747ca8e694826d35cf5f8_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtOC0xLTEtMA_081e124b-e61b-42c7-84a4-2f343828467d"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i59bb85378baf48b8aad7ccdddb9509d9_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtOS0xLTEtMA_d03acbb1-a0e4-4b3a-be1e-3736a4154ca7"
      unitRef="usd">89000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i901027a3abc14517a3a903a087117d8c_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjUtMTAtMS0xLTA_556f1b16-3def-47f7-b326-1351f57a3259"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i622f3878a0cb45db81deff9052aa0056_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctMS0xLTEtMA_f157ba42-5df3-4d2d-b60c-ed4b89a2eace"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i8b7b0c17478b4846abf9b2e8b4cc1801_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctMi0xLTEtMA_012d44b0-90d8-4dab-9431-91c8774404d7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="idc70d684244d4d12a5436ed3961b9126_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctMy0xLTEtMA_c33655b5-b2c4-46f3-94d2-4165b116e16c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i6882d65422ca4fe5ba1de209627b9d21_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctNC0xLTEtMA_5f3c4d9d-b34e-47f0-98d7-0778c4b803d2"
      unitRef="usd">65000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ic9e976af5cc446eebaf01b985dbc4a42_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctNS0xLTEtMA_e08b52bc-2bf6-4e88-973f-1a087477eba3"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i2a09f1a4ea2c46e6b142985640accc45_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctNi0xLTEtMA_c4f02f51-b20d-44a5-86c4-c05e6874efa9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="if1382ae0806f411facc9962211302f96_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctNy0xLTEtMA_07191ec4-5063-4bb9-9c4c-3e9f19ecadc2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ifca93b84479747ca8e694826d35cf5f8_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctOC0xLTEtMA_c00dc4b0-7408-4a29-99a7-288e3e62ce26"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i59bb85378baf48b8aad7ccdddb9509d9_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctOS0xLTEtMA_7974cc37-f9b8-475e-bd19-976df11ce10b"
      unitRef="usd">159000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i901027a3abc14517a3a903a087117d8c_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmMyNGM5MjAzMWIyMDRhZWE5YTMyOTc2ODUxMmJlY2QxL3RhYmxlcmFuZ2U6YzI0YzkyMDMxYjIwNGFlYTlhMzI5NzY4NTEyYmVjZDFfMjctMTAtMS0xLTA_938424c2-4f5c-4440-887b-da02149d7b4b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i29f87aaf8f2a484fafdef882e2e279a3_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtMS0xLTEtMA_510c846b-71ca-4556-9a81-255c68859513"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i7428937974c844969210c80b4d1269bb_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtMi0xLTEtMA_ecb86b2c-2e4a-4792-872c-78935443bda1"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i758bf9c10aaa4c5b85d3f371f710849d_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtMy0xLTEtMA_dec3933a-5633-4488-9728-fa25d7d027cf"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i6f3e6000257046239c2aa58024508811_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtNC0xLTEtMA_db77ddec-db14-4c68-b6df-22ee518e8059"
      unitRef="usd">118000000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i61bf4b75f5dc4a5d90e74e58ea5c592f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtNS0xLTEtMA_abf74730-18d5-47ef-8427-22c49eaba211"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i639cb007bfcd4af88897696baacb9819_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtNi0xLTEtMA_52d54bea-55a1-4350-9f85-1e0dcab56d0e"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i4251ad0c6ca846ebb628818d56f1251a_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtNy0xLTEtMA_1c4c6600-21f5-4d79-b3e4-0941c4d98385"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="ia4f491ac1fa844caacdc4e58ecd253f6_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtOC0xLTEtMA_cec6a7a0-b778-4c7a-adbc-d9eff33eed4c"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i32bc7bed7811453990b8957e62697591_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtOS0xLTEtMA_7d3a6acb-e125-48e1-97bb-e2cc049d8ccb"
      unitRef="usd">117000000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i292a1d5f47644ba2864bd3beb562b985_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTMtMTAtMS0xLTA_4e66075a-ed17-4e81-bbcd-003720ded949"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i29f87aaf8f2a484fafdef882e2e279a3_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtMS0xLTEtMA_07d1d059-fafc-4e1c-9cd1-6be99747e549"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i7428937974c844969210c80b4d1269bb_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtMi0xLTEtMA_538867c0-4c36-40a1-853d-34f025c8a686"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i758bf9c10aaa4c5b85d3f371f710849d_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtMy0xLTEtMA_d2aa8dbc-715d-4f0e-af3a-ff914db82580"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i6f3e6000257046239c2aa58024508811_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtNC0xLTEtMA_f7c98422-4111-4035-b641-4c15c3086352"
      unitRef="usd">118000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i61bf4b75f5dc4a5d90e74e58ea5c592f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtNS0xLTEtMA_03b1909a-5434-4529-a814-96a8d57c01dc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i639cb007bfcd4af88897696baacb9819_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtNi0xLTEtMA_2699b6c1-f74e-4e26-b8c7-d8ca0cb293cb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i4251ad0c6ca846ebb628818d56f1251a_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtNy0xLTEtMA_885d2cac-7404-4548-ab9f-ddac65207092"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ia4f491ac1fa844caacdc4e58ecd253f6_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtOC0xLTEtMA_8227005e-c1f4-4473-b75c-43cc2f300a2a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i32bc7bed7811453990b8957e62697591_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtOS0xLTEtMA_1ebb3460-1a80-4658-8069-cc3726dcd8b7"
      unitRef="usd">117000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i292a1d5f47644ba2864bd3beb562b985_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTQtMTAtMS0xLTA_e31c73a6-6262-46ed-b2e1-1d47f964829e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i01029a1173314478b27e2a88c1698d60_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtMS0xLTEtMA_faa14828-cefe-44d6-a125-372bf3d922c5"
      unitRef="usd">10000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ie0ba4e704712428ca90c45899f493ec2_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtMi0xLTEtMA_30f07bba-d30c-4a27-a01e-459bb314c330"
      unitRef="usd">-316000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i0e6b13cc13d249cea0793a26e097bf2b_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtMy0xLTEtMA_1ef49e45-a444-4f79-ae6e-c9a2c77cd494"
      unitRef="usd">-121000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="idb79bc61a7fd4785baa0abe8babcf4e9_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtNC0xLTEtMA_29d305a4-2d87-4ece-8920-42d7c7efce3f"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i192bf62c991e495aacd95b6a130d406f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtNS0xLTEtMA_f9db04bd-077b-489a-a1b0-56bd1100b843"
      unitRef="usd">-10000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ice1f7153b23149e6b9bdf5779859e8cf_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtNi0xLTEtMA_bb4e5381-e97b-4175-90df-2280e09eef14"
      unitRef="usd">-43000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i2f095d9205a94f68b57c820821576001_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtNy0xLTEtMA_89b51181-32fc-4364-b83e-7f6bbb463606"
      unitRef="usd">-213000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i4ec08d548cc34c89bc05df02e4c29100_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtOC0xLTEtMA_1afc100c-c3bf-423b-9539-d6ca2cfd961d"
      unitRef="usd">1808000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i6d1186e0f9dd4e6cbaa910c65af648f8_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtOS0xLTEtMA_63df4a8c-aa1d-4620-8a75-25438530d6b4"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i350db5668e464af6b375c3b4bbd5f0e8_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMTgtMTAtMS0xLTA_cfc52244-197a-4a79-9c4a-e9ec4bdfee63"
      unitRef="usd">9000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i01029a1173314478b27e2a88c1698d60_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItMS0xLTEtMA_c049f020-0828-4d26-b352-c0cc04b74c0e"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ie0ba4e704712428ca90c45899f493ec2_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItMi0xLTEtMA_5a52e211-501d-4909-8ec4-8d6185c9c27e"
      unitRef="usd">330000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i0e6b13cc13d249cea0793a26e097bf2b_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItMy0xLTEtMA_7bf428c7-e7c3-4fb7-86d2-d948734d0d0f"
      unitRef="usd">-156000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="idb79bc61a7fd4785baa0abe8babcf4e9_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItNC0xLTEtMA_6190fce5-ff46-45a2-875d-31f9b615d828"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i192bf62c991e495aacd95b6a130d406f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItNS0xLTEtMA_53e4028b-f495-4aae-b324-97db4f284f67"
      unitRef="usd">-55000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ice1f7153b23149e6b9bdf5779859e8cf_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItNi0xLTEtMA_330ed7ad-5735-490f-8b34-ae2485959cc6"
      unitRef="usd">-29000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i2f095d9205a94f68b57c820821576001_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItNy0xLTEtMA_30e30eb7-a918-428b-9bc0-e71a80e91591"
      unitRef="usd">-543000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i4ec08d548cc34c89bc05df02e4c29100_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItOC0xLTEtMA_2cac8936-2af3-4bbd-8f12-ccc440348c25"
      unitRef="usd">1847000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i6d1186e0f9dd4e6cbaa910c65af648f8_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItOS0xLTEtMA_6f0e6aeb-5423-4704-bca7-62f8a8e61aae"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i350db5668e464af6b375c3b4bbd5f0e8_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjItMTAtMS0xLTA_7ef021e7-aa90-4f78-af76-a902f0567fc7"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="iaac6fa6375624cbf89f14f995817172f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtMS0xLTEtMA_bba7bbba-e1c5-46af-ba75-669c1ed9519a"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i1d932d154b6049149af36416558320a0_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtMi0xLTEtMA_b7519e58-6293-4a57-b026-9e301babafce"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i6e091eab1cd14f03b93bd9d094df209a_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtMy0xLTEtMA_9be76cb0-a2af-45f5-b3df-d28d60a4dc07"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i372abf170594420094ccb2d5bcf0ec43_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtNC0xLTEtMA_2ece6a7b-59a7-4605-aa83-b55c44624cf2"
      unitRef="usd">265000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i2e53d4b575e548578cb08588b7acfcac_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtNS0xLTEtMA_d0205e95-e4f5-45ee-925f-6ce86e88c0e8"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i1c3a289ef5b14159b92eb7f4023a3e8d_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtNi0xLTEtMA_3d47fbcc-48e0-4871-a1f8-871094dad237"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i54d1f30235984b0d92230944638bbefc_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtNy0xLTEtMA_16c26425-5964-4235-b930-5c3e68b402fc"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i7a1e39c45d4d40a5aeeb99e4ac32a934_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtOC0xLTEtMA_3c68598a-9679-4d86-8af9-4905279a243c"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i8d23a00fc837488e8322cd4fa9f6eb80_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtOS0xLTEtMA_5a8093ac-8e56-4697-b11a-ef787c7ffc45"
      unitRef="usd">207000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i9954b9535f4046ada0661eb9c93f272f_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjUtMTAtMS0xLTA_01523deb-d6d8-4eaf-9dad-305f6bead28a"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="iaac6fa6375624cbf89f14f995817172f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctMS0xLTEtMA_f6a973b6-faac-412a-a711-86b720ea0739"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i1d932d154b6049149af36416558320a0_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctMi0xLTEtMA_1c47b04d-a32c-414b-856b-c521afd3b3e1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i6e091eab1cd14f03b93bd9d094df209a_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctMy0xLTEtMA_184effa2-c488-42bf-821b-d59a17781c49"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i372abf170594420094ccb2d5bcf0ec43_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctNC0xLTEtMA_2feb36ff-95b8-4635-8ced-151a49e500b2"
      unitRef="usd">790000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i2e53d4b575e548578cb08588b7acfcac_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctNS0xLTEtMA_a3dab2bf-2825-4539-ada3-8fa8d4e7b028"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i1c3a289ef5b14159b92eb7f4023a3e8d_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctNi0xLTEtMA_003d896f-feb6-4242-971b-1f348b97a412"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i54d1f30235984b0d92230944638bbefc_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctNy0xLTEtMA_bdcb4c1e-b3d0-40be-8a79-1ca91392d025"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i7a1e39c45d4d40a5aeeb99e4ac32a934_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctOC0xLTEtMA_ac413291-2135-4d58-96a9-8b5d6be06f1a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i8d23a00fc837488e8322cd4fa9f6eb80_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctOS0xLTEtMA_9c336211-1769-46df-8d65-a4145bf4e4b6"
      unitRef="usd">299000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i9954b9535f4046ada0661eb9c93f272f_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjA4YWQ5M2Q4ZDcxZDQ5MjY5ZmFjNTQ1MDczNWQ4M2IwL3RhYmxlcmFuZ2U6MDhhZDkzZDhkNzFkNDkyNjlmYWM1NDUwNzM1ZDgzYjBfMjctMTAtMS0xLTA_b3a99f24-1501-402f-bd8e-98bb62a377a6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIwNTM_30c78f66-7084-46f8-b0d7-748973caa048"
      xsi:nil="true"/>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIwNDQ_0c75a326-b0eb-41b5-a90d-5c1433905c16">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:27.160%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.698%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.871%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.959%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.494%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.814%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.494%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.494%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.118%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.498%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;br/&gt;Recognized In&lt;br/&gt;Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;br/&gt;Recognized In&lt;br/&gt;Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location of Gain /(Loss) Recognized in Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Third Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign Exchange Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="idbc5ce6f7f184806bd9942142222b820_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjU2ZDkxNDFhMDYzNTQ0OTM5NmU4Y2QyMjgwMGNkOGM3L3RhYmxlcmFuZ2U6NTZkOTE0MWEwNjM1NDQ5Mzk2ZThjZDIyODAwY2Q4YzdfNC00LTEtMS0w_e313a9ba-fe3c-4551-be94-d4ef2c205cbc"
      unitRef="usd">1000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i1c0ed7d0f118415182ad2034719558ca_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjU2ZDkxNDFhMDYzNTQ0OTM5NmU4Y2QyMjgwMGNkOGM3L3RhYmxlcmFuZ2U6NTZkOTE0MWEwNjM1NDQ5Mzk2ZThjZDIyODAwY2Q4YzdfNC02LTEtMS0w_3fea878b-76a4-449e-b101-21493aa5647d"
      unitRef="usd">-13000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ia4f1f0010d2342a8967ad0c59c55d4ec_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjU2ZDkxNDFhMDYzNTQ0OTM5NmU4Y2QyMjgwMGNkOGM3L3RhYmxlcmFuZ2U6NTZkOTE0MWEwNjM1NDQ5Mzk2ZThjZDIyODAwY2Q4YzdfNC03LTEtMS0w_397ac1e7-adbf-47ac-804a-695015faebc3"
      unitRef="usd">66000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i227f787e18a34f9bb38cccba24d02a79_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjU2ZDkxNDFhMDYzNTQ0OTM5NmU4Y2QyMjgwMGNkOGM3L3RhYmxlcmFuZ2U6NTZkOTE0MWEwNjM1NDQ5Mzk2ZThjZDIyODAwY2Q4YzdfNC05LTEtMS0w_5d3d718f-e78f-40eb-b6c7-55eb8c7492f9"
      unitRef="usd">-101000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjc4M2FmOWU3YWY2ZTQ0YjNhYTdhNDYwNjJjN2NkMzQ4L3RhYmxlcmFuZ2U6NzgzYWY5ZTdhZjZlNDRiM2FhN2E0NjA2MmM3Y2QzNDhfMy0yLTEtMS0w_0d1b17de-a9e2-4e12-8268-218f02403d8b"
      unitRef="usd">-169000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjc4M2FmOWU3YWY2ZTQ0YjNhYTdhNDYwNjJjN2NkMzQ4L3RhYmxlcmFuZ2U6NzgzYWY5ZTdhZjZlNDRiM2FhN2E0NjA2MmM3Y2QzNDhfMy00LTEtMS0w_7c082343-23e7-4fe8-8a9b-94f1bf130501"
      unitRef="usd">162000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i7af68fed7c3b4b4c8cd6739097abf04a_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjc4M2FmOWU3YWY2ZTQ0YjNhYTdhNDYwNjJjN2NkMzQ4L3RhYmxlcmFuZ2U6NzgzYWY5ZTdhZjZlNDRiM2FhN2E0NjA2MmM3Y2QzNDhfMy04LTEtMS0w_035ab332-3ec8-480e-8b7e-24f9750452f8"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i5a666010da7f4d2eb9c1b6cf6bd24a16_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjc4M2FmOWU3YWY2ZTQ0YjNhYTdhNDYwNjJjN2NkMzQ4L3RhYmxlcmFuZ2U6NzgzYWY5ZTdhZjZlNDRiM2FhN2E0NjA2MmM3Y2QzNDhfMy0xMC0xLTEtMA_6c0a5f10-548d-4c3f-b0f0-827bcf7495e7"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i468e8ec1c58344b5a45790f5c51e8c09_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjc4M2FmOWU3YWY2ZTQ0YjNhYTdhNDYwNjJjN2NkMzQ4L3RhYmxlcmFuZ2U6NzgzYWY5ZTdhZjZlNDRiM2FhN2E0NjA2MmM3Y2QzNDhfNC0yLTEtMS0w_0621337a-48b4-4684-a286-73d38d78d166"
      unitRef="usd">-234000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i4ab4dfe0a05c498895f727f1d1cdb016_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjc4M2FmOWU3YWY2ZTQ0YjNhYTdhNDYwNjJjN2NkMzQ4L3RhYmxlcmFuZ2U6NzgzYWY5ZTdhZjZlNDRiM2FhN2E0NjA2MmM3Y2QzNDhfNC00LTEtMS0w_170b950a-17e2-4bd5-82f8-094fd06b4be9"
      unitRef="usd">152000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ida55a615e74b412f9e17f752df014784_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjc4M2FmOWU3YWY2ZTQ0YjNhYTdhNDYwNjJjN2NkMzQ4L3RhYmxlcmFuZ2U6NzgzYWY5ZTdhZjZlNDRiM2FhN2E0NjA2MmM3Y2QzNDhfNC04LTEtMS0w_b307eb60-26c3-4e98-87f6-fc306e9ae764"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ia08c2e302e194315ab73624c233b25e5_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjc4M2FmOWU3YWY2ZTQ0YjNhYTdhNDYwNjJjN2NkMzQ4L3RhYmxlcmFuZ2U6NzgzYWY5ZTdhZjZlNDRiM2FhN2E0NjA2MmM3Y2QzNDhfNC0xMC0xLTEtMA_50e2dd3a-c1d4-423b-a0d1-158c2d0e0a47"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmU0MWFjOTljNTRlOTQ0M2JhOGNjYzc3OThjNzkxYTU5L3RhYmxlcmFuZ2U6ZTQxYWM5OWM1NGU5NDQzYmE4Y2NjNzc5OGM3OTFhNTlfNC0yLTEtMS0w_28371a27-07a2-4555-976f-42091ba1b400"
      unitRef="usd">-217000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmU0MWFjOTljNTRlOTQ0M2JhOGNjYzc3OThjNzkxYTU5L3RhYmxlcmFuZ2U6ZTQxYWM5OWM1NGU5NDQzYmE4Y2NjNzc5OGM3OTFhNTlfNC00LTEtMS0w_09a37aa3-2a19-4e42-a876-85eb686b3e5f"
      unitRef="usd">176000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ia6e8354567bd4a978607e65d30a26741_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmU0MWFjOTljNTRlOTQ0M2JhOGNjYzc3OThjNzkxYTU5L3RhYmxlcmFuZ2U6ZTQxYWM5OWM1NGU5NDQzYmE4Y2NjNzc5OGM3OTFhNTlfNC04LTEtMS0w_5aad3d32-d7ce-4416-bc93-e15eb641691f"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i43f2992b3ca941c3ad80001e95066a6b_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmU0MWFjOTljNTRlOTQ0M2JhOGNjYzc3OThjNzkxYTU5L3RhYmxlcmFuZ2U6ZTQxYWM5OWM1NGU5NDQzYmE4Y2NjNzc5OGM3OTFhNTlfNC0xMC0xLTEtMA_cbf705f9-738b-4cb2-be19-bbc80e677489"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i5173f4423f0449ce945bc91eb4676e98_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmU0MWFjOTljNTRlOTQ0M2JhOGNjYzc3OThjNzkxYTU5L3RhYmxlcmFuZ2U6ZTQxYWM5OWM1NGU5NDQzYmE4Y2NjNzc5OGM3OTFhNTlfNS0yLTEtMS0w_513ed814-cb90-436d-b295-c49ae9e62d40"
      unitRef="usd">407000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i8abc68185a784fcca778998cec6761df_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmU0MWFjOTljNTRlOTQ0M2JhOGNjYzc3OThjNzkxYTU5L3RhYmxlcmFuZ2U6ZTQxYWM5OWM1NGU5NDQzYmE4Y2NjNzc5OGM3OTFhNTlfNS00LTEtMS0w_5056c7a5-c5fe-4e0f-9ed4-c2a049f66424"
      unitRef="usd">465000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i095e59b2969f4ed8b53a10dc8c2219bc_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmU0MWFjOTljNTRlOTQ0M2JhOGNjYzc3OThjNzkxYTU5L3RhYmxlcmFuZ2U6ZTQxYWM5OWM1NGU5NDQzYmE4Y2NjNzc5OGM3OTFhNTlfNS04LTEtMS0w_2f59b140-9c12-4a25-8dd7-36f9bfb3e8b1"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i4e85a98890fd4f78b3493cdc6bbec1d5_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmU0MWFjOTljNTRlOTQ0M2JhOGNjYzc3OThjNzkxYTU5L3RhYmxlcmFuZ2U6ZTQxYWM5OWM1NGU5NDQzYmE4Y2NjNzc5OGM3OTFhNTlfNS0xMC0xLTEtMA_6c129029-1ead-42c0-bb13-87c5627cfd74"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIwMzM_9704a77d-ff02-44f2-9f94-1c3097a582c6">&lt;div style="margin-bottom:7pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is a summary of the activity related to equity investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:25.476%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.001%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.365%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.851%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.464%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.550%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.963%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.851%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.662%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.550%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.667%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;"&gt;Changes in Fair Value Reflected in Net Income &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;"&gt;Sales/ Purchases/Other &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non Current Other Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Equity Investments with readily determinable value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(169)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Equity Investments without readily determinable value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;Recorded in Other Income/Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt;padding-left:36pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt; (2)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;Other includes impact of currency&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i8c27b77222684cf6918b97cd45fc5ace_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfMi0yLTEtMS0w_d0578b79-c266-4802-8e25-65214f4a1ec8"
      unitRef="usd">1148000000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:EquityFairValueAdjustment
      contextRef="if0c4a4ae70f84c9bbbc600bb0718afe2_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfMi00LTEtMS0w_5ab3f1d6-631a-4687-9701-da40105b18fe"
      unitRef="usd">161000000</us-gaap:EquityFairValueAdjustment>
    <jnj:EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod
      contextRef="if0c4a4ae70f84c9bbbc600bb0718afe2_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfMi02LTEtMS0w_fb5fd23d-a820-4386-929e-ae2958159b42"
      unitRef="usd">-169000000</jnj:EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i24df639c9fc04ceeb8bd2cfaeedf32ae_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfMi04LTEtMS0w_c2551938-2861-4ae9-9a03-770cb8ed56e8"
      unitRef="usd">1140000000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i24df639c9fc04ceeb8bd2cfaeedf32ae_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfMi0xMC0xLTEtMA_c0acf3f7-3669-4f19-a7d1-fd51fd26438c"
      unitRef="usd">1140000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i0439badcd60b4553a7b6551b725bd8d8_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfNC0yLTEtMS0w_4922b710-a12b-44ab-8f0f-50e8e67e7257"
      unitRef="usd">712000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquityFairValueAdjustment
      contextRef="i8128a659f3a049a29db2519c8d080e12_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfNC00LTEtMS0w_3b21393d-7035-45df-bcab-4fdada1d70a6"
      unitRef="usd">-36000000</us-gaap:EquityFairValueAdjustment>
    <jnj:EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod
      contextRef="i8128a659f3a049a29db2519c8d080e12_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfNC02LTEtMS0w_3f1da12c-1de8-4a55-8487-880c1723f5a9"
      unitRef="usd">66000000</jnj:EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ia3f03d1d353d4af1b97302c91561ce50_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfNC04LTEtMS0w_bb2ae7f5-1bf0-4c8a-a605-e5ae8de64a82"
      unitRef="usd">742000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia3f03d1d353d4af1b97302c91561ce50_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjFlNTdmNTBmOWQ3YTQ0MDhiNWE2MmE3YjVhN2Q4ZTk0L3RhYmxlcmFuZ2U6MWU1N2Y1MGY5ZDdhNDQwOGI1YTYyYTdiNWE3ZDhlOTRfNC0xMC0xLTEtMA_916680b2-1202-4302-a9f4-d1513d32b0c6"
      unitRef="usd">742000000</us-gaap:OtherAssetsNoncurrent>
    <jnj:EquityFairValueAdjustmentImpairmentLoss
      contextRef="i8128a659f3a049a29db2519c8d080e12_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfNjUxMg_7feea5d4-ad9b-4874-bfca-49bf018f96f3"
      unitRef="usd">-48000000</jnj:EquityFairValueAdjustmentImpairmentLoss>
    <jnj:EquityFairValueAdjustmentChangeInObservablePrice
      contextRef="i8128a659f3a049a29db2519c8d080e12_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfNjYxNw_55ec054c-ebf6-46f7-80c0-7c596f0ef35c"
      unitRef="usd">12000000</jnj:EquityFairValueAdjustmentChangeInObservablePrice>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIwOTc_d78d8092-0376-4fb5-b40a-84e1d1361c3b">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company&#x2019;s significant financial assets and liabilities measured at fair value as of September&#160;27, 2020 and December&#160;29, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:48.229%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.245%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.202%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.904%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.245%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.850%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;"&gt;Total&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Interest rate contracts &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(2)(3)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Interest rate contracts &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(3) &lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Equity investments &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(4)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Debt securities&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(5)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Contingent consideration &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(6)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:42.905%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.992%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:20.098%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.087%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:23.318%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross to Net Derivative Reconciliation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Gross Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Credit Support Agreement (CSA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,117)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(841)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Net Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Gross Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Credit Support Agreement (CSA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(737)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(586)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Net Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Summarized information about changes in liabilities for contingent consideration is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:74.774%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:41.269%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.410%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:25.606%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.406%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:25.609%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Changes in estimated fair value &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(7) &lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,088)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:18pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;"&gt;December 30, 2019 assets and liabilities are all classified as Level 2 with the exception of equity investments of $1,148 million, which are classified as Level 1 and contingent consideration of $1,715 million, classified as Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:18pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;"&gt;Includes $1 million of non-current other assets as of December&#160;29, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(3)     &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Includes cross currency interest rate swaps and interest rate swaps.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;           (4)&#160;&#160;&#160;&#160;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Classified as non-current other assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(5)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;Classified within cash equivalents and current marketable securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:18pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(6)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&#160;&#160;&#160;Includes $608 million and $1,631 million (primarily related to Auris Health at December 29, 2019), classified as non-current other liabilities as of September&#160;27, 2020 and December&#160;29, 2019, respectively.  Includes $28 million and $84 million classified as current liabilities as of September&#160;27, 2020 and December&#160;29, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;           (7)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;    Ongoing fair value adjustment amounts are primarily recorded in Research and Development expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company recorded a contingent consideration reversal of $1,148 million related to the timing of certain developmental milestones associated with the Auris Health acquisition. The reversal of the contingent consideration was recorded in Other income and expense. For additional details see Note 10 &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;t&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;o the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i3ed67e743095488a967574c1fa9c061f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNC0yLTEtMS0w_669767be-f2d1-48d6-aa0d-243d1281ff7d"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="ia9ed98fbd4de41809e2bbc7eb1afd160_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNC00LTEtMS0w_b0c6f3bf-bb22-455d-81ca-d9cb41f8e405"
      unitRef="usd">612000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="ic041dfb9d11749aea360ec6976d75398_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNC02LTEtMS0w_97f9e81f-f4a6-433a-aee2-b0e73fc91664"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i602f0b572b2642298407a8c186b700b3_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNC04LTEtMS0w_be93ac3e-cca2-4226-92f3-61f12e3d2ba9"
      unitRef="usd">612000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i075b4e0d383b4d769029c92ebf7473f2_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNC0xMC0xLTEtMA_d36e41e9-e5ee-4c5c-b839-a629b19ea306"
      unitRef="usd">209000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i6b7b583681fa4180bb4ba14738b78ba9_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNS0yLTEtMS0w_9001a5b7-f0f5-4d71-b9b4-8c5a62382d65"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i26a4a5bdc75a469cbac1c40a5b7f4419_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNS00LTEtMS0w_a50745f7-e845-4c4a-aeea-73a0bde83ff2"
      unitRef="usd">635000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="icf7ba8da4a85439f9212ec5c6c3cdbbc_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNS02LTEtMS0w_184d8c59-4a5e-4bb3-9e0c-032284b1ddc0"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i4f6fc756c33f4aefbaa09c8db437ba3d_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNS04LTEtMS0w_e0d4bee1-2d3e-46d8-8a3a-f1275e85432a"
      unitRef="usd">635000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="id0c4a50667354367b5d5bc0ba2591ec7_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNS0xMC0xLTEtMA_56ff1f22-c466-423e-8637-b4807e534e55"
      unitRef="usd">693000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="ia1132e994a254a868feebb3f706ca20f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNy0yLTEtMS0w_86190e26-b888-4e9b-9d0e-f6ec18ac3de8"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i49bd4ba56a684b248e46d6b51af825e4_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNy00LTEtMS0w_3b960c7e-a507-4296-b6ce-49da0fd92458"
      unitRef="usd">1247000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="id07a8860c7464a1e83cd897bd0e82400_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNy02LTEtMS0w_8fb63092-0569-42ba-bc32-4d8f04518a5f"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNy04LTEtMS0w_7879f8c9-98d6-4091-b74a-40e6f770cc58"
      unitRef="usd">1247000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i075f06ffede94a0786d62da3dcbb7230_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfNy0xMC0xLTEtMA_de89169a-60e2-4197-8950-a9242ee67081"
      unitRef="usd">902000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i3ed67e743095488a967574c1fa9c061f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfOS0yLTEtMS0w_376b61db-fba6-4a08-9022-43deedb30c01"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="ia9ed98fbd4de41809e2bbc7eb1afd160_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfOS00LTEtMS0w_1eb31d81-72a7-4c1d-b720-d289bdbe0b30"
      unitRef="usd">327000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="ic041dfb9d11749aea360ec6976d75398_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfOS02LTEtMS0w_0f222164-fdec-476f-acd4-006627117fed"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i602f0b572b2642298407a8c186b700b3_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfOS04LTEtMS0w_65a59861-585a-4e23-afb7-7e0fb855e503"
      unitRef="usd">327000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i075b4e0d383b4d769029c92ebf7473f2_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfOS0xMC0xLTEtMA_2ef01c56-a7f7-4b04-bea4-62ca425fab1e"
      unitRef="usd">426000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i6b7b583681fa4180bb4ba14738b78ba9_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTAtMi0xLTEtMA_35363de1-48c3-4f06-a2c3-79ab3d755bd8"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i26a4a5bdc75a469cbac1c40a5b7f4419_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTAtNC0xLTEtMA_1491402e-c8a1-4d20-b0d3-8d99b0bd0e53"
      unitRef="usd">382000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="icf7ba8da4a85439f9212ec5c6c3cdbbc_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTAtNi0xLTEtMA_a8c03fbf-aea4-4c2e-99b5-eb82d33709b2"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i4f6fc756c33f4aefbaa09c8db437ba3d_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTAtOC0xLTEtMA_3c4fd053-22d8-4b2f-bf89-3557a4f33b0e"
      unitRef="usd">382000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="id0c4a50667354367b5d5bc0ba2591ec7_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTAtMTAtMS0xLTA_8e705702-d4f6-4d0b-9c40-817574a6e064"
      unitRef="usd">193000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="ia1132e994a254a868feebb3f706ca20f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTItMi0xLTEtMA_6d9ce200-9dfe-443b-911a-755a963ea86c"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i49bd4ba56a684b248e46d6b51af825e4_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTItNC0xLTEtMA_cae65bd7-af9d-4d47-b30f-51adb8420bbf"
      unitRef="usd">709000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="id07a8860c7464a1e83cd897bd0e82400_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTItNi0xLTEtMA_9c11c423-21e0-4eec-94f1-2ebdf6be038d"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTItOC0xLTEtMA_c5604f73-ed32-45dd-85c4-d81fffe5ca61"
      unitRef="usd">709000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i075f06ffede94a0786d62da3dcbb7230_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTItMTAtMS0xLTA_031127f7-128e-46ba-bbb0-4eb08644833f"
      unitRef="usd">619000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i3ed67e743095488a967574c1fa9c061f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTUtMi0xLTEtMA_80957ecd-40b6-4e98-8fb8-34e989b032f2"
      unitRef="usd">0</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="ia9ed98fbd4de41809e2bbc7eb1afd160_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTUtNC0xLTEtMA_4f1a2c70-abcb-4cd3-bc0c-3cd616cbfe35"
      unitRef="usd">64000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="ic041dfb9d11749aea360ec6976d75398_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTUtNi0xLTEtMA_b9185d1b-2b23-4ec7-a9b4-c85a65d7e9f6"
      unitRef="usd">0</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i602f0b572b2642298407a8c186b700b3_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTUtOC0xLTEtMA_a48113da-aacd-4fdd-a4c7-c680f7e09adf"
      unitRef="usd">64000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i075b4e0d383b4d769029c92ebf7473f2_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTUtMTAtMS0xLTA_ab2e9f39-0246-48ba-a8f8-f51ba03c692e"
      unitRef="usd">23000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="i3ed67e743095488a967574c1fa9c061f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTctMi0xLTEtMA_4be806cc-26ef-4b6e-999c-93a589150d3e"
      unitRef="usd">0</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="ia9ed98fbd4de41809e2bbc7eb1afd160_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTctNC0xLTEtMA_75be9506-a478-4d60-a077-3edcf52bc0df"
      unitRef="usd">56000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="ic041dfb9d11749aea360ec6976d75398_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTctNi0xLTEtMA_9d6d8faa-d789-48da-a462-df975604db69"
      unitRef="usd">0</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="i602f0b572b2642298407a8c186b700b3_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTctOC0xLTEtMA_3482bf06-0bc2-429d-a2dd-6608e09f35d7"
      unitRef="usd">56000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="i075b4e0d383b4d769029c92ebf7473f2_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTctMTAtMS0xLTA_fc64319d-5a03-49a7-ae1d-968de6e2477e"
      unitRef="usd">33000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia1132e994a254a868feebb3f706ca20f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTktMi0xLTEtMA_e30ceda7-2b07-47c5-8dcf-f55e6b5724dd"
      unitRef="usd">1140000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i49bd4ba56a684b248e46d6b51af825e4_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTktNC0xLTEtMA_9a349981-7501-4490-b6e9-aaa3bf8584b8"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id07a8860c7464a1e83cd897bd0e82400_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTktNi0xLTEtMA_86065327-d02e-418b-9111-50f46a9f3226"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTktOC0xLTEtMA_690baf6a-9d43-45f7-83cb-97ed53f5c714"
      unitRef="usd">1140000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMTktMTAtMS0xLTA_f45bd870-38d4-4f36-9e81-8e8133ed6dc6"
      unitRef="usd">1148000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia1132e994a254a868feebb3f706ca20f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjAtMi0xLTEtMA_9588f08f-ba56-4ce2-b343-7e4b2f5d496c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i49bd4ba56a684b248e46d6b51af825e4_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjAtNC0xLTEtMA_4e6041af-4767-4599-ada6-2feb28fb8de7"
      unitRef="usd">13391000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id07a8860c7464a1e83cd897bd0e82400_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjAtNi0xLTEtMA_5cf82142-eecd-4321-98f4-934109aa3895"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjAtOC0xLTEtMA_acc40250-f2c3-4b1e-994f-65227f254de9"
      unitRef="usd">13391000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjAtMTAtMS0xLTA_bc166e05-9f5a-4694-8c7a-1a1ad02dec85"
      unitRef="usd">4368000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia1132e994a254a868feebb3f706ca20f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjItMi0xLTEtMzk3Nw_b6d47828-e769-4bad-80d1-41ae1ffcf600"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i49bd4ba56a684b248e46d6b51af825e4_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjItNC0xLTEtMzk3OQ_2d2e7bd1-782d-4398-b15b-9533f3c8e0a6"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id07a8860c7464a1e83cd897bd0e82400_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjItNi0xLTEtMA_b1d6485f-abb1-4471-8e45-df2d5f11dd5e"
      unitRef="usd">636000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjItOC0xLTEtMA_2c0f8ffe-8e6d-4c4d-bc3b-9658d03aa694"
      unitRef="usd">636000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjVmNzY3ZWYyOGUwYTQxZGRiODlmZGQyY2M1OTg4NjE3L3RhYmxlcmFuZ2U6NWY3NjdlZjI4ZTBhNDFkZGI4OWZkZDJjYzU5ODg2MTdfMjItMTAtMS0xLTA_6c920fc9-c658-4ea2-89a2-e37c283983f8"
      unitRef="usd">1715000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfMi0yLTEtMS0w_909d5528-6cdd-4633-9cd1-98f18fb2d831"
      unitRef="usd">1311000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfMi00LTEtMS0w_b11e0859-0ed7-415e-a7f0-281e094f8173"
      unitRef="usd">925000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetFairValueGrossLiability
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfMy0yLTEtMS0w_008c0924-e782-49da-a2e6-a8d3fa399d77"
      unitRef="usd">1117000000</us-gaap:DerivativeAssetFairValueGrossLiability>
    <us-gaap:DerivativeAssetFairValueGrossLiability
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfMy00LTEtMS0w_778ba00f-f8f4-4edf-8f9a-7e6d88e0a2ae"
      unitRef="usd">841000000</us-gaap:DerivativeAssetFairValueGrossLiability>
    <us-gaap:DerivativeAssets
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfNC0yLTEtMS0w_0869e518-7e79-47f9-8eb9-9b524f910650"
      unitRef="usd">194000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfNC00LTEtMS0w_7c33e922-bb97-4811-aac2-032f5cf3bc01"
      unitRef="usd">84000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfNi0yLTEtMS0w_adbeff2e-41b1-42dc-a475-48815a4b0228"
      unitRef="usd">765000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfNi00LTEtMS0w_303ece42-91ba-4977-804d-2b4a4ce251cb"
      unitRef="usd">652000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityFairValueGrossAsset
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfNy0yLTEtMS0w_9569d3d4-b2c3-4671-a4fd-db2a1555fbfe"
      unitRef="usd">737000000</us-gaap:DerivativeLiabilityFairValueGrossAsset>
    <us-gaap:DerivativeLiabilityFairValueGrossAsset
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfNy00LTEtMS0w_57dc94a1-6e34-43d8-825e-fcbcc6383b91"
      unitRef="usd">586000000</us-gaap:DerivativeLiabilityFairValueGrossAsset>
    <us-gaap:DerivativeLiabilities
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfOC0yLTEtMS0w_3c0ffdd2-72c3-4b4b-8f0d-e77ece71d16c"
      unitRef="usd">28000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmQ4ZjQ1YWQ2NzAxYjQwZTFhNmU5YjM0Y2RiZDUyZDllL3RhYmxlcmFuZ2U6ZDhmNDVhZDY3MDFiNDBlMWE2ZTliMzRjZGJkNTJkOWVfOC00LTEtMS0w_15e0c5ae-8b77-4937-b8f8-7620a04f0e7b"
      unitRef="usd">66000000</us-gaap:DerivativeLiabilities>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ib25f8e90a94f4d8dbe80e2251fe68616_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfMy0yLTEtMS0w_c20f0a9c-b623-4d9a-9679-90edb257d366"
      unitRef="usd">1715000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="id0a2a626a2c244b9a56b493374930da0_I20181230"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfMy00LTEtMS0w_b35490de-beca-4fe2-a44b-ef6c689620ff"
      unitRef="usd">397000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <jnj:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfNC0yLTEtMS0w_04156088-9a00-4f90-aeb4-aaec1d1d04c3"
      unitRef="usd">-1088000000</jnj:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue>
    <jnj:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfNC00LTEtMS0w_0879376f-61a4-4e54-b03c-17c3a9965d1b"
      unitRef="usd">117000000</jnj:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfNS0yLTEtMS0w_94952d06-5fae-4736-b016-272ea1d05439"
      unitRef="usd">107000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfNS00LTEtMS0w_48368534-877c-42a4-9f56-8a12da3817c5"
      unitRef="usd">1133000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfNi0yLTEtMS0w_34e2fcba-c6e4-4ed0-a6d8-57787701ed73"
      unitRef="usd">98000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfNi00LTEtMS0w_cc09ada1-6ccf-4d3e-8948-76ba67d239d4"
      unitRef="usd">9000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfNy0yLTEtMS0w_be1dfbdf-24b3-4b65-b490-1f146fbc1778"
      unitRef="usd">636000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i7973ae70802a4ed0a4cd812adebb0210_I20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmZiMDAxMDVlZGIyYTQ1MDJiMTc1MWU0MDI0MmM1NjYwL3RhYmxlcmFuZ2U6ZmIwMDEwNWVkYjJhNDUwMmIxNzUxZTQwMjQyYzU2NjBfNy00LTEtMS0w_17973def-51d0-4278-9de1-c995d6a8d3c7"
      unitRef="usd">1638000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i5c550e4021f14358b75cb96f31b7315e_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfODg4Ng_241919ef-cd22-402a-b7ef-29332a1229fa"
      unitRef="usd">1148000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7f95053789564fc7ab821eb34ad95a92_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfODk1NA_2f25da2d-eb61-4549-9417-ff3dfcd98c7f"
      unitRef="usd">1715000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="icc1339831aaa4cbb833e93308c747d53_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfODk5OA_92ff2fbf-f4ef-4292-be0f-1f926261dbc0"
      unitRef="usd">1000000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i3463d9cf730744ada323be8c796f5190_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfOTI2MA_5d2f594e-7373-41c9-9b32-d709b8385dba"
      unitRef="usd">608000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ia9134ec591ce4337a548a5cdf634d5d0_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfOTI3NQ_292566f7-b17d-45fc-b4e4-8240e90ee552"
      unitRef="usd">1631000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1a53e8456ab744c7beec3f2ef4378d29_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfOTQwOA_6c40ada4-5066-4d94-94b1-5d9bad5f855c"
      unitRef="usd">28000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id49a521ff2d04c15901e39f520471d2b_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfOTQyMw_1e9585fa-7361-427c-9e75-b176b7b8a40a"
      unitRef="usd">84000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i3da82ce120b1479b8130fc2f67172a04_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfOTcxNw_52760b1f-928e-461d-b42c-f051a23da7c7"
      unitRef="usd">-1148000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIxMDc_698f4943-3d0c-43f2-afed-e9ade7fa7115">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company's cash, cash equivalents and current marketable securities as of September&#160;27, 2020 comprised:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.849%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:22.208%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.727%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.153%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.531%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.153%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.381%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.153%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.727%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.454%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.478%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.153%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.182%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrecognized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrecognized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash &amp;amp; Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Current Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Non-U.S. sovereign securities&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. reverse repurchase agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other reverse repurchase agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Corporate debt securities&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Time deposits&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Subtotal &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. Gov't securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other sovereign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;Subtotal available for sale debt&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total cash, cash equivalents and current marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Held to maturity investments are reported at amortized cost and gains or losses are reported in earnings. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(2) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Available for sale debt securities are reported at fair value with unrealized gains and losses reported net of taxes in other comprehensive income.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
    <us-gaap:HeldToMaturitySecurities
      contextRef="if1a4bb7f18ff46a49d5c2a061670c81f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMS0xLTEtMS0w_0fce78ed-e4c5-4cb3-ac7d-90129c6c3fc4"
      unitRef="usd">2231000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="if1a4bb7f18ff46a49d5c2a061670c81f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMS0zLTEtMS0w_4223a5e4-0ccd-43b9-a392-6cde4bc2d487"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="if1a4bb7f18ff46a49d5c2a061670c81f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMS01LTEtMS0w_9e80ad7d-41a9-4d3b-8f2e-9964e894917d"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="if1a4bb7f18ff46a49d5c2a061670c81f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMS03LTEtMS0w_b745c97d-cf51-4419-a38b-35e5843ba56b"
      unitRef="usd">2231000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if1a4bb7f18ff46a49d5c2a061670c81f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMS05LTEtMS0w_368b2743-9ddf-4b99-917a-6d5fc6e57d42"
      unitRef="usd">2231000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ie37a55c0ed28487097c8fd0b33e77426_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMy0xLTEtMS0w_0163b111-de79-4c14-9de1-ec4b53c54781"
      unitRef="usd">647000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="ie37a55c0ed28487097c8fd0b33e77426_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMy0zLTEtMS0w_44388b9e-69ec-4657-834c-f96383c26547"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="ie37a55c0ed28487097c8fd0b33e77426_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMy01LTEtMS0w_fdaace19-ade4-4cbd-a606-fc04f8218a79"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ie37a55c0ed28487097c8fd0b33e77426_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMy03LTEtMS0w_35af3061-f685-4006-952d-0697f719177c"
      unitRef="usd">647000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie37a55c0ed28487097c8fd0b33e77426_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMy05LTEtMS0w_c7bde271-5262-4e6b-9df9-f1b6df42bbf5"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ie37a55c0ed28487097c8fd0b33e77426_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMy0xMS0xLTEtMA_008a64e1-959f-4481-82d0-f51228e1ee2a"
      unitRef="usd">647000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ic8a100e64514437c862f0d1cd3d7ab0d_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNC0xLTEtMS0w_41104e61-1652-48a6-a9e6-9fabbe57eac2"
      unitRef="usd">3094000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="ic8a100e64514437c862f0d1cd3d7ab0d_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNC0zLTEtMS0w_d974bdc4-0e19-4a55-bb15-e31f017486fc"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="ic8a100e64514437c862f0d1cd3d7ab0d_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNC01LTEtMS0w_c1eae612-d251-4444-a49d-80c4878b34fa"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ic8a100e64514437c862f0d1cd3d7ab0d_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNC03LTEtMS0w_12482149-9884-481d-aef9-63a6454645f2"
      unitRef="usd">3094000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic8a100e64514437c862f0d1cd3d7ab0d_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNC05LTEtMS0w_6ada3e61-0c90-4b32-b362-977fd1b08294"
      unitRef="usd">3094000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ic8a100e64514437c862f0d1cd3d7ab0d_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNC0xMS0xLTEtMA_d20df36a-e55d-4b20-8d01-4642be56f6b2"
      unitRef="usd">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:HeldToMaturitySecurities
      contextRef="iac96af33cfc442a5917405a3caa3be5c_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNS0xLTEtMS0w_1bc4d07b-3535-48a3-b0e7-a7705a5f70bc"
      unitRef="usd">430000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="iac96af33cfc442a5917405a3caa3be5c_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNS0zLTEtMS0w_6ff86e4a-d5b6-4e55-b214-685ae269b72b"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="iac96af33cfc442a5917405a3caa3be5c_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNS01LTEtMS0w_fa9b8dd8-1ef5-47ef-9d82-0f1be02f7b66"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="iac96af33cfc442a5917405a3caa3be5c_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNS03LTEtMS0w_f4a41f7d-6559-488e-b289-17c424bd28f5"
      unitRef="usd">430000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iac96af33cfc442a5917405a3caa3be5c_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNS05LTEtMS0w_f6f5029e-5d04-48aa-b774-ab75cb6f62b6"
      unitRef="usd">430000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ib6d334f7d7524737a5a1e0b9b48367dd_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNi0xLTEtMS0w_52c65d7b-5c61-4542-93ed-6c0bfd8b63e5"
      unitRef="usd">1843000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="ib6d334f7d7524737a5a1e0b9b48367dd_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNi0zLTEtMS0w_21853a91-7497-42a5-ae99-1b053c836817"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="ib6d334f7d7524737a5a1e0b9b48367dd_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNi01LTEtMS0w_cf208744-1f7a-46d8-9bcb-2c70c55855b4"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ib6d334f7d7524737a5a1e0b9b48367dd_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNi03LTEtMS0w_cbd0a6bd-ca67-457f-a512-e4dd63252d1a"
      unitRef="usd">1843000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib6d334f7d7524737a5a1e0b9b48367dd_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNi05LTEtMS0w_df0a9da3-b00e-40b5-a158-cfcea9a8c697"
      unitRef="usd">571000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ib6d334f7d7524737a5a1e0b9b48367dd_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNi0xMS0xLTEtMA_f3a1f828-18a5-4804-970a-76b4428b6649"
      unitRef="usd">1272000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i9e99c71717f340a685ff09c95429db3f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNy0xLTEtMS0w_bacb3b40-5b0e-42fa-a226-80e00df4dc6b"
      unitRef="usd">8485000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="i9e99c71717f340a685ff09c95429db3f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNy0zLTEtMS0w_589d685a-9611-45a0-b648-07a7ed4bfa07"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="i9e99c71717f340a685ff09c95429db3f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNy01LTEtMS0w_578c5070-4a6c-407d-9d06-ef18cce2cc13"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i9e99c71717f340a685ff09c95429db3f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNy03LTEtMS0w_fe896c86-36e5-4621-966a-7a4c5b85cf49"
      unitRef="usd">8485000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9e99c71717f340a685ff09c95429db3f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfNy05LTEtMS0w_5a568059-66cd-45ee-81da-fac9acf44afd"
      unitRef="usd">8485000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i2a2ca294220e4bf68ba6b1a11fa1739a_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOC0xLTEtMS0w_99bbf28e-1b19-479a-a6f4-cb05da8be76d"
      unitRef="usd">660000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="i2a2ca294220e4bf68ba6b1a11fa1739a_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOC0zLTEtMS0w_9b6f72de-2c5c-4a82-b065-45304c80b601"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="i2a2ca294220e4bf68ba6b1a11fa1739a_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOC01LTEtMS0w_26e0a0ec-6442-4f32-b218-48da9e9eefbb"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i2a2ca294220e4bf68ba6b1a11fa1739a_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOC03LTEtMS0w_ba88e142-0471-4971-ab01-7f357870b32e"
      unitRef="usd">660000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2a2ca294220e4bf68ba6b1a11fa1739a_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOC05LTEtMS0w_8e0cce1d-cce7-49b3-8472-db4750295b02"
      unitRef="usd">660000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i7828932564cc42808d3bc1319ed98668_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOS0xLTEtMS0w_a89e6a66-2e94-4770-8346-43f0e2d62c22"
      unitRef="usd">17390000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="i7828932564cc42808d3bc1319ed98668_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOS0zLTEtMS0w_3c8d809c-ef62-42fc-aaf0-e3fe1d234168"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="i7828932564cc42808d3bc1319ed98668_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOS01LTEtMS0w_a2435e70-e2bd-49dd-8e58-a0e2aa1d39aa"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i7828932564cc42808d3bc1319ed98668_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOS03LTEtMS0w_36adad4a-5d77-43de-8bc5-e2c05ffd22f8"
      unitRef="usd">17390000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7828932564cc42808d3bc1319ed98668_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOS05LTEtMS0w_b3690da2-a0e1-4c71-a4fb-cda1e3f756e4"
      unitRef="usd">15471000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i7828932564cc42808d3bc1319ed98668_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfOS0xMS0xLTEtMA_6cc04b7c-2d4c-41b5-b9ba-6ca76900cab0"
      unitRef="usd">1919000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1ff57a4b24ad4de3bb98f30bf0dbc693_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTItMS0xLTEtMA_37a3f6e8-cf2f-4db3-9462-c0f013fe0277"
      unitRef="usd">13133000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1ff57a4b24ad4de3bb98f30bf0dbc693_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTItMy0xLTEtMA_070ed120-749d-40e6-880a-c4028b4a9a4a"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1ff57a4b24ad4de3bb98f30bf0dbc693_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTItNS0xLTEtMA_f9b8aaca-e376-44a2-a7b2-5fb3741cd174"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1ff57a4b24ad4de3bb98f30bf0dbc693_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTItNy0xLTEtMA_0c741243-2512-44c3-9b8e-1cd5d3523bc6"
      unitRef="usd">13134000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1ff57a4b24ad4de3bb98f30bf0dbc693_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTItOS0xLTEtMA_9687cc0c-09d8-471d-99a9-d56ade70d22a"
      unitRef="usd">3483000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i1ff57a4b24ad4de3bb98f30bf0dbc693_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTItMTEtMS0xLTA_c0d0ddba-e4d0-4d3d-a5a6-632a5fc0d363"
      unitRef="usd">9651000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2280350b15814286becfc035a03921a3_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTMtMS0xLTEtMA_46872f54-e206-4152-93f7-3f553c8ad5f1"
      unitRef="usd">10000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2280350b15814286becfc035a03921a3_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTMtMy0xLTEtMA_aecdc94a-4eb6-4bb4-929a-ee81d22b3b2f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2280350b15814286becfc035a03921a3_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTMtNS0xLTEtMA_58a313ce-6ca1-4261-b9f2-c9d16b9b7d6f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2280350b15814286becfc035a03921a3_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTMtNy0xLTEtMA_e9364a89-621c-41b6-a945-282fd7566af4"
      unitRef="usd">10000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2280350b15814286becfc035a03921a3_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTMtOS0xLTEtMA_a1f1a9a7-df72-462b-b5d0-6b89a201d6e3"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i2280350b15814286becfc035a03921a3_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTMtMTEtMS0xLTA_5009a4d7-7946-45bf-ac5e-763da238f40f"
      unitRef="usd">10000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i2280350b15814286becfc035a03921a3_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTMtMTEtMS0xLTA_dbe98eab-a59b-4aaa-b165-5f4a1c411a0e"
      unitRef="usd">10000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id5f928f37d1542b3bf86cc736479d215_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTQtMS0xLTEtMA_012e2431-b1a1-45f2-9883-4d24f4c7fc8c"
      unitRef="usd">247000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id5f928f37d1542b3bf86cc736479d215_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTQtMy0xLTEtMA_95e8938c-dc25-4099-a0a2-4f0ce9a75635"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id5f928f37d1542b3bf86cc736479d215_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTQtNS0xLTEtMA_5ecad952-1203-4927-9c1c-c7cace471ede"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id5f928f37d1542b3bf86cc736479d215_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTQtNy0xLTEtMA_f86fa7f5-c7f2-4bad-aa31-e2863684c59d"
      unitRef="usd">247000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id5f928f37d1542b3bf86cc736479d215_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTQtOS0xLTEtMA_52049649-cd89-487e-a940-1993a7f8fedd"
      unitRef="usd">11000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="id5f928f37d1542b3bf86cc736479d215_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTQtMTEtMS0xLTA_5a38bb4f-d689-4545-964f-95d73efa6a7d"
      unitRef="usd">236000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i0ffd52d1e0664f24b3f3822ede7a0cd1_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTUtMS0xLTEtMA_be543530-9915-4e4f-91bc-3f1e307286b4"
      unitRef="usd">13390000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0ffd52d1e0664f24b3f3822ede7a0cd1_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTUtMy0xLTEtMA_e956b70c-f633-4195-b5aa-157be2a3938c"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0ffd52d1e0664f24b3f3822ede7a0cd1_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTUtNS0xLTEtMA_3323cdff-ffc9-41f5-9fd0-bcfca248879f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0ffd52d1e0664f24b3f3822ede7a0cd1_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTUtNy0xLTEtMA_b6866e9c-4da8-4dbe-8cfe-0109cd8930a9"
      unitRef="usd">13391000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0ffd52d1e0664f24b3f3822ede7a0cd1_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTUtOS0xLTEtMA_4dd61ea6-347e-4b60-8e55-a5161afc3ef0"
      unitRef="usd">3494000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i0ffd52d1e0664f24b3f3822ede7a0cd1_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTUtMTEtMS0xLTA_975a2b34-33b3-4bd6-8bdc-1eedec26b307"
      unitRef="usd">9897000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTYtMS0xLTEtMA_1db4ddd1-ac01-4d39-8479-64819eda314d"
      unitRef="usd">30780000000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <jnj:CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTYtMy0xLTEtMA_ee0eea39-42a5-47a2-8073-f648be5eba84"
      unitRef="usd">1000000</jnj:CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain>
    <jnj:CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTYtNS0xLTEtMA_5786552f-0ec3-4646-bc60-908f5243c980"
      unitRef="usd">0</jnj:CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss>
    <jnj:CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTYtNy0xLTEtMA_f4b2cb8b-2ad0-42aa-ad6f-833dc33c3b18"
      unitRef="usd">30781000000</jnj:CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTYtOS0xLTEtMA_75f9ae33-9503-4b9c-8aa8-2e3f7aeb0abd"
      unitRef="usd">18965000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmFmYjAxM2U0YzhmNjRmOWM5MDk1N2MwMWEzMjQ2Mzk5L3RhYmxlcmFuZ2U6YWZiMDEzZTRjOGY2NGY5YzkwOTU3YzAxYTMyNDYzOTlfMTYtMTEtMS0xLTA_03adcb4a-0d61-43d0-9e2e-badd75196b80"
      unitRef="usd">11816000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIxMDk_308b51b3-921c-4e07-af46-ead2fc07f749">The Company classifies all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months from the date of purchase as current marketable securities. Available for sale securities with stated maturities of greater than one year from the date of purchase are available to fund current operations and are classified as cash equivalents and current marketable securities.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIwNjg_95f1d9b0-a273-4651-b8d2-9fee428890dc">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The contractual maturities of the available for sale securities as of September&#160;27, 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:76.426%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:43.104%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:2.829%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:22.279%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.157%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:25.031%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost Basis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjgxNTAzMmM1ODNiZTRjNDE4MDBmNDU4NmQ1MDU5NDRhL3RhYmxlcmFuZ2U6ODE1MDMyYzU4M2JlNGM0MTgwMGY0NTg2ZDUwNTk0NGFfMS0yLTEtMS0w_1d329857-fdd6-4574-9dda-8f77ba66663f"
      unitRef="usd">13368000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjgxNTAzMmM1ODNiZTRjNDE4MDBmNDU4NmQ1MDU5NDRhL3RhYmxlcmFuZ2U6ODE1MDMyYzU4M2JlNGM0MTgwMGY0NTg2ZDUwNTk0NGFfMS00LTEtMS0w_23fa0567-1994-4efd-82a4-d3f82fc26f45"
      unitRef="usd">13369000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjgxNTAzMmM1ODNiZTRjNDE4MDBmNDU4NmQ1MDU5NDRhL3RhYmxlcmFuZ2U6ODE1MDMyYzU4M2JlNGM0MTgwMGY0NTg2ZDUwNTk0NGFfMi0yLTEtMS0w_f2b62543-7726-43a1-9f99-0f5567b0e32d"
      unitRef="usd">22000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjgxNTAzMmM1ODNiZTRjNDE4MDBmNDU4NmQ1MDU5NDRhL3RhYmxlcmFuZ2U6ODE1MDMyYzU4M2JlNGM0MTgwMGY0NTg2ZDUwNTk0NGFfMi00LTEtMS0w_0c524f55-2e9b-423b-9927-f13f638ed356"
      unitRef="usd">22000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjgxNTAzMmM1ODNiZTRjNDE4MDBmNDU4NmQ1MDU5NDRhL3RhYmxlcmFuZ2U6ODE1MDMyYzU4M2JlNGM0MTgwMGY0NTg2ZDUwNTk0NGFfMy0yLTEtMS0w_aef7b77c-57d7-4c2f-b797-19f8f728a955"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjgxNTAzMmM1ODNiZTRjNDE4MDBmNDU4NmQ1MDU5NDRhL3RhYmxlcmFuZ2U6ODE1MDMyYzU4M2JlNGM0MTgwMGY0NTg2ZDUwNTk0NGFfMy00LTEtMS0w_74484454-4401-4ab3-bbd7-bb2633ebc18f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjgxNTAzMmM1ODNiZTRjNDE4MDBmNDU4NmQ1MDU5NDRhL3RhYmxlcmFuZ2U6ODE1MDMyYzU4M2JlNGM0MTgwMGY0NTg2ZDUwNTk0NGFfNC0yLTEtMS0w_21414077-3bce-440b-b70c-971aa7d7fec3"
      unitRef="usd">13390000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOjgxNTAzMmM1ODNiZTRjNDE4MDBmNDU4NmQ1MDU5NDRhL3RhYmxlcmFuZ2U6ODE1MDMyYzU4M2JlNGM0MTgwMGY0NTg2ZDUwNTk0NGFfNC00LTEtMS0w_d860dc0f-7ce2-429f-b0d1-3b995936bed9"
      unitRef="usd">13391000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTIwOTk_b8c5c877-4372-4894-a779-8d3f8f500570">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Financial Instruments not measured at Fair Value:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following financial liabilities are held at carrying amount on the consolidated balance sheet as of September&#160;27, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:79.838%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.533%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.137%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.533%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.259%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Current Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-Current Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.45% Notes due 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;0.250% Notes due 2022 (1B Euro 1.1641)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.25% Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;6.73% Debentures due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3.375% Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.05% Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;0.650% Notes due 2024 (750MM Euro 1.1641)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5.50% Notes due 2024 (500 MM GBP 1.2757)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.625% Notes due 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;0.55% Notes due 2025&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.45% Notes due 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.95% Notes due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;0.95% Notes due 2027&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.90%&#160;Notes due 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;1.150% Notes due 2028 (750MM Euro 1.1641)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;6.95% Notes due 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;1.30% Notes due 2030&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;4.95% Debentures due 2033&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;4.375% Notes due 2033&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;1.650% Notes due 2035 (1.5B Euro 1.1641)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3.55% Notes due 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5.95% Notes due 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3.625% Notes due 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3.40%&#160;Notes due 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;5.85% Debentures due 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;4.50% Debentures due 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.10% Notes due 2040&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;4.85% Notes due 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;4.50% Notes due 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3.70% Notes due 2046&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3.75% Notes due 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;3.50% Notes due 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.25% Notes due 2050&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;2.45% Notes due 2060&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Non-Current Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:ShortTermBorrowings
      contextRef="idce2d47fd1804a3f98973754ffded2a3_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNC0yLTEtMS0w_094e22be-a15e-4ef4-b843-f8c4a51a829c"
      unitRef="usd">5078000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i935d5ef44a4142eb80b98b85c665cdae_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNC00LTEtMS0w_4649d700-5f06-4b4f-9479-363ccff41ec8"
      unitRef="usd">5093000000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic1916a7de9304cc59832dd469de21cc9_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNy0wLTEtMS0wL3RleHRyZWdpb246ODI4MWVkZjI3YTUwNDg4YTg3ODhmNTAxOWIxYjllM2RfMTA0NDUzNjA0NjM5MDE_70f21d37-dc12-4723-9274-571dec54c7aa"
      unitRef="number">0.0245</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if11c31b2d6a44925b98b6b61c64e2daa_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNy0yLTEtMS0w_09c024c7-46cf-408c-b4a3-102aa0ad71c5"
      unitRef="usd">350000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1647f236f4204443831bf07df847e56f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNy00LTEtMS0w_1a4cd578-1b2d-48df-995f-681b515c9256"
      unitRef="usd">358000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0fe7d6eeef6547a081274e2ede3f5ff9_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfOS0wLTEtMS0wL3RleHRyZWdpb246NWRkYjUxYWE1N2I4NGVhMjkzNjQ4ZDYyYzBkMGMzYzVfMTA0NDUzNjA0NjM5MjA_885be458-a295-4a8e-b475-b32659466514"
      unitRef="number">0.00250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib9b43d320de345feb114bcda4919416f_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfOS0yLTEtMS0w_b327da5b-694f-4fdb-8b95-64fbba35eb9f"
      unitRef="usd">1163000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1538e33ce6b24f88a81816a950b4b247_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfOS00LTEtMS0w_7d3750b2-4960-44ba-b5c7-d08c7f85da20"
      unitRef="usd">1172000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i056990540d404780b0b73129befbc636_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOmIxMTBhM2U3YzMwNzQ2YzFhYjNlNzU4YTQ2NDA0YmFiXzEwNDQ1MzYwNDYzOTAx_2f7be948-f6d5-4531-a782-b733b8fd6730"
      unitRef="number">0.0225</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i19d6e666640143e29c89b138db0f6d22_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTAtMi0xLTEtMA_735762cd-1efb-4180-b331-97f6181914a4"
      unitRef="usd">998000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ica2fd4caec424e239a481a2bcaf79e6b_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTAtNC0xLTEtMA_ad08627d-407b-4043-b6ce-785fb76dd0d6"
      unitRef="usd">1025000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iafefab750a92478c87896b310434e7fe_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjIxNTRkNTUwMjg2ODQ4OWJiYTQzYjdlMGE4N2I5ZGFhXzEwNDQ1MzYwNDYzOTA2_ba89ab9a-7759-4711-8be6-af19600fca73"
      unitRef="number">0.0673</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i2e92a5dbc9214a8d9f87742c76176ff2_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTEtMi0xLTEtMA_faf04f1d-eaea-42d8-b702-b85973a618e4"
      unitRef="usd">250000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ieea3231abf62476ea5bcf5de0b5578f9_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTEtNC0xLTEtMA_56a9b66e-ecbd-45e9-9ed5-21ea1ab1d81b"
      unitRef="usd">299000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i02e32328220f4303a40455ed4b2da979_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTItMC0xLTEtMC90ZXh0cmVnaW9uOmI1MmVhYjE0YTVjOTQwODZhYWMxNWRjOTJjYjQzMDhhXzEwNDQ1MzYwNDYzOTAz_59498193-24d2-45c3-98c1-9a9fb4455564"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if268019a4de94135a6b62c5f0e256440_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTItMi0xLTEtMA_71b37674-c148-4dc1-acdb-56cf1cebda61"
      unitRef="usd">803000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i13cce8a254e449e083f46c20c1bbe797_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTItNC0xLTEtMA_2d1ece77-9e8e-4728-84de-73cabf2095ea"
      unitRef="usd">881000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ieef980882cf74f48864a6d1029945cef_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjNhNTZjNDEzN2VhMjQ2MjRiMjZmOWVhYTY2ZGY5NTFjXzEwNDQ1MzYwNDYzOTAx_05d19f64-6805-4eb1-a34a-68098e714ac3"
      unitRef="number">0.0205</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i536828fe3d9e41f894d6e23d6416769c_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTMtMi0xLTEtMA_7e729916-74a8-484b-8b8d-d8d00230df75"
      unitRef="usd">499000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie7c53e72904247ce8947b14425657966_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTMtNC0xLTEtMA_969ce178-5921-46f9-8f8b-ff0aa0423634"
      unitRef="usd">518000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id1ca9536dcaf404e8afcb2da4501ac6a_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOmEwOWNhNmE2MDc2NjRlZWE5NWU3YjRhMzgzN2RmNjY2XzEwNDQ1MzYwNDYzOTIz_1a75b076-53f9-427c-8894-a9c852ce9fef"
      unitRef="number">0.00650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie2e2c07a5d624a8598c2fdc999a47461_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTQtMi0xLTEtMA_14cc922f-e5e1-4511-92ea-39bbfad5a493"
      unitRef="usd">870000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i01dae954e6b6449b91fb72ad27b9bc51_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTQtNC0xLTEtMA_a2b384b2-a9f9-4eb5-b95a-0be24f286dd9"
      unitRef="usd">899000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i136b1f0e6fd14acaa8a68b132e09a0a6_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjIwZDI3OTM5MTJjMTRhMTBiY2I4YWYyYTQzMzNjOGYzXzEwNDQ1MzYwNDYzOTIx_4c9c3301-63e2-4220-b282-a0d90aed5368"
      unitRef="number">0.0550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i645cefa2669b4e44b397f9618653aa80_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTUtMi0xLTEtMA_9a4779df-a9c7-4a46-ad14-15d0d72fa1b4"
      unitRef="usd">634000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3150eb2704984084ac3204e1f7084267_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTUtNC0xLTEtMA_2ee29772-b03f-4be9-bb16-62292ec76317"
      unitRef="usd">768000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6f424501f76142b7a914b49ea7286203_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjMyNDFhMzg1YTdkNTQ1MzRhNmFhYTQyOGNhZmMwNGEwXzEwNDQ1MzYwNDYzOTAz_1d22be4f-cf2b-489f-93b2-b0183431f0e0"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i76b7bfb69eb9403b99deb7e7eef8d40a_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTYtMi0xLTEtMA_7fb76537-4629-40d8-ba5e-18aea4ad82fe"
      unitRef="usd">748000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i52179e2f9d674e078511c80f498c6c0a_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTYtNC0xLTEtMA_6d19d24f-7887-4a2e-bb63-e7205cd2445a"
      unitRef="usd">813000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idbc85d394a774ed9868d5b95e674664e_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTgtMC0xLTEtMzA0Ni90ZXh0cmVnaW9uOmVmYzdkYWY2YmU4ZTRhZjNiNmIyMzMxYWQ2OTY1NmMyXzEwNDQ1MzYwNDYzOTA3_bb97c625-ea6f-4091-b91b-9ab3d7dd8dfc"
      unitRef="number">0.0055</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id4dbf413e19e4cef9e7278a102ee7157_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTgtMi0xLTEtMzA0Ng_f4fe77d8-5a31-4ffb-b322-c058cede098d"
      unitRef="usd">996000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i078e08bd46af4e3f9e215207cc204105_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTgtNC0xLTEtMzA0Ng_e84a3044-ae5c-4333-a04a-70a806f37ee8"
      unitRef="usd">990000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i159981f414cb4bb18af0fbaee7927deb_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjkzZTg4YWZlZmQwZTRkYWVhMjg3M2UzMjQ0YWUwMjRjXzEwNDQ1MzYwNDYzOTAx_c9f9b340-ce4a-49e6-b9d6-070665c2816c"
      unitRef="number">0.0245</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i668b41dcf7f44976bf86a2f9db667fb5_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTctMi0xLTEtMA_442bba35-c2ac-4876-a639-5f7bad6ba51a"
      unitRef="usd">1994000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if1eeb605be014548afd510c0c8aa8eb3_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTctNC0xLTEtMA_d9160354-794b-4bf6-835d-d0883cc1067f"
      unitRef="usd">2180000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i165c4f1ce2ed4d76ab34c44c41db1255_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOmU1YzEwMjRiYjk0YzQwZjFiMjk5MzU3MTcxY2E0YmI5XzEwNDQ1MzYwNDYzOTAx_6dfcb6da-ab1c-4f8a-bc7f-22305c5b1841"
      unitRef="number">0.0295</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib2686d72e0c343febe8ff2bd5ac5e63a_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTgtMi0xLTEtMA_d2a82e25-5241-4093-8132-4497b9aa5b5d"
      unitRef="usd">997000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iab1049268d7f4fe8b4d96cce87cafc93_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTgtNC0xLTEtMA_83cf8cb1-b40b-43d6-84c8-160be4956adc"
      unitRef="usd">1119000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6059fa37b091494880a716afab863d00_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjItMC0xLTEtMzA1Ny90ZXh0cmVnaW9uOmRhYTFlZWY4MmZhNzRlMTE4MWE1YzFjYzZlNGRhZDdmXzEwNDQ1MzYwNDYzOTA0_02bce687-ab83-4ad6-b565-2289f42a33bb"
      unitRef="number">0.0095</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ifd980a324e5844119be04d1bb8b21864_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjItMi0xLTEtMzA1Nw_cd322b4b-16b3-44e1-97c3-985f28c8932e"
      unitRef="usd">1494000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic8948fc5022044e38940be61c4706a21_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjItNC0xLTEtMzA1Nw_4625e772-2252-4236-a468-723e938786c7"
      unitRef="usd">1510000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iae91b5c8065840b89f68ae84c662b898_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTktMC0xLTEtMC90ZXh0cmVnaW9uOjNmMWEyYjVlZDM1OTRkYWI4MDQ4NTU5NmFkYmExNTUyXzEwNDQ1MzYwNDYzOTAx_e8dce0d5-07f8-4b18-8604-05120107348e"
      unitRef="number">0.0290</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia36b73a057224ba4affcfc6bb3cea2e1_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTktMi0xLTEtMA_c70a32fb-f461-4af5-a6f4-f8c588a50524"
      unitRef="usd">1494000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6e79dc01a22a42a1b246532434f100c4_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMTktNC0xLTEtMA_56f967c8-1796-4cb1-9c2d-76eff00ffaf9"
      unitRef="usd">1680000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if7a2d03254ee4d5f9a357de70108e5b0_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjAtMC0xLTEtMC90ZXh0cmVnaW9uOjVkOTdhYzQwYjU1NzQwZTFiN2VlMjdiNzdhOTBkYWVhXzEwNDQ1MzYwNDYzOTIz_a3b78b2e-01ca-48ca-b576-edabe72c46d6"
      unitRef="number">0.01150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i21be7fdecb314fed8cd5a7cb7f876fdf_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjAtMi0xLTEtMA_62ef1028-4e8f-4459-9095-c314c9a6514e"
      unitRef="usd">867000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i51f2a2865858445bb19a36565773cc28_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjAtNC0xLTEtMA_44bdc4e1-a0f6-4025-b467-0011bf43dcf6"
      unitRef="usd">960000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9acb3bf537f748f9b2c3359991790afe_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjEtMC0xLTEtMC90ZXh0cmVnaW9uOjUwMDcxY2I4MjAwMzQzMWQ4OGFmMTYwYWY2MjFmZWFmXzEwNDQ1MzYwNDYzOTAx_5bf489a1-fa61-4cec-90f7-74d3ef1268f8"
      unitRef="number">0.0695</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i35c7685f5dd046aeb031adc37a8ca784_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjEtMi0xLTEtMA_058b229a-e6ff-42c5-8ee9-9f66638668fd"
      unitRef="usd">297000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1333214536b64c51ab1dacec5ddd05c6_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjEtNC0xLTEtMA_2a49a1a0-0079-41b2-99c3-6df6335bea65"
      unitRef="usd">441000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1245a84acd304e199ac2b7dc8d467d7e_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjctMC0xLTEtMzA4Ny90ZXh0cmVnaW9uOjE2ZDNkOTg1OGZiNDRkNjlhZmI3NGYyZTU4ZjEyMDU5XzEwNDQ1MzYwNDYzOTA0_aa085b08-7a0c-48b6-92b2-b5e83caa98e8"
      unitRef="number">0.0130</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="icca8ff318ac34efc92f4216ddfb91fb2_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjctMi0xLTEtMzA4Nw_1b0b2814-e74f-4b8a-bc5c-f351541a13b5"
      unitRef="usd">1743000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0ea632070b0e40e898b52619bced26b7_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjctNC0xLTEtMzA4Nw_24f448af-5085-4cd8-9d28-7b322c60f84d"
      unitRef="usd">1739000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia1378408d96d46e39591826c2abb98dc_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjItMC0xLTEtMC90ZXh0cmVnaW9uOjhjMGFjYjM5ZWE0NTQ2YmI5ZWU5OTY5MTgzZTJlNDQ5XzEwNDQ1MzYwNDYzOTA2_441e3d26-40bd-4b90-a7eb-7544b9488670"
      unitRef="number">0.0495</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id5f87b6d74d749babe28b84569bdf760_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjItMi0xLTEtMA_63436fc9-d0e6-4214-97a4-8881da79588a"
      unitRef="usd">498000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i995150be58c746e482284b146887f7d3_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjItNC0xLTEtMA_6d247f31-4524-418b-b329-dd6c29752f1c"
      unitRef="usd">690000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2622b7e579a8492eb15ec639424f7c89_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjMtMC0xLTEtMC90ZXh0cmVnaW9uOjNlOGM2YTM4NzU4MTQ0ZDk5YjJlZmVlNjA3YjBlMGM5XzEwNDQ1MzYwNDYzOTAz_1b1637bf-f499-41da-808f-93315c24aa22"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id36151c33f4848bbbcff81875e541568_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjMtMi0xLTEtMA_95297b06-bc2f-4586-8c6c-f44d7aba3198"
      unitRef="usd">855000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7e0d64b50fd84e3a8c7f405b55ccc1c7_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjMtNC0xLTEtMA_f818188a-0536-47d7-b38c-8e28c7c62233"
      unitRef="usd">1128000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id41e1a92e44e4a829be6caa81c1fccec_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjQtMC0xLTEtMC90ZXh0cmVnaW9uOjU2MmU1YmFlNmJiODRlOTBhN2IzOTc5ZGRhNmRhMzI5XzEwNDQ1MzYwNDYzOTIy_cfa340a4-de15-4e25-bb46-85685dbb45d4"
      unitRef="number">0.01650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib7803914447c4a189138f7ee1b3e91b1_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjQtMi0xLTEtMA_6b38264d-3c9c-47d9-8770-ed5025ec20cd"
      unitRef="usd">1731000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i256f4cdb5243490987a08f155c79ea6b_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjQtNC0xLTEtMA_2ab6f982-e68d-4efa-aef2-03aed6ccedc3"
      unitRef="usd">2101000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i62ebec4387da4562b9e6654db09a6b96_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjUtMC0xLTEtMC90ZXh0cmVnaW9uOjU4YmZjYmFkMGY5ZDQxNDQ5NDg0NmVlZWQ3Yjk3NDZlXzEwNDQ1MzYwNDYzOTAx_1175cf9d-7b85-4da0-ba69-27358d4f8461"
      unitRef="number">0.0355</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i69ab97fe3bda4a55b6837fd20fb4462a_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjUtMi0xLTEtMA_5cc142f2-bac6-43b4-bc73-94f0a9a1a643"
      unitRef="usd">989000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i480827ff0c054590abd0ec468b49c4e6_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjUtNC0xLTEtMA_0aad9a54-c109-470a-a045-48d6587e4272"
      unitRef="usd">1197000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia5536eadd4c94ef6a5ab2937cc959359_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjQ0Nzc5ODQzOGZmYTRmNWJiZjViYjEwZjc5ODVlMDM1XzEwNDQ1MzYwNDYzOTAx_8cea5ef2-c876-4e36-92cc-d2a26a9d38bc"
      unitRef="number">0.0595</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if1b4030a20b24ff0a711318c1a843cce_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjYtMi0xLTEtMA_16be318a-4603-4927-a79e-52e480db5f7f"
      unitRef="usd">992000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1da6151136fb464ca1c2c5796b81d7fc_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjYtNC0xLTEtMA_3a31d47f-a8b7-4c1e-8d1f-a24b310d837c"
      unitRef="usd">1536000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic8ef119f549949d08c1ae0df1c64dac7_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjctMC0xLTEtMC90ZXh0cmVnaW9uOmU1MzQwYzY0MDE2YjQ3NmE5ZmMyOTA1NDU0MTc4MzM1XzEwNDQ1MzYwNDYzOTAz_32cc5f77-9db9-46ff-9d01-ba7cc73913be"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i86d6509ed13b4aaf912a2823edcb1029_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjctMi0xLTEtMA_8d43c12e-d643-4a6c-918c-7e88b2edcc58"
      unitRef="usd">1488000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie8a5b10c02c54e47ab7d11d7d166c538_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjctNC0xLTEtMA_a09ba856-893b-493d-ae81-0e4ec62e7e71"
      unitRef="usd">1819000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9aa446f74b2d40f4aedc83ea2ea53439_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjgtMC0xLTEtMC90ZXh0cmVnaW9uOmU1ZGNhMjRkODRhNzQ1ODZhMzNlNTFlZWM1ZGM3YWEzXzEwNDQ1MzYwNDYzOTAx_e4c9e294-56b3-4392-a6dd-e7154e5dc455"
      unitRef="number">0.0340</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4f66b72f3c7f424b8a380c66e8da7d27_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjgtMi0xLTEtMA_13b48c7a-a896-477e-94f6-7022a57c6c46"
      unitRef="usd">991000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i48a1bd53e02644e6b26acc106519b804_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjgtNC0xLTEtMA_e6911a13-521e-4325-9ecd-54fba535226e"
      unitRef="usd">1176000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic49fdd1ce30c46f8badb4ff4bd1017bd_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjktMC0xLTEtMC90ZXh0cmVnaW9uOjYzMjFhYzlmM2UzYTRiZDFhNzJiODI2YmMzYjBlYmZhXzEwNDQ1MzYwNDYzOTA2_1372ff01-468e-4bf2-820e-46ceb2a575c8"
      unitRef="number">0.0585</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ibd0f7065260a48cda35109d9ae5386a1_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjktMi0xLTEtMA_c277bdb9-2e87-40bc-8253-7610fc1eece6"
      unitRef="usd">696000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5951d9504b1a4dff8f25e5796b4c0a9a_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMjktNC0xLTEtMA_376805f2-613a-40d3-a8f1-0380610ccf8d"
      unitRef="usd">1094000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i387cbe08835047789169cf51f45ee5fe_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjA5ZmJkOWFhYmIzODQ5ZGE4NmRhYmI5NzVmYjE1NWIxXzEwNDQ1MzYwNDYzOTA2_61908b7d-429f-4114-9ba2-7d6390aa523a"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ide6e5e064d024312addc5538bdaa7c85_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzAtMi0xLTEtMA_e9d4d4fe-f959-4801-80a4-fe9f6d6259e2"
      unitRef="usd">539000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib69bdfb1b7b94a449af780c7ad54b9da_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzAtNC0xLTEtMA_fdf6f7aa-c708-423a-9a54-ef690e3cadaa"
      unitRef="usd">737000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idcd460ebbac7457b8cb0a76ce59423a5_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzgtMC0xLTEtMzA5OS90ZXh0cmVnaW9uOjIyMDk1MTFiYjNiYzQ2NDU5NGNkMTBjZWVlNTE0MjhkXzEwNDQ1MzYwNDYzOTA0_115dac3e-0828-4cc7-a61f-62669978c077"
      unitRef="number">0.0210</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0c89e14a0fa3403581aa0e9723a4286c_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzgtMi0xLTEtMzA5OQ_ee836d60-4573-42d1-a005-bc8213f29567"
      unitRef="usd">986000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i98dd15586d034500902f9f3c99a576a5_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzgtNC0xLTEtMzA5OQ_105f9cb9-65fc-48bb-b89a-d20fc6163da8"
      unitRef="usd">991000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i324a2081f5854fad8130ebd189647549_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzEtMC0xLTEtMC90ZXh0cmVnaW9uOmMxNTc3YjA5NzZhYTRhNjE5OGJhYjY1MjYxNzMzYzk2XzEwNDQ1MzYwNDYzOTAx_55e7ad9f-6e3d-426a-9b56-1121f9e644ab"
      unitRef="number">0.0485</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1eb3f36ba8a74f5480d62d0a81bbc354_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzEtMi0xLTEtMA_11904038-cef4-4d7f-87b4-743c79af6187"
      unitRef="usd">297000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1b41d3fa848d4b0ea4f78009aec60a63_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzEtNC0xLTEtMA_b920c882-9e20-4842-9696-441b7c5d53b6"
      unitRef="usd">421000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5bdf805eaea4472d81e2786f92535e75_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzItMC0xLTEtMC90ZXh0cmVnaW9uOmU2YzVmODQxZjdjNDQ3NmFiNDM2Mjk3NzBiOTA1NmQ3XzEwNDQ1MzYwNDYzOTAx_01240cfe-fd5d-4ecc-9039-8121aa536bc8"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i24b0208298044a269325b9653684ec98_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzItMi0xLTEtMA_d7bbfdfb-d595-4fc2-b5ed-b7b35242f091"
      unitRef="usd">495000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id4ff4a9f1fb34cd2b7cbea524a570fba_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzItNC0xLTEtMA_e814f1d2-14d5-4911-87b5-f2215f303399"
      unitRef="usd">689000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if02c9f9f84d64647b122e66b2b1a6f36_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjY1MDQwM2FiMDViNTRiMmM5NTRlMDlmMzYyOTNhMTE2XzEwNDQ1MzYwNDYzOTAx_2add1e05-d9f8-4609-bd13-6de074c7e8c8"
      unitRef="number">0.0370</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i171dded75a42462f8691992184163a6a_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzMtMi0xLTEtMA_d0b37678-e338-4698-a030-585fd40c4c42"
      unitRef="usd">1974000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4e60bc8e3f0942bd832fc02168754abe_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzMtNC0xLTEtMA_2acfb1fc-ce8d-4811-b7f7-43ec0cbb391d"
      unitRef="usd">2478000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib3acfd6e023d48c49956f11aca1794a8_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjhjNTcxNTVkZTBlNDRjNTc5MmJjMDY5ODcxYzNmNjNiXzEwNDQ1MzYwNDYzOTAx_9bfc7b7c-89ef-4fe5-afa1-85466dc8340c"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia8fdd90a9a534e91a456c1d33c226809_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzQtMi0xLTEtMA_3507d67b-ea5a-47e5-909b-cea6dc65d078"
      unitRef="usd">991000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if3dc5cdf91884ac5a55987be998ef035_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzQtNC0xLTEtMA_8c02c8f0-a03c-49ba-8b12-ef4488beb795"
      unitRef="usd">1258000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2dc08c035fa24dcca70c9fdd3ca863ed_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjQwZGE3YjExOWEwZDQwNDM5MzY1OGJkNjhmNGNhOTc1XzEwNDQ1MzYwNDYzOTAx_cb42592b-e991-4939-a4b4-27ade8aab230"
      unitRef="number">0.0350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i43d605e8071140abb14e4a1b5c23edad_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzUtMi0xLTEtMA_b4dba26f-9e99-4a23-a3dd-9ef27d8d8825"
      unitRef="usd">742000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id5c0678f2622446789e384e30ddb3b34_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzUtNC0xLTEtMA_fb36f06a-ab97-48f5-a20d-27a45b7abeeb"
      unitRef="usd">921000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib1da88ade9134203bd9ab5f43e40ea74_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNDAtMC0xLTEtNjMwL3RleHRyZWdpb246OWM5MjZmNzc5ZGZhNGQ0NjliNmNiZjcyNDkzZGI4MDlfMTA0NDUzNjA0NjM5MDQ_c6e42356-3756-4f97-b994-adb29a3192be"
      unitRef="number">0.0225</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id9d8b34477a34cff93a83812f0c68017_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNDAtMi0xLTEtNjIz_80ce1eed-a633-42cb-9fa2-e127eef58f35"
      unitRef="usd">984000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5044fde7f5e441ac9def46cca0d955d7_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNDAtNC0xLTEtNjI3_d9daf664-c72a-42a9-8757-479b7f867a02"
      unitRef="usd">984000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i37cb21206af94c5da0e8b41d9ff52e60_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNDEtMC0xLTEtNjMwL3RleHRyZWdpb246ZjljMjNmZWE5NzExNDc2NWI1NmJmODVkMWQwMjE3MzdfMTA0NDUzNjA0NjM5MDQ_c7a1e690-a068-4b48-88a3-bf788fc4b7fd"
      unitRef="number">0.0245</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i930c3d7cca544f488362ecf22d4ba011_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNDEtMi0xLTEtNjIz_b6b0bbfc-c57e-46e3-bc40-360b0d38d184"
      unitRef="usd">1228000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6ecc4cdda5b24f6c8a06cf84bffb3461_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfNDEtNC0xLTEtNjI3_aae6153e-03fc-4327-80df-547bdab11436"
      unitRef="usd">1230000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i709d0243b3794243b831d6b6a562bf4b_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzYtMi0xLTEtMA_686d75ac-4799-47cc-ac1d-27a9ca43bf4e"
      unitRef="usd">7000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i278399ba66af46a19d5e0d9c2a66430e_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzYtNC0xLTEtMA_8531e604-1058-46d1-86a7-4662cc845584"
      unitRef="usd">10000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="idce2d47fd1804a3f98973754ffded2a3_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzctMi0xLTEtMA_c705f792-d736-44e7-ba87-f28e096a2f45"
      unitRef="usd">32680000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i935d5ef44a4142eb80b98b85c665cdae_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RhYmxlOmUzMDY0ZTU3NDk1YzQzZjM5YjdjMDQwYWNlNmI4NTRlL3RhYmxlcmFuZ2U6ZTMwNjRlNTc0OTVjNDNmMzliN2MwNDBhY2U2Yjg1NGVfMzctNC0xLTEtMA_4ffc7f1d-ed38-4e29-aa85-91726f7e72ce"
      unitRef="usd">37812000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTE1Mzc_470d2827-9718-40dc-b205-679de21cc008"
      unitRef="number">0.0285</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <jnj:ExcessOfFairValueOverCarryingValueOfDebt
      contextRef="i719d92c03acf4660873bf7164fbd0cdf_D20181231-20191229"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTE2MTc_e01edbeb-4943-4465-93c6-3de6538a6137"
      unitRef="usd">3000000000.0</jnj:ExcessOfFairValueOverCarryingValueOfDebt>
    <us-gaap:ShortTermBorrowings
      contextRef="ib12c2507851947309a7a823e9e3770dc_I20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTE2OTc_0868aca1-fe4f-41de-b683-80dd1b6d2f2c"
      unitRef="usd">3000000000.0</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="ib12c2507851947309a7a823e9e3770dc_I20200927"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTE3NjY_1e743d74-7544-4c1a-a84f-f9d21a0aefce"
      unitRef="number">0.0015</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7f434199d52940ed909adbee7e2ad0a8_I20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF82Ny9mcmFnOjlhOTc0M2UwNGZkZDQxN2JiMzQ2ZTUxMjIyM2MyZjYyL3RleHRyZWdpb246OWE5NzQzZTA0ZmRkNDE3YmIzNDZlNTEyMjIzYzJmNjJfMTA0NDUzNjA0Nzc5NDc_0f5aa49b-0ad1-4138-b2af-2fa800bac6e8"
      unitRef="usd">7500000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMTA5OTUxMTYyODk4NDE_8a542836-1f83-4d23-b9b4-5b4d5cea2362">INCOME TAXES&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;The worldwide effective income tax rates for the fiscal nine months of 2020 and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;2019 were 12.6% an&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;d 15.3%, respectively. In the fiscal third quarter of 2019, Switzerland enacted the Federal Act on Tax Reform and AHV Financing (TRAF), which became effective on January 1, 2020. More information on the provisions of TRAF, including the step-up transitional provisions, can be found in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. During the fiscal first quarter of 2020, the final canton where the Company maintains significant operations enacted TRAF legislation and, accordingly, the Company recorded an estimated deferred tax benefit of approximately $0.3 billion for the remeasurement of existing deferred tax liabilities offset by a related $0.2 billion increase in U.S. GILTI deferred taxes. During the second fiscal quarter of 2020, the Company received rulings from the Swiss Federal and cantonal tax authorities in the remaining jurisdictions where it has significant operations. These rulings resulted in the Company revising its estimate on the tax basis adjustment (i.e., &#x201c;step-up&#x201d;) for its assets. As a result, the Company recorded additional deferred tax benefits in the second fiscal quarter of 2020 to recognize this step-up. Consequently, the benefit recorded related to Swiss Tax reform in the first nine months of fiscal 2020 was approximately $0.4&#160;billion, or 2.7% benefit to the Company&#x2019;s fiscal nine months effective tax rate, inclusive of the impact of U.S. GILTI deferred taxes. Comparatively, in the fiscal third quarter of 2019, the Company recorded a tax benefit from the enactment of Swiss tax reform which reduced the effective rate for the fiscal nine months of 2019 by 3.0%.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;The Company does not expect to receive future rulings regarding the transitional provisions of TRAF.   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;In the fiscal third quarter of 2019, the Company recorded additional unrecognized tax benefit liabilities which increased the effective tax rate for the fiscal nine months of 2019 by approximately 2.0%. In the fiscal third quarter of 2020, the Company recorded additional net unrecognized tax benefit liabilities which increased the effective tax rate for the fiscal nine months of 2020 by approximately 1.1%.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;Additionally, the following items impacted the Company's effective tax rate as compared to the same period in the prior fiscal year:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;"&gt;the impact of the agreement in principle to settle opioid litigation (see Note 21 to the Consolidated Financial Statements) in the fiscal third quarter of 2019, which was recorded in the U.S., at an effective tax rate of 23.0%. In the fiscal third quarter of 2020, the Company reduced the effective tax rate of this agreement in principle to 21.4%. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;"&gt;the reduced income in lower tax jurisdictions due to the ongoing COVID-19 pandemic&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;"&gt;the 2019 divestiture gain related to Advanced Sterilization Products (ASP) which was primarily taxed in the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;"&gt;the accrual of additional legal costs, including an additional $1.0&#160;billion associated with a revised agreement in principle to settle opioid litigation at an effective tax rate of 21.4%, in fiscal nine months of 2020 (see Notes 9 and 11 to the Consolidated Financial Statements for more details). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company also generated additional tax benefits from stock-based compensation that were either exercised or vested; reduction of a contingent consideration liability related to the 2019 Auris Health acquisition; and reversal of some of its international unrecognized tax benefits due to the completion of several years of tax examinations in certain jurisdictions during the first fiscal three quarters of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of September&#160;27, 2020, the Company had approximately $3.3 billion of liabilities from unrecognized tax benefits. The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of jurisdictions. With respect to the United States, the IRS has completed its audit for the tax years through 2009 and is currently auditing the tax years 2010 through 2012. The Company currently expects completion of this audit in the fiscal year 2020. As of September&#160;27, 2020, the Company has classified unrecognized tax benefits and related interest of approximately $0.1 billion as a current liability on the &#x201c;Accrued taxes on Income&#x201d; line of the Consolidated Balance Sheet. This is the amount expected to be paid over the next 12 months with respect to the IRS audit. During the first fiscal quarter of 2020, the Company made a payment of approximately $0.6 billion to the U.S. Treasury with respect to the 2010-2012 tax audit in anticipation of a final settlement. The completion of this tax audit may result in additional adjustments to the Company&#x2019;s unrecognized tax benefit liability. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;In other major jurisdictions where the Company conducts business, the years that remain open to tax audit go back to the year 2006. The Company believes it is possible that tax audits may be completed over the next twelve months by taxing authorities in some jurisdictions outside of the United States. However, the Company is not able to provide a reasonably reliable estimate of the timing of any other future tax payments relating to uncertain tax positions.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMTE1_cc5f95fc-878d-4c05-b08f-657a04716ebb"
      unitRef="number">0.126</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMTIy_f289ce05-9184-4822-b953-3a543becc459"
      unitRef="number">0.153</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset
      contextRef="ic847fc16c1a54fb78d5fe18b8a9bd17b_D20191230-20200329"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfNjk5_3ea8a5e9-f85b-4017-8854-a85064239f44"
      unitRef="usd">300000000</jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset>
    <jnj:FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit
      contextRef="ic847fc16c1a54fb78d5fe18b8a9bd17b_D20191230-20200329"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfNzgx_50ae430c-2711-4aec-b194-169af17adf4f"
      unitRef="usd">200000000</jnj:FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit>
    <jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMTM4OA_e9bd5391-12b2-4374-8e3e-2628b59a75b3"
      unitRef="usd">400000000</jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset>
    <jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMTM5NQ_99f73bf2-50d7-4909-a80b-af5e2564eb99"
      unitRef="number">0.027</jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent>
    <jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfODc5NjA5MzAyNzMwNQ_3aa520d0-8307-4f56-b772-2d6cb2d2f509"
      unitRef="number">0.030</jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent>
    <jnj:EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMTkwMg_3722e9e4-a976-401d-8ed9-e8617ca7efdd"
      unitRef="number">0.020</jnj:EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent>
    <jnj:EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMjE3Mg_ea46c5df-ceb2-42d7-b88b-7b0d60000b54"
      unitRef="number">0.011</jnj:EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent>
    <jnj:EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMzI5ODUzNDg5NTM1NA_493848f0-e52d-495e-9cce-c8aec91de088"
      unitRef="number">0.230</jnj:EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement>
    <jnj:EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfODc5NjA5MzAzMTczNg_1adb3dd8-26e5-4a74-9620-8f63d76c085a"
      unitRef="number">0.214</jnj:EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement>
    <jnj:AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfODc5NjA5MzAzMTc1Mg_d0056736-f6bd-4390-a9cd-7b224582370d"
      unitRef="usd">1000000000.0</jnj:AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement>
    <jnj:EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfODc5NjA5MzAzMTc0Mw_0606d355-d043-4bfa-8fec-d0a717469960"
      unitRef="number">0.214</jnj:EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i19e7a320a15a49fc9131f6215c942e21_I20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMzA1Ng_340534c1-225c-4482-9f72-942fe280eca0"
      unitRef="usd">3300000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ibf5f634dad614276bd22344f56a80048_I20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMzY0Ng_8a278a51-fa8b-40c2-a445-9f325c7c257a"
      unitRef="usd">100000000</us-gaap:UnrecognizedTaxBenefits>
    <jnj:UnrecognizedTaxBenefitLiabilityPayment
      contextRef="ib105bdc301f94aa0bdad8883c084fba1_D20191230-20200329"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83My9mcmFnOjA2N2Q0NGYyMDNlNzQ5ZDFiZDg2MTgyNjRkYTMwNTdiL3RleHRyZWdpb246MDY3ZDQ0ZjIwM2U3NDlkMWJkODYxODI2NGRhMzA1N2JfMzkyNA_36dacc3a-df81-42fe-80bb-61365b909186"
      unitRef="usd">600000000</jnj:UnrecognizedTaxBenefitLiabilityPayment>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RleHRyZWdpb246YzlkOTNmOTU4NzQyNDUyMjhiOGRmZjcxOWIxOGQ2YTFfOTQ3_f65ccc86-c368-4a25-9a08-1bb835314526">PENSIONS AND OTHER BENEFIT PLANS&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Components of Net Periodic Benefit Cost&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Net periodic benefit costs for the Company&#x2019;s defined benefit retirement plans and other benefit plans for the fiscal third quarters and fiscal nine months of 2020 and 2019 include the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:25.331%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.534%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.270%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.534%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.270%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.534%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.270%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.534%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.270%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.827%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.270%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.534%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.270%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.534%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.270%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.534%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.714%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Third Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(617)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(578)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amortization of prior service cost/(credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Recognized actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Curtailments and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The service cost component of net periodic benefit cost is presented in the same line items on the Consolidated Statement of Earnings where other employee compensation costs are reported. All other components of net periodic benefit cost are presented as part of Other (income) expense, net on the Consolidated Statement of Earnings.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Company Contributions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;For the fiscal nine months ended September&#160;27, 2020, the Company contributed $364 million and $27 million to its U.S. and international retirement plans, respectively. The Company plans to continue to fund its U.S. defined benefit plans to comply with the Pension Protection Act of 2006. International plans are funded in accordance with local regulations.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RleHRyZWdpb246YzlkOTNmOTU4NzQyNDUyMjhiOGRmZjcxOWIxOGQ2YTFfOTQz_7701fac5-bfc5-479e-8d9f-a549940100ef">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Net periodic benefit costs for the Company&#x2019;s defined benefit retirement plans and other benefit plans for the fiscal third quarters and fiscal nine months of 2020 and 2019 include the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:25.331%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.534%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.270%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.534%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.270%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.534%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.270%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.534%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.270%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.827%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.270%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.534%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.270%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.534%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.270%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.534%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.714%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Third Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(617)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(578)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amortization of prior service cost/(credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Recognized actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Curtailments and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i76991a953ea2430ab905037bfcac327d_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMy0yLTEtMS0w_fc153d63-ea9d-44c3-9529-1629bddf9e5e"
      unitRef="usd">330000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i97db63a5b1bf481bbea39077a0761ca9_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMy00LTEtMS0w_b60a75a6-459b-443f-80bd-20c637bceffc"
      unitRef="usd">275000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i4dbd3aef0b5a4bbc9dc149f14c7e3d3b_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMy02LTEtMS0w_277e3ffb-9720-4d5e-8034-f3de142c4709"
      unitRef="usd">72000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i0ac819dd65a24ccea1e79d719e0d1cff_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMy04LTEtMS0w_c38641ee-e367-4815-bf83-63baf1bff97d"
      unitRef="usd">68000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i32b2b3e0644f45ff8702ea89bf54ad06_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMy0xMC0xLTEtMA_1b319509-c613-4679-9fe9-14cf79e54ba9"
      unitRef="usd">979000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i3a18f6b9ab22475b952191fef9a136c7_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMy0xMi0xLTEtMA_0b034814-9a6b-41ae-92fc-151ddf42593f"
      unitRef="usd">828000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i62d4b60ec8e44411a7c22519b07bcb56_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMy0xNC0xLTEtMA_6eca764c-1817-4bec-b7d0-8e51f6c262a8"
      unitRef="usd">216000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="id7d38e2b061c40569b6a15416f6b0063_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMy0xNi0xLTEtMA_e42465de-1d96-4f02-9e79-3e0e8ce9b45c"
      unitRef="usd">205000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i76991a953ea2430ab905037bfcac327d_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNC0yLTEtMS0w_474d8b01-3cac-4e5d-9905-49141d03bd1e"
      unitRef="usd">238000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i97db63a5b1bf481bbea39077a0761ca9_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNC00LTEtMS0w_111ffaeb-9621-44e2-8ddd-6914620897e7"
      unitRef="usd">273000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i4dbd3aef0b5a4bbc9dc149f14c7e3d3b_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNC02LTEtMS0w_fa67faee-7721-419d-8dfc-fd175c3720a1"
      unitRef="usd">33000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i0ac819dd65a24ccea1e79d719e0d1cff_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNC04LTEtMS0w_622682c9-1f39-40ba-b3f0-299903ab72e1"
      unitRef="usd">46000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i32b2b3e0644f45ff8702ea89bf54ad06_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNC0xMC0xLTEtMA_95574fc1-086e-498e-84ad-98b38c1c75a4"
      unitRef="usd">715000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i3a18f6b9ab22475b952191fef9a136c7_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNC0xMi0xLTEtMA_351f06b1-cf31-4964-a83f-1e8304c59f90"
      unitRef="usd">822000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i62d4b60ec8e44411a7c22519b07bcb56_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNC0xNC0xLTEtMA_80ec41a9-f2e2-4f6a-b0fa-8f108ebac008"
      unitRef="usd">99000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="id7d38e2b061c40569b6a15416f6b0063_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNC0xNi0xLTEtMA_fec36576-ad5b-43eb-8542-9016b86f30c5"
      unitRef="usd">138000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i76991a953ea2430ab905037bfcac327d_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNS0yLTEtMS0w_a75836b3-b21d-42ce-b30f-7c086ac94475"
      unitRef="usd">617000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i97db63a5b1bf481bbea39077a0761ca9_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNS00LTEtMS0w_e5b948ab-2693-45f5-a818-fe508d527a79"
      unitRef="usd">578000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i4dbd3aef0b5a4bbc9dc149f14c7e3d3b_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNS02LTEtMS0w_5297cbd6-a25a-4ec8-8712-693a91086ffa"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i0ac819dd65a24ccea1e79d719e0d1cff_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNS04LTEtMS0w_2521fdcb-ec2e-40a3-8ecf-6312b51fda54"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i32b2b3e0644f45ff8702ea89bf54ad06_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNS0xMC0xLTEtMA_57e14574-4638-4756-9a85-b6a6579b595f"
      unitRef="usd">1839000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i3a18f6b9ab22475b952191fef9a136c7_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNS0xMi0xLTEtMA_1f1de846-f036-4a59-9f9e-7128a2ee4034"
      unitRef="usd">1742000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i62d4b60ec8e44411a7c22519b07bcb56_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNS0xNC0xLTEtMA_9649e119-8f7c-4465-966a-5335d906d354"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="id7d38e2b061c40569b6a15416f6b0063_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNS0xNi0xLTEtMA_39186def-60db-4919-abfa-aef4782e269a"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i76991a953ea2430ab905037bfcac327d_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNi0yLTEtMS0w_32b76205-c32b-4919-b385-14a65de8c2df"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i97db63a5b1bf481bbea39077a0761ca9_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNi00LTEtMS0w_5c417bd0-a4d5-47c7-b482-aad14767d2f4"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i4dbd3aef0b5a4bbc9dc149f14c7e3d3b_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNi02LTEtMS0w_48eb9976-3669-4dd7-8feb-840df4daab20"
      unitRef="usd">-7000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i0ac819dd65a24ccea1e79d719e0d1cff_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNi04LTEtMS0w_4f62ebe3-d42e-4b1c-8e54-27c101ba257f"
      unitRef="usd">-7000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i32b2b3e0644f45ff8702ea89bf54ad06_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNi0xMC0xLTEtMA_09b5275f-a392-41c0-bdaa-7c39c92e4d11"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i3a18f6b9ab22475b952191fef9a136c7_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNi0xMi0xLTEtMA_f4495f5a-175f-44a2-ad6c-35db2039df6c"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i62d4b60ec8e44411a7c22519b07bcb56_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNi0xNC0xLTEtMA_0360df2f-d5ea-4208-9c79-2c217f39008a"
      unitRef="usd">-23000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="id7d38e2b061c40569b6a15416f6b0063_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfNi0xNi0xLTEtMA_7befcbc8-cb79-466b-a276-7b5bc2312290"
      unitRef="usd">-23000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i76991a953ea2430ab905037bfcac327d_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOC0yLTEtMS0w_48097b22-4b6b-4197-a484-7553b02f73a1"
      unitRef="usd">-224000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i97db63a5b1bf481bbea39077a0761ca9_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOC00LTEtMS0w_61bd1c4c-ce32-498b-99fb-7cb934fdd306"
      unitRef="usd">-145000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i4dbd3aef0b5a4bbc9dc149f14c7e3d3b_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOC02LTEtMS0w_c34c0629-7f49-4be3-ad7f-167a8d0a56fe"
      unitRef="usd">-36000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i0ac819dd65a24ccea1e79d719e0d1cff_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOC04LTEtMS0w_79fa4630-ec87-4c3c-be5c-c72f90656721"
      unitRef="usd">-32000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i32b2b3e0644f45ff8702ea89bf54ad06_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOC0xMC0xLTEtMA_f8e29a15-097c-4228-b208-318e82d7eb52"
      unitRef="usd">-669000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i3a18f6b9ab22475b952191fef9a136c7_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOC0xMi0xLTEtMA_9387a98f-01ad-455e-a22d-0df739755735"
      unitRef="usd">-435000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i62d4b60ec8e44411a7c22519b07bcb56_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOC0xNC0xLTEtMA_74d69438-9498-4df9-97d7-58358da7bf99"
      unitRef="usd">-107000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="id7d38e2b061c40569b6a15416f6b0063_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOC0xNi0xLTEtMA_7cf7b418-8c27-4e52-a4a5-fd966077fb16"
      unitRef="usd">-97000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i76991a953ea2430ab905037bfcac327d_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOS0yLTEtMS0w_2243a626-d020-453a-aa17-2c29ceae16b3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i97db63a5b1bf481bbea39077a0761ca9_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOS00LTEtMS0w_43bace1b-8708-482f-923c-5b2ab08de4a1"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i4dbd3aef0b5a4bbc9dc149f14c7e3d3b_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOS02LTEtMS0w_91677bc1-743a-4cfe-9ccc-71ab0baaec17"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i0ac819dd65a24ccea1e79d719e0d1cff_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOS04LTEtMS0w_cacb8f44-dac8-44bf-8fff-1ee10dbfaec5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i32b2b3e0644f45ff8702ea89bf54ad06_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOS0xMC0xLTEtMA_eb912b07-7211-4960-ae1a-59f30a9313f9"
      unitRef="usd">-19000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i3a18f6b9ab22475b952191fef9a136c7_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOS0xMi0xLTEtMA_c30c38fa-51e1-478c-b13d-05f1b34a94fc"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i62d4b60ec8e44411a7c22519b07bcb56_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOS0xNC0xLTEtMA_324fd2e6-ff15-41f6-bf44-1a88efd52f38"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="id7d38e2b061c40569b6a15416f6b0063_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfOS0xNi0xLTEtMA_2a7a558e-b347-431c-8820-476b09bbb5cc"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i76991a953ea2430ab905037bfcac327d_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMTAtMi0xLTEtMA_4430fec3-2d73-4d39-8727-31562765dda5"
      unitRef="usd">175000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i97db63a5b1bf481bbea39077a0761ca9_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMTAtNC0xLTEtMA_6010e13d-ddfa-4189-a115-d2fcc2afec7c"
      unitRef="usd">112000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i4dbd3aef0b5a4bbc9dc149f14c7e3d3b_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMTAtNi0xLTEtMA_5ad7508b-5666-4cd1-b7aa-f0e9e0a60575"
      unitRef="usd">132000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i0ac819dd65a24ccea1e79d719e0d1cff_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMTAtOC0xLTEtMA_5bcb262e-8910-40df-84c6-0b1ec763db1c"
      unitRef="usd">137000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i32b2b3e0644f45ff8702ea89bf54ad06_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMTAtMTAtMS0xLTA_8cd3dd0c-0b04-4abd-b5fb-73855dec45c0"
      unitRef="usd">544000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i3a18f6b9ab22475b952191fef9a136c7_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMTAtMTItMS0xLTA_e5de6bd1-c243-4e87-b42c-cc093d1f7369"
      unitRef="usd">349000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i62d4b60ec8e44411a7c22519b07bcb56_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMTAtMTQtMS0xLTA_165ef793-b663-440f-9d8a-039bacf015e3"
      unitRef="usd">394000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="id7d38e2b061c40569b6a15416f6b0063_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RhYmxlOjFlNzRiYWViNjY0YTQzOGZhYWQwYzU5NzFjNDI3MTg4L3RhYmxlcmFuZ2U6MWU3NGJhZWI2NjRhNDM4ZmFhZDBjNTk3MWM0MjcxODhfMTAtMTYtMS0xLTA_204e3487-38ae-4915-b10d-b54bb8c1c586"
      unitRef="usd">412000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:PensionContributions
      contextRef="iba89a9d0fc0d402d9b56774badd78c07_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RleHRyZWdpb246YzlkOTNmOTU4NzQyNDUyMjhiOGRmZjcxOWIxOGQ2YTFfNjcx_639f7f6e-66ee-4b44-b742-0fda6dcb315c"
      unitRef="usd">364000000</us-gaap:PensionContributions>
    <us-gaap:PensionContributions
      contextRef="i7aca824b885d4113af57a768e99be46f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83Ni9mcmFnOmM5ZDkzZjk1ODc0MjQ1MjI4YjhkZmY3MTliMThkNmExL3RleHRyZWdpb246YzlkOTNmOTU4NzQyNDUyMjhiOGRmZjcxOWIxOGQ2YTFfNjc4_43c84cdb-b8b7-4bf3-9c78-f5e3cbd7d7dc"
      unitRef="usd">27000000</us-gaap:PensionContributions>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RleHRyZWdpb246MWQxMjJiYjAzNDIzNDQ0ZmI2M2VlN2ViZGM5ODMyMzBfOTIx_cfadae39-08b4-4ac5-8124-d03687915956">ACCUMULATED OTHER COMPREHENSIVE INCOME&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Components of other comprehensive income (loss) consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:34.774%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.547%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.914%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.547%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.662%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.846%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.719%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.547%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.306%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.547%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.991%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Employee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Accumulated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;On&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;On Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Comprehensive&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&amp;amp; Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(295)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(741)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9,446)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Amounts in accumulated other comprehensive income are presented net of the related tax impact.  Foreign currency translation is not adjusted for income taxes where it relates to permanent investments in international subsidiaries.  For additional details on comprehensive income see the Consolidated Statements of Comprehensive Income. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Details on reclassifications out of Accumulated Other Comprehensive Income:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Gain/(Loss) On Securities - reclassifications released to Other (income) expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Employee Benefit Plans - reclassifications are included in net periodic benefit cost. See Note 6 for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Gain/(Loss) On Derivatives &amp;amp; Hedges - reclassifications to earnings are recorded in the same account as the underlying transaction. See Note 4 for additional details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RleHRyZWdpb246MWQxMjJiYjAzNDIzNDQ0ZmI2M2VlN2ViZGM5ODMyMzBfOTI4_068c7195-9e8c-4c52-b99e-22a363202ac6">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Components of other comprehensive income (loss) consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:34.774%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.547%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.914%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.547%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.662%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.846%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.719%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.547%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.306%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.547%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.991%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Employee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Accumulated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;On&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;On Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Comprehensive&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&amp;amp; Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(295)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(741)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9,446)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idee3ed30241e424493acca72e673afcd_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNC0yLTEtMS0w_6eb1a208-e9bb-4f7d-a457-a39e4ff34206"
      unitRef="usd">-8705000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iad56cf144ec847a8a16206fa418498c9_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNC00LTEtMS0w_6d554f12-d07a-407e-a9e7-4c01d68f0645"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iebebc2fd778f40798d1314b14d68d59c_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNC02LTEtMS0w_726537b0-ca53-4e1d-aff3-7747eb4a5900"
      unitRef="usd">-6891000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib49a989cb90342ab8cacece521c7d896_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNC04LTEtMS0w_f86e9013-1f9e-40f5-ad67-dc0ea29b9a25"
      unitRef="usd">-295000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4dff82851aa243f2a42e09821411d92e_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNC0xMC0xLTEtMA_12b7f8b0-f1a6-4a68-9572-e2657878b704"
      unitRef="usd">-15891000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1a657cd2705e49199faed73d18529a9f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNS0yLTEtMS0w_e51e939b-768b-46f4-9320-c345dce00f9a"
      unitRef="usd">-741000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i686763308513427ab8b79b989e11e0b5_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNS00LTEtMS0w_7093f5b4-c2a8-4fa4-a98e-c7ba0c67bf8d"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7b2070364dbe40199c021a5f19b0d7cd_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNS02LTEtMS0w_eff5ed47-4250-40c7-b982-bfd36bd3430b"
      unitRef="usd">587000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i240092c4b65b491c93381937b17173a3_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNS04LTEtMS0w_a0829c13-d65d-4572-98a0-045c5c1a5b3c"
      unitRef="usd">1106000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3494e72aac944cd896896e8cc599429d_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNS0xMC0xLTEtMA_e4cbc9fd-7e2c-4ae7-a107-e8904b5ef6c3"
      unitRef="usd">953000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i33664fe4d1f148e7bd9e8ade82e1790b_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNy0yLTEtMS0w_a2228727-fbf0-4d9f-a78f-fa638bd0e1d9"
      unitRef="usd">-9446000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9b60bad991094d70b3aa1309c7d2f70c_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNy00LTEtMS0w_6750c319-c309-4046-b0d2-14c8f924f252"
      unitRef="usd">1000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0247279f84684992bafc7f3bcd811a4c_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNy02LTEtMS0w_c2255170-132b-4b69-82ae-d2f2e18e77e4"
      unitRef="usd">-6304000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i258eab55a2d94c38a37a02b6761520fb_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNy04LTEtMS0w_ce641a43-cf55-408b-891d-27b04ebf582a"
      unitRef="usd">811000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b3f9043c47442aea143141642e7e123_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF83OS9mcmFnOjFkMTIyYmIwMzQyMzQ0NGZiNjNlZTdlYmRjOTgzMjMwL3RhYmxlOjdlNzRmNWQyMmYxZjQ4M2E5NDUzZDIxMTc1OWMwMTJkL3RhYmxlcmFuZ2U6N2U3NGY1ZDIyZjFmNDgzYTk0NTNkMjExNzU5YzAxMmRfNy0xMC0xLTEtMA_cf860933-981d-4838-96d1-7d0fac29a02c"
      unitRef="usd">-14938000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RleHRyZWdpb246YWViNzAzOWQ2OTFiNDVkOThlMDdjMzFiYTgwNGRmMjdfMTQ2NA_98aa9888-2285-4f43-b741-3a21e8140efd">EARNINGS PER SHARE&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following is a reconciliation of basic net earnings per share to diluted net earnings per share for the fiscal third quarters and fiscal nine months ended September&#160;27, 2020 and September&#160;29, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:48.325%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.805%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.400%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.380%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.974%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.518%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.518%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.248%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Third Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Shares in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Basic net earnings per share &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Average shares outstanding &#x2014; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,632.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,635.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,633.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,649.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Potential shares exercisable under stock option plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;115.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;117.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;120.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;137.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: shares which could be repurchased under treasury stock method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(78.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(83.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(82.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(99.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Convertible debt shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Average shares outstanding &#x2014; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,669.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,669.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,670.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,688.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Diluted net earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The diluted net earnings per share calculation for the fiscal third quarter ended September&#160;27, 2020 excluded 20 million shares related to stock options, as the exercise price of these options was greater than their average market value. In the fiscal third quarter ended September 27, 2020 the Company did not have convertible debt.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The diluted net earnings per share calculation for the fiscal third quarter ended September&#160;29, 2019 excluded 19&#160;million shares related to stock options, as the exercise price of these options was greater than their average market value. The diluted net earnings per share calculation for the fiscal third quarter ended September&#160;29, 2019 included the dilutive effect of convertible debt that was offset by the related reduction in interest expense. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The diluted net earnings per share calculation for the fiscal nine months ended September&#160;27, 2020 excluded 17&#160;million shares related to stock options, as the exercise price of these options was greater than their average market value. In the fiscal nine months ended September 27, 2020 the Company did not have convertible debt.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The diluted net earnings per share calculation for the fiscal nine months ended September&#160;29, 2019 excluded an insignificant number of shares related to stock options, as the exercise price of these options was greater than their average market value. The diluted net earnings per share calculation for the fiscal nine months ended September&#160;29, 2019 included the dilutive effect of convertible debt that was offset by the related reduction in interest expense.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RleHRyZWdpb246YWViNzAzOWQ2OTFiNDVkOThlMDdjMzFiYTgwNGRmMjdfMTQ2MA_18f4f0db-4b38-44b0-838a-483afecc4844">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following is a reconciliation of basic net earnings per share to diluted net earnings per share for the fiscal third quarters and fiscal nine months ended September&#160;27, 2020 and September&#160;29, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:48.325%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.805%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.400%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.380%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.974%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.518%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.532%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.518%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.248%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Third Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Shares in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Basic net earnings per share &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Average shares outstanding &#x2014; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,632.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,635.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,633.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,649.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Potential shares exercisable under stock option plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;115.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;117.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;120.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;137.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: shares which could be repurchased under treasury stock method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(78.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(83.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(82.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(99.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Convertible debt shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Average shares outstanding &#x2014; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,669.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,669.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,670.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,688.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Diluted net earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfMi0yLTEtMS0w_a979223c-8b60-4573-ac6c-2e0766f6bc07"
      unitRef="usdPerShare">1.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfMi00LTEtMS0w_696b7f98-8ab7-455a-9e35-eca7fe1558a9"
      unitRef="usdPerShare">0.67</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfMi02LTEtMS0w_f786c935-fdeb-4e41-86b7-9d423fcbfbf3"
      unitRef="usdPerShare">4.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfMi04LTEtMS0w_cef7d7de-e048-432d-9c0b-b4ade9d77f60"
      unitRef="usdPerShare">4.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfMy0yLTEtMS0w_8d5a1fc7-5510-44bd-8d1b-44507e24fe04"
      unitRef="shares">2632500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfMy00LTEtMS0w_21ddec9d-bcba-4fd0-9f3b-afe1633e1e6e"
      unitRef="shares">2635200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfMy02LTEtMS0w_5e8a55d6-76eb-4727-ad88-ab0611765f73"
      unitRef="shares">2633000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfMy04LTEtMS0w_70ea1c3e-22c7-46e9-a7b7-1e5a5899d263"
      unitRef="shares">2649500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNC0yLTEtMS0w_c390326c-5ce5-4714-a3b2-0b5835f0e0a9"
      unitRef="shares">115700000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNC00LTEtMS0w_bea68b3b-afa6-4bef-897c-f952faeacb02"
      unitRef="shares">117800000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNC02LTEtMS0w_5e0d066e-2424-4b36-a542-52cbae733d0c"
      unitRef="shares">120200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNC04LTEtMS0w_b6f5ab66-5a6e-4e04-8046-b2e3afb9ebe0"
      unitRef="shares">137600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNS0yLTEtMS0w_01f24b6e-4d92-4d0d-b841-172bb5473866"
      unitRef="shares">78900000</jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod>
    <jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNS00LTEtMS0w_1e5e4a96-7077-408a-beea-04e5d712a27b"
      unitRef="shares">83800000</jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod>
    <jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNS02LTEtMS0w_8cd9f03a-8054-4ac3-8e00-312372565c16"
      unitRef="shares">82400000</jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod>
    <jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNS04LTEtMS0w_30e03efe-3978-4a3c-8878-d93115eb49d1"
      unitRef="shares">99700000</jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNi0yLTEtMS0w_60e3e3bb-69ab-4b7a-a81a-c74079461700"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNi00LTEtMS0w_90b19f8f-5d5d-4ac8-b516-d4443fb2815f"
      unitRef="shares">700000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNi02LTEtMS0w_9c252e2c-4ea3-4a58-8c1e-9879e9d2764f"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNi04LTEtMS0w_aefb8bab-5fe9-4585-a610-45f0347b9d39"
      unitRef="shares">700000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNy0yLTEtMS0w_d7f43867-63ca-4913-903d-46f90e3338ad"
      unitRef="shares">2669300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNy00LTEtMS0w_932c1a32-57c4-4a18-b271-1bda79bcdd2c"
      unitRef="shares">2669900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNy02LTEtMS0w_4a9065ef-01db-4f1f-b894-7aaaba0097d6"
      unitRef="shares">2670800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfNy04LTEtMS0w_d2f7983f-f91a-4c80-ad89-f92de263d158"
      unitRef="shares">2688100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfOC0yLTEtMS0w_6d488999-dbb9-4975-ac30-fced36975eaf"
      unitRef="usdPerShare">1.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfOC00LTEtMS0w_8c57ff5d-5c83-442e-9358-7f3f5c4d32f7"
      unitRef="usdPerShare">0.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfOC02LTEtMS0w_c54306ee-1dca-4fd2-8c00-196acc6b6fbb"
      unitRef="usdPerShare">4.86</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RhYmxlOjhlYWE0YTIxNDQ4NTQ5NzI5ODYxZTNlOTU2ZTJiOWNmL3RhYmxlcmFuZ2U6OGVhYTRhMjE0NDg1NDk3Mjk4NjFlM2U5NTZlMmI5Y2ZfOC04LTEtMS0w_b41f3d8e-369f-45e2-b977-f44a6f239419"
      unitRef="usdPerShare">4.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RleHRyZWdpb246YWViNzAzOWQ2OTFiNDVkOThlMDdjMzFiYTgwNGRmMjdfNDg3_a07d7d73-49f0-4eee-95a4-ec9f05429d7d"
      unitRef="shares">20000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RleHRyZWdpb246YWViNzAzOWQ2OTFiNDVkOThlMDdjMzFiYTgwNGRmMjdfMTA5OTUxMTYyOTMwMA_53094e74-079c-414b-a76f-2cef91e53fa8"
      unitRef="shares">19000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84Mi9mcmFnOmFlYjcwMzlkNjkxYjQ1ZDk4ZTA3YzMxYmE4MDRkZjI3L3RleHRyZWdpb246YWViNzAzOWQ2OTFiNDVkOThlMDdjMzFiYTgwNGRmMjdfMTEwOQ_23b6cf12-8269-4677-a1eb-2e72800c3897"
      unitRef="shares">17000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTA5OTUxMTYyODcxMTA_cbebb887-4218-4bec-a504-959649310bad">SEGMENTS OF BUSINESS AND GEOGRAPHIC AREAS&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;SALES BY SEGMENT OF BUSINESS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:35.144%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.633%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.643%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Third Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent&lt;br/&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Consumer Health*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Skin Health/Beauty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Baby Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Wound Care/Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;"&gt;TOTAL &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"&gt;Consumer Health&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;* Previously referred to as Consumer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:35.144%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.633%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.643%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;PHARMACEUTICAL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Immunology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;&#160;REMICADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S. Exports&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;42.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;SIMPONI / SIMPONI ARIA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;STELARA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;TREMFYA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;54.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;78.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER IMMUNOLOGY&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Infectious Diseases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;EDURANT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / rilpivirine&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;PREZISTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / PREZCOBIX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; /  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;                         &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;                     REZOLSTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / SYMTUZA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER INFECTIOUS DISEASES&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:35.144%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.633%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.643%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Neuroscience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;CONCERTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / methylphenidate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(49.2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(22.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / XEPLION&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / INVEGA   TRINZA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / TREVICTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;&#160;RISPERDAL CONSTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER NEUROSCIENCE&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Oncology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;DARZALEX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;46.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;41.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;ERLEADA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;407&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;194&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;112&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;519&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;216&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;IMBRUVICA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;VELCADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(51.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(51.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt; / &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;abiraterone acetate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(75.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(53.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:35.144%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.633%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.643%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER ONCOLOGY&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pulmonary Hypertension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OPSUMIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;&#160;UPTRAVI&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER PULMONARY HYPERTENSION&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(32.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cardiovascular / Metabolism / Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;&#160;PROCRIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / EPREX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(45.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(44.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(33.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;TOTAL PHARMACEUTICAL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:35.144%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.633%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.643%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;MEDICAL DEVICES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interventional Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;HIPS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(19.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;KNEES&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(19.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(24.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(31.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(24.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;TRAUMA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;SPINE, SPORTS &amp;amp; OTHER&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;ADVANCED&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;GENERAL&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(29.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(19.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;CONTACT LENSES / OTHER&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:35.144%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.633%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.643%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;SURGICAL&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(36.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(25.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;TOTAL MEDICAL DEVICES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;WORLDWIDE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;61,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;*Percentage greater than 100% or not meaningful&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;EARNINGS BEFORE PROVISION FOR TAXES BY SEGMENT  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.710%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:36.109%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.365%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.219%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.475%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.365%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.219%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.192%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Third Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent&lt;br/&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Consumer Health &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(70.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(44.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Pharmaceutical&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(222)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Medical Devices&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(3)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(27.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(55.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Segment earnings before provision for taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Less: Expense not allocated to segments&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt; (4)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Worldwide income before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;*Percentage greater than 100% or not meaningful&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Consumer Health&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes a gain of $0.3 billion related to the Company's previously held equity investment in Ci:z Holdings Co., Ltd. (DR. CI: LABO) in the fiscal nine months of 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt;"&gt;Includes litigation expense of $0.5&#160;billion in the fiscal third quarter of 2020, primarily talc related costs, including certain settlements. Includes litigation expense of $1.2&#160;billion and $0.2&#160;billion in both the fiscal nine months of 2020 and 2019, primarily talc related costs, including certain settlements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes amortization expense of $0.1 billion in both the fiscal third quarters of 2020 and 2019, respectively and $0.3&#160;billion in both the fiscal nine months of 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes a restructuring related charge of $0.1&#160;billion in both the fiscal nine months of 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes an in-process research and development expense of $0.9 billion related to the Alios asset in the fiscal nine months of 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes litigation expense of $1.0&#160;billion and $4.0&#160;billion in the fiscal third quarters of 2020 and 2019 and $1.0&#160;billion and $4.3 billion in the fiscal nine months of 2020 and 2019, respectively. Litigation expense in all periods is primarily related to the agreement in principle to settle opioid litigation. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes an unrealized loss on securities of $0.1&#160;billion in the fiscal third quarter of 2019. Includes an unrealized gain on securities of $0.2&#160;billion in both the fiscal nine months of 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes a research and development expense of $0.3 billion in the fiscal nine months of 2019, for an upfront payment related to argenx. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes amortization expense of $0.8 billion in both the fiscal third quarters of 2020 and 2019. Includes amortization expense of $2.4&#160;billion in both the fiscal nine months of 2020 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes a restructuring related charge of $0.1&#160;billion in both the fiscal nine months of 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes Actelion acquisition related costs of $0.1&#160;billion in the fiscal nine months of 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;In the fiscal second and third quarters of 2020, the Company entered into a series of contract manufacturing arrangements for vaccine production with third party contract manufacturing organizations. These arrangements provide the Company with future supplemental commercial capacity for vaccine production and potentially transferable rights to such production if capacity is not required. Amounts paid and contractually obligated to be paid to these contract manufacturing organizations of approximately $0.8&#160;billion are reflected in the prepaid expenses and other, other assets, accrued liabilities and other liabilities accounts in the Company's consolidated balance sheet upon execution of each agreement. Additionally, the Company has entered into certain vaccine development cost sharing arrangements with government related organizations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:96%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(3) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Medical Devices &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes a contingent consideration reversal of $0.2&#160;billion in the fiscal third quarter of 2020 and $1.1 billion in the fiscal nine months of 2020 related to the timing of certain developmental milestones associated with the Auris Health acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes a gain of $2.0&#160;billion from the divestiture of the ASP business in the fiscal nine months of 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes litigation expense of $0.3&#160;billion in the fiscal nine months of 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes a restructuring related charge of $0.1 billion and amortization expense of $0.2 billion in both the fiscal third quarters of 2020 and 2019.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes a restructuring related charge of $0.2&#160;billion and amortization expense of $0.7&#160;billion in both the fiscal nine months of 2020 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes an in-process research and development expense of $0.1&#160;billion in the fiscal third quarter of 2020 and fiscal nine months of 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(4)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Amounts not allocated to segments include interest income/expense and general corporate income/expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;SALES BY GEOGRAPHIC AREA&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.275%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:32.038%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.529%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.994%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.529%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.410%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.529%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.243%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.821%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.994%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.821%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.410%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.529%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.253%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Third Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent&lt;br/&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Western Hemisphere, excluding U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Asia-Pacific, Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;61,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <jnj:SalesBySegmentOfBusinessTableTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMzM0NA_61652f19-e9b7-4793-858e-e9733c266f09">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;SALES BY SEGMENT OF BUSINESS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:35.144%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.633%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.643%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Third Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent&lt;br/&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Consumer Health*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Skin Health/Beauty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Baby Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Wound Care/Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;"&gt;TOTAL &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"&gt;Consumer Health&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;* Previously referred to as Consumer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:35.144%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.633%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.643%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;PHARMACEUTICAL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Immunology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;&#160;REMICADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S. Exports&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;42.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;SIMPONI / SIMPONI ARIA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;STELARA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;TREMFYA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;54.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;78.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;30.2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER IMMUNOLOGY&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Infectious Diseases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;EDURANT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / rilpivirine&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;PREZISTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / PREZCOBIX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; /  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;                         &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;                     REZOLSTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / SYMTUZA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER INFECTIOUS DISEASES&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(26.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:35.144%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.633%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.643%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Neuroscience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;CONCERTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / methylphenidate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(49.2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(22.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / XEPLION&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / INVEGA   TRINZA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / TREVICTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;&#160;RISPERDAL CONSTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER NEUROSCIENCE&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Oncology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;DARZALEX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;46.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;41.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;ERLEADA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;407&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;194&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;112&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;519&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;216&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;IMBRUVICA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;VELCADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(51.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(51.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt; / &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;abiraterone acetate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(75.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(53.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:35.144%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.633%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.643%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER ONCOLOGY&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pulmonary Hypertension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OPSUMIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;&#160;UPTRAVI&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER PULMONARY HYPERTENSION&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(32.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cardiovascular / Metabolism / Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;&#160;PROCRIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / EPREX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(45.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(44.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(33.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;TOTAL PHARMACEUTICAL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:35.144%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.633%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.643%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;MEDICAL DEVICES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interventional Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;HIPS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(19.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;KNEES&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(19.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(24.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(31.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(24.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;TRAUMA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;SPINE, SPORTS &amp;amp; OTHER&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;ADVANCED&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;GENERAL&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(29.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(19.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;CONTACT LENSES / OTHER&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:35.144%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.633%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.234%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.643%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;SURGICAL&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(36.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(25.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;TOTAL MEDICAL DEVICES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;WORLDWIDE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,996&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;61,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;*Percentage greater than 100% or not meaningful&lt;/span&gt;&lt;/div&gt;</jnj:SalesBySegmentOfBusinessTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d95454e2f2b47bba671c0f16ef3678d_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNS0yLTEtMS0w_727d99e7-3871-4a78-8f43-ba3ce8f67cb8"
      unitRef="usd">601000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i55c350243936480182afafc99c54f755_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNS00LTEtMS0w_5408856d-4869-4dc0-a089-acaded9385d3"
      unitRef="usd">477000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6d95454e2f2b47bba671c0f16ef3678d_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNS02LTEtMS0w_abc4d10b-70d1-4b3f-9169-cc4d92ebe3be"
      unitRef="number">0.260</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b916937f8b4417f970a191c21a50d7b_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNS04LTEtMS0w_bf6e7cec-5ad8-4814-8297-bbcb85b304af"
      unitRef="usd">1917000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icbdf62a6d4e04d9497cf6a3f7fe73fcc_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNS0xMC0xLTEtMA_aa3fd878-cc24-4d7e-8d67-ffa775533943"
      unitRef="usd">1468000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8b916937f8b4417f970a191c21a50d7b_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNS0xMi0xLTEtMA_5658b929-c77f-4466-87ca-028ceab6c30d"
      unitRef="number">0.306</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38c6793cfc6744c19666a02341ec9b31_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNi0yLTEtMS0w_6fb5b9ff-8119-4aa0-97fe-13dc1f41c62c"
      unitRef="usd">541000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieeebc720734846059822e5b88d5728d4_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNi00LTEtMS0w_4724dafb-0df3-441c-8771-0ae36066b56b"
      unitRef="usd">621000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i38c6793cfc6744c19666a02341ec9b31_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNi02LTEtMS0w_17070885-2ea1-49e0-9913-c5e133a7bd8c"
      unitRef="number">-0.129</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic3b1c962253f40358196e13a8dba4ab4_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNi04LTEtMS0w_1a38645e-af1a-4df1-93fd-7f5ccc6d7a7b"
      unitRef="usd">1722000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2da046285a854cbfba8fbfe14771ce6a_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNi0xMC0xLTEtMA_81cad5a5-e577-4b25-8b47-077b8b2a365b"
      unitRef="usd">1781000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic3b1c962253f40358196e13a8dba4ab4_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNi0xMi0xLTEtMA_888d55f1-a03f-4acd-8fc1-7033b8f838fc"
      unitRef="number">-0.033</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9b2fae840754a6ea4f68f1acc7268f9_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNy0yLTEtMS0w_50cb0e58-c5ec-44a4-9b2f-59caf059d55f"
      unitRef="usd">1142000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id933df11eed64928a3b3481a8a126bb8_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNy00LTEtMS0w_b3d8d279-51d4-4187-9b16-a4ba5743f8ac"
      unitRef="usd">1098000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia9b2fae840754a6ea4f68f1acc7268f9_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNy02LTEtMS0w_80a73f33-1e65-4c9d-85e7-7c27ea4864fe"
      unitRef="number">0.040</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ffccfe4dfab435e94684d4fcf3d976f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNy04LTEtMS0w_4d09ef2e-03c2-43d6-9d64-d94135b2a9ec"
      unitRef="usd">3639000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie757ee9c942f4859aab86954bd239d38_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNy0xMC0xLTEtMA_d6049b6e-46a1-4a7d-957e-5afc00132d5a"
      unitRef="usd">3249000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9ffccfe4dfab435e94684d4fcf3d976f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNy0xMi0xLTEtMA_ce86ba12-3aa8-4483-951f-eb324e9b60e6"
      unitRef="number">0.120</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i735a40d88d7e46dc9295f42c61e9310a_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOS0yLTEtMS0w_a92fde9f-a785-4973-86d8-c095cca7e858"
      unitRef="usd">572000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4183cb021584ec6b8420859ed1b2c0d_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOS00LTEtMS0w_676a812c-5a49-49f6-aa18-cd492226150c"
      unitRef="usd">559000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i735a40d88d7e46dc9295f42c61e9310a_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOS02LTEtMS0w_c7ccd5c1-5575-498b-a1e7-0906fa8aed04"
      unitRef="number">0.024</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9db0932464f74a4a8916179795da088d_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOS04LTEtMS0w_68536cd5-1ad4-44c5-a2c8-314ba79d5c42"
      unitRef="usd">1767000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8013563982e4faf92e1d4712047488c_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOS0xMC0xLTEtMA_2b9164fb-4947-43e9-928d-fc0ac0f70231"
      unitRef="usd">1810000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9db0932464f74a4a8916179795da088d_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOS0xMi0xLTEtMA_886b97d8-fde6-4a8a-b0df-9e02536ff560"
      unitRef="number">-0.024</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice288e8c219a4507ad03507ff5dd2f25_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAtMi0xLTEtMA_311584f6-2543-49c6-8f42-ec4879593f01"
      unitRef="usd">577000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6167e7598a3a497a987f9d52e44c47c0_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAtNC0xLTEtMA_b13055aa-108b-4cff-8dd9-c6d13b905f96"
      unitRef="usd">592000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ice288e8c219a4507ad03507ff5dd2f25_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAtNi0xLTEtMA_89769b5e-d8ad-4d83-bb1e-7b60185b52ed"
      unitRef="number">-0.027</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife45c684b85a4e89bfaae65632c76bed_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAtOC0xLTEtMA_0acd2edf-3dab-4371-9101-d3d45eeac7c8"
      unitRef="usd">1506000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2317353ffc6a4b6699b4670f8065adb7_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAtMTAtMS0xLTA_532dc4b4-7f33-4042-b60c-630352b314aa"
      unitRef="usd">1633000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ife45c684b85a4e89bfaae65632c76bed_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAtMTItMS0xLTA_7f3f9b26-12b0-4558-a9ac-42ea0541758d"
      unitRef="number">-0.078</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3cf576db9a634f2bbe83401cc15ae8ad_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEtMi0xLTEtMA_6c5df7c6-7a55-4e12-8cf8-b7200e63a438"
      unitRef="usd">1149000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5501bef72d543db9d17b8fb2870aa8f_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEtNC0xLTEtMA_7fdef7ab-3f67-4bbf-8f41-90e01a7988ae"
      unitRef="usd">1151000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i3cf576db9a634f2bbe83401cc15ae8ad_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEtNi0xLTEtMA_3989ff95-df78-4bd4-8495-6be480303b55"
      unitRef="number">-0.002</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d0c5dfa391d4390b7907e241d878e21_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEtOC0xLTEtMA_e61f5432-b233-4038-8fb0-ead08fae6389"
      unitRef="usd">3273000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b497129d20c4ad3a9e5f5c96133de85_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEtMTAtMS0xLTA_2bb3acc1-20b3-4402-a626-9b92009809a3"
      unitRef="usd">3443000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6d0c5dfa391d4390b7907e241d878e21_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEtMTItMS0xLTA_de238902-3740-4527-bdd9-b3e6db9679dc"
      unitRef="number">-0.050</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib88a939963264141828fb4d58e203838_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMtMi0xLTEtMA_59ce40e0-7e48-414c-aab1-224aad208e5e"
      unitRef="usd">164000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iccf1e8f3a0074a97b0f52772a56a8633_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMtNC0xLTEtMA_6a59cff3-ba7d-44ca-b755-38e2276bf953"
      unitRef="usd">156000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib88a939963264141828fb4d58e203838_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMtNi0xLTEtMA_8869bebe-7f71-4a97-b610-383733d56588"
      unitRef="number">0.055</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9bb84639aa354224b5d50732c027f3ca_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMtOC0xLTEtMA_dd3e4ecf-abbd-4133-9ae9-2651bc408bae"
      unitRef="usd">510000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i72078429833b482abb75ff2f963b1c95_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMtMTAtMS0xLTA_c4b36296-ccf8-4910-b115-37fc3b72315c"
      unitRef="usd">462000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9bb84639aa354224b5d50732c027f3ca_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMtMTItMS0xLTA_1b68506a-82e9-4c1a-a94b-2fcda7ada22e"
      unitRef="number">0.104</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a72efbbc13f4a9899424dc34768f292_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQtMi0xLTEtMA_0db0a5d2-a5fb-4a1d-b68b-f69741e5887c"
      unitRef="usd">248000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d8fa9621c1a4788aeed3179569fe294_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQtNC0xLTEtMA_56901577-b88f-4003-be37-484ec3fba7d0"
      unitRef="usd">223000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i1a72efbbc13f4a9899424dc34768f292_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQtNi0xLTEtMA_f87fa9c6-ce49-42c3-aa05-0316a8fd64c1"
      unitRef="number">0.107</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a9f94d741d04069bba045fd793e2102_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQtOC0xLTEtMA_3bc23450-ce6e-41fd-b241-f6a2f55f56c9"
      unitRef="usd">694000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i282eb35f5a6f4308a0133f28f9e9fe51_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQtMTAtMS0xLTA_3d1d1986-30b5-4751-a3b0-7ee42a7a8557"
      unitRef="usd">673000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7a9f94d741d04069bba045fd793e2102_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQtMTItMS0xLTA_ff02c864-ba96-4bb2-8059-f902d679f4b8"
      unitRef="number">0.030</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86ef51c7d032407cb30caef60d2e438e_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUtMi0xLTEtMA_b91e2bda-c34b-4c50-ae31-94cb797274e5"
      unitRef="usd">412000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1fc5a0ba168445cf92dcf88ef880150d_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUtNC0xLTEtMA_54fa346a-61a9-4d64-89f4-dcdf61e0a631"
      unitRef="usd">379000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i86ef51c7d032407cb30caef60d2e438e_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUtNi0xLTEtMA_d4af2685-831a-4555-94be-d2d76ef091d0"
      unitRef="number">0.085</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d63809b7b464394a1928e0d87c2b8e9_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUtOC0xLTEtMA_6256343a-23da-49c2-b1e4-b655dd083b3c"
      unitRef="usd">1204000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1d3e97e875047218ce5d543119f6e23_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUtMTAtMS0xLTA_72fd6458-4ad2-475d-a98e-efc76d1ba335"
      unitRef="usd">1135000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i3d63809b7b464394a1928e0d87c2b8e9_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUtMTItMS0xLTA_609acff0-8da9-4604-a8b7-726de2af5947"
      unitRef="number">0.060</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e589fe2a250489bae1d93a267c01624_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTctMi0xLTEtMA_4cfc0c5e-9fc1-4a3b-811f-281e9127b803"
      unitRef="usd">91000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibc8fefdc8c3146ef985668dfce568821_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTctNC0xLTEtMA_44143392-f06b-4125-8b13-434b5c82bef2"
      unitRef="usd">91000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9e589fe2a250489bae1d93a267c01624_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTctNi0xLTEtMA_7b117333-17bf-4ca7-adc3-d78c39f0c2ee"
      unitRef="number">-0.010</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0e7b1947201413e85946bcaada77275_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTctOC0xLTEtMA_ab468d4c-323f-488c-aa37-fae12dc54028"
      unitRef="usd">279000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i14fbc68dbd2745caa0dcaf30d0e59cd9_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTctMTAtMS0xLTA_f96d2bd9-44ca-4d15-b2de-8fe7a5aeb7b7"
      unitRef="usd">277000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id0e7b1947201413e85946bcaada77275_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTctMTItMS0xLTA_080a783c-fbd1-4562-a236-d3e18d70744d"
      unitRef="number">0.005</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee45030c44e44d0aaff586a9a06e0532_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgtMi0xLTEtMA_0875c8a0-4555-4d9e-82d6-209c76896674"
      unitRef="usd">302000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61637434781b4c8998469b74ad8a39e4_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgtNC0xLTEtMA_10299d3e-6738-457a-a320-876e1b35c624"
      unitRef="usd">326000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iee45030c44e44d0aaff586a9a06e0532_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgtNi0xLTEtMA_d00919bd-b9ba-486e-86bd-907bb9ea4224"
      unitRef="number">-0.072</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63c4e377a3ae40f4bcb7d5a4e5f8b84b_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgtOC0xLTEtMA_6ad34abd-1387-4716-bacf-abb7b3909d56"
      unitRef="usd">831000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61b21fa64d6040eb9fbae0bbae8c3b11_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgtMTAtMS0xLTA_f878c01a-019c-47d8-83a9-426cea9cb961"
      unitRef="usd">977000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i63c4e377a3ae40f4bcb7d5a4e5f8b84b_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgtMTItMS0xLTA_d6e11cb5-722e-497e-be9c-d2f75e9fae90"
      unitRef="number">-0.149</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58e8bc1a90394483be831705847d06fd_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTktMi0xLTEtMA_a71bd14c-3dd6-4a5f-8678-9b6ef7774a40"
      unitRef="usd">393000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia03a4e20bbbf43c28052fd90303aab5e_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTktNC0xLTEtMA_71a08f9c-6ad5-4ac8-a58d-9a99f5bcd92d"
      unitRef="usd">417000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i58e8bc1a90394483be831705847d06fd_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTktNi0xLTEtMA_d132d79b-73d5-4533-845e-c41232b465d4"
      unitRef="number">-0.059</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc43c3a1acde44b7a8a4d40d89e4efd5_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTktOC0xLTEtMA_ec334b3e-d45f-434c-b4a2-d9430d478636"
      unitRef="usd">1110000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id798043e75334798bf5217fb399c1997_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTktMTAtMS0xLTA_957ebc11-c498-4d9f-8723-dca5ca0cb74f"
      unitRef="usd">1254000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ifc43c3a1acde44b7a8a4d40d89e4efd5_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTktMTItMS0xLTA_3df92172-ebeb-4b50-83ce-238cf19e1767"
      unitRef="number">-0.115</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4cf6ca49a8e404cbbfb2fcf0ee82a44_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEtMi0xLTEtMA_9b6c8b2f-fb7f-4090-9dbe-c2550173a404"
      unitRef="usd">3000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d496bd90754417ebede4d9829a52df5_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEtNC0xLTEtMA_bb032b1f-37e3-4ef4-ba1f-201d07ddda6a"
      unitRef="usd">3000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib4cf6ca49a8e404cbbfb2fcf0ee82a44_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEtNi0xLTEtMA_9bd5ac5e-2096-4c21-834c-49fbdee2bada"
      unitRef="number">-0.069</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib0d8e990787d47c0b75a6b3923da8b2b_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEtOC0xLTEtMA_5cbf3441-1ba9-4851-84f3-e73d159cb9b0"
      unitRef="usd">10000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ae786e5f2804cd8b49c7613a74391d2_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEtMTAtMS0xLTA_2ca675c7-1773-4f85-86be-adb557f50969"
      unitRef="usd">9000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib0d8e990787d47c0b75a6b3923da8b2b_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEtMTItMS0xLTA_b4c6698e-2cb4-481e-9ea3-79ac2db34fc6"
      unitRef="number">0.073</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5751770904eb4b40aae931e43968e339_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjItMi0xLTEtMA_6cdd421a-1c92-4c42-a553-c28dbdd0143c"
      unitRef="usd">227000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if752582ef2ea49b69e87bafa1de27a77_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjItNC0xLTEtMA_8d99dde9-8634-4c2c-8849-57bac5425c3b"
      unitRef="usd">252000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i5751770904eb4b40aae931e43968e339_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjItNi0xLTEtMA_83353576-924c-4b94-a568-8579aa70f4b4"
      unitRef="number">-0.096</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie724f8c70c1e47fa9a3509c07877098c_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjItOC0xLTEtMA_ba6f578b-c74d-4926-8b1d-b828691dedde"
      unitRef="usd">654000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4c4a17d7588422db6a82c1ac5960f10_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjItMTAtMS0xLTA_03648b64-5098-4bc1-9dd3-3c4aefa7a297"
      unitRef="usd">724000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie724f8c70c1e47fa9a3509c07877098c_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjItMTItMS0xLTA_4be1daa7-0fd0-47f9-9f4c-179cb5f6cc48"
      unitRef="number">-0.096</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4360908e63cc43f4afd75a1169c42e6a_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMtMi0xLTEtMA_5778d179-da36-47c9-81ba-2f609357aeeb"
      unitRef="usd">230000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i585883c87d6f468ebbe4454a07b867aa_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMtNC0xLTEtMA_f1b5c7cd-e458-48a1-9f00-26003f33099e"
      unitRef="usd">255000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i4360908e63cc43f4afd75a1169c42e6a_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMtNi0xLTEtMA_252a1e0a-08af-41c9-9fb0-e5a57d40e267"
      unitRef="number">-0.096</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae3a3a38435f49649638b494f6bccee6_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMtOC0xLTEtMA_759f52ca-1a6f-45a7-9803-4964d3094acf"
      unitRef="usd">664000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iede096f8f0704067b69be6dae6af81dc_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMtMTAtMS0xLTA_98e01d98-2dc0-46df-bd18-d34c909b5e93"
      unitRef="usd">733000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iae3a3a38435f49649638b494f6bccee6_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMtMTItMS0xLTA_2df32704-9b21-4870-8f18-8e33849340f1"
      unitRef="number">-0.094</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7c75ec32bd0476981aaefd378fca34c_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjUtMi0xLTEtMA_9cc1a9e1-a980-46dd-947d-930cd5370949"
      unitRef="usd">125000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7eb47e278e24b51ba738fd66bd6e91e_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjUtNC0xLTEtMA_2eaee0ce-6c3b-4140-a4cf-6c6d9875fe5e"
      unitRef="usd">109000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia7c75ec32bd0476981aaefd378fca34c_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjUtNi0xLTEtMA_b3b9d341-12cc-4e9f-849d-0f2b7a7ba6df"
      unitRef="number">0.152</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i95d2bc3ef16c46d9b02250368f6f79fe_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjUtOC0xLTEtMA_39b64e6d-2ed0-4b0e-b044-b1a7a1995fd6"
      unitRef="usd">370000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19f91fce38e74e8abff653dd29e4e05b_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjUtMTAtMS0xLTA_b028a6d9-26dd-4d02-a00e-5674e7538387"
      unitRef="usd">343000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i95d2bc3ef16c46d9b02250368f6f79fe_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjUtMTItMS0xLTA_cf6b20c3-8e7d-429d-ad92-3a4aad456a89"
      unitRef="number">0.080</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08464ba4d52a4eb3914d1d9e020164be_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjYtMi0xLTEtMA_d8fabea5-b1de-49db-92c9-0408c991c8c5"
      unitRef="usd">64000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33b4445ad1ea4e698cc11d61facc127b_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjYtNC0xLTEtMA_bba5fa02-ca03-4665-9f2a-6af8ee750650"
      unitRef="usd">59000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i08464ba4d52a4eb3914d1d9e020164be_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjYtNi0xLTEtMA_db45a4c7-21df-43a2-8056-a4abac870d34"
      unitRef="number">0.074</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i077f80fe22fa40258a7a8564873d966a_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjYtOC0xLTEtMA_76383be8-3e9b-4385-b013-e2b9c1626564"
      unitRef="usd">175000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ddf71a7398d40838d9e518d97fe48b0_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjYtMTAtMS0xLTA_61deae16-7ad8-4bae-8928-d3b2771cb7c1"
      unitRef="usd">173000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i077f80fe22fa40258a7a8564873d966a_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjYtMTItMS0xLTA_6667fe63-b4d9-49cb-b4bf-8aad9d036fdb"
      unitRef="number">0.013</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2686d4d38b79478aa2b6dcfb62ab0339_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjctMi0xLTEtMA_0366fb34-79df-41bc-a9e2-e7c7004d586a"
      unitRef="usd">189000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if59b92da44574ef0b138a6fef376b519_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjctNC0xLTEtMA_c21c75a2-3c23-4ee8-9d68-79df4e3fac8b"
      unitRef="usd">168000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i2686d4d38b79478aa2b6dcfb62ab0339_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjctNi0xLTEtMA_0120a0bc-3f25-4188-bf73-251ae533e0e2"
      unitRef="number">0.125</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie69aec39506048e693f8810a2bec2f05_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjctOC0xLTEtMA_ac92b66d-337a-49bd-8c0b-cb7c24fdc31d"
      unitRef="usd">545000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99ad086b9b774548b75e48c3ae0dd0a6_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjctMTAtMS0xLTA_0f2c8790-8f3b-4b51-81ca-d123a046662c"
      unitRef="usd">516000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie69aec39506048e693f8810a2bec2f05_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjctMTItMS0xLTA_3ac699f4-ee59-4dd8-a8db-e29c6e1a9ef6"
      unitRef="number">0.058</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8fd225a39cf14e8fb13dbb1438b30e84_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjktMi0xLTEtMA_517e1906-ca50-4405-a098-17f10d0a2ea9"
      unitRef="usd">1556000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0494a1212b6c4384ad100f4b232c73a5_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjktNC0xLTEtMA_70815ddf-9f10-46f8-83b0-9d4788b3b3f3"
      unitRef="usd">1394000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8fd225a39cf14e8fb13dbb1438b30e84_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjktNi0xLTEtMA_afc61fb7-2b6d-4047-a1e6-5dc63ada0b15"
      unitRef="number">0.116</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a475264ce8941ce924ce89da6c1b1f8_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjktOC0xLTEtMA_4ae02f90-2c3b-4123-afe7-6466c864f139"
      unitRef="usd">4853000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i62a183893e91467983b0dbd1d2467359_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjktMTAtMS0xLTA_39c26e8d-da75-4353-8036-fcc6675d642f"
      unitRef="usd">4369000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i4a475264ce8941ce924ce89da6c1b1f8_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjktMTItMS0xLTA_27e6aaa5-db9e-473a-b860-210727426a9c"
      unitRef="number">0.111</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7721a842d6e04cd68272b2ceb8cd492d_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzAtMi0xLTEtMA_012a4f9b-95fe-4fe9-a90d-164828272161"
      unitRef="usd">1958000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie377154beabf45b18b5f586329899114_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzAtNC0xLTEtMA_a554a69e-11a6-4bfb-885b-2602e65d5d6e"
      unitRef="usd">2075000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7721a842d6e04cd68272b2ceb8cd492d_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzAtNi0xLTEtMA_3a7df013-cea8-437d-81c0-7a0dc4238cb1"
      unitRef="number">-0.056</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae10ea720f56417c9b64a77097323def_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzAtOC0xLTEtMA_7b4c5e6a-5ffa-4809-8a54-39dab63e2532"
      unitRef="usd">5582000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7d047e2d661467cbcc58d9b0a2b8f87_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzAtMTAtMS0xLTA_c953d3cb-ef58-4a45-ac36-bbeabfeb75d0"
      unitRef="usd">5962000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iae10ea720f56417c9b64a77097323def_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzAtMTItMS0xLTA_ec20e509-bbd4-4ec1-bacd-d91afd0869c0"
      unitRef="number">-0.064</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a3e920df42c47f494f7fad0bdd00892_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzEtMi0xLTEtMA_1a6d1608-62fb-4d71-bd6e-fc7bab462798"
      unitRef="usd">3514000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if1f5496c4f57420a9c9179ba0ecf286a_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzEtNC0xLTEtMA_53e4bf7e-04c4-4a2c-93bc-e2340c613514"
      unitRef="usd">3469000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i5a3e920df42c47f494f7fad0bdd00892_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzEtNi0xLTEtMA_186206c4-8148-49c2-b796-d7bbffcbe0f4"
      unitRef="number">0.013</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i498b81f2554f4e868dce4daa5736066a_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzEtOC0xLTEtMA_f0066b71-8f0f-4362-8610-cbbe344447ae"
      unitRef="usd">10435000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i80fc979b7821412b9354bc3c8c18f543_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzEtMTAtMS0xLTA_b7d6e28f-4ff8-47f7-a8b8-feed5a78b166"
      unitRef="usd">10331000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i498b81f2554f4e868dce4daa5736066a_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzEtMTItMS0xLTA_51d42475-d5ea-4a1a-b9f2-5f520c83ad76"
      unitRef="number">0.010</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0580a0f80a854712a683ccfae2bc01c7_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzYtMi0xLTEtMA_9193bd3a-2905-4bcf-9538-016150a8f324"
      unitRef="usd">2558000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i20a3b648a6b14250804ce2ee299db44a_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzYtNC0xLTEtMA_ad0a40bd-8b34-4cc3-94b2-0ead0002cf99"
      unitRef="usd">2582000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i0580a0f80a854712a683ccfae2bc01c7_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzYtNi0xLTEtMA_0cd7ae87-266e-452a-b11e-96a3415dc181"
      unitRef="number">-0.009</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4377262270cc41a59014888c45de668a_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzYtOC0xLTEtMA_2e945b40-60d0-4352-b9b1-14abd7066a32"
      unitRef="usd">7330000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1ac04085de547c09d5d0c96ced99ebf_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzYtMTAtMS0xLTA_b3d0170f-b239-4640-b053-9858f7a8ccfa"
      unitRef="usd">7124000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i4377262270cc41a59014888c45de668a_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzYtMTItMS0xLTA_1f9e17f9-5cdb-4343-ae34-4e882e6c023d"
      unitRef="number">0.029</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08189f8df3194c738e0366b591e994da_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzctMi0xLTEtMA_6b5d4a40-bbb5-4142-b44f-0da46468cb43"
      unitRef="usd">1230000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a49b61963434f44bc5c32db3f151981_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzctNC0xLTEtMA_0b922529-90e9-449e-974c-955cbbf6be99"
      unitRef="usd">1129000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i08189f8df3194c738e0366b591e994da_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzctNi0xLTEtMA_e179fed7-48f6-4db8-8c26-df3407c26766"
      unitRef="number">0.090</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4107f09a348348f5836beb164c41a295_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzctOC0xLTEtMA_62743cb2-5a0f-417f-bad2-182bea695709"
      unitRef="usd">3619000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia54c27d99b0c4b6e8967c1db2422520a_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzctMTAtMS0xLTA_ae8a90f3-0ceb-46bb-812b-05bd7e8c0de3"
      unitRef="usd">3304000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i4107f09a348348f5836beb164c41a295_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzctMTItMS0xLTA_4128ec6e-0968-4662-9916-9b66dff52680"
      unitRef="number">0.095</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28a313fee6cc48c980ee757740247668_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzgtMi0xLTEtMA_80a4da5a-28ec-4428-9316-0ad9924d0780"
      unitRef="usd">3789000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i57b326234b5040d2924a11d5a5d2f80a_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzgtNC0xLTEtMA_1ee317af-cd3f-4e63-a47b-9b23fb56a4bf"
      unitRef="usd">3711000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i28a313fee6cc48c980ee757740247668_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzgtNi0xLTEtMA_8fad4b43-46d4-4530-87db-9d32d781685b"
      unitRef="number">0.021</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1cced7a8930436b8bb62f6c2b776b00_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzgtOC0xLTEtMA_8e670e53-1a43-443a-846d-f6ece257d2b7"
      unitRef="usd">10950000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i49584bdd90da4200830477e258a1f18a_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzgtMTAtMS0xLTA_018d015a-eea5-423e-ac5a-9e8a46e3aae6"
      unitRef="usd">10428000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib1cced7a8930436b8bb62f6c2b776b00_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMzgtMTItMS0xLTA_a5092ba4-55c3-4e5e-b90c-9efdf9c1ef9f"
      unitRef="number">0.050</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i71de0a16958d4a86a067f40d027e87df_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDAtMi0xLTEtMA_7ba9f29d-581c-4831-8185-0bc942dd8286"
      unitRef="usd">634000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5991575feed545c4b92cb368006afbca_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDAtNC0xLTEtMA_54603e55-9f73-4afd-bd9c-3f18ff9b4d64"
      unitRef="usd">749000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i71de0a16958d4a86a067f40d027e87df_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDAtNi0xLTEtMA_94efead5-39d3-4214-a49d-c99df98484fa"
      unitRef="number">-0.154</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice0ca647d51147ab8d51aff745fcf585_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDAtOC0xLTEtMA_2fd1adc1-012a-472d-9d77-04099e508162"
      unitRef="usd">1852000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d625ffa896248a38279e2b4a29f3219_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDAtMTAtMS0xLTA_ea5d492b-05eb-448e-8e5b-208b98f0a85d"
      unitRef="usd">2324000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ice0ca647d51147ab8d51aff745fcf585_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDAtMTItMS0xLTA_2561d055-3cde-43ad-bc0d-cf01aa12421a"
      unitRef="number">-0.203</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38b3cd6b638a4e2096aef80289a086d8_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDEtMi0xLTEtMA_e6655086-39a2-458a-b6cf-a02806a169e8"
      unitRef="usd">78000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ed049d22c86487cbbb24c08237cf4b6_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDEtNC0xLTEtMA_3dcc631f-0124-4004-b51d-f6224ffb42ab"
      unitRef="usd">88000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i38b3cd6b638a4e2096aef80289a086d8_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDEtNi0xLTEtMA_9fba681c-d98e-406f-8e3b-6ea8030b6416"
      unitRef="number">-0.113</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4bef45a84dc4c01abdc1d98d90dcf34_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDEtOC0xLTEtMA_affd248d-21d2-4ab0-9d2a-e536d858759a"
      unitRef="usd">321000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i600cf308c1784241b70b032c5d68bd00_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDEtMTAtMS0xLTA_7067648f-a49f-46cd-90fe-17e3dd328abb"
      unitRef="usd">226000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic4bef45a84dc4c01abdc1d98d90dcf34_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDEtMTItMS0xLTA_8ce77c1c-cffc-4627-a670-ed9bd39f469e"
      unitRef="number">0.421</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63fb4ada15044f6c8fa99130ea93d6ab_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDItMi0xLTEtMA_7eb1a9e4-f589-4ed5-bd2e-24e10689e2c0"
      unitRef="usd">209000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i79355bad3e5e445082550bcd9d3f6dcf_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDItNC0xLTEtMA_9f760448-2eb7-45ba-b439-44cb95dad2f7"
      unitRef="usd">299000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i63fb4ada15044f6c8fa99130ea93d6ab_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDItNi0xLTEtMA_b9586037-0840-4b3b-a804-013b97491ae6"
      unitRef="number">-0.301</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i898fcee3d0f945379eea001f50fec410_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDItOC0xLTEtMA_e487c4ea-6fd7-4ec5-a5cb-1b932d388b55"
      unitRef="usd">673000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia77eb74fc24d4dee978633e876eeed4c_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDItMTAtMS0xLTA_53cf7a55-50ac-43c8-8d87-814ee865c4f0"
      unitRef="usd">795000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i898fcee3d0f945379eea001f50fec410_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDItMTItMS0xLTA_9b02b5d9-850b-4788-9bbb-f1d20d443da1"
      unitRef="number">-0.153</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd37483bbf104452b66657df9eec0a8e_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDMtMi0xLTEtMA_c0dd4f36-c611-4d54-a7cf-56643f24c4be"
      unitRef="usd">921000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb87e2b919d04ce0890e77ecba398e3c_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDMtNC0xLTEtMA_2b36393a-77ab-4212-a897-3fd951100c40"
      unitRef="usd">1136000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ibd37483bbf104452b66657df9eec0a8e_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDMtNi0xLTEtMA_e75be110-9980-4a70-82a8-86d0ff402ccb"
      unitRef="number">-0.189</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id7fe0e4ddc03461a8b43fc91268211aa_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDMtOC0xLTEtMA_a8c2c32c-fd0c-432e-8982-b86a445736a6"
      unitRef="usd">2846000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4219375293b47b3b667294bccd3f0d2_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDMtMTAtMS0xLTA_065b6568-1b5d-4eaa-8b85-bc3a4c0e3c7e"
      unitRef="usd">3345000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id7fe0e4ddc03461a8b43fc91268211aa_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDMtMTItMS0xLTA_e9bcf6ea-725b-42ef-957c-c2b9c1913a24"
      unitRef="number">-0.149</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie2a1050013c34d03af84c0a422360167_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDUtMi0xLTEtMA_bc775d02-cf3b-45d3-97e8-e1efd1ee56eb"
      unitRef="usd">312000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic3e62d93a7b248c084cbe02d4097ea9b_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDUtNC0xLTEtMA_c5d1e4a1-5600-4f72-b5c1-7b991c250d64"
      unitRef="usd">313000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie2a1050013c34d03af84c0a422360167_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDUtNi0xLTEtMA_fc98b186-67d0-4ee8-a20b-b2b1cde33953"
      unitRef="number">-0.004</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i41d2ba995c114bea8112dc3f01a44747_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDUtOC0xLTEtMA_218f016c-6229-4b08-aa31-296acad49d53"
      unitRef="usd">840000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic1735f2c1b584a5387b7afb371b2cced_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDUtMTAtMS0xLTA_2c2e5c46-6a5f-4591-ab0c-9a87a4dd1109"
      unitRef="usd">857000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i41d2ba995c114bea8112dc3f01a44747_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDUtMTItMS0xLTA_8de9efab-27e7-4ca4-869b-498508b7efc2"
      unitRef="number">-0.020</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3f96f7c0ee0405d828605b25d8ad883_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDYtMi0xLTEtMA_932c1857-4b98-48d9-bf36-17c10113500c"
      unitRef="usd">280000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic017a6711bd74dc0bfa3467c9d21905e_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDYtNC0xLTEtMA_19b4aeb5-0cba-40cb-8b1d-102291271443"
      unitRef="usd">273000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia3f96f7c0ee0405d828605b25d8ad883_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDYtNi0xLTEtMA_eb77629c-2ccf-417a-bdbd-eefc84f2ad3c"
      unitRef="number">0.024</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f8cb419ecd94801b4d8467fb355264b_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDYtOC0xLTEtMA_4d74b81d-062e-4e52-b068-8d5602fd758c"
      unitRef="usd">827000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia794884513314c399f7a15b03dabd0e8_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDYtMTAtMS0xLTA_aecf5a75-13d3-49f6-b154-14ed3b4b2992"
      unitRef="usd">816000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6f8cb419ecd94801b4d8467fb355264b_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDYtMTItMS0xLTA_dee81578-c400-49d4-bb00-81df0942f50c"
      unitRef="number">0.013</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab4590d1e9a54db1808fa18df4d4b0e7_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDctMi0xLTEtMA_cb5f1ca0-32b1-4a9e-91be-c74497be3b57"
      unitRef="usd">592000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3dc4de912284470885b7eab6009487a0_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDctNC0xLTEtMA_60e0f9f0-7b03-4648-b2f8-d03c5f2f46b4"
      unitRef="usd">586000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iab4590d1e9a54db1808fa18df4d4b0e7_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDctNi0xLTEtMA_8929710f-18cf-4555-be37-82d65051ca02"
      unitRef="number">0.009</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a91bcb926e849978bced69fbb28f834_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDctOC0xLTEtMA_40b44fbf-49cb-45b6-a9f3-6a2342064ac2"
      unitRef="usd">1667000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2550784b68a94c5e9a6680ddeb5a5dd9_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDctMTAtMS0xLTA_63e5c077-7b39-44a0-b24b-7cd83e9f3b85"
      unitRef="usd">1673000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8a91bcb926e849978bced69fbb28f834_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDctMTItMS0xLTA_9378faf7-4585-48b8-b20b-884d86e72a1b"
      unitRef="number">-0.004</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id05fcdc5a97449168a9c27235f88a4a3_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDktMi0xLTEtMA_06f6009c-19f0-45e2-a415-5396eca2fbc0"
      unitRef="usd">1313000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae663d548ab040e1b558e27622a655de_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDktNC0xLTEtMA_9488581b-f0d5-445f-b71e-3f1fa071aef0"
      unitRef="usd">1212000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id05fcdc5a97449168a9c27235f88a4a3_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDktNi0xLTEtMA_668281cf-f4a3-4bc6-aa3d-a226aa39740d"
      unitRef="number">0.084</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a44552997a1438b8dd35f1ec093c504_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDktOC0xLTEtMA_ed435b99-e52f-4a0d-9e7c-89da123f0283"
      unitRef="usd">3668000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a72154c44cf41628c31a554960fb0ef_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDktMTAtMS0xLTA_1e6a0c03-2309-4f1e-a679-9f167b0cc470"
      unitRef="usd">3152000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6a44552997a1438b8dd35f1ec093c504_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNDktMTItMS0xLTA_83a5a20f-4b3c-407e-8d9d-971dd62013fc"
      unitRef="number">0.164</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e256d64e1f14cda9becb9ce95293d74_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTAtMi0xLTEtMA_7258354e-a191-4cba-b5db-46e5a16be750"
      unitRef="usd">634000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9f32d7f981b49809c5a26d11cfd4bef_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTAtNC0xLTEtMA_3ff7adf6-bac3-42bb-88a2-f3277ae4b275"
      unitRef="usd">487000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i1e256d64e1f14cda9becb9ce95293d74_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTAtNi0xLTEtMA_11af1dcf-c513-40a4-a8a0-68ec5ffc1d95"
      unitRef="number">0.303</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1fa30f3e8d749dcb44364f361265101_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTAtOC0xLTEtMA_046c0113-c9bf-42c1-816c-93a6f7a2dc01"
      unitRef="usd">1795000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib09c328bd9b9495b850d67bcb81cf0e9_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTAtMTAtMS0xLTA_644a6ea8-6873-4e8f-94fa-cf53b2b9aa3d"
      unitRef="usd">1509000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib1fa30f3e8d749dcb44364f361265101_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTAtMTItMS0xLTA_9f389a16-e6eb-474e-b374-e8eb5de09135"
      unitRef="number">0.190</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7dc3572916fc412292b0f22a60e8ffa9_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTEtMi0xLTEtMA_2f89fb80-a662-4fd7-be4b-7825c7d0e739"
      unitRef="usd">1947000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibfb0a635e286413fa05216c24bd242a7_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTEtNC0xLTEtMA_030fbf1c-9f61-4765-92a0-9f78dc848c05"
      unitRef="usd">1698000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7dc3572916fc412292b0f22a60e8ffa9_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTEtNi0xLTEtMA_42f1747f-3de1-4139-b4f8-94ad0f8faeab"
      unitRef="number">0.147</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc83cb6294cb49adb420c6d0d9a84038_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTEtOC0xLTEtMA_7b6d9a69-71d3-411b-a1f3-8cf75a5964af"
      unitRef="usd">5463000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i24c66572a6274c88bc620e4593e2bee7_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTEtMTAtMS0xLTA_0ef29d08-f513-45e6-b329-366eda2bc734"
      unitRef="usd">4661000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="idc83cb6294cb49adb420c6d0d9a84038_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTEtMTItMS0xLTA_a3eb7245-4d45-4af5-bbe9-6c74a259981e"
      unitRef="number">0.172</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i833f6bdd0ed74fd890f7d87af9bf634b_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTMtMi0xLTEtMA_51306f98-ae36-4377-8157-4dadd881b344"
      unitRef="usd">222000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d16336042034ca19612e535c7203721_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTMtNC0xLTEtMA_3c604d11-b8e4-4b0c-ab73-5c051a2159e8"
      unitRef="usd">221000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i833f6bdd0ed74fd890f7d87af9bf634b_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTMtNi0xLTEtMA_13685dca-56ea-4054-bc2d-85c2a7651e31"
      unitRef="number">0.004</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f0843036b964e08a45d950a3620e639_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTMtOC0xLTEtMA_a3abbfcd-2fc2-492b-873c-be951b7f709e"
      unitRef="usd">650000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic56e7a163c104637a12666dccee0cccf_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTMtMTAtMS0xLTA_18c3079a-e649-4dbc-b092-c5c745945975"
      unitRef="usd">565000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7f0843036b964e08a45d950a3620e639_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTMtMTItMS0xLTA_a8a59c3e-6c89-4615-9136-7115ce6ceefb"
      unitRef="number">0.150</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if0b694b680c54fd3954e2c9de825640c_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTQtMi0xLTEtMA_47e4f4b8-660e-4db2-bcb1-e42f63694860"
      unitRef="usd">105000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i71cf25bbc69049d7a04ce269ab9edbfc_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTQtNC0xLTEtMA_a4787c54-fee9-40b9-98b4-255b78f10671"
      unitRef="usd">69000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if0b694b680c54fd3954e2c9de825640c_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTQtNi0xLTEtMA_48fe275d-0a1b-4c2d-8073-90a60d0678ea"
      unitRef="number">0.544</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9c6b2cd97644d858ea79595de3d0fb8_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTQtOC0xLTEtMA_c2c6ca8d-b4f2-4c33-92ea-143a81d372cb"
      unitRef="usd">316000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7d0e75dc93a4714a87669d7c1755832_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTQtMTAtMS0xLTA_b9fe9194-7006-4095-b509-4f8bea4aad9f"
      unitRef="usd">177000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie9c6b2cd97644d858ea79595de3d0fb8_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTQtMTItMS0xLTA_b81c4793-6cd0-4539-afc8-0d0a748e329c"
      unitRef="number">0.787</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib59aee6a72054b5cb1cbd5bddc82a106_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTUtMi0xLTEtMA_5739e68a-6802-4cab-87c0-2aec3f18b2cb"
      unitRef="usd">327000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6e3f978416814668818a1ac3d0016e08_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTUtNC0xLTEtMA_aac1a686-26f2-459b-b094-3bcb0cac9eca"
      unitRef="usd">290000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib59aee6a72054b5cb1cbd5bddc82a106_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTUtNi0xLTEtMA_481d2512-cb51-40a5-9f55-da0c575b3c1f"
      unitRef="number">0.131</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id5ccf929f2094fa7b1f560a94aef5455_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTUtOC0xLTEtMA_e11d4f2e-7b42-4c8d-b482-a010ccdaa179"
      unitRef="usd">965000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie48cd916e4a74a618757c125457112d0_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTUtMTAtMS0xLTA_3fa35d02-478e-4591-9834-a223ba2f2dd9"
      unitRef="usd">742000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id5ccf929f2094fa7b1f560a94aef5455_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTUtMTItMS0xLTA_1acb2122-e8b7-4b9e-8390-53401efd9f3d"
      unitRef="number">0.302</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i31dea148331149cca5a80f720044788b_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTctMi0xLTEtMA_c14a4e50-ad33-4d7a-b7d5-d07c56bb2a98"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iecdff515762e495ab6fc8d22e512e250_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTctNC0xLTEtMA_1de43011-3f19-4342-b36a-b9ede38cdd8a"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i31dea148331149cca5a80f720044788b_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTctNi0xLTEtMA_a3fd018e-141a-4468-8e9e-63b6a3cc97ee"
      unitRef="number">0</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1be2f593ae2b4c93ac28c4879f064560_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTctOC0xLTEtMA_ce569cfe-a01d-410c-a384-0d29586e0128"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d8ceba2b66d44b3a34e55b430bf0cd0_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTctMTAtMS0xLTA_608a5637-a2e2-47d8-bdcf-676f11f52c1d"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i1be2f593ae2b4c93ac28c4879f064560_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTctMTItMS0xLTA_346b8333-39b6-4935-9604-4d346b1a9ee8"
      unitRef="number">0</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie11aec75a6e74827a118fcb88d74e00f_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTgtMi0xLTEtMA_1d7c7cd5-0fa4-44e3-96d9-6e4e26a49d10"
      unitRef="usd">3000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97c1b4ea6d1a4ecb97e3016e1eee457b_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTgtNC0xLTEtMA_20c6249f-75ee-4803-bdb2-67a0bac67ee8"
      unitRef="usd">2000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie11aec75a6e74827a118fcb88d74e00f_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTgtNi0xLTEtMA_d7f6c23c-50e4-4c7f-af02-bc115ac7648b"
      unitRef="number">0.356</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d39e83bc807453883a50f25b55fa036_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTgtOC0xLTEtMA_d9da2e93-f24e-4332-b9f5-87b318af95ae"
      unitRef="usd">9000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04e9c913340f4fd9bd58f8191b92c901_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTgtMTAtMS0xLTA_c02f8350-1269-42af-b779-2c86b279a6e0"
      unitRef="usd">8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i5d39e83bc807453883a50f25b55fa036_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTgtMTItMS0xLTA_dbd46207-b623-48ec-a267-ff4f91e74a25"
      unitRef="number">0.124</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27a5631c2fb54ff69c55c3cfd8c73d66_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTktMi0xLTEtMA_09df019d-58c5-4f3b-9327-e9dbff41b9c0"
      unitRef="usd">3000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7577089dcd244daaab8e65459409715a_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTktNC0xLTEtMA_8527a6ac-7bf3-4224-a76c-d7c0dae0e29d"
      unitRef="usd">2000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i27a5631c2fb54ff69c55c3cfd8c73d66_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTktNi0xLTEtMA_32af84e3-6f4e-4a3c-a452-279b5174fb19"
      unitRef="number">0.356</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7e213faa318546279e9fd452570893b7_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTktOC0xLTEtMA_c219b32a-ad9e-4b12-800b-5fe023c5d20d"
      unitRef="usd">9000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib040cfc0c5614b24b802c847b9882e83_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTktMTAtMS0xLTA_f8b877ca-7fc5-4d1d-9d2e-dd36709dabd7"
      unitRef="usd">8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7e213faa318546279e9fd452570893b7_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNTktMTItMS0xLTA_3356bef2-127d-44da-8e8b-2bf2845e5bda"
      unitRef="number">0.124</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb1464cedac54631af9b25c35805ce37_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjItMi0xLTEtMA_f5d16986-cbea-4766-8350-c99bc94784fa"
      unitRef="usd">413000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0d6bb0f027f641e382fb220073c0b43f_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjItNC0xLTEtMA_f17e452d-5d7c-4515-b733-ad0f0c46baea"
      unitRef="usd">418000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ibb1464cedac54631af9b25c35805ce37_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjItNi0xLTEtMA_5b3c442f-317b-48fc-8637-ef436b1883d7"
      unitRef="number">-0.011</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f59ef10b8cc46cda0b50f4338e55776_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjItOC0xLTEtMA_4c499dd4-4ddf-4e05-ae1a-bb243486ef15"
      unitRef="usd">1265000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e29ce41396f48e889d97e03233e6707_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjItMTAtMS0xLTA_752cbaec-4bfd-4265-8fa2-ea63597b829e"
      unitRef="usd">1162000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9f59ef10b8cc46cda0b50f4338e55776_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjItMTItMS0xLTA_5e40081c-ff03-4bf8-9f95-f6bf06cd644d"
      unitRef="number">0.089</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idd7af9434c1d463397ad836760e61d27_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjMtMi0xLTEtMA_40bc992d-d6a3-4e98-91f6-7c7e8b237ff6"
      unitRef="usd">451000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8bc6696056e49588142a93df17780a2_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjMtNC0xLTEtMA_d05a2d6a-d084-4267-bfdd-6bd4c49417d1"
      unitRef="usd">421000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="idd7af9434c1d463397ad836760e61d27_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjMtNi0xLTEtMA_f3b055e9-f95f-45ed-969e-95998181226e"
      unitRef="number">0.070</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie776bdb04f934182825e29d6f3d24312_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjMtOC0xLTEtMA_5e6438c3-6347-40d9-830f-867ee612ad51"
      unitRef="usd">1397000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id50261a61f02491c979c43c1a7e12622_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjMtMTAtMS0xLTA_a22b7d4e-d4d3-4705-b867-c9c83e1447b5"
      unitRef="usd">1385000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie776bdb04f934182825e29d6f3d24312_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjMtMTItMS0xLTA_dadaf239-118a-4b75-b1a7-a25e598b57d9"
      unitRef="number">0.009</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a00e22875b445d8a301f09f4917837d_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjQtMi0xLTEtMA_391302d0-da9d-436a-8e26-b4858189f516"
      unitRef="usd">864000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86d495dddd6e45b0b86fb85e4b21a2dd_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjQtNC0xLTEtMA_ddfd4e6b-299d-4512-882f-e203e94da44b"
      unitRef="usd">839000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8a00e22875b445d8a301f09f4917837d_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjQtNi0xLTEtMA_985d7b0b-578d-439c-b954-12024bda68f1"
      unitRef="number">0.030</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7387eb05ef5c4fdb842526c456bbe3c5_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjQtOC0xLTEtMA_b3ca52e3-27f6-4575-9fcc-e48d6570cbdc"
      unitRef="usd">2662000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i313ef0d43b1b446cba4d11086db5cb51_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjQtMTAtMS0xLTA_c6e86073-1911-4799-8c88-ec223198a213"
      unitRef="usd">2547000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7387eb05ef5c4fdb842526c456bbe3c5_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjQtMTItMS0xLTA_43cc5c30-fedc-4730-b3db-7f2ec4b8486d"
      unitRef="number">0.045</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib77203578b1e4210a44754b41d738e9c_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjYtMi0xLTEtMA_43bb51a7-d4f4-443e-b405-faea92671961"
      unitRef="usd">11000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1173e423785c44f1b4f1120ba26ad0c8_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjYtNC0xLTEtMA_a655ff34-635b-4a4d-ba01-ac4935e7802c"
      unitRef="usd">12000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib77203578b1e4210a44754b41d738e9c_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjYtNi0xLTEtMA_bd91a17d-d5f4-4de8-8d71-ce76bd2712fd"
      unitRef="number">-0.120</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73165b608c644bd1908c9df7d2a34b56_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjYtOC0xLTEtMA_84c4efac-040e-42a2-a0fc-d043a9fb8c94"
      unitRef="usd">33000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d0350d7f7b0426fae4ab3e96ce6a2d0_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjYtMTAtMS0xLTA_6923fae0-4b7b-4c4c-97df-d02f5badbf60"
      unitRef="usd">36000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i73165b608c644bd1908c9df7d2a34b56_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjYtMTItMS0xLTA_5e1daaab-ea4b-4ae7-a770-ccfa14d660ff"
      unitRef="number">-0.086</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idab010351da041bdb2cbf40ef950465c_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjctMi0xLTEtMA_71f5811e-9f33-45a5-8ad0-415e83d0b3cf"
      unitRef="usd">226000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ede8c86463a4ca1900b7e1fd0a2b799_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjctNC0xLTEtMA_0924b0af-4484-418d-a163-e3899b2503f2"
      unitRef="usd">206000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="idab010351da041bdb2cbf40ef950465c_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjctNi0xLTEtMA_243864bc-6bb2-4d3c-9f27-b89163ae3692"
      unitRef="number">0.093</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia0bb26554dca476f8295e07cd23d1a30_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjctOC0xLTEtMA_4eb8ca09-603e-464e-a2c7-935544130c37"
      unitRef="usd">684000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ab4cc6bdbc94b5cbf46487897a3b4c1_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjctMTAtMS0xLTA_f055f164-163b-4bf2-bb02-72013b99386e"
      unitRef="usd">603000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia0bb26554dca476f8295e07cd23d1a30_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjctMTItMS0xLTA_3ce90bd7-6d1f-4881-84b7-f76dc6f6a601"
      unitRef="number">0.133</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f63caca7fb446d981bd3f55e5f83321_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjgtMi0xLTEtMA_62c8d1ed-d524-4c07-b0ab-a2cf23a3221d"
      unitRef="usd">236000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58ab3c81d40b4648b33db3b797bc2e2e_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjgtNC0xLTEtMA_e1a0904c-7d45-4d05-a675-41a34112c078"
      unitRef="usd">218000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i2f63caca7fb446d981bd3f55e5f83321_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjgtNi0xLTEtMA_1581681f-6162-4a2a-90ec-84b99b3db4c7"
      unitRef="number">0.081</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42d8379119de4f56aacbfe9fb385c84a_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjgtOC0xLTEtMA_5d254e7c-1fed-445b-82a2-b0cc66e3d986"
      unitRef="usd">716000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie267eb4c95db4a2490afebd4e223298d_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjgtMTAtMS0xLTA_fe75b590-7665-46fd-bbe8-8e92e084d4e7"
      unitRef="usd">639000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i42d8379119de4f56aacbfe9fb385c84a_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNjgtMTItMS0xLTA_3ff1c6c1-e376-427b-83a5-e2343c495de5"
      unitRef="number">0.121</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie025a2f5e9ec4234a5ed0d872620533d_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzAtMi0xLTEtMA_e8511915-74b1-4370-a09a-c802699da71a"
      unitRef="usd">379000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i022b92c911e04342ae67e207f4d0515e_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzAtNC0xLTEtMA_457a897a-95fe-47ab-a3ea-8b7992c67b77"
      unitRef="usd">373000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie025a2f5e9ec4234a5ed0d872620533d_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzAtNi0xLTEtMA_ed510fd5-f0df-4e0f-b356-649aca32a0ee"
      unitRef="number">0.015</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e38b2e1ebc14377b3723fca5ed4fc49_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzAtOC0xLTEtMA_83095e3b-193b-47f2-9d0b-30b58bf1fa9c"
      unitRef="usd">1154000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i836e6925162d4ab1800fa82a7ab90e71_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzAtMTAtMS0xLTA_283a5adb-b6cd-4913-8bdf-5dd82b0005a4"
      unitRef="usd">1032000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i2e38b2e1ebc14377b3723fca5ed4fc49_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzAtMTItMS0xLTA_e925b23d-b2b4-4b31-b513-f14f4ec37fb0"
      unitRef="number">0.118</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iccc032099418444abc0b942948f6db9c_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzEtMi0xLTEtMA_fc806402-f365-4b48-963c-3c8057e837e9"
      unitRef="usd">147000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7969cdb22dd40dcad77977375507b7c_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzEtNC0xLTEtMA_5f9c8860-5e4f-486e-8d5f-d8a79ae7ab37"
      unitRef="usd">135000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iccc032099418444abc0b942948f6db9c_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzEtNi0xLTEtMA_c94a811f-95bb-4dd5-a10f-aa35b8da1bdf"
      unitRef="number">0.091</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib23a110014b24e3e9dee37ef5d241637_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzEtOC0xLTEtMA_c30db1f2-deb7-4109-b0b6-d57ae3be3392"
      unitRef="usd">461000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i400fe3ea80954d2fa120c009dd823c28_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzEtMTAtMS0xLTA_a944977c-a4b2-4de4-92f6-e043afea9690"
      unitRef="usd">534000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib23a110014b24e3e9dee37ef5d241637_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzEtMTItMS0xLTA_8ed4bcf0-183e-4e02-aed4-a667c2f2777b"
      unitRef="number">-0.137</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb55b5529292435b9665dbde03853a33_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzItMi0xLTEtMA_9c226a55-a438-4442-91ba-dc35f74a1d03"
      unitRef="usd">526000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i760f73e5eac14ceaa22fe96b46943bbb_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzItNC0xLTEtMA_47aa01a1-a91e-4b5e-9df3-cc0e7c55baa0"
      unitRef="usd">508000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ibb55b5529292435b9665dbde03853a33_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzItNi0xLTEtMA_583043a3-75a3-41b7-ace2-69f34b290b00"
      unitRef="number">0.035</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie059b332397c41f9a9a476949ab0f9db_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzItOC0xLTEtMA_ce9e2ca6-6d21-4ac4-a845-3c4638930e69"
      unitRef="usd">1615000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77166f2077334d64bae7a52b781efe80_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzItMTAtMS0xLTA_c400c5f0-f7cf-41a5-8da7-82b8dbce1345"
      unitRef="usd">1566000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie059b332397c41f9a9a476949ab0f9db_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzItMTItMS0xLTA_a81b5ca1-9955-4373-9a1d-b9265eedc048"
      unitRef="number">0.031</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia076593d3cf644b2a4c230fb8aa33f2b_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzQtMi0xLTEtMA_c879bff6-492b-48be-bfcd-8d556ea004e2"
      unitRef="usd">24000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5cbc3463e1ae4fa096e2ee9db46c6632_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzQtNC0xLTEtMA_fec94e39-517e-40bd-8fd7-93fbe3f9341d"
      unitRef="usd">33000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia076593d3cf644b2a4c230fb8aa33f2b_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzQtNi0xLTEtMA_4f7cc8d3-5f2d-48b4-97a4-a83913be135e"
      unitRef="number">-0.266</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic670fa5873324341b652814d7990b6ae_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzQtOC0xLTEtMA_af5974fd-929d-44c5-9b01-943476ee6581"
      unitRef="usd">79000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i39d249731b8e4bafa48866d9284ba875_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzQtMTAtMS0xLTA_a21f40cd-0341-4f88-84b9-05a2d42467cf"
      unitRef="usd">94000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic670fa5873324341b652814d7990b6ae_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzQtMTItMS0xLTA_d7708874-1d3f-4e9c-8172-94f26517539c"
      unitRef="number">-0.166</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i74965ae98cf74a79a669cab97dcec19d_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzUtMi0xLTEtMA_43e06feb-ed2a-46de-b1ac-e5e12d059ad0"
      unitRef="usd">78000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37b6d89c8f7649f59cd7ed840dc6187b_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzUtNC0xLTEtMA_38580c0e-1f30-437c-89ef-f0dde914788e"
      unitRef="usd">80000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i74965ae98cf74a79a669cab97dcec19d_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzUtNi0xLTEtMA_a5c9df37-b3a5-4293-b6a4-f74d7a6113b4"
      unitRef="number">-0.023</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03e4b6fa743e46aba9b64898e02d6610_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzUtOC0xLTEtMA_78c016e8-cc66-4a60-8cb1-ee5c73f4d7c4"
      unitRef="usd">252000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i864fefcfe9ef4b1f8253371aa4da89d9_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzUtMTAtMS0xLTA_5ab99b93-5faa-4c5a-b2ac-104cb6d748bb"
      unitRef="usd">248000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i03e4b6fa743e46aba9b64898e02d6610_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzUtMTItMS0xLTA_db37388d-83c8-495b-b4fe-7006f9270b19"
      unitRef="number">0.018</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c99f12082bc4cb2903b1862521cb302_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzYtMi0xLTEtMA_7112eb81-f645-4156-ac16-6d0d06bc0b14"
      unitRef="usd">102000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75a1d3c0a8c34a149a347f13a9e28320_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzYtNC0xLTEtMA_a7fd1f5a-cb6e-46e4-a1bb-e477889141fd"
      unitRef="usd">113000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i4c99f12082bc4cb2903b1862521cb302_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzYtNi0xLTEtMA_ac346676-dde1-41eb-94df-498e0c77990f"
      unitRef="number">-0.094</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc9abc58a71044878c2aa7ae09ff8f8c_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzYtOC0xLTEtMA_b9e6de5b-52d3-4dfe-ac8f-12470f24296a"
      unitRef="usd">331000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia105d1087fa6441a9079ac5df861898e_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzYtMTAtMS0xLTA_6cfccbf7-4105-4842-a9f3-0d5ecce7c3c1"
      unitRef="usd">342000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="idc9abc58a71044878c2aa7ae09ff8f8c_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzYtMTItMS0xLTA_bb1dce30-59cd-4f03-a705-ede0f56f8483"
      unitRef="number">-0.032</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iacb6b77961a1479ebecb82fdc6fe00d7_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzktMi0xLTEtMA_34592acb-a827-43b2-94f3-d3676c5e7f72"
      unitRef="usd">759000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c08f4679ad1446eb19be39cc3bbf8cb_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzktNC0xLTEtMA_657bf99b-0937-4cd3-ad1b-10485e5def7b"
      unitRef="usd">785000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iacb6b77961a1479ebecb82fdc6fe00d7_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzktNi0xLTEtMA_0632ccc1-2eb6-4940-95dc-690780913e0e"
      unitRef="number">-0.035</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0c2f0fa25124f8b90b673fc8d30c977_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzktOC0xLTEtMA_f1027337-6e60-4b2e-888e-65f575302c87"
      unitRef="usd">2285000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3b86ebc40de4d02b5a15198e05e4dd2_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzktMTAtMS0xLTA_9fae2b05-5033-4477-a03d-18e407f56132"
      unitRef="usd">2172000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie0c2f0fa25124f8b90b673fc8d30c977_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfNzktMTItMS0xLTA_2162512f-7339-4885-85d3-6157c53f36c9"
      unitRef="number">0.052</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04d10f41995549958614dc5d62ead9fa_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODAtMi0xLTEtMA_1350b910-516f-41de-b93f-55c5a5330b11"
      unitRef="usd">846000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15bd82bcfc384cd1be06ff3479f7fe56_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODAtNC0xLTEtMA_1035b7a4-017c-4d4f-8d03-231c4fa1f3e6"
      unitRef="usd">810000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i04d10f41995549958614dc5d62ead9fa_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODAtNi0xLTEtMA_101d0041-c52c-44fe-ba99-61bcc2590928"
      unitRef="number">0.045</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77bd07ae97df45fe8f18bc29a8766b16_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODAtOC0xLTEtMA_d350c1cc-6860-4f22-980f-ad7fde708d1c"
      unitRef="usd">2565000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf7cf5a1f5484ad28076d05cc5bf5456_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODAtMTAtMS0xLTA_7ddc3c05-69f7-4694-a1c4-191a1735ea62"
      unitRef="usd">2590000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i77bd07ae97df45fe8f18bc29a8766b16_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODAtMTItMS0xLTA_699e10b5-3b2d-4b4c-922d-411c88295ee1"
      unitRef="number">-0.010</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb272bfc6aa14c8d833db65bd2d89c9f_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODEtMi0xLTEtMA_5c079367-4adb-41fa-8194-9990747cd66e"
      unitRef="usd">1605000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i024b31141065487eb47c8f27eacf8b94_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODEtNC0xLTEtMA_2676d7a2-058a-4a9f-b6b3-ae7ee5f78b6f"
      unitRef="usd">1595000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="idb272bfc6aa14c8d833db65bd2d89c9f_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODEtNi0xLTEtMA_f2cdee96-ae81-4ae3-9cca-bf7bef85b3b3"
      unitRef="number">0.006</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26d2bebfc5134ffea7bebf182f6bfe88_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODEtOC0xLTEtMA_4e3a44d4-6bfe-48be-9e7f-e3b75397a099"
      unitRef="usd">4850000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09fc122a66fd43d987b35c926766da1e_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODEtMTAtMS0xLTA_71e8f6bd-d74d-44e4-a610-1b3907fd3e46"
      unitRef="usd">4762000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i26d2bebfc5134ffea7bebf182f6bfe88_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODEtMTItMS0xLTA_9cdd5dcc-36a7-463a-b20b-edf32b4223d2"
      unitRef="number">0.018</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i838fec96a85e490a91abbe0f423852cd_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODMtMi0xLTEtMA_3546a6a7-40d3-4db4-ad0d-083f7326d584"
      unitRef="usd">43000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i205f53eb2b4844e4b0c11273e65d1efa_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODMtNC0xLTEtMA_bbe952bd-c660-4ac5-af07-05e9edca3691"
      unitRef="usd">84000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i838fec96a85e490a91abbe0f423852cd_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODMtNi0xLTEtMA_402542fc-fcde-4bef-94dc-d81ced49ebff"
      unitRef="number">-0.492</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i49d169f73b2a460ba9c3d0d74492a3fb_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODMtOC0xLTEtMA_7ceb3ff9-db45-4c53-b184-8334e33f90be"
      unitRef="usd">150000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc2604a22a5446d1b2baa44602c72c6b_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODMtMTAtMS0xLTA_b68bd9aa-f257-4f69-8d19-88eb95499a8e"
      unitRef="usd">196000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i49d169f73b2a460ba9c3d0d74492a3fb_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODMtMTItMS0xLTA_fe5acf98-2cb7-4e8a-bbef-2cdfe90466eb"
      unitRef="number">-0.236</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4603cfe6fe1046c6af473d0b35dc1e66_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODQtMi0xLTEtMA_4802d09a-204f-4ab2-9e82-b9e12a9eb9f9"
      unitRef="usd">107000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f7c241d8ff946ad9a3f1e8650b6d548_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODQtNC0xLTEtMA_4f9b5662-f3fe-4d9f-be59-66323c7ff17c"
      unitRef="usd">109000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i4603cfe6fe1046c6af473d0b35dc1e66_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODQtNi0xLTEtMA_c632aa32-3b34-495b-90ae-b8a83ec1722c"
      unitRef="number">-0.020</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e5b1f4897dc44e3889d6a11570ac3c3_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODQtOC0xLTEtMA_2686a450-33b2-4878-8b89-529b5ff3aac0"
      unitRef="usd">319000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idcd6dab96cbe45f7959c3a93eca497ca_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODQtMTAtMS0xLTA_58dd518e-69ce-445e-8c00-f98cc6c6bd21"
      unitRef="usd">348000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i3e5b1f4897dc44e3889d6a11570ac3c3_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODQtMTItMS0xLTA_cadace7b-2312-455c-8135-4cffa9d93924"
      unitRef="number">-0.082</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i54ccc3c917cf4242a4f575583368ce21_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODUtMi0xLTEtMA_59e9f334-ab16-47cc-8260-a0a0ee4c999c"
      unitRef="usd">149000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5377031ce1bd478a865faa89ac9e836d_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODUtNC0xLTEtMA_8c567a2f-842f-498a-9058-a40ae8d2a766"
      unitRef="usd">193000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i54ccc3c917cf4242a4f575583368ce21_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODUtNi0xLTEtMA_71e9119e-d143-4215-8d78-6917526c41ee"
      unitRef="number">-0.226</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief1076e1d3ec4608a9c69b0854bd5c3d_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODUtOC0xLTEtMA_f5c83774-df09-4bdf-aac7-4eed458b9e40"
      unitRef="usd">469000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d0623be30d649bdb8c119d1fb380cf5_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODUtMTAtMS0xLTA_a712d731-3d9d-4dfe-a69f-9e2250377b0e"
      unitRef="usd">544000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ief1076e1d3ec4608a9c69b0854bd5c3d_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODUtMTItMS0xLTA_c1bf17c5-4ef0-4bee-bfaa-8fc31f0ac972"
      unitRef="number">-0.138</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie5493cd95e9040eca88efc765e25c90b_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODctMi0xLTEtMA_cae8ae1e-4879-4c24-82c2-89725f41fd22"
      unitRef="usd">585000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8154cbc3358471d81b6c9e0cfca602b_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODctNC0xLTEtMA_2b343834-f064-4b22-a014-df7e5a9e5007"
      unitRef="usd">554000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie5493cd95e9040eca88efc765e25c90b_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODctNi0xLTEtMA_6d0cd26a-d128-459b-b539-079b3a0288b4"
      unitRef="number">0.056</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia65c328603194766a57c17632de4fa37_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODctOC0xLTEtMA_d9f37035-7ca9-4259-bcb7-4b687a80cabe"
      unitRef="usd">1704000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5abf17b6cb264cb197714b4eaa2858f6_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODctMTAtMS0xLTA_8a05f004-624a-4509-99ff-56bfd07e8e7a"
      unitRef="usd">1543000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia65c328603194766a57c17632de4fa37_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODctMTItMS0xLTA_f846e6df-83fe-47b6-b00e-3f8fc9155184"
      unitRef="number">0.105</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iebb810100f164a6f90ad8126497b2fee_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODgtMi0xLTEtMA_4c6c563b-cbaa-43a7-8538-5a92249f0d46"
      unitRef="usd">341000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id795ffd344cd44f3ae87465d76b3b61d_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODgtNC0xLTEtMA_b70b095d-d469-4a8b-b2a0-e2f3ac25adb5"
      unitRef="usd">297000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iebb810100f164a6f90ad8126497b2fee_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODgtNi0xLTEtMA_d4ab0bb8-ddcf-4f1f-a488-b459f489510d"
      unitRef="number">0.149</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i020804ccc75241b39a2537441aa2abb8_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODgtOC0xLTEtMA_3d3c8f2e-ed43-4a9a-a96a-4e63bfa10436"
      unitRef="usd">983000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i466ad16e878648bfa865eeba3f05858e_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODgtMTAtMS0xLTA_b8e8ec74-27cf-45b9-bb82-718ececca8c8"
      unitRef="usd">916000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i020804ccc75241b39a2537441aa2abb8_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODgtMTItMS0xLTA_04695bc3-52bf-404e-9583-92d4ed0a8b6a"
      unitRef="number">0.073</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i702c3ba78f294a499d08adca2c3e05d3_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODktMi0xLTEtMA_e04e2988-5fe1-4b6c-88ad-938164eb590f"
      unitRef="usd">926000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d5788dcb82e4eee98bd8058fbf39537_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODktNC0xLTEtMA_e2697c0e-332f-46e9-a322-64a150b77224"
      unitRef="usd">851000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i702c3ba78f294a499d08adca2c3e05d3_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODktNi0xLTEtMA_2762d273-b55e-4543-a747-953112cb22e1"
      unitRef="number">0.088</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa520d7163634d8fae3b61f2452fa6a9_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODktOC0xLTEtMA_5ef3740e-5f78-440e-a740-3fe3adb811d7"
      unitRef="usd">2688000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3397044102204bdea03afee12e1ddbe8_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODktMTAtMS0xLTA_bd341b65-2184-4092-adc4-2db6ca101115"
      unitRef="usd">2459000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ifa520d7163634d8fae3b61f2452fa6a9_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfODktMTItMS0xLTA_3a679471-3755-4722-b188-464bd19c5e51"
      unitRef="number">0.093</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i230206d0e0be406ea6ed74138f698967_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTEtMi0xLTEtMA_00336bea-aaff-4d56-bb62-ee6990619950"
      unitRef="usd">70000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8af9975ac5e84f31902e2dc3297b1c31_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTEtNC0xLTEtMA_adbb135f-4010-42f7-9998-bef6fdc80514"
      unitRef="usd">79000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i230206d0e0be406ea6ed74138f698967_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTEtNi0xLTEtMA_61eba95f-9c55-4f19-b292-cdab1ddadf00"
      unitRef="number">-0.110</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc11f05a7e144bb8a612662099fd1476_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTEtOC0xLTEtMA_295725d2-5b65-417b-b800-8e1ce94f94f6"
      unitRef="usd">220000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec74f00dc144400fbf71837c3f85d010_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTEtMTAtMS0xLTA_1250390c-4c57-4599-a2c1-8a09d500daf8"
      unitRef="usd">237000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ifc11f05a7e144bb8a612662099fd1476_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTEtMTItMS0xLTA_0a0f449a-afcc-44d2-bdc1-4266d9036ef6"
      unitRef="number">-0.069</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88615927a6634ebe93715f2ce1c8ffed_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTItMi0xLTEtMA_5d04f67b-b853-4ac5-9404-47fe6943e6a4"
      unitRef="usd">81000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i542156a6acd14373931ce4b7ccae05f5_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTItNC0xLTEtMA_90fe8255-f05e-40ff-9e6a-56de9ac8687f"
      unitRef="usd">89000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i88615927a6634ebe93715f2ce1c8ffed_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTItNi0xLTEtMA_94b3f172-d998-475a-afde-b87ce0f7cc45"
      unitRef="number">-0.078</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4492bef684ea46c1a3ae25b9fe930f14_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTItOC0xLTEtMA_44944fe9-0b72-4a86-83d9-d61bce85c945"
      unitRef="usd">254000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i721706f8e045481c86dc8e07627a8f0c_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTItMTAtMS0xLTA_0c76f9c2-1fe9-41a9-999a-390f620fc702"
      unitRef="usd">292000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i4492bef684ea46c1a3ae25b9fe930f14_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTItMTItMS0xLTA_1153d387-03ff-4455-8956-f1b9ef684206"
      unitRef="number">-0.127</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69abd303a0a949469442142f029642f9_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTMtMi0xLTEtMA_22335350-ffc9-4708-a235-609f44fe12dc"
      unitRef="usd">152000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba3f0ee0c4f3486faa522e60acb01051_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTMtNC0xLTEtMA_9b882c8d-7933-4332-9c1c-7ccdb9b7cf18"
      unitRef="usd">167000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i69abd303a0a949469442142f029642f9_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTMtNi0xLTEtMA_9130e858-8805-41d1-a0af-041b30dd988b"
      unitRef="number">-0.093</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if4a66bae60fa4ef0af457100fe8a6b2b_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTMtOC0xLTEtMA_657b3298-e95e-4aa6-829f-4c9af448a972"
      unitRef="usd">475000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1b81e17f99cf4307aca1954a29ad581c_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTMtMTAtMS0xLTA_43383ce2-57fd-4568-8de8-202bb2f5e795"
      unitRef="usd">528000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if4a66bae60fa4ef0af457100fe8a6b2b_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTMtMTItMS0xLTA_b5d823f1-4e9c-4e02-9a93-3dd2db4794b0"
      unitRef="number">-0.101</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c1f3898bb4b45dda42e758bda36a669_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTUtMi0xLTEtMA_35823277-a107-438c-8b65-3c378e439ce8"
      unitRef="usd">60000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5054190d146a4cd188e4ff52a2ac195c_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTUtNC0xLTEtMA_291a9ce1-81a0-4213-87d4-92efe55ea29b"
      unitRef="usd">68000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i3c1f3898bb4b45dda42e758bda36a669_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTUtNi0xLTEtMA_d850e2af-5b91-4f90-b581-3a1e5638b55a"
      unitRef="number">-0.113</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia396ef4400a04721bcb9eb751d28c14c_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTUtOC0xLTEtMA_c4d29c51-76ec-4ead-b614-1d123afcb9f1"
      unitRef="usd">210000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e196f60c8f84d0e863995c395467711_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTUtMTAtMS0xLTA_e0747f8b-08ae-4ca2-bf5b-909bd4a16b3e"
      unitRef="usd">196000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia396ef4400a04721bcb9eb751d28c14c_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTUtMTItMS0xLTA_0a7799ad-59b4-4d08-9549-d0d9b89d93eb"
      unitRef="number">0.071</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7fe837c300e64a599158923b9a3e0ccb_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTYtMi0xLTEtMA_f857955f-1062-4460-8544-d35cd9eb7162"
      unitRef="usd">317000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73c197aa1c3f4a2983242ba4675beaa2_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTYtNC0xLTEtMA_b84bc8c6-884d-4e52-b9b4-11fa67714146"
      unitRef="usd">316000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7fe837c300e64a599158923b9a3e0ccb_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTYtNi0xLTEtMA_558deeeb-bd2c-408b-891f-0c1ad2ce46a5"
      unitRef="number">0.003</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic939d8552fd24ed6815d0c7676ad9233_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTYtOC0xLTEtMA_138e5e43-ea5e-41cf-b61f-0bd1d9a42ed3"
      unitRef="usd">1008000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a78f12a5dbb4fbfba94b0044e46b502_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTYtMTAtMS0xLTA_a01b72ca-61e2-44f1-b62f-775a3c2ae474"
      unitRef="usd">1035000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic939d8552fd24ed6815d0c7676ad9233_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTYtMTItMS0xLTA_8c50e204-94e0-494c-ba33-bda513d70afb"
      unitRef="number">-0.026</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8646c210ca8d446ebfb79435ca8cbfcd_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTctMi0xLTEtMA_1d0d393d-4cf4-4eb7-93b8-9d655b9f19b2"
      unitRef="usd">377000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9bb13790d6ad4aad86f8fce7a1c50f3b_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTctNC0xLTEtMA_3dd13e41-b4dd-4379-8ada-229d6438b364"
      unitRef="usd">384000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8646c210ca8d446ebfb79435ca8cbfcd_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTctNi0xLTEtMA_4aa13b3a-15b0-40f6-a1bc-87cba897efb2"
      unitRef="number">-0.018</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9d9bffedef249fdb93057aafdd09a8a_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTctOC0xLTEtMA_a6305373-e826-4b71-b535-9950319950a6"
      unitRef="usd">1218000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbaf2076fc654fa1a5fe9210a7f4452c_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTctMTAtMS0xLTA_7681619c-3334-43f7-9fa5-b31d1f0b0acb"
      unitRef="usd">1231000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie9d9bffedef249fdb93057aafdd09a8a_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfOTctMTItMS0xLTA_d8fb90bd-5b25-4390-84bd-055e7bd4d69c"
      unitRef="number">-0.011</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2778860e516341fdac7a99b7214a99dc_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAwLTItMS0xLTA_e4110e04-0b41-45b3-b558-124cb856334b"
      unitRef="usd">1267000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6dd83f9144404cd69bdacd864d641631_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAwLTQtMS0xLTA_ca048f89-0786-40a9-a794-5be759bc1149"
      unitRef="usd">1171000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i2778860e516341fdac7a99b7214a99dc_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAwLTYtMS0xLTA_65dc7588-b4c4-481e-90fb-2b32f1e629c3"
      unitRef="number">0.082</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i752cd2edd61e4f58b473965cea3aafd4_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAwLTgtMS0xLTA_648176ac-a806-4bb4-9842-249a97f19511"
      unitRef="usd">3623000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic26bca171f714ec08510fa419cbd9f78_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAwLTEwLTEtMS0w_3ef9d008-d0ed-4d5f-ac4d-1bd274a4b012"
      unitRef="usd">3146000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i752cd2edd61e4f58b473965cea3aafd4_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAwLTEyLTEtMS0w_61cfce41-a835-46d2-9e63-c4b16422026c"
      unitRef="number">0.152</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idfe3e7487808413aa0811c36064223df_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAxLTItMS0xLTA_9ba09e84-7aa6-4508-a46c-06d862175c29"
      unitRef="usd">1862000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieec92b888fc2475ba4b45585fa0376f8_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAxLTQtMS0xLTA_86f63094-8504-404c-a282-4e3a8398237e"
      unitRef="usd">1590000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="idfe3e7487808413aa0811c36064223df_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAxLTYtMS0xLTA_9f71c7dc-6c5a-48e8-bbf1-0784a71850f2"
      unitRef="number">0.171</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1205be94e68d4cda8b85bdc70cf76ba2_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAxLTgtMS0xLTA_d87f4707-734a-4833-bcda-1db6ede9a701"
      unitRef="usd">5310000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4cb44ddf8cc45cf985f507e2ad63eed_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAxLTEwLTEtMS0w_905c8d00-df17-4278-9540-251ab8147014"
      unitRef="usd">4830000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i1205be94e68d4cda8b85bdc70cf76ba2_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAxLTEyLTEtMS0w_56ab9f51-0ada-494f-84ca-b0221083c233"
      unitRef="number">0.099</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d9559b960f641bb99edabc691773a8a_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAyLTItMS0xLTA_f5b2957d-e7a9-4989-825d-c50f7ebcc12c"
      unitRef="usd">3129000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b155857af2742ec98b26f0e8bd6f63c_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAyLTQtMS0xLTA_1c1394f2-e0c7-4f9a-90c2-91c1cec4790a"
      unitRef="usd">2761000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i1d9559b960f641bb99edabc691773a8a_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAyLTYtMS0xLTA_3e20a026-96e4-4df8-a30b-f3ff9fe5fac0"
      unitRef="number">0.133</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i02575caf89d44152bc3372011aef005e_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAyLTgtMS0xLTA_1ec7fdf6-979f-4698-8be8-b2989299614f"
      unitRef="usd">8933000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i425fac1e024e4a3985d9c88eadccb208_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAyLTEwLTEtMS0w_40313351-6afc-44ea-8b5f-36cf3c32ea55"
      unitRef="usd">7976000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i02575caf89d44152bc3372011aef005e_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTAyLTEyLTEtMS0w_fee9935c-c6dd-466c-ba3d-f1ec5a662b44"
      unitRef="number">0.120</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8ea9ee18248c41a0990af9a8bd2d9634_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA0LTItMS0xLTA_b8feee55-9b03-4b0c-969f-47622ce9f624"
      unitRef="usd">585000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c4aac1ba6bb45aab22decf4191b4c08_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA0LTQtMS0xLTA_158cb70f-cd8c-48cd-b6c9-3bd40f7e26e1"
      unitRef="usd">402000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8ea9ee18248c41a0990af9a8bd2d9634_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA0LTYtMS0xLTA_a4cd1b51-57fc-4a51-8d6a-058684781785"
      unitRef="number">0.460</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97b82273e4234a9a905cbcb65c575356_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA0LTgtMS0xLTA_1afeb25a-9839-4018-84b5-6d3c09bd3bfa"
      unitRef="usd">1540000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ddb0f73dd2a4c0a8d3fcfa0f7522b98_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA0LTEwLTEtMS0w_b45ca6dc-7298-4749-9c6a-7184c51a37f9"
      unitRef="usd">1123000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i97b82273e4234a9a905cbcb65c575356_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA0LTEyLTEtMS0w_765c2628-43dc-44b2-bd62-0d907e4bd042"
      unitRef="number">0.372</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5381d639283543639418c19ee2938e11_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA1LTItMS0xLTA_e160dc8a-df44-4e96-871b-79af166ef486"
      unitRef="usd">514000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1910340b47b743deb6e4133b4aa1b30c_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA1LTQtMS0xLTA_b3db6e66-ef73-45f5-a85e-eaefcd155ed3"
      unitRef="usd">363000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i5381d639283543639418c19ee2938e11_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA1LTYtMS0xLTA_22c9ad37-4959-42d1-8d86-622c5b1632cd"
      unitRef="number">0.415</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40dc71d902444824a22852a9b082d005_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA1LTgtMS0xLTA_ddf145e0-0d37-4117-8fce-0a1619f45dcc"
      unitRef="usd">1397000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8cf7bb68342d478abe812d2082348d36_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA1LTEwLTEtMS0w_e484c340-26d9-4906-919a-79c189cc364e"
      unitRef="usd">1045000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i40dc71d902444824a22852a9b082d005_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA1LTEyLTEtMS0w_53b81de1-e346-4452-8704-4bf08a55d12f"
      unitRef="number">0.337</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i705ab2d26ecf4df3a64a2a7de556d9ba_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA2LTItMS0xLTA_c0544147-4163-462f-b33e-40f794926bd1"
      unitRef="usd">1099000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9749eeca9e1e4d8db5458ec220a2454c_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA2LTQtMS0xLTA_8c365315-a2f3-43ed-b2ba-4e2dd39cbbcd"
      unitRef="usd">765000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i705ab2d26ecf4df3a64a2a7de556d9ba_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA2LTYtMS0xLTA_5b11a21c-5052-4a21-84eb-3599fbb13de6"
      unitRef="number">0.438</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5920e241198f48f38ebd20ae56e19795_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA2LTgtMS0xLTA_201a84b2-d969-49a4-9f74-c84dde6fa451"
      unitRef="usd">2937000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibfe72bbf690841b18512fbf1d62a9972_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA2LTEwLTEtMS0w_f967805d-a748-436a-8f11-de9e74995b6b"
      unitRef="usd">2168000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i5920e241198f48f38ebd20ae56e19795_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA2LTEyLTEtMS0w_e6d0b0f4-1431-4799-b5de-961431aa5a1f"
      unitRef="number">0.355</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iff059545ae6e4221920a372b17db3e2f_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA4LTItMS0xLTA_5ab2ed0d-6776-49dc-9c94-02e29de64a73"
      unitRef="usd">152000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic9675c62f8e7451998e302272f33726b_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA4LTQtMS0xLTA_e1588570-d0b5-4a72-b37a-1bf9e7aa81e7"
      unitRef="usd">74000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b963caee0e54df9b30e44510c6584c3_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA4LTgtMS0xLTA_df3c7648-aae2-448d-a095-5b49fdd5d8dc"
      unitRef="usd">407000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibc13c87f32fe44c191a0a792e991354a_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA4LTEwLTEtMS0w_75b018fb-9c66-462f-86d2-45d44ba85872"
      unitRef="usd">194000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i81b57ee3c6154482a279f76aead7f4af_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA5LTItMS0xLTA_60bd0331-56c3-4444-85fb-ac647eec8297"
      unitRef="usd">55000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib57a13d3edd943ca817dd9ead9e296ae_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA5LTQtMS0xLTA_2eac2fc8-bee4-43e4-9256-9779e83af041"
      unitRef="usd">12000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ca84dcf326c430cbe701477a9c57a9e_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA5LTgtMS0xLTA_ae4eec7d-e326-4f07-b9c9-47b4e62d902d"
      unitRef="usd">112000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77adc61bfc404ed98cdd17cd48df3b1c_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTA5LTEwLTEtMS0w_9c97a6e9-a0ba-45e5-8842-5f6845ba8808"
      unitRef="usd">22000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i372932b60c2c4cedac8377b6bac57e40_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEwLTItMS0xLTA_91bfa0b7-0f81-4acd-8b29-f87ce4105cde"
      unitRef="usd">206000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifc0025ae94a8482b889201ee8f579b2a_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEwLTQtMS0xLTA_29a1de8e-2fc0-4ac7-b24d-02d8888759ce"
      unitRef="usd">86000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e76cc62521e4a5b9a91e983d896f049_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEwLTgtMS0xLTA_f0b90a9c-9aca-4718-8448-0fbb0e58da28"
      unitRef="usd">519000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ee09d3943c845e39af6dba238d48fe3_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEwLTEwLTEtMS0w_2a727308-5826-438a-8cee-9f6a4e052173"
      unitRef="usd">216000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i34735177370944c4801a9842bf884fbd_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEyLTItMS0xLTA_8eca85fa-2e41-4d6f-ade4-5140260e918f"
      unitRef="usd">450000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i796fcef4d74540e6bf307cbf351c2bed_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEyLTQtMS0xLTA_21ce4cf9-7c6f-45ff-9117-64b9bcb42e86"
      unitRef="usd">447000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i34735177370944c4801a9842bf884fbd_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEyLTYtMS0xLTA_420b8578-8096-4050-8bed-0af9b8307a22"
      unitRef="number">0.007</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b57e3ca4ff34279b822c3d9d12fc1e1_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEyLTgtMS0xLTA_26cc99ba-65f8-474e-bb4f-0baeb6031c85"
      unitRef="usd">1329000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9465452a2864f51a42faf1511d0fd43_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEyLTEwLTEtMS0w_ed29d1fc-f922-4ee2-a4c2-5dfaaf5d9305"
      unitRef="usd">1163000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6b57e3ca4ff34279b822c3d9d12fc1e1_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEyLTEyLTEtMS0w_81fc03bd-3b86-4fe2-bb87-0596692a97de"
      unitRef="number">0.142</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i72c72074c6ba43788b7c9742c486d2df_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEzLTItMS0xLTA_5901cc6e-4139-424d-b63b-abfc78a93d4e"
      unitRef="usd">581000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ba0577bcdd34b8d86faec42ec29417e_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEzLTQtMS0xLTA_44697a48-38c3-4817-bf17-0b1d87434295"
      unitRef="usd">475000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i72c72074c6ba43788b7c9742c486d2df_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEzLTYtMS0xLTA_db6c792f-322c-4564-ab95-614e5b051171"
      unitRef="number">0.225</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia0693b80dea945c2978dab63fda27374_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEzLTgtMS0xLTA_79b3d7cd-4ff6-45ac-b762-05e6d2c53b5c"
      unitRef="usd">1682000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e3e511ff0b44224b63d2ea86eadb7e7_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEzLTEwLTEtMS0w_a9dbd8f3-dca2-4a04-9b95-1ffa80f5c150"
      unitRef="usd">1373000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia0693b80dea945c2978dab63fda27374_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTEzLTEyLTEtMS0w_6424ba37-5528-44fe-9d9b-887d5d24e592"
      unitRef="number">0.225</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45dfcb3ffb3e4a97a4cd1f22832657d1_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE0LTItMS0xLTA_b9386978-a5bb-41c4-8cf9-58c0b7fa065f"
      unitRef="usd">1031000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf94b5c46b474da196e27de4e267114a_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE0LTQtMS0xLTA_2bd56c9f-3ed2-41a1-a775-657cf87b7c43"
      unitRef="usd">921000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i45dfcb3ffb3e4a97a4cd1f22832657d1_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE0LTYtMS0xLTA_7a086808-d77e-4179-af35-3587cedabd3d"
      unitRef="number">0.119</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i62b6d2dac7db484986c41d5f29e1baf5_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE0LTgtMS0xLTA_bc10ffb8-e34c-47da-a1ed-dd3a64077c4e"
      unitRef="usd">3011000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5446e8f0ab454edea3b3c38dd20556eb_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE0LTEwLTEtMS0w_a8ce0533-2c2b-483d-9807-0d0ba2f09c41"
      unitRef="usd">2536000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i62b6d2dac7db484986c41d5f29e1baf5_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE0LTEyLTEtMS0w_6a95a962-a0e2-4672-b148-785143e0db0e"
      unitRef="number">0.187</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67ccf902b8ca4f778d40454a90bd5dd6_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE2LTItMS0xLTA_c89a713c-ea70-4bd0-aa29-2baa80ba9b3c"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4109c4932c754685876797c6af614e62_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE2LTQtMS0xLTA_34af6a3f-7fb4-4504-9a67-fc082834ca56"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i67ccf902b8ca4f778d40454a90bd5dd6_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE2LTYtMS0xLTA_759c82f9-ee5a-4990-a75e-d6fe208a8eab"
      unitRef="number">0</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i330bc9af1877499b8065d4b7b3fa2e01_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE2LTgtMS0xLTA_9e8b020c-4347-4d8d-8148-0e99a2cd66ac"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if3c3b9971d0b4acc9e1042b91d15ebe2_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE2LTEwLTEtMS0w_540a6909-804a-44c1-99af-3deeeba41437"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i330bc9af1877499b8065d4b7b3fa2e01_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE2LTEyLTEtMS0w_e1f59d83-9cb4-440d-b1ab-e2fa362a3899"
      unitRef="number">0</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4955df2646f4d2db40aeaab35a9f11e_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE3LTItMS0xLTA_7438fb38-53a2-4e3f-b44d-ca74f9827fa9"
      unitRef="usd">105000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e0a71362e3743e4b1f4d0012e92b109_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE3LTQtMS0xLTA_e450928e-0836-421b-b614-601cfb5e8f67"
      unitRef="usd">149000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic4955df2646f4d2db40aeaab35a9f11e_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE3LTYtMS0xLTA_c7510752-3a2a-447b-b3b4-9e6a422a3ee2"
      unitRef="number">-0.301</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i53f5011996b74418b2ae013de7b25fe8_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE3LTgtMS0xLTA_bee61e4b-008a-4a76-8cdd-99df042be6ba"
      unitRef="usd">311000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iabef23428a1c4d3b94722d03cb22cc1f_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE3LTEwLTEtMS0w_ae1cbda4-a54a-4f75-9e4e-a1cc4b6c1191"
      unitRef="usd">636000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i53f5011996b74418b2ae013de7b25fe8_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE3LTEyLTEtMS0w_8910f9eb-8a1d-43fb-adb9-8125f9e9d483"
      unitRef="number">-0.512</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09245da0ca9744d097847bbacddaaba3_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE4LTItMS0xLTA_96b50f34-a87b-4ffc-af28-74d6b2f8c686"
      unitRef="usd">105000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c8552621f43462f820822d0db06546b_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE4LTQtMS0xLTA_99e1f854-a739-4d91-884a-ef6accebd407"
      unitRef="usd">149000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i09245da0ca9744d097847bbacddaaba3_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE4LTYtMS0xLTA_98ba851c-06fb-40a6-9be6-ad1b8ccb9ef0"
      unitRef="number">-0.301</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i268dbe75625d4f94821b1992136466b5_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE4LTgtMS0xLTA_3a4da4a9-07ef-4c96-8004-f489c17cd39f"
      unitRef="usd">311000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i54921a8e1bae412499c1ed6066b7babb_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE4LTEwLTEtMS0w_c00809a2-e41f-4e54-bdd8-81a4cbc88dab"
      unitRef="usd">636000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i268dbe75625d4f94821b1992136466b5_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTE4LTEyLTEtMS0w_2d06b06e-21f8-48b1-93b3-ecaeee89166a"
      unitRef="number">-0.512</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00b989b237614d92886abe9728179769_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIwLTItMS0xLTA_304d8450-61ba-44f0-a551-3adffe5d56cf"
      unitRef="usd">58000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18c083bcea8740cb90e264a1f6f78d34_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIwLTQtMS0xLTA_00d09980-14ad-4514-8e0a-6bb8cdaa3863"
      unitRef="usd">233000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i00b989b237614d92886abe9728179769_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIwLTYtMS0xLTA_a52076a7-772c-4d17-b8c1-78ac1a7a3084"
      unitRef="number">-0.752</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ica56f357873048e8b05d7f37a64550b7_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIwLTgtMS0xLTA_3aa42d75-b5af-4df0-9561-d2430c1449cd"
      unitRef="usd">284000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd88bb111cfc4697a30d5ec9e6455e68_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIwLTEwLTEtMS0w_a3904400-7d6c-4e49-a548-08df3700a344"
      unitRef="usd">616000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ica56f357873048e8b05d7f37a64550b7_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIwLTEyLTEtMS0w_eaacaab7-5279-4acb-aa6d-64b70d6cc68e"
      unitRef="number">-0.539</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id7c1dfd0ab824a55aa683fc2853c811c_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIxLTItMS0xLTA_d466695a-3953-4920-9838-250c13b6b851"
      unitRef="usd">532000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7515a418c4d04e6696b8dea069d6787d_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIxLTQtMS0xLTA_108ed01e-37df-428d-be71-5bcb9a454194"
      unitRef="usd">508000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id7c1dfd0ab824a55aa683fc2853c811c_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIxLTYtMS0xLTA_1c5a09c0-7c7e-4f2f-9f7d-0608d523f9b2"
      unitRef="number">0.048</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea069e1f599749b4955a9badba8f5442_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIxLTgtMS0xLTA_c21f34c4-102e-46dc-9759-831a6788a171"
      unitRef="usd">1564000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c31b8af359a42f99b7d8bce11dc8b0e_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIxLTEwLTEtMS0w_465a990b-2e73-4812-bfe5-e93f194e037b"
      unitRef="usd">1502000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iea069e1f599749b4955a9badba8f5442_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIxLTEyLTEtMS0w_1513702a-a6c8-431f-bea0-715beeab8a3b"
      unitRef="number">0.041</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if3bad18a87304c4cbc3c2dc4d1ce3cb1_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIyLTItMS0xLTA_89dc1683-12b0-417c-b983-f943c72cbc1d"
      unitRef="usd">590000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa05f30dbe0343b0b935c997aa17c4a3_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIyLTQtMS0xLTA_20bb77a0-9ef3-43c7-8cf4-6e4c3b189c81"
      unitRef="usd">741000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if3bad18a87304c4cbc3c2dc4d1ce3cb1_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIyLTYtMS0xLTA_655424df-56f4-4a24-8e45-fd49b7104b55"
      unitRef="number">-0.204</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icfb336e5668642d095d254e92dbd3662_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIyLTgtMS0xLTA_5b0175b0-4203-40f3-9aa5-ebd80dfcae3e"
      unitRef="usd">1848000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if54134f7c5b24e07917d778ac41dce41_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIyLTEwLTEtMS0w_dd903eb8-3ffc-4c18-b0a5-e1616eb50f4f"
      unitRef="usd">2118000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="icfb336e5668642d095d254e92dbd3662_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTIyLTEyLTEtMS0w_ff06a169-d63b-475d-bbe9-28495d546118"
      unitRef="number">-0.127</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id920a9ae68314dba941e6bd37d23c794_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI1LTItMS0xLTA_c4ef052f-c813-43ee-8604-edb2ae8a379a"
      unitRef="usd">21000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99dbd0f9ca734810b3b3cebdf13dccf7_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI1LTQtMS0xLTA_a9aa9d49-bdf9-41c6-ad9d-93830cfd7aa4"
      unitRef="usd">17000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id920a9ae68314dba941e6bd37d23c794_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI1LTYtMS0xLTA_31833767-6009-4395-8abc-4397ff964303"
      unitRef="number">0.353</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5ea83560e2c4220bda25b528dac795f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI1LTgtMS0xLTA_71125675-5b52-403d-8edd-e24fc538096d"
      unitRef="usd">63000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc48547d5c2d45b18b0cffc58b8418d0_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI1LTEwLTEtMS0w_c134a758-6538-4596-a50c-84dc6c283a6b"
      unitRef="usd">51000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib5ea83560e2c4220bda25b528dac795f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI1LTEyLTEtMS0w_c3b9fe27-a56c-42e2-8eab-267e0b9dc6f6"
      unitRef="number">0.258</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2930e4636157460e97c87253a644ebee_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI2LTItMS0xLTA_ede4be9b-bb29-4740-8a7b-197303db68fb"
      unitRef="usd">76000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idde0b706304b45b88a9d831118eea942_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI2LTQtMS0xLTA_e7e2f7bd-ed6a-4d5f-ac3c-2a44502a872d"
      unitRef="usd">83000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i2930e4636157460e97c87253a644ebee_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI2LTYtMS0xLTA_e81fabce-0eb1-4066-bcfc-8634e90b9d7d"
      unitRef="number">-0.088</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3555c8eb101047b7b3e6f5fd9a92fdfa_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI2LTgtMS0xLTA_35108503-fb95-4d8b-bd70-c5423652ff47"
      unitRef="usd">244000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c8089c225324cd2bee3241e1f84f5e1_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI2LTEwLTEtMS0w_9a0764f2-4619-4008-91e1-342ab0733572"
      unitRef="usd">252000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i3555c8eb101047b7b3e6f5fd9a92fdfa_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI2LTEyLTEtMS0w_68c00e91-df24-4c47-96a9-3438d3663d30"
      unitRef="number">-0.031</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf2f109a663b489da13497ab8eee8ac3_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI3LTItMS0xLTA_9148490c-9f3d-42df-a790-bc831bd1c043"
      unitRef="usd">98000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32579ea231594ff8ac2d8f4ae4ce03a9_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI3LTQtMS0xLTA_7161b942-8b4f-48b2-9ffa-24876456e6cf"
      unitRef="usd">100000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="icf2f109a663b489da13497ab8eee8ac3_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI3LTYtMS0xLTA_73419643-d235-494b-8fd1-9234d38bb223"
      unitRef="number">-0.017</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i121970d9573c4f7ead61761fc53904c1_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI3LTgtMS0xLTA_86315c70-2d3b-4502-b479-0f8837aff41e"
      unitRef="usd">308000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie5ea45ba97f246528bda5b3f66a608de_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI3LTEwLTEtMS0w_1a0dcc8f-406d-48a2-83af-df2006ad3283"
      unitRef="usd">303000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i121970d9573c4f7ead61761fc53904c1_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTI3LTEyLTEtMS0w_bab589b6-9451-4fa1-aa76-afa7591918cb"
      unitRef="number">0.017</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i398b379cf9824522a2ced7cf59facc66_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMwLTItMS0xLTA_8b564168-b052-4471-bdcf-b6bdd819d063"
      unitRef="usd">510000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia701d7201ccb4861bb77be7093c08db4_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMwLTQtMS0xLTA_c959090a-eff2-473f-af8f-60fa8721dc58"
      unitRef="usd">427000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i398b379cf9824522a2ced7cf59facc66_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMwLTYtMS0xLTA_806da948-5c6c-47ae-be66-162c59a7f845"
      unitRef="number">0.194</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8263c917767241278ccdb61c3e4e2803_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMwLTgtMS0xLTA_9d352cfd-2f70-439c-a160-86d052ce9a25"
      unitRef="usd">1541000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4175bbda9cfe43b6be2edab57371b4ab_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMwLTEwLTEtMS0w_999067d1-107f-427c-95f1-6e95a70c9842"
      unitRef="usd">1296000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8263c917767241278ccdb61c3e4e2803_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMwLTEyLTEtMS0w_189e72a6-06f4-4e8b-89bf-7721e2a11023"
      unitRef="number">0.189</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib373300898e546d283fc33d0388ff705_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMxLTItMS0xLTA_adc0e009-3d23-49e2-af70-326ef0afabe0"
      unitRef="usd">239000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1044002d40e647fd8326e72b1451460f_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMxLTQtMS0xLTA_d3a4586a-0047-47c1-8b75-2599e593dad3"
      unitRef="usd">227000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib373300898e546d283fc33d0388ff705_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMxLTYtMS0xLTA_485366e4-b887-40c0-acba-d238b271723f"
      unitRef="number">0.052</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42c60d3862824ccd828e4b74762f6418_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMxLTgtMS0xLTA_cfc3e054-a191-4c07-9192-af075fb80ead"
      unitRef="usd">742000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if420f4bfc54a4c239ff4a7c3b49fa4b8_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMxLTEwLTEtMS0w_78fa3baa-740c-46eb-a5a2-93c305eadaa4"
      unitRef="usd">704000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i42c60d3862824ccd828e4b74762f6418_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMxLTEyLTEtMS0w_785423e8-f92a-4a65-ab08-7772c0ef9399"
      unitRef="number">0.053</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16cf6062a6ae470696458b6461568e25_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMyLTItMS0xLTA_30ce0d17-8d7e-4363-9df9-b33f92cfa0cd"
      unitRef="usd">749000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d4fcfc7f7e247ac9b236ab2cc9b7610_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMyLTQtMS0xLTA_ce8a6f57-823f-4f32-ab3f-969a37f274f9"
      unitRef="usd">654000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i16cf6062a6ae470696458b6461568e25_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMyLTYtMS0xLTA_5c3315f2-04ba-4e46-bc1e-5d07822dcbac"
      unitRef="number">0.145</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i191ce2e499304831a66740e08cdd128a_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMyLTgtMS0xLTA_a1de8c61-32c0-40ba-8ef5-e918681be31f"
      unitRef="usd">2283000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37e02e11e60a431296858d46dcb92eb9_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMyLTEwLTEtMS0w_de33134c-6c08-45df-8c2b-89eaabab2364"
      unitRef="usd">2000000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i191ce2e499304831a66740e08cdd128a_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTMyLTEyLTEtMS0w_8a6161cf-85f6-4ff4-ad6e-9065c7d59ffc"
      unitRef="number">0.141</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37fe03909d0c42c2a5d1a9b179769776_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM0LTItMS0xLTA_031acb9f-20ef-4f0b-bc0c-6d42586e4a5f"
      unitRef="usd">244000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic80413ba702646b38fbb6b8bcb646200_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM0LTQtMS0xLTA_48578c98-eef2-4c3f-8348-a94192f7a5c1"
      unitRef="usd">206000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i37fe03909d0c42c2a5d1a9b179769776_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM0LTYtMS0xLTA_3fae3edb-dc66-47e3-a462-87d013eb277d"
      unitRef="number">0.181</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if047c787f50d450e8de9249ed46afe73_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM0LTgtMS0xLTA_9acef53f-e50f-4287-adcf-5a886eedc23e"
      unitRef="usd">729000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic9a361df298440088f461b4343dc1a17_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM0LTEwLTEtMS0w_56d4b408-134b-4e3b-89a9-344c4f7c57d5"
      unitRef="usd">581000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if047c787f50d450e8de9249ed46afe73_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM0LTEyLTEtMS0w_ee074bfd-844c-4fa7-9c56-146ed9035b06"
      unitRef="number">0.253</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94465a7eb96141d99ff73e62a319bfb8_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM1LTItMS0xLTA_1e1b4984-26a2-4491-9fb1-72919a93d841"
      unitRef="usd">148000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0698ee2dd7914e2abe8fa68b898a1a28_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM1LTQtMS0xLTA_494c5ab4-e42a-4b75-88a3-1ad44abc9ece"
      unitRef="usd">140000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i94465a7eb96141d99ff73e62a319bfb8_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM1LTYtMS0xLTA_e306f309-6b21-4e1a-bf80-1193ca5a8432"
      unitRef="number">0.055</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if08abe1920f04bf98dd739839be93b65_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM1LTgtMS0xLTA_e429fa43-3e31-495a-8cb1-525deadc7729"
      unitRef="usd">458000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i217e2c9aa29f4999bafbb343189c1d78_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM1LTEwLTEtMS0w_d94acd3f-13f6-4359-9539-253f51e97867"
      unitRef="usd">419000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if08abe1920f04bf98dd739839be93b65_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM1LTEyLTEtMS0w_41b4756f-5e5e-4933-8cd6-8361db70fb74"
      unitRef="number">0.093</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic56fe73198cf4b13a4b507b21a942116_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM2LTItMS0xLTA_f52c3119-ed00-412b-8c43-6f2da5c99052"
      unitRef="usd">392000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i318c310c110a410ebd87a7483d92e09c_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM2LTQtMS0xLTA_cdf1d360-5bd1-4657-9755-833b8860ff27"
      unitRef="usd">347000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic56fe73198cf4b13a4b507b21a942116_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM2LTYtMS0xLTA_80add949-ba18-45a0-b0ef-48e36bfc9717"
      unitRef="number">0.130</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2be36e5216d54100a37a610a312db40a_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM2LTgtMS0xLTA_482735a4-de3f-4a53-aaa2-897b54e95521"
      unitRef="usd">1187000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e63c1418afa4562877a6c19653bb704_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM2LTEwLTEtMS0w_d1e92a51-17c2-46d8-bb5d-2b7e5fc40ed8"
      unitRef="usd">1001000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i2be36e5216d54100a37a610a312db40a_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM2LTEyLTEtMS0w_43f0c6ff-79cc-4edd-9f32-7ef43492a009"
      unitRef="number">0.186</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73eb95bb08bd41cb8d99dd2c4a0b8742_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM4LTItMS0xLTA_ee1c6f44-180e-4fc8-a01d-fa2471c7c262"
      unitRef="usd">226000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3aa4dd5cd6a94deb9b074d8cc077c127_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM4LTQtMS0xLTA_1c98e9b0-411f-4923-8339-68e1362708c7"
      unitRef="usd">185000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i73eb95bb08bd41cb8d99dd2c4a0b8742_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM4LTYtMS0xLTA_51806c86-989e-4461-baa7-eac44de5e18f"
      unitRef="number">0.224</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia179bce14d4544eda2428c53ec509422_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM4LTgtMS0xLTA_419ab4fe-0082-476c-8a2c-de8c794775b8"
      unitRef="usd">692000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a8eaf42923c495eb5579fd7097cba34_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM4LTEwLTEtMS0w_ce3104a1-3ef5-42a9-806f-58bf0b23d640"
      unitRef="usd">536000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia179bce14d4544eda2428c53ec509422_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM4LTEyLTEtMS0w_b7679d1c-2100-482a-8ca6-d9e4ab5f4f03"
      unitRef="number">0.291</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i010426648d814b3aa129307a75a78d2a_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM5LTItMS0xLTA_d2ea6dad-7012-49c0-a1d4-adc33a28e6d5"
      unitRef="usd">34000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id454beb1da294c5abf1642ce831df07b_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM5LTQtMS0xLTA_d29e1acd-7591-4b01-af06-db67c0cf7bd4"
      unitRef="usd">25000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i010426648d814b3aa129307a75a78d2a_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM5LTYtMS0xLTA_32e1b69f-1363-48bf-9732-1b0d656e4bfb"
      unitRef="number">0.323</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie15c767fe2ab4976b0a06babdc79238d_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM5LTgtMS0xLTA_b853c707-9c9d-4020-a472-6694f21c5859"
      unitRef="usd">100000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id44c86afd635403a91e902792dfb4c5c_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM5LTEwLTEtMS0w_d5a474ed-9be7-4d8e-a84b-20c764b6a325"
      unitRef="usd">75000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie15c767fe2ab4976b0a06babdc79238d_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTM5LTEyLTEtMS0w_2fe08fa0-fbff-4bca-933a-8a0cd6ca693b"
      unitRef="number">0.331</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e2e06db53a2451dbf125d3629e771b6_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQwLTItMS0xLTA_145320ea-80d9-4d6d-a066-5520a31a8dab"
      unitRef="usd">260000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9cd752a9056749c1b4ecc334a21ed7c3_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQwLTQtMS0xLTA_06f88380-33ad-400a-b784-b180100026f1"
      unitRef="usd">210000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i0e2e06db53a2451dbf125d3629e771b6_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQwLTYtMS0xLTA_f02ed27a-baa9-43d5-9cd1-310d3b72462d"
      unitRef="number">0.236</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8257d323d64145da8c90884eb259a7d2_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQwLTgtMS0xLTA_68091055-0c11-4c07-a1ab-bc42d8000e3a"
      unitRef="usd">792000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c2832df4f35417caf2fffb8cb822af6_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQwLTEwLTEtMS0w_0f458a6e-ff9c-4803-b619-ebd67c4b7e9f"
      unitRef="usd">611000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8257d323d64145da8c90884eb259a7d2_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQwLTEyLTEtMS0w_924e69e4-f173-4611-9ce5-e69aa769274d"
      unitRef="number">0.296</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5075a6f43b343338c5062f76a48e067_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQyLTItMS0xLTA_5d566d67-5481-48e3-a954-8b7aa9b1f80a"
      unitRef="usd">40000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i01d88a3108764d0bb869889f44b14203_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQyLTQtMS0xLTA_a57c20eb-194f-4590-966d-0a2f56a6e6d7"
      unitRef="usd">36000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic5075a6f43b343338c5062f76a48e067_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQyLTYtMS0xLTA_6dca144f-3208-4450-9e62-c719d9e37ed1"
      unitRef="number">0.115</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id644fa2e713f49e1a5ae05b7fc4e4f1c_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQyLTgtMS0xLTA_60c88a79-ab7f-42d4-bec4-9a53fb545b86"
      unitRef="usd">121000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ed3772815cc4a3faa703e73bf58e0a1_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQyLTEwLTEtMS0w_294ea7ae-bb3e-4be5-bbc0-731d66b5d80f"
      unitRef="usd">179000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id644fa2e713f49e1a5ae05b7fc4e4f1c_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQyLTEyLTEtMS0w_6c180928-56f7-4e92-9c54-88b5d2e3d872"
      unitRef="number">-0.323</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iba2b4531ff2140fabce85ea3fb293461_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQzLTItMS0xLTA_91c3505c-f480-4efa-9e0e-83ac26b8bc32"
      unitRef="usd">57000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63eb447b40dd454fb968053fddf79121_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQzLTQtMS0xLTA_038466e2-0232-4ba4-b5e6-5251fc791902"
      unitRef="usd">61000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iba2b4531ff2140fabce85ea3fb293461_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQzLTYtMS0xLTA_66655ae1-d4af-47b7-a2d0-36a70281f316"
      unitRef="number">-0.067</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i013947f80a9443098796115f97595392_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQzLTgtMS0xLTA_c48db382-ad80-498c-864a-6ea5569dbe5d"
      unitRef="usd">183000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a0434c21b524a9bb6ea856dd5969c76_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQzLTEwLTEtMS0w_e7a841be-e902-458d-a5eb-d69b4f4cac1f"
      unitRef="usd">210000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i013947f80a9443098796115f97595392_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQzLTEyLTEtMS0w_2543b31f-38f0-4938-b50f-2b25af1dbf37"
      unitRef="number">-0.127</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i80e3dc1f3fb94925ba1c451b2ab83aee_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ0LTItMS0xLTA_29e5be81-9db8-4c2c-9790-f620396cda56"
      unitRef="usd">97000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id389da37c3cb472483e3c18b6f953869_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ0LTQtMS0xLTA_6413098a-88af-48ba-8871-0124434c5cc8"
      unitRef="usd">96000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i80e3dc1f3fb94925ba1c451b2ab83aee_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ0LTYtMS0xLTA_795da8ca-473d-4e53-86b1-fdc4575bd904"
      unitRef="number">0.001</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00da0f84c86847d7a8655fdf18a81a3d_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ0LTgtMS0xLTA_cb29361e-420c-441a-9917-8e600d85f1ad"
      unitRef="usd">304000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i41759335282246b889e936ec23f879ff_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ0LTEwLTEtMS0w_b791faa6-1bd8-4357-9078-8c323ea7d359"
      unitRef="usd">388000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i00da0f84c86847d7a8655fdf18a81a3d_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ0LTEyLTEtMS0w_a6beecaa-5a81-44f6-9a0b-ad15ba8fcab2"
      unitRef="number">-0.217</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i43ecfa483f6c4bd19953e3fdca33dd8d_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ3LTItMS0xLTA_d29935ba-4a03-40c6-af4a-4f981d005f90"
      unitRef="usd">931000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9f66f37ff7a44b583b3c5e7100eff8d_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ3LTQtMS0xLTA_614eb7f2-799c-445f-b69f-6fc7e53ec6ff"
      unitRef="usd">955000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i43ecfa483f6c4bd19953e3fdca33dd8d_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ3LTYtMS0xLTA_924557ae-152f-4f89-b1ed-1e8bd0f7e18f"
      unitRef="number">-0.026</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i57a9bf838edd4528ace0d2c9eba6e86d_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ3LTgtMS0xLTA_7a5cf93a-0e20-4b1b-a012-5dc203f74e6e"
      unitRef="usd">2574000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d744e86513440f39ebc068eda44b32b_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ3LTEwLTEtMS0w_77f9ba2f-e094-47bc-b399-39c9ced1b611"
      unitRef="usd">2804000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i57a9bf838edd4528ace0d2c9eba6e86d_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ3LTEyLTEtMS0w_60dbb741-cc7d-41df-b9a9-57d78743a46a"
      unitRef="number">-0.082</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i95265ffca9d34d798871d9fa7c192928_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ4LTItMS0xLTA_a2fbe11a-32e7-455c-86dd-cd689cef5940"
      unitRef="usd">351000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i861817aea75241f3a7830b21a7873c16_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ4LTQtMS0xLTA_6c9cbfd7-23e6-42c8-ba82-395cc4437f74"
      unitRef="usd">360000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i95265ffca9d34d798871d9fa7c192928_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ4LTYtMS0xLTA_c82eb521-0402-4370-b893-3e7a2bfe4c5d"
      unitRef="number">-0.027</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i57cdedd2e4924130b9f973dccbf1425f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ4LTgtMS0xLTA_102380bc-ae3c-4a25-8012-9d31b979223d"
      unitRef="usd">1052000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i966b90600060495180cde77fff0831e5_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ4LTEwLTEtMS0w_cd1e8239-2d66-4eea-98a8-6a65020f3839"
      unitRef="usd">1131000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i57cdedd2e4924130b9f973dccbf1425f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ4LTEyLTEtMS0w_9a5e0293-46f5-4aef-a8a8-f4fd259bd50d"
      unitRef="number">-0.071</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33cef8db85f6459a8f53ef7046c5bfa7_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ5LTItMS0xLTA_35b0a64f-3e3d-4b9c-a4b8-2fe6459fd85a"
      unitRef="usd">1281000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i21c25d970b094401ac14010054e1f3ca_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ5LTQtMS0xLTA_ca1467eb-0780-4af1-b9a2-cf2df68a82c3"
      unitRef="usd">1316000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i33cef8db85f6459a8f53ef7046c5bfa7_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ5LTYtMS0xLTA_d99d2d31-737b-4cb9-bf41-91491d29466f"
      unitRef="number">-0.026</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8c574d380a348e68b4cc617a801ea6e_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ5LTgtMS0xLTA_fc1a9212-7ae4-4106-8f23-581dd2990e6d"
      unitRef="usd">3625000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id37ad7cfc12b41428d45ab46b67de2b0_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ5LTEwLTEtMS0w_d4b9492a-4769-4af0-813c-eef466fb83ca"
      unitRef="usd">3936000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if8c574d380a348e68b4cc617a801ea6e_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTQ5LTEyLTEtMS0w_05db078e-8a36-4d63-a379-30aae56be882"
      unitRef="number">-0.079</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i892fd133b58a4cadb07bdf935bc6af34_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUxLTItMS0xLTA_7fabd7b0-0407-4db4-810d-981a3770fdd6"
      unitRef="usd">630000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9a6429a54d841c1bcde5ff62985a777_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUxLTQtMS0xLTA_3b611100-3b56-44e8-837b-031cf6983ca1"
      unitRef="usd">613000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i892fd133b58a4cadb07bdf935bc6af34_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUxLTYtMS0xLTA_e55b9a8c-2cff-4890-bfd2-f1186be2763a"
      unitRef="number">0.029</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id21567f828814171bae17a473a89e0af_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUxLTgtMS0xLTA_9ed200b2-eae2-4e97-84f2-bff7a1f70220"
      unitRef="usd">1716000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96d11501e2ac4574bacde0ae4de62fd8_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUxLTEwLTEtMS0w_889e3f0b-22b2-441f-b009-eee85ad93bf3"
      unitRef="usd">1704000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id21567f828814171bae17a473a89e0af_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUxLTEyLTEtMS0w_589f1bec-a68d-45b1-b2cf-5a24fd004d75"
      unitRef="number">0.007</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i762b4c937c7f46559a1d1ebdea00839f_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUyLTItMS0xLTA_c86173a5-bf1a-49cb-8dbb-8fed08a457b7"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ca2df401f3e4b03a03bb594e14680e5_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUyLTQtMS0xLTA_b83ac249-defe-4852-a587-340a82a9a0d9"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i762b4c937c7f46559a1d1ebdea00839f_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUyLTYtMS0xLTA_c6e21927-7b1d-44bd-a21a-40c0f68e2d2b"
      unitRef="number">0</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0242667ce51c4802826573ff14607be2_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUyLTgtMS0xLTA_3bd36a10-1c82-4c3b-97be-903d42f6cd41"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a3f0f519f304581a495ee44fa8e215e_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUyLTEwLTEtMS0w_9d798f4c-51fa-4fae-8a53-b322553e2174"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i0242667ce51c4802826573ff14607be2_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUyLTEyLTEtMS0w_9b29fc43-3985-42b1-8ed7-353fea61fb69"
      unitRef="number">0</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d38ab9af5db42ec82566d7e0b60d483_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUzLTItMS0xLTA_a27ab660-5f64-400b-b726-6b03972e9ecd"
      unitRef="usd">630000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id7d07f6f95354ba9ad6ec0fd6afb8f1d_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUzLTQtMS0xLTA_1aed4cb4-103e-4734-abd3-51cf89633ae2"
      unitRef="usd">613000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i4d38ab9af5db42ec82566d7e0b60d483_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUzLTYtMS0xLTA_ad120679-c18b-4f24-b87f-373d8ad3c5f1"
      unitRef="number">0.029</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic78f1097f5d748cb869eb5b503824ebe_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUzLTgtMS0xLTA_f79c3c96-02d1-4ce7-9549-45c099253b20"
      unitRef="usd">1716000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6563c54cfc0a46558fb408ed4e9fd465_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUzLTEwLTEtMS0w_5458b9d7-de80-441e-97a7-2a10f0538264"
      unitRef="usd">1704000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic78f1097f5d748cb869eb5b503824ebe_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTUzLTEyLTEtMS0w_a565b388-d83a-4e99-b648-5317f34d2280"
      unitRef="number">0.007</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1bb45cec18df4abb9e67780a9955c6f4_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU1LTItMS0xLTA_4184c6f9-73a0-4883-bc90-6e30c8fee8c7"
      unitRef="usd">156000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c8d711197c44ef8aa825b062094402b_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU1LTQtMS0xLTA_721b8036-43d1-4ce0-9414-f284d52a1966"
      unitRef="usd">125000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i1bb45cec18df4abb9e67780a9955c6f4_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU1LTYtMS0xLTA_3870cc16-4765-4196-8748-1ed098c21330"
      unitRef="number">0.247</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f4b21e1fd1a4652b30fc4578fce9c11_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU1LTgtMS0xLTA_da435413-c275-4cd0-9d01-77cda847207c"
      unitRef="usd">405000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a3a40f9c30840b1927ebacddcf845ac_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU1LTEwLTEtMS0w_53ed8abc-0e79-4b12-92c9-641579a84c2c"
      unitRef="usd">411000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i0f4b21e1fd1a4652b30fc4578fce9c11_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU1LTEyLTEtMS0w_17045783-6d7f-44ac-a855-0b309a25b0b2"
      unitRef="number">-0.016</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3694631e7fff4ce1b73ec6332f8f1114_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU2LTItMS0xLTA_d29b5279-a10e-4b68-9c2f-285583f8344c"
      unitRef="usd">68000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic32d7dcacf84400d91757b36f9215e72_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU2LTQtMS0xLTA_a447fcf1-5a14-44a3-bbc0-e28f54347894"
      unitRef="usd">55000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i3694631e7fff4ce1b73ec6332f8f1114_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU2LTYtMS0xLTA_f8e7cdf1-d53f-4017-b7ea-78b0dfadf447"
      unitRef="number">0.247</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a75613a853b432d954dc4de396f1b7b_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU2LTgtMS0xLTA_5ba1051e-f99f-438c-9911-e8d0d0a364a9"
      unitRef="usd">173000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ff9e6b244664dcc8c57f0d6c1e416d0_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU2LTEwLTEtMS0w_e59b293e-1dd8-47b6-987e-4191d4c52ea6"
      unitRef="usd">147000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9a75613a853b432d954dc4de396f1b7b_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU2LTEyLTEtMS0w_902eecfc-d08a-425a-80de-458b90ca74d2"
      unitRef="number">0.180</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia756fd0cfb2e474196776e501a411735_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU3LTItMS0xLTA_357cc481-3a45-43ea-9216-e9521a44b408"
      unitRef="usd">224000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i31cd8eb3320a41a397704a1328b8854c_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU3LTQtMS0xLTA_fac0cbd8-7ab6-4764-96e0-c35f13bc7f73"
      unitRef="usd">179000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia756fd0cfb2e474196776e501a411735_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU3LTYtMS0xLTA_a96edcf5-22b7-4c69-afd2-b04d0fc47f51"
      unitRef="number">0.247</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7fd6606fa19d4019bc87ef7e6ba6eb73_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU3LTgtMS0xLTA_c7dbdb61-2b22-4a79-bfc2-dbac02b12c1d"
      unitRef="usd">578000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i34aaafb86ca14d2d9716c717162ad440_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU3LTEwLTEtMS0w_f603af30-7150-4d33-b4f0-6a7ba2750e7d"
      unitRef="usd">558000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7fd6606fa19d4019bc87ef7e6ba6eb73_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU3LTEyLTEtMS0w_16ba9b5e-4d72-4bc0-bc60-fc801e8ec19e"
      unitRef="number">0.036</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7fe0b9644764d87866372cd691decb6_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU5LTItMS0xLTA_6a4de73a-aa32-4ddf-9e3a-f7edd9948ba6"
      unitRef="usd">69000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia85d0ddfb054423a9895f28c3b06f8cf_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU5LTQtMS0xLTA_5f2f2893-b813-453b-974b-e0adfdecd445"
      unitRef="usd">126000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia7fe0b9644764d87866372cd691decb6_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU5LTYtMS0xLTA_a71cf3a3-5bde-4ca5-9767-1e6303aaca0c"
      unitRef="number">-0.454</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4763443528342868e35179cf61ecdde_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU5LTgtMS0xLTA_3820c9eb-85eb-439b-b0b0-060107338da4"
      unitRef="usd">215000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i333c0de72c3a4698981d349cac512c7e_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU5LTEwLTEtMS0w_36a5b643-c11c-410b-a710-47215c4710cc"
      unitRef="usd">387000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic4763443528342868e35179cf61ecdde_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTU5LTEyLTEtMS0w_4fcd87da-20ee-4714-ad50-4f4058b490c2"
      unitRef="number">-0.445</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id724502ba8f2486cac318bef4c54fd96_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYwLTItMS0xLTA_d2d7c8bf-2380-438a-9a90-8569622d76a7"
      unitRef="usd">63000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69ceed544ddc4d9b88e01a94fdf9e5a1_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYwLTQtMS0xLTA_4eafb480-4c36-4216-97d7-072449e96c3c"
      unitRef="usd">72000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id724502ba8f2486cac318bef4c54fd96_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYwLTYtMS0xLTA_bc26c856-d2e0-49b6-9c48-1a38a7c2945f"
      unitRef="number">-0.122</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i392f000005e74b13ae8ec4fd2245bab8_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYwLTgtMS0xLTA_e597c079-2994-4087-a26f-8fca7d13bc15"
      unitRef="usd">208000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0ebe2acbb28427fb07907d3d7cc84c8_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYwLTEwLTEtMS0w_4c150528-877d-48fb-bc1a-6dd055aaf324"
      unitRef="usd">220000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i392f000005e74b13ae8ec4fd2245bab8_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYwLTEyLTEtMS0w_a8a7957d-fff2-45ff-aa21-310bac073e11"
      unitRef="number">-0.055</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d4f2c99a1f249c49d42d6f746af5a57_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYxLTItMS0xLTA_e9b42dcc-55d6-4c66-ab21-6ad3a0eacd5c"
      unitRef="usd">132000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8603b809d89437c8397bde709854409_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYxLTQtMS0xLTA_3ceadd37-fb3e-42b2-82fe-844d00ac5fed"
      unitRef="usd">198000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i2d4f2c99a1f249c49d42d6f746af5a57_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYxLTYtMS0xLTA_359f59e0-f02a-4abf-ace0-bb9edeaad131"
      unitRef="number">-0.333</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f2972e6f6484e36b1d2a91c5cc8c877_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYxLTgtMS0xLTA_2989231b-e32f-49bf-91aa-3dd05136b5de"
      unitRef="usd">423000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c5a38578aa04cd7a11950dd9aea6179_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYxLTEwLTEtMS0w_1ea94b63-d214-4578-8a3c-d625529e1c0f"
      unitRef="usd">607000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9f2972e6f6484e36b1d2a91c5cc8c877_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYxLTEyLTEtMS0w_afabd479-4f5c-49e2-b1c1-c7ecf1672220"
      unitRef="number">-0.304</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8308cb00a64487ca422779891052509_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYzLTItMS0xLTA_045db9a0-8fc7-4c8d-8ed7-6db1dccc5b39"
      unitRef="usd">75000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i72b87b179f8b450ca58c7e90f207c8cf_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYzLTQtMS0xLTA_5646c779-3193-414f-ba1e-fb03256d511b"
      unitRef="usd">91000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic8308cb00a64487ca422779891052509_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYzLTYtMS0xLTA_ee7d7320-496f-47b0-8377-c679f3f00945"
      unitRef="number">-0.179</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5882b17221ff476797f83dbe3709f9f7_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYzLTgtMS0xLTA_bc8f27e8-5aa3-4696-9d28-39b75e6f2f1b"
      unitRef="usd">238000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1276e4c945994ec68e5b1a60f0f2e568_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYzLTEwLTEtMS0w_d7f228b1-d1ed-4d92-b19c-f4b00dd50ae3"
      unitRef="usd">302000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i5882b17221ff476797f83dbe3709f9f7_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTYzLTEyLTEtMS0w_166a034d-e802-40df-864d-1d455d0cba47"
      unitRef="number">-0.214</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iebff1eb342264ce2915080aaeaaff91f_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY0LTItMS0xLTA_caca0e67-9135-458c-80de-4361fe4c64b3"
      unitRef="usd">219000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9141ca3c0a1c484a869bed176ba77cae_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY0LTQtMS0xLTA_815aa94b-7133-4e31-aa06-695ecad3a1f2"
      unitRef="usd">234000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iebff1eb342264ce2915080aaeaaff91f_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY0LTYtMS0xLTA_f0173d46-7b46-4693-83a3-143a8a41faf7"
      unitRef="number">-0.062</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e756c09a365446ba32b0f4451a03c98_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY0LTgtMS0xLTA_5a24df37-7f5e-4db8-90f5-06a835f8cbd7"
      unitRef="usd">670000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id74229a2d6f0451fb97e2c96709af358_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY0LTEwLTEtMS0w_33f65ea0-793d-4062-ab78-07f6bd87835b"
      unitRef="usd">765000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i1e756c09a365446ba32b0f4451a03c98_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY0LTEyLTEtMS0w_21ec0e4c-4161-4e2e-8ecc-b73b7fa8ecd8"
      unitRef="number">-0.123</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18dad1ee5f9340d5a35c3c37e4cec4ab_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY1LTItMS0xLTA_64521778-69fd-4678-97fc-55c14edb0565"
      unitRef="usd">294000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ideea0ce4a35c49a0a45ee282bf1b4beb_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY1LTQtMS0xLTA_aabd849a-563d-474d-8e84-8914c50feae3"
      unitRef="usd">325000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i18dad1ee5f9340d5a35c3c37e4cec4ab_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY1LTYtMS0xLTA_3c05a80d-094f-4df6-974c-aa1a66fed56c"
      unitRef="number">-0.095</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id554573e94b84b8cab2eb20188d60570_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY1LTgtMS0xLTA_2c42dfdf-97c8-4693-96dd-02ad2db2bc69"
      unitRef="usd">908000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i49cd0b4d91974b7da8bf40cd67d178c1_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY1LTEwLTEtMS0w_7da3a3e7-e001-4d9f-854e-f870d8806231"
      unitRef="usd">1067000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i49cd0b4d91974b7da8bf40cd67d178c1_D20181231-20190929"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY1LTEyLTEtMS0w_56a34d37-b72f-4c1d-9d1b-8cccf1d20b22"
      unitRef="number">-0.149</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i53b2c0aad4df4af0b03896d334176f20_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY4LTItMS0xLTA_b544bffb-d269-46ab-9a3e-4eab65ccee8f"
      unitRef="usd">6438000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2badccfe6cf04b1c9d7f2fa0fc294693_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY4LTQtMS0xLTA_ff518b70-1759-4ab6-9254-fe08cd040b8f"
      unitRef="usd">6340000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i53b2c0aad4df4af0b03896d334176f20_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY4LTYtMS0xLTA_6fa3efba-3e1c-45af-b1d7-778d1d35e004"
      unitRef="number">0.015</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d5c80efe6b1469391e9a4a07886a5a9_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY4LTgtMS0xLTA_2a5ca937-5b03-4e59-ae1e-d6c961f92391"
      unitRef="usd">18619000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idff7cfe33b4c4b039394833c97daf9f1_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY4LTEwLTEtMS0w_68e741e1-3e45-4fd4-ba53-877633537b07"
      unitRef="usd">17705000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i3d5c80efe6b1469391e9a4a07886a5a9_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY4LTEyLTEtMS0w_9baa54af-91af-487c-a9b8-0ab05f1aeccc"
      unitRef="number">0.052</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe12ceed34eb4a389dbacc45771bab50_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY5LTItMS0xLTA_adc3324f-15ce-4b77-8c83-0bb6ef0f37a2"
      unitRef="usd">4980000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaec3c39feb634238a2be7772b9926fde_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY5LTQtMS0xLTA_70ef72cf-9091-4fa4-8b93-d317b3cf8646"
      unitRef="usd">4537000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ibe12ceed34eb4a389dbacc45771bab50_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY5LTYtMS0xLTA_ec489a50-2afa-4438-b7c4-b9213c3fd17c"
      unitRef="number">0.097</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73fa6421e055482c920a5e447a1f8675_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY5LTgtMS0xLTA_7be79c91-89b0-4b7c-bb4c-d86bfa56f2ff"
      unitRef="usd">14685000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9b7a1c7831f4541b7d5fbf0ef0a1e55_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY5LTEwLTEtMS0w_47395ad6-beae-4048-96c8-80ab9b450db4"
      unitRef="usd">13945000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i73fa6421e055482c920a5e447a1f8675_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTY5LTEyLTEtMS0w_9113bbaa-20af-436a-9c60-3a7153a1affb"
      unitRef="number">0.053</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7db38f4a02ec46bd9364e821dfd12084_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTcwLTItMS0xLTA_ac395b38-010f-4dfa-8f48-fb720e85025b"
      unitRef="usd">11418000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08b63855cabe4bbdbeb0a69f02efd745_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTcwLTQtMS0xLTA_7fe8f8f0-4a94-4bf5-9910-6a21b53942c3"
      unitRef="usd">10877000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7db38f4a02ec46bd9364e821dfd12084_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTcwLTYtMS0xLTA_ad115a67-909c-4b90-87de-3ae0e5524553"
      unitRef="number">0.050</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i31c5bebe5faa45388656d1dcb0238be9_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTcwLTgtMS0xLTA_bc5b3f05-6106-41ac-bb28-1e9a582b50e3"
      unitRef="usd">33304000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie736ef5792a9408d9d187416e6bf80ae_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTcwLTEwLTEtMS0w_816ac62d-f61e-4922-977a-8820c8b2efdc"
      unitRef="usd">31650000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i31c5bebe5faa45388656d1dcb0238be9_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTcwLTEyLTEtMS0w_4061685f-e519-4447-93a0-79163e1779f7"
      unitRef="number">0.052</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1666eaae52c4401935f050f08c6ad04_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgyLTItMS0xLTA_d959252b-8ad7-4640-95db-912274a00c44"
      unitRef="usd">399000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icff6620acad14e70ba4ae22cb2b1c5ab_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgyLTQtMS0xLTA_7c7980cf-c4e1-479e-b478-ede63c2ac4f9"
      unitRef="usd">357000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id1666eaae52c4401935f050f08c6ad04_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgyLTYtMS0xLTA_f58c9245-4a83-4ddb-8f30-66c8e71718be"
      unitRef="number">0.118</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8dcb3df9a1d84367b2ad2572e6f5d507_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgyLTgtMS0xLTA_a48a52af-743d-4901-ac72-d552af3854e8"
      unitRef="usd">1019000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide630ed019df43bb97fc9e366da29198_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgyLTEwLTEtMS0w_7495063e-5833-437b-bbf7-05b1634fa636"
      unitRef="usd">1066000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8dcb3df9a1d84367b2ad2572e6f5d507_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgyLTEyLTEtMS0w_5485c29e-1508-4ebd-9c81-952f3fc537f6"
      unitRef="number">-0.044</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1940a237e8c44075af2c9cefe451512d_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgzLTItMS0xLTA_14a4d9e3-576a-4e48-81d4-55fb252e9edc"
      unitRef="usd">437000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1111a41f19b54df1a08a52959ba8a81a_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgzLTQtMS0xLTA_19586fb1-f71f-4f6c-a632-c68b0d40da2a"
      unitRef="usd">382000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i1940a237e8c44075af2c9cefe451512d_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgzLTYtMS0xLTA_7419aadf-db86-46a5-82fd-5826e88d09ab"
      unitRef="number">0.140</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if89b08d6774845f39dbd843c88a623e4_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgzLTgtMS0xLTA_d444e71f-6c91-47ac-882f-dea1f8887c99"
      unitRef="usd">1134000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ab8b554e029447da97b0eeb058f7784_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgzLTEwLTEtMS0w_24183536-6d72-4dea-be8d-7d7f1dbac220"
      unitRef="usd">1156000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if89b08d6774845f39dbd843c88a623e4_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTgzLTEyLTEtMS0w_a5ca7138-27b3-4917-9598-2c0d030c580a"
      unitRef="number">-0.020</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i362aa1da8517434aa7ec7cdae445543f_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg0LTItMS0xLTA_a5cd398f-56b6-4aa1-86c2-0ff1d70b3649"
      unitRef="usd">836000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ef01fc2d1d144f591e77eb42bf26fa1_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg0LTQtMS0xLTA_64ca95a5-4d44-40d3-8008-c383bf45bd75"
      unitRef="usd">741000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i362aa1da8517434aa7ec7cdae445543f_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg0LTYtMS0xLTA_7001cd5e-3810-4cb3-9bc1-f969eb4a52bf"
      unitRef="number">0.129</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a7520101a8347d8b81b529c44f5e031_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg0LTgtMS0xLTA_38a1091e-b1f0-49e9-9e8f-b6c7d0975975"
      unitRef="usd">2153000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7455b437e0ee48eb9473a4538a82626d_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg0LTEwLTEtMS0w_0f2a2f1d-54d4-4342-b5ee-1f7747eebc42"
      unitRef="usd">2223000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6a7520101a8347d8b81b529c44f5e031_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg0LTEyLTEtMS0w_2497badd-a3b5-44c8-8ab5-367cb6cb0248"
      unitRef="number">-0.031</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i331b2defbc4b495580cbf5071b32f36e_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg2LTItMS0xLTA_10c59487-7529-41f4-a5f4-8549ba3df043"
      unitRef="usd">1308000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i700c383f769a4f039b3dadd10d216a66_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg2LTQtMS0xLTA_14c507e6-85fc-4a7e-b51c-cfcda6c8c2aa"
      unitRef="usd">1301000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i331b2defbc4b495580cbf5071b32f36e_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg2LTYtMS0xLTA_c4392862-75a5-4c86-b75b-cb119f780045"
      unitRef="number">0.006</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a16cc194cf149e188ec098d494aa4eb_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg2LTgtMS0xLTA_cc1ab3f2-ccb8-400a-9d39-9578e247ef0d"
      unitRef="usd">3427000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61e9bd42de204e38b485cae7266baf3f_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg2LTEwLTEtMS0w_3d114266-b19b-46ed-be1e-48bbe4b7efb0"
      unitRef="usd">3950000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9a16cc194cf149e188ec098d494aa4eb_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg2LTEyLTEtMS0w_c607f067-a702-430d-9352-e2b570fa43a0"
      unitRef="number">-0.132</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ebcff1d99364d61b75d91cd03f2edbd_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg3LTItMS0xLTA_a91088fd-2e83-4f76-be93-da1540370972"
      unitRef="usd">774000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f5862c1f9554aeaad6ec3149da92dcd_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg3LTQtMS0xLTA_4a1f700f-ac23-4911-ba36-fea07124b02f"
      unitRef="usd">837000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9ebcff1d99364d61b75d91cd03f2edbd_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg3LTYtMS0xLTA_26a288cd-832e-458c-85df-fb263c41d9fc"
      unitRef="number">-0.075</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56570f28521e4309bb5acfbc1d861206_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg3LTgtMS0xLTA_9bd24084-21ec-464e-bbf4-6ca8a54ec4a0"
      unitRef="usd">2145000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4772bb2f70594c609f15d55b5b840ce3_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg3LTEwLTEtMS0w_0627e584-eb37-4376-a176-0d6f25d4b21d"
      unitRef="usd">2616000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i56570f28521e4309bb5acfbc1d861206_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg3LTEyLTEtMS0w_71e8068e-c181-4223-93ec-f78e54e49c13"
      unitRef="number">-0.180</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96b312422bef422894f64737926c8653_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg4LTItMS0xLTA_03c78e08-39dc-4d6b-a63e-2faba5670d23"
      unitRef="usd">2083000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94c1dc95b63b47a19b2b55e786fda0a6_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg4LTQtMS0xLTA_4b149d77-32f3-433d-822a-a458d96252bb"
      unitRef="usd">2138000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i96b312422bef422894f64737926c8653_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg4LTYtMS0xLTA_f6308c93-a37a-4a9a-ac4a-34bdfe8aebab"
      unitRef="number">-0.026</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i620ad18d8b8e4ee4b483bbd4fc7e9e5a_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg4LTgtMS0xLTA_d7930c62-6b5c-4d23-b04b-385ecc1c5eb6"
      unitRef="usd">5572000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i79e0912ed4304749a55e7ac7a0fe0ec5_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg4LTEwLTEtMS0w_4ea7d097-97a9-41e3-b7ad-9defb9d4a486"
      unitRef="usd">6566000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i620ad18d8b8e4ee4b483bbd4fc7e9e5a_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTg4LTEyLTEtMS0w_8f32c422-0452-408b-bf0d-85bc3c4cb204"
      unitRef="number">-0.151</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibc0fcc5f2a24455490a6a544350ae618_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkwLTItMS0xLTA_3d79c5c3-eafc-4f61-9ffc-c8c52dba573c"
      unitRef="usd">221000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86a18dd116e24e96b3485a5f6169baf3_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkwLTQtMS0xLTA_92a23f23-bddf-425f-bfd9-361c4791de2d"
      unitRef="usd">204000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ibc0fcc5f2a24455490a6a544350ae618_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkwLTYtMS0xLTA_e3eca164-203b-402d-bd13-fb354943e5d1"
      unitRef="number">0.087</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b766c43eb6240ba8bbdaa57b4a094d3_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkwLTgtMS0xLTA_0a2345f0-0531-40ba-9dfa-ee3678371ca4"
      unitRef="usd">564000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i228a88e232a3439ba7508d3f89efab11_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkwLTEwLTEtMS0w_12a87224-c85a-4013-880e-e62547edb00e"
      unitRef="usd">633000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9b766c43eb6240ba8bbdaa57b4a094d3_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkwLTEyLTEtMS0w_2c14ff86-776c-4534-a88c-c6d31fee1dd9"
      unitRef="number">-0.109</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8e0f6bad1de4c50a2da26602cdee485_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkxLTItMS0xLTA_8cbd0e67-9766-4895-93a1-e9e3018a9f23"
      unitRef="usd">124000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5478e07cbf10492b94c7f95ded249535_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkxLTQtMS0xLTA_1913ea83-beda-4d61-9963-66d00f535a3c"
      unitRef="usd">133000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic8e0f6bad1de4c50a2da26602cdee485_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkxLTYtMS0xLTA_36d6cc9b-2547-4c1a-8637-e470756ca67f"
      unitRef="number">-0.072</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd8aa81948f24b89a510f6d5974fe76b_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkxLTgtMS0xLTA_23e540e9-0710-4d94-a7f3-841d4861d03a"
      unitRef="usd">344000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5470093de4834bc093bb3471c8a0d68a_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkxLTEwLTEtMS0w_ed70cde3-6395-4264-bd30-d4668474251c"
      unitRef="usd">428000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ifd8aa81948f24b89a510f6d5974fe76b_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkxLTEyLTEtMS0w_a23e5c96-e72e-4a17-bd96-2bc907844683"
      unitRef="number">-0.198</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9e844cd7770412489bfc37a68ec0c16_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkyLTItMS0xLTA_5e60f27f-ba07-4886-80b1-40a1cabba9e3"
      unitRef="usd">345000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1801a6a1406d4302bae15df4fc5e6e72_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkyLTQtMS0xLTA_c18450d4-3b69-4371-ae4c-7909f32425c4"
      unitRef="usd">336000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia9e844cd7770412489bfc37a68ec0c16_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkyLTYtMS0xLTA_5340904a-7859-4028-b552-302921a83c91"
      unitRef="number">0.024</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia35085eaa6c748a5bfddc85e2da15d60_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkyLTgtMS0xLTA_afa1c3cb-686c-441b-8e9c-ba36d935898f"
      unitRef="usd">908000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if25d735005cc4622a33272df76697e88_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkyLTEwLTEtMS0w_61224774-43c8-42f7-a79e-7b2179f494ef"
      unitRef="usd">1061000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia35085eaa6c748a5bfddc85e2da15d60_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTkyLTEyLTEtMS0w_505ec258-fd9a-49ce-a8e9-7244d44b79c3"
      unitRef="number">-0.145</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5faf7b6f7a9d42c58b9a332270703b95_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk0LTItMS0xLTA_785c772b-5264-4fee-9090-615753e174f0"
      unitRef="usd">205000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i59e7895988ef4dae840116b8f041c33c_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk0LTQtMS0xLTA_bb9a40be-822c-4d5a-b292-cef360c1ee28"
      unitRef="usd">209000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i5faf7b6f7a9d42c58b9a332270703b95_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk0LTYtMS0xLTA_0eb849de-7ab6-4177-9ec3-40b9bf79cd05"
      unitRef="number">-0.019</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic339811f8c7445d4af842ec97e4900dc_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk0LTgtMS0xLTA_50075dc8-db0d-4ea1-a744-924656c0c41b"
      unitRef="usd">527000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e17bddbdca5483e9fb788af9d2d8cd4_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk0LTEwLTEtMS0w_1e1bb852-c2e8-4dba-8b76-e19269b829e9"
      unitRef="usd">650000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic339811f8c7445d4af842ec97e4900dc_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk0LTEyLTEtMS0w_839ed226-c487-4eab-9f63-a34f335a1617"
      unitRef="number">-0.190</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i83d80cb8b62742239c836bc6aed6077c_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk1LTItMS0xLTA_329d9e2c-b55a-4a08-aa77-5c26629783f4"
      unitRef="usd">102000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf702c0dd8c14d8a908386735f728ab2_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk1LTQtMS0xLTA_1b6489e6-79df-46f7-a8a4-da03370753b4"
      unitRef="usd">136000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i83d80cb8b62742239c836bc6aed6077c_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk1LTYtMS0xLTA_c90e53e9-876e-480d-b65f-e3128e30283a"
      unitRef="number">-0.248</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i06f5aba171ac42868d1d0f93dc180a43_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk1LTgtMS0xLTA_66aff24a-33e4-4c1f-9dfe-b7a2a64bd564"
      unitRef="usd">298000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i62ede8edf37b48389570fe7528e37670_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk1LTEwLTEtMS0w_f442c215-c9b2-40d4-80e0-3f0770e980fc"
      unitRef="usd">435000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i06f5aba171ac42868d1d0f93dc180a43_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk1LTEyLTEtMS0w_ecdb5df7-9fd8-4363-90c4-33ced16aaa2d"
      unitRef="number">-0.315</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4eb2ce198ed40b7b248f09b87ca97ce_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk2LTItMS0xLTA_4f9f29f7-1ec7-404f-b052-71fcc67d1efa"
      unitRef="usd">308000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic63cd8e33f3e404aa8678a6a0bd21989_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk2LTQtMS0xLTA_8ad22c73-baaf-48e1-b9a5-ed4763e31fbb"
      unitRef="usd">344000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia4eb2ce198ed40b7b248f09b87ca97ce_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk2LTYtMS0xLTA_e79d7f57-d758-41ab-b783-ee174cb9ad7b"
      unitRef="number">-0.109</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd0f4a74ca2f4dac9fb438dfe7c99571_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk2LTgtMS0xLTA_1622e895-b414-4451-a2a2-bfad3bb7a969"
      unitRef="usd">825000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i257430a4bde64ea48d158e7205d2c483_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk2LTEwLTEtMS0w_0c9d5312-f1a0-4352-b67b-fa7867b5cb07"
      unitRef="usd">1085000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ifd0f4a74ca2f4dac9fb438dfe7c99571_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk2LTEyLTEtMS0w_cdf7717d-2acd-4e6f-a4c8-8082f97102ad"
      unitRef="number">-0.240</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8ec3b3d8e35c4d95bf1c4fbbecbbe0dd_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk4LTItMS0xLTA_9cb193a7-9ee3-4faf-ba82-651d9ec034d8"
      unitRef="usd">433000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id2e2712a0d5049f5a4531ceefce9f03a_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk4LTQtMS0xLTA_5ed3812d-c02c-4c0f-a6a8-aabbd893812e"
      unitRef="usd">415000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8ec3b3d8e35c4d95bf1c4fbbecbbe0dd_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk4LTYtMS0xLTA_8ec3b87f-aade-4b85-a466-f26605f7f02d"
      unitRef="number">0.042</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i80bf15618213433798636c636144fd62_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk4LTgtMS0xLTA_0e785b12-6400-450e-8b8d-ed51de44fdb2"
      unitRef="usd">1194000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i680358c8ea674cb9ad8f59a84f3e2968_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk4LTEwLTEtMS0w_39aaee49-5d69-42dc-9584-79654135efc7"
      unitRef="usd">1239000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i80bf15618213433798636c636144fd62_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk4LTEyLTEtMS0w_54511a72-46aa-439a-a47b-9bd2ce266bba"
      unitRef="number">-0.036</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i506f1906854848fab0375dee9395568d_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk5LTItMS0xLTA_5de39a7e-4b29-40b0-b810-a381920bdc3d"
      unitRef="usd">253000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic59c453b839243f1910be25d60212165_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk5LTQtMS0xLTA_54873a02-3f5e-4c20-bd7f-f2f0965de27b"
      unitRef="usd">262000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i506f1906854848fab0375dee9395568d_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk5LTYtMS0xLTA_a79ad8d0-dbcd-497f-9c50-45393aa846a2"
      unitRef="number">-0.034</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92e00f4cd50544f1a6fc1c21b5eff033_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk5LTgtMS0xLTA_a80ed276-d10a-40c1-903b-d82f956d5c9f"
      unitRef="usd">698000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9a73c4de08348d0aebe04a72f25b265_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk5LTEwLTEtMS0w_5401d589-2232-46f0-8962-76f4e11b8a7c"
      unitRef="usd">795000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i92e00f4cd50544f1a6fc1c21b5eff033_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMTk5LTEyLTEtMS0w_c2c57e41-b14a-4439-9d7b-9b26434bf64c"
      unitRef="number">-0.122</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa548762232c4bf1ab0a3a867110e217_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAwLTItMS0xLTA_c3e16b4c-cfc2-4d3e-83d7-ef54e3674b4a"
      unitRef="usd">685000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i80e7c2e2168a439eb1b8ec9732ba396f_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAwLTQtMS0xLTA_eee1f156-b891-400e-895c-50728a84ed2f"
      unitRef="usd">677000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iaa548762232c4bf1ab0a3a867110e217_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAwLTYtMS0xLTA_fe408291-5444-495f-a855-a3175cb40483"
      unitRef="number">0.013</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i159a3081cf544186938c908e8fa7c674_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAwLTgtMS0xLTA_05e41478-113a-4e75-ba1f-19c39ad9246e"
      unitRef="usd">1892000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i126743cd6a3047e9838e7e77686dec4f_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAwLTEwLTEtMS0w_fd151b86-c1c8-471a-b40e-d327974959a2"
      unitRef="usd">2034000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i159a3081cf544186938c908e8fa7c674_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAwLTEyLTEtMS0w_0793c981-ea06-41e3-a4d2-896f57e2b110"
      unitRef="number">-0.070</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f7d40b1ae56403c89c4041e353c5f2d_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAyLTItMS0xLTA_9445607b-c182-4dad-b748-e6758da39ef0"
      unitRef="usd">449000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i279d140c5f3b4e169fdb57f7f0df5aa2_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAyLTQtMS0xLTA_4f60ae31-c0ce-47d5-84f5-7ae2e990dfbf"
      unitRef="usd">472000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9f7d40b1ae56403c89c4041e353c5f2d_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAyLTYtMS0xLTA_716031f1-7edb-449f-91d8-843f7e6ad51d"
      unitRef="number">-0.049</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id82df2ce137f4d92afc976d33692c8bf_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAyLTgtMS0xLTA_730af72b-673b-4b9f-93ca-f613a6082bd9"
      unitRef="usd">1142000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b733e335d8e4c1fb383d893bb64d6c6_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAyLTEwLTEtMS0w_3196b863-8827-4f3b-a2bd-936ddbd753ef"
      unitRef="usd">1427000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id82df2ce137f4d92afc976d33692c8bf_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAyLTEyLTEtMS0w_f902bf2f-e339-4c45-940e-9d706f2f3b55"
      unitRef="number">-0.200</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i078e82fb2a1e41d6810522efa7753a85_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAzLTItMS0xLTA_443be0ca-6d05-4460-ae02-c471ebd46425"
      unitRef="usd">295000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic3b18e1cdfb2424b8ef0500cab9b37e1_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAzLTQtMS0xLTA_7bb863a4-5345-4b67-bdae-7a83fc40dbdf"
      unitRef="usd">306000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i078e82fb2a1e41d6810522efa7753a85_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAzLTYtMS0xLTA_fe22d945-d0e1-4dd1-967c-e173a4076b8f"
      unitRef="number">-0.034</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i549bc38f2f2e4815adbcbdca90f24d9e_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAzLTgtMS0xLTA_f21063f9-a349-4620-91bd-2a0f12414e44"
      unitRef="usd">805000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i46022c7e16be41ff96edd7e762e38dc9_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAzLTEwLTEtMS0w_b94e3e82-c158-4433-b932-83a98dfbcc47"
      unitRef="usd">957000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i549bc38f2f2e4815adbcbdca90f24d9e_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjAzLTEyLTEtMS0w_5b7e9e77-781c-4e71-a05c-85cfe496ad3d"
      unitRef="number">-0.158</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iafa8ab4bd43341708edcefb67a5354af_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA0LTItMS0xLTA_69e13a75-02b9-4eb1-a100-52a02333518c"
      unitRef="usd">745000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i445e1d6a7f2f49918827c8cb78f49926_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA0LTQtMS0xLTA_ae6169b8-40e8-4a5b-b28e-a20f9983fe3d"
      unitRef="usd">778000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iafa8ab4bd43341708edcefb67a5354af_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA0LTYtMS0xLTA_6c05694f-7c8d-4380-978c-0b3f8092753b"
      unitRef="number">-0.043</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c6117a9799b4fe0b16e620b0cb21f30_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA0LTgtMS0xLTA_c379b399-b22a-4e1e-9314-97af1f2e13ef"
      unitRef="usd">1947000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3f23ca283834dfca4b73d913c0b495a_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA0LTEwLTEtMS0w_34e21ad4-9cff-4546-9dec-4ec7485f20a9"
      unitRef="usd">2384000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i5c6117a9799b4fe0b16e620b0cb21f30_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA0LTEyLTEtMS0w_15d0e2ca-db33-453f-a25b-8f81be3c7555"
      unitRef="number">-0.183</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i662c0af4be474f6287c7693841b01f99_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA2LTItMS0xLTA_8457b936-c20a-42c8-acab-c71e0dde5e48"
      unitRef="usd">913000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if783cccc272c4ee5b8d37788be2343c1_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA2LTQtMS0xLTA_1980ee5f-0cd8-4806-bfd1-afe7538f8d87"
      unitRef="usd">940000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i662c0af4be474f6287c7693841b01f99_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA2LTYtMS0xLTA_4f65c667-ba7f-495f-9623-8d32bbec6238"
      unitRef="number">-0.030</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib233b0caa2d24cce930843ce9532eb98_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA2LTgtMS0xLTA_1f7fbfcf-9a39-454c-8283-6c6d59119992"
      unitRef="usd">2247000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e809c62413f4b6eaf0f1f74674cd8a3_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA2LTEwLTEtMS0w_e9372207-23e0-41e7-82b8-a9b5f1c9c16c"
      unitRef="usd">2867000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib233b0caa2d24cce930843ce9532eb98_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA2LTEyLTEtMS0w_fcd965dc-52ec-4c00-b728-21603fa66e2e"
      unitRef="number">-0.217</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c35c71d39d448d08df9def2add49a90_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA3LTItMS0xLTA_6a193412-a474-461c-8c3d-972b32cde473"
      unitRef="usd">1239000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1321854500714d2386badf8f4f85c1b7_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA3LTQtMS0xLTA_68ef949f-8d16-4cda-a0b1-b52acf829103"
      unitRef="usd">1371000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i0c35c71d39d448d08df9def2add49a90_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA3LTYtMS0xLTA_e2defaa6-36a2-4c1d-b369-ade395284c64"
      unitRef="number">-0.096</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08939ac29dae4ffeb1039b346ac2884e_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA3LTgtMS0xLTA_a6787604-fa43-4314-bb15-9f9aaee0b90b"
      unitRef="usd">3556000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61d23b7f2d4241a38597ec38811725dd_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA3LTEwLTEtMS0w_6a1a2efd-4b60-4aaf-bb35-53ae05cff276"
      unitRef="usd">4192000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i08939ac29dae4ffeb1039b346ac2884e_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA3LTEyLTEtMS0w_152569b3-ff13-4716-a389-6c50c756109c"
      unitRef="number">-0.152</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e5acb865e574efe9eca9f998ed83da8_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA4LTItMS0xLTA_a9da1b71-1a60-41dd-be04-9c02c5a9ebd6"
      unitRef="usd">2152000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i421903ae07dc46e8b1403cf39867c316_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA4LTQtMS0xLTA_2cb5f36f-2a89-4498-a3be-8d78accc7376"
      unitRef="usd">2311000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i0e5acb865e574efe9eca9f998ed83da8_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA4LTYtMS0xLTA_2bd621d6-0758-48aa-b6b7-85cf40dd7616"
      unitRef="number">-0.069</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97a2b98ae57b4c268d8ebab5c60642d4_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA4LTgtMS0xLTA_454d553d-9be7-4c5f-a763-14f9660e1257"
      unitRef="usd">5803000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i35f618e2b32f4a35bc3855d06290605d_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA4LTEwLTEtMS0w_c45ff5e2-784c-4a44-b50c-42426dc11dcc"
      unitRef="usd">7059000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i97a2b98ae57b4c268d8ebab5c60642d4_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjA4LTEyLTEtMS0w_4e1d44dc-7370-454d-8484-db22e2c059e2"
      unitRef="number">-0.178</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b15a4efca2e45b29ee3e92ad084572f_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEwLTItMS0xLTA_f4c7993d-8631-4acb-ada0-cb88eba42771"
      unitRef="usd">421000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i656d3fc14e6a4325bd24b770e013526b_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEwLTQtMS0xLTA_572827af-d226-4972-b627-2d51be08d218"
      unitRef="usd">409000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7b15a4efca2e45b29ee3e92ad084572f_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEwLTYtMS0xLTA_52e66283-1621-47f3-96da-692fd6bde580"
      unitRef="number">0.030</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8258fdc417094593a4a129bf9b40a2af_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEwLTgtMS0xLTA_ebde7b0d-0796-441b-a6e9-756da753d937"
      unitRef="usd">1079000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52d7cf57476d45a5ad57d74c0085b847_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEwLTEwLTEtMS0w_442b30b4-908b-43ba-8a91-5212f2f26abf"
      unitRef="usd">1209000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8258fdc417094593a4a129bf9b40a2af_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEwLTEyLTEtMS0w_49af79e2-c0dc-4827-94ba-158d9097f972"
      unitRef="number">-0.107</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d714fa9dc89438e93a39c79621b1d01_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjExLTItMS0xLTA_fffcdd01-91e0-4a02-80b0-cb0b7af03ac7"
      unitRef="usd">579000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1851455e464849f5bd9f21eb2518567d_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjExLTQtMS0xLTA_ce5e406f-e0d7-4f59-95d6-f9c3678ac533"
      unitRef="usd">602000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i3d714fa9dc89438e93a39c79621b1d01_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjExLTYtMS0xLTA_fea1b556-cea6-473a-8205-f35117d40a15"
      unitRef="number">-0.039</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66ae8fc90597499185a5d9eff2fa78f6_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjExLTgtMS0xLTA_b8fe2620-b1de-4b69-b844-1c444a6fac4c"
      unitRef="usd">1644000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ef142f0f71444aab8fd23edf4a5fc2d_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjExLTEwLTEtMS0w_e72e9710-96a4-4b1d-b7d3-6d0c6a60df76"
      unitRef="usd">1811000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i66ae8fc90597499185a5d9eff2fa78f6_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjExLTEyLTEtMS0w_44562c92-a3f2-4810-a702-4b778269f929"
      unitRef="number">-0.092</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib11b611985894d70b30457565b4d7fa7_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEyLTItMS0xLTA_17cef861-d54d-42cc-bc2d-0b42a19f11ae"
      unitRef="usd">1000000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8de79cd48b68455aa26dbbe51313f2ee_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEyLTQtMS0xLTA_a1e8b664-c196-45da-a175-d968a9a8c54b"
      unitRef="usd">1010000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib11b611985894d70b30457565b4d7fa7_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEyLTYtMS0xLTA_5ef2341f-0d0e-4017-b3a2-8396f4d5f365"
      unitRef="number">-0.011</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1531b5603bb54e4c933c82c142112323_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEyLTgtMS0xLTA_8f12775e-f92b-496b-aca6-476803799c9d"
      unitRef="usd">2723000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i39a68f7975ed486181d4f5f3f67d31c7_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEyLTEwLTEtMS0w_9b27138b-c7d7-4a44-b081-bec02ec76a83"
      unitRef="usd">3019000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i1531b5603bb54e4c933c82c142112323_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjEyLTEyLTEtMS0w_eacccb98-ae6c-4ac2-9579-4aa948057392"
      unitRef="number">-0.098</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8fb64d50c40401c93c4477200e096b0_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE0LTItMS0xLTA_5117e591-e9e2-49cf-8243-a1217785addb"
      unitRef="usd">492000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6aa2716ac6604a51a4a3c42da27fccb4_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE0LTQtMS0xLTA_09f01973-5406-45b7-8029-bc36238e794b"
      unitRef="usd">531000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if8fb64d50c40401c93c4477200e096b0_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE0LTYtMS0xLTA_65846c11-f3b8-4aa8-9c8d-2b1256863caa"
      unitRef="number">-0.076</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56e42d0e762d48c888f6a1c64e9490e6_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE0LTgtMS0xLTA_834041ba-93f3-4466-a2dd-c513fe601e29"
      unitRef="usd">1168000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea38e5177c29474eb554d7141dcd0f68_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE0LTEwLTEtMS0w_aa842f03-8085-4d7c-a251-f021153e3815"
      unitRef="usd">1658000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i56e42d0e762d48c888f6a1c64e9490e6_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE0LTEyLTEtMS0w_a9eb7fd3-222e-4189-b8b5-f449b97d661c"
      unitRef="number">-0.296</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5049c06813234998b24265d8cb35cedc_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE1LTItMS0xLTA_57f0a68e-960f-42fe-b4d4-76173fb3f624"
      unitRef="usd">660000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie31d7e3dc1b64e3eb43c6b2090aa773e_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE1LTQtMS0xLTA_daa9e22f-d9a2-4a2c-b2dc-375aadba012d"
      unitRef="usd">769000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i5049c06813234998b24265d8cb35cedc_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE1LTYtMS0xLTA_b6c5fa3e-acd0-48ba-bf15-e667ef8e93cc"
      unitRef="number">-0.141</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i59920036dbf249039599856c49398657_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE1LTgtMS0xLTA_1527f507-b9c4-43b8-8316-598bcc2ae5aa"
      unitRef="usd">1912000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i84b634865f474f6b8bc070ee303b8b91_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE1LTEwLTEtMS0w_8ffc1e4c-fa3c-47a0-84c0-69b0a73ce7ae"
      unitRef="usd">2381000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i59920036dbf249039599856c49398657_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE1LTEyLTEtMS0w_10f493a6-b9b9-4d96-be50-bc5b893d0b55"
      unitRef="number">-0.197</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaffa1a11347d4888924b6e99e98c8764_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE2LTItMS0xLTA_8746e0bd-7b9c-4440-b887-25892b2f8f47"
      unitRef="usd">1152000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib7042183f12643f98389d82808fc723d_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE2LTQtMS0xLTA_2cf350a1-0d44-4061-96d1-f0fc4f0690e4"
      unitRef="usd">1301000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iaffa1a11347d4888924b6e99e98c8764_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE2LTYtMS0xLTA_ae7940b8-5d2d-432f-97a1-59c717a65ad8"
      unitRef="number">-0.114</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75a76bf8abad43c5960ec48d79f04f36_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE2LTgtMS0xLTA_c731ff32-c5c2-4cf8-b01c-1380d223d81b"
      unitRef="usd">3080000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if38c2f57b46d452f93dafc3b162a0fde_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE2LTEwLTEtMS0w_9f0b14bf-1284-412a-9810-d06c99d312aa"
      unitRef="usd">4040000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i75a76bf8abad43c5960ec48d79f04f36_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE2LTEyLTEtMS0w_789e945a-b0a3-4757-b4c8-72e420e3ae23"
      unitRef="number">-0.238</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i296b0e556e1b48a3bf64b25710ec956e_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE4LTItMS0xLTA_35b4645a-1575-44f5-b22b-2011b1bb91cc"
      unitRef="usd">473000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i260e88f62d2843a188e4c53283699a2e_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE4LTQtMS0xLTA_6c2b8a5e-9d4c-4941-9d84-a66b7be89853"
      unitRef="usd">459000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i296b0e556e1b48a3bf64b25710ec956e_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE4LTYtMS0xLTA_4543026a-ef15-464f-b2dc-7547d3f786d9"
      unitRef="number">0.031</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie77c8050b8fd472e8e5678efee8c7de9_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE4LTgtMS0xLTA_ec5b8773-477b-4a89-b336-dc9910eeffa9"
      unitRef="usd">1160000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4444b1a6e50447f2aad3784749794afb_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE4LTEwLTEtMS0w_8bfa696d-1b10-40a1-b9f3-f9ea6eec7d89"
      unitRef="usd">1366000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie77c8050b8fd472e8e5678efee8c7de9_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE4LTEyLTEtMS0w_267bd593-9ed1-4413-a13e-8543104a6990"
      unitRef="number">-0.151</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i625fb1ccccb948cba7bfb675b72f1fc5_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE5LTItMS0xLTA_dd6fd5aa-d7ae-442a-ade0-5d0452e9a4f5"
      unitRef="usd">608000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab8d758e1db8401fbac59a2421221ac2_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE5LTQtMS0xLTA_651ad6f2-747e-4840-bdc9-adaa54c7e8ba"
      unitRef="usd">734000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i625fb1ccccb948cba7bfb675b72f1fc5_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE5LTYtMS0xLTA_3718128b-ad0d-4b25-b6d5-6919a09e3ca8"
      unitRef="number">-0.172</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f6c0b9d80c34d16ae17316c585ff15c_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE5LTgtMS0xLTA_c25cf7b9-0908-4ce9-bbd7-f0cc824a2826"
      unitRef="usd">1683000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e71fdd99cd04db297741c300cd7ab55_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE5LTEwLTEtMS0w_1ad52a07-1e6d-45fc-929f-ec83480907af"
      unitRef="usd">2117000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i3f6c0b9d80c34d16ae17316c585ff15c_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjE5LTEyLTEtMS0w_13ac2b75-e477-4d1b-9e73-a26b6d2d3167"
      unitRef="number">-0.205</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i963e0700cb4d4671b572343d69b2232f_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIwLTItMS0xLTA_7f9a1e6b-609c-41fc-ab65-51e9caea5b04"
      unitRef="usd">1081000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibc4c63f509c84cbe8f5ff6e2c6ca1ebb_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIwLTQtMS0xLTA_189461d0-efcb-4545-a880-f091c6c32d89"
      unitRef="usd">1193000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i963e0700cb4d4671b572343d69b2232f_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIwLTYtMS0xLTA_aa8ebbdb-295c-40ed-8bea-3b652f332dd7"
      unitRef="number">-0.094</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67aaaec919ba4dc6be289f8f6538f686_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIwLTgtMS0xLTA_b0e060a6-df7b-4712-b6c5-0b52eacb393b"
      unitRef="usd">2843000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9886d032efa5433a993723420ebb6645_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIwLTEwLTEtMS0w_82459ebd-c178-4017-bbae-8fbd940503c9"
      unitRef="usd">3483000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i67aaaec919ba4dc6be289f8f6538f686_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIwLTEyLTEtMS0w_8c17a416-25de-46ab-9fca-4d3e21a7aa96"
      unitRef="number">-0.184</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i01334be3ea4e40c3b74d0c4ce690baf7_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIyLTItMS0xLTA_2c1b9139-e486-4d1e-a1dc-78aec601e030"
      unitRef="usd">375000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66d42047ed1546a99c98157dc227337c_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIyLTQtMS0xLTA_7fcefa17-43a9-42f2-82b5-652365c36351"
      unitRef="usd">339000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i01334be3ea4e40c3b74d0c4ce690baf7_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIyLTYtMS0xLTA_8b664a20-f0a8-4f2a-97c5-5e9261bf9a56"
      unitRef="number">0.109</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1029f059b6514bd2b972b5ccf27ad129_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIyLTgtMS0xLTA_7bd78a0a-14d9-44f2-9782-83a9386e44c6"
      unitRef="usd">924000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3a6480a1e04142e5bd0b115b8b7beda4_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIyLTEwLTEtMS0w_96a19754-36e5-4eba-b705-7914bcc964ba"
      unitRef="usd">993000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i1029f059b6514bd2b972b5ccf27ad129_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIyLTEyLTEtMS0w_2ee10f7a-977b-4db7-bfd1-f8e5554b4de8"
      unitRef="number">-0.069</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ied4375401e354a6bbb3e8ac51c6e0bf0_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIzLTItMS0xLTA_8dd2264f-e922-423f-9b70-d241470b2da0"
      unitRef="usd">455000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b2e30c0de694d49b6f122976eebf086_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIzLTQtMS0xLTA_6f64c792-14b2-4c1e-9174-869940529d6f"
      unitRef="usd">555000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ied4375401e354a6bbb3e8ac51c6e0bf0_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIzLTYtMS0xLTA_afc58ad2-f5ae-41c1-a247-c9ae7077d736"
      unitRef="number">-0.181</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i17aa526e89604821b23f94ff90695ac7_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIzLTgtMS0xLTA_adfda639-b9ec-43e7-b581-00c6ea2f1e6f"
      unitRef="usd">1274000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a837853bdd94ee2b05b75ff02e99532_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIzLTEwLTEtMS0w_e18923ea-477c-4ffc-9131-45da02264ab0"
      unitRef="usd">1566000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i17aa526e89604821b23f94ff90695ac7_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjIzLTEyLTEtMS0w_fd432289-dcf3-43b7-9bc0-08cb0d489e5a"
      unitRef="number">-0.187</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac6c465d42c648babbe737db5a107e69_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI0LTItMS0xLTA_c4d40a3b-4186-4f5d-a655-34d542209709"
      unitRef="usd">830000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if61ce55cf8dc49728545a3f242ea36bf_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI0LTQtMS0xLTA_c9c1b959-0e06-4113-aeb1-d2937c67c342"
      unitRef="usd">893000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iac6c465d42c648babbe737db5a107e69_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI0LTYtMS0xLTA_bb3119b4-4516-4e05-aed0-665c7f42b571"
      unitRef="number">-0.071</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i708a5f3cd9c14d6b90cc957a086ad592_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI0LTgtMS0xLTA_6e1de135-5df7-4ebc-97ac-7c3a66c89a8d"
      unitRef="usd">2198000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9958a497e25348dbb14e5c5271ce2fb9_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI0LTEwLTEtMS0w_62c41319-08b9-4eb6-a928-5abd0a8539ce"
      unitRef="usd">2559000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i708a5f3cd9c14d6b90cc957a086ad592_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI0LTEyLTEtMS0w_1230db39-a88c-4c83-830a-f1e78d881417"
      unitRef="number">-0.141</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i245a692de7db476e92675c28db36afcb_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI3LTItMS0xLTA_c081b738-2a7c-4d20-b547-d3d580dfdf9b"
      unitRef="usd">98000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2abfd02ddda74dfb962822b218cefdb2_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI3LTQtMS0xLTA_258f1b38-3231-4e14-9915-47a410a1a5db"
      unitRef="usd">120000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i245a692de7db476e92675c28db36afcb_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI3LTYtMS0xLTA_000e6b2e-2786-49a2-a23d-c07597af0536"
      unitRef="number">-0.189</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7338276873e1496e803482ff1f8104cd_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI3LTgtMS0xLTA_d0473bd4-232b-460f-a73b-fbcf9be20e6e"
      unitRef="usd">236000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib7bcddb586564ee4905b520cba578975_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI3LTEwLTEtMS0w_2fce1add-0f93-409d-bf9e-5a2839cd384c"
      unitRef="usd">373000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7338276873e1496e803482ff1f8104cd_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI3LTEyLTEtMS0w_10c1b2ba-bf6e-47b9-90a4-8b25fe64c933"
      unitRef="number">-0.368</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d02bf81fd4147c3961e6b66bf6df83c_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI4LTItMS0xLTA_95a9b3fc-435a-495c-9a1e-6aac3ad1fcf9"
      unitRef="usd">153000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d33df78c2d74a9794b67f99c431b4c4_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI4LTQtMS0xLTA_661935cb-1e77-47a8-ad82-bac9c41f4fb1"
      unitRef="usd">180000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i1d02bf81fd4147c3961e6b66bf6df83c_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI4LTYtMS0xLTA_28c7ba8c-3e1d-4005-9ffd-8dcc1f0bee0e"
      unitRef="number">-0.146</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e88a966742642f7beacda981f64e553_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI4LTgtMS0xLTA_4504a4c9-a442-4616-a6ef-86e2135b65b7"
      unitRef="usd">409000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0fbb6beed0b4039960cc5369a53a72b_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI4LTEwLTEtMS0w_73bf9a51-9753-4365-aecc-4e7a180d2a55"
      unitRef="usd">551000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9e88a966742642f7beacda981f64e553_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI4LTEyLTEtMS0w_0094ef8c-c749-45c0-8604-1264ed91242f"
      unitRef="number">-0.257</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5a04b866c0148a38d04d0efd708709f_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI5LTItMS0xLTA_a23d40ed-af23-4ae7-86f9-b70c60afc805"
      unitRef="usd">251000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4593bade2d004b69994c70585546ce89_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI5LTQtMS0xLTA_62c6ef58-c1b2-41dc-beaf-c1b1b417c39a"
      unitRef="usd">299000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib5a04b866c0148a38d04d0efd708709f_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI5LTYtMS0xLTA_78b29b8f-456f-4c59-b6a2-81992528a0ba"
      unitRef="number">-0.163</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b89d826ccd04092ab54bd782548a003_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI5LTgtMS0xLTA_aad4bd96-5bf0-4dff-8d59-c46884d86433"
      unitRef="usd">645000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i453c063241274887b6d6b9fd8f525a52_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI5LTEwLTEtMS0w_1e08b280-9f41-4e1c-ad37-a2a96d2e64be"
      unitRef="usd">923000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8b89d826ccd04092ab54bd782548a003_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjI5LTEyLTEtMS0w_07197dbc-9378-49b4-8b88-cad1f4a6ea12"
      unitRef="number">-0.302</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea21a9f89725422d8afcbf963b29af87_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMyLTItMS0xLTA_5ce02491-cf38-4d08-88f8-3cd9673d4b0a"
      unitRef="usd">3092000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cbcdfd43e8f485799e205dfb983107b_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMyLTQtMS0xLTA_e40d86a1-f89a-4d4d-9990-049a403e9462"
      unitRef="usd">3057000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iea21a9f89725422d8afcbf963b29af87_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMyLTYtMS0xLTA_d379d1eb-b704-42fb-b6a9-9f08b757b19c"
      unitRef="number">0.012</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a1e0fd24f2240dfbfc672acac04a0c6_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMyLTgtMS0xLTA_d568f364-ee75-498a-9443-2718754d5cc6"
      unitRef="usd">7852000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i120a34db825e4d07a1e15b8566101ff7_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMyLTEwLTEtMS0w_d38b9e4b-5e61-4f15-85bf-cf88306d1a1b"
      unitRef="usd">9249000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9a1e0fd24f2240dfbfc672acac04a0c6_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMyLTEyLTEtMS0w_d40a289f-9dd3-40fa-a6a0-575425598cfa"
      unitRef="number">-0.151</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b6741314c5f4ad1b9cf58499b18ac5b_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMzLTItMS0xLTA_20537dbd-f139-4c30-89a8-66dad69a5580"
      unitRef="usd">3058000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8fbd398566b04e5496711b52c150ddcf_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMzLTQtMS0xLTA_632658bd-080c-420d-b131-8b24f41dede7"
      unitRef="usd">3326000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7b6741314c5f4ad1b9cf58499b18ac5b_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMzLTYtMS0xLTA_b1eb6c53-1e39-4933-bf3f-88f33d57403d"
      unitRef="number">-0.081</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52a54bb5fdd2493ab00d5b1e8462304f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMzLTgtMS0xLTA_5ca9b0bc-94ee-4510-ab3d-f3f3b0e6b54c"
      unitRef="usd">8518000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie84d5ea9d4f740178ee2bd661a5b76bb_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMzLTEwLTEtMS0w_ef40fd52-c17d-45cd-83bc-4f1a90743f3c"
      unitRef="usd">10082000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i52a54bb5fdd2493ab00d5b1e8462304f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjMzLTEyLTEtMS0w_44c9c493-abf1-42ef-bf84-29c7c00cd74a"
      unitRef="number">-0.155</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ef0bd79dd674186aa6f73f88e7a8163_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM0LTItMS0xLTA_d0544df4-4d72-4f98-98d5-c2ec22b3c41c"
      unitRef="usd">6150000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i444727e6684545a7a9f22d74975fa1b6_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM0LTQtMS0xLTA_a94d41aa-a1a8-48b6-8b84-1d51e54121d3"
      unitRef="usd">6383000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i2ef0bd79dd674186aa6f73f88e7a8163_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM0LTYtMS0xLTA_8a3e43f9-eff5-4491-84ba-f02e649c6eed"
      unitRef="number">-0.036</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic80539fe5fa44b869a360326b6dee52a_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM0LTgtMS0xLTA_61ecf50d-d76b-458f-80e0-43a700876003"
      unitRef="usd">16370000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33ce4e97b0f24651ad32677d55f5fc93_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM0LTEwLTEtMS0w_cef6cdc8-8487-4964-9950-0da6cb01c9ad"
      unitRef="usd">19331000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic80539fe5fa44b869a360326b6dee52a_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM0LTEyLTEtMS0w_04451196-0cb1-4c40-b573-21d8cf082f49"
      unitRef="number">-0.153</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c18e167d7fe4b04a6ac423556324888_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM3LTItMS0xLTA_d62cbfaa-99ee-4ddc-9afe-7e5ceac7f77a"
      unitRef="usd">11086000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i708014e4e6e44faf8244b75bda858331_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM3LTQtMS0xLTA_06646a01-5b22-41c7-8181-d53c1658c16f"
      unitRef="usd">10791000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i4c18e167d7fe4b04a6ac423556324888_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM3LTYtMS0xLTA_9c3b38ba-51ad-4d39-9d91-4645c1a2166b"
      unitRef="number">0.027</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie499303b87b94c58b5bfac0841a99079_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM3LTgtMS0xLTA_6a48a770-891c-4ed9-afca-cd520a9365a8"
      unitRef="usd">31324000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7c244381d0c4963b4d71699e772e533_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM3LTEwLTEtMS0w_6c7c420d-0f5a-4824-b233-4e403df74cff"
      unitRef="usd">31323000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie499303b87b94c58b5bfac0841a99079_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM3LTEyLTEtMS0w_d90749b5-aad7-423f-a806-59a5fcb5054e"
      unitRef="number">0.000</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e8ec55bd4294e1d97f2c5160d99527e_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM4LTItMS0xLTA_367256c8-492c-4d5d-93df-1102a60933e7"
      unitRef="usd">9996000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1168ff1f8da940379fbadf2e0fb141f7_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM4LTQtMS0xLTA_6b4938e9-3111-4195-9380-cedbd1357b00"
      unitRef="usd">9938000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8e8ec55bd4294e1d97f2c5160d99527e_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM4LTYtMS0xLTA_fe022263-d020-4e41-b017-88d782bc6dc9"
      unitRef="number">0.006</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28eeee657bbb42488adc0e5f6326d3e0_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM4LTgtMS0xLTA_8ed76b9d-e1df-4a35-8776-fed4c159421d"
      unitRef="usd">28785000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52821a5a2b214804b0a20989602dc348_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM4LTEwLTEtMS0w_0848a56f-e3e3-4798-98c4-112bd5273b93"
      unitRef="usd">29989000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i28eeee657bbb42488adc0e5f6326d3e0_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM4LTEyLTEtMS0w_a500c0e9-53ef-44b4-a81c-1a3fac4c85b8"
      unitRef="number">-0.040</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM5LTItMS0xLTA_e23e01c6-173a-4743-857a-7d26e2a655fd"
      unitRef="usd">21082000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM5LTQtMS0xLTA_a858fcc5-9eb1-40dc-b847-c4038094dd9f"
      unitRef="usd">20729000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM5LTYtMS0xLTA_71d956cc-730a-4b13-9967-17ffc7580d64"
      unitRef="number">0.017</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM5LTgtMS0xLTA_8baa2b60-827d-4a1b-881d-2207da4f23c0"
      unitRef="usd">60109000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM5LTEwLTEtMS0w_19d03080-80e5-4592-a23f-1c888eeb797b"
      unitRef="usd">61312000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOmEyZjkyN2JkNDQ3OTRhNGU4YzkzOTQ4NGFjMWNkZWQ4L3RhYmxlcmFuZ2U6YTJmOTI3YmQ0NDc5NGE0ZThjOTM5NDg0YWMxY2RlZDhfMjM5LTEyLTEtMS0w_95b0041b-028c-482d-a8e4-85240aeee5d6"
      unitRef="number">-0.020</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTA5OTUxMTYyODcxMTE_515cdefa-a213-4424-8a12-fd092570f55c">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;EARNINGS BEFORE PROVISION FOR TAXES BY SEGMENT  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.710%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:36.109%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.365%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.219%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.475%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.365%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.219%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.192%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Third Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent&lt;br/&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Consumer Health &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(70.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(44.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Pharmaceutical&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(222)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Medical Devices&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(3)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(27.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(55.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Segment earnings before provision for taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Less: Expense not allocated to segments&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt; (4)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Worldwide income before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;*Percentage greater than 100% or not meaningful&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Consumer Health&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes a gain of $0.3 billion related to the Company's previously held equity investment in Ci:z Holdings Co., Ltd. (DR. CI: LABO) in the fiscal nine months of 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt;"&gt;Includes litigation expense of $0.5&#160;billion in the fiscal third quarter of 2020, primarily talc related costs, including certain settlements. Includes litigation expense of $1.2&#160;billion and $0.2&#160;billion in both the fiscal nine months of 2020 and 2019, primarily talc related costs, including certain settlements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes amortization expense of $0.1 billion in both the fiscal third quarters of 2020 and 2019, respectively and $0.3&#160;billion in both the fiscal nine months of 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes a restructuring related charge of $0.1&#160;billion in both the fiscal nine months of 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes an in-process research and development expense of $0.9 billion related to the Alios asset in the fiscal nine months of 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes litigation expense of $1.0&#160;billion and $4.0&#160;billion in the fiscal third quarters of 2020 and 2019 and $1.0&#160;billion and $4.3 billion in the fiscal nine months of 2020 and 2019, respectively. Litigation expense in all periods is primarily related to the agreement in principle to settle opioid litigation. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes an unrealized loss on securities of $0.1&#160;billion in the fiscal third quarter of 2019. Includes an unrealized gain on securities of $0.2&#160;billion in both the fiscal nine months of 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes a research and development expense of $0.3 billion in the fiscal nine months of 2019, for an upfront payment related to argenx. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes amortization expense of $0.8 billion in both the fiscal third quarters of 2020 and 2019. Includes amortization expense of $2.4&#160;billion in both the fiscal nine months of 2020 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes a restructuring related charge of $0.1&#160;billion in both the fiscal nine months of 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes Actelion acquisition related costs of $0.1&#160;billion in the fiscal nine months of 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;In the fiscal second and third quarters of 2020, the Company entered into a series of contract manufacturing arrangements for vaccine production with third party contract manufacturing organizations. These arrangements provide the Company with future supplemental commercial capacity for vaccine production and potentially transferable rights to such production if capacity is not required. Amounts paid and contractually obligated to be paid to these contract manufacturing organizations of approximately $0.8&#160;billion are reflected in the prepaid expenses and other, other assets, accrued liabilities and other liabilities accounts in the Company's consolidated balance sheet upon execution of each agreement. Additionally, the Company has entered into certain vaccine development cost sharing arrangements with government related organizations. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:96%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(3) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Medical Devices &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes a contingent consideration reversal of $0.2&#160;billion in the fiscal third quarter of 2020 and $1.1 billion in the fiscal nine months of 2020 related to the timing of certain developmental milestones associated with the Auris Health acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes a gain of $2.0&#160;billion from the divestiture of the ASP business in the fiscal nine months of 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes litigation expense of $0.3&#160;billion in the fiscal nine months of 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes a restructuring related charge of $0.1 billion and amortization expense of $0.2 billion in both the fiscal third quarters of 2020 and 2019.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes a restructuring related charge of $0.2&#160;billion and amortization expense of $0.7&#160;billion in both the fiscal nine months of 2020 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;"&gt;Includes an in-process research and development expense of $0.1&#160;billion in the fiscal third quarter of 2020 and fiscal nine months of 2020. &lt;/span&gt;&lt;/div&gt;(4) Amounts not allocated to segments include interest income/expense and general corporate income/expense.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib9afc9d0e42b478ea02c980b18106ca2_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMi0yLTEtMS0w_656fba7b-90d2-4233-b186-abb49c4e7939"
      unitRef="usd">191000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i938f7adae1b841d3aa77845e6f04e5bf_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMi00LTEtMS0w_18bc31d3-fdf8-4806-bbb4-1ccf74435f33"
      unitRef="usd">653000000</us-gaap:OperatingIncomeLoss>
    <jnj:PercentageChangeInOperatingIncomeLoss
      contextRef="ib9afc9d0e42b478ea02c980b18106ca2_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMi02LTEtMS0w_53c549de-bd96-4d66-a83f-dc170ec7c693"
      unitRef="number">-0.708</jnj:PercentageChangeInOperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ife1a6848c3604397bdf131dedd495ada_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMi04LTEtMS0w_f9ef2832-f19f-48a0-abec-a31a5f688cf5"
      unitRef="usd">993000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1ae290a5603746f8b45d01b27ea9d896_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMi0xMC0xLTEtMA_a4419b1a-3bec-4f4c-a58c-31793394c7bf"
      unitRef="usd">1800000000</us-gaap:OperatingIncomeLoss>
    <jnj:PercentageChangeInOperatingIncomeLoss
      contextRef="ife1a6848c3604397bdf131dedd495ada_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMi0xMi0xLTEtMA_6e9aa34f-5788-476b-a332-11fb6ea08b7d"
      unitRef="number">-0.448</jnj:PercentageChangeInOperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i52dbcdb545674f538361e9912a01a050_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMy0yLTEtMS0w_bfbbd8b3-ffb2-4b9c-bc97-f8fa1fc5212c"
      unitRef="usd">3439000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i080887d60f0940a59368f26c445c633c_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMy00LTEtMS0w_90d00965-e821-4e2f-a369-a304b885f944"
      unitRef="usd">-222000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia7d6c21b42a6409195bfc194bb649b2d_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMy04LTEtMS0w_b2211ef9-4026-4015-95bb-ce6a76b85016"
      unitRef="usd">11787000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5bdc0915d2ea4d4ebcf9bd0941e693ad_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfMy0xMC0xLTEtMA_463a7308-e2dd-4da1-bb09-2a05ef61acc1"
      unitRef="usd">5786000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i091d9a98d2f448dda83641c2c3ce380a_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNC0yLTEtMS0w_2761c1b1-2b00-4a67-ae66-585898a2f228"
      unitRef="usd">1010000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if32c09ac0b5647a1ad0e4dc7ce139472_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNC00LTEtMS0w_9a146f6e-25fb-4a67-8424-95166e7412b3"
      unitRef="usd">1392000000</us-gaap:OperatingIncomeLoss>
    <jnj:PercentageChangeInOperatingIncomeLoss
      contextRef="i091d9a98d2f448dda83641c2c3ce380a_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNC02LTEtMS0w_d6cdbd1c-5f1c-4a13-88fa-09dfdcb0b1c8"
      unitRef="number">-0.274</jnj:PercentageChangeInOperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4126d8e6b9664efda5bedc99ff1ad067_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNC04LTEtMS0w_87608bdd-3f1b-4f07-bf5b-b05d3e2bed69"
      unitRef="usd">2681000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1e561884e759475b9165f1413e1beae5_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNC0xMC0xLTEtMA_a91ee15f-35aa-48fc-b443-d4936edc8bdd"
      unitRef="usd">6078000000</us-gaap:OperatingIncomeLoss>
    <jnj:PercentageChangeInOperatingIncomeLoss
      contextRef="i4126d8e6b9664efda5bedc99ff1ad067_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNC0xMi0xLTEtMA_5f6ca18a-b2c4-417c-ad21-0b203e262ce2"
      unitRef="number">-0.559</jnj:PercentageChangeInOperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i74d121d1b483489e95a357c286e4c8ac_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNS0yLTEtMS0w_9151aaf6-e0a0-4393-a20d-1a5f64d7eb48"
      unitRef="usd">4640000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2bdb1c21f8014a99a12c45d0019dd537_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNS00LTEtMS0w_66edc548-1366-4a9e-8b11-00e2ebd77dfa"
      unitRef="usd">1823000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4e4204b60fad4fc7a1648e3538b6dc63_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNS04LTEtMS0w_c3591dc0-5a9b-43d8-98ad-0df6510c172a"
      unitRef="usd">15461000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5dbb3222fd984af2a17fc6f092a9ae02_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNS0xMC0xLTEtMA_63e30e67-3a37-4ab4-b987-4eddc3e4a663"
      unitRef="usd">13664000000</us-gaap:OperatingIncomeLoss>
    <jnj:PercentageChangeInOperatingIncomeLoss
      contextRef="i4e4204b60fad4fc7a1648e3538b6dc63_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNS0xMi0xLTEtMA_be483e99-de9b-481d-b3da-4cae9438b9f2"
      unitRef="number">0.132</jnj:PercentageChangeInOperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i66b302567e9241048a2995dae38b25c6_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNi0yLTEtMS0w_382779af-c2d2-4094-b5ec-6497823168b7"
      unitRef="usd">239000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4150ce8a62e645fb8abfee3ebb12c773_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNi00LTEtMS0w_f5580388-eb48-4c30-a4e2-2acbb86b830f"
      unitRef="usd">176000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1b18393bc5c64f7b83e0397afdb39c21_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNi04LTEtMS0w_58d6c6fc-43eb-452f-a41e-03c7eca8b6a8"
      unitRef="usd">611000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4ae77b0256144a08b4e114c88ef9700d_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNi0xMC0xLTEtMA_6f2195a7-ad70-4a63-866d-dd6017d229b3"
      unitRef="usd">554000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNy0yLTEtMS0w_e5fc939e-1edc-4a8f-b703-a57e3de337ab"
      unitRef="usd">4401000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNy00LTEtMS0w_0e3f835f-b05b-461f-b949-77d6557ed865"
      unitRef="usd">1647000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNy04LTEtMS0w_311e2dec-a4ba-43d7-8b63-9441acdf53e3"
      unitRef="usd">14850000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNy0xMC0xLTEtMA_a5d20945-aa94-4d17-9f75-f13b37f051d7"
      unitRef="usd">13110000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <jnj:PercentageChangeInOperatingIncomeLoss
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjVmOTBiZTcwYmVjYjQwYzBiYTQwMGI4MGFmN2FiZGY2L3RhYmxlcmFuZ2U6NWY5MGJlNzBiZWNiNDBjMGJhNDAwYjgwYWY3YWJkZjZfNy0xMi0xLTEtMA_1d13abe4-c8db-4482-b85b-6e3db918a152"
      unitRef="number">0.133</jnj:PercentageChangeInOperatingIncomeLoss>
    <us-gaap:GainLossOnSaleOfEquityInvestments
      contextRef="i4067541252a744ed90386e112cdd837b_D20181231-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMjYy_411b7fee-d88c-4cb2-819b-13819fd80a2d"
      unitRef="usd">300000000</us-gaap:GainLossOnSaleOfEquityInvestments>
    <us-gaap:LitigationSettlementExpense
      contextRef="i5a3e920df42c47f494f7fad0bdd00892_D20200629-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNDMx_93d8ddd9-d9b9-4822-ba4c-87778ae0d729"
      unitRef="usd">500000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i498b81f2554f4e868dce4daa5736066a_D20191230-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNTY5_fc5d3fba-e258-4cca-8a0e-99bb85c90385"
      unitRef="usd">1200000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i80fc979b7821412b9354bc3c8c18f543_D20181231-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNTc2_0aef883f-c108-43e5-a391-0e4f21be22c9"
      unitRef="usd">200000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:AdjustmentForAmortization
      contextRef="i938f7adae1b841d3aa77845e6f04e5bf_D20190701-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzA0_1ea4be71-b37c-42f3-9c4d-ea4cc02203f3"
      unitRef="usd">100000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ib9afc9d0e42b478ea02c980b18106ca2_D20200629-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzA0_ebd9edd2-5b62-4015-9ab9-3d8adfe3e50d"
      unitRef="usd">100000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ife1a6848c3604397bdf131dedd495ada_D20191230-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzc3_79755341-9470-4e4b-bbf7-ef399eb6f9b5"
      unitRef="usd">300000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i1ae290a5603746f8b45d01b27ea9d896_D20181231-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzc3_c2d0b1da-78b0-413d-836f-47975e2f7302"
      unitRef="usd">300000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:RestructuringCharges
      contextRef="i498b81f2554f4e868dce4daa5736066a_D20191230-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzY5NjU4MTM5OTk0NQ_48486e1b-0daa-4774-a55e-dac8c354c568"
      unitRef="usd">100000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i80fc979b7821412b9354bc3c8c18f543_D20181231-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzY5NjU4MTM5OTk0NQ_79772533-83b3-4233-9331-e1b9fd4268e6"
      unitRef="usd">100000000</us-gaap:RestructuringCharges>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="ie736ef5792a9408d9d187416e6bf80ae_D20181231-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfOTA5_c1aacf02-760e-4888-a5c6-ed9340318e13"
      unitRef="usd">900000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:LitigationSettlementExpense
      contextRef="i7db38f4a02ec46bd9364e821dfd12084_D20200629-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzY5NjU4MTQwMDIwMQ_70235eed-f8cb-4fec-8f4a-55cd15b59772"
      unitRef="usd">1000000000.0</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i08b63855cabe4bbdbeb0a69f02efd745_D20190701-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzY5NjU4MTQwMDIxNQ_f8db08ad-d774-4c1e-87dc-9c658804a7ef"
      unitRef="usd">4000000000.0</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i31c5bebe5faa45388656d1dcb0238be9_D20191230-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzY5NjU4MTM5ODU4NQ_7a3a78be-16a6-42f2-bdd4-3dbed84921e0"
      unitRef="usd">1000000000.0</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="ie736ef5792a9408d9d187416e6bf80ae_D20181231-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTAwNA_bb4ec229-b821-4a93-9ddf-fc2687cc3ba7"
      unitRef="usd">4300000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:UnrealizedGainLossOnSecurities
      contextRef="i080887d60f0940a59368f26c445c633c_D20190701-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTA5Mw_1c666174-c64d-47b1-82fd-2fce68bba144"
      unitRef="usd">-100000000</us-gaap:UnrealizedGainLossOnSecurities>
    <us-gaap:UnrealizedGainLossOnSecurities
      contextRef="i5bdc0915d2ea4d4ebcf9bd0941e693ad_D20181231-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTIwMg_6a2707ac-2d80-4413-8d6f-a56ddfe16360"
      unitRef="usd">200000000</us-gaap:UnrealizedGainLossOnSecurities>
    <us-gaap:UnrealizedGainLossOnSecurities
      contextRef="ia7d6c21b42a6409195bfc194bb649b2d_D20191230-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTIwMg_8b1cb51e-16d4-4aa4-91f2-30e40da3a000"
      unitRef="usd">200000000</us-gaap:UnrealizedGainLossOnSecurities>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ie736ef5792a9408d9d187416e6bf80ae_D20181231-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTM2MA_9c1c44af-855d-47cf-84ef-b63665923b82"
      unitRef="usd">300000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:AdjustmentForAmortization
      contextRef="i080887d60f0940a59368f26c445c633c_D20190701-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTQzOA_0b3d6f8e-9674-4ff9-8345-3f7fc948bacd"
      unitRef="usd">800000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i52dbcdb545674f538361e9912a01a050_D20200629-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTQzOA_523ccaea-9edb-47fc-ad54-4fb60a59be9f"
      unitRef="usd">800000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i5bdc0915d2ea4d4ebcf9bd0941e693ad_D20181231-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTUyNw_3d1b6f6e-0e70-4dd5-bab4-d50c7cb27b04"
      unitRef="usd">2400000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ia7d6c21b42a6409195bfc194bb649b2d_D20191230-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTUyNw_f9ad5edc-5d44-4267-b9b3-f713731720da"
      unitRef="usd">2400000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:RestructuringCharges
      contextRef="i5bdc0915d2ea4d4ebcf9bd0941e693ad_D20181231-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzY5NjU4MTM5OTcwNA_0c2d5d88-578b-4c5e-bf12-29d716cdf2d4"
      unitRef="usd">100000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia7d6c21b42a6409195bfc194bb649b2d_D20191230-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzY5NjU4MTM5OTcwNA_6ca0fdb0-dd35-49bf-9fe2-be7af8ef12d0"
      unitRef="usd">100000000</us-gaap:RestructuringCharges>
    <us-gaap:AcquisitionCosts
      contextRef="i5bdc0915d2ea4d4ebcf9bd0941e693ad_D20181231-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfNzY5NjU4MTM5OTg1MA_88ae87ab-b669-44dc-9d81-033e3d7f1b5c"
      unitRef="usd">100000000</us-gaap:AcquisitionCosts>
    <jnj:AmountPrepaidAndDueToManufacturers
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMTA5OTUxMTYyODcwOTc_5d446118-e0af-44f1-aa17-1ef20e9312d6"
      unitRef="usd">800000000</jnj:AmountPrepaidAndDueToManufacturers>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="iaa10b3392f3547b5aa32d11feeed9344_D20200629-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfODI0NjMzNzIxNTA1NA_a6229bdf-a6c4-4e13-9234-6764a4ff6e77"
      unitRef="usd">-200000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i47a7c165a7d648d29d77c01df838e0c8_D20191230-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMjU1Nw_814151fd-277f-4a75-a314-11f57f0d3973"
      unitRef="usd">-1100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i93f441a7dbae4cb0928cf691ada790e5_D20181231-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMjcxNg_4b6e1146-1855-487e-b2f9-d2eafbd32d13"
      unitRef="usd">2000000000.0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:LitigationSettlementExpense
      contextRef="i33ce4e97b0f24651ad32677d55f5fc93_D20181231-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMjg1MQ_7406fc34-9177-442f-8665-43aaef4e80dd"
      unitRef="usd">300000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:RestructuringCharges
      contextRef="i2ef0bd79dd674186aa6f73f88e7a8163_D20200629-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMjk3MQ_38ad1241-a6ca-4520-aa30-7d9cae141deb"
      unitRef="usd">100000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i444727e6684545a7a9f22d74975fa1b6_D20190701-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMjk3MQ_982a76cd-1c3e-43e4-9bfd-6580d77e658a"
      unitRef="usd">100000000</us-gaap:RestructuringCharges>
    <us-gaap:AdjustmentForAmortization
      contextRef="if32c09ac0b5647a1ad0e4dc7ce139472_D20190701-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMzAwMg_00ebe624-4714-4044-9858-6902d85afcc2"
      unitRef="usd">200000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i091d9a98d2f448dda83641c2c3ce380a_D20200629-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMzAwMg_a7c63789-14a6-4800-8eaa-11ca2db25c3d"
      unitRef="usd">200000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:RestructuringCharges
      contextRef="i33ce4e97b0f24651ad32677d55f5fc93_D20181231-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMzEwMg_3271b35b-9caa-4ca4-87c2-b3c71ea69ced"
      unitRef="usd">200000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic80539fe5fa44b869a360326b6dee52a_D20191230-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMzEwMg_df2919d6-a673-4ca6-890e-933f51016077"
      unitRef="usd">200000000</us-gaap:RestructuringCharges>
    <us-gaap:AdjustmentForAmortization
      contextRef="i4126d8e6b9664efda5bedc99ff1ad067_D20191230-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMzEzMw_2b27b13a-deb8-4f6c-926c-59013802541a"
      unitRef="usd">700000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i1e561884e759475b9165f1413e1beae5_D20181231-20190929"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMzEzMw_3866195c-b2f7-43b7-bd12-c0ad61beabbc"
      unitRef="usd">700000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i091d9a98d2f448dda83641c2c3ce380a_D20200629-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfODI0NjMzNzIxNDg2Ng_bdd5a229-432c-4948-bf61-9a6e4383ec1e"
      unitRef="usd">100000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i4126d8e6b9664efda5bedc99ff1ad067_D20191230-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfODI0NjMzNzIxNDg2Ng_c9868d55-9b48-4223-9565-ab639001cf9f"
      unitRef="usd">100000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RleHRyZWdpb246MGJmZGNhM2QxMTcwNDMzZGFkMTZiMzMwZTRmYzVkMjJfMzM0MQ_2aa1a20e-c75b-40f1-9763-b5fc5b21e7b8">&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;SALES BY GEOGRAPHIC AREA&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.275%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:32.038%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.529%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.994%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.529%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.410%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.529%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.243%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.821%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.994%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.821%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.410%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.529%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.253%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Third Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent&lt;br/&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;September 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Western Hemisphere, excluding U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Asia-Pacific, Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;60,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;61,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c18e167d7fe4b04a6ac423556324888_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMi0yLTEtMS0w_047b5a0c-15f4-485e-9d8f-b6e3c2f34f5d"
      unitRef="usd">11086000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i708014e4e6e44faf8244b75bda858331_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMi00LTEtMS0w_a208bdd2-7039-4d82-905e-0fcc5ad79924"
      unitRef="usd">10791000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="i4c18e167d7fe4b04a6ac423556324888_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMi02LTEtMS0w_515d08f5-70eb-4d50-88d4-18e6ba241d35"
      unitRef="number">0.027</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie499303b87b94c58b5bfac0841a99079_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMi04LTEtMS0w_885da1c6-0444-485b-8250-12273ebafa1a"
      unitRef="usd">31324000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7c244381d0c4963b4d71699e772e533_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMi0xMC0xLTEtMA_65ccd5ac-c16b-4670-8da6-6f9a17d2b5be"
      unitRef="usd">31323000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="ie499303b87b94c58b5bfac0841a99079_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMi0xMi0xLTEtMA_f7b695e3-f1ee-4d1d-896d-b1bf2acdc4c9"
      unitRef="number">0.000</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4048e18828d34f3daefe8f21a5eb3078_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMy0yLTEtMS0w_f29870c0-10ff-48d8-91ba-3c8f25b4681c"
      unitRef="usd">4819000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i390edd640d8a484e89238123183ad634_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMy00LTEtMS0w_7ebfc64d-5665-41e7-8e4c-8943804e9b11"
      unitRef="usd">4461000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="i4048e18828d34f3daefe8f21a5eb3078_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMy02LTEtMS0w_6d84b352-deb6-4532-8411-7d8ec490b600"
      unitRef="number">0.080</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic337c3dd3159462ebc2978ca7661b3b5_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMy04LTEtMS0w_25f7499a-8aad-4bc5-8808-f114c4464c76"
      unitRef="usd">13709000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e8913d91dfd40939075cfdac19606a5_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMy0xMC0xLTEtMA_bd356a8c-cf95-42ac-887d-bd675221ffcc"
      unitRef="usd">13803000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="ic337c3dd3159462ebc2978ca7661b3b5_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfMy0xMi0xLTEtMA_13cf1370-f128-4c6e-ad74-edf8d36b2993"
      unitRef="number">-0.007</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i02c1a908c32b4cb8a265199c069d86b6_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNC0yLTEtMS0w_22c9ed9a-7e33-4b4a-8f5e-c4f43b3299c5"
      unitRef="usd">1296000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia292ce2a3c634451b0fd283ea27bc5cc_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNC00LTEtMS0w_5b1a3652-8b9f-462c-82fe-57da41d16838"
      unitRef="usd">1488000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="i02c1a908c32b4cb8a265199c069d86b6_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNC02LTEtMS0w_34085a0c-e2db-4bed-b779-a14dd317be38"
      unitRef="number">-0.129</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id25c49104c0e46f0bbff08ef9bf0330f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNC04LTEtMS0w_5430bcda-e96b-4f35-b9a9-6feb21317d25"
      unitRef="usd">3931000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i875527922e5949c8a80b0260e40653b8_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNC0xMC0xLTEtMA_2908ce43-69ee-4ae1-906c-ef943ecab9fa"
      unitRef="usd">4446000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="id25c49104c0e46f0bbff08ef9bf0330f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNC0xMi0xLTEtMA_32bb3ce5-2a3c-469a-8a3a-aaf948bfbb11"
      unitRef="number">-0.116</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67ea74e368284b5383248520a5e39f2a_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNS0yLTEtMS0w_e625ef33-3e49-49a6-80eb-036d9811b32f"
      unitRef="usd">3881000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb167b63c624424bb3e66daffa308d4b_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNS00LTEtMS0w_04fb4677-e459-4954-aa57-2c824e52ab05"
      unitRef="usd">3989000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="i67ea74e368284b5383248520a5e39f2a_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNS02LTEtMS0w_bc483051-f3c4-4a7e-9c68-901f17172992"
      unitRef="number">-0.027</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i557d36686f0d404b8f74fbd282b65bac_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNS04LTEtMS0w_2c888768-25ff-4c26-acd6-5fe3e1f8839b"
      unitRef="usd">11145000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e7337ef99574e5ab6458deb6e8bb89b_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNS0xMC0xLTEtMA_c6bacb8c-e0ba-4ef2-8945-ec90ab73f432"
      unitRef="usd">11740000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="i557d36686f0d404b8f74fbd282b65bac_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNS0xMi0xLTEtMA_31a118dc-b224-4683-9bee-038adbe4352e"
      unitRef="number">-0.051</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNi0yLTEtMS0w_c7d3af79-2961-485f-83aa-3a7480ddde4c"
      unitRef="usd">21082000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b511957d9f045e087992edabfe78505_D20190701-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNi00LTEtMS0w_13f7d125-ce04-4765-8ba2-ad36a6894d12"
      unitRef="usd">20729000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNi02LTEtMS0w_214da28d-d331-48d3-8822-2597acf85ec6"
      unitRef="number">0.017</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNi04LTEtMS0w_51ae2da1-2ed8-49b9-b1ab-418fbc70b634"
      unitRef="usd">60109000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0483a4a8f6a84631ba1f8306bfb2f257_D20181231-20190929"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNi0xMC0xLTEtMA_375ec43c-065c-43bd-8cf9-5fc55c099859"
      unitRef="usd">61312000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84NS9mcmFnOjBiZmRjYTNkMTE3MDQzM2RhZDE2YjMzMGU0ZmM1ZDIyL3RhYmxlOjEwNGIxZmU3MjVjMTQ1YjU4ZWZhYTJiZjAyNWMxNGUwL3RhYmxlcmFuZ2U6MTA0YjFmZTcyNWMxNDViNThlZmFhMmJmMDI1YzE0ZTBfNi0xMi0xLTEtMA_ca31902e-aa4e-41db-92dd-482bb8972f8c"
      unitRef="number">-0.020</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNjA1Nw_8750c616-8ec3-4b60-afa2-3c1db7d067b2">BUSINESS COMBINATIONS AND DIVESTITURES&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Subsequent to the fiscal third quarter, on October 1, 2020, the Company completed the acquisition of Momenta Pharmaceuticals, Inc. (Momenta) a company that discovers and develops novel therapies for immune-mediated diseases, for a purchase price of approximately $6.5&#160;billion, primarily allocated to IPR&amp;amp;D. In the fiscal fourth quarter of 2020, the transaction will be accounted for as a business combination and included in the Pharmaceutical segment. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During the fiscal third quarter of  2020, the Company sold 11.8&#160;million shares of Idorsia LTD (Idorsia), or its 8.3% ownership in the company. The transaction resulted in gross proceeds of approximately CHF337&#160;million ($357&#160;million) based on a sales price of CHF 28.55/share and an immaterial net loss. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The Company currently has rights to at least an additional 38.7&#160;million shares (or approximately 20% of Idorsia equity) through a convertible loan with a principal amount of CHF 445&#160;million (due June 2027). Idorsia also has access to an approximate CHF 243&#160;million credit facility with the Company. As of September 27, 2020, Idorsia has not made any draw-downs under the credit facility.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During the fiscal first quarter of 2020, the Company completed the acquisition of all rights to the investigational compound bermekimab, which has multiple dermatological indications, along with certain employees from XBiotech Inc., for a purchase price of $0.8 billion. The fair value of the acquisition was allocated primarily to non-amortizable intangible assets, primarily IPR&amp;amp;D, for $0.8 billion. XBiotech may be eligible to receive additional payments upon the receipt of certain commercialization authorizations. The transaction was accounted for as a business combination and included in the Pharmaceutical segment. Additionally, the Company completed the acquisition of all outstanding shares in Verb Surgical Inc., a company with world-class robotics and data science capabilities, including those shares previously held by Verily. The transaction was accounted for as a business combination and included in the Medical Devices segment. The fair value of the acquisition was allocated primarily to non-amortizable intangible assets, primarily IPR&amp;amp;D, for $0.4 billion, goodwill for $0.2 billion, other assets of $0.2 billion and liabilities assumed of $0.3 billion. The fair value of the Company's previously held equity investment in Verb Surgical Inc. was $0.4 billion. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On April 1, 2019, the Company completed the divestiture of its ASP business to Fortive Corporation for an aggregate value of approximately $2.8&#160;billion, consisting of $2.7&#160;billion of cash proceeds and $0.1&#160;billion of retained net receivables.  The Company recognized a pre-tax gain recorded in Other (income) expense, net, of approximately $2.0&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On April 1, 2019, the Company&#160;completed the acquisition of Auris Health, Inc. for approximately $3.4 billion, net of cash acquired. Additional contingent payments of up to $2.35 billion, in the aggregate, may be payable upon reaching certain predetermined milestones. Auris Health was a privately held developer of robotic technologies, initially focused in lung cancer, with an FDA-cleared platform currently used in bronchoscopic diagnostic and therapeutic procedures. The Company treated this transaction as a business combination and included it in the Medical Devices segment. The fair value of the acquisition was allocated primarily to amortizable and non-amortizable intangible assets, primarily IPR&amp;amp;D, for $3.0 billion, goodwill for $2.0 billion, marketable securities of $0.2 billion and liabilities assumed of $1.8 billion, which includes the fair value of the contingent payments mentioned above. During the fiscal second quarter of 2020, the Company finalized the purchase price allocation.  During the fiscal nine months of 2020, the Company recorded Other income of approximately $1.1 billion for the reversal of all of the contingent consideration related to the timing of certain developmental and commercial milestones, which are not expected to be met based on the Company&#x2019;s current timelines. During the fiscal third quarter of 2020, the Company recorded a partial IPR&amp;amp;D impairment charge of $0.1&#160;billion related to timing and progression of the digital surgery platforms.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On January 17, 2019, the Company acquired DR. CI:LABO, a Japanese company focused on the marketing, development and distribution of a broad range of dermocosmetic, cosmetic and skincare products for a total purchase price of approximately &#xa5;230 billion, which equates to approximately $2.1 billion, using the exchange rate of 109.06 Japanese Yen to each U.S. Dollar on January 16, 2019. Additionally, in the fiscal first quarter of 2019, the Company recognized a pre-tax gain recorded in Other (income) expense, net, of approximately $0.3 billion related to the Company's previously held equity investment in DR. CI:LABO. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company treated this transaction as a business combination and included it in the Consumer Health segment. During the fiscal first quarter of 2020, the Company finalized the purchase price allocation. The fair value of the acquisition was allocated primarily to amortizable intangible assets for $1.5 billion, goodwill for $1.2 billion and liabilities assumed of $0.4 billion. The adjustments made since the date of acquisition were $0.1 billion to intangible assets, accrued liabilities, deferred taxes on income and property, plant and equipment with the offset to goodwill. The amortizable intangible assets were comprised of brand/trademarks and customer relationships with a weighted average life of 15.3 years. The goodwill is primarily attributable to synergies expected to arise from the business acquisition and is not expected to be deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;During the fiscal third quarter of 2018, the Company accepted a binding offer to form a strategic collaboration with Jabil Inc., one of the world&#x2019;s leading manufacturing services providers for health care products and technology products.&#160;The Company is expanding a 12-year relationship with Jabil Inc. to produce a range of products within the Ethicon Endo-Surgery and DePuy Synthes businesses. This transaction includes the transfer of certain employees and manufacturing sites. The majority of the transfers were completed in 2019 with a minor amount remaining in 2020.&#160;As of September 27, 2020, the assets held for sale on the Consolidated Balance Sheet were $0.1 billion of inventory and property, plant and equipment, net. For additional details on the global supply chain restructuring see Note 12 to the Consolidated Financial Statements.</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ia0178d1d89bd4d1a9069a8e871ea628f_D20201001-20201001"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTY0OTI2NzQ0OTQ5Ng_5587fdec-3669-4dab-86a6-8f3742e07a49"
      unitRef="usd">6500000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i5e557174a06c44d49bfcc86bb2b3d0fd_D20200629-20200927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTE1_07b5448d-7f9e-4614-8cf7-5ff17af66700"
      unitRef="shares">11800000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPercentageOfOwnershipBeforeTransaction
      contextRef="i5e557174a06c44d49bfcc86bb2b3d0fd_D20200629-20200927"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTYw_2e6bc028-c1f0-42bd-8e83-7bc9b14b2ea4"
      unitRef="number">0.083</us-gaap:SaleOfStockPercentageOfOwnershipBeforeTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="i5e557174a06c44d49bfcc86bb2b3d0fd_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjkx_16082f2b-647f-40cb-8d05-1162a09af1ae"
      unitRef="chf">337000000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="i5e557174a06c44d49bfcc86bb2b3d0fd_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjk1_7b864360-eaea-4059-bfc4-76289325a536"
      unitRef="usd">357000000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i88a026e754eb416abcce4c71f9725a45_I20200927"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMzI5_028b7a93-866b-4fb4-9c43-4f8545f165b7"
      unitRef="chfPerShare">28.55</us-gaap:SaleOfStockPricePerShare>
    <jnj:EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares
      contextRef="i5e557174a06c44d49bfcc86bb2b3d0fd_D20200629-20200927"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDAw_b16cf9e9-0504-42a2-9396-25cd4f4f23a8"
      unitRef="shares">38700000</jnj:EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction
      contextRef="i5e557174a06c44d49bfcc86bb2b3d0fd_D20200629-20200927"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDI4_efb431af-a31f-4ed9-80e9-b5f91f10b87b"
      unitRef="number">0.20</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:LongTermDebt
      contextRef="ifb9d663934dc4e77a2227f263e7e9b90_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNTA4_0c3f424b-acbc-4528-aec0-a022156c3e5d"
      unitRef="chf">445000000</us-gaap:LongTermDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i39abb4a782c7412fb74f873a3b89e52c_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNTc0_6ce42720-0c16-4c9b-8ddf-7d6a459d399d"
      unitRef="chf">243000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i1cc26d706e3948b0839e40d3e0521660_D20191230-20200329"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfOTU1_9ed8e14d-1565-494b-9ebe-986b82a99db3"
      unitRef="usd">800000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i514e624a05cb4ac3b06eb3d5591e1ae9_I20200329"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTA3Ng_98a01361-4213-4752-a60e-4c3c79ded5a5"
      unitRef="usd">800000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i6fe29d550e3c4c2ba9f8054b3e1472ce_I20200329"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTc0Mg_30ca3f08-888e-4c49-a687-49d7d666a970"
      unitRef="usd">400000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="i6fe29d550e3c4c2ba9f8054b3e1472ce_I20200329"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTc1OQ_391d2ca7-5a20-49f4-942d-3d92f7b78fe1"
      unitRef="usd">200000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="i6fe29d550e3c4c2ba9f8054b3e1472ce_I20200329"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTc3OQ_fad5dc04-39aa-4736-bc9c-2ed1b8daff91"
      unitRef="usd">200000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i6fe29d550e3c4c2ba9f8054b3e1472ce_I20200329"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTgwOQ_3f997196-3e04-46ba-9dfc-027c69bce35a"
      unitRef="usd">300000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="i6fe29d550e3c4c2ba9f8054b3e1472ce_I20200329"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTkwNQ_28c5af0f-cfaf-42f4-9cb8-3590ff819f09"
      unitRef="usd">400000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i80809b7f6de042b2930962754b585f17_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjA1MA_1fcf42cf-1aa2-498c-8087-faba4dc5243f"
      unitRef="usd">2800000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCash
      contextRef="i80809b7f6de042b2930962754b585f17_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjA2OA_b1ebdc84-a8dc-4a7b-8da2-f5bc8b309908"
      unitRef="usd">2700000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCash>
    <jnj:DisposalGroupIncludingDiscontinuedOperationReceivablesRetained
      contextRef="i80809b7f6de042b2930962754b585f17_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjA5Mg_a4eee08d-461b-42e7-8f05-8b4a1f011308"
      unitRef="usd">100000000</jnj:DisposalGroupIncludingDiscontinuedOperationReceivablesRetained>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i6f42cd49f093497bb053a9863a95db49_D20190401-20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjIyMQ_63574175-35cb-415c-b92b-b83af06742a3"
      unitRef="usd">2000000000.0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i88ab1a165c864c2099402645c6315d0f_D20190401-20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjMyMg_5193f922-f695-4494-a6c1-eddd5aa6570e"
      unitRef="usd">3400000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie7bbcc036f7349cb94794a2287751afb_I20190401"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjM4OA_871cfb66-dd56-406d-8ce1-8d017974cff3"
      unitRef="usd">2350000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ie7bbcc036f7349cb94794a2287751afb_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjkyMA_7ceea8c5-a3a1-4aa9-9469-e3eccd3f7428"
      unitRef="usd">3000000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="ie7bbcc036f7349cb94794a2287751afb_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjkzNw_23c02392-05f0-49c6-89f6-762fbc77c0de"
      unitRef="usd">2000000000.0</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities
      contextRef="ie7bbcc036f7349cb94794a2287751afb_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjk2Ng_58a02c04-93ed-4222-86b9-ec190a2109fc"
      unitRef="usd">200000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="ie7bbcc036f7349cb94794a2287751afb_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMjk5Ng_aee7732b-6b2b-41c1-8e77-c8d7206d2fef"
      unitRef="usd">1800000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ibf3d6533ad0042b69ef23b269adffb17_D20191230-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMzMyNQ_a6d30a48-855d-4a75-bd24-2906409803c9"
      unitRef="usd">-1100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:AssetImpairmentCharges
      contextRef="i24e7ef5b16d34adf9098ddac81e8905a_D20200629-20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfMTA5OTUxMTYyODU4NTE_86d938da-316f-4839-b876-d7b092bed54b"
      unitRef="usd">100000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ic5e8b6d3c30e45ffaa54a4a9227592ed_D20190117-20190117"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDA0Nw_9e0e4029-8fc7-4ec1-9afe-47467b9a5ea6"
      unitRef="jpy">230000000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ic5e8b6d3c30e45ffaa54a4a9227592ed_D20190117-20190117"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDA4Mg_0d5377fd-b341-46e2-b3a3-cbe75b152bd1"
      unitRef="usd">2100000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1
      contextRef="ia0d30897acc34d6aa8fc665dca7ddd1c_I20190116"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDExMw_5356f26d-1e86-4e30-84ec-13536a3cd1d2"
      unitRef="number">109.06</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i273f8b995c6b4f499a8b328d60523fbe_D20181231-20190331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDMxNw_258d9de8-9c1d-4ab3-98a6-df8bdca6347d"
      unitRef="usd">300000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="ia56f405e259a45239a2888912d6a9972_I20200329"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDY5Nw_53bfb8c9-db46-4673-920d-2d552ae2f594"
      unitRef="usd">1500000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="ia56f405e259a45239a2888912d6a9972_I20200329"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDcxNA_d8124d6b-21ad-49dc-8056-3396481bc02d"
      unitRef="usd">1200000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="ia56f405e259a45239a2888912d6a9972_I20200329"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDc0NA_8cec488d-1321-4fef-9240-91650c69ec91"
      unitRef="usd">400000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <jnj:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill
      contextRef="ia56f405e259a45239a2888912d6a9972_I20200329"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNDgwNA_3f04864b-ee13-4ed8-adc6-8e534df744c5"
      unitRef="usd">100000000</jnj:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i0ba1319bb59843d6a0cf051fb471834a_D20191230-20200329"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNTA2Ng_0f649a3e-be01-40d1-baf4-130f425ee752">P15Y3M18D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="ia2b1e0bfe69940ce9a25d129f9820402_I20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF84OC9mcmFnOjUzYjBkZWE0ZTI1NTQ1MzBhODAyYjk5MWZkNGM1Mjk4L3RleHRyZWdpb246NTNiMGRlYTRlMjU1NDUzMGE4MDJiOTkxZmQ0YzUyOThfNTg4NA_c2b3a384-f07b-4d3a-9a1c-2a535e497774"
      unitRef="usd">100000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:LegalMattersAndContingenciesTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfODg3MTQ_6b968899-f294-4475-a814-d38efadcdaae">LEGAL PROCEEDINGS&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Johnson &amp;amp; Johnson and certain of its subsidiaries are involved in various lawsuits and claims regarding product liability; intellectual property; commercial; supplier indemnification and other matters; governmental investigations; and other legal proceedings that arise from time to time in the ordinary course of their business. Due to the ongoing impacts of the COVID-19 pandemic, certain trials have been rescheduled or delayed.  The Company continues to monitor its legal proceedings as the situation evolves.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred, and the amount of the loss can be reasonably estimated. As of September&#160;27, 2020, the Company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated. The Company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with ASC 450-20-25. For these and other litigation and regulatory matters discussed below for which a loss is probable or reasonably possible, the Company is unable to estimate the possible loss or range of loss beyond the amounts already accrued. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions including timing of related payments. The ability to make such estimates and judgments can be affected by various factors including, among other things, whether damages sought in the proceedings are unsubstantiated or indeterminate; scientific and legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; procedural or jurisdictional issues; the uncertainty and unpredictability of the number of potential claims; ability to achieve comprehensive multi-party settlements;  complexity of related cross-claims and counterclaims; and/or there are numerous parties involved. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's balance sheet, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of, or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company's results of operations and cash flows for that period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;"&gt;PRODUCT LIABILITY&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Johnson &amp;amp; Johnson and certain of its subsidiaries are involved in numerous product liability claims and lawsuits involving multiple products. Claimants in these cases seek substantial compensatory and, where available, punitive damages. While the Company believes it has substantial defenses, it is not feasible to predict the ultimate outcome of litigation. From time to time, even if it has substantial defenses, the Company considers isolated settlements based on a variety of circumstances. The Company has established accruals for product liability claims and lawsuits in compliance with ASC 450-20 based on currently available information, which in some cases may be limited. The Company accrues an estimate of the legal defense costs needed to defend each matter when those costs are probable and can be reasonably estimated. For certain of these matters, the Company has accrued additional amounts such as estimated costs associated with settlements, damages and other losses. Product liability accruals can represent projected product liability for thousands of claims around the world, each in different litigation environments and with different fact patterns. Changes to the accruals may be required in the future as additional information becomes available.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The most significant of these cases include: the DePuy ASR&#x2122; XL Acetabular System and DePuy ASR&#x2122; Hip Resurfacing System; the PINNACLE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Acetabular Cup System; pelvic meshes; RISPERDAL&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;; XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;; body powders containing talc, primarily JOHNSONS&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Baby Powder; INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;; and ETHICON PHYSIOMESH&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Flexible Composite Mesh. As of September&#160;27, 2020, in the United States there were approximately 600 plaintiffs with direct claims in pending lawsuits regarding injuries allegedly due to the DePuy ASR&#x2122; XL Acetabular System and DePuy ASR&#x2122; Hip Resurfacing System; 8,200 with respect to the PINNACLE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Acetabular Cup System; 15,400 with respect to pelvic meshes; 10,400 with respect to &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;RISPERDAL&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;; 15,000 with respect to XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;; 21,800 with respect to body powders containing talc; 300 with respect to INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;;&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; and 4,000 with respect to ETHICON PHYSIOMESH&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Flexible Composite Mesh.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In August 2010, DePuy Orthopaedics, Inc. (DePuy) announced a worldwide voluntary recall of its ASR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#x2122;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; XL Acetabular System and DePuy ASR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#x2122;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Hip Resurfacing System used in hip replacement surgery. Claims for personal injury have been made against DePuy and Johnson &amp;amp; Johnson. The number of pending lawsuits is expected to fluctuate as certain lawsuits are settled or dismissed and additional lawsuits are filed. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Ohio. Litigation has also been filed in countries outside of the United States, primarily in the United Kingdom, Canada, Australia, Ireland, Germany, India and Italy. In November 2013, DePuy reached an agreement with a Court-appointed committee of lawyers representing ASR Hip System plaintiffs to establish a program to settle claims with eligible ASR Hip patients in the United States who had surgery to replace their ASR Hips, known as revision surgery, as of August 31, 2013. DePuy reached additional agreements in February 2015 and March 2017, which further extended the settlement program to include ASR Hip patients who had revision surgeries after August 31, 2013 and prior to February 15, 2017. This settlement program has resolved more than 10,000 claims, therefore bringing to resolution significant ASR Hip litigation activity in the United States. However, lawsuits in the United States remain, and the settlement program does not address litigation outside of the United States. In Australia, a class action settlement was reached that resolved the claims of the majority of ASR Hip patients in that country. In Canada, the Company has reached agreements to settle two pending class actions which have been approved by the Qu&#xe9;bec Superior Court and the Supreme Court of British Columbia. The Company continues to receive information with respect to potential additional costs associated with this recall on a worldwide basis. The Company has established accruals for the costs associated with the United States settlement program and DePuy ASR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#x2122;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Hip-related product liability litigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Claims for personal injury have also been made against DePuy Orthopaedics, Inc. and Johnson &amp;amp; Johnson (collectively, DePuy) relating to the PINNACLE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Acetabular Cup System used in hip replacement surgery.  Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Texas. Litigation has also been filed in some state courts and in countries outside of the United States.  Several adverse verdicts have been rendered against DePuy, one of which was reversed on appeal and remanded for retrial.  During the first quarter of 2019, DePuy established a United States settlement program to resolve these cases. As part of the settlement program, adverse verdicts have been settled. The Company has established an accrual for product liability litigation associated with the PINNACLE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Acetabular Cup System and the related settlement program.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Claims for personal injury have been made against Ethicon, Inc. (Ethicon) and Johnson &amp;amp; Johnson arising out of Ethicon's pelvic mesh devices used to treat stress urinary incontinence and pelvic organ prolapse. The Company continues to receive information with respect to potential costs and additional cases. Cases filed in federal courts in the United States had been organized as a multi-district litigation (MDL) in the United States District Court for the Southern District of West Virginia. The MDL Court is remanding cases for trial to the jurisdictions where the case was originally filed and additional pelvic mesh lawsuits have been filed, and remain, outside of the MDL.  The Company has settled or otherwise resolved a majority of the United States cases and the estimated costs associated with these settlements and the remaining cases are reflected in the Company's accruals. In addition, class actions and individual personal injury cases or claims have been commenced in various countries outside of the United States, including claims and cases in the United Kingdom, the Netherlands, and class actions in Israel, Australia and Canada, seeking damages for alleged injury resulting from Ethicon's pelvic mesh devices.  In November 2019, the Federal Court of Australia issued a judgment regarding its findings with respect to liability in relation to the three Lead Applicants and generally in relation to the design, manufacture, pre and post-market assessments and testing, and supply and promotion of the devices in Australia used to treat stress urinary incontinence and pelvic organ prolapse. In March 2020, the Court entered damages awards to the three Lead Applicants. The Company is appealing the decision. With respect to other group members, there will be an individual case assessment process which will require proof of use and causally related loss.  The class actions in Canada are expected to be discontinued in 2020 as a result of a settlement of a group of cases. The Company has established accruals with respect to product liability litigation associated with Ethicon's pelvic mesh product&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;s. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Following a June 2016 worldwide market withdrawal of ETHICON PHYSIOMESH&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Flexible Composite Mesh, claims for personal injury have been made against Ethicon, Inc. and Johnson &amp;amp; Johnson alleging personal injury arising out of the use of this hernia mesh device.&#160; Cases filed in federal courts in the United States have been organized as a multi-district litigation (MDL) in the United States District Court for the Northern District of Georgia. A multi-county litigation (MCL) has also been formed in New Jersey state court and assigned to Atlantic County for cases pending in New Jersey.  In addition to the matters in the MDL and MCL, there are additional lawsuits pending in the United States District Court for the Southern District of Ohio, which are part of the MDL for polypropylene mesh devices manufactured by C.R. Bard, Inc., and lawsuits pending outside the United States.   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;Claims have also been filed against Ethicon and Johnson &amp;amp; Johnson alleging personal injuries arising from the PROCEED&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt; Mesh and PROCEED&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt; Ventral Patch hernia mesh products.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;In March 2019, the New Jersey Supreme Court entered an order consolidating these cases pending in New Jersey as an MCL in Atlantic County Superior Court.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;Additional cases have been filed in various federal and state courts in the US, and in jurisdictions outside the US.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt; The Company has established accruals with respect to product liability litigation associated with ETHICON PHYSIOMESH&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;Flexible Composite Mesh, PROCEED&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt; Mesh and PROCEED&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt; Ventral Patch products. In September 2019, plaintiffs&#x2019; attorney filed an application with the New Jersey Supreme Court seeking centralized management of 107 PROLENE&#x2122; Polypropylene Hernia System (&#x201c;PHS&#x201d;) cases.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;The New Jersey Supreme Court granted plaintiffs application in January 2020 and those cases have also been transferred to an MCL in Atlantic County Superior Court.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Claims for personal injury have been made against Janssen Pharmaceuticals, Inc. and Johnson &amp;amp; Johnson arising out of the use of RISPERDAL&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;, and related compounds, indicated for the treatment of schizophrenia, acute manic or mixed episodes associated with bipolar I disorder and irritability associated with autism. Lawsuits have been primarily filed in state courts in Pennsylvania, California, and Missouri. Other actions are pending in various courts in the United States and Canada. Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has successfully defended a number of these cases but there have been verdicts against the Company, including a recent verdict in October 2019 of $8 billion of punitive damages related to one single plaintiff which was subsequently reduced in January 2020 to $6.8 million by the trial judge. The Company and plaintiff are each appealing this judgment. The Company has settled or otherwise resolved many of the United States cases and the costs associated with these settlements are reflected in the Company's accruals.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Claims for personal injury arising out of the use of XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;, an oral anticoagulant, have been made against Janssen Pharmaceuticals, Inc. (JPI); Johnson &amp;amp; Johnson (J&amp;amp;J); and JPI&#x2019;s collaboration partner for XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;, Bayer AG and certain of its affiliates. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Eastern District of Louisiana. In addition, cases have been filed in state courts across the United States. Many of these cases have been consolidated into a state mass tort litigation in Philadelphia, Pennsylvania and in a coordinated proceeding in Los Angeles, California. Class action lawsuits also have been filed in Canada. In March 2019, JPI and J&amp;amp;J announced an agreement in principle to the settle the XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; cases in the United States; the settlement agreement was executed in May 2019, the settlement became final in December 2019, and the settlement was funded in January 2020.  This resolved the majority of cases pending in the United States. The Company has established accruals for its costs associated with the United States settlement program and XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; related product liability litigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Personal injury claims alleging that talc causes cancer have been made against Johnson &amp;amp; Johnson Consumer Inc. and Johnson &amp;amp; Johnson arising out of the use of body powders containing talc, primarily JOHNSON&#x2019;S&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; Baby Powder.  The number of pending personal injury lawsuits continues to increase, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Lawsuits have been primarily filed in state courts in Missouri, New Jersey and California, and suits have also been filed outside the United States. The majority of cases are pending in federal court, organized into a multi-district litigation in the United States District Court for the District of New Jersey. In the multi-district litigation, the parties have sought to exclude experts, through Daubert motions.  In April 2020, the Court issued rulings that limit the scope of testimony, including some theories and testing methods, for certain plaintiff expert witnesses and denied  plaintiffs&#x2019; attempt to limit the scope of testimony of certain of the Company&#x2019;s witnesses.  With this ruling made, case-specific discovery has begun, per the court&#x2019;s directive to proceed.  In talc cases that have previously gone to trial, the Company has obtained defense verdicts in a number of these cases but there have also been verdicts against the Company, many of which have been reversed on appeal.  Most recently, in June 2020, the Missouri Court of Appeals reversed in part and affirmed in part a July 2018 verdict of $4.7&#160;billion, reducing the overall award to $2.1&#160;billion. The Company has filed an application for transfer of the case to the Missouri Supreme Court.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The Company continues to believe that it has strong grounds for the appeal of this verdict, as well as other verdicts that it has appealed. Notwithstanding the Company&#x2019;s confidence in the safety of its talc products, in certain circumstances the Company has and may settle cases.  The Company has established an accrual for defense costs and reserves for settlement of certain cases and claims in connection with product liability litigation associated with body powders containing talc.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In February 2019, the Company&#x2019;s talc supplier, Imerys Talc America, Inc. and two of its affiliates, Imerys Talc Vermont, Inc. and Imerys Talc Canada, Inc. (collectively, Imerys) filed a voluntary chapter 11 petition commencing a reorganization under the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (Imerys Bankruptcy).  The Imerys Bankruptcy relates to Imerys&#x2019; potential liability for personal injury from exposure to talcum powder sold by Imerys (Talc Claims).  In its bankruptcy filing, Imerys noted certain claims it alleges it has against the Company for indemnification and rights to joint insurance proceeds.  Based on such claims as well as indemnity and insurance claims the Company has against Imerys, the Company petitioned the United States District Court for the District of Delaware to establish federal jurisdiction of the state court talc lawsuits under the Bankruptcy Code.  The Company's petition was denied and the state court talc lawsuits that have been removed to federal court on such basis have been remanded.  The Company previously proposed to resolve Imerys' (and the Company&#x2019;s) obligations arising out of the Talc Claims by agreeing to assume the defense of litigation &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;of all Talc Claims involving the Company's products, waiving the Company&#x2019;s indemnification claims against Imerys, and lifting the automatic stay to enable the Talc Claims to proceed outside the bankruptcy forum with the Company agreeing to settle or pay any judgment against Imerys. In May 2020, Imerys and the asbestos claimants&#x2019; committee filed their Plan of Reorganization and the Disclosure Statement related thereto agreeing to put its North American operations up for auction which was subsequently amended.  The Company has objected to the Disclosure Statement and intends to object to the Plan of Reorganization as currently structured. Additionally, in June 2020, Cyprus Mines Corporation and its parent filed an adversary proceeding against the Company as well as Imerys seeking a declaration of indemnity under certain contractual agreements.  The Company denies such indemnification is owed and filed a motion to dismiss the adversary complaint arguing, among other things, that the Court does not have subject matter jurisdiction over Cyprus&#x2019;s claims against the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;In February 2018, a securities class action lawsuit was filed against Johnson &amp;amp; Johnson and certain named officers in the United States District Court for the District of New Jersey, alleging that Johnson &amp;amp; Johnson violated the federal securities laws by failing to disclose alleged asbestos contamination in body powders containing talc, primarily JOHNSON'S&#xae; Baby Powder, and that purchasers of Johnson &amp;amp; Johnson&#x2019;s shares suffered losses as a result.  Plaintiff is seeking damages. In April 2019, the Company moved to dismiss the complaint and briefing on the motion was complete as of August 2019.  In December 2019, the Court denied, in part, the motion to dismiss.  In March 2020, Defendants answered the complaint. Discovery is underway.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;In June 2019, a shareholder filed a complaint initiating a summary proceeding in New Jersey state court for a books and records inspection. In August 2019, Johnson &amp;amp; Johnson responded to the books and records complaint and filed a cross motion to dismiss. In September 2019, Plaintiff replied and the Court heard oral argument. The Court has not yet ruled in the books and records action. In October 2019, December 2019, and January 2020, four shareholders filed four separate derivative lawsuits against Johnson &amp;amp; Johnson as the nominal defendant and its current directors and certain officers as defendants in the United States District Court for the District of New Jersey, alleging a breach of fiduciary duties related to the alleged asbestos contamination in body powders containing talc, primarily JOHNSON&#x2019;S&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;Baby Powder, and that Johnson &amp;amp; Johnson has suffered damages as a result of those alleged breaches. In February 2020, the four cases were consolidated into a single action under the caption &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:99%;"&gt;In re Johnson &amp;amp; Johnson Talc Stockholder Derivative Litigation&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;In July 2020, a report was delivered to the Company&#x2019;s Board of Directors by independent counsel retained by the Board to investigate the allegations in the derivative lawsuits and in a series of shareholder letters that the Board received raising similar issues.  The independent counsel recommended that the Company reject the shareholder demands and take the steps that are necessary or appropriate to secure dismissal of the derivative lawsuits.  The Board unanimously adopted the recommendations of the independent counsel&#x2019;s report.  Four of the shareholders who had sent demands are plaintiffs in th&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;e &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:103%;"&gt;In re Johnson &amp;amp; Johnson Talc Stockholder Derivative Litigation&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;In January 2019, two ERISA class action lawsuits were filed by participants in the Johnson &amp;amp; Johnson Savings Plan against Johnson &amp;amp; Johnson, its Pension and Benefits Committee, and certain named officers in the United States District Court for the District of New Jersey, alleging that the defendants breached their fiduciary duties by offering Johnson &amp;amp; Johnson stock as a Johnson &amp;amp; Johnson Savings Plan investment option when it was imprudent to do so because of failures to disclose alleged asbestos contamination in body powders containing talc, primarily JOHNSON&#x2019;S&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt; Baby Powder.  Plaintiffs are seeking damages and injunctive relief. In September 2019, Defendants filed a motion to dismiss. In April 2020, the Court granted Defendants&#x2019; motion but granted leave to amend.  In June 2020, Plaintiffs filed an amended complaint, and in July 2020, Defendants moved to dismiss the amended complaint.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;A lawsuit is pending in the Superior Court of California for the County of San Diego alleging violations of California&#x2019;s Consumer Legal Remedies Act relating to JOHNSON&#x2019;S&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt; Baby Powder.  In that lawsuit, the plaintiffs allege that Johnson &amp;amp; Johnson violated the CLRA by failing to provide required Proposition 65 warnings.  In July 2019, the Company filed a notice of removal to the United States District Court for the Southern District of California and plaintiffs filed a second amended complaint shortly thereafter.  In October 2019, the Company moved to dismiss the second amended complaint for failure to state a claim upon which relief may be granted.  In response to those motions, plaintiffs filed a third amended complaint.  In December 2019, the Company moved to dismiss the third amended complaint for failure to state a claim upon which relief may be granted.  In April 2020, the Court granted the motion to dismiss but granted leave to amend. In May 2020, plaintiffs filed a Fourth Amended Complaint but indicated that they would be filing a motion for leave to file a fifth amended complaint. Plaintiffs filed a Fifth Amended Complaint in August 2020. The Company moved to dismiss the Fifth Amended Complaint for failure to state a claim upon which relief may be granted.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In January 2020, the Abtahi Law Group filed an action under Proposition 65 against Johnson &amp;amp; Johnson and Johnson &amp;amp; Johnson Consumer Inc. as well as a number of other alleged talcum powder manufacturers and distributors, including one California company.  In that action, the plaintiff alleges contamination of talcum powder products with unsafe levels of arsenic, hexavalent chromium and lead.  The plaintiff seeks civil penalties and injunctive relief. The case has been stayed by the court pending an initial status conference.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In addition, the Company has received preliminary inquiries and subpoenas to produce documents regarding these matters from Senator Murray, a member of the Senate Committee on Health, Education, Labor and Pensions, the Department of Justice, the Securities and Exchange Commission and the U.S. Congressional Subcommittee on Economic and Consumer Policy.  The Company is cooperating with government inquiries and continues to produce documents as required in response. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Claims for personal injury have been made against a number of Johnson &amp;amp; Johnson companies, including Janssen Pharmaceuticals, Inc. and Johnson &amp;amp; Johnson, arising out of the use of INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, a prescription medication indicated to improve glycemic control in adults with Type 2 diabetes. Lawsuits filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the District of New Jersey. Cases have also been filed in state courts. Class action lawsuits have been filed in Canada. Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has settled or otherwise resolved many of the cases and claims in the United States and the costs associated with these settlements are reflected in the Company's accruals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;"&gt;INTELLECTUAL PROPERTY&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Certain subsidiaries of Johnson &amp;amp; Johnson are subject, from time to time, to legal proceedings and claims related to patent, trademark and other intellectual property matters arising out of their businesses. Many of these matters involve challenges to the coverage and/or validity of the patents on various products and allegations that certain of the Company&#x2019;s products infringe the patents of third parties. Although these subsidiaries believe that they have substantial defenses to these challenges and allegations with respect to all significant patents, there can be no assurance as to the outcome of these matters. A loss in any of these cases could adversely affect the ability of these subsidiaries to sell their products, result in loss of sales due to loss of market exclusivity, require the payment of past damages and future royalties, and may result in a non-cash impairment charge for any associated intangible asset. The most significant of these matters are described below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"&gt;Medical Devices&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In November 2016, MedIdea, L.L.C. (MedIdea) filed a patent infringement lawsuit against DePuy Orthopaedics, Inc. in the United States District Court for the Northern District of Illinois alleging infringement by the ATTUNE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Knee System. In April 2017, MedIdea filed an amended complaint adding DePuy Synthes Products, Inc. and DePuy Synthes Sales, Inc. as named defendants (collectively, DePuy).  MedIdea alleges infringement of United States Patent Nos. 6,558,426 (&#x2019;426); 8,273,132 (&#x2019;132); 8,721,730 (&#x2019;730)   and 9,492,280 (&#x2019;280) relating to posterior stabilized knee systems. Specifically, MedIdea alleges that the SOFCAM&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;TM&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Contact feature of the ATTUNE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; posterior stabilized knee products infringes the patents-in-suit. MedIdea is seeking monetary damages and injunctive relief. In June 2017, the case was transferred to the United States District Court for the District of Massachusetts.  A claim construction hearing was held in October 2018, and a claim construction order was issued in November 2018. In December 2018, MedIdea stipulated to non-infringement of the &#x2019;132, &#x2019;730 and &#x2019;280 patents, based on the district court&#x2019;s claim construction and reserving its right to appeal that construction, leaving only the &#x2019;426 patent at issue before the district court. In May 2019, DePuy filed a motion for summary judgment of non-infringement of the claims of the &#x2019;426 patent. In November 2019, judgment was entered in favor of DePuy.  In December 2019, MedIdea filed a notice of appeal and the appeal is fully briefed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In December 2016, Ethicon Endo-Surgery, Inc. and Ethicon Endo-Surgery, LLC (now known as Ethicon LLC) sued Covidien, Inc. in the United States District Court for the District of Massachusetts seeking a declaration that United States Patent Nos. 6,585,735 (&#x2019;735); 7,118,587; 7,473,253; 8,070,748 and 8,241,284 (&#x2019;284), are either invalid or not infringed by Ethicon&#x2019;s ENSEAL&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; X1 Large Jaw Tissue Sealer product. In April 2017, Covidien LP, Covidien Sales LLC, and Covidien AG (collectively, Covidien) answered and counterclaimed, denying the allegations, asserting willful infringement of the &#x2019;735 patent, the &#x2019;284 patent and United States Patent Nos. 8,323,310 (&#x2019;310); 9,084,608; 9,241,759 (&#x2019;759) and 9,113,882, and seeking damages and an injunction. In June 2020, after a bench trial, the district court entered judgment in Ethicon&#x2019;s favor.  In July 2020, Covidien filed a notice of appeal, and Ethicon filed a cross appeal.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In August 2020, the parties agreed to dismiss their respective appeals.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In December 2016, Dr. Ford Albritton sued Acclarent, Inc. (Acclarent) in United States District Court for the Northern District of Texas alleging that Acclarent&#x2019;s RELIEVA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Spin and RELIEVEA SpinPlus&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; products infringe U.S. Patent No. 9,011,412 (&#x2019;412).  Dr. Albritton also alleges breach of contract, fraud and that he is the true owner of Acclarent&#x2019;s U.S. Patent No. 8,414,473. Trial is scheduled to begin in March 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In November 2017, Board of Regents, The University of Texas System and TissueGen, Inc. (collectively, UT) filed a lawsuit in the United States District Court for the Western District of Texas against Ethicon, Inc. and Ethicon US, LLC (collectively, Ethicon) alleging the manufacture and sale of VICRYL&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Plus Antibacterial Sutures, MONOCRYL&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Plus Antibacterial Sutures, PDS&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Plus Antibacterial Sutures, STRATAFIX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; PDS&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Antibacterial Sutures and STRATAFIX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; MONOCRYL&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Plus Antibacterial Sutures infringe plaintiffs&#x2019; United States Patent Nos. 6,596,296 (&#x2019;296) and 7,033,603 (&#x2019;603) directed to implantable polymer drug releasing biodegradable fibers containing a therapeutic agent.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;UT is seeking damages and an injunction.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In December 2018, Ethicon filed petitions with the United States Patent and Trademark Office (USPTO), seeking &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Inter Partes Review (IPR) of both asserted patents. &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2020, the USPTO denied institution of the &#x2019;296 patent IPR and granted institution of the &#x2019;603 patent IPR.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;UT dismissed the &#x2019;603 patent from the suit and no longer accuses PDS&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Plus Antibacterial Sutures or STRATAFIX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; PDS&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Plus Antibacterial Sutures of infringement. The previously scheduled district court trial has been postponed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; In August 2018, Intuitive Surgical, Inc. and Intuitive Surgical Operations, Inc. (collectively, Intuitive) filed a patent infringement suit against Auris Health, Inc. (Auris) in United States District Court for the District of Delaware.  In the suit, Intuitive alleges willful infringement of U.S. Patent Nos. 6,246,200 (&#x2019;200); 6,491,701 (&#x2019;701); 6,522,906 (&#x2019;906); 6,800,056 (&#x2019;056); 8,142,447 (&#x2019;447); 8,620,473 (&#x2019;473); 8,801,601 (&#x2019;601); and 9,452,276 (&#x2019;276) based on Auris&#x2019; Monarch&#x2122; Platform.  Auris filed IPR Petitions with the USPTO regarding the &#x2019;200, &#x2019;056, &#x2019;601 &#x2019;701, &#x2019;447, &#x2019;276 and &#x2019;906 patents.   Intuitive subsequently dropped the &#x2019;200, &#x2019;473 and &#x2019;701 patents from the suit.  In December 2019, the USPTO instituted review of the &#x2019;601 patent and denied review of the &#x2019;056 patent.  In February and March 2020, the USPTO instituted review of the &#x2019;200, &#x2019;447, &#x2019;701 and &#x2019;906 patents and denied review of the &#x2019;276 patent.   The district court trial is scheduled to begin in June 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In August 2019, RSB Spine LLC (RSB Spine) filed a patent infringement suit against DePuy Synthes, Inc. in United States District Court for the District of Delaware.  In October 2019, RSB Spine amended the complaint to change the named defendants to DePuy Synthes Sales, Inc. and DePuy Synthes Products, Inc.  In the suit, RSB Spine alleges willful infringement of United States Patent Nos. 6,984,234 and 9,713, 537 by one or more of the following products:  ZERO-P-VA&#x2122; Spacer, ZERO-P&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; Spacer, ZERO-P NATURAL&#x2122; Plate, SYNFIX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; LR Spacer and SYNFIX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; Evolution System.  RSB Spine seeks monetary damages and injunctive relief. In November 2019, the suit was consolidated for pre-trial purposes with other patent infringement suits brought by RSB Spine in the United States District Court for the District of Delaware against Life Spine, Inc., Medacta USA, Inc., Precision Spine, Inc., and Xtant Medical Holdings, Inc. In June 2020, the case was stayed pending IPR proceedings involving the asserted patents. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In March 2020, Osteoplastics, LLC filed a patent infringement suit against DePuy Synthes, Inc., DePuy Synthes Products, Inc., Medical Device Business Services, Inc., and Synthes, Inc. (collectively, DePuy Synthes)  in the United States District Court for the District of Delaware.  In the suit, Osteoplastics alleges willful infringement of U.S. Patent Nos. 8,781,557; 9,929,920; 9,330,206; 9,626,756; 9,672,617; 9,672,302; and 9,275,191 based on the PROPLAN CMF&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Virtual Surgical Planning Services and the TruMatch&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; CMF Personalize Solutions.  In April 2020, Osteoplastics filed an amended complaint to substitute U.S. Patent No. 9,292,920 for U.S. Patent No. 9,929,920.  Osteoplastics seeks monetary damages and injunctive relief. In June 2020, DePuy Synthes filed a motion to dismiss the complaint. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Litigation Against Filers of Abbreviated New Drug Applications (ANDAs)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following summarizes lawsuits pending against generic companies that have filed ANDAs with the FDA or undertaken similar regulatory processes outside of the United States, seeking to market generic forms of products sold by various subsidiaries of Johnson &amp;amp; Johnson prior to expiration of the applicable patents covering those products. These ANDAs typically include allegations of non-infringement and invalidity of the applicable patents. In the event the subsidiaries are not successful in an action, or the automatic statutory stay of the ANDAs expires before the United States District Court rulings are obtained, the third-party companies involved would have the ability, upon approval of the FDA, to introduce generic versions of their products to the market, resulting in the potential for substantial market share and revenue losses for the applicable products, and which may result in a non-cash impairment charge in any associated intangible asset. In addition, from time to time, subsidiaries may settle these types of actions and such settlements can involve the introduction of generic versions of the products at issue to the market prior to the expiration of the relevant patents. The IPR process with the USPTO, created under the 2011 America Invents Act, is also being used at times by generic companies in conjunction with ANDAs and lawsuits, to challenge the applicable patents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In November 2017, Janssen initiated a Notice of Application under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex Inc. (Apotex) and the Minister of Health in Canada in response to Apotex&#x2019;s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;before the expiration of Canadian Patent No. 2,661,422 (the &#x2019;422).  The final hearing concluded in May 2019.  In October 2019, the court issued an order prohibiting the Canadian Minister of Health from approving Apotex&#x2019;s ANDS until the expiration of the &#x2019;422 patent.  In November 2019, Apotex filed an appeal.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In January 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex in Canada in response to Apotex&#x2019;s filing of an Abbreviated New Drug Submission (ANDS) seeking &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;approval to market a film-coated generic version of ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of the &#x2019;422 patent. The final hearing is scheduled to begin in October 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In January 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Pharmascience Inc. (Pharmascience) in Canada in response to Pharmascience&#x2019;s filing of an ANDS seeking approval to market a generic version of ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;  &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;250 mg,&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;before the expiration of the  &#x2019;422 patent. The final hearing is scheduled to begin in October 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In November 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Pharmascience in Canada in response to Pharmascience&#x2019;s filing of an ANDS seeking approval to market a generic version of ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, 500 mg, before the expiration of the &#x2019;422 patent.  The final hearing is scheduled to begin in October 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories, Inc. (collectively, DRL) in Canada in response to DRL's filing of an ANDS seeking approval to market a generic version of ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of the &#x2019;422 patent. The final hearing is scheduled to begin in October 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;In August 2020, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against JAMP Pharma Corporation (Jamp) in Canada in response to Jamp&#x2019;s filing of an ANDS seeking approval to market a generic version of ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt; before the expiration of the &#x2019;422 patent.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In each of these Canadian actions, Janssen is seeking an order enjoining the defendants from marketing their generic versions of ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of the &#x2019;422 patent.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;In June 2017, Janssen Pharmaceuticals, Inc. (JPI) and Bayer Pharma AG and Bayer Intellectual Property GmbH (collectively, Bayer) filed a patent infringement lawsuit in the United States District Court for the District of Delaware against InvaGen Pharmaceuticals Inc. (InvaGen) who filed an ANDA seeking approval to market generic versions of XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt; before expiration of Bayer AG&#x2019;s United States Patent No. 9,539,218 (&#x2019;218) relating to XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;. JPI is the exclusive sublicensee of the asserted patent. In August 2020, JPI and Bayer AG entered into a settlement agreement with InvaGen. &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;"&gt;In May 2020, JPI and Bayer AG filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Unichem Inc. (a/k/a Unichem Laboratories, Ltd.) and Unichem Pharmaceuticals (USA), Inc.(collectively, Unichem) who filed an ANDA seeking approval to market a generic version of XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:88%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;"&gt; before expiration of &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:88%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;"&gt;the &#x2019;218 patent and United States Patent No. 7,157,456 relating&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:88%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;"&gt;to XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:88%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;"&gt;. &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:88%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:88%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;"&gt;In September 2020, JPI and Bayer entered into a settlement agreement with Unichem.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;"&gt;In August 2020, JPI and Bayer filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Dr. Reddy&#x2019;s Laboratories, Inc. and Dr. Reddy&#x2019;s Laboratories, Ltd. (collectively, DRL) who filed an ANDA seeking approval to market a generic version of XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:88%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;"&gt; before expiration of &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:88%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;"&gt;the &#x2019;218 patent.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:88%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;"&gt;In this lawsuit, JPI is seeking an order enjoining DRL from marketing their generic versions of XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:88%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;"&gt; before the expiration of the relevant patents.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;/INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;/INVOKAMET XR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;Beginning in July 2017, Janssen Pharmaceuticals, Inc., Janssen Research &amp;amp; Development, LLC, Cilag GmbH International and Janssen Pharmaceutica NV (collectively, Janssen) and Mitsubishi Tanabe Pharma Corporation (MTPC) filed patent infringement lawsuits in the United States District Court for the District of New Jersey against a number of generic companies who filed ANDAs seeking approval to market generic versions of INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;, INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt; and/or INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt; XR before expiration of MTPC&#x2019;s United States Patent Nos. 7,943,582 (&#x2019;582) and/or 8,513,202 (&#x2019;202) relating to INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;, INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt; and/or INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt; XR. Janssen is the exclusive licensee of the asserted patents. The following generic companies were named as defendants:&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;Dr. Reddy&#x2019;s Laboratories, Inc. and Dr. Reddy&#x2019;s Laboratories Ltd (DRL); MSN Laboratories Private Ltd. and MSN Pharmaceuticals, Inc. (MSN); Zydus Pharmaceuticals (USA) Inc. (Zydus); Sandoz, Inc. (Sandoz); and Lupin Ltd. and Lupin Pharmaceuticals, Inc. (Lupin).&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;These cases were consolidated into one action (Polymorph Main Action), which has been scheduled for trial starting in February 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;In July 2017, Janssen and MTPC filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus who filed an ANDA seeking approval to market generic versions of INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;, INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt; and/or INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt; XR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"&gt; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;before expiration of MTPC&#x2019;s United States Patent No. 7,943,788 (&#x2019;788), 8,222,219 (&#x2019;219) and/or 8,785,403 (&#x2019;403) relating to INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;, INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;and/or INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt; XR (Compounds Main Action). Janssen is the exclusive licensee of the asserted patents. Trial began in September 2020 and will conclude in October or November 2020.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%;"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;In July 2019, Janssen and MTPC filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against MSN, who filed an ANDA seeking approval to market a generic version of INVOKAMET XR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt; before expiration of the &#x2019;582 patent and &#x2019;202 patent relating to INVOKAMET XR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;In October 2019, Janssen and MTPC initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against MSN, who filed ANDAs seeking approval to market generic versions of INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt; and INVOKAMET XR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt; before expiration of the &#x2019;788 patent.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;In October 2019, Janssen and MTPC initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against DRL, who filed an ANDA seeking approval to market a generic version of INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt; before expiration of the &#x2019;788 patent.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"&gt;These lawsuits have not been consolidated with the Main Actions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;In each of these lawsuits, Janssen and MTPC are seeking an order enjoining the defendants from marketing their generic versions of INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;, INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt; and/or, INVOKAMET XR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;before the expiration of the relevant patents.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;OPSUMIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In January 2018, Actelion Pharmaceuticals Ltd (Actelion) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus Pharmaceuticals (USA) Inc. (Zydus) who filed an ANDA seeking approval to market a generic version of OPSUMIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;before the expiration of United States Patent No. 7,094,781 (&#x2019;781).  In the lawsuit, Actelion was seeking an order enjoining Zydus from marketing generic versions of OPSUMIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; before the expiration of the patent. &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In September 2020, Actelion and Zydus entered into a settlement agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;I&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;n October 2020, Actelion initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Laurus Labs Limited and PharmaQ, Inc. (collectively, Laurus), who filed an ANDA seeking approval to market generic versions of OPSUMIT&#xae; before the expiration of U.S. Patent No. 7,094,781 (&#x2019;781).  Actelion is seeking an order enjoining Laurus from marketing generic versions of OPSUMIT&#xae; before the expiration of the &#x2019;781 patent.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In May 2020, Janssen Inc. (Janssen) and Actelion initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Sandoz Canada Inc. (Sandoz) in Canada in response to Sandoz&#x2019;s filing of an ANDS seeking approval to market a generic version of OPSUMIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;  &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;10 mg,&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;vertical-align:top;"&gt; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;before the expiration of Canadian Patent No. 2,659,770 (&#x2019;770). Trial is scheduled to begin in January 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In May 2020, Janssen and Actelion initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex Inc. (Apotex) in Canada in response to Apotex&#x2019;s filing of an ANDS seeking approval to market a generic version of OPSUMIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;10 mg,&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;before the expiration of the &#x2019;770 patent. Trial is scheduled to begin in February 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In July 2020, Janssen and Actelion initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against JAMP Pharma Corporation (JAMP) in Canada in response to JAMP&#x2019;s filing of an ANDS seeking approval to market a generic version of OPSUMIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; 10 mg before the expiration of the &#x2019;770 patent and Canadian Patent No. 2,621,273 (&#x2019;273).  Trial is scheduled to begin in April 2022.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In each of these Canadian actions, Janssen and Actelion are seeking an order enjoining the defendants from marketing their generic versions of OPSUMIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of the relevant patents.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In January 2018, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Teva Pharmaceuticals USA, Inc. (Teva), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of United States Patent No. 9,439,906 (&#x2019;906).  Trial commenced in October 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In August 2019, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Mylan Laboratories Limited (Mylan), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; before the expiration of the &#x2019;906 patent.  In February 2020, Mylan filed a Petition for Inter Partes Review with the USPTO seeking to invalidate the &#x2019;906 patent. The USPTO denied the Petition in September 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In December 2019, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Courts for the Districts of New Jersey and Delaware against Pharmascience Inc., Mallinckrodt PLC and Specgx LLC (collectively, Pharmascience), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of the &#x2019;906 patent.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In February 2018, Janssen Inc. and Janssen Pharmaceutica NV (collectively, Janssen) initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Teva Canada Limited (Teva)  in response to Teva's filing of an ANDS seeking approval to market a generic version of INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of Canadian Patent Nos. 2,309,629 (&#x2019;629) and 2,655,335 (&#x2019;335).  Janssen subsequently discontinued the portion of the lawsuit relating to the &#x2019;629 patent.  In  May 2020, the Canadian Federal Court issued a Public Judgment and Reasons declaring that Teva&#x2019;s generic version of INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, if approved, would infringe claims of the &#x2019;335 patent and that the claims of the &#x2019;335 patent are not invalid for obviousness. Teva appealed the court&#x2019;s decision.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In April 2020, Janssen Inc. and Janssen Pharmaceutica NV (together, Janssen) initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Pharmascience Inc. (Pharmascience)  in response to Pharmascience's filing of an ANDS seeking approval to market a generic version of INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; before the expiration of the &#x2019;335 patent.  In September 2020, Pharmascience withdrew its ANDS and Janssen discontinued the lawsuit.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In each of these lawsuits, Janssen is seeking an order enjoining the defendant from marketing a generic version of INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of the relevant patents.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;IMBRUVICA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;Beginning in January 2018, Pharmacyclics LLC (Pharmacyclics) and Janssen Biotech, Inc. (JBI) filed patent infringement lawsuits in the United States District Court for the District of Delaware against a number of generic companies who filed ANDAs seeking approval to market generic versions of IMBRUVICA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt; 140 mg capsules before expiration of Pharmacyclics&#x2019;  United States Patent Nos. 8,008,309, 7,514,444, 8,697,711, 8,735,403, 8,957,079, 9,181,257, 8,754,091, 8,497,277, 8,925,015, 8,476,284, 8,754,090, 8,999,999, 9,125,889, 9,801,881, 9,801,883, 9,814,721, 9,795,604, 9,296,753, 9,540,382, 9,713,617 and/or 9,725,455 relating to IMBRUVICA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;. JBI is the exclusive licensee of the asserted patents. The named defendants include the following generic companies: Cipla Limited and Cipla USA Inc. (collectively, Cipla); Sandoz Inc. and Lek Pharmaceuticals d.d. (collectively, Sandoz); and Zydus Worldwide DMCC and Cadila Healthcare Limited (collectively, Zydus).  The trial commenced in October 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In January 2019, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Zydus, who filed an ANDA seeking approval to market a generic version of IMBRUVICA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; 70 mg before the expiration of U.S. Patent Nos. 7,514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753, 9,540,382, 9,713,617, 9,725,455, 10,106,548, and 10,125,140. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In February 2019, Pharmacyclics and JBI amended their complaint against Cipla to allege infringement of United States Patent Nos. 10,106,548, and 10,125,140.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In March 2019, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Alvogen Pine Brook LLC and Natco Pharma Ltd. (collectively, Alvogen), who filed an ANDA seeking approval to market generic versions of IMBRUVICA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; tablets, asserting infringement of United States Patent Nos. 7,514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753,  9,655,857, 9,725,455, 10,010,507, 10,106,548, and 10,125,140.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In May 2019, Pharmacyclics and JBI amended their complaint against Cipla to further allege infringement of United States Patent No. 10,016,435.  In June 2019, Pharmacyclics and JBI amended their complaint against Alvogen to further allege infringement of United States Patent No. 10,213,386.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In August 2019, Pharmacyclics and JBI amended their complaints against Cipla and Sandoz to further allege infringement of U.S. Patent Nos. 10,294,231 and 10,294,232.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In March 2019, Sandoz filed an&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;IPR Petition with&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;the USPTO, seeking to invalidate United States Patent No. 9,795,604.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In September 2020, the USPTO issued a final decision in the IPR invalidating certain claims of the &#x2019;604 patent and upholding the validity of certain claims in the &#x2019;604 patent.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;In March 2020, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Alvogen, Zydus and Sandoz asserting infringement of United States Patent No. 10,478,439.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;In April 2020, Pharmacyclics and JBI amended their complaint against Sandoz to further allege infringement of U.S. Patent No. 10,463,668. In October 2020, Pharmacyclics and JBI amended their complaint against Sandoz to further allege infringement of U.S. Patent Nos. 10,752,634 and 10,695,350, amended their complaint against Zydus to further allege infringement of U.S. Patent Nos.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;10,752,634 and 10,653,696, and amended their complaint against Alvogen to further allege infringement of U.S. Patent No. 10,653,696.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April 2020, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Zydus, who filed an ANDA seeking approval to market generic versions of IMBRUVICA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; tablets, asserting infringement of United States Patent Nos. 7,514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753,  9,655,857, 9,725,455, 10,010,507, 10,106,548, 10,125,140, 10,213,286 and 10,478,439.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In October 2020, Pharmacyclics and JBI entered into a settlement agreement with Zydus.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In each of the lawsuits, Pharmacyclics and JBI are seeking an order enjoining the defendants from marketing generic versions of IMBRUVICA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;before the expiration of the relevant patents.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;UPTRAVI&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April 2020, Actelion Pharmaceuticals Ltd and Nippon Shinyaku Co., Ltd. initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against a number of generic companies who filed ANDAs seeking approval to market generic versions of UPTRAVI&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;before expiration of Nippon Shinyaku&#x2019;s United States Patent Nos. 7,205,302; 8,791,122; and 9,284,280 relating to UPTRAVI&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;.  Actelion is the exclusive licensee of the asserted patents. The following generics are named defendants in the complaint: Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals Inc. (Alembic); MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. (MSN); Aizant Drug Research Solutions Private Limited (Aizant); VGYAAN Pharmaceuticals LLC (VGYAAN); and Zydus Pharmaceuticals (USA), Inc. and Zydus Worldwide DMCC (Zydus). In June 2020, the court entered a joint stipulation dismissing Aizant from suit.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Actelion and Nippon Shinyaku are seeking an order enjoining the defendants from marketing generic versions of UPTRAVI&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;before the expiration of the relevant patents.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;INVEGA TRINZA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In September 2020, Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica NV, and Janssen Research &amp;amp; Development, LCC (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., and Mylan Institutional LLC (collectively, Mylan). Mylan filed an ANDA seeking approval to market generic versions of INVEGA TRINZA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;before expiration of United States Patent No. 10,143,693 relating to INVEGA TRINZA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;. Janssen is seeking an order enjoining Mylan from marketing a generic version of INVEGA TRINZA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; before the expiration of the relevant patent.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;"&gt;GOVERNMENT PROCEEDINGS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Like other companies in the pharmaceutical, consumer and medical devices industries, Johnson &amp;amp; Johnson and certain of its subsidiaries are subject to extensive regulation by national, state and local government agencies in the United States and other countries in which they operate. As a result, interaction with government agencies is ongoing. The most significant litigation brought by, and investigations conducted by, government agencies are listed below. It is possible that criminal charges and substantial fines and/or civil penalties or damages could result from government investigations or litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"&gt;Average Wholesale Price (AWP) Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Johnson &amp;amp; Johnson and several of its pharmaceutical subsidiaries (the J&amp;amp;J AWP Defendants), along with numerous other pharmaceutical companies, were named as defendants in a series of lawsuits in state and federal courts involving allegations that the pricing and marketing of certain pharmaceutical products amounted to fraudulent and otherwise actionable conduct because, among other things, the companies allegedly reported an inflated Average Wholesale Price (AWP) for the drugs at issue. Payors alleged that they used those AWPs in calculating provider reimbursement levels. The plaintiffs in these cases included three classes of private persons or entities that paid for any portion of the purchase of the drugs at issue based on AWP, and state government entities that made Medicaid payments for the drugs at issue based on AWP. Many of these cases, both federal actions and state actions removed to federal court, were consolidated for pre-trial purposes in a multi-district litigation in the United States District Court for the District of Massachusetts, where all claims against the J&amp;amp;J AWP Defendants were ultimately dismissed. The J&amp;amp;J AWP Defendants also prevailed in a case brought by the Commonwealth of Pennsylvania. Other AWP cases have been resolved through court order or settlement. The case brought by Illinois was settled after trial.  In New Jersey, a putative class action based upon AWP allegations is pending against Centocor, Inc. and Ortho Biotech Inc. (both now Janssen Biotech, Inc.), Johnson &amp;amp; Johnson and ALZA Corporation. All other cases have been resolved.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"&gt;Opioid Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Beginning in 2014 and continuing to the present, Johnson &amp;amp; Johnson and Janssen Pharmaceuticals, Inc. (JPI), along with other pharmaceutical companies, have been named in more than 3,100 lawsuits related to the marketing of opioids, including DURAGESIC&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, NUCYNTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; and NUCYNTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; ER.  The suits also raise allegations related to previously owned active pharmaceutical ingredient supplier subsidiaries, Tasmanian Alkaloids Pty, Ltd. and Noramco, Inc. (both subsidiaries were divested in 2016). The majority of the cases have been filed by state and local governments. Similar lawsuits have also been filed by private plaintiffs and organizations, including but not limited to the following: individual plaintiffs on behalf of children suffering from Neonatal Abstinence Syndrome; hospitals; and health insurers/payors. To date, complaints against pharmaceutical companies, including Johnson &amp;amp; Johnson and JPI, have been filed by the state Attorneys General in Arkansas, Florida, Idaho, Illinois, Kentucky, Louisiana, Mississippi, Missouri, New Hampshire, New Jersey, New Mexico, New York, Ohio, Oklahoma, South Dakota, Texas, Washington and West Virginia. Complaints against the manufacturers also have been filed in state or federal court by city, county and local government agencies in the following states: Alabama, Arizona, Arkansas, California, Connecticut, Florida, Georgia, Illinois, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Mississippi, Missouri, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina; Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia and Wisconsin. The Government of Puerto Rico filed suit in Superior Court of San Juan. There are more than 370 cases pending in various state&#160;courts. There are over 2,700 federal cases coordinated in a federal Multi-District Litigation (MDL) pending in the U.S. District Court for the Northern District of Ohio (MDL No. 2804).&#160;In addition, the Province of British Columbia filed suit in Canada.  In October 2019, an anti-trust complaint was filed by private plaintiffs in federal court in Tennessee and is pending transfer to the MDL. These actions allege a variety of claims related to opioid marketing practices, including false advertising, unfair competition, public nuisance, consumer fraud violations, deceptive acts and practices, false claims and unjust enrichment. The suits generally seek penalties and/or injunctive and monetary relief and, in some of the suits, the plaintiffs are seeking joint and several liability among the defendants. An adverse judgment in any of these lawsuits could result in the imposition of large monetary penalties and significant damages including, punitive damages, cost of abatement, substantial fines, equitable remedies and other sanctions.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The trial in the matter filed by the Oklahoma Attorney General resulted in a judgment against Johnson &amp;amp; Johnson and JPI in the amount of $572 million, subject to a final order to be issued by the court.&#160; The court issued a final judgment reducing the amount to $465 million. Johnson &amp;amp; Johnson and JPI have appealed the judgment. The Company believes that it has strong grounds to overturn this judgment.&#160; In October 2019 Johnson &amp;amp; Johnson and JPI announced a settlement of the first case set for trial in the MDL with two counties in Ohio. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Johnson &amp;amp; Johnson, JPI and other pharmaceutical companies have also received subpoenas or requests for information related to opioids marketing practices from the following state Attorneys General: Alaska, Indiana, Montana, New Hampshire, South Carolina, Tennessee, Texas and Washington. In September 2017, Johnson &amp;amp; Johnson and JPI were contacted by the Texas and Colorado Attorney General&#x2019;s Offices on behalf of approximately 38 states regarding a multi-state Attorney General investigation. In October 2019, the Company announced a proposed agreement in principle that would include the Company paying $4 billion as settlement of these lawsuits.  In October 2020, the Company agreed to contribute up to an additional $1&#160;billion to an all-in settlement amount that would resolve opioid lawsuits filed and future claims by states, cities, counties and tribal governments, for a total of $5&#160;billion, subject to various conditions and an agreement being finalized. This agreement in &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;principle is not an admission of liability or wrong-doing and would resolve opioid lawsuits filed and future claims by states, cities and counties.  The Company cannot predict if or when the agreement will be finalized and individual cases are ongoing. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; In August 2019, Johnson &amp;amp; Johnson received a grand jury subpoena from the United States Attorney&#x2019;s Office for the Eastern District of New York for documents related to the Company&#x2019;s anti-diversion policies and procedures and distribution of its opioid medications, in what the Company understands to be part of a broader investigation into manufacturers&#x2019; and distributors&#x2019; monitoring programs and reporting under the Controlled Substances Act.&#160; In September 2019, Johnson &amp;amp; Johnson received subpoenas from the New York State Department of Financial Services (NYDFS) as part of an industry-wide inquiry into the effect of opioid prescriptions on New York health insurance premiums.&#160;In September 2020, the Company learned that NYDFS filed a statement of charges related to this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In November 2019, a shareholder filed a derivative complaint against Johnson &amp;amp; Johnson as the nominal defendant and certain current and former directors and officers as defendants in the Superior Court of New Jersey.  The complaint alleges breaches of fiduciary duties related to the marketing of opioids, and that Johnson &amp;amp; Johnson has suffered damages as a result of those alleged breaches.  In December 2019, two additional shareholders filed two separate derivative complaints making similar allegations against Johnson &amp;amp; Johnson as the nominal defendant and certain current and former directors and officers as defendants in the United States District for the District of New Jersey. In April 2020,  the two federal cases were consolidated into a single action captioned&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"&gt; In re Johnson &amp;amp; Johnson Opioid Stockholder Derivative Litigation&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;.  Pursuant to an agreed stipulation entered by the Court, the shareholders have until July 2020 to file a consolidated complaint or identify a previously filed complaint as the operative complaint. In July 2020, an additional shareholder filed a derivative complaint in the United States District Court for the District of New Jersey making similar allegations against the same defendants named in the consolidated action.  Pursuant to an order in the consolidated action, the newly-filed case will be consolidated into the consolidated action.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April 2020, a report was delivered to the Company&#x2019;s Board of Directors by independent counsel retained by the Board to investigate the allegations in the derivative lawsuits and in a series of shareholder letters that the Board received raising similar issues.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The independent counsel recommended that the Company reject the shareholder demands and take the steps that are necessary or appropriate to secure dismissal of the derivative litigation. &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Board unanimously adopted the recommendations of the independent counsel&#x2019;s report.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In August 2012, DePuy Orthopaedics, Inc., DePuy, Inc. (now known as DePuy Synthes, Inc.), and Johnson &amp;amp; Johnson Services, Inc. (collectively DePuy) received an informal request from the United States Attorney's Office for the District of Massachusetts and the Civil Division of the United States Department of Justice (the United States) for the production of materials relating to the DePuy ASR&#x2122; XL Hip device. In July 2014, the United States notified the United States District Court for the District of Massachusetts that it had declined to intervene in a &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"&gt;qui tam&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; case filed pursuant to the False Claims Act against the companies. In February 2016, the district court granted the companies&#x2019; motion to dismiss with prejudice, unsealed the &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"&gt;qui tam&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; complaint, and denied the &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"&gt;qui tam&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; relators&#x2019; request for leave to file a further amended complaint. The &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"&gt;qui tam&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; relators appealed the case to the United States Court of Appeals for the First Circuit. In July 2017, the First Circuit affirmed the district court&#x2019;s dismissal in part, reversed in part, and affirmed the decision to deny the relators&#x2019; request to file a third amended complaint. The relators&#x2019; remaining claims are now pending before the district court. In July 2020, the Court ordered the relators to complete discovery by August 2020; the Relators have requested an extension of the August 2020 deadline that DePuy opposed and additional discovery-related motions have been filed by both parties. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In October 2012, Johnson &amp;amp; Johnson was contacted by the California Attorney General's office regarding a multi-state Attorney General investigation of the marketing of surgical mesh products for hernia and urogynecological purposes by Johnson &amp;amp; Johnson's subsidiary, Ethicon, Inc. (Ethicon). In May 2016, California and Washington filed civil complaints against Johnson &amp;amp; Johnson, Ethicon and Ethicon US, LLC alleging violations of their consumer protection statutes. Similar complaints were filed against the companies by the following states:  Kentucky, Mississippi, West Virginia and Oregon. In April 2019, Johnson &amp;amp; Johnson and Ethicon settled the Washington case.  The California case started trial in July 2019 and concluded in September 2019. The trial date for the Kentucky case was scheduled for September 2019 but has been adjourned and no new trial date has been scheduled. The trial date for the Mississippi case is scheduled for April 2021. In October 2019, Johnson &amp;amp; Johnson and Ethicon settled the multi-state investigation with 41 other states and the District of Columbia. In January 2020, the Court in California issued a statement of decision, finding in favor of the State of California, and awarded civil penalties in the amount of $344 million. In April 2020, the Court in California denied the Company's motion for a new trial. In August 2020, the Court entered judgment with respect to the penalties of $344&#160;million, but denied the Attorney General&#x2019;s request for injunctive relief. The Company is appealing the &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;penalty judgment. In April 2020, the Company settled the West Virginia case. In June 2020 the Court in Oregon denied the Company's motion to dismiss. Trial in Oregon is set for February 2022. The Attorney General of &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Mississippi filed a second amended complaint in April 2020 and the Company filed a motion to dismiss in May 2020. The motion to dismiss argument was heard in August 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In December 2012, Therakos, Inc. (Therakos), formerly a subsidiary of Johnson &amp;amp; Johnson and part of the Ortho-Clinical Diagnostics, Inc. (OCD) franchise, received a letter from the civil division of the United States Attorney's Office for the Eastern District of Pennsylvania informing Therakos that the United States Attorney's Office was investigating the sales and marketing of Uvadex&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; (methoxsalen) and the Uvar Xts&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; and Cellex&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; Systems during the period 2000 to the present. The United States Attorney's Office requested that OCD and Johnson &amp;amp; Johnson preserve documents that could relate to the investigation. Therakos was subsequently acquired by an affiliate of Gores Capital Partners III, L.P. in January 2013, and OCD was divested in June 2014. Following the divestiture of OCD, Johnson &amp;amp; Johnson retains OCD&#x2019;s portion of any liability that may result from the investigation for activity that occurred prior to the sale of Therakos. In March 2014 and March 2016, the United States Attorney&#x2019;s Office requested that Johnson &amp;amp; Johnson produce certain documents, and Johnson &amp;amp; Johnson is cooperating with those requests.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2014, the Mississippi Attorney General filed a complaint in Chancery Court of The First Judicial District of Hinds County, Mississippi against Johnson &amp;amp; Johnson and Johnson &amp;amp; Johnson Consumer Companies, Inc. (now known as Johnson &amp;amp; Johnson Consumer Inc.) (JJCI).&#160;The complaint alleges that defendants violated the Mississippi Consumer Protection Act by &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;failing to disclose alleged health risks associated with female consumers' use of talc contained in JOHNSON'S&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; Baby Powder and JOHNSON'S&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; Shower to Shower (a product divested in 2012) and seeks injunctive and monetary relief.  The matter is stayed pending interlocutory appeal of a December 2018 denial of Johnson &amp;amp; Johnson and JJCI's motion for summary judgment. The Mississippi Supreme Court granted J&amp;amp;J and JJCI's request to file an interlocutory appeal of the denial of the motion for summary judgment in late 2019. Briefing is complete.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In January 2020, the State of New Mexico filed a consumer protection case alleging that the Company deceptively marketed and sold its talcum powder products by making misrepresentations about the safety of the products and the presence of carcinogens, including asbestos.  The State of New Mexico filed an Amended Complaint in March 2020. The Company has moved to dismiss certain of the claims in the Amended Complaint, which was granted, but the State of New Mexico was given leave to amend its complaint. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Forty-one states have commenced a joint investigation into the Company&#x2019;s marketing of its talcum powder products. At this time, the multi-state group has not asserted any claims against the Company. Several states have issued Civil Investigative Demands seeking documents and other information. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In March 2016, Janssen Pharmaceuticals, Inc. (JPI) received a Civil Investigative Demand from the United States Attorney&#x2019;s Office for the Southern District of New York related to JPI&#x2019;s contractual relationships with pharmacy benefit managers over the period from January 1, 2006 to the present with regard to certain of JPI's pharmaceutical products.  The demand was issued in connection with an investigation under the False Claims Act.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In July 2016, Johnson &amp;amp; Johnson and Janssen Products LP were served with a &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;qui tam&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; complaint pursuant to the False Claims Act filed in the United States District Court for the District of New Jersey alleging the off-label promotion of two HIV products, PREZISTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; and INTELENCE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, and anti-kickback violations in connection with the promotion of these products.&#160; The complaint was filed under seal in December 2012.&#160; The federal and state governments have declined to intervene, and the lawsuit is being prosecuted by the relators.&#160; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In March 2017, Janssen Biotech, Inc. received a Civil Investigative Demand from the United States Department of Justice regarding a False Claims Act investigation concerning management and advisory services provided to rheumatology and gastroenterology practices that purchased REMICADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; or SIMPONI ARIA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;. In August 2019, the Unites States Department of Justice notified Janssen Biotech, Inc. that it was closing the investigation. Subsequently, the United States District Court for the District of Massachusetts unsealed a qui tam False Claims Act complaint, which was served on the Company.  The Department of Justice had declined to intervene in the qui tam lawsuit in August 2019.  The Company has filed a motion to dismiss the relator&#x2019;s complaint. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April and September 2017, Johnson &amp;amp; Johnson received subpoenas from the United States Attorney for the District of Massachusetts seeking documents broadly relating to pharmaceutical copayment support programs for DARZALEX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, OLYSIO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, REMICADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, SIMPONI&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, STELARA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;and ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;.&#160;The subpoenas also seek documents relating to&#160;Average Manufacturer Price and Best Price reporting to the Center for Medicare and Medicaid Services related to those products, as well as rebate payments to state Medicaid agencies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2017, Johnson &amp;amp; Johnson received a subpoena from the United States Attorney's Office for the District of Massachusetts seeking information regarding practices pertaining to the sterilization of DePuy Synthes, Inc. spinal implants at &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;three hospitals in Boston as well as interactions of employees of Company subsidiaries with physicians at these hospitals. Johnson &amp;amp; Johnson and DePuy Synthes, Inc. have produced documents in response to the subpoena and are fully cooperating with the government&#x2019;s investigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In July 2018 the Public Prosecution Service in Rio de Janeiro and representatives from the Brazilian antitrust authority CADE inspected the offices of more than 30 companies including Johnson &amp;amp; Johnson do Brasil Ind&#xfa;stria e Com&#xe9;rcio de Produtos para Sa&#xfa;de Ltda. The authorities appear to be investigating allegations of possible anti-competitive behavior and possible improper payments in the medical device industry.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We continue to actively respond to inquiries regarding the Foreign Corrupt Practices Act from the United States Department of Justice and the United States Securities and Exchange Commission. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;From time to time, the Company has received requests from a variety of United States Congressional Committees to produce information relevant to ongoing congressional inquiries. It is the policy of Johnson &amp;amp; Johnson to cooperate with these inquiries by producing the requested information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;"&gt;GENERAL LITIGATION&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In May 2014, two purported class actions were filed in federal court, one in the United States District Court for the Central District of California and one in the United States District Court for the Southern District of Illinois, against Johnson &amp;amp; Johnson and Johnson &amp;amp; Johnson Consumer Companies, Inc. (now known as Johnson &amp;amp; Johnson Consumer Inc.) (JJCI) alleging violations of state consumer fraud statutes based on nondisclosure of alleged health risks associated with talc contained in JOHNSON'S&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Baby Powder and JOHNSON'S&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; Shower to Shower (a product no longer sold by JJCI). Both cases seek injunctive relief and monetary damages; neither includes a claim for personal injuries. In October 2016, both cases were transferred to the United States District Court for the District Court of New Jersey as part of a newly created federal multi-district litigation. In July 2017, the district court granted Johnson &amp;amp; Johnson's and JJCI&#x2019;s motion to dismiss one of the cases.  In September 2018, the United States Court of Appeals for the Third Circuit affirmed this dismissal.  In September 2017, the plaintiff in the second case voluntarily dismissed the complaint.  In March 2018, the plaintiff in the second case refiled in Illinois State Court. Following motion practice to remove the case to United States District Court, as of September 2020 the case will remain in Illinois State Court. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In August 2014, United States Customs and Border Protection (US CBP) issued a Penalty Notice against Janssen Ortho LLC (Janssen Ortho), assessing penalties for the alleged improper classification of darunavir ethanolate (the active pharmaceutical ingredient in PREZISTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;) in connection with its importation into the United States. In October 2014, Janssen Ortho submitted a Petition for Relief in response to the Penalty Notice. In May 2015, US CBP issued an Amended Penalty Notice assessing substantial penalties and Janssen Ortho filed a Petition for Relief in July 2015. In May 2019, US CBP issued its Mitigation Decision and determined that Janssen Ortho had negligently misrepresented that darunavir ethanolate is entitled to duty free treatment.  In June 2019, Janssen Ortho filed a Supplemental Petition for Relief. The Penalties Proceeding will be impacted by the related Classification Litigation pending in the United States Court of International Trade. The Classification Litigation will determine whether darunavir ethanolate was properly classified as exempt from duties upon importation into the United States. The trial in the Classification Litigation was held in July 2019. In February 2020, the Court ruled that darunavir ethanolate is eligible for duty free treatment. In April 2020, the United States filed a Notice of Appeal to the United States Court of Appeals for the Federal Circuit. In August 2020, Janssen Ortho received notice that Janssen's Supplemental Petition for Relief from the Amended Penalty Notice was denied. In October 2020, USCBP agreed to hold the enforcement of penalties in abeyance pending resolution of the Classification litigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In September 2020, Genmab A/S brought an arbitration against Janssen Biotech, Inc. pursuant to a 2012 License Agreement between the parties.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The arbitration relates to royalties for certain Janssen daratumumab products.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In March and April 2015, over 30 putative class action complaints were filed by contact lens patients in a number of courts around the United States against Johnson &amp;amp; Johnson Vision Care, Inc. (JJVCI) and other contact lens manufacturers, distributors, and retailers, alleging vertical and horizontal conspiracies to fix the retail prices of contact lenses. The complaints allege that the manufacturers reached agreements with each other and certain distributors and retailers concerning the prices at which some contact lenses could be sold to consumers. The plaintiffs are seeking damages and injunctive relief. All of the class action cases were transferred to the United States District Court for the Middle District of Florida in June 2015. The plaintiffs filed a consolidated class action complaint in November 2015. In December 2018, the district court granted the plaintiffs' motion for class certification. Defendants filed two motions for interlocutory appeal of class certification to the United States Court of Appeals for the Eleventh Circuit. Both motions were denied. Defendants' motions for summary judgment were denied in November 2019. The parties await a trial date. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In August 2015, two third-party payors filed a purported class action in the United States District Court for the Eastern District of Louisiana against Janssen Research &amp;amp; Development, LLC, Janssen Ortho LLC, Janssen Pharmaceuticals, Inc., Ortho-&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;McNeil-Janssen Pharmaceuticals, Inc. and Johnson &amp;amp; Johnson (as well as certain Bayer entities), alleging that the defendants improperly marketed and promoted XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; as safer and more effective than less expensive alternative medications while failing to fully disclose its risks.  The complaint seeks damages.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In September 2017, Pfizer, Inc. (Pfizer) filed an antitrust complaint against Johnson &amp;amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) in United States District Court for the Eastern District of Pennsylvania.  Pfizer alleges that Janssen has violated federal antitrust laws through its contracting strategies for REMICADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;.  The complaint seeks damages and injunctive relief. Discovery is ongoing. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Beginning in September 2017, multiple purported class actions of direct and indirect purchasers were filed against Johnson &amp;amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) alleging that Janssen&#x2019;s REMICADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; contracting strategies violated federal and state antitrust and consumer laws and seeking damages and injunctive relief.  In November 2017, the cases were consolidated for pre-trial purposes in United States District Court for the Eastern District of Pennsylvania as In re Remicade Antitrust Litigation. Motions to dismiss were denied in both the direct and indirect purchaser cases.  A motion to compel arbitration of the direct purchaser case was denied by the district court. The United States Court of Appeals for the Third Circuit reversed the district court's ruling.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2018, Walgreen Co. and Kroger Co, filed an antitrust complaint against Johnson &amp;amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) in the United States District Court for the Eastern District of Pennsylvania.  The complaint alleges that Janssen has violated federal antitrust laws through its contracting strategies for REMICADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;.  The complaint seeks damages and injunctive relief. In March 2019, summary judgment was granted in favor of Janssen. In February 2020, the United States Court of Appeals for the Third Circuit reversed the District Court&#x2019;s decision.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2019, the United States Federal Trade Commission (FTC) issued a Civil Investigative Demand to Johnson &amp;amp; Johnson in connection with its investigation of whether Janssen&#x2019;s REMICADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; contracting practices violate federal antitrust laws. The Company has produced documents and information responsive to the Civil Investigative Demand.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In October 2017, certain United States service members and their families brought a complaint against a number of pharmaceutical and medical devices companies, including Johnson &amp;amp; Johnson and certain of its subsidiaries, alleging that the defendants violated the United States Anti-Terrorism Act.&#160; The complaint alleges that the defendants provided funding for terrorist organizations through their sales practices pursuant to pharmaceutical and medical device contracts with the Iraqi Ministry of Health. In January 2020, plaintiffs filed a Third Amended Complaint adding further plaintiffs to the lawsuit. In July 2020, the District Court dismissed the Third Amended Complaint.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In October 2018, two separate putative class actions were filed against Actelion Pharmaceutical Ltd., Actelion Pharmaceuticals US, Inc., and Actelion Clinical Research, Inc. (collectively Actelion) in United States District Court for the District of Maryland and United States District Court for the District of Columbia.&#160; The complaints allege that Actelion violated state and federal antitrust and unfair competition laws by allegedly refusing to supply generic pharmaceutical manufacturers with samples of TRACLEER&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;.&#160; TRACLEER&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; is subject to a Risk Evaluation and Mitigation Strategy, which imposes restrictions on distribution of the product.&#160; In January 2019, the plaintiffs dismissed the District of Columbia case and filed a consolidated complaint in the United States District Court for the District of Maryland.&#160; In October 2019, the Court granted Actelion&#x2019;s motion to dismiss the amended complaint. Plaintiffs have appealed the decision.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In December 2018, Janssen Biotech, Inc., Janssen Oncology, Inc, Janssen Research &amp;amp; Development, LLC, and Johnson &amp;amp; Johnson (collectively, Janssen) were served with a &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;qui tam&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; complaint filed on behalf of the United States, 28 states, and the District of Columbia.&#160; The complaint, which was filed in December 2017 in United States District Court for the Northern District of California, alleges that Janssen violated the federal False Claims Act and state law when providing pricing information for ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; to the government in connection with direct government sales and government-funded drug reimbursement programs.&#160; At this time, the federal and state governments have declined to intervene. The case has been transferred to United States District Court for the District of New Jersey. In September 2019, Janssen moved to dismiss the complaint. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April 2019, Blue Cross &amp;amp; Blue Shield of Louisiana and HMO Louisiana, Inc. filed a class action complaint against Janssen Biotech, Inc, Janssen Oncology, Inc, Janssen Research &amp;amp; Development, LLC and BTG International Limited in the United States District Court for the Eastern District of Virginia on behalf of indirect purchasers of ZYTIGA&#xae;. Several additional complaints were filed thereafter in Virginia and New Jersey.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The indirect purchaser complaints generally allege that the defendants violated the antitrust and consumer protections laws of several states and the Sherman Act by pursuing patent litigation relating to ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;vertical-align:top;"&gt; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;in order to delay generic entry and seek damages. The Virginia cases have been transferred to &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;the United States District Court for the District of New Jersey and consolidated with the New Jersey case for pretrial purposes.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In May 2020, a class action complaint was filed against Janssen Biotech Inc., Janssen Oncology, Inc., Janssen Research &amp;amp; Development LLC and BTG International Limited in the United States District Court for the District of New Jersey, on behalf of direct purchasers of ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The direct purchaser complaint alleges that defendants violated the Sherman Act by pursuing patent litigation relating to ZYTIGA&#xae; in order to delay generic entry, and seek damages and injunctive relief. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In May 2019, a class action antitrust complaint was filed against Janssen R&amp;amp;D Ireland (Janssen) and Johnson &amp;amp; Johnson in the United States District Court for the Northern District of California.  The complaint alleges that Janssen violated federal and state antitrust and consumer protection laws by agreeing to exclusivity provisions in its agreements with Gilead concerning the development and marketing of combination antiretroviral therapies (cART) to treat HIV.  The complaint also alleges that Gilead entered into similar agreements with Bristol-Myers-Squibb and Japan Tobacco.  In March 2020, the Court granted in part and denied in part defendants&#x2019; motions to dismiss.  Plaintiffs filed an amended complaint in April 2020. Defendants moved to dismiss the amended complaint.  In July 2020, the court granted in part and denied in part the renewed motion to dismiss.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;In October 2019, Innovative Health, LLC filed a complaint against Biosense Webster, Inc. (BWI) in the United States District Court for the Middle District of California.  The complaint alleges that certain of BWI&#x2019;s&#160;business practices and contractual terms violate the antitrust laws of the United States and the State of California by restricting competition in the sale of High Density Mapping Catheters and Ultrasound Catheters. In January 2020, BWI filed a motion to dismiss the complaint. &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;In August 2020, the court granted in part and denied in part BWI&#x2019;s motion to dismiss.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In November 2019, Johnson &amp;amp; Johnson received a demand for indemnification from Pfizer Inc., pursuant to the 2006 Stock and Asset Purchase Agreement between the Company and Pfizer.  Also in November 2019, Johnson &amp;amp; Johnson, Inc. received a demand for indemnification from Sanofi Consumer Health, Inc., pursuant to the 2016 Asset Purchase Agreement between J&amp;amp;J, Inc. and Sanofi.  In January 2020, Johnson &amp;amp; Johnson received a demand for indemnification from Boehringer Ingelheim Pharmaceuticals, Inc., pursuant to the 2006 Asset Purchase Agreement among the Company, Pfizer, and Boehringer Ingelheim.  The notices seek indemnification for legal claims related to over-the-counter Zantac (ranitidine) products. Plaintiffs in the underlying actions allege that Zantac and other over-the-counter ranitidine medications contain unsafe levels of NDMA (N-nitrosodimethylamine) and can cause and/or have caused various cancers in patients using the products, and seek injunctive and monetary relief.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;In October 2020, Fortis Advisors LLC (Fortis), in its capacity as representative of the former stockholders of Auris Health Inc. (Auris), filed a complaint against Johnson &amp;amp; Johnson, Ethicon Inc., and certain named officers and employees (collectively, Ethicon) in the Court of Chancery of the State of Delaware.   The complaint alleges breach of contract, fraud, and other causes of action against Ethicon in connection with Ethicon&#x2019;s acquisition of Auris in 2019.  The complaint seeks damages and other relief.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Johnson &amp;amp; Johnson or its subsidiaries are also parties to a number of proceedings brought under the Comprehensive Environmental Response, Compensation, and Liability Act, commonly known as Superfund, and comparable state, local or foreign laws in which the primary relief sought is the cost of past and/or future remediation.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <jnj:ProductLiabilityContingencyNumberOfClaimant
      contextRef="i0b429fd585e64f27b994198388c6251a_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNDQ2MA_21bc8713-07b9-4214-8bc6-f17f21b1d018"
      unitRef="claimant">600</jnj:ProductLiabilityContingencyNumberOfClaimant>
    <jnj:ProductLiabilityContingencyNumberOfClaimant
      contextRef="i0930560d9bb641e1bf17cd07a2da8aca_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNDYyNA_38be2a8e-4fb3-4ec2-845b-5fe6e0e8cdab"
      unitRef="claimant">8200</jnj:ProductLiabilityContingencyNumberOfClaimant>
    <jnj:ProductLiabilityContingencyNumberOfClaimant
      contextRef="i5f0486c287ba4a878933882831daf68c_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNDY4MA_46438e25-03dc-4102-b8c4-dce0504c4095"
      unitRef="claimant">15400</jnj:ProductLiabilityContingencyNumberOfClaimant>
    <jnj:ProductLiabilityContingencyNumberOfClaimant
      contextRef="icd9edb018cc04c2d919c3af6e6effdc2_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNDcxNA_71881eae-1e54-4289-90da-78ac203dec78"
      unitRef="claimant">10400</jnj:ProductLiabilityContingencyNumberOfClaimant>
    <jnj:ProductLiabilityContingencyNumberOfClaimant
      contextRef="ib10ac8fdffb7462695332fde36b80854_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNDc0NQ_15b8aa80-8dac-432b-bbfa-cf800ff58528"
      unitRef="claimant">15000</jnj:ProductLiabilityContingencyNumberOfClaimant>
    <jnj:ProductLiabilityContingencyNumberOfClaimant
      contextRef="ic41bf8ae137a4af1b760ea9606804331_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNDc3NA_4d49e4db-72d7-44a7-a487-4478073c44a7"
      unitRef="claimant">21800</jnj:ProductLiabilityContingencyNumberOfClaimant>
    <jnj:ProductLiabilityContingencyNumberOfClaimant
      contextRef="i6c15628b0bdb4b959f8610f3fd7e5d48_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNDgyMw_ecfaf879-0ba1-4c71-a85a-87df29ff36b3"
      unitRef="claimant">300</jnj:ProductLiabilityContingencyNumberOfClaimant>
    <jnj:ProductLiabilityContingencyNumberOfClaimant
      contextRef="id21618e853834a89ac8ad0c7b9c482b7_I20200927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNDg1OA_bed9eb92-8ea7-4565-a371-e44ff0469e7f"
      unitRef="claimant">4000</jnj:ProductLiabilityContingencyNumberOfClaimant>
    <jnj:Numberofpatientsinsettlement
      contextRef="icb6f889e341146e590594ffb796f5067_I20200927"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNjI0OA_adbe63e7-3da8-4b58-becf-c7551d576d7c"
      unitRef="patient">10000</jnj:Numberofpatientsinsettlement>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="iea72f2ed06994c33932765fa19c03cd3_D20190930-20191229"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfMTMxNzc_817d00a8-f78e-4343-a7e5-5cfdab850ceb"
      unitRef="usd">8000000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i488a067b9a194c0186abeac5734fa68b_D20191230-20200329"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfMTMyODI_e078e981-17fb-4b4d-92e5-9eb73b5560a7"
      unitRef="usd">6800000</us-gaap:LossContingencyDamagesAwardedValue>
    <jnj:LossContingencyPreviousDamagesAwardedAndRevisedValue
      contextRef="i6ae80716a299488b87b2be5a3f4dbfb5_D20180701-20180731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfMTYyNTA_735e856a-5e88-4833-a01f-20ae41197baf"
      unitRef="usd">4700000000</jnj:LossContingencyPreviousDamagesAwardedAndRevisedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i06c65d19de8543ca8bdc65646de599c7_D20200601-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfMTYyODQ_6daa8a06-53e2-40c5-9bd5-7661f3d59516"
      unitRef="usd">2100000000</us-gaap:LossContingencyDamagesAwardedValue>
    <jnj:ProductLiabilityContingencyNumberOfClaimant
      contextRef="ic4f17482cf3c41e598a0357f6aaae45c_I20191229"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNTkzMjc_6e78d94e-a9c8-4c7c-9a45-99f7e88c40ba"
      unitRef="claimant">3100</jnj:ProductLiabilityContingencyNumberOfClaimant>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i8b7242888eaf4e6d93abf906006a26fe_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNjIxNDc_a0137513-123c-45fa-ba8c-e367588a8780"
      unitRef="usd">572000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i63a02018e9aa4b8fab85aa8bf8d518c8_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNjIyNjE_1d339bab-067e-416f-8084-f74426838fe2"
      unitRef="usd">465000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i4957f58a493d49f5bef49186ecf1dbf7_I20191031"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNjMxMzc_fb476e26-2ac9-49a5-97e1-34e35b0a0b49"
      unitRef="usd">4000000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <jnj:LossContingencyEstimateOfAdditionalPossibleLoss
      contextRef="ia877cf56320947748ba1727613e928d1_I20201031"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfMTA5OTUxMTY0NDg2ODM_c20e4520-40b7-4ccd-8aec-4f7cc1d64463"
      unitRef="usd">1000000000</jnj:LossContingencyEstimateOfAdditionalPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="ia877cf56320947748ba1727613e928d1_I20201031"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfMTA5OTUxMTY0NDg2OTU_70d700c3-09ad-4262-9499-0c669a94132a"
      unitRef="usd">5000000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i12cbe2e6652048f1abbf81f0d8f8b6cc_D20200101-20200131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfNjg3OTk_7d46a908-98a7-4f0c-bb97-3b30c047476a"
      unitRef="usd">344000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="ibb5dd3fead9e4921a49ec475665dfe71_D20200401-20200430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85MS9mcmFnOjg1MDBjNGU3NDBiZTQ0MDU4NmUyZGRlYzFlZTVhZTM5L3RleHRyZWdpb246ODUwMGM0ZTc0MGJlNDQwNTg2ZTJkZGVjMWVlNWFlMzlfMTA5OTUxMTY0NDc1NjM_a253a3a3-f143-4c05-b667-40dccb6c8b0a"
      unitRef="usd">344000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMjg0Mg_55fd2a7f-2e04-459a-9f56-601d6b87fe01">RESTRUCTURING&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company announced plans to implement a series of actions across its Global Supply Chain that are intended to focus resources and increase investments in the critical capabilities, technologies and solutions necessary to manufacture and supply its product portfolio, enhance agility and drive growth. The Global Supply Chain actions will include expanding the use of strategic collaborations and bolstering initiatives to reduce complexity, improve cost-competitiveness, enhance capabilities and optimize the Supply Chain network. For additional details on the Global Supply Chain restructuring strategic collaborations see Note 10 to the Consolidated Financial Statements. In the fiscal third quarter of 2020, the Company recorded a pre-tax charge of $130 million, which is included on the following lines of the Consolidated Statement of Earnings, $68 million in restructuring, $32 million in cost of products sold and $30 million in other (income) expense. In the fiscal nine months of 2020, the Company recorded a pre-tax charge of $363&#160;million, which is included on the following lines of the Consolidated Statement of Earnings, $187&#160;million in restructuring, $69&#160;million in cost of products sold and $107&#160;million in other (income) expense. Total project costs of approximately $1.2 billion have been recorded since the restructuring was announced. See the following table for additional details on the restructuring program. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In total, the Company expects the Global Supply Chain actions to generate approximately $0.6 billion to $0.8 billion in annual pre-tax cost savings that will be substantially delivered by 2022. The Company expects to record pre-tax restructuring charges of approximately $1.9 billion to $2.3 billion, over the 4 to 5 year period of this activity. These costs are associated with network optimizations, exit costs and accelerated depreciation and amortization.&#160; &#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes the severance related reserves and the associated restructuring expenses through the fiscal nine months of 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:33.603%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.272%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.881%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.272%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:2.400%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.972%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Asset Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"&gt;Other&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Reserve balance, December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Current year activity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Charges  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(297)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Settled non cash &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Reserve balance, September 27, 2020&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;Cash outlays for severance are expected to be substantially paid out over the next 2 years in accordance with the Company's plans and local laws. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt; Other includes project expense such as salaries for employees supporting these initiatives and consulting expenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(3) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;Relates to pension related actuarial losses associated with the transfer of employees to Jabil Inc. as part of the strategic collaboration.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company continuously reevaluates its severance reserves related to restructuring and the timing of payments due to the planned release of associates regarding several longer-term projects. The Company believes that the existing severance reserves are sufficient to cover the Global Supply Chain plans given the period over which the actions will take place. The Company will continue to assess and make adjustments as necessary if additional amounts become probable and estimable.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="i09487d9b040c41f5b1f1ac6a4eb69ecb_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfNzg1_263bac29-9ed0-4b9e-8f8f-3ec7721818ee"
      unitRef="usd">130000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5110f18fd4f34d9986fb039d56af95c6_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfODcz_a49343f3-2230-4b58-bbc4-705da9bd1954"
      unitRef="usd">68000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic998353501c74da5afda8d2b3ead50c5_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfODk0_68660d53-9423-4356-ab6a-517a79fcd3af"
      unitRef="usd">32000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i023474a55b284cd99429e03503a8a901_D20200629-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfOTI2_d1628a25-a5b0-4e91-a703-55975e972d8e"
      unitRef="usd">30000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i82b8a8526a0b4f7c9f84a00039d7fa45_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTAzNw_99e06efe-2edb-4fb0-b644-bf244daca471"
      unitRef="usd">363000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2a9ec615fd2b43679132d3c41485de92_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTEyNQ_a9a15f3a-204c-4c92-91d4-05a92b5bbbd2"
      unitRef="usd">187000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i98f8797e4aa74fdd9e5fa8711131743e_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTE0Ng_244ffc7c-ebbc-4db0-955d-2e4034fb5fd2"
      unitRef="usd">69000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i82ffccf862f04217ba5474adbd9d48c9_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTE3OA_7493087f-38a9-4263-b11a-664600decd27"
      unitRef="usd">107000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i867dc8a2a19c4423b9b7ee18ce1d36b5_I20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTI0NA_b64a350a-ec4e-4378-9ef8-3c878892ae98"
      unitRef="usd">1200000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <jnj:RestructuringandRelatedCostExpectedFutureSavings
      contextRef="i405860c539564ee5b8e0b222554dba38_I20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTQ3Mg_32dc013a-a61e-4dbf-86ca-c0337d4ace18"
      unitRef="usd">600000000</jnj:RestructuringandRelatedCostExpectedFutureSavings>
    <jnj:RestructuringandRelatedCostExpectedFutureSavings
      contextRef="i410f9ae233db4a80981d7bcef1e0749a_I20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTQ3OA_343cb7f6-62a2-4202-9681-2e1c6768ec28"
      unitRef="usd">800000000</jnj:RestructuringandRelatedCostExpectedFutureSavings>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i405860c539564ee5b8e0b222554dba38_I20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTYzNQ_50b84ffd-e393-4a9c-94d6-c61526cea2c2"
      unitRef="usd">1900000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i410f9ae233db4a80981d7bcef1e0749a_I20200927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTY0MQ_eb876a05-be2e-411e-84a1-28eff367f59b"
      unitRef="usd">2300000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <jnj:RestructuringandRelatedCostDurationofRestructuringPlan
      contextRef="i9c3e80cad55d41f6a3525d636c512e88_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTY1NA_370bab07-8597-4e86-9e41-81289ace5ac1">P4Y</jnj:RestructuringandRelatedCostDurationofRestructuringPlan>
    <jnj:RestructuringandRelatedCostDurationofRestructuringPlan
      contextRef="ib2a9ba204bdd4530ae30c6d71d30d92f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMTY2MA_29a77cac-b3a0-484e-a358-bd845f0476e2">P5Y</jnj:RestructuringandRelatedCostDurationofRestructuringPlan>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMjg0MA_a0bef5cb-2970-4455-9ed2-67d50f3a912d">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes the severance related reserves and the associated restructuring expenses through the fiscal nine months of 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:33.603%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.272%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.881%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:14.272%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:2.400%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.972%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Asset Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"&gt;Other&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Reserve balance, December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Current year activity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Charges  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(297)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(315)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Settled non cash &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Reserve balance, September 27, 2020&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;Cash outlays for severance are expected to be substantially paid out over the next 2 years in accordance with the Company's plans and local laws. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt; Other includes project expense such as salaries for employees supporting these initiatives and consulting expenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(3) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;Relates to pension related actuarial losses associated with the transfer of employees to Jabil Inc. as part of the strategic collaboration.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company continuously reevaluates its severance reserves related to restructuring and the timing of payments due to the planned release of associates regarding several longer-term projects. The Company believes that the existing severance reserves are sufficient to cover the Global Supply Chain plans given the period over which the actions will take place. The Company will continue to assess and make adjustments as necessary if additional amounts become probable and estimable.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i6cd238e746ca494b962a8cdfec78532f_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfMS0xLTEtMS0w_7f66c1e7-a3b7-4998-a6bc-2ae637ae8399"
      unitRef="usd">164000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ib5ccab87c7704f459a110126f42d578f_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfMS0yLTEtMS0w_13fee103-2586-4ee0-a28e-c7b0179965cf"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ib44160c8cfcb4364a86afc1ebf7ea5db_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfMS0zLTEtMS0w_3cdfdbfd-6293-4fb6-bb95-667b209ce4e1"
      unitRef="usd">16000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i7153539e0f5345cc86253ed5aadc3d3c_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfMS01LTEtMS0w_16d02fc3-8718-4553-a545-6ad21a84e073"
      unitRef="usd">180000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="ic763bc82f42c427fa881f68d00497d2c_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNC0xLTEtMS0w_1a70efa6-5ac5-471b-8be8-4d6285a957f8"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id36fda814d6046bfa30b6bdd0fe5d257_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNC0yLTEtMS0w_e5507b75-1317-44e0-8b8c-53ab4a1d8d25"
      unitRef="usd">55000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i254209b7e3f54f69a129c76d5b0d3e93_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNC0zLTEtMS0w_6a1ff226-f185-4b6a-8de5-2b1a292bfcd6"
      unitRef="usd">308000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7392cf4986564b5e9e2afd38679fb669_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNC01LTEtMS0w_f74b0dab-1972-4d3f-bdcd-a23e6c8e4bac"
      unitRef="usd">363000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="ic763bc82f42c427fa881f68d00497d2c_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNS0xLTEtMS0w_9ac01fe3-b45c-4de8-a3e4-148991cb3ddf"
      unitRef="usd">18000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="id36fda814d6046bfa30b6bdd0fe5d257_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNS0yLTEtMS0w_81705a88-bb88-4459-b571-1f4ccb915f30"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i254209b7e3f54f69a129c76d5b0d3e93_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNS0zLTEtMS0w_99a74814-f632-4270-bf54-917ebe18baeb"
      unitRef="usd">297000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i7392cf4986564b5e9e2afd38679fb669_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNS01LTEtMS0w_20abdb1b-5eb0-4697-a46b-5ab168e25a21"
      unitRef="usd">315000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ic763bc82f42c427fa881f68d00497d2c_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNi0xLTEtMS0w_471d4423-7532-4e33-b7df-93d901d9515c"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="id36fda814d6046bfa30b6bdd0fe5d257_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNi0yLTEtMS0w_cd9c635d-dbab-49e2-a134-58ba26808929"
      unitRef="usd">55000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i254209b7e3f54f69a129c76d5b0d3e93_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNi0zLTEtMS0w_7b81ecdd-48c0-4731-a88b-1ba587e290b5"
      unitRef="usd">17000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i7392cf4986564b5e9e2afd38679fb669_D20191230-20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfNi01LTEtMS0w_1be2085f-a659-4d28-a8cd-08a3f5aeddf5"
      unitRef="usd">72000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserve
      contextRef="i61bba3fc154c46aba1e0aeb8dc224242_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfOS0xLTEtMS0w_edbcb6ce-e92f-4670-af63-c0bca2b2c706"
      unitRef="usd">146000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i0c0bc17c52f34567b49e094ed620eb73_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfOS0yLTEtMS0w_9fbb3fad-349e-4052-bcf4-01df570dc446"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="id5b06f3dcb1c4d1f94c7dbe9b3ce5ef1_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfOS0zLTEtMS0w_027431eb-0636-4fe2-9a60-d6cd05140f77"
      unitRef="usd">10000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ib046be1bad564ea69c1c677f161cf688_I20200927"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RhYmxlOmVhN2EyYTAzMjRkYzQ3NjNhN2FlMGJhMmVhOGI1MWQzL3RhYmxlcmFuZ2U6ZWE3YTJhMDMyNGRjNDc2M2E3YWUwYmEyZWE4YjUxZDNfOS01LTEtMS0w_925f93b6-5727-4f73-8cde-f47865746031"
      unitRef="usd">156000000</us-gaap:RestructuringReserve>
    <jnj:RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid
      contextRef="iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927"
      id="id3VybDovL2RvY3MudjEvZG9jOmVmOTdjMjRjOGMxNDQ4ODdhYjJhZDM3NmZjNDU3ZDRkL3NlYzplZjk3YzI0YzhjMTQ0ODg3YWIyYWQzNzZmYzQ1N2Q0ZF85NC9mcmFnOmM5Njk0MDE3MmE4NjQ0OWU5YzU3MjM3NDFiYzBlYjI2L3RleHRyZWdpb246Yzk2OTQwMTcyYTg2NDQ5ZTljNTcyMzc0MWJjMGViMjZfMjAyNw_43f1c5ee-cc4a-473d-bc69-c8e2189f8a85">P2Y</jnj:RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982107554264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Oct. 19, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 27,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-3215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Johnson & Johnson<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-1024240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Johnson & Johnson Plaza<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New Brunswick<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">524-0400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,632,542,672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000200406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--01-03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock, Par Value $1.00</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JNJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=jnj_A0.250NotesDue2022Member', window );">0.250% Notes Due January 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.250% Notes Due January 2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JNJ22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=jnj_A0.650NotesDue2024Member', window );">0.650% Notes Due May 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.650% Notes Due May 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JNJ24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=jnj_A5.50NotesDue2024Member', window );">5.50% Notes Due November 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">5.50% Notes Due November 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JNJ24BP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=jnj_A1.150NotesDue2028Member', window );">1.150% Notes Due November 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.150% Notes Due November 2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JNJ28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=jnj_A1.650NotesDue2035Member', window );">1.650% Notes Due May 2035</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.650% Notes Due May 2035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JNJ35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=jnj_A0.250NotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=jnj_A0.250NotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=jnj_A0.650NotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=jnj_A0.650NotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=jnj_A5.50NotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=jnj_A5.50NotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=jnj_A1.150NotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=jnj_A1.150NotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=jnj_A1.650NotesDue2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=jnj_A1.650NotesDue2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982185127288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 18,965<span></span>
</td>
<td class="nump">$ 17,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">11,816<span></span>
</td>
<td class="nump">1,982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, trade, less allowances for doubtful accounts and credit losses $292 (2019, $226)</a></td>
<td class="nump">14,579<span></span>
</td>
<td class="nump">14,481<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories (Note 2)</a></td>
<td class="nump">9,599<span></span>
</td>
<td class="nump">9,020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">2,528<span></span>
</td>
<td class="nump">2,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther', window );">Assets held for sale (Note 10)</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">57,578<span></span>
</td>
<td class="nump">45,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment at cost</a></td>
<td class="nump">45,162<span></span>
</td>
<td class="nump">43,332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(27,307)<span></span>
</td>
<td class="num">(25,674)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">17,855<span></span>
</td>
<td class="nump">17,658<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net (Note 3)</a></td>
<td class="nump">47,006<span></span>
</td>
<td class="nump">47,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill (Note 3)</a></td>
<td class="nump">34,307<span></span>
</td>
<td class="nump">33,639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred taxes on income (Note 5)</a></td>
<td class="nump">7,816<span></span>
</td>
<td class="nump">7,819<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">6,131<span></span>
</td>
<td class="nump">5,695<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">170,693<span></span>
</td>
<td class="nump">157,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Loans and notes payable</a></td>
<td class="nump">5,078<span></span>
</td>
<td class="nump">1,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">7,044<span></span>
</td>
<td class="nump">8,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">9,629<span></span>
</td>
<td class="nump">9,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_AccruedRebatesReturnsAndPromotions', window );">Accrued rebates, returns and promotions</a></td>
<td class="nump">12,418<span></span>
</td>
<td class="nump">10,883<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and employee related obligations</a></td>
<td class="nump">3,012<span></span>
</td>
<td class="nump">3,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Accrued taxes on income (Note 5)</a></td>
<td class="nump">1,666<span></span>
</td>
<td class="nump">2,266<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">38,847<span></span>
</td>
<td class="nump">35,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt (Note 4)</a></td>
<td class="nump">32,680<span></span>
</td>
<td class="nump">26,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred taxes on income (Note 5)</a></td>
<td class="nump">5,615<span></span>
</td>
<td class="nump">5,958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent', window );">Employee related obligations (Note 6)</a></td>
<td class="nump">10,184<span></span>
</td>
<td class="nump">10,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Long-term taxes payable (Note 5)</a></td>
<td class="nump">6,745<span></span>
</td>
<td class="nump">7,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">12,149<span></span>
</td>
<td class="nump">11,734<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">106,220<span></span>
</td>
<td class="nump">98,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 11)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock &#8212; par value $1.00 per share (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)</a></td>
<td class="nump">3,120<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss) (Note 7)</a></td>
<td class="num">(14,938)<span></span>
</td>
<td class="num">(15,891)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">114,831<span></span>
</td>
<td class="nump">110,659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Less: common stock held in treasury, at cost (487,676,000 and 487,336,000 shares)</a></td>
<td class="nump">38,540<span></span>
</td>
<td class="nump">38,417<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">64,473<span></span>
</td>
<td class="nump">59,471<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 170,693<span></span>
</td>
<td class="nump">$ 157,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">4,320,000,000<span></span>
</td>
<td class="nump">4,320,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">3,119,843,000<span></span>
</td>
<td class="nump">3,119,843,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_AccruedRebatesReturnsAndPromotions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated obligations due within one year for rebates, returns and promotions. Reserves include such items related to Medicaid rebates, product returns due to expiration, product recalls, current portion of coupons and volume-based sales incentives programs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_AccruedRebatesReturnsAndPromotions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4428-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 15<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=77912953&amp;loc=d3e400-110220<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31931-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982107236360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowances for doubtful accounts</a></td>
<td class="nump">$ 292<span></span>
</td>
<td class="nump">$ 226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">4,320,000,000<span></span>
</td>
<td class="nump">4,320,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">3,119,843,000<span></span>
</td>
<td class="nump">3,119,843,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares</a></td>
<td class="nump">487,676,000<span></span>
</td>
<td class="nump">487,336,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118955202&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982107607640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Earnings - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 21,082<span></span>
</td>
<td class="nump">$ 20,729<span></span>
</td>
<td class="nump">$ 60,109<span></span>
</td>
<td class="nump">$ 61,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_SalesRevenueGoodsNetPercentToSales', window );">Sales to customers percent to sales</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">$ 6,972<span></span>
</td>
<td class="nump">$ 6,867<span></span>
</td>
<td class="nump">$ 20,613<span></span>
</td>
<td class="nump">$ 20,422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_CostOfGoodsSoldPercentToSales', window );">Cost of products sold percent to sales</a></td>
<td class="nump">33.10%<span></span>
</td>
<td class="nump">33.10%<span></span>
</td>
<td class="nump">34.30%<span></span>
</td>
<td class="nump">33.30%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">$ 14,110<span></span>
</td>
<td class="nump">$ 13,862<span></span>
</td>
<td class="nump">$ 39,496<span></span>
</td>
<td class="nump">$ 40,890<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_GrossProfitPercentToSales', window );">Gross profit percent to sales</a></td>
<td class="nump">66.90%<span></span>
</td>
<td class="nump">66.90%<span></span>
</td>
<td class="nump">65.70%<span></span>
</td>
<td class="nump">66.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, marketing and administrative expenses</a></td>
<td class="nump">$ 5,431<span></span>
</td>
<td class="nump">$ 5,374<span></span>
</td>
<td class="nump">$ 15,627<span></span>
</td>
<td class="nump">$ 16,139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_SellingGeneralAndAdministrativeExpensePercentToSales', window );">Selling marketing and administrative expenses percent to sales</a></td>
<td class="nump">25.80%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">26.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development expense</a></td>
<td class="nump">$ 2,840<span></span>
</td>
<td class="nump">$ 2,599<span></span>
</td>
<td class="nump">$ 8,127<span></span>
</td>
<td class="nump">$ 8,123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales', window );">Research and development expense percent to sales</a></td>
<td class="nump">13.50%<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="nump">13.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="nump">$ 138<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
<td class="nump">$ 890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ResearchAndDevelopmentInProcessPercentToSales', window );">In-process research and development percent to sales</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="num">$ (12)<span></span>
</td>
<td class="num">$ (89)<span></span>
</td>
<td class="num">$ (98)<span></span>
</td>
<td class="num">$ (276)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_InvestmentIncomeInterestPercentToSales', window );">Interest income percent to sales</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net of portion capitalized</a></td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">$ 114<span></span>
</td>
<td class="nump">$ 233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_InterestExpensePercentToSales', window );">Interest expense, net of portion capitalized percent to sales</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">$ 4,214<span></span>
</td>
<td class="nump">$ 545<span></span>
</td>
<td class="nump">$ 2,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_OtherNonOperatingIncomeExpensePercentToSales', window );">Other (income) expense, net percent to sales</a></td>
<td class="nump">5.70%<span></span>
</td>
<td class="nump">20.30%<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring (Note 12)</a></td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 187<span></span>
</td>
<td class="nump">$ 162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_Restructuringchargepercenttosales', window );">Restructuring charge percent to sales</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Earnings before provision for taxes on income</a></td>
<td class="nump">$ 4,401<span></span>
</td>
<td class="nump">$ 1,647<span></span>
</td>
<td class="nump">$ 14,850<span></span>
</td>
<td class="nump">$ 13,110<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales', window );">Earnings before provision for taxes on income percent to sales</a></td>
<td class="nump">20.90%<span></span>
</td>
<td class="nump">7.90%<span></span>
</td>
<td class="nump">24.70%<span></span>
</td>
<td class="nump">21.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for taxes on income</a></td>
<td class="nump">$ 847<span></span>
</td>
<td class="num">$ (106)<span></span>
</td>
<td class="nump">$ 1,874<span></span>
</td>
<td class="nump">$ 2,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IncomeTaxExpenseBenefitPercentToSales', window );">Provision for (benefit from) taxes on income (Note 5)</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET EARNINGS</a></td>
<td class="nump">$ 3,554<span></span>
</td>
<td class="nump">$ 1,753<span></span>
</td>
<td class="nump">$ 12,976<span></span>
</td>
<td class="nump">$ 11,109<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_NetIncomeAttributableToParentPercentToSales', window );">Net earnings percent to sales</a></td>
<td class="nump">16.90%<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="nump">21.60%<span></span>
</td>
<td class="nump">18.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>NET EARNINGS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (per share)</a></td>
<td class="nump">$ 1.35<span></span>
</td>
<td class="nump">$ 0.67<span></span>
</td>
<td class="nump">$ 4.93<span></span>
</td>
<td class="nump">$ 4.19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (per share)</a></td>
<td class="nump">$ 1.33<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="nump">$ 4.86<span></span>
</td>
<td class="nump">$ 4.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>AVG. SHARES OUTSTANDING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (shares)</a></td>
<td class="nump">2,632,500<span></span>
</td>
<td class="nump">2,635,200<span></span>
</td>
<td class="nump">2,633,000<span></span>
</td>
<td class="nump">2,649,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (shares)</a></td>
<td class="nump">2,669,300<span></span>
</td>
<td class="nump">2,669,900<span></span>
</td>
<td class="nump">2,670,800<span></span>
</td>
<td class="nump">2,688,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_CostOfGoodsSoldPercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of goods sold percent to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_CostOfGoodsSoldPercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_GrossProfitPercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross profit percent to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_GrossProfitPercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income loss from continuing operations before income taxes minority interest and income loss from equity method investments percent to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_IncomeTaxExpenseBenefitPercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax expense benefit percent to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_IncomeTaxExpenseBenefitPercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_InterestExpensePercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest expense percent to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_InterestExpensePercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_InvestmentIncomeInterestPercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment income interest percent to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_InvestmentIncomeInterestPercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_NetIncomeAttributableToParentPercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income Attributable to Parent Percent to Sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_NetIncomeAttributableToParentPercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_OtherNonOperatingIncomeExpensePercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other non operating income expense percent to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_OtherNonOperatingIncomeExpensePercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and development expense excluding acquired in process cost percent to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_ResearchAndDevelopmentInProcessPercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>research and development in process percent to sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_ResearchAndDevelopmentInProcessPercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_Restructuringchargepercenttosales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring charge percent to sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_Restructuringchargepercenttosales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_SalesRevenueGoodsNetPercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales revenue goods net percentage to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_SalesRevenueGoodsNetPercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_SellingGeneralAndAdministrativeExpensePercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Selling general and administrative expense percent to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_SellingGeneralAndAdministrativeExpensePercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982108299496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 3,554<span></span>
</td>
<td class="nump">$ 1,753<span></span>
</td>
<td class="nump">$ 12,976<span></span>
</td>
<td class="nump">$ 11,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Foreign currency translation</a></td>
<td class="nump">222<span></span>
</td>
<td class="num">(667)<span></span>
</td>
<td class="num">(741)<span></span>
</td>
<td class="num">(575)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized holding gain (loss) arising during period</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Reclassifications to earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net change</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Employee benefit plans:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax', window );">Prior service cost amortization during period</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax', window );">Gain (loss) amortization during period</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="nump">604<span></span>
</td>
<td class="nump">460<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net change</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">587<span></span>
</td>
<td class="nump">442<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Derivatives &amp; hedges:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">1,922<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
<td class="nump">1,706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassifications to earnings</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(1,955)<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="num">(1,885)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change</a></td>
<td class="nump">175<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="nump">1,106<span></span>
</td>
<td class="num">(179)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">595<span></span>
</td>
<td class="num">(564)<span></span>
</td>
<td class="nump">953<span></span>
</td>
<td class="num">(311)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">4,149<span></span>
</td>
<td class="nump">1,189<span></span>
</td>
<td class="nump">13,929<span></span>
</td>
<td class="nump">10,798<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign Currency Translation</a></td>
<td class="nump">139<span></span>
</td>
<td class="num">(94)<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Employee Benefit Plans</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Derivatives &amp; Hedges</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="num">$ (9)<span></span>
</td>
<td class="nump">$ 293<span></span>
</td>
<td class="num">$ (48)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit), Net of Amortization, Arising During Period, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI Pension and Other Postretirement Benefit Plans for Net Gain Loss, Net of Amortization, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e557-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118948100&amp;loc=d3e30304-110892<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982100214488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>MEDICAL DEVICES</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Common Stock Issued Amount</div></th>
<th class="th"><div>Treasury Stock Amount</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 30, 2018</a></td>
<td class="nump">$ 59,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106,216<span></span>
</td>
<td class="num">$ (15,222)<span></span>
</td>
<td class="nump">$ 3,120<span></span>
</td>
<td class="num">$ (34,362)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">11,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends paid</a></td>
<td class="num">(7,417)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,417)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Employee compensation and stock option plans</a></td>
<td class="nump">1,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(666)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="num">(6,320)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,320)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(311)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(311)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Sep. 29, 2019</a></td>
<td class="nump">58,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,242<span></span>
</td>
<td class="num">(15,533)<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
<td class="num">(38,619)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring (Note 12)</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Jun. 30, 2019</a></td>
<td class="nump">60,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,809<span></span>
</td>
<td class="num">(14,969)<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
<td class="num">(37,175)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">1,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends paid</a></td>
<td class="num">(2,499)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,499)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Employee compensation and stock option plans</a></td>
<td class="nump">363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="num">(1,628)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,628)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(564)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(564)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Sep. 29, 2019</a></td>
<td class="nump">58,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,242<span></span>
</td>
<td class="num">(15,533)<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
<td class="num">(38,619)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring (Note 12)</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 29, 2019</a></td>
<td class="nump">59,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,659<span></span>
</td>
<td class="num">(15,891)<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
<td class="num">(38,417)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">12,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends paid</a></td>
<td class="num">(7,823)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,823)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Employee compensation and stock option plans</a></td>
<td class="nump">1,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(911)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="num">(2,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,900)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(70)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Sep. 27, 2020</a></td>
<td class="nump">64,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,831<span></span>
</td>
<td class="num">(14,938)<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
<td class="num">(38,540)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring (Note 12)</a></td>
<td class="nump">187<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Jun. 28, 2020</a></td>
<td class="nump">62,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,898<span></span>
</td>
<td class="num">(15,533)<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
<td class="num">(38,507)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">3,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends paid</a></td>
<td class="num">(2,659)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,659)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Employee compensation and stock option plans</a></td>
<td class="nump">559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="num">(483)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(483)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(71)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(71)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Sep. 27, 2020</a></td>
<td class="nump">64,473<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 114,831<span></span>
</td>
<td class="num">$ (14,938)<span></span>
</td>
<td class="nump">$ 3,120<span></span>
</td>
<td class="num">$ (38,540)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring (Note 12)</a></td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982094965816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Equity (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Cash dividends paid (in dollars per share)</a></td>
<td class="nump">$ 1.01<span></span>
</td>
<td class="nump">$ 0.95<span></span>
</td>
<td class="nump">$ 2.97<span></span>
</td>
<td class="nump">$ 2.80<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982107740104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 12,976<span></span>
</td>
<td class="nump">$ 11,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization of property and intangibles</a></td>
<td class="nump">5,291<span></span>
</td>
<td class="nump">5,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="nump">845<span></span>
</td>
<td class="nump">817<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset write-downs</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration reversal</a></td>
<td class="num">(1,148)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Net gain on sale of assets/businesses</a></td>
<td class="num">(60)<span></span>
</td>
<td class="num">(2,125)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax provision</a></td>
<td class="num">(238)<span></span>
</td>
<td class="num">(2,126)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Credit losses and accounts receivable allowances</a></td>
<td class="nump">74<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities, net of effects from acquisitions and divestitures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Increase in accounts receivable</a></td>
<td class="num">(440)<span></span>
</td>
<td class="num">(665)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Increase in inventories</a></td>
<td class="num">(784)<span></span>
</td>
<td class="num">(424)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">(Decrease)/Increase in accounts payable and accrued liabilities</a></td>
<td class="num">(119)<span></span>
</td>
<td class="nump">2,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Increase in other current and non-current assets</a></td>
<td class="num">(1,983)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Increase in other current and non-current liabilities</a></td>
<td class="nump">581<span></span>
</td>
<td class="nump">2,043<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH FLOWS FROM OPERATING ACTIVITIES</a></td>
<td class="nump">15,193<span></span>
</td>
<td class="nump">17,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property, plant and equipment</a></td>
<td class="num">(2,024)<span></span>
</td>
<td class="num">(2,238)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from the disposal of assets/businesses, net</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">3,103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="num">(949)<span></span>
</td>
<td class="num">(5,562)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(16,243)<span></span>
</td>
<td class="num">(2,684)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Sales of investments</a></td>
<td class="nump">6,585<span></span>
</td>
<td class="nump">2,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_Proceedsfromcreditsupportagreements', window );">Proceeds from credit support agreements, net</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other (primarily licenses and milestones)</a></td>
<td class="num">(516)<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH USED BY INVESTING ACTIVITIES</a></td>
<td class="num">(12,922)<span></span>
</td>
<td class="num">(4,850)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfOrdinaryDividends', window );">Dividends to shareholders</a></td>
<td class="num">(7,823)<span></span>
</td>
<td class="num">(7,417)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(2,900)<span></span>
</td>
<td class="num">(6,320)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term debt</a></td>
<td class="nump">3,335<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayment of short-term debt</a></td>
<td class="num">(310)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt, net of issuance costs</a></td>
<td class="nump">7,431<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(562)<span></span>
</td>
<td class="num">(1,008)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits', window );">Proceeds from the exercise of stock options/employee withholding tax on stock awards, net</a></td>
<td class="nump">922<span></span>
</td>
<td class="nump">580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(569)<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH USED BY FINANCING ACTIVITIES</a></td>
<td class="num">(476)<span></span>
</td>
<td class="num">(13,943)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(135)<span></span>
</td>
<td class="num">(83)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase/(Decrease) in cash and cash equivalents</a></td>
<td class="nump">1,660<span></span>
</td>
<td class="num">(1,858)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash equivalents, beginning of period</a></td>
<td class="nump">17,305<span></span>
</td>
<td class="nump">18,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash equivalents, end of period</a></td>
<td class="nump">18,965<span></span>
</td>
<td class="nump">16,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract', window );"><strong>Acquisitions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1', window );">Fair value of assets acquired</a></td>
<td class="nump">1,173<span></span>
</td>
<td class="nump">6,861<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1', window );">Fair value of liabilities assumed and noncontrolling interests</a></td>
<td class="num">(224)<span></span>
</td>
<td class="num">(1,299)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1', window );">Net cash paid for acquisitions</a></td>
<td class="nump">949<span></span>
</td>
<td class="nump">$ 5,562<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember', window );">Auris Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration reversal</a></td>
<td class="num">$ (1,148)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From The Exercise Of Stock Options And Excess Tax Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_Proceedsfromcreditsupportagreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from credit support agreements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_Proceedsfromcreditsupportagreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net book value of a nonmonetary asset transferred or exchanged in connection with the acquisition of a business or asset in a noncash transaction. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Nonmonetary assets and liabilities are assets and liabilities that will not result in cash receipts or cash payments in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of [all] liabilities that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfOrdinaryDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfOrdinaryDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982258793208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">The accompanying unaudited interim consolidated financial statements and related notes should be read in conjunction with the audited Consolidated Financial Statements of Johnson &amp; Johnson and its subsidiaries (the Company) and related notes as contained in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. The unaudited interim financial statements include all adjustments (consisting only of normal recurring adjustments) and accruals necessary in the judgment of management for a fair statement of the results for the periods presented.<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Columns and rows within tables may not add due to rounding. Percentages have been calculated using actual, non-rounded figures.</span></div><div><span><br/></span></div><div style="margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The extent to which COVID-19 impacts the Company&#8217;s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts COVID-19 as of September 27, 2020 and through the date of this report. The accounting matters assessed included, but were not limited to, the Company&#8217;s allowance for doubtful accounts and credit losses, inventory and related reserves, accrued rebates and associated reserves, and the carrying value of the goodwill and other long-lived assets. While there was not a material impact to the Company&#8217;s consolidated financial statements as of and for the quarter ended September 27, 2020, the Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the Company&#8217;s consolidated financial statements in future reporting periods.</span></div><div style="margin-top:3pt;"><span><br/></span></div><div style="margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">New Accounting Standards</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company assesses the adoption impacts of recently issued accounting standards by the Financial Accounting Standards Board on the Company's financial statements as well as material updates to previous assessments, if any, from the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. There were no new material accounting standards issued in the fiscal third quarter of 2020 that impacted the Company.</span></div><div style="margin-top:3pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Recently Adopted Accounting Standards</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There were no new accounting standards adopted in the fiscal third quarter of 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Reclassification</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certain prior period amounts have been reclassified to conform to current year presentation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982091760232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">INVENTORIES <div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.070%;"><tr><td style="width:1.0%;"/><td style="width:51.896%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.736%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:20.622%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.736%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:22.310%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Raw materials and supplies</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,363&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,117&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goods in process</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,916&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,832&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,320&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,071&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Total inventories </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,599&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,020&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">See Note 10 to the Consolidated Financial Statements for details on assets held for sale and the related divestitures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982094086280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Intangible Assets and Goodwill</a></td>
<td class="text">INTANGIBLE ASSETS AND GOODWILL<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Intangible assets that have finite useful lives are amortized over their estimated useful lives. The latest annual impairment assessment of goodwill and indefinite lived intangible assets was completed in the fiscal fourth quarter of 2019. Future impairment tests for goodwill and indefinite lived intangible assets will be performed annually in the fiscal fourth quarter, or sooner, if warranted.</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%;"><tr><td style="width:1.0%;"/><td style="width:61.104%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.587%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.325%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.587%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:16.697%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and trademarks &#8212; gross</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38,381&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,634&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,098&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,154&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and trademarks &#8212; net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,283&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,480&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer relationships and other intangibles &#8212; gross</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,455&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,056&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less accumulated amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,427&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,462&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer relationships and other intangibles&#160;&#8212; net*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,028&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,594&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,995&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,922&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Purchased in-process research and development </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,700&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,647&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total intangible assets with indefinite lives</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,695&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,569&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total intangible assets &#8212; net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">47,006&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">47,643&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">*The majority is comprised of customer relationships</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">In the fiscal first quarter of 2020, the Company completed the acquisition of bermekimab and certain related assets from XBiotech Inc., as well as the acquisition of all outstanding shares in Verb Surgical Inc. and recorded in-process research and development intangible assets of $0.8 billion and $0.4 billion, respectively.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Goodwill as of September&#160;27, 2020 was allocated by segment of business as follows:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.859%;"><tr><td style="width:1.0%;"/><td style="width:40.177%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.578%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.205%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:2.447%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.984%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:2.292%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.361%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:2.447%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.209%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consumer Health</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharmaceutical</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Medical Devices</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at December 29, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,736&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,169&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,734&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,639&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill, related to acquisitions</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">183&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">184&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency translation/Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">171&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">280&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">484&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at September 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,907&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,450&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,950&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,307&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The weighted average amortization period for patents and trademarks is 12 years. The weighted average amortization period for customer relationships and other intangible assets is 21 years. The amortization expense of amortizable intangible assets included in cost of products sold was $1.2 billion and $1.1&#160;billion for the fiscal third quarters ended September&#160;27, 2020 and September&#160;29, 2019, respectively. The amortization expense of amortizable intangible assets included in cost of products sold was $3.4 billion and $3.3&#160;billion for the fiscal nine months ended September&#160;27, 2020 and September&#160;29, 2019, respectively. Intangible asset write-downs are included in Other (income) expense, net. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The estimated amortization expense for approved products, before tax, for the five succeeding years is approximately:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%;"><tr><td style="width:1.0%;"/><td style="width:18.528%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.833%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:18.114%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.833%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.908%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.833%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.908%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.833%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.910%;"/><td style="width:0.1%;"/></tr><tr><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="margin-top:13pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">(Dollars in Millions)</span></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2021</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2022</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2023</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2024</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$4,500</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,300</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,100</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,100</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,900</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> See Note 10 to the Consolidated Financial Statements for additional details related to acquisitions and divestitures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982093496520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company uses forward foreign exchange contracts to manage its exposure to the variability of cash flows, primarily related to the foreign exchange rate changes of future intercompany product and third-party purchases of materials denominated in a foreign currency. The Company uses cross currency interest rate swaps to manage currency risk primarily related to borrowings. Both types of derivatives are designated as cash flow hedges. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Additionally, the Company uses interest rate swaps as an instrument to manage interest rate risk related to fixed rate borrowings.  These derivatives are designated as fair value hedges. The Company uses cross currency interest rate swaps and forward foreign exchange contracts designated as net investment hedges.  Additionally, the Company uses forward foreign exchange contracts to offset its exposure to certain foreign currency assets and liabilities. These forward foreign exchange contracts are not designated as hedges, and therefore, changes in the fair values of these derivatives are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company does not enter into derivative financial instruments for trading or speculative purposes, or that contain credit risk related contingent features. The Company maintains credit support agreements (CSA) with certain derivative counterparties establishing collateral thresholds based on respective credit ratings and netting agreements. As of September&#160;27, 2020, the total amount of cash collateral held by the Company under the CSA amounted to $380 million, net. On an ongoing basis, the Company monitors counter-party credit ratings. The Company considers credit non-performance risk to be low, because the Company primarily enters into agreements with commercial institutions that have at least an investment grade credit rating.  Refer to the table on significant financial assets and liabilities measured at fair value contained in this footnote for receivables and payables with these commercial institutions. As of September&#160;27, 2020, the Company had notional amounts outstanding for forward foreign exchange contracts and cross currency interest rate swaps of $43.6&#160;billion and $26.5&#160;billion, respectively.  As of December&#160;29, 2019, the Company had notional amounts outstanding for forward foreign exchange contracts and cross currency interest rate swaps of $45.3 billion and $20.1 billion, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">All derivative instruments are recorded on the balance sheet at fair value. Changes in the fair value of derivatives are recorded each period in current earnings or other comprehensive income, depending on whether the derivative is designated as part of a hedge transaction, and if so, the type of hedge transaction.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The designation as a cash flow hedge is made at the entrance date of the derivative contract. At inception, all derivatives are expected to be highly effective. Foreign exchange contracts designated as cash flow hedges are accounted for under the forward method and all gains/losses associated with these contracts will be recognized in the income statement when the hedged item impacts earnings. Changes in the fair value of these derivatives are recorded in accumulated other comprehensive income until the underlying transaction affects earnings and are then reclassified to earnings in the same account as the hedged transaction. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Gains and losses associated with interest rate swaps and changes in fair value of hedged debt attributable to changes in interest rates are recorded to interest expense in the period in which they occur.  Gains and losses on net investment hedges are accounted for through the currency translation account within accumulated other comprehensive income. The portion excluded from effectiveness testing is recorded through interest (income) expense using the spot method. On an ongoing basis, the Company assesses whether each derivative continues to be highly effective in offsetting changes of hedged items. If and when a derivative is no longer expected to be highly effective, hedge accounting is discontinued. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company designated its Euro denominated notes issued in May 2016 with due dates ranging from 2022 to 2035 as a net investment hedge of the Company's investments in certain of its international subsidiaries that use the Euro as their functional currency in order to reduce the volatility caused by changes in exchange rates. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of September&#160;27, 2020, the balance of deferred net gain on derivatives included in accumulated other comprehensive income was $811&#160;million after-tax. For additional information, see the Consolidated Statements of Comprehensive Income and Note 7. The Company expects that substantially all of the amounts related to forward foreign exchange contracts will be reclassified into earnings over the next 12 months as a result of transactions that are expected to occur over that period. The maximum length of time over which the Company is hedging transaction exposure is 18 months, excluding interest rate contracts and </span><span style="background-color:rgb(255,255,255, 0.0);color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">net investment hedge</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> contracts. The amount ultimately realized in earnings may differ as foreign exchange rates change. Realized gains and losses are ultimately determined by actual exchange rates at maturity of the derivative.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of the activity related to derivatives and hedges for the fiscal third quarters ended in 2020 and 2019, net of tax:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:19.102%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.259%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.836%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.547%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.413%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.125%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:5.970%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.836%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.836%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.413%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.563%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The effects of fair value, net investment and cash flow hedging:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on net investment hedging relationship:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on cash flow hedging relationship:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(81)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(77)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,911&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">156&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(36)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(41)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(197)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,939&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">84&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">89&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">65&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">159&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of the activity related to derivatives and hedges for the fiscal nine months ended in 2020 and 2019, net of tax:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:18.493%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.302%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.882%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.172%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.172%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.172%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.011%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.172%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.592%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.172%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.760%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The effects of fair value, net investment and cash flow hedging:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on net investment hedging relationship:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">117&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">117&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on cash flow hedging relationship:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(316)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(121)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(43)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(213)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,808&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">330&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(156)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(55)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(543)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,847&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">265&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">207&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">299&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div style="margin-top:5pt;margin-bottom:12pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:29.455%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.823%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.689%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.969%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.689%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.992%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.835%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.700%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.548%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is the effect of derivatives not designated as hedging instruments for the fiscal third quarters and fiscal nine months ended in 2020 and 2019: </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:27.160%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:2.698%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:16.871%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.959%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.494%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.814%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.494%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.494%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:2.118%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.498%;"/><td style="width:0.1%;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Income on Derivative</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Income on Derivative</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain /(Loss) Recognized in Income on Derivative</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(101)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="display:none;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is the effect of net investment hedges for the fiscal third quarters ended in 2020 and 2019</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:21.363%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.524%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.769%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.524%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.769%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.814%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:28.610%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.959%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.769%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.524%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.775%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Accumulated<br/>OCI</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From<br/>Accumulated OCI<br/>Into Income</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(169)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">162&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross Currency interest rate swaps</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(234)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is the effect of net investment hedges for the fiscal nine months ended in 2020 and 2019</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:21.396%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.525%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.075%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.525%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.785%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.815%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:28.072%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.961%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.930%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.525%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.791%;"/><td style="width:0.1%;"/></tr><tr><td colspan="33" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Accumulated OCI</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From<br/>Accumulated OCI<br/>Into Income</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(217)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">176&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross Currency interest rate swaps</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">407&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">465&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div style="margin-bottom:7pt;"><span><br/></span></div><div style="margin-bottom:7pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company holds equity investments with readily determinable fair values and equity investments without readily determinable fair values.  The Company has elected to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.</span></div><div style="margin-bottom:7pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of the activity related to equity investments:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:25.476%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.001%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.365%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.851%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.464%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.550%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.963%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.851%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.662%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.550%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.667%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Changes in Fair Value Reflected in Net Income </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Sales/ Purchases/Other </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non Current Other Assets</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity Investments with readily determinable value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,148&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">161&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(169)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,140&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,140&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity Investments without readily determinable value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">712&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(36)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">742&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">742&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Recorded in Other Income/Expense</span></div><div style="text-indent:-36pt;padding-left:36pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> (2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Other includes impact of currency</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For equity investments without readily determinable market values, $48 million of the decrease in the fair value reflected in net income were the result of impairments.  There were $12 million of increase in fair value reflected in net income due to changes in observable prices.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fair value is the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement determined using assumptions that market participants would use in pricing an asset or liability. In accordance with ASC 820, a three-level hierarchy was established to prioritize the inputs used in measuring fair value. The levels within the hierarchy are described below with Level 1 inputs having the highest priority and Level 3 inputs having the lowest.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of a derivative financial instrument (i.e., forward foreign exchange contracts, interest rate contracts) is the aggregation by currency of all future cash flows discounted to its present value at the prevailing market interest rates and </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">subsequently converted to the U.S. Dollar at the current spot foreign exchange rate. The Company does not believe that fair values of these derivative instruments materially differ from the amounts that could be realized upon settlement or maturity, or that the changes in fair value will have a material effect on the Company&#8217;s results of operations, cash flows or financial position. The Company also holds equity investments which are classified as Level 1 and debt securities which are classified as Level 2. The Company holds acquisition related contingent liabilities based upon certain regulatory and commercial events, which are classified as Level 3, whose values are determined using discounted cash flow methodologies or similar techniques for which the determination of fair value requires significant judgment or estimations.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following three levels of inputs are used to measure fair value:</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 1 &#8212; Quoted prices in active markets for identical assets and liabilities.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 2 &#8212; Significant other observable inputs.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 3 &#8212; Significant unobservable inputs.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#8217;s significant financial assets and liabilities measured at fair value as of September&#160;27, 2020 and December&#160;29, 2019 were as follows:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:48.229%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.245%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.202%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:5.904%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.245%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.850%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Total</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">612&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">612&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">209&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Interest rate contracts </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)(3)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">635&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">635&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">693&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,247&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,247&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">902&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">327&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">327&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">426&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Interest rate contracts </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3) </sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">382&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">382&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">193&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">709&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">709&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">619&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">56&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">56&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Investments:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Equity investments </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(4)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,140&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,140&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,148&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Debt securities</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(5)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,391&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,391&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,368&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Contingent consideration </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(6)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">636&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">636&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,715&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><span><br/></span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:42.905%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.992%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:20.098%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.087%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:23.318%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross to Net Derivative Reconciliation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Gross Assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,311&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">925&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Credit Support Agreement (CSA)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,117)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(841)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Net Asset</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">194&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">84&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Gross Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">765&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">652&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Credit Support Agreement (CSA)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(737)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(586)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Net Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Summarized information about changes in liabilities for contingent consideration is as follows:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:74.774%;"><tr><td style="width:1.0%;"/><td style="width:41.269%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:2.410%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:25.606%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.406%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:25.609%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Beginning Balance</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,715&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">397&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Changes in estimated fair value </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(7) </sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,088)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">117&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additions</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">107&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,133&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Payments</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(98)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ending Balance</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">636&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,638&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;">December 30, 2019 assets and liabilities are all classified as Level 2 with the exception of equity investments of $1,148 million, which are classified as Level 1 and contingent consideration of $1,715 million, classified as Level 3.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;">Includes $1 million of non-current other assets as of December&#160;29, 2019.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(3)     </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Includes cross currency interest rate swaps and interest rate swaps.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">           (4)&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Classified as non-current other assets. </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(5)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;Classified within cash equivalents and current marketable securities.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(6)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;Includes $608 million and $1,631 million (primarily related to Auris Health at December 29, 2019), classified as non-current other liabilities as of September&#160;27, 2020 and December&#160;29, 2019, respectively.  Includes $28 million and $84 million classified as current liabilities as of September&#160;27, 2020 and December&#160;29, 2019, respectively.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">           (7)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">    Ongoing fair value adjustment amounts are primarily recorded in Research and Development expense. </span></div><div style="padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company recorded a contingent consideration reversal of $1,148 million related to the timing of certain developmental milestones associated with the Auris Health acquisition. The reversal of the contingent consideration was recorded in Other income and expense. For additional details see Note 10 </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">t</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">o the Consolidated Financial Statements.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company's cash, cash equivalents and current marketable securities as of September&#160;27, 2020 comprised:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.849%;"><tr><td style="width:1.0%;"/><td style="width:22.208%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.727%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.153%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.531%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.153%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.381%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.153%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.727%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.454%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.478%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.153%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.182%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrecognized Gain</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrecognized Loss</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash &amp; Cash Equivalents</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current Marketable Securities</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,231&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,231&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,231&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Non-U.S. sovereign securities</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">647&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">647&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">647&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. reverse repurchase agreements</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,094&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,094&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,094&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other reverse repurchase agreements</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">430&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">430&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">430&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Corporate debt securities</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,843&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,843&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">571&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,272&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,485&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,485&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,485&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Time deposits</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">660&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">660&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">660&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Subtotal </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,390&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,390&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,471&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,919&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized Gain</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized Loss</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. Gov't securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,133&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,134&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,483&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,651&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other sovereign securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate debt securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">247&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">247&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">236&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;Subtotal available for sale debt</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,390&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,391&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,494&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,897&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total cash, cash equivalents and current marketable securities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30,780&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30,781&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,965&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,816&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Held to maturity investments are reported at amortized cost and gains or losses are reported in earnings. </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Available for sale debt securities are reported at fair value with unrealized gains and losses reported net of taxes in other comprehensive income.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the fiscal year ended December&#160;29, 2019 the carrying amount was the same as the estimated fair value.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fair value of government securities and obligations and corporate debt securities was estimated using quoted broker prices and significant other observable inputs.</span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company classifies all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months from the date of purchase as current marketable securities. Available for sale securities with stated maturities of greater than one year from the date of purchase are available to fund current operations and are classified as cash equivalents and current marketable securities.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The contractual maturities of the available for sale securities as of September&#160;27, 2020 are as follows:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:76.426%;"><tr><td style="width:1.0%;"/><td style="width:43.104%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:2.829%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:22.279%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:2.157%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:25.031%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost Basis</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Due within one year</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,368&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,369&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Due after one year through five years</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Due after five years through ten years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,390&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,391&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Financial Instruments not measured at Fair Value:</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following financial liabilities are held at carrying amount on the consolidated balance sheet as of September&#160;27, 2020:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:79.838%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.533%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.137%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.533%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.259%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Financial Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current Debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,078&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,093&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-Current Debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.45% Notes due 2021</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">350&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">358&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">0.250% Notes due 2022 (1B Euro 1.1641)</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,163&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,172&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.25% Notes due 2022</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">998&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,025&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">6.73% Debentures due 2023</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">250&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">299&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3.375% Notes due 2023</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">803&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">881&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.05% Notes due 2023</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">499&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">518&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">0.650% Notes due 2024 (750MM Euro 1.1641)</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">870&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">899&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5.50% Notes due 2024 (500 MM GBP 1.2757)</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">634&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">768&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.625% Notes due 2025</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">748&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">813&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">0.55% Notes due 2025</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">996&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">990&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.45% Notes due 2026</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,994&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,180&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.95% Notes due 2027</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">997&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,119&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">0.95% Notes due 2027</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,494&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,510&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.90%&#160;Notes due 2028</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,494&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,680&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">1.150% Notes due 2028 (750MM Euro 1.1641)</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">867&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">960&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">6.95% Notes due 2029</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">441&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">1.30% Notes due 2030</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,743&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,739&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">4.95% Debentures due 2033</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">498&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">690&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">4.375% Notes due 2033</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">855&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,128&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">1.650% Notes due 2035 (1.5B Euro 1.1641)</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,731&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,101&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3.55% Notes due 2036</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">989&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,197&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5.95% Notes due 2037</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">992&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,536&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3.625% Notes due 2037</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,488&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,819&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3.40%&#160;Notes due 2038</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">991&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,176&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5.85% Debentures due 2038</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">696&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,094&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">4.50% Debentures due 2040</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">539&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">737&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.10% Notes due 2040</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">986&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">991&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">4.85% Notes due 2041</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">421&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">4.50% Notes due 2043</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">495&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">689&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3.70% Notes due 2046</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,974&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,478&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3.75% Notes due 2047</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">991&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,258&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3.50% Notes due 2048</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">742&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">921&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.25% Notes due 2050</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">984&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">984&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.45% Notes due 2060</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,228&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,230&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Non-Current Debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,680&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37,812&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The weighted average effective interest rate on non-current debt is 2.85%.</span></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The excess of the estimated fair value over the carrying value of debt was $3.0 billion at December 29, 2019.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Current Debt balance as of September 27, 2020 includes $3.0&#160;billion of commercial paper which has a weighted average interest rate of 0.15% and a weighted average maturity of 1.2 months. There was no commercial paper as of December 29, 2019.</span></div><div><span><br/></span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:107%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">In the fiscal third quarter of 2020, the Company issued senior unsecured notes for a total of $7.5&#160;billion.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fair value of the non-current debt was estimated using market prices, which were corroborated by quoted broker prices and significant other observable inputs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982190085112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">The worldwide effective income tax rates for the fiscal nine months of 2020 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">2019 were 12.6% an</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">d 15.3%, respectively. In the fiscal third quarter of 2019, Switzerland enacted the Federal Act on Tax Reform and AHV Financing (TRAF), which became effective on January 1, 2020. More information on the provisions of TRAF, including the step-up transitional provisions, can be found in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. During the fiscal first quarter of 2020, the final canton where the Company maintains significant operations enacted TRAF legislation and, accordingly, the Company recorded an estimated deferred tax benefit of approximately $0.3 billion for the remeasurement of existing deferred tax liabilities offset by a related $0.2 billion increase in U.S. GILTI deferred taxes. During the second fiscal quarter of 2020, the Company received rulings from the Swiss Federal and cantonal tax authorities in the remaining jurisdictions where it has significant operations. These rulings resulted in the Company revising its estimate on the tax basis adjustment (i.e., &#8220;step-up&#8221;) for its assets. As a result, the Company recorded additional deferred tax benefits in the second fiscal quarter of 2020 to recognize this step-up. Consequently, the benefit recorded related to Swiss Tax reform in the first nine months of fiscal 2020 was approximately $0.4&#160;billion, or 2.7% benefit to the Company&#8217;s fiscal nine months effective tax rate, inclusive of the impact of U.S. GILTI deferred taxes. Comparatively, in the fiscal third quarter of 2019, the Company recorded a tax benefit from the enactment of Swiss tax reform which reduced the effective rate for the fiscal nine months of 2019 by 3.0%.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">The Company does not expect to receive future rulings regarding the transitional provisions of TRAF.   </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">In the fiscal third quarter of 2019, the Company recorded additional unrecognized tax benefit liabilities which increased the effective tax rate for the fiscal nine months of 2019 by approximately 2.0%. In the fiscal third quarter of 2020, the Company recorded additional net unrecognized tax benefit liabilities which increased the effective tax rate for the fiscal nine months of 2020 by approximately 1.1%.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">Additionally, the following items impacted the Company's effective tax rate as compared to the same period in the prior fiscal year:</span></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;">the impact of the agreement in principle to settle opioid litigation (see Note 21 to the Consolidated Financial Statements) in the fiscal third quarter of 2019, which was recorded in the U.S., at an effective tax rate of 23.0%. In the fiscal third quarter of 2020, the Company reduced the effective tax rate of this agreement in principle to 21.4%. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;">the reduced income in lower tax jurisdictions due to the ongoing COVID-19 pandemic</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;">the 2019 divestiture gain related to Advanced Sterilization Products (ASP) which was primarily taxed in the U.S.</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;">the accrual of additional legal costs, including an additional $1.0&#160;billion associated with a revised agreement in principle to settle opioid litigation at an effective tax rate of 21.4%, in fiscal nine months of 2020 (see Notes 9 and 11 to the Consolidated Financial Statements for more details). </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company also generated additional tax benefits from stock-based compensation that were either exercised or vested; reduction of a contingent consideration liability related to the 2019 Auris Health acquisition; and reversal of some of its international unrecognized tax benefits due to the completion of several years of tax examinations in certain jurisdictions during the first fiscal three quarters of 2020.</span></div><div><span><br/></span></div><div style="margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of September&#160;27, 2020, the Company had approximately $3.3 billion of liabilities from unrecognized tax benefits. The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of jurisdictions. With respect to the United States, the IRS has completed its audit for the tax years through 2009 and is currently auditing the tax years 2010 through 2012. The Company currently expects completion of this audit in the fiscal year 2020. As of September&#160;27, 2020, the Company has classified unrecognized tax benefits and related interest of approximately $0.1 billion as a current liability on the &#8220;Accrued taxes on Income&#8221; line of the Consolidated Balance Sheet. This is the amount expected to be paid over the next 12 months with respect to the IRS audit. During the first fiscal quarter of 2020, the Company made a payment of approximately $0.6 billion to the U.S. Treasury with respect to the 2010-2012 tax audit in anticipation of a final settlement. The completion of this tax audit may result in additional adjustments to the Company&#8217;s unrecognized tax benefit liability. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">In other major jurisdictions where the Company conducts business, the years that remain open to tax audit go back to the year 2006. The Company believes it is possible that tax audits may be completed over the next twelve months by taxing authorities in some jurisdictions outside of the United States. However, the Company is not able to provide a reasonably reliable estimate of the timing of any other future tax payments relating to uncertain tax positions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982093090008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pensions and Other Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pensions and Other Benefit Plans</a></td>
<td class="text">PENSIONS AND OTHER BENEFIT PLANS<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Components of Net Periodic Benefit Cost</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net periodic benefit costs for the Company&#8217;s defined benefit retirement plans and other benefit plans for the fiscal third quarters and fiscal nine months of 2020 and 2019 include the following components:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%;"><tr><td style="width:1.0%;"/><td style="width:25.331%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.534%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.270%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.534%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.270%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.534%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.270%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.534%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.270%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.827%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.270%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.534%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.270%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.534%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.270%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.534%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.714%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retirement Plans</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Benefit Plans</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retirement Plans</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Benefit Plans</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Service cost</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">330&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">275&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">72&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">68&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">979&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">828&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">216&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">205&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">238&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">273&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">715&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">822&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">99&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">138&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(617)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(578)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,839)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,742)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of prior service cost/(credit)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Recognized actuarial losses</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">224&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">145&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">669&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">435&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">107&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">97&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Curtailments and settlements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net periodic benefit cost</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">175&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">112&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">544&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">349&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">394&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">412&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The service cost component of net periodic benefit cost is presented in the same line items on the Consolidated Statement of Earnings where other employee compensation costs are reported. All other components of net periodic benefit cost are presented as part of Other (income) expense, net on the Consolidated Statement of Earnings.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Company Contributions</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the fiscal nine months ended September&#160;27, 2020, the Company contributed $364 million and $27 million to its U.S. and international retirement plans, respectively. The Company plans to continue to fund its U.S. defined benefit plans to comply with the Pension Protection Act of 2006. International plans are funded in accordance with local regulations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982093084184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Income</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE INCOME<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Components of other comprehensive income (loss) consist of the following:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%;"><tr><td style="width:1.0%;"/><td style="width:34.774%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.547%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.914%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.547%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.662%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.846%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.719%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.547%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.306%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.547%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:16.991%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Accumulated</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">On</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefit</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">On Derivatives</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Comprehensive</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Translation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Securities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Plans</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&amp; Hedges</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income (Loss)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8,705)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6,891)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(295)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15,891)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(741)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">587&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,106&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">953&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9,446)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6,304)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">811&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14,938)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Amounts in accumulated other comprehensive income are presented net of the related tax impact.  Foreign currency translation is not adjusted for income taxes where it relates to permanent investments in international subsidiaries.  For additional details on comprehensive income see the Consolidated Statements of Comprehensive Income. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Details on reclassifications out of Accumulated Other Comprehensive Income:</span></div><div style="padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Gain/(Loss) On Securities - reclassifications released to Other (income) expense, net.</span></div><div style="padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Employee Benefit Plans - reclassifications are included in net periodic benefit cost. See Note 6 for additional details.</span></div><div style="padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Gain/(Loss) On Derivatives &amp; Hedges - reclassifications to earnings are recorded in the same account as the underlying transaction. See Note 4 for additional details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982093036168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">EARNINGS PER SHARE<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following is a reconciliation of basic net earnings per share to diluted net earnings per share for the fiscal third quarters and fiscal nine months ended September&#160;27, 2020 and September&#160;29, 2019:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:48.325%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.805%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.400%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.380%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.974%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.518%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.532%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.518%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.248%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Shares in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic net earnings per share </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.35&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.67&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.93&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.19&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Average shares outstanding &#8212; basic</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,632.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,635.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,633.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,649.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Potential shares exercisable under stock option plans</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">115.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">117.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">120.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: shares which could be repurchased under treasury stock method</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(78.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(83.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(82.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(99.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Convertible debt shares</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Average shares outstanding &#8212; diluted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,669.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,669.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,670.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,688.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted net earnings per share</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.86&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.13&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The diluted net earnings per share calculation for the fiscal third quarter ended September&#160;27, 2020 excluded 20 million shares related to stock options, as the exercise price of these options was greater than their average market value. In the fiscal third quarter ended September 27, 2020 the Company did not have convertible debt.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The diluted net earnings per share calculation for the fiscal third quarter ended September&#160;29, 2019 excluded 19&#160;million shares related to stock options, as the exercise price of these options was greater than their average market value. The diluted net earnings per share calculation for the fiscal third quarter ended September&#160;29, 2019 included the dilutive effect of convertible debt that was offset by the related reduction in interest expense. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The diluted net earnings per share calculation for the fiscal nine months ended September&#160;27, 2020 excluded 17&#160;million shares related to stock options, as the exercise price of these options was greater than their average market value. In the fiscal nine months ended September 27, 2020 the Company did not have convertible debt.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The diluted net earnings per share calculation for the fiscal nine months ended September&#160;29, 2019 excluded an insignificant number of shares related to stock options, as the exercise price of these options was greater than their average market value. The diluted net earnings per share calculation for the fiscal nine months ended September&#160;29, 2019 included the dilutive effect of convertible debt that was offset by the related reduction in interest expense.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982212844312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business and Geographic Areas<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments of Business and Geographic Areas</a></td>
<td class="text">SEGMENTS OF BUSINESS AND GEOGRAPHIC AREAS<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">SALES BY SEGMENT OF BUSINESS </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:35.144%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.633%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.643%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent Change</span></td></tr><tr><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consumer Health*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">OTC</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">601&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">477&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,917&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,468&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">541&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">621&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,722&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,781&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,142&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,098&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,639&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,249&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Skin Health/Beauty</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">572&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">559&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,767&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,810&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">577&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">592&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,506&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,633&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,151&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,273&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,443&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oral Care</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">164&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">156&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">510&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">462&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">248&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">223&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">694&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">673&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">412&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">379&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,204&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,135&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Baby Care</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">279&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">277&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">302&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">326&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">831&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">977&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">393&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">417&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,110&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,254&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Women's Health</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">227&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">252&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">654&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">724&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">230&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">255&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">664&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">733&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Wound Care/Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">125&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">109&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">370&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">343&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">175&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">173&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">189&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">168&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">545&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">516&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">TOTAL </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Consumer Health</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,556&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,394&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,853&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,369&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,958&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,075&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,582&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,962&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,514&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,469&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,435&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,331&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">* Previously referred to as Consumer</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:35.144%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.633%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.643%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PHARMACEUTICAL</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Immunology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,558&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,582&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,330&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,124&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,230&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,129&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,619&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,304&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,789&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,711&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,950&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,428&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">634&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">749&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,852&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,324&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S. Exports</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">88&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">321&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">209&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">299&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">673&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">795&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">921&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,136&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,846&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,345&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">SIMPONI / SIMPONI ARIA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">312&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">840&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">857&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">280&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">273&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">827&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">816&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">592&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">586&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,667&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,673&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">STELARA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,313&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,212&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,668&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">634&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">487&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,795&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,509&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,947&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,698&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,463&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,661&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">TREMFYA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">222&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">221&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">650&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">565&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.0%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">105&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">54.4</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">316&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">177&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78.7</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">327&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">290&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.1</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">965&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">742&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.2%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER IMMUNOLOGY</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.6</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.4</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.6</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.4</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Infectious Diseases</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">413&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">418&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,265&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,162&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">451&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">421&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,397&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,385&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">864&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">839&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,662&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,547&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">EDURANT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / rilpivirine</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">206&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">684&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">603&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">236&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">218&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">716&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">639&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / PREZCOBIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> /  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">                         </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">                     REZOLSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / SYMTUZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">379&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">373&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,154&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,032&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">147&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">135&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">461&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">534&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">526&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">508&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,615&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,566&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER INFECTIOUS DISEASES</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(26.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">79&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">94&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">80&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">252&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">248&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">102&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">113&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">331&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">342&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:35.144%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.633%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.643%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Neuroscience</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">759&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">785&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,285&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,172&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">846&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">810&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,565&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,590&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,605&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,595&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,850&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,762&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">CONCERTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / methylphenidate</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">84&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(49.2)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">107&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">109&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">319&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">348&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">193&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">469&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">544&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / XEPLION</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / INVEGA   TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / TREVICTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">585&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">554&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,704&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,543&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">341&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">983&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">916&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">926&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">851&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,688&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,459&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;RISPERDAL CONSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">70&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">79&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">220&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">237&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">81&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">89&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">254&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">292&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">167&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">475&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">528&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER NEUROSCIENCE</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">68&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">317&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">316&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,008&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,035&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">377&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">384&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,218&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,231&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,267&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,171&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,623&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,146&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,862&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,590&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,310&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,830&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,129&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,761&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,933&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,976&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">DARZALEX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">585&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">402&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,540&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,123&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">514&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">363&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,397&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,045&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,099&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">765&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,937&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,168&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">ERLEADA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"> </span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">74&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">407</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">194</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">112</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">206&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">86&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">519</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">216</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">450&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">447&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,329&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,163&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">581&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">475&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,682&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,373&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,031&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">921&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,011&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,536&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">VELCADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">105&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">311&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">636&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(51.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">105&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">311&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">636&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(51.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"> / </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">abiraterone acetate</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">58&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">233&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(75.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">284&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">616&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(53.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">532&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">508&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,564&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,502&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">590&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,848&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,118&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:35.144%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.633%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.643%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER ONCOLOGY</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.3</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">63&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">76&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">83&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.8)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">244&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">252&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">98&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.7)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">308&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">303&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pulmonary Hypertension</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">510&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">427&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.4</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,541&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,296&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">239&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">227&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.2</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">742&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">704&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">749&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">654&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.5</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,283&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">244&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">206&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.1</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">729&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">581&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">148&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.5</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">458&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">419&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">392&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">347&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.0</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,187&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,001&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">185&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.4</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">692&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">536&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.3</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">260&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23.6</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">792&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">611&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER PULMONARY HYPERTENSION</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.5</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">121&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">179&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(32.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">57&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.7)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">183&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">97&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">96&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">304&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">388&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cardiovascular / Metabolism / Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">931&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">955&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,574&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,804&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">351&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">360&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,052&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,131&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,281&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,316&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,625&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,936&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">630&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">613&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,716&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,704&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">630&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">613&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,716&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,704&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">156&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">125&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">405&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">411&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">68&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">173&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">147&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">224&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">179&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">578&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">558&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;PROCRIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / EPREX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">126&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(45.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">215&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">387&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(44.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">63&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">72&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">208&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">220&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">198&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">423&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">607&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">238&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">302&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">219&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">234&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">670&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">765&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">294&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">325&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">908&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,067&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TOTAL PHARMACEUTICAL</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,438&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,340&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,619&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,705&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,980&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,537&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,685&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,945&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,418&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,877&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,304&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,650&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:35.144%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.633%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.643%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MEDICAL DEVICES</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interventional Solutions</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">399&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">357&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,019&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,066&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">437&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">382&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,134&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,156&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">836&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,153&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,223&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Orthopaedics</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,308&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,301&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,427&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,950&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">774&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">837&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,145&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,616&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,083&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,138&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,572&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,566&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">HIPS</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">221&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">204&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">564&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">633&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">124&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">133&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">344&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">428&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(19.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">345&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">336&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">908&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,061&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">KNEES</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">205&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">209&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">527&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">650&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(19.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">102&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">136&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">298&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">435&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(31.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">308&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">344&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">825&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,085&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">TRAUMA</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">433&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">415&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,194&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,239&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">253&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">262&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">698&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">795&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">685&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">677&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,892&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,034&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">SPINE, SPORTS &amp; OTHER</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">449&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">472&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,142&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,427&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">295&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">306&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">805&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">957&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">745&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">778&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,947&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,384&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Surgery</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">913&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">940&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,247&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,867&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,239&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,371&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,556&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,192&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,311&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,803&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,059&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">ADVANCED</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">421&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">409&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,079&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,209&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">579&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">602&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,644&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,811&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,010&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,723&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,019&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#160;&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">GENERAL</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">492&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">531&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,168&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,658&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">660&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">769&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,912&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,381&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(19.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,301&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,080&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,040&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vision</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">473&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">459&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,160&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,366&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">608&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">734&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,683&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,117&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,081&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,193&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,843&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,483&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#160;&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">CONTACT LENSES / OTHER</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">375&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">339&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">924&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">993&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">455&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">555&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,274&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,566&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">830&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">893&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,198&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,559&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:35.144%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.633%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.643%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#160;&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">SURGICAL</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">98&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">120&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">236&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">373&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(36.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">153&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">180&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">409&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">551&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">251&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">299&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">645&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">923&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TOTAL MEDICAL DEVICES</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,092&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,057&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,852&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,249&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,058&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,326&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,518&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,082&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,150&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,383&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,370&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,331&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">WORLDWIDE</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,086&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,791&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,324&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,323&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,996&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,938&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28,785&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,989&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,082&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,729&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60,109&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61,312&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">*Percentage greater than 100% or not meaningful</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">EARNINGS BEFORE PROVISION FOR TAXES BY SEGMENT  </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.710%;"><tr><td style="width:1.0%;"/><td style="width:36.109%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.365%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.219%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.475%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.365%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.219%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.192%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29,<br/>2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>Change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29,<br/>2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Consumer Health </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">191&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">653&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(70.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">993&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,800&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(44.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Pharmaceutical</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,439&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(222)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,787&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,786&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Medical Devices</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,010&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,392&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(27.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,681&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,078&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(55.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment earnings before provision for taxes</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,640&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,823&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,461&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,664&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Less: Expense not allocated to segments</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"> (4)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">239&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">176&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">611&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">554&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Worldwide income before tax</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,401&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,647&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,850&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,110&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">*Percentage greater than 100% or not meaningful</span></div><div><span><br/></span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Consumer Health</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a gain of $0.3 billion related to the Company's previously held equity investment in Ci:z Holdings Co., Ltd. (DR. CI: LABO) in the fiscal nine months of 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt;">Includes litigation expense of $0.5&#160;billion in the fiscal third quarter of 2020, primarily talc related costs, including certain settlements. Includes litigation expense of $1.2&#160;billion and $0.2&#160;billion in both the fiscal nine months of 2020 and 2019, primarily talc related costs, including certain settlements. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes amortization expense of $0.1 billion in both the fiscal third quarters of 2020 and 2019, respectively and $0.3&#160;billion in both the fiscal nine months of 2020 and 2019, respectively.</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a restructuring related charge of $0.1&#160;billion in both the fiscal nine months of 2020 and 2019, respectively.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Pharmaceutical</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes an in-process research and development expense of $0.9 billion related to the Alios asset in the fiscal nine months of 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes litigation expense of $1.0&#160;billion and $4.0&#160;billion in the fiscal third quarters of 2020 and 2019 and $1.0&#160;billion and $4.3 billion in the fiscal nine months of 2020 and 2019, respectively. Litigation expense in all periods is primarily related to the agreement in principle to settle opioid litigation. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes an unrealized loss on securities of $0.1&#160;billion in the fiscal third quarter of 2019. Includes an unrealized gain on securities of $0.2&#160;billion in both the fiscal nine months of 2020 and 2019, respectively. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a research and development expense of $0.3 billion in the fiscal nine months of 2019, for an upfront payment related to argenx. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes amortization expense of $0.8 billion in both the fiscal third quarters of 2020 and 2019. Includes amortization expense of $2.4&#160;billion in both the fiscal nine months of 2020 and 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a restructuring related charge of $0.1&#160;billion in both the fiscal nine months of 2020 and 2019, respectively. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes Actelion acquisition related costs of $0.1&#160;billion in the fiscal nine months of 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">In the fiscal second and third quarters of 2020, the Company entered into a series of contract manufacturing arrangements for vaccine production with third party contract manufacturing organizations. These arrangements provide the Company with future supplemental commercial capacity for vaccine production and potentially transferable rights to such production if capacity is not required. Amounts paid and contractually obligated to be paid to these contract manufacturing organizations of approximately $0.8&#160;billion are reflected in the prepaid expenses and other, other assets, accrued liabilities and other liabilities accounts in the Company's consolidated balance sheet upon execution of each agreement. Additionally, the Company has entered into certain vaccine development cost sharing arrangements with government related organizations. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:96%;"> </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(3) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Medical Devices </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a contingent consideration reversal of $0.2&#160;billion in the fiscal third quarter of 2020 and $1.1 billion in the fiscal nine months of 2020 related to the timing of certain developmental milestones associated with the Auris Health acquisition. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a gain of $2.0&#160;billion from the divestiture of the ASP business in the fiscal nine months of 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes litigation expense of $0.3&#160;billion in the fiscal nine months of 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a restructuring related charge of $0.1 billion and amortization expense of $0.2 billion in both the fiscal third quarters of 2020 and 2019.  </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a restructuring related charge of $0.2&#160;billion and amortization expense of $0.7&#160;billion in both the fiscal nine months of 2020 and 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes an in-process research and development expense of $0.1&#160;billion in the fiscal third quarter of 2020 and fiscal nine months of 2020. </span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(4)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Amounts not allocated to segments include interest income/expense and general corporate income/expense. </span></div><div style="margin-bottom:10pt;"><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">SALES BY GEOGRAPHIC AREA</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.275%;"><tr><td style="width:1.0%;"/><td style="width:32.038%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.994%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.410%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.243%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.821%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.994%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.821%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.410%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.253%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,086&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,791&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,324&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,323&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Europe</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,819&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,461&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,709&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,803&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Western Hemisphere, excluding U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,296&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,488&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,931&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,446&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asia-Pacific, Africa</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,881&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,989&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,145&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,740&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,082&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,729&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60,109&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61,312&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982093466392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Divestitures<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Business Combinations and Divestitures</a></td>
<td class="text">BUSINESS COMBINATIONS AND DIVESTITURES<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Subsequent to the fiscal third quarter, on October 1, 2020, the Company completed the acquisition of Momenta Pharmaceuticals, Inc. (Momenta) a company that discovers and develops novel therapies for immune-mediated diseases, for a purchase price of approximately $6.5&#160;billion, primarily allocated to IPR&amp;D. In the fiscal fourth quarter of 2020, the transaction will be accounted for as a business combination and included in the Pharmaceutical segment. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the fiscal third quarter of  2020, the Company sold 11.8&#160;million shares of Idorsia LTD (Idorsia), or its 8.3% ownership in the company. The transaction resulted in gross proceeds of approximately CHF337&#160;million ($357&#160;million) based on a sales price of CHF 28.55/share and an immaterial net loss. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company currently has rights to at least an additional 38.7&#160;million shares (or approximately 20% of Idorsia equity) through a convertible loan with a principal amount of CHF 445&#160;million (due June 2027). Idorsia also has access to an approximate CHF 243&#160;million credit facility with the Company. As of September 27, 2020, Idorsia has not made any draw-downs under the credit facility.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the fiscal first quarter of 2020, the Company completed the acquisition of all rights to the investigational compound bermekimab, which has multiple dermatological indications, along with certain employees from XBiotech Inc., for a purchase price of $0.8 billion. The fair value of the acquisition was allocated primarily to non-amortizable intangible assets, primarily IPR&amp;D, for $0.8 billion. XBiotech may be eligible to receive additional payments upon the receipt of certain commercialization authorizations. The transaction was accounted for as a business combination and included in the Pharmaceutical segment. Additionally, the Company completed the acquisition of all outstanding shares in Verb Surgical Inc., a company with world-class robotics and data science capabilities, including those shares previously held by Verily. The transaction was accounted for as a business combination and included in the Medical Devices segment. The fair value of the acquisition was allocated primarily to non-amortizable intangible assets, primarily IPR&amp;D, for $0.4 billion, goodwill for $0.2 billion, other assets of $0.2 billion and liabilities assumed of $0.3 billion. The fair value of the Company's previously held equity investment in Verb Surgical Inc. was $0.4 billion. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On April 1, 2019, the Company completed the divestiture of its ASP business to Fortive Corporation for an aggregate value of approximately $2.8&#160;billion, consisting of $2.7&#160;billion of cash proceeds and $0.1&#160;billion of retained net receivables.  The Company recognized a pre-tax gain recorded in Other (income) expense, net, of approximately $2.0&#160;billion.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On April 1, 2019, the Company&#160;completed the acquisition of Auris Health, Inc. for approximately $3.4 billion, net of cash acquired. Additional contingent payments of up to $2.35 billion, in the aggregate, may be payable upon reaching certain predetermined milestones. Auris Health was a privately held developer of robotic technologies, initially focused in lung cancer, with an FDA-cleared platform currently used in bronchoscopic diagnostic and therapeutic procedures. The Company treated this transaction as a business combination and included it in the Medical Devices segment. The fair value of the acquisition was allocated primarily to amortizable and non-amortizable intangible assets, primarily IPR&amp;D, for $3.0 billion, goodwill for $2.0 billion, marketable securities of $0.2 billion and liabilities assumed of $1.8 billion, which includes the fair value of the contingent payments mentioned above. During the fiscal second quarter of 2020, the Company finalized the purchase price allocation.  During the fiscal nine months of 2020, the Company recorded Other income of approximately $1.1 billion for the reversal of all of the contingent consideration related to the timing of certain developmental and commercial milestones, which are not expected to be met based on the Company&#8217;s current timelines. During the fiscal third quarter of 2020, the Company recorded a partial IPR&amp;D impairment charge of $0.1&#160;billion related to timing and progression of the digital surgery platforms.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 17, 2019, the Company acquired DR. CI:LABO, a Japanese company focused on the marketing, development and distribution of a broad range of dermocosmetic, cosmetic and skincare products for a total purchase price of approximately &#165;230 billion, which equates to approximately $2.1 billion, using the exchange rate of 109.06 Japanese Yen to each U.S. Dollar on January 16, 2019. Additionally, in the fiscal first quarter of 2019, the Company recognized a pre-tax gain recorded in Other (income) expense, net, of approximately $0.3 billion related to the Company's previously held equity investment in DR. CI:LABO. </span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company treated this transaction as a business combination and included it in the Consumer Health segment. During the fiscal first quarter of 2020, the Company finalized the purchase price allocation. The fair value of the acquisition was allocated primarily to amortizable intangible assets for $1.5 billion, goodwill for $1.2 billion and liabilities assumed of $0.4 billion. The adjustments made since the date of acquisition were $0.1 billion to intangible assets, accrued liabilities, deferred taxes on income and property, plant and equipment with the offset to goodwill. The amortizable intangible assets were comprised of brand/trademarks and customer relationships with a weighted average life of 15.3 years. The goodwill is primarily attributable to synergies expected to arise from the business acquisition and is not expected to be deductible for tax purposes.</span></div>During the fiscal third quarter of 2018, the Company accepted a binding offer to form a strategic collaboration with Jabil Inc., one of the world&#8217;s leading manufacturing services providers for health care products and technology products.&#160;The Company is expanding a 12-year relationship with Jabil Inc. to produce a range of products within the Ethicon Endo-Surgery and DePuy Synthes businesses. This transaction includes the transfer of certain employees and manufacturing sites. The majority of the transfers were completed in 2019 with a minor amount remaining in 2020.&#160;As of September 27, 2020, the assets held for sale on the Consolidated Balance Sheet were $0.1 billion of inventory and property, plant and equipment, net. For additional details on the global supply chain restructuring see Note 12 to the Consolidated Financial Statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982091755352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Legal Proceedings<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Legal Proceedings</a></td>
<td class="text">LEGAL PROCEEDINGS<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Johnson &amp; Johnson and certain of its subsidiaries are involved in various lawsuits and claims regarding product liability; intellectual property; commercial; supplier indemnification and other matters; governmental investigations; and other legal proceedings that arise from time to time in the ordinary course of their business. Due to the ongoing impacts of the COVID-19 pandemic, certain trials have been rescheduled or delayed.  The Company continues to monitor its legal proceedings as the situation evolves.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred, and the amount of the loss can be reasonably estimated. As of September&#160;27, 2020, the Company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated. The Company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with ASC 450-20-25. For these and other litigation and regulatory matters discussed below for which a loss is probable or reasonably possible, the Company is unable to estimate the possible loss or range of loss beyond the amounts already accrued. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions including timing of related payments. The ability to make such estimates and judgments can be affected by various factors including, among other things, whether damages sought in the proceedings are unsubstantiated or indeterminate; scientific and legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; procedural or jurisdictional issues; the uncertainty and unpredictability of the number of potential claims; ability to achieve comprehensive multi-party settlements;  complexity of related cross-claims and counterclaims; and/or there are numerous parties involved. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's balance sheet, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of, or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company's results of operations and cash flows for that period.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">PRODUCT LIABILITY</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Johnson &amp; Johnson and certain of its subsidiaries are involved in numerous product liability claims and lawsuits involving multiple products. Claimants in these cases seek substantial compensatory and, where available, punitive damages. While the Company believes it has substantial defenses, it is not feasible to predict the ultimate outcome of litigation. From time to time, even if it has substantial defenses, the Company considers isolated settlements based on a variety of circumstances. The Company has established accruals for product liability claims and lawsuits in compliance with ASC 450-20 based on currently available information, which in some cases may be limited. The Company accrues an estimate of the legal defense costs needed to defend each matter when those costs are probable and can be reasonably estimated. For certain of these matters, the Company has accrued additional amounts such as estimated costs associated with settlements, damages and other losses. Product liability accruals can represent projected product liability for thousands of claims around the world, each in different litigation environments and with different fact patterns. Changes to the accruals may be required in the future as additional information becomes available.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The most significant of these cases include: the DePuy ASR&#8482; XL Acetabular System and DePuy ASR&#8482; Hip Resurfacing System; the PINNACLE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Acetabular Cup System; pelvic meshes; RISPERDAL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; body powders containing talc, primarily JOHNSONS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Baby Powder; INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; and ETHICON PHYSIOMESH</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Flexible Composite Mesh. As of September&#160;27, 2020, in the United States there were approximately 600 plaintiffs with direct claims in pending lawsuits regarding injuries allegedly due to the DePuy ASR&#8482; XL Acetabular System and DePuy ASR&#8482; Hip Resurfacing System; 8,200 with respect to the PINNACLE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Acetabular Cup System; 15,400 with respect to pelvic meshes; 10,400 with respect to </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">RISPERDAL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; 15,000 with respect to XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; 21,800 with respect to body powders containing talc; 300 with respect to INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">;</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and 4,000 with respect to ETHICON PHYSIOMESH</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Flexible Composite Mesh.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2010, DePuy Orthopaedics, Inc. (DePuy) announced a worldwide voluntary recall of its ASR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#8482;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> XL Acetabular System and DePuy ASR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#8482;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Hip Resurfacing System used in hip replacement surgery. Claims for personal injury have been made against DePuy and Johnson &amp; Johnson. The number of pending lawsuits is expected to fluctuate as certain lawsuits are settled or dismissed and additional lawsuits are filed. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Ohio. Litigation has also been filed in countries outside of the United States, primarily in the United Kingdom, Canada, Australia, Ireland, Germany, India and Italy. In November 2013, DePuy reached an agreement with a Court-appointed committee of lawyers representing ASR Hip System plaintiffs to establish a program to settle claims with eligible ASR Hip patients in the United States who had surgery to replace their ASR Hips, known as revision surgery, as of August 31, 2013. DePuy reached additional agreements in February 2015 and March 2017, which further extended the settlement program to include ASR Hip patients who had revision surgeries after August 31, 2013 and prior to February 15, 2017. This settlement program has resolved more than 10,000 claims, therefore bringing to resolution significant ASR Hip litigation activity in the United States. However, lawsuits in the United States remain, and the settlement program does not address litigation outside of the United States. In Australia, a class action settlement was reached that resolved the claims of the majority of ASR Hip patients in that country. In Canada, the Company has reached agreements to settle two pending class actions which have been approved by the Qu&#233;bec Superior Court and the Supreme Court of British Columbia. The Company continues to receive information with respect to potential additional costs associated with this recall on a worldwide basis. The Company has established accruals for the costs associated with the United States settlement program and DePuy ASR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#8482;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Hip-related product liability litigation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Claims for personal injury have also been made against DePuy Orthopaedics, Inc. and Johnson &amp; Johnson (collectively, DePuy) relating to the PINNACLE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Acetabular Cup System used in hip replacement surgery.  Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Texas. Litigation has also been filed in some state courts and in countries outside of the United States.  Several adverse verdicts have been rendered against DePuy, one of which was reversed on appeal and remanded for retrial.  During the first quarter of 2019, DePuy established a United States settlement program to resolve these cases. As part of the settlement program, adverse verdicts have been settled. The Company has established an accrual for product liability litigation associated with the PINNACLE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Acetabular Cup System and the related settlement program.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Claims for personal injury have been made against Ethicon, Inc. (Ethicon) and Johnson &amp; Johnson arising out of Ethicon's pelvic mesh devices used to treat stress urinary incontinence and pelvic organ prolapse. The Company continues to receive information with respect to potential costs and additional cases. Cases filed in federal courts in the United States had been organized as a multi-district litigation (MDL) in the United States District Court for the Southern District of West Virginia. The MDL Court is remanding cases for trial to the jurisdictions where the case was originally filed and additional pelvic mesh lawsuits have been filed, and remain, outside of the MDL.  The Company has settled or otherwise resolved a majority of the United States cases and the estimated costs associated with these settlements and the remaining cases are reflected in the Company's accruals. In addition, class actions and individual personal injury cases or claims have been commenced in various countries outside of the United States, including claims and cases in the United Kingdom, the Netherlands, and class actions in Israel, Australia and Canada, seeking damages for alleged injury resulting from Ethicon's pelvic mesh devices.  In November 2019, the Federal Court of Australia issued a judgment regarding its findings with respect to liability in relation to the three Lead Applicants and generally in relation to the design, manufacture, pre and post-market assessments and testing, and supply and promotion of the devices in Australia used to treat stress urinary incontinence and pelvic organ prolapse. In March 2020, the Court entered damages awards to the three Lead Applicants. The Company is appealing the decision. With respect to other group members, there will be an individual case assessment process which will require proof of use and causally related loss.  The class actions in Canada are expected to be discontinued in 2020 as a result of a settlement of a group of cases. The Company has established accruals with respect to product liability litigation associated with Ethicon's pelvic mesh product</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">s. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Following a June 2016 worldwide market withdrawal of ETHICON PHYSIOMESH</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Flexible Composite Mesh, claims for personal injury have been made against Ethicon, Inc. and Johnson &amp; Johnson alleging personal injury arising out of the use of this hernia mesh device.&#160; Cases filed in federal courts in the United States have been organized as a multi-district litigation (MDL) in the United States District Court for the Northern District of Georgia. A multi-county litigation (MCL) has also been formed in New Jersey state court and assigned to Atlantic County for cases pending in New Jersey.  In addition to the matters in the MDL and MCL, there are additional lawsuits pending in the United States District Court for the Southern District of Ohio, which are part of the MDL for polypropylene mesh devices manufactured by C.R. Bard, Inc., and lawsuits pending outside the United States.   </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">Claims have also been filed against Ethicon and Johnson &amp; Johnson alleging personal injuries arising from the PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> Mesh and PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> Ventral Patch hernia mesh products.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In March 2019, the New Jersey Supreme Court entered an order consolidating these cases pending in New Jersey as an MCL in Atlantic County Superior Court.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">Additional cases have been filed in various federal and state courts in the US, and in jurisdictions outside the US.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> The Company has established accruals with respect to product liability litigation associated with ETHICON PHYSIOMESH</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">Flexible Composite Mesh, PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> Mesh and PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> Ventral Patch products. In September 2019, plaintiffs&#8217; attorney filed an application with the New Jersey Supreme Court seeking centralized management of 107 PROLENE&#8482; Polypropylene Hernia System (&#8220;PHS&#8221;) cases.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">The New Jersey Supreme Court granted plaintiffs application in January 2020 and those cases have also been transferred to an MCL in Atlantic County Superior Court.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Claims for personal injury have been made against Janssen Pharmaceuticals, Inc. and Johnson &amp; Johnson arising out of the use of RISPERDAL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, and related compounds, indicated for the treatment of schizophrenia, acute manic or mixed episodes associated with bipolar I disorder and irritability associated with autism. Lawsuits have been primarily filed in state courts in Pennsylvania, California, and Missouri. Other actions are pending in various courts in the United States and Canada. Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has successfully defended a number of these cases but there have been verdicts against the Company, including a recent verdict in October 2019 of $8 billion of punitive damages related to one single plaintiff which was subsequently reduced in January 2020 to $6.8 million by the trial judge. The Company and plaintiff are each appealing this judgment. The Company has settled or otherwise resolved many of the United States cases and the costs associated with these settlements are reflected in the Company's accruals.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Claims for personal injury arising out of the use of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, an oral anticoagulant, have been made against Janssen Pharmaceuticals, Inc. (JPI); Johnson &amp; Johnson (J&amp;J); and JPI&#8217;s collaboration partner for XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">, Bayer AG and certain of its affiliates. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Eastern District of Louisiana. In addition, cases have been filed in state courts across the United States. Many of these cases have been consolidated into a state mass tort litigation in Philadelphia, Pennsylvania and in a coordinated proceeding in Los Angeles, California. Class action lawsuits also have been filed in Canada. In March 2019, JPI and J&amp;J announced an agreement in principle to the settle the XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> cases in the United States; the settlement agreement was executed in May 2019, the settlement became final in December 2019, and the settlement was funded in January 2020.  This resolved the majority of cases pending in the United States. The Company has established accruals for its costs associated with the United States settlement program and XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> related product liability litigation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Personal injury claims alleging that talc causes cancer have been made against Johnson &amp; Johnson Consumer Inc. and Johnson &amp; Johnson arising out of the use of body powders containing talc, primarily JOHNSON&#8217;S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Baby Powder.  The number of pending personal injury lawsuits continues to increase, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Lawsuits have been primarily filed in state courts in Missouri, New Jersey and California, and suits have also been filed outside the United States. The majority of cases are pending in federal court, organized into a multi-district litigation in the United States District Court for the District of New Jersey. In the multi-district litigation, the parties have sought to exclude experts, through Daubert motions.  In April 2020, the Court issued rulings that limit the scope of testimony, including some theories and testing methods, for certain plaintiff expert witnesses and denied  plaintiffs&#8217; attempt to limit the scope of testimony of certain of the Company&#8217;s witnesses.  With this ruling made, case-specific discovery has begun, per the court&#8217;s directive to proceed.  In talc cases that have previously gone to trial, the Company has obtained defense verdicts in a number of these cases but there have also been verdicts against the Company, many of which have been reversed on appeal.  Most recently, in June 2020, the Missouri Court of Appeals reversed in part and affirmed in part a July 2018 verdict of $4.7&#160;billion, reducing the overall award to $2.1&#160;billion. The Company has filed an application for transfer of the case to the Missouri Supreme Court.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company continues to believe that it has strong grounds for the appeal of this verdict, as well as other verdicts that it has appealed. Notwithstanding the Company&#8217;s confidence in the safety of its talc products, in certain circumstances the Company has and may settle cases.  The Company has established an accrual for defense costs and reserves for settlement of certain cases and claims in connection with product liability litigation associated with body powders containing talc.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In February 2019, the Company&#8217;s talc supplier, Imerys Talc America, Inc. and two of its affiliates, Imerys Talc Vermont, Inc. and Imerys Talc Canada, Inc. (collectively, Imerys) filed a voluntary chapter 11 petition commencing a reorganization under the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (Imerys Bankruptcy).  The Imerys Bankruptcy relates to Imerys&#8217; potential liability for personal injury from exposure to talcum powder sold by Imerys (Talc Claims).  In its bankruptcy filing, Imerys noted certain claims it alleges it has against the Company for indemnification and rights to joint insurance proceeds.  Based on such claims as well as indemnity and insurance claims the Company has against Imerys, the Company petitioned the United States District Court for the District of Delaware to establish federal jurisdiction of the state court talc lawsuits under the Bankruptcy Code.  The Company's petition was denied and the state court talc lawsuits that have been removed to federal court on such basis have been remanded.  The Company previously proposed to resolve Imerys' (and the Company&#8217;s) obligations arising out of the Talc Claims by agreeing to assume the defense of litigation </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">of all Talc Claims involving the Company's products, waiving the Company&#8217;s indemnification claims against Imerys, and lifting the automatic stay to enable the Talc Claims to proceed outside the bankruptcy forum with the Company agreeing to settle or pay any judgment against Imerys. In May 2020, Imerys and the asbestos claimants&#8217; committee filed their Plan of Reorganization and the Disclosure Statement related thereto agreeing to put its North American operations up for auction which was subsequently amended.  The Company has objected to the Disclosure Statement and intends to object to the Plan of Reorganization as currently structured. Additionally, in June 2020, Cyprus Mines Corporation and its parent filed an adversary proceeding against the Company as well as Imerys seeking a declaration of indemnity under certain contractual agreements.  The Company denies such indemnification is owed and filed a motion to dismiss the adversary complaint arguing, among other things, that the Court does not have subject matter jurisdiction over Cyprus&#8217;s claims against the Company.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">In February 2018, a securities class action lawsuit was filed against Johnson &amp; Johnson and certain named officers in the United States District Court for the District of New Jersey, alleging that Johnson &amp; Johnson violated the federal securities laws by failing to disclose alleged asbestos contamination in body powders containing talc, primarily JOHNSON'S&#174; Baby Powder, and that purchasers of Johnson &amp; Johnson&#8217;s shares suffered losses as a result.  Plaintiff is seeking damages. In April 2019, the Company moved to dismiss the complaint and briefing on the motion was complete as of August 2019.  In December 2019, the Court denied, in part, the motion to dismiss.  In March 2020, Defendants answered the complaint. Discovery is underway.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">In June 2019, a shareholder filed a complaint initiating a summary proceeding in New Jersey state court for a books and records inspection. In August 2019, Johnson &amp; Johnson responded to the books and records complaint and filed a cross motion to dismiss. In September 2019, Plaintiff replied and the Court heard oral argument. The Court has not yet ruled in the books and records action. In October 2019, December 2019, and January 2020, four shareholders filed four separate derivative lawsuits against Johnson &amp; Johnson as the nominal defendant and its current directors and certain officers as defendants in the United States District Court for the District of New Jersey, alleging a breach of fiduciary duties related to the alleged asbestos contamination in body powders containing talc, primarily JOHNSON&#8217;S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:99%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">Baby Powder, and that Johnson &amp; Johnson has suffered damages as a result of those alleged breaches. In February 2020, the four cases were consolidated into a single action under the caption </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:99%;">In re Johnson &amp; Johnson Talc Stockholder Derivative Litigation</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In July 2020, a report was delivered to the Company&#8217;s Board of Directors by independent counsel retained by the Board to investigate the allegations in the derivative lawsuits and in a series of shareholder letters that the Board received raising similar issues.  The independent counsel recommended that the Company reject the shareholder demands and take the steps that are necessary or appropriate to secure dismissal of the derivative lawsuits.  The Board unanimously adopted the recommendations of the independent counsel&#8217;s report.  Four of the shareholders who had sent demands are plaintiffs in th</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">e </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:103%;">In re Johnson &amp; Johnson Talc Stockholder Derivative Litigation</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">In January 2019, two ERISA class action lawsuits were filed by participants in the Johnson &amp; Johnson Savings Plan against Johnson &amp; Johnson, its Pension and Benefits Committee, and certain named officers in the United States District Court for the District of New Jersey, alleging that the defendants breached their fiduciary duties by offering Johnson &amp; Johnson stock as a Johnson &amp; Johnson Savings Plan investment option when it was imprudent to do so because of failures to disclose alleged asbestos contamination in body powders containing talc, primarily JOHNSON&#8217;S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> Baby Powder.  Plaintiffs are seeking damages and injunctive relief. In September 2019, Defendants filed a motion to dismiss. In April 2020, the Court granted Defendants&#8217; motion but granted leave to amend.  In June 2020, Plaintiffs filed an amended complaint, and in July 2020, Defendants moved to dismiss the amended complaint.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">A lawsuit is pending in the Superior Court of California for the County of San Diego alleging violations of California&#8217;s Consumer Legal Remedies Act relating to JOHNSON&#8217;S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> Baby Powder.  In that lawsuit, the plaintiffs allege that Johnson &amp; Johnson violated the CLRA by failing to provide required Proposition 65 warnings.  In July 2019, the Company filed a notice of removal to the United States District Court for the Southern District of California and plaintiffs filed a second amended complaint shortly thereafter.  In October 2019, the Company moved to dismiss the second amended complaint for failure to state a claim upon which relief may be granted.  In response to those motions, plaintiffs filed a third amended complaint.  In December 2019, the Company moved to dismiss the third amended complaint for failure to state a claim upon which relief may be granted.  In April 2020, the Court granted the motion to dismiss but granted leave to amend. In May 2020, plaintiffs filed a Fourth Amended Complaint but indicated that they would be filing a motion for leave to file a fifth amended complaint. Plaintiffs filed a Fifth Amended Complaint in August 2020. The Company moved to dismiss the Fifth Amended Complaint for failure to state a claim upon which relief may be granted.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In January 2020, the Abtahi Law Group filed an action under Proposition 65 against Johnson &amp; Johnson and Johnson &amp; Johnson Consumer Inc. as well as a number of other alleged talcum powder manufacturers and distributors, including one California company.  In that action, the plaintiff alleges contamination of talcum powder products with unsafe levels of arsenic, hexavalent chromium and lead.  The plaintiff seeks civil penalties and injunctive relief. The case has been stayed by the court pending an initial status conference.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In addition, the Company has received preliminary inquiries and subpoenas to produce documents regarding these matters from Senator Murray, a member of the Senate Committee on Health, Education, Labor and Pensions, the Department of Justice, the Securities and Exchange Commission and the U.S. Congressional Subcommittee on Economic and Consumer Policy.  The Company is cooperating with government inquiries and continues to produce documents as required in response. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Claims for personal injury have been made against a number of Johnson &amp; Johnson companies, including Janssen Pharmaceuticals, Inc. and Johnson &amp; Johnson, arising out of the use of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, a prescription medication indicated to improve glycemic control in adults with Type 2 diabetes. Lawsuits filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the District of New Jersey. Cases have also been filed in state courts. Class action lawsuits have been filed in Canada. Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has settled or otherwise resolved many of the cases and claims in the United States and the costs associated with these settlements are reflected in the Company's accruals.</span></div><div style="margin-bottom:10pt;"><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">INTELLECTUAL PROPERTY</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certain subsidiaries of Johnson &amp; Johnson are subject, from time to time, to legal proceedings and claims related to patent, trademark and other intellectual property matters arising out of their businesses. Many of these matters involve challenges to the coverage and/or validity of the patents on various products and allegations that certain of the Company&#8217;s products infringe the patents of third parties. Although these subsidiaries believe that they have substantial defenses to these challenges and allegations with respect to all significant patents, there can be no assurance as to the outcome of these matters. A loss in any of these cases could adversely affect the ability of these subsidiaries to sell their products, result in loss of sales due to loss of market exclusivity, require the payment of past damages and future royalties, and may result in a non-cash impairment charge for any associated intangible asset. The most significant of these matters are described below.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Medical Devices</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2016, MedIdea, L.L.C. (MedIdea) filed a patent infringement lawsuit against DePuy Orthopaedics, Inc. in the United States District Court for the Northern District of Illinois alleging infringement by the ATTUNE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Knee System. In April 2017, MedIdea filed an amended complaint adding DePuy Synthes Products, Inc. and DePuy Synthes Sales, Inc. as named defendants (collectively, DePuy).  MedIdea alleges infringement of United States Patent Nos. 6,558,426 (&#8217;426); 8,273,132 (&#8217;132); 8,721,730 (&#8217;730)   and 9,492,280 (&#8217;280) relating to posterior stabilized knee systems. Specifically, MedIdea alleges that the SOFCAM</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">TM</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Contact feature of the ATTUNE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> posterior stabilized knee products infringes the patents-in-suit. MedIdea is seeking monetary damages and injunctive relief. In June 2017, the case was transferred to the United States District Court for the District of Massachusetts.  A claim construction hearing was held in October 2018, and a claim construction order was issued in November 2018. In December 2018, MedIdea stipulated to non-infringement of the &#8217;132, &#8217;730 and &#8217;280 patents, based on the district court&#8217;s claim construction and reserving its right to appeal that construction, leaving only the &#8217;426 patent at issue before the district court. In May 2019, DePuy filed a motion for summary judgment of non-infringement of the claims of the &#8217;426 patent. In November 2019, judgment was entered in favor of DePuy.  In December 2019, MedIdea filed a notice of appeal and the appeal is fully briefed.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In December 2016, Ethicon Endo-Surgery, Inc. and Ethicon Endo-Surgery, LLC (now known as Ethicon LLC) sued Covidien, Inc. in the United States District Court for the District of Massachusetts seeking a declaration that United States Patent Nos. 6,585,735 (&#8217;735); 7,118,587; 7,473,253; 8,070,748 and 8,241,284 (&#8217;284), are either invalid or not infringed by Ethicon&#8217;s ENSEAL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> X1 Large Jaw Tissue Sealer product. In April 2017, Covidien LP, Covidien Sales LLC, and Covidien AG (collectively, Covidien) answered and counterclaimed, denying the allegations, asserting willful infringement of the &#8217;735 patent, the &#8217;284 patent and United States Patent Nos. 8,323,310 (&#8217;310); 9,084,608; 9,241,759 (&#8217;759) and 9,113,882, and seeking damages and an injunction. In June 2020, after a bench trial, the district court entered judgment in Ethicon&#8217;s favor.  In July 2020, Covidien filed a notice of appeal, and Ethicon filed a cross appeal.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In August 2020, the parties agreed to dismiss their respective appeals.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2016, Dr. Ford Albritton sued Acclarent, Inc. (Acclarent) in United States District Court for the Northern District of Texas alleging that Acclarent&#8217;s RELIEVA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Spin and RELIEVEA SpinPlus</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> products infringe U.S. Patent No. 9,011,412 (&#8217;412).  Dr. Albritton also alleges breach of contract, fraud and that he is the true owner of Acclarent&#8217;s U.S. Patent No. 8,414,473. Trial is scheduled to begin in March 2021.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2017, Board of Regents, The University of Texas System and TissueGen, Inc. (collectively, UT) filed a lawsuit in the United States District Court for the Western District of Texas against Ethicon, Inc. and Ethicon US, LLC (collectively, Ethicon) alleging the manufacture and sale of VICRYL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures, MONOCRYL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures, PDS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures, STRATAFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> PDS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Antibacterial Sutures and STRATAFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> MONOCRYL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Plus Antibacterial Sutures infringe plaintiffs&#8217; United States Patent Nos. 6,596,296 (&#8217;296) and 7,033,603 (&#8217;603) directed to implantable polymer drug releasing biodegradable fibers containing a therapeutic agent.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">UT is seeking damages and an injunction.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2018, Ethicon filed petitions with the United States Patent and Trademark Office (USPTO), seeking </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Inter Partes Review (IPR) of both asserted patents. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2020, the USPTO denied institution of the &#8217;296 patent IPR and granted institution of the &#8217;603 patent IPR.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">UT dismissed the &#8217;603 patent from the suit and no longer accuses PDS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures or STRATAFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> PDS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures of infringement. The previously scheduled district court trial has been postponed.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> In August 2018, Intuitive Surgical, Inc. and Intuitive Surgical Operations, Inc. (collectively, Intuitive) filed a patent infringement suit against Auris Health, Inc. (Auris) in United States District Court for the District of Delaware.  In the suit, Intuitive alleges willful infringement of U.S. Patent Nos. 6,246,200 (&#8217;200); 6,491,701 (&#8217;701); 6,522,906 (&#8217;906); 6,800,056 (&#8217;056); 8,142,447 (&#8217;447); 8,620,473 (&#8217;473); 8,801,601 (&#8217;601); and 9,452,276 (&#8217;276) based on Auris&#8217; Monarch&#8482; Platform.  Auris filed IPR Petitions with the USPTO regarding the &#8217;200, &#8217;056, &#8217;601 &#8217;701, &#8217;447, &#8217;276 and &#8217;906 patents.   Intuitive subsequently dropped the &#8217;200, &#8217;473 and &#8217;701 patents from the suit.  In December 2019, the USPTO instituted review of the &#8217;601 patent and denied review of the &#8217;056 patent.  In February and March 2020, the USPTO instituted review of the &#8217;200, &#8217;447, &#8217;701 and &#8217;906 patents and denied review of the &#8217;276 patent.   The district court trial is scheduled to begin in June 2021.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In August 2019, RSB Spine LLC (RSB Spine) filed a patent infringement suit against DePuy Synthes, Inc. in United States District Court for the District of Delaware.  In October 2019, RSB Spine amended the complaint to change the named defendants to DePuy Synthes Sales, Inc. and DePuy Synthes Products, Inc.  In the suit, RSB Spine alleges willful infringement of United States Patent Nos. 6,984,234 and 9,713, 537 by one or more of the following products:  ZERO-P-VA&#8482; Spacer, ZERO-P</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Spacer, ZERO-P NATURAL&#8482; Plate, SYNFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> LR Spacer and SYNFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Evolution System.  RSB Spine seeks monetary damages and injunctive relief. In November 2019, the suit was consolidated for pre-trial purposes with other patent infringement suits brought by RSB Spine in the United States District Court for the District of Delaware against Life Spine, Inc., Medacta USA, Inc., Precision Spine, Inc., and Xtant Medical Holdings, Inc. In June 2020, the case was stayed pending IPR proceedings involving the asserted patents. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In March 2020, Osteoplastics, LLC filed a patent infringement suit against DePuy Synthes, Inc., DePuy Synthes Products, Inc., Medical Device Business Services, Inc., and Synthes, Inc. (collectively, DePuy Synthes)  in the United States District Court for the District of Delaware.  In the suit, Osteoplastics alleges willful infringement of U.S. Patent Nos. 8,781,557; 9,929,920; 9,330,206; 9,626,756; 9,672,617; 9,672,302; and 9,275,191 based on the PROPLAN CMF</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Virtual Surgical Planning Services and the TruMatch</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> CMF Personalize Solutions.  In April 2020, Osteoplastics filed an amended complaint to substitute U.S. Patent No. 9,292,920 for U.S. Patent No. 9,929,920.  Osteoplastics seeks monetary damages and injunctive relief. In June 2020, DePuy Synthes filed a motion to dismiss the complaint. </span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Pharmaceutical</span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Litigation Against Filers of Abbreviated New Drug Applications (ANDAs)</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following summarizes lawsuits pending against generic companies that have filed ANDAs with the FDA or undertaken similar regulatory processes outside of the United States, seeking to market generic forms of products sold by various subsidiaries of Johnson &amp; Johnson prior to expiration of the applicable patents covering those products. These ANDAs typically include allegations of non-infringement and invalidity of the applicable patents. In the event the subsidiaries are not successful in an action, or the automatic statutory stay of the ANDAs expires before the United States District Court rulings are obtained, the third-party companies involved would have the ability, upon approval of the FDA, to introduce generic versions of their products to the market, resulting in the potential for substantial market share and revenue losses for the applicable products, and which may result in a non-cash impairment charge in any associated intangible asset. In addition, from time to time, subsidiaries may settle these types of actions and such settlements can involve the introduction of generic versions of the products at issue to the market prior to the expiration of the relevant patents. The IPR process with the USPTO, created under the 2011 America Invents Act, is also being used at times by generic companies in conjunction with ANDAs and lawsuits, to challenge the applicable patents.</span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2017, Janssen initiated a Notice of Application under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex Inc. (Apotex) and the Minister of Health in Canada in response to Apotex&#8217;s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of Canadian Patent No. 2,661,422 (the &#8217;422).  The final hearing concluded in May 2019.  In October 2019, the court issued an order prohibiting the Canadian Minister of Health from approving Apotex&#8217;s ANDS until the expiration of the &#8217;422 patent.  In November 2019, Apotex filed an appeal.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex in Canada in response to Apotex&#8217;s filing of an Abbreviated New Drug Submission (ANDS) seeking </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">approval to market a film-coated generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;422 patent. The final hearing is scheduled to begin in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Pharmascience Inc. (Pharmascience) in Canada in response to Pharmascience&#8217;s filing of an ANDS seeking approval to market a generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;  </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">250 mg,</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of the  &#8217;422 patent. The final hearing is scheduled to begin in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Pharmascience in Canada in response to Pharmascience&#8217;s filing of an ANDS seeking approval to market a generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, 500 mg, before the expiration of the &#8217;422 patent.  The final hearing is scheduled to begin in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories, Inc. (collectively, DRL) in Canada in response to DRL's filing of an ANDS seeking approval to market a generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;422 patent. The final hearing is scheduled to begin in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In August 2020, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against JAMP Pharma Corporation (Jamp) in Canada in response to Jamp&#8217;s filing of an ANDS seeking approval to market a generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> before the expiration of the &#8217;422 patent.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of these Canadian actions, Janssen is seeking an order enjoining the defendants from marketing their generic versions of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;422 patent.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In June 2017, Janssen Pharmaceuticals, Inc. (JPI) and Bayer Pharma AG and Bayer Intellectual Property GmbH (collectively, Bayer) filed a patent infringement lawsuit in the United States District Court for the District of Delaware against InvaGen Pharmaceuticals Inc. (InvaGen) who filed an ANDA seeking approval to market generic versions of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> before expiration of Bayer AG&#8217;s United States Patent No. 9,539,218 (&#8217;218) relating to XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">. JPI is the exclusive sublicensee of the asserted patent. In August 2020, JPI and Bayer AG entered into a settlement agreement with InvaGen. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;">In May 2020, JPI and Bayer AG filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Unichem Inc. (a/k/a Unichem Laboratories, Ltd.) and Unichem Pharmaceuticals (USA), Inc.(collectively, Unichem) who filed an ANDA seeking approval to market a generic version of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:88%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;"> before expiration of </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:88%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;">the &#8217;218 patent and United States Patent No. 7,157,456 relating</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:88%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;">to XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:88%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;">. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:88%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:88%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;">In September 2020, JPI and Bayer entered into a settlement agreement with Unichem.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;">In August 2020, JPI and Bayer filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Dr. Reddy&#8217;s Laboratories, Inc. and Dr. Reddy&#8217;s Laboratories, Ltd. (collectively, DRL) who filed an ANDA seeking approval to market a generic version of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:88%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;"> before expiration of </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:88%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;">the &#8217;218 patent.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:88%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;">In this lawsuit, JPI is seeking an order enjoining DRL from marketing their generic versions of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:88%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:88%;"> before the expiration of the relevant patents.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">/INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">/INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">Beginning in July 2017, Janssen Pharmaceuticals, Inc., Janssen Research &amp; Development, LLC, Cilag GmbH International and Janssen Pharmaceutica NV (collectively, Janssen) and Mitsubishi Tanabe Pharma Corporation (MTPC) filed patent infringement lawsuits in the United States District Court for the District of New Jersey against a number of generic companies who filed ANDAs seeking approval to market generic versions of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> and/or INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> XR before expiration of MTPC&#8217;s United States Patent Nos. 7,943,582 (&#8217;582) and/or 8,513,202 (&#8217;202) relating to INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> and/or INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> XR. Janssen is the exclusive licensee of the asserted patents. The following generic companies were named as defendants:</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">Dr. Reddy&#8217;s Laboratories, Inc. and Dr. Reddy&#8217;s Laboratories Ltd (DRL); MSN Laboratories Private Ltd. and MSN Pharmaceuticals, Inc. (MSN); Zydus Pharmaceuticals (USA) Inc. (Zydus); Sandoz, Inc. (Sandoz); and Lupin Ltd. and Lupin Pharmaceuticals, Inc. (Lupin).</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">These cases were consolidated into one action (Polymorph Main Action), which has been scheduled for trial starting in February 2021.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">In July 2017, Janssen and MTPC filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus who filed an ANDA seeking approval to market generic versions of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> and/or INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">before expiration of MTPC&#8217;s United States Patent No. 7,943,788 (&#8217;788), 8,222,219 (&#8217;219) and/or 8,785,403 (&#8217;403) relating to INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">and/or INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> XR (Compounds Main Action). Janssen is the exclusive licensee of the asserted patents. Trial began in September 2020 and will conclude in October or November 2020.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%;">  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">In July 2019, Janssen and MTPC filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against MSN, who filed an ANDA seeking approval to market a generic version of INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> before expiration of the &#8217;582 patent and &#8217;202 patent relating to INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">In October 2019, Janssen and MTPC initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against MSN, who filed ANDAs seeking approval to market generic versions of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> and INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> before expiration of the &#8217;788 patent.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">In October 2019, Janssen and MTPC initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against DRL, who filed an ANDA seeking approval to market a generic version of INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:99%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;"> before expiration of the &#8217;788 patent.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:99%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%;">These lawsuits have not been consolidated with the Main Actions.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In each of these lawsuits, Janssen and MTPC are seeking an order enjoining the defendants from marketing their generic versions of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> and/or, INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">before the expiration of the relevant patents.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In January 2018, Actelion Pharmaceuticals Ltd (Actelion) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus Pharmaceuticals (USA) Inc. (Zydus) who filed an ANDA seeking approval to market a generic version of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">before the expiration of United States Patent No. 7,094,781 (&#8217;781).  In the lawsuit, Actelion was seeking an order enjoining Zydus from marketing generic versions of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> before the expiration of the patent. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In September 2020, Actelion and Zydus entered into a settlement agreement.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">I</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">n October 2020, Actelion initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Laurus Labs Limited and PharmaQ, Inc. (collectively, Laurus), who filed an ANDA seeking approval to market generic versions of OPSUMIT&#174; before the expiration of U.S. Patent No. 7,094,781 (&#8217;781).  Actelion is seeking an order enjoining Laurus from marketing generic versions of OPSUMIT&#174; before the expiration of the &#8217;781 patent.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In May 2020, Janssen Inc. (Janssen) and Actelion initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Sandoz Canada Inc. (Sandoz) in Canada in response to Sandoz&#8217;s filing of an ANDS seeking approval to market a generic version of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;  </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">10 mg,</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">before the expiration of Canadian Patent No. 2,659,770 (&#8217;770). Trial is scheduled to begin in January 2022.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2020, Janssen and Actelion initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex Inc. (Apotex) in Canada in response to Apotex&#8217;s filing of an ANDS seeking approval to market a generic version of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">10 mg,</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of the &#8217;770 patent. Trial is scheduled to begin in February 2022.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In July 2020, Janssen and Actelion initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against JAMP Pharma Corporation (JAMP) in Canada in response to JAMP&#8217;s filing of an ANDS seeking approval to market a generic version of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> 10 mg before the expiration of the &#8217;770 patent and Canadian Patent No. 2,621,273 (&#8217;273).  Trial is scheduled to begin in April 2022.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of these Canadian actions, Janssen and Actelion are seeking an order enjoining the defendants from marketing their generic versions of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the relevant patents.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2018, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Teva Pharmaceuticals USA, Inc. (Teva), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of United States Patent No. 9,439,906 (&#8217;906).  Trial commenced in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In August 2019, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Mylan Laboratories Limited (Mylan), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> before the expiration of the &#8217;906 patent.  In February 2020, Mylan filed a Petition for Inter Partes Review with the USPTO seeking to invalidate the &#8217;906 patent. The USPTO denied the Petition in September 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Courts for the Districts of New Jersey and Delaware against Pharmascience Inc., Mallinckrodt PLC and Specgx LLC (collectively, Pharmascience), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;906 patent.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2018, Janssen Inc. and Janssen Pharmaceutica NV (collectively, Janssen) initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Teva Canada Limited (Teva)  in response to Teva's filing of an ANDS seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of Canadian Patent Nos. 2,309,629 (&#8217;629) and 2,655,335 (&#8217;335).  Janssen subsequently discontinued the portion of the lawsuit relating to the &#8217;629 patent.  In  May 2020, the Canadian Federal Court issued a Public Judgment and Reasons declaring that Teva&#8217;s generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, if approved, would infringe claims of the &#8217;335 patent and that the claims of the &#8217;335 patent are not invalid for obviousness. Teva appealed the court&#8217;s decision.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In April 2020, Janssen Inc. and Janssen Pharmaceutica NV (together, Janssen) initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Pharmascience Inc. (Pharmascience)  in response to Pharmascience's filing of an ANDS seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> before the expiration of the &#8217;335 patent.  In September 2020, Pharmascience withdrew its ANDS and Janssen discontinued the lawsuit.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of these lawsuits, Janssen is seeking an order enjoining the defendant from marketing a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the relevant patents.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">Beginning in January 2018, Pharmacyclics LLC (Pharmacyclics) and Janssen Biotech, Inc. (JBI) filed patent infringement lawsuits in the United States District Court for the District of Delaware against a number of generic companies who filed ANDAs seeking approval to market generic versions of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> 140 mg capsules before expiration of Pharmacyclics&#8217;  United States Patent Nos. 8,008,309, 7,514,444, 8,697,711, 8,735,403, 8,957,079, 9,181,257, 8,754,091, 8,497,277, 8,925,015, 8,476,284, 8,754,090, 8,999,999, 9,125,889, 9,801,881, 9,801,883, 9,814,721, 9,795,604, 9,296,753, 9,540,382, 9,713,617 and/or 9,725,455 relating to IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">. JBI is the exclusive licensee of the asserted patents. The named defendants include the following generic companies: Cipla Limited and Cipla USA Inc. (collectively, Cipla); Sandoz Inc. and Lek Pharmaceuticals d.d. (collectively, Sandoz); and Zydus Worldwide DMCC and Cadila Healthcare Limited (collectively, Zydus).  The trial commenced in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2019, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Zydus, who filed an ANDA seeking approval to market a generic version of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> 70 mg before the expiration of U.S. Patent Nos. 7,514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753, 9,540,382, 9,713,617, 9,725,455, 10,106,548, and 10,125,140. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2019, Pharmacyclics and JBI amended their complaint against Cipla to allege infringement of United States Patent Nos. 10,106,548, and 10,125,140.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2019, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Alvogen Pine Brook LLC and Natco Pharma Ltd. (collectively, Alvogen), who filed an ANDA seeking approval to market generic versions of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> tablets, asserting infringement of United States Patent Nos. 7,514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753,  9,655,857, 9,725,455, 10,010,507, 10,106,548, and 10,125,140.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2019, Pharmacyclics and JBI amended their complaint against Cipla to further allege infringement of United States Patent No. 10,016,435.  In June 2019, Pharmacyclics and JBI amended their complaint against Alvogen to further allege infringement of United States Patent No. 10,213,386.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2019, Pharmacyclics and JBI amended their complaints against Cipla and Sandoz to further allege infringement of U.S. Patent Nos. 10,294,231 and 10,294,232.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In March 2019, Sandoz filed an</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">IPR Petition with</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">the USPTO, seeking to invalidate United States Patent No. 9,795,604.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In September 2020, the USPTO issued a final decision in the IPR invalidating certain claims of the &#8217;604 patent and upholding the validity of certain claims in the &#8217;604 patent.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In March 2020, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Alvogen, Zydus and Sandoz asserting infringement of United States Patent No. 10,478,439.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In April 2020, Pharmacyclics and JBI amended their complaint against Sandoz to further allege infringement of U.S. Patent No. 10,463,668. In October 2020, Pharmacyclics and JBI amended their complaint against Sandoz to further allege infringement of U.S. Patent Nos. 10,752,634 and 10,695,350, amended their complaint against Zydus to further allege infringement of U.S. Patent Nos.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">10,752,634 and 10,653,696, and amended their complaint against Alvogen to further allege infringement of U.S. Patent No. 10,653,696.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Zydus, who filed an ANDA seeking approval to market generic versions of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> tablets, asserting infringement of United States Patent Nos. 7,514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753,  9,655,857, 9,725,455, 10,010,507, 10,106,548, 10,125,140, 10,213,286 and 10,478,439.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In October 2020, Pharmacyclics and JBI entered into a settlement agreement with Zydus.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of the lawsuits, Pharmacyclics and JBI are seeking an order enjoining the defendants from marketing generic versions of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of the relevant patents.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, Actelion Pharmaceuticals Ltd and Nippon Shinyaku Co., Ltd. initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against a number of generic companies who filed ANDAs seeking approval to market generic versions of UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before expiration of Nippon Shinyaku&#8217;s United States Patent Nos. 7,205,302; 8,791,122; and 9,284,280 relating to UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Actelion is the exclusive licensee of the asserted patents. The following generics are named defendants in the complaint: Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals Inc. (Alembic); MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. (MSN); Aizant Drug Research Solutions Private Limited (Aizant); VGYAAN Pharmaceuticals LLC (VGYAAN); and Zydus Pharmaceuticals (USA), Inc. and Zydus Worldwide DMCC (Zydus). In June 2020, the court entered a joint stipulation dismissing Aizant from suit.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Actelion and Nippon Shinyaku are seeking an order enjoining the defendants from marketing generic versions of UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of the relevant patents.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">INVEGA TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In September 2020, Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica NV, and Janssen Research &amp; Development, LCC (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Mylan Laboratories Limited, Mylan Pharmaceuticals Inc., and Mylan Institutional LLC (collectively, Mylan). Mylan filed an ANDA seeking approval to market generic versions of INVEGA TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:115%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">before expiration of United States Patent No. 10,143,693 relating to INVEGA TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">. Janssen is seeking an order enjoining Mylan from marketing a generic version of INVEGA TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> before the expiration of the relevant patent.</span></div><div style="margin-top:12pt;margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">GOVERNMENT PROCEEDINGS</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Like other companies in the pharmaceutical, consumer and medical devices industries, Johnson &amp; Johnson and certain of its subsidiaries are subject to extensive regulation by national, state and local government agencies in the United States and other countries in which they operate. As a result, interaction with government agencies is ongoing. The most significant litigation brought by, and investigations conducted by, government agencies are listed below. It is possible that criminal charges and substantial fines and/or civil penalties or damages could result from government investigations or litigation.</span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Average Wholesale Price (AWP) Litigation</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Johnson &amp; Johnson and several of its pharmaceutical subsidiaries (the J&amp;J AWP Defendants), along with numerous other pharmaceutical companies, were named as defendants in a series of lawsuits in state and federal courts involving allegations that the pricing and marketing of certain pharmaceutical products amounted to fraudulent and otherwise actionable conduct because, among other things, the companies allegedly reported an inflated Average Wholesale Price (AWP) for the drugs at issue. Payors alleged that they used those AWPs in calculating provider reimbursement levels. The plaintiffs in these cases included three classes of private persons or entities that paid for any portion of the purchase of the drugs at issue based on AWP, and state government entities that made Medicaid payments for the drugs at issue based on AWP. Many of these cases, both federal actions and state actions removed to federal court, were consolidated for pre-trial purposes in a multi-district litigation in the United States District Court for the District of Massachusetts, where all claims against the J&amp;J AWP Defendants were ultimately dismissed. The J&amp;J AWP Defendants also prevailed in a case brought by the Commonwealth of Pennsylvania. Other AWP cases have been resolved through court order or settlement. The case brought by Illinois was settled after trial.  In New Jersey, a putative class action based upon AWP allegations is pending against Centocor, Inc. and Ortho Biotech Inc. (both now Janssen Biotech, Inc.), Johnson &amp; Johnson and ALZA Corporation. All other cases have been resolved.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Opioid Litigation</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Beginning in 2014 and continuing to the present, Johnson &amp; Johnson and Janssen Pharmaceuticals, Inc. (JPI), along with other pharmaceutical companies, have been named in more than 3,100 lawsuits related to the marketing of opioids, including DURAGESIC</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, NUCYNTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and NUCYNTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> ER.  The suits also raise allegations related to previously owned active pharmaceutical ingredient supplier subsidiaries, Tasmanian Alkaloids Pty, Ltd. and Noramco, Inc. (both subsidiaries were divested in 2016). The majority of the cases have been filed by state and local governments. Similar lawsuits have also been filed by private plaintiffs and organizations, including but not limited to the following: individual plaintiffs on behalf of children suffering from Neonatal Abstinence Syndrome; hospitals; and health insurers/payors. To date, complaints against pharmaceutical companies, including Johnson &amp; Johnson and JPI, have been filed by the state Attorneys General in Arkansas, Florida, Idaho, Illinois, Kentucky, Louisiana, Mississippi, Missouri, New Hampshire, New Jersey, New Mexico, New York, Ohio, Oklahoma, South Dakota, Texas, Washington and West Virginia. Complaints against the manufacturers also have been filed in state or federal court by city, county and local government agencies in the following states: Alabama, Arizona, Arkansas, California, Connecticut, Florida, Georgia, Illinois, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Mississippi, Missouri, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina; Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia and Wisconsin. The Government of Puerto Rico filed suit in Superior Court of San Juan. There are more than 370 cases pending in various state&#160;courts. There are over 2,700 federal cases coordinated in a federal Multi-District Litigation (MDL) pending in the U.S. District Court for the Northern District of Ohio (MDL No. 2804).&#160;In addition, the Province of British Columbia filed suit in Canada.  In October 2019, an anti-trust complaint was filed by private plaintiffs in federal court in Tennessee and is pending transfer to the MDL. These actions allege a variety of claims related to opioid marketing practices, including false advertising, unfair competition, public nuisance, consumer fraud violations, deceptive acts and practices, false claims and unjust enrichment. The suits generally seek penalties and/or injunctive and monetary relief and, in some of the suits, the plaintiffs are seeking joint and several liability among the defendants. An adverse judgment in any of these lawsuits could result in the imposition of large monetary penalties and significant damages including, punitive damages, cost of abatement, substantial fines, equitable remedies and other sanctions.</span><span style="background-color:rgb(255,255,255, 0.0);color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The trial in the matter filed by the Oklahoma Attorney General resulted in a judgment against Johnson &amp; Johnson and JPI in the amount of $572 million, subject to a final order to be issued by the court.&#160; The court issued a final judgment reducing the amount to $465 million. Johnson &amp; Johnson and JPI have appealed the judgment. The Company believes that it has strong grounds to overturn this judgment.&#160; In October 2019 Johnson &amp; Johnson and JPI announced a settlement of the first case set for trial in the MDL with two counties in Ohio. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Johnson &amp; Johnson, JPI and other pharmaceutical companies have also received subpoenas or requests for information related to opioids marketing practices from the following state Attorneys General: Alaska, Indiana, Montana, New Hampshire, South Carolina, Tennessee, Texas and Washington. In September 2017, Johnson &amp; Johnson and JPI were contacted by the Texas and Colorado Attorney General&#8217;s Offices on behalf of approximately 38 states regarding a multi-state Attorney General investigation. In October 2019, the Company announced a proposed agreement in principle that would include the Company paying $4 billion as settlement of these lawsuits.  In October 2020, the Company agreed to contribute up to an additional $1&#160;billion to an all-in settlement amount that would resolve opioid lawsuits filed and future claims by states, cities, counties and tribal governments, for a total of $5&#160;billion, subject to various conditions and an agreement being finalized. This agreement in </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">principle is not an admission of liability or wrong-doing and would resolve opioid lawsuits filed and future claims by states, cities and counties.  The Company cannot predict if or when the agreement will be finalized and individual cases are ongoing. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> In August 2019, Johnson &amp; Johnson received a grand jury subpoena from the United States Attorney&#8217;s Office for the Eastern District of New York for documents related to the Company&#8217;s anti-diversion policies and procedures and distribution of its opioid medications, in what the Company understands to be part of a broader investigation into manufacturers&#8217; and distributors&#8217; monitoring programs and reporting under the Controlled Substances Act.&#160; In September 2019, Johnson &amp; Johnson received subpoenas from the New York State Department of Financial Services (NYDFS) as part of an industry-wide inquiry into the effect of opioid prescriptions on New York health insurance premiums.&#160;In September 2020, the Company learned that NYDFS filed a statement of charges related to this investigation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In November 2019, a shareholder filed a derivative complaint against Johnson &amp; Johnson as the nominal defendant and certain current and former directors and officers as defendants in the Superior Court of New Jersey.  The complaint alleges breaches of fiduciary duties related to the marketing of opioids, and that Johnson &amp; Johnson has suffered damages as a result of those alleged breaches.  In December 2019, two additional shareholders filed two separate derivative complaints making similar allegations against Johnson &amp; Johnson as the nominal defendant and certain current and former directors and officers as defendants in the United States District for the District of New Jersey. In April 2020,  the two federal cases were consolidated into a single action captioned</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"> In re Johnson &amp; Johnson Opioid Stockholder Derivative Litigation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.  Pursuant to an agreed stipulation entered by the Court, the shareholders have until July 2020 to file a consolidated complaint or identify a previously filed complaint as the operative complaint. In July 2020, an additional shareholder filed a derivative complaint in the United States District Court for the District of New Jersey making similar allegations against the same defendants named in the consolidated action.  Pursuant to an order in the consolidated action, the newly-filed case will be consolidated into the consolidated action.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, a report was delivered to the Company&#8217;s Board of Directors by independent counsel retained by the Board to investigate the allegations in the derivative lawsuits and in a series of shareholder letters that the Board received raising similar issues.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The independent counsel recommended that the Company reject the shareholder demands and take the steps that are necessary or appropriate to secure dismissal of the derivative litigation. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Board unanimously adopted the recommendations of the independent counsel&#8217;s report.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Other</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In August 2012, DePuy Orthopaedics, Inc., DePuy, Inc. (now known as DePuy Synthes, Inc.), and Johnson &amp; Johnson Services, Inc. (collectively DePuy) received an informal request from the United States Attorney's Office for the District of Massachusetts and the Civil Division of the United States Department of Justice (the United States) for the production of materials relating to the DePuy ASR&#8482; XL Hip device. In July 2014, the United States notified the United States District Court for the District of Massachusetts that it had declined to intervene in a </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> case filed pursuant to the False Claims Act against the companies. In February 2016, the district court granted the companies&#8217; motion to dismiss with prejudice, unsealed the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> complaint, and denied the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> relators&#8217; request for leave to file a further amended complaint. The </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> relators appealed the case to the United States Court of Appeals for the First Circuit. In July 2017, the First Circuit affirmed the district court&#8217;s dismissal in part, reversed in part, and affirmed the decision to deny the relators&#8217; request to file a third amended complaint. The relators&#8217; remaining claims are now pending before the district court. In July 2020, the Court ordered the relators to complete discovery by August 2020; the Relators have requested an extension of the August 2020 deadline that DePuy opposed and additional discovery-related motions have been filed by both parties. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In October 2012, Johnson &amp; Johnson was contacted by the California Attorney General's office regarding a multi-state Attorney General investigation of the marketing of surgical mesh products for hernia and urogynecological purposes by Johnson &amp; Johnson's subsidiary, Ethicon, Inc. (Ethicon). In May 2016, California and Washington filed civil complaints against Johnson &amp; Johnson, Ethicon and Ethicon US, LLC alleging violations of their consumer protection statutes. Similar complaints were filed against the companies by the following states:  Kentucky, Mississippi, West Virginia and Oregon. In April 2019, Johnson &amp; Johnson and Ethicon settled the Washington case.  The California case started trial in July 2019 and concluded in September 2019. The trial date for the Kentucky case was scheduled for September 2019 but has been adjourned and no new trial date has been scheduled. The trial date for the Mississippi case is scheduled for April 2021. In October 2019, Johnson &amp; Johnson and Ethicon settled the multi-state investigation with 41 other states and the District of Columbia. In January 2020, the Court in California issued a statement of decision, finding in favor of the State of California, and awarded civil penalties in the amount of $344 million. In April 2020, the Court in California denied the Company's motion for a new trial. In August 2020, the Court entered judgment with respect to the penalties of $344&#160;million, but denied the Attorney General&#8217;s request for injunctive relief. The Company is appealing the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">penalty judgment. In April 2020, the Company settled the West Virginia case. In June 2020 the Court in Oregon denied the Company's motion to dismiss. Trial in Oregon is set for February 2022. The Attorney General of </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Mississippi filed a second amended complaint in April 2020 and the Company filed a motion to dismiss in May 2020. The motion to dismiss argument was heard in August 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In December 2012, Therakos, Inc. (Therakos), formerly a subsidiary of Johnson &amp; Johnson and part of the Ortho-Clinical Diagnostics, Inc. (OCD) franchise, received a letter from the civil division of the United States Attorney's Office for the Eastern District of Pennsylvania informing Therakos that the United States Attorney's Office was investigating the sales and marketing of Uvadex</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> (methoxsalen) and the Uvar Xts</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> and Cellex</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Systems during the period 2000 to the present. The United States Attorney's Office requested that OCD and Johnson &amp; Johnson preserve documents that could relate to the investigation. Therakos was subsequently acquired by an affiliate of Gores Capital Partners III, L.P. in January 2013, and OCD was divested in June 2014. Following the divestiture of OCD, Johnson &amp; Johnson retains OCD&#8217;s portion of any liability that may result from the investigation for activity that occurred prior to the sale of Therakos. In March 2014 and March 2016, the United States Attorney&#8217;s Office requested that Johnson &amp; Johnson produce certain documents, and Johnson &amp; Johnson is cooperating with those requests.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2014, the Mississippi Attorney General filed a complaint in Chancery Court of The First Judicial District of Hinds County, Mississippi against Johnson &amp; Johnson and Johnson &amp; Johnson Consumer Companies, Inc. (now known as Johnson &amp; Johnson Consumer Inc.) (JJCI).&#160;The complaint alleges that defendants violated the Mississippi Consumer Protection Act by </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">failing to disclose alleged health risks associated with female consumers' use of talc contained in JOHNSON'S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Baby Powder and JOHNSON'S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Shower to Shower (a product divested in 2012) and seeks injunctive and monetary relief.  The matter is stayed pending interlocutory appeal of a December 2018 denial of Johnson &amp; Johnson and JJCI's motion for summary judgment. The Mississippi Supreme Court granted J&amp;J and JJCI's request to file an interlocutory appeal of the denial of the motion for summary judgment in late 2019. Briefing is complete.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In January 2020, the State of New Mexico filed a consumer protection case alleging that the Company deceptively marketed and sold its talcum powder products by making misrepresentations about the safety of the products and the presence of carcinogens, including asbestos.  The State of New Mexico filed an Amended Complaint in March 2020. The Company has moved to dismiss certain of the claims in the Amended Complaint, which was granted, but the State of New Mexico was given leave to amend its complaint. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Forty-one states have commenced a joint investigation into the Company&#8217;s marketing of its talcum powder products. At this time, the multi-state group has not asserted any claims against the Company. Several states have issued Civil Investigative Demands seeking documents and other information. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2016, Janssen Pharmaceuticals, Inc. (JPI) received a Civil Investigative Demand from the United States Attorney&#8217;s Office for the Southern District of New York related to JPI&#8217;s contractual relationships with pharmacy benefit managers over the period from January 1, 2006 to the present with regard to certain of JPI's pharmaceutical products.  The demand was issued in connection with an investigation under the False Claims Act.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2016, Johnson &amp; Johnson and Janssen Products LP were served with a </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> complaint pursuant to the False Claims Act filed in the United States District Court for the District of New Jersey alleging the off-label promotion of two HIV products, PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and INTELENCE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, and anti-kickback violations in connection with the promotion of these products.&#160; The complaint was filed under seal in December 2012.&#160; The federal and state governments have declined to intervene, and the lawsuit is being prosecuted by the relators.&#160; </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2017, Janssen Biotech, Inc. received a Civil Investigative Demand from the United States Department of Justice regarding a False Claims Act investigation concerning management and advisory services provided to rheumatology and gastroenterology practices that purchased REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> or SIMPONI ARIA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. In August 2019, the Unites States Department of Justice notified Janssen Biotech, Inc. that it was closing the investigation. Subsequently, the United States District Court for the District of Massachusetts unsealed a qui tam False Claims Act complaint, which was served on the Company.  The Department of Justice had declined to intervene in the qui tam lawsuit in August 2019.  The Company has filed a motion to dismiss the relator&#8217;s complaint. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April and September 2017, Johnson &amp; Johnson received subpoenas from the United States Attorney for the District of Massachusetts seeking documents broadly relating to pharmaceutical copayment support programs for DARZALEX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, OLYSIO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, SIMPONI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, STELARA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">and ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.&#160;The subpoenas also seek documents relating to&#160;Average Manufacturer Price and Best Price reporting to the Center for Medicare and Medicaid Services related to those products, as well as rebate payments to state Medicaid agencies. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2017, Johnson &amp; Johnson received a subpoena from the United States Attorney's Office for the District of Massachusetts seeking information regarding practices pertaining to the sterilization of DePuy Synthes, Inc. spinal implants at </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">three hospitals in Boston as well as interactions of employees of Company subsidiaries with physicians at these hospitals. Johnson &amp; Johnson and DePuy Synthes, Inc. have produced documents in response to the subpoena and are fully cooperating with the government&#8217;s investigation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2018 the Public Prosecution Service in Rio de Janeiro and representatives from the Brazilian antitrust authority CADE inspected the offices of more than 30 companies including Johnson &amp; Johnson do Brasil Ind&#250;stria e Com&#233;rcio de Produtos para Sa&#250;de Ltda. The authorities appear to be investigating allegations of possible anti-competitive behavior and possible improper payments in the medical device industry.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We continue to actively respond to inquiries regarding the Foreign Corrupt Practices Act from the United States Department of Justice and the United States Securities and Exchange Commission. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">From time to time, the Company has received requests from a variety of United States Congressional Committees to produce information relevant to ongoing congressional inquiries. It is the policy of Johnson &amp; Johnson to cooperate with these inquiries by producing the requested information.</span></div><div style="margin-top:12pt;margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">GENERAL LITIGATION</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In May 2014, two purported class actions were filed in federal court, one in the United States District Court for the Central District of California and one in the United States District Court for the Southern District of Illinois, against Johnson &amp; Johnson and Johnson &amp; Johnson Consumer Companies, Inc. (now known as Johnson &amp; Johnson Consumer Inc.) (JJCI) alleging violations of state consumer fraud statutes based on nondisclosure of alleged health risks associated with talc contained in JOHNSON'S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Baby Powder and JOHNSON'S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Shower to Shower (a product no longer sold by JJCI). Both cases seek injunctive relief and monetary damages; neither includes a claim for personal injuries. In October 2016, both cases were transferred to the United States District Court for the District Court of New Jersey as part of a newly created federal multi-district litigation. In July 2017, the district court granted Johnson &amp; Johnson's and JJCI&#8217;s motion to dismiss one of the cases.  In September 2018, the United States Court of Appeals for the Third Circuit affirmed this dismissal.  In September 2017, the plaintiff in the second case voluntarily dismissed the complaint.  In March 2018, the plaintiff in the second case refiled in Illinois State Court. Following motion practice to remove the case to United States District Court, as of September 2020 the case will remain in Illinois State Court. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In August 2014, United States Customs and Border Protection (US CBP) issued a Penalty Notice against Janssen Ortho LLC (Janssen Ortho), assessing penalties for the alleged improper classification of darunavir ethanolate (the active pharmaceutical ingredient in PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">) in connection with its importation into the United States. In October 2014, Janssen Ortho submitted a Petition for Relief in response to the Penalty Notice. In May 2015, US CBP issued an Amended Penalty Notice assessing substantial penalties and Janssen Ortho filed a Petition for Relief in July 2015. In May 2019, US CBP issued its Mitigation Decision and determined that Janssen Ortho had negligently misrepresented that darunavir ethanolate is entitled to duty free treatment.  In June 2019, Janssen Ortho filed a Supplemental Petition for Relief. The Penalties Proceeding will be impacted by the related Classification Litigation pending in the United States Court of International Trade. The Classification Litigation will determine whether darunavir ethanolate was properly classified as exempt from duties upon importation into the United States. The trial in the Classification Litigation was held in July 2019. In February 2020, the Court ruled that darunavir ethanolate is eligible for duty free treatment. In April 2020, the United States filed a Notice of Appeal to the United States Court of Appeals for the Federal Circuit. In August 2020, Janssen Ortho received notice that Janssen's Supplemental Petition for Relief from the Amended Penalty Notice was denied. In October 2020, USCBP agreed to hold the enforcement of penalties in abeyance pending resolution of the Classification litigation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In September 2020, Genmab A/S brought an arbitration against Janssen Biotech, Inc. pursuant to a 2012 License Agreement between the parties.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The arbitration relates to royalties for certain Janssen daratumumab products.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In March and April 2015, over 30 putative class action complaints were filed by contact lens patients in a number of courts around the United States against Johnson &amp; Johnson Vision Care, Inc. (JJVCI) and other contact lens manufacturers, distributors, and retailers, alleging vertical and horizontal conspiracies to fix the retail prices of contact lenses. The complaints allege that the manufacturers reached agreements with each other and certain distributors and retailers concerning the prices at which some contact lenses could be sold to consumers. The plaintiffs are seeking damages and injunctive relief. All of the class action cases were transferred to the United States District Court for the Middle District of Florida in June 2015. The plaintiffs filed a consolidated class action complaint in November 2015. In December 2018, the district court granted the plaintiffs' motion for class certification. Defendants filed two motions for interlocutory appeal of class certification to the United States Court of Appeals for the Eleventh Circuit. Both motions were denied. Defendants' motions for summary judgment were denied in November 2019. The parties await a trial date. </span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2015, two third-party payors filed a purported class action in the United States District Court for the Eastern District of Louisiana against Janssen Research &amp; Development, LLC, Janssen Ortho LLC, Janssen Pharmaceuticals, Inc., Ortho-</span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">McNeil-Janssen Pharmaceuticals, Inc. and Johnson &amp; Johnson (as well as certain Bayer entities), alleging that the defendants improperly marketed and promoted XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> as safer and more effective than less expensive alternative medications while failing to fully disclose its risks.  The complaint seeks damages.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In September 2017, Pfizer, Inc. (Pfizer) filed an antitrust complaint against Johnson &amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) in United States District Court for the Eastern District of Pennsylvania.  Pfizer alleges that Janssen has violated federal antitrust laws through its contracting strategies for REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  The complaint seeks damages and injunctive relief. Discovery is ongoing. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Beginning in September 2017, multiple purported class actions of direct and indirect purchasers were filed against Johnson &amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) alleging that Janssen&#8217;s REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> contracting strategies violated federal and state antitrust and consumer laws and seeking damages and injunctive relief.  In November 2017, the cases were consolidated for pre-trial purposes in United States District Court for the Eastern District of Pennsylvania as In re Remicade Antitrust Litigation. Motions to dismiss were denied in both the direct and indirect purchaser cases.  A motion to compel arbitration of the direct purchaser case was denied by the district court. The United States Court of Appeals for the Third Circuit reversed the district court's ruling.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2018, Walgreen Co. and Kroger Co, filed an antitrust complaint against Johnson &amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) in the United States District Court for the Eastern District of Pennsylvania.  The complaint alleges that Janssen has violated federal antitrust laws through its contracting strategies for REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  The complaint seeks damages and injunctive relief. In March 2019, summary judgment was granted in favor of Janssen. In February 2020, the United States Court of Appeals for the Third Circuit reversed the District Court&#8217;s decision.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2019, the United States Federal Trade Commission (FTC) issued a Civil Investigative Demand to Johnson &amp; Johnson in connection with its investigation of whether Janssen&#8217;s REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> contracting practices violate federal antitrust laws. The Company has produced documents and information responsive to the Civil Investigative Demand.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In October 2017, certain United States service members and their families brought a complaint against a number of pharmaceutical and medical devices companies, including Johnson &amp; Johnson and certain of its subsidiaries, alleging that the defendants violated the United States Anti-Terrorism Act.&#160; The complaint alleges that the defendants provided funding for terrorist organizations through their sales practices pursuant to pharmaceutical and medical device contracts with the Iraqi Ministry of Health. In January 2020, plaintiffs filed a Third Amended Complaint adding further plaintiffs to the lawsuit. In July 2020, the District Court dismissed the Third Amended Complaint.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In October 2018, two separate putative class actions were filed against Actelion Pharmaceutical Ltd., Actelion Pharmaceuticals US, Inc., and Actelion Clinical Research, Inc. (collectively Actelion) in United States District Court for the District of Maryland and United States District Court for the District of Columbia.&#160; The complaints allege that Actelion violated state and federal antitrust and unfair competition laws by allegedly refusing to supply generic pharmaceutical manufacturers with samples of TRACLEER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.&#160; TRACLEER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> is subject to a Risk Evaluation and Mitigation Strategy, which imposes restrictions on distribution of the product.&#160; In January 2019, the plaintiffs dismissed the District of Columbia case and filed a consolidated complaint in the United States District Court for the District of Maryland.&#160; In October 2019, the Court granted Actelion&#8217;s motion to dismiss the amended complaint. Plaintiffs have appealed the decision.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2018, Janssen Biotech, Inc., Janssen Oncology, Inc, Janssen Research &amp; Development, LLC, and Johnson &amp; Johnson (collectively, Janssen) were served with a </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> complaint filed on behalf of the United States, 28 states, and the District of Columbia.&#160; The complaint, which was filed in December 2017 in United States District Court for the Northern District of California, alleges that Janssen violated the federal False Claims Act and state law when providing pricing information for ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> to the government in connection with direct government sales and government-funded drug reimbursement programs.&#160; At this time, the federal and state governments have declined to intervene. The case has been transferred to United States District Court for the District of New Jersey. In September 2019, Janssen moved to dismiss the complaint. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2019, Blue Cross &amp; Blue Shield of Louisiana and HMO Louisiana, Inc. filed a class action complaint against Janssen Biotech, Inc, Janssen Oncology, Inc, Janssen Research &amp; Development, LLC and BTG International Limited in the United States District Court for the Eastern District of Virginia on behalf of indirect purchasers of ZYTIGA&#174;. Several additional complaints were filed thereafter in Virginia and New Jersey.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The indirect purchaser complaints generally allege that the defendants violated the antitrust and consumer protections laws of several states and the Sherman Act by pursuing patent litigation relating to ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in order to delay generic entry and seek damages. The Virginia cases have been transferred to </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">the United States District Court for the District of New Jersey and consolidated with the New Jersey case for pretrial purposes.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2020, a class action complaint was filed against Janssen Biotech Inc., Janssen Oncology, Inc., Janssen Research &amp; Development LLC and BTG International Limited in the United States District Court for the District of New Jersey, on behalf of direct purchasers of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The direct purchaser complaint alleges that defendants violated the Sherman Act by pursuing patent litigation relating to ZYTIGA&#174; in order to delay generic entry, and seek damages and injunctive relief. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In May 2019, a class action antitrust complaint was filed against Janssen R&amp;D Ireland (Janssen) and Johnson &amp; Johnson in the United States District Court for the Northern District of California.  The complaint alleges that Janssen violated federal and state antitrust and consumer protection laws by agreeing to exclusivity provisions in its agreements with Gilead concerning the development and marketing of combination antiretroviral therapies (cART) to treat HIV.  The complaint also alleges that Gilead entered into similar agreements with Bristol-Myers-Squibb and Japan Tobacco.  In March 2020, the Court granted in part and denied in part defendants&#8217; motions to dismiss.  Plaintiffs filed an amended complaint in April 2020. Defendants moved to dismiss the amended complaint.  In July 2020, the court granted in part and denied in part the renewed motion to dismiss.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In October 2019, Innovative Health, LLC filed a complaint against Biosense Webster, Inc. (BWI) in the United States District Court for the Middle District of California.  The complaint alleges that certain of BWI&#8217;s&#160;business practices and contractual terms violate the antitrust laws of the United States and the State of California by restricting competition in the sale of High Density Mapping Catheters and Ultrasound Catheters. In January 2020, BWI filed a motion to dismiss the complaint. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In August 2020, the court granted in part and denied in part BWI&#8217;s motion to dismiss.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2019, Johnson &amp; Johnson received a demand for indemnification from Pfizer Inc., pursuant to the 2006 Stock and Asset Purchase Agreement between the Company and Pfizer.  Also in November 2019, Johnson &amp; Johnson, Inc. received a demand for indemnification from Sanofi Consumer Health, Inc., pursuant to the 2016 Asset Purchase Agreement between J&amp;J, Inc. and Sanofi.  In January 2020, Johnson &amp; Johnson received a demand for indemnification from Boehringer Ingelheim Pharmaceuticals, Inc., pursuant to the 2006 Asset Purchase Agreement among the Company, Pfizer, and Boehringer Ingelheim.  The notices seek indemnification for legal claims related to over-the-counter Zantac (ranitidine) products. Plaintiffs in the underlying actions allege that Zantac and other over-the-counter ranitidine medications contain unsafe levels of NDMA (N-nitrosodimethylamine) and can cause and/or have caused various cancers in patients using the products, and seek injunctive and monetary relief.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In October 2020, Fortis Advisors LLC (Fortis), in its capacity as representative of the former stockholders of Auris Health Inc. (Auris), filed a complaint against Johnson &amp; Johnson, Ethicon Inc., and certain named officers and employees (collectively, Ethicon) in the Court of Chancery of the State of Delaware.   The complaint alleges breach of contract, fraud, and other causes of action against Ethicon in connection with Ethicon&#8217;s acquisition of Auris in 2019.  The complaint seeks damages and other relief.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Johnson &amp; Johnson or its subsidiaries are also parties to a number of proceedings brought under the Comprehensive Environmental Response, Compensation, and Liability Act, commonly known as Superfund, and comparable state, local or foreign laws in which the primary relief sought is the cost of past and/or future remediation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982091775912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring</a></td>
<td class="text">RESTRUCTURING<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company announced plans to implement a series of actions across its Global Supply Chain that are intended to focus resources and increase investments in the critical capabilities, technologies and solutions necessary to manufacture and supply its product portfolio, enhance agility and drive growth. The Global Supply Chain actions will include expanding the use of strategic collaborations and bolstering initiatives to reduce complexity, improve cost-competitiveness, enhance capabilities and optimize the Supply Chain network. For additional details on the Global Supply Chain restructuring strategic collaborations see Note 10 to the Consolidated Financial Statements. In the fiscal third quarter of 2020, the Company recorded a pre-tax charge of $130 million, which is included on the following lines of the Consolidated Statement of Earnings, $68 million in restructuring, $32 million in cost of products sold and $30 million in other (income) expense. In the fiscal nine months of 2020, the Company recorded a pre-tax charge of $363&#160;million, which is included on the following lines of the Consolidated Statement of Earnings, $187&#160;million in restructuring, $69&#160;million in cost of products sold and $107&#160;million in other (income) expense. Total project costs of approximately $1.2 billion have been recorded since the restructuring was announced. See the following table for additional details on the restructuring program. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In total, the Company expects the Global Supply Chain actions to generate approximately $0.6 billion to $0.8 billion in annual pre-tax cost savings that will be substantially delivered by 2022. The Company expects to record pre-tax restructuring charges of approximately $1.9 billion to $2.3 billion, over the 4 to 5 year period of this activity. These costs are associated with network optimizations, exit costs and accelerated depreciation and amortization.&#160; &#160;</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the severance related reserves and the associated restructuring expenses through the fiscal nine months of 2020:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%;"><tr><td style="width:1.0%;"/><td style="width:33.603%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.272%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.881%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.272%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:2.400%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.972%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Severance</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset Write-offs</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Other</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Reserve balance, December 29, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">164&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">180&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current year activity:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Charges  </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">308&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">363&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Cash payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(297)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(315)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Settled non cash </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(55)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(72)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Reserve balance, September 27, 2020</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">146&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">156&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Cash outlays for severance are expected to be substantially paid out over the next 2 years in accordance with the Company's plans and local laws. </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"> Other includes project expense such as salaries for employees supporting these initiatives and consulting expenses.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(3) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Relates to pension related actuarial losses associated with the transfer of employees to Jabil Inc. as part of the strategic collaboration.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company continuously reevaluates its severance reserves related to restructuring and the timing of payments due to the planned release of associates regarding several longer-term projects. The Company believes that the existing severance reserves are sufficient to cover the Global Supply Chain plans given the period over which the actions will take place. The Company will continue to assess and make adjustments as necessary if additional amounts become probable and estimable.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982094925224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The extent to which COVID-19 impacts the Company&#8217;s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts COVID-19 as of September 27, 2020 and through the date of this report. The accounting matters assessed included, but were not limited to, the Company&#8217;s allowance for doubtful accounts and credit losses, inventory and related reserves, accrued rebates and associated reserves, and the carrying value of the goodwill and other long-lived assets. While there was not a material impact to the Company&#8217;s consolidated financial statements as of and for the quarter ended September 27, 2020, the Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the Company&#8217;s consolidated financial statements in future reporting periods.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards Recently Adopted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">New Accounting Standards</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company assesses the adoption impacts of recently issued accounting standards by the Financial Accounting Standards Board on the Company's financial statements as well as material updates to previous assessments, if any, from the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. There were no new material accounting standards issued in the fiscal third quarter of 2020 that impacted the Company.</span></div><div style="margin-top:3pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Recently Adopted Accounting Standards</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There were no new accounting standards adopted in the fiscal third quarter of 2020.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Reclassification</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certain prior period amounts have been reclassified to conform to current year presentation.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982091705128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents, Policy</a></td>
<td class="text">The Company classifies all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months from the date of purchase as current marketable securities. Available for sale securities with stated maturities of greater than one year from the date of purchase are available to fund current operations and are classified as cash equivalents and current marketable securities.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982093495800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Summary of Inventories</a></td>
<td class="text"><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.070%;"><tr><td style="width:1.0%;"/><td style="width:51.896%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.736%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:20.622%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.736%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:22.310%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Raw materials and supplies</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,363&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,117&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goods in process</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,916&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,832&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,320&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,071&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Total inventories </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,599&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,020&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">See Note 10 to the Consolidated Financial Statements for details on assets held for sale and the related divestitures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982215042152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock', window );">Intangible Assets and Goodwill</a></td>
<td class="text"><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%;"><tr><td style="width:1.0%;"/><td style="width:61.104%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.587%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.325%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.587%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:16.697%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and trademarks &#8212; gross</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38,381&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,634&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,098&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,154&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and trademarks &#8212; net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,283&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,480&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer relationships and other intangibles &#8212; gross</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,455&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,056&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less accumulated amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,427&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,462&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer relationships and other intangibles&#160;&#8212; net*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,028&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,594&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,995&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,922&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Purchased in-process research and development </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,700&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,647&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total intangible assets with indefinite lives</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,695&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,569&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total intangible assets &#8212; net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">47,006&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">47,643&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">*The majority is comprised of customer relationships</span></div>(1) In the fiscal first quarter of 2020, the Company completed the acquisition of bermekimab and certain related assets from XBiotech Inc., as well as the acquisition of all outstanding shares in Verb Surgical Inc. and recorded in-process research and development intangible assets of $0.8 billion and $0.4 billion, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Goodwill</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Goodwill as of September&#160;27, 2020 was allocated by segment of business as follows:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.859%;"><tr><td style="width:1.0%;"/><td style="width:40.177%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.578%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.205%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:2.447%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.984%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:2.292%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.361%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:2.447%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.209%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consumer Health</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharmaceutical</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Medical Devices</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at December 29, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,736&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,169&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,734&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,639&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill, related to acquisitions</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">183&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">184&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency translation/Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">171&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">280&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">484&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at September 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,907&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,450&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,950&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34,307&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Intangible Asset Amortization Expense</a></td>
<td class="text"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The estimated amortization expense for approved products, before tax, for the five succeeding years is approximately:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%;"><tr><td style="width:1.0%;"/><td style="width:18.528%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.833%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:18.114%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.833%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.908%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.833%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.908%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.833%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.910%;"/><td style="width:0.1%;"/></tr><tr><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="margin-top:13pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">(Dollars in Millions)</span></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2021</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2022</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2023</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2024</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$4,500</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,300</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,100</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,100</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,900</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Finite and Indefinite-Lived Intangible Assets Excluding Goodwill by Major Class [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982094866008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Summary of Derivative Activity</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of the activity related to derivatives and hedges for the fiscal third quarters ended in 2020 and 2019, net of tax:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:19.102%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.259%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.836%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.547%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.413%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.125%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:5.970%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.836%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.836%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.413%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.563%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The effects of fair value, net investment and cash flow hedging:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on net investment hedging relationship:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on cash flow hedging relationship:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(81)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(77)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,911&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">156&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(36)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(41)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(197)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,939&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">84&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">89&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">65&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">159&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of the activity related to derivatives and hedges for the fiscal nine months ended in 2020 and 2019, net of tax:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:18.493%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.302%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.882%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.172%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.172%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.172%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.011%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.172%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.592%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.172%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.760%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The effects of fair value, net investment and cash flow hedging:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on net investment hedging relationship:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">117&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">117&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on cash flow hedging relationship:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(316)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(121)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(43)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(213)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,808&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">330&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(156)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(55)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(543)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,847&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">265&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">207&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">790&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">299&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is the effect of net investment hedges for the fiscal third quarters ended in 2020 and 2019</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:21.363%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.524%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.769%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.524%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.769%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.814%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:28.610%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.959%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.769%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.524%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.775%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Accumulated<br/>OCI</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From<br/>Accumulated OCI<br/>Into Income</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(169)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">162&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross Currency interest rate swaps</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(234)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is the effect of net investment hedges for the fiscal nine months ended in 2020 and 2019</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:21.396%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.525%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.075%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.525%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.785%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.815%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:28.072%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.961%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.930%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.525%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.791%;"/><td style="width:0.1%;"/></tr><tr><td colspan="33" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Accumulated OCI</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From<br/>Accumulated OCI<br/>Into Income</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(217)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">176&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross Currency interest rate swaps</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">407&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">465&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock', window );">Schedule of Derivatives Recorded in Consolidated Balance Sheet</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Effect of Derivatives not Designated as Hedging Instruments</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:27.160%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:2.698%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:16.871%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.959%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.494%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.814%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.494%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.494%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:2.118%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.498%;"/><td style="width:0.1%;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Income on Derivative</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Income on Derivative</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain /(Loss) Recognized in Income on Derivative</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(101)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="display:none;"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Summary of Activity Related to Equity Investments</a></td>
<td class="text"><div style="margin-bottom:7pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of the activity related to equity investments:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:25.476%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.001%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.365%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.851%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.464%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.550%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.963%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.851%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.662%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.550%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.667%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Changes in Fair Value Reflected in Net Income </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Sales/ Purchases/Other </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non Current Other Assets</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity Investments with readily determinable value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,148&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">161&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(169)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,140&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,140&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity Investments without readily determinable value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">712&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(36)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">742&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">742&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Recorded in Other Income/Expense</span></div><div style="text-indent:-36pt;padding-left:36pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> (2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Other includes impact of currency</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Financial Assets and Liabilities at Fair Value</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#8217;s significant financial assets and liabilities measured at fair value as of September&#160;27, 2020 and December&#160;29, 2019 were as follows:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:48.229%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.245%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.202%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:5.904%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.245%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.850%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Total</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">612&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">612&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">209&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Interest rate contracts </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)(3)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">635&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">635&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">693&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,247&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,247&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">902&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">327&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">327&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">426&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Interest rate contracts </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3) </sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">382&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">382&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">193&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">709&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">709&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">619&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">56&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">56&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Investments:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Equity investments </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(4)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,140&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,140&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,148&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Debt securities</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(5)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,391&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,391&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,368&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Contingent consideration </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(6)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">636&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">636&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,715&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><span><br/></span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:42.905%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.992%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:20.098%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.087%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:23.318%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross to Net Derivative Reconciliation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Gross Assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,311&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">925&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Credit Support Agreement (CSA)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,117)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(841)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Net Asset</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">194&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">84&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Gross Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">765&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">652&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Credit Support Agreement (CSA)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(737)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(586)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Net Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Summarized information about changes in liabilities for contingent consideration is as follows:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:74.774%;"><tr><td style="width:1.0%;"/><td style="width:41.269%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:2.410%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:25.606%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.406%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:25.609%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Beginning Balance</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,715&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">397&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Changes in estimated fair value </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(7) </sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,088)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">117&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additions</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">107&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,133&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Payments</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(98)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ending Balance</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">636&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,638&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;">December 30, 2019 assets and liabilities are all classified as Level 2 with the exception of equity investments of $1,148 million, which are classified as Level 1 and contingent consideration of $1,715 million, classified as Level 3.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;">Includes $1 million of non-current other assets as of December&#160;29, 2019.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(3)     </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Includes cross currency interest rate swaps and interest rate swaps.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">           (4)&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Classified as non-current other assets. </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(5)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;Classified within cash equivalents and current marketable securities.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(6)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;Includes $608 million and $1,631 million (primarily related to Auris Health at December 29, 2019), classified as non-current other liabilities as of September&#160;27, 2020 and December&#160;29, 2019, respectively.  Includes $28 million and $84 million classified as current liabilities as of September&#160;27, 2020 and December&#160;29, 2019, respectively.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">           (7)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">    Ongoing fair value adjustment amounts are primarily recorded in Research and Development expense. </span></div><div style="padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company recorded a contingent consideration reversal of $1,148 million related to the timing of certain developmental milestones associated with the Auris Health acquisition. The reversal of the contingent consideration was recorded in Other income and expense. For additional details see Note 10 </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">t</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">o the Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Marketable Securities</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company's cash, cash equivalents and current marketable securities as of September&#160;27, 2020 comprised:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.849%;"><tr><td style="width:1.0%;"/><td style="width:22.208%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.727%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.153%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.531%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.153%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.381%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.153%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.727%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.454%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.478%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.153%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.182%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrecognized Gain</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrecognized Loss</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash &amp; Cash Equivalents</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current Marketable Securities</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,231&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,231&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,231&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Non-U.S. sovereign securities</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">647&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">647&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">647&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. reverse repurchase agreements</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,094&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,094&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,094&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other reverse repurchase agreements</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">430&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">430&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">430&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Corporate debt securities</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,843&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,843&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">571&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,272&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,485&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,485&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,485&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Time deposits</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">660&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">660&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">660&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Subtotal </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,390&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,390&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,471&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,919&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized Gain</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized Loss</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. Gov't securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,133&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,134&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,483&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,651&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other sovereign securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate debt securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">247&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">247&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">236&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;Subtotal available for sale debt</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,390&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,391&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,494&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,897&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total cash, cash equivalents and current marketable securities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30,780&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30,781&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,965&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,816&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Held to maturity investments are reported at amortized cost and gains or losses are reported in earnings. </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Available for sale debt securities are reported at fair value with unrealized gains and losses reported net of taxes in other comprehensive income.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Available for Sale Securities Maturities</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The contractual maturities of the available for sale securities as of September&#160;27, 2020 are as follows:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:76.426%;"><tr><td style="width:1.0%;"/><td style="width:43.104%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:2.829%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:22.279%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:2.157%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:25.031%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost Basis</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Due within one year</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,368&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,369&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Due after one year through five years</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Due after five years through ten years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,390&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,391&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Financial Liabilities not Measured at Fair Value</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Financial Instruments not measured at Fair Value:</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following financial liabilities are held at carrying amount on the consolidated balance sheet as of September&#160;27, 2020:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:79.838%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.533%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.137%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.533%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.259%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Financial Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current Debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,078&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,093&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-Current Debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.45% Notes due 2021</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">350&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">358&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">0.250% Notes due 2022 (1B Euro 1.1641)</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,163&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,172&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.25% Notes due 2022</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">998&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,025&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">6.73% Debentures due 2023</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">250&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">299&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3.375% Notes due 2023</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">803&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">881&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.05% Notes due 2023</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">499&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">518&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">0.650% Notes due 2024 (750MM Euro 1.1641)</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">870&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">899&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5.50% Notes due 2024 (500 MM GBP 1.2757)</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">634&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">768&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.625% Notes due 2025</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">748&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">813&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">0.55% Notes due 2025</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">996&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">990&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.45% Notes due 2026</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,994&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,180&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.95% Notes due 2027</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">997&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,119&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">0.95% Notes due 2027</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,494&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,510&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.90%&#160;Notes due 2028</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,494&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,680&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">1.150% Notes due 2028 (750MM Euro 1.1641)</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">867&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">960&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">6.95% Notes due 2029</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">441&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">1.30% Notes due 2030</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,743&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,739&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">4.95% Debentures due 2033</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">498&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">690&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">4.375% Notes due 2033</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">855&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,128&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">1.650% Notes due 2035 (1.5B Euro 1.1641)</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,731&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,101&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3.55% Notes due 2036</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">989&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,197&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5.95% Notes due 2037</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">992&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,536&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3.625% Notes due 2037</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,488&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,819&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3.40%&#160;Notes due 2038</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">991&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,176&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">5.85% Debentures due 2038</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">696&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,094&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">4.50% Debentures due 2040</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">539&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">737&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.10% Notes due 2040</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">986&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">991&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">4.85% Notes due 2041</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">421&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">4.50% Notes due 2043</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">495&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">689&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3.70% Notes due 2046</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,974&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,478&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3.75% Notes due 2047</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">991&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,258&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">3.50% Notes due 2048</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">742&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">921&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.25% Notes due 2050</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">984&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">984&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">2.45% Notes due 2060</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,228&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,230&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Non-Current Debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32,680&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37,812&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative liabilities at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982092970344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pensions and Other Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Components of Net Periodic Benefit Cost</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net periodic benefit costs for the Company&#8217;s defined benefit retirement plans and other benefit plans for the fiscal third quarters and fiscal nine months of 2020 and 2019 include the following components:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%;"><tr><td style="width:1.0%;"/><td style="width:25.331%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.534%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.270%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.534%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.270%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.534%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.270%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.534%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.270%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.827%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.270%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.534%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.270%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.534%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.270%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.534%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.714%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retirement Plans</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Benefit Plans</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retirement Plans</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Benefit Plans</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Service cost</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">330&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">275&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">72&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">68&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">979&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">828&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">216&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">205&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">238&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">273&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">715&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">822&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">99&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">138&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(617)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(578)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,839)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,742)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of prior service cost/(credit)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Recognized actuarial losses</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">224&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">145&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">669&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">435&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">107&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">97&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Curtailments and settlements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net periodic benefit cost</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">175&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">112&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">544&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">349&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">394&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">412&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982206699784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Components of Accumulated Other Comprehensive Income</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Components of other comprehensive income (loss) consist of the following:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%;"><tr><td style="width:1.0%;"/><td style="width:34.774%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.547%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.914%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.547%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.662%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.846%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.719%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.547%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.306%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.547%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:16.991%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Accumulated</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">On</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefit</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">On Derivatives</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Comprehensive</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Translation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Securities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Plans</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&amp; Hedges</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income (Loss)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8,705)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6,891)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(295)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15,891)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(741)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">587&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,106&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">953&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9,446)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6,304)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">811&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14,938)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982091791864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of Basic Net Earnings per Share to Diluted Net Earnings per Share</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following is a reconciliation of basic net earnings per share to diluted net earnings per share for the fiscal third quarters and fiscal nine months ended September&#160;27, 2020 and September&#160;29, 2019:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:48.325%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.805%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.400%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:1.380%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.974%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.518%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.532%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.518%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.248%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Shares in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic net earnings per share </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.35&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.67&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.93&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.19&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Average shares outstanding &#8212; basic</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,632.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,635.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,633.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,649.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Potential shares exercisable under stock option plans</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">115.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">117.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">120.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: shares which could be repurchased under treasury stock method</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(78.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(83.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(82.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(99.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Convertible debt shares</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Average shares outstanding &#8212; diluted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,669.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,669.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,670.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,688.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted net earnings per share</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.86&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.13&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982093060584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business and Geographic Areas (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_SalesBySegmentOfBusinessTableTextBlock', window );">Sales By Segment Of Business</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">SALES BY SEGMENT OF BUSINESS </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:35.144%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.633%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.643%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent Change</span></td></tr><tr><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consumer Health*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">OTC</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">601&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">477&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,917&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,468&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">541&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">621&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,722&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,781&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,142&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,098&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,639&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,249&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Skin Health/Beauty</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">572&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">559&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,767&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,810&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">577&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">592&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,506&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,633&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,151&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,273&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,443&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oral Care</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">164&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">156&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">510&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">462&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">248&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">223&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">694&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">673&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">412&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">379&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,204&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,135&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Baby Care</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">279&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">277&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">302&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">326&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">831&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">977&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">393&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">417&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,110&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,254&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Women's Health</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">227&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">252&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">654&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">724&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">230&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">255&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">664&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">733&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Wound Care/Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">125&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">109&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">370&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">343&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">175&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">173&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">189&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">168&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">545&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">516&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">TOTAL </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Consumer Health</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,556&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,394&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,853&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,369&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,958&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,075&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,582&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,962&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,514&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,469&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,435&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,331&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">* Previously referred to as Consumer</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:35.144%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.633%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.643%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PHARMACEUTICAL</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Immunology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,558&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,582&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,330&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,124&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,230&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,129&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,619&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,304&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,789&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,711&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,950&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,428&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">634&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">749&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,852&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,324&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S. Exports</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">88&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">321&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">209&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">299&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">673&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">795&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">921&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,136&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,846&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,345&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">SIMPONI / SIMPONI ARIA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">312&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">840&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">857&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">280&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">273&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">827&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">816&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">592&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">586&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,667&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,673&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">STELARA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,313&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,212&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,668&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">634&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">487&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,795&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,509&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,947&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,698&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,463&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,661&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">TREMFYA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">222&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">221&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">650&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">565&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.0%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">105&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">54.4</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">316&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">177&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78.7</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">327&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">290&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.1</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">965&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">742&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">30.2%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER IMMUNOLOGY</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.6</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.4</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.6</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.4</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Infectious Diseases</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">413&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">418&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,265&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,162&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">451&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">421&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,397&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,385&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">864&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">839&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,662&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,547&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">EDURANT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / rilpivirine</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">206&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">684&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">603&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">236&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">218&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">716&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">639&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / PREZCOBIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> /  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">                         </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">                     REZOLSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / SYMTUZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">379&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">373&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,154&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,032&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">147&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">135&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">461&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">534&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">526&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">508&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,615&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,566&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER INFECTIOUS DISEASES</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(26.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">79&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">94&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">80&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">252&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">248&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">102&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">113&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">331&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">342&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:35.144%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.633%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.643%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Neuroscience</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">759&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">785&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,285&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,172&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">846&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">810&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,565&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,590&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,605&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,595&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,850&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,762&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">CONCERTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / methylphenidate</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">84&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(49.2)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">107&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">109&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">319&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">348&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">193&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">469&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">544&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / XEPLION</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / INVEGA   TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / TREVICTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">585&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">554&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,704&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,543&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">341&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">983&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">916&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">926&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">851&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,688&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,459&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;RISPERDAL CONSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">70&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">79&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">220&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">237&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">81&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">89&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">254&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">292&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">167&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">475&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">528&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER NEUROSCIENCE</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">68&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">317&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">316&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,008&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,035&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">377&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">384&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,218&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,231&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,267&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,171&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,623&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,146&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,862&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,590&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,310&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,830&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,129&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,761&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,933&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,976&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">DARZALEX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">585&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">402&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,540&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,123&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">514&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">363&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,397&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,045&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,099&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">765&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,937&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,168&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">ERLEADA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"> </span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">74&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">407</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">194</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">112</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">206&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">86&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">519</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">216</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">450&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">447&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,329&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,163&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">581&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">475&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,682&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,373&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,031&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">921&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,011&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,536&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">VELCADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">105&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">311&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">636&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(51.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">105&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">311&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">636&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(51.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"> / </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">abiraterone acetate</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">58&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">233&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(75.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">284&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">616&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(53.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">532&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">508&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,564&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,502&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">590&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,848&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,118&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:35.144%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.633%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.643%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER ONCOLOGY</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.3</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">63&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">51&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">76&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">83&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.8)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">244&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">252&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">98&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.7)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">308&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">303&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pulmonary Hypertension</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">510&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">427&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.4</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,541&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,296&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">239&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">227&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.2</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">742&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">704&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">749&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">654&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.5</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,283&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">244&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">206&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.1</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">729&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">581&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">148&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.5</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">458&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">419&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">392&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">347&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.0</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,187&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,001&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">185&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.4</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">692&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">536&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.3</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">260&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23.6</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">792&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">611&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER PULMONARY HYPERTENSION</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.5</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">121&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">179&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(32.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">57&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.7)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">183&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">97&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">96&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">304&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">388&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cardiovascular / Metabolism / Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">931&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">955&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,574&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,804&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">351&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">360&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,052&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,131&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,281&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,316&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,625&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,936&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">630&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">613&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,716&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,704&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">630&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">613&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,716&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,704&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">156&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">125&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">405&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">411&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">68&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">173&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">147&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">224&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">179&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">578&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">558&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;PROCRIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / EPREX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">126&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(45.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">215&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">387&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(44.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">63&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">72&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">208&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">220&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">198&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">423&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">607&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">91&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">238&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">302&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">219&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">234&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">670&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">765&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">294&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">325&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">908&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,067&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TOTAL PHARMACEUTICAL</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,438&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,340&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,619&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17,705&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,980&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,537&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,685&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,945&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,418&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,877&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,304&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,650&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:35.144%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.633%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.643%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MEDICAL DEVICES</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interventional Solutions</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">399&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">357&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,019&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,066&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">437&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">382&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,134&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,156&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">836&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,153&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,223&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Orthopaedics</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,308&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,301&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,427&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,950&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">774&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">837&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,145&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,616&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,083&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,138&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,572&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,566&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">HIPS</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">221&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">204&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">564&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">633&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">124&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">133&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">344&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">428&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(19.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">345&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">336&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">908&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,061&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">KNEES</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">205&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">209&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">527&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">650&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(19.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">102&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">136&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">298&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">435&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(31.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">308&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">344&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">825&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,085&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">TRAUMA</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">433&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">415&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,194&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,239&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">253&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">262&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">698&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">795&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">685&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">677&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,892&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,034&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">SPINE, SPORTS &amp; OTHER</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">449&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">472&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,142&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,427&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">295&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">306&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">805&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">957&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">745&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">778&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,947&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,384&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Surgery</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">913&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">940&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,247&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,867&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,239&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,371&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,556&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,192&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,311&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,803&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,059&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">ADVANCED</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">421&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">409&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,079&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,209&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">579&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">602&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,644&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,811&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,000&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,010&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,723&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,019&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#160;&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">GENERAL</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">492&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">531&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,168&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,658&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">660&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">769&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,912&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,381&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(19.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,301&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,080&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,040&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vision</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">473&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">459&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,160&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,366&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">608&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">734&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,683&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,117&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,081&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,193&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,843&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,483&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#160;&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">CONTACT LENSES / OTHER</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">375&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">339&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">924&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">993&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">455&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">555&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,274&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,566&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">830&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">893&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,198&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,559&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:35.144%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.525%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.633%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.234%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.643%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#160;&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">SURGICAL</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">98&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">120&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">236&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">373&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(36.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">153&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">180&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">409&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">551&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">251&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">299&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">645&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">923&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TOTAL MEDICAL DEVICES</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,092&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,057&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,852&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,249&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,058&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,326&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,518&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,082&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,150&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,383&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16,370&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,331&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">WORLDWIDE</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,086&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,791&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,324&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,323&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,996&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,938&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28,785&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,989&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,082&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,729&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60,109&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61,312&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">*Percentage greater than 100% or not meaningful</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Operating Profit by Segment of Business</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">EARNINGS BEFORE PROVISION FOR TAXES BY SEGMENT  </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.710%;"><tr><td style="width:1.0%;"/><td style="width:36.109%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.365%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.219%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.475%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.365%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.219%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.192%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29,<br/>2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>Change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29,<br/>2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Consumer Health </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">191&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">653&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(70.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">993&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,800&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(44.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Pharmaceutical</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,439&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(222)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,787&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,786&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Medical Devices</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,010&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,392&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(27.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,681&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,078&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(55.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment earnings before provision for taxes</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,640&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,823&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15,461&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,664&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Less: Expense not allocated to segments</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"> (4)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">239&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">176&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">611&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">554&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Worldwide income before tax</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,401&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,647&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,850&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,110&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">*Percentage greater than 100% or not meaningful</span></div><div><span><br/></span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Consumer Health</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a gain of $0.3 billion related to the Company's previously held equity investment in Ci:z Holdings Co., Ltd. (DR. CI: LABO) in the fiscal nine months of 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:13.8pt;">Includes litigation expense of $0.5&#160;billion in the fiscal third quarter of 2020, primarily talc related costs, including certain settlements. Includes litigation expense of $1.2&#160;billion and $0.2&#160;billion in both the fiscal nine months of 2020 and 2019, primarily talc related costs, including certain settlements. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes amortization expense of $0.1 billion in both the fiscal third quarters of 2020 and 2019, respectively and $0.3&#160;billion in both the fiscal nine months of 2020 and 2019, respectively.</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a restructuring related charge of $0.1&#160;billion in both the fiscal nine months of 2020 and 2019, respectively.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Pharmaceutical</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes an in-process research and development expense of $0.9 billion related to the Alios asset in the fiscal nine months of 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes litigation expense of $1.0&#160;billion and $4.0&#160;billion in the fiscal third quarters of 2020 and 2019 and $1.0&#160;billion and $4.3 billion in the fiscal nine months of 2020 and 2019, respectively. Litigation expense in all periods is primarily related to the agreement in principle to settle opioid litigation. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes an unrealized loss on securities of $0.1&#160;billion in the fiscal third quarter of 2019. Includes an unrealized gain on securities of $0.2&#160;billion in both the fiscal nine months of 2020 and 2019, respectively. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a research and development expense of $0.3 billion in the fiscal nine months of 2019, for an upfront payment related to argenx. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes amortization expense of $0.8 billion in both the fiscal third quarters of 2020 and 2019. Includes amortization expense of $2.4&#160;billion in both the fiscal nine months of 2020 and 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a restructuring related charge of $0.1&#160;billion in both the fiscal nine months of 2020 and 2019, respectively. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes Actelion acquisition related costs of $0.1&#160;billion in the fiscal nine months of 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">In the fiscal second and third quarters of 2020, the Company entered into a series of contract manufacturing arrangements for vaccine production with third party contract manufacturing organizations. These arrangements provide the Company with future supplemental commercial capacity for vaccine production and potentially transferable rights to such production if capacity is not required. Amounts paid and contractually obligated to be paid to these contract manufacturing organizations of approximately $0.8&#160;billion are reflected in the prepaid expenses and other, other assets, accrued liabilities and other liabilities accounts in the Company's consolidated balance sheet upon execution of each agreement. Additionally, the Company has entered into certain vaccine development cost sharing arrangements with government related organizations. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:96%;"> </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(3) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Medical Devices </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a contingent consideration reversal of $0.2&#160;billion in the fiscal third quarter of 2020 and $1.1 billion in the fiscal nine months of 2020 related to the timing of certain developmental milestones associated with the Auris Health acquisition. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a gain of $2.0&#160;billion from the divestiture of the ASP business in the fiscal nine months of 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes litigation expense of $0.3&#160;billion in the fiscal nine months of 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a restructuring related charge of $0.1 billion and amortization expense of $0.2 billion in both the fiscal third quarters of 2020 and 2019.  </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes a restructuring related charge of $0.2&#160;billion and amortization expense of $0.7&#160;billion in both the fiscal nine months of 2020 and 2019. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Includes an in-process research and development expense of $0.1&#160;billion in the fiscal third quarter of 2020 and fiscal nine months of 2020. </span></div>(4) Amounts not allocated to segments include interest income/expense and general corporate income/expense.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas</a></td>
<td class="text"><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">SALES BY GEOGRAPHIC AREA</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.275%;"><tr><td style="width:1.0%;"/><td style="width:32.038%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.994%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.410%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.243%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.821%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.994%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.821%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.410%;"/><td style="width:0.1%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.253%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Third Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Nine Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 27, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">September 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,086&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,791&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,324&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31,323&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Europe</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,819&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,461&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,709&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,803&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Western Hemisphere, excluding U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,296&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,488&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,931&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,446&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asia-Pacific, Africa</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,881&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,989&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,145&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,740&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,082&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,729&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">60,109&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61,312&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_SalesBySegmentOfBusinessTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales by segment of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_SalesBySegmentOfBusinessTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8721-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982093496520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 27, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the severance related reserves and the associated restructuring expenses through the fiscal nine months of 2020:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%;"><tr><td style="width:1.0%;"/><td style="width:33.603%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.272%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.881%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:14.272%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:2.400%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.972%;"/><td style="width:0.1%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Severance</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset Write-offs</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Other</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Reserve balance, December 29, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">164&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">180&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current year activity:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Charges  </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">308&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">363&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Cash payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(297)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(315)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Settled non cash </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(55)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(72)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Reserve balance, September 27, 2020</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">146&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">156&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"/></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Cash outlays for severance are expected to be substantially paid out over the next 2 years in accordance with the Company's plans and local laws. </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"> Other includes project expense such as salaries for employees supporting these initiatives and consulting expenses.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(3) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Relates to pension related actuarial losses associated with the transfer of employees to Jabil Inc. as part of the strategic collaboration.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company continuously reevaluates its severance reserves related to restructuring and the timing of payments due to the planned release of associates regarding several longer-term projects. The Company believes that the existing severance reserves are sufficient to cover the Global Supply Chain plans given the period over which the actions will take place. The Company will continue to assess and make adjustments as necessary if additional amounts become probable and estimable.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982091507736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Raw materials and supplies</a></td>
<td class="nump">$ 1,363<span></span>
</td>
<td class="nump">$ 1,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Goods in process</a></td>
<td class="nump">1,916<span></span>
</td>
<td class="nump">1,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">6,320<span></span>
</td>
<td class="nump">6,071<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 9,599<span></span>
</td>
<td class="nump">$ 9,020<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982108375608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets and Goodwill (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Intangible assets with indefinite lives:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-Lived Intangible Assets</a></td>
<td class="nump">$ 12,695<span></span>
</td>
<td class="nump">$ 11,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets - net</a></td>
<td class="nump">47,006<span></span>
</td>
<td class="nump">47,643<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Intangible assets with indefinite lives:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-Lived Intangible Assets</a></td>
<td class="nump">6,995<span></span>
</td>
<td class="nump">6,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PurchasedInProcessResearchAndDevelopmentMember', window );">Purchased In-Process Research And Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Intangible assets with indefinite lives:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-Lived Intangible Assets</a></td>
<td class="nump">5,700<span></span>
</td>
<td class="nump">4,647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PatentsAndTrademarksMember', window );">Patents And Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Intangible assets with definite lives:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">38,381<span></span>
</td>
<td class="nump">36,634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less accumulated amortization</a></td>
<td class="nump">16,098<span></span>
</td>
<td class="nump">13,154<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">22,283<span></span>
</td>
<td class="nump">23,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Customer relationships and other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Intangible assets with definite lives:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">22,455<span></span>
</td>
<td class="nump">22,056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less accumulated amortization</a></td>
<td class="nump">10,427<span></span>
</td>
<td class="nump">9,462<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 12,028<span></span>
</td>
<td class="nump">$ 12,594<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PurchasedInProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PurchasedInProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PatentsAndTrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PatentsAndTrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982108369304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Goodwill By Segment (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 27, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning of Period</a></td>
<td class="nump">$ 33,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, related to acquisitions</a></td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Currency translation/Other</a></td>
<td class="nump">484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill End of Period</a></td>
<td class="nump">34,307<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health*</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning of Period</a></td>
<td class="nump">9,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, related to acquisitions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Currency translation/Other</a></td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill End of Period</a></td>
<td class="nump">9,907<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning of Period</a></td>
<td class="nump">9,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, related to acquisitions</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Currency translation/Other</a></td>
<td class="nump">280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill End of Period</a></td>
<td class="nump">9,450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">Medical Devices</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning of Period</a></td>
<td class="nump">14,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, related to acquisitions</a></td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Currency translation/Other</a></td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill End of Period</a></td>
<td class="nump">$ 14,950<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillOtherIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease), classified as other, of an asset representing the future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillOtherIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982107756840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Mar. 29, 2020</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">$ 12,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IntangibleAssetsAndGoodwillTextualsAbstract', window );"><strong>Intangible Assets and Goodwill (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense of amortizable intangible assets</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PatentsAndTrademarksMember', window );">Patents And Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IntangibleAssetsAndGoodwillTextualsAbstract', window );"><strong>Intangible Assets and Goodwill (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Assets, Weighted-Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Customer relationships and other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IntangibleAssetsAndGoodwillTextualsAbstract', window );"><strong>Intangible Assets and Goodwill (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Assets, Weighted-Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">21 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PurchasedInProcessResearchAndDevelopmentMember', window );">Purchased In-Process Research And Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">$ 5,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PurchasedInProcessResearchAndDevelopmentMember', window );">Purchased In-Process Research And Development | bermekimab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PurchasedInProcessResearchAndDevelopmentMember', window );">Purchased In-Process Research And Development | Verb Surgical Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_IntangibleAssetsAndGoodwillTextualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets and Goodwill Textuals Abstract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_IntangibleAssetsAndGoodwillTextualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PatentsAndTrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PatentsAndTrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PurchasedInProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PurchasedInProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_BermekimabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_BermekimabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_VerbSurgicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_VerbSurgicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982093100456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Intangible Asset Amortization Expense (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 27, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2020</a></td>
<td class="nump">$ 4,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2021</a></td>
<td class="nump">4,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2022</a></td>
<td class="nump">4,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2023</a></td>
<td class="nump">4,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2024</a></td>
<td class="nump">$ 3,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982099471464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Available-for-sale Securities, Equity Securities</a></td>
<td class="nump">$ 1,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">Accumulated other comprehensive income on derivatives, after tax</a></td>
<td class="nump">811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss', window );">Reclassification of foreign exchange contracts into earnings, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">next 12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge', window );">Maximum length of time for hedge exposure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gains on equity investments</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average interest rate on non-current debt</a></td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ExcessOfFairValueOverCarryingValueOfDebt', window );">Excess of the estimated fair value over the carrying value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Current Debt</a></td>
<td class="nump">$ 5,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue', window );">Reversal of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,088<span></span>
</td>
<td class="num">(117)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Current Debt</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate</a></td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Forward foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollateralAlreadyPostedAggregateFairValue', window );">Collateral Already Posted, Aggregate Fair Value</a></td>
<td class="nump">$ 380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">43,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">26,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest Rate Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithoutReadilyDeterminableValueMember', window );">Equity Investments without readily determinable value | Equity Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EquityFairValueAdjustmentImpairmentLoss', window );">Equity, Fair Value Adjustment, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EquityFairValueAdjustmentChangeInObservablePrice', window );">Equity, Fair Value Adjustment, Change In Observable Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity Securities without Readily Determinable Fair Value, Amount</a></td>
<td class="nump">742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityFairValueAdjustment', window );">Changes in Fair Value Reflected in Net Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithReadilyDeterminableValueMember', window );">Equity Investments with readily determinable value | Equity Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityFairValueAdjustment', window );">Changes in Fair Value Reflected in Net Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember', window );">Other (income) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging [Member] | Sales [Member] | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging [Member] | Cost of Sales [Member] | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging [Member] | Research and Development Expense [Member] | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging [Member] | Interest Income Expense Net Member | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging [Member] | Other (income) expense | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Sales [Member] | Forward foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">16<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Sales [Member] | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Cost of Sales [Member] | Forward foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="num">(81)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="num">(316)<span></span>
</td>
<td class="num">(213)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">156<span></span>
</td>
<td class="num">(197)<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="num">(543)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Cost of Sales [Member] | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Research and Development Expense [Member] | Forward foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="num">(13)<span></span>
</td>
<td class="nump">1,911<span></span>
</td>
<td class="num">(121)<span></span>
</td>
<td class="nump">1,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="num">(36)<span></span>
</td>
<td class="nump">1,939<span></span>
</td>
<td class="num">(156)<span></span>
</td>
<td class="nump">1,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Research and Development Expense [Member] | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Interest Income Expense Net Member | Forward foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Interest Income Expense Net Member | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">159<span></span>
</td>
<td class="nump">790<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Other (income) expense | Forward foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="num">(41)<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Other (income) expense | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_EquityFairValueAdjustmentChangeInObservablePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity, Fair Value Adjustment, Change In Observable Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_EquityFairValueAdjustmentChangeInObservablePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_EquityFairValueAdjustmentImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity, Fair Value Adjustment, Impairment Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_EquityFairValueAdjustmentImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_ExcessOfFairValueOverCarryingValueOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of fair value over carrying value of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_ExcessOfFairValueOverCarryingValueOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Change In Estimated Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollateralAlreadyPostedAggregateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value of assets that are already posted, at the end of the reporting period, as collateral for derivative instruments with credit-risk-related contingent features.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4H<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollateralAlreadyPostedAggregateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings. Excludes recognition under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109974929&amp;loc=SL110061172-113977<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=112277219&amp;loc=d3e80845-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the transactions or other events that will result in the reclassification into earnings of gains or losses reported in accumulated other comprehensive income. May include the time period over which gains or losses will be reclassified to earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=112277219&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which an instrument classified in shareholders' equity could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116654751&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=112277219&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109974929&amp;loc=SL110061190-113977<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithoutReadilyDeterminableValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithoutReadilyDeterminableValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithReadilyDeterminableValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithReadilyDeterminableValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jnj_InterestIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jnj_InterestIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982108441352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Derivative Activity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Gain/ (Loss) reclassified from Accumulated OCI into income</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">$ 1,955<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="nump">$ 1,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">1,922<span></span>
</td>
<td class="nump">1,052<span></span>
</td>
<td class="nump">1,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember', window );">Other (income) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Forward foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollateralAlreadyPostedAggregateFairValue', window );">Collateral Already Posted, Aggregate Fair Value</a></td>
<td class="nump">380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">43,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">26,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Cross currency interest rate swaps | Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Cross currency interest rate swaps | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Cross currency interest rate swaps | Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Cross currency interest rate swaps | Other (income) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Cross currency interest rate swaps | Interest (income)/Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Forward foreign exchange contracts | Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">16<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Forward foreign exchange contracts | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">156<span></span>
</td>
<td class="num">(197)<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="num">(543)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="num">(81)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="num">(316)<span></span>
</td>
<td class="num">(213)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Forward foreign exchange contracts | Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="num">(36)<span></span>
</td>
<td class="nump">1,939<span></span>
</td>
<td class="num">(156)<span></span>
</td>
<td class="nump">1,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="num">(13)<span></span>
</td>
<td class="nump">1,911<span></span>
</td>
<td class="num">(121)<span></span>
</td>
<td class="nump">1,808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Forward foreign exchange contracts | Other (income) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="num">(41)<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="num">(8)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Forward foreign exchange contracts | Interest (income)/Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Cross currency interest rate swaps | Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Cross currency interest rate swaps | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Cross currency interest rate swaps | Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Cross currency interest rate swaps | Other (income) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Cross currency interest rate swaps | Interest (income)/Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">159<span></span>
</td>
<td class="nump">790<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
<td class="nump">$ 265<span></span>
</td>
<td class="nump">$ 207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative instruments gain loss on statement of financial performance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollateralAlreadyPostedAggregateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value of assets that are already posted, at the end of the reporting period, as collateral for derivative instruments with credit-risk-related contingent features.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4H<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollateralAlreadyPostedAggregateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings. Excludes recognition under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109974929&amp;loc=SL110061172-113977<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=112277219&amp;loc=d3e80845-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109974929&amp;loc=SL110061190-113977<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jnj_InterestIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jnj_InterestIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982189239528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Derivatives Recorded in Consolidated Balance Sheet (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 636<span></span>
</td>
<td class="nump">$ 1,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Carrying Amount of the Hedged Liability</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982107337032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Effect of Derivatives not Designated as Hedging Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,715<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Forward foreign exchange contracts | Other (income) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain/(Loss) Recognized In Income on Derivative</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
<td class="num">$ (101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982100737320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Effect of Net Investment Hedges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax</a></td>
<td class="num">(169)<span></span>
</td>
<td class="nump">$ 162<span></span>
</td>
<td class="num">(217)<span></span>
</td>
<td class="nump">$ 176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SaleOfSubsidiaryGainLossMember', window );">Sale of Subsidiary Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember', window );">Other Income Expense Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross Currency Interest Rate Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax</a></td>
<td class="num">$ (234)<span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
<td class="nump">$ 407<span></span>
</td>
<td class="nump">$ 465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=112277219&amp;loc=d3e80845-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL109998896-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109974929&amp;loc=SL110061190-113977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SaleOfSubsidiaryGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SaleOfSubsidiaryGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982112812328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Activity Related to Equity Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherInvestmentNotReadilyMarketableLineItems', window );"><strong>Other Investment Not Readily Marketable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 636<span></span>
</td>
<td class="nump">$ 1,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EquityInvestmentRollForward', window );"><strong>Equity Investment [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Non Current Other Assets</a></td>
<td class="nump">6,131<span></span>
</td>
<td class="nump">$ 5,695<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities | Equity Investments with readily determinable value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EquityInvestmentRollForward', window );"><strong>Equity Investment [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Carrying value, beginning of period</a></td>
<td class="nump">1,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityFairValueAdjustment', window );">Changes in Fair Value Reflected in Net Income</a></td>
<td class="nump">161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod', window );">Sales/ Purchases/Other</a></td>
<td class="num">(169)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Carrying value, end of period</a></td>
<td class="nump">1,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Non Current Other Assets</a></td>
<td class="nump">1,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities | Equity Investments without readily determinable value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EquityInvestmentRollForward', window );"><strong>Equity Investment [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Carrying value, beginning of period</a></td>
<td class="nump">712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityFairValueAdjustment', window );">Changes in Fair Value Reflected in Net Income</a></td>
<td class="num">(36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod', window );">Sales/ Purchases/Other</a></td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Carrying value, end of period</a></td>
<td class="nump">742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Non Current Other Assets</a></td>
<td class="nump">$ 742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_EquityInvestmentRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Investment [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_EquityInvestmentRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Investments, Increase (Decrease) from Acquisition (Sale) During Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which an instrument classified in shareholders' equity could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116654751&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestmentNotReadilyMarketableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestmentNotReadilyMarketableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithReadilyDeterminableValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithReadilyDeterminableValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithoutReadilyDeterminableValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithoutReadilyDeterminableValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982102981160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Financial Assets and Liabilities at Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
<th class="th"><div>Apr. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">$ 1,247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Available-for-sale Securities, Equity Securities</a></td>
<td class="nump">1,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">13,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Gross Assets</a></td>
<td class="nump">1,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueGrossLiability', window );">Credit Support Agreement (CSA)</a></td>
<td class="num">(1,117)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(841)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Total Net Asset</a></td>
<td class="nump">194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Gross Liabilities</a></td>
<td class="nump">765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueGrossAsset', window );">Credit Support Agreement (CSA)</a></td>
<td class="num">(737)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(586)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Total Net Liabilities</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning Balance</a></td>
<td class="nump">636<span></span>
</td>
<td class="nump">$ 1,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue', window );">Changes in estimated fair value (7)</a></td>
<td class="num">(1,088)<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">1,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments</a></td>
<td class="num">(98)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending Balance</a></td>
<td class="nump">1,715<span></span>
</td>
<td class="nump">397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration reversal</a></td>
<td class="num">(1,148)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted prices in active markets for identical assets and liabilities Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Available-for-sale Securities, Equity Securities</a></td>
<td class="nump">1,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant other observable inputs Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">1,247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Available-for-sale Securities, Equity Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">13,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant unobservable inputs Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Available-for-sale Securities, Equity Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest Rate Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Assets, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest Rate Contract | Quoted prices in active markets for identical assets and liabilities Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest Rate Contract | Significant other observable inputs Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest Rate Contract | Significant unobservable inputs Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Forward foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">43,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivatives not designated as hedging instruments : Assets</a></td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Derivatives not designated as hedging instruments : Liabilities</a></td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Forward foreign exchange contracts | Quoted prices in active markets for identical assets and liabilities Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivatives not designated as hedging instruments : Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Derivatives not designated as hedging instruments : Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Forward foreign exchange contracts | Significant other observable inputs Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivatives not designated as hedging instruments : Assets</a></td>
<td class="nump">64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Derivatives not designated as hedging instruments : Liabilities</a></td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Forward foreign exchange contracts | Significant unobservable inputs Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivatives not designated as hedging instruments : Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Derivatives not designated as hedging instruments : Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">26,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember', window );">Auris Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration reversal</a></td>
<td class="num">(1,148)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities | Auris Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Change In Estimated Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26610-111562<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetFairValueGrossLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226003-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetFairValueGrossLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118948506&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118948506&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentDetailAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentDetailAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate fair value of all derivative assets designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate fair value of all derivative liabilities designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityFairValueGrossAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226003-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityFairValueGrossAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivative assets not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivative liabilities not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982102722152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Cash, Cash Equivalents and Marketable Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities - Estimated Fair Value</a></td>
<td class="nump">$ 13,391<span></span>
</td>
<td class="nump">$ 4,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">18,965<span></span>
</td>
<td class="nump">17,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">11,816<span></span>
</td>
<td class="nump">$ 1,982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Total cash, cash equivalents and current marketable securities, Carrying Amount</a></td>
<td class="nump">30,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain', window );">Total cash, cash equivalents and current marketable securities, Unrecognized Gain</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss', window );">Total cash, cash equivalents and current marketable securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue', window );">Total cash, cash equivalents and current marketable securities, Estimated Fair Value</a></td>
<td class="nump">30,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember', window );">Held-to-maturity Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Debt Securities, Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity Securities - Carrying Amount</a></td>
<td class="nump">17,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Held-to-maturity Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Held-to-maturity Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held-to-maturity Securities - Estimated Fair Value</a></td>
<td class="nump">17,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">15,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">1,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember', window );">Held-to-maturity Securities | Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Debt Securities, Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity Securities - Carrying Amount</a></td>
<td class="nump">2,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Held-to-maturity Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Held-to-maturity Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held-to-maturity Securities - Estimated Fair Value</a></td>
<td class="nump">2,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">2,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember', window );">Held-to-maturity Securities | Non-U.S. sovereign securities(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Debt Securities, Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity Securities - Carrying Amount</a></td>
<td class="nump">647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Held-to-maturity Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Held-to-maturity Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held-to-maturity Securities - Estimated Fair Value</a></td>
<td class="nump">647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember', window );">Held-to-maturity Securities | U.S. reverse repurchase agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Debt Securities, Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity Securities - Carrying Amount</a></td>
<td class="nump">3,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Held-to-maturity Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Held-to-maturity Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held-to-maturity Securities - Estimated Fair Value</a></td>
<td class="nump">3,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">3,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember', window );">Held-to-maturity Securities | Other reverse repurchase agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Debt Securities, Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity Securities - Carrying Amount</a></td>
<td class="nump">430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Held-to-maturity Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Held-to-maturity Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held-to-maturity Securities - Estimated Fair Value</a></td>
<td class="nump">430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember', window );">Held-to-maturity Securities | Corporate debt securities(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Debt Securities, Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity Securities - Carrying Amount</a></td>
<td class="nump">1,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Held-to-maturity Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Held-to-maturity Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held-to-maturity Securities - Estimated Fair Value</a></td>
<td class="nump">1,843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">1,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember', window );">Held-to-maturity Securities | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Debt Securities, Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity Securities - Carrying Amount</a></td>
<td class="nump">8,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Held-to-maturity Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Held-to-maturity Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held-to-maturity Securities - Estimated Fair Value</a></td>
<td class="nump">8,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">8,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember', window );">Held-to-maturity Securities | Time deposits(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Debt Securities, Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity Securities - Carrying Amount</a></td>
<td class="nump">660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Held-to-maturity Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Held-to-maturity Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held-to-maturity Securities - Estimated Fair Value</a></td>
<td class="nump">660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Available-for-sale Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale Securities - Carrying Amount</a></td>
<td class="nump">13,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale Securities, Unrecognized Gain</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities - Estimated Fair Value</a></td>
<td class="nump">13,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">3,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">9,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Available-for-sale Securities | Non-U.S. sovereign securities(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale Securities - Carrying Amount</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities - Estimated Fair Value</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Available-for-sale Securities | Corporate debt securities(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale Securities - Carrying Amount</a></td>
<td class="nump">247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities - Estimated Fair Value</a></td>
<td class="nump">247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Available-for-sale Securities | US Treasury and Government [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale Securities - Carrying Amount</a></td>
<td class="nump">13,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale Securities, Unrecognized Gain</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities - Estimated Fair Value</a></td>
<td class="nump">13,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">3,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">$ 9,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, And Short-Term Investments, Accumulated Gross Unrealized Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, and Short-term Investments, Estimated Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, and Short-term Investments, Accumulated Gross Unrealized Gain</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26610-111562<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26610-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesClassifiedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_SovereignDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_SovereignDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=jnj_OtherReverseRepurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=jnj_OtherReverseRepurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_BankTimeDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_BankTimeDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_AvailableforsaleSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_AvailableforsaleSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982092797464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Available for Sale Securities Maturities (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 27, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Cost Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due within one year</a></td>
<td class="nump">$ 13,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years</a></td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost', window );">Due after five years through ten years</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis', window );">Total debt securities</a></td>
<td class="nump">13,390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due within one year</a></td>
<td class="nump">13,369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years</a></td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Due after five years through ten years</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Total debt securities</a></td>
<td class="nump">$ 13,391<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth fiscal year through tenth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982105673032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Financial Liabilities not Measured at Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Current Debt</a></td>
<td class="nump">$ 5,078<span></span>
</td>
<td class="nump">$ 1,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">32,680<span></span>
</td>
<td class="nump">$ 26,494<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Current Debt</a></td>
<td class="nump">5,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">32,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Current Debt</a></td>
<td class="nump">5,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 37,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2021Member', window );">2.45% Notes due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2021Member', window );">2.45% Notes due 2021 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2021Member', window );">2.45% Notes due 2021 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A0.250NotesDue2022Member', window );">0.250% Notes due 2022 (1B Euro 1.1641)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A0.250NotesDue2022Member', window );">0.250% Notes due 2022 (1B Euro 1.1641) | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A0.250NotesDue2022Member', window );">0.250% Notes due 2022 (1B Euro 1.1641) | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.25Notesdue2022Member', window );">2.25% Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.25Notesdue2022Member', window );">2.25% Notes due 2022 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.25Notesdue2022Member', window );">2.25% Notes due 2022 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A6.73Debenturesdue2023Member', window );">6.73% Debentures due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">6.73%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A6.73Debenturesdue2023Member', window );">6.73% Debentures due 2023 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A6.73Debenturesdue2023Member', window );">6.73% Debentures due 2023 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.375Notesdue2023Member', window );">3.375% Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.375Notesdue2023Member', window );">3.375% Notes due 2023 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.375Notesdue2023Member', window );">3.375% Notes due 2023 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.05Notesdue2023Member', window );">2.05% Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.05Notesdue2023Member', window );">2.05% Notes due 2023 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.05Notesdue2023Member', window );">2.05% Notes due 2023 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A0.650NotesDue2024Member', window );">0.650% Notes due 2024 (750MM Euro 1.1641)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A0.650NotesDue2024Member', window );">0.650% Notes due 2024 (750MM Euro 1.1641) | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A0.650NotesDue2024Member', window );">0.650% Notes due 2024 (750MM Euro 1.1641) | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 899<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A5.50NotesDue2024Member', window );">5.50% Notes due 2024 (500 MM GBP 1.2757)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A5.50NotesDue2024Member', window );">5.50% Notes due 2024 (500 MM GBP 1.2757) | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A5.50NotesDue2024Member', window );">5.50% Notes due 2024 (500 MM GBP 1.2757) | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.625Notesdue2025Member', window );">2.625% Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.625Notesdue2025Member', window );">2.625% Notes due 2025 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.625Notesdue2025Member', window );">2.625% Notes due 2025 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A0550NotesDue2025Member', window );">0.550 Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A055NotesDue2025Member', window );">0.55% Notes due 2025 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A055NotesDue2025Member', window );">0.55% Notes due 2025 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2026Member', window );">2.45% Notes due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2026Member', window );">2.45% Notes due 2026 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2026Member', window );">2.45% Notes due 2026 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 2,180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.95Notesdue2027Member', window );">2.95% Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.95Notesdue2027Member', window );">2.95% Notes due 2027 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.95Notesdue2027Member', window );">2.95% Notes due 2027 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A095NotesDue2027Member', window );">0.95% Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A095NotesDue2027Member', window );">0.95% Notes due 2027 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A095NotesDue2027Member', window );">0.95% Notes due 2027 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.900Notesdue2028Member', window );">2.90%&#160;Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.900Notesdue2028Member', window );">2.90%&#160;Notes due 2028 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.900Notesdue2028Member', window );">2.90%&#160;Notes due 2028 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A1.150NotesDue2028Member', window );">1.150% Notes due 2028 (750MM Euro 1.1641)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">1.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A1.150NotesDue2028Member', window );">1.150% Notes due 2028 (750MM Euro 1.1641) | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A1.150NotesDue2028Member', window );">1.150% Notes due 2028 (750MM Euro 1.1641) | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A6.95Notesdue2029Member', window );">6.95% Notes due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">6.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A6.95Notesdue2029Member', window );">6.95% Notes due 2029 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A6.95Notesdue2029Member', window );">6.95% Notes due 2029 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 441<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A1300NotesDue2030Member', window );">1.300% Notes due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.95Debenturesdue2033Member', window );">4.95% Debentures due 2033</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">4.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.95Debenturesdue2033Member', window );">4.95% Debentures due 2033 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.95Debenturesdue2033Member', window );">4.95% Debentures due 2033 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 690<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.375Notesdue2033Member', window );">4.375% Notes due 2033</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.375Notesdue2033Member', window );">4.375% Notes due 2033 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.375Notesdue2033Member', window );">4.375% Notes due 2033 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A1.650NotesDue2035Member', window );">1.650% Notes due 2035 (1.5B Euro 1.1641)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">1.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A1.650NotesDue2035Member', window );">1.650% Notes due 2035 (1.5B Euro 1.1641) | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A1.650NotesDue2035Member', window );">1.650% Notes due 2035 (1.5B Euro 1.1641) | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 2,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.55Notesdue2036Member', window );">3.55% Notes due 2036</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.55Notesdue2036Member', window );">3.55% Notes due 2036 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.55Notesdue2036Member', window );">3.55% Notes due 2036 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A5.95Notesdue2037Member', window );">5.95% Notes due 2037</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">5.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A5.95Notesdue2037Member', window );">5.95% Notes due 2037 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A5.95Notesdue2037Member', window );">5.95% Notes due 2037 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.625Notesdue2037Member', window );">3.625% Notes due 2037</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.625Notesdue2037Member', window );">3.625% Notes due 2037 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.625Notesdue2037Member', window );">3.625% Notes due 2037 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.400Notesdue2038Member', window );">3.40%&#160;Notes due 2038</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.400Notesdue2038Member', window );">3.40%&#160;Notes due 2038 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.400Notesdue2038Member', window );">3.40%&#160;Notes due 2038 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A5.85Debenturesdue2038Member', window );">5.85% Debentures due 2038</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">5.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A5.85Debenturesdue2038Member', window );">5.85% Debentures due 2038 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A5.85Debenturesdue2038Member', window );">5.85% Debentures due 2038 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.50Debenturesdue2040Member', window );">4.50% Debentures due 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.50Debenturesdue2040Member', window );">4.50% Debentures due 2040 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.50Debenturesdue2040Member', window );">4.50% Debentures due 2040 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A210NotesDue2040Member', window );">2.10% Notes due 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A210NotesDue2040Member', window );">2.10% Notes due 2040 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A210NotesDue2040Member', window );">2.10% Notes due 2040 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.85Notesdue2041Member', window );">4.85% Notes due 2041</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">4.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.85Notesdue2041Member', window );">4.85% Notes due 2041 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.85Notesdue2041Member', window );">4.85% Notes due 2041 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.50Notesdue2043Member', window );">4.50% Notes due 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.50Notesdue2043Member', window );">4.50% Notes due 2043 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.50Notesdue2043Member', window );">4.50% Notes due 2043 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.70Notesdue2046Member', window );">3.70% Notes due 2046</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.70Notesdue2046Member', window );">3.70% Notes due 2046 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.70Notesdue2046Member', window );">3.70% Notes due 2046 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 2,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.75Notesdue2047Member', window );">3.75% Notes due 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.75Notesdue2047Member', window );">3.75% Notes due 2047 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.75Notesdue2047Member', window );">3.75% Notes due 2047 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.500Notesdue2048Member', window );">3.50% Notes due 2048</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.500Notesdue2048Member', window );">3.50% Notes due 2048 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.500Notesdue2048Member', window );">3.50% Notes due 2048 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2250NotesDue2050Member', window );">2.250% Notes due 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2450NotesDue2060Member', window );">2.450% Notes due 2060</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2450NotesDue2060Member', window );">2.450% Notes due 2060 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2450NotesDue2060Member', window );">2.450% Notes due 2060 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">1,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_NotesDuePeriodFifteenMember', window );">Other | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_NotesDuePeriodFifteenMember', window );">Other | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A130NotesDue2030Member', window );">1.30% Notes due 2030 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">1,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A130NotesDue2030Member', window );">1.30% Notes due 2030 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">1,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A225NotesDue2050Member', window );">2.25% Notes due 2050 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A225NotesDue2050Member', window );">2.25% Notes due 2050 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A0.250NotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A0.250NotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A2.25Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A2.25Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A6.73Debenturesdue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A6.73Debenturesdue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A3.375Notesdue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A3.375Notesdue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A2.05Notesdue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A2.05Notesdue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A0.650NotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A0.650NotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A5.50NotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A5.50NotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A2.625Notesdue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A2.625Notesdue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A0550NotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A0550NotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A055NotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A055NotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A2.95Notesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A2.95Notesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A095NotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A095NotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A2.900Notesdue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A2.900Notesdue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A1.150NotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A1.150NotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A6.95Notesdue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A6.95Notesdue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A1300NotesDue2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A1300NotesDue2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A4.95Debenturesdue2033Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A4.95Debenturesdue2033Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A4.375Notesdue2033Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A4.375Notesdue2033Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A1.650NotesDue2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A1.650NotesDue2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A3.55Notesdue2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A3.55Notesdue2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A5.95Notesdue2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A5.95Notesdue2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A3.625Notesdue2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A3.625Notesdue2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A3.400Notesdue2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A3.400Notesdue2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A5.85Debenturesdue2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A5.85Debenturesdue2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A4.50Debenturesdue2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A4.50Debenturesdue2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A210NotesDue2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A210NotesDue2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A4.85Notesdue2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A4.85Notesdue2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A4.50Notesdue2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A4.50Notesdue2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A3.70Notesdue2046Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A3.70Notesdue2046Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A3.75Notesdue2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A3.75Notesdue2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A3.500Notesdue2048Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A3.500Notesdue2048Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A2250NotesDue2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A2250NotesDue2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A2450NotesDue2060Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A2450NotesDue2060Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_NotesDuePeriodFifteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_NotesDuePeriodFifteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A130NotesDue2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A130NotesDue2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A225NotesDue2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A225NotesDue2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982100430680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Mar. 29, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IncomeTaxTextualsAbstract', window );"><strong>Income Tax (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Worldwide effective income tax rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.60%<span></span>
</td>
<td class="nump">15.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset', window );">Deferred tax benefit related to TRAF</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit', window );">Deferred tax liability related to TRAF</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent', window );">Deferred tax benefit related to TRAF, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent', window );">Impact to effective tax rate, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent', window );">Net impact to tax rate due to change in contingent consideration liability</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement', window );">Effective income tax rate from revised agreement (as a percent)</a></td>
<td class="nump">21.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">21.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement', window );">Accrued legal fees, revised agreement from litigation settlement</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=jnj_AccruedTaxesOnIncomeMember', window );">Accrued Taxes On Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IncomeTaxTextualsAbstract', window );"><strong>Income Tax (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Internal Revenue Service (IRS) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IncomeTaxTextualsAbstract', window );"><strong>Income Tax (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_UnrecognizedTaxBenefitLiabilityPayment', window );">Payment on unrecognized tax benefit liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Professional Fees, Revised Agreement from Litigation Settlement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Change In Contingent Consideration Liability, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Increase (Decrease), Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Percent, Revised Agreement from Litigation Settlement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Federal Act On Tax Reform And AHV Financing, GILTI Remeasurement, Income Tax Expense (Benefit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_IncomeTaxTextualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Textuals Abstract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_IncomeTaxTextualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_UnrecognizedTaxBenefitLiabilityPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefit Liability, Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_UnrecognizedTaxBenefitLiabilityPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=SL37586934-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=jnj_AccruedTaxesOnIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=jnj_AccruedTaxesOnIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982102965208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pensions and Other Benefit Plans - Components of Net Periodic Benefit Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Retirement Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract', window );"><strong>Components of net periodic benefit cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 330<span></span>
</td>
<td class="nump">$ 275<span></span>
</td>
<td class="nump">$ 979<span></span>
</td>
<td class="nump">$ 828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">238<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="nump">715<span></span>
</td>
<td class="nump">822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(617)<span></span>
</td>
<td class="num">(578)<span></span>
</td>
<td class="num">(1,839)<span></span>
</td>
<td class="num">(1,742)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service cost/(credit)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Recognized actuarial losses</a></td>
<td class="nump">224<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="nump">669<span></span>
</td>
<td class="nump">435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Curtailments and settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">544<span></span>
</td>
<td class="nump">349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Benefit Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract', window );"><strong>Components of net periodic benefit cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service cost/(credit)</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Recognized actuarial losses</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Curtailments and settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
<td class="nump">$ 394<span></span>
</td>
<td class="nump">$ 412<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982107717720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pensions and Other Benefit Plans (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 27, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionContributions', window );">Contribution to pension plans</a></td>
<td class="nump">$ 364<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">International retirement plans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionContributions', window );">Contribution to pension plans</a></td>
<td class="nump">$ 27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for pension benefit. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree. Excludes other postretirement benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982100654184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance</a></td>
<td class="nump">$ 62,978<span></span>
</td>
<td class="nump">$ 60,785<span></span>
</td>
<td class="nump">$ 59,471<span></span>
</td>
<td class="nump">$ 59,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net change</a></td>
<td class="nump">595<span></span>
</td>
<td class="num">(564)<span></span>
</td>
<td class="nump">953<span></span>
</td>
<td class="num">(311)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance</a></td>
<td class="nump">64,473<span></span>
</td>
<td class="nump">58,210<span></span>
</td>
<td class="nump">64,473<span></span>
</td>
<td class="nump">58,210<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Foreign Currency Adjustment Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,705)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(741)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance</a></td>
<td class="num">(9,446)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,446)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Accumulated Net Investment Gain (Loss) Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Accumulated Defined Benefit Plans Adjustment Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,891)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance</a></td>
<td class="num">(6,304)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,304)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(295)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance</a></td>
<td class="nump">811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance</a></td>
<td class="num">(15,533)<span></span>
</td>
<td class="num">(14,969)<span></span>
</td>
<td class="num">(15,891)<span></span>
</td>
<td class="num">(15,222)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net change</a></td>
<td class="nump">595<span></span>
</td>
<td class="num">(564)<span></span>
</td>
<td class="nump">953<span></span>
</td>
<td class="num">(311)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance</a></td>
<td class="num">$ (14,938)<span></span>
</td>
<td class="num">$ (15,533)<span></span>
</td>
<td class="num">$ (14,938)<span></span>
</td>
<td class="num">$ (15,533)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982108364152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Reconciliation of basic net earnings per share to diluted net earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net earnings per share</a></td>
<td class="nump">$ 1.35<span></span>
</td>
<td class="nump">$ 0.67<span></span>
</td>
<td class="nump">$ 4.93<span></span>
</td>
<td class="nump">$ 4.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Average shares outstanding &#8212; basic</a></td>
<td class="nump">2,632,500<span></span>
</td>
<td class="nump">2,635,200<span></span>
</td>
<td class="nump">2,633,000<span></span>
</td>
<td class="nump">2,649,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Potential shares exercisable under stock option plans</a></td>
<td class="nump">115,700<span></span>
</td>
<td class="nump">117,800<span></span>
</td>
<td class="nump">120,200<span></span>
</td>
<td class="nump">137,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod', window );">Less: shares which could be repurchased under treasury stock method</a></td>
<td class="num">(78,900)<span></span>
</td>
<td class="num">(83,800)<span></span>
</td>
<td class="num">(82,400)<span></span>
</td>
<td class="num">(99,700)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Convertible debt shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Average shares outstanding &#8212; diluted</a></td>
<td class="nump">2,669,300<span></span>
</td>
<td class="nump">2,669,900<span></span>
</td>
<td class="nump">2,670,800<span></span>
</td>
<td class="nump">2,688,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net earnings per share</a></td>
<td class="nump">$ 1.33<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="nump">$ 4.86<span></span>
</td>
<td class="nump">$ 4.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock assumed to be purchased using the proceeds that could be obtained upon exercise of potential shares exercisable under stock option plans, at the average market price during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1930-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1500-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982019367272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 21,082<span></span>
</td>
<td class="nump">$ 20,729<span></span>
</td>
<td class="nump">$ 60,109<span></span>
</td>
<td class="nump">$ 61,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">1.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 11,086<span></span>
</td>
<td class="nump">10,791<span></span>
</td>
<td class="nump">$ 31,324<span></span>
</td>
<td class="nump">31,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 9,996<span></span>
</td>
<td class="nump">9,938<span></span>
</td>
<td class="nump">$ 28,785<span></span>
</td>
<td class="nump">29,989<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 3,514<span></span>
</td>
<td class="nump">3,469<span></span>
</td>
<td class="nump">$ 10,435<span></span>
</td>
<td class="nump">10,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,556<span></span>
</td>
<td class="nump">1,394<span></span>
</td>
<td class="nump">$ 4,853<span></span>
</td>
<td class="nump">4,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">11.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,958<span></span>
</td>
<td class="nump">2,075<span></span>
</td>
<td class="nump">$ 5,582<span></span>
</td>
<td class="nump">5,962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(5.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | OTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,142<span></span>
</td>
<td class="nump">1,098<span></span>
</td>
<td class="nump">$ 3,639<span></span>
</td>
<td class="nump">3,249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | OTC | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 601<span></span>
</td>
<td class="nump">477<span></span>
</td>
<td class="nump">$ 1,917<span></span>
</td>
<td class="nump">1,468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | OTC | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 541<span></span>
</td>
<td class="nump">621<span></span>
</td>
<td class="nump">$ 1,722<span></span>
</td>
<td class="nump">1,781<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(12.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Skin Health/Beauty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,149<span></span>
</td>
<td class="nump">1,151<span></span>
</td>
<td class="nump">$ 3,273<span></span>
</td>
<td class="nump">3,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(0.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Skin Health/Beauty | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 572<span></span>
</td>
<td class="nump">559<span></span>
</td>
<td class="nump">$ 1,767<span></span>
</td>
<td class="nump">1,810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">2.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Skin Health/Beauty | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 577<span></span>
</td>
<td class="nump">592<span></span>
</td>
<td class="nump">$ 1,506<span></span>
</td>
<td class="nump">1,633<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(2.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Oral Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 412<span></span>
</td>
<td class="nump">379<span></span>
</td>
<td class="nump">$ 1,204<span></span>
</td>
<td class="nump">1,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Oral Care | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 164<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="nump">$ 510<span></span>
</td>
<td class="nump">462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Oral Care | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 248<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="nump">$ 694<span></span>
</td>
<td class="nump">673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">10.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Baby Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 393<span></span>
</td>
<td class="nump">417<span></span>
</td>
<td class="nump">$ 1,110<span></span>
</td>
<td class="nump">1,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(5.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Baby Care | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 91<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="nump">$ 279<span></span>
</td>
<td class="nump">277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(1.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Baby Care | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 302<span></span>
</td>
<td class="nump">326<span></span>
</td>
<td class="nump">$ 831<span></span>
</td>
<td class="nump">977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(7.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Women's Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 230<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="nump">$ 664<span></span>
</td>
<td class="nump">733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(9.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Women's Health | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(6.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Women's Health | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 227<span></span>
</td>
<td class="nump">252<span></span>
</td>
<td class="nump">$ 654<span></span>
</td>
<td class="nump">724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(9.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Wound Care/Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 189<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="nump">$ 545<span></span>
</td>
<td class="nump">516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Wound Care/Other | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 125<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="nump">$ 370<span></span>
</td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">15.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Wound Care/Other | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">7.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 11,418<span></span>
</td>
<td class="nump">10,877<span></span>
</td>
<td class="nump">$ 33,304<span></span>
</td>
<td class="nump">31,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 6,438<span></span>
</td>
<td class="nump">6,340<span></span>
</td>
<td class="nump">$ 18,619<span></span>
</td>
<td class="nump">17,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 4,980<span></span>
</td>
<td class="nump">4,537<span></span>
</td>
<td class="nump">$ 14,685<span></span>
</td>
<td class="nump">13,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">9.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 3,789<span></span>
</td>
<td class="nump">3,711<span></span>
</td>
<td class="nump">$ 10,950<span></span>
</td>
<td class="nump">10,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 2,558<span></span>
</td>
<td class="nump">2,582<span></span>
</td>
<td class="nump">$ 7,330<span></span>
</td>
<td class="nump">7,124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(0.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,230<span></span>
</td>
<td class="nump">1,129<span></span>
</td>
<td class="nump">$ 3,619<span></span>
</td>
<td class="nump">3,304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | REMICADE&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 921<span></span>
</td>
<td class="nump">1,136<span></span>
</td>
<td class="nump">$ 2,846<span></span>
</td>
<td class="nump">3,345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(18.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | REMICADE&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 634<span></span>
</td>
<td class="nump">749<span></span>
</td>
<td class="nump">$ 1,852<span></span>
</td>
<td class="nump">2,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(15.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | REMICADE&#174; | U.S. Exports</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="nump">$ 321<span></span>
</td>
<td class="nump">226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(11.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | REMICADE&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 209<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="nump">$ 673<span></span>
</td>
<td class="nump">795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(30.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 592<span></span>
</td>
<td class="nump">586<span></span>
</td>
<td class="nump">$ 1,667<span></span>
</td>
<td class="nump">1,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 312<span></span>
</td>
<td class="nump">313<span></span>
</td>
<td class="nump">$ 840<span></span>
</td>
<td class="nump">857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(0.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 280<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="nump">$ 827<span></span>
</td>
<td class="nump">816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">2.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | STELARA&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,947<span></span>
</td>
<td class="nump">1,698<span></span>
</td>
<td class="nump">$ 5,463<span></span>
</td>
<td class="nump">4,661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">14.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | STELARA&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,313<span></span>
</td>
<td class="nump">1,212<span></span>
</td>
<td class="nump">$ 3,668<span></span>
</td>
<td class="nump">3,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">8.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | STELARA&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 634<span></span>
</td>
<td class="nump">487<span></span>
</td>
<td class="nump">$ 1,795<span></span>
</td>
<td class="nump">1,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">30.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | TREMFYA&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 327<span></span>
</td>
<td class="nump">290<span></span>
</td>
<td class="nump">$ 965<span></span>
</td>
<td class="nump">742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">13.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | TREMFYA&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 222<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="nump">$ 650<span></span>
</td>
<td class="nump">565<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | TREMFYA&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">$ 316<span></span>
</td>
<td class="nump">177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">54.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">35.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">35.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 864<span></span>
</td>
<td class="nump">839<span></span>
</td>
<td class="nump">$ 2,662<span></span>
</td>
<td class="nump">2,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 413<span></span>
</td>
<td class="nump">418<span></span>
</td>
<td class="nump">$ 1,265<span></span>
</td>
<td class="nump">1,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(1.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 451<span></span>
</td>
<td class="nump">421<span></span>
</td>
<td class="nump">$ 1,397<span></span>
</td>
<td class="nump">1,385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | EDURANT&#174; / rilpivirine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 236<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="nump">$ 716<span></span>
</td>
<td class="nump">639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">8.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | EDURANT&#174; / rilpivirine | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(12.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | EDURANT&#174; / rilpivirine | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 226<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="nump">$ 684<span></span>
</td>
<td class="nump">603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">9.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | PREZISTA&#174; / PREZCOBIX&#174; / REZOLSTA&#174; / SYMTUZA&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 526<span></span>
</td>
<td class="nump">508<span></span>
</td>
<td class="nump">$ 1,615<span></span>
</td>
<td class="nump">1,566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | PREZISTA&#174; / PREZCOBIX&#174; / REZOLSTA&#174; / SYMTUZA&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 379<span></span>
</td>
<td class="nump">373<span></span>
</td>
<td class="nump">$ 1,154<span></span>
</td>
<td class="nump">1,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | PREZISTA&#174; / PREZCOBIX&#174; / REZOLSTA&#174; / SYMTUZA&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 147<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="nump">$ 461<span></span>
</td>
<td class="nump">534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">9.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 102<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="nump">$ 331<span></span>
</td>
<td class="nump">342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(9.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(26.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">$ 252<span></span>
</td>
<td class="nump">248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(2.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,605<span></span>
</td>
<td class="nump">1,595<span></span>
</td>
<td class="nump">$ 4,850<span></span>
</td>
<td class="nump">4,762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 759<span></span>
</td>
<td class="nump">785<span></span>
</td>
<td class="nump">$ 2,285<span></span>
</td>
<td class="nump">2,172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(3.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 846<span></span>
</td>
<td class="nump">810<span></span>
</td>
<td class="nump">$ 2,565<span></span>
</td>
<td class="nump">2,590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | CONCERTA&#174; / methylphenidate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 149<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">$ 469<span></span>
</td>
<td class="nump">544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(22.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | CONCERTA&#174; / methylphenidate | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(49.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | CONCERTA&#174; / methylphenidate | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 107<span></span>
</td>
<td class="nump">109<span></span>
</td>
<td class="nump">$ 319<span></span>
</td>
<td class="nump">348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(2.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA&#174; / XEPLION&#174; / INVEGA TRINZA&#174; / TREVICTA&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 926<span></span>
</td>
<td class="nump">851<span></span>
</td>
<td class="nump">$ 2,688<span></span>
</td>
<td class="nump">2,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">8.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA&#174; / XEPLION&#174; / INVEGA TRINZA&#174; / TREVICTA&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 585<span></span>
</td>
<td class="nump">554<span></span>
</td>
<td class="nump">$ 1,704<span></span>
</td>
<td class="nump">1,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">5.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA&#174; / XEPLION&#174; / INVEGA TRINZA&#174; / TREVICTA&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 341<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="nump">$ 983<span></span>
</td>
<td class="nump">916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">14.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 152<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="nump">$ 475<span></span>
</td>
<td class="nump">528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(9.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">$ 220<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(11.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">$ 254<span></span>
</td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(7.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 377<span></span>
</td>
<td class="nump">384<span></span>
</td>
<td class="nump">$ 1,218<span></span>
</td>
<td class="nump">1,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(1.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">$ 210<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(11.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 317<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="nump">$ 1,008<span></span>
</td>
<td class="nump">1,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 3,129<span></span>
</td>
<td class="nump">2,761<span></span>
</td>
<td class="nump">$ 8,933<span></span>
</td>
<td class="nump">7,976<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">13.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,267<span></span>
</td>
<td class="nump">1,171<span></span>
</td>
<td class="nump">$ 3,623<span></span>
</td>
<td class="nump">3,146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">8.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,862<span></span>
</td>
<td class="nump">1,590<span></span>
</td>
<td class="nump">$ 5,310<span></span>
</td>
<td class="nump">4,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">17.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | DARZALEX&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,099<span></span>
</td>
<td class="nump">765<span></span>
</td>
<td class="nump">$ 2,937<span></span>
</td>
<td class="nump">2,168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">43.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | DARZALEX&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 585<span></span>
</td>
<td class="nump">402<span></span>
</td>
<td class="nump">$ 1,540<span></span>
</td>
<td class="nump">1,123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">46.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | DARZALEX&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 514<span></span>
</td>
<td class="nump">363<span></span>
</td>
<td class="nump">$ 1,397<span></span>
</td>
<td class="nump">1,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">41.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | ERLEADA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 206<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">$ 519<span></span>
</td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | ERLEADA | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | ERLEADA | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | IMBRUVICA&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,031<span></span>
</td>
<td class="nump">921<span></span>
</td>
<td class="nump">$ 3,011<span></span>
</td>
<td class="nump">2,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">11.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | IMBRUVICA&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 450<span></span>
</td>
<td class="nump">447<span></span>
</td>
<td class="nump">$ 1,329<span></span>
</td>
<td class="nump">1,163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | IMBRUVICA&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 581<span></span>
</td>
<td class="nump">475<span></span>
</td>
<td class="nump">$ 1,682<span></span>
</td>
<td class="nump">1,373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">22.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | VELCADE&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="nump">$ 311<span></span>
</td>
<td class="nump">636<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(30.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | VELCADE&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | VELCADE&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="nump">$ 311<span></span>
</td>
<td class="nump">636<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(30.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | ZYTIGA&#174; / abiraterone acetate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 590<span></span>
</td>
<td class="nump">741<span></span>
</td>
<td class="nump">$ 1,848<span></span>
</td>
<td class="nump">2,118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(20.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | ZYTIGA&#174; / abiraterone acetate | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 58<span></span>
</td>
<td class="nump">233<span></span>
</td>
<td class="nump">$ 284<span></span>
</td>
<td class="nump">616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(75.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | ZYTIGA&#174; / abiraterone acetate | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 532<span></span>
</td>
<td class="nump">508<span></span>
</td>
<td class="nump">$ 1,564<span></span>
</td>
<td class="nump">1,502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | OTHER ONCOLOGY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 98<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">$ 308<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(1.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">51<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">35.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">$ 244<span></span>
</td>
<td class="nump">252<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(8.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 749<span></span>
</td>
<td class="nump">654<span></span>
</td>
<td class="nump">$ 2,283<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">14.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 510<span></span>
</td>
<td class="nump">427<span></span>
</td>
<td class="nump">$ 1,541<span></span>
</td>
<td class="nump">1,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">19.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 239<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="nump">$ 742<span></span>
</td>
<td class="nump">704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">5.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 392<span></span>
</td>
<td class="nump">347<span></span>
</td>
<td class="nump">$ 1,187<span></span>
</td>
<td class="nump">1,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 244<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="nump">$ 729<span></span>
</td>
<td class="nump">581<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">18.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 148<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="nump">$ 458<span></span>
</td>
<td class="nump">419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 260<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="nump">$ 792<span></span>
</td>
<td class="nump">611<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">23.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 226<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="nump">$ 692<span></span>
</td>
<td class="nump">536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">22.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">32.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | OTHER PULMONARY HYPERTENSION</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 97<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="nump">$ 304<span></span>
</td>
<td class="nump">388<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | OTHER PULMONARY HYPERTENSION | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">$ 121<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">11.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | OTHER PULMONARY HYPERTENSION | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">$ 183<span></span>
</td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(6.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,281<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
<td class="nump">$ 3,625<span></span>
</td>
<td class="nump">3,936<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(2.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 931<span></span>
</td>
<td class="nump">955<span></span>
</td>
<td class="nump">$ 2,574<span></span>
</td>
<td class="nump">2,804<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(2.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 351<span></span>
</td>
<td class="nump">360<span></span>
</td>
<td class="nump">$ 1,052<span></span>
</td>
<td class="nump">1,131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(2.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 630<span></span>
</td>
<td class="nump">613<span></span>
</td>
<td class="nump">$ 1,716<span></span>
</td>
<td class="nump">1,704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 630<span></span>
</td>
<td class="nump">613<span></span>
</td>
<td class="nump">$ 1,716<span></span>
</td>
<td class="nump">1,704<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA&#174; / INVOKAMET&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 224<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="nump">$ 578<span></span>
</td>
<td class="nump">558<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">24.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA&#174; / INVOKAMET&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 156<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">$ 405<span></span>
</td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">24.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA&#174; / INVOKAMET&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">24.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT&#174; / EPREX&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="nump">$ 423<span></span>
</td>
<td class="nump">607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(33.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT&#174; / EPREX&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">$ 215<span></span>
</td>
<td class="nump">387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(45.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT&#174; / EPREX&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 63<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="nump">$ 208<span></span>
</td>
<td class="nump">220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(12.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER PULMONARY HYPERTENSION</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 294<span></span>
</td>
<td class="nump">325<span></span>
</td>
<td class="nump">$ 908<span></span>
</td>
<td class="nump">$ 1,067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(9.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14.90%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER PULMONARY HYPERTENSION | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="nump">$ 238<span></span>
</td>
<td class="nump">$ 302<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(17.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER PULMONARY HYPERTENSION | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 219<span></span>
</td>
<td class="nump">234<span></span>
</td>
<td class="nump">$ 670<span></span>
</td>
<td class="nump">765<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(6.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 6,150<span></span>
</td>
<td class="nump">6,383<span></span>
</td>
<td class="nump">$ 16,370<span></span>
</td>
<td class="nump">19,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(3.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 3,092<span></span>
</td>
<td class="nump">3,057<span></span>
</td>
<td class="nump">$ 7,852<span></span>
</td>
<td class="nump">9,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 3,058<span></span>
</td>
<td class="nump">3,326<span></span>
</td>
<td class="nump">$ 8,518<span></span>
</td>
<td class="nump">10,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(8.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Interventional Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 836<span></span>
</td>
<td class="nump">741<span></span>
</td>
<td class="nump">$ 2,153<span></span>
</td>
<td class="nump">2,223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">12.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Interventional Solutions | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 399<span></span>
</td>
<td class="nump">357<span></span>
</td>
<td class="nump">$ 1,019<span></span>
</td>
<td class="nump">1,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">11.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Interventional Solutions | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 437<span></span>
</td>
<td class="nump">382<span></span>
</td>
<td class="nump">$ 1,134<span></span>
</td>
<td class="nump">1,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 2,083<span></span>
</td>
<td class="nump">2,138<span></span>
</td>
<td class="nump">$ 5,572<span></span>
</td>
<td class="nump">6,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(2.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,308<span></span>
</td>
<td class="nump">1,301<span></span>
</td>
<td class="nump">$ 3,427<span></span>
</td>
<td class="nump">3,950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 774<span></span>
</td>
<td class="nump">837<span></span>
</td>
<td class="nump">$ 2,145<span></span>
</td>
<td class="nump">2,616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(7.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | HIPS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 345<span></span>
</td>
<td class="nump">336<span></span>
</td>
<td class="nump">$ 908<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">2.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | HIPS | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 221<span></span>
</td>
<td class="nump">204<span></span>
</td>
<td class="nump">$ 564<span></span>
</td>
<td class="nump">633<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">8.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | HIPS | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 124<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="nump">$ 344<span></span>
</td>
<td class="nump">428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(7.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | KNEES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 308<span></span>
</td>
<td class="nump">344<span></span>
</td>
<td class="nump">$ 825<span></span>
</td>
<td class="nump">1,085<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(10.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | KNEES | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 205<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="nump">$ 527<span></span>
</td>
<td class="nump">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(1.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | KNEES | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 102<span></span>
</td>
<td class="nump">136<span></span>
</td>
<td class="nump">$ 298<span></span>
</td>
<td class="nump">435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(24.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | TRAUMA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 685<span></span>
</td>
<td class="nump">677<span></span>
</td>
<td class="nump">$ 1,892<span></span>
</td>
<td class="nump">2,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | TRAUMA | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 433<span></span>
</td>
<td class="nump">415<span></span>
</td>
<td class="nump">$ 1,194<span></span>
</td>
<td class="nump">1,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | TRAUMA | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 253<span></span>
</td>
<td class="nump">262<span></span>
</td>
<td class="nump">$ 698<span></span>
</td>
<td class="nump">795<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(3.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS &amp; OTHER</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 745<span></span>
</td>
<td class="nump">778<span></span>
</td>
<td class="nump">$ 1,947<span></span>
</td>
<td class="nump">2,384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(4.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS &amp; OTHER | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 449<span></span>
</td>
<td class="nump">472<span></span>
</td>
<td class="nump">$ 1,142<span></span>
</td>
<td class="nump">1,427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(4.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS &amp; OTHER | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 295<span></span>
</td>
<td class="nump">306<span></span>
</td>
<td class="nump">$ 805<span></span>
</td>
<td class="nump">957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(3.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 2,152<span></span>
</td>
<td class="nump">2,311<span></span>
</td>
<td class="nump">$ 5,803<span></span>
</td>
<td class="nump">7,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(6.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Surgery | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 913<span></span>
</td>
<td class="nump">940<span></span>
</td>
<td class="nump">$ 2,247<span></span>
</td>
<td class="nump">2,867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(3.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Surgery | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,239<span></span>
</td>
<td class="nump">1,371<span></span>
</td>
<td class="nump">$ 3,556<span></span>
</td>
<td class="nump">4,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(9.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Surgery | ADVANCED</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">1,010<span></span>
</td>
<td class="nump">$ 2,723<span></span>
</td>
<td class="nump">3,019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(1.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Surgery | ADVANCED | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 421<span></span>
</td>
<td class="nump">409<span></span>
</td>
<td class="nump">$ 1,079<span></span>
</td>
<td class="nump">1,209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Surgery | ADVANCED | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 579<span></span>
</td>
<td class="nump">602<span></span>
</td>
<td class="nump">$ 1,644<span></span>
</td>
<td class="nump">1,811<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(3.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Surgery | GENERAL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,152<span></span>
</td>
<td class="nump">1,301<span></span>
</td>
<td class="nump">$ 3,080<span></span>
</td>
<td class="nump">4,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(11.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Surgery | GENERAL | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 492<span></span>
</td>
<td class="nump">531<span></span>
</td>
<td class="nump">$ 1,168<span></span>
</td>
<td class="nump">1,658<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(7.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Surgery | GENERAL | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 660<span></span>
</td>
<td class="nump">769<span></span>
</td>
<td class="nump">$ 1,912<span></span>
</td>
<td class="nump">2,381<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(14.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Vision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,081<span></span>
</td>
<td class="nump">1,193<span></span>
</td>
<td class="nump">$ 2,843<span></span>
</td>
<td class="nump">3,483<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(9.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Vision | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 473<span></span>
</td>
<td class="nump">459<span></span>
</td>
<td class="nump">$ 1,160<span></span>
</td>
<td class="nump">1,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">3.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Vision | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 608<span></span>
</td>
<td class="nump">734<span></span>
</td>
<td class="nump">$ 1,683<span></span>
</td>
<td class="nump">2,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(17.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 830<span></span>
</td>
<td class="nump">893<span></span>
</td>
<td class="nump">$ 2,198<span></span>
</td>
<td class="nump">2,559<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(7.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 375<span></span>
</td>
<td class="nump">339<span></span>
</td>
<td class="nump">$ 924<span></span>
</td>
<td class="nump">993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">10.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 455<span></span>
</td>
<td class="nump">555<span></span>
</td>
<td class="nump">$ 1,274<span></span>
</td>
<td class="nump">1,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(18.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Vision | SURGICAL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 251<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="nump">$ 645<span></span>
</td>
<td class="nump">923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(16.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Vision | SURGICAL | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 98<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="nump">$ 236<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(18.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Vision | SURGICAL | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 153<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="nump">$ 409<span></span>
</td>
<td class="nump">$ 551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(14.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_PercentageChangeInSalesBySegmentOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage change in sales by segment of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_PercentageChangeInSalesBySegmentOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_OTCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_OTCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_BeautyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_BeautyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_OralCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_OralCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_BabyCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_BabyCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_WomensHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_WomensHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_WoundCareandOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_WoundCareandOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_ImmunologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_ImmunologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_RemicadeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_RemicadeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=jnj_UNITEDSTATESExportsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=jnj_UNITEDSTATESExportsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_SimponiSimponiAriaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_SimponiSimponiAriaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_StelaraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_StelaraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_TremfyaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_TremfyaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_OtherImmunologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_OtherImmunologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_InfectiousDiseasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_InfectiousDiseasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_EDURANTrilpivirineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_EDURANTrilpivirineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_OtherInfectiousDiseasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_OtherInfectiousDiseasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_NeuroscienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_NeuroscienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_CONCERTAMethylphenidateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_CONCERTAMethylphenidateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_RISPERDALCONSTAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_RISPERDALCONSTAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_OTHERNEUROSCIENCEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_OTHERNEUROSCIENCEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_OncologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_OncologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_DARZALEXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_DARZALEXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_ERLEADAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_ERLEADAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_IMBRUVICAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_IMBRUVICAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_VELCADEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_VELCADEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_ZYTIGAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_ZYTIGAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_OtherOncologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_OtherOncologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_PulmonaryHypertensionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_PulmonaryHypertensionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_OPSUMITMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_OPSUMITMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_UPTRAVIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_UPTRAVIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_CardiovascularMetabolismOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_CardiovascularMetabolismOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_XareltoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_XareltoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_INVOKANAINVOKAMETMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_INVOKANAINVOKAMETMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_PROCRITEPREXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_PROCRITEPREXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_InterventionalSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_InterventionalSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_OrthopaedicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_OrthopaedicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_HIPSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_HIPSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_KNEESMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_KNEESMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_TRAUMAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_TRAUMAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_SPINEOTHERMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_SPINEOTHERMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_SurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_SurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_ADVANCEDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_ADVANCEDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_GENERALMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_GENERALMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_VisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_VisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_CONTACTLENSESOTHERMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_CONTACTLENSESOTHERMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_SURGICALMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_SURGICALMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982103004536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business and Geographic Areas - Operating Profit by Segment of Business (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2019</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,082<span></span>
</td>
<td class="nump">$ 20,729<span></span>
</td>
<td class="nump">$ 60,109<span></span>
</td>
<td class="nump">$ 61,312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInOperatingIncomeLoss', window );">Percentage Change in Operating Income Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Earnings before provision for taxes on income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,401<span></span>
</td>
<td class="nump">1,647<span></span>
</td>
<td class="nump">$ 14,850<span></span>
</td>
<td class="nump">13,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="nump">890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reversal of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,148<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">187<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_AmountPrepaidAndDueToManufacturers', window );">Amount prepaid and due to manufacturers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,514<span></span>
</td>
<td class="nump">3,469<span></span>
</td>
<td class="nump">10,435<span></span>
</td>
<td class="nump">10,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,418<span></span>
</td>
<td class="nump">10,877<span></span>
</td>
<td class="nump">33,304<span></span>
</td>
<td class="nump">31,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">4,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">4,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">Medical Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,150<span></span>
</td>
<td class="nump">6,383<span></span>
</td>
<td class="nump">16,370<span></span>
</td>
<td class="nump">19,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total Segment Operating Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,640<span></span>
</td>
<td class="nump">1,823<span></span>
</td>
<td class="nump">$ 15,461<span></span>
</td>
<td class="nump">13,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInOperatingIncomeLoss', window );">Percentage Change in Operating Income Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Consumer Health*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total Segment Operating Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 191<span></span>
</td>
<td class="nump">653<span></span>
</td>
<td class="nump">$ 993<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInOperatingIncomeLoss', window );">Percentage Change in Operating Income Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(70.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | PHARMACEUTICAL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total Segment Operating Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,439<span></span>
</td>
<td class="num">(222)<span></span>
</td>
<td class="nump">11,787<span></span>
</td>
<td class="nump">5,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnSecurities', window );">Unrealized Gain (Loss) on Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquisitionCosts', window );">Acquisition Costs, Period Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total Segment Operating Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,010<span></span>
</td>
<td class="nump">1,392<span></span>
</td>
<td class="nump">$ 2,681<span></span>
</td>
<td class="nump">6,078<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInOperatingIncomeLoss', window );">Percentage Change in Operating Income Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate, Non-Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total Segment Operating Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 239<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="nump">611<span></span>
</td>
<td class="nump">554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jnj_CizHoldingsCo.Ltd.Member', window );">Ci:z Holdings Co. Ltd. | Consumer Health*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfEquityInvestments', window );">Gain on sale of equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember', window );">Auris Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reversal of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,086<span></span>
</td>
<td class="nump">10,791<span></span>
</td>
<td class="nump">$ 31,324<span></span>
</td>
<td class="nump">31,323<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Consumer Health*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,556<span></span>
</td>
<td class="nump">1,394<span></span>
</td>
<td class="nump">4,853<span></span>
</td>
<td class="nump">4,369<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | PHARMACEUTICAL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,438<span></span>
</td>
<td class="nump">6,340<span></span>
</td>
<td class="nump">18,619<span></span>
</td>
<td class="nump">17,705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Medical Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,092<span></span>
</td>
<td class="nump">3,057<span></span>
</td>
<td class="nump">$ 7,852<span></span>
</td>
<td class="nump">9,249<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,819<span></span>
</td>
<td class="nump">4,461<span></span>
</td>
<td class="nump">$ 13,709<span></span>
</td>
<td class="nump">13,803<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=jnj_WesternHemisphereExcludingUSMember', window );">Western Hemisphere, excluding U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,296<span></span>
</td>
<td class="nump">1,488<span></span>
</td>
<td class="nump">$ 3,931<span></span>
</td>
<td class="nump">4,446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=jnj_AsiaPacificAfricaMember', window );">Asia-Pacific, Africa</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,881<span></span>
</td>
<td class="nump">$ 3,989<span></span>
</td>
<td class="nump">$ 11,145<span></span>
</td>
<td class="nump">11,740<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jnj_AdvancedSterilizationProductsMember', window );">AdvancedSterilizationProducts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from divestiture of business</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jnj_AdvancedSterilizationProductsMember', window );">AdvancedSterilizationProducts | Medical Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from divestiture of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember', window );">Other Income | Auris Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reversal of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember', window );">Other Income | Auris Health | Medical Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reversal of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_AmountPrepaidAndDueToManufacturers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount Prepaid and Due to Manufacturers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_AmountPrepaidAndDueToManufacturers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_PercentageChangeInOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage change in operating income loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_PercentageChangeInOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_PercentageChangeInSalesByGeographicArea">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage change in sales by geographic area.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_PercentageChangeInSalesByGeographicArea</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(7)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=82851474&amp;loc=d3e511914-122862<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 932<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(3)(ii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=82851474&amp;loc=d3e511914-122862<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of equity securities, not separately or otherwise categorized as trading or available-for-sale. This element includes investments in which the entity holds a small ownership stake (generally, less than 20% of the shares outstanding) and cannot exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in the income statement on unsold other securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_CizHoldingsCo.Ltd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_CizHoldingsCo.Ltd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=jnj_WesternHemisphereExcludingUSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=jnj_WesternHemisphereExcludingUSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=jnj_AsiaPacificAfricaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=jnj_AsiaPacificAfricaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jnj_AdvancedSterilizationProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jnj_AdvancedSterilizationProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982112788248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business and Geographic Areas - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Sales by geographic area</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 21,082<span></span>
</td>
<td class="nump">$ 20,729<span></span>
</td>
<td class="nump">$ 60,109<span></span>
</td>
<td class="nump">$ 61,312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="nump">1.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Sales by geographic area</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 11,086<span></span>
</td>
<td class="nump">10,791<span></span>
</td>
<td class="nump">$ 31,324<span></span>
</td>
<td class="nump">31,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Sales by geographic area</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 4,819<span></span>
</td>
<td class="nump">4,461<span></span>
</td>
<td class="nump">$ 13,709<span></span>
</td>
<td class="nump">13,803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=jnj_WesternHemisphereExcludingUSMember', window );">Western Hemisphere, excluding U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Sales by geographic area</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 1,296<span></span>
</td>
<td class="nump">1,488<span></span>
</td>
<td class="nump">$ 3,931<span></span>
</td>
<td class="nump">4,446<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="num">(12.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=jnj_AsiaPacificAfricaMember', window );">Asia-Pacific, Africa</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Sales by geographic area</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 3,881<span></span>
</td>
<td class="nump">$ 3,989<span></span>
</td>
<td class="nump">$ 11,145<span></span>
</td>
<td class="nump">$ 11,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="num">(2.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_PercentageChangeInSalesByGeographicArea">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage change in sales by geographic area.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_PercentageChangeInSalesByGeographicArea</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentsGeographicalAreasAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentsGeographicalAreasAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=jnj_WesternHemisphereExcludingUSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=jnj_WesternHemisphereExcludingUSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=jnj_AsiaPacificAfricaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=jnj_AsiaPacificAfricaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982098692600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Divestitures - Narrative (Details)<br> SFr / shares in Units, shares in Millions, SFr in Millions, $ in Millions, &#165; in Billions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 17, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 17, 2019 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Sep. 27, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 27, 2020 </div>
<div>CHF (SFr) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 29, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 29, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 27, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 29, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 27, 2020 </div>
<div>CHF (SFr) </div>
<div>SFr / shares</div>
</th>
<th class="th">
<div>Dec. 29, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jan. 16, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reversal of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,148<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset write-downs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(545)<span></span>
</td>
<td class="num">$ (2,509)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jnj_BermekimabMember', window );">bermekimab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business acquisition cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jnj_VerbSurgicalInc.Member', window );">Verb Surgical Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Fair value of previously held equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember', window );">Auris Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business acquisition cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities', window );">Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reversal of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember', window );">Auris Health | Purchased In-Process Research And Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset write-downs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jnj_CizHoldingsCo.Ltd.Member', window );">Ci:z Holdings Co. Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business acquisition cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="nump">&#165; 230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyExchangeRateTranslation1', window );">Foreign exchange rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill', window );">Adjustments made to intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jnj_MomentaMember', window );">Momenta [Member] | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business acquisition cost</a></td>
<td class="nump">$ 6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jnj_AdvancedSterilizationProductsMember', window );">AdvancedSterilizationProducts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from divestiture of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember', window );">Discontinued Operations, Held-for-sale or Disposed of by Sale | Supply Chain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Assets held for sale, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember', window );">Discontinued Operations, Held-for-sale or Disposed of by Sale | AdvancedSterilizationProducts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal group consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash', window );">Disposal group consideration, cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained', window );">Receivables retained</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jnj_IdorsiaLTDMember', window );">Idorsia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued in transaction (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.8<span></span>
</td>
<td class="nump">11.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction', window );">Percentage ownership before transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.30%<span></span>
</td>
<td class="nump">8.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Gross proceeds on sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 357<span></span>
</td>
<td class="nump">SFr 337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sales price per share (in CHF per share) | SFr / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 28.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares', window );">Ownership interest after sale | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.7<span></span>
</td>
<td class="nump">38.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction', window );">Percentage ownership after transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jnj_IdorsiaLTDMember', window );">Idorsia | Convertible Debt | Idorsia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jnj_IdorsiaLTDMember', window );">Idorsia | Idorsia | Line of Credit | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember', window );">Other Income | Auris Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reversal of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Adjustments Made To Intangible Assets, Other than Goodwill</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Receivables Retained</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment Retained After Disposal, Ownership Interest After Disposal, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand, demand deposits with banks or financial institutions, and  other kinds of accounts that have the general characteristics of demand deposits, held by a disposal group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investments accounted under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117311354&amp;loc=d3e32014-111567<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyExchangeRateTranslation1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6897108&amp;loc=SL6897125-166521<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyExchangeRateTranslation1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity investee's stock owned by parent company before stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_BermekimabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_BermekimabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_VerbSurgicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_VerbSurgicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PurchasedInProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PurchasedInProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_CizHoldingsCo.Ltd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_CizHoldingsCo.Ltd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_MomentaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_MomentaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jnj_AdvancedSterilizationProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jnj_AdvancedSterilizationProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jnj_SupplyChainMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jnj_SupplyChainMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jnj_IdorsiaLTDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jnj_IdorsiaLTDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=jnj_IdorsiaLTDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=jnj_IdorsiaLTDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=jnj_IdorsiaLTDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=jnj_IdorsiaLTDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982112843080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Legal Proceedings (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 28, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 29, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 29, 2019 </div>
<div>USD ($) </div>
<div>claimant</div>
</th>
<th class="th">
<div>Sep. 27, 2020 </div>
<div>USD ($) </div>
<div>claimant </div>
<div>patient</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=jnj_AsrMember', window );">ASR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProductLiabilityContingencyNumberOfClaimant', window );">Product Liability Contingency Number Of Claimants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=jnj_PinnacleAcetabularCupSystemMember', window );">Pinnacle Acetabular Cup System</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProductLiabilityContingencyNumberOfClaimant', window );">Product Liability Contingency Number Of Claimants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=jnj_PelvicMeshesMember', window );">Pelvic Meshes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProductLiabilityContingencyNumberOfClaimant', window );">Product Liability Contingency Number Of Claimants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=jnj_RisperdalMember', window );">Risperdal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProductLiabilityContingencyNumberOfClaimant', window );">Product Liability Contingency Number Of Claimants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=jnj_XareltoMember', window );">XARELTO&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProductLiabilityContingencyNumberOfClaimant', window );">Product Liability Contingency Number Of Claimants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=jnj_TalcMember', window );">Talc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProductLiabilityContingencyNumberOfClaimant', window );">Product Liability Contingency Number Of Claimants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=jnj_InvokanaMember', window );">Invokana</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProductLiabilityContingencyNumberOfClaimant', window );">Product Liability Contingency Number Of Claimants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=jnj_PhysiomeshMember', window );">Physiomesh</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProductLiabilityContingencyNumberOfClaimant', window );">Product Liability Contingency Number Of Claimants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=jnj_OpioidMember', window );">Opioid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProductLiabilityContingencyNumberOfClaimant', window );">Product Liability Contingency Number Of Claimants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_JudicialRulingMember', window );">Judicial Ruling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 344.0<span></span>
</td>
<td class="nump">$ 344.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="nump">$ 8,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss Contingency, Estimate of Possible Loss | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending Litigation | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss Contingency, Estimate of Possible Loss | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LossContingencyEstimateOfAdditionalPossibleLoss', window );">Loss Contingency, Estimate of Additional Possible Loss | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=jnj_DePuyASRU.S.Member', window );">DePuy ASR U.S. | settled litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_Numberofpatientsinsettlement', window );">Number of patients in settlement | patient</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=jnj_BabyPowderMember', window );">Baby Powder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue', window );">Previous damages awarded and revised | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=jnj_BabyPowderMember', window );">Baby Powder | Judicial Ruling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded | $</a></td>
<td class="nump">$ 2,100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember', window );">Oklahoma Attorney General vs. Johnson &amp; Johnson and JPI | settled litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 465.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember', window );">Oklahoma Attorney General vs. Johnson &amp; Johnson and JPI | Judicial Ruling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 572.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_LegalProceedingTextualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Legal Proceeding Textuals Abstract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_LegalProceedingTextualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_LossContingencyEstimateOfAdditionalPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Estimate of Additional Possible Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_LossContingencyEstimateOfAdditionalPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Previous Damages Awarded And Revised, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_Numberofpatientsinsettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of patients in settlement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_Numberofpatientsinsettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_ProductLiabilityContingencyNumberOfClaimant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability contingency number of claimant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_ProductLiabilityContingencyNumberOfClaimant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14435-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118943654&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_AsrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_AsrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_PinnacleAcetabularCupSystemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_PinnacleAcetabularCupSystemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_PelvicMeshesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_PelvicMeshesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_RisperdalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_RisperdalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_XareltoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_XareltoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_TalcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_TalcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_InvokanaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_InvokanaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_PhysiomeshMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_PhysiomeshMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_OpioidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_OpioidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_JudicialRulingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_JudicialRulingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=jnj_DePuyASRU.S.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=jnj_DePuyASRU.S.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=jnj_BabyPowderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=jnj_BabyPowderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982102776376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 187<span></span>
</td>
<td class="nump">$ 162<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_SupplyChainMember', window );">Supply Chain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring charges recorded to date</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_SupplyChainMember', window );">Supply Chain | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_SupplyChainMember', window );">Supply Chain | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_SupplyChainMember', window );">Supply Chain | Other (income) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_SupplyChainMember', window );">Supply Chain | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring estimated cost</a></td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_RestructuringandRelatedCostExpectedFutureSavings', window );">Cost savings expected</a></td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_SupplyChainMember', window );">Supply Chain | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring estimated cost</a></td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_RestructuringandRelatedCostExpectedFutureSavings', window );">Cost savings expected</a></td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_MedicalDevicesMember', window );">Medical Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">Medical Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">Medical Devices | Supply Chain | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_RestructuringandRelatedCostDurationofRestructuringPlan', window );">Period for activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">Medical Devices | Supply Chain | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_RestructuringandRelatedCostDurationofRestructuringPlan', window );">Period for activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_RestructuringandRelatedCostDurationofRestructuringPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring and Related Cost, Duration of Restructuring Plan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_RestructuringandRelatedCostDurationofRestructuringPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_RestructuringandRelatedCostExpectedFutureSavings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring and Related Cost, Expected Future Savings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_RestructuringandRelatedCostExpectedFutureSavings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=jnj_SupplyChainMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=jnj_SupplyChainMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=jnj_MedicalDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=jnj_MedicalDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm139982099453320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring - Schedule of Restructuring Reserve (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
<th class="th"><div>Sep. 27, 2020</div></th>
<th class="th"><div>Sep. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 187<span></span>
</td>
<td class="nump">$ 162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid', window );">Period of cash outlays for severance expected to be paid out</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_MedicalDevicesMember', window );">Medical Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve balance beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(315)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Restructuring Reserve, Settled without Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve balance ending</a></td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_MedicalDevicesMember', window );">Medical Devices | Employee Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve balance beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Restructuring Reserve, Settled without Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve balance ending</a></td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_MedicalDevicesMember', window );">Medical Devices | Asset Write-off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve balance beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Restructuring Reserve, Settled without Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve balance ending</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_MedicalDevicesMember', window );">Medical Devices | Other Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve balance beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(297)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Restructuring Reserve, Settled without Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve balance ending</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring And Related Cost, Expected Period Of Cash Outlays For Severance Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=jnj_MedicalDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=jnj_MedicalDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=jnj_AssetWriteoffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=jnj_AssetWriteoffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>82
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M2,O-&6<1E_H$^'XBH#]7._H"FU==^O\#4$L#!!0    ( +N 5U%]7+7.G <
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M*:E&LVGS[H[-IO19%*3"=PSPY[),V>L<%W1_,X*CXXM[LMZ(^H4SFV[3-7[
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MP'0@@+0!1 UP!P)H&T#5@"%+=AM@*P$T& APV@!'"2#>0(#;!KAJ !D(\-H
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MC^<']B\^=AO+BFB82OZ345.,@^L 45B3+3?W<O\5FG@&CB^77/LOVM>^5TF
M\JTVLFS ]@0E$_5(GIH\' $L3S<@;@#Q:T#_!"!I ,E[%?H-H/]>A4$#\*'C
M.G:?N!DQ)$N5W"/EO"V;F_CL>[3-%Q.N3I9&V5UF<2:;2J$E9Y08H&AI[&"+
MP&@DUVC^N&7F&5TLB+*F @S+";]$G]$'A)$NK%6GV-@S.":<-WJ36B\^H9>@
M.VG)-)H+"K0#/SN/'YW!8QM[FX#XD(!)?)9P"54/Q<-/* [CL.,\T_? 1PX>
MC;K"^3_U^3^KOTA&TE9#XOF24WR' G#WOS0R?R@DIZ#TQT,U_+I=::/L\_Y]
M1J[?RO6]7/]4\1%=(,IVC(*@&E6$473!!**2<Z*L 51=:)==A59S#SVW:X>[
M+.J%48IWQ[?WUBGLC08OG69OG>+>:/C2:=[E=-WZU/'CHX=8@MKX#JA1+K?"
MU+?06MLF>^M[RRO[)+J91AWVF6W*=0_]2U]W]#NB-DQHQ&%MI<+>T/8)57?)
M>F%DY=O 2AK;5/RTL#\64,[![J^E-(>%$VA_5=D?4$L#!!0    ( +N 5U$S
M4]U(=@@  $(C   8    >&PO=V]R:W-H965T<R]S:&5E=#@N>&ULS9I1;]LX
M$L>_"F'L0PLTM4C1LEPD 1PGN0:XID'<=G&/C$3;O$JBEZ+CY#[]#2G%DB52
M21X6V)?$LH?4G\/A_(:43O=2_2XWG&OTE&=%>3;::+W],AZ7R8;GK/PLM[R
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M$HK+-^GLDRV:Q-U-A<.*T(FG<B<-_\@P_XX#.:FJMW*WW<(^#K&UXM69A3^
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MB]1%1^HG],#7HC /,NSC ZZ$=&Y#:)^1>!H&W0EPF<4X\&1\VJ"4OG+,Z1\
M5"ZO2'?P,IY%/>D.,]B]>"I^VH"5#I]QMK=]0X_+6L_+ANEWS81",/Q=ZRA]
M< M)'03#TV[)YK"*XLB#.MJ@C@ZC[EAMZPS)*-_E/'TY9TIDH97,,A.*H@ >
M<@^VJ8-SI'<2X;*"\MTWG0T-Z3 -S>,,N^"W3*1H)=71:;13KP-IO0U\;=1^
M@.G?O].&:728:?.=$B7ZREFF-T/!U_"(QO^,1Z*T00W]&QZ'U7U&1^'1+Z/'
MK;<1<J[6]B6-$MG#ZNK!_N';PXL@<_OZ0^?["_QE4;W.T713O5WRC2G(P"7*
M^ JZ##Y/(5!4]<)&=:'EUK[S\""UEKG]N.$,1FD,X/>5E/KEPMS@\-K,^?\!
M4$L#!!0    ( +N 5U&.Z3(Z- 8  &X/   8    >&PO=V]R:W-H965T<R]S
M:&5E=#DN>&ULM5==;QLW$/PKA JD*2!+LNPT<6(;L)T$38NT1MPD#T4?J.-*
M8L(C+R1/%_W[SI+4279D(RB0%UO'6^['[.R0=]HY_SDLB:+X6AL;S@;+&)OG
MXW&HEE3+,'(-6;R9.U_+B$>_&(?&DU1I4VW&T\GDUW$MM1V<GZ:U:W]^ZMIH
MM*5K+T);U]*O+\FX[FQP.-@LO-.+9>2%\?EI(Q=T0_%]<^WQ-.Z]*%V3#=I9
MX6E^-K@X?'YYS/;)X(.F+NS\%ES)S+G/_/!&G0TFG! 9JB)[D/BWHBLRAATA
MC2_%YZ /R1MW?V^\OTZUHY:9#'3ES$>MXO)L\&P@%,UE:^([U_U&I9XG[*]R
M)J2_HLNVQT<#4;4ANKIL1@:UMOF__%IPV-GP;'+/AFG9,$UYYT IRY<RRO-3
M[SKAV1K>^$<J->U&<MIR4VZBQUN-??'\)C=#N+FXT0NKY[J2-HJ+JG*MC=HN
MQ+4SNM(43L<1\7C7N"J^+[/OZ3V^3\1;9^,RB%=6D;J]?XP\^V2GFV0OIP\Z
MO*%F)*9/AV(ZF4X>\'?4%W^4_!W=XV]/E>*?BUF('F3Y]X$ QWV XQ3@^(>@
M^[#OOY<$3E>N;J1=LZO6RE;I2$IH&\GK6E3.!OA7DA?GVDI;:6E$B%C 8,4@
MI%48+9,,K(NH/RQ=:Y28D> 9AROV\JFU>8@Z'9<B<N02ZFHWQ.L^Q,TV!&K_
MW2UA9<4C63<O^B>.K6$0VEG02DO/\#]FYU>YJ%_VI"<#YQ.A-JE.L6/^Z*=G
MT\.G+X*XL+9%#N^H<3X*1.+Y%8>3@S\$5"QMF>M0P61-T@MB=HJ75%$](R^F
M)\ROPY.18(2_!74OCMI6IE6 Q1@AU2?,;5Y_S"W0(;7:69.88%E-#.JJ6N_Y
MQ<Z&7#+:ZE%!$!9)A< ,*J5^:M6"#=E/+2UD,SUQ65+,I?;;I-B$MW@*4*C0
ME]Z@"J>"@(8'F)$: 4#3UK:PP74AM9DCRID!YK5<,_K(4PG5DH@.5JU5R'TD
MKLE7<(-,@EC*%8$Y!,Y(4[6Y;VU(-581%0WAQQZDS8F1BQ9)C,3[0)SM*^ $
MG84C1IZ^1JX"P;JEKI;BZJ\/;UX>')X(C6Y7*&A?ZV<<#9"E4K:=VF#0:?1'
M$4XTQ;RP;4U()@A:.;/B-.?P[/RFGU@9PF5,U1M=)QY$]SR%KB4&.J:F6\;%
MRS0AJ&.3Z3#9W:U#QYQ&+H,/+:.@^>RP\HY &%?KBED.WL'C3C*9@Q2B\ S3
M4%#=&+=.W4XK*94E28,IU38@)UL17*W(HT$YG] 0JBCD@!I!?IK4*!"2#=?#
MY&7!ORV[!GZ\T$,+7:AR8J@I,0JO"3GGB2DMP:0&6,-O19[G-8E543UT&85P
M"V44"[)(SV X/'UIM:>D6T!DBRBX2Y4,MV5,VWPG89LL4Q%8;R5J]SURAN2
MSLAK);5A8F_2[Q-&D3&-_&?K.BOF;00]>[KU_)-)TW 6Q2(8Y4 J#D"H14Z
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MKEX\WR</\E[6O^[?5?#7E5UEG>UDH;*R$)7<_'!V[3U[.<?Q-."W3#XJY[-
M3%9E^3O^<;?^X6R& ,E<IC6ND,!_'^6-S'-<",#X0Z]Y9K?$B>YGL_IKPAUP
M625*WI3Y?V;K>OO#67PFUG*3-'G]OGS\26I\%KA>6N:*?HM''AO,ST3:J+K<
MZ<D P2XK^/_DDZ:#,R&>'9C@ZPD^P<T;$92ODCIY\;PJ'T6%HV$U_$"HTFP
M+BN0*?=U!6\SF%>_>)UDE?@MR1LIWLA$-94$BM?J^54-B^.0JU0O])(7\@\L
MM!1ORJ+>*G%;K.6Z._\*@+*0^0:RE_YG%[R7^ZGPHXGP9_[L,^L%%M. U@N.
M8_HJ4VE>(K)*_-?U2M45",=_?V:/N=UC3GO,_SPUCRQT??=>_';]\Z^WXLWM
M]?VO[V_?W+[]<"\^;*6X*7?[I'@2C0+P02T?DVJ-_X, %D)^2K=)\2!%"MQ
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M3WC[EJ[IZ]9G-RSBJSP8_O*Y'1Q%51.#J!Z&D'#G-::>V\9K.\5I[.9(Y_H
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MURHVUON>2/UJ8<]TLB>'TMO<9$).]0R$W><!'UB[?_!S-1S3P0S59K668[)
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M'"_ [TN+X:9^X0W:?P4Y^Q]02P,$%     @ NX!740@OMRO$!   (@L  !D
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M-X&<",4"6IOG*%!O>T/5/S^_NAB<#=Z\MVM__X\8-OCQJ__OX*6"=.0I\$R
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MBD;ME[VX\)&H?BA@'/B6]T"G:$\;H6JLA1:F+'"[H R>UZI@[&R0S$A+WY,
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MC\65Q;=^8R65N=!.&LVLF+_J3(8O3O?I^?# )RF6KO69420S8S[3EXOT56=
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MV1SK7YF[H]/K3Q=G+P;'T5S1<-(D=A-=EQAO%4W5@XY&6A-$$62.FPR37)2
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M-W7\"_ H&=Z57D3OB18O0S?#EFT!TT3<3^J,_2[J4VZRA&)C;'2BU5;+3%K
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M'1Z^B,J4>-A8N1DT5UDN-(VK,ED;MXIAH_(T"=U541.DTX:DL9V;KB:@CQ.
M)F6J#(I5:F+V,Q'2LM3:N!0OKU6MUFZG%7&EI:0])+9"]1$YEW:51WM7D<1
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MF<W<;3C&B\RL>V[9UN=@%E>HTU',%3M8:#F7(NF)#DH@K)6B__JI"KDB7Z(
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ME_Y5>N!NQ--_$[P#%2EXK&D!U?'P]'@@7'IZIT6P=7SNSFW XSG^+$D6Y%@
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MW]6W'D^3'D7IBFS0S@I/R\O1]>&+^2FO3PO>:]J$G;'@3!;.?>2'-^IR-.6
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MSXK:253V IVOI#3/"VM@:%#G_P)02P,$%     @ NX!749AQ0\8 #@  O3,
M !D   !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL[5MM;^,V$OXK1"[M.8!K
MB]1[NKM XF2W 9IM;K/M?3C<!T6F8UUER97D9'.__F:&E$19LN--4Z# %8@=
M621GAC//O%'VF\>\^+5<2EFQ+ZLT*]\>+:MJ?3J=EO%2KJ)RDJ]E!B.+O%A%
M%7PL[J?ENI#1G!:MTJFP+&^ZBI+LZ-T;NG=3O'N3;ZHTR>1-P<K-:A453^<R
MS1_?'O&C^L:GY'Y9X8WINS?KZ%[>RNKG]4T!GZ8-E7FRDEF9Y!DKY.+MT1D_
M/>>T@&;\DLC'TKAFN)6[//\5/US-WQY9*)%,95PAB0C^/<B93%.D!'+\IHD>
M-3QQH7E=4W]/FX?-W$6EG.7I/Y-YM7Q[%!RQN5Q$F[3ZE#_^(/6&7*07YVE)
M[^Q1S?7%$8LW996O]&*08)5DZG_T12O"6!!8.Q8(O4"0W(H127D15=&[-T7^
MR J<#=3P@K9*JT&X)$.KW%8%C":PKGKW/DH*]DN4;B2[EE&Y*22HO"K9Z'-T
ME\KRY,VT BXX=QIKBN>*HMA!,637>58M2W:9S>6\NWX*TC4BBEK$<[&7X*U<
M3YCPQTQ8PMI#SVZV;!,]^_DM7R1EG.:XZY+]Z^RNK I R;_W\' :'@[Q<';)
MK$#.\@6[D$7R$"'VV!E",*F>AI2ZEQ[ZYFFYCF+Y]@B<KY3%@SQZ]WDIV2)/
MP;&2[)Y5:#"6E"RJ70RY5S GTFS!B]*HDG-6Y0#<6BI8D,W94L[OX1+<G)8L
M0#%1"I=),6>_;:*BDD7))%J4)1E9@I8)BX=CED'T0%[1EU,&UJKDZDX6C<G,
M6^&8EK#1!<@= 4D@=IVD*3AH><)N(X <F^4ED;LI\ODF!BS>YNF<??HV6JV_
MOV"77R @E9)=92"2A)FCJRS.5_*D&?D)-E#T;_^AQ-$4<K&02!&H+Q!B#P@Q
MI9PD SU7Z%FDM3@JEVP!=B.U@_%.V0<(H&ST8UZ"&B!8;2W2TY0!45?+9'W*
M9@5,AR!1%#*+GV"^%KH ([/R,5K#(+@B8KH\96>K?)/1WN^1%QAZE!*[0L;Y
M?9;\5YDVH9VA#"U$6*36RB]QND$(+(I\I?<+PYD$,2K@C")^^[= </%][[\=
M[AP:F'*@L&<_S:Y>B>.6 7HFVM(]I(3'"'P#' 8"?X:J64;9O3Q4XVE4ELDB
MJ75)&P$#YK7^;38*^ D;<?ND$7$4G*B7[Y\P/@XY;X;X5VF,>XR['AO9GD'<
M07;"1IZAHF]HQWU%L#VW]5W&"IS=0R]#SO%.@I[[+':XVS+]XR-Q!@F!K51B
M_2L,_Q6&7QJ&.0^>1S;W7S40?RW//UDHYA9$2NYA8!3<")C<@EL.!DR!49J/
M ZO=9_A5FA,NLVU@ U'98."Z2#N$-]=1#!S?"#]_@I L#HB3PGH9FG8'9S^T
MGN<:/AN=JR98H$ #KO[">ICP.]7X_3&/":K(XD.]9S7TJ:_W.-ZL-BHSJ @W
MRU=0[R^Q"W[ >$C6N$++Z&N35X?@>R2X([X?E!L.FW4A[RHPU8A[@%/N"2-F
M)SHX2QV<MTVDX#O;!]]CK$@<(.Q^#>'7L_?S6??_TMB"8X'H>Z]M; ="A0,A
MY7"R>UIUMVG5W?VM>@RVWP!$.KUZB0K."VWR&:@R3Y,Y&>L\2J,LADH&#UV&
M6OF]_(9;^7T;\9J-> =OY++!N;FE+*_@<PE)DC82E>P'G5&OLK(J-G3T,[2C
M_8Q-6)K7PX#L.8F!:",'7#4%D'& \EZYY6<*P_]085B=,]5#']%CS0.HC@(^
M'J* 5W69][HHN:R+DEF=D>L:=AOBQ]#,4=OG>5AC\),]T/ ;:/B''D?59U"@
M[J8%N?QM@W>NFG X"(+]+'Y/"R05_S8<0[DR#)X+&3]OAEE4%$\HA3KDFY'B
MB9!Q]/=)+O!D6('M(R0##;@1UPW0E-UL"C!:"9?:5.)DF_9'P*<*:I6VYUE9
M2C!N7Z7L,:F6#$_.D_0)JGJ [BK)2$_4HJ#AQ]P)((OR.I_"9TN_[R"8;ZK]
M-'TN5*,/</(=02_<HQG>E.1* =.ZE\+=J@% */8;H,$5Q"V**G71N0>;08/-
M8"]PWH/ 69R [VK586K],8GNDC2I$FR**\-N0\#<3Q^!B9DURIXH:_C?EPPC
M &3.. *S+1K^4<L_-?BOU+GX' 5I.TH,'J"( ?CA^CY.'R&CX1KE(^5@A]Y?
MM2.$R@>90IA0_X7^;[//>871D=[1QF;HFW?"7MU))6W8.]7Z/Z2A,HIS#_!E
M7@LK;/,W9?=V%4!J9)QG>;;;N?;">@M-DS,69LM#GT)+F/ X2-SFO$_XG6M'
M>+N%-22U ]&YYCU)?2OL7'M4+G53[^N:H-&<8UX*^\7*<3WSTK:;L&!$Y<M>
MI(86N Y4O9Z^"5^!*AU+"7%#.=7(;;7+[;$=\NV/SMCV BV#&0XP@8+>,.+"
M'LID+@M53XP@R/6;1L_VZ,7'/K3,'Z@,A92#$=\H+# :0A  MR=2O\,W%2P4
M'QW0,+#;G+-08,\NYTG%;C?K=5Y4[.R^D/3$C8UFMV=XQ##F6%R/ CR.5;10
M5*($L'/P%-1D86K&A]+9@T[I.1Z^C1S<P#,YF(2.F0@P7ZBR05=DZ@DP/4F]
MPZP3MVG5C);80<6[3(0%P?X0>/ AY;D$[\G0@>IZ_%C;^)C9H6]F?3P26Y';
M&>%[Y).VK2 XH<.GLSGH#$DS#ET(F $<X"9ZTA@/\=@=,C*4E%V6""UD[-F!
M#KD:)K:EQ=^152),!VG*C"X.5%-'=*H5J&']$H-&=+G<KY/P[K'RL)52S9@]
M+I-X2?2':'-U]+G+0HH>JK&A-T3%GE!]<%57!L>\GD^]=9Y]%^NJ*"<'KI50
MJI9DRY4F%&P;8O'SYUJXAX'[$XI&LX[ NX294 PRYJ+.$WW<B)H&G)"*25^:
M +C#KU(5MVTPFU#H:77A68TU:/$QPJ-5T&A=).A6::<&/@-BV(Y$*5@^JOI*
M.MFV1']C'7Q]57DR!E'*M3I'3I\FQF;$UEX@_M2?N^+4HKR>$.BB/V7W.7J<
M67C-_[.I3_'I/%$YDZG5MK3]!!UV5* _$$<@G*]IJ6ZW)LRH#]N5T6X/*8!(
M44+4[+F>:4[T78@Z*#J6R[*HL-6=MP(  5@&\,TS4E290PU::1C2\BXB8D!D
M21%*B6R*@;-WROL(1BAZQ;X^V$6M-)J 6@&4J\(@$(9V(DI2*)8E]CD5'80#
MTHA;YT"DK>!O*[A!@6FRIS,(F\X@W%NY7[?.=MLXVU #L)^,8>"_E^3>XQ<X
M^6XLQWALEY1ROJMI;7I&??S]<V8<=],12.<.GH:PRR9G&3WK#*6F9V3J\M+8
M0-V%#BI-38>T/A8V[Y5(ZJYZAX;VNY\GMQ-6YH O*AG-J@TRG&=4Y&WAZ7>N
MB8)"*")UK1MI%M6E2,GLL17V'^BJN]TQ!=C]U!R[7W[B/7S-\@+J(,P1\^TB
ME*NG*O9 Z8IW79]CT^$+/%&23QH8;+')YB4+QD[0?_JA[JKWS\D*>:YS\%NM
M.Z\O)M[#U^WFKJ)JC/M0_PY4T^HV=\<.B15";8&XB=(NCO1G0A'9X4/^\/?.
MMJ' QNJF4W%S&]7N!#8+QY[+M=('0< '9+/,R]T*%P/8P7M0' O;:U40/4#D
M(0QC.0E13I/"FN-8-0@6ZW4,(#_ )AP'4/ZIPO;%SGZ,]9L?F$SH!B@^&(=0
M9W- "/?(J#_(E$(^N"LN[]9GF)D LE"'JP,$R%A%10:*\1$X2H*/PDI\5("/
MPN36$BQ?HP+KW%*57&<[5&-&JBV>1NZDY+)I4:)X4VVJF#?KVB\3J"):51AQ
MYQ&%2B+[0CVWVN\A6@>?7G?WB*=Q9BR[5GK>D0OVL]G]1;JZ']Y@8FXX-*>6
M?:T?DAJBK3.?'?D!D7 >E9#MS>\F:G.A[C/)G@ &&OO0%M._D.9$"SP$;Z94
MRR+?W"_9 @V$=\#K!/ZU<XVA>G8E,WVG]S"-'&D;8JT3*M?;!P'CJZC\P)-
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M?I'13E<_;(&&[!Z+K%0N8*D%"CIBA?JMB/I0Y6OZ?<9=7E7YBBZ7,H+^'2?
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M(6ZM&$$"ZWD=-UB^XS'2**S'2+$\EWNU7'@.KE;?JZLR?9\5ZRI_8,E-RQ(
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MH@-U?34=]]\.=Y@MUY5$@.O)TLF'XGV\I+U!7J6)@X<%%=I^UP!>PBWK)HJ
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M&L#[C93F:6"O!-T5</$O4$L#!!0    ( +N 5U$'8/HXE ,  %(.   9
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M+*D^KFFXH#D#P._++"M?O[ 3[-Z<>/%?4$L#!!0    ( +N 5U'U9&+U;@D
M *Y&   9    >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;-6<6V_;.!;'OPIA
MS$,+.+5UH20'28#$4G8"M#-%T\X^+/9!L6E;&%V\I)RDB_WP2\JRCR72I%-'
M1O*2V-*?MW,.^3NB9%T\%?1OMB"D1,]9FK/+WJ(LE^># 9LL2!:S3\62Y/S,
MK*!97/*O=#Y@2TKB:54H2P?V<.@-LCC)>U<7U;&O].JB6)5IDI.O%+%5EL7T
MYPU)BZ?+GM7;'/B6S!>E.#"XNEC&<W)/RA_+KY1_&VQKF289R5E2Y(B2V67O
MVCJ_#7Q1H%+\E9 GMO,9B:$\%,7?XLO=]+(W%#TB*9F4HHJ8_WLD8Y*FHB;>
MC__4E?:V;8J"NY\WM=]6@^>#>8@9&1?I/Y-IN;CL!3TT);-XE9;?BJ??23T@
M+.J;%"FK_J*G6COLH<F*E456%^8]R))\_3]^K@VQ4X#7HRY@UP7L=@%W3P&G
M+N <VH);%W /;0'7!?"A!;RZ@%?9?FVLRM)A7,97%[1X0E2H>6WB0^6NJC0W
M<)*+R+HO*3^;\'+EU6V<4/17G*X(^D)BMJ*$ATW)T!FZ7\<:*F8H)#1YC$4(
MH&L1"4GY$WT(21DG*?O(I3_N0_3AMX_H-Y3DZ$N2ICQFV,6@Y/T3K0PF=5]N
MUGVQ]_3%05^*O%PP%.53,E64#_7E1YKR VZ7K7'LC7%N;&V%]V3Y"=E^']E#
M>ZCHS_B0XB-1W!JIAG-<Z]%QK=_JBX=DLJ]XPY;.-M"<JCYG;WW;&+K+64E7
M59SUT3_XZH<^?"X8CZ1_?>:%T%U),O9O39/NMDFW:M+=T^3-BO$CC*%QD3TD
M>2R6LC[_DI=)/N>MBX\LF1):G_F<Q ])RH-;%;KKIKRJ*;%</UYYCG<Q>-SU
MYP&:6UEC^1;>BAH#Q=N!8JUM=Z;JE+!DSH=*IOSCQN),8TQOVX:G-:;PTV#C
M*$HF:<Q8,DMX.S-:9'Q=F*RR55HU_.?XCB\$9<'_3(J,J*RY;@OO6,%VFX8:
M>[*A1ABW+"[7<X9;%46*BH)@C\7]K35\K37^+!>$BKCB.%\(SE9A+49;FXC'
M6<P6Z):3&_U.IG/2B/0^>B \*R#HV]:0DSH(XUG):_X>/ZO,YDO#M4:CEMU4
M&MMNV4TA&N*6*%*(_*&G-ERP-5QP@.$^K"/C(R+//$5B1!.?HVW%H\[F@#4$
M6@ZUW3]D%6O[5#U!^/18!TP?1:Q,LNK$'SR5O,Z*%5^;^/D'@K[3.&<S0JF2
MAS=U;W==-&R%@UD2FB615M*TY4[F86EMR3/#IYCR]8-/!.XO'@N31<P79C3A
M*S3E*:?6938T8Y\*/!; SG*T8^.)KG UC5-TG8J,_R?Z6C#NXCZZGL\IF?.3
M"'(OI6\=R>1.(+E.+VKV'KAIZ<$))NNC/PH1PV(<55PJ>^I*G7 =;RCU]2#9
MK4J&G>&^00$C+:QW">6NYBDUGTOYY*< %*&$E8@*5["G>*D--\"DY9TLW(!&
MEAY'+W68O++;'I8==I#LMI;M I;GC'L=!J2P]*C8N301!.4Y&_H?,GN1B^[C
ME#"Q@JXOH C5NA8(8^D1\XJNM8$X]JL0IYCGR7\Y0?C!#5;N<C*;D>K*G2\^
M='TAGT\W@(F>)^EJNLG?HHVT2IB_<Y-R>_<%D%0!9)NY8Y:$9DFDE30M"MRQ
M]=SYD?,%.:VL-:^,F%9&C&G"1(Q-5U3\6W*[%TKHUM5K!V^4A&9)I)4T!P\T
MM.V.)M68\TMD5TM:3%<<SH@5J?8B&V!IG^S2T ;&V8<R[BW-*YE]4F@9):%9
M$FDE38L"8&T]8(^>5]@\>*,D-$LBK:0Y>,"^K;\\_O5Y]8TP$M/)HHJAD#R2
MM%B*6.2!9+HVLB%!L/V333$ N*T'^-N<8H$YRHR2T"R)M)*F12$#L4?=3K&1
M>?!&26B61%I)<_\0,B%'GPG]^A1[\::# \F$8YUJ8CD <4</\3<YL>H^ZV++
M+ G-DD@K:5IT9W-:?[U^[,1RY.MP:?!&26B61%I)<_"0"CGZ5.C7)];=YNAF
M;@VV1^I)UD=Y.UR:O83TPM%O<K_F3 .L.WJLO\V9)N]Z.^U=X ,TH4)C64$[
MX%0B?T_(03[BZ#<LCIYO\M:$; *S)E1H%"90B?:9 +(C1Y\=->\/K">=>4OT
MI;L;#N06SLEV-UQ@NJMG^K%QX,K[ U;KCMM8H3FSG?:M.UEDMVXV1<J*1NHX
M<"&#</49Q#$W+EQ(&=Q721E.=>/"E1GNM-TF2\Z"MM=DC=4FIJH>U]GC-4@8
M7,,&_Z_.WI=NH[@[=[O=DTU@H++;[46_*U^+6UB:P;+HS!KY[6"058XC18.B
M*KPW'"!/</6[_D=-8J"F>^@V_]N8Q#(7SP*K[3N%R)=<IQ Y[84\4JEL:Y_O
M ,1N1R ^8N?&!2R[)\,R!BSC;K&,%:1L/PDS5HBLD92AJ:J25HA(55?@[LG1
M,+ 9=\=F#&S&[XK-6 %,JTUGA<@:65;;>:JJ;*OM/$5=P3#8XSQ -.X(T2_>
M+L+ :'PR1N.=I\.Z9316,--MK_,*4?MA+54][2>Z(H5H[^-Q@&?<'9XQX!F_
M*SQC%9[;7E-<VK:]IJA&2K(5HCT71ABXC#OB\O&[4ACPC$^&9P_P['6+9\]\
M^]XL"<V22"MI#AZ8['7'9 ^8[+TK)GOFS76S)#1+(JVD:4L L?=R$+_^<SP>
M0-@[&80]@+#7+80]\]UQLR0T2R*MI#GXG6?'N^.O!_SUWA5_/9F)DL>,DM L
MB;22IBT!OM[+X=O)8T(>H-8[&6I]0*W?+6I],VK-DM LB;22YN !M7YWJ/4!
MM?Z[0JUO1JU^0.+'H.=L&4_(96_))PBACZ1WA50_ #.W%6DE38L#D/V.@'S$
MCI</>/9/AF<?\.QWBV??C&>S)#1+(JVD.7C L]\=GOV=GTR]*SS[9CR;):%9
M$FDE35L"GOV.\/SBO2T?^.R?C,\!\#GHEL^!F<]F26B61%I)<_# YZ [/@?
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MV+3GO?<@P3G+A7U0JVNL\FD[OE@)4_S#JK)M>!#GQJJL E,$&9?EDSU5==@
M$,]N0%@!PFU :P^@60&:QWIH58#6L1[:%:!]+""J %%1^[)81:5'S+)^5ZL5
M:&=-;&Y0;%>!I@)SZ80UM9K><L+9_H1Q#5^9R!'ND)E<(ZG&&G@'4])PD@L$
M-8?Q?$Y*<*,1:O[(G!H,2&5I;OA",HL), /7F"RX7,"--%;G)=/I""WCPIP1
MYY?I"$Y/SN $N(0[+@2)RW1]2XFX</RX"GI0!AWN";H)=TK:U,!8)ICLP(\.
MXR\/X'TJ8%W%<%W%07B0<(K+"P@[YQ VPL:.>(;'P"\=/+C<E<Z_>1__F_?)
M8?@(XWWP5[5LUHIL%GS-O7QKA6W*Z!P^TBD)I[?*D)*^WQ((;BQFYL<!EZW:
M9:MPV=KC<I ;6C$&ABJ;<5(SR?*<)M*2F,F[&QJ>H*[>W'(VXX+;YUW2+5U%
MA2MWK#_VHV;4]1\W]_,(F\E;FZ 3M&NC5XFVZT3;!Q/]=,07"W^ SNP5TPE0
MWZ*360(^Q2FC2D!,)='4# P9?;8I:CCE,E89GI$-]3J#!W8CJH.,_I< .K7+
MSL&Z.&J_HG[ 6"TD_TWUN9'T<^D!]<"7L';M>N?M;KW>S^%;BW=!<TL7;VVB
M+5F,=]$T@BU9^!L-(4.]*%JWH>W+I2V_Q'JUOAU\*)KBUOH@N!H&.]9'P=6X
M;/XO].55Y(YI$I0!@7-RU;CHD")UV=[+B57+HAW-E*7F5@Q3NA&A=@;T?JZ4
M74^<@_J.U?\+4$L#!!0    ( +N 5U&.K\I>%P0  .4.   9    >&PO=V]R
M:W-H965T<R]S:&5E=#0P+GAM;-576V_B.!3^*U8T#QV)-A<@E J0N.Y4:G>J
M,C/[L-H'DYR =Y*8M1V@_WZ/G31<&E*DD:K=%_#E?.?X?/GL8_>V7/R4*P!%
M=DF<RKZU4FI]9]LR6$%"Y0U?0XHS$1<)5=@52UNN!=#0@)+8]AS'MQ/*4FO0
M,V-/8M#CF8I9"D^"R"Q)J'@90<RW?<NU7@>>V7*E]( ]Z*WI$N:@OJ^?!/;L
MTDO($D@EXRD1$/6MH7LW<UL:8"Q^,-C*@S;1J2PX_ZD[]V'?<O2*((9 :1<4
M_S8PACC6GG =_Q1.K3*F!AZV7[W/3/*8S()*&//X#Q:J5=^ZM4@($<UB]<RW
M7Z!(J*W]!3R6YI=L"UO'(D$F%4\*,*X@86G^3W<%$0< ]%,-\ J =PIHG0$T
M"T#ST@BM M"Z-$*[ +0O!?@%P#?<YV09IB=4T4%/\"T1VAJ]Z8;Y7 :-!+-4
M*VNN!,XRQ*G!C#)!?M X _((5&8"4#9*DFLR1Q&'60R$1V0:1:@$W?H=Q7Z?
M;D J;4>^0+@$2:XFH"B+Y6?$?9]/R-6GS^0382EY9'&, I(]6^%B=4@[*!8V
MRA?FG5E8DSSR5*TDF:8AA!7X23V^6X.WD:22*>^5J9%7ZW .ZQOB=1K$<SRG
M8CWC2^!=#7>[5>G\6O3IKT6?U<,G$)R#'W'9+%77-/Z:9_T)MJ'Z3$$Q224R
M([H&^0V/0G+UP"4JZ<\'!)%[!8G\JR9DJPS9,B%;9T*.,HDC4I(Q3Q8LI?I<
M:V G52Q=:BEC4[(01#'SP.B"Q4R]5$DW#^6;4/KLW@S\IM^S-X??\P*;V5L;
MM^.V2Z.C1-MEHNW:1+^J%0B=)5::E2X!AN2 )U PVR![^AMDN@OB#'>(0? 4
MF6AH<ZQ2$O2^SEL(6@#6,2##\.\LW_R2T#0DW^BNBJ%\C>V#S*Y=OWN<_KC]
M-GW?.Z&QPI'G=HZ-IA6..GXUC7Y)HU]+XYSF1]\\6Z L&%;=0W76"+)3!NA\
MU!ZX+4/>UN9T2<AG"&(J)8M88'8"B01/R# (LB2+J4*A?!W?$\4+3:& I&*)
MF="U89CP##<3SB^ ?!,TE1$(47F CV[??%KG1"#O6DS>M9C661RQV"U9[%ZP
MP8HM-=WA'0]W"N9>\X%<9U^.G8]2A7MP!W#_3[HH5ELGC/=-)N^;3&M-CKGT
M]EQZM5R.!==%)L/DTN %V5 @\+9$GI$*4VX$7J;KOMJ^AKH?5D3=?15UZ\OH
M?Z.ZN&\+Y[77;)V*I**\MD_K2X51RSFM+U5&_FF=M@]NX0F(I7DO21)HX>=7
MHW*T?),-S4OD9'SDWHW=BO&)>S?-7UQ[]_D#\)&*)4LEB2'"4,Y-!R4M\C=5
MWE%\;=X "Z[P16&:*WR'@M &.!]QKEX[.D#YLAW\"U!+ P04    " "[@%=1
MVS\>2.0#  "D#0  &0   'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6RU5\%N
MVS@0_15"Z*$%TDB4;=DN; .)TV(#--G 1MM#L0=:&EM$*-$E*;L!^O$[E!1)
MB2QUTVTOMDCQS;R9X3Q2LZ-4]SH&,.1[(E(]=V)C]N]<5X<Q)$R?RSVD^&8K
M5<(,#M7.U7L%+,I!B7!]SPO<A/'46<SRN3NUF,G,")["G2(Z2Q*F'BY!R./<
MH<[CQ(KO8F,GW,5LSW:P!O-I?Z=PY%96(IY JKE,B8+MW+F@[Y:^9P'YBL\<
MCKKQ3&PH&RGO[> ZFCN>900"0F--,/P[P!*$L):0Q[?2J%/YM,#F\Z/U#WGP
M&,R&:5A*\85')IX[$X=$L&69,"MY_ O*@$;67BB%SG_)L5SK.23,M)%)"48&
M"4^+?_:]3$0#@'9. _P2X#\'##L @Q(PR ,MF.5A73'#%C,ECT39U6C-/N2Y
MR=$8#4]M&==&X5N..+/XP+@BGYG(@-P TYD"K)'1Y"U9%X4E<DLN;*ZY>2 K
M$,Q 1(PD[[]E=N8Z/8 V!>;U%1C&A7Z#Z$_K*_+ZU1ORBO"4W' AL&9ZYAJD
M;!V[84GOLJ#G=]";DAN9FEB3]VD$T5.\BZ%6\?J/\5[ZO0;7L#\G_OB,^)[O
MG>"S[(=?08CPJ873:0^=097^06YOT&'O;Q.#:B21W$J#6681%P_DAJE[S.A&
M /GZ$8'DVD"B_^EQ.ZS<#G.WPPZWEYG&&:W)4B8;GC+;46<X2 U/=Y8&/FH>
M@2K??.1LPP76^U0%"U=![LJJQF$1#(*9>VAFM;V&CNFH6O0DB%$5Q*@W=ZT=
M2+ZNI! $V_O(5-27IZ!R$?3FZ1:%9IDI98T7I;K0&LS)C5Q8&C730 ?T61Z"
M5AY&P;0C#^.*Y+B79)F'-829XH:#)C].=>>1FYBH<FM%8$"AG.2;ZV#;OR=;
MDXK(Y$\59%JYF/;&NF1*/> >+3B?D0WL>)K:"92I/2@NHU.UF;9J0^EP<CKM
MU*NET^LG$S/L%FT5KB&C*]C:,PI5$N=O\2"^3D.9P$GM\]J\ MI!JZ'HM)?6
MF@G0+KG+5!CC :?=?.>>]$];_M_28-I!P*\)^"\J$J11?WE*>\_JXW7PJ+65
M#GY;]Y:F_B.%6F=IO]"^H#?QCO5K[4EKP:1_3#%I+9FT7S-_L45I6S_'U._(
M?RV-M%\;_W^+CMLMTCC=GM*JA9).?E>+3MK'2I?[6D3IRU3TYPW:%M#QL*,X
M?JV??K]^OJ0_2U-!+P.W<0].0.WRSP--0IFEIK@25[/5)\A%?O%VZ^7%]PO>
MO7#;:B)@BU#O?(RQJ^*3H!@8N<]OU1MI\(Z>/\;8O:#L GR_E=(\#JR#ZL-L
M\2]02P,$%     @ NX!746]WVG;W"   *SP  !D   !X;"]W;W)K<VAE971S
M+W-H965T-#(N>&ULO5M;;]LV%/XKA+&'%FAJB10IJ4@")$ZZ#5BWKMGE6;$9
M6Z@L>12=M,!^_*A+?&3Q8J75]-+:SB'U\7*^[YQ#ZORI$)_+#><2?=EF>7DQ
MVTBY>S>?E\L-WR;EVV+'<_67AT)L$ZF^BO6\W F>K.I&VVR./8_-MTF:SR[/
MZ]\^BLOS8B^S-.<?!2KWVVTBOE[SK'BZF/FSYQ\^I>N-K'Z87Y[ODC6_X_+/
MW4>AOLT/O:S2+<_+M,B1X \7LRO_W6W,J@:UQ5\I?RH[GU$UE/NB^%Q]^7EU
M,?,J1#SC2UEUD:C_'OF"9UG5D\+Q3]OI[/#,JF'W\W/O[^O!J\'<)R5?%-G?
MZ4IN+F;1#*WX0[+/Y*?BZ2?>#HA6_2V+K*S_14^MK3=#RWTIBVW;6"'8IGGS
M?_*EG8A. ]6/N0%N&^!^@\#2@+0-R- &0=L@&-J M@WJH<^;L=<3=Y/(Y/)<
M%$](5-:JM^I#/?MU:S5?:5YME#LIU%]3U4Y>OD]2@?Y*LCU''WA2[@57NT"6
MZ R]3_,D7Z9)AJ[*DJN?DGR%?DF3^S1+9<K5=XDZK5_=<)FD6?E:-?WS[@:]
M^N$U^@&E.?J09IG:$N7Y7"J\U5/GRQ;;=8,-6[#%Z$.1RTV);O,57QVWGZMQ
M'@:+GP=[C9T=WO'=6X3#-PA[V#/@60QI'E?-_=C0_,;=_(8OG<UOW<VO=N(M
M\GQ3\Z/)((>5)W5_Q+;RA_5-8'VSX_5]J-;WL5I?QP.#PP.#^H&!=?PB?4PJ
M7BB5*Y?I.D\D7ZFGHPU?K=-\K79+*<6^V8#OVFUGVC;-<UC]G(H)'R]]'(3G
M\T<#.GI 1T=%U_$$$\3F8;0#,?1B,T)V0,B<"*\>E7\E]QD_4_IP5B891W=\
MN1<UAC?H]I]]*K]V?C+!8AHLWP^\ ZYF&S-]>OT@,H,/#^##;P=O0AKJ2 F)
M_1Y4W2H@S (U.D"-G%#_**1RBA]%49:./1@9\/E]>+I1C*D977Q %SO1+01?
MI1+=[7>[0DATM1:\IFST:G%W]=J$--9 G/F^'_:@&JRBP#=C]3U0%V_ 7/ZJ
M IYZ)HT:X.DS&0<]= :C*+" ZTB?/WBA3[ASV].1/S/:!ZD;,8HM*#&@Q",O
M>-OAT5J&I+_@)BL:,0M<4!6?#%SQ4U-*M.?CJ(]1MV$VA"!#OEN'KKFB\[QB
M].LD4Q+(C>@"_<F$'<-;^ 8A8L1"/SXHD>^6HL4FR==*AE3PQ$N9;FLA BE&
MKT+SLNN:<^9[4=0'K9MUV> 8,VB3?T*<5FJ36L,\@^QX81^729L(L0 #W?'=
MPO,Q^5I+MA&7+A]GL39?)B,+*I 8WZTQ*J(]M0$- A/ZM ].MR*Q;3%!8OP3
M&J/";@6O(IFE6M)TQ452+:X1IRX<FJ/<&(R.!G,<S8.Z8+>ZV'"J#/:1"Q5D
MF !C74K.CN*;-A7P--_V+'A!<+!;<'[?%Y4K[T2Z;-R[29-5/B<^5Q&X"HV0
M&H0:U-(>EO^BQI8AWY4.@;9@/$T.@$$?L%L?QLL"L"X.MA4";<#CYB@G- [K
M*F*#".J W>HP1AJ 31J@Y0%F*XN\89 *_!UYC!&MK@RV6019P&Y9> G%85T!
M;,\' <!N ;A36RM]4'ZN !1RPP4J[DLN'JMY47MLMY?/GHY=;@>4CN-I/)T
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MERN9+&797*"^ORJ*^N%-4]2__Q>'D_\#4$L#!!0    ( +N 5U%%)"C0F (
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M%5)O<,.<NC%HNX"^9TKA/K -PO?WX5]02P,$%     @ NX!74:A*J8N2$
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M;?&NG:[O5FWW2]JLBV^*'V:+Z>)R-IT7_YI-/\[FL\VL71>+Y>;A&Z^*Z::
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M[P.^"MC;HS5S)UEK_>R,>38)NDX02$C1(7!Z[> !I'1 ).-G@QFTE"[Q>'U
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MUL?V! U(-K68"H0"E68H:()DDB4JRDA3:5'?RRL8OB6EVG-G1M074 6:AJI
M JM 1;@*A( ((7EU08B($%%<D9:/"ZF EO.I%ZP"KT"E^0J:($ 8[2:JI$YJ
M'94@+)""6!CGT>R(+Y +- US@01T@8I0%PC $J@*^Y8(T!+BNU 0P8&BT@ @
M12GP @GR I5&+VB"SB;-JHRLFS@!"^8E(J/"7A@VZ\GYS]WI[.C5JS?')R]/
M?OIE\$-%=)H&Q4""Q4!%8 P$& I1_H1@#)$Y8YVHJ@KHI&I1:WE'3_%+>H8%
MC4O>$*6,)/#J*IB7B(8*C&&<,3."O4 ST#1L!A)P!BI"9R  5HC>D@*P0K0;
MU76Z89U@HB(6E48T:(+@^KO=)$</#&8EPI\":1CMSNPP+Y -- VS@02T@8I0
M&PC %J)E%%$;(IN"I"FR*3B'2ME4A*32S 9-<& 954;JRZB -I!";0"]3[_=
MWR_]Y7:VO+A=KV[7PUX1D6@:< ,U\OJV(BD2("XT45\R >1"$U[ILT1:['U4
MY@?$V-G4QE,0'*@TPD$3!%S-W52U:X.4DFD!<2"%XI!CRYS+^40<F@;D0(+D
M0$50#@0(##9^:P\0#%&;\Q)I$<>OF1 9@E+L8A)$!RJ-=- $YY0ND5*I#DK+
MB< ZD,)UR/1G=E079 >:!NU @NU 1> .!*@,-KQX94$ RV#C-TV(\&#:Z)0>
M,1Y,DWK7)"@/5!KSH G6R654&0A*JH)9B7@X"O60M&FW?'-Z>'S^\,[I8'9S
M<?GYXO>+FXW:X#<B[SZ=Z/)3>?MIF>M/ 80[;#19,, Y<+2Z(JTZ>N6$M.35
M@,&$Q?VGI<$0FF"3>H6O#22M6IH%&8+'DB%&>U;?&+"@2? T- D6- DN0I-@
MQ'\(EUM&\(<PCT)*)BPY04HF41#%@B'!I1D2FN"<4%7>;J;*V$8#X+$ 2?!X
MD,1XZV9?^"O@$SP-?((%?(*+P"<8X"(X1"@O&, B.+Q[:(FT?!.2>9"6KQ*U
MU"RP$UP:.Z$)MJGS?6T@&:6RCP5W@D=S)Z"'7Y]V_S@Z.S]\-/'V"XN3%T=_
M?_S*Y@LG+^4C9[^\.G_S#[TX@$E> CY)VL8"8L%%(!8,L!,N=C: 3K@JVE@@
MA(6G,&U#8N1\:HT6  LN#;#0!$V*\Z,/5'86 F#!HP$6TU@[8_\A:!@\#0V#
M!0V#B] P&/ KHBN[%@SP%28JRD9:1!%_%XE195)7M@L6!I=F86B"29*5.I 4
M]BD+% :/1F%,9O'L?8K@:O T7 T67 TNPM5@Q-6(:KP9835,R.%'6M:'?;5(
MRYE$'S@+I@:79FIH@FTR350&SC<;E?@:QF!B(BZ/QFI KS\<MAW_M5N<'YV\
M.9LMC\ZZP[/N;/#;$+%R&M0&"]0&%T%M,*!C4'2'"6/41N19E"'&G@4I8JH\
MD05G@TMS-C1!> W$;JK*4 ,N00EF)D+M:,K&.--F["T$>8.G(6^P(&]P$?(&
M UH&AR=R#%@9X6N+)5**[H-"2FURK17QJS1S0Q.<LT^R_=6QA,;NSTTP-W@T
M<V.T<[.W# +$P=. .%B .+@(B(-S0!R,0!QA-0Y2BBZPZ)"4O$XRF*X(:*5!
M')K@G),<#FVHNC<6& X>B^$X7G^YN;Y]=[&^>C=TSL&"L\'3<#98<#:X"&>#
M 1N#?%1:RP".02YLDUDB-=M$E>!(S=:I<V06K TNS=K0!*M4]8TV4'>DB(UC
M*1O2D1F17O T>!J>!@N>!A?A:3!@8-0A\'_! (%1AU#A)=+:A/;H/1D0VV3E
M*5L*G@:7YFEH@G,#+A3=3?;;Z.PL>!H\EJ<1&#,[D MV!D_#SF#!SN B[ R&
MO(OH32[B7827FBV1%KNH  >)L6L3Y;4LZ!E<FIZA"8(JK]U4M6,ZC9W!@IW!
M8]D9@4,7)\>+[E2\OOJTOOOXY^7GC^NKB_>KN\%X+X@9/ TQ@P4Q@XL0,QA0
M+BB$$BX84"XHO )ZB;1LV'#3(2UG4TF4(&9P:6*&)CAG3B=1VE@RVX _:%O!
MS>"QW(R1MLW8% BF!D_#U&#!U. B3 T&% QK0O,"!D9XW+M$2A1O5!&<HTT=
MG F:!I>F:6B"<]LF[^!5Q[)17P (H@:/)6J,]V[VOD'P-G@:W@8+W@87X6TP
MXFU4T9D!PFU$M[ A+1.!N)&62;X"$*P-+LW:T 0A.&LW565HH[Y_%;@-'HO;
M"'>VQV^[GPYG9V_.SKOCX][+?^]>OSPZ.7[\^\-SYZ='Q__HGSH_[=X>+<XS
M2AP$GX.GX7.PX'-P$3X' Z9&&Y<X *1&$Y8%+Y$6^Y!)VR&QS48S53TI^!Q<
MFL^A"3;QBX'=5+7S-*5ZQXMPZ[\Q<2MH[XR]B*!\\#24#Q:4#RY"^6! YG#A
M.X4% S*'"^L7EDB+ZNCV."1&+G6A)@O.!Y?F?&B"R:XU;2!52GL0"\P'C\5\
M3&OS[&V+ (;P-, 0%L 0+@(,80#Y,#:J*T; D+ _8XFTVB:J+ 9:;8JUR (8
MPJ6!(9K@UQL6L-V'1VKWO;, AO!88$C@]M.CL]?=Z7+S3YLM^%G.[D.P0G@:
M5@@+5@@7884P8H6$IV(+1H"/D+"\1%HVNE 6:;G4_6 L8"%<&A:B"<[;] F;
M-I00=#R8FHBQ8WDA65[-V$H(? A/@P]A@0_A(O@0!MB/\"[M!0/N1UBPL$1*
MS-%K#80B,8DF8Q80$2X-$=$$MW<S)!-";:S7KKUAP1'AL1R17,-F;PH$6(2G
M 8NP (MP$; ( R!($^T) !$DO+5QB90X+O0%4MRF3N@$7H1+XT4TP7D-W@?O
MIJK5/[):_R@8(SR6,1(X]VLESG'WYO3D;''4'2^ZP0\6X6L:K@@+K@@7X8HP
MXHJ$=W@O&!!!3/SB&&A1U//9(3%BDP QLR",<&G"B"8XIP&GJD.U/8%@C/!8
MQHAJU(S]@ "/\#3@$1;@$2X"'F$ "_'1?@"@0D+,\A(I<7CZW"&I]#&'@(YP
M:>B()CAT5Y,VMM9:A 1WA,=R1W*LFKT3$#@2G@9'P@)'PD5P) P0(H:B-180
M1"+ZXA)I416VOW5(C"J3H#RPP)%P:1R))IAD,FL#Y^A(.IB7")=C<20G5^^T
MJ\)9,$=X&N8("^8(%V&.,."$F.@BVP4#3L@F.8H.(8!:T\:=\$"M;NO4.BJH
M(UR:.J()HE;@W5Q5..,P_HX%=X3'<D=V?LP([((JPM-018R@BI@B5!$#2"#$
MX6NGA0$H$*(ZM"52,YY#6R(U0S9A2R/((J8T6403;.+:Q-U4%;*(5M5H!%G$
MC"6+"%?FQG CR"%F&G*($>004X0<8A YI DA=0N#V"$N0M<C-6>BS2=2LXU)
MU#0:01 QI0DBFB"!+>1NKL,C6P769 0]Q(REAPA[+@]/_W'XLON[^FK?""J(
MF88*8@05Q!2A@AA \J JO.]S80#*HPYK:9=(;+,;"U%B2(S))][N&P$&,:7!
M()J@-:G2 FVD<<JAJQ%D$#.6#)+TIQ[EC4!\F&D0'T8@/DP1Q(=!B(^H,L
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M(T0T04H7F"DC=8*H%101JU!$\OVIAW@G^"%N&GZ($_P05X0?X@#SP[1AYN,
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MH0GBQ7 W664L6W4+*F <3H%QY+DS(](+ZH:;AKKA!'7#%:%N.$#*X.C:>@=
M&5R%#;-(R\6I/")X)#-YP=QPI9D;FN"<!BRJ#6UUBXI@J( WLBV:'>P%8\--
MP]AP@K'ABC V'.)B5&'YB$-8C#AM EH<-F5U2,N:U'HJ"!NN-&%#$]RNB:E;
M%-6QAM3$27 VG,+94,UZ?GKXYM7AX*>)R#0-.L,)=(8K@LYP 'GA0\;\P@'H
MA:^C-TY BYH(18_$N#() HP3$ U7&J*A"5**Z:T-W.QBM8548#2<@M'(]&9&
ML!=T##<-'<,).H8K0L=P@&AAPSQHX0#1PH:M>TND111VHW1(C.1U>/M3%GP,
M5YJ/H0G:5/F=-A#6D0;S$K%0 63D6S0[V ORA9N&?.$$^<(5(5\X0*O@L$9I
MX0"M@GUT,@^T?!SL@5;=IH*](%^XTN0+37!CN%0OJCH4-OP%4Q.A46%?J&8]
M>WUTW/WGYC\GI^=GL_]8??K\7U];0P:_ 1&HIL%9.(&S<$5P%@Y *.KXG3Z
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M>,!R8!<E^(#EP"&M=(FT?$1_0EIM"I;K!1?"E^9":()S\LEB?'6LJ;3#)2_
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M)GS/2!5@BF+LP:D*UE$(G%$X3T[4P,<E'&<REU$VGE:P/I$/:CFQ* $ &GL
M^"*,H=LRQHB&@!7&C%';,B)L&+-8CUDXQWREQI;ET:PDHW&:E#59XIQZF<>3
MJDC3!"I,8;NK\F3X:PLU>!NNO0UW>)L7V7)<++-R[HRG478O0? (K2=S,R6
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M>9@'JPQ"%NW^D^^Y$0<!T"X)@'D K!J \@!4-0#G ;AJ@),'.%4#VGE ^VU
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M1Q$MWGW!W1U(OLJ^U<VX>K)A]G-)B2)3>H.Z/N=<[@_2!HKOZ/V?4$L#!!0
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M04K60GW.]>/PTC;%@A\ECDE1VD7<".BBN]UTE*9T\XF2%6?8/OS)"0,/U?M
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M15:-(JM&D56CR*I19-7_*>N3M>N__J6@O^>MJ;OW?#;\MW'U"E!+ 0(4 Q0
M   ( +N 5U$'04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ NX!74>M/U<CN    *P(  !$
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M970R+GAM;%!+ 0(4 Q0    ( +N 5U&? A-:L@(  (8'   8
M  " @8$6  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " "[
M@%=1?,SHU=,'   ,*0  &               @(%I&0  >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&UL4$L! A0#%     @ NX!743X]PA,X!0  7!8  !@
M         ("!<B$  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0
M   ( +N 5U'F!I7X=08  'H@   8              " @> F  !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " "[@%=1O0F=E(<"  "V!@
M&               @(&++0  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!
M A0#%     @ NX!743-3W4AV"   0B,  !@              ("!2#   'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( +N 5U&.Z3(Z- 8
M &X/   8              " @?0X  !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"% ,4    " "[@%=1=GFM,J,"  !\!0  &0              @(%>
M/P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( +N 5U&/
M(4[-+@8  * /   9              " @3A"  !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&UL4$L! A0#%     @ NX!74:G%";2I%P  #E0  !D
M     ("!G4@  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
M" "[@%=1ES[#92\)   1&0  &0              @(%]8   >&PO=V]R:W-H
M965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( +N 5U$(+[<KQ 0  "(+   9
M              " @>-I  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L!
M A0#%     @ NX!742]YK;L:!   ,PD  !D              ("!WFX  'AL
M+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " "[@%=1U)FWXC0$
M  "U#0  &0              @($O<P  >&PO=V]R:W-H965T<R]S:&5E=#$V
M+GAM;%!+ 0(4 Q0    ( +N 5U&[D/O9,14  ,4V   9              "
M@9IW  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ NX!7
M43#SP/^O"0  .!L  !D              ("! HT  'AL+W=O<FMS:&5E=',O
M<VAE970Q."YX;6Q02P$"% ,4    " "[@%=1@>>=LD4H  #6AP  &0
M        @('HE@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0
M   ( +N 5U'4=L@/%0<   L1   9              " @62_  !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ NX!743FD-_![!0  90X
M !D              ("!L,8  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q0
M2P$"% ,4    " "[@%=181OWPZL"  !?!@  &0              @(%BS
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( +N 5U&^B?#5
MI@(  (0%   9              " @43/  !X;"]W;W)K<VAE971S+W-H965T
M,C,N>&UL4$L! A0#%     @ NX!74=A3[/A=!   K H  !D
M ("!(=(  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " "[
M@%=1F'%#Q@ .  "],P  &0              @(&UU@  >&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( +N 5U&+S!R*IP,  #8(   9
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M970S,"YX;6Q02P$"% ,4    " "[@%=1PC'J:6\"   Y!@  &0
M    @($'"@$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (
M +N 5U$7&Q?]H0,   X.   9              " @:T, 0!X;"]W;W)K<VAE
M971S+W-H965T,S(N>&UL4$L! A0#%     @ NX!740=@^CB4 P  4@X  !D
M             ("!A1 ! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"
M% ,4    " "[@%=1MENF6!L$   ?$0  &0              @(%0% $ >&PO
M=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( +N 5U%%HD;$.P(
M +4%   9              " @:(8 0!X;"]W;W)K<VAE971S+W-H965T,S4N
M>&UL4$L! A0#%     @ NX!74;LDG4*6"P  15$  !D              ("!
M%!L! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " "[@%=1
M]61B]6X)  "N1@  &0              @('A)@$ >&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;%!+ 0(4 Q0    ( +N 5U%:,=P_=0(  ( %   9
M      " @88P 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%
M  @ NX!74<8@6'L[ P  ;PD  !D              ("!,C,! 'AL+W=O<FMS
M:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " "[@%=1CJ_*7A<$  #E#@
M&0              @(&D-@$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+
M 0(4 Q0    ( +N 5U';/QY(Y ,  *0-   9              " @?(Z 0!X
M;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ NX!746]WVG;W
M"   *SP  !D              ("!#3\! 'AL+W=O<FMS:&5E=',O<VAE970T
M,BYX;6Q02P$"% ,4    " "[@%=1TB5N19\(  #100  &0
M@($[2 $ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( +N
M5U%%)"C0F (  .L'   9              " @1%1 0!X;"]W;W)K<VAE971S
M+W-H965T-#0N>&UL4$L! A0#%     @ NX!74:A*J8N2$   '9$  !D
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M=#0Y+GAM;%!+ 0(4 Q0    ( +N 5U%;@4*9!P0   4.   9
M  " @6!U 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @
MNX!74=H<WH/H+P  5ZL! !D              ("!GGD! 'AL+W=O<FMS:&5E
M=',O<VAE970U,2YX;6Q02P$"% ,4    " "[@%=1AZR#$BD+  !(0P  &0
M            @(&]J0$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4
M Q0    ( +N 5U'NAJRC1 0  +(1   9              " @1VU 0!X;"]W
M;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ NX!747O'93\L"0
M<"T  !D              ("!F+D! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX
M;6Q02P$"% ,4    " "[@%=13+*0VOT%  !3'P  &0              @('[
MP@$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( +N 5U$Z
M$PKI@P0  "87   9              " @2_) 0!X;"]W;W)K<VAE971S+W-H
M965T-38N>&UL4$L! A0#%     @ NX!74?I$<56.!   >Q4  !D
M     ("!Z<T! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4
M" "[@%=15ENHP'L"  !8#@  #0              @ &NT@$ >&PO<W1Y;&5S
M+GAM;%!+ 0(4 Q0    ( +N 5U&7BKL<P    !,"   +              "
M 535 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( +N 5U'SL!6?: 0   <F   /
M              "  3W6 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "[
M@%=1\R"+>>D!   2(@  &@              @ '2V@$ >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "[@%=1LFA)V-4!  "_(0  $P
M            @ 'SW $ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     00!!
+ +X1  #YW@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1063</ContextCount>
  <ElementCount>399</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>194</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Consolidated Statements of Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/ConsolidatedStatementsofEarnings</Role>
      <ShortName>Consolidated Statements of Earnings</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Statements of Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/ConsolidatedStatementsofEquity</Role>
      <ShortName>Consolidated Statements of Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Statements of Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2106103 - Disclosure - Intangible Assets and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/IntangibleAssetsandGoodwill</Role>
      <ShortName>Intangible Assets and Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2112104 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2125105 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2127106 - Disclosure - Pensions and Other Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/PensionsandOtherBenefitPlans</Role>
      <ShortName>Pensions and Other Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2131107 - Disclosure - Accumulated Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome</Role>
      <ShortName>Accumulated Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2134108 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2137109 - Disclosure - Segments of Business and Geographic Areas</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas</Role>
      <ShortName>Segments of Business and Geographic Areas</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2142110 - Disclosure - Business Combinations and Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/BusinessCombinationsandDivestitures</Role>
      <ShortName>Business Combinations and Divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2144111 - Disclosure - Legal Proceedings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/LegalProceedings</Role>
      <ShortName>Legal Proceedings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2146112 - Disclosure - Restructuring</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/Restructuring</Role>
      <ShortName>Restructuring</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.jnj.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2213202 - Disclosure - Fair Value Measurements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsPolicies</Role>
      <ShortName>Fair Value Measurements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.jnj.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jnj.com/role/Inventories</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2307302 - Disclosure - Intangible Assets and Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/IntangibleAssetsandGoodwillTables</Role>
      <ShortName>Intangible Assets and Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jnj.com/role/IntangibleAssetsandGoodwill</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2314303 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jnj.com/role/FairValueMeasurements</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2328304 - Disclosure - Pensions and Other Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/PensionsandOtherBenefitPlansTables</Role>
      <ShortName>Pensions and Other Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jnj.com/role/PensionsandOtherBenefitPlans</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2332305 - Disclosure - Accumulated Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2335306 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jnj.com/role/EarningsPerShare</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2338307 - Disclosure - Segments of Business and Geographic Areas (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables</Role>
      <ShortName>Segments of Business and Geographic Areas (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2347308 - Disclosure - Restructuring (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/RestructuringTables</Role>
      <ShortName>Restructuring (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jnj.com/role/Restructuring</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jnj.com/role/InventoriesTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2408402 - Disclosure - Intangible Assets and Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails</Role>
      <ShortName>Intangible Assets and Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jnj.com/role/IntangibleAssetsandGoodwillTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2409403 - Disclosure - Intangible Assets and Goodwill - Goodwill By Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails</Role>
      <ShortName>Intangible Assets and Goodwill - Goodwill By Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Intangible Assets and Goodwill - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails</Role>
      <ShortName>Intangible Assets and Goodwill - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Intangible Assets and Goodwill - Intangible Asset Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails</Role>
      <ShortName>Intangible Assets and Goodwill - Intangible Asset Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2416407 - Disclosure - Fair Value Measurements - Summary of Derivative Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Derivative Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2417408 - Disclosure - Fair Value Measurements - Schedule of Derivatives Recorded in Consolidated Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Derivatives Recorded in Consolidated Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2418409 - Disclosure - Fair Value Measurements - Schedule of Effect of Derivatives not Designated as Hedging Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Effect of Derivatives not Designated as Hedging Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2419410 - Disclosure - Fair Value Measurements - Schedule of Effect of Net Investment Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Effect of Net Investment Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2420411 - Disclosure - Fair Value Measurements - Summary of Activity Related to Equity Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Activity Related to Equity Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2421412 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Financial Assets and Liabilities at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2422413 - Disclosure - Fair Value Measurements - Cash, Cash Equivalents and Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails</Role>
      <ShortName>Fair Value Measurements - Cash, Cash Equivalents and Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2423414 - Disclosure - Fair Value Measurements - Schedule of Available for Sale Securities Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Available for Sale Securities Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2424415 - Disclosure - Fair Value Measurements - Financial Liabilities not Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Financial Liabilities not Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2426416 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jnj.com/role/IncomeTaxes</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2429417 - Disclosure - Pensions and Other Benefit Plans - Components of Net Periodic Benefit Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails</Role>
      <ShortName>Pensions and Other Benefit Plans - Components of Net Periodic Benefit Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2430418 - Disclosure - Pensions and Other Benefit Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails</Role>
      <ShortName>Pensions and Other Benefit Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jnj.com/role/PensionsandOtherBenefitPlansTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2433419 - Disclosure - Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2436420 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jnj.com/role/EarningsPerShareTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2439421 - Disclosure - Segments of Business and Geographic Areas - Sales By Segment Of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails</Role>
      <ShortName>Segments of Business and Geographic Areas - Sales By Segment Of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2440422 - Disclosure - Segments of Business and Geographic Areas - Operating Profit by Segment of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails</Role>
      <ShortName>Segments of Business and Geographic Areas - Operating Profit by Segment of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2441423 - Disclosure - Segments of Business and Geographic Areas - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails</Role>
      <ShortName>Segments of Business and Geographic Areas - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2443424 - Disclosure - Business Combinations and Divestitures - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails</Role>
      <ShortName>Business Combinations and Divestitures - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2445425 - Disclosure - Legal Proceedings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/LegalProceedingsDetails</Role>
      <ShortName>Legal Proceedings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jnj.com/role/LegalProceedings</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2448426 - Disclosure - Restructuring - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/RestructuringNarrativeDetails</Role>
      <ShortName>Restructuring - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="jnj-20200927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2449427 - Disclosure - Restructuring - Schedule of Restructuring Reserve (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails</Role>
      <ShortName>Restructuring - Schedule of Restructuring Reserve (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="jnj-20200927.htm">jnj-20200927.htm</File>
    <File>a202010-q3qexhibit311c.htm</File>
    <File>a202010-q3qexhibit312c.htm</File>
    <File>a202010-q3qexhibit321c.htm</File>
    <File>a202010-q3qexhibit322c.htm</File>
    <File>jnj-20200927.xsd</File>
    <File>jnj-20200927_cal.xml</File>
    <File>jnj-20200927_def.xml</File>
    <File>jnj-20200927_lab.xml</File>
    <File>jnj-20200927_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>jnj-20200927_g1.jpg</File>
    <File>jnj-20200927_g10.jpg</File>
    <File>jnj-20200927_g11.jpg</File>
    <File>jnj-20200927_g12.jpg</File>
    <File>jnj-20200927_g13.jpg</File>
    <File>jnj-20200927_g2.jpg</File>
    <File>jnj-20200927_g3.jpg</File>
    <File>jnj-20200927_g4.jpg</File>
    <File>jnj-20200927_g5.jpg</File>
    <File>jnj-20200927_g6.jpg</File>
    <File>jnj-20200927_g7.jpg</File>
    <File>jnj-20200927_g8.jpg</File>
    <File>jnj-20200927_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2017-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>88
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "jnj-20200927.htm": {
   "axisCustom": 0,
   "axisStandard": 39,
   "contextCount": 1063,
   "dts": {
    "calculationLink": {
     "local": [
      "jnj-20200927_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "jnj-20200927_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "jnj-20200927.htm"
     ]
    },
    "labelLink": {
     "local": [
      "jnj-20200927_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "jnj-20200927_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "jnj-20200927.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 694,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2019-01-31": 1,
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 6
   },
   "keyCustom": 51,
   "keyStandard": 348,
   "memberCustom": 120,
   "memberStandard": 62,
   "nsprefix": "jnj",
   "nsuri": "http://www.jnj.com/20200927",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.jnj.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Inventories",
     "role": "http://www.jnj.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106103 - Disclosure - Intangible Assets and Goodwill",
     "role": "http://www.jnj.com/role/IntangibleAssetsandGoodwill",
     "shortName": "Intangible Assets and Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112104 - Disclosure - Fair Value Measurements",
     "role": "http://www.jnj.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125105 - Disclosure - Income Taxes",
     "role": "http://www.jnj.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127106 - Disclosure - Pensions and Other Benefit Plans",
     "role": "http://www.jnj.com/role/PensionsandOtherBenefitPlans",
     "shortName": "Pensions and Other Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131107 - Disclosure - Accumulated Other Comprehensive Income",
     "role": "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome",
     "shortName": "Accumulated Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2134108 - Disclosure - Earnings Per Share",
     "role": "http://www.jnj.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137109 - Disclosure - Segments of Business and Geographic Areas",
     "role": "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas",
     "shortName": "Segments of Business and Geographic Areas",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142110 - Disclosure - Business Combinations and Divestitures",
     "role": "http://www.jnj.com/role/BusinessCombinationsandDivestitures",
     "shortName": "Business Combinations and Divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144111 - Disclosure - Legal Proceedings",
     "role": "http://www.jnj.com/role/LegalProceedings",
     "shortName": "Legal Proceedings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Consolidated Balance Sheets",
     "role": "http://www.jnj.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146112 - Disclosure - Restructuring",
     "role": "http://www.jnj.com/role/Restructuring",
     "shortName": "Restructuring",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2213202 - Disclosure - Fair Value Measurements (Policies)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsPolicies",
     "shortName": "Fair Value Measurements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - Inventories (Tables)",
     "role": "http://www.jnj.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "jnj:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307302 - Disclosure - Intangible Assets and Goodwill (Tables)",
     "role": "http://www.jnj.com/role/IntangibleAssetsandGoodwillTables",
     "shortName": "Intangible Assets and Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "jnj:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314303 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328304 - Disclosure - Pensions and Other Benefit Plans (Tables)",
     "role": "http://www.jnj.com/role/PensionsandOtherBenefitPlansTables",
     "shortName": "Pensions and Other Benefit Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2332305 - Disclosure - Accumulated Other Comprehensive Income (Tables)",
     "role": "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables",
     "shortName": "Accumulated Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2335306 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.jnj.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "jnj:SalesBySegmentOfBusinessTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338307 - Disclosure - Segments of Business and Geographic Areas (Tables)",
     "role": "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables",
     "shortName": "Segments of Business and Geographic Areas (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "jnj:SalesBySegmentOfBusinessTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2347308 - Disclosure - Restructuring (Tables)",
     "role": "http://www.jnj.com/role/RestructuringTables",
     "shortName": "Restructuring (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - Inventories (Details)",
     "role": "http://www.jnj.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "jnj:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408402 - Disclosure - Intangible Assets and Goodwill (Details)",
     "role": "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
     "shortName": "Intangible Assets and Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "jnj:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i68c2ad5bd3504e018130bc2faeb63dfc_I20200927",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "ib25f8e90a94f4d8dbe80e2251fe68616_I20191229",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409403 - Disclosure - Intangible Assets and Goodwill - Goodwill By Segment (Details)",
     "role": "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails",
     "shortName": "Intangible Assets and Goodwill - Goodwill By Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "jnj:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Intangible Assets and Goodwill - Narrative (Details)",
     "role": "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
     "shortName": "Intangible Assets and Goodwill - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Intangible Assets and Goodwill - Intangible Asset Amortization Expense (Details)",
     "role": "http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails",
     "shortName": "Intangible Assets and Goodwill - Intangible Asset Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:DescriptionOfReclassificationOfCashFlowHedgeGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416407 - Disclosure - Fair Value Measurements - Summary of Derivative Activity (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails",
     "shortName": "Fair Value Measurements - Summary of Derivative Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417408 - Disclosure - Fair Value Measurements - Schedule of Derivatives Recorded in Consolidated Balance Sheet (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails",
     "shortName": "Fair Value Measurements - Schedule of Derivatives Recorded in Consolidated Balance Sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418409 - Disclosure - Fair Value Measurements - Schedule of Effect of Derivatives not Designated as Hedging Instruments (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
     "shortName": "Fair Value Measurements - Schedule of Effect of Derivatives not Designated as Hedging Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "idbc5ce6f7f184806bd9942142222b820_D20200629-20200927",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Consolidated Statements of Earnings",
     "role": "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
     "shortName": "Consolidated Statements of Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927",
      "decimals": "3",
      "lang": "en-US",
      "name": "jnj:SalesRevenueGoodsNetPercentToSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419410 - Disclosure - Fair Value Measurements - Schedule of Effect of Net Investment Hedges (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
     "shortName": "Fair Value Measurements - Schedule of Effect of Net Investment Hedges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420411 - Disclosure - Fair Value Measurements - Summary of Activity Related to Equity Investments (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails",
     "shortName": "Fair Value Measurements - Summary of Activity Related to Equity Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i8c27b77222684cf6918b97cd45fc5ace_I20191229",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421412 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities at Fair Value (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
     "shortName": "Fair Value Measurements - Financial Assets and Liabilities at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422413 - Disclosure - Fair Value Measurements - Cash, Cash Equivalents and Marketable Securities (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails",
     "shortName": "Fair Value Measurements - Cash, Cash Equivalents and Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423414 - Disclosure - Fair Value Measurements - Schedule of Available for Sale Securities Maturities (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails",
     "shortName": "Fair Value Measurements - Schedule of Available for Sale Securities Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBorrowings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424415 - Disclosure - Fair Value Measurements - Financial Liabilities not Measured at Fair Value (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails",
     "shortName": "Fair Value Measurements - Financial Liabilities not Measured at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i7f434199d52940ed909adbee7e2ad0a8_I20200927",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426416 - Disclosure - Income Taxes (Details)",
     "role": "http://www.jnj.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i76991a953ea2430ab905037bfcac327d_D20200629-20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429417 - Disclosure - Pensions and Other Benefit Plans - Components of Net Periodic Benefit Cost (Details)",
     "role": "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails",
     "shortName": "Pensions and Other Benefit Plans - Components of Net Periodic Benefit Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i76991a953ea2430ab905037bfcac327d_D20200629-20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iba89a9d0fc0d402d9b56774badd78c07_D20191230-20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionContributions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430418 - Disclosure - Pensions and Other Benefit Plans (Details)",
     "role": "http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails",
     "shortName": "Pensions and Other Benefit Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iba89a9d0fc0d402d9b56774badd78c07_D20191230-20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionContributions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i0cf38c3475e441fb8f8267516f5f6e04_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433419 - Disclosure - Accumulated Other Comprehensive Income (Details)",
     "role": "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "idee3ed30241e424493acca72e673afcd_I20191229",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Consolidated Statements of Comprehensive Income",
     "role": "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareBasic",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436420 - Disclosure - Earnings Per Share (Details)",
     "role": "http://www.jnj.com/role/EarningsPerShareDetails",
     "shortName": "Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439421 - Disclosure - Segments of Business and Geographic Areas - Sales By Segment Of Business (Details)",
     "role": "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails",
     "shortName": "Segments of Business and Geographic Areas - Sales By Segment Of Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927",
      "decimals": "3",
      "lang": "en-US",
      "name": "jnj:PercentageChangeInSalesBySegmentOfBusiness",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "jnj:PercentageChangeInSalesByGeographicArea",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440422 - Disclosure - Segments of Business and Geographic Areas - Operating Profit by Segment of Business (Details)",
     "role": "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
     "shortName": "Segments of Business and Geographic Areas - Operating Profit by Segment of Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": "3",
      "lang": "en-US",
      "name": "jnj:PercentageChangeInOperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441423 - Disclosure - Segments of Business and Geographic Areas - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details)",
     "role": "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails",
     "shortName": "Segments of Business and Geographic Areas - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i19e7a320a15a49fc9131f6215c942e21_I20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443424 - Disclosure - Business Combinations and Divestitures - Narrative (Details)",
     "role": "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
     "shortName": "Business Combinations and Divestitures - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i1cc26d706e3948b0839e40d3e0521660_D20191230-20200329",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i0b429fd585e64f27b994198388c6251a_I20200927",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "jnj:ProductLiabilityContingencyNumberOfClaimant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claimant",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445425 - Disclosure - Legal Proceedings (Details)",
     "role": "http://www.jnj.com/role/LegalProceedingsDetails",
     "shortName": "Legal Proceedings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i0b429fd585e64f27b994198388c6251a_I20200927",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "jnj:ProductLiabilityContingencyNumberOfClaimant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claimant",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448426 - Disclosure - Restructuring - Narrative (Details)",
     "role": "http://www.jnj.com/role/RestructuringNarrativeDetails",
     "shortName": "Restructuring - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i09487d9b040c41f5b1f1ac6a4eb69ecb_D20200629-20200927",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449427 - Disclosure - Restructuring - Schedule of Restructuring Reserve (Details)",
     "role": "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails",
     "shortName": "Restructuring - Schedule of Restructuring Reserve (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "lang": "en-US",
      "name": "jnj:RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "id0a2a626a2c244b9a56b493374930da0_I20181230",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Statements of Equity",
     "role": "http://www.jnj.com/role/ConsolidatedStatementsofEquity",
     "shortName": "Consolidated Statements of Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "i140bd62410d04a73af76e67490f68df5_I20181230",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Statements of Equity (Parenthetical)",
     "role": "http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical",
     "shortName": "Consolidated Statements of Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "ic5216dc5aa034f63af33911b6eb4bf67_D20200629-20200927",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.jnj.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200927.htm",
      "contextRef": "iade1c02e80d34242b7a0310325d8f18f_D20191230-20200927",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 194,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States",
        "verboseLabel": "U.S."
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2017-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "jnj_A0.250NotesDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "0.250% Notes Due 2022 [Member]",
        "label": "0.250% Notes Due 2022 [Member]",
        "terseLabel": "0.250% Notes due 2022 (1B Euro 1.1641)",
        "verboseLabel": "0.250% Notes Due January 2022"
       }
      }
     },
     "localname": "A0.250NotesDue2022Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/Cover",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A0.650NotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "0.650% Notes Due 2024 [Member]",
        "label": "0.650% Notes Due 2024 [Member]",
        "terseLabel": "0.650% Notes due 2024 (750MM Euro 1.1641)",
        "verboseLabel": "0.650% Notes Due May 2024"
       }
      }
     },
     "localname": "A0.650NotesDue2024Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/Cover",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A0550NotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "0.550 Notes due 2025",
        "label": "0.550 Notes due 2025 [Member]",
        "terseLabel": "0.550 Notes due 2025"
       }
      }
     },
     "localname": "A0550NotesDue2025Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A055NotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "0.55% Notes due 2025",
        "label": "0.55% Notes due 2025 [Member]",
        "terseLabel": "0.55% Notes due 2025"
       }
      }
     },
     "localname": "A055NotesDue2025Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A095NotesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "0.95% Notes due 2027",
        "label": "0.95% Notes due 2027 [Member]",
        "terseLabel": "0.95% Notes due 2027"
       }
      }
     },
     "localname": "A095NotesDue2027Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A1.150NotesDue2028Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "1.150% Notes Due 2028 [Member]",
        "label": "1.150% Notes Due 2028 [Member]",
        "terseLabel": "1.150% Notes due 2028 (750MM Euro 1.1641)",
        "verboseLabel": "1.150% Notes Due November 2028"
       }
      }
     },
     "localname": "A1.150NotesDue2028Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/Cover",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A1.650NotesDue2035Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "1.650% Notes Due 2035 [Member]",
        "label": "1.650% Notes Due 2035 [Member]",
        "terseLabel": "1.650% Notes due 2035 (1.5B Euro 1.1641)",
        "verboseLabel": "1.650% Notes Due May 2035"
       }
      }
     },
     "localname": "A1.650NotesDue2035Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/Cover",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A1300NotesDue2030Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "1.300% Notes due 2030",
        "label": "1.300% Notes due 2030 [Member]",
        "terseLabel": "1.300% Notes due 2030"
       }
      }
     },
     "localname": "A1300NotesDue2030Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A130NotesDue2030Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "1.30% Notes due 2030",
        "label": "1.30% Notes due 2030 [Member]",
        "terseLabel": "1.30% Notes due 2030"
       }
      }
     },
     "localname": "A130NotesDue2030Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A2.05Notesdue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.05% Notes due 2023 [Member]",
        "label": "2.05% Notes due 2023 [Member]",
        "terseLabel": "2.05% Notes due 2023"
       }
      }
     },
     "localname": "A2.05Notesdue2023Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A2.25Notesdue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.25% Notes due 2022 [Member]",
        "label": "2.25% Notes due 2022 [Member]",
        "terseLabel": "2.25% Notes due 2022"
       }
      }
     },
     "localname": "A2.25Notesdue2022Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A2.45Notesdue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.45% Notes due 2021 [Member]",
        "label": "2.45% Notes due 2021 [Member]",
        "terseLabel": "2.45% Notes due 2021"
       }
      }
     },
     "localname": "A2.45Notesdue2021Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A2.45Notesdue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.45% Notes due 2026 [Member]",
        "label": "2.45% Notes due 2026 [Member]",
        "terseLabel": "2.45% Notes due 2026"
       }
      }
     },
     "localname": "A2.45Notesdue2026Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A2.625Notesdue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.625 Notes due 2025 [Member]",
        "label": "2.625 Notes due 2025 [Member]",
        "terseLabel": "2.625% Notes due 2025"
       }
      }
     },
     "localname": "A2.625Notesdue2025Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A2.900Notesdue2028Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.900% Notes due 2028 [Member]",
        "label": "2.900% Notes due 2028 [Member]",
        "terseLabel": "2.90%\u00a0Notes due 2028"
       }
      }
     },
     "localname": "A2.900Notesdue2028Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A2.95Notesdue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.95% Notes due 2027 [Member]",
        "label": "2.95% Notes due 2027 [Member]",
        "terseLabel": "2.95% Notes due 2027"
       }
      }
     },
     "localname": "A2.95Notesdue2027Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A210NotesDue2040Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.10% Notes due 2040",
        "label": "2.10% Notes due 2040 [Member]",
        "terseLabel": "2.10% Notes due 2040"
       }
      }
     },
     "localname": "A210NotesDue2040Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A2250NotesDue2050Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.250% Notes due 2050",
        "label": "2.250% Notes due 2050 [Member]",
        "terseLabel": "2.250% Notes due 2050"
       }
      }
     },
     "localname": "A2250NotesDue2050Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A225NotesDue2050Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.25% Notes due 2050",
        "label": "2.25% Notes due 2050 [Member]",
        "terseLabel": "2.25% Notes due 2050"
       }
      }
     },
     "localname": "A225NotesDue2050Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A2450NotesDue2060Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.450% Notes due 2060",
        "label": "2.450% Notes due 2060 [Member]",
        "terseLabel": "2.450% Notes due 2060"
       }
      }
     },
     "localname": "A2450NotesDue2060Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A3.375Notesdue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.375% Notes due 2023 [Member]",
        "label": "3.375% Notes due 2023 [Member]",
        "terseLabel": "3.375% Notes due 2023"
       }
      }
     },
     "localname": "A3.375Notesdue2023Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A3.400Notesdue2038Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.400% Notes due 2038 [Member]",
        "label": "3.400% Notes due 2038 [Member]",
        "terseLabel": "3.40%\u00a0Notes due 2038"
       }
      }
     },
     "localname": "A3.400Notesdue2038Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A3.500Notesdue2048Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.500% Notes due 2048 [Member]",
        "label": "3.500% Notes due 2048 [Member]",
        "terseLabel": "3.50% Notes due 2048"
       }
      }
     },
     "localname": "A3.500Notesdue2048Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A3.55Notesdue2036Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.55% Notes due 2036 [Member]",
        "label": "3.55% Notes due 2036 [Member]",
        "terseLabel": "3.55% Notes due 2036"
       }
      }
     },
     "localname": "A3.55Notesdue2036Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A3.625Notesdue2037Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.625% Notes due 2037 [Member]",
        "label": "3.625% Notes due 2037 [Member]",
        "terseLabel": "3.625% Notes due 2037"
       }
      }
     },
     "localname": "A3.625Notesdue2037Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A3.70Notesdue2046Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.70% Notes due 2046 [Member]",
        "label": "3.70% Notes due 2046 [Member]",
        "terseLabel": "3.70% Notes due 2046"
       }
      }
     },
     "localname": "A3.70Notesdue2046Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A3.75Notesdue2047Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.75% Notes due 2047 [Member]",
        "label": "3.75% Notes due 2047 [Member]",
        "terseLabel": "3.75% Notes due 2047"
       }
      }
     },
     "localname": "A3.75Notesdue2047Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A4.375Notesdue2033Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.375% Notes due 2033 [Member]",
        "label": "4.375% Notes due 2033 [Member]",
        "terseLabel": "4.375% Notes due 2033"
       }
      }
     },
     "localname": "A4.375Notesdue2033Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A4.50Debenturesdue2040Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.50% Debentures due 2040 [Member]",
        "label": "4.50% Debentures due 2040 [Member]",
        "terseLabel": "4.50% Debentures due 2040"
       }
      }
     },
     "localname": "A4.50Debenturesdue2040Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A4.50Notesdue2043Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.50% Notes due 2043 [Member]",
        "label": "4.50% Notes due 2043 [Member]",
        "terseLabel": "4.50% Notes due 2043"
       }
      }
     },
     "localname": "A4.50Notesdue2043Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A4.85Notesdue2041Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.85% Notes due 2041 [Member]",
        "label": "4.85% Notes due 2041 [Member]",
        "terseLabel": "4.85% Notes due 2041"
       }
      }
     },
     "localname": "A4.85Notesdue2041Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A4.95Debenturesdue2033Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.95% Debentures due 2033 [Member]",
        "label": "4.95% Debentures due 2033 [Member]",
        "terseLabel": "4.95% Debentures due 2033"
       }
      }
     },
     "localname": "A4.95Debenturesdue2033Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A5.50NotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "5.50% Notes Due 2024 [Member]",
        "label": "5.50% Notes Due 2024 [Member]",
        "terseLabel": "5.50% Notes due 2024 (500 MM GBP 1.2757)",
        "verboseLabel": "5.50% Notes Due November 2024"
       }
      }
     },
     "localname": "A5.50NotesDue2024Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/Cover",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A5.85Debenturesdue2038Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "5.85% Debentures due 2038 [Member]",
        "label": "5.85% Debentures due 2038 [Member]",
        "terseLabel": "5.85% Debentures due 2038"
       }
      }
     },
     "localname": "A5.85Debenturesdue2038Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A5.95Notesdue2037Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "5.95% Notes due 2037 [Member]",
        "label": "5.95% Notes due 2037 [Member]",
        "terseLabel": "5.95% Notes due 2037"
       }
      }
     },
     "localname": "A5.95Notesdue2037Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A6.73Debenturesdue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "6.73% Debentures due 2023 [Member]",
        "label": "6.73% Debentures due 2023 [Member]",
        "terseLabel": "6.73% Debentures due 2023"
       }
      }
     },
     "localname": "A6.73Debenturesdue2023Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A6.95Notesdue2029Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "6.95% Notes due 2029 [Member]",
        "label": "6.95% Notes due 2029 [Member]",
        "terseLabel": "6.95% Notes due 2029"
       }
      }
     },
     "localname": "A6.95Notesdue2029Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_ADVANCEDMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ADVANCED [Member]",
        "label": "ADVANCED [Member]",
        "terseLabel": "ADVANCED"
       }
      }
     },
     "localname": "ADVANCEDMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued Professional Fees, Revised Agreement from Litigation Settlement",
        "label": "Accrued Professional Fees, Revised Agreement from Litigation Settlement",
        "terseLabel": "Accrued legal fees, revised agreement from litigation settlement"
       }
      }
     },
     "localname": "AccruedProfessionalFeesRevisedAgreementFromLitigationSettlement",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_AccruedRebatesReturnsAndPromotions": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the estimated obligations due within one year for rebates, returns and promotions. Reserves include such items related to Medicaid rebates, product returns due to expiration, product recalls, current portion of coupons and volume-based sales incentives programs.",
        "label": "Accrued Rebates Returns And Promotions",
        "verboseLabel": "Accrued rebates, returns and promotions"
       }
      }
     },
     "localname": "AccruedRebatesReturnsAndPromotions",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_AccruedTaxesOnIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued Taxes On Income [Member]",
        "label": "Accrued Taxes On Income [Member]",
        "terseLabel": "Accrued Taxes On Income [Member]"
       }
      }
     },
     "localname": "AccruedTaxesOnIncomeMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_AdvancedSterilizationProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "AdvancedSterilizationProducts [Member]",
        "label": "AdvancedSterilizationProducts [Member]",
        "terseLabel": "AdvancedSterilizationProducts"
       }
      }
     },
     "localname": "AdvancedSterilizationProductsMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_AmountPrepaidAndDueToManufacturers": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount Prepaid and Due to Manufacturers",
        "label": "Amount Prepaid and Due to Manufacturers",
        "terseLabel": "Amount prepaid and due to manufacturers"
       }
      }
     },
     "localname": "AmountPrepaidAndDueToManufacturers",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_AsiaPacificAfricaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asia-Pacific, Africa [Member]",
        "label": "Asia-Pacific, Africa [Member]",
        "terseLabel": "Asia-Pacific, Africa"
       }
      }
     },
     "localname": "AsiaPacificAfricaMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_AsrMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ASR.",
        "label": "ASR [Member]",
        "terseLabel": "ASR"
       }
      }
     },
     "localname": "AsrMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_AssetWriteoffMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset Write-off [Member]",
        "label": "Asset Write-off [Member]",
        "terseLabel": "Asset Write-off"
       }
      }
     },
     "localname": "AssetWriteoffMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_AurisHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Auris Health",
        "label": "Auris Health [Member]",
        "terseLabel": "Auris Health"
       }
      }
     },
     "localname": "AurisHealthMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_BabyCareMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Baby Care [Member]",
        "label": "Baby Care [Member]",
        "terseLabel": "Baby Care"
       }
      }
     },
     "localname": "BabyCareMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_BabyPowderMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Baby Powder [Member]",
        "label": "Baby Powder [Member]",
        "terseLabel": "Baby Powder"
       }
      }
     },
     "localname": "BabyPowderMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_BeautyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Beauty [Member]",
        "label": "Beauty [Member]",
        "terseLabel": "Skin Health/Beauty"
       }
      }
     },
     "localname": "BeautyMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_BermekimabMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "bermekimab [Member]",
        "label": "bermekimab [Member]",
        "terseLabel": "bermekimab"
       }
      }
     },
     "localname": "BermekimabMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Adjustments Made To Intangible Assets, Other than Goodwill",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Adjustments Made To Intangible Assets, Other than Goodwill",
        "terseLabel": "Adjustments made to intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_CONCERTAMethylphenidateMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "CONCERTA/Methylphenidate [Member]",
        "label": "CONCERTA/Methylphenidate [Member]",
        "terseLabel": "CONCERTA\u00ae / methylphenidate"
       }
      }
     },
     "localname": "CONCERTAMethylphenidateMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_CONTACTLENSESOTHERMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "CONTACT LENSES/OTHER [Member]",
        "label": "CONTACT LENSES/OTHER [Member]",
        "terseLabel": "CONTACT LENSES / OTHER"
       }
      }
     },
     "localname": "CONTACTLENSESOTHERMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_CardiovascularMetabolismOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cardiovascular/Metabolism/Other [Member]",
        "label": "Cardiovascular/Metabolism/Other [Member]",
        "terseLabel": "Cardiovascular / Metabolism / Other"
       }
      }
     },
     "localname": "CardiovascularMetabolismOtherMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash, Cash Equivalents, And Short-Term Investments, Accumulated Gross Unrealized Loss",
        "label": "Cash, Cash Equivalents, And Short-Term Investments, Accumulated Gross Unrealized Loss",
        "negatedTerseLabel": "Total cash, cash equivalents and current marketable securities, Unrecognized Loss"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash, Cash Equivalents, and Short-term Investments, Estimated Fair Value",
        "label": "Cash, Cash Equivalents, And Short-Term Investments, Estimated Fair Value",
        "terseLabel": "Total cash, cash equivalents and current marketable securities, Estimated Fair Value"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash, Cash Equivalents, and Short-term Investments, Accumulated Gross Unrealized Gain",
        "label": "Cash, Cash Equivalents, and Short-term Investments, Accumulated Gross Unrealized Gain",
        "terseLabel": "Total cash, cash equivalents and current marketable securities, Unrecognized Gain"
       }
      }
     },
     "localname": "CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_CizHoldingsCo.Ltd.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ci:z Holdings Co. Ltd. [Member]",
        "label": "Ci:z Holdings Co. Ltd. [Member]",
        "terseLabel": "Ci:z Holdings Co. Ltd."
       }
      }
     },
     "localname": "CizHoldingsCo.Ltd.Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_ConsumerMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Consumer.",
        "label": "Consumer [Member]",
        "terseLabel": "Consumer Health*"
       }
      }
     },
     "localname": "ConsumerMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_CostOfGoodsSoldPercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "jnj_GrossProfitPercentToSales",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cost of goods sold percent to sales.",
        "label": "Cost Of Goods Sold Percent To Sales",
        "terseLabel": "Cost of products sold percent to sales"
       }
      }
     },
     "localname": "CostOfGoodsSoldPercentToSales",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_DARZALEXMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "DARZALEX [Member]",
        "label": "DARZALEX [Member]",
        "terseLabel": "DARZALEX\u00ae"
       }
      }
     },
     "localname": "DARZALEXMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_DePuyASRU.S.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "DePuy ASR U.S. [Member]",
        "label": "DePuy ASR U.S. [Member]",
        "terseLabel": "DePuy ASR U.S."
       }
      }
     },
     "localname": "DePuyASRU.S.Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instruments gain loss on statement of financial performance.",
        "label": "Derivative Instruments Gain Loss On Statement Of Financial Performance Abstract",
        "verboseLabel": "Summary of designated derivatives"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Receivables Retained",
        "label": "Disposal Group, Including Discontinued Operation, Receivables Retained",
        "terseLabel": "Receivables retained"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationReceivablesRetained",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_EDURANTrilpivirineMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "EDURANT/rilpivirine [Member]",
        "label": "EDURANT/rilpivirine [Member]",
        "terseLabel": "EDURANT\u00ae / rilpivirine"
       }
      }
     },
     "localname": "EDURANTrilpivirineMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_ERLEADAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ERLEADA",
        "label": "ERLEADA [Member]",
        "terseLabel": "ERLEADA"
       }
      }
     },
     "localname": "ERLEADAMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Change In Contingent Consideration Liability, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Change In Contingent Consideration Liability, Percent",
        "terseLabel": "Net impact to tax rate due to change in contingent consideration liability"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Increase (Decrease), Percent",
        "label": "Effective Income Tax Rate Reconciliation, Increase (Decrease), Percent",
        "terseLabel": "Impact to effective tax rate, percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation, Percent, Revised Agreement from Litigation Settlement",
        "label": "Effective Income Tax Reconciliation, Percent, Revised Agreement from Litigation Settlement",
        "terseLabel": "Effective income tax rate from revised agreement (as a percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationPercentRevisedAgreementFromLitigationSettlement",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_EquityFairValueAdjustmentChangeInObservablePrice": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity, Fair Value Adjustment, Change In Observable Price",
        "label": "Equity, Fair Value Adjustment, Change In Observable Price",
        "terseLabel": "Equity, Fair Value Adjustment, Change In Observable Price"
       }
      }
     },
     "localname": "EquityFairValueAdjustmentChangeInObservablePrice",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_EquityFairValueAdjustmentImpairmentLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity, Fair Value Adjustment, Impairment Loss",
        "label": "Equity, Fair Value Adjustment, Impairment Loss",
        "terseLabel": "Equity, Fair Value Adjustment, Impairment Loss"
       }
      }
     },
     "localname": "EquityFairValueAdjustmentImpairmentLoss",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_EquityInvestmentRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Investment [Roll Forward]",
        "label": "Equity Investment [Roll Forward]",
        "terseLabel": "Equity Investment [Roll Forward]"
       }
      }
     },
     "localname": "EquityInvestmentRollForward",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Investments, Increase (Decrease) from Acquisition (Sale) During Period",
        "label": "Equity Investments, Increase (Decrease) from Acquisition (Sale) During Period",
        "terseLabel": "Sales/ Purchases/Other"
       }
      }
     },
     "localname": "EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_EquityInvestmentswithReadilyDeterminableValueMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Investments with Readily Determinable Value [Member]",
        "label": "Equity Investments with Readily Determinable Value [Member]",
        "terseLabel": "Equity Investments with readily determinable value"
       }
      }
     },
     "localname": "EquityInvestmentswithReadilyDeterminableValueMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_EquityInvestmentswithoutReadilyDeterminableValueMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Investments without Readily Determinable Value [Member]",
        "label": "Equity Investments without Readily Determinable Value [Member]",
        "terseLabel": "Equity Investments without readily determinable value"
       }
      }
     },
     "localname": "EquityInvestmentswithoutReadilyDeterminableValueMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investment Retained After Disposal, Ownership Interest After Disposal, Shares",
        "label": "Equity Method Investment Retained After Disposal, Ownership Interest After Disposal, Shares",
        "terseLabel": "Ownership interest after sale"
       }
      }
     },
     "localname": "EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "jnj_ExcessOfFairValueOverCarryingValueOfDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of fair value over carrying value of debt.",
        "label": "Excess Of Fair Value Over Carrying Value Of Debt",
        "terseLabel": "Excess of the estimated fair value over the carrying value of debt"
       }
      }
     },
     "localname": "ExcessOfFairValueOverCarryingValueOfDebt",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Change In Estimated Fair Value",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Change In Estimated Fair Value",
        "negatedTerseLabel": "Reversal of contingent consideration",
        "terseLabel": "Changes in estimated fair value (7)"
       }
      }
     },
     "localname": "FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset",
        "label": "Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset",
        "terseLabel": "Deferred tax benefit related to TRAF"
       }
      }
     },
     "localname": "FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset, Percent",
        "label": "Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset, Percent",
        "terseLabel": "Deferred tax benefit related to TRAF, percent"
       }
      }
     },
     "localname": "FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Federal Act On Tax Reform And AHV Financing, GILTI Remeasurement, Income Tax Expense (Benefit)",
        "label": "Federal Act On Tax Reform And AHV Financing, GILTI Remeasurement, Income Tax Expense (Benefit)",
        "terseLabel": "Deferred tax liability related to TRAF"
       }
      }
     },
     "localname": "FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finite-Lived And Indefinite-Lived Intangible Assets [Line Items]",
        "label": "Finite-Lived And Indefinite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived And Indefinite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jnj_GENERALMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "GENERAL [Member]",
        "label": "GENERAL [Member]",
        "terseLabel": "GENERAL"
       }
      }
     },
     "localname": "GENERALMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_GrossProfitPercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross profit percent to sales.",
        "label": "Gross Profit Percent To Sales",
        "totalLabel": "Gross profit percent to sales"
       }
      }
     },
     "localname": "GrossProfitPercentToSales",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_HIPSMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "HIPS [Member]",
        "label": "HIPS [Member]",
        "terseLabel": "HIPS"
       }
      }
     },
     "localname": "HIPSMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_IMBRUVICAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "IMBRUVICA [Member]",
        "label": "IMBRUVICA [Member]",
        "terseLabel": "IMBRUVICA\u00ae"
       }
      }
     },
     "localname": "IMBRUVICAMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "INVEGA SUSTENNA/XEPLION/TRINZA/TREVICTA [Member]",
        "label": "INVEGA SUSTENNA/XEPLION/TRINZA/TREVICTA [Member]",
        "terseLabel": "INVEGA SUSTENNA\u00ae / XEPLION\u00ae / INVEGA TRINZA\u00ae / TREVICTA\u00ae"
       }
      }
     },
     "localname": "INVEGASUSTENNAXEPLIONTRINZATREVICTAMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_INVOKANAINVOKAMETMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "INVOKANA/INVOKAMET [Member]",
        "label": "INVOKANA/INVOKAMET [Member]",
        "terseLabel": "INVOKANA\u00ae / INVOKAMET\u00ae"
       }
      }
     },
     "localname": "INVOKANAINVOKAMETMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_IdorsiaLTDMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Idorsia LTD",
        "label": "Idorsia LTD [Member]",
        "terseLabel": "Idorsia"
       }
      }
     },
     "localname": "IdorsiaLTDMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_ImmunologyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Immunology [Member]",
        "label": "Immunology [Member]",
        "terseLabel": "Immunology"
       }
      }
     },
     "localname": "ImmunologyMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "jnj_NetIncomeAttributableToParentPercentToSales",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income loss from continuing operations before income taxes minority interest and income loss from equity method investments percent to sales.",
        "label": "Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments Percent To Sales",
        "totalLabel": "Earnings before provision for taxes on income percent to sales"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_IncomeTaxExpenseBenefitPercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "jnj_NetIncomeAttributableToParentPercentToSales",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income tax expense benefit percent to sales.",
        "label": "Income Tax Expense Benefit Percent To Sales",
        "terseLabel": "Provision for (benefit from) taxes on income (Note 5)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitPercentToSales",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_IncomeTaxTextualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income Tax Textuals Abstract.",
        "label": "Income Tax (Textuals) [Abstract]",
        "verboseLabel": "Income Tax (Textuals)"
       }
      }
     },
     "localname": "IncomeTaxTextualsAbstract",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jnj_InfectiousDiseasesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Infectious Diseases [Member]",
        "label": "Infectious Diseases [Member]",
        "terseLabel": "Infectious Diseases"
       }
      }
     },
     "localname": "InfectiousDiseasesMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_IntangibleAssetsAndGoodwillTextualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intangible Assets and Goodwill Textuals Abstract.",
        "label": "Intangible Assets and Goodwill (Textuals) [Abstract]",
        "verboseLabel": "Intangible Assets and Goodwill (Textuals)"
       }
      }
     },
     "localname": "IntangibleAssetsAndGoodwillTextualsAbstract",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jnj_InterestExpensePercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 5.0,
       "parentTag": "jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest expense percent to sales.",
        "label": "Interest Expense Percent To Sales",
        "terseLabel": "Interest expense, net of portion capitalized percent to sales"
       }
      }
     },
     "localname": "InterestExpensePercentToSales",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_InterestIncomeExpenseNetMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest Income Expense Net Member.",
        "label": "Interest Income Expense Net Member",
        "terseLabel": "Interest Income Expense Net Member",
        "verboseLabel": "Interest (income)/Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNetMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_InterventionalSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interventional Solutions [Member]",
        "label": "Interventional Solutions [Member]",
        "verboseLabel": "Interventional Solutions"
       }
      }
     },
     "localname": "InterventionalSolutionsMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_InvestmentIncomeInterestPercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 4.0,
       "parentTag": "jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investment income interest percent to sales.",
        "label": "Investment Income Interest Percent To Sales",
        "terseLabel": "Interest income percent to sales"
       }
      }
     },
     "localname": "InvestmentIncomeInterestPercentToSales",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_InvokanaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Invokana [Member]",
        "label": "Invokana [Member]",
        "terseLabel": "Invokana"
       }
      }
     },
     "localname": "InvokanaMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_KNEESMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "KNEES [Member]",
        "label": "KNEES [Member]",
        "terseLabel": "KNEES"
       }
      }
     },
     "localname": "KNEESMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_LegalProceedingTextualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Legal Proceeding Textuals Abstract.",
        "label": "Legal Proceeding (Textuals) [Abstract]",
        "terseLabel": "Legal Proceeding (Textuals)"
       }
      }
     },
     "localname": "LegalProceedingTextualsAbstract",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jnj_LitigationSettlementByCompaniesAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Litigation settlement by companies.",
        "label": "Litigation Settlement By Companies [Axis]",
        "terseLabel": "Litigation Settlement By Companies"
       }
      }
     },
     "localname": "LitigationSettlementByCompaniesAxis",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jnj_LitigationSettlementByCompaniesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Litigation settlement by companies.",
        "label": "Litigation Settlement By Companies [Domain]",
        "terseLabel": "Litigation Settlement By Companies"
       }
      }
     },
     "localname": "LitigationSettlementByCompaniesDomain",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_LossContingencyEstimateOfAdditionalPossibleLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Estimate of Additional Possible Loss",
        "label": "Loss Contingency, Estimate of Additional Possible Loss",
        "terseLabel": "Loss Contingency, Estimate of Additional Possible Loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfAdditionalPossibleLoss",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Previous Damages Awarded And Revised, Value",
        "label": "Loss Contingency, Previous Damages Awarded And Revised, Value",
        "terseLabel": "Previous damages awarded and revised"
       }
      }
     },
     "localname": "LossContingencyPreviousDamagesAwardedAndRevisedValue",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_MedicalDevicesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medical Devices [Member]",
        "label": "Medical Devices [Member]",
        "terseLabel": "MEDICAL DEVICES",
        "verboseLabel": "Medical Devices"
       }
      }
     },
     "localname": "MedicalDevicesMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_MomentaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Momenta",
        "label": "Momenta [Member]",
        "terseLabel": "Momenta [Member]"
       }
      }
     },
     "localname": "MomentaMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_NetIncomeAttributableToParentPercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net Income Attributable to Parent Percent to Sales",
        "label": "Net Income Attributable to Parent Percent to Sales",
        "totalLabel": "Net earnings percent to sales"
       }
      }
     },
     "localname": "NetIncomeAttributableToParentPercentToSales",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_NeuroscienceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Neuroscience [Member]",
        "label": "Neuroscience [Member]",
        "terseLabel": "Neuroscience"
       }
      }
     },
     "localname": "NeuroscienceMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_NotesDuePeriodFifteenMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Notes due period fifteen.",
        "label": "Notes Due Period Fifteen Member",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "NotesDuePeriodFifteenMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_Numberofpatientsinsettlement": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of patients in settlement",
        "label": "Number of patients in settlement",
        "terseLabel": "Number of patients in settlement"
       }
      }
     },
     "localname": "Numberofpatientsinsettlement",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "jnj_OPSUMITMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "OPSUMIT [Member]",
        "label": "OPSUMIT [Member]",
        "terseLabel": "OPSUMIT\u00ae"
       }
      }
     },
     "localname": "OPSUMITMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OTCMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "OTC [Member]",
        "label": "OTC [Member]",
        "terseLabel": "OTC"
       }
      }
     },
     "localname": "OTCMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OTHERNEUROSCIENCEMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "OTHER NEUROSCIENCE [Member]",
        "label": "OTHER NEUROSCIENCE [Member]",
        "terseLabel": "OTHER NEUROSCIENCE"
       }
      }
     },
     "localname": "OTHERNEUROSCIENCEMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Oklahoma Attorney General VS. Johnson And Johnson And JPI [Member]",
        "label": "Oklahoma Attorney General VS. Johnson And Johnson And JPI [Member]",
        "terseLabel": "Oklahoma Attorney General vs. Johnson &amp; Johnson and JPI"
       }
      }
     },
     "localname": "OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OncologyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Oncology [Member]",
        "label": "Oncology [Member]",
        "terseLabel": "Oncology"
       }
      }
     },
     "localname": "OncologyMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OpioidMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid",
        "label": "opioid [Member]",
        "terseLabel": "Opioid"
       }
      }
     },
     "localname": "OpioidMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OralCareMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Oral Care [Member]",
        "label": "Oral Care [Member]",
        "terseLabel": "Oral Care"
       }
      }
     },
     "localname": "OralCareMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OrthopaedicsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Orthopaedics [Member]",
        "label": "Orthopaedics [Member]",
        "terseLabel": "Orthopaedics"
       }
      }
     },
     "localname": "OrthopaedicsMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit), Net of Amortization, Arising During Period, Net of Tax",
        "label": "Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit), Net of Amortization, Arising During Period, Net of Tax",
        "negatedTerseLabel": "Prior service cost amortization during period"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI Pension and Other Postretirement Benefit Plans for Net Gain Loss, Net of Amortization, Net of Tax",
        "label": "Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI Pension and Other Postretirement Benefit Plans for Net Gain Loss, Net of Amortization, Net of Tax",
        "negatedTerseLabel": "Gain (loss) amortization during period"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_OtherImmunologyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Immunology [Member]",
        "label": "Other Immunology [Member]",
        "terseLabel": "OTHER IMMUNOLOGY"
       }
      }
     },
     "localname": "OtherImmunologyMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OtherIncomeExpenseNetMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Income Expense Net [Member]",
        "label": "Other Income Expense Net [Member]",
        "terseLabel": "Other (income) expense",
        "verboseLabel": "Other Income Expense Net"
       }
      }
     },
     "localname": "OtherIncomeExpenseNetMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OtherInfectiousDiseasesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Infectious Diseases [Member]",
        "label": "Other Infectious Diseases [Member]",
        "terseLabel": "OTHER INFECTIOUS DISEASES"
       }
      }
     },
     "localname": "OtherInfectiousDiseasesMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other [Member]",
        "label": "Other [Member]",
        "terseLabel": "OTHER PULMONARY HYPERTENSION"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OtherNonOperatingIncomeExpensePercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 6.0,
       "parentTag": "jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other non operating income expense percent to sales.",
        "label": "Other Non Operating Income Expense Percent To Sales",
        "terseLabel": "Other (income) expense, net percent to sales"
       }
      }
     },
     "localname": "OtherNonOperatingIncomeExpensePercentToSales",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_OtherOncologyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Oncology [Member]",
        "label": "Other Oncology [Member]",
        "terseLabel": "OTHER ONCOLOGY"
       }
      }
     },
     "localname": "OtherOncologyMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OtherReverseRepurchaseAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Reverse Repurchase Agreements [Member]",
        "label": "Other Reverse Repurchase Agreements [Member]",
        "terseLabel": "Other reverse repurchase agreements"
       }
      }
     },
     "localname": "OtherReverseRepurchaseAgreementsMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA [Member]",
        "label": "PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA [Member]",
        "terseLabel": "PREZISTA\u00ae / PREZCOBIX\u00ae / REZOLSTA\u00ae / SYMTUZA\u00ae"
       }
      }
     },
     "localname": "PREZISTAPREZCOBIXREZOLSTASYMTUZAMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_PROCRITEPREXMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "PROCRIT/EPREX [Member]",
        "label": "PROCRIT/EPREX [Member]",
        "terseLabel": "PROCRIT\u00ae / EPREX\u00ae"
       }
      }
     },
     "localname": "PROCRITEPREXMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_PatentsAndTrademarksMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Patents And Trademarks [Member]",
        "label": "Patents And Trademarks [Member]",
        "terseLabel": "Patents And Trademarks"
       }
      }
     },
     "localname": "PatentsAndTrademarksMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_PelvicMeshesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pelvic meshes.",
        "label": "Pelvic Meshes [Member]",
        "terseLabel": "Pelvic Meshes"
       }
      }
     },
     "localname": "PelvicMeshesMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_PercentageChangeInOperatingIncomeLoss": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage change in operating income loss.",
        "label": "Percentage Change in Operating Income Loss",
        "terseLabel": "Percentage Change in Operating Income Loss"
       }
      }
     },
     "localname": "PercentageChangeInOperatingIncomeLoss",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_PercentageChangeInSalesByGeographicArea": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage change in sales by geographic area.",
        "label": "Percentage Change In Sales By Geographic Area",
        "terseLabel": "Percentage Change In Sales By Geographic Area"
       }
      }
     },
     "localname": "PercentageChangeInSalesByGeographicArea",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_PercentageChangeInSalesBySegmentOfBusiness": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage change in sales by segment of business.",
        "label": "Percentage Change In Sales By Segment Of Business",
        "terseLabel": "Percent Change (as a percent)"
       }
      }
     },
     "localname": "PercentageChangeInSalesBySegmentOfBusiness",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_PharmaceuticalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pharmaceutical.",
        "label": "Pharmaceutical [Member]",
        "terseLabel": "PHARMACEUTICAL"
       }
      }
     },
     "localname": "PharmaceuticalMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_PhysiomeshMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Physiomesh [Member]",
        "label": "Physiomesh [Member]",
        "terseLabel": "Physiomesh"
       }
      }
     },
     "localname": "PhysiomeshMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_PinnacleAcetabularCupSystemMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pinnacle Acetabular cup system.",
        "label": "Pinnacle Acetabular Cup System [Member]",
        "terseLabel": "Pinnacle Acetabular Cup System"
       }
      }
     },
     "localname": "PinnacleAcetabularCupSystemMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds From The Exercise Of Stock Options And Excess Tax Benefits",
        "label": "Proceeds From The Exercise Of Stock Options And Excess Tax Benefits",
        "verboseLabel": "Proceeds from the exercise of stock options/employee withholding tax on stock awards, net"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_Proceedsfromcreditsupportagreements": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds from credit support agreements",
        "label": "Proceeds from credit support agreements",
        "terseLabel": "Proceeds from credit support agreements, net"
       }
      }
     },
     "localname": "Proceedsfromcreditsupportagreements",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_ProductLiabilityContingencyNumberOfClaimant": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product liability contingency number of claimant.",
        "label": "Product Liability Contingency Number Of Claimant",
        "terseLabel": "Product Liability Contingency Number Of Claimants"
       }
      }
     },
     "localname": "ProductLiabilityContingencyNumberOfClaimant",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "jnj_PulmonaryHypertensionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pulmonary Hypertension [Member]",
        "label": "Pulmonary Hypertension [Member]",
        "terseLabel": "Pulmonary Hypertension"
       }
      }
     },
     "localname": "PulmonaryHypertensionMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_PurchasedInProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchased In-Process Research And Development [Member]",
        "label": "Purchased In-Process Research And Development [Member]",
        "terseLabel": "Purchased In-Process Research And Development"
       }
      }
     },
     "localname": "PurchasedInProcessResearchAndDevelopmentMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_RISPERDALCONSTAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "RISPERDAL CONSTA [Member]",
        "label": "RISPERDAL CONSTA [Member]",
        "terseLabel": "RISPERDAL CONSTA\u00ae"
       }
      }
     },
     "localname": "RISPERDALCONSTAMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_RemicadeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Remicade [Member]",
        "label": "Remicade [Member]",
        "terseLabel": "REMICADE\u00ae"
       }
      }
     },
     "localname": "RemicadeMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 3.0,
       "parentTag": "jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Research and development expense excluding acquired in process cost percent to sales.",
        "label": "Research And Development Expense Excluding Acquired In Process Cost Percent To Sales",
        "terseLabel": "Research and development expense percent to sales"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_ResearchAndDevelopmentInProcessPercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 8.0,
       "parentTag": "jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "research and development in process percent to sales",
        "label": "Research and development in process percent to sales",
        "terseLabel": "In-process research and development percent to sales"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcessPercentToSales",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring And Related Cost, Expected Period Of Cash Outlays For Severance Paid",
        "label": "Restructuring And Related Cost, Expected Period Of Cash Outlays For Severance Paid",
        "terseLabel": "Period of cash outlays for severance expected to be paid out"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "jnj_RestructuringandRelatedCostDurationofRestructuringPlan": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring and Related Cost, Duration of Restructuring Plan",
        "label": "Restructuring and Related Cost, Duration of Restructuring Plan",
        "terseLabel": "Period for activity"
       }
      }
     },
     "localname": "RestructuringandRelatedCostDurationofRestructuringPlan",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "jnj_RestructuringandRelatedCostExpectedFutureSavings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring and Related Cost, Expected Future Savings",
        "label": "Restructuring and Related Cost, Expected Future Savings",
        "terseLabel": "Cost savings expected"
       }
      }
     },
     "localname": "RestructuringandRelatedCostExpectedFutureSavings",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_Restructuringchargepercenttosales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 7.0,
       "parentTag": "jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring charge percent to sales",
        "label": "Restructuring charge percent to sales",
        "terseLabel": "Restructuring charge percent to sales"
       }
      }
     },
     "localname": "Restructuringchargepercenttosales",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_RisperdalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Risperdal.",
        "label": "Risperdal [Member]",
        "terseLabel": "Risperdal"
       }
      }
     },
     "localname": "RisperdalMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_SPINEOTHERMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "SPINE &amp; OTHER [Member]",
        "label": "SPINE &amp; OTHER [Member]",
        "terseLabel": "SPINE, SPORTS &amp; OTHER"
       }
      }
     },
     "localname": "SPINEOTHERMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_SURGICALMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "SURGICAL [Member]",
        "label": "SURGICAL [Member]",
        "terseLabel": "SURGICAL"
       }
      }
     },
     "localname": "SURGICALMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_SalesBySegmentOfBusinessTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sales by segment of business.",
        "label": "Sales By Segment Of Business [Table Text Block]",
        "terseLabel": "Sales By Segment Of Business"
       }
      }
     },
     "localname": "SalesBySegmentOfBusinessTableTextBlock",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "jnj_SalesRevenueGoodsNetPercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "jnj_GrossProfitPercentToSales",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sales revenue goods net percentage to sales.",
        "label": "Sales Revenue Goods Net Percent To Sales",
        "terseLabel": "Sales to customers percent to sales"
       }
      }
     },
     "localname": "SalesRevenueGoodsNetPercentToSales",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Finite and Indefinite-Lived Intangible Assets Excluding Goodwill by Major Class [Table Text Block]",
        "label": "Schedule of Finite and Indefinite-Lived Intangible Assets Excluding Goodwill by Major Class [Table Text Block]",
        "verboseLabel": "Intangible Assets and Goodwill"
       }
      }
     },
     "localname": "ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Finite-Lived And Indefinite-Lived Intangible Assets By Major Class [Table]",
        "label": "Schedule of Finite-Lived And Indefinite-Lived Intangible Assets By Major Class [Table]",
        "terseLabel": "Schedule of Finite-Lived And Indefinite-Lived Intangible Assets By Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jnj_SellingGeneralAndAdministrativeExpensePercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Selling general and administrative expense percent to sales.",
        "label": "Selling General And Administrative Expense Percent To Sales",
        "terseLabel": "Selling marketing and administrative expenses percent to sales"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensePercentToSales",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/EarningsPerShareDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common stock assumed to be purchased using the proceeds that could be obtained upon exercise of potential shares exercisable under stock option plans, at the average market price during the period.",
        "label": "Shares Which Could Be Repurchased Under Treasury Stock Method",
        "negatedTerseLabel": "Less: shares which could be repurchased under treasury stock method"
       }
      }
     },
     "localname": "SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "jnj_SimponiSimponiAriaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Simponi/Simponi Aria [Member]",
        "label": "Simponi/Simponi Aria [Member]",
        "terseLabel": "SIMPONI / SIMPONI ARIA\u00ae"
       }
      }
     },
     "localname": "SimponiSimponiAriaMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_StelaraMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stelara [Member]",
        "label": "Stelara [Member]",
        "terseLabel": "STELARA\u00ae"
       }
      }
     },
     "localname": "StelaraMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_SupplyChainMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Supply Chain",
        "label": "Supply Chain [Member]",
        "terseLabel": "Supply Chain"
       }
      }
     },
     "localname": "SupplyChainMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_SurgeryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Surgery [Member]",
        "label": "Surgery [Member]",
        "terseLabel": "Surgery"
       }
      }
     },
     "localname": "SurgeryMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_TRAUMAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "TRAUMA [Member]",
        "label": "TRAUMA [Member]",
        "terseLabel": "TRAUMA"
       }
      }
     },
     "localname": "TRAUMAMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_TalcMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Talc [Member]",
        "label": "Talc [Member]",
        "terseLabel": "Talc"
       }
      }
     },
     "localname": "TalcMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_TremfyaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tremfaya",
        "label": "Tremfya [Member]",
        "terseLabel": "TREMFYA\u00ae"
       }
      }
     },
     "localname": "TremfyaMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_UNITEDSTATESExportsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "UNITED STATES Exports [Member]",
        "label": "UNITED STATES Exports [Member]",
        "terseLabel": "U.S. Exports"
       }
      }
     },
     "localname": "UNITEDSTATESExportsMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_UPTRAVIMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "UPTRAVI [Member]",
        "label": "UPTRAVI [Member]",
        "terseLabel": "UPTRAVI\u00ae"
       }
      }
     },
     "localname": "UPTRAVIMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_UnrecognizedTaxBenefitLiabilityPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unrecognized Tax Benefit Liability, Payment",
        "label": "Unrecognized Tax Benefit Liability, Payment",
        "terseLabel": "Payment on unrecognized tax benefit liability"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitLiabilityPayment",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_VELCADEMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "VELCADE [Member]",
        "label": "VELCADE [Member]",
        "terseLabel": "VELCADE\u00ae"
       }
      }
     },
     "localname": "VELCADEMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_VerbSurgicalInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Verb Surgical Inc. [Member]",
        "label": "Verb Surgical Inc. [Member]",
        "terseLabel": "Verb Surgical Inc."
       }
      }
     },
     "localname": "VerbSurgicalInc.Member",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_VisionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Vision[Member]",
        "label": "Vision [Member]",
        "terseLabel": "Vision"
       }
      }
     },
     "localname": "VisionMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_WesternHemisphereExcludingUSMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Western Hemisphere, excluding U.S. [Member]",
        "label": "Western Hemisphere, excluding U.S. [Member]",
        "terseLabel": "Western Hemisphere, excluding U.S."
       }
      }
     },
     "localname": "WesternHemisphereExcludingUSMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_WomensHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Women's Health [Member]",
        "label": "Women's Health [Member]",
        "terseLabel": "Women's Health"
       }
      }
     },
     "localname": "WomensHealthMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_WoundCareandOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Wound Care and Other [Member]",
        "label": "Wound Care and Other [Member]",
        "terseLabel": "Wound Care/Other"
       }
      }
     },
     "localname": "WoundCareandOtherMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_XareltoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Xarelto [Member]",
        "label": "Xarelto [Member]",
        "terseLabel": "XARELTO\u00ae"
       }
      }
     },
     "localname": "XareltoMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_ZYTIGAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ZYTIGA [Member]",
        "label": "ZYTIGA [Member]",
        "terseLabel": "ZYTIGA\u00ae / abiraterone acetate"
       }
      }
     },
     "localname": "ZYTIGAMember",
     "nsuri": "http://www.jnj.com/20200927",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r158",
      "r166"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case Type"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r168",
      "r271",
      "r273",
      "r434",
      "r435"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r169",
      "r271",
      "r274",
      "r436",
      "r443",
      "r444"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r12",
      "r30",
      "r171",
      "r172",
      "r272"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable, trade, less allowances for doubtful accounts and credit losses $292 (2019, $226)"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r24",
      "r405",
      "r424"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "verboseLabel": "Accrued taxes on income (Note 5)"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r26",
      "r405",
      "r424"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Long-term taxes payable (Note 5)"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "verboseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r76",
      "r82",
      "r85",
      "r288",
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r46",
      "r226"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r82",
      "r92",
      "r331"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r73",
      "r74",
      "r75",
      "r82",
      "r85"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Accumulated Net Investment Gain (Loss) Attributable to Parent"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r79",
      "r81",
      "r82"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive income (loss) (Note 7)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r78",
      "r82",
      "r85",
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income",
        "verboseLabel": "AOCI Attributable to Parent"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r70",
      "r82",
      "r85",
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Foreign Currency Adjustment Attributable to Parent"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted average useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AcquisitionCosts": {
     "auth_ref": [
      "r400",
      "r401"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.",
        "label": "Acquisition Costs, Period Cost",
        "terseLabel": "Acquisition Costs, Period Cost"
       }
      }
     },
     "localname": "AcquisitionCosts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r121",
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net earnings to cash flows from operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r33",
      "r173",
      "r195"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "verboseLabel": "Allowances for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r121",
      "r209",
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "verboseLabel": "Amortization expense of amortizable intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": {
     "auth_ref": [
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax",
        "negatedTerseLabel": "Accumulated other comprehensive income on derivatives, after tax"
       }
      }
     },
     "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r121",
      "r223"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Asset write-downs"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r163",
      "r403",
      "r423"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r62"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther": {
     "auth_ref": [
      "r222"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.",
        "label": "Assets Held-for-sale, Not Part of Disposal Group, Current, Other",
        "terseLabel": "Assets held for sale (Note 10)"
       }
      }
     },
     "localname": "AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r177"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Available-for-sale Securities, Unrecognized Gain"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r178"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Available-for-sale Securities, Unrecognized Loss"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r175",
      "r197"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Available-for-sale Securities - Carrying Amount"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale [Abstract]",
        "terseLabel": "Debt Securities, Available-for-sale [Abstract]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": {
     "auth_ref": [
      "r182"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth fiscal year through tenth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Amortized Cost",
        "terseLabel": "Due after five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r179",
      "r182",
      "r419"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Fair Value",
        "terseLabel": "Due after five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r181"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r179",
      "r181",
      "r418"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Cost Basis"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "auth_ref": [
      "r179",
      "r183",
      "r420"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value",
        "totalLabel": "Total debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis": {
     "auth_ref": [
      "r179",
      "r183",
      "r420"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost",
        "totalLabel": "Total debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r180"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r179",
      "r180",
      "r417"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r174",
      "r176",
      "r197"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Available-for-sale Securities",
        "verboseLabel": "Available-for-sale Securities - Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableforsaleSecuritiesMember": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available-for-sale Securities [Member]",
        "terseLabel": "Available-for-sale Securities"
       }
      }
     },
     "localname": "AvailableforsaleSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r343",
      "r349"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BankTimeDepositsMember": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest.",
        "label": "Bank Time Deposits [Member]",
        "terseLabel": "Time deposits(1)"
       }
      }
     },
     "localname": "BankTimeDepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r316",
      "r317"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r321",
      "r322",
      "r324"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business acquisition cost"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r120",
      "r326"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "negatedTerseLabel": "Reversal of contingent consideration",
        "terseLabel": "Contingent consideration reversal"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r320",
      "r323",
      "r325"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration",
        "verboseLabel": "Business Combination, Contingent Consideration, Liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities": {
     "auth_ref": [
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r318"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "terseLabel": "Liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r384",
      "r385"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "verboseLabel": "Carrying Amount"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r10",
      "r43",
      "r123"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and Cash Equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Cash and Cash Equivalents [Line Items]",
        "terseLabel": "Cash and Cash Equivalents [Line Items]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r17",
      "r124",
      "r129"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents, Policy"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-term Investments",
        "terseLabel": "Total cash, cash equivalents and current marketable securities, Carrying Amount"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r117",
      "r123",
      "r128"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and Cash equivalents, end of period",
        "periodStartLabel": "Cash and Cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r117",
      "r387"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase/(Decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging",
        "verboseLabel": "Cash Flow Hedging [Member]"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashMember": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.",
        "label": "Cash [Member]",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollateralAlreadyPostedAggregateFairValue": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate fair value of assets that are already posted, at the end of the reporting period, as collateral for derivative instruments with credit-risk-related contingent features.",
        "label": "Collateral Already Posted, Aggregate Fair Value",
        "terseLabel": "Collateral Already Posted, Aggregate Fair Value"
       }
      }
     },
     "localname": "CollateralAlreadyPostedAggregateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r58",
      "r248",
      "r412",
      "r430"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies (Note 11)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Cash dividends paid (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock Issued Amount",
        "verboseLabel": "Common Stock, Par Value $1.00"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity",
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value per share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock \u2014 par value $1.00 per share (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r88",
      "r90",
      "r91"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "verboseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r279",
      "r300",
      "r437"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities(1)"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate, Non-Segment"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of products sold",
        "verboseLabel": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r279",
      "r359"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross Currency Interest Rate Contract",
        "verboseLabel": "Cross currency interest rate swaps"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r22",
      "r24",
      "r25",
      "r404",
      "r406",
      "r421"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Long-term Debt, Type"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale and Held-to-maturity [Abstract]",
        "terseLabel": "Debt Securities, Available-for-sale and Held-to-maturity [Abstract]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Schedule of Available for Sale Securities Maturities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Debt, Weighted Average Interest Rate",
        "terseLabel": "Weighted average interest rate"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r310"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "verboseLabel": "Deferred taxes on income (Note 5)"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r130",
      "r312",
      "r313"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "verboseLabel": "Deferred tax provision"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r305",
      "r310"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "verboseLabel": "Deferred taxes on income (Note 5)"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Defined Benefit Plan [Abstract]",
        "verboseLabel": "Components of net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r285",
      "r297",
      "r300"
     ],
     "calculation": {
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Recognized actuarial losses"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r286",
      "r298",
      "r300"
     ],
     "calculation": {
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "verboseLabel": "Amortization of prior service cost/(credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r284",
      "r296",
      "r300"
     ],
     "calculation": {
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r278",
      "r283",
      "r295",
      "r300"
     ],
     "calculation": {
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "verboseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r281",
      "r293",
      "r300"
     ],
     "calculation": {
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1": {
     "auth_ref": [
      "r287",
      "r299"
     ],
     "calculation": {
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment",
        "negatedLabel": "Curtailments and settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r277",
      "r282",
      "r294",
      "r300"
     ],
     "calculation": {
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "verboseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r121",
      "r161"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization of property and intangibles"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetFairValueGrossLiability": {
     "auth_ref": [
      "r64",
      "r68",
      "r346"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeAssets",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Asset, Fair Value, Gross Liability",
        "negatedTerseLabel": "Credit Support Agreement (CSA)"
       }
      }
     },
     "localname": "DerivativeAssetFairValueGrossLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r65",
      "r66",
      "r383"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "totalLabel": "Total Net Asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsNoncurrent": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Noncurrent",
        "terseLabel": "Derivative Assets, Noncurrent",
        "verboseLabel": "Derivative Asset, Noncurrent"
       }
      }
     },
     "localname": "DerivativeAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings": {
     "auth_ref": [
      "r352",
      "r368"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings. Excludes recognition under systematic and rational method.",
        "label": "Derivative, Excluded Component, Gain (Loss), Recognized in Earnings",
        "terseLabel": "Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net",
        "verboseLabel": "Derivative, Excluded Component, Gain (Loss), Recognized in Earnings"
       }
      }
     },
     "localname": "DerivativeExcludedComponentGainLossRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r63",
      "r67",
      "r346",
      "r398"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Total Gross Assets"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r63",
      "r67",
      "r346",
      "r398"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Total Gross Liabilities"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r345"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Gain/(Loss) Recognized In Income on Derivative"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentDetailAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Instrument Detail [Abstract]",
        "verboseLabel": "Financial assets and liabilities at fair value"
       }
      }
     },
     "localname": "DerivativeInstrumentDetailAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r344",
      "r347",
      "r354",
      "r361"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r341",
      "r344",
      "r354"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r341",
      "r344",
      "r354",
      "r361",
      "r362",
      "r367",
      "r370"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred": {
     "auth_ref": [
      "r373"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.",
        "label": "Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred",
        "terseLabel": "Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate fair value of all derivative assets designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.",
        "label": "Derivative Instruments in Hedges, Assets, at Fair Value",
        "verboseLabel": "Derivatives designated as hedging instruments : Assets"
       }
      }
     },
     "localname": "DerivativeInstrumentsInHedgesAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate fair value of all derivative liabilities designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.",
        "label": "Derivative Instruments in Hedges, Liabilities, at Fair Value",
        "verboseLabel": "Derivatives designated as hedging instruments : Liabilities"
       }
      }
     },
     "localname": "DerivativeInstrumentsInHedgesLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r65",
      "r66",
      "r383"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Carrying Amount of the Hedged Liability",
        "totalLabel": "Total Net Liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityFairValueGrossAsset": {
     "auth_ref": [
      "r64",
      "r68",
      "r346"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Liability, Fair Value, Gross Asset",
        "negatedTerseLabel": "Credit Support Agreement (CSA)"
       }
      }
     },
     "localname": "DerivativeLiabilityFairValueGrossAsset",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r336",
      "r338"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r134",
      "r335",
      "r337",
      "r338",
      "r341",
      "r342",
      "r350",
      "r354",
      "r365",
      "r366",
      "r370"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of the transactions or other events that will result in the reclassification into earnings of gains or losses reported in accumulated other comprehensive income. May include the time period over which gains or losses will be reclassified to earnings.",
        "label": "Description of Reclassification of Cash Flow Hedge Gain (Loss)",
        "verboseLabel": "Reclassification of foreign exchange contracts into earnings, period"
       }
      }
     },
     "localname": "DescriptionOfReclassificationOfCashFlowHedgeGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember": {
     "auth_ref": [
      "r3",
      "r4",
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Component or group of components classified as held-for-sale or disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations, Held-for-sale or Disposed of by Sale [Member]",
        "terseLabel": "Discontinued Operations, Held-for-sale or Disposed of by Sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand, demand deposits with banks or financial institutions, and  other kinds of accounts that have the general characteristics of demand deposits, held by a disposal group.",
        "label": "Disposal Group, Including Discontinued Operation, Cash",
        "terseLabel": "Disposal group consideration, cash"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCash",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Disposal group consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r7",
      "r224",
      "r229"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "terseLabel": "Assets held for sale, current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends paid"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]",
        "verboseLabel": "NET EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r97",
      "r136",
      "r140",
      "r143",
      "r144",
      "r145",
      "r148",
      "r414",
      "r433"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (per share)",
        "verboseLabel": "Basic net earnings per share"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r97",
      "r136",
      "r140",
      "r143",
      "r144",
      "r145",
      "r148",
      "r414",
      "r433"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net earnings per share",
        "verboseLabel": "Diluted (per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]",
        "verboseLabel": "Reconciliation of basic net earnings per share to diluted net earnings per share"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r387"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "verboseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r133",
      "r306",
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Worldwide effective income tax rate (as a percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Accrued compensation and employee related obligations"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r411",
      "r431"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Employee-related Liabilities",
        "verboseLabel": "Employee related obligations (Note 6)"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Severance"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityFairValueAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of addition (reduction) to the amount at which an instrument classified in shareholders' equity could be incurred (settled) in a current transaction between willing parties.",
        "label": "Equity, Fair Value Adjustment",
        "terseLabel": "Changes in Fair Value Reflected in Net Income"
       }
      }
     },
     "localname": "EquityFairValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r193"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of investments accounted under the equity method.",
        "label": "Equity Method Investments, Fair Value Disclosure",
        "terseLabel": "Fair value of previously held equity investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Available-for-sale Securities, Equity Securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r18",
      "r23",
      "r191",
      "r409",
      "r422",
      "r442"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity Securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r192"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "periodEndLabel": "Carrying value, end of period",
        "periodStartLabel": "Carrying value, beginning of period",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value, Amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r374",
      "r379"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r374",
      "r384",
      "r385"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r374",
      "r384"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "verboseLabel": "Financial Liabilities not Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r279",
      "r280",
      "r300",
      "r375",
      "r394"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "verboseLabel": "Fair Value, Hierarchy"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r374",
      "r380"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping, Disclosure Item Amounts"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging",
        "verboseLabel": "Fair Value Hedging [Member]"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r279",
      "r280",
      "r300",
      "r375",
      "r395"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "verboseLabel": "Quoted prices in active markets for identical assets and liabilities Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r279",
      "r280",
      "r300",
      "r375",
      "r396"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Significant other observable inputs Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r279",
      "r280",
      "r300",
      "r375",
      "r397"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "verboseLabel": "Significant unobservable inputs Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r377"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r376"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Beginning Balance",
        "periodStartLabel": "Ending Balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "verboseLabel": "Fair Value, Measurements, Fair Value Hierarchy"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r343",
      "r350",
      "r367"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Financial Liabilities"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "verboseLabel": "Finite-Lived Intangible Assets, Weighted-Average Useful Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r216"
     ],
     "calculation": {
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "verboseLabel": "Less accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-lived Intangible Assets Amortization Expense [Table Text Block]",
        "terseLabel": "Intangible Asset Amortization Expense"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r210",
      "r213",
      "r216",
      "r220",
      "r399"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r216",
      "r399"
     ],
     "calculation": {
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Finite-Lived Intangible Assets, Gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r210",
      "r215"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r216"
     ],
     "calculation": {
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Finite-Lived Intangible Assets, Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net [Abstract]",
        "verboseLabel": "Intangible assets with definite lives:"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue": {
     "auth_ref": [
      "r348"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivative assets not designated as hedging instruments.",
        "label": "Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value",
        "verboseLabel": "Derivatives not designated as hedging instruments : Assets"
       }
      }
     },
     "localname": "ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue": {
     "auth_ref": [
      "r348"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivative liabilities not designated as hedging instruments.",
        "label": "Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Liability at Fair Value",
        "verboseLabel": "Derivatives not designated as hedging instruments : Liabilities"
       }
      }
     },
     "localname": "ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyExchangeRateTranslation1": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.",
        "label": "Foreign Currency Exchange Rate, Translation",
        "terseLabel": "Foreign exchange rate"
       }
      }
     },
     "localname": "ForeignCurrencyExchangeRateTranslation1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r279",
      "r358"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "verboseLabel": "Forward foreign exchange contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "verboseLabel": "International retirement plans"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r121",
      "r333"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "terseLabel": "Gain from divestiture of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfEquityInvestments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The difference between the carrying value and the sale price of equity securities, not separately or otherwise categorized as trading or available-for-sale. This element includes investments in which the entity holds a small ownership stake (generally, less than 20% of the shares outstanding) and cannot exert significant influence.",
        "label": "Gain (Loss) on Sale of Equity Investments",
        "terseLabel": "Gain on sale of equity investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfEquityInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.",
        "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges",
        "negatedTerseLabel": "Net gain on sale of assets/businesses"
       }
      }
     },
     "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r202",
      "r203"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill End of Period",
        "periodStartLabel": "Goodwill Beginning of Period",
        "terseLabel": "Goodwill (Note 3)",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r204"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, related to acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "Intangible Assets and Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillOtherIncreaseDecrease": {
     "auth_ref": [
      "r205"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease), classified as other, of an asset representing the future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Other Increase (Decrease)",
        "terseLabel": "Currency translation/Other"
       }
      }
     },
     "localname": "GoodwillOtherIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r341",
      "r362"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HeldToMaturitySecurities": {
     "auth_ref": [
      "r174",
      "r184"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity",
        "totalLabel": "Held-to-maturity Securities - Carrying Amount"
       }
      }
     },
     "localname": "HeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain": {
     "auth_ref": [
      "r186"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain",
        "terseLabel": "Held-to-maturity Securities, Unrecognized Gain"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss": {
     "auth_ref": [
      "r187"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss",
        "negatedLabel": "Held-to-maturity Securities, Unrecognized Loss"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesClassifiedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Held-to-maturity [Abstract]",
        "terseLabel": "Debt Securities, Held-to-maturity [Abstract]"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesClassifiedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesFairValue": {
     "auth_ref": [
      "r185"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity, Fair Value",
        "terseLabel": "Held-to-maturity Securities - Estimated Fair Value"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldtomaturitySecuritiesMember": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investments in debt securities classified as held-to-maturity.",
        "label": "Held-to-maturity Securities [Member]",
        "terseLabel": "Held-to-maturity Securities"
       }
      }
     },
     "localname": "HeldtomaturitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Earnings before provision for taxes on income",
        "totalLabel": "Earnings before provision for taxes on income"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]",
        "verboseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]",
        "verboseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r130",
      "r162",
      "r314"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for taxes on income"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "verboseLabel": "(Decrease)/Increase in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Increase in accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Increase in inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in assets and liabilities, net of effects from acquisitions and divestitures:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Increase in other current and non-current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Increase in other current and non-current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "auth_ref": [
      "r142",
      "r147"
     ],
     "calculation": {
      "http://www.jnj.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "verboseLabel": "Convertible debt shares"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r141",
      "r147"
     ],
     "calculation": {
      "http://www.jnj.com/role/EarningsPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Potential shares exercisable under stock option plans"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r212",
      "r219"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r219"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "verboseLabel": "Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]",
        "verboseLabel": "Intangible assets with indefinite lives:"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r212",
      "r219"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InformationByCategoryOfDebtSecurityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by category of debt security, either available-for-sale or held-to-maturity.",
        "label": "Debt Security Category [Axis]",
        "terseLabel": "Debt Security Category [Axis]"
       }
      }
     },
     "localname": "InformationByCategoryOfDebtSecurityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r208",
      "r214"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Total intangible assets - net",
        "verboseLabel": "Intangible assets, net (Note 3)"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]",
        "verboseLabel": "Intangible assets and Goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r94",
      "r160",
      "r391",
      "r392",
      "r415"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense, net of portion capitalized"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateContractMember": {
     "auth_ref": [
      "r279",
      "r357"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.",
        "label": "Interest Rate Contract [Member]",
        "terseLabel": "Interest Rate Contract"
       }
      }
     },
     "localname": "InterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Internal Revenue Service (IRS) [Member]"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r34",
      "r200"
     ],
     "calculation": {
      "http://www.jnj.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "verboseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r11",
      "r61",
      "r199"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.jnj.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Total inventories",
        "verboseLabel": "Inventories (Note 2)"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r36",
      "r37",
      "r200"
     ],
     "calculation": {
      "http://www.jnj.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "verboseLabel": "Raw materials and supplies"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r35",
      "r200"
     ],
     "calculation": {
      "http://www.jnj.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "verboseLabel": "Goods in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r103",
      "r159"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "negatedTerseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r438",
      "r439",
      "r440",
      "r441"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r438",
      "r439",
      "r440",
      "r441"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_JudicialRulingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Litigation outcome that occurs as a result of judicial intervention, supervision, or approval.",
        "label": "Judicial Ruling [Member]",
        "terseLabel": "Judicial Ruling"
       }
      }
     },
     "localname": "JudicialRulingMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "verboseLabel": "Legal Proceedings"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r32",
      "r407",
      "r428"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r49",
      "r131"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Litigation expense"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r25",
      "r265",
      "r406",
      "r426"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Non-Current Debt",
        "verboseLabel": "Long-term debt (Note 4)"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Long-term Debt, Excluding Current Maturities [Abstract]",
        "terseLabel": "Non-Current Debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r56",
      "r263"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Weighted average interest rate on non-current debt"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r248",
      "r249",
      "r250",
      "r253",
      "r254",
      "r255",
      "r258",
      "r260",
      "r261"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "verboseLabel": "Product Liability Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r248",
      "r251",
      "r256"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Damages awarded"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r252",
      "r257",
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "terseLabel": "Loss Contingency, Estimate of Possible Loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r13",
      "r52"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "periodEndLabel": "Carrying value, end of period",
        "periodStartLabel": "Carrying value, beginning of period"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments.",
        "label": "Maximum Length of Time, Foreign Currency Cash Flow Hedge",
        "terseLabel": "Maximum length of time for hedge exposure"
       }
      }
     },
     "localname": "MaximumLengthOfTimeForeignCurrencyCashFlowHedge",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r9",
      "r327"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "verboseLabel": "Business Combinations and Divestitures"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "NET CASH USED BY FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "NET CASH USED BY INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r117",
      "r119",
      "r122"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "NET CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r86",
      "r89",
      "r96",
      "r122",
      "r147",
      "r413",
      "r432"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "netLabel": "Net earnings",
        "terseLabel": "Net earnings",
        "totalLabel": "NET EARNINGS"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "New Accounting Pronouncements and Changes in Accounting Principles [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Standards Recently Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "verboseLabel": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1": {
     "auth_ref": [
      "r125",
      "r126",
      "r127"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net book value of a nonmonetary asset transferred or exchanged in connection with the acquisition of a business or asset in a noncash transaction. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Nonmonetary assets and liabilities are assets and liabilities that will not result in cash receipts or cash payments in the future.",
        "label": "Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)",
        "totalLabel": "Net cash paid for acquisitions"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) [Abstract]",
        "verboseLabel": "Acquisitions"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1": {
     "auth_ref": [
      "r125",
      "r126",
      "r127"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Value of Assets Acquired",
        "verboseLabel": "Fair value of assets acquired"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1": {
     "auth_ref": [
      "r125",
      "r126",
      "r127"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of [all] liabilities that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Value of Liabilities Assumed",
        "negatedLabel": "Fair value of liabilities assumed and noncontrolling interests"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "verboseLabel": "Total Segment Operating Income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r158",
      "r166"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Non Current Other Assets",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Securities:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent [Abstract]",
        "terseLabel": "Employee benefit plans:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent [Abstract]",
        "terseLabel": "Derivatives &amp; hedges:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r69",
      "r79",
      "r386",
      "r388",
      "r389"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r73",
      "r74",
      "r79"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax",
        "totalLabel": "Net change"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r71",
      "r79"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "totalLabel": "Net change"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Derivatives &amp; Hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r71",
      "r79"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Unrealized gain (loss) arising during period",
        "verboseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r79",
      "r83"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Reclassifications to earnings",
        "verboseLabel": "Gain/ (Loss) reclassified from Accumulated OCI into income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax": {
     "auth_ref": [
      "r72",
      "r79",
      "r351",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax",
        "verboseLabel": "Unrealized gain (loss) arising during period"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax": {
     "auth_ref": [
      "r72",
      "r79",
      "r351",
      "r356",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r69",
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r87",
      "r90",
      "r92",
      "r266"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Net change",
        "totalLabel": "Other comprehensive income (loss)",
        "verboseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r77",
      "r79"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTotalLabel": "Net change"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r77",
      "r80",
      "r330"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "negatedTerseLabel": "Employee Benefit Plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r79",
      "r83",
      "r84",
      "r190"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "negatedTerseLabel": "Reclassifications to earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r73",
      "r79"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax",
        "terseLabel": "Unrealized holding gain (loss) arising during period",
        "verboseLabel": "Unrealized gains on equity investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIncomeMember": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other revenue.",
        "label": "Other Income [Member]",
        "terseLabel": "Other Income"
       }
      }
     },
     "localname": "OtherIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "verboseLabel": "Customer relationships and other intangible assets"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInvestmentNotReadilyMarketableAxis": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Group of items that represent other investments not readily marketable, including description of investment, fair value, and value as measured by quoted value method.",
        "label": "Other Investment Not Readily Marketable [Axis]",
        "terseLabel": "Other Investment Not Readily Marketable [Axis]"
       }
      }
     },
     "localname": "OtherInvestmentNotReadilyMarketableAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherInvestmentNotReadilyMarketableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Investment Not Readily Marketable [Line Items]",
        "terseLabel": "Other Investment Not Readily Marketable [Line Items]"
       }
      }
     },
     "localname": "OtherInvestmentNotReadilyMarketableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherInvestmentNotReadilyMarketableNameDomain": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the investment category or actual investment title.",
        "label": "Other Investment Not Readily Marketable, Name [Domain]",
        "terseLabel": "Other Investment Not Readily Marketable, Name [Domain]"
       }
      }
     },
     "localname": "OtherInvestmentNotReadilyMarketableNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInvestmentNotReadilyMarketableTable": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of the information about other investments not readily marketable, including, but not limited to, description of investment, fair value and value as measured by quoted price.",
        "label": "Other Investment Not Readily Marketable [Table]",
        "terseLabel": "Other Investment Not Readily Marketable [Table]"
       }
      }
     },
     "localname": "OtherInvestmentNotReadilyMarketableTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other (income) expense, net",
        "terseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r276",
      "r289",
      "r290",
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "verboseLabel": "Other Benefit Plans"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other Restructuring"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Provides the categories of debt securities, available-for-sale or held-to-maturity, on which an entity may recognize other than temporary impairments (OTTI) for which a portion related to credit losses has been recognized in earnings and a portion related to all other factors has been recognized in other comprehensive income.",
        "label": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]",
        "terseLabel": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r107",
      "r110",
      "r135"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other (primarily licenses and milestones)"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r116",
      "r233"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments for Restructuring"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfOrdinaryDividends": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings.",
        "label": "Payments of Ordinary Dividends",
        "negatedLabel": "Dividends to shareholders"
       }
      }
     },
     "localname": "PaymentsOfOrdinaryDividends",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions to property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for pension and other postretirement benefits.",
        "label": "Pension and Other Postretirement Benefits Disclosure [Text Block]",
        "terseLabel": "Pensions and Other Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionContributions": {
     "auth_ref": [
      "r118"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for pension benefit. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree. Excludes other postretirement benefit.",
        "label": "Payment for Pension Benefits",
        "terseLabel": "Contribution to pension plans"
       }
      }
     },
     "localname": "PensionContributions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r275",
      "r289",
      "r290",
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "verboseLabel": "Retirement Plans"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r14",
      "r41",
      "r42"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "verboseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.",
        "label": "Reclassification, Policy [Policy Text Block]",
        "terseLabel": "Reclassification"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from long-term debt, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r112",
      "r115",
      "r135"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.",
        "label": "Proceeds from Sale, Maturity and Collection of Investments",
        "verboseLabel": "Sales of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Proceeds from Sale of Productive Assets",
        "verboseLabel": "Proceeds from the disposal of assets/businesses, net"
       }
      }
     },
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-term Debt",
        "verboseLabel": "Proceeds from short-term debt"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r45",
      "r225"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r19",
      "r20",
      "r227",
      "r429"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r98",
      "r196"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "verboseLabel": "Credit losses and accounts receivable allowances"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-term Debt",
        "negatedLabel": "Repayment of short-term debt"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r303",
      "r445"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and Development Expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r303"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and Development Expense",
        "verboseLabel": "Research and Development Expense [Member]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentInProcess": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "Research and Development in Process",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcess",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Restructuring"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r232",
      "r235",
      "r242",
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Restructuring charges recorded to date"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r232",
      "r235",
      "r242",
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Restructuring estimated cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r121",
      "r231",
      "r238",
      "r244"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring (Note 12)",
        "verboseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity",
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesMember": {
     "auth_ref": [
      "r234",
      "r238",
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about restructuring charges have been included.",
        "label": "Restructuring Charges [Member]",
        "terseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringChargesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r233",
      "r240"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Reserve balance ending",
        "periodStartLabel": "Reserve balance beginning"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r231",
      "r239"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "negatedTerseLabel": "Restructuring Reserve, Settled without Cash"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r31",
      "r267",
      "r427"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r290",
      "r292"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r290",
      "r292"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r275",
      "r276",
      "r289",
      "r290",
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r275",
      "r276",
      "r289",
      "r290",
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r270",
      "r271"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "netLabel": "Sales",
        "terseLabel": "Sales to customers",
        "verboseLabel": "Sales to customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.",
        "label": "Sale of Stock, Consideration Received Per Transaction",
        "terseLabel": "Gross proceeds on sale"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedPerTransaction",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Shares issued in transaction (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.",
        "label": "Sale of Stock, Percentage of Ownership after Transaction",
        "terseLabel": "Percentage ownership after transaction"
       }
      }
     },
     "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company before stock transaction.",
        "label": "Sale of Stock, Percentage of Ownership before Transaction",
        "terseLabel": "Percentage ownership before transaction"
       }
      }
     },
     "localname": "SaleOfStockPercentageOfOwnershipBeforeTransaction",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sales price per share (in CHF per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SaleOfSubsidiaryGainLossMember": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which reported facts about gain (loss) from sale of equity interest in subsidiary have been included.",
        "label": "Sale of Subsidiary Gain (Loss) [Member]",
        "terseLabel": "Sale of Subsidiary Gain (Loss)"
       }
      }
     },
     "localname": "SaleOfSubsidiaryGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesMember": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.",
        "label": "Sales [Member]",
        "terseLabel": "Sales [Member]",
        "verboseLabel": "Sales to customers"
       }
      }
     },
     "localname": "SalesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "verboseLabel": "Components of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Summary of Activity Related to Equity Investments"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r316",
      "r317"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of cash and cash equivalent balances. This table excludes restricted cash balances.",
        "label": "Schedule of Cash and Cash Equivalents [Table]",
        "terseLabel": "Schedule of Cash and Cash Equivalents [Table]"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash, cash equivalents, and investments.",
        "label": "Cash, Cash Equivalents and Investments [Table Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r289",
      "r290",
      "r291",
      "r292",
      "r300"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r344",
      "r354",
      "r362"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "verboseLabel": "Summary of Derivative Activity"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "verboseLabel": "Financial Assets and Liabilities at Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of derivative liabilities at fair value.",
        "label": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivatives Recorded in Consolidated Balance Sheet"
       }
      }
     },
     "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Reconciliation of Basic Net Earnings per Share to Diluted Net Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r210",
      "r215"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r206",
      "r207"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r206",
      "r207"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r16",
      "r38",
      "r39",
      "r40"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "verboseLabel": "Summary of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "verboseLabel": "Components of Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r353",
      "r355"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Schedule of Effect of Derivatives not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r236",
      "r237",
      "r241"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r233",
      "r243"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Reserve"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r99",
      "r169"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r93",
      "r95",
      "r169"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r157",
      "r163",
      "r164",
      "r165",
      "r206"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r157",
      "r163",
      "r164",
      "r165",
      "r206"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "verboseLabel": "Operating Profit by Segment of Business"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of securities that an institution sells and agrees to repurchase at a specified date for a specified price, net of any reductions or offsets.",
        "label": "Securities Loaned or Sold under Agreements to Repurchase [Member]",
        "terseLabel": "U.S. reverse repurchase agreements"
       }
      }
     },
     "localname": "SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]",
        "verboseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segments of Business and Geographic Areas"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting Information, Revenue for Reportable Segment [Abstract]",
        "verboseLabel": "Sales by segment of business"
       }
      }
     },
     "localname": "SegmentReportingInformationRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentsGeographicalAreasAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segments, Geographical Areas [Abstract]",
        "verboseLabel": "Sales by geographic area"
       }
      }
     },
     "localname": "SegmentsGeographicalAreasAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r102",
      "r198"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, marketing and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "settled litigation"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Stock based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r21",
      "r404",
      "r425"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "terseLabel": "Current Debt",
        "verboseLabel": "Loans and notes payable"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SovereignDebtSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt security issued by foreign government (not within the country of domicile of the entity).",
        "label": "Sovereign Debt Securities [Member]",
        "terseLabel": "Non-U.S. sovereign securities(1)"
       }
      }
     },
     "localname": "SovereignDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r6",
      "r163",
      "r206",
      "r230",
      "r235",
      "r246",
      "r434"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Statement, Business Segments"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r266"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r60",
      "r266"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued": {
     "auth_ref": [
      "r28",
      "r29",
      "r266",
      "r267",
      "r268"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.",
        "label": "Stock Issued During Period, Value, Treasury Stock Reissued",
        "terseLabel": "Employee compensation and stock option plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueTreasuryStockReissued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' equity:",
        "verboseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r328",
      "r329",
      "r334"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails",
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r59",
      "r268"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock Amount"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r59",
      "r268"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "verboseLabel": "Treasury stock, shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r59",
      "r268",
      "r269"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "verboseLabel": "Less: common stock held in treasury, at cost (487,676,000 and 487,336,000 shares)"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r266",
      "r267",
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r279",
      "r408",
      "r437"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "US Treasury and Government [Member]"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnSecurities": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) recognized in the income statement on unsold other securities.",
        "label": "Unrealized Gain (Loss) on Securities",
        "terseLabel": "Unrealized Gain (Loss) on Securities"
       }
      }
     },
     "localname": "UnrealizedGainLossOnSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r304",
      "r309"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r139",
      "r145"
     ],
     "calculation": {
      "http://www.jnj.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (shares)",
        "totalLabel": "Average shares outstanding \u2014 diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "verboseLabel": "AVG. SHARES OUTSTANDING"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r138",
      "r145"
     ],
     "calculation": {
      "http://www.jnj.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (shares)",
        "verboseLabel": "Average shares outstanding \u2014 basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4273-108586"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1500-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1930-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8475-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5074-111524"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26610-111562"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27232-111563"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27232-111563"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27232-111563"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27232-111563"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27340-111563"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=SL6284393-111563"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27357-111563"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=116654751&loc=SL75117539-209714"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=117311354&loc=d3e32014-111567"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955202&loc=SL82895884-210446"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118942338&loc=SL82898722-210454"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=77912953&loc=d3e400-110220"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2473-110228"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(c))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14394-108349"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14453-108349"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14472-108349"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12021-110248"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12053-110248"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=SL37586934-109318"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31931-109318"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109998890-113959"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109998896-113959"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624186-113959"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624258-113959"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109974929&loc=SL110061172-113977"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109974929&loc=SL110061190-113977"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=112277219&loc=d3e80748-113994"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=112277219&loc=d3e80748-113994"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=112277219&loc=d3e80845-113994"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13433-108611"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13467-108611"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13476-108611"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118948100&loc=d3e30304-110892"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=SL51823488-111719"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=82851474&loc=d3e511914-122862"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii))",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=82851474&loc=d3e511914-122862"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "820",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=35710923&loc=d3e45360-110995"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6)(a)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Subparagraph": "b.",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6477933&loc=d3e60009-112784"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117420044&loc=d3e19393-158473"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(2)(i))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611133-123010"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12C(1)(a))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611225-123010"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611282-123010"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611379-123010"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611379-123010"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r446": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r447": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r448": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r449": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r451": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226003-175313"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(dd)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e640-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e689-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724391-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-03(e))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868656-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>89
<FILENAME>0000200406-20-000056-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000200406-20-000056-xbrl.zip
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M0OL,X4U0O 9,XH*1$P7V.RHW1V6,?#F8<E5X7J&009*@Q))3G&Q[5RIA\MZ
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M?=O]?'<WQY4 :;N]56:Z,M.5KGS2E4]TNY99;;O=MFY6<QJE35]*5MMV4AV
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MT(C#^L?SL_EG-LZK!XO[?P-02P,$%     @ NX!74=C)M5>1A 0 -/!* !
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MY%G[7N,V!!BGH;T$QTVU%J6&BM3>?G^Y_AN#]HOQ^L>V@ON'P/WQ]D<+L!<
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M8I3J O+4<R]S]HFV=:QB"8+Z$@6N/I\?G2^%Z#?R^:/QXQOGGR*CME-I1CU
M\8"-*+FQ=&]80GE2[4=VCWL7/]!6A.'/JFI85HW\ 126A])+@/T%E10 ,P-C
MKXQ0<Q2.'7.HTB7U5)ZH)!PJ:7NO&UZHD>N^;MKS\.S0B@/$/E0$ICI4PW"
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MY )TKL0,QHH.-+YWYNN[ M.7HBO!1U/FU@OVZA%4([564NP1DX9:8]H9?+;
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M1*VFVT^:W\7CGWXB]\Y/'NSK<I2GOG-9))@VWUPB=09=!'H'M]J@I3185%K
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MWO1R[9T%D4BC\M;Q!T*$[(D426)&D]"KI;3]B$PIZ*?DBG+J!LJND(8^R\2
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M)"B-Z@2#L+/E^4F3BD5E&IG%E/O0\D,;=%VT/)006>L$BSU^9P*EOC*! I-
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M4W9364Z"N4&0K(G^=61QY")+<YN1WL&AL32+(\5;K%5+GF Z9[9$/VM:(6:
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MK<0^ANU8T&VT)YS.'AN\DPUNFLK1PJF'-$!$!E0 GJ!BC2%:FR<)'!M\@$C
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M!>^? N:HV7H764:(G0UTL_^()(-9R2<%'!>\?QQ0RX*!P-H=8R<#)(!HPPW
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MRJ:#5N)* [DWNUI/I47U$>Y%#Z#98X%WL< ]W&PSE<=<+<$1H%DH3)O 5[-
MF?4 ;CX6>",+W%%\XL@3*:9#X+3.UKS*)QMCYV@/(/1C@;>QP"U9 &2TQ#56
MGX1[+Q!R)IA#%V):/J'GR;OI\[SSO:N/=V0S:FLTM+T=,*O$CLB]<UY32)[0
M]O!XX>V\<%,7Q#FG<UIOO2%=W0]SU:P0%:@H?4 Z.%YX1R_<\6+4N;$X;"P"
M]("-1?N+GKT8:^8YR#]>^#!YP0NJ-]&UAB%+:!\HI+81*5G]";U0WLT++ZK/
M>QA^P"1)W6OQ%*S:DH3@0DWT;$.?T+WPZ/.-N;I#%VHADX9C46JL3JN7SR$-
M_0G=Q8\^WYAU<Z;B-!4JP#6!+73:J+5T-8Y3A'WT>2M_#F$;)%["@!- P3/(
M:TJI^WK*7)X[KVQ^^]<__NL/?](?_^T?_VW_P?_EY_^?-Q7I/1"J&R^#MN[=
M=TA:W8S(DIH,WVNHG68F1Z3WDRC#&BZ=:!%@!V+WL-5]7(-+N8T'D.@1Z;OC
M*'::MA%T;_B)PY8E9*CM]$3=4)_2K.^(])V9= /I&*VQ<$Y< 5<3CS&B#>8J
M:O,!3/KY%71.\._JM-<0MW0"6RZD"AZPDL ZSHZKU0/@]*CUPU J@J\6@Q?L
MO+\)E8$3C9 6U,+^A#DL1ZT?!E<+H15:^41%AR%5J.3#4$K1GM#-[JCUPW!K
M7UYK8ZDN3:2V9.%D6[CZ7)QPN/5!"KKI&5U@>3D5)2"I7\W+EQKX_HI6;X<E
MGZ.@F^[#I7M"HLC5^WAT78MV,FGL$1WX\76F'TQ!-S#7H&R0O>=JBJ.#+)X<
MN,)-($T.<SU(0??<*5-E&UL9T7SG3= 97<5^'KI!=.Z4WTRD_Z$_S5\H[OCM
M=[_[S5??OR//.3?LPY3:-03=!I?9,C:_4L%6ZP-X[CCAS9QP#Y=60W)BJMD"
M9TN.%$#)#19:2>=V_#CA#B?<T21!=*P>!<+7Q1%SX>J& T=XUTX/X.OCA'=S
MPBTY01#75-J9<G7L(5)%(Q?HZ&+U\^G^B^>$<[K_KI:X:0#U$LZ$")*."6K)
MI8N-A;4K\ ,"P['$NUKBKN3 VP9=H.T,826\S3&$AUC*L/6$R=?'$F]LB1LB
M!'1*V#E"00I%Q+3,=H#H+-Z#3EG$L<1'RQ(^UW6,U(6]T/I0M-G(H%^-IGI_
MPIW#B;SOS_=[B?;1F_?>%'M+"R8EY!$"V<0/WQ^9O@!S@^4U @3ZBKEEVO0:
MGKTE.SJ$83M5)$>FK\#!(]?PCIVU%.<"IBU3[[+F,*.&AX./3%^ 36FDR31K
M;('=C4,D ARU&=//?5!?G$U_^;/[W6^___:+WW_U=TYHYUKI^?BKBA'38^U8
M%ML5U@B#W1N1=WC*F)#CA#=RPCV$K9WDFL6+@1,Q0P&!?8[TV03A"5/VCA/>
MSPDW0'Q73BT$@>$H,VU.D@IJ0FXZG@#QQPGOYH1;<L+5&A[60@[N:)N5^C5-
MA)2F$@?HR0GG[NB#!8:+CBRM;SX2]*E6?2%X\NA1C>P$AF.)#Y8<LD^G1755
MAZ'0LJ9MF5HX;83B.,GA6.*#18A =%Y:L<;$JRM]3VFP[1!E>]?P$R&.)3Y:
MEDC(ML+F4,#98X,3S!@[.R11MR?4P[RI)5Y4IC<U//&@"2IM+D+Q;ICN8Z!"
MO]J0C\/W1Z8OP-P,DV+ B(4=9RB[-&9,@RE*<4[KCTQ?@8/9@<>&7JS-P9U<
M"ZK*V(T!M-;AX"/3%V!3GXVFKL)Q/5H8@_<W%A0M1=[02H]GTY_&U9S[GN?X
MX*;'GCV8=?3&M#":&2]AED*TCM">#[_'!P_SP3UTO:D:2R&ICT+)KE.S3:-R
M3*SNCZ?KXX/G^>".N=@9@PBX3W?44:K41M*PFIN+] ESL8\/WLL']\Q_43"<
MHU=!QU9JGCQS&\) !JY^\L&YS/E006&--$0R;'$5Q)3)XC9'111M+NHG*!Q#
M?*C$T/H0I.*F@CB:,,GJ?9;0E#GD^>?QQQ /-L0M1?0-!SITFX J9BN5YXJ8
MLL3I^2?_QQ"/-<0M&8);7OU4:X<&08%IVAUG-U#CH9DG0YR@>SO7QV )'>3#
M#0F01P[O;*LVQ?"2P_5'I/>S=@MMQ5>%+2,%*:\Y*ZJS<M?Q_'KS(]+G\^\U
MUUS&F,  N(Q94L9*AU$[&U8=_CTBO9U)<:27[EV^EJ-%E[W+YZAP'2/BYY<[
M#V#2SW7Y\KG[$_VB.[[4'^,//_PO_;/_]8^ZC?@7M1_^^(<__^M_Q)>/9%.5
M6JL&59$BVN1APV=2;RVK_O;,[.79](CU\XKU'D:=I&+%@_.Z( '>?\PMP"5-
M5_)Z"J,>L7YVL=[ JA*$N%4Y^T!L-;9*O:TMW6N='6 /8=4CUL\LUGMF]$Q8
ML\I58F"0,%,/*27O6Y?PA!D][W &_UC5W@.OO/8"2II*$[#74.+1KF;PQ#3\
MYV[PSX;7H]IWI%B/#;#7]/:MVBU8*:$1[E8=8=;S*?:H]@UQ=BV3MK:,5D.9
MG=M6,5%5-1X]Y_-Q]JCV_;AV#,_B,)ZU<(IRS9%%#9=/VWC[ *X]2GH)UH3N
M,$.H69.=Y[MZWS^W-C$W>;H^@#6/DEZ"_XI]$L;@I@,Y%QNZKYUCN/74E0_@
MOZ.DEV"R&*1!7M[!<&<'#IQJN&Q1)%A[ ),=);T$)[% 11_#)BNZAC6R*!G3
M?&G]W)W[Q3GIEPLK_DE_S#_^Y8?_K&K.B?A'X;T070BB$X.Q>[<==V?5=@!/
M)7K^#)/CB,<ZXJ;^#=#GHF)@[MBIF^:&5J2A+-GT*>>6QQ'OZ8A;SD2C][E3
M&ZCCSG2F>Y-HFABY-D\]84#W<<2[.N*>&8AK)U&704Z%:T[1'CTM4EOC(75R
MQ+F*N-T:-QT@NUX].UNOD6AM:!MF4S [+F[_?H%V L6QQL=+%@VN@5CD.;LC
M-V!8DT;5=D8CR^?W>3C6> MKW-'K64>UFEUJ-)S<]9J=F%<C1<Z=Q_-$C&.-
M^ZUQSSN[&*PF6C,,(9UAKA64S58+Y'&RQI'K"_%_4#2JGWH^3#05C97>*I:6
M<?6GO+0[<OT83.ZT1=F$]NI*>(V66)(V;;;!@&E/J%(Y<OTXG+SF&C[1RYM>
M!X]<AHTS,*5B?^-P\I'K"[%K-\/IZ9VC4,TD%]'5YU+F]%5/J;?Y.U_J_+(C
MOOKZ]]_\]R^^_N+G7W_SZ?OCC;< Y>4<U'L7<L0L5MW)SK87?BJ\AJ<, S_>
M>&MOW'127FC0LU?T"W/ 1JNK](#+4[SWAU#Y\<:[>^.&"$ Z%%N)C\;8K&_M
MYU61$UZ,4Y\R'OQXX[V]<<\[R"6X1L_KO2YZ=J.1OL: XMJH]92\\1F%>RZ4
M/ESP\ %!X7KM%]A:2*=)-E;)==-*\)#@<4SR,4QR3P(1I;GZ4)[#<!M&)H9C
MY)!5>UNQAR208Y(/8Y(;HDBKDEP&B&MM>_CUXKM:+.^)?<43'N8>DWP@D]R2
M2:Z-I*)Y&202=EE$*V?KBKW3F">3'.&^9$X8W8/3=GIN6ZHZA*BA]@%LS!/]
MY(0CW)=D=ZI8JZW2+H'[;VS.E$6;5'2ET3CL?H3[DCP]4/4JDURN'6.'3NK+
MJ>^?00/Q\/01[JLR;F4S68BT@R 3KS4(/);T2+?U$,9]U\?;OVS*WW[[S9??
M?O7]I]]^^^F?WM46-TV=X1DMHJQ-1!@J++. ?=BF$_9Z"$$?6[RK+6ZJN=^[
MQ$"\YML-!%Z<8W82K]73(YY2<W]L\<:VN(/^Q_ 6N;EI**Z]5W"/@>+JLX/3
M4][ 'EN\K2UNR19!@+.!*1?@%8U]=+8L](D5\@;9XCUN?8X_;GI'()X9.V#$
M5: @QIRMJVQOE.34_OR0<?SQ'OZX)VT,@;KDVF826A^:G+[= 7M;,35^?MHX
M_G@;?]S17;^E79T]S8 1J*S1WBUB!+DS^E.Z>QY_O+\_;LD?$%C@(MIW_A!'
M"8181;BTILXS6^EH]N4R@?-JP[A)L. @YR%DD=2$=U!H\H!,<#3[P3A="H0@
M5RUDS+&L!ZATGU==,?]M$L5+<_K1[ =C9_"I@R>Q:D,/TMYEM@C1U-5)'L#.
M1[,?C&<W##1V:TT7(I,K A )2V\3YL]L\.(\^\O2^8]\<O_92/GHFZQ7]<,]
MK$Q@3+87ZV+#V5PG.Z6T@K;!^3%%.L</;^>'>SA\,L.V T"O0EHD5#S"<NST
M6%)/X/#CAW?UPPV,WX%6H@M.$4Q?G-.ZKE9[A\BYGG(^?OSP?GZX)3^D5?6T
ML6/#0D^0/ALWW8E7JZ0_?_;5Y_##>UQ)O:HQ[@D2TK&[#F]ZC?=!Y266T6F9
MTH[9>8+$,<;=.\8MB:(GS>5-=*R)N.TPP%HASJYMN#RE N<8XZV-<4?I#6V(
M$KW*"=IV0YE0@LO:25MKS!,MCC%N-\8]<P,X-'KF+!G88NJ8/GS0SN'IJ'8R
MQA'KRW!_9&KSQ$ND*-H49R8P6'5#RZ<T\C]B_0@L'G/BI)&"QOO_7 W2KF6>
M8[5)[;#X$>O+\#&*1S,,Z4)H%,I6V#P612?V?OCXB/5EF'4. V^J@=>LJVK6
M!LN*,;#3*F@/8=:'7N(\DAS!--PKE^_\;]TEJ*"TE8/@DO$0<OR8DKGI-6-,
MYY9;,]8OB4A/4=1&S$NGRD/X[<-*YHY3QBK:B\P8AHY[5]JB01[#90-523V%
MHCZH9&YA&<L.5U>!@6FHFV/"U*\!;-1-;;X!RSSBU/B14*-Y'=5*I:V!,%C!
MDHC 1&!5/.4:_(-KYZ;.S:-T(?1L<R*#"S2=B4C:BQ?-Y]/-!]'.#9A38ELF
M3CQZX<1N%+.L-BLW[3F?,AK]HVOG%MZAL,&U8Q2DX[*0L3 9>E1T:/R$N8$O
M^GG>PR"--WSPG*Z6:!:6UG1)[<^W@G ^@$%>]/.\APN2QLJ:)*""C4.B,V%?
MN:RXZ1-:8[[JYWE/3\>^UDK5G.!XC>@8L]ILU=B71GO4>ON_N_SX:O^[_OB_
MKK_Y#W_2/W[WPQ__>GWUG]ZS7^L8Y#<9US_[5WG=:?W__;L]<AOQJK5V!'&-
MCDG-%#4!W,"Z3WU"9<>1Z>>4Z3V[(X?;B!+MP3@6&6C _*F7RHS9GO!B\\CT
M,\OTCGN(7*-E[']Z% XSH7+)L58H2)<G5#L?F7Y6F=Y3>[P3AL*@Y M-:>K5
M_<^S$F>?'>*PZ9/.KMX?4OO^H=BKBTV,ZMI8)\@44U;N>B#UZ/65:+58K'$L
M(F2<-23LPE9GU@4C\=#JT>LK82NIL<V)V4 0*53(6J:UR47T\]W P=:CUU?A
MU[% M8?R[(371%E*)P]-Q*WB\83^''?H]44U=--,F:S6RR%Z=,2:TI,H#<$*
MKKG:ARF?I*%[.&\IS?TW;%UY[&V3C;OM7.*7GK*-?CCO81JZ@[WVEF4X*#=P
M(:<)TE"<8P=;6+#BL->C-'0/#XUN$%GF:"AS<G.KV:C;@!HK'\!#G_,(^'\G
MTV]^_,N__/ _]9+*NVKSIM[#K?G@4;1$L=H0&Z$1O07TI6L]@+..-M^4WT3[
M<N^"7ATE.W-Z$PZ4G2GQ;VTM7IK?CC;?E M73[%K#E="PQQLR-,U"=8RK9_/
M.%Z<"X\VWY0W)<VK>LA51!ZK&\V0[M%&088]_O[XOU(XYY#X)O"<-7F!]]J!
M"*_6S;'2Q][G0P7"XP'@>43Z[@0ZUZ16P!-ZXFAB-M5WCN_!JT-;#R#0(])W
M1U&\GC8;%+6YH])J4GW&G#:-L7F.!Z#H$>G;,^FRT0$!+&O_S(*UD 8)+.<U
MQV'2EQ?.33,-<.^V+M/6L.L5OAC8G$F\*K3I$PXH/[IP;KK]A:;1^;KV3<Q$
M0QYF@77-ULNIA]V>()P[KGPEV]9%QB9^)!2]EAMUTE;9TI_0QN'#"^>>GE7>
MRGT6*/Q4Z29[>]*).&;37)T?P#CO=";\RXUO__&KWW[WINJ_!]1XZ=YMH_>5
M@'GQ/O+46:LON:Y$'@!J1_UOH/Z;[JJ-UG(<:0NPF?)&3=5)AMH$8SR -H_Z
MWT/]-R S "MSP@ =./9R3[-QC&+)4NNGP>M1_QMSOW.V6J;1(]$W[$,HK-7
MXRH:G@_@_C>2YCGBO^M&'VD;@=RJ-Q0P0:>2&1F ,L>C6MX=&[R!#6YZ71ZL
MREV0"]!8=/:].\04PDI:3ZA:/39X,QO<$ GV;K"U/381\4#S_:790.K.VF*Q
M/B 2'!N\E0UNR08JR8@>1-2P [)8^2!=UUL&[^MD@Q-;[VK;Q*WKTKYE<EUU
M@FGV&87E,U<2'%X_TKR)H77,QC-5EQ.R3JL(W]^ T"W1]809L4>:[\FU!3-H
MR[--=UP .@801-%:0LF/[R%ZI/E8UIRE1;:*5 +!)YM<Z@3:>_@P><(Y],>Y
MA?GO7W_Z]*[RO^G\69)8IC!G8>C.7:WW95P[>/D8_@">/?)_!_G?P\Q;XL*]
M%V]DQAFHQ0CI&TI06@M_ #,?^;^)_&_@<LY.%F'A.I%'2ADQ:TE L,<3FJ0>
M^;^%_&]A?QYQM15C6T (,,1Y+/.U/\W5B/P![/^6CT _K@]NFOU<U,!;[#6_
M8[!*X\&+QBP"5CN'VL<''R(-M%5333MU=01>'#U:R0COW!2?4(]^?/!N/KBC
M3QMD)&?4H.L!,,O5T"5I N>@1>T!L>#XX+U\<$\="J:!9Y?M!6Q&!LC5Q)A<
MA?P)/8A/=GU39O<U//9Z/&HD-E3=P,ZZM%G %JP<9C_:O*^:NQ4JH2M<ETHN
M93@X-D*X;)9X_ R)H\WGLBU,PK'#G$4N3,6=\28G09L!OF'WL.W1YFWGT>G#
MQK6K3\>0:=4=RRQ]_Z?%$WH0?YSKF.^__>)WO_GB3?5_#],&)% ';3$;2LUK
M9E#WS/*4:N,),W&/_M]"__=P,[>]XL_5&?K ,4AXC;6#WKJF^<6"!W#ST?^[
MZ/^.<V=N8[)SZMKAT42#:XHRUDB0]80R\:/_]]#_/;7H;=66]>*)C%QJ;=",
M3!DRY^(G\/];B?,\ +[K<'N*;_8W'@(XMB=ZLX3K$1MTZ.MT13E&^!B)0"!;
M*_0=B.?. %U7>7?H-K-V(CX5*<<('R,:A"@-Q\C& SF:IF5#)2B8!NOT%S]&
M^!@90:^7&K0 !CC:WA&LZ;@N_WMO"9U.1C@!]KYVYBW)8<MPL>*0M&Y\O:8;
M8#IDU>'V(\[;6+I/T=&X>VV4[KQDL$OCY%+R17A8^HCS-K[ML!4X/)9>\W-2
M>'!2$BU>D8Y/&(U]Q/FNS"E%5_USUYP+VW 6QX8]QQS7Y)XGG$M_AGN97Y;E
M=[_]ZNM/WWS_CY^^_2^3Y@>=4W4/V@))=&Q;[\,P^Y(*FU14+6JJ/N&-Y/'
MVWC@'H(.AJCK0<R@PA#0VMENQ1A+P-GJ 01]//!.'KBC98K1&#G&#$[T7C:N
M+A)7H^Z%L7P] -2/!][' [?D@4:<#&6@/;''XMXF0)82S:&/F-WS=@(]%S)W
MU:H,ZYS=8_L!K^$E66VVYFIB@[(_)!@<,[R7&>Y)"!/%?'!!02+WJ6%^=9>3
M5K 30SXD(1PSO)T9;H@*N!J [RU@V<:D*ED904D+<G"X/"0J'#.\F1GNJ5LI
M936TP#&P4^,,S[)%.L=$K9,93JB]E>,19^XLJ[3A!44Z,Y"S&_'U6UB'XX]
M[V5K7[V3"HD85C;K*Q<T:V[0:SQAOL\1Z#OS;HZ"X0H\>&"4*QJ-D#Z\&<I\
MPO3*(]!W9M"UP)L6[CA&6 N8G*XR0.S6>HD\@$%_43C?_?7'_Y$__MO?.2/]
ME[YA?BU9WD.>13Q\_P "Q\QI'(.(V1(&#G_""?*1Y?OQIL$8&RY5(0#=4T;C
M+<>4.2!-^ &\>63Y?I39DIOX NQC[^0KM5KU(KQ:A@3KXQOX'5D^DBV;C^G4
M8TC@]4"5HR2R0"-05-IARW/^?B=D]@&=)\[6J&/ X&4:Q87%T[O1@<RCSSMI
ML[$,40<)3:Q*ZVV(#5S[>\SXA,J!H\\WQL[5]Z)I5!"XT5,'3Z'TP=P[P?RY
M-^_!SJ//V_@SI[KQFCD)LU+254JNT24\0OGPYRMKYJ8K;]@+U=!L%(XKV?KU
MNK.&\"(?_0E7WA]8,S=U)",%$]:]S!@Z+ Y.4YN^VD*(QW=1>'O-W,!.8];J
MG& #"G7,JT1XSK@VH[;:/.STVIJYA6?(^M0-,JZ0. TD<Z2 1F.<!$^H%WP!
MWG[E8][_T+_;_[D8XXM?_?Z+K[_\]*MW!+,U5XSRCKD4!TP+0"-JV?J8L.R
MV1'_9Q#_35,P8'+M0-*I"4X9BMI!K,2P*>@3N@P<\;^%^&] Y0E!7I.05N#4
MJ3$I"+TUGL9(!Y6/^#^'^&]A_A'4L53"67!P[K5_B),LZ-:C]</\;W/&_@@7
MW'13S[/CG(D+^9J"9R$%/0WF_BN+XL#_<<'[IX"U-+E<VA3ZZ3G>AJ&0K()2
MXEHG!1P7O'\<P*R.4*TV&"&JVD[&,#(*=9;#.3D_+O@ N<!ZM]6[\-RY(*C9
M:#AIKFG[=WL[.+G@*/.F@1>1)![(MG@SNRJL,,O91Q\%F8?5CS+OFG8QNLW5
MAMG$1)<QG,$W3?2-"_#XR7%'F4]EVB&ZN$AHYEXXU\;7P)HU:E&,[N>(^RCS
M)LXLKJN+\VS7>(O6]YKIB$1;-]EDV7G#]2+]H__AT]>?OOWBUZ_JL$>2[-KL
M2GVIK]509U?4K7Z(_=UR-SPD>[3_KC7-<^56>KLZ<VXB<6:NI=T7IJ"T/&?-
M1_MO6YN=.CAG)W(0)$R;$Z]K^!X>K18?&C_:?]<:\]E0O"WN P:*\-7 ?\U@
MMS$]PP_O?_;;E8]L@GO /T</RA'>=_;-D8;#ET&3IDHTSA'V,<$'2  B6XYC
MA15LY!^RO\%S.<KU&';220#'!&\?!1AM#=QRKY_:HQJ;[V4_<[2QOY9^HL Q
MP=MG JW2KKT/I$!F%KB:#(JDL#,M/)G@PPOS'DXW:@B=1W58.$IXL 0#-RXG
M&*<L_ CS'G:FJ;2L6$UC9\<IJZ4C!TDUK'%.SX\P[^'9&NQ05Y^:ZRTEE(S0
MNL9U+M!6D8=GCS!O84RXBDERSI7=D'58+328U/?"*?N[#V#,=WZ ^XNF^_T?
MKO_2.P(F['W[NOF& ,:AG:\!]W, CR6B\(2#X*/*MZ/+)')NLUTOGY @.><B
MSLIDITAY %T>5;X=6N+^85U7SH9(!:HQB)%02%#+'H"61Y5OQY4+9EF_1DF9
M(+LIV35A=QI!]?+Y?*Y\CY><M\OS'L!4XZ#)V<,86R]3GQLL$3I 5X?G ^:1
MYX-)<]3R9A+<?&#TI=EI].639U6?_GS2//)\,')"4J\($8^&82!$V'VTYD%J
M<SX?.8\\'\R>LD;NK;NY8>"B;I.NZ:6QQ #&L_HU?SC)W'2C[>AKU&SBC&[)
MM3?:E>#+M:<]JLOQAY/,35W!2%73I8LIAB]+8"FN-<?^B1]UU_P1)7,#-PGS
MBC8@2R>.H2+CVIF@[15F+7P"-WU@R=PS2ZN/@98C%1-W&C3":'NSRB7-M)[0
M;^KV]VI??O/U]U]\^?VO/WW]W:?OOOG^'S]]>XC^67BV5NQ5$BFC3UQ[W73A
M/BD<@,8@?P">'1>\D0MNZJ/50*I-L34[6H )@4WW M+H<.Z?CPL^ $0/7<AM
MI_*&'2&G1;/>I[&192@^ **/"][)!;?D@@P<-+'U'!-UF=E(5I_=5S:K)_0'
M^]P2/4?^[QL0P"!'\Q8[%V/@1J3J $(K<YN!GS ^^-CA'>UP4U(@U0DK659#
MAFXP2K!*VI*I_H0> L<.;VJ'.R;9*0_B.2Q",!.L3:-9U2!%YH"'1(9CA[>S
MPSU]!7PYKAD(OJ.TJ5G2H+"IO=$&J),=CD1OYOE:W7-.+PY'(>")4T<!0NI8
M5H?GCT3O[C706&<-#_&.L4R:NTS2G38UIL!A["/1N^M-9++NY3-A#N0PZYC3
M)]!>7*%,#O<>B=[=?V#OZTL@<O,GTDJ!1=-ABW4L+;>'L.B[OE[\9?M]][MO
M_^&K+_\+.W)\+,@%M8H&$:&$L=?C!0Q@T-FSPM[@$=K1_NMK_R9Z'H.!%M/(
MCK*2VR84J.K%O:''0^CY:/_IVK\!RXW,(VSRF@LS4=JT"<U-)['0$\K C_:?
MK_U;>+]OX+&]QE=@1_(AJ^>RM:Q6%(\GS+GX$%<C'\0$]X"_Q!A1Q Y!J%>?
M'EM4(HZC&_H3!MP=$[R/">Y) )+,*FL1PD(HLE0/E;TU;"B:\PE3H8\)WLH$
M=XR\:V6V+#.:81LBJ[G/L43G4((W:-YV3/ D$]R2"6QJ0^.UO/6K!S%?765:
M5E!C:G+Z=1QAWL/I.&681D)LH=@2$71JD^?$Y<GR $X_PGQ'=F;[:>#*\JL!
MUY:=VD0+8IA[_6SM">Q\A/F./(MS>%L#L ,A,]FZ*J,JN"9,G4^HM#["?$?&
M3(6N4BRTUTB X*NXI&0- ]'BTT?E[ZK]1](?N'E4X$@NY$DB"6U>=1H\>J,G
M](3[N)*YZ4SS:DM0 5@ V+94RA>!NGI#;?Z$GG ?6C(W$%.'I@/#-KLG1J.M
MH*N9Q5RKMUX_-_AZ<6+ZP)*YA64V51/VT=%GH48W\9J,(M:O%A!O4#/[B$/C
M1T(-E\6XYLDO:Y@395'O-L'[;!'^E(=5'UP[]]#-!)UH-BLVX<A0:RVF]61<
MFVBPGD\W'T0[=UQT,L9,E< B;)WX>H8?&W)T&BT[%YW/T,X];X2RF@5)Q,4]
MO%17T2CF).6^Q@-XYT4_SYNNU1 )*-=BO)YUD\J.RW$-K)NEW9[0K.E%/\^;
MIA4-3TPA:P6X9M<8L(ABSIKE,AZPMK_JYWG+>HO>.?NBH$K<,4&7.L*8\[K8
M8>8'K+?_^2.)1ZZLU+AUW&9<B5A:#(A&TT)Y\AC] 2OK[9_<3;.%462T84PF
MZ)-M6JDWQJZR/["/T=OYD<E&R;?+!O=K+L-UH8A!?8DD$>0<3]C][O_D;MGG
M.#E][M4103!["!7X[*N%R-R ^OQ][O\FDSYRP^M]\4^/AD,%VR ITRBXRJH[
M]G^_/7GTAO<9/\)[=C[@W#_6)#/#BR\UO.6L#9LK1K;G[WR?]R.\H[\F,'2=
M>O6N0&X[,R@TN9K/0OA ?OX6^#D_PGMJ\$5W5(^6"(;$J0U<N-G^V-IRA8?L
MA5_^\*<___#'/X3^97_KJ_UI_OG_^_E]L_](]E_[T__X6Z[_C >UU_^VO_YK
M_OB.^[ ,+M+0[+8C2PQ5(L:9JZY;QL?T:SSR^7_9^]*NN)%D[;^BP\P[M_L<
M1.>N3'O&Y] &N^EK"ANP??$7G]P$PE4E1E4%QK_^C914"YO-CJK0+*8652J5
M&?'$$Y&1D4_# 5*/M9!,6BH0HRHQ+L44.^\<4QS$:DXX0"L^3Y1#I3U12',!
M'@ 3J32,.X0-N'!:.: A<\(_6O%Y&N[#B3/6&<ZX2%C*J:0">P5PHQ'6B,_+
M63I-%I_W![KH:>M'P\"I%Y$!(8FD3)Q *5(,L$A1(5,B+&/<"DKGY8C*5HB>
MD@=I$"!+L&%$"X845D"=+5;,&,&4(?-2%:\5HB>-QAAG07:X(UXSQ[RQJ3(.
M4 E[H:AV+1N:+R%ZFG/'%79**^E(RIAT3@,I8M@22ZVG$NF6$\U5(LD3G>)!
M"2"1MLAPP1*-=8@O.IM8CZEBR;P4.&Z%Z"DY$<-$..F%44(PGSK-C7=6J30-
M\B3FY2R[5HB>-$+DN<!2,I]P !YN%!8\Q0Q3CXW7?EY*[K9"])2<*&$.$^S
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MF3[Z,KCJH:7*V9FJ R!M$/S0B5H;_'>@*(.J:Z7JZ*,LD*9 -X+^18-RNW-
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MR-;+&2<"?M#+QZOKLW@_;:G*$RJ1LWJ@K&=&0/,FA"@XFF4":UXL7]I&91R
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MRY0_QIIT&WU\:A[9UGI^ID#^> O4DSJL+8#?#L#/E'I&6"B7"AXG%O.8.6$
MNU,12Y,*S##Q*L4APUR(MM1SBS +3A5;A+DOA)FAB"E3'"8-Q9A*&3,9%J@3
M:V)JM/9)8J7CR=(KLDSF"F&:%6J<JQ)_]F*-BC:BN.#@_0CTL'7L[XC:9\H^
M)\S8A'$<R[3<U>QU;&22QM09@5), =,]./9R6;+V8+@66Q:<&+;8<F=LF6&$
M2"2<:YS$2BD:,Y^H6#*!XD0C2W2BC402L(4O*]%&#1<Y:O@N#^/ABQ[HI1G6
MP4+6!@L7';$?@PV":(4Z%&L@6&VI_ENB]IF*R(P#'S36Q5(*!XR0X%AC)&+-
MDH0I9+AG"E";+ N)YLB1;_%E\?#E,1AABR_W@2^S<4+!4L\,B[7T 5^PBQ5%
M24QP2(;&3$L%K)"(9:;:_<T/41ZYV46/KSQ.>#SI/^W\>,@>K;L7%KY_58&Y
MC4',L\5YBJ..9X(2[6&D-S4]^[/4-DU-RHT4L74LB9EQ*#8TH;%-D3-6)2E-
M='D*U5SMH6QQ9O%PYBG..VYQYDXX,T-Q!:$) B\Z]B:< 2*UCHW7.,;:)99H
M)PE7 6<4GZ=2L6W<\Z8*O_Z3S35U%%2T4=!%Q_(F[+)9[;LV>G%+:/]VAD)*
MB8C'));& H4D3,4*61&G.#544F^59^6.2BSG*7K1XL[BX4X3]MRTN',7W)FA
ME([:1".!8LF=!=?5@NO*E(E=(B1V%GN*TA)WA&AW<B_R3N[I6GH5(*TKA=]M
M!TX;&I@?6'^2'3@MB-\.Q'^<.4*&.<HI\RH&\\M#9=\D5HRBF&G&7<)2I;!?
M>B66$];&'UN067#NV(+,/8+,#%-4*556$1Y[&TXT3Q6)%4]-3(B1Q*3$2X[#
MZ03L4<J'M\''I]+VK>&!+^Z\^:9U^.<'M!^!&99"-;M0U$+V[2#[S($RA*4T
M!288N]23F"FB8T,5(#AC2A.MO2"\+ >)V6.4#V^#BBW&/"$Q;#'FWC!FAA8R
MJ[G&DL8241\S[VVL+4MC92QGF)I4,PL8@Y<3.D\+%\T*(,[5_NQV7_;S@>W'
MW9?=XO2-</K,23*I-BSUQL5<RB1FS--84P1<$"=8)R3%C@4NB,0R(8^Q_Z:-
M$K:HTHP=V2VJW!!59MB?1M*)DO@1"?\(KF+EA8B=92:Q2F#,Y-(K)4$2YJG,
M0QL5O*EVO\Y[O6S8\^&0Z5#_^S7<#_KK^Q8TK%Y$QKBY28F/?/^'85C?!]F+
M?M;]S]*P&/GSB#<S0ZM]=V9^6MR[!NZ=.6@E206S'M".F 2%S<PLUDJQV(7C
M5JS%C(<='Q<0[\GE[JGO_S <H)7[!Y7[V7K-"4MA9E"<6,)![D4(]"0V3K0W
M2&B,P,FX4NZ;%5.9!ZNZ<Z +?Y!WG2\&__J')#AY&?G_CK+AZ8O&AE;N?4+O
MX 0U;T8OY[SMY,WKY,V)I]#X[?G!2N>A=[G]%I501UY&1[J(CG5WY*-__HPY
MO/=%"93W$D78Z+RYC$'D_9W0M?>ZV"IVAB$I_5/HV/36=0P!M9SB&ISBXW!S
MS"E>*_3E_PZ0[7WJZ\]JM'6XB;^$,?K\Z5OGQT>\]V.[M]?[^V#SQ_K)WN%!
M=_/'!CSQ.MU<>]/[/_@,Q@]O_MB#OWL_MG;WT5<NG$E,ZL-1MCH.A85B RY4
M3(5)#4A!BJC\.1&]0IQN%^INQ6F^Q4E0K'6:XAB9E,9,!'$B!L?62(]M@@Q-
MW-(KO((NQLPO?! =^2(:A/F-?M.CX4%> $*ZZ$I9+"\=W)\87CLX.B.AI3@.
M5B>];27SZ243;:ZMGGQ%U@@),QX3$BKL>HUBS8@+H5?BP?(E2B<_ ;I+A>L.
M)K,5KD42+ILHI1)/8XNUBQE'+-;4IW'J7$*HH4A)L*)L&8!H&9AA^/\U\*^2
MN9=1-AB,;@Q\_Y^]<V]J*U?V]E=Q<?8Y[TP58G2_3'9110+),+5MDD!FBOR3
MTC68,3;;-I.03_]*RP:;0":8BUG+Z;VG', W+4GKZ5^W6JT[+@JQ^TS-W:JA
M,"UK,2UWZ =,O(C.:Y3G8MG>0A+20N2?(N:,:.J]9XLR[XXI##"O5FA>.:>9
MT HCG[*KP*/PR&GND>"!Y?]KQ[TLQ] 18M8U9POA[CXEW!YQ!>#I A3UBNG\
MJR[9ATU.V%A"&M@<0RM7&;(V%H7G;/62F12RTR"0SYV-.,[@LX0*1+CB3CMI
M<.(5[I:2"0;; F!;P!-F@@%8[@F6^3VBGO,@0U9/E#+$F5;(!<M1]A@#]X)Z
M0FWSP +KUHO>X5O>GYV<36O35?M%_>#D=!B/8G_4_3M>GN[;&XQ&/T^SPQ24
M&&DDS7]:BDX<Y1[*/RU6!^!B#E8[OU[,S\!)=8#_Y.G7B>.]=& _ _87POZ5
MP]X$Y5@;KY%**;O/1FOD2,*(<BJ]9E*14AJ \'7#KA<FO7;;UR$!&.BS@O2Y
MNY@$^M2-/G.BDQ"MA(S9??4X(:Y8*6''!.).),Z8T]:5)5JQK@UI!GT:DE14
M(PR\C6/;[6>U&>VPGQL*14D:2?-ZA1PO)M7.=$[-,7T[IJ[O0N& Q;!]Y3PX
MGYC$@5!D=#*("Q&1BS*@1*G*2)<ZF+(A-:M&S:YSN[[1 H#-ZL%F"6%(@,V#
MPV9>(T:EG>$*2>&R,K1!(RTC*67L8LB#J/)P%MC@=2F:5 JI(:')VJ>?_R>.
M1K^6(.4L"?TH]D*KVV^-A]&.SH;GZRT[SJ\8C5O?]CF?*L'D8-K&N1032"Y9
MB!8?_RFYY/R0_M'K5.]]W\O7^ZFSW>:'!^^^[!WXSWO;6Y_:].U?A\=_=*^G
M$!_R#TP2YA6+2"7F$,^_()=D1"P)X;DA/G&RMLFU6I=*WIA:4NVHKEVV'$RZ
MNDZZC^<?%$_)>RX1Q1XC+KE&SDJ!*/&..*I3UM>32<?8-R;=_=.7(#K:'(F[
M!'_Z"C!@K?U.O)CYSXZ([#TK@5@H!9U$?C"*9_^YY.^$9*AD;&V3Z77!H9X3
ML&7%W6=@R[W9<J76NPY)"HV\H#2K!Y6R>F :R4"$Y)9$*FG%%DZ@K--=PWB-
M*NHY^F8E"EAI67%Z+T$95M2>SJZ=:E;M]GWOK'3@Z\&P-'!K/!YVW=FXG$EU
M,"BEFW,3AX->+[]D-S<V>RH0(%V,^%?.G]06YPF+*<*.!L25RVHR$8Q"]A8-
MP1Q;:=<V)5_GJDGGP &/5H]'2U"3P*,GX=&< F6"9+OC*:(LRE+&0R.;I$,B
M,L\H8X&4!1MA,H^:M#A<K_6:1BG0N;+R53Q\7I'^O_MHT4>,)#S=,ER]1O!!
M-UG>QQMLLMU;;JW]K7ZX;@7!HBU@T?+KYA5VE-9KJ31*VF:+ABE!Q@6',+9:
M&&."<7IMDRB\+LTR)#8$;"%@6X\"_(":AT#-?)5>IX53+B+F5*F!YP.R5@;D
M-*/)*",9+J@1:EW1ZQMRZHN:2CW_4OE<%^O1^>&B:7,?[V-QP;Z^_^J3=$0K
M..S'V"I;'T>M\: 4S!\->MU0[9E\V>W;ON]FU5L5!ZR*5U]=AY^[[M/!J%L&
M[M=A[-EQ]^_X[%,WC(\FJ4W3;^1T(O77;GZG=?F[S\;QV708\?Q'K#6[E\E7
M"0QSC^6R*K;$?%=XRKWVA'.ME774!J9D\ERHP,,'6FI&3MYT-)S="Q\C<L-H
M_\J^:>Z)7VWODST?K?URI<-.NGWTU2A<Z]S[]F!*C]>#U8!GB ^&MIHKV6YD
M2I>7E<;;YC6Z=30L1NY_OC_J!&?GL]"F-4C5B19YPO_[%[MYTXQJ\BWR^]YO
MG?V]3NO_[,GIL];%;UN=[=;^N^?[N]N[6V]W=_:_":#&7>^+O7R!_]G=WCK8
MR9=XD/]I[W0.]EM[+UL[6V\[NYU7*W2Q/[WKV[/0S6;E66M[T.O9X6@ZT).<
MO9+CVN[V>ODV&;5V/OMX.FZ]CL/)LZVMDWPEXZ^SP.;Q9H<?,^&*'BAHF_XZ
MM2-3DU-9[,O^&0SSK5CZIF=/1_'7BQ^>A>[HM&?/?^WVJZNHWO2U1,A?,Z6G
M,1N<B J@TWC:]/.G<-V8P/4K^3)Y4O -I>FWG\<;Y,Y/"B;N^-Y_;++9D'?^
MX*=IL<ZV#OKX\?M8WO*#'R'T?#/9'G^+J:Y'[?];1CX>OY>NQT'(XX[KU/*M
MQLB^[)9(0^O@J#L,K3=G=I@OK;63]6*XQ6A?&*WL0,?OA,0:_]+O$*0.$[^N
MK8&[\+M''67=&4]<OO6H6O^W&_ZR658S&L);&.C;#W3V+<KU5$,\'K3V;>]N
MYX3#,-=ZF.?N9W-Q/Q,# [UR _W=^[E>.2]-J&93]6%9%/!GHWP!<7AQ@JZI
M78U$R'"!#)<'6W;V@A(9O+ 6,YXDLXDQ0XB3T7&7I/JP766X2&K0 Q3W^3OV
MS^++X>"D1/9+Z_[LCH]>3.^XG<_3?,^MT2CF_T*=BK3MO;A8DGY^?'BP]>GP
MY!U]?_"1O#]^0]^_*LO+?]'V]M:7SL&[\_:K-ND<',Z6I$_>GG0.WG?S:\]S
M*TX.C]^P-GU_M%=>=_SNO'/RLML^.#H^/#YD7R])OW]U2#HGOY]TMG\_R>_I
M=K9].5>!'WYY1SL'NS2W]_/>JTZW<QQ2NXO/J^7H??SI0U*!8!PP<KAD<X:H
MD=&$(&)2DE$3X5U:VZ1D'6O:H/7H&O 74E_NQ:",B"Q1'Q9#[ (UQ_WC7RM3
M/F7-J\$@E(J/4\5T,*B>O*0*HH"5VV %7V*%<VN,Q@1%P@GB!"=D8S!(><PE
M32KQ%-<V,WDV&K(#ND:WS/^"T@2EN;)*4[BROT2H8!+F(F*MC*$Q6)>BT@*+
M@GABL,ILJ7XP]ZKL!DKSD4T"O30)E 2%>=(H&^]2Z,U+9(EC91M1M@<J:J:+
MTL3KBBZCSALH35":_Z T[XDA4)J/BQ4^4YK.)^&20+ILV>#E9%0MA$%8!..H
M%4I4)QR TKRWTJQ7C8XF1(M?E)J4@]0Z'0["F1^/6J-![S:I"[ +OCG6XVEC
MI66&[:7*J)2].G'X=]?'T7Z>9B!4%[$HYW,AT6A=8$YF>4J-RD)5)&1(I"AP
M)UT>6ZUQ6-N4ZT8M(R(*]3: -$N*B,[!I! $).J]@#(7#+4DT&0<"L%FSU?2
ME-'"!3*>JIA5*C-!KVTRMM&D>AG DZ;SY&EC;Z!<'@HTLQ ;XWFL#([9 _8)
M\9 ",BHYE+#V+@B/ S-%N6BYC-J00!H@S9(B;*!<'A(HL^":S@,D+$[(!^+*
M<?0!64DP(C(K3&>2R./1..4"68^+WMBOAH/1J$2Q4G=<M\5G6/QH</BJFEBO
MJWD%JF\!2'=>S,6KI$A*Z,!1,H0B+D)"6A.&F+#*",JM]+HZXYF0ABR! %M6
M@BV/'K":PP=(OGO19!:L\D[XP+% GC&+N H*F4KRD<BTQ9ZS4*+?<@.2-( E
M/TJP"G3*G<DR%YU*,H\590@'%K(SZ3W2!&M$*.$A:&PE*SG!;%U+V&H ;%FA
M\!3HE(>BR2PT10.527N&:+0:\>0\LI8GY%UP@49,B6^>3H$4J\4WLU<'.ZRW
M3NSPKSC./U8EZ&TXZ?:[H_&P*KO9BI]/8W]TMVH&L*[PU&-<T^#5=.J]BOTX
MM+VM?MBZ,NEV)G,.].(BA-^?BVL9S:*S+B*'RU%WC'%D S?(YZ$5@3L7/5[;
M%.N<-6GU :C3=.H\_L[46X$%E.2].#.+>"63C/2$H(!YY@S664E&G4I-=A6X
M4MEO96N;5&PLHR [8 8P4X>(%XB;QX#.+!A&G))4*IK]5<DS= Q#1F&.@L#6
M)*(UY>44M76F.% 'J+,ZL3 0-TO@#)]SHC)FDE%(2AT03RJB+&N*$V5,'KT\
MCKCLNI9+V1T)&5Q/=;^_C:-HA_ZH"HZ%^'?L#4[+V347D3'(ZEHIBC]U ;?)
M9,MPWYY-M2G99T4U_'_/NL,8=ONOAP,?1Z.2Q N"<A'0SQ=R4U$F$JQ%*?"R
MR4@JI*44B-GH@M*.69(%)5W7')+  $4K%"V[!VU 9=X+/K,06G3,6^>RRJQ2
M.R37R&"9$+%"1<)MHJ*DH+(- >P!]OP@(32004LCT2RN9JW#."B.?!(*<4(P
MRES"V=_56D>FG!.XR"!AFI07 BAJ.HH>/:X&,NBIX#,+MMFD+0TL(6P81MQD
M&>2XB4@'K(@SF#!JLPRBC9)!D).V* 1V^^AT<G>UAM^(NT$BVDK1_5'B;;=1
MDY<<!\6X"+3GRWW94GV6*84"+M5YE)+(\N219H2):"C!DA??%;(_@"@K'S:[
MY EHPGOA918:DYX;1V) Q)6XO)8.F9CQXK0T@7EB0I1KFWA# EX +ZL3&?L2
MAX-@1T<@8QZ5,W/E]9WG-JL5))BILE@ETMH%)+5D+-N";#IL.2M;4T*? 6N
M-4T/??T3;4#@/#9X9D$O%Y+SADG$&9:ENFG6-LXHA&-@U&A/,1--! \DF2T>
M]QK'81R-6]V^'YQ 3EDC,?[34P:Y=OM_Y_DSX7290A<S"F3A G3>FR\.9EPB
MV B)F. E_Y<RI*G*DP G;*.FTC-9EB2N@?G:><9U6(L BC2>(H\4V!KESLI$
MF1> WX()*+][L66NKKV6*5&:D,8J(BZRWVF-\RAQ:B*.W"KC2FCK^O9L@ O
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M%Z;,!;.T,%8Y'!%/P66F*(U<S,,2@T[<>LV,\V7]<QF2#Z "4%E:/A:(DX<
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M;2SCU#'(#(+,H#J-'=B/![,?]ZT"!?:C+O9C;M7+NX"53@:Y1+/]<$(B*ZQ
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M/SL)@_'T><!3S? T"ZU);9E6(2):UA]+)!79:&0&E<B LBFQ5#9=K!L*VRX
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M$B9GPR;G%_\A:6R(=QX)S1WBBD6DDR'("!,98S9:YK(#CQ\Y[/0T9T:!5]_
M6;NWW?[@@LL3,UJ4HA99>6*#-),2D>BY=YH&ZOS:)I&-1RK,T$;.T(\?M(Y.
M21.0M=E!XGEB(I/G)6+6!,RQ-PJ+M4WY;3?IH>).2Y6GX-4W<;YVONQ^L%1J
M5<J7,R&S2/4B^_?8&22E9EQ'S/-_6:2:ZW5>&D94F*)-G*)[!^T/S##*\S1
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MKH<Q6Z=QV!J5D?WYZK[CU5EBJ-L1J\N,@EW>OW/W=+F%P65=[/:=!<2,).6
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MK=H)#ZM6^J[#8;63Z$[XAJ5^XH3S99"D91U-D>NOR?540+Q:KZDSQ?E,KQ$
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M$+&$!"I2%K/XQZ""G=YGZ(WZ@\XC@\W+Z7>#T'H!%'#W6IX*3,\$TWZ:^_D
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M?!9I(!7P>3+PF8X0YM0:L!Y9[1/X*&V15E(A23 $KA41-B3P4>MI71L$/L5
M*D-I\E"*@31SU9];QM%N^Z^=MTTQCLK*/DT1G[)VR[=VRQ5+V81)W$K#&Y<E
M&_5S,X3$@$?GZ]5)UT[.P^&_IYV3W%^EA% VT0!;UA#*U_:\[A6YW]_*M?$&
M\'HB>Z^SY&WUPLZEW!4+;"8+[-V-C&^'65!@4%HKCCCC'CDC!0K"<1$H2.]#
M?4+5E"S-@CLKB#N+]/P4W'DRW)EN2NMT6CD5D0G9\R.%0<8'BSQ6S'BBJ76T
MSM1I2M^68C//"@!I7Z6Y#Y,"N*-#J'('L_[0=N]M2EO7S5U:.ZSX^)?F@/%.
MG?-:REXF(<O](?=B>B:<9O<]E&#Y1\#XC6*1!!P)7F+D@K&(IZ5"CAN.)'6Y
M$0Y($_G:)L%WBT4NK_>^P,KJP<I""61!G'DCSA1QC!0SKT AL%CF&A,8V9 ,
M5F^4=Y8%JJ-=VV3K26<T"'.*6W)FM^14PX2KE@K>#@_'K10&$(H[LHF@_JR%
M)>_8_K]=F1]M&.W%'!(R>244$)\)Q&_4F0Q:Z 3C&AG @'C.X-:$"T2PU"19
M_C:0L+9I^!,7"BH^QP(NRT$9"^X\'>Y,D4>FL+2@%'*",<0),&2)DLA2&Z-*
MMBRF=&U3K M)FX$\Q>LXL]?Q=. /;6[8FOAB+D,^'-5;KW@65QW0G_7P>O=:
MT@J SP3@-RI,RB0=5$:#N+,"\< ],I)IY+B-2H$PK X8ENOTGHS*4F2R0,T/
MP!T+U#P>:J;K #$FDBD*"+#-U<N)0,XGO.% N8_"46YE/J&63]T-H?@8GVO+
M9^_]7'AB,?R;<U2T4)IXZZBH94>G@\[H?*L77O2[7:@'.]R+!=(?"^DW:D9B
M$ ISR/6 %4T4TA"DK0(4C=-*11 :W-JF7!?Z;A^R^9\=%>]C :&E() %A)X<
MA*9X)68\"NL]8B3]X)X)9$*0*'JKL7*$>%%'7'-Q]_1C>4&H."*_+_S1#R!T
M1M7P].2D/QA5]N, H-YJ)>SQ1\#[N9UD'_6.K@ ]"]98KB9B=2U5!<!G ?"+
M&_4DM3<D*5^'8E+-B)OTR# 5D%$A)$VL0M+2:YN$+H)#%B]DP90%<<@+&/2#
M'1X6I'E:I)D^K@:C$NIK)'$R53E$B8P-"7B\BDQIA[5T.<M94T)_;1#:%$_D
MK-N^KLY:_70R2)MSD+ZDZG8\]/(I=L[ 3E^;++-^#X9W',_%,] $5%^*H,>7
M_<&T*Z 6N;'-WRGUKAX-Z#LWJ"-GD7%GD]F?;7_C,'*@TY],.6=E(#H7VQ-$
M-B/ZJ.!+0_!EL:SQ@7ZL!6>>%F>FB:,,QCDJ$3:03%2G"7**)2F1R5*5$%A2
M(FN;ZFZ08V,=C/]8)VVQA9C*4,I0BLTSQZ+C[][N;%>_'<ROJ%[A(S^6O7-%
M2+ZW_&^A*=]+4UHW>GA"<)09@:(2R1Q*-A#2+%I$!3#L! $M7/:DKQO:D'R,
M@D KB$#S-(D* CT_ DT92I(0HK$D*&AK$/="(*L-1XISH[C7)#B\MLG7M;A;
MP60I :B8264H31Y*,9.^M_3XR]WV5OM%0ZRDLK)/4WJ\K-WRK5T)D9QU$K<[
MF?OV0EUZ?'AH!W#8[P88E&3ME;>YGB-9>R_N#=+\V<'YE> 5VVHFV^I&;<A@
M:  7 2DL<YRDTLAA11'VDE(I 7L:UC;5NJ8E5;L 38.=.P5HG@%HIIPXU%HI
MB3>(N> 03ZN%- !'@(,)$ TQEF2@X40U VB*$3SKCG\#)Y.Z/G49R/[Q<3\/
MK>\_+:WY5-SS#::*+_N#:Y';BR]J@7N;Y:T ^4Q ?J,LI)%*<"H),DR0Q!BE
M049$CXAEE"?J& (3.372W%-/?"F]\05O5A!OGH,Q%KR9&]Y,$4?.C 9)!1(Y
M"YMC0I'CA"/& $SN/VP\S_4@&&T(WA07X_=E80\/^X,1&L'@.&U85]*N&XGE
MRTH=I\ML9#G;3V*VG:2L(/A,"'ZC'B3F5N"DC1'ATB*NC4*&)RS7#(AC,6*O
M('>#8*QD8Q>H:7A>3<&3I\&3*4:HA#(,AX"8#1%Q("S9HCXBC['7V+O(@ES;
M)/QN4\+E19/B37R$-W%L=V5GXCPX8;'O&V3?SSW!^DJ<AGNQ(/7CD?I&+4>G
MN<"22:1,9(@[RI!3F*"8UL:8 -@1EY@?:8CE7I!D!9%D[IRO(,F\D&2:\UE%
MN&,<&8HYXB0XI(E02"FM*+;&J&Q#ZB<^.RXNP.5P 7;[>78NV=Y59\'.<'AJ
M>Q[2G Y+LYAF0G<#'(.[$S';BW\D.2SH_@AT;V_?J-9HL3"!6);]@CBAN\5(
M6\V0MY&!$Q$TT#HXB)$&V?0%<U8/<Y[40UB 92[ ,DT;*=4\)DQ)EFA$G N'
MK&$4:0A6"A4A_;&VV210*8["[W(4WF2.Q4_81+A>&C]A0>E'H_3.S98O0&2@
M#A'O".)1QMQSVB+/A&6821*]7=ML3+_7 B0K""2+#"@L&#,GC)EB@E92K)73
M2&.?BXA8B0P6&#$AJ">)!W*>&P*L8WSWV'@I4:;X$+_/AS@ZA J^P,!WQODH
M=2)*U3^I&RG]#,<GW?XY0'76&1WFA.9T8]7(?JDN4U8J>V8'H71^:2[Z/W?G
MEVSQ[TP$<"_6<>)[8^G;ZH6=+QZ&PWW[Y3?H0>R4%@TS8O_NC6-HX,!5HI86
M"$8\*(-<\!PY+H30,G L\=KF??7KEM</4&!F]6!F;L[% C,+@YDIBBFX-Y(J
MAIBW&G&)-3*<RX0Z2BI"DPJA+)FQ^FZTR_+"3'$W/JH+3'$L-A&JGZOB\<,G
M0E.IA;5<O>ST;,]W2F711R/VC=K&6D?JDD0CS!@@3A5'VG*#@!)I(C:!1Y(=
MCW>;O"ZE2Z  34. 9ED.G N\S!]>I@AA3!!BP$5D1:2(BP#(@9-(FB"4"\DJ
M5<GN3-2OM'A9E=*X92A+/I1BT'QWBY=&%2\N/&3I#9X'NB@4,O*]9.3=M*WC
MK3+ '4=&YCXN+&CD@O3(1 )2<\-%#H7CJK2U+!C3X""+N35Q*?#S_? SW>W2
M,<4=B2@9-B&'^&N4EQAAJQE1E$57VT)LW? GKC1<+*$RE#*48@G-KLIV8@1?
MAY'#%W]H>Q^A&M@15./'PQP;Y),FJ6POC!_ ?T\[GY/&Z#TR&[&0EP:1EZ<S
MD,9RMQ=W)E+W)@G=7B^3EJU>R+]VKN6L<)29.,J-TK9$<*68PPAK+Q&/-B#K
M5$12$14IXY:ZW.KRGC)E2TE0"LJL(,K,TT0J*+,PE)D.$R+>1,XLTA[JHC@6
M6:X-TC)R28P6Q)FU3;T:5E )0[^SVW=[?@!V"#__M WC1_^J.O-FCB7LLSE'
M_(NL8Y%Q_!:6OX'A:-#Q(P@3K+_YQ-0[7Z<)Z8=+^;V4WO1W]S0OQ;3B&"N3
MHB9F4A,WJN:&H#2$2)%,ZAYQ X",$QB!PD(Y9;C6/"<LR86$#Y2P]1\,OY;>
M;5^0;*F1;-KU;QDPJ22RV;;FPBMD<)#(1PK2$)]^9+-Z78LG3KTL0?'/UO_Z
MDMR^N$5NURL''SN]7AI\]JN>U/NR^$J;J#%F4!B.BJC!8&MXY$$'E[@O4"I(
M!*DED7_OCAGO=^30?Y=Z*&@_$]K?J/D+W!*K*4[PKCWBH#@RN>:OTL[Q*#$#
M"@GMU3K#BVCW4)RI!88>@J& +;622DL]Y=P9*Z3CAC'%<W\!BVL8RKP5%QAJ
M! Q-D4[C0P#%+ J,,L2U33#$14S6-)-<>0;<9QC2ZP3?+1J\O#!4W*TS4\\<
MNKS5WA[',._\^6[WKZT_=MK[;]>KG?3LWLOJ]<Z;W;WM97.S/M^*+M?Z_>^R
M6(!-UG3$@+*,8DN$Y29Z0QB)DA+A#:= 2=9TS^E9+IIN%DVW?Z-X,D0N@$N.
MF'(1\20^R! 9D.7>6.N$EX+6FL[(TE^M>(J?$X:428P,%-:86@Z)?G,?$K^V
M 9S#E(P)]_?5SBLPM$@8FBZU' (U3 .BBBC$)7"DB:;("P-4JFA<[@M.Y#KE
M=]/IEQ>&OB?*>Q&^@#*4,I3OB/(.G>%)UY[GS0A?&?YROK7<WQ(.NMQ?<=@\
MFD]N^43(AIVZ1-VR.67*"G[+"M[/YLK:-73M2KC#K)/XTG8&5;(I3^O*TG8X
MA-&PLAG7!K!TT0W/MXS+M6AS=31_SWE/DST\BXQE;O=[.59^;_#:#D:3/Z;(
MPU]Y_^W%K7KW;4TV'RDNGIE</#?RXS0&"4YC1((GB#/JD9-"(L>H"CH$ZJC-
M@7Q$W4U>6=XCU26 X!+9L7Q5$PL,+14,37F:J1'.18B(LAQA9C5%6@B-K!+*
M"^,\Y6)M4ZYKN8C&?B6R8SE8=K=C7:=;U^G)C/OT&$(=<9Q6/T/#H-_MYB#C
M3D*) 93VT W5 <_:^^_;D/Z/:T'<&LMA0?O9T/Y&'IPWD#2W(D@&GDAG<!PY
MZ@$I[Y71$K0/<6V34MZ,W)&"-"N(-,M'-PL(?3\(35%.S"3C!#N4ZWDG$*(8
M6:T< I:6->&2Y(QERY>:)VX54%+8GJT,,HS&I1E.;"?D[3IVZ'[/055QZA:G
M;A.\*8LFTFFKI2>/^ST8V<'Y3<])46S?J]AN9.LQD=:6:X^4@L2NA3;(Q:3B
M#/8DT6QBA1!KFV8A(7O%H5L<N@U@V 6=GA:=IFBW]"8JI6DR]HU&W&*,'+,>
M1:&XC)I >F9M4ZP+N8C6K0OR]"YG'%L)Z;MY?S^/K.M"^ATZGS?_G7Y<?F1*
M/#QD9_-MT/U&>+R)J=\,Q5^!]&ZG!V@2B$QHK1'> E3M_BA=<=2O7B1;IM_M
M!#N"4$U*X-MN]7:4GCB^48WN]GV?],?P^,L NG;4^0R_GG7"Z# -(WW+Y!NI
M&F^#^SYF7?KBTQ'\.MF#>/KS:\V>8G5SUJ9_YMNJU0)$HSSE7GO"N=;*.FH#
M4S)Z+E3@X6]NUBX_=#BX!K*/@-P ["=D8YJ)7VSWS)X/UWZ^,6''G=[EB#C=
M4"*-^L[D?N\,QOAT,U@O>-+6_8&M924QA0"#_+8\>-N\05>'@TQK_N?KJTZ2
M@MO/4)//N%YD2M0;_?MGNWF?1,UA%9]V'[3W]G?>5OM[U8N]]MN]/W:WM_9W
MMB_[26W]4;W=3T^T<G+V'9@9W]CFO]W@Y\V[&/1M.RCG039EJJH\5Q6I_L__
M:$KHK]6$*[<3IQQT_!SL\]M-4,ZVO$^W/TJ<Y?6@WTL/_1CQ<_7?<8'[W=[T
M>SI)-9QT8;B?QO%;M^\_/2^_):U+?GN\B_?V/R:N>?#EX"+QS(L_+UJO/ARV
M+SQ-/)1_V$[7.FX?MU]].$I<M0O_>7/^X7TX<93+@Z,_Q=[VUL6'HY='Z;LN
MVMNMLP_'.RQ]5[=U<?@IC?O\@![@#\?MV#KR+)?S-='90'*O;X(1-S@BIZE%
MCBH,T49.+8R-F4[O%,)6MD!\Y)BDY0$B'0=&M0K$@@^&LB0.))DND(R&DZSJ
M!J>0 . 0*INF_C@)['D^Q3[MV=/0R3JZ/L_N'.<ON%;<\4IQ#Z\4=WT87NMF
MR(?B6=\/#_NGW5 Y2,_;4!>A[?>.TL+7UMA99W18C?(W3[[JJ]P@0]3O_</T
MKE[U?^SQR:]7?^7O[J0W#$_=L!,Z=I!/Z7_*%W\QOJE_W3,\.ZRGS:;-40]N
MZNWUKE"_#JNM7N\TC>$-G/0'H]R X66R\JJT$/]O[:+-'XF=;(!5YV '%20(
M#M4V)-%V,!B;"-2L5WE_;%1YFN_.[+V3V:E+!::YZ78K&XY.AZ/Q\S_E=>@,
M\PY)H^F>YRGI9<.SFV[.GPX&^86I#XSO.ZWM(-W&L.JED0V'R:R\O-^CT_ Q
MOS%?)X%*TO;U7[7[N8HY .)J4/DM^2,#&)YVTU N[W]<4VU8G:07,EL*&Y>V
MT@1,[N+IPV";/C@1Y5JIC7?\5\6Y 7C[(I'/X]YDE_3/AK7XYT7(NG>8YOX\
M2V5:NE"%4\A4N1Y\6LZ-ZC4,,@^UN0?(H?T,:4=!+NC<]:=C>3X=ULON1VF1
MUW-$"JH_7._4CZ=I739F6X(G5 3OAK 7=Y( 'Z>1#W\\2*?ML[]]$-P*Y5""
M\(BX-;EIGE;(2>F9-X9I!;<A^@;=MH./B7%GYP*[>R+R;)*O[I?\M.(9.J[6
MO'I %I]]_ _LW(S::0=D!$R[\NRPXP\3O_QK=QL14W62NO )#._3'2YORP2W
M]9Z_1OE+_#SK)&P/<))T1E8LO;SA^J?#"C[WNY_S?H[IROW!I2Y(SZRG2XYJ
MF.AVCFL=,NK_4G_UL?W8ZXQJA='+ #(V"6I*/QGI>OV^V_?1&8V',;Z-ZJP_
MZ(9DN>4+^D$_V1:]_O$8!,+X'/)Z,%>1;G6/HN%Z!<<GW7[=[WO\3#V40[#=
MI.8[O6$:4V)\Z5*?89"0;#R>X0FDNY@H%IMP/U&^&M&2,LMO/%^OK_(Q/^[E
M2Z?YRT]<36TB%GX\L'1/M39*+T,:\UC;3I:D3I%)_T+E89 5?LUVQD0SW>HH
MW4A>0CNJ/D(O#:^;%.L :I=K37S2C%S/:-)[X.WP)@_J],;NWUIG]2Y1\YKC
M3+^>:P'W>PGWT[@^VTZWMKXFP[\:<+K)44T7/O7Z9[TJGHX2CE^)VY7\V9H4
MO8634<TX*JHRV:!X<H$D4!_' \BL:CS1G3QKF<Z,I^B>F;B:K0D+"6/!.TO+
M?4OZUN\5_#1__;-ZM3-'"/U3-XJGW<MO&@N&'T 2J:K;S]^UGK[I<UK=_N#\
M!D_+C&+P.;]>,YCZ&7<E6VF8_33YM]XXF3AO!X.:REX%<.9G/_;[H1;X_+9^
M;DF?1I!/-#J?(4P2J3:J]X>=O"*'^7[/T@S7BCG/3D(0>[59;J[8U<U_ U&N
MUZP&A0F%^N^I':2+3^CCW=6\?YHG,C%>K6F&]BUHD 9Q!GDBAI-YF*#->KJ!
M3-K'*)5E^=9]#Q]_XYTK.1X+8%Z>"7N\15!N$\BO*K_%$YE_L&A?IVGPY^.?
M/[#U2O>V_C8Q35]4@#!(CCA0@IRA@)AAS.@ U.D[UFASJ4Z^SK509,NU%^P@
MW'5J+\EM_ /CN:4YQPS'AO[)6,5-H"!!2E*&2>:3+NL,AQFAI_3)\/+^*W=>
M?_[:J+]OEJK?^NE7YD)3\/+_#!\$T4O\N@*HTY-@)^<,R1C]W,ELZAH=LY;)
ML)LX11STCQ=B[F<%,M::R?0^NQ[IO9,TF<")93[YGJ2OTYQ<*H@TW[5VK[G*
M>!$@3-_)74-O=MQ<'OE\8)N]N12YK2R/:0)68\_=$I9[9<1.[O@;A.3K*O51
MJE,;HZ/W3%!).0_>!LRQX,9K%V)Z\;;JE%3?5IVOD\H?C%MDI*7LIBW:B1U?
MDY2M*]?5=E(*@TX--S^BZOSS;QF!.^DL FR2ZG00D<L=W9@6RDJ. W'A/M6Y
M)'+^\-Z]L> -VZ8O)O;C21;A"7FM[/'8KKGVS0VN[K(VD_(.RO9?_?!T,,A<
MO58@$Y]I/1-?V:\_WW*-?OW4ZO$O?NMYE[Y[WK7<"N4?S@TKNJBSL-U+6W<[
MH7<R@)-!M"Q6PMZ+2ZC[O9,@C;0NVI\^O']WD3Y'6]OM3FO[T]G!4?M3:_M#
MMWVTDZ[5/;X#=<>_)TA+GZ%ONND::8P'"3)WS_;V?^NTZ)]G[>-W-%V/[[W_
M$%O[!^=_@Q8R..:1="J?<"F"C, *>:*93HK&,A)OGW!9Z<!%SCQ8SS6 XS&(
MM!"0%!(/\0XP[K;_VFGO[[W9W7E;_?/QQ+TG$%_]NJ>V-M_Z0PBG7=B+5]+S
M8@PD]>']#RP_^&]"DJ),GT3*684XE74&GT.26N62_0G&TF^T,7/DRN3/29B0
M&'/E^ICF"K[Z@P"##%U=>S*$7RX?_'H9SM7IU2!3?^AV^%[ZFDEPC-(;6(WC
M8R;1;)/K3V)G-L:OW0HM'+\HR(8V\N'7\09Y](N*/?;"_SCDQ$@EI<T:,MU(
M^_0;K_P$*4_WJ\6G3X#2SY$/N9UW47W<4;4ZW6YVZM]);?N6N/NGG[0Y5WS[
MZH G08@KDNAVU[U=5GGU5OG2*59=^L-*R;_OFL\W]MI].#[^&IZ>G'0[4%)#
M2VKHZJ:&+J"QS)5!E;98ZW*';?7"V\G^:L-H+[Z9'# O2[;58RVM<;;5T1;^
ML-WMM%[MT@/Z[FQO.SW__J_.0;*Z]E[MT/0\:Q^]/&SM[Y[?SK9JI?'NO=]-
MU_YP]&%_B[=?O3S\\/[WH_9^BQ_L'Z3G/6V]W_G2.OH]MM[B\SK3ZBT^^SL(
M06E:.^1Y,O"YPA0EJYHC:I@)6A'+6-VEE\E2W*_D@JYX]]B".4^(.?@*<XS0
M7A 64!3>(4Y\1$8JAP33W"?,\2:8NJ H*3T:5[F2WZM^#E"OCVWZ.0"^U.9;
M<0A?)&U\WQ]\VNV]'DM6 >Y' W=GBBPFV(X6'$5:*HTX]@0YG1YY2564WCHJ
M:^ V1#:HUU=!FM5#FD62Q8(T\T*::XIHHPQ:&H:(5Q9QG<Q29ZU!DAKL'7.<
M69F11K-%E  IY?>>K=ASI]<9'D*H4P26SJ=:;/P&$\1+T:JMD +;CX;M\RF"
MJ *5Q!.'(@2&N D"&4B&?K )K\%A =KD&OTLGRXVQK(O2+-Z2+-(@EB09EY(
M<TT0LZ;P5'D40%+$ PBDM5.(>VZ,)2X:7B,-5J4;R-S-UB6.'!Y7MMKOC^KL
MW_$&[$QEMP]/3Q8]:+DAOF74]P0DKFW^1'*PU>G)5?CYDC@LGD\@ETOCS#6:
MX'O,S";KXD6R_J1^B]*=0>FV7TS1>T*Q5]$Y1)A(JE: 1\X0D1YY2X74B>OK
MM4VS+N[IA["\7IDE@-/B_VTPO2^0,C.D3,<"<!5SF6<ALL<@4(J<9!*)P EP
M(JEA.$,*7HC'8*Z.WCNU@I>5?=*OL\_E)/N3FIG/R.W%AG[\]%;/.+EFMBK1
M%<'7!6:^5@^R+B\$(]OI#G.QADDC]$/HCDOK#!-27A4$NJPIE+8'#$>=T3UE
M\9XXY7:62M:7991_P&+6>A[%K"4IQ:Q+,>O&%[.NV**2TE]-*J-M]<)N;V1[
M'SMI&L?-1Y8N39VVWEZU&CDZ.-JE+?JG:%V\/#I(Y'-<:>/#8>O5.[*W_?+3
MP47HMM_OBMMIQJU7B:0>'=1M15KOVX?M[0^=]O8GWC[>.?NP_XZWWK\Y:M-W
MY."HF].,6>OCWQ AGS0Q!#+DNIV 4:+X%L5DFF)CM.!8W$Y4-QPT$0$<X8S'
MJ"SP %I8'G+ @6%W$]7WM]JO=G_[8Z?:>OMV9_]MM=7>KE[M[6V_W_WCCWE7
MUOWJZ!JP3Z[%]9( U-61ZF(<L9,L-ZA.AY +$.8J?\/*YIIYQ[G\W$6N/9D(
M4^8'G4$%DPJEX<;[QU42,W<8CA*9J.M#Y<I+G4%=<N]F];T;]04["<(F QC7
M%^S<&>E978/Z^*0+=XOZQ/[I8'1XLZI/+BOU\KH4Y&0,>6AC,C3S]^?WNKJ&
M<S9'ZY;6^0Z[Y_\XF/4JLZM^OY<?=F*ZC<' 3DH_/WT%OJ/>T50]A)?U'=:P
M=7F[?^2[O8UB.U\FA4LOD>ZW\Y8]Z@]>Y$(MRU1$X3G0C;:W_@[ '$DHAB+E
M&'$7'')IVA&76@NJO)4>WT8WY0QS3@<.SG+JN>68$\=R.0\)X9NK&"^T[(*A
M&WI2+F#FL@N2;!#,GZ:&@=#J*6H8$+61-E6SABPWI/G6*Y>R"Z7L0DG(+V47
MRBJ7L@OSG\^[QD5=TOT&L1[^LK3APF5M_V%M[S_5*6O7T+5;(2+X+%/ZVHZN
M^GB-!LD^3Q;9I^&5_S%=XW&)LXNC#,NRTLNUKO.,'/OJ-/T@<61<*LJ=L4X*
M;CW+^09,I.<(8PI;.H<XLI</>[)>Y9VX+($@C_5630)!NH=[KP[2=0_H =WE
M[8LWQWO;?^96WE_:^[O\X/WOQZU<<7O[W<7M0)"]]SO\0[Z'HP_I>S^R]JL#
MWM[^A#_L[Y#6T6%Z;VXWOG76WF_?S"V6GGB@ B.K(2+N'4$F8(&,CS0(YQE(
M6-MD>IWI!41TSW%'/2+4[!G,N>\+/)O+=*U@&%KD0ECL-07P7$IF'3=,&<$L
M5XY8/(<PM()(\T6DZ]"TJ -H8SA2F!'$A0*DE<.Y8(UWTAFNA$V()-<EXXU%
MI.)[F'7[_U'W#O3^]'C2YG-R:GFS;\*RF:TE;W 5..;6M=AM34E=P?A9,'XZ
M81F"9H"U08'HG+#,#7(A44\MTF(&+[0SN<Z$7,=&-RB/L"#/ZB'/\W+)@CQS
M09YK=NE8U%C(B+QF.8&9&&09-<@8K)E+2H5F=DG8.A$+8)?+G,%<W+W7[MX>
MC);;V5L<"BM,/Y<HTZT1@'\C>=;2B D(BUCT&G$;';+6!>1BT,IS%2.&M4U*
MUZE>0*GMXN L>-1X4EKP:&8\NB:@."U:#)BA$#%'/ )%CE&/A+*!"9V,WZ@3
M'K%UKA>0>EO<FTNR^5^<#M.X83#.S,QQIX>=DS$?[8\.T_/7Z0ISB$(H'HCG
M7N]9P!ZL%<$S$B'PQ#HM3K8I!4.=)RZQT7*^OF1P?Z/1"Z-4YLXNCF.?X%YJ
M9(7S2!/(*7*,:: U_4P:O4'^AH(SJX<S&#SA5%OO@N+:,NN%E80#=SZ)K'#E
MU'SI<&;JU-R+9,":B)0T"6>4E\A9#LC;X+70RNH@:YS!8A%- HI?<SFV_]Q/
MS8L+8470_GE993G7F@/^W^@1@XDG&DO$?&[N)7U$29-S!%0*KUPTH,+:)L'K
MG"Z@NU=Q<Q:,:CPC+1@U%XRZYJ@,,\&EP(BH8! GH% .Z$0N5R*,V@NG>"XZ
MR.4"NLL4S^>2X,$LGL^Q%$R=RO_?XOU<<1WPO#RU''7-B/<WVM(8B-IPCJ(P
M"G&L'-(B_2F]\<$%B8-+>$_H.J8ERK.@S(_+- O*S(PRUZQ2!TCF;10(:RR2
MY4L!.1<\8L%'1L"Q *%&&6%*1.>/X_E\H%;)K3* CZM6LGIU?U9IY1]?R:2L
M:\/6M5C;LT[B_E5P>[&<5YS32NVI#<(%)C '3#1AV'F:6\E+%N(\+.=9J\P6
MECL#R]U[>Z,'E*;>)PM:4)IL:9 2:9I8+M>!\(2+A%J>&R\:4\*("NP\)^RH
M0".)T@=J&7<F.@Z.8,,L2Q89L3"7'E %=IX2=J:,:X^CI#$@ZWDRKAGWR$85
M$ ^!*V<E#]S6L$,7<&3S8]O62]QZ8-P*YO7IP!_:85U:'YT,^C[''@U@"#8]
M7Y_G!/@,W?Y)7:;_!^P,6^(25D3%F:@Y:,Y$\)A3$K35)AJPB5Z#D5@79KW<
M*JZUOS5J=?"76LUM_2T=<3%1:A0BCXE;@T'62I9TGM$2+-4NQ+5-L:YP<S.R
M"D3]8!!E' ^>*4LYYU1'[:1E5(,4DE'#8F'ARP]1[1=7$ 6@<BE.B9S,[%N*
M@#17!C$.)OW/M'-J;9.O2][<Z,[BS)W9F=L?Y?Y;WW;25?R]*P[YQ(!*&(\M
M$9:;Z UA)!GO1'C#*5!26.FR0_[.-"MU)@ !XI$UFB+N16*EDAHD&:/40](!
MS-9Q#;*X? OR/"OR."JB!H.MX9$''1QH#)0*$D%J260AF\N//%-DDW.2VTY:
MI*RQB-, *!L0V1ZFT@G*32Z91,BZD*9!R--(K^\2 <)#;+,Q1?*69:&7:UE+
M1Y1F,O$[(<1%!WZ?#MR]P;ZEA1BH0J!YTH'1)O67%@UQ&9B+$H-V>FV3JW6,
M%U!/H3B%BU.X*3R]X-+<<6F:FTL"1@J+G*60<$EIY!36"&/O8G!11,-J7)*\
MN>5,:Z;^<]VY_/*<_=FB'\S70@5HC0C_=_\0JF-[U!]T1N=59Y@VWO')H).C
M(?JQ\O?FN%XMQ#B28+Q8[=/TOHZ_O./%1T>(#?W5\ CZ4'A$!J,,.9W>:7V?
MX_VMG&'.Z<#!64X]MQQSXI@,Z7\("L8PE3X#82N## @FI _*$ANY9\1I3;P#
MKPT')0*OPS"J>L:FOVQS$IFQQ&)R__Q\_7YW>]4H"5CL9.1,OP;#4?7?4SL8
M)9E*\I7IY'K]CA=)[&SOO!:_+N2*/_E9Z_][VAEVZF],;W<P.(9/";Y='9;C
MTTK:3F\LG+E&T-BNBX/^<?7__=;IC\ ?5KL]O[&>7JK.H-O-O^^YKDVO]$]'
MPZ0"\LZNAH=V '4S];]@X*JWIX./66+J:]7?/ #?'X1OC!BZ:WFFK_S?&=2?
M-3Y$IHT05G*!I=':1A<"U5(P)\V$EK/G<%.99JK"+OSGS?F']^'$42Y;K]J=
MUM'!Q8?M3Q>M]^W#]O:'3E)KO'V\<_9A_QUOO7]SU*;OR,%1-[8O/E[\[43N
MZ24($L%)Q+4!9'$BV<)1KQ(IB9S*M4V\<3<[N')I\O)R9R&9109(<&EK.4J8
MTESII#2C=);XM/+$R^"+#"Q2!CZ=_:V\B:!%1%@[C[B@&MGH1?H!RG!&0X+%
M+ -W<S<O96 ]0\8)I"<35IQOW%4+5753TUYQB<U_N\'/FS=?O*&%;^%' .(Q
M3:0Y,$XY=<IB1I*LB.PNU?'O[3%]9AA=V_<W9>.M/X1PVH6]>+GZ^^GROW7[
M_M,/MOBM_71W?_Z-%;%@&4D$UBK$+20(2'H0R:A8--PP*\A:!6F'G*1I' U.
M8;E#8<=J_G)QLYY,2NHMG(S@.&G=,0&G:KW6V-59>CGIS+ZOU:X[KX;PL59U
M64>?#M-U<_6^I(G[Z4UG4[FJEV)\>?_'-FG67DW=,W>;_#EA[F+,K&LZ?35A
M6>T.\F1U[<D0?KE\\&OH#$^Z]OR73J^^K?I#]U&]LTX8'?YB6"*+IB8V$\?Z
MY/KCE\G&F/3<LC3&+W*\091Z^/7T\J-?%$H_\K/_.&1"-B@63S%DNL'Y8^?B
M:T,VFC_-D*FA3S1D)A^_]L\TRQ2;;[SR"IU#Z6?P=_VTG;%J4)L5K3$#&/YK
MN0^>%K7*/ND.&#S!.M]GW3YY7;"TKIF%5?\!VQT=EA5>N15^?6B32>7AM+Z7
MLL KM\ M"+6_9QL^=_SC(E#+"B_U"M<Q(:4DQW?-X;6Q.$H[Q=>&8D5-MA&)
M6;:H[>=;QN5:M'E&S7Q7A%N3SZ.YTH['R"%(Q16ESE&AL&;&><' S.,\>L7.
MG#_BUM''B];%01K3I_,/^W^>M=__R3]L;Y'613@Z.'YWWJ:M+RVZB^^<.6__
M>;ZWW;IH'WWD>_N_=]OI,Q^V#S_E\^DV;7<^[.^F>]BY.#AZ$ULW*H](&S40
MBS#C''&A !GO8G[DJ-4*<V=SU6;%FM189 F@M(2ASQE.&'%1<R$DS55G@]4.
M$Q&T4]I8$STO</)L<')=401<"(QICZ0T 7$E S(T!(2]P>"%L\'@#">D4;'E
M!4Y6#TZTDH+D)EH4*XXC=H$&):7@)BD]X^91R*C R>/@A%[!"94@G# TET2#
M](-HI*.D*"C*HV'. "0X(3S1DR95_RUXLGIXLH#HVX(GC\,3?EWPC%+&(^#$
M3')($F<".6-R*ESN-J&UH"#7-AE;EZQ)_.0IO'*Q_F_5O7+K5V&1H_YTO./C
MZBD\P9S-&Z_O#O$'Q>O$\YPF,7TZX35HJ8.'9%5:H9C$4MI[P[T>!NX+&/2#
M'1X^A-E;6;8&$+9/!VG^7J>;[(>"X[/@^'0_1.$B,[E,CJ*Y>@+5B1=R4$@X
M'2S!TC 9<TGQ.G5U 4#^N%WU>&)8@*8Y0,.(%PX<B&@M%TQK*60@P3M,F79@
MO@%H"J0\%:1,>:Y(@+0Z J6EB8C+9&]:[@4*EAF'M38QY$8S!4P*F#PCF'B-
M!3,Q@PGG3DMC$UMA5#H9  3]%M92P.2IP.3:;Z4EI9%H@HP;UUAAR :5S$[/
M@Q)&$)D+:Q.]@"3. B<%3A[.F7M,SDN!D\7 R;7;*DH/*A^C.2L2G#"GD(M&
M(@"G@@A&.&DRG"S"!SXO./F*S^HR4R7=#'P%@LI;O_>M):IOYO#UT\$ >OZ\
M&@W2M<99_S_OY8;6RQ;25PYZEL]Q>+_.K,5GM^<'8(>P#>/?16G.H#3;+Z;[
M4UMK8YI])#3UB#O.D79&(.&X@R"D28N7E*9:A$E?#HX+GBS</UCP9 YX,N4@
MU$'ZW")+^638<Z,2':>8HY#8>512>@=L;9/J!701*7A2\&3Q+L*")W/ DVL?
MH?"4&"XYHDSP<=,/*X5 7(.*Q!,EF,BQ* 5."IRLHHNPP,D<X.3:1TBX%Q!S
M!XD@)<J%))$.EB.+9:Y\Q11 6-OD"_$1EKBVYXYKR]FF5W6)JLN21,L6U/9\
MZ[A<JS;7=-/O<= W65$QT(PYSP2PR)D.VD?GN7+ (Q.)3,VA+'L)P'Z,EII.
M-Y6)-% %! 5"*.+"9M)+.5*,&Z>=!4E]S@\S> &=[LK1>#D:?Q!.!/#@I=9
M02:3S&@678A212YIQ)86.'DV.+GVR1%AG;:6(6>E1ARX0);JQ($!"RE]D#;6
MV>M<+,(K5^"DP,F#E8D)1!F5<-%[+C37 M, F# #AB8<*7#R;'!R[9+#5OFH
M/4'8A!RV9W*7<&")G6#L*6&,"E^GFYJ")P5/5KT)5<&3Q^')M4].**4HYQ3%
MB$FB)Y0A(RA%F&.:V*6C.%<_9WR=-<K<N:>!R_WM31XHPK[T!;YSMY?Q.W*_
MC#0]]B-4]KB?INEBW-CCI(YHS7NI.K$CZ(V&=:^"T< &.+:#3\/<).:?JLU'
MP;PQV"NNDT61+%^<A$4$X2.ES'I\KUM]:NNF>_._A-/!.=C![8W[\L'V!.^&
M$$^[?W0B-',K/[H>_=[^NXN_&5,Z*(.19L$E]:X",D&RW&>)FNB<TIKGGLNW
MI;G*DSS<J&82B_N; M52TL\G'_<T//F*R!!'M;).&,8B)RYQ% SI/V%P""[9
MJ$5DYMS"8(NV/OZMK:2.9$[(;*X;D)M7.&(1C81@8[73%*]M4O)/0G-#1N#+
M"?2&4'?4F3R?9> ><>CE5B)U^YPD",.Z;\#)X/]G[\V;VDBRO>&OHN#>YWE[
M(IQT[HM['B(8+W/I&/"X34\'_L>1*Y(M)*X68_SIWY-5$A*;$1B)DLB>"2Q0
M5>6IS)._L^19^F'LX<MAOQNJ#@/W:8_B!24R>&$M9CQ)9A-CAA GH^,N294Y
M"!@G]R&_47O0]] >=N?>^5VZVB;EV79%V3]\0]_M?L*"! _,A,#BH,!5G"!G
MDT!)&\*M<0S8#J!HFSY>;QSA!"%&J& 2YB)BK8RA,5B7H@)K5-3P@15H*M4'
M<Z5225G\1VB)<R0./L/?#O?AWS??<X<4YK$VUB(K T@B001R&5Z<<EY%S9,@
M-#/";5&J4V[((F>NA]BHW1F$:0^Q82OV,H[<UJ@D<]+5[R8%:J]TWVD4FOUL
M9$)AZ$= LSUQ</8)9 ?,&V<HAYXASBU!5M" . .=5GMJN0I@Y_R@R].]T0QS
MS2RW.DFKN63$69(TP](E1Q,5E2@C&A:_H-EJT&SO#- ,9$ER,FD4B)!@\ :-
M+%$6>0&+DX-"&,>9$6X+:KL%S7I@HK5.8/G;CPAE>U<@JG4V !48A?Y9#]3T
M0;R$6%6P4NL7^!/H]'^;HMZ+5B^.MN_3?^P)FY/=KN(/YQG\3?UJAQG&GW'W
M,K*_^XDP)T%CHHAJ1T V1Y#-6G(D"0&U/X#6K/!-W<NF;HTY1\MGL 8[Z?RJ
MO[&)CH\(E)[4G4)O$O1Y:]I3D-S 1Q<"_$7+1?@BMD;VVXNYW?LUMH;C' V6
M/4FU192MW.K^;]4H\ ZW]CV[WE;AJ3JA*;RM)'Y8)S2BMP5]:,.R.[[4C"VE
MX97>)F0I;<661[+:-GC-9GD]228_^/[N3FBFX9W0;FZ[2-CUF,%58??5+FSJ
M*G3C:D%^W#BM=M*O.MF\6?U^"C6%FG6BYBDZ22ZM?=4U#50M_3R]>JV0>]!7
M&NS+%MP0!QDZ@<R'AL.7CF7KO.2D+/ES6W):EORY+3DK2_[<EIP_09?*U<WO
M:G+0&A5\>#]O]0&0=G@6NU_C?G5*L"$ABWOG^X?' N@@!]_W!-S#CPY#^]U?
MOW\Y^FO__-VA9_N'1_2 [HNK(8O[G_>^O7O=_;+__4^V_[G;/GC=;A_0-^+H
M!*Z#9QU\]]\./A_!>W1SJ<&SBY!%JS"C) 1@-<L0-SH@[85$E"LI>3!$$;6U
MPU\(?#T"NK&ES\K67Z.PX_OM_*-H!X=G_;+A[[?A9QF9AN'<YY,BX5@N4&P$
M<M(+E"@.SCC!E&=YP[.RX<N&;\J&;P_BII0*6=F6GV5-<H,QD]P@'[! '"N&
M=)3PPWAF9;3:.)JW/"E;OFSYAFSYM_WQH.SX^^WX66)C3C6*CEN4E%:()VJ1
M5H8@+P0GW.'(K"\[ONSX1NUXN+;L^/OM^%GJH771V!0<\M(8Q"F8\!;L]URW
ME!D;-7/";>VP%^:N';_QR7ZM#S&V#OJCV"(X=X',D6NO^KUAO]L)51@<L*[M
M^8[MMCZ,X \G5;9?%08' ) G#+X)<60[W>%MW22KN%28B1Q;-QH/XG#[2F0&
MS&C>D9W>V-9+<-><7D!?OQ[B99UF]C5.(M:JJ)#)BW*ZK<2U\):+.ZV#=QV/
MXF\3N,3SC[@UHG$"E@T/:#17YGGN9WZM"E-B,LI3[K4GG.N<8D=M8$HFSX4*
M/'R2:FMZ4WLPDSG'$;E!M%^033 3+VWWS)X/MWZ]'$/4Z:$KJW!M<G]V!E-:
MW@S^T._^=[M^1+? = 21]U]WKSK!6SM5%'3.5'F5Q65O]/=?[<Y-'-5XD#MX
M=_BFQ5N3CI@_3#-]C%!SVQG\QW;'\75GZ+O]84:\IL22'YQ/)7FW#9(7[],_
MSP[^^?'+Q]?OOQW0WSO[W]_3CX=_?MO/4IONGW_\?'1^-9;\W5]O0/*^__[Q
M<!=_//GCR\'K-^SH9._[P>N/W8/#-^=P[_>C[[^?''S^/:?(?-L__/+))L<(
M!U/;NP "F7N,M#<*>6^)(U%8+V6MEH$0B&$W*U56 R]2[UA2AC,PS(FR,FAF
M&?'62GHU^/SM[MX?K?_L_NO/-ZW]-[L?_OSCS?Z;@\,/UP3VO5(2YN52O71W
MDW7Y-2A+Q%,=+5.)!T(=J)6<),4%<=80\C@PN/S(^%?]$Z#PO#4>QDH!.+.#
M*M<;+LSQ\;X-:FVLWCUK4L.L!,# .4F\ [_%;Z?53ICJ&%_MH&-=I]L9G6>$
M\7;8;J5N_VSXHG4Z !5Z &\QKT]4$?57!P.$@Q&KS\/\E#3.ZD5.OXL#/R%W
M$J1?%RC(>8'HU Y@T-/Q .X<UC?F6'R@!U28$'M]$%O5L)U>RUX,ZB<];^HL
MP$N3X0?]X?#B@GIXT'5J\H9G]G1^,BXN&W2&7VY^5]<?#/IG8%T-MUO_Z(_:
MK='Y:4TG 'GG:Z7HU$DZ(0Z!MCI=83B;Q%8[!IB2A^7F-)4'=R_TS>[YBXF>
M.K<(-\VZS:HG?#,$@,B*ZSQ/7KJ\6HNY%4B=;_"A^FI^,?+2#^,=JY  _H&]
M ?\OEN$A')/Y=8%==GGL7AS!P[*B7;WN=/S6'7.WV&[NIY03Q:[N9A\'H/WW
MKFV4:>IK?I'N9*]W)K-19]+<-6:>VUY_=.4=ZY=Z,=G0,&_Y"2\N8  HJ;#B
M8A6JC3.Z<>$&H"4=]X )J[T.5G<OK_.+^K'N?/+&HYR]DY]9O]GHXL)63"GZ
MT>3Y%_RS\$1LTNZ<9_'0AP?GA:N,I,S=_;FIA\TUM2AG.[,V*7,!F3S9\#'G
M*HYKFRY#-;!;7O,JM<J.*A[)/.<'$1C[\O:MI>]Q7J@4;6UO7MJ!)[93W3V<
MWCX<GY[V!R BC@=Q8N#^\NK#[M]:9QT WRE_S[V!AWF'-\N"!!8RYXR!IMP9
MMC/M58X5?%FEH</8[7XW#%L.)$UH@0HQR\*\(-Z.*F;*[-&;<-N,DNW6;L7
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MA#RU7D3JL1<K/7DJ<-%<N%A1W&F!BZ;!Q<Q!(4 J2&4(BDJ#=I$<R3GJ%@7
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MF,O6"UPEYSWB.F+XH0BR)&D$'[)E:@-EQ10IL%'!AN"!) 8@(8SF#@=#0;$
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M.(<E!.VV=HB\WNEXC>*W2F!HXU#I'J DG"#$"!5,PEQ$K)4Q- ;K4E1:8+%
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M(BC0SGF-HU2*:[..L+5!X0RE4&,IU-A 1_<F%VJ\3]%CHECBG+*$.3<^&BY
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M4OSJSOONB:F7(6#)=;&R36Q[YZUVOQN&K?B_X\[H?*X.UK!UUAFU6V E!R
M8  4YI-.KZI*E6QGT/IJNV,@*9>_NN7F_GATY_W;K=8E8BR0THT^IQ^/^JT3
ML-''@WC3 *.V';5"O]7KC^"NKW$!2D< AZ#RPW?C8:L# W8&^5DO6IT$KW'^
MHG7:A2_Z@\D5OFU[N1(8V GC+C#,<5TIH.]@UK]63S\=='R\N*ZJ,!#B &@8
M992J-\NLDE@GP&"9??,0MC7LP,K:P7SIL7ZJ+AP"G+8ZP^$X#K8O\UR]#P\
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MG#60)$/$F0?B&"XK;U61HC0@I7? ;7!).!,MYU&1)#,/;)EHIE&\"DD5EE)
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M$"+379!IH@)<-MG5$%BVSC-PS4$+1K)<O6V5FW(TGD0DPM,\X&FN8D,(1'<
MHLGV.N!D;/U(>4R2@?29!9DS,X:[PGU5.EL2D8A!%!]"#+I;>]%$C$A-!I1
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M[H*!(E!*\94!.,&<S)Q5+:1T190BPZ+)*Y3D=N/D[^;/.RD%V4I"?CH<I*V
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MBNA#]'DX]"$WVBQ),Y$#5)PWR1FF3-$,C!0H\9C ;("DH].I-IL4Z5C$F5^
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MYN4DNW!$I'ZG4\?35^U1[ XG2OUD+DTFZ?][FT&0@WI]K=R/O1:U@R3OCYQ
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M>(' (.0H8":U MO#"+EV.?W"9F:J4M'$".(($L,)K,U:4"R"3-$DZVQ<JR(
M] 1Z?C0XC6L;FZ]?_]7XZS^;K>VM:K?U^_;[ZO5NX\_WV[]O-S_L_+U=[33A
M]?8-@^#KE<!K\VP\C ^V<N.9Q>V#/XSAM!-WTZ;WI]T,B1AJ!?D60<P'DUK9
M//J!I9$?8*F](D8@$[5'W N*G#$146J99-#1ULOKTK7\E'M]Q:J:6EJ7(E"-
M[:7JIUQT_5]9$(?M8;TTU5IWO]/I?P;#Z)>;Z\7DB;MV\*G=JTU[ 6V:O)Q8
M]F)LA]?&]V47P4(6![E[.O9D&'^Y^.77T!["TG?V2[M7/TA]T75K'[[FU\_M
M,#K\Q:AUC57M(9L<CIK<?_PV61][SZYY(L9O,KX.6OS=[^-U\N0W!5=/O/;>
M)NMU0U:KQ69=2OH\+=9</D>+U3H 8*7ZF)!UAI_:%PMJLEPWYFM;]<#9QPGK
M-%#F*\'[K'L'I6&E8:5AI6&E83]"PY[A7/[SM_SVS62]@+WDVS<,OR8.8*&"
M]RS#ZO-FUN 9!M8L8&#?] ?P9;TRLB]N9',6FY]_RNZB&S4(RNBN_.AN3S;M
MR]"^N*$M$_<ECVZK/[*=:L;1?V6,'U!3EVNPEZLU1?2^HD[B(/;\6:'*BQO:
MW:+!O[Q!G<1)EY%]<2.[VZNVX/I_;(YE>E*-VC+ RSW ]=[]E?"-Q^AYQ1UY
M?_?^M)7#$ ;#'&S7& <3%F/I!4ZCU@!N,8Z9+*/[XD;W0_2G@_:H75; %SBX
M^<Q?&=>7-Z[_QW9/?JU^C^%3F;8O<'AW)@&F-]W/SY'9_AEJ<RS1 >RMZ.NS
M;A4U^9A;+COW^/GRG/5+%C=TRS50WS6C_;=4DEBZ' (_/2:)0(PL!H8I)Y%3
MS@VSWEM%HU3,)A\.=L8G(>XI9O?5I_$^C/K^^+#?"7$PW/[O:7MT!N#JG.:N
M_+,_R"W='(W/Z=5')?K-?J\^50IF(WRD/L$5ERC[P!//4$RR#X2<?:#;_ B?
M[^Y]V3]ZQQMT6T![SO>W=KXT6I[L?FQ\;K3^.+Z>?:!)<_:!/0*?.]L_>M-M
M;GTZWVL=XV:K>=PXVO[2//]+[)UO?FETWZ?F:WQV6?%71D<LQ1I%XQSB205D
MN5#(,A-Y2HQ3+-<V]"N%;^;"OV&H+VJV/26K2:DFM3I936P0TB?">?2:*ZLM
MD2"6R7*BN='>W VDKRDB51"T" 3A*8*"$#P1B@)6%G&L(K(F*L0])D'JA"4O
M1<<+B99#-XHN.D]34$HG$%6C V&$.\)!4H,PONA&JPXF>@DF1:5@RF'DK<@I
M)0GH1J 2(:6XBHY;83!>VY"OM"%%-RI$6A"1',\GW8UW!H.V;IWVUD<?!25>
M!6WD5Q"I8&?QV.&7V$E:1H,)0R29"/I0$L@&J5#P.%IJG+$4]"%JBD%6H+,H
MZ/"0DJ9:$)NK'B9J.8W8@(;."0F&QJ(&K3J/OC2F=4$(=2II4(02L1)Q*S4R
M0E$404%26FFG,%_;(&)U-*%2W?>Q=,C5??VA[7UZTDF5DD1XT>/W&+K#+!?*
M!ZJPB-P08Y*-0;% M*"@;'Y-.KX[=,O[DB&!A.VFEOU22/T84G^8<>9'0:)A
MQB$EM4-<)HX,HV"_,BZ"CQ@G8]<V%']F2)<$Y3\86QY3_D!+)1G#H#J"M:IL
M3CD))HTVD9"(G7AT^8-"E.]/E*EO7F'#DG <>6HUXLER9(V.R"MGL9?*)1U
M\UNAO.0%*B\/*LI1K#"3/+C( 1_&8TJL2+FJ2@!%ID!E": R]:N#!2=BX IQ
M*G*92:\0K  4N128=(%QAMW:AM"ES&3!RB*Q0GE&A>=.P@IHB#>,:6*8<D01
MQ2S[GEG)"W&^/W&F+G6+-36>,!2D"(AGWY71%B/,A1<>E@K'<F';5P3+PIS"
MG$46G^2&1T6M]89SG_?OX+^HO1?&<&J**K,,8)GUC4?NG3<I(!6I1]Q&A2S!
M"D5M,'<B)NG9VH81;(7 \H!W_")C-#Q,? !&Y:/+^=%R!N3Q9QPG!8^JBUI'
MY1!(.03R<@^!,"8E3Y$'D@C74;E@HK8A:AJ),MCE'?X'MG[*#O\2:S%G,_M&
MEE*J%54HN801#R8AJW0"491,NX C"09TF%><WS2/EG)[?PEH7&*.OK-E9)S$
MS@9C"#8\*.R8M81AXU6@26%_-Y *;!8/FYGC'DI@SXA!'@8/<<PE<CA01+C7
MR5">J*#SV5(JM/G!:/,8_0=3#BNB29I+S8VASB:O$G,^:$(LOP<W1?]9#21-
M-Z0\!2DA"B/"J$/<28,TM1'!P@+:+BB_*O)\T(/AFS5/B_Y3B#2?W2BAHW5"
M6!H,]TQ;IBRF3BI)!,7I'H.LP&;QL)GN1?DH.2P@#/DD!.@_VB%M2$!4.<RC
M2P+0L[8!BTS1@ IO%JD!*<>2P9QYKCB'Y= 2S@@GDM.H(J&L:$"K#J79?2R?
MM,2&,60TP(AKII&1@2 5<+*>&EAK\A8Y?V687@TEJ-[C^+D6F(V9^MRS!8=7
MNY;V9A?:,AI."I5?E"&XK]QLKFX.?QWF1&>AZL7+BK.#.+YV9+]4[>X)#.MZ
M54U*"E5^DFZ^&DVS>%;M8=7KCRH;CDZ'^4J8ZA?? C>!I_P,K8 O'DWN75=H
M/XG @UP7%S[Z#TS8;IRT_VK!^.&I&[9#VP[:<3AN1Y5'>?)NB"/;[@PK:,2M
M#SF,L7ZFU_W>L-]IA_K!/HS@1_>B(N^5_?!JO"&^7CVB_O32R\;6M),&T7?L
M<-A.,'GJHO55_[0>^)G:%=4M>8XG_7)W#>(KBQ^3-S>"EJU39@JR5+N]:IJV
MM$*W]!+(;;3#/"GZD^[Y:2QA_ZKBEQ/HH_@J3Z'UE],_%[6(JDG"^JK._7EK
MYV22M.LE&CH()G!F"<SN=C^T?>4FE_O^$#CR 6[8[(]B)6M(W)S)+Z@'KTG8
M3&[X:C;?YJU="F(6[: 'SSON7OA$KME==V_FV=!F@GN?H5_98?TW>/ XZ)S!
M-6,XC]?CF3[G7]?G>6',"E6[=UJWYNHH](?UU;_4)(>'F=0")QB>>?+\G*ZK
M2=GQVZZT#E!\.HJ_3E9^/'N+J]?<3,BYY&,^$PDP[LN9?_-SU9IH3$9YRKWV
MA'.ME774!J9D\ERHP,.!IFL7%QT.IO+_*2(WB/88V01=\8OM?+9GP[6?K]:"
M;_?0M6&XT;O?VH4I/5\7UB,>LK37LO?+1*K;XW@5NWJ-K@X'V8+ZGX='G>"U
MC5;64,=:"8A[;_3OG^W&;1*UV@I)<[>U7>EJDL:K^O<53?QZNK=(/*91X\ X
MY=0IBQG!C(J@$]&W'S^]:D]N3T#Z9QQ\. 28MN#FOW7 QERL8<@;[8EAV'W3
MV3OR8!1VCIM'QU_VCMZ!T7;,]UN;<*_&E[WN-F_ =^P?[3 P\CKQ]_=G^Q_#
MB:-<[GW\N]T\WSS?_?B.[K;>M)M;?Q_OM@X[C2UH]_F;]E[KT^?FV_?=QE%(
MT![:W#PPVEJCM4:4:H%XX@PYQ0EBEI*H"<<Q3:Q_6 !BV,PF.W:.JB <<]+S
M**-A6%%/E'?.2Y_L6A7!VC[)Q!Z<1E >-M\W=YIO/U1_;K^O/OR^^7[[AKGU
M]?KUM>5H/&@/MFCCF:7J@S^,X;03=]-U^?K-#MM^LQ>VVGF5"_64_I%E+B>-
MT(DG'/)^"M.(<X>19MIFUX)-T7NN.;\N0\N/L18H7:G?Z?0_9YT+C&!;ZVD]
MW^ZTQZ(*('=9&FJ5^%*A ]VX&F9)R6I>&$O)79_(&EM6[E([N[/@U_8@5/\]
MM0/0 . +>^'B';@P5EUH].&PBKVL*EY&*8Y]Q1>ABO5%U]^;Y+*^V[[KVL$G
M4"VR\R;K%).7$PUNHNS5[I7+P<KZZB /5,>>#.,O%[_\>A&#VN[575I?=-V?
M U\S55O6\41UF<2H3KY@\O[Z^+UKSJ;QFUROPY2^^WV\3I[\IL9/O?&]329D
MG>-[WG]ZD\DZTT^]\4---HH_3R\+HI^CR69=,+IB+:;\:V]<ZE!]6S&,6[?6
MOF9/:P%E,,R*EL%8Q,"^&:^4K7H-?3=>0ZOMO%9^Q6 _SX&,(D(K*4+-K&PU
MQLK6O 2H4/W;=KMKVZP4%WSA$_3[',TJ@[PJ@_P-19C*(*_*()>9_ ,,\FTS
MN1Q-?FR'_G:?N[&<4BZGE%?KE/)](:H7^RW70E6]H$0&+ZS%C"?);&+,$.)D
M=-PEJ?+>#L584G-KUA3ZT/9A/<,NHTOQ:F[H3*)+#SM['[?Q7FNG;E>S]4XT
MSW?$[M;>E_U6L[/;^HONM_YH[WYL=J]'E^Z^_?MPK_7^L'&TC9M;GTASZY@U
MCHYY\^A-IT'_$LW6?J?1W1%[=#\UVK/GBXTRE#*/M),XIU]BR'KI$8U829FD
M\UBM;9!U=K.D08EY+S'O\^>)<((0(U0P"7,1L5;&T!BL2U%I@2=9:K'"!-6_
MF*MU#@I/GH,G,T>(C70J&8VT=0IX(BPRD0D4O54I$B&T-6L;>%W.(X-DX4GA
MR4,\>5+L2>')\_)D>OXW*2V] 8"D$!WBD1.D@3#(!$Y9\BZYQ-8V^+J91Q*W
MPI/"DX=X@G,0%;<Z2:NY9,19DC3#$B25)BIJ>X=HX$G13^;'D]DCODD%%2**
M,%"(,QJ0\=@AQV$A,$&I)''F2?9\K0Q/2LFDQT[L37@.^RF.'7'UJ:OAR/9R
MDR_#H.M(P5)0Z45A>SS<W]=#A<0C#E-_K#LAAHG\-4^SLWTWC3?#=Z=2>)7R
M"SXSO1J4G\V:IX. 9=<K) 3!.< Y(!T(Z(]<8!4I3S%7Q:.O)*/K\W!LE;3B
MA4#W$.@;?5J%0,M"H*D?C)(  V "<MY9Q%/ R"3FD$V12,8BB3*."236:2%0
M(=!B"?2-7K!"H&4AT-1S)J*V0@2)E,R>LYQ#V :MD758$J*D2(J-"<36<2%0
M(=!B"?2-?K-"H&4A$)^I4!DM\2PB2L$4XS(:9)53B$1AA38F4#DF$#<K9865
M,+C'HN#/?LZ>T,[YH\8.M_@E#GQ[6)]0K;,S0$/[_KCJG]2H.,G);98M/*YL
MF2RE[^TJVG=Z?E G$[.=U_UNM]\;0_UJBL*+C908_K1G^<.;@X'M?1HG(2N\
M?P3OFZ]GO&Z>&; 8I$?"1P$:)^'(,D<1=D(SD7#$.?:#$+%>@C\*>5;?YU;(
MLUCR3+UM+EJI7>U>LQ)Q%Q/21GF4C*#)1NL=SH4KB%J_F2"UD*>09]5\;84\
MBR7/K)<-!RPEV+@PE#F?DD16<(H$]<Y&Q5C .3<SQ7/Q\A?R%/(\KX^MD&>Q
MY)EZUYQ,PCHID;" 'QXQ1[JNV$4CF-'.1!<QD(>I]7D43B^A;(M"P'_B</C+
MA5_M\V';'T+'G79"Y7*>XI/3@3^L4V6/W6RC0;3#T\'9Q-_6C:/#_M>D2RG[
M*TO'_KL+ACROJ^VH=_3+F/,?L[2]SL+V6WP_%;6_LJ2U)H)6EP]IU&)66/\8
MUG^8\:QADBAW&?/!4/@'!^0T)X@HZIS@BFDIUS:47K\9M?Q=ZW^4/=S"F+DX
MU0ICYL28J0^-1!&Y-1(IK%0N?F:1B]$BS*,(BE!+E5O;T.P6%UIA3&',W!CS
MW=QGA3%S8LS46Z9]7AF8!4M5<,2M9TA'C!&#X5)42.$)Z#&:KC]S,=?"F,*8
MN3C*"F/FQ)BI7XSAB%E,$3&C-# FY[;1\%LPC! !QJX)9&W#F%N"$):2,27:
M[+&3_76_5S])#BX+T8TFSK$23[:*Y%[H6<[S..@'.SQ\TK['6 R'T.C=M 5B
M.*UI6.#^&+C/IBN3.++(G$/2V%R^1EED-;'(*XZ5X9(HC'/)@/H(]PIM>Q0<
MO4@<+2;(K(#G>X%GZATSV!&3=$(BB) M5XU@;"4*G',&5H$F(N6\9B6RM4!G
M]>/+B@ZT="B:.M&,IX)&ZA&/E@&*A$;:DX@,K"[1!*HD3T4'*CA:$APM)NBL
M@.=[@6?J6;,Q.>W [A(I&L2%%LC*G%]')+"VE3.!F573@4J\V3.D3IL442UA
M92^?[DN0/&U2V/G&Z?T"^L> ?C9]6E"),RT5DLQ;Q UAR& &9J],!D?&F+:A
M/K@OS?H\\NZ6[=K"H.5.GU88]'T8-.-P8]03RR@2RN=0$:*1HXH@XH)5QOD0
MJ+]@T#QR]18&%08M=P*UPJ#OPZ"IIXU;@Z6("6$2'.*)).2TX4A9:YV%051!
MU@Q2>"X'RPN#"H.6.X5:8=#W8=#4Z19H4D:SA)(A8(MYC7,:1P,O:8A4LD"$
MKAFD]3I9(0:5L+;'PF RM^ZH)KILT6VEF&@I)OK$Q6UQQ40G4ZR4UWG$:K4[
MFP).!JZU,08%YPSB1@ED/=@\R<? )+R,-M7E1$NYKK(QO0Q$>>YRHH4H3R(*
MGCDR)E1*(B#A-4.<TX@,$QJIQ)+P/##0C^N"HJN4Y:00Y>42Y;D+BA:B/(DH
M4Z^>%YQA&2,BP=>E62C2'F-$C+3>2R>3<[D$H"Y$*419!J(\=TG10I0G$64F
M%1LGB04=$9@X"8$:29$S2J'$N96),L.)J8N*KI+54SOH?J[#*>%G:/^S<='X
MYFD79H#?^'?]QW'+W>#GC<NGJ/]^^>:=,+I]BER=5U\]'1^8UIUV+Z+#\6M"
M1*9"ZS!>1*K=X5.KH+O\:<?6$S7U!]4(+DGM/$W@U_8@5/\]M8,1?#SV MSE
M0SP9Q>P('X\J5:^JO,17\8OOG.8/S#>VBCW"G[_9&[7KSFC_$Z>QLMN3AK\9
M]+NO^]V3TU'=%[OI.D(VNS"NHU7W\G?B[^_/]C^&$T>YW/OX=[MYOGF^^_$=
MW6V]:3>W_C[>;1UV&EO0[O,W[;W6I\_-M^^[C:.0@!;LP.)<65B!D0*V).(1
M- PC+$?1PVO!J8%WUS;HS5I+%4AW)XO#)*1R$$'D0%I&_2M5,8:O*CNL17!2
M/2-6)S -8]5/^:_P<O*YZC-\[M,@VBR9HT.8@?!V>U#92>1FUPZ.0=[_L9W3
MN%[M]+Y:K*M+B<Y79(&PO3.80S!_^J/J$.Z?!?C*V>OU.Z!0B'$K,4SN7V*>
M2HQOC80JQ)@7,1JM30&ZR)=&:^]LM]7XW-@\$ P;'A5'6!F/..$.6243HCXF
M0Z)@R>JUC3L+DR\4(O.;&>W>9&:,+KX2Y*\"C2?Z47Z(ZP#*;1_5#]-/:0A-
M<V?UI1?],XCA=#RUVOD_:$ <0ON_G,3>$![L9>"+XF_'%WP41AV^Y7#X/.K.
MMX90%7C-#U[;GW??'5#FI$^$(DVE05R"Q6-)=(A&137&GFFC %AW'0=:(JWG
M'MG^<76>^4#CAL9C,X:'8**V$YBKO5'5JV.+\GBOX-+V]1TPWX7MJA3F"9I9
MW.Z=UD]1R^6%1,YX$GS,]_D5.NA3NU>[)01(T>3EQ"LAQCZ$VG%P*=3]08B#
M+- =>S*,OUS\\FMH#T\Z]NR7=J\6O?JBZYX*^)I?/[?#Z/ 7H=895;5';Q(Y
M-+G_^&VR/O;V7?.B_/_LO6V37<61KOU7%'UBXCGG!"E7569597HF.D(V,F9B
M),8@/P[\Q9%9+X#!X)!@;/SK3ZV6H+=H"22VV"^MG,%--ZU6[=ZUUK7NK,R\
M\^DW,=U-B"__?K@;7_[-8_[-](I_\T\45'WW3B\.CY\X-=[WCY[8*WG^#&OG
MPO[[5T\^VZ[V7U_=,NMN>W:9Q;#VY!D%*=VMSZ[H%_VDVI.O-C3\^[.+/^S^
M%1<_<1M=G#;Y4_P!)'8^;K_7E>19H4EMB1JW2,1<U9)V7&%+HQ6&4O\+YXOO
M?NC3Q]<'FY\,L$7@ST'G>BM^K5_\0[]]<O&KY]ZQORVH_& ;;KR[^[Z%<_YR
M;^'5CB\!^M7C*ZC^^ND(ANV/;2]>S^]%W_GT\:;4_]=/[WH,2SE</0'6D^NW
MF\K_\NO_^)5>ONB*.GD)]/"#1_?OR/?=S?_QW"GX&XAAG@]-/AJ?;.8&'XZ_
M?[4>@U]^\NX2$E]\]>2;Q^/16N8W7RS!<^1PX^%'S\*-O_[FLS__[<._?OSH
MX><K), '[_[A7P_2AVN-^^GC%30\>.^/X<]_>[!"D/>__6&X\>"]__S;G]][
M^.F#](=_/GC4_O'PW0?_^O-[OUM_SY\_6S_YCS\_^G"M^?]__N"O__G\6<F[
M;?W[WE^:#;-UY0&ER-O$OP:: X%D*23K+3?M3^/+I6E&O[<%A267GD7J^@FF
MD%5DI+2UDT4+LXE>W!E+L_U]8_7C;\;%Y4?WWWMP_^&CC^Y\\+L[O_GC1^\_
MO/_11W?N/7SWSGOW/WCOPWO__?OW?WOGWH?W[WUT(S'RZOK_!\+KZ<;^] M]
M_A=+L:VWP3"'7(FG*F*9H0GW:4.&?)]U?-/7[)6][0J!G_SFVV>7[0?S-]\\
M6;?0DR=7M_];>\G^ZT%X>.\O)9:<9A088NM2K8+ F<?ZLB*V5-8NR0\WDVH*
M@BFT5MH"$MLV-I=PA-X;69D_O$I/GY\?W?NO^Q_=^<W'=Y[=4,_=3S?NE>^?
M_D<*,D3NYI)_9I"1[ZX'XL\,!7[BF_E9Y/.&8XSUVZ;LK_@7?<7U;OG9 >*Q
MWN-7#SS]%?_LJX)>]:KX!;JE7OQ0^.5[I_@(15<OKK)YE8*Y7_Y=NO%J8OYE
M]_79Z</MV-G?/3UF?7250?S#LPSB_>V@]15V^X G47O_4;\RS_/*?+@E !X\
M30"<]W7ISZ#]1M"\N\4CCY]LZ9@'3U.?3VX,'#G1&_\7WN5;==\_ESF^.O'9
M3DU\HV_S1LMW&[U59_E&W[*-_N_Q>/M]KK;XMY]NH^M]DV_=)CNVW[Z-=FR_
MTD9O9^/GMLO/F'WG!;S^B3CF6>YBRS"<UH[["_,7YB_,7YB_,']A_L)NIX]@
M/<QXW"=;'="=WP_]XNM/_^^I.0>>_RZ>=DK3]\[WSO?NUN^=K^_K'V;]VS5#
M[1 2[(-'OSW9X6B^OJ_OZ_OZOO[AUK]=AQB'D^$O^_C'NQ_=/36)?KR]/*V=
M\X$(/\<:] =>.:5+IDPCS614S;34V,*,94PLE?M/60.6'W:=?CC^9WSYS7CJ
M?//EU]M+^--G7W_ZVV^>K#=N/'[JC+/>NWM/GHSU3W^D_SP9^YN?V=SWU"_T
M;_>_76M]^S#]Y^?K=>$'CS[\].%[?Z2/__7YOSYX] =Z^-[O_OK@3P\___.?
M_D _] O]^-%_KM_K??SX;W\(#]]M^>%[]\.?'WWZUP\>/<@/W_TD?/RG!__\
M.'WXQ9_?_70^_&AG2D)-M8N,"L@U FEEX$D(IM@&SU*;\<5E"8>8Y^,&Q&Y
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MBI37L-Y,U5O)M/\]^FM4F$:FXDJ.#W_YV?M_^<7)\>&DG--,!,DI [$C.+-
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M.%+$8$4*T,0M0U4*MF/XXC/6F/,:%+IP6/M$.11A[=D \YA"U-5R;Z-#[6Q
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M2<JF0L67""T?D6B^OLC_;Z>)9IG=A)=!F92!1EU@8Q)PIE1JFIIEW=T3IT@
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M,CJ-W"=VSY$%O#ZB_^TT"R@Z>JZ"D(LGH-PZN.XOEQ+V5O:"YG%WSYJB?"Q
M<TG06.*%:?@.8@@]N2+WK1S-]BU+7ULV1Q;PZD#SF 4LR;VU+15UKAV;;KB
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MVB*PU0PIBXPLV+4O\9A.DGY[BJ!QPY3W&)X^4M9X>'HRP!S2;\092QD$QKP
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M>D4N)<Z9I\>9@L.(JE'HVR!ZFA0.&6?OLRZI&#V/=I&<.6IJ1Z921H*0,*T
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MY0DVNP"6V*A*["/M_IAP"M\3!XV#YGMVM!\I:MR<_&1X.50.#1Q-8Z&U(FA
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MC6G)+;K4?$V:?!O+QBV<\4YLW Q#[QB&;AAPW5(06<"U!]9LI021$E0!IW&
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M55BUB\H.QQJ!FRLYZ@(IE"%*ZVFW/S>^&%_V*62"!QF>I"0*6!H4R7,;K'5
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M#T@5D6J*L;Y&DOE'&MR(\L:(LLDVBV^3[XE<9P@..XPIN9/,#QX+,PU!/+T
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M<\,B34V$.5IIM.K*IBL!LH-KZ999RO[A6W*4&\T-83H$\9.$+ ?9E!MIPAQ
M(X\%,!3IVLZOVZ"#QH_D;8I6%%7P08SGCBY6*?L,)5+G8UKXG8#&X9$A@!<
M-_^X^(X"(.;DV"$=4==F5O?]5)UKRI/DC2Q0A)DT!F"<*)!GBDH@1,#$29(3
M0X3)&T%VRU3WQJCR> (\1>]H ,^%+7"2VVYB+B(#*'![HE_!U\@@"U/#;_-3
M]).TR^ OWD>?\.&)F/Q2EAH=;-\MV>X>;M.]XZ.<BXA0+(,0$QJR+(E#D48&
MI")56:Z-3D1R%>%V7.Y4G*/#THP+3WE EY6W%O;U^:DX1U49Y-NT]&9U=]'4
MP>Z6D0)_/@5-J1!C(&COWIR#JETU?]7K)O@S#]=NW56ZW8U\?'Y#$53.9S70
M'P9VMIHIO.P/4\G@8%YYB>(EPR*LP8F3L[(:@W >P]$-JE*6,*0FPD',!%!L
M828@.12@N9;>1\U\O" M0;HT+YQ6YD-1SFNTMI@QR+MS' !P@=M?P5VCW91>
MP!L!-B^6\$%PMM2:. =&%AFJF(JER"V/$B8I\/4L5F;@; ^&LZEH]_B(1DI0
M&_&0<X[\C.7 V7@&PED#T$]3D6<1<C9V(6<;!<?-6MY'8AKV^5"1_=^/:$YT
MK$06)@)4.I9;%N8LUB'5>6PSF7%K".[S>D[18I]+/#P-.[DI(']@?..Y-[[W
MF,;W3$ 4",@*G6@5L9#F0@ $HFDH5:XP699(CAU3\BL(R$G#\6*ID9)PK;\/
M4NK]\!V3TO$9\B*;YQG)TY"ZJCZI%&&NK0JC.%-I+I6AB4!26K<L7:4&-ICS
MO]<!G3=S-P8.Q%N;,::#6/>,&#?[T.J?8?9_X.07$?7?,6&]/]O[_2CF*A$V
MLJ&RPH*NAD).21[2)(^LY22W47XYF/E6W,G>9+@_";8!]8]]I#G)+U/,8#)H
M^IL!&>%IPA"^[8/7"[4&=(R?4;WX@ ^HIDV&C==_@+4?'U?F&$W^W7G\]+AP
M'O$HEYE--?"'6,8YC?(TSN!4)3RQ),,S1?*(?48X>.M6_@5V:[K3ZH1XDMK$
MA/UI8[Y;LN5]OR?LW3;9W3XB5ED6*QL2(6* D5R%L%L9T*\43*LD9M1BUNA%
M4:0=EE2XJD!OH(C?4/S?,^H0]<GW3!3Q_O:1)$9JQ5DHL/ U$QEZBH \;"(5
ME[ ]><0W]S9:(@IGV(+E7 2%(F"\)Z2!P2PW( L?_H<(L6Z#7;YG*DEVCX\$
M,\9$7&/PN03A;+*0VP@+.C)!;$0(12J)-E1&7Z.2JEE2%P56+99Z*PCZ$515
M!]E=](()9^)C<(QV4_RE:FQR3KL+?B@F( _-X\!\G)I);4;X[-'GR;$46:5F
MB#HHRS,IHX2*G*?P3Z(ERYNRI*PM2_HY+.L7F-:KLJ[W)SZ*IM5@OF.JVSG?
M_?THI4G&2)8 !E18RBE1H<QC&4I. 2FF&8L%W5SF8(GJMKX;6.BG?:G1?GM>
M%77PJQ'CV4F3>FC70LENQ+>YD$20-%$\!24*! :+XI0E*J4DT9&]S8,R>&NO
M=7AVSX%E)R0'73T&29[F2<A8#B(^520T6NM$B#3)(HS>O]0XC"RZ%>RBL9/T
MW45-*O QJN2=SPMNF$]1Y;@)%1G@L$I%-+49L%LE<Y;E3,0QS[*$""LOD/[9
M9Q-/,_PE,FK-/>??,PTQ (<\(\K*- V!9-*012G6LS($TT!(EF=,6>L8,%T/
M0UL04>,ZZ[3,4>M$!8IQ[B[G)*V,4">H4;3N49#Y&IA8=>K  K!2T'#+">*$
M/@OS;C5TCWWPK,L9C)HL:1]8TW@7 _3?3ER8B_<E @VCPQ,(2,UK#R?&<QR
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M$T3IIQN9W"SVRDGI0Z FQSMN/B_];+YCO@5S.#N*$ZYS;7B8*X)*K:1AS@6
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MX)"Q$>[)L#9S"Y#%#Q36QP?J ]CX@*XC;[DY\6:H90>KRR9H,QG.N^^W?!Q
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MA1FC*#?!#\WL%G<];@[%V@^-*<KQ#O]CJTPLU-L%!6]R;+K</U!4RGI>>0$
M:SH_;:@9=)^QR[ANWOR#7W%W:AY[U(\;)Q<#PAW$PC#-#9/218.U!Z\Y;K.F
MZD[=L:-UD.Z-HK#JI[[8LC]X>,"1(-V,WV&1=K@&AH[\I=5&D(4\$PV*K^<
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MY\,-6@"_'.K;:[+4^%%\HB;0;5DMM>S$/+X>*U1-5,%"0OCYK0B(+N9W65U
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MHRLFUV29=C4H8'TN6K-&JUU>P<6HW"O[VP3O[1[KFAV@OZBQX(D/9>4+1<'
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M'Y#3("L@K+1PJ@V8$/ =6%(TG?&QO2$.Y7((AVX@(T=\$%6F4I<5>(N:\V1
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MC MW:IU1PH[WR0 BO8=]Y3+!G8_DCA(^,.QEGJ,FA:YZ#+,"&1,5H6X23:C
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MY8$0X;=%.T47PFH/RH10\D-J AF]R+W;#C(6ZNEKL%2F7>!U*A^$DN9$(9'
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MZHHC T]59_&X#6/'O77@M7G:*YT! Z7$LI'OYBGKGK(H3=*HH^TF61HQS"Y
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M0;5M=0A$9GM3LM6,.C(;,ALRVUN0;<]2+\=)H>U9T8WS0,R,_*3+:,Y?R&7
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M!.F"H.J6D_L1065#D&E82B)(D]B20A7DB:'B\6^-[K$AL(Y= &H5T^J4H@\
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MKZDZ?0TAI!&$MMNJ!B%4,@CE8I-A<9-.-MF??]ST?BU$P$QE&AP0VG<"&K'
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MD.NO5[_VOIQ>:"KI03%NU3_J(.\7I+L?"A(#[20.@#2#F*5H!,7(O^4D W3
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ME&J.L$'8P%HN66 GEM!;(ZA W<5VH04L]A([2WN)::(4Z*KM[4BR3R,VZ;.
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M7!'J$ZA)X@Q($L<2BT\D>RZ=0R2, ?L\ZV8YF6SN'GB81#4+1LED.N$9&,;
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M"CN:Q##L2>%YPY<1YH@\09EN]DMA42%Z64.-/#6EA]'P9R_ZH#C9@S!SV1D
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M6Z:7F..6W-<RY087A+(_@5RFNT+F+I>M5#B%:J54*)?6H'-VT5;.:>DQ6CJ
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M/- XRC<D-@^ZNBCO1U1X:M_?HP2_% /<2#8L&!L>+@:2]P:L-]HAK)^FF(Q
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MP\ZOLAW\/*1V[I'G =N%ELU< .8+M,+E:.531-E--SFF;N'&=(*8KB2GEUM
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M.F6%N KA_[JYY>=K*HAOS^$"_/+3_P%02P,$%     @ O(!742%U:JL3*0
M^:L! !0   !J;FHM,C R,# Y,C=?8V%L+GAM;.U]67-C-Y+N>_^*NI[7BS;V
MI6.Z)VIQN2O"MBJJRN.Y3PPL"8EMBM0<DK+5O_XFCBB)4FGA E!'#K>CJR05
M!7R9^0'(!!*)__ROWT\GK\ZAFX]GT[]_P_Y*OWD%TSA+X^GQW[_Y^<M[8K_Y
MKW_\Y2__^7\(^9\WGWYX]6X6EZ<P7;QZVX%?0'KUVWAQ\NJ7!/-?7^5N=OKJ
MEUGWZ_C<$_*/_I?>SLXNNO'QR>(5IYS>_=?N;SGR9#RU1 :1B'1"D0")D:0I
M=8%'[FS^O\=_D]8)9K,F-$9*I,V).+"!9&J9<"$:[Z%O=#*>_OJW\D?P<WB%
MPDWG_;=__^9DL3C[V[??_O;;;W_]/723O\ZZXV\YI>+;JT]_L_KX[U]]_C?1
M?YHYY[[M__7ZH_/Q?1_$9MFW__/C#Y_C"9QZ,I[.%WX:2P?S\=_F_0]_F$6_
MZ'7^)*Y7#WZB?$>N/D;*CPCC1+"__CY/W_SC+Z]>7:JCFTW@$^17Y>^?/WVX
MU>6_IO_Z:YR=?EO^[=NW,V0"HNQ_:W%Q!G__9CX^/9O U<]..LA__P9_AQ1K
M4L=-Z>H_+G_OVYL>HY_$Y:07\ ?\?O7;I8^M.H??%S!-D-:;WD*8Z7PV&:?"
MTC=^4@SP^01@,=])P(?:VEOHC4!>*Z+T=M7?9!9O?6A2*#6[5N'$!YCT/QTM
MY^38^[/1Z_D<FQ[YQ(06@1.01N.8,YR$G"1)C!IA?/+!T-L*6<'OV9?]//04
M7+6*5&3N6Y@LYE<_(>4GA+(5$__C=O>7*MM7B+?+KL-I:*2\<QFPN\P5)Q)P
M_K J,((3A^=1L:1#;B?+"L5MD=9X\+J+KV9=@@ZGUF]>_09E(ES-LI>0?!>_
M(LCM,;[ZQ+?SY>EIWR89+^#TZO?+E+NWC1>S6AJ^M"%"WM?('[O9&72+BX\X
M)!:OI^F[_UV.S\JZ\Q,41%EY83EQC DB><:OG$U$.Y13Y\BD;V+SQT!M0@'^
M<BA03?_5&/%ABFOH\3A,X%(\!/+=[W&R+)[*][-9^FT\F8PT8Z"%#$1;5;P)
MB5PU(>-7+C&?DA!6M6#&)N V88AX.0RI;H]J3+GNW5IJ*).%G481J:@FGAE/
M$O6&!:-Q>8<6;-C&XO+E6'PGO5:SZCO(@ M2^H#1R2E\\;]?TVYDD\T0E2!!
M<D<DBYHX*R2)CBF3N+(INA9V?AC2)I97+\?RE71?C0M'BQ/H5AAFT[AR5+33
MU&>/EG(XX\@4&;%:4\*ES"Q(H)RG%C2X%\TF#- OAP'[:[R:\7\8^S">C!=C
MN'91 Z<A&LO0%PF(@V$0[$),A%M/E<@L^61:6/YK*/L*]_EDUBV^0'?Z9M9U
ML]]P+9V/<@+K@W4$3,9%5*,7[JRT1!CE+0TV^QA;2'</EB$%.GORX"[#]]5\
M-7Z_CG&VG"[F'_V%1^_J2C8=?)3:)X*"8!AF#"66R4Q2\M%I 4EEUB30O1?.
MD,*=RD2HH/^:7.B6D.Z1D+LL:1:!,.41CF2)!&Z0I":$ &"=2$TBG0<1#2F\
MJ<^("E;8FQ3_FO[K"LHG"'X!\T^P6';3.<;G&*^?SHIFYB,PAG,=35F*/7KG
M&)A;RBC1C"8M<@J:RR>V.S?K:4CA326+-U!QM;G@N].SR>P"X!-,RF[Q/1(;
MPSAD#,FB!4,DH"<6!.?$9S Q2>!)-7$4GD0VI'"H\MQ0URJU%X[K@&UMR@(%
M+',,TSS.6S*+2+R+97,F:ITEYU0V(<F#B(84*;59./:T0C52?%[,XJ\GLPFJ
M=%XV=!<7B.QRQ^XC.K]%Y8M%-P[+17%\OLQ*I#>;+E"#V.+QA^D".I@O1LID
M;H(*!#V>3&0PCEB+HI@@5':*N@RZ23Q2!7Z%D;4\7?:#O0^*W\Y.SSHX@>E\
M? Z7EOYA-B][(T<933[*&KRG 1U%63;+33;$X6)+($41 O=12]%HO&V#<TB1
MW3/P])Z1V\S*U<8S^B9^/(7TG>^F)5Y= _T.\CB.%Z/$N+>:XY+#$))TPA+;
M9UN L@:<3B:%%NQ[&MJ0(L@!$*ZR+:MQ#(E_.IOV"OIO/UG"")06BK$2_4;T
M?0T/Z/L64%1*(6UBPC:9_>\"&5*\.0#^[&6G:FSYTH&?+[N+-1S)YXC  T%'
M)R)KE20V.$4P4M+.4Q<Q5&[!EZ^A;!FODC\Z9?8T5HL-_5%"!S@QQ4A24J(\
M5!''5"9@?70B"0VF"5O6,#0XGTA6&IVH)L)%#"08?N6B=(0E"QD'8U:T2<+*
M;I'X,VS@;V7WNSS>4^'U>#R;'I<#A'<0%FN'9#)+(WD2Q"2!KF%(EG@J@' E
M$LU1<TA--N[OAS,DMZL: ?97?+LTA34ARWFYB][E$"P)"?%($2B"PADVQQBT
M]A@IT";;+T_@&I(W58L6-4UQN%W<U].TQF&P@O$H<4%V%#GL;23!2UR:K7":
MVVQE:'+,LQW,@9X$[,6>AH9JN,N[AHA2R922C'ANR\:ER,0FJP@3E#'&@PFT
MU<;3@Z &>A"P%U&J&:%N>M3Z9'>#Q].<!0L"'2,%*"A7),B4B(%LC#:,9]?$
MOWX8TD"W__>B1"4#U)LG;B7T!_2$<L:IRJ6 $*Q+Q&G-RAEVYBYKD6V3=,E'
MKDSLL"_EYR<X Y>_2OA\[B?8Z/SUXJWON@N,D%>;(#$H Q2(,ZD8,002>,PH
M+R[T7%'CC6VR6;4)NB'%8KLSY*N-J.J&J38,?O3=K]#OIWP&'(^W(D9<I4TN
MXSLP[XD$&HE5D(@/3(0@512IR:!X!-.00K5Z_*AEA.KY=I\@ M(5@6%P<(V(
M69& <9*<Q_5;,$5\]I(DJ3A-4EO(O&76W7V@AA2KU>-%-3-4O'%TCGW/NHL2
M+()D5(4L,42$DM^E@7CM-3$8)/*@F32\B3>]#F)(858]P^^LYHJ7#>',C]-W
MOY_!= ZX>*UENU])Z!!5*-<>J4R&R!@,NO1 2="!L:0YRZ')G=D-L TIJ*I'
MB]I&J>Q,_Q,FZ?VL^XSNS4^SQ4??+8[RN_'\;#;WD^^[V?)LA;%'/<K"2>YX
M(N! $YG*'5JF ^$Z!2JSL#0U.33= >N0XK&*JTMCH[4X#$/.?WU*.%+&1J.H
M(%9DADLA326'# @H&V6P0&GTC<^2[@56\Q30:*VX<Y8PZE#S(C'BBS.($8-1
MFD>!P_N@IX"#.2C;GQ./G)YMI?>A925:G/&Y%10CAE1TX% ;5&HBE#/68U#I
M0I-QT2(K<3#'<O7I]@S6KIH+-5Z<]OL9T_0682$DF,9^Z"@:!41.1"K[_U(B
MM,PCP37$ADR=C+K-3M/#F(84)S;E5"V['*9Z22B96=I&HDPHU3-8PF"'4N)8
MN48FDH+<Q!?<O'I)18'1JYK/1])'9B35)"H3B608U05CT28^JX(VZ3:;:X_#
M&M(27XTQ&Q=RV=XR-7?<;G);SSJ(XUY%^/4$>OU/T^O3LAC\N__Y@R*,-&AJ
M#0/B67_4*DN:#WBBLS YHS @6NW.51%@RU6_;49B,PH^B[GOD/4_O[VKXA_P
M^YI5Y3":1(PG*!%V<AO%?B7F;C?<JM[<(_"K5>'[O, _^V5ZEJ_RW/?4U+U-
M5M31TY KE>:[N5/R'D?FI0^SQ-Z.<"ST\.=O(,\Z6$LS^'$\G76] WWI%.-8
MN=W*I6OU(RQ.9JGLLLXO?:21"I X,ZHDA.=R5UD3BS,]"8IQZ34-P<D6T^8!
M9=R[AE19'7$FRF.<=F12+'A*8M &UTA;YCX,DJT50;"L<+)M4EUD#<.07)6A
M,O6K<E4[FK#>Q@;T,>OW,$7%3,HJET['T_%\4=1T#JN=[9&C+D44A7 M%)'4
M1US?@!,/6C!M@Z"N296RS> -RD5Y*=1K8/F*EP;G@,V4'(UW< Z36>];K2!=
M5_!['5$M?>XLCJ (\_G;V7PQBJD4/E"2:,D1L$?H+F1'?(I<2!TX58UN$^Z,
M><M-D#_Y>TB.-";U-; 1U3HQJX#H4J!.&I\Q<I&>R,!8#DP*G9J<WCZ!:U W
MTEXV.7>S==5<D4OA+A5PO5&-4WS22:-\-OA2*U?@2#"E3A[WP0N0OLUNWT.
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M^1"^+"KF)F1=F5P2LZ!I]Z.#DW/P6BMP(@OO3,RJ;--J<K^GGRQ1CJ20!A'
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MR(V-/!FIM;3Z+EDO/W]_%^1572W^UO^,^=DPOQXNUC__SNJ3KP*"SC&BB.3
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M.$2? EB3R)QCBAO59.;V8[%%NE;<=E;%+E)O8%6LJXQ]UY_\:U[_2E:2=$R
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M:%0M^Z)=S:,EIB;)-?I,>FR2G+L%ME/B1M>JZ-!_N6_HNN2"9ZT1O).T;$$
M@ZTSV&NC#.*UYVG%=WGJH^OW47274NS09ZBPEB[S!F1%,<$Y6A"ED&M>'>C@
M= +4@9><R#./9@O]WOV44U%QA[+<6.76MM5+.L-\,<#K;4EFY>\$(?=K'X;)
M:-#/-;WY>1C4XICW9XC3KMO '(:B18N8#N6RTCY&ZI0C[>TE>*UX95:(G$?+
MN1':&;:A?4QG(NJ*,+^6@FEZ \]P1 ^<]#\.*XPP601OK@5VFO'F$#!-Z=.9
ME%98Y'5Q6#(='#8IQ9SSBG,9>.!<1XGZ/A8=@NLH?8I,#H%,8DN68AV3)1(Y
M28870-HW&:*4D3>Q1!]OGR+MH]+H#"1;0LT=(IN!3BEPSC+#Z_ E;!(U/J4^
M1;NPJHL^1;OHK&F?HJOBUVLU^3CM62%%+#:!SY8 FCH)#&OC4R%Y"2$ISQNW
M ]N ["0IU*T^CI3.U^@Z1M%QY9*N_11S[8,8!:W9%:BC8H+47&5VM/$IWT2M
M6#?$?52\>"RU8HOU+\VGY46!=(SGI 2D7 .](FF2.#$RH14H G-*EQ847P_G
M&[CBW8D[ZZLL#M%ANW*<:ZB6':6WP'6$4JY;P![F3K<+Y=W+AP,D?TQF^"!%
M"=X#3[4F6-04!QLX,)N-"C7[I4V^VG$9<<_][3$)L8O &Q#AS6B8+_WV9>0Q
MVRC<S-M@ I0W$IS4EA:KF#$Z)VPS^W8-E@<KOSE04:-NI=S4NUN3O2V,\SE&
M!\SSZGDBK;4D43/N#'D1*F%ITL_]&Z^].<0"Z4R?QZZ]V0;;]]J;_52Y2V'%
M/GHX=NV-B$Z*.FDG^L3I!:G!,)D%V&1*Y#&RT&;4R-.JO6E'D1W$WZ)B_,Y<
M?W1UKJ.K X1M!F6R!R]I&Q6.!;1DNJ%I4SC^A"HM=E+@3I46NTB_@35S5\:E
M0EV4,QH"-QY4B1'H9(V S*(KB:G2IOWEMYTP?X@MTY4VCYXPOPVX[PGS^^ER
MIUSH?11Q](1Y9[RS5M<L7L: 7A@/,9(;6#+*A#IJ;9N4?3VMA/EV)-E%_AV2
MX[[TOLR5"0H=P;)T2(=$>ZBFG5,;&83TM)VF^Q)>GEB2Y$Z*V#))<A<I/M"D
MM%OY-(3^]? SSL=IS%KEMD]ZNN.91\EMVG;-JW/43-2BQ&!R*4HX%WVH0_84
M8\25&-RV*4QW//XHF4J\WMG7C'[#@P*5ZRPJ+PP([I/+3@A6CM;EYG%D*B5;
M8^S5/6&%-H.L.7A1ZV]]"BE*(^F'WS.5NF-5%YE*N^CL2+'L)LV8K5+*2+F8
M0J-$5N!9T& 4=S+0VBU^;]7]V C]*-GQE(:\#7-MQZ^="!E= N%,'7.O.+B4
M"M"W H_HG;=-4J[:+NLD&?^(F-#T-JEY$(MS783A"2Q+D3P)%R':Z,'*8%U2
MR137>.3F-Y9FV&R??SA>/)8TPSNOC%PM'ZHCBE!R"2IE!R%D"](6\J(%DRH=
MK6#B&[KPWXE'NUSX[Z+/8U_B;H/M^X7_?JK<Y39W'ST<O=EF8EF4I$ D9LB[
M5 6"BAQ,UF1W**.2;9*.^+0N_)M19!?Q/V#_/%ELR:IH(.LA@=(,P?.00+LH
M-=<IV-1D<M 3[9^WBU+W[)^WBT:.G X0L@^8R!0@5Z7>.&""4/O[E< +YY;<
M=-V$+-]V.L AEDY7VCQ>H\;%F[8-N._I /OI<J>;WGT4<?1T (\YE51;U,8X
MJ]ZLS9U* I&C30*+=<*>"$L.2 =H1Y)=Y-^H?][;\OXB3OJY'\9?E_OPXD3E
MIMBH"$XI2A$Z9R%&;<CDR\SX(IF038HR[H;UV#()=M+AFBY['2F@0Y/FOCR'
ME+RPVBO@1=&*2\V=,-7P<M[E[#TW?H473SU;9!\==RG%C>]^VVR1B_-S(N6H
M/$MD8_6G7V=F&>;IZ-?_NJ"_7F4Q=)XSLON36V2.'+C^E?P1##&3B^PCK\UO
MT#J3R"AEK B&R6'8D#^R.X@.[O2N/O7-:/H.0^X/OOX>QO^B)Y!I?14\1V8,
MK0@!-;T.R@D)T4F$*(.D%2;/=),>+[N ?(B,$J]D5;8!5_U0)96IB0FUAL^Z
MHKBB?:3)S>63R"AIQK N\DIVT5S'9^[J"_UN-!B\&HW_#./<T\Q[IW6H=Y\D
M!A$5.#I\R!K59(;J+(I06YRY=SSB!'G0I5 ;F-]7RWR/Z6),TL;)F]$PS6)=
MTUXNGGP-;Z%V^@>53"1.>@%:YDRV'V?)-\G5OAO6\6C2J?9&S43?@!CS55\A
M^T=_>C:Z6+X==,SC^)SV,T)_:3+,TX-Z5J#)DF0BM3$$G$MPQDD0A:-4J*18
M-<V[X<S>B$^#3L=16(-@XASX%:C+Q)N>2H7Q&NI(O HAU&H(3S@M-U$GF44R
M32R[C8A.B2F'"KSC%LNW/(G5M*PR2U&DWYK,1%[#%B^)ZL./?^"X/\H]5VSV
M+)-_S"RQ6'$&]"T)R:.QECP=X],>ULFN.)XV18ZNB8TMG)N9-$)C3(%EL"K1
MN>KI2 W,:RA92.-C<MPV:3"VBTESS./:."U"G8-L2ITKYJK><G)@8I :C9$,
MF\BCH^-ZS^#"L\D$IS?,+1=33N1N&3KS0!FDMX6,>DAD\@M!!G_$)CF/:]$\
M[4VD.T'?WAUL)]J_V^&;7]U&7ACCY'J;Q FG(H,H:NT@)C2*,6:D:N+Z; OP
M6"FL1XN4--',8TE#O=S#GG^=O1$O:OG%8F2P#B[:4D?L27H?C(5@<X8LG$X9
M,6ML$J;;B.BATC+:Z'^UG4<G>FC1Y>7RD)MMF(OP>WX[?%=/R&I=/0^3_N3O
MPU&<X/AS%<3KX:=Z7A)C4W_07^2C7*WJ<KCX_>MJF8W1:F$/D\C1$7\VL?(Q
M*/\ID=M+@3Y;,B%*)F.>S4KHG0.A8Y;(/#.KDW>^15+?DW?RQ#B]B\Z/$!A=
M-EXP(5HL$H(RU8UB!7RT&7BR4FLO1.!-CO'U<(Y_D?(XU'U/3'0/735(T]W"
MT)GGMVM9DLH:T"=11V'5;&*RI5P.K& FPSHU:0FP);Z3MA-;Z*A!['P+F&_"
M^67IRQ9@6YJ".Z%]&/NNB=YWY]:!2FM59K\U:)9\X+;0EIH+@=8V@ N!K >9
MK>&96=.FE_8C8-@]QM;C(]@NNNJX']BMJX8_^].S-1'@14;:O.6FL,JBE* 5
MR425VFO1!0/,F%1<=B2@;?J$[?'H1YF=LJ\B[[KPZ5@+C5.49G#7WQQ<1UQR
M3K4%&M2F660-"!*,<A8*EX599YUB?%_>W/OT;XHZW>KB8?*.7Q%H<DO"8.[.
MA&%>IN>1&Q&FE_^FXZ3C71_;(./XH)6OI!LKP9T(C 53BN+).*TT)\\K^"*E
M<'%]NO&N"+HJQ)Y<?O+5A4;)&CW& /1>N#E38PH<@M"&IYS)^6QR.WHGJA8]
M,>;"?!8GLWK6'KE-RMKDH5C:VE4@WRDD9\ AIWW"9)[5T49AW(3VD&7%AS)D
MFV86!RBB:8\Y.D%(RO12+M(&E+=UG"YP'NM4(*/!IT)_>..+ELDQ;#R3X":@
MQ]'1ZA#E;>3& 9(_UKC+U\-Y$]'YCOWL:H_N:<&,,%( EZ&FL48%,5A&?QB9
M<S"67I9C;22;89XP>SK7TK%ZFRW17CO\KT,NSDJC<H3H(P?%@P-'+P-X6H8J
M%B/RXS4INQOKM\6N#O358(+!8H['LHG'VA6\N3[-_=F::>ZS%^?ZHD*T27IK
MR'/AY#<%>GD"=PQTYB%)YZT237:W)JLY.9H^O,X;I+=VLJC+6K/K"XNH14%4
MD&RV= @4!8XI))O68W#:)A>;=,-KMJ+OA&ZB^]NDUEU?JK_Z_*;?BUY[Z[2B
M-ZN09^5X@6"$!&=U"K)(X=OXWNO G!R5#I;X;1:80UGP[#.M;I;Q/1K7JH(K
M="\Q3J_^ULN"EZ)"!A%-Y:CR0)MR@L"X=A&9%;Z)\[DMP)-C2Q/--,CNOA+#
M[;SSI)$7[4#7%OV*H8:HBP0;8C(IQD*?UM9?>+@L_Z.[!0=)_S8O7'>\N#SR
MWI85N+W(1.!1.(B&:5"ZGH$N!4A,1:YYCJY-J_=MP)UFU+,C932-<LW@7 +]
MZWC6N'O9J<$D,H^XL6"\)UHG'VK(1("V(F(IAI72I'G9=O!.DS2=*:1I(&N^
M _:\RB'5LNKBR+A60B^&8[A04!<"E'7CT2ES("=,A=V$W""T=,]^=D5.IW+Q
MUCNHW;I R5P@EE@[^97,K+9:EH<X8$Y\O^A0*0W".6L@W=S;YL=A\88)E 9$
M+9A4S OPM5$##T%*'F)QJ7&T^RYXITF<SA32(&!R&V7UOJSS5A?!0.:<0/&:
M-:]- 89U""0*%;%)VN5:-*=-BEW%W2!<LBYYIE;1WZJQF-PLLIC<+,FXI/D\
M$B@]45AG7IM^U&'II7;5+PBHBD?-F0FQR>R!)JLY)0X^O+H[#-C4Y,%U"_IS
MBP7=7,^+LS#\2+]W.:CN*JC-D^<^6I*VK^U-(_T1Z@2 R(V6PD82^<KMW-J4
MS]8X3X&DCTZ?#8)(^[Z &]Z_/R[&Z2Q,Z!SAP5K'60+K)2.!9U:'-AL(4OA@
MC<NZ30OT5@LZ!4(_*J7?)K-_9&1^C]/IO&4&B9MKC;(HR#K7NCN9R1,GZ?N"
M9!1%M%&W+<KN?$G?"=VYXM?$; ].5FUC(;D4"MGV"(4+LI"RE?4RQ ,7&*V)
M++/<9%;Y$0SBW46\UYALYJ2NJ5Z"%5]KA1QX'VH_@6(SX]J(-C=O3Z(1=;L7
MO;6JUKS!!\?/M\?\;#RN=N)LXUF:C/,$Z;?EOF7R7B2YL>)2'6A![W2B%]N%
MDL':))179$VB>EA*'K2^;Y/&QZ/$&NH?GJ"Z%-NU6=63YV$0A@G?GR&NG3EV
M?<[=Y>2R9?H7_>Z\$4)RDLXN5N=Z"#J7O0L0I1# 9.:>_B9*F]EO[99T_/G-
MS<RPAU7W8^F/MV[ELSKXDFVP+F?PR&3- Z#%N&1(T)Q%Z[,)HDFJUR9 #]7U
MY+'P975W[D)O#?(WUN%:U#IO@ZQE%Y3-T!ZFY4DW*MR"%P?(_[@,015+4 Q!
M)%U ,>/!<ZE!JJQ*B3[XT&9RSI&9<4^KDF,38Q>QM^IP<Y6R>.VB;]&U@!5)
M6V*4P)7/-3/>0Q29 PN1ML\ZR]4W"03<!^SXUGY72ES7MZ8K#;1JW/9B$SB?
MI52!CM$H.3D06I(AJ,F+%L)+EPM/03<)<]R)ZK2XT8GL6YPE"Q_UVE2$^=16
M'9S+W (::4%)^HJ(*L#-DENU$4XTB81OP//==NU<:PUR2-?!JE^.<=FM9QN
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M,4IL-))(8ZQ.@E.:<A/5>1S>PU.J'?!6T9TMYY>K2/ #X,NP@&M<UVBO1ET
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M5[9_KQ+;[_)[=*KG-ZSORSFDR?)44@4V6X&*PBV1JAR)2R$)^O/@O+1>M<D
M/P[N7_K8FN.*-QF'HOX)>5B4U#LL3H%YR5,NDTJT1 .NRP14G4C*)CNFH@NB
M2>7]%AC_TL$F;%:\#;D9ZH>KXO2WL"Q("]!7Y_!Q=GTII0CUY?F\)!Q6W[+3
MJ%W&:$N7I&X@$BB4HN=(HF'<"*4RR!TIY:/P_Z6P.]>"BK<K-S]&?ZKL-'GJ
M CH=Q $4/T0@XIP]449;,%RBY1>[T=9^@'^I8WT>*UZN['">Q,^0SL_@7;Z+
M^(9,NB-RHYSG( DKDZFDS)&XH"C1(C!A; C&-*D_W0KEKJ[/M,_LM2/GJ5RG
M^7#K);SJ LH5E0">$@H17PKF/;$675GK&. ;(IUA38Q;/YQ]%:PTI']6G88&
MF;N[J"[/S(?@:EF^L@G8?LI7:I#WH#Z,D/PN-<,PQ46,";5>%GR2E>N*FFB,
M@!D5,IHV0R%VJQ$/E*_L4B&V$7B+"30WO+S;1O*R(%,SD.!C(#QHW'X9.EJV
M=$RQE#/F$Y4NV18*\1"PW;O'=2A<GR]34_X-SA)710BWO?U;FV@?9!,,E8%9
M$J%<'Q*6HD=N2R%O#$I34#0UR0,\ NN!:%%KEO9:-]>FIJA]Q="0>J"DA+5E
M< ^W68K(@U66:>J5*XD2=W^5URZK?208%AC+1*A01GVZDM7AG"01I(DT!<=V
M=/[1H-KG4LBE?]A\$LXO^O(F[AP'C6^%#X)(7@X"0C+$Z,@E<]QSU:2^J0_,
MWG-!%;1BP\[W>*$WV.VV"QAE"EI"0#MM/6[-JZ:72AFBE(:8T'XJTZ3RX1DG
M<\8H3#MRGF8RY^0KOA&S^>W+=%E2J7"K%C1:@B(3N%^K0!B37 M'1:)-R@@?
M1/8\4CQ;*<6]$=Q8<IK']&L N^NT R#N+O'3B_$IY(!&L[N-[HR@9D]:Y)*F
M-,@R%4C[<I'7X2XM TE26YYBQ!"BR7#'O6G/5OFB?2C/-HQ45)I8!I;.OY_^
M>G(JO0')(A :=.GH7(YIG =B<J")@E%*]-Q[6W0$+""^^#3[]O?+%8M.F.Z;
MH@[FACI<?^J^P_<*9,Q&2;*!#_SC; Z33ZN,U&6F@&GAC8^<:-13(IW4!/]?
M$0\8M0H!*LLF5QKO(#D<NNL(NWE:YBC&\R_G9WX)%]F'<@-I#I^+6>R:(S\B
M+3-DU7%IF:UQKZ5EN-+)Z9Q%UEI::ZS7 $&G<K^190.G6SY"38$_^L;C\+6;
M"W_ _4<# "8B#]DGZ0/S0B@(+C)C\8%,'$+!B&N0 U9_?%YRB\6;4S$D2UFZ
M-T2+5EIZ)UD0Y=ZB+:.A93;:\T&O0YUDY8 /*D5JUPD'G:VEH 0!5K+<I46)
MY3X1[CU3WLO,VW3GV1;H>+<]GOG%8I(G%WM3:24^ ,/+\_F\;&ZKNJJWL'R7
MRPW[KGY+\Z"9CI0X&G!G*Z<#SAF+X;+P7@OJ/&V2 FWQ,+OW'9KJZMT@8<_\
MM\C&+F?Q7Y]G9[C:XOA_SB?+[PCZ[#Q-II_>EU)J)&]YD3LN=O[C[.UL6A)S
MR!&N^*F[\'2:0T#CE0/)'ITIR1TCCF5TURCGQ@E&O6T2K=:!OP^?=]^JM)[X
MW;T>-$BLW&<#.G&AF!2C1N&+KXN82L-_7P8]T&"=Y-0QW68ZYQ!P?VEB?0X;
M7*ZL]+:HP*0(EA)\$HY1;2I#"(0@%'U H5SVP371Q!96LYF?>7&J8)16T2+A
M$;=IW+<S)58P($G*Z'(PG*T/4=ZIC[G38\"=.CW-6'HJ!X(G2WRVLM#%FW#=
M &:55#8J\4@5(P!E7*?0@'N9D(1F:3.%; UO4F=U+ZI]'02VTX4[WD@M3AHX
M&6N8NM*R :!:GOKUHMK/.5]%]M9'?E<3_<[T F)RAB5*T"&R1#KFRU I(* 8
M)",HV#;SNW:H#P^<W.U:';:1> ,UN&$D/\[]='%V<4*9_OM\L2Q2N#R#$#*F
M<EV3@)2E-!3Q.JU6\S*5B$%X!TT.?(;!VWT<4H'+S9Y++2(:)&!NH,3HILPL
M\V?E.O#KZ3>XP-G="NX.KQBU5@2'&VF,1!I 9PY8(C11GJT"8-#D>N.V0 ],
MA>J3T];V])1JW5%][9G *#,3$1BJ/DN26 :>*$F%9BIP:6EC51H \\ 4J38Q
M#=(;-]!V^HWJ_](O/O]X-OO]9TB?X+V?7\-%/==@F" L*I0,*SV'=>1$2"F]
M#"XKW>3^TI8X#TR1JE/3H!/4@(CQ$FAD*2FN!!$<S:?D:#1=*=#1-NE 3>1,
MQ,8Z=#_" ].>BG1L[--4JT3FV,^GD^FGQ7N8GWQ&[7Y$.<"=)<8=^M^/:/T"
M4F"0067@6LHHN$\8W.2(9(E,632G]X%[M) >7<.R8:&Z AM0G2(%"UF! ZF\
MS-1Y"(FK(%62S"MO[XAM1"G*^E*/KSO9M%)=\0WJ@RV=L,&+J"W'T$99@_^-
MACJ% C7YKOQZH X6X,E%,G8QRS^<+]"_693;=#_![-/<?_T\B4?H.3]&FH.6
M'2?:[9&O5^Y$;X&&#)%G]/J9-3DGC!Q#T(HY*DZW?8BJ0G^T&=AB\?8$## 7
M5"L7N*;@0I8<M\$$:%Z=UE09%[T:1,,($S)D^1./J__P_?)7WUW]YN/-38U/
M;4_?5L^]O@U8'X("K2&BSYJTE0PB@T"Y\MH;.XC7AP",/$*Z6/8#?"VGI^6$
M-,_F7_RE&+L>2^B;J2@3X49((I,MQ<R*$I%35-ED:523=D%#P(T^0]O\&9<S
M2J]* Z@*-,2@"=4T$%D*L(,QG-!H&)29N,HVN>0\'.+N'?WJ^G/G/*T-/PW2
MH9=P2A7*ZM8R0OKG9/GYY?EBB<')_/B/RSJ%TN@8_U?FVYW*X!D+%EGG2I>3
M1D5L\B6-JZ-S O_/-TEC/0+KD]*M4=3?J8ULRUOE\9+H\D:4BO\$+S_[Z2>,
M?3?M$*?4.,># 9*XPWC;1DLLE8+DH!)CUBJS7MK8.VYR^"<>G(XT%'B+VJZK
MV\[WB.4*]T6M T_.H>9ZDET41 ;.B9<TH9"<5RR@OV+:[.W;8]U5D5+[/:TQ
M3T^E/JE[+X[B_YQ/%I.KZZZ@9=1EH$06.I9)H(9XS03A/G/O*'ZIFQP@;\"S
M_^8$C=1@?5QR!3H:G/SUP2I?SJ'K?34$8-,IZP\AW-.P]1I\#M"1\63L16N<
MLR9;1$:]R?BJ&$5<4I[HF'.67%/:IEA^3]KRT #VO2C+-APT4)*K^JT.:9=P
MN7ATP] [<^@+,HJ/KKG 1T^2&,H]YS%):)36N _5GV4SJD=-"T?Z DMG\0:
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M>2BWD(:T<-FT_G-GL(K<>L@<=QOHUP\_O7YYI5>.<A-E:0H?8TEN*DX\S8R
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MO@7HU/4_J,#[YLPM_[C^%&&&__S'_P!02P,$%     @ O(!74741&5A,I@
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MA]B"2 AI<U%I"M;O+3WU.W$J_:5UX-V@%T_Z6U_G+^'OGJL+?B:2]Q-&J>1
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M5"-!Y0+"S9K?!97UE@5$N$U4?"I5_E$47=\K9KZNE?IQR6KQ]<=[7$9_Q6Q
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M8YU#NP@5^#<0IL0(79>5]GM4NY]M,L<TO:[7J,!+T_,;%U^S?]-0[/@Y.3=
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M++J.0C)8]%UQ.;Y#[(,OIXMK+5RCY09<>,&.?W:+JV^$FT'J"I//C:WXS5,
M3;[;@XI OH"PYR$]Q5X=5(.@3[_=B,!:=TM:##F[PB: E>'-"Y-US=<[%[A
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MS9_W\A3%=\3??6:NIQ,ZJ>!8?8QZE,*H9YC#+>I974W4KNZ134@PC$PP'(?
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M"R-VPSLSQ9D1R3T]^X9U,6WZY<D!*^YQ]QGLODX> )BT\1QU3A)E7V_,Q7%
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MST_V^GLUDNP/7=;U<GIA>5G=2B?_X0,E"[2F -5$M+G/.*<8N3!C_[Q#S&/
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M3FRX_OD@:S]6WYS$ICNR+"(0 0A;UV]Y-+NTWH.N(PT]<NG&XY:WLA@NK&+
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MUUJ<7F-TF9Y-[BG@QT9RM8VM8QM1Q$;2C\ZZ"[<:])M"%&9VC5N>Z5E4@:?
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MG9%L0%17R%.U;N[2]R'OE[>,I+T7-> S3WS$8-F8K!R"GBJW0+5S[W<,KW4
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MA5"^1(E-5NK5+T3?'MUZQX,G%;QN2'Q(NYMYX"-GZ5&.2-S;@0\8BB4N^59
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M$BTYX$%UC-4(PG* 2TW]=LX=-]67/:NJ[W0*-)W[["AS+6]&; O!G"$ +DW
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M"PI!2B'U3?L1'@*,X4I>$@]=;QT8TZ)F5@6^\LW.:+&)B A2FLGHMK/Y 4P
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MFZ'4QI=B5AO*!\M+)F]OT;D3=]6=JR18Y\S<V1""8P3T[H#U'=M"&9?<RJ6
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M?\9UYG.6,4.FA\6/$A_ ,0S&Q1KW@9FRL L#.B4F#GTWOR6,C""ZD1+=M<<
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M7;=:^?MC[0G/TCX> :YD3Z+YT=^P;PL79&]$7*)8D5G)9)D&/3Y_S6(_9=5
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MHXDW%1:V^>Z9UU\":N$Y+TI[CG [].OX*;0:7B%J$ I<$$XC+[H2K=Y+G2]
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MYW.?*TY^NPY?)&W%9G[V HB18--J\_63?$ ";"K!5<263N[Q?%!L;I7'/3A
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M.U<_!-1>N>-1,?;JGNKS_<.!5S*W;'QW2.).V5.9J3F:7 1(/Y* )N&/!'
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ME\)$G&MW__"[2.Q\9:3FL2KWDGG]O/UI5GHAXK4[T\3O1DD"Q"LK&R@GY=_
M/SF"!"PODRN)/"(33L)S#-):^)+$?K6\JP[4[NWMW/(#M\NQGXY>LE58WC<V
ME%+;#%^M##I-9+<QSA^>F5IG);Q3Z#WS6;Q*Z>T[NFV(%#JL!>C7$S5A"/&!
MU"OZ!E2/]\_HW3N]31O]V]1W#!@_X.KZ:XA.J.TUV'0WN-.Z2.:^X([;HETQ
M@$??(/;T_&B[.Z_B2@^\>6TN?283)CV/V,+5/5V<[$'?GQ7DH)4G^1K<\NA*
M&??+Y3B+Q'TB[[#K^( /10QLVF+LF(*I7FSJ&;_L#;M!PVV&#DPPGK1VN'E(
MN=C-;/+SU5KS3'>._J>!5Z7%#JK?%@XE_?&R+:$&I26_B&TT=!A?J9&3G#9*
M14GZ%S*5G*QN-M"P,:+'<>"XQ",Q,K=4H;Y16,(@7;938\XYS5%#VH39\&@(
M])F//FD,Y[W@GH;)^)=P_XD/H7(@(Y[@\K+C<OZW</.Y)T.-P94I5];L]WJ0
M=44HYL[9J8&"?]"^OZ-]M\"F?93SCK)$*FD-P9AUK 4$ZGU81M,GC:M[7W$Q
M$,?&='GPHZ&']]N3?1]EOAH%B]LVWC&ON//9Q_C';\FA['R:8_#EZZ?7]+EW
M^56DG8@VDI4/Z'R&#:W:\\IFCW?<_@#!GQ@/-$XS"5HLTY3?8$+#%A1O+H-!
M^IY4Y87Q5^2B<[3R+]D#PQJBW-=E?1^K3%[(^Z@*?#^)(II0'>\%081S$/E
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M4??RQE" $Q]6:\#!W$KDZ^]SZLIS:J31JN?UV8<FO[2Y?_P8$:!$ONY^]73
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MR1HC<[_1E\O'=?^1C59_$N)3 /$C@$9XCMR7?_F9+SJ>HS+P7F\2_ZYWA/P
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ME7.K9[SH3?EMV@O5G<MAF1QC3F^I#AL"P# )4&LZV]JS#!0]6810LRE;O'[
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MX[\Z_8S.O-LY06T[JZ:"KLAVV4FDAC?X'JZWTJV\L\$<8BQ .;8-"JXI@?*
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M< R\YB+'WI_ $&ZHJ^("E'=5=E!('2(C:X21F?M?G94XPG"&*LA)I _&!OI
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M4SL#JYXC[C7;?THXJ+'U8LA5K:7%(Q=EY[VRI()N#!Z4&W:JQ?4$6\-HC0P
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M.LW '"&KJF)+:_FK7MC#B3FS?G[).]@C(WB/SRN7$JG ^ G\$&K&XPU'!)*
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MQFS-\IMZJR^CNQH?SGW>S/75](S=$*N+B-.4?MJ0KZ65EK]X3DU5T>0OR4/
M]!LNT)C#DO+A"!.8&BS/J:Y]G/=( 7-(C:+;^Z^%+"6WU\UBW.GZA0H?_(PC
M^A_YV?99[?7FOX5RE OV\'3M6TW7X5LVFF%RA"":Q[_&CN_:3<:$LW.[!%>Q
M4G2U)^&,E[5K."ESYLP&]7);#<V/[ 1Q ,NWHA5RJ'N25Y_I,;H@@H$E4 H1
M+=-#]NS*KCT8X8XF>OX$_5U-E)H<776^(,;^(&_'%[Y;)F?%ALM"SHF]Z!XB
MNKO"2D!MQG%V,585^QY'>\79!IJ7>[,LHI47C^%[!4EOF]J:_MI;LDM:/B*S
M*^B^ZAOKS+6W VGFR_!Z"9:T*8-O:P]_U)^J=$0P.>%4N *Q[*[UYKS&A+E1
M0V6Q=7^KS^LE2<'OY6*O^-JR^!KY76WR_K=OE_G_W?X7FJSWWMJ)Z<=YU[5M
M A/S"%U-G;]?]9KVQHDS2F<5!AY-.=1BK-7;^?9AK/U+!6\YI_,Q^URC5!C6
M[ Y"2!UIO*<5:\4N[-)P?C;C=<]Y#!EN20SIM36^+-"=P% ,"=>2>KWT]FD0
MSO!@S;&]KA)G_V5'U_^$]C=?N,&2_V=\'9KO1Q]')(RY!QU%7<E"X<)RLN$T
M5]0MLCA'A&5''[R_*)%6*DE7G?-0VS4=V)C\7N917XSYJCUC=[%+:VC>\ _)
M)ZYOTZ4[VQD68!Z%"V3"FU/Z-Z1 O<6Z7I3,YS^P!)9Y)3JJ#R_2W#RA<' <
M.UIM%LH([\Y\8[5S5EK *W<&J+IXAV/)+HM!S4PO%+)D6Q?9(T,H4!TYB"3Z
MN$_]DI"8QRM"3)OGRHB"]Y<JIC)1*BC"X..H>XNPR#'C^M<KSA<RBS6RBC_G
M@)KD;%PH4@D3#;81&E-8THN#R$:1,Z!/+XZDC,S$RGF#=L[HYO>=2\YR#XO-
M+M4$!+OMLTK+"P#L*F_>Z/NW7WSZ#S>Y(4P<2%K(F64N=)+[43+A?P9K G.M
M;I@>I,W_A3(_$/C=CB1>4BERJ"#L_'W=U+)2.X?1CP>ME/46<;.%'%&>"I8?
MNR&(G8@(Q\_*4!$]$FG*78DVS92/5D.B80=:4\^5B8W=,]1?SC75+7=8XM'E
M/R7.+(Q@JD-IO6)$BN.(^-%R&(J0 '1)*46 %Q>C@US!AW0%1UILTO5*](UI
MY^8.0DF072DC^C:M-+C4U\Y1*"WY@TW SVA =FOCWS\UN;_=H5E'6OV;N>D*
MP__--[L\*1)_]RTPZ.Z^VH,Y1.UN!*_Y"#\:-TC$$JPY"#I&3>5#L2WMU[N?
M%_V=MN?J^7;H]!*W'YTM.*[[2Q-P 'ZC%EN[D:0<Q@]V94=<.<:*W1F3<Y,+
MB&-5HSR*Q)11?5GR1&=<OR=DUE3A]X_S_B-Y42*BG[+UKGAL>QI\#G72OYBI
M&(E7M%'$!-(+UZ[2"8S;&=1O=0L(T<\OEPJSSO^TBE(-U+.:K5O('G)S\CW\
M?6=CA/H]_6C=X\R\/?>U?D.JX X]C".<MX@BXOL18E@-,(_QF 8?0&WS]CZ#
MKN@G-Q;DUYUQ>CS[FG?.Q_ZR0>8IDO^.['-Z+TVKWL;?/%4Q"16K5(XA^V:-
M&]6SNVXF; '1?V.7'^\!!1_Z2@96/\*20=Q(0_V2G]#(=DJ9D HM?N-LO7!3
M2F+OK=-6;X ;*_^CF7F\2.>OFH:##6;'S^@_UO+A#PXKZ]&PN37^=1AW#I%%
M5N4"85P@R8,+2"+"(,7D ;Y^*GYIGNQ&>Y9$=7*V^"8*\S29/SJ-U%Q7<N<%
M3A>_?4^1+0+ L"%X<]G6YE20I3N..X^?J1M 2%#PO<2J9(A3;/>+*O"<LB26
M+(\_=KQBH-1OZB1]*$K6/TJQ8\BPTK=ZX,]5I!HD5Q<4^NM G>G!C7BR=)<&
MY[V:%HBD$!)+(=9\:^4-_>/@7^:U2*_LL7#]]9T)O:M+9UNR5B(>Y49(E3Q(
M-\O*+W+_Q?99M%]WCF!>^8+D^3DRZ[..%#)D\>VJ?LQ"0O?(E66J/=>^XF>Y
M%HPZ-_B8%+_R;L2!M .NB^OI1WS7Y0R1&1!?ER#\%#]&./)U 0$:#'4CB#F,
MPD3&51J$-&2FV==Y,V0*O*DUJ6LGNO3/$'+T7'G.\?&"];#T/3@<W^L+F)^Z
M9;';M[?5M?V\_K7$Q:EUPNC*]1*;B#+/W$%Z><390).3;T]\]KIBY9U29L83
M^F^?U?^O>.[>X<3X!/8Q S'*-,L4<\1,.^/L&%873/&D'[T6^[ B2DUWO[6'
M?!;*^A&]ROA5F1S5X=7>Y9#!:YXMTZF<.;(@(A*5Q1&FC21Q@6"H+^FOE)8Z
MA?3%0C^Z>%7RFKFWD1FYT1?6G"TZ,RN6C-S9QUNIC]I\Z0I+].%\0-#\1)WM
M5CR;H-1PPRBD?Z/M:'^1L[@\JRTD='#-;*WE@X/2E[STGUQ@YC(5R9*%42T'
M4:D-V#ED RZ)H^0S"Z+Z,A9VLXRHP5/ED_>K)M_-7.\1<[E7'\U,5LQY/X^8
MWOY[B&55",U'+N"X D)A2W;K);-RH*BL[6'NYXS! 9L#+*<<QFW(@IM(S,6N
M28SV0N*COFHP=,BQ_4-@]HK/W!E1.:^B?427@L.6>2CU4JEPOM7_/J92=Q-'
MJ<?33B*)EHQ=X-8WV+:QI">NW(LVKY6^7KPT<>5A6Y#ZN^>27IEBL<\R=\E(
M9??W21RV'B]V-%Q?:]Y7C^ZPX1.UMKUZJ5>XA:G5_H'Y)YT%X74*DT-&_%2A
MC7!D+G(!NCNNCPTA-?Z/. A-4N$V* 6>_AD!4_Z"?CN8PP5X4[B )J:0=?2\
M"!=X\ HJ,:9<X)/+7)$>I'WA&TQ(RWU ]2% YR$N,' 22O1-=A?NL^4"GK4+
MJLG4K?^LY>H@[J<0%Z#IX+Y#U5U*)8'PV00!0OSWM\SFKO^H30BJVD4\FQ?!
M$OF_VOO2J"8:9LT@*"@@LLLB80=%X$4!99&([/(B*,HJ1$7V)0JRJ"&MH.P[
M"@JO1 4$9(FL04#"CH#*#A*0+(B($$E08DL6IOEFSIP[[S?WS/R8[YX[Y]P?
M_2_IKJJN>NJI[JIJ.#L+Z+$FXS:%,KF\"*XE9^ Y09A X6[!\,.<76Q(O'MS
M /L"' HN8':)&X^1V8)UA2&XAS+_IA6<(=JLQ8U7V8+=@7A>-B(\ ->- @$"
M#8H#\^U^0,HQ^!9,TH:-(#%_0\J3$@!Z(?3GE&*NTA)TTA'HGQW/H!S&__^?
M=6X-K^I!E54.IQX1H$OLAT" GWV[*D"D.+B%Z!ET,/1I2;B^KQO%#?[@\][@
M3'@GVC'OLD9*[^6_ ONC8Y:K6PQ_^?OQIH.N^GT6@O=[*L[G#8Y-VV^D>*IL
M=*5HXO+-RO]5HQE:D)&#MV"\W+>Y(,*2 YD_Q.UGH9<XN:^MZ.@HVZHZ*,+3
M_!EIMH]1.K/^R;+D<%6E7*+0AZ=*H8TK#]>CV9*_J/#5?OHXN:R;M(]+]'AS
MOZSK/MA=@D@G-%:5O*XO.*Z]ID,3H^X??3<:VS[_]H'F8!2[6^:I2"(B$)E,
MH >A:'K^#!'NGON,N!5[L.+FRQ7BF>3*67?/E2AB24M60T#UT_@SZI,#>8(V
M*(,1E=@"BR_H9OAYB,+L;1.%BL.<"33O@B/1@KO[&$4&?:PDILG+Q)HQG*!3
MQ-#1_V3A<"S<.K<S^G"Z4*^!U("U7LM+2=4$@Q^)*9!O52#H83026Z*?@J/=
M+&%'TE5=O>7!RU1/08*H1XS.IFKBV>#W,C>FKFGSZJ^$;';U4<Y,Y%QR#[_#
ML8(N_)F#0UPAS!YEKH"0%SDR%1GSCZE>4BA8S,XVUZIEX\C>JFCC86*;HUQ#
MJNGU^G?:2G7.BN?V' [.<8;QTE+^=QBE-=1FP0K!#'B+@]5;L#TV/4"#QOU5
MME/+_7:L6;YA^9U9[P\\^/H"QXUK%P=ET,VJOCD.*XV>UX;+1WBLKH)K_?,[
M02^*'!0%<#&V?VG,;?.QZG>;18TU07I$#P]+X[;ZTX/9N-9]![%[VY5 %>K2
MG1O(%*2PJ4-@=<SM'H^KLAF)E1\'VN5F[;+L)$;QD5<O=?S:=<<PX.]C0NNZ
MW+UV6["<5OH2MS<5QSDHN;F,S ;HX8[LAZ1$!/.P%[!LBRLEDWX?HB,WUN&/
M?\A#E8!JG@GWC>,ZXNC7YRG<?D1JW+_7#->>N#WM!@R:FTE#.><]G'MGXT=O
M+.3>?"50?12WO<"CM@#!X5FA;H^>YAR57H9S=#1F8R*V8&HU(NQS4&BH A8-
M9ZT %>Q'\W_1(@0W!1.(^,"3^VT5$/3&/)S"_4IA1P?\A'9>0''+/H<= [6=
M?"\=U8^3LVP473@2/! D=KT (;IK.;[='*X.Q6W22ZXXJ$<G=!293&%48XYV
M&D?E5X+Q]J_&-R Z\EZ)]:=4N)==V'Y%&<UI_'Z-^H5&M 7CA>-LZ@*6AF-X
M=N01Z"ZAQR#:4Q:OH_\(+4K1AG>V['UVO?+C7"!]2*?T>D1%6.R7-=JUFX>D
MAZ0&;7M2UK[!Z6>@]$N2PAR BI]BZ5XL>- 9,RI]K$B<7D_4)UH_\=%(' V+
M[#!//;-#N#ZW&ZA2_Q1_3>R.6=,_E;8&G/KVH]](]8FKMQE(9N)(J!B5U8$4
MCB2)NILKQ]79^Y8-AZ>8?Q.TY%_P?GCQ& U!=QEBYG *,$K<#RUYST-H[%AR
MJ&=WOO0EL4OV*T:A[N#2W8.(^S T/VLG9O@6?\\P:!C^JYL@9L.LJ60X4Q#)
M;'?JIW#P=[YQ0FUYX=!HN;W2XG?1=T(U-YWY@$^2/^'L?7CF8T8_#8!<Y1&H
MP5BA>E<8< GE,5="35PGPBXVX.N7I_&RP1=M^_-R+ *_'(WVUWB#KF?I8":(
MT:LDZ%_[IR "!:2*=[]@H\$(\IL(2CGHI.$ZU2B,3BT,/21G;\79F(@^.Q2H
M']Y3E2Y>'W=A?^8U3@[; :KD!9RW9_\X168PS#17-]>R_<V;.GHKX+^<2])@
MJQ94X8_]F/WR"?DK4#]?Y3WBH.CG\ XG_NUW4%<Q\FS$-BWB:^(\TV!,Q^D_
M\7.0(^>G&AQ0<'!TS(BJ;4VU:<G12K*/\\GVDHRO$3AD5(FDVV3^MN)?G84$
M1G3#-T/PY1"_*3*A.]X%R'GP!A-PNG?3+\O ,<Y;:[QAF&8"DEE>GXDGYJ[-
M]K9E'G&-VE/^VD\5=BB3+6K3QQ5BX-AB\4RTV5Y&V.-*P)>M2&=B*[9@?J1^
MQ(P.=?RI7>CB1\?\0W\<>OO15X5O#VPSXY]HL3($J9^QO[4(>X%5MQ8H"+.1
M-0]_0R',KPKE)R\0"L\KO=/<!RF;WL)0V.)V;L&02K^Q>GW8=3L?PLK$%DSE
MAQF4[58CP.9_;UI0ZRL JFFP2\0I "=M= OV501IZCH"I?O3CK]M-;J@")<I
MACB"0KMN#^*WBAX&8IQCU%A\(F+= R)\O;H<99N?)E82KNM&G'O_NJ)9D@K@
M =HBY!.[9^AE-N :R_K;,1<%D3;&A?;4E]^FHL2]WMPM$DQ,0:I+!JKN<LL6
ML%+=?>P2]4U=?2-) $3U3&^>*<,%BGHY/@M2ASASSL4M6/'%1^KX'^?]9=;+
M'M[\<&RIG ^&,4('<IJW'ZD!1(N%LF0@@$3DM4+NCZGOO?(NJ"4!3\?VX+9@
M"E,K*)F33?8-C\;^N+5T"5<*D).W8&( .8NTK_TH.P@)JF*[>T;U"T7V@E:F
MH2>*DF-?S%[TTM]DW)4B,O6S;)/D&^Z$7E:]%)Z(>&:0[T_&"7Z,&7<"D_V+
M^Q4:7R[GW8IZAA%$%1&G[!]K+Z@<[SJQ., GQ/WY^2\A6-!_[R:_B: 5L]QB
M;C-U025$WQ9,'#SSRZ,Q_AR^WM!0O"1<ZF&2</X"KP3/BH3KDB[;TI?NR4WO
M[X6#!DU0&D10573C2#_#S#2A6U"-!YWXOTY*_AZ"R)W,]M!<\76&#5<XE-"5
M"28-D?$<N<P4!#TXE"O!LVE@A0G?@O58(W<2OLZA(<H4[XFB%W.5CX#:6S#K
M!6HF6W86N _#) Q1AD4<:GJIR0UR&A.4.YU[GT^5^V<HAY^]VD<N63]YO,+@
MA+3-5,[^C2?J1%KH]W/43V%/W?F<E09M6^\2!V\*&1VH_-'Z]_-"?#B_$[5Y
M#"X!D*=FV9J\/X-2V(L0[*>U"P*CS2#DJ+N:2!2;O^L+X\@^)Q@!?]/Z[#_I
M>P=A78[[@/R;UL#?U'TJ,OI2ZT?^_XUP'^C1261&XKT;.&E/3U.];RTATMG=
M2CNS?=,O'E2IX*GUT(>Y?D:RY7.A/!M-&>:D2B,WSVEMC!%4$.3/MB6%"_S=
M#Y(%X:"U3C-\8UWK:_/IZD.FCO$5YT[K75">#1O0V@CY_4&WU(4@Z'-P//7!
M$R/5G-:P654\XFAY!:%^#5CZ5,X=?K,%PT;A5AQI[%1N'(1 9(B@/F;'<W%+
MI)^[H?2Y<YB=%/"WGQ>S  A\GKX$P".(+_!OW%BH*GD(T*&H>9N04L@R^\6-
M)6:NLDB_?P4A\.NZFWL@U(U7X5[^__2DP?\,@@C ?WX+-MSJ.H*EGZX,A+ N
M[BY;YZCE>;BX3=H6K'EC7?[V7[[[BT1[G8N3[I6,U3FGHN8S!DRP/A2NPU^7
MF[MWNS3)EEPI;+V68_\ICU8)'YF4.(L<XM^X\R^:/''] )7BNJDD:3-X $F8
M"V>K.,I\=%@@)64%>N"2VT11)7:Q9<3NX(A;H139AM0P]9;@"TTND9>DW$]S
M?PVX;NJ\1J9C^<S$N*,D(0-D/%R^;6<96-BU.:>E4%;\[7I8BE--39J 4O;V
M0CS;&Y$NY_;O@"&. 2&ZH":"YL-R95\;1Y#SD:_X[W&U8H*1=&HGP#K%MJKC
M=F&]Z5.9]]>KJQ5,UNILRKWT.K65[<3BAF3D4F*WVPQ^,(!^QWM;,'FT/4L>
M;=T*SE Y>X:ZC5%);294(&W:X\!\8XE:#W[$/O1F=-E<;J10CGL"/BII4(XF
M0*L[_O878D:%*<_))5R&\WJSC3@YW-V!WD)CC28_;K_4SAW2_S7-Y_.NB$KY
M7'!EU\EY6H/8KJ.>V#T$OV$H6^UDHZC#R=Z\(XV2#/X,M49 (EB6D*R[89+:
M&5*GW6:^YO^@5^)48)25PL?I=R&: T_W?M].S14K\_+T7RDW?I2 V%-U$Z'V
M"8;3S I]WT2+QDX9R? 4&(1*%-MM<'EN00'8^SP!A@30E;4-&):)4%(%%2%<
MHFJ5/[]C!(#GX!"\9(%(R!12)+85G%YB!L&9$IW %= F@"G?-)_N17(E$B%P
M4=WF[YT[\1!RV; /BD!H9KO-W>,$45SEEA1-WOSM96$0]"6+W(<RN#F42'L@
M/]IC <&9&%P0"OTXB-PDU3S_SR]?R#[SX!V>GJ>R^V5W9N@[29X7@L&^PLJV
MG\SG4A$P4+Q/O#^"NK8S4+8JZYG;U8D;'\NNG@L_J5/&:_:PV@H&):F_28GX
MF[J2$V=/RA/^+F3FWY6-E'#BU_UG$8O_25\O*PD>*(/^DPTU_UEEU[/_F00\
MU)=/SZ>X))=;5080A-@G_"-YO\=]F;:*,U)!7? ]:;[I:OZO?R5B]2\[_B.E
M1IH G9[L2$8P)9\M+K> SVS?.1S-G]* 2S!NV+PPC\4V>%SYU#:4E+*NFJ*B
MFF*C^/1$.6]U(^<-P<>$E!Q%$J@& A&[V]_$5K5G7@[EE#_7>N,@R/\JA<S]
MXMFH^2UT]-W3XAU/X[2FM=9_4=NS6:9L/TB'LU<FV K$\*_&&JOO?2J_YAOJ
ME$_)<A_[R \.K@QZJ1>'O5W=^T,I2\Q>GK/=:=$!#B\0B!K<W>-TFX7$'E:R
M!@.>S-T?,$U<G.O^TMIRVY8]!)G,RTT&0;[!,QF,:(I>S:80TICP^ORD+5@@
MBG>9BYCTW[>,$6IG&#08/_E\[Y6@9'USSJG3K^3,!\Z9N+YP_4Q@R_NR5*"$
MQ<2"2V01*3;_F]8ZL)">2D:EM:NBS5K&[_X@G1O=6-MM6ULNW_I(HU44AWAS
M@]H^R7D D$L!*"T$($%U/XA6[U2?VG#37]N;N<.A&FS?OW?AA9=['Y4[>?ZO
M>E6&O>S>&D/17[VP6X[)B)#,F6.=6S"97&8$PX:F0BZ$PP>$(C3BPM#V(2T5
MZ=.W$#/1OUM/LSMH?4;+W@^1*4CZGVL)$'=&0QF7_S"8V0]7>%Z 2(+O@Q+P
M3;3_@HE<LCU4#,Z3ODUI*Q0\_MKD\IS8XU/>^(EM3;"+Q,X"?<A]&%-PC1G!
MR6@7#,0@IKC2%@&FP$LPM2_TV;++L6FGAI' +$?))Y_SCQ4YB2C_MI,X92FB
M&>X$BQ6U0M^DL[B"HO0%JLUJ+,.'^9"^!>L0D1F@8N]&&Y?F]Q+ND0+'%R;9
M)Z(O2]3-A>4$)U$*2%>/''$0-[%]&67]H7K_.I0S(8>]R?8EZ\[P=B#I3K%(
M[F[*@BC=T?O5: T:M1!HZNDO4:0@>R_;4H'8.W(QZ(_^PP.BCTI;6O?YS-\[
M <,D3^<C:-6L0UNP;D</3)_A%DSNIR<V1;K@XF9*C&'O//6;7(#UU9MI00.H
MNZ.^5_VX^X(_X\"#:[1&UF4V9+:X^YA!9'UB!^&^L5\QQ3')[- D:K'93%<J
M LSS%-:Q,11"EWD&7SUV]HQ7_&-O5:?R?8^/PXDXJG]:FR1D]!V8807C-Z#!
MRV_MAUHXCPQ&3,4IK4DU?J&G[!/41[SL%D_5%N?M^N(L87Z^MN]4ELC$::U%
M^,=6[I[KMUD6;!=PB&7"'07JMZ>4(= #^,X-_NJ5%28E*TV%UNA7#D4WX]OQ
M+?ATJ9-G=U\5?# 7KY9ZJ*P;8BR$7EP*0:A=FCOF+<EY>'C-3)+M/OVS4%NP
M1Q;HD2P\/Q:R(7<_8?[7N5K6OA2>U]D>FF%E5_,LTYGLU3MPUW\[5^R"2D/[
M4D02,9(3II$0-D@L$Q622SQ.3%56!?VJG?68Z8B/&#I<MR_[^1T[/T4>CPN_
MMYNA!=@76\"+"%\MU(&Y5-1]8QS-D5(*ED9$]!9ZF"L5">".KA>BCAPUJ427
M$"M.Z)V$^Z%E.:^V8'ZZ1,'>8_,[P1.,2LNIQD_&O;HU/X\OZ7E7%S9-M$BM
MW\^FS21,/C[?Y\B3?DM[@_;BL:]A:?E%U3\\>\8<#R?N22I62_X)$T<6(NE(
MI/00761A>M6==9YMT,Q"9(00 C@F7=DGBN\7GAN)='ML(*?>)Y1]/$.M\ZU+
MEFA<!++T/,\2'$++$/B,(S.>D==(7R'[TPZ0L=(Q\=VIK3VR\$2T?6CTS1?I
M7/>CW7+YJ2+K3SHN-Z]X9R(3X(WG-TEL<1QWS^(""CQ,NC^_:'J@##.6Q=8%
MEP+#9(H=]WY3$*&_>2>=EDK4JBA[A*4^#,TG("I(=*?,U*+#8V:\@02!=KZ8
M+/,%4KKQ.P5ANE29KV)4[;'LMOR"%DG3ZKPGDHM?+V=YS!MP];+VDLAKM&R6
M.G=D7G4"K4279F;3'=,-')3]$B_4TO')H;C/]=EV0CE)7FU-<IX)G>1-UU+7
M16FV[#,*L).]G_.($ CL7C[77_;53))3CK;SY?N%YY5BNC2Y:";8R=7U/3[<
M/U&P:;^],^0EVGX*X5OMR.2 VBS9^9AN<D*^Y"=P<H&10XS)/3]:?35;QR!8
M6XDF>U"[JU>UMF0ZRT'5OG7P8KDBW'<4*8.9P-(]'..Q/ A_4MP6K%&W&[CG
MK0JFDN'I[=JC-T[P]WH<Z&V+8IX+VDL^/!)V>^J)F,Q G(G?4,\5G8R3QTRW
M7Y.<!N^6<N?G^3DIB$"1C_D]!"$:5SNPH'&Z"R45A-$:7_M0J_Y$H/DUOK6Q
M09>YVY+ON//AMI:#G5<D>%=F*RL]Y=QU<34^"?M]=/7'FB]8\:HEF\+X50M^
M(&=(S"$.1-N"'9Q[6QQ79QF%=HQ<4-K-2ZM7_&N"G?;JFHR]P+U%2V=YWESQ
MXWR7LF)P&00_W&PJ\]OV$_>=)> /EFE,+EGGX19, -?]1K#+(\3CO(+)>2^%
MKHVRUECWSCNIK17/'PN>*MRAW7:=W^>QW""!C"4=:#^&/L"I0:!2@9E6IL,4
M1CL&"O* FSKYEHW3U3<\-9]Y6N1J<^9]Q$S0%1+!JFEGW)1]._A7K"09:]UP
M\'!FQQ8LF41W( A#T&!YF"W\,I .YB,;Z9.$> .MM\^*9GO$OZ66:C_XM9?O
MNB5>^TW-?M@K7O7WI%:<)XB$"I=;$X2 >I8).X)3^'--R'1>&-LCBTQ!&RVX
M3ND/480GW[3E)8U])/Y9KT$4G=._?*KMMOLOPPX1_W]YG]+_<I2O616Z#[;<
M29I]5#@L[N/W#CU;WZ?WUY>2<@/MHPY3-W[_3/=QC/L^]D4]Y<O4%R75\&*A
M(W6OE.[*[XO1Y_E]D!4*=!H#/IG$(NX2=_?VLIIN4)CRR:CM,C5)%W,<;4?_
MF3,7<YO"?2R_;- 35?M88?" W]*0VSGBC-2%Y)(CO\^^"N*X@+[TI2XX/U<N
M!J!H=-/4#NO#!;_F%5@G7TG40@6&[ND6\IDY*X&1K"A9ECUS]T5W<8"'UYN'
M3UI"\ T-=WTRU'Y><-J1>=E%DW=A+1G;H-L1>Y0K:$_'=QB7]2$$9U?^P RW
M'Z\K_!/KA7?/^;9PD5[<&>;4;EFG]F3\\-6PR[Q9 LZ9&0C?X8](YEU0#O(Y
M:Q"B<7RUH^QC>.;%*=/04G8D_E'"OLZ@NM>.(D\[D3H.'O,C#5=_A);8"B "
M0C ]9T_"<[P%08B2ZSB")JX]OP88N5TT%&*5H'!?N&.Z^EUX$$"4RN4D>V*$
MN.?RU^]^:A#/T"K?[O)EVXQ E!N+I3OCB+^8[IQ7;9Z7R2QL"D&B!J/!/@Q1
M*]S46']/RX65M^/FH=>/'D9I/PWP";@[9_CVY*R,P6:J^[P:';C7YA]\(#'-
M5+LLZ)6%9IYFI-;^)<OKHW>NG33=6#D)S]X4B?_II47I9TO"N7MD=)-6;Q 2
M %E3[>AB]+%)71V7^=D>#0?ZXD;#-+/FLW;/,>EH;7DQ)>4K&<[7?#72.568
M(VC5[?Y-PY\G9(>H47<-%H>[< (!3.;U;_2&L6]2FT6/_!O."S>_WV_MGR8\
M^-(.)C1-RU&VCCL^<:B\JWP_[-P(_Z(-6Z)U >A"PKB3D*4<2,2U7JBL^%D)
M)-PR?$TUB47V7V'XCFM?;1O5OH+_H2.N^>QSAGG.=19>XWN3@=D?W%$$7]OV
MJE!5[H>6.;A80Z'E&\Z3R'(?_*3.U!C5Z'M9CF>,6L*5.G/][+@AH92Z***(
MY.;MV++ S;_L=Y7Z"'>I5BJK,OCW? NOXOEJ#HO_F%)P!W%X"^8/9!+X]8=!
MW5^TREB1M+83U?5H67I/4X&E1YL(ISRDX=.TRW)<YPS/GF^\DI]^[&VD%@G3
MR^(0/@XH,HF6#;G*84Y=6*0C#'T9S"Y>YBIS'NAN+$Z&^&8ZY7+T/W:\\QLO
M:S17>?\Z^I2RWTV^ZX\*F43;A0+#%+?)[ <)+C)\"D]3WM?2'>/UA_<Y4M\?
MZ_+P;:^,A.='5'1>EKWXYU_H:D6O=\?EQ3_><MKUY-^.O5S#-A"Z<3/#U/[.
M$]$=\,;,Q#;=ES&"3HU];_P7Q 5>Z57,'R">DSIRWZ+R\Q%)(0%%T4^3PD!7
MNS3CHI,Y-5/X8Y!=\#6\U #@ERO@"[NKG,@?##NS/_Q( .\ZB8Q@BV/)CK3M
M%?V[P5 &BRS2P:!@9[J9X8$Z;%&JMMWW&AV,$OC@P;I??<'&YR<_;XL<E)6Q
M$+CZ")&C8.@/?QGMZM)D6(=$7NP7^J//.[#TVLN47?9B,;"]=@9J$CR_5^BY
M4 E9AV5+Y)[BM!)\*@DI\[)3---H1H8GH/OG9/7W,OP%.BI!^_F$<OK%_'U(
M][<7N&N% 8-GSJ>0 7(\1IY3UNB8Z,1V@<(H3>W%/5*]0G8%&DZ_,%5]>['[
MJ"<R=*(Q,<>I,EZX_7%9OTZXR^ B'BCY S>1HLG+<.4*>*,/LIPQ$,SCRU8[
MZ?G4^3NFG@PYZG2/0-L?62NBOU\(.]IE$,<XDIXW[PPT)Y\/Y<Q>8GAO;S6L
MWMX#X0\D;._AC-G^& 31L5<V.KY=&2U#SWM&)L#9N@S)0?-J[=4= =7DE('A
M)^'3UQN4E<3PA:HO].<Z4C@GJV:QNV+,?O1< [O6N@I"6MZT8;S:*]320B/$
M(M:K2L+.#I 5OMQ![&DW1BL2( 4!H',?XM+PS#@SG^'RA+(%VQ\(-,+OLQUJ
MOMYJ>B9_3-:KM._9RV]BR2I10JEA^6=+WJ=7*%ZR?8NK0I!?;L$.F FY YV7
MMY%&6ISM39^P\Z4B9+SF!XFT9L_;M]\H3YD$7@T%+1]G?/Q(M@V7-MA$6<$P
M5]"[00J]GPGY0'PZ(0@KR/9A:# -RQ@6G44P()&(GJIK:%F?78:,\:2ZJV*^
MUFQ!)?;CV$&OP9)S1[!T*R 3X/5DCG/>?-^"4<)CW$YMP11FG>TR"&&B57F[
MDFLL4)U)QG6/^0<%.@TV@S:CL&J;03EN7=-G>T;[PZ_LLK16K$OXQJ,H9D*^
M=7Z"!X1J.;Y></M[#1R&/WN?%(N"I-7??K:"%=X8SKB5%[_@S&E0-N8A3'FM
M1LJHIJWASV=U:N8?VN$[<*A*!#)BI_Y/7:(*TP R9P;VXS&*/ZVT'#-"J.\K
MIC>AQ);Q[8H3SR<V$(EUI8,6@8':;-6J[(L'KTOXARVF%QP?.4736.Y]7UJZ
MBG%8; @O0QPNWQ\N8 J_8K-POLV (K(;/#+PD\0/(L^,A98\&%)K+_25%QC;
MQQ->#CM\4GZ#[+0K_3]L6FW[V/?-^'Y>;MGPRV^N=CL;&[2U>\;D#P<\S;MR
M&\9C\!DI")"?85_E]XLH8.\#NP@AN@E<+<8??L*09^T%^SZL,TXW6W\2.G>T
M9O]](WDQGL_3M=.+_&R))<K4]C[6VY )[WV%TR_JWO46RT$E<(_$H+58SC$1
M]DT#]I[)5]P,/BZ<Y;ZRK46I["S-T)OZX@*#%P,'(!:(FPEF>AD#;/U,FC"9
MQ)/NS@P,I:Z)>BY3:;]_^QPU3@P3X=5(6<(H0R:R(ES"WE-0K*-C>U&S6A1L
M0J.7O7WJN?&?[Z/[HJ+RI:7"I43G5,/?5HW6VG3SQ#=LNN;'.#O11=@2T\S\
M$:[VU_KE>550C6[OZF71V?*7N7\#PS'=XU,6J:M?2ZW],>JZJNV"$D['[^O4
M:<?1=AE0E_ZC"Y!@.S+*3H] H7*OL/?5C.>*;$.VTN/J:I6#.^N:G>;/Y>6=
M+,$6^9_H@"F<!,@U!+J]4M"O?NX>#;J;A=QJ#@IT-PZ;1'W/7;JD8",YRK:%
M+)6*Z83S:S>DDE(13:[="*%.JK"Q%F?7@C>C]$G)K8=5M3;Z$1UC;_E&&\)[
M*%E9+E9&G9*0@\NI/?V*.<A)Q2!B@GN(!C7%94CN!/<HOOU5.][]<G,R>7QR
MX<:E"Q-QYN<$%*>WUTP00%<*/!XN@2 7('>Q98(6K.CY-".*MHBM?4ZU,M'3
ML:Q3MA:V(\KZ=0<L>\2)GP3=; 3Y.>+5L3X1R5E0A(*B5=/+>F1I"SS^SY;-
M$.,OVII5R3>O'>ZS&5A8=!Z67(U< / VJRHL8Z#S%!>V@H A K [9H)<"N[_
M55D2+!R4P#K5JI6T%K*(T#]2'!HFL)?'1BAM$&,% 8C/=MF73FHH6S6@(N[!
M&X#D&H.U_6A1,/XVN3)SWZ</XPX5[AW9;UJ'5")4DUMLH^7S;'W\U!XGPUBD
M!7@?X1ZB?KC[O05UNA^97 "_9ZI7JAAJX<60*CM06B67=&&7G8#<XZ0+9X?T
M8#ML)0<Q[^!-2ZOIK," ?*XBYP'$_+%[8M9)]@]])J6[B74.VKF&43='K]KM
M"SE0^F 7\?I?LJV,8J8G>()E 4YWF1T$)RGV"'$W4,=SZ(U*M\>GDFCCZQ-^
M;L49''*6Y$URLG^&^J53@J]MY9KJV"<NLY1!W@X$/5PDH5V5^[9(J)9>_22S
M0VME.%.J7;;>WLOLZR<O4]G3CO(G%5L*;#U"+AU5NQ,QKLK['96.;71<I;&,
MYI8W@;[AU!9$XIJ!6VG^F?'O2]J1UX5.RI2YJ0@K)9P8^F*/OWH[/T+'^M:P
M,+C4Z7V$'HKM00J A#\G31'E']4V$EZ7(?L-GKRO5-\H,LIZ$#/([NQ4S(A(
M83,A%S1@GYS8@@4A0,U$6B?K?,R\\\WR $!*&?2EN/QU=;E /25LG_DN8%)U
M[%5SMO4QNQ\*5N%8^NEAP:\$:8SR/V9?3V=*!TD#]!I37L:8UB>X=>.CDJA-
MJ<;($[2^A$=]0T;"I3VZLN35MD<[!'E/P@/_L3RUZ!^[)P((J<[H/: ,RX]M
MPG!,?1ZX(\ #D?PT+SAWOQIW.*'WP\ANL[-HF.-)AUMEO<A4@B"7/^;0$A71
M!X<'>LN.5'T2BW5V?V.K+&;"E_&'6_J8R4-+JR&3/R[P96G]*.0*5K!VHG=/
MHG?2=_4SSX,&E&%^=*!CIL*!<:[$MR+!$?*KEH;T ]]U!6.?2'!RYJ=VZR!5
M0C"GBHXFS&]/[0<!$.,G+V3.3#/MIA>/@O:4_*Y8)!7%/%_\AU=P1./\DU"3
M9Y3Y&>=WR9ES@6XUN_5Y?D5W$C*QNP@!)W:L])!VF:D$%BDUOFH/UO[3;9@U
M*UAZP0_?G'PG9]ZI*GWQ[<M9KS-_=!2U$XS:==#F$PA_1] (H#@FH)7"IXA(
MFCA=]^RXZ>47EK8IOYQ&,;.W P'E#*%EOM"PFEO6O<$__?YG*YH1+A60P8BC
M^>A6PSV$=(*8/G(W&/7V[LV:F,2S&6-C0C])A^\=\C]@)QE/EV/B.?E D*<]
ME#9F<,QX>G1FZ*I\*6WXGJD%JMR&5[BDLFUOIZ=0&=_2%X7&N94"]71JJ-2/
M;HS*6"CN)^?4E'TP2^ZME%O8Y>S3;>$J.P[(V.VT58PSQPV(S$CW*\"A<+X-
MD)^V0^0Y#LV.9!PVUE@=AGC;%DR6+<S(J[W>--L]S>BK!HKG_N1(*"N>Z_FK
M^O7B=V0 _[)U(RN4VS\O#P[!5VDX[CAF5SWCYP<I^,XY,&_&P&[W!T-B_@^W
M:S<%,T1*PV]MP=B2SMS=6$HHZCQ].AE $>*9L@G)M[6+ZGVC&2*.&9YR27,E
MV:=?7.S[-CAXX94Y7U05[F,^):J"H=N_G6?CTMB^=/O HJ-@;JGG<OO>L0TY
MAWS,?OI%,3M#[&7%RRU:J8D%]BNEY"K\P=UO&RV\ST(XFKF="LC\['VXA>EN
M1(*QD*&L+_XN*DS>1DQK;FXX*M<QXJ"5T]B05EO&1QD_]3LGQKO@=.<U4$.Z
M1T3Z*TF$+<R*0JM-;@R+>O?Z/UV6C<ZL4G\]$:9VJ;:7+_A@H-?C!X?*57-@
M*PX,5[:D-'<W@8R4NA@CV$?"([MBX5X-E_ >.A4+0W*WF^V<R/I'3A\(+SFF
M\HR_- *H170B$@%Y@/R(5*^>S1 Q3V'<$$E$B+19%7\8Z1LC(I>9MV+GQ/H^
M5+]:NZ<BV:G76F.].CV$V$6Y!W3.05>Q;,U<O1\R,_L!:+QQ&5MS?!/* MO[
MW8.Q,\[,!P5?IIG1G-(VWH6*J@>--,(]4Z1O^5 (3^</L=TRQ9\7OO 6_#1F
M?X1N?R9P55<0.\._3;YSV4+]<>TF:,&"\1Z%_>!]RH9G,"OU?'.&5JK68VEX
MP+UNE9:2PCM79[KL#^%G@%<(FE(TZQ*F%[%G"Q;(<;3/Z/O5[\TW'AE[>A"&
M;M99Q%L_$3==%5O;XZAV\NEN($AD%LL\P4GY23-QYE0" 6N[06&#1-^QRXQ=
M55GO;^+EWIV-4$UY[?7NY85HH>QLK[(N5!I\3[LI&S'>KH46!].?Q]1W&[=9
M.QSUIC-+)3^5#L:9SZJ&G,_JJ) 9S#*'Q6FE3@!7,F=:>P'IM@N,?FIFUQ/^
M/F]EAE5C8_(;AE\J"G.#=D0N,OW&RN4C?Z3,#8;IR/"3<KZ=ZKES%S ED)\4
M_(FEGR'-X+A[1%FVW.$IX6!Z?+>"$<.ZFAY\RBA8*:(D<#QUJ='Y8;#S;5EB
MI<B#5.4C41"YMV3_]]92B>U-2GOL_T=KZ9F6-%DT\2KQN4@]Z0Q/W(= Q&1W
MA*:O7J?*X3J4U\MHH<W0R<GJ]*K\Z6F];B&]_(+ BX>>W\WI*8+QYCA@_+A=
MI'I< E<#0MXZ/$82C-M56<$^"]I0D9)@F6>[F>][;F.Y7.OBA'K6YS;&X"7?
MK,_Q*/BOD[BH[6V]Z."6[25IY$S"+JXF9D0VMBRE9F-8T/ )%4%;L6QQ.+/@
MT%[06:-A9^Y^X'.=6(Z-3O0M)_XQ@!]CRI;B/$.?N$U=NXN4:-"57C;&X,SR
MHU^"T><ROL_H*LU^Z5)+>^#G,+AW[-H9XS@MD044[2[K"/>#<8FQ=!\A;5,G
MOMRAK/UI2V3/%_L'==;$7YD2EXM,?%$/RZZI.'=>"J9NP4!#+<NQ-@/6SIBU
M[@+)M*@F8X FN" 8;!)P_I"%1+3>(>6[(SMA/+0SD"HZ;,]F,)UU@SOOP=];
M2=Z"B=X@$/?8.Z-N-;]6$(_3:!J5-#<RI&J6^L)\CN:9#KSE_ZH;C_:GB"2U
M2XZSH^E;L%Z/J-?/@Z:2(TN#9:U6HPWQ6<<'[25J<W)4>+,&;94;*G_X< 5V
M4E^WZ3'JF1\X66R56ZI@+!W/3(9JC7M[!A$;QG]*K\\-F&%A7[-Z#_.]W,MK
MNU0IS\T=^0_\&A@/\@C0Z8?>?L"&H)\F$&5UD^8U1AL^;B#BN!IU8[GN;2E*
MD8#ZPVM-(SVJ*NCW>FG*-6ZO+T:D;(:EP,!"KO L8[A[36K[^R=<_D S 89?
M;KEC<8Q1:&.AER'32*%OB2:^EG'UU)^H9CVE.ZJ?IV>\-1FN]]FB3^? RKXB
MU5=C^JVJ(C<K@O*34:@=GX6'5>\=2LLZ8OLYA0 5F!>@\[Z$RYA)QK0R T$*
M!2[,MAC%&;@#@5B)H%>!6=_T"I.K-.(ZNJ-JP^9'VJ<$U0USTHYV5@V#Q[=@
M"]&=.#[N).%5*2X-HP5&V.=W(QJEDJO!C!,6'G%28PT?PU:+/&>SWIDF29Y9
M4*&<7#J.F[JER?L92_3G"BJQ%-EZH'^Y/>L(VWZTW9AMVU8?PY:F3U-V%<.3
MUC;LO_"=JJLI\F5IM[.EB\Z]+,?A(V")N9!G[0 ZC;B:0*<)<.5VM0HSL24!
MF0(7:_.,7H##>_F&#GWTFBL)R+MB^?MBO_SEOVI<W^<Y50U*9LZ==^(?@GB4
M<R9XB+"Z_46,?O!FZ3>$#$8Y@&FFR? =J*=C4LL'C-SABB<6!V=M#H_.F#?K
MUZF&]=]+][:^8 :%-!\7NGXM9+2#Z+,,.0<.%O#3)?K]@D*CSS%E7BUX"R85
MU&2V9Z):)S*U%Z][/?;H)\]>X<8GU55RRG=LT>6*&9H]F3FD9P^<^+\LK8H&
MD@F@.H(M8<)L H^RK,%Q&SHJ 7,(?(=V!T.I*-%O>NYN05-X3.#DI8R;CWW$
M9C[XN*9&4>23U0T-@^6XN]]0"8G(6M0=(!@)'@9HT51INDT<UP#MT3+%UE-_
MC5)U=?66J<NA"JM?P%]3.^KU>[W!:>?<X*CD_NO(TDU2HND)JIMR$T,AWK?<
M9F?7,%]T4\6A_D.<&8D_CE^>252N&>%?%.E< X^+< 46<>B36&87YQDB>,@>
M"[<K>5\&ZG8: _&1K?64 SHNKL'[94+0KQL%7]BF3WR;%51UZONB:9FS":?=
M):]LP>X@Z6Z9,T/</14+H5*A_!W>&F!$-'V8:L4M/^O:Y7I,(?++8[65RB.6
M.5YG0A5"YSV,^P0ITXCB2$G:PZ)2?YTGY42KZRC34'FZP_X;V0*=+LZ=?-?,
MGXH,:ZMT1!'PTFSIM6Y28W\7YYRP/Z5L=9F>L&)IICW^0MP-&8-SSOEF5!7Z
MXF*_45Q?[+A^"+I"1@6MU\$1>[GIDEL:X''#V"SQA><,T?.I_6U/6Y?CU+.C
M%\[#BC]>^+?]_?[<O0-@*CW"EH,E^).$05P?YD"B>QVGS-2D8F[Y%_X5Y^4!
MM<,;HA'71FOGFR@%L%7K=P^&@SA^S^]H@J@>KAPC+S&4"O"#"?T7QG552/[E
MR_A 4_$:V[D<I4/=BFGQQ':#[:UQ9LH@/X1(=)OA#%G7M+;@TL#H6TOQJO6C
MH:BUA11/5D+13M%3:1:G?_M2S%6,3%UG)9SX/V#I=O!D,QB8#[GH>U"P'.3M
M\_"K/9#?.2SD3MIN6;;1:VA)/=UD%[HHX)A_R+BNSE#&W58E!81WDAK75I_1
ME[A[7X'5#'ZJ-,V +,S?O8X9FMJ4O_6]?D%0RU-]HN]9R;N0>^N#M8_9)='K
M^#!BVO5.W$=C3=X?(EQ!7I8KY,-89NP$@OP(DMP^\"F(H^*2IYL*@#3T3<I-
MX>G[;)EBM9Z(BXZW7_;(SKZ[+OU ,7W^5+7N4)MU3NQOEB9FV%N&DXOP0\*X
M[XKVOLE9<:!+WPO1-PD>R-+Z)!@@IOZD@ZR?5OI6WO?]K9T2/+^W5TVJ0Z%(
MW%X]S#UJQQ( AYD]=6!LY; _@:J;VK"B-3N$VSMS7*:N@76@;=; :+3=Y9K4
MU!$_HRP+B<(M& \A$ EJ:+ E=9EGP>VFB@WH;#$@EF71P83O#D/KE0<1D0FH
MD!O#(B^>!9]X4MK"J=,L*;A2J3]CA1:PBQ9::?WNH<F[GL_TY;S4'YY9X@HH
M57,'X.+JJ6? W_0?G1Y+W9+@68G.C=:U?=G7@U]8!09AVULROAB%^F<$/,Q^
M'I6E=_Z*62]T52_N>Z?M)18$\F.$(."/2U50&K_1BMT98W>5X46;_'F=2$1^
M<E#[1/S][E2(9^KC?4:*?\!^X9ZKTI<22Z=]&'^V".<&7?=\I#SA,2FT+&JD
MEZS7?-"4]N$0#88) CI?(<3;Y6.&F(9@9G&,<W^!6?$M,T1,JU.PW EK(PU/
MNYHK ?YZ"7,JU\Q=5/A-93?@X$&1[F%0(SK!] ;I0)L]2W\9$"4$%'+4&G!\
M(*+KV+@Y5432]J1;=<W8F-N[/(%3-\<_)<0)G/^NN-.9.>F_;"9!;XH';K[\
MZBT[OEK3*(/^=.K+V'N5G.7?OTM\8:\_KX???"KR$$%.1=+/:)% ];755(TX
M=*S.0T2/XP$P8Z67(%:C;Q*9,JA];B4LA';AI" *)5MBNTOB5?:$9FSQ2LO_
MDYE3KB- S@?H;L@$$MV& &K":9(,%:I-YZ>(OC]B^B\2QD.K&TS 2[>C4UV*
MSJWZ[E>,3]O#@7AZTCS@B]W46TN"@V?=MF#W81C26>BB#+GAU?HMF/4)!B]$
M);7@]&*NRDU.'O"UOUT1H%CY<"5X6+%6VP51#PI1-\S9_ZM'A*U9!71E@NE+
M3/<M6+'"]K3#?<E,T(F?MO&/GB?1-NX0XJ</:1^"_KSV'TW?Q[ S_MRTVU1^
MKH0+@G(2CI_8?A]I_8,%U8&CF>B36["NE'ZVYG])^5]2_I>4_V<I__>3HG^_
MMB0=SI8>YPHNTU.Y@KOIJ1UP8:X<FX>A$5]&CT[6:=0J?!+AC'^B(^9Y?9^5
MJ%"<P <'&+ U\]\ 4$L#!!0    ( +R 5U&8TG9&Q5H  &9T   4    :FYJ
M+3(P,C P.3(W7V<Q,RYJ<&?LO E4$]^6+UP(R"2",HDHD4E4)ID5D:@H@XA1
M49F4J B(B(B(@(24@LQ@! 54_A 5%5 &952F,",X,"H0A Q,@@P5A%"0I/+*
M>^][K_MJ?ZO?M[Y^7_=:7:R31>#4J;WWV?NW?_N<D_#[^'1 ^J"5K14@L$(
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M-.M-5.W*]B[Y9 ;&5"QD)#[+7]_<9>WM'28K.GID19W 3O>_BF7>>U.@?7P
MWFQ%ACBV,-8?LFY<)H>7[-Q?@;MEOI<5WW0C\];%@0^CUSY4'[;#U=B=:4I(
MOO$(X%Y$BQ 'B@<NCEQJS973;*9!#M,^]6F/_,*YQOX%WZ@7 _:?U/KD=\)
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M6<+_=5J"-M@.6:W*RZ=XM_?9(6+CH9SC2!LH/]"@K KQ@=AK'%O?L8X\O^E
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MXVA,W:8=.W;,YZ_?(IC&!R)5(%<D5BH219"]Z)"-1_F N"6]G+<6(X&Z;_@
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MOZ-F_X_=6/D/:?\711Y%= D787M(J3Y^&$P@2U^CK/:^ZG; RR_PY6E1I#M
M1757L..LO>'=?8VW,EY?D0R46^KDV!/<WJ+<C#XJU3_,P#>]*HVN^TE8V5M
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MJZIK:NOJ&QJ;.CJ[NGMZ^_H'QL8G)J>F9V;GL+B5U;5?ZQN;6X3]/W\/B(?
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MUR%5N:_L8?CD:HNXLVRQHJ"/-%OG93N.%R])+JAV&,H#/:M.O B\(#E6QAS
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M\\%;Y*Y7^*!HBC+;J\U>>FG*)D"[87.D%=3V!Y(T]0<23/A1BA=>Y(FMJ?#
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M9'%0,:]G.G7??0LZ"[R";4:+?WPX^SLGM*J33W?M7/S0_+6YST./&32/^0Q
MR)NH]CHP!PWDL3Q73V5KQ^=BI^,T4WBV).4 7\)#J.!<5PK7<7)4J#ON#$J
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M^U^=XG?U*1HJ3SB38%=]NGQR7>:"MM/EVKJJV@[9&776M$$,JQXE=%NZR)[
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M ,Y _$J7DS#AW7K, ?CD@H_21Y8+!DQQ04(=W:<R1=/<T[0XU,45I?CO@9P
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MLRR8*>CV#]*[RUZ0O"L>6\C.:#Q:51"3OJXB1@'_IV8&D<2H@S00WH=[;_N
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MFH'2B\S%]\$^(3@F5A;/@:?G=E;!C/IJR!Z=>O)I[,I>Y''6MN13U90Z2<'
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M*X4HY6C,>UBUR+9'R3KN,-GJ(.[LL@?VA81!3^&EGFO[+T_(7LFS-KAT288
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M*,0-Y@/6D%K#5$IEJ1=Q X+5KTEP(Q[IFI\O,*]S67C57TL0YZ_B'8*8_I5
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MP$2V:"E_:=IX%4M$SR>0YY)J24W+L(G%718#IG2PQ%=27UJR6D%J,3Q:B@+
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MVB6'U22#&^\^2VAWZDOI_5*C !B27TN^'">-KWXWAB@0H53 .+4A7OI108A
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ML2I4H0"\:B;(!L_@/ %IZ8W=<3XOFM^[,9!G]4#$S-T_+T!\S2P$$ ;^5I0
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M,8/E8@.'[_?4]1\IR?"4IZ[+G?IMKON-$KPNJ]HCV)Z9Q@J?;OBGJ(R3J K
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MU9.-.'9E[4*TSN9X6_6<6]RVK> VM7[R(X+!AB6VT%PVLVTFHV^\,D'IP,O
M?:&7YVF +Y<64TBQOGY>)R11YZC^0USV\%C3[<#*YMQF75(TU)!VV[#0"FI#
M*M"XY5J/BH;>B0O.A4H-$^^_GW*I#Q3I_&.I+;:9P0,*L%_4"_,#G*4'V0+8
MSQN_N77&;LK\::6M5$>;\KOJN&G/A7F#I6"/5X?C@UH1ROV.R>AYWA>-F"^E
MF7$40/U"1[U]KW)5_:@$,ANTF >IFH@ETQ$9<6(IV"?G<F3 S.JD :Q7VMV1
MGR%LKU;)KQMJTR["V2)@YEPE0EC].7=+'/,6$_;4"G>AS#<X4+WI.&=G[U6J
M%=VHYQOIGWIJ@)OJYWVUU-H?#<Z;G9M-43%NCAZ.#83.UP:7>>QZ9BQ;9D(U
M*EVK<C>DW-3M,)*^@3+2#?.GUA2 &[G37BRI#5ZM$E+-/9D LN!\0.OC'4=+
M'B4!#_515\AT;J I(5[HU1+/[BFH<>$ PK#V.F(=@DPA(&)'V7V?RWA^#X40
M&)%4[R!4%R!IUR_1:;S.&T65$,:UY&DJA88IPD;_%8=E<+GZN#9[-[:Y#CHK
M)^>'<]YZ:J-*RGF.LA^+P(6&V=@'0\TZ-TTT,;7ZX:AFC*>9 Y&0<IS=%BU1
M<.6?#A!H\ IDIKEA0]16#'K;(^G")EH:=U;7++ZM9W4]@WG9?;>/P$9F6I@P
MW\=KXYPCTHEXT.75-/(9F;ATH5(/2/ $KC"2?V$S1^7C,06@[=5"'L/NIY'T
M6_8H /&-7<+?\#]_</I_U;=E;Y#(D=JBAU5IGT8$0"T3X0NO)F@I@&?(-^Z[
MNP2@Z(8N5J']Q">)22Y&^+UXD8'-&_!2(\P/RP0W(9@-D M'4/M&"_!C1)^]
MS L*H-Q,AO@>-4?6_0 ;6C@'=P9/+]N1?RUP'V@WC#Y_F5[M+HE^PC$7ZZLG
M?2W(-?!*Q)L(6_:;L?*/[R#?P1?3+1!4PM9Z^A!ZB\ 3A$X;(S+CW%O<T2XO
MEYU<2LT-;CJSAGD=WBC]EIX>6J/M)\(YS74 1'MMC6 ;T(7QB@O1O*.ON[+1
MP=<&2@_^MMB%0^J_U<5/I3?<Z>+A>!9;T6MASA%WJ@BCP@@#!> TP/8@33_:
MSJ%C',97->39:%$\()W&.G,GNH3=0"1>YG'?SM[3JV>6E_?MCM,N8:X3M2*Z
M[UXOE'KA,1J;^2(,LZ-G8U/NLC-LO;"% @'1#S@A[>E9YU:D$DO84VYJJW:]
M2D/QV$T/IMJ(S:>>&BQ[$:0_2I!*X,ZQWS V3P,I@,)-J;^-TALRN:+\O";K
MNQ\."2=N*P[R6]EN"EJJ6C)R70=>)^]F2VMM]*_;;^(2\!RD=+@+,Y=UP"Y5
MW;SUDW$W&^DF&NPXXF EEZN.C\CKU^H>Q?QI/;ZSIG[^M5@)]K1-\ I6>[ =
MP>:",1_RDA&<WNNWS-@]WV&8W2_\X.?@1 FK+O>:%!#;?)M'>ES)D;N;,Z]O
MQ*/<\L5I?XKGV(&7(</GS@!^_A=1)K'YTL)IMUQ%95WW@Y 96]G5!G;@GT(S
MFZV9M&$@9]"4+R9BBP+X-.-J#_QH\"T"W/A[VP084SR07UKA*7'&WRKTT@O_
M^RV'2B>WY;;%L7?[,4K(K=5BHOZ(,&YL['T=F/D"7!Z9^JS%HT'K^?DVSOE'
MGETWRWU;X-\6MC:Q1Z;8G;S\ .>'30FMPX;BH54D=YNZINK?T^:7MCW8?_65
MO9<?J$NC<>7(@Y]>@0U.IVT+>9U:V@=P@^)E/.Y==X,_3W.ZI\-R->95&_K:
MP^O\C/Z F+X7:JM2':,=QH]&OJX5Z^RM&+^[Z2PQ)0<#NY=8 3=S8Q?4>Q6>
M*TDK.1M_-2[% '4S^KX<?^:Q0[T !MV>:W M(=S&OR=$G :M@RJ9.^: Z-6M
MIZG*S5*OZG!>\7]P['+7KF2<N_K$0O1IM%*\!(:GI9^_\K;*$ *K(\=".+4B
M11ZH"W?"Z.P4#(9W/)]@_WR1U<HVGRMW^J 7'>\PHZ GR&R7L0O1(X()#HOP
MV/DSHV1NJ-X0J*I*_>F92WD.^(PG^^_EGWM%I4RDT$JUX(RA(@0#[.DBI'U
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MV%@4?J&##,5UBWH\J;24/5@A] F=^B\&V%%-'X48U/R/H>SU02)+/_EB\9<
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M+Q7&J[&GY'!F8G(:!1!9NAN/VI.8@4_J@0YL4Y8/#ZP\C<.[GICIU63/CU,
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MKF%D97KVH-M+%?8CB%2YN7?6E?M^UR@ FBTA6GC/7#Y\4I^9Q%V]:W8\@37
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M8J59$5)61IS%] K_D$#>T("MXGZ?0Q*(,X?$W/@)8Y-!M4&QQBK-1[:?Q>O
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MM_7O/WYN;)+V]G\?D ^!/W__Z<4$8F;Z/\9_5R\^AE['_OF [9]>3,?"__V
MC^7X*2U6?F-;-L]@ =FS,>R"E[.*&WHXY+3MB$)W'DUR"LOKX!5(_U3[#\W^
M<XK%_D]I]G\J]G_IA0%Q,S,QG,?,!X* :-22%&70_YNEGA](/0(=EZ'%TX6
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MR_S)+$'V+)+HX] 32-QS9)---W1Q;>B)8C%^3*+_,1^@R*/OGG!0UZQO+4[
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M#%@+XAX(JW)>:O#=UF5??-,9P_&M+%SK6HJ-O+)2 ?D=2+DDY7^I .;T$VZ
M(6$B'4(T1::+@V-K%3]T3=;H;$=LOQ';5W^@J^I?71*\J+Y68$.YIRI"O@P4
MX_0U@7-!O?3S<U2;MQOM#JBM-L/T@8/9$1-.FQ,OU$M/W3N_>N_RR\WQX+17
M3C]9J\O]GNSDA13_>A(JDNO4NGM\O7Q&UJ(B>::ZM/J8F(LEBS2[O-/X$>B]
MTI8] 0HHM>2V4?2H9^<?M-C$!E5[_#)B>M_5_B+,AOW3##T4<S$]+>^QQX,<
M:\$O&SK>7P*;[EY] TY#$RW R>@3.D& KC[Y [&K86U%?-H^TYYTV>AU6-6
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MN&'C=FY>O]VQ[0W\&JVVBQ^N0[+.C G4# R3\KK1F;*J;\7.X3SZ66YY[YP
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M[K#/"BTO+00/2441\MN!G+ =O+5K<E:#UB>WJST=/ -^&LOB,UR1$&B2QZ*
M>M'SX%7?%73_#J4_IJ\NI#1P&$,NWQZE Y*7I./U%&*ERRP^Q?=UB22,_#T,
MW5O^^==Q.,9MIYVQGC.K!X\UU62%^+Z\*HDYIWGRU9E]E",IF.%'@OBN4,5
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M!2'M8&5V@JR4<&$/=0T,(^XB'4F@CJ"N"QZ=G.JY?<T3Q<Y^.\D^)%0KS7_
M4F4P-],D3F4PTP*XE7U-]!,9P*S1UIP_G[41BR*)_,1!PPN5\K_&--6\=J^K
M!FK2RG4+%OP$N%&)<"78Y(]HVOE@>:/ZMI:\-?")L/O!ZGP-NU4>6BS4+N'V
M9W7AB7.BW@?;0@<VP"7XA:QGY=:J?>7O*ZU\DUTUBG>P9>'"!/;.QZ3A=O9
MH86J=_Z^U[\!2IY2<4R$&PL[GNF. %.NBV9K"LYW0T4?LG0#/XZ5/FXV>^S^
M-[W)DN__1#M_X&8IV=P)4M[?BB!97JJ)4N0OWK1DD]*I2%KN#C.H3_S-YS Q
M;>WRX<?&=\YWW_ENH:Q1"M02T MT&(/$VUB1;X&<92*U8<3%%T-0MP4C]=P-
MIT71".6SK6K?S1IX!'R$X"\KF9)&S;D3W<U^3/^94FN6RSU0%_BR./CS6E.
M.U)^V0!NV^BZ[N96DY^0OWF!;$,R?D+(CW+_C ?'4D!S8)[55'CAL^S5 V[.
M#@>?/&<LV,_U1J9/BK!R;E3#8B(?IN"JPI$P#M0.8J5(X!]^(9SH5$:>R\K#
MM$ DY7=Z%D+O9VOVQ3=69%]>S$C4%4-+MW!2G*@Y=,#L!XB (CJT146; ,5<
MP?4&@RQ'YFJ>9OL.;XJ;A?;_%%AUE$%O67]\QB\)3.X#Z@4%,;1N!*U/2(":
MMX\X3?$F:.2X.N,/V^' P=*J2'?AII'%VK,3,26ORZ[J!148DRQRW\<<:FMP
M2N#^*$H+0DM-O(LE=E1, HP3O/R6$1?]35/7YAS<[;8KX>SMHYV#1[E<IM'A
MMS.X2N_GGL1>)3GT[0]KJS;N9"Q3.+6(/83ES<(YI"",W'G)+3<V,PLW[/K9
MW$HWK*;RAE3V?3I@9[#3WUW>ZS43URJHQFQ3PH$L"O]U=-#%FG&J6J]J-$J*
M34VOW+$^53ON^D]DXC&WOH"Y^P(?('R(5G36135A8!C%#6]1MDB;3B*Y.C.]
MG]3HC#Q[JG9O:NEV;+/GSV!'.N#460+B>]9IV@^:= ,U>\^J%(SQ2QJ<4$I[
MVNKN[F[3^OINUSN?#Z9WEJ\$5=Q_Z:9>?PX:W8EGQ]IX%P?>COUE6=#MY4)5
M&)KT7O%8/M3@/(%C'[$+AW=-&.M?&.R12UK3:%@//MI7T\4!-T<)C/5!;^3@
MYXFC8TV&<P@N)YH4N@K9GLD]O/>BFOO#'VWI,%4+RO(S:1G.>]/N^#[FMGDN
M8FE&GU_-!]M[)1Q.HR.W$Y^>^?%#G;T:+K<&8M=0@G\G4&1(2$)"&X'4.Z?4
M6&!)2L*TF05\3+"TG%8[]>Y5WH53"QX_[C_/DV#)Y)5@)2M^<542$AZ4IFCE
MWK<=HXVI1CM*A0PVA!G'_;E@W,I7HWRC-"(_ZE7,W"6S?+%)PXYI9W2EL4[B
M7N7$$59@@210$R>4=T'G47K1Q%<.O5Q1)Q54-?C)C-5^35)!=A050,'_^[Y6
MHDE&R-5XO>^ 5X8 T8"NC6:R".4.-?=OSA;'B)LJAE@1.K(_GM,C[B6@A91_
MX"MP-J3=WG&8#G! DL0.HN!7TJ#\%$^##,Y[+_5.QYWN[1U=4U[^=)Y,67 \
M]NI2RQ:^-K3IUFP6^P3,K,U2L24KW[S][_M7D2XZ.9/UXO%@D?B'>J@?#"#Y
M(VO&]W2G4&)LO!^&&?Z:2Y*M_4T-#U&3ZUBJB+NI%)VOZ\.6"[(M1^*.K+QX
MYIA:T8"@L_B7&F=(_MFEI24(A5WEGXHC=:U)9FM]B,O7&<QT._4::ME:YVJ+
M9%.Q:<+'A:U)/[?#RB-=]O O[[Y<4KB:<Z98)#'>)IZA:\N5_E^K=(2'3(")
MQTE&A($_L#1,028_0:3>%UWYSI\'C#T@G#VNM[8>UMT]-=2\%K7WJFE&OMO3
MX$)(T9SB)"K!2G%A6#<M=9'/W>\=[*6/J(H&,C\U,'\IU7$AOW-FO!_7OT$M
MI0/L*=KX2<S9.-/A)S5]2<F0+;VX9F(-K]_Q.A=J"C8(] 66HY]VER ;ZUI@
M82T[OBGG-F;^52BFY(SB#AW0!2&)]F.VN9FK^T-2N_&;9(Z9\>28H?'[P1=W
M1=2.H"<^&T$:\<O1G\X^L=-50E9F[79NL8]"@1W^.7A943SB>IN^244DV1PA
M4I+7+!0%>;OC^'W$S)/@1?0D]>,U]C=I5V'<.V-3D)<!Z3=2W$3W)N477R$:
M[D,?286CL-?KFF25HDK#4].%?LDH'N00-DPYN=Z4K> DZ@S=OZ8BO!A3V'#N
MWY(VRTX0PTAZ\W+1MOR#\R0?@ASM@GH@9OKJ6_.A:M/A4PLO[L\G*869U^:M
M+.AE\)\]QUQ&B^JZ$)X;E;WZ9)SH!DHP5* ,U]< +YBQ6BHZ;S5^Q?Y4&+89
M-M4P' ,]@T9E5<G%4/0<R(](2"UDFQ_H@C?#(0SR8%X/?&[OU1S))*8BY2VF
M2MT.M"75'![$:)U?R]4["C3%0\,4(Y;)D/ -(8MY!^>%"IV7'V+B=0Q=C*S-
MI7-.O/81?:C\<6IA86NZ--=OT$M53NG K67#UPO95>19**636O7$)'Y0;*.A
MQ<27+%JA%S1(YF<(.U7VC5@\N'.&N01^\V>1+:GIX66"8-([:7>%?OG);C;>
MW47I'L_+JLGO5;;-@><0LTE)-9#RY B0/3H&<LD'>$'0#N)F!1[[4FM/Z_YT
MAH*6O"6X(Q_SB_E8$_8$TS+(RLCZ^IQUV$6)P2?!/^X^,D@U?-6/>[AM=>#G
MFJ.:WY%"U=^7NCU-66:)W>G0< J2L7!V[^G>?W#HUT4'?#-KAR)GF"G,9!!\
M ,&M$-C/#!/;&@O,'U"XY;9=W5]YAX@O08KTU7SOW&SZ_+R=DJN"RG]94JJP
MKE)%9O4..W/5?"Y*L2W[VO='J@  EPS7RFQ%$S?DUI,<8("^1,VDF[:EY&8S
M!V4RH*9?53!UOI+%,]_2=L,Z54\D(:$I(]ZR]E"D2N_OM8TWRZ>XIBB"U%2X
M0I!OHSE-D"2VA,/"QWT,WBQ,:*^G6 $^4$=[ \VPZ).@V20TNYKDL[$6!==^
MG-0H1E"^KTKI?C S3@^.OJS.DGKX@!P+"PPWCA,K79,K!P9 %"OH@-I4C=IP
MDG $*;;PF=-$&OG5@=U.8"]MZL$A)R,F'R4$$M^,PC'X \PY8@'9O3JPI,L9
M2MM[]PHQ_NCG)L27UO>W"' ;'?!ZJ!6'.G^;A&PO?]V-\#ESWE*9>CUB^20B
MN.*/9ZV(69U3JE#T7*DD&RNFP; Z-K'JF<RF]*SY?*2N@PG@V%ZQ"0EX$?8A
MP_-X(@NH/GMO,?K@*[I9;M#"VP_TN<X,HY80GNZ*I>[[H!22&WFHOVEEVT5_
MLQL.!X_N_ZLOUO[OMMYHF.QLH%4!A_G7QQ6Z5\-,F0HN[W/ALKC_%M_/JD1T
M@)6(,VWYF(:8%) ;_O"\!)3XI35F%\O"O(]RSVX^VZC85Y$ZC66$=8O4L5&J
M:?_@G]U*@7SIGRMD:3?>$>1!O.\> PA+^E_3KB):)>!R3K8.6$P6W^IMBE3\
M-^NPRCJ-UR<:;N[+2K6U7*;U P4TN)*A0A2Y,062'1G[8J ;2@<@<J;X*)?0
MUDZHP9U^GKIP5B?<'$MO<[WH0=<4'= -_GD3S*3BQ>/_=/FV7/7A_('!-.-3
M9$>#U/YZ1]:)%C;8NA<,,P<)W^>!5UJOWE!XNT+V8_^.386ET9@[R!*P*"U%
M5 A*(1_:-/&B]#H3[<05'^!K+F(=B$_^=L-SIR=O=Q;C*3@ZX 3N1@NK8U4&
M_G>4EVW0(.)C,@[N9 1!K-$!>+V9-\DB-='S_1<G. <,U9MZ0.RBX'7K32R%
M0UC+/]J<XM,8I]$K%SXZN<N)VD'Y)D=9\QL%CN8"S0WV'N"E8,:=55,Y=^7W
MTD&FR(@"5 T_C9GMZ9-W)/)UE=FLLV\9-JZHE$8'G(P<N"I,MIO/6)A'CU>=
MC*8#[J:L.^+\3HDB2NB A430(:?H'%1 &5J42P=X2C#DGV.[@MG,D2.%PVO6
MFO=V+;+)S$/7Z"QQ\,1A6]=^V7#;WU=F(\=U,=KV=7C!7\62WLE/1E\$44WX
M'M&D;-V%.UHN9C?W.X/N3](!^DY[WZ;9"6[.\-WQ5O\>.N!(_\-ABDW7:\0+
M-!+"202%:%Q<5W[??2 [/8!Q1VR6-!K3 4*H$3D6"AOIYJROGMH5?#%FPCLR
MI')B]7Q)BB!S<&/D@5A#T>%+1,R.<PDW1W_3(H*2I$0'#"&+>RF<(<[SY7XV
M7_@1"T-H6GP0,WZ2QFQ(@-HDJ:(B,V\,[?';A> MEG:6_SQUBPG6JAW #H%8
MT$_9QXOG/.,(30)!FL%"[)-!]W"SCA/29\+5->[JE@::<!UN0;O^&*?G7ZK^
M<YG6ISYZ@/*G3(*TNRD:<P\2"Q]C"G\&%Y*WM^!KAR+R$Q,3/5,RTIM#UW(>
ME7=PG'IB- !0.9ZES47X6;/57Z4G:G_12/O*?^4FT?_?_C_>'A/D(JH09V"^
M=$!'YM4FLD96[KB!7[#G8N7AH\[0J9H"Z=\FX@ .S^^*OG7H"0.:X637#%'4
M!7VD)^,]6]#%&9.O;Z6OI^I?%6?MYC_WS<15%]9I"''].MZ!P& 0=C-'4G3
M(70-2$'J4M24B>IT0#::#DBB?:$#?NP?1FHCM.F =H$YY"'5B@XX'DX'2('2
MT#@%3S#ED!$-O^YG?!=80>,G<",9$'CN-ZP24YOE-+QO<*ULPUVM!JS$=_ZV
MTMBQ9,GOLZ]U_(^787G(#/_M;H0QT=I+&7^M=[5L")UQH\HNO/-)KF".6"(E
M37<OCJ6)H")IDMN4P[U9/?&WN,[2[9 H*1QD<ID81ZK'0VDLFF1%"OLW:BFJ
M18BB02K-(4V >;8J!Q(OI^F5?TOJPW@56.@_EQ/M#3_;Q[_(POU:8R*[Q64
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MT_=ESEY#7WT:DOXUP$6+J$3G=&-H2*%]HE]<@ O2T+@G_G'M2B3GDO24N ]
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MN#9UI2^T% :=7EYA?#%_SZ(2+_P2$(.P7G'/Z1UD03Y%3(ZDED41G$+J&..
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M=1#I#ZV;][: E/'(-(&( 3]+-ZLZ<3<@CZ'SB>1,6O7!:AG<&XC2Z4D*%%6
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M]_YPSKOOI_/A^;B2M>:9^<]_GIEY)K^#IH88@(@A1.$<1(ZQ+/(M55JX-\^
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MV-=VC**0[>:?UO=F[;>]$?-+I'CRA>>2%K;7+;Y;_8YL"QB@\.;33L@0%&X
MH0+K*+Q$H7N#6(AN*EX#<,C:*:IXUY4=*7;K>,$S%^?S(:]/-_E+DPYF@UM&
ME=)0CHO/P[[B5+/=3=6,K0?57B:58!PXWW96(2/^+.TV?.G/TNPRY;2U?%.
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MMZF_84YXB2Y8LV2SW6ITJ"^8Z?6%WQ]<\@) @D9 &N;KW%00R8HPOI%,UO!
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M=L6UDVGG4SL&K[UTM1_V2=8)K>S"\&,>H;$#\[8I9E&HTKFHLGR8\M(JJU%
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M/1,*.*:S:'8.&=-T4.T^TNC/1;0$5]I"L;#12X<4%,',B?/]_&5LNT#P+(;
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M)]_E.6M2W?82!B)79C2VF.JYB7#J$#N#+ H(D[49JT^5#/#LZ@NVKS]8F/,
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M^#4E/V[.?W#?[LM]V(_[8:_]W7M]OFOMM:LJO\W:#\;5_9[[FL^LV*$@",M
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M+W@%] R;Y,WXH&).)FV2J5,81#=,HC< M&F3>]W99P'*29(R!AV )KK]:6'
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M_MXE/D>?Y86.W_LA(5<K Z;C'OR[' IM#]T$0ANIC!8N:< 1*9$K?RGJ<39
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M[556V;?_B):VSM%CQ\^<-3 T,C8Y9W7)^C+"QM;.Z8;S31=7-W=?O[O^ :C
M>V$/PB,BHZ)CDI(?IZ2F/7GZ+"L[Y]7KW+S\-\4EI67E%1\JJ^H;&IN:6SZW
M?NGJ[NGMZ_\Q,$@BCXU/3$[]FIZA+2XMK]!7P;7U#;VX &ZN_WW\I5XBD%Z;
M-M: ;T,OKDT!&P-$>'AW']J\XY0%WS4?T3V:][>(G7[TLJANJ\)A2ZKX]3N=
M_!**1TA*M W5_M#L/Z=8Z/\KS?Y=L?^CUR"PC9L+6CQN$0 .L)A9,2K _[3_
M:?_>:J^S7G( 5VR</B_8\ YE7U^KP5 +QP\PH^ E%*+7+&JXUB6NJ.V07N9*
M$[;!EOT=O@SG !/[NSE /&* A)+5;B)=<Q0-?_TXY2?^9B%^'B<:._8UFR\F
M_[3?C,[6H]4J@],#0R,_&.=BP JV3 ?]/@> ;L@!]EW&,=T300_X(!\[D@,P
M7]EA:6]^<8"HX QLQQ<LFK#&C6/O43?A /HSP9T<8+RC- \?BR6]@V8+6X=Q
M@,44-P[0G,<!(DI8+["_L!S@BW4N!Y#)9N^FW^4 \'VL1>@J[O^1\2^1\780
M>P,6BQ3&J'" ^C,<8"LQ2G^8#BL.3F/M4"GW7JK OC7XYJ]Q9;EP6T=8B=Y;
M;CUKV[IF[8_/\6]-WR$P4R]3:*\1Z4XO'V1OS3]'KXHO-5M.#E)O*>TT$%]T
MZ><5LSCY]PWQ#4LE$E=,"(L?.<"@:D_;G5MM.E/KK_2][)&7"H*&_*L/?_FZ
M]*Y$>7Q]^(*CQY")[F#_@/ZL[Z\OJE-PT'MA/8>XYL@!*&+8!BRV=R^D^"JD
M$-Z<948V7Z-Q@&1(AR0]PDI_!':* [!-X>RSZYHQ:QUL608[7X>-(# ,8/]A
M I#65JAD-AH[_ATR41CK+@FWMN'U21T<X)%^7%:M+V1C-@=X8\8!4A;8G49,
MG566I3<3CZ7'P'M&%#D #K9V!+ZVBP,XH%S8T$*,ET#-/%L%_YP#D B$F63L
M1! '*+7@ ((L#G IG0.H$EE9B2LZT?"I%K:9$-L8WN\H#<GA &L'H";ZSS7-
M_CM%A?Y[Z_D<-!WC * =7*B4 \AQ@!NL2,J(][H&;G)N0+5EM;S0M^0$WQ6$
M$5+7,?Z*EIME7H%*^;.Y[I(?Z^?$IZ^[&I;IH%KWXOQZ^];GQ"P,;KA#'?"/
M&MJ>88=M_02&L8?ARTDR2\^6O0>[V1?X&F'T:0Z0\[#_>?_R!2A:]ES1805%
MLI,2)YE+;",4?GT-SMH7+F;A^'0B7 R1BOD.*]M[GVK?>!S1<$*@OBHR1L^3
M+*A-YP"&U)'4SMWVII<$M88;2XXK"N^^<27)82 TJ_*S=&_!A0?')N<('09+
MP8*NG?F.N8KBQ#4O9M),AU56C0O=D_5.RSRN8A >RM[%W-F/5B++(>HDV'M+
MDD;K]-/S[>!)Q2?>4;],J2PUR^RS5KPX8[S[OKX+#<_F+\M![TFSHF%2& K,
M2S2CAHS--,H*(=I./5ZX.ZWM3E*[5[$QWG?34>?#(45)N1X'&^1-)E'[_:QM
MO[1U$K_-]%^>&8F:R4T9>]/O]U*@-?"M1UG&W-"OY&K]XJP:^A(]#Q2ZQM#&
M#9)GR;QO0&ZVR$J?8759>?KEBXBM\>QKUX4-XAG?OGJ1*[VWLP<NTU 5=2,[
MP59JD"-U&TSD2M-H\!F'JK)'ZH4U!*T#7I>EI0:&:P)O1%>HWO(CUMS2-96.
MB#5I]7"9<,D*&-B[C""^?'S;)O]UCWR:8X!=F>>0Z>7487./K)BEA01X*:$!
M=U_RGD;$2D^/5J(HF#E1P%0;)0K9%S3GO_V<[?LD^Z:U<2?&Y1DB0:5EY.[G
M;[W[N[.WNU4KR%QZ<QD'F7N%I=_RHM-FA*]/S[G0E3"HKTV]92?X-?%)Z7*O
MQ/S91&YYIST\B&^G+KDX;MXY%?\LK]7$043EPY<.9GV,RNM=^&SX5=A:.I;2
MP &\5*>.KQ^F<W& IQ7LGW ZN=8ICC">CH?.<(!I'_W<4,+X:RA[>F.G=T#!
M%:-*S5Y]_^>4CO]VCR6UT>DV)*[%<( *.'UID;B#,"G))F,I]PW$$-,M$R\-
MQ"YR&01V-.,'V^A8%JY,5U" G-@8K]]BV>/E.19YSB35]%6"VUG3V]3\D?<1
M>I\-CQYM)5?AN='G05^:;OTC<);4DG@D.,C@L7:[O5%/5F6Y+H:ZI'"]4J[Y
MCFZ?!=[06DY+Z6L%HG]>*U6^QFU_@D;*'"5[+?TQXC%3BU5)<"+$(87'00MJ
M!3V%ZE]-5FGCZ2H=OK-/\7F>4LWSG68A6_5M;P'FIQP6$C&[04F22X0R+;<1
M*^FVOC?EEO5-0L]\JDK#8=ZSO(E?YQKWY[4=%@84[Y^3BCMQSNOV,Q_[TFZ[
MP 34+8/],:)AED%[GWDQ7&]U7EEHP,8B!6LUID5G<8)ZSL[O[ <=M I^E26O
MIB:'2#4<\8R,,'M74%1?+GWAX*G"F-*X[*-+!L/27W8\J+SQKCYF"J/ M ,]
MJ&$7NE>0T;5:[SO55CRO#YET*Q*>*P_B<SW?#S4?+RGB _QYEGGZ#4X_OO+<
MJI?[P>-+SSJA0+]D;&$@QD5/FTOC 'M9) [ @'"MJ_)MY]MOV!N$-9T%(0XP
M1&2GM#O&([^M$9D)1?"51>RZ%3Q[$;ZVXQIV]B=\^3&$.($N;_ZK\0@=RP%X
M][$>0WD!+@%F-Q#+D7-8<K6 =Y0^UW?OY5F"D(<-0S+J2'1/:5]3-)<B[-"5
M%)[WNM^SRH+O.BHP3J+/@&O4!;+$ZSX8WUUO<>:Q7KTMG:9!)$;L8=^LF:*/
MK0&HO:G'E")L;D1)Q%4:AES3OZDU->F7UU=_U/IC85G\_+/>$UJ7@_T77G6<
M47UKEZ!V(:4PN>MR:7)G@5^ N2?#P^D;=C2-4-Y?AQQ,)HV$4<?!>ZL-<%$,
M#'6\_T*?GAIYRS;$HX$G!?>K0M[+>Y:^5O7_">P_'Q2R+8Y=S;CDP98"3S%4
M9T?D.M'*<F..KD*DCBW@A6_"%UX%^FPM+WT?HT^*OABDZ#[_X])U/6ZZ)2@Z
MEAA-E,=(8P8"B )>3(ULE,*H SZR="E JWA&_T#ELRW?.(#Z,5NGLFCN+5_G
M$CKV^K\!FF&@/0>@6K;6'B$R$30=YHY,#H#4WM'N.8I2!CM(#)OE(&4N1W,5
MO9#AKWP+2B/^K_<DNJ_%:Z1$-I'W37P1)__,(+^2N1,0GU;38U7AU>4^.SS4
MWWB5NG)8^?B.F)C2Y\Z6^[NJ5ZV2$0[>-58EJQ6+^*&ET9L%#"@/UFER !?S
M'_.KU@SKCQU-B8*_,M4^1"4+MCX<=NB0^G98NE(V#=X@-7;B!((ML/36$;2G
M2W<S@U^6[,63"-'WY'-?MDNOD:L33+2/.V7\N#G=H37 Q+(RX:X:0POTG;74
M_F9SGFFL(%L!PJ;"ZE&*F'MK7LN+X8%V=E2:Y,4)9<VLVC4%*8.J3Y9.Q][2
M&"279B%090?S,&A/$QK%%(UZ"Z*\F^B.RF"R=G6 ZW2 VG/ODG,E#+U%V0=)
M;IK=#Z.*7NQ*4^+30LN97W-,D:J^E'OA8.>TQUO=67G[?-TAS/10KE!<+H6Z
MXF'FF'(N*?]-'SW@<M>5/I_+M<//]$OPWQ)_9%NS\N!NQ$$G>CBK%"-MC]H3
M?*&M65*>AVK='S]9G7H";M[]&5ML(/C!:D?[9-V!I&BAA<-10XK] X.1C81$
M"0Y09A99'PL+R<0VO$W<>H(UU8BDY/7/K4>E/+8-?A)/6>31C60N=YS5&L.6
M5-3#HG'O$YO-8VIE.O7%9QT/@ $TT:8EL*U!IU9&NT/_:?Z5K((1G(]8MZ&U
M28+"MA=/Z*%R#U>6:334<VO)!973EI/%'H[(NY0WO3.EU7:9-Y%*$?5]CK//
MQ^3M2UDCWH'>V9VN*\7WY"J8H@SZMW1Z.XAX-ZN_CRJ*0C3K"](,^B.8WJ02
MWRFES&POPR7948GXDF9#ZY1^M0K?H(\H^)P<0Q.5.,H7R0P<PT5I4X=0N61<
MHX-YT_IDFN?MO8GG)"UORHKL6G-V'>,.PF\V"L[)LPPF5Q>O1J-4@IW&RC_"
M4OJ-/)!?EY;$PVVF6<C1V@Q$!LXZ:(#.KY)5?>%?F,?X)LU;A&+UU5CA',#3
M6\J6W5V[HRKV$T&\5@/ET3@B [Y[]-3S +DD27@]> BP.R1F\=Y@IMHV-.5.
MVZH286Z%ZMO, ;;KV;\$KZ]O16O0=!T2'7N;8S6#TR_&V!1(D,3'CJ(*L\OU
MG?:UQ3[=?F< +\[*@;O!!]+ID=0+V51=<GD^J<T#)\2\V;V,E$*=::SHW)W4
MK&9K[?7L6'EJQ;.?BK57><5*U,D7GY$)HYF.6F  0Y0-$609_3U@-EFP-W*.
M V2A3U6ED?1?%I@KUOKC2@-CG0EJ/MP_Y1Z*=SRO^WFCTFGQB5MGP]@KL]8+
M<96O_%<B&\=?L8;MJDO,<A8J5SX\032..ED8U)<&.CF7LL4E80NN&2G=)F6>
ML3BJ-7+@,,E@-10C.L#D 5VR4+YD2^;ESENU,"+H<B[F6Y#S]NXK+JW6<)>8
M+3D9A'"]%ZB% L9)5"T'("<R)9Q&"7,+;XZE-8QLH<IGCST] &-=6G^.<RVI
M2.FA=@!F-!Q)LTAN]B$(%8B\ 1P@U'MF1".-'@\V, R&VLCEW3FEU)9PBI[6
MFRO8>EVGW9<]7)_8S24M^AM_7<P?/->RXU "7/-" SV>.CQ5CP-5\'7>0TN-
MS\X/&CU82=S\$Z7:HA,P88T^<8#MW!0[?%#)R?##DZ'2G#G#+0+7THY]0QUG
M]E*[8V,SE)4D,K*E72<\"U<"&*H.3]_MCF_((]$N)B6%6TLJ]DZHS&0'SY5>
M9IB;?5^(EM>L!8]!\_T !KP$[]R,:!F3K&^CP!M3+6AR3=^>J!<6S/_<7OS.
M]7O$"9$H?-'"PIS?6^D5,TNZJH>'JYU];/3XED>&+U+]G>KS@"1S@!^D=]>G
M0H"AP11O.,5Z4<,7O#EW%!<&$U+WFZ+)/<ZRM\<)(TMI'Y]KYN_;%]/GT"6F
MW';STBU1Q^@Q#4GT;LAJCYB*8 ;C.%H>;'_K6J$O1U.A+L1JZ9Z0BE8K5)L7
MF0Q1^A(8(&(RH:>N?\-/?<O^G^NH_?.X"@_$OM9NA.FS3D09!ZAYM9;I>/R!
M>\WQE*[XH_L3VA='+K0/,0J/HQ/3"*,Y6PO1;MWZVS"]^@J2_E5F_11!4K .
MJ39>^Q?SX^[Q9R9:TME'62MC3:)YUYY0QAY<DS>YSU+$?X6#^Q;FBAA&:'VJ
M<GU0HC2;J*])\SL>V8+<[K8>7/B*]%&=M]OKQN&U@,XGURR[#$HIAE_D6G;1
MD-E$ :8J&<F#AG?5*(\)14G6[N^94SN+J-W3XYD5$;3:JN^4<W)/ID\XX&/K
MK/[FJP__;;>RS4,^O0-T[XD!57^M]E[EU&O/]^]3G$PZ9Z=:..W97QTP[VUA
M(+ZL_&VC[(>Y85JQB]XC, @=""S59Q]E:J;HIE -BZ%R !94GTY?Z?W5RUS(
MX "?9T6AY*O, 5X=7H=#2>O17DGV1PBJ3$Y!0))Z[V]\^*\;7Q.A+)?Y7"@*
M3NF&+MB-/X8W9!7 QT?1IR! PZV;" :V8\^.XQ:5&K#]'[#3*FSO#OAX  19
M^&2(X3V!YCN=:0.1/^"O&J(3]UZ(V4Z@0XRP0GPI(UB: =7/7X<@T3"&#_)0
M,W+1K!\ZA5W^@+.J0RY:7=Q0=CD:9@C)!2T8/WX3.'4"$[?199!:F$W8(1PC
M<,T[&KDDP %\X/1/$-HNCRU^AQ"6.Y.V6H^-X !BV46)9*&P=V46K]T/(FW2
M\Q:O94KS/'JOP!,RL]5JL>+T%G*5\*:0-P!PFU?L4IZ!2:N:[84[/A;>9\7:
M8H."V@)*J^\KQ5S:IVBIXGQ7@4<8M2NA9WU_].[N90K<N#C6K.O=M;+R<.T&
M;V_AL_'!XH8 [)SI"9T+W<]<NN=VA?S\>O/#P4;)]H<A N5\7QL!S<#12\N6
MQ7(;BC7^;U8;_(JAQ %:"2@L>X0#+!>Z+[LOX08TV&8,: WIJ]"R^B*R$4NU
M$/XHO#-GH7'LQQV_F(GLLT^0ZZM"+"7(6QQM9\)_VS;Z/PTFP>[#+=[6WP69
MUYRE&%$S^5&67@KYTGT:'ZL*.ZVH-:7%$DW"?DX3Y ".T&+E9*\1]"!'&E%E
MUYIS@'/7($=Z'7CM'SD2TA#S";ZD#7'\2/9/Q+>[RRYSW!S@L#?K Y;2A&Z1
MQK;J(-G#D+^0@\UYL:UF9S84[5(,EH;$DHP6?I.+?+ZR?FBC"XB$+8E#WH*E
M3$W4*F&_:K :H9MLBE'!=R>VG8Y1>;'I'S2A4L*?Z@Y'W]^LS Z F.WXW>A_
M<^:G+-@C*)B2!?[-!B\@=VH[<?&?;#%SDXE_KC^R,7^R-"'KCOG:#A+ACQ('
MJS.%6]1MPO:W0O%[7B4K9KGC -0#?]54?W7\X&/?)#)N0SK$K'VKC6.%8"<]
M(<%"K _X)V,::WMGH3.$]2OF^:/XM7UYV"'B^MG$;.A:I@IK[C=Q2YD$PXWN
M G6,?9U Z6#5,"L:\6L0L?B 8UR% F[=9\WU'T7R?YOR[A]%P9^@YUC_WT/3
M3F<.H#B,94 Q9AJ]H@?YG)*6T(:6QH^6G<4LD.&PC[^)QOCV_VJ"NNF1G=BO
M"%8E) B7"J9P@(.$50B0;T'<D7 !K@;]%?*/FGX7*PER06(-?(,PKB.T[FD%
M=OQNY36B+A2,?<I_"T:798P19(3S&G\8(10*A@,K_S068K$>YFM'8<+8H5QV
MTAE'7\?X/]F9'=T*'S>%T!(/^5J7!9.8B?V\(/YO.>4@% ;=>K]1V'^GLO_"
M/9Y_D-,&D<5(9OIJ) >@+$#VFL0;XH_]9F>L[A1V\3@$)W^+17;B9VB 2?B_
MV> B% \3F7G_+!QHWA0W#J#,319B^$%7&'M\\^@D_+VAD9W'E)G1MXDK\[#U
M<_#TI8XU.3)A=AR"G]>0O]]S2?UW[T=$8WK@%;EU&@.(1COX@QH/'Y_@_)F
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MZLQ@"/&4D"DM.G'7[FJ]?9\R%HV6.BA_KW" PC9D\LO+K_FM2D_(D/,$;A*
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M"_>U6!_&8B28$\,G_\O+[, >)M4>MA(-B1>Y I7AC)-(/Y&F)]\4M.<Z;3(
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ME)F5!N\+-'GW6KKB968,=J4$G1XL9*H9H#61G9>_PY-&>WS?W"0R#=OO?""
M[.OC-SH6X7WLDL[?U#_=_G$]Z/PIPA':, B=/5=*Z$R5S<L%BNEY(!'4R:ZC
MN24ZNT2C7AH<^K"]A^G(+3G3O4[])B.AQ\_1UJB4?^ P]6TD"K:HBR7M8<I
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MQ@\L:E3W^6]%A ^!=J&3*QBUS(JMU<6G__LGYO]K WN__@=02P,$%     @
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MX-8:F,"8PNPY>29P$X5DH#$_!YC SU"Z+Q&YS0280&(+$TC0BF$"X0PF\-Z
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M"S$.)0LO41[(^NN+PM1G>P^3VWP$;K##WZ%43 <8D@L99UYU/,SISLARV'T
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M>WYHH'F?@M3GJ(/&>@4'7 )$6/$>+?![\5&-9T()$*$RY-+.X5JPB*QRK79
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M@(UKB W9?B1A:FK;!+/1Q "P<@P@CLX RL#WL];I_2Y:_49_^%3("HH?T<<
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M/6W3<W-'"-%M]'#;9<_T%[N.V?WX2\D<%*M/RJ0]Q7@AF)>A3,T*/GE':C^
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MCD1 J"IF :-(W.2+&1<(.=XZR8107H'1>;>D<?<32FIRF:^=H_@M3X?:6YZ
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MQ6%W%Y4E]=IY.3FK6;C&AE2&7^N1G.T(EZR-EW8;MS U6859[DO>A3\+W0O
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M.#UVKF%H43]4&1L&!HGT+KHIL58#MZ\(I*]@Z/O&/:W.;HZ,_:37('U%@1'
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M>TE_!L'?1I&5OP\K%TA+]-A[A/'8*<1+0U!"^TVID ED,%CUK(K2%_X9VC\
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ME#!(ER$M:$O1# Z95A:]<*\4;_@T/!7:Z=>!4&M;&E CKM,%]XU#@]QP+AZ
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M.P*#;3."XT!<M='KIQW&0VB%E$@.1'W)@0,ID\%O[]5:0<(XD)0AT#03',A
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M3#SZ%W8"2NY=[F;XL-M:A"J&3?:&X#!)V]'1F>W^^\O,"B9?XPY4V&0\%V#
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M;<3(U-[;V^:I\Q\G MY]\<\V2R0X[P\-Z>Q@?/_P@>R+IUY(TB*)M^.5D6>
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MCB#.=- E";D+=Q"![;B;5-O&@]^^G"<Z)-X?+>L_R2=U\6]/Z5EXG1VEF.K
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M],F*_4&JX9X>@\N$$,3UVR:I@LSEDF!U>]8C&+'\OETW&MAGD0AV%M.$0A)
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M2W[Z<2+F44&G%Q?2(RQ3\MVC%0$#_%_?L/OO/[DXX_\#4$L#!!0    ( +R
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MCK8UZIKHE,:[2Z.3UW?T>]!T\2'+\T^+&SJ7GU03TSN+$:.,QP2&#%.(PC"
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M_("',*&1,JGJE5[A2@5C*1E&1)*$T.8PZ*WE0K<GV:P&[/9)T=LQ#J";,#G
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MIF9YE&*"33GM%R#'8#R]5.L!G($I8!^7#H'?QP"R7YWU -1(*[,N@#DMRDY
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M)! AX4/L>P*&*$"(,4DB2MW.DW26Q6J<C7K@Y!U-E^"K$;@\<;(6>540VM1
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M*H <4\(Y00@+IRPXM@U/;:27<F^FTM:2@UITL)9=SX3FAR,/6/>&'4,,@?'
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M/F2>2<\6AKZ*0JDG3>5FT+Y@UXYC!E?; UL:-LD-?S3Z_.D"&#V!4124FEZ
MG\JWH/XK*Q4&NQI? &IT-AD27_:=<-C8>9E^'F7_YV4ZN-N>4?_=T/O64H\B
MCK\#U3^^!S>J!FC&S7P0,IU=URZP?WNB2_VP^7-EI\SB ,>4D  F21!#E(0*
MDL!CD&&/4Q%Z$9-6F^\M;4QM&F_$!"LY:VO;CI_;T&SGV)XP&I@GW>&Q9C<+
M -8,E3<4E4O^ZB[[^EK?7;&3_K!+2FU/'H58+%1KR,'FTLYE!ZJLOY=/Q7VV
M3(OGNM21HBA)_##0B"4(HB@)(&/:'A0R%E)YG(38ZES7J8:F-M37V:G!2M*.
M%:6.8FMG5_6!V, #OQM876H&M"+1<YV PVV-71N@5>,#]0#:K^^8(2![>$C+
M@)G\<B'6E;]3F<_BD!-?)!@&/(RT&>!YD(J 02\6(48>40%W<F:VM#4UCM@0
MM8S=WQ*VK@/@^XZ% -JPMB.,GA <F#-:P>OQ?/EI,'H]4][2W+CGR$_KO7=V
MW.*6COG_L\5=46^PW.I'U/-?X-&(8LFAQ%Q % 8))%)QB! /<4 C$3&G;!:'
MFYD::ZSKAA@Y+X"1M*-E<017.YHX'ZV!&:(;4.XI_UMQZ#7=_^&6QDWUWZKM
M7IK_]JN[L4%SWDWS#4L7=80:S^X6QC_^7FC^255JXA ORPR$9=6UI12:D_;+
MK37%!\HKUS&\-Y(_+<OKM'V",9$RA"3 %"(1)I"B4$$O0EY(3/E<[&2?C"K]
MU+AK(]@]7PGIQEGC]KX=%4ZV3P=FV-7)TPW%35!PHSK8U!U4*H%&^])J.U (
M<UV@I;KA8O.(Q,WIM\:9P%^D]_J<%\958-3IYD7Z9G<6>QDANI;**M*[4L2;
M@A9/>6W218B% 2<(Q@'1LY@B'L3*$Y J17SB80]AZF0J'VQF:M/-6DI0B>E:
M&^L@EI;F\=D(#6T>[X(SA&W<"D*_I; .MC1R&:PV;?=+8+5>W='31O-[\Y\Y
M3_N5SF59R3,OEBDO-/>8&L0+L?W%QI6S((C-<5@!&?/U,CH1%-( ">@SCX4\
M2/1R.YI5429:YF5AZ9$[1R:7 ;,KV8#.)[-=7WJ=S >Y%M?LU=^EBX4)QS'9
M9SI$Y)S7A5$0$\EBSU0%41"%B8D-57JYPG'B2X\I09*Z"]\N+(L[C]R!C5PO
MTGU2?_LB'6?IFQVK*X;VWFK)ZJB7MYOPKV4'JT[:_6[CAA[]O'T VZLG^"R!
MQO45]X'=GC>YEX=VFT7?I8NTD!_2KZ:<;:'?VW1EW'^4ZP*IDE!)HR2"G.O^
M0PDQA=?T)^XCS;8D08@YUIZU:WAZ(8QK89NR']_2XAX(J4J%P%QKY%J9UK(3
M['BS?V ')LA*8%A*##;@;7PB6NI!CE>[ =4GX5FV/"JSN:&Q2V&.=[L?IWZ_
M^)K]3A>T/MD:L,0CG##H(53F4":0E1%U0J$P-.G=H]CV%/7VHZ>VL&^DLS\-
MO -5.VN<!\# S- (UN%(] X(]B>ANX,QT@%H>U"<#CT?UKOEK//.#:,=<3XL
MZ.;)YB-7N)-.E:IKG0,G-U-]G07G6IK=OG1A7)I_,P6^FC?-YQ$E&$&" J(M
M)1Y $HL(,D9X&# AHC"R9:8.[4^-ONID<ALZ5/;2LLX))3;4<"F4UK5[3K/A
MP* /3)G'\&YR<&UJ $H5.I!KIW%AS< #=\!(-#U$1S@1^ADPMK!^EZ>.-C6<
MH?+F_''.8SKZLLU)E$_JILCX[_762R)"+#QMX2*,M86+D9Y">$QAF$2AI_N$
MA\+*PCW>Q-2FBE)"XY$L9>P8YW4 24MWXUGX#.U#=(3&W2=X5/M>'7W[K8SK
MO3NJY9Y+[OB5;B,\7Q:SJVR19_-4E#-.>42]?C-IP ,5QQP*/U(0^;&"1+ 8
ML@@)CRN<>)Z5K=C6R.1&^::<598%QZ'>"FG[8.\+J*&'>Q>,K,>\#0@MHU[?
MOC'B]6^[H[WU^:.,=QL-FQ%O=:W[TO'OVG:0R\7/\B'-'^_E4K[]SN=/(EW<
M_7I36\3*"T3 4 *5IY>+B!GWE8Q"Z&'LTT2&B4>M3H7:-3<U'J@E!FN1+X!L
MA :_OKIY9;\>L0#[]+JO7P@'9HC3Z'58UEG :+^*ZQ?.D19M?<#JM$BS1ZEE
M36;QD-&68/8*;:ZX'.[J'BQD3NIL[YU^UJ3/G]?U7E@81:' &.JEES!K+F9"
M!PE4E(913#WI<>*TYK)I=6K$O!TQLA6R4$GN'BIR&GG+-5K?> YMQYV"$OQ6
M_QRD[HX37'T'=)QN>/3 #6LL#@5HV-_<C:&N-?-E.9W_M,R>'J^V,Y-\3_.9
M2/0:47HAC,R18103 K$D/O03(;W$#Q.,K?)&6[8W-59JQ 6EO&!;8/";$=G1
M4W0*<#M*ZA'&@<GH+ 2=N<<2ESY9YU23H_*-I?Z[3&-[6S>.N?Q*T[GQ7+_+
MEJ9\Q/HHACFU^ LMZM_^GA;WZ>+30OZ'I,MW-%V6GNX9BN-$(!K"( HD1!$2
MIH80@EY (QEY,B")4PVA\\29'$,]R7*')UV ;"'!LY;5C9#.[!T[OAH/\Z'I
M3(N[<4;N JPT@RI;0CV&I#E.5^KSK/\Z+SFK/HMWHU<6<[GZ,[C6?[EH>D\K
M#8S6%\#H7>W-]4>,_71 G[QYID2CTFH_Z.VR;D]/[4;*OVBVJ&LJO7M:B+SV
MM&"?Q;[T B@CKLF6"PR)0!+Z*N1!%-$8^8$+V1YN9FHD6DH)'DHQ@3)RNG'H
M$3#MN/%\B ;FO J=2D)0BMBC.\H.A3Z)YTA+HQ)*N[:[1''BZ@Y5@H)7:+,(
MAU^_L#%/:.0K 4D21!"9DVF$!APFG,:*$Y1@N]W_EC:F-O2-E#N%77R'$CA'
M@#SM]^\!GH&'_2%DNE0).@*10Y6@\Z$:R9'?#3*W*D'M8+15"3IRYWA5@MI%
MWZH2=.+2CJ>.&MNI3@X@J2EE+3Z99 -/2Y/A_0W-T_S71<9RN?QJ3+/WB\>G
MPN0B6/!TGI:OSYOG\O9RF5QO_\>$",Q)#$4HS1*5(T@8]Z *0\Q\@1(6..7@
M'$K0J9%O*5_E$^H8>#58E]K9;E/HJ(&G :<^<C\--3" O9Z?&DK6<4]<#8SX
MWAFMH=OK=*JKCK&MTK&^7VBRT]]\EGK,+(K;K"QR.V-2KWQIY$$_0,AD/_0@
M"P,?\I PQA$C48P=3GM9-#DU?FZD!&F5/_BQDA84&3">+LM5L@/DI^WF_H$<
MF#\WJI+769A7J-8R@]L,W P"I]/YLYYA'>]<6@-O_9*F#;R[;^OQT"[7(VL.
M4+4?9;-YT)A'W!P4VSGZYG)GQ\I]_%Z*I[G\I,JL!$^\*(LRE5D*YL;'?I7E
M15X6AY_A@%)&B8*A#!1$G#)(0R*ABJ4TU3 B#SD9Y YM3XW#&]%-'/^6\'7J
MCU)\4,H/?BLU<"WHY] O=E;U0&@/3/1] NU>Y\\=LE[+_3DT/V[5/W=<]HK_
M=7A$1X:CII7R],?G9<JEIL^;>[J4,\9]'G@BA '!TF3?)A +W0LD05$08\18
MXA2%<ZRAR7&7F3; HQ'1S.8@-T*"'],%N/KYW?H;QP3^1V&V9*<>P!N:BFA%
M0Z60%Z 4TUB;H!2T1]8Y 46O%'.LK7'YY(3&>^1QZGKW<E]O%T5:/+]+Y_+C
M4^E)9R)@GB<%E-B+38GS"!(I!!2A\K&'(H]&S+;.U^[#I\8(E7S " @J">TK
M>^T!US[>SX5CX#'N@(13$:]C*I]1O6OOD:.5[3JFS&:]KJ/7N#N6.N8QIH?R
M&%^*_WJJ#X+_0H6\S78S')4%"(M[NO@IR\2W=*[?Y-CC@H<8>H0*;2:$"%(O
M,MNW.,)84*+_9NNP>EE5ID8[&QJ !ZV"\2FDNRG9[-TW+_R>G/:R_?/T_L L
M.U "_LWWR8!B7( '<M!5=6T--*#!YI_F);/W/?[SO&PC^33_>5XZ)\?I-/JY
MQ2'[P@*.YNB=1D=L.I G(I&[Q5<^ZV.V^/0HE]248ZL<X&^_/\I%+G>V8Y($
M>X%(&.0D,N748I,Y4O@0T8"0 *$X#)2M?>;2\-2LJ8IA?JSV:_X$9"7S!5C(
M_4T;^_G.J2M.FT!# 3RPP5)AJ^4&*\&;?<=:]#.V'9T@MC< AH)ZI.FZ@GRA
M(<]6D-=[D?6K/=169!?@6N8_I\>--EMU47)S;NET?]>LG>MHE]4L=*5GFCOY
M?O%I%=]2>@)GL8^Y)Q"%A(L$(B_ $(<DA,0/<(1XG!#IF++3OO&IS0B5_)M'
MGS:LU0M0::%Y#*SUJ+S:KMDC'?KG]!0Q).I#>P\G"+AKKLYA@!\U46>?'= A
M3:<[@B=S=#H\<N0$G>[*[F?G[/",;EO!GY<9EU+D[[0BG^ESN9IYERW+N>R=
M7B$MN-F"YD7ZM2JC*6@8^R3Q8>![>C)1$8,D]I!>7R0)\R3V)+%R_79L?VKS
M22FGVZZP*^)VF\4#XCCP#-%(#LQ8 C\VP@.5+?]4^XA6"H"U!OUM+G>$KL\]
M9U<11MV*[HC/[@YUU\=TX[7;91G__5SNB-<GP3S]*JJ0(DA18/:O.8?4Y"84
M3 1AR&08$J<"T ?:F!H_-2+6F74O'[*G1>'&5X>0M..D,_$9F'=VH.G_I'&+
M^GURQZ%F1N6'%CUW.:#MTHZA;+(HYE*L2W#6;VCB)]S'.(%11$K'IX0DC .-
M7R)]+S 'YMP"<P^W,[7QGE=B@OE*3L>0M2-PV@WX'D :>-#7$H*-DKG]#_P3
M,/0:K':DJ7%CU=KUW0M5.W%YAW 829^*YV;D2Y9P+Y0P$HF */#T+!\+!5E$
M9!*3((RIU2R_^^"I#?6;WU.3R97.B_O7E9P.6_:;@%E$:72$8>B8B5*L#JD"
MMM1WB!_H",-8N_F6<+CMI1_0N6UG>_/R\?:9#PBYM>M[Z.\=/.]*2;,^D95C
M_Y9^_T(+N7U^M/'27&4+LP5@_#;9(D]%N260+9I=Y.=Z.V 6^YY?GNB/DSB$
MB"0,,APK*'@L?4X"S+!53.U \DV-]$RQS/1!_['<XBKH=Z#EEF4.#/T[KYR9
MFA?Y2CWS<:V?-HQJ!1W\RP-TNX7/_V4[<^AM@4:[9L]8ZP>,@F!;PTT']5I+
ML*7F*@CI^:+9<G[9SG787WC93AYK"^*%.MMMHV*XKFC;RQB@U?&V.X:#;&M'
M9,!F.CH=](B19N TX60W\J[T9Y:9E8, >8@* E5LTNQ3Z>NU!_,A"A,?!2((
M(^5VB*ZMM:E-T(ULG7)6G\ UQ&&(4 *9) 0BCQ)(8AQ"0;D>5Q(G ?7=BK3W
MANPXM=E7XEZ 5>1N(W&?0%LZ>_H";W"7C]T;Z>[FL0&@5V=/:X/CNGQL=-]S
M_%C=U+&^@%RF7VDU2YC#T^5SWR]^EN).YINQN\4ZI;3O!9C&/H8J,0F_ \TE
M3(4$1H)[(2:22J[<"*6#%-.CF;42.1 R3^\656+I'-QK/:J@PY5RX,^;9P <
M2Q1TZ#,[;AJX'P9FK+7T8$-\4+K[C (7FY!? %H,DLG[# Q[+7O008QQ2R%T
MQVFO/,(9CW(_WWU=K_[>I3FG<VT9IYEXI[_+9UB;JY%'!!1<(HC*^NXQUA9L
M)"+J2>X%<6)[T/MH*U.S7!M!024IJ$0%I:SV9[^/@]K.7+U!-30W=4')Z5SX
M213.."!^_-FCG10_J=[FD?'3%_==*>62:>*AO)@))*/(9Q0&A.M5K.\KR+PH
MAHC$/F=AA+AR*A9WNLG)$<+I$AQZ35$+[[C2M>@ .TNG7U@'-VQZ0;3'HB2[
M((U3>&35ZD2*B^RB8%] 9._.;GST11;ILEP:?M8OS*U^2.7Q$0E/@HC#*/$B
MB"26$(<FSY[R%.=Q&.+ R9-VN)FI\<Y:2F#$!$;.3NZT(ZC:$<OY6 U,)EU@
M<F:.=A3Z9(LC+8W*$.W:[K+"B:N[,4$9#GR5/3PNY;U<Y"NO_X<LS[](OETR
M;G4VPL047WZZ>E_STR>U9JB/LOBD;NGW610&D>*!@%Z9O2K&$<28*YA0%5$:
M8RR"<+:0=\;9<6O/*8,);#742#74]L0><MAMZY2;C7=)EXMT<>?H_QFNK^TH
M[F6[;LQCVEM*-KNP/QH]_U3F^]@NEKG6M3J38;0UQS' *MW?A@EG(C+T5UKK
M_EAW\([ID[B'$W94[A\<\]WI8_@&>S@Y4CF=!<<"<QS (/"IV=%-()&A#^.
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M2 ]^(G@8Z5_^(/&@O6)U_GA8"=RS\%T&KX+H8U;(7#S)P N".H]CK(* L9A
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M4J0%,/LZ>B4,+N^6LDJ:^^/5S:5CG(EE-]@12H^HCE7J9W7NN93X JRCUBY
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M?!)#/T 11$@$D!#E0R\FW _"@$:AU4[1U-^($?P7_X>\$=83]13[>?B9?GW
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MT(1T7IN]!U&'K^O>']Y[:\+W.)S_YN,CXV\7;*XJ$RM52(4LII!A'D 2F[6
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M-& "88JDLX%R=+2Q\<-*8+"1&!B102FSA]_M*,P.3LTNP>O;C]F(6QO'Y5$
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M@D)R>YAV(SNPPGLD<#K.P'$/2@^X]DPO/QA2CS39[J$=*G-V [$H(<YF8%%
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MM+%+XD#!5&NJ LJTBCT/-OL)X/..#G.N>2/TJ@:X+<^ZTLK/F^ Y&6[>AOX
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M=US,E<R6UHFJ%G=*Y(^S['_M/F!5;.Z"+=5C/C?;@!N]2;M<5#FE7(LHXHF
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MS!&V>./O]STX/_>HVVE>0^WQPR8L[.JUDXFPYY(6#?JRA7DOJU>,1P&.C9$
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MD#+U_>?!:_R#9U?/SZ^S?)H_OE6QAR@Q MLJ3:&T6?<R0C!5L821-"99D.B
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M%G<7[ETK%Y^-Z:GJQ></X+<6+!>K1YMF]U(7\!)9QO(848!$B@ RW U(EB
M(22,,YK'U*E"TNZ#Q\;$I6QN5+L'4CM3GJ-ZWZ?$A5@![:UCNK9PA[FEP1OF
MIUW.V'OF()_\,4WJ+_;HW[L97UMY 38;H,@-6*K%#_5ITW(/PESB/+<]K1A
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M'"L.-!$:($088!PR(&-(,YR*--9.F[^6,<;&".DOZ6[!S"SVB+P\@N3I0ZL
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M$^6=(E$[X74\2+7;X\*Z1!L6[1^SQ7K<W^=3F\9MA7E4!$N*4@QB2:T+@L6
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M.VY U71J'ZEFRNQJ+V?R4CY/9A/K(K76V<W/%S5;JD>>0$%83 #D/#?,@'-
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MM*P$]V49GVEPI9V>H.V=ARJY+R(+[^<M>&OA+XHLCKF.:@5"<E,'W,*2E8\
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MEVQ:=!Q9&K(NT^FM^V]NSUI>E;Q[48LRZNZ+>6.K+!S%#?7Q% %CPQ.;U"0
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M$#D$"$,)&&-F24KB%!(,8Y1Z)B3Z##^^G<)&^FJ[4!!++;=OA3R/B7"C_;[
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M&W>?!P43I 2- <X8!(C%&+!42EN^7)FO02>8DA!%RSN__T-$%!J 1=&5HP>
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M,IL_*KNTUN$)W3CM=S65#_,ZNVB3'W(IC*W^6CAF_I@MUJ5.?I]/BUJJUE#
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MAMIMX[Y/'VT')(ZVSW:Y-U#7[+K<4K&[N]/6F*K^(A^S)&49UCD0C"< $8X
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M0RWG?L*-9CWOA*G/@MYM@#/+?A0%!.\67Q?S'X9NU&.>)+E.& 0X41@@F6C
M$Q$#@K26..,8<Z<3]5,#C>TT:+>D12%N9)LK5P)WK/ZQBV\[JX9$K6>2[ Y8
M]R(@1] (50=D]_'O4PKDB))'JX$<N[Z;J5_24?%,NX_X-*]HQ\:)428EAS9C
MG<0:(!5S0(E,@:(T5L9ZSV+BE4S1,M;8Z*%:_M>R1K6PG8+SVD!F3&&%<@QT
MJE.S0S*;(YX2 3A5"L&4P9PY]H0+#/,P=O)P0+O9MX' ZYF,.Z/F;74ZX!'2
MCFP;;E#+T$'O75O/Y1;_>(B;;Y]N+J\O*\]2KBG):<J V8K;+B,X,92<:8 S
MG2BND:0B=0V V'KRV BX$L[=6[^-T^F AL[:]VUGE7)UB%?81L ]0*$S$@-%
M))QZ%;S"#@XJVQ)GL'W]8($%!\5L1A(<OJ"K#2BMO^)8>/7-3S%]E9/9TV_S
MN?QS,IVND\EI@K.8<0@840B@'.: P40 (I&@G%(D\MS7=NDFRA@-FW7N 2MS
M#_Z<K+Y'D[6"T=0FO/TO7P.GXU2Y6C_]P]^[:52K *9'DD ^K/6(:D7^VDO5
M@'/A#&M9=91E8+/K/,3V;;(SGQ>N.)S=@]B&/UPA#3C,"$"9;;UKUAN@,IE@
MH=*<:*> ]1/CC,V8.U2_K-/^[ABN;NP6 *V>R:L+4$&*N_6TG3LVU+L7<FO9
MQIVZO&-I@1]L,K7M%GZ=+^[95-VOFR[89C^?V:KZZ=Z0T515/[]=F[WDY?-\
ML;+5OZ_FR]5'MK1G1DF6\!AA(%-)#8T@!9C"V'()HQ GJ4J%3U9:2.&\N&>
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M&Y\D4:FTYAEEQ+J'"FF7F$:AQHG,DEQ*41#O_9'#8XR-J)R4N_%LC )"_T>
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M#Z0HA-$)AL0@ G'.<\@4R2 7J)!$"R&1EU,2-?K8G)=**/!35*.H,-A-(9C
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MWU&!_P+^#"I15S_Y6R0'4#QM[IV'3<_?>"W<GROI(DX0'D#$WP([#YF![*M
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M.*@D[RZ'>#,#GK96Q[CV;7)U &F7^<%[& V4%+P9=RR9P'M(!*3_[M\;T]L
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M%_TD4RPSHH")(,12$N*094D",Y)(F1O*>8Y](PW[CQ^;(;8MH;]O>@"VTY&
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MQE$'Q=QFH<,7G)&[N:E<\FFVO-5<E9.77_G\G[KBMX_E5%\O]9,+#S'&\XQ
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M56(")^>?V\/8WB">=N0[@*9GRMF@4IF#JU(3X?[],8C\/?T.H!K(YX^#+"@
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M8T2Q/5D?[;_^^]^:W]C_$7RA__O?_C]02P,$%     @ O(!74:_B=%=]S0
M8AH) !0   !J;FHM,C R,# Y,C=?<')E+GAM;.2]67=;R8XF^MZ_(F_VZT5F
MS$.MJNKEM-/G>+4S[;9]ZG3?%ZX8$#9/4J2+I)QV_?J+H&:)DCGLT Z=KB$M
M4=+>&+Y   @$\*__X^O)[(<ON%Q-%_-_^Y'_Q'[\ >=ID:?SC__VX]\^O 3W
MX__X]__VW_[U_P'XW[^\>_W#BT4Z/<'Y^H?G2PQKS#_\.5U_^N'O&5=__%"6
MBY,?_KY8_C']$@#^??-'SQ>?ORVG'S^M?Q!,L-L_7?Y+22+;P!RH*#,H+S5$
MS!RR8<Q'D81WY?_]^"_*><E=,<!28J!<R>#112C,<>ECLB'@YJ&SZ?R/?ZG_
MB6&%/Q!S\]7FVW_[\=-Z_?E??O[YSS___.EK7,Y^6BP__BP8DS]?_/:/Y[_^
M]<[O_RDWO\V]]S]O?GKYJZOIME^DQ_*?__=OK]^G3W@28#I?K<,\U1>LIO^R
MVGSX>I'">B/S[]+UP[V_4;^#BU^#^A%P 9+_]'65?_SW__;##V?B6"YF^ [+
M#_7?O[U[=>.5_YC_XZ>T./FY_NSGYPM" E&Y^:OUM\_X;S^NIB>?9WCQV:<E
MEG_[D?X&JC:9%[:^ZK^?_=W/5V_\O,05@63#X6OZX/S/ZTOV>CM^7>,\XQDS
M%P^?+=*-7YI542XN_W(6(LXVGTXR3B>;ISZ+J_4RI/6D**=+,AZ4X(0C%A&\
MY0%28"BU<5QI>9/92NV*R-U(?H7IIX^++S_3@TD#W-<OH'X!C)_+_;_?>>F9
M8 ZC_M?Y>KJ>XNI#B#.<N$A4^AA!>T$K1BL#T01#;V8N:R]%2FH ZF^\]";U
MUQ7[;)E^6"PS+LEN7+PU+-,=)=_$[/EO_/PY+.E!D#Y-9_GBKZL!&4)SZ\40
M$CS3#]'[XP_$=L'E$O/K,_7<R]V&M3694]S\YJ&J/UW!QQ ^3]Z3I+&:V^>S
ML%J]*>_7B_3'LZ_3U41Y90+'!(KL'ZC$$SB!##0F$DTP(DMW%PH72"AA%3=$
MG[_H# XX6Z\N/KF-B^]2-!Y.CM#PHH6X.\#-=?I?+$["=#XQQ2@9)(G$.5,Y
ML."C4\"<R#Y83#GD%H"Y2\HX2!E8QXM!!=X#9!8G)XOYAH'?\"3B<B*ME4H6
M"T(I3@QX!MX+)*%(M)G^+T?=!#&W*1D7,,>J]C92CI+SP4"AK30NCH0*>6N3
M9^PGH=GOBS6N7IPB>8'BG L1=(C$"+B2:/4P+\$GKT"78)-%;ISCWW$C'WK^
M3A@0G6-@, 'V  -S@PMUP44.+FD*QC@&3?%<$A!+$.2UE<2]T4'HM!L,MCY_
M)QC(IP&#XP4X/@ST3UN9X*9X9B@<U5%05(^93)JP%)UJI=%&HRB*WP4%VQ^_
M$PC44P#! .(;'P/\)WZ#"W?.A35%)\\E)!$#(9DEB(EY$!R=X19=N.UQ;@?!
M/<_?"07Z*:!@" 'V (,;!DWJ<RYT\>0[HP&4EO8U[3UXG34DKI.567%483<8
M;'W^3C P3P,&QPMP5!A<!N/?7LW+8GERD?[#5Q1QK292<UVBBJ"R(:L65:D9
M'&+&Z&10%A?CEI3%8=FKK12,XT,.DZ(84+8C!IN5BXL3A _TNQ.*M(W1-@/3
MF1:+TAQ"0 3#F+!",)_0#X")Z^\<.5$U@/X6 PBS$Q#\K].PI"?.OKW#SXOE
M>H)8 L]! C/>DASJ.4_19/6*Y<EFGI(<(C]_S^M'-A!MH'&,B#M!R5M<3A?Y
MUWE^$=8X0<50T/\ NHQD/BE6BB8[$*4$1O_KC-R2R3P8(S=>/D[\V1@AAXNW
M$WQ\6(;Y:EJ%<HYQ'XORR",@TZ5:PD0ND\M0R/_*ON2<[:#;RJWWCQ.@MMYB
MCA'RR$ Y$\O+Z0Q_/]WXU-EEHIZ\<N., F43@I-D#J62'ID4!LMPONC5>\>)
M61L!XRBA=@&(=_AQ6H^7Y^O?PPE9/L&B55Z \UJ#8D9"M+11FL*SB;F0-(:P
M&MO>/4X4VQ081PBW"W"\FJ?%D@S=1BB;4\/GB]/Y>OGM^2+C)!7'N0X.:O$1
MA?I"@9><-DW&/-<\FL0'*\5XF)2=H&.?%'2&$WT72/H0OK[*),MIF9X5?9W;
M2^LL*V0R@:F:!W"*@2N10= Y6ITQL6(&P] ]1.R$'O>DT#.$N+O S;.<21^K
M\W^J>/A$<!:SX0%LKC&^$8R<+HKQ<] NL2A$<L/M45L(V DO_DGAY5@Q]X25
MY_3EF^6'Q9_SB2777"NIH3A+<.>.@]N<(T@5A#(F"SU$F'S/ZW?+LK&G")0#
M9=P33#9[ZIOEV^7BRW2><,(=8D05(#++2#AHR32R"#H4Z:/C@O;;H;%RBX;=
M /-4\K*#2;LGU+Q=K-9A]O]-/V_<,)$B%A4"R"!KGLAJ$HW@$(33%J,+GI6A
M,7.#@MT0\U32M0-)>F2\5-OX;(EA0S<7*D3/:A6+JN<1@:0@M(5@I$<GR5-7
M0\1(U]^Y&R:>2H+V8&F.C()ZN67V]M-B?I$9$B6S$*4'%T0MWI=D^P(WI,WB
M&>V@S/DATFVWW[L;&IY*(O8HJ7:QCSP_75:YG>6/I_./=6,\74VTX$(6"NAY
MJ?!./$-4@0*SI$V.(?.B^& [R78:=D/*T\K,#B#M+E#S:DY/"VD]_8(OPCJ<
MLS71M">BM8+B=R]!(4_T5:GG5)J8$CPSBX.A9CL-NZ'F::5M!Y!V%ZBIYQ++
MY^1X?UPLOTV\E=8J6T'/!85G!L&7ZD)%GY-)CL4!4VTW7KT;1IY6?O9PV78!
MC?<G83;[Y71%TEBM)MRC3MS0!JK(L5:2X!TE1A!)!,*U5L6QP:!QX]6[0>-I
M)5\/EVT7T/CU!)<?::_\RW+QY_K3\\7)YS#_-I$J&8$4H;-:@ZL4:388XT$7
MVD=+LB6KX9*N6TG8#2I/*^]ZO*R[@,S[3SB;75"?DM(D%%GW14)]$AJ"% E<
MS%*XI-$K.YPQN?;FW4K7GE:^]6#)CHR+]YA.ET0_%_'#=#VKH;N/C%M%9&>B
MG3B'4*P'HV+FS&0*WX<(?V^_=S=,/)64ZE%2'1D1'Y:A=E1Y_^TD+F835IPA
M9@L@F3>*VXEZDH(':QSZ&)21?HCMY,9+=\/"4TF6'B[/3DS#KU_3IS#_B)O2
M&*V%]RD7*#$$$H73$*W+4$MQ7?"$\CQ$)GW;NW>#Q5/)EQXMW2X<BFLWQ-]_
M(C&NWIRN:P.ABOA)$M9Y9CF(F$DTSB?BQCBPR3 O"T91ACMU>8B2W9#S5'*K
M TN^#QR1&)=A]FJ>\>O_1/*L1>*,4XANN*!-TT0RD](R\"RJQ ++O*3AH'/S
MY;NAY8GE5X^0[]C'=&=9O9?350JS_X-A>5'\3_&5Q1(I^HHUS6<R)_)]@(Q:
MR&"(C32$>;GO_;O!Y*DD5 >1<B=7+*Z8>$F?K"882M*6<)YKF3>%9A'BQ@6S
M"A5G6H0X1$+UGM?OAI.GDE0=0L9=P>3L0M$9$\Q%;V54$)0WM&T&!$\N.1CR
MQE ('] ,85'N)6 WJ#R5).LP<AX9+,^(@[SA8A8^3HI,CJP>!QYKPB^J#"$F
M";X@+Z*P& ;Q:&^\=#=0/)5TZN'R' P(__KS'4D27W\<U(-TOEK,IKDVE_TE
MS&K?U/>?$->KFS3OV)?TOF<=WZMT)RJ/[%]ZIV?=F_)R.J>736GM+\XNXUTV
MR$0I9&%&@+0AUI+E>J[/'>100G'U4L15>J=)1\@'B#NV.=VSU8ID>\DJ*UHH
MC8Y8K1TQ:CSFD#PIC5DQ)[,(8HO).)[5FV1TTL=P*$S<;E1WA,Q'[4)RD_YS
M'_Q*(BP:9R6#DIVOV2 +'ED!H;CG6MM(,7T[Z-RB9EP$':/@K5@Y1M9=0.9Y
M6'UZ-L_UGU__\W3Z)<R(G=6S]?.P7'Z;SC_^1YB=XD0C2UYK!UH;<LLY!F*+
ME)YT+@(UT\8VL3X[4=<#I(["P>UVF8.KI ND_1:6?^"Z=@,ZSUE/\4)L$Y]L
ML%@":%G+O:7W$+/-X&/@VAN6G&N"KP=H&K?[YO"H&DK\'?3M?992O1N[>H<)
M:7D02[_C^H(7&1*)@BM(PJ>:DN00#;D#7FBAD:(-&[?4-@VPVSU U+@M/(?'
MTF *Z,(PO9I_(;H7RV_$Q$1;7VC?9Z#0TE*PM!XB65IPUO.<R+CFW,19ND[$
MN,T^AX?+P0+N AYOE_@Y3/.O7S_C?(6T,;]9?\+E#2E-2A2QJ&P!ZR&\,N1#
M!F\3L%Q09YF2LK$%:G:@;=R>H<.#:6AU=(&Q,_+_BK/\<K%\3P[?[XOUV["D
M0/?%=/5YL0JSORP7IY_/^=MP/&%D2@//!61@K%Z1(Q/KR=B*Q(,.@663M]3=
M#176[47KN U+&^Q_C=75@X]U8T%)[C7]OP*.*H,*@GQ#KPWX4*+D,=EDFXQ>
MV=^2#7X UAI%AXCX<'PLUF$VT*ZX^(S+];>WLT#BF.<:J7ZNN3E"_FHU,5QA
M=H$#!A=!>2O!L2S 6A^2"&BTVW*[?H@-\2&R>HCI!DD^#2C]'FQ-2J<GI[-Z
ML/ "B8@TW>B$OI[A1CGS_.RD7NC[K\WG]S(_"3&4E(H$@UZ0@VD2A.(DH(W"
M*R>-2TU0-Q0#/<2)PR1'Q]#H_DCV9TB>X\=*Z8?! 'TO/S4 DK1=,$VA<8Y<
MUV:C' )/"I@@^\\-YKBMY5Y#T]A)Q-G6,.XK^0ZVV%>D@OG':9SAF8"(A5^_
MIMEI+<W\RV*1_YS.9A,>1!0AUU9P]10]*DT>@[0$@B"E=JYVKVV3K_@^<3V$
MGH.@:G!-=!%T7E*.&HD&\A2L%&1D"];F_'GCSFH1C-0L;VE:<CR&]L))X_!P
M$)P<)-$.'+ 7YZ^M32A/\$/X>@GS">8@!2^ZUO5RLIFR#FE+%GA$QZ.7(84F
MZ?3[2>HA#!P$+0-)O0M;<BT)]_MBGLYCVLA$TH(C*"%K'%*KNX33D%WT7O*"
MFF_I<G(\>+92,T[;SP:X.5[674#FC(.)$G7NCTT@D56H\PA.6@$IT[Z99')D
M2MNEEL;I[=FL'&4O:7;@XKZ>ACB=;<ZBR5G?W$+ZM)B1T%?5<5]_NQ1-I-V4
MBU)#0!1U6JTETU@<>,T=JL"##4TB^UT)'#>SU+PPKHF>NK!"USB[G=OE@B43
MG >IZU00KQP)C)%7GP(FVJ&3:N/ZW$_2N)5.;4!P/]*.T4<7V'K_:;%<?\#E
MR2^+Y7+Q)P6+JTFPTC-)LDFI=@Y*2D&,R4#1,A57TQ&\2:73%EJZ0=-1BKX]
MS_Y(F7<!G(OZFK?A6RVNN3PB\H4').,M8NWF+NL=NA(Y9&T<"B69QU;I[2WD
MC+OE-8+/ )+O!4'+4WKO'2G18K!<9%TG7#D%2B6RRUEFL,%$@T)KE=OXV_=1
M-.ZA1SL<#2#_\2?<GK'Q#B,YF*MWN#Y=SNOF_Y;DN*@J6DV<#HB:"7 ,$QG7
M1&ZES0DVY]\%LT-[JPQE^ZS;[[YIW#.*@7'20+A=V)U?3S[/%M\0W^'F\&\+
M_C&B"($5T$X32\[RVL_*@F168G+&,;5EW.7Q]N>[E(U[6M'(#@VKCRX@=KYL
M+K.F5ZQ()-^.ZPC,;%B)M%H2(IE63W;5\)AEDRK,>RD:]V"C[=9VI/R[@-*6
MY5"RD"K7]IVA]MSS-?->@@7#D^1":HUMS-.!]JC9.4<C\!PI\1Y2EHOYQQI?
MOL"XOI9^+P698<8 &DYN'5,,*&!@D+3T64=AO&MRU+&=G&YBLX:)HN/UT(4-
MNG,*>$UZ]2@P,2FYE0:85[QV^J/]V4H-IJ I/$K#VFQJWZ&KFZBM'<*&U$P7
M4/NN,TBRO+:4:A]S(VC_1IOK?"^!X&/4@#XBLT4E8_4HGOH-,KL)"]L!L:'>
MNL#E78_R&C=6.!3<6 @Y.?(16(90Z@55CT[QXH)N<_7\(:*Z"17;86XPG710
MWK0IF+ANO*\XX20&Y%F#()& ,D[6Z)=!X<XQ83/CO,D9W_TD=1,SML/60/KH
MPG9=8V,2G=(F^ #<UZ;,+M0K/(E<4>635,&4HINDUJ_1T$W0^"@GQ'M)O(/8
ML3;;G:YKH4:5S_/%O,ZHPGG:L"*%SJEDT%F3-VFL@9BUA(@&-<_,Y#8!Y ,T
MC5LQ]RA@&DHC'>QR#TA(!)\RCYY"X<J)C DBBQ)8G52CK0_(FQP<'UDOU:SN
M[E&@-9 ^NMCEKG4)/^L^9$VPUD8%0EJ*,7Q*X(JH.4"I=,Z60I MC;6'L5;7
M"1F[(=TP*MYBE Z6=A=XN7;_;^/LU8DV2_R$\]7T"Y[%%*\7JYI%>5,HN)C8
M9 K/44 42E) 0<&KBQ9!""L])A>NS9YO='%S%SK'KO)L@K:6NNH"C.]P':9S
MS+^&Y;S6@]VXG%JF:;J>%*.23"J RS&#$LR3'QDX4- A99#26]'D!M3W21LW
MS]H(<@-KI N4?5AB6)TNOUTSVTY((RQ+0(NBU$Y8GKR'K"!S)Y&"%9]#DUY2
M=TD9-TG:"$5'2KP+U-P5#5G<LXNE;^O]>%+0>KV<QM--Y[X/BYHJH2"%Z* G
M?MP,KL55/9)5Q65%@:^M!ZF"UY[H+@%J5Y(JS 35)/,P#/GCIE,;H7,$S7:0
MX?A>9#4)5GLLG $:2Q&5IZ^")G^V!(-*Q>@*;Q(X?(^PW0*)P8=)CI4Y.UXY
M'8#M6IST-BS?+#?7H/)F)WB+R\TXJXD1+C!+ B*6*'0J=4<0]6*=9LZR@!';
M=*[:@;:Q7;O&=\:&UDX'*;8[P]*>G:X_+9;3_\(\L<XH-+P V_1<LK7CJ?:%
MU@X*+Z230C?+W]Y#T]A>W^,!["AM] BL5ZO5*;'A$FWV2I';H1+YLUYG\*)(
MP@#'4(IS13;QZ^ZA9VQ'[;$!=8 6GM)XF;<;L7_"]32%V4T&CILU<_/!S0;/
M/$#_8TZA,3HY99('K16"4H6#=UP"#T(G+66(OLV5SD>;0G.[ KB@"45Z!)3U
M0J6U#)Q !RXACYB*<>S_EHDB@R-DMSDC^VB@BT3'L]EL\6==NB\7RQ>+T[@N
MI[.[;>0O:L)M4,9QGT DZ4#%VBP7*>KU09-3:*2,OLU-UWVH[''NR%ZXN(VT
M9BKJ H$/!-5(X:TLRH/U,H.2SM#ZC 5D$D%'$YG73:K GG0_D6.,VD"ZZ,MS
MOS?*C;E$93B'(@7YI$HP\%9;R-GJPCS/UK3VXH_*08QQ?KX7# [(/.RCDR[,
MUT/1;I0V.\X#('>VWJ.*X%C1P+GFF,CN^S8]M([-/8QQ5#X0L([209^ .H]V
MC5,A&2)?Y\WY/GWE ZT1LO?H7$#+77<YAS$.P <%T@&R[P)$-\Y@SUB9Z)R3
MX6C!6$,K@3E:"<07V$1K(&3+0VGB36VA9>P,:!/P'"OS 8'3)DEUZ7ZN%N6B
M1.3(]-361PZ9F/H^S0.EI,XJLBY?=W56+:.PT69(/E'DIZ.%8+&>53,MG$=E
M5*/!95OI.;YHZPO.3_$E+:I:E5T?^??I^M/ST]6:7K>\;+]=PV#ZOUPKTRCN
MU5R:38JVSH-W#B@4I>60H\\<,>K4)!%W *WC^MU#8.AN35=;A8T8Z]5F/77*
MT^J<Q]KFN]9#4C"12'P?%IL?3I@SSBCMP!3N:I6N!Q<9 QTU(P?0!V?2=TS6
M;F\:U[<>$CP-)-M%3F"U?E,VO-0Z"UQ^F29<O2='8**]=M*7#$(9"CM%0$)\
MMF"1:55\8!B:W*F^GZ1Q_>L6EF@@\8]L<*YQ44F_M2)B+")G%R#P0):3%4'^
M(WU;#/JHI?3F]DSWK;;FP9>,ZSP/;6:&DV<'%F8SYNOM<E&FZXF1-G-5"KAD
M7'7]-7B3,G#FC6&ZN-RF3<,U&L:M"VAA0PX5\(A5<17DU\B^!7!MF"]>%DCR
M;) 6;:'%<RA""HH<*=[DNQB,>U\P[K7UH8W%,'+LH$3R/6[*B?^"<UR&61V[
MED^F\VD5SWKZ!<^GZ$Y,3"QKY4"GI$#%6F7,T=0ZO! L8YGY)O>O=B-OW$OM
M+<Q+ [6,'1_MQ-&MQ83<.UN$ *ZK"&WV$%$&L!8C(]:=CVP'HW3(N\>]VSYX
M#-5:^AWX/.](143 )^+N!46+L\5FKM\Y:U?IA?2?I]--TRXRW^3VKZK?-_$D
MSA"C ,D,)ZNM,X1Z>['DXIE(#GV;F8M'T#SN#?DV&:+'4>#(EO (-F\MT&*+
M=3XK*"G7-DNJ-@TO#%"0M)/4W$JW@WD<C*"1[\@,;33'452WEO22P4D@<6I=
M FT'48.BE0=.Z@+D^L82/5-"V\>SEI=T[0:_)Y8T'TX379J]2U9NK1CEHV8J
MU3-N)VKY30*'N1;B%%2,&\.+.MBTW?/2W?#S9/+F[03>@8EZ-?^"J_490U5L
ME_=A?<S2U-FZ+&[N8D@!WEH)/"54T6$(N4FVZSZ"=@/5D\J?#R+[\8>QUS5R
M'RNW%D<VBL5H$O@ZF$7E1 8W90J,'/?9<F,5QAVLT6YOVPTQ3R:OWD#$7=B?
M,RXN,C%!\B@D$6U0>U"L-AITT4#FJ1B442)K$D#>HF,W[#RI3/LQDA[9Y;E%
M^BW$\VR<4PG!LWILX$K-VWD-F39<SP+7^7;.X1ZC\L!+=L/#DTF[#R?0#DS(
MIIG6[XOYXC/6+%SMZ5&E=8'S&%)TGMPP^B*0C 1MIL9D"B&%2R8[8JC)%:>'
MR=H-4$\JUSZ@'OIP:BX8>K.5H5N+QA7.="D2?)"I5A1K"(@9B$]4@C->^"Z!
MUC[OW U#3R:WWDS<'=@HBB'7R].T/ET27\\_A>7'&BK*1*J7#(I-F01%(@LZ
M66 ^J1!+33PTF3BRC9C=L/34TN#'R7S\1,\5_6E#_^>S1;!>K#:+P'-6BA<9
M<JYSP)BGY9!T@$!K((B".LA=CO6^^Z+=ZB"?4CYZ0,%V8%VNFH=>5 5/YZ?$
MV[DE7<Q7OV!9+/':D(G?IO/%<M,K[<P3?#;/-Y]R=H_B-UQ_6N2KT+,:WB*D
M3@60=NQ:0%P@:N_ ,N5<PAHX-+ET\H@\[@;W)Y7_[A4A(Y=Q/:)8;ODO0D3E
MZE@_C77@+*H"P3,-4K.B-8_%BEU,]V@,[+9&GDR._VD H8,ZMTL!G+OEO^ <
M-[6;AGLA,@.ML@852?#>60V)>9N"%3RT:?]W#SV[P?.)G18<+_G1\WA;6;B=
M?JI.> @29'2T(CB/X HM$&L"%Z(8SCG?V31^YV6[X>0)G1$,+> .O-O?<7UE
M6"<V%X^N!! ^UO.-8,$%3L!7IDYN8"F&)O[G#2IV@\V3.AXX7,HC^W"7A-]L
M\WS6L^XV\H5+4?H C'%R31W6B8T)(6F'1:*H1ZL[F)8]7KD;4I[,P4$K87?@
MV5Q<)K_H7',I*UTL89_,I;+<T K0$8+&VE' >1V\#"PV2=/=1]!ND'I21P>#
MR+Z+/AVW.?DEK*9IHKCWJ7:+TS51K7R)X#U]6X+1.3AM2GX4"&VH&?=*_#"J
M_@Y^]I=Z!W[.;29>3&>G:\R3$(+26FFP:'0]CL4ZF2 "MY9;\N6"P_P8X#FG
M9]Q+\8\"GT,DWX7U^3M./WXBRI_10\-'_/WT).+R33GK7?/F=+U:A_FFUOJR
MC:43RC):'4S86@1B%<1B.6!MXJQ*-MC&F]Z7T-U ]R2..A]%5T\*C6?6.AE6
M)$L%F*]3-QRSX*7FD*13+AM=DFQ2I[$7E>/NG6TA<R ^]]=>!WOM/<R=&_X[
M/$X$2N&=+&"UIEB&1PXQ>@?)21>R=TGA8]K)^^@<=V_N 9Z#:+ #@#Z;KZ>Y
M\C+]@N\QG2XWTX3.+DMA/CND./E\>J;<-^6.6W12NTE/G$$L62'!JJY*+0RM
M2D__,6@P:RN9:3)N<1#J=P/SDRI)>7RM=CXFXWHWORWS4&]R<50SPFU/;]67
M\+N<##\UXSPK5T>KWWGW)70Y%]P7DR#Q>E1$4JM=F2@@EIQ1.,RM5$U&)^U)
MY[ '!MP4QASM*FHSX-18#9X;B@Z9CU;J$EWNY,#@,69G#(Z3A\\1]A'^$46_
MZ^$*R;\SE9E,\;0>YZ?:&Q9?X-F_EY)C:&J'*P/2Z=KJ@0>(K'BP1KMD O'O
M1 NP'4_ZV'W$'P^ACZSF#IS)^SA^N5B2%ST_FS22OGU8AOF*V*LZG^?-=[,-
M OX2IO,JG;,:F'>89F&UFI9I"A>_&[Y.$E=1!Q8AF]J7W;,$$6OU9. \9%-D
M<$T&CCX&<^.:[\<&[([K933T=+RBGGT)TUD]$R56:RGQE9/_+/_C]*P"[%)E
MVZ83GYVD7NHM<UM$(2^?Y7JE'%EMG,CJM$4AO-<)C6AR"_N1^!MWT^ET78V)
MH8Z7UM_F)/I9'0'RU\6LIG0N[,J;^34)+:<K^M&+36G_F>XN1$5R,,SG3,J1
MS-51I0BNJ A8HI#>AIAUDQ+%5@SUN2F-BMX=5]BC0JGC)559OK,?7VJIIJ.>
MO7G^BO;Y6M#SIES)YDH0@N>BHP'- H(JJ@XR#Q3D6:8$%HLQ-!F&T(RC/G>D
MI["H'A=,X]\0WD4>EWH[9_LAO4V\Y(KGP"F2=0841;'@2XID8[)C%-5*71Y]
M+>W#P+@-[I_ZTFD&E0Y**^_C^P66Z1SS197ZC$+&PY2"SF63I00C<QV1Z3W$
MI!1873 +*6T431+;K1GK<TF-'!^-@IJ1;\X\I(JW]8/%/,SSYK?>+H@]7$^7
MFWSJ=2G5>2^DK>7YI([:7_,YL3&M0EN49R=59/]UCJYMON]B8WM4*#*@K*,]
MN#R[L.:EUZ!%1F628<K=2DG<W^BB"X[ZC*/&0?GM=AQ=*&@OR(WO&'Y/>/<[
MR>7<2=Y9O.33D) NHM<[,KT4H$PA,A')2XB%XE7C%82B-: Q)NE@#+L]#6GO
M-?OX7/49JG6];CN'WOAK=Q?7YUQ$S[XKHBV.>Y%H?$@,5+2*_*':6DVE>H)I
MK)4,A79-BA$:\=.G?SKJ$NP)04>OIT>( )?3+YO1&:O_=1IFT_)M,[GRKY@_
M7B6&=E&5HJ!<BY ILD@4$<L0P/EL238^JIBB9=BDTK$U8^/.ANLV AP!-9WG
M\9^'U:>7L\6?&R%\Y\B]$$F;0_><3"%.P<HBZP4Y!RZ2N9-HA0W<<;1-YO@.
MS$>O =P8(-UC%VJ-F*>X8.YEW!5!DG8%DE:B7E7($# HH*C4EB0U)NQCJ1RU
M2$:(EI[B(AD$)4\CV-G*_X;?>PJYI-;,:FZA6%>]TI@@:G)253%.IY0C#X^:
MBC^$B5[#FJ>X5H;"2L?'6->]X0D+,9K:^%![XT$EZ>KUH$ A)/=<F%3G8H]5
M 3XNKGNK\=Y+51W ;PL[EZPXQ60.)0*1G&M6H(#+CI:T%1@%TX[Y)N[) S2-
M&[D^)MB&4DP'&'MHW6RK]Y[=2B-7EHWWF@5> *TDEK.@B-\%6F BZ> RKU4^
MCVT!=Z1]W/GJO1C(%HKN/!C<.2-;^;;!2PSDL1@FR%GQPD*0-4NL,<1BM%;\
MT0&^#P/CCI#O!>7-5/[/%MAM"LZX49;B D@E%@H9DJLA@P1A92+O*6:5.H[J
M=L5\LYYYO6"^G=*?4)^!L[[< [86.']@JVX"V^@=OH' ^_4B_?%I,:.%L#I[
MXR4:@^(QHZ7=W8O:#-8+^BIM+NBAT2D6V69.S4[4'6LC+U_RH>9*)CJPS'CT
M4")GH)3+$)AF@,%[9H*3ULNFO&[(Z*9=P$"HN&VCCA!Z!X[D)?5G$JFV=C&O
M:_79U^EJHC5J0?P U[6AO_-(P5Y"""9ZI9/U+#>Y9O8@59T Z@!UWX><HV7?
M 9!N\?!B<4);\B0RKD.QI&/E2#R.O,ZZU=8QTDP%JTTV3:;";Z6F$^ <K^W;
M+3^/%GT'^'F'ZU KG2[Z1/V&M0G:Q-FHLHZ*N&#DMSE-<G'H("OE4ZX3I$,3
M &TG9^1VP\?K^<Y8N:.%W@%TGJ5T>G(ZJ[[F?0'#.6/19!VTJ@-J2.LJ!P>^
MGOM'K;Q%2=_[)@<:.U,X<D/BP0'61C4=8(X8.5G,-R[E.0.L*%-TRF!<-K6P
M/T'P/(/%XD-A,NC2ZMCB)B7CGHP-CZ'C1-T!5C[4*L+3Y;?K+&@LS$05P7!3
MY]:X6E3.-=0,'!,^ANRP!5JVT#+NX=;P>#E6W!T@YM)7_.5T1?OS:O4>/YY<
M^HHL\FPX.8<H90"5;"2Y> -9.^2RF%)2D\O5#U+52<^U :.RHV7? Y#.:#]?
M51X#YYR$@5K6X0(^@3?10'3:JV!\XJ&)^W.#BDZBL..U>QLW!XMZY/NXOV&>
MIC![@?56XT4($#22P;4%A/=$O]:FVMX B*IP28LK^>^EF.][]L@ .%Q-BP%E
MUH-MN%@*KVDAO*(O5Y/LC-/D/H%FM$,J8H$XT IR+)FV7^N9:KNS7)+227G7
M@-O)85+N B>W\^84N,U.:Z^IK16:OR\HKINOB0IZXL>+D;(39+SHD@KP*$B(
M3#'P4CA:)UA,)E.K0A./=QCR.]FU#@31'4P^ND8/QO'GS94L$L!RF,;(-WLZ
M1^\U66T.3 M-+.0ZUT]8J!- /):8B)$6H#Q@ N<3P=;A\NW U+V8?IEFG.?5
MM9Q#K3.8%%^D0C+^FBO:V@.!/F"=4\P#=\Z0]Q":'*7>1U GV^,PD!E$ZOU4
M*FWH?[5:G6*^W@'D/\+L%&_D)M[A=/-;Q*=73J@,N3*K@BS@3+UOHV1$EHJ.
MHLDAQ]Z4=E('/> NV$Q/'5BS&TQLV'J6:+<G0FKOFM]P_6F1)\%H1XLI L4[
M-3/F _B4+"C:V!D+4=O8I,O_+L1U4L(\#-P&UT9G%N^&/[DY[)D$J;6C( E"
MKET=DC3@ T77KG@45D3,NDD;_7OHZ:16N)4/O[_,^T'03G><C/,J1:S'TE5<
MU?+&4@J8I'5FTBH9FM3N#78=K7U-[C#8&EP;78SP'"CJ]2PG'FNE3F8!E$\*
M/*L%@R6C+458G9MT9WG$/$:SV;-]YC'VT>B1>8Q?YWF@:JG5>GF:UAN_]?FG
ML/R(%&P7YI6IJ9CJHRIC/'C'%* J]>-"VT*3#-LV8G;"6;-YAP/C[&AI/[D;
M!6>W[#_ANIYR#'Z]X.;3V]XU>("31[UX8$(H%K6LN8S:3D-3V)BE@F#JG(6H
M6(Q-RH,>Y>+!M<3-93+G8M!GS>2\#=,\T<B(44-N0B:G5$5+"T9("86Y$F+.
M6;1I.[,+<9VD]P=#T ,U5,,HZ E9M(N+8JL![=C5,YO-7=U.]? VZ_)%5V,!
M,$;4)8*N3I'"Y"%ZI\"QQ&R,5GC59%#70T0-?#5*J(*>0A1 82A*SK7W5[:.
MG#],6N7-P.ZF+/9U->HX#'SG1M0^LNX@:WI1&+3)SJVF&VW4VB#AN"L\D'5T
MIIYV,E<O9VBP06KBJ2;HFAP5WD-/)]@Y0,6+X>7=*6S.\KMX7FN4A(F6T?[-
MC:+ME:?:2,46BD <,125S++)9;KO4C8NE ;1_PZ8.EP9(]?G/:.P<_57#+/U
MI_-"LV23=<;0<L.B:)%%\@2CB2 X>A64X?2?'8KS[CRX/R <H;3%4!+LP+AL
MRV<DZ7WP!4(Q)(L0%42&N0Z32"):GA)OE(8\J%3OL2J_C]F)CI1R!SCY'=>;
M:&ZYJ#%>_N7;WU:87\W??,8E*63^\5E:4_2W&<1UV=,Z*V6(L7K;BE9""05<
M, (T0T^+@V6AF]2$[T]J)Q[/@>"X6R;54E-='+C<+ 4+A6N,%B$9C*"$8Q1,
MF$S[N=:!:2<":Y*=WK_4KAF&6BO]P5*\?>3?@2F[:L^V^K!XAVDQ3],9WF#I
MPV)?:3II; K: '>&I(G2DPQ0@DF,G(><A4Q-ROA:,#/NMOO(4!X=#5T8U!=(
M[T[3C9+IZQF>]Q^^/JQHHIFP5I.3'+BH=YBDANB9A\"RQT@! "WV)J6J.Q W
MKOD='T2W"U^'UF<7*-T<*OP25KAI"X?SU3D?Y!LEGBQ892QYYBX!16P):.7;
M4OWRQ-KT$MI*SKC6LSLD#J"S+K#W;+4B(9Y\#M-EE>[%67T.W"C-.= >)$%%
MI\ G3AQ%9I6(P>O8I.7C=G+&+=[O#GL#Z*P#?_4B>T7K)T[G&VT^7\RKN"I/
MB_F*1+D\5_(RT*<;#1"S].6K.5G\T\U!S/8_>3T-<3J;KK_Q2?#2:2,B:.[(
MC7?((>C" ;-W/@0IE&IR5^"1^!OWAD%W:Z-'5'6PV"[:O;Z9U_'RJS=E8T-6
MU77:;DRT*Z)8R4'$VD\DI 0A*0V2I&]+XH)L3(M5LR^AX]YXZ [^3?7<3_7[
MB_.WGXGY0_CZZ]?J@^%YY^Z),C(9421M@)ZX2IC *0H&K!/.&!9M*$URM-^A
M:]S[%-V!=4@M=N%,;P17^\J_7"Q?+$[CNIS.GJ54]Y35Q/J8E(](Y,>:3K3D
MGAD=ZE<E,,FDEDTN8SQ$U+B7,+H#Y&#ZZP*-MZ>R7I/;\_!YN@ZS2Z%)+S2M
M* 4IU]+LF!!B-@A)61%R\-R))D<-NY,X;@CXR,G;1IKK%)47*XPL $Z_; ZE
M$_<I!V-!BWKWP*8,'DT Y#E+(4LTI<D]R%V(&S<EVPH:WT7@D5HZUG=LA+U7
M\R\D],625N[$%VU9MAJ8J:XP"@Z.!UJ[CF,BO\,EW211\"!5XZ9=1T/;H7KI
M%&87B^=M^%973@W'4EJ>TOO.,PH;/IVUK/9GK<VD0:D4(?I,7D9PEDFD!66;
MU,L>1NZX&_+H9G P37:Z*6]N-%_Y-YLLPJ3VX]-HR),1"D$9K'W_. -6B#,>
MDE&Y20BS&WGC9D)'0^31FNK49M[DZ_KRRF3]E:30RWM;JUHS!Y]* A]C2AJ5
MM9*- <-]K6.SM&0G6#Q49QWDRW</^"894<?:-22I4 =A,@G>14=BQ!@L3\6U
MN>:R.XGCIAT?"8R---;!6-Y[.*LN\NJ>Y$-(N13!/#G*VH,J+D(@SP,<1J&R
MS-R*Q\3D Z1V4@O_NF6-\E":ZL)5),?W/&-[?M>$N*4UMOY6QZ6NR1^NE[ _
MUU^91.>35DA.B"N;P<"E!FX"A(D*R>"GP)L4D>Q.8I?5S8/!Y79VNXWFNG ?
MB96$F%<O2<CUY/--H4_R:14@GKO$TL0<%8^0E5:TN?AZ03<B,"PJ89#2^"9]
M^[Y/6I>%R<U0.*RF^K2)%U4H>-;]J\KWHG<A<:=XR9Z!R$&"<D%!R-I"+#$Q
M&[CR;=(\^Q#9Y6G+H]G%H;37AV6\S=V9&#>?35BTGC'E@"?B@;QAXL8:"3:6
M$()A+,8F)<8/$35N&F=L[!VJG3ZP=LNV_Q9J![#UM\W \]D,4]7BJHY!OV(R
M.$F>MHX@)$-:4,2N2W5(64'C"^=89!MSN#^MXR9U1MZGA];EJ!MWO>-^P6"5
M=**73]>KT\^?%\MU^+C$L[+02:H52#D8B)Q"0%6/.9V4'E)(,4@N;'&W[./6
MO@$[O&K<',TC8:N%V#M(%EX8\9>+Y?55LTF&;A'A) A6G8@ 5G%!RR0Q<*6F
MH[)4W"1R<GW377='.L<M#AMI(VZAPR[VYMWE.=%HA*D#)"CFYZ"RT&3&60!,
MSJ+B3&";OCN[DSAN4]Y'AF8CS?6;V7XYG8=YVBY(70I+M2MMT+7?O\XU/4N1
M6.(^9&:CB.$Q,]L/D-K?Q)GA,]M#::JK+,Z;\F:9B;'EM\O.GQ.1/-<*-?#:
M0TD%Y<\2HLATLM'[(ER3ZS /T-1E[GHP0-RS/1^KFRZVXFN^QCO\?+I,G\(*
MZZ6SRY:S$Y9]T2$FD,[*.GY9U[5:0$N.0I5D66A2XO!]TKI,5K>&W4":Z@-]
MUP/[3Q1X?<#ER0N,ZTD.R(U7"@+1#*I6K$6^N;Q._FU)60O7ZH;*=HJZ3$,W
MP]H@>NEB)Z6U<FFO;[*B:_M PQTX+\@/QI(@.FE!>IE%HH#*^B;NV[T4=9EM
M;@6Q8?32G16K(^E(7F287R_F'R]Y\@D#D6\A%7)ZE<WD^4J3(&2,*5KC=9N+
M_]\GK<M$\F/8M0$TU4&^[_HRNLE'QF ,%Y"#KA=6/4+P6=!_1!(D.9:PR09Z
M'T%=)I4?P[@=K)51;=OU]'A=+;]^Q66:5H=SXVJ^^;PY<JF%.E\3KE8?PM?S
MF](K\D)-+HE9T&2IR47@'+S6"IS(PCL3LRK?F]QP^-N[3!0/#;-'4DX7_MMU
M/J^%0)MD^!:Y3F)4F4RU!)-CIA5F"Y"[*NC;8D0ART[_M-YI=Z"SRZSQ8VR[
M0^NP@SUX=VE.HM)<<?)H,?,ZI<<'"$$D,$QQ7W()5C0I0]V=Q'%GOSTR,!MI
MKH/CC%]+P;1^4V@'V/23>D<>P9OYIGQLGNL_M<#V2YAMSKAM"EE&[<%$[RCB
M"AXJ2\""U38Z\GO;W*7;A\C^II<?<8313#M=;-F5@5M,;(8P3A-YI>=,WOS@
MVF^>S7&_>U'G?#3H=8F=27'"G$=9B@*F!0?EC(601(!8#)=%J<ARDX8AC\MF
M?^/4C\!_QPCIP'8?)9T)N?!*1T;:\#: ,@1<CUY"4?5*F?!%W)XOT\%RZ&^Z
M^UCHWDM_1PXT)KZ7ZPX@*YF4-E942:5!J6S!L^1 8$J1^"W&-AGHUQZRCSHT
M?C3([J._3F9PUVGBQ,6;Y5M: N??7)M=18$!?7BRF",MD6_GC2O/[UU<NTI.
M/S@]P7S5:$OY7%A <#HI$H21$&.(X(J00B>)1;8)[UIPT]^T^6.*AD;7=Q>N
M^7?$\!]A=HJ7C5K/^>>3++/6P05@+I/_I!6IP 93)W0E)5E*3C1Q*0ZB=N1:
MI/%QMA_R!U#Y$T+V71GS21+%>E09&(K:=I@,C"/V(?C$LC"&P!G&0_<6BD<N
M>WJB"#]6]5V4&@PJ?#X)(23%;0:,J&LI>(&8N /CM!(Z!!U$$\=[6#9&+LUZ
M:NNA)4@&RY[\Z\]WE$F.X!^;'VU^4O_J'98?ZK]_>_?JQO/_,?_'3VEQ<O;D
M]Z<G)\3GHKR??IQ/RS35!A-GG?.F\X]O%[-IJL<>-QA834\^S[YW2+WC@W^^
MHODV-^?/OP/'H^G'KVN<9\P_'CF0Y\YK+O%I=;'<<0*D$S4I[3A$\AB@E"PT
M&5*F4I.DZ_TD'7^*]^>UAR\7<_HRG5T"K$GY34YQ==ET<?,[TWF:$DY6'TC>
MO\QJ!:[+(3+#-&@=ZRF1(P%IRX QFZQ2SJ0VM=)#$#_R?+=AL';WA.^1M3K8
M>?1C6\#FEO"1+>)8EM$G$R+' #KS4 ^*.>%6)T@JVUR,QY*:S/MH9QG_5BN+
M?EVMIR?DQ]:3<(.>42QH2LKD-".%AD;6ECBL&,>UDJI)DNLF&=U:JWWT?]M:
M'2'I+NI@[K6U&RE]._OOE5TE2<F %D&+FF3(SD*4ED.H)A6E3#XUJ8K>E]"1
MYTVVP5I3;76 1MK(%\NSL^)WF&9AM=IL%1NM70Y[>8&KM)QNZB4GMNB8N8K
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M45 YL,Z>UA6TJZO*%^7"+>ZDW?N6AI?4=N-LE%MK)2=IBR^@$X%(B6+ &19
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MKZ<%)ZF8$FJ&)PO#07GO(49K07B=G*Z-N&*3=C^[$#=>V]QFN-AY@SU015T
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MJQZWP*&5OMMFMH\&.L#1MKM([Z:K/\YN'-%F+AT38!6O)S*B;LPA OFPP8A
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MXO&FNMH'*4KP'GBJ^1I12U1MX,!L-BK4%]!MNA]L(V@47<P.4O8O\;.'Y$>
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M]N+GV6*!RY?5AUJEGE/6P45;ZD0S"<H8"\'F#%DXG3)BUMCDU-]*T;#(:@.
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MAQ%@ZID1.^A5E%%P4+G>X%IEP5.0!#RQX&+RW+?)*9SDS*.=U/[$!^M%!R-
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M)$ 7:ABFI4[:RJ1SDYN&9V@:"=SZQ\(VU!VHEM%B3*R]#FF<,5B )5T#*<'
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M X_!:9M<;%+5W(RC82\73V$['(R#46R)QS6]O_]X-[F(7GOKM**=7"A^=;Q
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M&[#%)$1@,OA.=Y:;E^\&A!/*/?8@Q1$ X;Y1NXV/C;0RDU/#JSU3">E@,[F
M--QGC=ZE;C[CYN6[ >&D4H\'2W%X(.C[T;%:1T'>>%6<(#"7FD<7R=?G?AJR
M-:;P&)*-G=Y#;%F_&Q1.*/G8AQR'QH)XT"- KUW>9$/@4D4HUM52?L/!F:)
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M#WH9Q57>1JMZ(4LD3XXB1,9X'>TJ,SA7*\118++:1Q_;5)]NHF9<:.I#\;_
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M1?X=,'6X,(;N?3#Z]U^GXW+XSM].?WB_2#_<MD ,,G!4Y!G=/=QU8$H?>B#
M<@"> N30Q;1Y[OGMP>(($4Y[YN?0)LUR-IK_%?QX<;5MR,04MP9-,<I"*NY;
M:9N'^@"M=F24#;S;;)8G#Q[V=JP>"H[CX, .\-OI9#X=E[%TR)!55<I:93H9
M ^6>J#*30DJ1T!Q30)+E/EEMF*9=DIPZN<*[27A]31$.#;GV((+F0+3U$D2(
M.5A&'"N1("4LL=%J7$A$9T&9[+*M!Z.AHZU]"/9%G!S Y0;LV]O$ZFT6]K99
MF)->6XOZE[M0AJ0P8B4XE#55T@)JYSJ9S<_0TQ)N#A'TXPRE'KC> 'C>3F>H
MB/T"?IU.-BO9MA6,WDB/FI?9,E") 276:U[:2DJ>00)E55SO9RD:+JQ;!4#]
M<+X!"-VEC6Q,PNV.6&GGH(-'>@UQO S:8[E<7GA6[L4XY)4A:&K Z$6J7E]I
M_3%QG/X$U$0U\X;ZS1:,V1L3?"1:EMDBV4B"ZP&2.3,1'0>/*K<*ONY3,7#!
M0'_RW5T4?P"KAX[,H,9>7M]VKD_)<"J=)U8X3J30^)7-0+0'DQGE@8HNC68?
M/K6)4J1#1#/MA4]#C^ZX\J@I(RP7Y19E>_65A=8B24)M\&A\X?'IG=9$28YG
ML[62A2X]1W<]NXGBW".E?33/!I;Y!TBK*S-8M=^\G06IN$E"$I_*$+%((PG9
M9C3)8E#!)AD>)[3ME/FN9P^<IM:+S(_F64MG_LOM7S0+'#68))Q;9)%4R"*K
M%2G]$(/35GH9*YH"QS=SZKU;\6 69]_B&OJP>:X]QL,:]XML&#@:.;&X*Y%G
MT> F-9$(ZI7TX).BNLOYT^UU31@@/<JX2S^2(QC>@*M\2!,? 1ZHYIH8I1F1
MWJ+6MIR2@/0)Y6C*4*4XOU8CIB':Y!P'R%-)KP& WD8UUQ5![Z?S^04@QZ)4
MFB1?+E^%-L0Z+8B!A,X"]9+F*GUR=M#2A$%6#V#'<K_!'EZ[EE3*92(R@X12
MSRL5&K76((LR.!V,#&A^QH-.R4,14R]CZ[1GY+',;D !W5&^5;.CR1)7=%?L
M]0:0A[#^/=2PZ-.,)M/9:/'MW03)@'FI6'SXE)_^N<2//\#B:HJ??(5U0ZKY
MA;1HWWKM"36E72F4>B[F'7$Z:J=BI.'QJ,\^BZ=/LL:!;_UK*\Q6T=+ 1GJ^
M\QK-7EJ:,X%21((V,Q"OT$*AH*6-J"PH--CWKMYM3&V0]B.)!B#U&06#!%SA
MEOD13>'Q]*8LZETIDXVKSI"1Q>29)"KX<M-0W#*+.$@R62&34TGNF,C0AZ?R
M(ET#AU[J>R7]2:4!D&WOL-Y.K\-HLN+36J]?XJK*=<4H;73[V6Q6S)Z5=MY:
M0+B]EJ5;Z3-_\G[DPVB,ZIU=.).--882QF,);]E$K*"">,%Q4W(!.E1IN'VB
M]74"?>^#LDX&^A91LO_F<>O-,X%+OX#TI;<]](L?38HY\W$5-?N8UR;-?6,&
MP#B?O"54^=+3%;T"7*HF3.D8%',JU&E@]5W*.N'6O5K<]BN9!M0UGCZ+V3(N
MEC-D%^ZOV24@A[20.GE)4N)XY!A+B<LR$HI[1DB?LK)5>N_L(J9;D)R^6D0=
M+8 F[O?>CQ:CRQ57SF&Q&*_4]4]_W,!D#A>.91U]+M(6)2F! [%)E>PX$:(-
MI8]]E0RR%VCJ!JK7=_72MS@:4%"_36;@QZ-_0[JG>R'B=EF,<*<(%WDP5!&G
ME",R^U7G(" FVA2$0J>^SIWQRV1UP]?KO4GI42@-0&RW![;=+Y C2(B)\&S1
MA.2EJ%NF2$PP1DJGO1)5'(T7J>H&L-=[D]*?2!K UV.C\7841X[4:6T"GNNB
M<*AT';>EYM\K#\:X<&_>5DTK?J\Q*>SUW;;T*H@& '6O9O/M=(Y.1Z >,2\M
MR=I:(H$&4CKTDL@ -X<4EK$JI4*/">D&H-=[7W$4XQL SET>V2878GUC\D=I
M2>/'VT2(,B/]_71R^7[T%5))AEC,UREEH'*P$FU%31W#U;+2%"TRHKTI<XMS
MMG4L^>/(;BNKI>>1$]7EV )J7ZR/\-J93!.:F+9DZ-!L23"<$V$5;FZCN$JA
M"BB/+E ZP02*^O#8JU9I'UFU +P'&=R0)95".L)!2B2^^#=9:%R!!0\:6*95
M[EU?J%0ZJJA&19=3+G.[A Q$)@;$296)"%ZB I*"N4?:?.^BFH,S++L"]NY8
M+\W2$@@@<76]3Y4N-_N.6 5<490<,U74P*$$M](;_^0:XB02;D!YO!2#DRI$
MW&24:)U1E8B,_!,4"%#JK77"Q%#EIOWHD&@M/)X&%'M$2?>1T- =BU:WH9]F
M<.-'J01,EO!E^L%/EMF7:P5\QX5DT8-%+F7#2P.>Y(C'LXMPZ:PT)1YGN]1/
M?O]-;27X'F5K5V#M*YV#N3TLIMO#(N_:I?[)+@W?'K35+H^J.S"S J&GF*Q9
MF[^U1W#*B(9\I)* 1?-1JF(31]Q=SFEPRM 4Q2L=P7F0<122$-:87,X@6MHK
M1A*L" 1,-"IP+6*=;I0GB)*<?C#G/MCJ.4JRCQR''O#P[!R#'"5:Y(D2&YU&
M^ZB4+LG2?E'FC/_09&F71*$3C MI-1JR%PPZ30[91R9# ^O9AM=))6ZSUT2O
MRHM!E;8#W)$(P=.LC0?3VW" 5S4Y9"_I=IH<L@^KVY@<(JAB*8(BV09.)/.4
M.(B:6.F )>I5$CN",7_"R2%[B>[IY)!]^-C2Y)#@K0.PJ"Y%Z4DB!7I>4EGB
MC$./2"ME8V]CA5J?''((!(YB:/N30VST604EB3(6\$A-BGAA-*%":A5!>Y\>
MI=3\B2:''(*'"GP=.FCUS-P+'[S*F@-AV:TNU$MKB)P)C9)I$T-6^4\V.>10
M//3!P0;"Y ='?IT1'E=CB1)>E21#3ZS#?QD;E9-<>M!52B#^(R]\#G&"3BKA
M!I"\#?4]"<K=!C,8M]11= VX0B-.,H9<#,82XQV-N-\C;MN*@;+G*7NEES][
M 61WBZN>I-5$$<9!_6U<Z2 1'$FQW'.!YJ57L25,!!M\R#3(*DD-M;H3U8Y0
M]H67/EH3[2&Z(VH;%R?KOL:$4[HT5Q*I="^UZ.YX3C4:,EI8%W,6NHOMUV?W
MM=II@3W#J1:W&[RXW%%!7*[(?AR54LQ1N9P]Y):QRU./O1+<F_*>[N]VO??N
MAEPH8] #(=Z+3*3T@81('?'2%GUBM'H\Y*A:.?TS5LG^"_X L\MB0=PE;1=K
M8CV9?OUM&4<_GLX+R[\@E]_@7_]^$1UU:$6$,@J@M.\WBK@@%8DL1&F,-Z;3
MK)^]67$8N6W,$CL:4X\/Q!/(KD>;[:1J[5<_*WT.OL+AR12'O.4$:N_EE9U"
M#7))<\XEDY&6;!Y')7&E0E:@)Z%-SBJS*N9P335XY_KOF/F&=L&][];.?I8R
M*>\2H4DX(KT.Q&<-!'F?$].<<5JEXG%?0AM6??O@Z/FTA0KR:B!.LF[7=GN!
M^K[\P6@SFI0JQY6)E*3,T:,//)0XDR-*:B.DBV6D00WHO4!3*\D+-<"PLQW?
M\9)I%V2;F#OZ/AE$$B1YEXN9((C#38JN4'0N,T6EJ-@Y\AFJA@5:;[+OAJD#
M!-$ JCXNKF"V7M%V7!PS63'/"+((<+L95[I*9M3[.JB<P>@ZN8]/*&D2/8=(
M^7%/Y:-8/G3ZU*WVWMV5].E/ 7[UU[#:==*(8C-80F5 7R9JBYZ3B$19G4K=
MEHNB2^/X;AE61Q#:RL56Q0/RI+(<.I'GF75LY]AH'H6AI;]9&3VC<1$V"=S+
MG"F##'0^]Y;W]S(I ^9[G0P*TRIR&3CWXUV:SN8C__[+CQN-+IVG7'%#C(R<
M2"[+.*,HB$]<0**@M?E>1&/7<X<#2)^RFO;$N ;,IW7XSH]_F4V7-V_'?CXO
MV2MW=J:,4:OL.5$,#)'96N*88,78%#%09FCH,AY[;V/J.W0-7-1V2@^P3PFU
M#;C-5A14:.:EQ5T(90<Q(,BP2'PT+EC\B.8J_>.^2]FP]GRO..B.L0.$T@;*
MXGIT :2[R05_A7'Z>3I;=9J:K=>,'^<WW\I/-OK;4!?PO,==:G1$QQI](FND
M),Q252;?2^6JA+L.IKA95!Z"G*>X/($8&\#K(V?]C1_[283S*X R3>,LI=5A
MXL?W;MC>?'O ^SD^8IV0LIMI*QW!2]]:4S)91?1%%I1XZS3ASMB0D^6251E\
M=IKE#3R8:,"P< MX:6 7[;7 >\8_$]1364)@V>(RDV'$>DC$\Y1\HBD;6TOG
M'T)O4W'%)J#WDCE3"0<#.^SGRYN;\;>W5TCV=M"XE**,1BSG7"G+MHI8:TL^
M. !/QKC(N@SJ?O+@ANR+6J*<]L77H2MXTM>R%],Y/FXTWHQ$^C2;IF5<;.=4
M6Y,U-=Z2D $-(Z<"<92A:HK@\,SQTN4N\W0[O&K8(/2I@=,W[UL+"(I8LERA
M9+RN,\<\"0R-ET19TEG1Y#/K@)N# H+5 CFG!LE17!T0$0E&%^_ATH]_0JXL
MOJV+ZH&5 B1.XLI\I:;DT^"W&55DXM89IG9TRGY24(Z/7AM,^,5C.VG':P>>
MOG@*&_]89@^,DS75VTI*&0-H*XF2N$>D=H+@/K&H^[(,S&8AW([RJKU!<O^=
MP]@K1PMMV@,'6SLS6)FMK!'NT2<@,FM% BW=6FFR(O D* ^USHPJ$CY<,B\=
M ONPJ0$O>X?J6\$=EPW>2$9,Q)-1&L>(TX(3CH=BY*CK3*R2I/\,/0./0#UE
M-*@/B30*K/+E#+9VEU2X%9@,:&TEW'(> @F2!H)^F "P5N=<93K'=REK(^_Y
M*/EWP-3APACX9'H#LVOX?73MPS9AS=NL#9[%-F4TX+TJ=3 9G7JA3 )A%.M4
MU_CXN>W!X B137OBW\"R_QO,POER=EG*.='#^V'K>4GCF4J^9/K@F1U*RJ+'
MTUL;APK7!.,?YQOO1,#NIP\;^JB'@QYX.72(;#D;S?\*?KRXVA*O(@.F'<D9
M.5!&S9!@2DD<UPJ5IXB090<@/'GPL)&->A@XCH,#B__MZ-]_G8Y+C&?^=OK#
M^T7:0MA[QRDJ+F(T*]Q(FKB23*%1S0FK=/9,=$#!<\\?]FJR'AAZX>? F/@P
M+?=8VUY-/#O.(MI,/D>TPYF-Q/E2C:\4L&"T3,QW ,*#APX;M*HG_<,YUX"W
M45K8X-.N?X2P^()_LTZBT@E_,T22@;,RB=40[RPG3AD%2E$EZHS_VT5,)]28
M6J@YJ0-[M"P:Q--F;WE\E\SH>6E5YABJ",0EF@E+05%JN.!UNOGL)F=8!^5X
M,7\'-P?PO 'DO)U.OL)L,<)=5!:R4:>@ *BP0, $-*IEE,1K;TE.,7#!A(RL
M2LGW3FK:PLTA8I[VS?,&@/,>]?+'_!9?/-JN@*L4D^.<@&1X].HR),>B/U:N
M'#SZ8<&$.@?8$U*&]8$K0.9(;C> ES7M/_LX&F_OJ&3P/H9@B!8.Z48#D#@N
MH'1*IX:5X7^NRO'TE)1.>+%_"G/G2#DTAZ3MYE(ATH#[*N?2&EVC0Q%\E@2\
M"])"Z6Q6Y0)H%S'#'EC'"OA%O!S [080\QF^3L=?1Y/+AXO97H&*+*1BNHR3
MP8,W:4J\\I%HS;E4/-&@JG1_>)&JEC!TB-"?-K3L20(-P.G^8?Q@GZ7(LS8R
M$= QH@F'[H1S/N"RP#!FF;6YBMG\'$&=0.3^%,=:+S)I%%OO2Y^SV687&H_Z
M6UI'T$65)8^3$B>L(<QYD6PP0NHJ0]>_1]C 7EHOXN^ J8-ET5I^E,9-93DX
M$G76ZR*U8+0C(%Q6AI=6/J^GR+Z.Q%[*F]J'?0VHE?-EF,,_EZ49Q5?\UVT
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MI?X\X,EVGCB+T7@EB8:22>A]1N4J! &== H\>F.J6#S/$33L%5X=!=(+\QL
M4:=+ 6 LR.03027!BX,!Q$6>"1-,)VLHMX\O31I+NFJBXT(E._HP,;4&O<UB
M/D_'XY^GLS)XIK3SU'CF9I)I2=NG"9<CT:TUH3BAEB49JK3_^0Y=S1K6!P+A
M):0=*95&07:!^ATTLP&]CXR*W] RB$TBNTQ.*2H3J*Q_6[0AIB$X'2OM#DC:
MB_4'P^<&9J-I.E_XV:)>>JAUECFN XD9Z9<I9N)]B,0ZH)HAEV1P]0_%/=)#
M3Y.P5Q-$A["^B1CE)_]MU;4-.?)@01<2F,LQ,,*8+/E<:'TZ)0-1S&F6E#;\
M<>.8?D#T'$$-9=OU#*1>1+ _F-P:3!.X+-;@EZKGVOEJU&CZ^VAQ-5TNWOKY
M%2\-6ZA*U!%4MV7F*)J?5IA M%112:,"5?7O9)^GKZ'DNQ.<?L<*J&WX74C)
M3/0^$N'*V4X]^C::XP%/F:(V<72+3V:P-Y1J=PJS:A_6'VE6_31)_29O[L[
M_[1ZV<=<=LG'Y6+LOQ75?1NO_>1'Z<(J!5XP3U)D9>^$3"SH3&2YNV0*G*1=
M2@;[H:8A&ZQ/OW @<=5/]MQ\4/X5_!S^[__Y_U!+ 0(4 Q0    ( +N 5U'R
M;,+/RP<  & D   :              "  0    !A,C R,#$P+7$S<65X:&EB
M:70S,3%C+FAT;5!+ 0(4 Q0    ( +N 5U$+OPR<\ <  (XI   :
M      "  0,(  !A,C R,#$P+7$S<65X:&EB:70S,3)C+FAT;5!+ 0(4 Q0
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M !               ( !6*($ &IN:BTR,#(P,#DR-RYX<V102P$"% ,4
M" "\@%=1(75JJQ,I  #YJP$ %               @ &3NP0 :FYJ+3(P,C P
M.3(W7V-A;"YX;6Q02P$"% ,4    " "\@%=1<2*!I-.I   )'P< %
M        @ '8Y 0 :FYJ+3(P,C P.3(W7V1E9BYX;6Q02P$"% ,4    " "\
M@%=1=1$96$RF  !:N0  $P              @ '=C@4 :FYJ+3(P,C P.3(W
M7V<Q+FIP9U!+ 0(4 Q0    ( +R 5U&U#XL=XSP  !%3   4
M  "  5HU!@!J;FHM,C R,# Y,C=?9S$P+FIP9U!+ 0(4 Q0    ( +R 5U'Y
M?7U(RF(  '-[   4              "  6]R!@!J;FHM,C R,# Y,C=?9S$Q
M+FIP9U!+ 0(4 Q0    ( +R 5U%*5O+\F'(  .F(   4              "
M 6O5!@!J;FHM,C R,# Y,C=?9S$R+FIP9U!+ 0(4 Q0    ( +R 5U&8TG9&
MQ5H  &9T   4              "  35(!P!J;FHM,C R,# Y,C=?9S$S+FIP
M9U!+ 0(4 Q0    ( +R 5U&Z0I<9Z)0  !FH   3              "  2RC
M!P!J;FHM,C R,# Y,C=?9S(N:G!G4$L! A0#%     @ O(!74;1L),+^FP
MT:X  !,              ( !13@( &IN:BTR,#(P,#DR-U]G,RYJ<&=02P$"
M% ,4    " "\@%=1@&\$QHV)  "2G   $P              @ %TU @ :FYJ
M+3(P,C P.3(W7V<T+FIP9U!+ 0(4 Q0    ( +R 5U$C%YG;:4D  "A?   3
M              "  3)>"0!J;FHM,C R,# Y,C=?9S4N:G!G4$L! A0#%
M  @ O(!743 S!EL:.   _T<  !,              ( !S*<) &IN:BTR,#(P
M,#DR-U]G-BYJ<&=02P$"% ,4    " "\@%=1K:T'77I*  ")8@  $P
M        @ $7X D :FYJ+3(P,C P.3(W7V<W+FIP9U!+ 0(4 Q0    ( +R
M5U$ ;0G9TCP  &10   3              "  <(J"@!J;FHM,C R,# Y,C=?
M9S@N:G!G4$L! A0#%     @ O(!743@QE2>7/P  >UH  !,
M ( !Q6<* &IN:BTR,#(P,#DR-U]G.2YJ<&=02P$"% ,4    " "\@%=1J(8C
M,J%. 0!_E0T %               @ &-IPH :FYJ+3(P,C P.3(W7VQA8BYX
M;6Q02P$"% ,4    " "\@%=1K^)T5WW-  !B&@D %               @ %@
M]@L :FYJ+3(P,C P.3(W7W!R92YX;6Q02P4&     !< %P#U!0  #\0,

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
